concept,cuis,hasMesh,number
heart failure ( class l - lll ),C0018801;C0456387;C1261077;C1518526;C1705943;C0018802;C4554158,true;false;false;false;false;true;false,0/20013
duration of hypertension,C0449238;C0020538;C1963138;C2926735,false;true;false;false,1/20013
type nmbr diabetes 一 no . ( % ),C1320657,false,2/20013
tofacitinib nmbr mg bid [n = nmbr |,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3/20013
high - density lipoprotein cholesterol mean ( mg / dl ± sd ),C0023822;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,4/20013
temporary discontinuation of study drug,C0205374;C0457454;C0013175;C1444662;C4552847;C1548539;C3245481,false;false;true;false;false;false;false,5/20013
death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6/20013
race and ss at baseline,C0034510;C1706779;C3853635,true;false;false,7/20013
high intensity,C4081854,false,8/20013
prior percutaneous coronary intervention,C0332152;C1532338;C2826257,false;true;false,9/20013
pre - randomization pci,C0332152;C0034656;C4049621;C0740175;C2257086;C3669034,false;true;false;false;false;false,10/20013
p,C0369773;C2603361,false;false,11/20013
hosji fcrhypoglycemia,,,12/20013
apixaban vs . placebo,C1831808,true,13/20013
medication use — no . ( % ),C0013227;C3244316;C4284232,true;false;false,14/20013
second prior mi,C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false,15/20013
subarachnoid hemorrhage,C0038525,true,16/20013
total invasive cancer,C0439175;C0677898;C0439810,false;false;false,17/20013
acute stent thrombosis,C0205178;C3897493,false;false,18/20013
alteplase ( n = nmbr ),C0032143,true,19/20013
relative decrease > nmbr %,C0080103;C0392756;C0547047;C0205345;C1547039,true;false;false;false;false,20/20013
nmbrth - nmbrth percentiles,C0039725;C1264641;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,21/20013
number of ( % ) females,C0237753;C0086287;C0449788,false;true;false,22/20013
emphysema ( % ),C0013990;C0034067,true;true,23/20013
argentina,C0003761;C1504311,true;false,24/20013
ccq score § §,,,25/20013
vents / patients,C0030705,true,26/20013
number of patients with,C2360800,false,27/20013
concomitant mtx —,C0521115;C0025677;C1417487,false;true;false,28/20013
europe / lsrael,C0015176,true,29/20013
thromboaspiration — no . ( % ),,,30/20013
cardiac - biomarker status — no . / total no . ( % ) $,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,31/20013
receiving insulin therapy,C1514756;C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,false;true;true;true;false;false;false;false,32/20013
pulmonary embolism ± deep vein thrombosis,C0852030;C0226514;C0034065;C0149871,false;false;true;true,33/20013
abdominal or perianal fistula at baseline,C0000726,true,34/20013
cyclosporine ( n = nmbr ),C0010592;C0010594,true;true,35/20013
geographic region - europe,C0017446;C0015176,true;true,36/20013
indian ( indian subcontinent ),C0454693,false,37/20013
percutaneous coronary intervention,C1532338,true,38/20013
antiplatelet or anticoagulant therapy,,,39/20013
lesion length,C0221198;C1444754;C1706316;C1546698,false;false;false;false,40/20013
non - q wave,C1518422;C0429089;C1305738,false;false;false,41/20013
continued thienopyridine n = nmbr subjects,C0549178;C1120149,false;true,42/20013
weight ( kg / mnmbr ) [median ( nmbrth to nmbrth percentile ) ],C0552346;C1532718;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false,43/20013
left ventricular ejection fraction,C0428772;C0488728,false;false,44/20013
single - vessel disease,C0037179;C0042373;C0087136;C0205171,true;true;true;false,45/20013
geographic region — no . ( % ),C0017446,true,46/20013
pad lower extremities,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,47/20013
bmi > nmbr kg / mnmbr ( % ),C0578022;C1532718,false;false,48/20013
total gadolinium - enhancing lesion count,C0439175;C1333400;C0750480;C1705566;C0439810,false;false;false;false;false,49/20013
fatigue,C0015672;C3463815;C4050243;C4554645,true;false;false;false,50/20013
nmbr to < nmbr kg / mnmbr,C1532718,false,51/20013
st - elevation mi,C0520886;C3810814,false;false,52/20013
azathioprine ( n = nmbr ),C0004482,true,53/20013
serum uric acid ( mg / dl ),C0455272;C0439269;C0700634,false;false;false,54/20013
baseline mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,55/20013
cv death,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,56/20013
atenolol ( « = nmbr nmbr ),C0004147,true,57/20013
previous antiarrhythmic treatment — no . ( % ),C0205156;C0003195;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3537142;C1552607,false;true;true;true;false;false;false;false;false;false;false,58/20013
drugs used in diabetes,C0013227;C3687832,true;false,59/20013
after pci,C4049621,false,60/20013
secukinumab,C3179547,true,61/20013
mean a ± sem ( % ),C0444504;C2347634;C2348143,false;false;false,62/20013
ppi but no aspirin,C0358591;C0871125;C3811894,true;true;false,63/20013
nmbr mg / kg ( n = nmbr ),C0439272,false,64/20013
family history of cad ( diagnosed at < nmbr yr of age ) — no . ( % ) cigarette smoker — no . ( % ),C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,65/20013
trend / het . test,C1521798;C4554533,false;false,66/20013
cv death + hf hospitalization,C3538987;C0011065;C0018488;C0019993;C1313497;C1538440;C3273279;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;true;false;false;false;false;false;true;false,67/20013
mepolizumab,C0969324,true,68/20013
medical therapy only ( n = nmbr ),C0418981;C0205171;C1720467,false;false;false,69/20013
caucasian ethnicity,C0007457;C0015031;C0243103;C0043157,true;true;true;true,70/20013
crcl at baseline < nmbr ml / min,C1846718;C0168634;C0439445;C1442488,false;true;false;false,71/20013
elevated hscrp > nmbr mg / l,C0205250;C0439268;C3163633,false;false;false,72/20013
seizure types reported during baseline,C0036572;C0332307;C1959629;C4553401,true;false;false;false,73/20013
median total cholesterol,C0549183;C0201950;C0543421;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,74/20013
mean ± sd bmi,C0444504;C2699239;C0578022;C2347634;C2348143,false;false;false;false;false,75/20013
first mace,C0205435;C0349381;C0949745;C1445339;C1279901,false;false;true;false;false,76/20013
disease duration nmbr to bnmbr years ( n = nmbr ),C0872146;C0439234,false;false,77/20013
history of amputation — no . ( % ),C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,78/20013
lipid - lowering medication ( % ),C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,79/20013
previous hf hospitalization,C0205156;C0018488;C0019993;C1313497;C1538440;C3273279;C1552607,false;true;true;true;false;false;false,80/20013
mean lipid values,C0444504;C0023779;C0042295;C2347634;C2348143,false;true;false;false;false,81/20013
prior years taking warfarin,C0332152;C0439234;C2826257,false;false;false,82/20013
bnp,C0054015;C1095989;C1417808;C2982014,true;false;false;false,83/20013
hbanmbrca,C0019016;C3887642;C1825777;C3538758,true;true;false;false,84/20013
latin america hr ( nmbr % cl ),C0023122;C0596019,true;false,85/20013
current atrial fibrillation or flutter on ecg,C0521116;C0004238;C0344434;C1963067;C1705970,false;true;false;false;false,86/20013
invasive,C0205281;C1334278,false;false,87/20013
estimated glomerular filtration,C0750572;C0232809,false;false,88/20013
pasi score ! * *,C4528685;C0449820;C4050231,false;false;false,89/20013
amiodarone,C0002598,true,90/20013
american indian or alaska,C0002460,true,91/20013
pooled simvastatin factorial studies,C1709595;C0074554;C2826344;C2349200;C4522255,false;true;false;false;false,92/20013
implantable cardioverter - defibrillator,C0162589;C2825184,true;false,93/20013
varespladib ( n = nmbr ),C2713485,true,94/20013
acute coronary event,C0205178;C0741923,false;false,95/20013
ntpro - cnp ( ng / ml ),C3889729;C0439275,false;false,96/20013
useofmedical therapyathospitaldischarge,,,97/20013
coenzyme qnmbr,C0041536,true,98/20013
dyspnoea - mmrc grade,C0013404;C3826977;C0441800;C0919553;C3244287;C1963100,true;false;false;false;false;false,99/20013
triglycerides — mmol / liter,C0041004;C0439190;C0475211,true;false;false,100/20013
baseline ecrcl,C0168634;C1442488,true;false,101/20013
cardiovascular history,C1880008,false,102/20013
with placebo ( n nmbr nmbr ),C0032042;C1696465;C1706408,true;false;false,103/20013
cardiovascular medications,C0007220,true,104/20013
after bronchodilation,C1371299;C3537072,false;false,105/20013
mean nmbrmwd *,C0444504;C2347634;C2348143,false;false;false,106/20013
angiotensin - converting enzyme inhibitors / angiotensin receptor blockers,C0003015;C0597357;C2757044,true;false;false,107/20013
medication taken alone or in combination,C0013227;C3244316;C4284232,true;false;false,108/20013
etoricoxib dose,C0972314;C0178602;C0869039;C1114758,true;false;false;false,109/20013
ischemic cerebrovascular disease,C0475224;C0007820,false;true,110/20013
bare metal stent,C2825200,false,111/20013
mean age ( years ) ( s . d . ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,112/20013
dasnmbr ( esr ),C0051767;C3811131;C0057671,true;false;true,113/20013
absolute,C0205344,false,114/20013
wml load at follow - up mri,C1550025;C0589120;C0024485;C1824234;C3890166;C1522577;C1704685;C3274571;C1704782;C1708715,false;false;true;false;false;false;false;false;false;false,115/20013
clopidogrel ( n = nmbr,C0070166,true,116/20013
ancestry ( % ) f,C0016327,true,117/20013
no p - blocker intake at randomisation ( n = nmbr ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,118/20013
valsartan / hctz,C0216784;C0020261,true;true,119/20013
> nmbr oral agents,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,120/20013
total chol,C0439175;C0201950;C0439810,false;false;false,121/20013
calcium channel blockers,C0006684;C2757014,true;false,122/20013
bsa > nmbr %,,,123/20013
benralizumab nmbr mg qnmbrw ( n = nmbr ),C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,124/20013
blood pressure,C0005823;C1271104;C1272641,true;false;true,125/20013
atenolol n = nmbr,C0004147,true,126/20013
type of mi ( % ),C0332307;C3810814;C1547052,false;false;false,127/20013
mtx + non - mtx,C0025677;C1518422;C1417487,true;false;false,128/20013
concomitant corticosteroid use,C0521115;C0239126,false;false,129/20013
estimated glomerular filtration rate ( mdrd ),C3811844;C3839656,false;false,130/20013
mild impairment ( nmbr to < nmbr ),C2945599;C0221099;C0684336,false;false;false,131/20013
years since menopause,C0439234,false,132/20013
major cvd /,C0205082;C0007222;C0205164;C4318856;C4521762,false;true;false;false;false,133/20013
medical therapy ( n = nmbr ),C0418981,false,134/20013
no . of tnfi among non - tnfi naive,,,135/20013
use of ace inhibitor,C1524063;C0003015;C4541021,false;true;false,136/20013
haemorrhagic,C0333275,false,137/20013
stroke ( vs tia ),C0038454;C4554100,true;false,138/20013
detemir / insulin glargine,C0537270;C0907402,true;true,139/20013
screening prebronchodilator fevnmbr,C0220908;C2599602;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;true;false;false;false;false;false,140/20013
stent plus placebo,C0038257;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,141/20013
coronary revascularization nmbr days after randomization,C0877341;C0439228;C0034656,false;false;true,142/20013
sacubitril / valsartan,C4033631,true,143/20013
no . of prior bdmards,C0332152;C2826257,false;false,144/20013
mean prebronchodilator fevnmbr ( sd ),C0444504;C2599602;C3714541;C2699239;C2347634;C2348143,false;false;true;false;false;false,145/20013
paracetamol,C0000970,true,146/20013
aspirin / other antiplatelet agents,C0004057,true,147/20013
randomized to receive beta carotene,C0034656;C3815594,true;false,148/20013
bsa,,,149/20013
erosion score,C0333307;C0449820;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false,150/20013
peripheral arterial disease,C0085096;C1704436,true;true,151/20013
primary end point,C2986535,false,152/20013
lvdd ( mm ),C4330985;C4554674,false;false,153/20013
draining cutaneous fistula at baseline,C0013103;C0180499;C4265177,true;false;false,154/20013
tg < nmbr,C0337445,false,155/20013
comorbidities other than diabetes,C0009488;C0011847;C0011849,true;false;true,156/20013
toast classification of qualifying stroke,C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,157/20013
rasagiline,C0525678,true,158/20013
metabolic syndromenmbr baseline lipids,C0524620;C0168634;C0023779;C1442488,true;true;true;false,159/20013
crude analysis,C0002778;C0936012;C1524024,false;false;true,160/20013
bypass surgery,C1536078,false,161/20013
missing — number / n ( % ),C1551393;C0237753;C0449788;C1705492;C3272743,false;false;false;false;false,162/20013
cholesterol,C0008377,true,163/20013
right coronary,C0225808,false,164/20013
health habits,C0679786,false,165/20013
homa . % b,,,166/20013
severity of copd,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,167/20013
prior myocardial infarction,C0155668,false,168/20013
both ptca and cabg,C2936173,true,169/20013
major cerebrovascular,C0205082;C1880018;C0205164;C4318856;C4521762,false;false;false;false;false,170/20013
hazard ratio ( nmbr % cl ) nmbr . nmbr ( nmbr . nmbr,C2985465;C0596019,false;false,171/20013
diastolic blood pressure ( mm hg ) medications,C0428883;C0439475;C0013227;C0802604;C2598133;C4284232;C1305849,true;false;true;false;false;false;false,172/20013
iglar dose at randomization ( u / day ),C0178602;C0034656;C0456683;C0869039;C1114758,false;true;false;false;false,173/20013
prior cv event at randomization !,C0332152;C3538987;C0441471;C0034656;C4019010;C4048877;C4318503;C2826257,false;false;false;true;false;true;false;false,174/20013
mean ± sd waist circumference,C0444504;C2699239;C0455829;C2347634;C2348143,false;false;true;false;false,175/20013
risk of bleeding,C3251812,false,176/20013
cv medication,C3538987;C0013227;C3244316;C4284232;C4048877;C4318503,false;true;false;false;true;false,177/20013
total updrs score ( range,C0439175;C3639721;C0439810,false;true;false,178/20013
atrial fibrillation,C0004238;C0344434;C1963067,true;false;false,179/20013
known duration of diabetes,C0205309;C0449238;C0011847;C0011849;C2926735,false;false;false;true;false,180/20013
nmbr % < hbanmbrc < = nmbr %,C0019016;C1825777;C3538758,true;false;false,181/20013
dactylitis count,C0239161;C0750480;C1705566,false;false;false,182/20013
previous disease :,C0205156;C0012634;C1552607,false;true;false,183/20013
previous dmards use,C0205156;C0242708;C1552607,false;true;false,184/20013
gly nmbr . nmbr gg b . i . d n / n ( % ),C1415124;C0017454;C0152277;C0018370,false;true;false;true,185/20013
previous percutaneous coronary intervention,C0205156;C1532338;C1552607,false;true;false,186/20013
unfractionated heparin before randomisation,C0019134;C0034656;C2825026,true;true;false,187/20013
oad plus insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,188/20013
diabetes with target organ disease *,C0011847;C1521840;C0178784;C0012634;C2986546;C0011849,false;false;false;true;false;true,189/20013
unknown type,C0439673;C0332307;C1547052;C3541433;C4050014,false;false;false;false;false,190/20013
beta - blocker — no . ( % ),C0001645,true,191/20013
cognitive functioning,C0392334;C0392335,false;false,192/20013
( % ) nmbr - nmbr,,,193/20013
history of hyperlipidemia ( % ),C4695788,false,194/20013
evenls per nmbr,,,195/20013
fasting free fatty acids ( ^mol / liter ),C0015663,true,196/20013
treatment after admission,C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,197/20013
rarertd antocagibtcn before andorrtzafon,,,198/20013
intestinal area involved,C0021853;C0017446;C0205146,true;true;false,199/20013
ethnicity ( % ),C0015031;C0243103,true;true,200/20013
all cardiovascular,C0007226;C3887460,true;false,201/20013
smoking in the past year,C0037369;C4086728;C0453996;C1881674,true;false;true;false,202/20013
diskus only,C1553480;C0205171;C1720467,false;false;false,203/20013
jsn score,C0449820;C4050231,false;false,204/20013
number omega - nmbr number placeb fatty acid,C0237753;C1719844;C0015684;C0449788,false;false;true;false,205/20013
high - intensity statin vs medium - or low - intensity statin at randomization,C4081854;C0360714,false;true,206/20013
score on nih stroke scale — median ( iqr ),C0449820;C1697238;C0549183;C0876920;C2347635;C2348144;C2939193;C3484372;C4050231,false;false;false;false;false;false;false;false;false,207/20013
initiation of insulin,C0589507;C0021641;C1533581;C1579433;C3714501;C1158830;C1704686,false;true;false;false;false;false;false,208/20013
nmbrnd > nmbr . nmbr / < nmbr . nmbr,,,209/20013
cad and abi < nmbr - nmbr §,C1504769;C2239547;C3813548;C4284121,true;false;false;false,210/20013
pioglitazone events / n ( % ),C0071097;C0441471;C3541888,true;false;false,211/20013
acecoumarol,,,212/20013
cigarette users,C0677453;C1706077;C1704760;C3890423,true;false;false;false,213/20013
gfr ( mdrd ) ( ml / min / nmbr - nmbr mnmbr ),C0017654;C3839656;C0439445;C0369637;C0441923;C1424601,true;false;false;false;false;false,214/20013
bmi ( kg / mnmbr ) cardiac parameters,C0578022;C1532718;C0018787;C0449381;C1522601,false;false;true;false;false,215/20013
ace inhibitor or arb at last follow - up,C0003015;C4541021,true;false,216/20013
blood urea nitrogen ( mg / dl ),C0005845;C0439269;C0600137,true;false;false,217/20013
grip strength ( kg ),C0429271;C0022718;C0439209;C4054209;C2598165,false;true;false;false;false,218/20013
current smoker — no . of patients ( % ),C3173209;C3241966,false;false,219/20013
one - third radius,C0205447;C0205437;C0034627;C1306504,false;false;true;false,220/20013
psychosocial risk factors,C0033963;C0035647;C4552904;C0542298;C0035648;C1553898;C1458132,true;true;false;false;true;false;false,221/20013
bursitis,C0006444,true,222/20013
non - hdl - c in nmbr classes,C1518422;C3715113;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false;false,223/20013
family history ol diabetes ?,C1313937,false,224/20013
age ( years ) : nmbr - < nmbr,C1510829,false,225/20013
digital clubbing,C0009080;C0149651,true;false,226/20013
death or myocardial infarction,C0011065;C1306577;C4082313;C4552775,true;false;false;false,227/20013
risk reduction,C1137094,true,228/20013
a mini - mental state examination,C0451306,true,229/20013
pain vas,C0042815,true,230/20013
smoking : ex - smoker,C0037369;C0453996;C1881674,true;true;false,231/20013
statin treatment,C0360714;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,232/20013
pre - bronchodilator fevnmbr / fvc ratio *,C2599602;C3714541;C0456603;C1547037,false;true;false;false,233/20013
prior stroke or transient ischemic attack,C0332152;C0038454;C4554100;C2826257,false;true;false;false,234/20013
czp nmbr mg ( n nmbr nmbr ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,235/20013
microvascular eye diseased,C0443258;C0015392;C0700042,false;true;false,236/20013
extent of disease,C0449279;C4553144,false;false,237/20013
mean ( nmbr % ci ) difference vs saxa + dapa + met,C0444504;C0008107;C1705241;C1705242;C3259781;C2347634;C2348143,false;true;false;false;false;false;false,238/20013
urgent coronary revascularization,C0439609;C0877341;C3272275,false;false;false,239/20013
caucasian simva,C0007457;C0043157,true;true,240/20013
full analysis set,C0443225;C0002778;C0036849;C1442518;C1705195;C0936012;C1524024,false;false;true;false;false;false;true,241/20013
serious ae,C0205404;C3887670,false;false,242/20013
smoking history ( ever ),C1519384;C3887636,false;false,243/20013
uncodable,,,244/20013
no pah therapy,C0030123;C0039798;C0087111;C1363945;C3203102;C4284467,true;true;true;false;true;false,245/20013
standard ( n = nmbr ),C1442989;C2828392,false;false,246/20013
patent foramen ovale,C0016522;C0344724,true;true,247/20013
laboratory values,C0022877;C0042295;C3244292;C4283904,true;false;false;false,248/20013
years,C0439234,false,249/20013
hscrp < nmbr . nmbr mga . nmbr ( nmbr . nmbrxnmbr ( nmbr . nmbr ),C0065879,true,250/20013
physician ' s judgment that vka,C0031831;C0022423;C0804815,true;true;false,251/20013
calcium - channel blocker ( ratelowering ),C0006684;C3536851;C4521885,true;false;false,252/20013
left ventricular hypertrophy ( % ),C0149721;C3484363,true;false,253/20013
randomized to aspirin use,C0034656;C0004057;C0042153;C0457083;C1947944;C3815594,true;true;true;false;false;false,254/20013
antihypertensive,C0003364,true,255/20013
glp - nmbr receptor agonist ( other than study drug ),C0018301;C4543206;C0013175;C1422069;C1425391;C1539338;C2350813,true;false;true;false;false;false;true,256/20013
primary renal endpoint or death,C2986535;C0022646,false;true,257/20013
metabolic syndrome characteristics,C0524620;C1521970,true;false,258/20013
mean duration of disease,C0444504;C0872146;C2347634;C2348143,false;false;false;false,259/20013
other oral hypoglycemic drug ( s ),C0359086,false,260/20013
> nmbr additional cv risk factorsnmbr,C1524062;C3538987;C0035648;C1553898;C4048877;C4318503,false;false;true;false;true;false,261/20013
pancolitis,C0868908,false,262/20013
death from any cause,C0007465,true,263/20013
high - density lipoprotein cholesterol,C0023822,true,264/20013
diabetes mellitus status,C1317301,false,265/20013
fibrinolysis primary pci ( n = nmbr ) ( n = nmbr ) no . of patients / total no . ( % ),C0016017;C0205225;C4049621;C0439612;C0439631;C1305868,true;false;false;false;false;false,266/20013
stool frequency subscore,C0015733;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0183622,true;true;false;false;false;false;false;false;false,267/20013
psap - b ( ng / ml ),C1418975;C0439275;C1420002;C1425004,false;false;false;false,268/20013
no use of nmbr - asa compounds,C1524063;C0004057;C0205198;C1706082;C3853627,false;true;false;false;false,269/20013
visit nmbr ldl cholesterol strata,C0545082;C0023824;C0202117;C1512346;C2826704,false;true;false;false;false,270/20013
endothelin nmbr ( pg / ml ),C0079284;C0439297,true;false,271/20013
normal ( egfr > nmbr ),C0205307;C1739039;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,272/20013
py = nmbr . nmbr ),C0030428;C3538810,true;false,273/20013
fibrinogen,C0016006;C1167394;C2587184;C3540039,true;false;false;false,274/20013
total haq,C0439175;C0102923;C0451208;C0439810,false;true;false;false,275/20013
mean baseline ibdq score ( sd ) § crp concentration,C3533236;C0168634;C2699239;C3890735;C0086045;C1446561;C3827302;C4048285;C1442488,false;true;false;false;true;false;false;false;false,276/20013
dipyridamole,C0012582,true,277/20013
aspirin and other antiplatelet,C0004057,true,278/20013
positive,C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,279/20013
age [years] ( interaction : p = nmbr . nmbr ),C1510829;C1704675,false;false,280/20013
decreased appetite,C0232462,false,281/20013
beta - blocker ( except sotalol ),C0001645;C0037707,true;true,282/20013
geometric mean crp concentration ( mg / l ),C2986759;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285,false;false;true;false;false;false;false,283/20013
duration of morning,C0449238;C0332170;C2926735,false;false;false,284/20013
hr ( enl vs lcz ) ( nmbr % cl ),,,285/20013
rf positive — number ( % ),C0035448;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false,286/20013
selected medications — no . ( % ),C1707391;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,287/20013
no peripheral revascularization ( n = nmbr,C0205100;C0581603,false;false,288/20013
white / european,C0007457;C0239307;C1535514;C0043157;C0220938,true;false;false;true;false,289/20013
at least nmbr flare,,,290/20013
time to admission,C3854258;C3854259,false;false,291/20013
octave sustain,,,292/20013
lm bifurcation not treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,293/20013
radial access,C0442038;C0444454;C1554204;C0920847,false;false;false;false,294/20013
history of peripheral artery disease,C0683519;C0489868;C0730226;C0850708;C0944983,false;false;false;false;false,295/20013
baseline fev,C0168634;C3714541;C1442488,true;true;false,296/20013
combined trials,C0205195;C0008976,false;true,297/20013
negative,C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,298/20013
severe dysfunction,C3274777,false,299/20013
fasting c - peptide,C0015663;C0006558,true;true,300/20013
aggressive ( n = nmbr ),C0001807;C0580822,true;false,301/20013
aldosterone blocker,C0002006,true,302/20013
management of event — no . ( % ),C0001554;C0441471;C4019010;C0376636;C1273870;C3273539,true;false;false;true;false;false,303/20013
> nmbrmg / dl chd status,C0439269;C0280604;C0449438;C3542407,false;false;false;false,304/20013
serum albumin,C0036773;C0728877,true;false,305/20013
intraperitoneal,C0442120,false,306/20013
headache,C0018681;C4553197,true;false,307/20013
left main artery,C0205091;C0205225;C0003842;C0226004;C1542147;C0443246;C1552822,false;false;true;false;false;false;false,308/20013
> nmbr to < nmbr egfr,C0040363;C1739039;C3811844;C3812682;C0041260;C1883351,true;true;false;false;true;false,309/20013
established,C0443211;C1272684,false;false,310/20013
gender ( % ) male / female,C0079399;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;true;false;false;false;false;false;true,311/20013
chondroitin sulfate ( n = nmbr ),C0008466,true,312/20013
unstable angina ( biomarker negative ),C0002965;C0005516;C0205160;C1513916;C2825415;C2825491;C3853545,true;true;false;false;false;false;false,313/20013
american indian or native alaskan,C0002460,true,314/20013
symptom onset to start of reperfusion treatment : tenecteplase or arterial sheath insertion !,C4086878,false,315/20013
age ( years ) [median ( nmbrth to nmbrth percentile ) ],C1510829;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,316/20013
formoterol nmbr gg bid,C0060657;C0017454;C0018370,true;true;true,317/20013
race or ethnic group ( % ),C0034510;C1706779;C3853635,true;false;false,318/20013
dihydropyridine,C0012315;C0220821,true;true,319/20013
canakinumab,C2718773,true,320/20013
lev status,C0023556;C0449438,true;false,321/20013
steroids § §,C0038317,true,322/20013
normal / mild ckd,C0205307;C2945599;C1561643;C0231683;C0439166;C2347086;C4553972,false;false;true;false;false;false;false,323/20013
number of stent = nmbr,C0237753;C0038257;C0449788,false;true;false,324/20013
previous medications,C0205156;C0013227;C0802604;C2598133;C4284232;C1552607,false;true;false;false;false;false,325/20013
nyha class nmbr - nmbr : no { n = llll ),C1882083,false,326/20013
tofacitinib nmbr mg twice daily n = nmbr,C2930696;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,327/20013
verapamil sr n = nmbr no . ( % ),C1527129,false,328/20013
no prior ml or stroke,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,329/20013
stent length per lesion,C0038257;C1444754;C0221198;C1546698;C1706316,true;false;false;false;false,330/20013
chf history,C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,331/20013
anti - ccp antibody positive,C4318437;C0741132,true;false,332/20013
oral medications,C0304289,false,333/20013
no antidiabetic drug,C0935929,true,334/20013
tofacitinib nmbr mg two times a day,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,335/20013
no . of nmbr - mg acetaminophen tablets / day,C0439422;C1243102,false;false,336/20013
acpa positive,C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,337/20013
timi major / minor,C4441842,false,338/20013
severity of airflow limitation ( gold nmbr - nmbr ),C0439793;C0231999;C0443288;C0018026;C1304897;C0449295;C0522510,false;false;false;true;false;false;false,339/20013
pooled simva,C1709595;C2349200;C4522255,false;false;false,340/20013
timi risk score — no . ( % ) : t,C0035647;C0449820;C4050231;C4552904,true;false;false;false,341/20013
baseline dyspnea index,C1511069,false,342/20013
number ( % ) of patients with event,C2360800,false,343/20013
atrial fibrillation onset,C0004238;C0206132;C0332162;C0344434;C1963067,true;true;false;false;false,344/20013
infarct characteristics,C0021308;C1521970,true;false,345/20013
caucasian simva ( „ = nmbr },C0007457;C0043157,true;true,346/20013
ticagrelor nmbr mg nmbr yr km %,C1999375;C0024671;C0439234;C3887676;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;true;false;false;false;false;false,347/20013
galectin - nmbr ( ng / ml ),C0607430;C0439275,true;false,348/20013
hctz = hydrochlorothiazide . * based on wilcoxon nmbr - sample rank - sum tests for age and body mass index,C0020261,true,349/20013
nmbr mg clopidogrel load,C0024671;C0070166;C1550025;C1704782;C1708715;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,350/20013
intravenous dobutamine,C0348016;C0012963,false;true,351/20013
family history of diabetes — no . ( % ),C1313937,false,352/20013
primary prevention subgroup,C0033144;C1079230;C1515021,true;false;false,353/20013
telmisartan ( n = nmbr,C0248719,true,354/20013
ppi use ( p = nmbr - nmbrt ),C0358591;C0871125;C3811894,true;true;false,355/20013
large mi,C0549177;C3810814,false;false,356/20013
never / rarely,C2003901;C0522498,false;false,357/20013
medication adherence,C2364172,true,358/20013
no concomitant cortcosteroid use,C0521115;C0042153;C0457083;C1947944,false;true;false;false,359/20013
severity of hypertensionb,C0439793;C0522510,false;false,360/20013
clopidogrel,C0070166,true,361/20013
fevnmbr percent predicted ( sd ),C3714541;C0439165,true;false,362/20013
antidiabetic medication | |,C0935929,true,363/20013
gad positive — no . ( % ) ^,C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false,364/20013
intravenous vasodilators ( % ),C0443081,false,365/20013
european trial,C0239307;C0008976;C1535514,false;true;false,366/20013
systemic corticosteroid use,C4053960;C0042153;C0457083;C1947944;C0205373;C0239126,false;true;false;false;false;false,367/20013
weight,C0005910;C0043100;C1305866;C1705104,true;true;false;false,368/20013
indacaterol nmbr ug versus placebo,C1722260;C0041573;C0439211,true;true;false,369/20013
crohn ’ s disease related surgery,C0010346,true,370/20013
peripheral arterial disease — no . ( % ) §,C0085096;C1704436,true;true,371/20013
mases ( nmbr - nmbr ),,,372/20013
duration of coronary artery disease — yr,C0449238;C0018787;C0852949;C0439234;C2926735,false;true;false;false;false,373/20013
hbanmbrc,C0019016;C1825777;C3538758,true;false;false,374/20013
total cholesterol ( week nmbr ),C0201950;C0332174;C0439230;C0543421,false;false;false;false,375/20013
at least nmbr severe flare,C0205082;C1517205;C3540542;C4050465;C4050466,false;false;false;false;false,376/20013
baseline / concomitant therapies,C0168634;C1707479;C1442488,true;false;false,377/20013
chd eze / simva ( n = nmbr],C0280604;C3542407,false;false,378/20013
heart failure criteria met,C0018801;C0243161;C0018802;C4554158,true;true;true;false,379/20013
left atrial diameter,C0225860;C1301886;C0225861,true;false;false,380/20013
pulmonary function tests,C0024119;C2598152,true;false,381/20013
other nsaids,C0003211,true,382/20013
rheumatic heart disease,C0035439,true,383/20013
coronary angiography and intervention,C0085532;C1548829,true;false,384/20013
time of qualifying ecg to balloon inflation ( hrs ),C0040223;C1514624;C1623258;C3541383,true;false;true;false,385/20013
time from symptoms to treatment,C0040223;C0683368;C1457887;C3541383,true;true;false;false,386/20013
ratio fp / sal : sal ( nmbr % ci ),C0456603;C0016704;C0036140;C0008107;C3259781;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412;C1547037,false;true;true;true;false;true;true;false;false;false;false;false,387/20013
coexisting conditions — no . ( % ),,,388/20013
crp ( mg / dl ) < nmbr . nmbr,C3890735;C0439269;C4048285,false;false;false,389/20013
mean ± s . d . duration of diabetes,C0444504;C0449238;C0011847;C0011849;C2926735;C2347634;C2348143,false;false;false;true;false;false;false,390/20013
russia / georgia ( n = nmbr ),C0035970;C0017452;C0017454,true;true;true,391/20013
fatal and nonfatal ml,C1302234;C1705232,false;false,392/20013
hypertension ( n 二 nmbr ),C0020538;C1963138,true;false,393/20013
cv event,C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;true;false,394/20013
oxidative stress,C0242606,true,395/20013
age ( yrs ) < nmbr,C0001779,false,396/20013
no . of previous anti - tnf drugs — no . ( % ),C0205156;C1448177;C0013227;C3687832;C1552607,false;true;true;false;false,397/20013
< nmbr . nmbr mmol / liter apob : apoa - l ratio,C1532563;C0475211;C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,false;false;true;true;false;false;false;false;false;true,398/20013
former smoker,C0337671,false,399/20013
less than nmbr %,C0439092,false,400/20013
hispanic ( n = nmbr ),C0086409,true,401/20013
ischemic tvr,C0475224,false,402/20013
any albuminuria — no . ( % ),C0001925,true,403/20013
baseline ics use,C0168634;C0815320;C4551720;C1442488,true;false;true;false,404/20013
bosentan ( n = nmbr ),C0252643,true,405/20013
nitrates ( oral or topical ),C0028125;C0699857;C3848573,true;false;false,406/20013
left - sided disease only,C3842976;C0012634,false;true,407/20013
third heart sound,C0232237;C0232278,false;false,408/20013
other antiarrhythmics^,C0003195,true,409/20013
psa duration,C3810537;C0449238;C2926735;C3813209,false;false;false;false,410/20013
low molecular weight ( lmw ) heparin before randomisation,C0019139;C0034656;C3536766,true;true;false,411/20013
interval study drug to pci,C1272706;C0013175;C4049621;C1552654;C1552713,false;true;false;false;false,412/20013
atrial fibrillation / atrial flutter,C0155709,false,413/20013
anmbr + ez n = nmbr,C0206578,true,414/20013
initial aspirin — no . ( % ),C0205265;C0004057;C1279901;C1555582;C1705685,false;true;false;false;false,415/20013
symbol digit score,C0679214;C0582802;C0449820;C4050231;C3241971;C1698987,false;false;false;false;false;false,416/20013
time from qualifying event to randomization,C0040223;C1514624;C0441471;C4019010;C3541383,true;false;false;false;false,417/20013
serum hdl cholesterol ( mmol / l ),C0428472;C1532563,false;false,418/20013
pav,C0058890,true,419/20013
events treatment ( nmbr ),C0441471;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3541888,false;true;true;false;false;false;false;false;false,420/20013
annt or bnnh ( nmbr % ci ),,,421/20013
geographic region,C0017446,true,422/20013
drug - related teaesnmbr,C0013227;C0439849;C0445223;C1254351,true;false;false;false,423/20013
atorvastatin dose,C0286651;C0178602;C0869039;C1114758,true;false;false;false,424/20013
ldl - cihdl - c,,,425/20013
prior biologic therapy ( including anti - tnfs ),C0278947,false,426/20013
left ventricular ejection fraction within previous nmbr mo |,C0428772;C0205156;C0026544;C0332177;C1552607;C0488728,false;false;true;false;false;false,427/20013
cabg or pci,C0010055,true,428/20013
ace inhibitor monotherapy,C0003015;C4541021,true;false,429/20013
treated with cabg — no . / total no . ( % ),C0332293;C0010055,false;true,430/20013
psoriatic arthritis pain],C4317006;C0003872;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;true;false;false;false;false;false;false;false;false,431/20013
erythrocyte sedimentation rate — mm / hr | |,C1176468;C4330985;C4554674;C1619634,false;false;false;true,432/20013
dose of aspirin,C4696290,false,433/20013
p - val . ( nmbr ),C0369773;C0042285;C0523975;C2603361,false;true;false;false,434/20013
small - artery occlusion ( lacune ),C0226001;C0001168;C0241970;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;false;true;false;false;false;false;false;false,435/20013
atorvastatin,C0286651,true,436/20013
baseline heart rate,C0168634;C0018810;C1442488,true;true;false,437/20013
apo b ( mg / dl ) - mean ± sd,C0003593;C0439269;C0444504;C2699239;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,438/20013
peak procedural act — sec,C0444505;C0025664;C0184661;C2700391;C3274430;C3538935;C3539779,false;true;true;false;false;false;false,439/20013
extended - duration enoxaparin,C0231448;C0449238;C0206460;C2926735;C0231449;C0439792,false;false;true;false;false;false,440/20013
total stent length,C0439175;C0038257;C1444754;C1706316;C0439810,false;true;false;false;false,441/20013
triglycerides,C0041004,true,442/20013
efficacy,C1280519;C1707887,false;false,443/20013
non - stemi,C3537184,false,444/20013
mri substudy ( n = nmbr ),C0024485;C1824234;C3890166,true;false;false,445/20013
lv mass index ( g / mnmbr - nmbr ),C0455825;C0600653;C0456715;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false,446/20013
all with coenzyme qnmbr ( n = nmbr,C0041536,true,447/20013
serum total cholesterol,C0587184;C1287371,false;false,448/20013
visits nmbrenmbr,C0545082;C1512346;C2826704,false;false;false,449/20013
week nmbr ( itt population ),C0332174;C0032659;C1257890;C0439230,false;true;true;false,450/20013
puerperium,C0034042;C0086839;C1879329,true;true;false,451/20013
gold group d — no . ( % ) | |,C0018026;C0441838;C1304897,true;false;false,452/20013
atv nmbr mg study protocol,C0210243;C0024671;C1507394;C2348563;C2599718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;false;false;true;true;false;false;false;false;false;true;true;false,453/20013
aml / val nmbr / nmbr mg,C0023465;C0042285;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523975;C0023467,true;true;true;true;false;false;false;false;false;false;true,454/20013
median albumin / creatinine ratio ( g / mg ),C0549183;C0486293;C0439267;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false;false;false;false,455/20013
smoking ( a ),C0037369;C0453996;C1881674,true;true;false,456/20013
tirofiban ( n = nmbr ),C0247025,true,457/20013
time from acs to randomization ( median,C0040223;C0742343;C4318612;C3541383,true;true;false;false,458/20013
smoking pack - years,C0037369;C1277691;C0453996;C1881674,true;false;true;false,459/20013
serum creatinine > nmbr mmol / l,C0201976;C1532563;C0600061,false;false;false,460/20013
nonaspirin antiplatelet agent,C0722138;C0085826,false;true,461/20013
use of concomitant lipid - modifying therapy,C1524063;C1707479;C0023779;C0392747,false;false;true;false,462/20013
% stenosis,C0678234;C1261287;C2632116,false;true;false,463/20013
parenteral anticoagulalion before randomization,C0030547;C0034656;C4522267,true;true;false,464/20013
lesions bnmbr / c,C0221198;C1546698,false;false,465/20013
median fasting insulin ( iqr ) — pu per milliliter,C0549183;C0015663;C0021641;C0018387;C0439242;C1533581;C1579433;C3714501;C0876920;C2347635;C2348144;C2939193,false;true;true;true;false;false;false;false;false;false;false;false,466/20013
death or stent thrombosis,C0011065;C1306577;C4082313;C4552775,true;false;false;false,467/20013
measured at home with automated device,C0444706;C3541902,false;false,468/20013
atenolol *,C0004147,true,469/20013
neuropilin ( ng / ml ),C0287275;C0439275,true;false,470/20013
individuals with diabetes,C0027361;C0011847;C0011849;C0237401,true;false;true;false,471/20013
basal insulin analogue : insulin,C0650607;C0243071;C0205112;C2825028,false;false;false;false,472/20013
mean pulse pressure,C0445074;C0232117;C0391850;C1947910;C0444504;C0949236;C2347634;C2348143,false;true;false;false;false;true;false;false,473/20013
oral hypoglycemic drug,C0359086,false,474/20013
antihypertensive treatment,C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,475/20013
patients with > nmbr exacerbations resulting in hospital admission,C0030705;C4086268,true;false,476/20013
ranolazine ( n = nmbr,C0073633,true,477/20013
final timi flow grade post - ppci,C0205088;C3272266;C0441800;C0687676;C1704687;C3469826;C0919553;C3244287;C1546485;C3853528,false;false;false;false;false;false;false;false;false;false,478/20013
duration of disease,C0872146,false,479/20013
ace inhibitor or arb at enrollment,C0003015;C4541021,true;false,480/20013
psoriasis duration,C0033860;C0449238;C2926735,true;false;false,481/20013
nmbr to < nmbr . nmbr %,C0040363;C0041260;C1883351,true;true;false,482/20013
simvastatin monotherapy ( n = nmbr,C0074554,true,483/20013
timi major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,484/20013
small - artery occlusion,C0226001;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;true;false;false;false;false;false;false,485/20013
left ventricular hypertrophy — no . ( % ),C0149721;C3484363,true;false,486/20013
laboratory findings,C0587081,false,487/20013
crp,C3890735;C4048285,false;false,488/20013
bivariate frailty model ( statin users vs non - users ),C0424594;C3161035;C0360714;C1706077;C3274659;C3714583;C3853906,true;false;true;false;false;false;false,489/20013
resection performed,C0015252;C0728940,false;false,490/20013
liraglutide nmbr . nmbr mg ls means ( n ),C1456408;C0024671;C0023668;C1704970;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,491/20013
ada ifg,C1060325;C1334085;C1708411;C3811629,false;false;false;false,492/20013
median change,C0549183;C0392747;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,493/20013
sita nmbr + pio nmbr,C0030800;C2347712,true;false,494/20013
combined estimated gfr and albuminuria status,C0205195,false,495/20013
neoplasia,C0027651;C1882062,true;false,496/20013
venous graft,C0042449;C0181074;C0332835;C1961139;C0348013,true;false;true;false;false,497/20013
mean age,C0444504;C0001779;C2347634;C2348143,false;false;false;false,498/20013
body - mass index ( kg / mj ) previous diagnosis,C0005893;C0022718;C0439254;C0332132;C4284025;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;true,499/20013
antihyperglycemic,C0020616,true,500/20013
duration of ra ( time from symptom onset ),C0449238;C3538806;C0040223;C3541383;C4048756;C2926735,false;false;true;false;false;false,501/20013
grouped region,C0439745;C0017446;C0205147;C4319846,false;true;false;false,502/20013
nitrate — no . ( % ),C0028125;C0699857;C3848573,true;false;false,503/20013
shs,,,504/20013
oral antidiabetes monotherapya,C0442027;C4521986,false;false,505/20013
patients without ra,C0030705;C3538806;C4048756,true;false;false,506/20013
treatmentofpulmonary embolismpriorto randomization,C0034656,true,507/20013
renin - angiotensin inhibitors,C2917241;C0003018;C4521302;C3653375,false;true;false;false,508/20013
fevnmbr,C3714541,true,509/20013
upper respiratory tract infection nmbr ( nmbr . nmbr ),C0041912,true,510/20013
age at diagnosis,C1828181;C3173302,false;false,511/20013
change in mtss ( mean ),C0392747;C0444504;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;false;false;false;false;false,512/20013
aliskiren ( n = nmbr ),C1120110,true,513/20013
number of exacerbations in last nmbr months,C0237753;C4086268;C0449788,false;false;false,514/20013
fasting plasma insulin — mu / liter,C0015663;C0857690;C0028971;C0475211;C0347978;C3714918,true;false;true;false;false;false,515/20013
baseline albumin / creatinine ratio in nmbr classes,C0168634;C0486293;C0456387;C1518526;C1705943;C4019422;C1318293;C1442488,true;false;false;false;false;false;false;false,516/20013
cvd risk factors ( age > nmbr ),C0007222;C0035648;C0001779;C1553898;C0035647;C0001783;C4552904,true;true;false;false;true;true;false,517/20013
former smoker ( n = nmbr ),C0337671,false,518/20013
prior use of biologics,C0332152;C1524063;C0005515;C0005522;C4553887;C2826257,false;false;true;true;true;false,519/20013
amlodipine nmbrmg / v = nmbr,C0051696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,520/20013
moderate or less airflow limitation,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,521/20013
ethnic group — no . ( % ) ',C0015031;C1879937,true;false,522/20013
any event,C0441471;C4019010,false;false,523/20013
pain in extremity,C0030196;C4553007,false;false,524/20013
hospitalized for asthma,C0701159;C0004096;C2984299,false;true;false,525/20013
sex : male ( n = nmbr ),C0086582,true,526/20013
apolipoprotein b^,C0003593,true,527/20013
abnormal angiogram,C0205161;C0002978;C1548816;C3891555;C4255126;C2347472;C2699333,false;true;false;false;true;false;false,528/20013
three or more drugs,C0205449,false,529/20013
data missing,C1511726;C3245479;C3714741,false;false;false,530/20013
heart failure nyha ii - iii,C0018801;C1275491;C1710602;C0439070;C1705160;C4082587;C0018802;C4554158,true;false;false;false;false;false;true;false,531/20013
cerebrovascular disease,C0007820,true,532/20013
western europe hr ( nmbr % cl ),C0043129;C0596019,true;false,533/20013
biologic agents,C0005515,true,534/20013
ls mean difference ± seb,C0023668;C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false,535/20013
factor xa inhibitor,C2825027;C4553708,false;false,536/20013
mean bmi,C0444504;C0578022;C2347634;C2348143,false;false;false;false,537/20013
anti - ischaemia agents *,C0040616;C0022116;C4321499,true;true;false,538/20013
exposure,C0274281;C0332157,false;false,539/20013
mycophenolate mofetil,C0209368,true,540/20013
age when diabetes first diagnosed — yr,C0001779,false,541/20013
randomization to placebo or telmisartan,C0034656;C0032042;C1696465;C1706408,true;true;false;false,542/20013
aspirin nmbr clopidogrel,C0004057;C0070166,true;true,543/20013
chd risk equivalents,C1282512;C0439185;C4049980,false;false;false,544/20013
systolic blood pressure [mmhg] ( interaction : p = nmbr . nmbr ),C0488055;C0439475;C1704675;C0871470;C1306620,false;false;false;true;false,545/20013
clinical history,C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,546/20013
ezetimibe + simvastatin ( n = nmbr * ),C1532737,true,547/20013
duration of psoriasis,C0449238;C0033860;C2926735,false;true;false,548/20013
procedures for index event,C0025664;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0184661;C2700391;C3538935,true;true;false;false;true;false;false;false;true;false;false,549/20013
killip class at admission — no . / total no . ( % ),C1881332;C0184666;C0809949,false;false;false,550/20013
other lipid parameters,C0023779;C0449381,true;false,551/20013
tc / hdl - c ratio,C0039411;C3715113;C0456603;C1547037;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;true;true;true;false;false;false,552/20013
ct or mr scan of the brain *,C0007673;C3540513;C3813556;C3888140,true;false;false;false,553/20013
peri - or postmenopausal,C0347985,false,554/20013
indeterminate or unknown,C0205258,false,555/20013
ratet ( nmbr % cl ),C0596019,false,556/20013
> nmbr % stenosis of coronary,C0242231,true,557/20013
atrial fibrillation / flutter,C0155709,false,558/20013
hypertension — no . ( % ) hypercholesterolemia — no . ( % ),C0020538;C1963138,true;false,559/20013
pulmonary disease,C0024115,true,560/20013
region of enrollment,C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,561/20013
baseline bmi nmbr to < nmbr kg / mnmbr,C0168634;C0578022;C1532718;C1442488,true;false;false;false,562/20013
statin + ezetimibe,C0360714;C1142985,true;true,563/20013
ldl - c ( calculated ) *,,,564/20013
evaluable for acrnmbr at week nmbr,C1516986;C1412134;C1515941,false;false;false,565/20013
tertile nmbr ( nmbr . nmbr - nmbr . nmbr pg / ml ) n = nmbr,C0439297,false,566/20013
ez / simva n = nmbr n ( % ),C0206578,true,567/20013
event rates,C0441471;C0871208;C1521828;C4019010,false;false;false;false,568/20013
baseline nmbr - h ppg,C0168634;C0033727;C1418888;C0369286;C0441932;C0564385;C4528284;C1442488,true;true;false;false;false;false;false;false,569/20013
nontrial ppi,C0358591;C0871125;C3811894,true;true;false,570/20013
cardiac resynchronization therapy,C1167956,true,571/20013
nyha class iii or iv ( n = nmbr ),C1882086,false,572/20013
oral agents use,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,573/20013
recurrent ischemia - urgent revascularization,C1455761;C0022116;C0439609;C0581603;C3272275;C4321499;C2945760,false;true;false;false;false;false;false,574/20013
rheumatoid factor positive §,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,575/20013
serum pnmbrnp ( ^g / liter ),C0229671;C0065827;C0439267;C0475211;C1706141;C3887659;C1546774;C1550100,true;true;false;false;false;false;false;false,576/20013
investigator - reported hypoglycaemia *,C0035173,true,577/20013
diuretic — no . / total no . ( % ),C0012798,true,578/20013
interleukin - nmbr ( ng / l ),C0021764;C0439297;C1527200,true;false;false,579/20013
non - caucasian eze / simva ( „ = nmbr },C1518422;C0007457;C0043157,false;true;true,580/20013
median ( qnmbr : qnmbr ) tgs,C0549183;C1156212;C1537574;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,581/20013
indacaterol nmbr ug versus indacaterol nmbr ug,C1722260;C0041573;C0439211,true;true;false,582/20013
score of > nmbr . nmbr — %,C0449820;C4050231,false;false,583/20013
nmbr - nmbr ( n = nmbr,C0369718;C0441922,false;false,584/20013
anti - cholinergics ( short - acting ) a,C0242896,true,585/20013
north america n z nmbr,C0028405,true,586/20013
diabetes durationa < median,C0011847;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849,false;false;false;false;false;false;true,587/20013
discontinuations,C0457454,false,588/20013
available baseline blood specimen n,C0470187;C0168634;C0178913;C1442488,false;true;false;false,589/20013
quicki,,,590/20013
ratio of women to men — %,C0456603;C0043210;C1547037,false;true;false,591/20013
randomization to arterial sheath insertion,C0034656;C0003842;C0227952;C0021107;C0441587;C1512796;C1883719;C0221464,true;true;true;false;false;true;false;false,592/20013
p value versus placebo,C1709380,false,593/20013
history of cardiac arrhythmia,C3494593,false,594/20013
n analysed,C0369718;C0441922,false;false,595/20013
body mass,C0518010,false,596/20013
mean cdai score,C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,597/20013
placebo plus aspirin,C0032042;C0332287;C0004057;C1696465;C1706408,true;false;true;false;false,598/20013
ii - iv ( % ),C1710602;C0022326;C4265176;C4082587,false;true;false;false,599/20013
previous bowel resection performed — no . of patients ( % ),C0205156;C0741614;C1552607,false;false;false,600/20013
left anterior descending,C0441998;C0205386;C1547177,false;false;false,601/20013
postmenopausal hormone use,C0232970;C0019932;C0042153;C0457083;C1947944;C4521914,false;true;true;false;false;false,602/20013
femoral neck,C0015815,true,603/20013
standard control ( n = nmbr ) no . of patients ( percent ),C1442989;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;false;false;false;false;false;false,604/20013
other asian,C0078988,true,605/20013
measurements,C0242485,false,606/20013
antithrombotic / coagulant,C0009117,true,607/20013
myocardial infarction within the previous nmbr yr,C0027051;C0205156;C0439234;C1552607;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false;false;false,608/20013
receiving concomitant nsaids and / or cox - nmbr inhibitors,C1514756,false,609/20013
b digit symbol substitution,C0582802;C0679214;C1555721;C1706204;C1698987;C3241971,false;false;false;false;false;false,610/20013
post - bronchodilator ratio of fevnmbr to fvc — %,C2599594;C0456603;C3714541;C1547037,false;false;true;false,611/20013
statin with niacin,C0360714;C0027996;C1142562,true;true;false,612/20013
neither glucocorticoids nor immunosuppressive agents,C0017710;C3540777;C3540778,true;false;false,613/20013
anti - inflammatory drugs,C0003209,true,614/20013
i & ii : fevnmbr > nmbr % predicted,C0021966;C1710602;C3714541;C4082587;C0221138,true;false;true;false;false,615/20013
interval clopidogrel to pci,C1272706;C0070166;C4049621;C1552654;C1552713,false;true;false;false;false,616/20013
procedure,C0184661;C2700391;C3274430;C3539779,true;false;false;false,617/20013
electrophysiological study — no . ( % ) weight — ibj,C0850293,false,618/20013
montelukast ( n = nmbr ),C0298130,true,619/20013
nmbr - h pmg ( mg / dl ),C0033727;C0439269;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,620/20013
phenytoin,C0031507;C0202454,true;false,621/20013
enact - nmbr trial rerandomization to natalizumab ( n = nmbr ),,,622/20013
nmbr bmi,C0578022,false,623/20013
baseline ldl cholesterol,C0168634;C0023824;C0202117;C1442488,true;true;false;false,624/20013
iglar ( insulin glargine lnmbr u ),C0907402;C0439148,true;false,625/20013
llv wlalil nmbr statin,C0360714,true,626/20013
number of prior csdmards,C0237753;C0332152;C2826257;C0449788,false;false;false;false,627/20013
efficacy and safety : net adverse clinical events *,C1280519;C1707887,false;false,628/20013
glucocorticoids and immunosuppressants,C0017710;C3540777;C3540778,true;false;false,629/20013
heart disease risk factors,C0741920,false,630/20013
statin use at baseline,C0360714;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,631/20013
current smoker : ex - smoker ( % ),C3173209;C3241966,false;false,632/20013
aspirin but no ppi,C0004057,true,633/20013
nsaid use — no . / total no . ( % ),C0003211;C3536840,true;false,634/20013
dx at presentation,C3538936;C0449450,false;false,635/20013
recent surgery or trauma,C0332185;C0038894;C0038895;C0543467;C1274039,false;false;true;true;true,636/20013
ezetimibe nmbr mg + statin ( n = nmbr,C1142985;C0024671;C0360714;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,637/20013
coumadin,C0699129,true,638/20013
device group,C1706365,false,639/20013
glargine,C0907402,true,640/20013
safety population,C0036043;C0032659;C1257890;C1705187,true;true;true;false,641/20013
pef,C0030771;C1518922;C1542834,true;false;false,642/20013
all randomized patients ( range ),C0034656;C0030705;C1514721;C2348147;C3542016;C3815594,true;true;false;false;false;false,643/20013
permanent,C0205355,false,644/20013
tocilizumab,C1609165,true,645/20013
nmbr = help needed  still independent,C1269765;C1552861,false;false,646/20013
non - metsyn,C1518422,false,647/20013
hemoglobin,C0019046,true,648/20013
level of renal impairment,C0441889;C1565489;C0456079;C1547707;C2946261,false;true;false;false;false,649/20013
soe or sue,,,650/20013
previous stroke ortransient ischaemic attack ( % ),C0205156;C0038454;C0745413;C4554100;C1552607,false;true;false;false;false,651/20013
clopidogrel / ticlopidine,C0070166;C0040207,true;true,652/20013
selexipag,C2000145,true,653/20013
mi type unknown ( % ),C3810814;C0332307;C1547052,false;false;false,654/20013
crohn ' s disease,C0010346,true,655/20013
high - sensitivity crp — mg / liter | |,C1441604;C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;false;true;false;true;false;false;false;false;false;false,656/20013
prior coronary revascularization,C0332152;C0877341;C2826257,false;false;false,657/20013
severe teaes,C0205082;C4050465;C4050466,false;false;false,658/20013
any statin + other llt,C0360714,true,659/20013
arb at last follow - up,C3888198;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,660/20013
ml without st - segment elevation !,C0439526;C0520886;C1705224;C3887665,false;false;false;false,661/20013
hydralazine,C0020223,true,662/20013
multivessel pci,C4049621,false,663/20013
oral anticoagulant — no . / total no . ( % ),C0354604,false,664/20013
notable abnormalities,C4288581;C0000768;C0000769,false;true;true,665/20013
contrast nephropathy risk score,C0009924;C0022658;C0035647;C0449820;C4050231;C4552904;C1979874,true;true;true;false;false;false;false,666/20013
aspirin at last follow - up,C0004057;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,667/20013
physical component,C0031809;C0449432;C1705248;C0205485;C1509143,true;false;false;false;false,668/20013
indacaterol nmbr gg qd,C1722260;C0017454;C0332173;C0018370,true;true;false;true,669/20013
elderly ( > nmbr years ),C0001792;C0439234;C1999167,true;false;false,670/20013
odds ratio versus placebo ( nmbr % ci ),C0028873,true,671/20013
geographic region - north america,C0017446;C0028405,true;true,672/20013
all patients with fistulas ( n = nmbr ),C0030705;C0016169,true;true,673/20013
fevnmbr / fvc ( post - albuterol ),C3714541,true,674/20013
prior medications,C0332152;C0013227;C0802604;C2598133;C4284232;C2826257,false;true;false;false;false;false,675/20013
location of ml,C0450429;C0439526;C1705224;C3887665;C1515974;C4284930;C4284931,false;false;false;false;false;false;false,676/20013
use of hormone replacement therapy ( a ),C1524063;C0282402,false;true,677/20013
versus tiotropium nmbr . nmbr pg,,,678/20013
duration of infusion — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,679/20013
beta - blocker at last follow - up |,C0001645;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,680/20013
rentrop score,C0449820;C4050231,false;false,681/20013
randomisation visit ( baseline ),C0034656;C0545082;C0168634;C1442488;C1512346;C2826704,true;false;true;false;false;false,682/20013
gastrointestinal area involved — no . / total no . ( % ),C0521362;C0017446;C0205146,false;true;false,683/20013
baseline pulmonary medication,C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,684/20013
median serum periostin,C0549183;C0229671;C0219433;C1424662;C3812270;C1546774;C1550100;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false;false,685/20013
multiple tnfi *,C0439064,false,686/20013
diet + pravastatin ( n = nmbr ),C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,687/20013
prior coronary artery bypass graft surgery,C0332152;C0010055;C2826257,false;true;false,688/20013
c - peptide,C0006558,true,689/20013
enoxaparin,C0206460,true,690/20013
vorapaxar placebo nmbr - yr %,C2974521;C0032042;C0439234;C1696465;C1706408,true;true;false;false;false,691/20013
missing data,C4684714,false,692/20013
risk reduction ( %  nmbr % ci ),C1137094;C0008107;C3259781,true;true;false,693/20013
fastest third,C0015663;C0205437;C0456962;C2985769,true;false;false;false,694/20013
gemfibrozil,C0017245,true,695/20013
chanmbrdsnmbr - vasc,C1420648;C3714751,false;false,696/20013
ezetimibe / simvastatin nmbr / nmbr mg ( n = nmbr ),C1532737;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,697/20013
( nmbr % ci] nmbr,C0008107;C3259781,true;false,698/20013
triglycerides mean ( mg / dl ± sd ),C0041004;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,699/20013
incidence rate,C1708485,false,700/20013
urinary albumin / creatinine ratio,C0455271;C1318330,false;false,701/20013
minimum stent diameter,C4054490;C0038257,false;true,702/20013
nt - probnp pg / mla ( iqr ),C0669479;C0030827;C0599973;C0072225;C1266240;C0754710,true;true;true;true;false;true,703/20013
body mass index ( bmi ),C0005893;C0578022;C1305855,false;false;true,704/20013
diet plus pravastatin group ( n = nmbr ),C0012155;C0332287;C0085542;C0441848;C0012159;C1519433;C2983588;C3668949,true;false;true;false;true;false;false;false,705/20013
duration of clopidogrel pretreatment 一 hr median,C0449238;C0070166;C1550147;C0549183;C0876920;C2347635;C2348144;C2939193;C2709094;C3539075;C3539076;C2926735,false;true;false;false;false;false;false;false;false;false;false;false,706/20013
family history of coronary artery disease,C2317524,false,707/20013
sex,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,708/20013
cv risk factor - no . ( % ),C3538987;C0035648;C4048877;C4318503,false;true;true;false,709/20013
valvular disease ( % ),C3258293,false,710/20013
no corticosteroid + no imm,C0001617;C3536709,true;false,711/20013
antimalarials only,C0003374;C0205171;C1720467,true;false;false,712/20013
tnl ultrapositive > nmbr . nmbr pg / l,C1540071;C0439278,false;false,713/20013
dactylitis count ( nmbr - nmbr ),C0239161;C0750480;C1705566,false;false;false,714/20013
nasal polyps,C0027430,true,715/20013
verapamil sr n = nmbr,C1527129,false,716/20013
continued thienopyridine n ( % ),C0549178;C1120149,false;true,717/20013
disease - progression composite outcome !,C0679250;C0242656;C0205199;C1547335;C0449258;C3542417;C1274040;C1335499;C1947900;C4552808,false;true;false;false;false;false;false;false;false;false,718/20013
egfrmdrd < nmbr ml - min - nmbr - nmbr . nmbr m - nmbr,C0439445;C0369637;C0441923,false;false;false,719/20013
diarrhea,C0011991;C1963091;C3641756;C4084784;C4084802;C4085317,true;false;false;false;false;false,720/20013
uric acid ( mg / dl ),C0041980;C0439269,true;false,721/20013
pasi score,C4528685;C0449820;C4050231,false;false;false,722/20013
theophylline compound,C0039771;C0205198;C1706082,true;false;false,723/20013
heterogeneity / trend test,C0019409;C1521798;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4554533;C0242960,false;false;false;false;false;false;false;false;false;false;true,724/20013
disease,C0012634,true,725/20013
hispanic / latin american,C0019576,true,726/20013
isolated pulmonary embolism,C0205409;C0034065;C1548221,false;true;false,727/20013
middle tertile ( range  nmbr . nmbr - nmbr . nmbr mg / dl  mean ± sd  nmbr . nmbr ± nmbr . nmbr mg / dl ),C0444598;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016;C0549183;C1552826,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false,728/20013
total cholesterol ( mg / dl ),C0201950;C0439269;C0543421,false;false;false,729/20013
geometric mean of baseline,C2986759;C0168634;C1442488,false;true;false,730/20013
baseline fvc,C0168634;C3714541;C1442488,true;true;false,731/20013
csf nmbrs - hydroxy -,C3540512;C3889436,false;false,732/20013
mean annualized exacerbation rate,C0444504;C4086268;C0871208;C1521828;C2347634;C2348143,false;false;false;false;false;false,733/20013
placebo no . / total ( % ),C0032042;C1696465;C1706408,true;false;false,734/20013
not reported / unknown,C1518422,false,735/20013
prior therapy with tnf antagonist,C1514463;C1448177;C0231491;C0332152;C0279936;C2826257,false;true;false;false;false;false,736/20013
difference from baselinea,C1705241;C1705242,false;false,737/20013
age at randomization ( years ),C1510829;C0034656,false;true,738/20013
never used lev,C2003901;C1273517;C0023556,false;false;true,739/20013
single vessel coronary artery disease *,C0581374,false,740/20013
non - sulfonylurea secretagogues,C1518422;C0038766;C4704833;C3536898,false;true;true;false,741/20013
index event asymptomatic or unconfirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,742/20013
baseline medical therapy,C0168634;C0418981;C1442488,true;false;false,743/20013
prior corticosteroid failure only,C0332152;C0001617;C0231174;C0205171;C1720467;C0680095;C3536709;C2826257,false;true;false;false;false;false;false;false,744/20013
one or more blood pressure medications,C0205447,false,745/20013
evomab ( n = nmbr ),,,746/20013
baseline post - bronchodilator % predicted fev,C0168634;C1442488,true;false,747/20013
cardiovascular hospitalization,C0007226;C0019993;C3887460,true;true;false,748/20013
crohn ' s disease activity index score],C0451071;C0449820;C4050231,false;false;false,749/20013
prior use of biologic agents,C0332152;C1524063;C0005515;C2826257,false;false;true;false,750/20013
relative risk reduction ( nmbr % cl ),C0242492;C0301630;C0596019;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;false;false;false;false;true;true;false;false,751/20013
hbanmbrc distribution,C0019016;C0520511;C1704711;C1825777;C3538758,true;false;true;false;false,752/20013
diuretic agent,C0012798;C0450442;C1254351;C1521826,true;false;false;false,753/20013
patients treated with insulin,C0030705,true,754/20013
estimated gfr ( ml / min / nmbr . nmbr mnmbr ) ^ |,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,755/20013
nmbr - aminosalicylic compounds — no . ( % ),C0205198;C1706082,false;false,756/20013
iwqol - lite physical score ( arbitrary units ),C4483112;C0439183,false;false,757/20013
bdi total score ( baseline ),C0006448;C2964552;C0168634;C1442488;C0451022;C3714938;C3889415,true;false;true;false;false;false;false,758/20013
estimated * creatinine clearance < nmbr mlvmin,C0750572;C0812399,false;false,759/20013
low - density lipoprotein cholesterol,C0023824,true,760/20013
education,C0013621;C0013622;C0013658;C0039401,true;true;true;true,761/20013
partial mayo clinic scored,C0728938;C0454788;C0002424;C0442592;C1077578;C1550516,false;false;true;false;false;false,762/20013
prior lipid - modifying therapy,C1514463;C0023779;C0392747,false;true;false,763/20013
cv risk factor,C3538987;C0035648;C4048877;C4318503,false;true;true;false,764/20013
mets w / o tnmbrdm,C0812270;C0011816;C3250443;C1705694;C2939420,false;true;false;false;false,765/20013
other countries,C0454664,false,766/20013
smoking history — no . ( % ),C1519384,false,767/20013
other vascular disease — no . ( % ),C0042373,true,768/20013
mean — g / dl,C0444504;C0439267;C2347634;C2348143,false;false;false;false,769/20013
outcome,C1274040,false,770/20013
ccbs,C0006684,true,771/20013
sfc nmbr / nmbr | ig bid n = nmbr,C4521536;C0021027;C0305052;C0360506,false;true;false;false,772/20013
cangrelor,C1121991,true,773/20013
losartan n = nmbr,C0126174,true,774/20013
laba + ics,C0815320;C4551720,false;true,775/20013
short - acting anticholinergics,C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;false;true;false;false;false;false,776/20013
> nmbr vessels with > nmbr % stenosis,C0679403,false,777/20013
concomitant antihyperglycaemic drugs,C0521115;C0020616;C0013227;C3687832,false;true;true;false,778/20013
losmapimod,C3272847,true,779/20013
history of myocardial infarction ( % ),C1275835,false,780/20013
nmbr - nmbr with cv disease ( n = nmbr ),C0007222,true,781/20013
severely impaired,C0205082,false,782/20013
estimated creatinine clearance < nmbr ml / min *,C0750572;C0812399;C0439445,false;false;false,783/20013
anticyclic citrullinated peptide positive^,C1320283;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,784/20013
wrist fracture,C0435630;C4553927,false;false,785/20013
mtx exposure ( mg / week ),C0025677;C0274281;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0332157;C1417487,true;false;true;false;false;true;false;false;false;false;false;false;false,786/20013
ischaemic,C0475224,false,787/20013
atenolol n = nmbr no . ( % ),C0004147,true,788/20013
vascular disordersb,C0005847;C1558950;C1801960,true;false;false,789/20013
adjusted mean change from baseline ( nmbr % ci ),C0456081;C0444504;C0392747;C0168634;C0008107;C3259781;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;true;false;false;false;false;false;false;false,790/20013
< nmbr . nmbr mmol / liter triglyceride level,C0439190;C0475211;C0428475,false;false;false,791/20013
previous myocardial infarction — no . ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,792/20013
time since diagnosis of diabetesa,C0040223;C3541383,true;false,793/20013
fevnmbr / fvc,C3714541,true,794/20013
> nmbr . nmbrmmol / l ( n = nmbr ),C1532563,false,795/20013
classification of af,C0008902;C0344434;C4049859;C0008903;C0678229,true;false;false;true;false,796/20013
age at screening,C0001779;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,797/20013
change in sbp ( nmbr months ),C0392747;C0085805;C0439231;C0443172;C1705241;C4319952,false;true;false;false;false;false,798/20013
bronchitis,C0006277,true,799/20013
left ventricular ef,C0225897,true,800/20013
pdenmbr inhibitor monotherapy,C0031638,true,801/20013
ischemic heart disease,C0010054;C0151744,true;true,802/20013
neither pbo + statin eze + statin,C0031962;C0360714,true;true,803/20013
impaired fasting glucose level ( n = nmbr ),C1272092;C0441889;C0456079;C1547707;C2946261;C0221099;C0202045,false;false;false;false;false;false;false,804/20013
cancer ( n = nmbr ),C0006826;C0998265;C1306459,true;false;false,805/20013
selected clinical characteristics,C1707391;C0683325,false;false,806/20013
lumbar spine,C0024091;C3887615,true;false,807/20013
reversibility of fevnmbr ( % ),C0449261;C3714541,false;true,808/20013
missing data — no . / total no . ( % ),C4684714,false,809/20013
insulin ( pmol / l ) t vital signs,C0021641;C0439284;C0150404;C0518766;C1533581;C1579433;C3714501,true;false;false;true;false;false;false,810/20013
glucose - lowering therapies,C0017725;C0441994;C0087111;C2003888,true;false;true;false,811/20013
baseline heart failure severity nyha class i,C0168634;C0018801;C0439793;C1882084;C0522510;C0018802;C4554158;C1442488,true;true;false;false;false;true;false;false,812/20013
selected baseline medications,C1707391;C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,false;true;true;false;false;false;false,813/20013
endovascular — no . ( % ),C0524425,false,814/20013
aspirin - erdp ( n = nmbr,C0004057,true,815/20013
previous treatment with tnf antagonist — no . ( % ) §,C0205156;C0039798;C1448177;C0231491;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;true;false;false;false;false;false;false,816/20013
zotarolimus - eluting,C1700035,true,817/20013
change in nt - probnp at nmbr months ( log - transformed ),C0392747;C0669479;C0754710;C0443172;C1705241;C4319952,false;true;true;false;false;false,818/20013
low - molecular - weight,C0041667;C1521991;C0205251;C0026385;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;true;false;false;false;false;false,819/20013
heart rate ( b . p . m . ),C0018810;C0369637;C0441923,true;false;false,820/20013
vorapaxar group ( n = nmbr ),C2974521;C0441848,true;false,821/20013
glucose test,C0337438;C0595310,false;false,822/20013
number of concomitant aeds,C0237753;C0521115;C0180309;C0449788,false;false;true;false,823/20013
mean number of exacerbations ( per patient - year [nmbr % ci] ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,824/20013
use nmbr - asa compounds,C0042153;C0004057;C0205198;C1706082;C3853627;C0457083;C1947944,true;true;false;false;false;false;false,825/20013
glycemic drugs,C0005802;C0013227;C3687832,true;true;false,826/20013
balloon angioplasty — no . ( % ),C0002996;C0002997,true;true,827/20013
prior history of cardiovascular disease,C0332152;C0455539;C2826257,false;false;false,828/20013
accp bleeding risk at inclusion,C3251812;C0007637;C1512693,false;true;false,829/20013
angina pectoris — no . ( % ),C0002962,true,830/20013
history of systemic hypertension,C0455527;C0205373,false;false,831/20013
angiography — no . ( % ),C0002978,true,832/20013
prasugrel,C1620287,true,833/20013
cardiovascular disease,C0007222,true,834/20013
prior congestive heart failure,C0332152;C0018802;C2826257,false;true;false,835/20013
post - bronchodilator reversibility fevnmbr ( % ) mean ( sd ),C2599594;C0449261;C3714541;C0444504;C2699239;C2347634;C2348143,false;false;true;false;false;false;false,836/20013
diabetes therapy,C3274787;C3539002,false;false,837/20013
low - dose aspirin use at baseline yes,C2608320;C0042153;C0168634;C1549445;C1705108;C1710701;C1442488;C0457083;C1947944,false;true;true;false;false;false;false;false;false,838/20013
medication at enrollment — no . ( % ),C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,839/20013
age,C0001779,false,840/20013
no . of predictors of cardiovascular risk,C2698872;C0007226;C0035647;C4552904;C3887460,false;true;true;false;false,841/20013
mean ( s . d . ) free pcsknmbr,C0444504;C0332296;C1880497;C1996904;C2347634;C2348143,false;false;false;false;false;false,842/20013
enrollment in lmwh,C1516879;C0019139;C3536766;C1696073;C3888021,false;true;false;false;false,843/20013
coronary angiography during the index hospital stay,C0085532;C0600653;C3489408;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,844/20013
primary pci ( n = nmbr ),C0205225;C4049621;C0439612;C0439631,false;false;false;false,845/20013
versus tiotropium + olodaterol nmbr . nmbr / nmbr pg,,,846/20013
long - acting or short - acting nitrates,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,847/20013
cardiovascular and respiratory,C0007226;C3887460,true;false,848/20013
hispanic ethnic group — no . ( % ) f,C0086409;C0015031;C1879937,true;true;false,849/20013
placebo,C0032042;C1696465;C1706408,true;false;false,850/20013
calcium antagonists,C0006684,true,851/20013
egfr,C1739039;C3811844;C3812682,true;false;false,852/20013
lipid lowering medication use,C0023779;C0441994;C0240320;C2003888,true;false;false;false,853/20013
opg,C1262886;C1336645;C1412836;C1710303,false;false;false;false,854/20013
final timi flow,C0205088;C3272266;C1546485;C3853528,false;false;false;false,855/20013
patient ' s global assessment of disease activity,C4054228,false,856/20013
with revascularisation,C0581603,false,857/20013
antihypertensive medication or,C0003364,true,858/20013
level nmbr immobility § | |,C0441889;C0231441;C0456079;C1547707;C2946261,false;false;false;false;false,859/20013
serum creatinine,C0201976;C0600061,false;false,860/20013
central / eastern europe / russia,C0682369;C1707877;C0035970;C0205099;C0015177;C1879652,false;false;true;false;true;false,861/20013
role physical,C0035820;C0031809;C0205485;C1509143;C1705810;C3871154,true;true;false;false;false;false,862/20013
hbanmbrc category,C0019016;C0683312;C3889287;C1825777;C3538758,true;false;false;false;false,863/20013
not reported in ecrf,C1518422,false,864/20013
beta - blockers ( all ),C0001645,true,865/20013
laba users,C1706077,false,866/20013
creatinine clearance at admission ( ml / min ),C0184666;C0151280;C0809949,false;false;false,867/20013
egfr nmbr - nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,868/20013
other anticoagulant,C0003280;C0848112;C3536711,true;false;false,869/20013
severe impairment ( < nmbr ),C0205082;C0221099;C0684336;C4050465;C4050466,false;false;false;false;false,870/20013
pre - bronchodilator fevnmbr ( % predicted normal ),C2599602;C3714541,false;true,871/20013
insulin + oad,C0021641;C1533581;C1579433;C3714501,true;false;false;false,872/20013
clopidogrel ( n = nmbr ),C0070166,true,873/20013
first - generation stentt,C0205435;C0079411;C3146294;C1279901,false;true;false;false,874/20013
least square mean ( se ),C0023189;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,875/20013
preoperative heart rate ( beats per minute ),C0445204;C0018810,false;true,876/20013
angiography during index hospitalization,C0002978;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,877/20013
allhat - llt,C2347090,false,878/20013
prior cardiovascular event — no . ( % ) - j -,C0332152;C1320716;C2826257,false;false;false,879/20013
baseline killip class,C0168634;C1881332;C1442488,true;false;false,880/20013
score on modified rankin scale — no . ( % ) §,C0449820;C2984908;C3854213;C4050231,false;false;false;false,881/20013
energy / fatigue,C0424589;C0015672;C3463815;C4050243;C4554645;C0542479;C1442080;C4330907,false;true;false;false;false;false;false;false,882/20013
atrial flutter,C0004239;C0344423;C1963068,true;false;false,883/20013
subjects randomized,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,884/20013
active a,C0205177;C3853793;C3888249,false;false;false,885/20013
rec . ischemia leading to hasp,C1424025;C0022116;C4321499;C2606415,false;true;false;true,886/20013
history of cabg surgery,C0455610;C0010055,false;true,887/20013
western europe and other,C0043129,true,888/20013
qualifying mi type,C1514624;C3810814;C0332307;C1547052,false;false;false;false,889/20013
potassium - sparing at last follow - up,C0032821;C0589120;C1522577;C1704685;C3274571;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,890/20013
congestive heart failure,C0018802,true,891/20013
score distribution : < nmbr,C0449820;C0520511;C1704711;C4050231,false;false;true;false,892/20013
candesartan nmbr / nmbr,C0717550,true,893/20013
planned treatment strategy,C0599880;C0679199,false;false,894/20013
/ ’ - valuenmbr ’,C1522609,false,895/20013
parental history of myocardial infarction before nmbr yr of age ( % ),C0030551;C1275835,true;false,896/20013
hbanmbrc distribution at baseline,C0019016;C0520511;C0168634;C1442488;C1704711;C1825777;C3538758,true;false;true;false;true;false;false,897/20013
change in haq - di ( mean ) t,C0392747;C3826998;C0444504;C2347634;C2348143;C4321476;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,898/20013
normoalbuminuria at baseline ( nmbr % of patients treated ),C0168634;C0030705;C1442488,true;true;false,899/20013
previous deep - vein thrombosis or pulmonary embolism,C0205156;C0149871;C1552607,false;true;false,900/20013
placebo mean ( n ),C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false,901/20013
previous coronary revascularization — no . ( % ),C0205156;C0877341;C1552607,false;false;false,902/20013
medical history and risk factors — no . ( % ),C0262926;C1704706,false;false,903/20013
rankin grade,C0441800;C0919553;C3244287,false;false;false,904/20013
previous heart failure,C0205156;C0018801;C0018802;C4554158;C1552607,false;true;true;false;false,905/20013
ptca or pci,C2936173,true,906/20013
inflammatory disease,C1290884,false,907/20013
exacerbations,C4086268,false,908/20013
statin ( open ),C0360714,true,909/20013
glyburide ( n = nmbr ),C0017628,true,910/20013
history of cardiovascular disease — no . ( % ) ^ |,C0455539,false,911/20013
heart failure — no . ( % ),C0018801;C0018802;C4554158,true;true;false,912/20013
normoglycemicnmbr,C0580545,false,913/20013
fevi,C0849974;C1561566;C4528367,false;false;false,914/20013
cardiac failure,C0018801;C0018802,true;true,915/20013
previous vascular disease,C0205156;C0042373;C1552607,false;true;false,916/20013
ethnic origin,C0015031,true,917/20013
abatacept monotherapy ( n = nmbr ),C1619966,true,918/20013
calcium channel antagonists,C0006684;C2757014,true;false,919/20013
high potencyc,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,920/20013
ra symptom duration — year,C3538806;C1457887;C0449238;C0439234;C0439508;C2926735;C3854129;C4048756,false;false;false;false;false;false;false;false,921/20013
previous myocardial infarction ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,922/20013
post - bronchodilator fvc ( l ) a,C2599594;C3714541,false;true,923/20013
moderate risk,C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,924/20013
< nmbr . nmbr mm hg diastolic blood pressure,C0439475;C0428883;C1305849,false;true;false,925/20013
nmbr mg cohort,C0024671;C0009247;C0599755;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,926/20013
exercise times per week,C0015259;C0456698;C1522704,true;false;false,927/20013
other ( nmbr . nmbr % ) t,C2603360,false,928/20013
medical conditions,C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,929/20013
smoking status at screening,C1519386;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0037369;C0421330;C0453996;C1881674,false;true;true;false;false;false;false;false;true;false;true;false,930/20013
low - dose rivaroxaban + aspirin ( n / n ),C2608320;C1739768,false;true,931/20013
revascularization,C0581603,false,932/20013
hoehn and yahr stage ( range,C0205390;C1514721;C2348147;C3542016;C1300072;C1306673,false;false;false;false;false;false,933/20013
blood leukocyte count ( nmbr cells per l ),C0023508;C0347983;C0023516;C0427512,true;false;true;false,934/20013
low risk and fewer symptoms ( group a ),C3272281;C3538919,false;false,935/20013
alt and / or ast > nmbr times uln consecutive #,C1266129;C4553172,false;false,936/20013
nmbr yr km % ( n ),C0439234;C3887676,false;false,937/20013
history of symptomatic,C0019664;C0231220;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,938/20013
time of symptom onset to balloon inflation ( hrs ),C1320528,false,939/20013
statin potency stratum,C0360714;C3245505,true;false,940/20013
no dysglycaemia or mets,C1960636,false,941/20013
weight $ nmbr . nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,942/20013
race or ethnic group,C0034510;C1706779;C3853635,true;false;false,943/20013
moderate impairment ( nmbr to < nmbr ),C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,944/20013
ascvd including tia,C3665365,false,945/20013
receiving concomitant corticosteroids,C1514756,false,946/20013
laba + ics ( free or fixed - dose combination ),C0815320;C4551720,false;true,947/20013
fc - ldl - c,C2983605,false,948/20013
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr n = nmbr ( nmbr . nmbr % ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,949/20013
receptor blockers,C0597357,false,950/20013
hyperkalemia ( > nmbr . nmbr meq / l ),C0020461;C0439375;C4552983,true;false;false,951/20013
mean score on haq - di §,C3533236;C3826998;C4321476,false;false;false,952/20013
medications at randomization,C0013227;C0034656;C0802604;C2598133;C4284232,true;true;false;false;false,953/20013
nmbr,,,954/20013
history of cardiovascular disease,C0455539,false,955/20013
> nmbr yr warfarin experience,C0439234;C0043031;C0237607;C0596545,false;true;false;false,956/20013
intervention in complex lesions,C1292781;C0221198,false;false,957/20013
peak creatine kinase - mb,C0444505;C0010290;C0523584,false;true;false,958/20013
secondary ( change in total updrs score from baseline to final visit in phase nmbr ),C0027627;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0175668;C0205436,true;false;false;true;false;false;false;false;false;false,959/20013
leflunomide ( mean dose : nmbr . nmbr mg / day ),C0063041;C0444504;C0178602;C0439422;C0869039;C1114758;C2347634;C2348143,true;false;false;false;false;false;false;false,960/20013
antithrombotic agents,C1704311,true,961/20013
leisure,C0086542,true,962/20013
angiotensin receptor blocker and / or ace,C0034787;C1622222,true;true,963/20013
type of treatment,C0455708,false,964/20013
pancreatic cancer,C0235974;C0346647;C2984259,true;true;false,965/20013
mean iglar dose ± sd ( u / day ),C0444504;C0178602;C2699239;C0456683;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false;false;false,966/20013
int . p *,C3272375,false,967/20013
hawaiian / pacific,C0337920,true,968/20013
aspirin at any dose,C4696290,false,969/20013
baseline fpg,C0168634;C1442488,true;false,970/20013
crp ( mg / l ) : < nmbr,C3890735;C0439268;C4048285,false;false;false,971/20013
large - artery atherosclerosis,C0226003;C0003850;C0004153,false;true;true,972/20013
antihyperglycemic medication usage,C0020616;C0013227;C0457083;C3244316;C4284232,true;true;false;false;false,973/20013
carotid,C0741968,false,974/20013
western european includinq australia,C0043128;C0239307;C1535514;C0239312;C0004340,true;false;false;false;true,975/20013
low density lipoprotein cholesterol,C0023824,true,976/20013
blood eosinophil count ( nmbr cells per l ),C0200638,false,977/20013
egfr < nmbr ml / min / nmbr . nmbr mnmbr ( mdrd ),C1739039;C0439445;C0369637;C3839656;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,978/20013
placebo n = nmbr subjects,C0032042;C1696465;C1706408,true;false;false,979/20013
treatment with candesartan,C0039798;C0717550;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,980/20013
hbanmbrc nmbr - < = nmbr %,C0019016;C1825777;C3538758,true;false;false,981/20013
eze / simva nmbr / nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,982/20013
pulmonary rales,C0034642,true,983/20013
loop at last follow - up,C0445022;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,984/20013
modified rankin scale score,C2984908;C0449820;C4050231;C3854213,false;false;false;false,985/20013
qualifying event — no . ( % ),C1514624;C0441471;C4019010,false;false;false,986/20013
claudication ( fontaine class > nmbr ),C0021775;C0456387;C1518526;C1705943;C0311395;C1456822,true;false;false;false;false;false,987/20013
steroid use at baseline,C0281991;C0168634;C1442488,false;true;false,988/20013
metabolic syndrome ( > nmbr of nmbr characteristics ),C0524620;C1521970,true;false,989/20013
killip class,C1881332,false,990/20013
respiratory medication ( % ),C0418986,false,991/20013
concomitant lipid - lowering therapy,C0521115;C0585943,false;false,992/20013
duration of tnmbrdm,C0449238;C0011816;C3250443;C2926735,false;true;false;false,993/20013
smoking status ( % ),C1519386,false,994/20013
bare - metal stent — no . ( % ),C2825200,false,995/20013
rate / nmbr patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,996/20013
> nmbr servings / wk ( n = nmbr ),C1519269;C0332174;C0439230,false;false;false,997/20013
key secondary end point : st,C4528314;C0036056;C3272372,false;true;false,998/20013
no . of risk factors ( % ) | |,C0035648;C1553898,true;false,999/20013
prior antihypertensive medication,C0332152;C0003364;C2826257,false;true;false,1000/20013
mean yearly decline,C0444504;C2347634;C2348143,false;false;false,1001/20013
standard therapy,C2936643,true,1002/20013
phosphorus,C0031705;C0080014;C3714498,true;true;false,1003/20013
lipid levels — mg / dl,C0428460;C0439269,false;false,1004/20013
smoking habit,C4505437,true,1005/20013
open triple ( n = nmbr ),C0175566,false,1006/20013
no prior hf hospitalization ( n = nmbr,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,1007/20013
glyburide,C0017628,true,1008/20013
mean ( sd ) extent of exposure,C0444504;C2699239;C0439792;C0274281;C0332157;C2347634;C2348143,false;false;false;false;false;false;false,1009/20013
triple therapy use at screening,C0205174;C0039798;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C0087111;C1363945,false;true;true;true;true;false;false;false;false;false;false;false;true;false,1010/20013
europe nmbr ( n = nmbr ),C0015176,true,1011/20013
ankle - brachial index < nmbr . nmbr — no . ( % ),C1328319;C3888326,true;false,1012/20013
number of subjects,C0237753;C0681850;C1550501;C1706203;C2349001;C2697811;C0449788,false;false;false;false;false;false;false,1013/20013
fasting insulin,C0015663;C0021641;C1533581;C1579433;C3714501,true;true;false;false;false,1014/20013
ace - i or arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,1015/20013
pfo closure group ( n = nmbr ),C0185003;C0441848;C1521802,false;false;false,1016/20013
median ( qnmbr : qnmbr ) duration of insulin use,C0549183;C1881378;C0021641;C1533581;C1579433;C3714501;C2826775;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false,1017/20013
control group ( n = nmbr ),C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false;false,1018/20013
normal troponin,C0205307;C0041199;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false,1019/20013
ind / glynmbr / nmbr pg o . d . n = nmbr,C4049864;C0017890;C2827928;C0523677,false;true;false;false,1020/20013
traditional chinese medicine for respiratory disease — no . ( % ),C0025124;C0035204;C0035242;C1515884,true;true;true;false,1021/20013
baseline copd exacerbation history,C0168634;C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1442488,true;false;true;true;false;false;false;false;false,1022/20013
european union,C0015179,true,1023/20013
blood pressure - lowering treatment,C0596197;C0033095;C0441994;C2003888;C0460139;C1306345;C4284008;C0005823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1271104;C1272641,false;true;false;false;false;false;false;true;true;true;false;false;false;false;false;false;true,1024/20013
ezetimibe,C1142985,true,1025/20013
fish oil,C0016157,true,1026/20013
cardiovascular inclusion criteriat,C0007226;C0007637;C1512693;C3887460,true;true;false;false,1027/20013
median duration of study - drug administration,C0549183;C2348354;C0013175;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false,1028/20013
psoriasis body surface area > nmbr %,C0033860;C0005902,true;true,1029/20013
exenatide,C0167117,true,1030/20013
cardiovascular risk factors — no . / total no . ( % ),C0850624,false,1031/20013
( nmbr % ci ) p value,C0008107;C1709380;C3259781,true;false;false,1032/20013
time from symptom onset to randomization,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,1033/20013
percentage difference ( nmbr % cl ),C0439165;C1705241;C0596019;C1705242;C1549488;C1561533,false;false;false;false;false;false,1034/20013
fpg ( mmol / l ),C1532563,false,1035/20013
apo anmbr ( g / l ),C0003592;C0439294;C0456615;C0523508;C4553344;C4553379,true;false;false;false;false;false,1036/20013
fibrinolysis ( n = nmbr ),C0016017;C1305868,true;false,1037/20013
ticagrelor nmbr mg vs . placebo hr ( nmbr % ci ),C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1038/20013
combined n = nmbr,C0205195,false,1039/20013
simplified disease activity index,C3869582,false,1040/20013
ratio of ldl to hdl,C0456603;C1547037,false;false,1041/20013
st ( arc definite only ),C0036056;C0439544;C0205171;C1720467;C1704787;C3272372,true;false;false;false;false;false,1042/20013
duration of diabetes mellitus,C0449238;C0011849;C2926735,false;true;false,1043/20013
total study population ( n = nmbr,C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,1044/20013
sita / pio nmbr / nmbr,C0030800;C2347712,true;false,1045/20013
blood eosinophils count,C0014467,true,1046/20013
who / idf ifg,C1334085;C1708411,false;false,1047/20013
cardiovascular history 一 no . ( % ),C1880008,false,1048/20013
ace inhibitor at last follow - up,C0003015;C0589120;C1522577;C1704685;C3274571;C4541021,true;false;false;false;false;false,1049/20013
prior cardiac surgery,C0455610;C0018787;C1522601;C0332152;C0018821;C0524727;C2826257,false;true;false;false;true;true;false,1050/20013
ischemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,1051/20013
placebo nmbr year km ( % ),C0032042;C0439234;C3887676;C0439508;C1696465;C1706408,true;false;false;false;false;false,1052/20013
vorapaxar n = nmbr,C2974521,true,1053/20013
postmenopausal,C0232970,false,1054/20013
difference vs placebo,C1705241;C1705242,false;false,1055/20013
urinary albumin - to - creatinine ratio^,C0455271;C1318330,false;false,1056/20013
percent change,C0439165;C0392747;C0443172;C1705241;C4319952,false;false;false;false;false,1057/20013
standard care ( n = nmbr ),C1442989;C1947933;C2828392,false;false;false,1058/20013
cerebrovascular disorders,C0007820,true,1059/20013
ace inhibitor — no . ( % ),C0003015;C4541021,true;false,1060/20013
location of treatment center,C0039798;C0205099;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,1061/20013
indacaterol nmbr ug ( n = nmbr ),C1722260;C0041573;C0439211,true;true;false,1062/20013
history of peripheral arterial disease ( % ),C0683519;C0205100;C0003842;C0221464;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,1063/20013
creatinine,C0010294;C1561535,true;false,1064/20013
sfnmbr - pcs,C0037712;C1864389;C1882368,true;false;true,1065/20013
randomization groups nmbr and nmbr,C0034656;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429,true;false;false;true;false;false;false;false,1066/20013
presence of honeycombing,C0150312;C0332468;C0349384;C0392148;C3854307,false;false;false;false;false,1067/20013
very severe n z nmbr,C3641272;C4050419,false;false,1068/20013
years since pah diagnosis,C0439234,false,1069/20013
partial mayo score $ | |,C0728938;C0454788;C0449820;C4050231;C1077578;C1550516,false;false;false;false;false;false,1070/20013
rosuvastain + fenofibric acid nmbr = nmbr,C0060179,true,1071/20013
severity n ( % ),C0439793;C0522510,false;false,1072/20013
history of hypercholesterolemia,C1533076,false,1073/20013
> nmbr years education,C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,1074/20013
angiographic complications,C0002978;C0009566;C1171258,true;false;true,1075/20013
acute coronary syndrome nmbr,C0948089,true,1076/20013
asastoppedat randomization,C0034656,true,1077/20013
mean blood pressure,C0428886;C0488053,true;false,1078/20013
baseline lipids  mean ± sd ( mmol / l ),C0168634;C0023779;C0444504;C2699239;C1532563;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,1079/20013
philippines,C0031529,true,1080/20013
active cancer at randomization,C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,1081/20013
current (,C0521116;C1705970,false;false,1082/20013
aspirin and ppi,C0004057,true,1083/20013
screening % reversibility fevnmbr,C0220908;C0449261;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;true;false;false;false;false;false,1084/20013
prior pci or cabg surgery,C0332152;C4049621;C2826257,false;false;false,1085/20013
lower - limb arterial — no . ( % ),C0023216,true,1086/20013
baseline disease and quality - of - life scores,C0168634;C0012634;C1442488,true;true;false,1087/20013
index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1088/20013
endoscopy subscore,C0014245,true,1089/20013
intended clopidogrel dose nmbr mg,C1283828;C0070166;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C1551357,false;true;false;true;true;false;false;false;false;false;false;false;false,1090/20013
placebo + mtx,C0032042;C0025677;C1417487;C1696465;C1706408,true;true;false;false;false,1091/20013
celecoxib ( n = nmbr ),C0538927,true,1092/20013
oral hypoglycemic agent,C0359086,false,1093/20013
unacceptable adverse events,C1883420;C0877248;C1705413,false;false;false,1094/20013
tolal choleslerol - lo - hdl choleslerol ralio,C0206579;C3715113;C1232424,true;false;false,1095/20013
median ( days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1096/20013
ldl particle size ( week nmbr ),C3641256;C0332174;C0439230,false;false;false,1097/20013
gold nmbr groups,C0018026;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1304897,true;false;false;true;false;false;false;false;false,1098/20013
parameter,C0549193;C1704769;C2350001,false;false;false,1099/20013
vascular intervention,C0005847;C0184661;C0886296;C1273869;C1558950;C1801960,true;true;false;false;false;false,1100/20013
anmbr + ezio anmbr ( n = nmbr ) ( n = nmbr ),,,1101/20013
amlodipine / vaisartan ( n = nmbr ),C0051696,true,1102/20013
ldl cholesterol — mg / dl | |,C0023824;C0439269;C0202117,true;false;false,1103/20013
week nmbr ( geometric mean,C0332174;C2986759;C0439230,false;false;false,1104/20013
triglycerides ( week nmbr ) a,C0041004;C0332174;C0439230,true;false;false,1105/20013
cause of heart failure,C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1106/20013
copd or asthma,C0024117;C1412502;C3714496,true;false;false,1107/20013
latin and north america,,,1108/20013
comorbid diseasesa diabetesb,C0009488,true,1109/20013
cardiac rhythm,C0232187,false,1110/20013
proactive intervention ( n = nmbra ),C0184661;C0886296;C1273869,true;false;false,1111/20013
nmbr = minor symptoms  no limitations,C0026193;C0683368;C1457887;C0205165,true;true;false;false,1112/20013
patients ' characteristics age ( years ),C0815172;C1510829,false;false,1113/20013
acc / aha lesion class bnmbr or c,C4072694;C0221198;C0456387;C1518526;C1705943;C1546698,false;false;false;false;false;false,1114/20013
enact - nmbr trial,,,1115/20013
fasting insulin — / tiu / ml §,C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,1116/20013
biomarker low ( periostin < nmbr ng / ml or blood eosinophils < nmbr cells per pl ),C0005516;C0205251;C0219433;C0439275;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;true;false;false;false;false;false;false;false;false,1117/20013
lipoprotein ( a ) ( mg / dl ),C0065058;C0439269;C0125953;C1096202;C1439335,true;false;true;false;false,1118/20013
any pulmonary medication,C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false,1119/20013
non - study ppi use,C1518422;C0557651;C0358591;C0871125;C3811894;C2603343,false;false;true;true;false;false,1120/20013
> nmbr : obese class iii,C1319441,false,1121/20013
acute dvt study,C0205178;C0149871;C0557651;C2603343;C2926618;C3899446,false;true;false;false;false;false,1122/20013
high subgroup,C0205250;C1079230;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,1123/20013
mean ( sd ) body mass index,C0444504;C2699239;C0005893;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,1124/20013
diuretic drugs,C0012798;C0013227;C3687832,true;true;false,1125/20013
gallbladder - related aes,C0016976;C0439849;C1412268;C2699274;C0445223,true;false;false;false;false,1126/20013
rivastigmine ( n = nmbr ),C0649350,true,1127/20013
vitamin e,C0042874;C3714803,true;false,1128/20013
jvp > nmbrcm,,,1129/20013
family history of venous thromboembolism ( % ),C0241889;C1997614;C0015576;C0455533;C0042449;C0348013;C1704727,true;false;true;false;true;false;false,1130/20013
post - bronchodilator fevnmbr ( % predicted * ),C2599594;C3714541,false;true,1131/20013
creatinine clearance by c - g ( ml / min ),C0439267;C0151280,false;false,1132/20013
associated with hiv infection,C0332281;C0019693,false;true,1133/20013
muscle spasms,C0037763,true,1134/20013
copd severity ( gold stage ),C0024117;C0439793;C0018026;C0205390;C1300072;C1306673;C1304897;C0522510;C1412502;C3714496,true;false;true;false;false;false;false;false;false;false,1135/20013
rivaroxaban nmbr mg,C1739768;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1136/20013
baseline cardiac biomarkers elevated,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1137/20013
mental component score ( mcs ),C0229992;C0449432;C0449820;C4050231;C1705248,false;false;false;false;false,1138/20013
combined end points,C0205195;C2349179,false;false,1139/20013
race,C0034510;C1706779;C3853635,true;false;false,1140/20013
elevated tg,C0205250;C0337445;C3163633,false;false;false,1141/20013
baseline scales,C0168634;C1442488,true;false,1142/20013
formal education,C0681344,false,1143/20013
tiotropium nmbr gg qd,C0213771;C0017454;C0332173;C0018370,true;true;false;true,1144/20013
thrombocytopenia,C0040034;C0392386,true;false,1145/20013
presence of mets,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,1146/20013
treatment at randomization — no . ( % ),C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,1147/20013
other biologic agent,C0005515,true,1148/20013
hdl < nmbr / nmbr mg / dl ( nmbr . nmbr / nmbr . nmbr mmol / l ) for men / women,C3715113;C3642216;C3898312;C0025266;C0043210,false;false;false;true;true,1149/20013
baseline systolic bp,C0168634;C0871470;C1442488,true;true;false,1150/20013
angina class iii or iv prior myocardial infarction,C0264677,false,1151/20013
mucolytic agent,C0026698,true,1152/20013
acenocoumaroi,,,1153/20013
multiple,C0439064,false,1154/20013
emotional well - being,C2984554;C3641833,false;false,1155/20013
nmbr ( fevnmbr < nmbr % pred ),C3714541,true,1156/20013
rec . ischemia due worsening angina,C1424025;C0022116;C0678226;C0002965;C3146286;C4321499;C2606415,false;true;false;true;false;false;true,1157/20013
current ( nmbr + cigs / day ),C0521116;C1570610;C0332173;C0439228;C0439505;C1705970,false;true;false;false;false;false,1158/20013
prior surgery : no,C0455610,false,1159/20013
carotid stenosis,C0007282,true,1160/20013
smoking history,C1519384,false,1161/20013
ever smoked ( current / former ),,,1162/20013
estimated gfr,C0750572;C0017654;C1424601,false;true;false,1163/20013
isolated systolic hypertension,C0745133,false,1164/20013
feno placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,1165/20013
no . of prior tnfi,C0332152;C2826257,false;false,1166/20013
non - fatal myocardial infarction,C1518422;C1302234;C0027051;C0428953;C2926063;C3810814;C4552959;C1705232,false;false;true;false;false;false;false;false,1167/20013
involved intestinal area,C1879646;C0021853,false;true,1168/20013
normal fasting glucose level ( n = nmbr ),C0522082;C0015663;C0205307;C0202045;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,1169/20013
saxa + dapa + met n = nmbr,,,1170/20013
joint damage outcomes ( mitt population ),C0022417;C0010957;C1274040;C0032659;C1257890;C1883709;C0392905;C1706309,true;false;false;true;true;false;false;false,1171/20013
discontinuations teaes,C0457454,false,1172/20013
aldosterone inhibitor,C0002007,true,1173/20013
adverse outcome,C1274040,false,1174/20013
etoricoxib nmbr mg n = nmbr n ( % ),C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1175/20013
asia - pacific hr ( nmbr % cl ),C0003980;C0596019,true;false,1176/20013
left bundle - branch block,C0023211;C0344420;C2828132,true;false;false,1177/20013
any prior anti - tnf treatment failure,C1514463;C1448177;C0231174;C0680095;C0332152;C0162643;C0235828;C0521983;C1547544;C2826257,false;true;false;false;false;true;false;false;false;false,1178/20013
pioglitazone pts / n ( % ),C0071097;C1419129;C2698747,true;false;false,1179/20013
central / eastern europe and russia hr ( nmbr % cl ),C0682369;C1707877;C0205099;C0015177;C1879652,false;false;false;true;false,1180/20013
copd - rosuvastatin ( n = nmbr ),C0024117;C0965129;C1412502;C3714496,true;true;false;false,1181/20013
abatacept / open - label abatacept,C1619966;C1709323,true;false,1182/20013
nonblack race — no . ( % ) - j -,,,1183/20013
prior ischemic stroke,C0332152;C0948008;C2826257,false;false;false,1184/20013
ff / vi nmbr / nmbr gg ( n = nmbr,C4554348;C0205999;C0017454;C0018370,false;true;true;true,1185/20013
baseline nihss score ( % ) #,C0168634;C1697238;C1442488,true;false;false,1186/20013
free fatty acids ( mmol / l ),C0015688;C1532563,true;false,1187/20013
laba or lama ’ versus ind / gly lsm difference ( nmbr % cl ),,,1188/20013
change from baseline in hbanmbrc ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1189/20013
aspirin group ( n = nmbr nmbr ) ( nmbr nmbr person years ),C0004057;C0441848;C0027361;C0439234;C2347489,true;false;true;false;false,1190/20013
angiogenin ( ng / ml ),C0051844;C0439275;C1367482,true;false;false,1191/20013
weight  mean ± sd ( kg ),C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,1192/20013
race / ethnicity,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,1193/20013
etanercept ( n = nmbr ),C0717758,true,1194/20013
serum creatinine — pmol / liter,C0201976;C0439192;C0475211;C0600061,false;false;false;false,1195/20013
prior carotid intervention,C0332152;C0741968;C0184661;C0886296;C1273869;C2826257,false;false;true;false;false;false,1196/20013
abx - facil . pci,C4049621,false,1197/20013
antiplatelet — no . / total no . ( % ),,,1198/20013
other lipid - modifying drug use at study entry,C0023779;C0392747;C0242510;C0557651;C1705654;C2603343;C0042153;C0013175;C0457083;C1947944;C0013227;C0869040;C1254351,true;false;false;false;false;false;true;true;false;false;true;false;false,1199/20013
without dm ( n = nmbrinmbr * ),C0011816;C3250443,true;false,1200/20013
potassium,C0032821;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false,1201/20013
difference ( tiotropium - placebo ) ml ( nmbr % ci ),C1705241;C0213771;C0032042;C0439526;C0008107;C3259781;C1705224;C3887665;C1696465;C1706408;C1705242,false;true;true;false;true;false;false;false;false;false;false,1202/20013
any relevant infarct,C2347946;C0021308,false;true,1203/20013
baricitinib,C4044947,true,1204/20013
ls mean % change from baseline _ se,C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,1205/20013
established ascvd or > nmbr cv risk factors,C0443211;C3665365;C1272684,false;false;false,1206/20013
fasting plasma glucose,C0015663;C0202042;C0455280,true;false;false,1207/20013
enmbr + anmbr -,,,1208/20013
filtration rate nmbr - nmbr,C0016107;C0871208;C1521828,true;false;false,1209/20013
placebo secukinumab nmbr mg,C0032042;C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;false;false;false;false;false;false;false,1210/20013
sf - nmbr physical component summaryjj,C0037712;C0031809;C0449432;C1705248;C0205485;C1509143,true;true;false;false;false;false,1211/20013
angiographic data,C0002978;C1511726;C3245479;C3714741,true;false;false;false,1212/20013
community hospital ( % ),C0020003,true,1213/20013
death or absolute fvc decrease > nmbr %,C0011065;C1306577;C4082313;C4552775,true;false;false;false,1214/20013
indacaterol nmbr mg[n z nmbr],C1722260;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1215/20013
other statin,C0360714,true,1216/20013
median ( iqr ) age,C0549183;C0001779;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1217/20013
estimated glomerular filtration rate < nmbr ml / min / nmbr . nmbr mnmbr : i : §,C3811844;C0023806;C0702093;C0369637;C0441923;C1524029;C3813700;C0439445;C0021966;C0221138,false;true;false;false;false;false;false;false;true;false,1218/20013
homa_ % b tx difference vs pbo,C0041403;C1705241;C1705242,true;false;false,1219/20013
tim nmbr nsk score,C1313407;C0449820;C4050231;C3541335;C3711667;C3827754;C3890185;C4319633,true;false;false;false;true;false;false;false,1220/20013
indication for pci,C0392360;C4049621;C3146298,false;false;false,1221/20013
percutaneous coronary intervention or coronary artery bypass graft surgery,C1532338,true,1222/20013
nmbr - aminosalicylates ’ i   i ‘,C0368663;C0021966;C0221138,false;true;false,1223/20013
native latin,C0302891,false,1224/20013
patient history of disease,C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1225/20013
copd severity : severe / very severe,C0024117;C0439793;C0442824;C2984081;C0522510;C1412502;C3714496,true;false;false;false;false;false;false,1226/20013
mean platelet volume,C0200665;C0344388,true;false,1227/20013
in ibdq total score at week nmbr,C2964552;C0332174;C0439230,false;false;false,1228/20013
baseline ezetimibe usec,C0168634;C1142985;C0439224;C1442488,true;true;false;false,1229/20013
ics use at screening,C0815320;C4551720,false;true,1230/20013
mdi / hfa,C0993596;C0015458;C1839839;C4049613,true;true;true;false,1231/20013
moderate or severe exacerbations in the previous year ( range ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1232/20013
mixed chronic bronchitis and emphysema,C0205430;C0008677;C3160715,false;true;false,1233/20013
triple - vessel disease,C0856738,false,1234/20013
mean ( sd ) crp,C0444504;C2699239;C3890735;C4048285;C2347634;C2348143,false;false;false;false;false;false,1235/20013
epa / aa ratio,C0282379;C0456603;C1547037;C1235746;C1882141;C4554792,true;false;false;false;false;false,1236/20013
one or more requiring hospitalization in nmbr mo before screening — no . ( % ) nmbr,C0205447,false,1237/20013
health state index score,C0683314;C0600653;C0449820;C4050231;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,1238/20013
time from onset of pain to randomization,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,1239/20013
homajr tx difference vs pbo,C0041403;C1705241;C1705242,true;false;false,1240/20013
ticagrelor,C1999375,true,1241/20013
dpp - nmbr inhibitor therapy,C1414174;C1999216;C0039798;C0087111;C1363945,false;false;true;true;false,1242/20013
median cardiac troponin t ( iqr ) — pg / ml,C0549183;C3538889;C0439297;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1243/20013
> nmbr ( ml ) additional angiography,C0439526;C1524062;C0002978;C1705224;C3887665,false;false;true;false;false,1244/20013
sbp < nmbr mmhg and dbp < nmbr mmhg,C0085805;C0439475,true;false,1245/20013
insulin and oral hypoglycemic drugs,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1246/20013
other antiplatelet,,,1247/20013
use of ics,C1524063;C0815320;C4551720,false;false;true,1248/20013
mean hscrp,C0444504;C2347634;C2348143,false;false;false,1249/20013
carotid revascularization,C0741968;C0581603,false;false,1250/20013
time from onset to randomization,C0449244,false,1251/20013
beta - adrenergic blocker,C0001645;C2757061;C3536830,true;false;false,1252/20013
class l / ll heart failure,C0456387;C1518526;C1705943,false;false;false,1253/20013
rerandomization to placebo ( n = nmbr ) f,C0032042;C0016327;C1696465;C1706408,true;true;false;false,1254/20013
triglycerides > nmbr mg / dl,C0041004;C0439269,true;false,1255/20013
vomiting,C0042963;C1963281;C3898969;C4084766;C4084767;C4084768;C4084769,true;false;false;false;false;false;false,1256/20013
thoracic cage fractures,C0222762,true,1257/20013
baseline sgrq score,C0168634;C1442488,true;false,1258/20013
usa and canada,C0041703,true,1259/20013
obesity ( body mass index > nmbr kg / mnmbr ),C0028754;C0005893;C1532718;C0578022;C1305855;C1963185,true;false;false;false;true;false,1260/20013
clopidogrel plus aspirin ( n = nmbr ),C0070166;C0332287;C0004057,true;false;true,1261/20013
intent of early invasive strategy,C0162425;C1279919;C0205281;C0679199;C1334278;C1283828;C1550453,true;false;false;false;false;false;false,1262/20013
mean fevnmbr,C0444504;C3714541;C2347634;C2348143,false;true;false;false,1263/20013
heavy calcification,C0439539;C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,false;true;true;false;false;false;false,1264/20013
only peripheral artery disease,C0205171;C1704436;C4025272;C1720467,false;true;false;false,1265/20013
inhaled anticholinergic §,C0004048;C0242896;C3537004,true;true;false,1266/20013
nmbr - h plasma glucose during ogtt ( mmol / l ),C2827804;C0202042;C0029161;C0455280,false;false;true;false,1267/20013
uacra,,,1268/20013
western europe and israel,C0043129,true,1269/20013
sglt - nmbr inhibitors^,C3665045,false,1270/20013
myocardial infarction — no . ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,1271/20013
united states,C0041703,true,1272/20013
number of antidiabetes drugs at screening,C0237753;C0013227;C3687832;C0449788,false;true;false;false,1273/20013
any type,C0332307;C1547052,false;false,1274/20013
glucocorticoids plus immunosuppressive agents,C0017710;C0021081;C3540777;C3540778,true;true;false;false,1275/20013
left anterior descending artery,C0226032,false,1276/20013
albuterol reversibility,C0001927;C0449261,true;false,1277/20013
rivaroxaban + aspirin,C1739768;C0004057,true;true,1278/20013
anyantianginal agent,C0450442;C1254351;C1521826,false;false;false,1279/20013
patients with diabetic nephropathy,C0030705;C0011881;C1442864,true;true;false,1280/20013
hbanmbrc in patients with baseline hbanmbrc > nmbr % to < nmbr % ( > nmbr to < nmbr mmol / mol ),C0019016;C0030705;C0168634;C1442488;C1825777;C3538758,true;true;true;false;false;false,1281/20013
health - related quality of life,C4279947,true,1282/20013
risk factors,C0035648;C1553898,true;false,1283/20013
concomitant therapy,C1707479,false,1284/20013
any cardiovascular disease history,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,1285/20013
cardiac history,C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1522601,true;true;true;false;false;false;false;false,1286/20013
subgroup by treatment interaction p - value,C1079230;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021,false;true;false;false;true;false;false;false;false;false;false,1287/20013
anmbr + eznmbr anmbr ( n = nmbr ) ( n = nmbr ),C0206578,true,1288/20013
dpi ( other than diskus ),C1553480,false,1289/20013
previous copd treatment,C0205156;C0024117;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1412502;C3714496;C1552607,false;true;true;true;false;false;false;false;false;false;false;false,1290/20013
body mass index ( kg / mnmbr ) - mean ± sd,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,1291/20013
positive for anti - cyclic citrullinated peptide antibody — no . ( % ) f,C0741132;C1320283,false;false,1292/20013
ldl cholesterol at baseline ( mmol / l ) * ldl cholesterol at screening,C0023824;C0168634;C1532563;C1442488;C0202117,true;true;false;false;false,1293/20013
black race,C0005680,true,1294/20013
lp ( a ),C0065058;C1439335;C4553379,true;false;false,1295/20013
previous transient ischaemic attack / ischaemic stroke previous warfarin use,C0205156;C0007787;C0038454;C0043031;C0042153;C0457083;C1947944;C4554100;C0917805;C1552607,false;true;true;true;true;false;false;false;true;false,1296/20013
calculated ldl - c in nmbr classes,C0444686;C0456387;C1518526;C1705943;C4019422;C1441506,false;false;false;false;false;false,1297/20013
rosiglitazone,C0289313,true,1298/20013
without revascularsation,,,1299/20013
odds ratio,C0028873,true,1300/20013
body mass index,C0005893;C0578022;C1305855,false;false;true,1301/20013
exenatide n = nmbr,C0167117,true,1302/20013
total score on the sgrq - c  i ,C2964552;C3826872;C0021966;C0221138,false;false;true;false,1303/20013
elevated creatinine ( > nmbr pmol / l ),C0151578;C0439284;C0700225,false;false;false,1304/20013
baseline : < nmbr . nmbr meq / l eos : > nmbr . nmbr or < nmbr . nmbr meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,1305/20013
history of currently treated hypertension,C0455527;C0521116;C1522326,false;false;false,1306/20013
tg,C0337445,false,1307/20013
terminal ileum,C0227327,false,1308/20013
dasnmbr - esr lda,C0051767;C3811131;C4553195;C0057671,true;false;false;true,1309/20013
prior tnfi,C0332152;C2826257,false;false,1310/20013
liraglutide nmbr . nmbr mg / day ( n = nmbr ),C1456408;C0439422,true;false,1311/20013
established ascvd,C0443211;C3665365;C1272684,false;false;false,1312/20013
depressed and low perceived social support,C0344315;C0549249,false;true,1313/20013
limb ( sd ),C0015385;C2699239,true;false,1314/20013
emergent / urgent surgery,C0750573;C2188405,false;false,1315/20013
laboratory measurements,C0681902,false,1316/20013
simva n = nmbr n ( % ),,,1317/20013
czp nmbr mg,C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,1318/20013
fibrinogen ( pmol / l ) c,C0016006;C0439284;C1167394;C2587184;C3540039,true;false;false;false;false,1319/20013
frailty status,C0424594;C0449438,true;false,1320/20013
basal insulin dose at run - in ( u / day ),C0650607;C0178602;C3274438;C0456683;C0869039;C1114758;C0205112;C0366513,false;false;false;false;false;false;false;false,1321/20013
worsening angina,C0002965,true,1322/20013
use of parenteral antithrombotic,C1524063;C0030547;C4522267,false;true;false,1323/20013
cvd or mi,C0007222,true,1324/20013
screening bmi ( kg / mnmbr ),C0220908;C0578022;C1532718;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;true;false;false;false;false;false,1325/20013
atherosclerosis^,C0003850;C0004153,true;true,1326/20013
none ( cdmard - naive or past use at baseline ),,,1327/20013
tender joint count ( nmbr - nmbr ),C0451530,false,1328/20013
ldl - c < nmbr . nmbr mmol / l,C1532563,false,1329/20013
duration of last qualifying episode of atrial fibrillation > nmbr days,C0449238;C1514624;C0332189;C0004238;C0439228;C0344434;C1963067;C2926735,false;false;false;true;false;false;false;false,1330/20013
saxagliptin nmbr . nmbr mg ( n = nmbr,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1331/20013
years [range],C0439234;C1514721;C2348147;C3542016,false;false;false;false,1332/20013
potassium - sparing at enrollment,C0032821;C1516879;C1696073;C3888021;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false,1333/20013
body mass index > nmbr kg / mnmbr,C0005893;C1532718;C0578022;C1305855,false;false;false;true,1334/20013
modmy al randcnxzaton,C0202311,false,1335/20013
additional investigations,C2359834,false,1336/20013
peri - op amiodarone : no ( n = nmbr ),C0347985;C0002598,false;true,1337/20013
ejection fraction,C0489482;C2700378,false;false,1338/20013
class i or iii aad use in nmbr months before enrollment,C0441885;C1319793;C2698967,false;false;false,1339/20013
intravenous anticoagulant during hospitalization,C0348016;C0003280;C0019993;C0848112;C3536711,false;true;true;false;false,1340/20013
high density lipoprotein cholesterol,C0023822,true,1341/20013
functional assessment of chronic illness,C0278372;C0008679,false;true,1342/20013
hormonal status,C0458083;C0449438,false;false,1343/20013
spironolactone ( n = nmbr ),C0037982,true,1344/20013
any disease,C0012634,true,1345/20013
endothelin - receptor antagonists plus phosphodiesterase type nmbr inhibitors,C1134681;C0031638;C0332307;C1547052;C1656262;C3539996;C2266875,true;true;false;false;false;false;false,1346/20013
bolus administered — no . ( % ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,1347/20013
tofacitinib,C2930696,true,1348/20013
medical history — no . / total no . ( % ),C0262926;C1704706,false;false,1349/20013
tobacco use ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,1350/20013
infliximab - naive ( n = nmbr ),C0666743,true,1351/20013
week nmbr mean 士 sd,C0332174;C0444504;C2699239;C2347634;C2348143;C0439230,false;false;false;false;false;false,1352/20013
hr ( nmbr % ci ) p value for interaction *,C0008107;C1709380;C1704675;C3259781,true;false;false;false,1353/20013
history of congestive heart failure,C0455531;C0742742,false;false,1354/20013
events,C0441471;C3541888,false;false,1355/20013
event / total,C0441471;C0439175;C0439810;C4019010,false;false;false;false,1356/20013
serum cholesterol — mmol / liter,C0587184;C0439190;C0475211,false;false;false,1357/20013
pooled empagliflozin ( n = nmbr ),C1709595;C3490348;C2349200;C4522255,false;true;false;false,1358/20013
statin monotherapy,C0360714,true,1359/20013
total comparators,C0439175;C1707454;C4553389;C4553390;C0439810,false;false;false;false;false,1360/20013
( % ) control ( nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,1361/20013
hypertension : no ( n = nmbr ),C0020538;C1963138,true;false,1362/20013
angiotensin - converting enzyme inhibitor or angiotensin receptor blocker,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1363/20013
bdmard - ir,C0022065;C0022071;C1448132,true;true;true,1364/20013
estimated glomerular filtration rate,C3811844,false,1365/20013
periprocedural medications — no . / total no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,1366/20013
proportion of predicted normal fevnmbr value   §,C1709707;C0681842;C0086715;C3714541;C0520835;C1522609;C1882327,false;false;true;true;false;false;false,1367/20013
mellitus,,,1368/20013
permanently stopped study drug because of adverse events,C1272691;C0557651;C0041755;C2603343,false;false;true;false,1369/20013
median ( qnmbr : qnmbr ) tg - rich lipoprotein cholesterol,C0549183;C0337445;C0699759;C0065055;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false,1370/20013
apolipoproiein anmbr ( tng / nmbr ),,,1371/20013
metformin dose,C0025598;C0178602;C0869039;C1114758,true;false;false;false,1372/20013
placebo no . of events / total no . ( % ),C0032042;C1696465;C1706408,true;false;false,1373/20013
hbanmbrc nmbr % - < nmbr % ( n - nmbr ),C0019016;C1825777;C3538758,true;false;false,1374/20013
hypoglycaemic agents,C0020616,true,1375/20013
apremilast nmbr mg bid n = nmbr,C1678805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1376/20013
duration,C0449238;C2926735,false;false,1377/20013
patient global assessment of disease activity ( vas nmbr - nmbr mm ),C4054228;C0042815;C4330985;C4554674;C3536884;C3827561,false;true;false;false;true;false,1378/20013
intermittent claudication,C0021775,true,1379/20013
myocardial ischaemia,C0010054;C0151744,true;true,1380/20013
arb at enrollment,C3888198;C1516879;C1696073;C3888021,false;false;false;false,1381/20013
rosuvastatin of patients ( rate ),C0965129;C0030705;C0871208;C1521828,true;true;false;false,1382/20013
recent cardioversion ( within nmbr days before randomization ) —,C0332185;C0013778;C0439228,false;true;false,1383/20013
denosumab ( n = nmbr ),C1690432,true,1384/20013
genotyping,C1285573,false,1385/20013
remission,C0544452;C0687702,false;false,1386/20013
radius fracture,C0034628,true,1387/20013
clopidogrel dose on / before pci,C0070166;C0178602;C4049621;C0869039;C1114758,true;false;false;false;false,1388/20013
enoxaparin / vka,C0206460,true,1389/20013
sf - nmbr score,C0037712;C0449820;C4050231,true;false;false,1390/20013
seropositivity,C0521143,false,1391/20013
interval pain onset to admission,C1272706;C1507009;C0184666;C0809949;C1552654;C1552713,false;false;false;false;false;false,1392/20013
metrex modified intention - to - treat population with an eosinophilic phenotypey,,,1393/20013
number of previous anti - tnf treatments for psoriatic arthritis,C0237753;C0205156;C1448177;C0087111;C1552607;C0449788,false;false;true;true;false;false,1394/20013
coronary heart disease ( % ),C0010054;C0010068;C1956346,true;true;true,1395/20013
bmi ( kg / mnmbr ) < nmbr,C0578022;C1532718,false;false,1396/20013
abdominal aortic — no . ( % ),C0003484,true,1397/20013
mean weight,C0444504;C0005910;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;false,1398/20013
severe hyperkalemiac,C0205082;C4050465;C4050466,false;false;false,1399/20013
history of bone disease ( predefined ),C0683519;C0262950;C0730226;C0850708;C0944983;C0019664;C0005940;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;true;true;true;false;false;false;false,1400/20013
abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,1401/20013
/ j - valuc ! l,,,1402/20013
> nmbr days warfarin,C0439228;C0043031,false;true,1403/20013
non - hdl - c ( mmol / l,C1518422;C3715113;C1532563,false;false;false,1404/20013
yes,C1549445;C1705108;C1710701,false;false;false,1405/20013
nmbr - nmbr . nmbr kg / mnmbr,C1532718,false,1406/20013
baseline lp ( a ) in nmbr classes,C0168634;C0065058;C0456387;C1518526;C1705943;C4019422;C1439335;C4553379;C1442488,true;true;false;false;false;false;false;false;false,1407/20013
primary + gusto moderate or severe bleeding,C0205225;C0439612;C0439631,false;false;false,1408/20013
dyspepsia,C0013395;C4552968,true;false,1409/20013
south asian,C1519427,false,1410/20013
claudication,C0021775;C0311395;C1456822,true;false;false,1411/20013
anticoagulant therapy,C0150457,false,1412/20013
dactylitis,C0239161,false,1413/20013
prior immunnosupressive failure but no anti - tnf failure,C0332152;C0231174;C0680095;C2826257,false;false;false;false,1414/20013
sf - nmbrvnmbr domain scores,C0037712;C1880389;C1883221;C3541951,true;false;false;false,1415/20013
reversibility ( bnmbr - agonist ),C0449261;C2987634,false;false,1416/20013
icd therapy vs . placebo no . hazard ratio ( nmbr . nmbr % cl ),C0021122;C0039798;C0087111;C1363945,true;true;true;false,1417/20013
fev,C3714541,true,1418/20013
qualifying type of atherosclerosis — no . ( % ),C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,1419/20013
white : black : other,C0007457;C0005680;C0027567;C0085756;C0439541;C0043157;C0220938,true;true;true;true;false;true;false,1420/20013
placebo estimated mean,C0032042;C1696465;C1706408,true;false;false,1421/20013
salmeterol - fluticasone group,C0939232;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1422/20013
impaired glucose tolerance or impaired fasting glucose — no . ( % ),C0271650,true,1423/20013
duration of tnmbrdm ( % ),C0449238;C0011816;C3250443;C2926735,false;true;false;false,1424/20013
therapy ( asa nmbr,C0039798;C0004057;C3853627;C0087111;C1363945,true;true;false;true;false,1425/20013
antihyperglycemic oral agent therapy,C0020616;C0442027;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826;C4521986,true;false;false;true;true;false;false;false;false,1426/20013
gender,C0079399;C1522384,true;true,1427/20013
planned thienopyridine at baseline,C1301732;C1120149;C0168634;C1442488,false;true;true;false,1428/20013
medical history,C0262926;C1704706,false;false,1429/20013
medium - or low - intensity statin,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,1430/20013
current / past,C0521116;C1444637;C4284302;C1705970,false;false;false;false,1431/20013
rosuvastatin n = nmbr,C0965129,true,1432/20013
pulse rate ( bpm ),C0232117,true,1433/20013
anti - cholinergics ( long - acting ),C0242896,true,1434/20013
primary + gusto severe bleeding,C0205225;C0205082;C0019080;C4050465;C4050466;C0439612;C0439631,false;false;true;false;false;false;false,1435/20013
vertebrobasilar infarct,C0545733;C0021308,false;true,1436/20013
alathosterol ( % ),,,1437/20013
blood oxygenation,C0005767;C0231940;C0282636;C0005768;C0229664,true;false;true;true;false,1438/20013
rf positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,1439/20013
sf - nmbr ( health transition score ),C0037712;C0376627;C0449820;C4050231,true;true;false;false,1440/20013
time since diagnosis of osteoarthritis — yr,C0040223;C3541383,true;false,1441/20013
no . of days to homa - ir testing — median ( iqr ),C0439228,false,1442/20013
certolizumab group ( n = nmbr ),C1872109;C0441848,true;false,1443/20013
nmbr - nmbr / week,C0332174;C0439230,false;false,1444/20013
pnmbrynmbr inhibitor,C0369773;C1999216;C2603361,false;false;false,1445/20013
previous cardiovascular disease !,C0205156;C0007222;C1552607,false;true;false,1446/20013
acute and delayed reaction,C0205178,false,1447/20013
atenolol strategy,C0004147;C0679199,true;false,1448/20013
nationality,C0027473,true,1449/20013
bl updrs : high,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1450/20013
history of paroxysmal atrial fibrillation,C0729790;C0205311,false;false,1451/20013
biomarker status,C0449442,false,1452/20013
nicotine pack - years,C0028040;C1277691,true;false,1453/20013
congestive heart failure — no . ( % ) | |,C0018802,true,1454/20013
fibrin - specific,C0015982,true,1455/20013
≥ nmbr . nmbr to < nmbr . nmbr years,C0439234,false,1456/20013
duration of hypertension ( years ),C0449238;C0020538;C0439234;C1963138;C2926735,false;true;false;false;false,1457/20013
therapy ( asa nmbr / placebo nmbr ),C0039798;C0004057;C0032042;C1696465;C1706408;C3853627;C0087111;C1363945,true;true;true;false;false;false;true;false,1458/20013
nmbr prolonged antithrombotic pretreatment ( n = nmbr ),C0439590;C1550147;C2709094;C3539075;C3539076,false;false;false;false;false,1459/20013
isolated igt,C0205409;C1548221,false;false,1460/20013
pasi < nmbr *,C4528685,false,1461/20013
nmbr locf ),C2825507,false,1462/20013
uacr ( mgg - nmbr ),,,1463/20013
vorapaxar placebo nmbr - yr . km % rate,C2974521;C0032042;C0439234;C3887676;C0871208;C1521828;C1696465;C1706408,true;true;false;false;false;false;false;false,1464/20013
change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1465/20013
paclitaxel - eluting,C0144576,true,1466/20013
distal anastomosis ( % ),C0448964,false,1467/20013
< nmbr ml / min / nmbr . nmbr mnmbr — no . ( % ),C0439445;C0369637;C0441923,false;false;false,1468/20013
uacr,,,1469/20013
fasting glucose,C0015663;C0017725,true;true,1470/20013
coronary artery bypass surgery,C0010055,true,1471/20013
prior cardiovascular event — no . ( % ),C0332152;C1320716;C2826257,false;false;false,1472/20013
concomitant atorvastatin dose,C0521115;C0286651;C0178602;C0869039;C1114758,false;true;false;false;false,1473/20013
n ( indacaterol nmbr ug / indacaterol nmbr ug / placebo ),C0369718;C1722260;C1319635;C0032042;C1696465;C1706408;C0441922,false;true;false;true;false;false;false,1474/20013
etanercept,C0717758,true,1475/20013
aortic stenosis,C0003507,true,1476/20013
pretreatment / concomitant treatment,C1550147;C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2709094;C3539075;C3539076,false;false;true;true;false;false;false;false;false;false;false;false,1477/20013
circumflex,C1880089,false,1478/20013
baseline median ( iq range ),C0168634;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false;false;false,1479/20013
serum sodium — meq / liter,C0523891;C0439152;C0475211,false;false;false,1480/20013
pacific islander,C0242191,true,1481/20013
hbalc > = nmbr % ( n - nmbr ),,,1482/20013
hbanmbrc ( % ) all countries,C0019016;C0454664;C1825777;C3538758,true;false;false;false,1483/20013
prior diabetes,C0332152;C0011847;C0011849;C2826257,false;false;true;false,1484/20013
number of events / patients,C4330837;C0030705;C2360800;C0441471;C3541888,false;true;false;false;false,1485/20013
coronary heart disease,C0010054;C0010068;C1956346,true;true;true,1486/20013
mean sgrq total score ( sd ),C3533236;C0439175;C2699239;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,1487/20013
managed medically — no . / total no . ( % ),C1273870,false,1488/20013
postoperative glucocorticoid use,C0032790;C0017710;C0042153;C0457083;C1947944,true;true;true;false;false,1489/20013
losartan + placebo,C0126174;C0032042;C1696465;C1706408,true;true;false;false,1490/20013
geographical region ( % ),C0017446,true,1491/20013
serum haemoglobin anmbrc concentration ( % ),C0683149;C0019016,false;true,1492/20013
creatinine ≥ nmbr . nmbr mg / dl,C0010294;C0439269;C1561535,true;false;false,1493/20013
previous balloon angioplasty,C0205156;C0002996;C0002997;C1552607,false;true;true;false,1494/20013
thrombolytic treatment before randomization,C0016018;C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0520997,true;true;true;true;false;false;false;false;false;false,1495/20013
apixaban,C1831808,true,1496/20013
urgent cor revasc,C0439609;C0018787;C0378365;C0056331;C3272275,false;true;true;true;false,1497/20013
diabetic treatments !,C0241863;C0087111,false;true,1498/20013
primary ep ( cvd / mi / ri ),C0205225;C1880476;C0007222;C3810814;C0035487;C1826843;C4321526;C0439612;C0439631,false;false;true;false;true;false;false;false;false,1499/20013
cv death / mi / stroke,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,1500/20013
ticlopidine ( n = nmbr ),C0040207,true,1501/20013
alt,C1266129;C4553172,false;false,1502/20013
qualifying nstemi,C1514624;C3537184;C4255010,false;false;true,1503/20013
baseline nihss score,C0168634;C1697238;C1442488,true;false;false,1504/20013
scr,C1539487;C4050416,false;false,1505/20013
baseline cardiovascular medication,C0168634;C0007220;C1442488,true;true;false,1506/20013
thienopyridine drug at start of open - label period,C1120149;C2348346;C1709323;C0439531;C1948053,true;false;false;false;false,1507/20013
egfr ( mumin / nmbr . nmbr mnmbr ),C1739039;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false,1508/20013
median ( sd ),C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1509/20013
double - vessel disease,C0205173;C0042373;C1705764;C1705765,false;true;false;false,1510/20013
lipid profile,C0023779;C1979963;C2003903,true;false;false,1511/20013
chronic obstructive pulmonary disease,C0024117,true,1512/20013
treatment difference,C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,1513/20013
homa - ir,C0022065;C0022071;C1448132,true;true;true,1514/20013
nmbr placebo n = nmbr,C0032042;C1696465;C1706408,true;false;false,1515/20013
concomitant mtx use,C0521115;C0025677;C0042153;C0457083;C1947944;C1417487,false;true;true;false;false;false,1516/20013
atorvastatin ls means difference nmbr mg ( nmbr % ci ) a ( n = nmbr ),C0286651;C0023668;C1704970;C1705241;C0024671;C0008107;C3259781;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1705242,true;true;false;false;true;true;false;true;false;false;false;false;false;false,1517/20013
dmard | |,C0242708,true,1518/20013
calculated ldl cholesterol ( week nmbr ),C0444686;C0023824;C0332174;C0439230;C0202117;C1441506,false;true;false;false;false;false,1519/20013
median ( qnmbr : qnmbr ) total daily insulin dosenmbr,C0549183;C2348070;C0021641;C1533581;C1579433;C3714501;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,1520/20013
hematologic,C0018943;C0205488,true;false,1521/20013
physician global assessment ( nmbr - nmbr mm vas ),C4050369;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,1522/20013
ipf - related,C0034069;C1800706,true;true,1523/20013
history of major bleeding,C0019664;C0205082;C0019080;C0205164;C4318856;C4521762;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;true;false;false;false;false,1524/20013
fpg,,,1525/20013
ldl - c ( bq ) ( mg / dl ) - mean ± sd,C2346983;C3642216;C0444504;C2699239;C2347634;C2348143;C0560038;C0439269;C3541236,false;false;false;false;false;false;false;false;false,1526/20013
body - mass index  !  waist - to - hip ratio,C0005893;C0205682;C0578022;C1305855,false;true;false;true,1527/20013
hba,C0019016;C1825777;C3538758,true;false;false,1528/20013
current tobacco abuse,C0521116;C0040336;C1705970,false;true;false,1529/20013
hormone therapy,C0279025,false,1530/20013
total group ( n = nmbr ),C0439175;C0441848;C0439810,false;false;false,1531/20013
smoking pack year ( years ) fl,C0037369;C1277691;C0439234;C1300812;C1708024;C0439508;C0453996;C1881674,true;false;false;false;false;false;true;false,1532/20013
( nmbr % ell ' ll,C1427925;C3273466,false;false,1533/20013
terol  hdl - c  high - density lipoprotein cholesterol ,C0023822,true,1534/20013
age at first seizure,C0001779;C0205435;C0036572;C1959629;C4553401;C1279901,false;false;true;false;false;false,1535/20013
glomerular,C0022663;C0268731,true;false,1536/20013
median blood eosinophil count,C0549183;C0014467;C0750480;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664;C0876920;C2347635;C2348144;C2939193,false;true;false;false;true;false;false;true;false;false;false;false;false,1537/20013
cv death or first hhf,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,1538/20013
balloon angioplasty plus abciximab,C0002996;C0332287;C0288672;C0002997,true;false;true;true,1539/20013
lipoprotein ( a ),C0065058;C0125953;C1096202;C1439335,true;true;false;false,1540/20013
osteoporosis,C0029456;C4554622,true;false,1541/20013
acute rheumatic disorders,C0001314,true,1542/20013
intensive control,C0162425;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,1543/20013
treatment duration,C0444921;C3259042,false;false,1544/20013
warfarin ( n = nmbr ),C0043031,true,1545/20013
reported hypertension *,C0684224;C0020538;C1963138;C0700287;C4319718,true;true;false;false;false,1546/20013
before bronchodilation,C1371299;C3537072,false;false,1547/20013
ccv history / condition at baseline,C0683519;C0168634;C1442488,false;true;false,1548/20013
ivabradine ( n = nmbr ),C0257190,true,1549/20013
bmi ( nmbr . nmbr  nmbr . nmbr ),C0578022,false,1550/20013
physical function ( nmbr - nmbr,C0516981;C4049916,false;false,1551/20013
prior cerebrovascular disease,C0332152;C0007820;C2826257,false;true;false,1552/20013
reason for enrollment in active a — no . ( % ),C0392360;C1516879;C1696073;C3888021,false;false;false;false,1553/20013
medical characteristics,C0199168;C1521970;C0205476,false;false;false,1554/20013
medication use at baseline — no . ( % ),C0240320;C0168634;C1442488,false;true;false,1555/20013
age < nmbr years — no . ( % ),C1510829,false,1556/20013
planned valve surgery,C1301732;C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;false;true;true;true;false;false;false,1557/20013
time from randomization to pci ( st - elevation mi ),C0040223;C0034656;C3541383,true;true;false,1558/20013
haq - di score ( nmbr - nmbr ),C3826998;C0449820;C4050231;C4321476,false;false;false;false,1559/20013
mean ( sd ) dasnmbr - nmbr ( esr ) *,C0444504;C2699239;C0051767;C3811131;C0057671;C2347634;C2348143,false;false;true;false;true;false;false,1560/20013
randomised treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,1561/20013
v alsartan / hctz,C0020261,true,1562/20013
nmbr year or more,C0439234;C0439508,false;false,1563/20013
crcb - ( ml / min ),C0439445,false,1564/20013
three - vessel disease,C3272265,false,1565/20013
st - segment depression > nmbr . nmbr mv on admission,C0520887;C1454484;C1705503;C4281602,false;true;false;false,1566/20013
planned treatment duration,C4528394,false,1567/20013
z\tonastaiin,,,1568/20013
inadequate response / intolerance to prior therapy,C0205412;C0871261;C0231199;C0332152;C0039798;C0087111;C1363945;C1744706;C2355652;C1704632;C1706817;C2911692;C0439856,false;false;false;false;true;true;false;false;false;false;false;false;false,1569/20013
change from baseline in dasnmbr - esr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1570/20013
cause of heart failure — no . ( % ),C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1571/20013
predominant type of heparin,C1542147;C0332307;C0019134;C0770546;C1547052,false;false;true;false;false,1572/20013
western europe / australia / israel,C0043128;C0015176;C0022271;C0043129;C0004340,true;true;true;true;true,1573/20013
preoperative blood pressure ( mm hg ) patients fulfilling eligibility criteria,C0445204;C0005823;C0439475;C0030705;C1271104;C1272641,false;true;false;true;false;true,1574/20013
glucose,C0017725,true,1575/20013
aspirin + clopidogrel ( n = nmbr ) nmbr . nmbr,C0004057;C0070166,true;true,1576/20013
retinopathy — %,C0035309;C1962966,true;false,1577/20013
pulmonary embolism,C0034065,true,1578/20013
mild or moderate copd,C2945599,false,1579/20013
prior ml ( before index acs ),C0332152;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C2826257,false;false;true;true;false;true;false;false;false;false;false;false,1580/20013
diabetes duration ( known ),C0011847;C0449238;C2926735;C0011849,false;false;false;true,1581/20013
creatinine clearance ， : : nmbr ml / min,C0812399;C0439445,false;false,1582/20013
baseline hb < nmbr g nmbr nmbr n = nmbr,C0168634;C0062408;C0439267;C1442488,true;true;false;false,1583/20013
joint swelling,C0152031,false,1584/20013
nmbrmwd decrease > nmbr m,C0392756;C0369637;C0441923;C0547047,false;false;false;false,1585/20013
profound thrombocytopenia ( < nmbrxnmbr / l ),C0439808;C0040034;C0392386,false;true;false,1586/20013
associated with connective tissue disease,C0332281;C0009782,false;true,1587/20013
postbronchodilator lung function at screening,C2599594;C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,1588/20013
non – small - cell lung cancer,C0007131;C2984258;C3539721,true;false;false,1589/20013
prior anti - tnf therapy — no . ( % ),C0332152;C0281481;C2826257,false;false;false,1590/20013
all rosuva,,,1591/20013
peripheral edema,C0085649,false,1592/20013
insulin - na ' ive,C0021641;C0597484;C3435805;C4554334;C1272460;C1546968;C1879645;C4049872;C4552882;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false;false;false,1593/20013
mean ( sd ) swollen joint count *,C0444504;C2699239;C0451521;C2347634;C2348143,false;false;false;false;false,1594/20013
diuretic drugs ( excluding antialdosterone ),C0012798;C0013227;C3687832,true;true;false,1595/20013
hfpef ( ef n nmbr ),,,1596/20013
tendonitis,C0039503,true,1597/20013
previous hypertension,C0205156;C0020538;C1963138;C1552607,false;true;false;false,1598/20013
oral contraceptives,C0009905,true,1599/20013
syncope — no . ( % ),C0039070;C3541349;C4554644,true;false;false,1600/20013
anatomic complexity characteristics,C0502371;C0439855;C1704241,false;false;false,1601/20013
conventional treatment,C2945704,false,1602/20013
left circumflex,C0205091;C1880089;C0443246;C1552822,false;false;false;false,1603/20013
amiodarone vs . placebo no . hazard ratio ( nmbr . nmbr % cl ),C0002598,true,1604/20013
number of pack - years,C0237753;C1277691;C0449788,false;false;false,1605/20013
baseline cardiac biomarkers,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1606/20013
type nmbr diabetes duration,C1320657;C0449238;C2926735,false;false;false,1607/20013
oral study drug administered — no . / total no . ( % ),C0442027;C0013175;C4521986,false;true;false,1608/20013
diltiazem or verapamil,C0012373,true,1609/20013
major bleeding ( statin use vs non - use ),C0205082;C0019080;C0360714;C0042153;C0457083;C1947944;C0205164;C4318856;C4521762,false;true;true;true;false;false;false;false;false,1610/20013
placebo secukinumab pooled,C0032042;C3179547;C1696465;C1706408,true;true;false;false,1611/20013
bilateral disease ( % ) ' j ' ' j ',C1511113,false,1612/20013
pathological q waves,C0429090,false,1613/20013
leukocytes,C0023516,true,1614/20013
lipid - lowering agents ( % ),C0086440,true,1615/20013
history of second prior mi,C0019664;C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;false;false;true;false;false;false;false,1616/20013
study medication — no . ( % ),C0557651;C0013227;C3244316;C4284232;C2603343,false;true;false;false;false,1617/20013
laboratory data,C0022877;C1511726;C3245479;C3714741;C3244292;C4283904,true;false;false;false;false;false,1618/20013
p value ( men versus women ),C1709380;C0025266,false;true,1619/20013
former n z nmbr,C0205156;C0750523,false;false,1620/20013
insulin : glucose ratio,C0021641;C0017725;C0456603;C1547037;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,1621/20013
tnmbrdm duration ( years ),C2603360;C0011816;C0449238;C0439234;C2926735;C3250443,false;true;false;false;false;false,1622/20013
serum creatinine > nmbr pmol / l . n ( % ) |,C0201976;C0439284;C0600061,false;false;false,1623/20013
kellgren and lawrence radiographic reading grade nmbr — no . ( % ),,,1624/20013
data missing or no drug given,C1511726;C1551393;C1705492;C3272743;C3245479;C3714741,false;false;false;false;false;false,1625/20013
gpiib / iiia receptor inhibitor,C0016011;C0597357;C1999216,true;false;false,1626/20013
supine after nmbr minutes change from baseline,C0038846;C0439232;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false,1627/20013
omega - nmbr fatty acid ( n = nmbr ),C1719844;C0015684,false;true,1628/20013
< nmbr months,C0439231,false,1629/20013
right ventriculardysfunction atinclusion,C0205090;C0444532,false;false,1630/20013
nace ( primary endpoint ),C2986535,false,1631/20013
micro - / macro - albuminuria,C0085672;C2984010;C0001925;C1553035;C3811161;C4049106,false;false;true;false;false;false,1632/20013
interaction : treatment by psoriasis p valuenmbr,C1704675;C3258078;C1709380,false;false;false,1633/20013
score > nmbr %,C0449820;C4050231,false;false,1634/20013
any aes,C1412268;C2699274,false;false,1635/20013
ace inhibitors or angiotensin ii,C0003015,true,1636/20013
des ( % previous stenting ),C0011702;C0205156;C0038257;C2348535;C1552607;C4551552,true;false;true;false;false;true,1637/20013
comparison with placebo ( mean,C1707455;C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,false;true;false;false;false;false;false,1638/20013
mean ( s . d . ) hbalc,C0444504;C2347634;C2348143,false;false;false,1639/20013
exercise,C0015259;C1522704,true;false,1640/20013
vascular territory # nmbr,C0005847;C1301808;C2983136;C1558950;C1801960,true;false;false;false;false,1641/20013
native hawaiian or other pacific islander,C0337920,true,1642/20013
control baseline ( n - nmbr ),C0243148;C0168634;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,1643/20013
rando . in na * *,C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false,1644/20013
estimated glomerular filtration rate - ml / min,C3811844;C0439445,false;false,1645/20013
nyha class within past month — no . / total no . ( % ),C1882083;C4331910,false;false,1646/20013
aspirin group,C0004057;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1647/20013
non - hdl - c ( mg / dl ) - mean ± sd,C1518422;C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false;false,1648/20013
fibrinolytic for qualifying event,C0040044;C1514624;C0441471;C4019010,true;false;false;false,1649/20013
nmbr degree of ica stenosis 丰,C0201519;C4034225,false;false,1650/20013
calcium - channel blockers ( % ),C0006684;C2757014,true;false,1651/20013
duration of ra ( years ),C0449238;C3538806;C0439234;C4048756;C2926735,false;false;false;false;false,1652/20013
min,C0702093;C1524029;C3813700,false;false;false,1653/20013
ctn - l,C0917591,true,1654/20013
chd + cerebral infarction,C0280604;C0007785;C3542407,false;true;false,1655/20013
fenofibric acid + moderate - dose statin,C0060179;C1709056;C0360714,true;false;true,1656/20013
highest tg tertile,C1522410;C0337445,false;false,1657/20013
days of study - drug administration ( % ) * * nmbr day,C2826182;C0150270;C3469597,false;false;false,1658/20013
emotional role,C0013987;C0035820;C1705810;C3871154;C0849912,true;true;false;false;false,1659/20013
antithrombotic therapy,C0039798;C0087111;C1363945,true;true;false,1660/20013
periprocedural medications — no . / total no .,C0013227;C0802604;C2598133;C4284232,true;false;false;false,1661/20013
kim nmbr ( pg / ml ),C0439297,false,1662/20013
mi or cad,C3810814,false,1663/20013
d - dimer levelsatinclusion,C0060323,true,1664/20013
any immunosuppressive agent,C0021081,true,1665/20013
tender joint count,C0451530,false,1666/20013
increased waist circumference,C0205217;C0455829;C0442805,false;true;false,1667/20013
cross - damp time : < l : llhrs : min ( n = nmbr ),C2828360;C0205381;C0040223;C0702093;C1524029;C3813700;C3541383;C3891560,false;false;true;false;false;false;false;true,1668/20013
aspirin only ( n = nmbr,C0004057;C0205171;C1720467,true;false;false,1669/20013
high risk with atherosclerotic vascular disease *,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,1670/20013
metrex overall modified intention - to - treat population ? :,C0282416;C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737;C1561607,true;false;true;true;true;true;false;false;false;false;false,1671/20013
basmi ( linear ),,,1672/20013
cor revasc,C0018787;C0378365;C0056331,true;true;true,1673/20013
high ( > nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,1674/20013
adl subscale ( range,C0001288;C1514721;C2348147;C3542016;C1420005,true;false;false;false;false,1675/20013
baseline statin usec,C0168634;C0360714;C0439224;C1442488,true;true;false;false,1676/20013
unbound pcsknmbr ( nmol / l ),C0439282,false,1677/20013
months from mi — median ( iqr ),C0439231;C3810814;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1678/20013
enthesitis count,C1282952;C0750480;C1705566,false;false;false,1679/20013
enalapril,C0014025,true,1680/20013
history of alcohol use,C0551571;C0552479,false;false,1681/20013
initiation of dialysis,C0589507;C0011945;C0011946;C1059964;C4551529;C1158830;C1704686,false;true;false;false;true;false;false,1682/20013
female race / ethnicity,C0043210;C0034510;C0015031;C0243103;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;true;true;false;false;true;false;false,1683/20013
bsa affected,,,1684/20013
timing of clopidogrel loading dose,C0449243;C0070166;C3714444;C1704250,false;true;false;false,1685/20013
week nmbr fpg,C0332174;C0439230,false;false,1686/20013
crohn ' s disease - related medication at baseline,C0010346,true,1687/20013
post - menopausal ( a ),C0232970,false,1688/20013
saxagliptin nmbrmg ( n z nmbr ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1689/20013
weight ( range ) ( kg ),C0005910;C1514721;C0022718;C0439209;C4054209;C2348147;C3542016;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;true;false;false,1690/20013
monotherapy,,,1691/20013
small vessel,C0225988,false,1692/20013
history of microvascular disease — no . ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,1693/20013
baseline sitosterol,C0168634;C0037215;C0220914;C1442488,true;true;true;false,1694/20013
hypertension and left ventricular hypertrophy,C0020538;C1963138,true;false,1695/20013
ls mean ( s . e . ) primary endpoint : % change from baseline to week nmbr,C0023668;C0444504;C2986535;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;true;false;false;false;false;false;false,1696/20013
severe n z nmbr,C0205082;C4050465;C4050466,false;false;false,1697/20013
arthritis,C0003864;C4552845,true;false,1698/20013
concurrent treatment of crohn ' s disease at study entry — no . of patients ( % ) ff,C0205420;C0039798;C0010346;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;false;false;false;false;false,1699/20013
extensive,C0205231,false,1700/20013
baseline corticosteroids *,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,1701/20013
lv hypertrophy,C0149721,true,1702/20013
sex ( interaction : p = nmbr . nmbr ),C0009253;C1704675;C0036864;C0079399;C0804628;C1314687;C1522384,true;false;true;true;false;false;true,1703/20013
native hawaiian / other,C0337920,true,1704/20013
pain ( nmbr - nmbr mm vas ),C0042815;C4330985;C4554674,true;false;false,1705/20013
randomized,C0034656;C3815594,true;false,1706/20013
nmbrbaseline mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,1707/20013
patients with previous loss of response to and intolerance of infliximab *,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,1708/20013
other glp - nmbr receptor agonist,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,1709/20013
baseline hematocrit,C0168634;C0018935;C0518014;C1442488,true;true;false;false,1710/20013
placebo event rate ( n = nmbr ),C0032042;C0441471;C0871208;C1521828;C4019010;C1696465;C1706408,true;false;false;false;false;false;false,1711/20013
history of amputation,C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,1712/20013
low - dose rivaroxaban + aspirin group,C2608320;C1739768;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;true;false;false;true;false;false;false,1713/20013
documented asymptomatic cardiac ischemiac,C1301725;C0231221;C0018787;C1522601;C1609436,false;false;true;false;false,1714/20013
seropositive ( rf + ve and / or acpa + ve ) subgroup,C0521143;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,1715/20013
| ? ) - blocker,,,1716/20013
metabolizer phenotype ( % ) §,C0031437;C1285572,true;false,1717/20013
disease location / type : terminal ileum,C0457464;C0450429;C0227327;C1515974;C4284930;C4284931,false;false;false;false;false;false,1718/20013
selexipag ( n = nmbr ),C2000145,true,1719/20013
clinical presentation,C2708283,false,1720/20013
patients not receiving corticosteroids at baseline,C0030705,true,1721/20013
alteplase group ( n = nmbr ),C0032143;C0441848,true;false,1722/20013
obesity,C0028754;C1963185,true;false,1723/20013
cardiovascular history — no . / total no . ( % ),C1880008,false,1724/20013
cardiac therapy,C3654025,false,1725/20013
femoral access — no . / total no . ( % ),C0015811,true,1726/20013
other drugs,C0013227;C3687832,true;false,1727/20013
apob : apoa - nmbr ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,1728/20013
length of stay ( randomization to discharge,C0023303;C0034656,true;true,1729/20013
nmbr - aminosalicylates | | | |,C0368663,false,1730/20013
peripheral - artery disease ( % ),C1704436;C4025272,true;false,1731/20013
severity of the disease ( gold nmbr ),C0521117;C0018026;C1304897,false;true;false,1732/20013
coronary bypass graft,C1260596,false,1733/20013
vascular disease indicator no ( n = nmbr ),C0042373;C0021212;C1235732;C1522602,true;true;false;false,1734/20013
laboratory values at randomization ( median and iqr ),C0022877;C0042295;C0034656;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904,true;false;true;false;false;false;false;false;false;false,1735/20013
acr,C1412134;C1515941,false;false,1736/20013
tc / hdl - c,C0039411;C3715113;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,1737/20013
hbanmbrc at baseline,C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,1738/20013
indication for stent,C0392360;C0038257;C3146298,false;true;false,1739/20013
history of intermittent claudication and abi < nmbr - nmbr or substantial peripheral arterial stenosis > nmbr %,C2315493;C0205267,false;false,1740/20013
months since ra was first diagnosed,C0439231,false,1741/20013
hemorrhagic stroke ( n = nmbr ),C0553692,true,1742/20013
mini - mental state examination,C0451306,true,1743/20013
number of stents implanted,C0237753;C0038257;C0449788,false;true;false,1744/20013
risk score category ( points ),C0035647;C0449820;C0683312;C3889287;C4050231;C4552904,true;false;false;false;false;false,1745/20013
microvascular complications,C0443258;C0009566;C1171258,false;false;true,1746/20013
fevnmbr / fvc ( post salbutamol ),C3714541;C0687676;C0001927;C1704687;C3469826,true;false;true;false;false,1747/20013
type nmbr diabetes,C1320657,false,1748/20013
% predicted pre - bronchodilator fevnmbr,C0681842;C2599602;C3714541;C1882327,false;false;true;false,1749/20013
patients receiving corticosteroids at baseline,C0030705,true,1750/20013
odds ratio adj ( nmbr % cl ),C0028873;C0001552;C0596019;C2826286,true;true;false;false,1751/20013
no statin vs statin alone vs any statin plus other llt,C0360714,true,1752/20013
general and lumbar epidural,C0205246;C3812897;C3891294;C4521767,false;false;false;false,1753/20013
rf and acpa negativenmbr,C0035448;C0201660;C0748398;C1547111,true;false;false;false,1754/20013
hispanic,C0086409,true,1755/20013
onsetofaf,,,1756/20013
percentage with disease duration < nmbr years,C0439165;C0872146;C0439234;C1549488;C1561533,false;false;false;false;false,1757/20013
doubling of creatinine †,C0205173;C0010294;C1561535;C1705764,false;true;false;false,1758/20013
diameter stenosis,C1301886;C0678234;C1261287;C2632116,false;false;true;false,1759/20013
biologic naive,C0005515;C0205460,true;false,1760/20013
systemic corticosteroids,C4053960,false,1761/20013
europe ( non - eu ),C0015176;C1518422;C0015179;C3665627,true;false;true;false,1762/20013
fasting blood glucose ( mg / dl ),C0428568;C0439269;C1261430,false;false;false,1763/20013
fevnmbr reversibilityz ( pre / post ipratropium ),C3714541;C0332152;C0687676;C0027235;C1704687;C3469826;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false,1764/20013
mean eosinophil count,C0444504;C0200638;C0750879;C2347634;C2348143,false;false;false;false;false,1765/20013
men,C0025266,true,1766/20013
rhabdomyolysis,C0035410;C4552660,true;false,1767/20013
without insulin or insulin - modifying therapy,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1768/20013
hospitalized for heart failure during that time period,C0701159;C0018801;C0018802;C4554158,false;true;true;false,1769/20013
phospholipid omega - nmbr levels : < nmbr % ( n = nmbr ),C0031676;C1719844;C0441889;C0202177,true;false;false;false,1770/20013
clinical and laboratory measurements,C0205210,false,1771/20013
current medication — no . ( % ),C0746467,false,1772/20013
infliximab nmbr mg / kg,C0666743;C0439272,true;false,1773/20013
randomization - to -,C0034656,true,1774/20013
low hdl cholesterol,C0151691,false,1775/20013
history of chronic hf,C0019664;C0205191;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;true;false;false;false;false,1776/20013
race - non - white ( n = nmbr,C0034510;C1706779;C3853635,true;false;false,1777/20013
moderate teaes,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1778/20013
sfc nmbr / nmbr mg twice daily ( n = nmbr ),C4521536;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,1779/20013
time since diagnosis of type nmbr diabetes,C0040223;C3541383,true;false,1780/20013
riva roxa ban n / n { % ) nmbr ( nmbr . nmbr ),C0683610;C4553947,false;false,1781/20013
disease and quality - of - life scores,C0012634,true,1782/20013
laba / ics use at screening,C0815320;C4551720,false;true,1783/20013
mean change in radiographic end points,C0444504;C0392747;C0444708;C2349179;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,1784/20013
screening % predicted fevnmbr,C0220908;C0681842;C3714541;C1882327;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;false;true;false;false;false;false;false,1785/20013
lntensityd,,,1786/20013
angina class at baseline,C0002962;C0456387;C0168634;C1442488;C1518526;C1705943,true;false;true;false;false;false,1787/20013
emotional status,C0013987;C0449438;C0849912,true;false;false,1788/20013
albuminuria ( g / g ),C0001925;C1319635,true;false,1789/20013
thrombophilia,C0398623,true,1790/20013
mean — mg / dl level — no . ( % ),C0444504;C0439269;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,1791/20013
urine albumin - to - creatinine ratio - no . ( % ) § §,C0455271;C1318330,false;false,1792/20013
mean a ± sd ( mmhg ),C0444504;C2347634;C2348143,false;false;false,1793/20013
hdl cholesterol ( week nmbr ) a,C0023822;C0332174;C0439230;C0392885,true;false;false;false,1794/20013
low - dose rivaroxaban plus aspirin ( n = nmbr ),C2608320;C1739768;C0332287,false;true;false,1795/20013
clinical criterianmbr,C0205210;C0243161,false;true,1796/20013
abatacept ( n = nmbr * ),C1619966,true,1797/20013
ind nmbr gg q . d . n / n ( % ),C4049864;C0017454;C0018370,false;true;true,1798/20013
lvef ( % ),C0428772;C0488728,false;false,1799/20013
menopausal status and use of hrt ( % ) y,C1513126,false,1800/20013
renin inhibitor ( e . g . aliskerin ),C1960108;C3537174;C4521920,false;false;false,1801/20013
urine albumin - to - creatinine ratio,C0455271;C1318330,false;false,1802/20013
total n = nmbr n ( % ),C0439175;C0439810,false;false,1803/20013
chronic heart failure,C0018802;C0264716,true;false,1804/20013
type nmbr diabetes mellitus ’,C1320657,false,1805/20013
mean score on dasnmbr - nmbr ( crp ) ^,C3533236;C0051767;C3890735;C4048285;C0057671,false;true;false;false;true,1806/20013
orthostatic hypotension,C0020651,true,1807/20013
previous oral glucose - lowering agents,C0205156;C0442027;C0017725;C0441994;C0450442;C1254351;C1521826;C2003888;C4521986;C1552607,false;false;true;false;false;false;false;false;false;false,1808/20013
no . of patients / total no . ( % ),C0030705,true,1809/20013
any dose reduction,C0178602;C0301630;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;false;false;false;false;false,1810/20013
hazard ratio for event ( nmbr % ci ),C2985465;C0441471;C0008107;C3259781;C4019010,false;false;true;false;false,1811/20013
prior implantable cardiodefibrillator,C0332152;C0021102;C2826257,false;false;false,1812/20013
crp ( mg / l ),C3890735;C0439268;C4048285,false;false;false,1813/20013
enalapril + aliskiren dm = nmbr non - dm = nmbr,C0014025;C1120110;C0011816;C3250443,true;true;true;false,1814/20013
ics,C0815320;C4551720,false;true,1815/20013
psoriasis covering > nmbr % bsa,C0033860;C0180153;C0439844,true;false;false,1816/20013
antihypertensive drug,C0003364,true,1817/20013
mean ( sd ) post - bronchodilator fevnmbr reversibility,C0444504;C2699239;C2599594;C3714541;C0449261;C2347634;C2348143,false;false;false;true;false;false;false,1818/20013
nmbr - nmbr ( severe ),C0205082;C4050465;C4050466,false;false;false,1819/20013
stroke or pvd,C0038454;C4554100,true;false,1820/20013
cabg > nmbr month ago,C0010055;C0332177;C0439231,true;false;false,1821/20013
history of percutaneous coronary intervention,C1320647;C4554713,false;false,1822/20013
current or previous atrial fibrillation,C0521116;C1705970,false;false,1823/20013
ace - inhibitor use,C0003015;C0042153;C0457083;C1947944;C4541021,true;true;false;false;false,1824/20013
anemia — no . ( % ) | |,C0002871;C1000483;C4554633,true;false;false,1825/20013
low - dose corticosteroid user,C0445550;C0001617;C1548600;C1706077;C3536709;C1708745,false;true;false;false;false;false,1826/20013
upper gastrointestinal,C3203348,true,1827/20013
cad history and risk factors,C1504769;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2239547;C3813548;C4284121,true;true;true;false;false;false;false;false;false;false,1828/20013
das - nmbr ( crp ) < nmbr . nmbr,C0051767;C3890735;C4048285;C0057671,true;false;false;true,1829/20013
repaired chd,C0205340;C0280604;C3542407,false;false;false,1830/20013
gusto - defined bleeding,,,1831/20013
peripheral vasodilators,C0724804,false,1832/20013
mean ( sd ) number of albuterol per day,C0444504;C2699239;C0237753;C0001927;C0449788;C2347634;C2348143,false;false;false;true;false;false;false,1833/20013
liraglutide ( n = nmbr,C1456408,true,1834/20013
angiotensin - converting enzyme or angiotensin receptor blocker,C0022709;C1452534,true;true,1835/20013
perianal or anus,C0442158,false,1836/20013
framingham nmbr - year cv risk score,C3166866;C0439234;C3538987;C0035647;C0449820;C4050231;C4552904;C4048877;C4318503;C0439508,false;false;false;true;false;false;false;true;false;false,1837/20013
native coronary - artery lesions,C0302891;C0205042;C0221198,false;true;false,1838/20013
current drinker,C0556297,false,1839/20013
placebo ls means ( n ),C0032042;C0023668;C1704970;C1696465;C1706408,true;true;false;false;false,1840/20013
( %,,,1841/20013
musculoskeletal,C0497254;C2707260,false;false,1842/20013
severe ( gold nmbr ),C0205082;C0018026;C1304897;C4050465;C4050466,false;true;false;false;false,1843/20013
moderate thrombocytopenia ( < nmbrxnmbr / l ),C0205081;C0040034;C0392386;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,1844/20013
st change > nmbr mm,C0036056;C0392747;C4330985;C4554674;C0443172;C1705241;C4319952;C3272372,true;false;false;false;false;false;false;false,1845/20013
received an oral aha within nmbr weeks prior to screening,C1514756,false,1846/20013
stiffness subscale,C0427008,false,1847/20013
egfr < nmbr,C1739039;C3811844;C3812682,true;false;false,1848/20013
rec . ischemia requiring revasc,C1424025;C0022116;C0378365;C4321499;C2606415,false;true;true;false;true,1849/20013
type of concomitant statin,C0332307;C0521115;C0360714;C1547052,false;false;true;false,1850/20013
bmi ( kg / mnmbr ) [median ( nmbrth to nmbrth percentile ) ],C2923536;C1532718;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false,1851/20013
moderate ( nmbr risk factor ),C0205081;C0035648;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,1852/20013
timi risk score nmbr - nmbr,C0035647;C0449820;C4050231;C4552904,true;false;false;false,1853/20013
glycopyrronium nmbr mg ( n = nmbr ),C3814772;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,1854/20013
history of microvascular eye disease 本,C0683519;C0443258;C0015392;C0700042;C0730226;C0850708;C0944983;C0019664;C0015397;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;true;false;false;false;false;true;true;true;false;false;false;false,1855/20013
oral aminosalicylates,C0442027;C0368663;C4521986,false;false;false,1856/20013
bmi kg - m - nmbr,C0578022;C1532718,false;false,1857/20013
mean ± sd triglycerides,C0444504;C2699239;C0041004;C2347634;C2348143,false;false;true;false;false,1858/20013
type of des,C0332307;C0011702;C4551552;C1547052,false;true;true;false,1859/20013
white,C0007457;C0043157;C0220938,true;true;false,1860/20013
aspirin / antiplatelet,C0004057,true,1861/20013
any peripheral arterial disease,C0085096;C1704436,true;true,1862/20013
ldl cholesterol mean ( mg / dl ± sd ),C0023824;C0444504;C0439269;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,1863/20013
index event — no . ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1864/20013
hospital factor # nmbr,C0019994;C1521761;C2827422;C1510665,true;false;false;false,1865/20013
baseline tobacco use,C0168634;C0040335;C0543414;C0841002;C3853727;C1442488,true;false;true;false;false;false,1866/20013
persistent anemia bsl hb < nmbrg i - nmbr  yr nmbr < nmbrg i nmbr,C0741008;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138,false;false;true;false;true;false;false,1867/20013
previously taken tnfi,,,1868/20013
troponin t,C0077404;C1420827,true;false,1869/20013
exacerbations in the previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,1870/20013
omega - nmbr fatty acid,C1719844;C0015684,false;true,1871/20013
stroke risk score,C1277291;C0449820;C4050231,false;false;false,1872/20013
daily insulin dose,C2348070;C0021641;C1533581;C1579433;C3714501;C0332173;C0366513,false;true;false;false;false;false;false,1873/20013
former or never,C0205156;C0750523,false;false,1874/20013
ccv history / condition,C0683519,false,1875/20013
microalbuminuria or proteinuria,C0730345,false,1876/20013
absolute risk difference ( ci ),C1549031;C0035647;C0008107;C3259781;C4552904;C1519101;C1705241;C1705242,false;true;true;false;false;false;false;false,1877/20013
elevated at wk nmbr — no . ( % ) nmbr,C0205250;C0332174;C0439230;C3163633,false;false;false;false,1878/20013
proctosigmoiditis,C0033252,true,1879/20013
mean age ( years ) race,C0444504;C1510829;C2347634;C2348143,false;false;false;false,1880/20013
cat total score,C0007450;C2964552;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;true;false;false;false;false,1881/20013
nmbr no . of events,C0441471;C3541888,false;false,1882/20013
intervention group ( n = nmbr ),C0184661;C0441848;C0886296;C1273869,true;false;false;false,1883/20013
( nmbr % cl ) interaction,C0596019;C1704675,false;false,1884/20013
apoa - nmbr,C0003592;C0523508;C4553344;C4553379,true;false;false;false,1885/20013
epa treatment ( n = nmbr ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,1886/20013
responders of three - item end point at nmbr weeks *,C0205449;C1551338;C2349179;C2826544;C4554251,false;false;false;false;false,1887/20013
systemic glucocorticoid use at randomisation,C0205373;C0017710;C0042153;C0034656;C0457083;C1947944,false;true;true;true;false;false,1888/20013
ace inhibitors or angiotensin ii blockers,C0003015,true,1889/20013
physician ' s global assessment of dis -,C4050369;C0451119;C1444662;C1970187,false;false;false;true,1890/20013
clopidogrel no . of patients % ),C0070166,true,1891/20013
duration of crohn ' s disease ( yrs ),C0449238;C0010346;C2926735,false;true;false,1892/20013
multivessel intervention,C0184661;C0886296;C1273869,true;false;false,1893/20013
tertile nmbr,,,1894/20013
cabg surgery,C0010055;C0038894;C0038895;C0543467;C1274039,true;false;true;true;true,1895/20013
crp concentration > nmbr . nmbr mg / dl ( nmbr mg / l ),C3890735;C0086045;C2827881;C3642216;C1446561;C3827302;C4048285,false;true;false;false;false;false;false,1896/20013
fatal and nonfatal stroke,C1302234;C1705232,false;false,1897/20013
angiotensin - converting - enzyme inhibitor or angiotensin - receptor blocker §,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1898/20013
ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,1899/20013
gliclazide ( modified release ) 一 no . ( % ) ^,C0017631,true,1900/20013
conventional treatment ( n = nmbr ),C2945704,false,1901/20013
currentother ( notpredefined ) medical conditions,C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,1902/20013
history of coronary revascularization,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,1903/20013
concomitant conventional dmard use,C0521115;C0439858;C0242708;C0042153;C0457083;C1947944,false;false;true;true;false;false,1904/20013
dual antiplatelet,C0205173;C1554184,false;false,1905/20013
digitalis,C0012252;C0304520,true;false,1906/20013
active or previous cancer,C0205177;C3853793;C3888249,false;false;false,1907/20013
therapy at discharge,C0039798;C0012621;C0030685;C2926602;C0087111;C1363945,true;false;true;false;true;false,1908/20013
north america hr ( nmbr % cl ),C0028405;C0596019,true;false,1909/20013
intermediate ( nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205103;C1550465;C2827755;C3889971,false;false;false;false,1910/20013
male sex — no . ( % ) race — no . ( % ) ) :,C0086582,true,1911/20013
primary end point kaplan - meier rate,C2986535;C0871208;C1521828,false;false;false,1912/20013
all ~ cause mort / hf hosp .,C0015127;C3815322;C0018488;C1313497;C1538440;C3273279;C1524003,true;false;true;true;false;false;false,1913/20013
haemodynamics and lv function,C0019010;C4281788,true;false,1914/20013
duration of study - drug infusion,C0449238;C0557651;C0392877;C2603343;C2926735,false;false;false;false;false,1915/20013
salmeterol nmbr gg bid,C0073992;C0017454;C0018370,true;true;true,1916/20013
p value for adjusted hr,C1709380;C0456081,false;false,1917/20013
vitamin k antagonist ( e . g . warfarin / coumarol ),C1096489;C2267235,false;false,1918/20013
a / v ( n = nmbr ),C1272460,false,1919/20013
unknown,C0439673;C3541433;C4050014,false;false;false,1920/20013
ff / vi nmbr / nmbr pg od,C4554348;C0205999;C0030827;C0229089;C0439164;C1512019;C3273373;C3665488;C0072225;C1266240,false;true;true;false;false;false;true;true;true;false,1921/20013
ivabradine group,C0257190;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1922/20013
comparison with baseline ( mean,C1707455;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,1923/20013
irofiban,,,1924/20013
laba / lama,C0999593;C1416775,false;false,1925/20013
< nmbr years eze / simva,C0439234,false,1926/20013
placebo ( dm - vs . dm + ),C0032042;C0011816;C3250443;C1696465;C1706408,true;true;false;false;false,1927/20013
o total randomized,C0483204;C0439175;C0439810,false;false;false,1928/20013
cabgorptca,,,1929/20013
total patients n = nmbr,C0439175;C0030705;C0439810,false;true;false,1930/20013
left circumflex artery,C0226037,false,1931/20013
lebrikizumab ( n = nmbr ),C2981360,true,1932/20013
disease duration,C0872146,false,1933/20013
bl updrs : low,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1934/20013
fevnmbr % reversibility,C3714541;C0449261,true;false,1935/20013
lipoprotein ( a ) tx difference vs pbo,C0065058;C0041403;C1705241;C1705242;C0125953;C1096202;C1439335,true;true;false;false;true;false;false,1936/20013
( $ nmbr mg / dl [nmbr . nmbr mmol / l] ),C0439269;C1532563,false;false,1937/20013
very high risk,C0442804;C0035647;C4552904;C4321397;C0442824;C0332167;C3272283;C4050568;C4319571;C2984081,false;true;false;false;false;false;false;false;false;false,1938/20013
location of crohn ' s disease,C0450429;C0010346;C1515974;C4284930;C4284931,false;true;false;false;false,1939/20013
baseline diabetes,C0168634;C0011847;C0011849;C1442488,true;false;true;false,1940/20013
number of vessels disease,C0237753;C0042373;C0449788,false;true;false,1941/20013
patient history of disease n ( % ),C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1942/20013
tocilizumab ( n = nmbr ),C1609165,true,1943/20013
mean ( sd ) duration of smoking,C0444504;C2699239;C0449238;C0037369;C0453996;C1881674;C2926735;C2347634;C2348143,false;false;false;true;true;false;false;false;false,1944/20013
difference ( a ) vs placebo ( nmbr % cl ),C1705241;C1705242,false;false,1945/20013
nmbr . nmbr - nmbr . nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,1946/20013
demographic characteristics,C0683970,false,1947/20013
ezetimibe use,C1142985;C0042153;C0457083;C1947944,true;true;false;false,1948/20013
subset of patients on metformin,C1515021;C0030705,false;true,1949/20013
nmbr vessels or left main,C0005847,true,1950/20013
congenital shunts,C0009678;C0232180;C0542331;C1442858;C1744681,true;false;false;false;false,1951/20013
eze / simva gender,C0079399;C1522384,true;true,1952/20013
methotrexate dose at baseline,C0025677;C0178602;C0168634;C1442488;C0869039;C1114758,true;false;true;false;false;false,1953/20013
mesothelin ( ng / ml ),C0380162;C0439275;C1334533,true;false;false,1954/20013
non - smoker ( n = nmbr,C0337672;C0425293;C4554605,false;false;true,1955/20013
amlodipine / valsartan nmbr / nmbr mg / v = nmbr,C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1956/20013
> nmbr . nmbr hdl cholesterol level,C0023822;C0441889;C0456079;C1547707;C2946261;C0392885;C3715113;C0201950;C0428466,true;false;false;false;false;false;false;false;false,1957/20013
past or current angina pectoris,C1444637;C4284302,false;false,1958/20013
history of peripheral vascular disease,C1881056,false,1959/20013
group — no . ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,1960/20013
number of treated vessels ( per patient ),C0237753;C1522326;C0005847;C0449788,false;false;true;false,1961/20013
ranolazine,C0073633,true,1962/20013
prior failure of anti - tnf therapy — no . ( % ),C0332152;C0231174;C0281481;C0680095;C2826257,false;false;false;false;false,1963/20013
concomitant medications for ulcerative colitis — no . ( % ),C0521115;C0013227;C0009324;C0802604;C2598133;C4284232,false;true;true;false;false;false,1964/20013
lipid - lowering therapy,C0585943,false,1965/20013
dlqi,C3899393,false,1966/20013
patients treated for > nmbr weeks ( % ),C0030705,true,1967/20013
immunomodulatory agents,C0005525,true,1968/20013
endothelin - receptor antagonists,C1134681;C2266875,true;false,1969/20013
nt - probnp,C0669479;C0754710,true;true,1970/20013
hosp . for hf,C0018488;C1313497;C1538440;C3273279,true;true;false;false,1971/20013
alcohol use ( > nmbr drink / wk ),C0556297;C0042153;C0332174;C0439230;C0457083;C1947944;C0001948;C0452428,false;true;false;false;false;false;true;false,1972/20013
st - segment elevation mi,C0520886;C3810814,false;false,1973/20013
history of dyspepsia,C0019664;C0013395;C4552968;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,1974/20013
ncep risk category at study entry,C0035647;C2983287;C1705654;C2983669;C4552904,true;false;false;false;false,1975/20013
treated hypertension :,C1522326;C0020538;C1963138,false;true;false,1976/20013
presence of dactylitis,C0150312;C0239161;C0392148;C3854307,false;false;false;false,1977/20013
placebo every nmbr weeks ( n = nmbr ),C0032042;C1696465;C1706408,true;false;false,1978/20013
heart rate,C0018810,true,1979/20013
post - bronchodilator fevnmbr,C2599594;C3714541,false;true,1980/20013
intense physical activity,C0522510;C0015259;C0026606,false;true;true,1981/20013
concomitant drugs,C0521115;C0013227;C3687832,false;true;false,1982/20013
cholesterol absorption inhibitor ( ezetimibe ),C0003277;C0000854;C1142985;C2347023;C2347080;C2698776;C2825050;C2945742;C1999216,true;false;true;true;false;false;false;false;false,1983/20013
chanmbrdsnmbr - vasc score ( median,C1420648;C3714751;C0449820;C0549183;C0876920;C2347635;C2348144;C2939193;C4050231,false;false;false;false;false;false;false;false;false,1984/20013
serum potassium — mmol / liter,C0302353;C0439190;C0475211;C0543465,false;false;false;false,1985/20013
nadroparin vs control,C0206232,true,1986/20013
type of event — no . ( % ),C1561488,false,1987/20013
stroke or tia — no . ( % ),C0038454;C4554100,true;false,1988/20013
previous major bleeding,C0205156;C0205082;C0019080;C0205164;C4318856;C4521762;C1552607,false;false;true;false;false;false;false,1989/20013
coexisting conditions,C0679225,false,1990/20013
characteristics of pulmonary embolism at inclusion,C1521970;C0034065,false;true,1991/20013
time of symptom onset to randomization ( hrs ),C1320528,false,1992/20013
recurrent heart failure,C1455761;C0018801;C0018802;C4554158;C2945760,false;true;true;false;false,1993/20013
all completers ( n nmbr nmbr ),,,1994/20013
qualifying hbanmbrc ( % ),C1514624;C0019016;C1825777;C3538758,false;true;false;false,1995/20013
medically important infectionsa,C3898777;C4084912,false;false,1996/20013
three arm,C0205449;C0446516;C3715044;C4553528,false;true;false;false,1997/20013
after nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,1998/20013
fevnmbr % pred,C3714541,true,1999/20013
copd assessment test ( cat ) score,C4284282;C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461,false;true;false;false;false;true;false;false;false,2000/20013
aspirin use ( > nmbr mg ),C0004057;C0042153;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0457083;C1947944,true;true;true;true;false;false;false;false;false;false;false,2001/20013
moderate ( gold nmbr ),C0205081;C0018026;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,2002/20013
no ascvd + additional cv risk factors,C3665365;C1524062;C3538987;C0035648;C1553898;C4048877;C4318503,false;false;false;true;false;true;false,2003/20013
arb / ace,C3888198;C1452534;C4284014,false;true;false,2004/20013
hypertension serum lipid values,C0020538;C0428462;C0042295;C1963138,true;false;false;false,2005/20013
measured at clinic visit with usual device,C0444706;C0008952;C3541902,false;true;false,2006/20013
average maximum cimt ( mm ),C1510992;C0806909;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false,2007/20013
health assessment questionnaire - disability index,C4321476,false,2008/20013
median ( qnmbr : qnmbr ) lp ( a ),C0549183;C0065058;C1439335;C4553379;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,2009/20013
any clinical ae,C0205210;C3887670,false;false,2010/20013
mean ( sd ) feno,C0444504;C2699239;C2347634;C2348143,false;false;false;false,2011/20013
cdai score §,C0683448;C1413248;C3273706,false;false;false,2012/20013
unfractionated,,,2013/20013
physical and cognitive examination : ! :,C0031809;C0205485;C1509143,true;false;false,2014/20013
syst . bp ( mmhg ),C0037623;C0439475;C1415692;C1708288;C4318478,true;false;false;false;false,2015/20013
medications at discharge or day nmbr,C0806915,false,2016/20013
drug discontinuation not due to death,C0013227;C0457454;C1444662;C4552847;C1254351,true;false;false;false;false,2017/20013
congestive heart failure ( < nmbr wk ),C0018802;C0332174;C0439230,true;false;false,2018/20013
aliskiren,C1120110,true,2019/20013
physician global assessment of disease activity ( vas nmbr - nmbr mm ),C4050369;C0042815;C4330985;C4554674;C3536884;C3827561,false;true;false;false;true;false,2020/20013
baseline dlco . mmol kpa - ’ -,C0168634;C1516251;C0439190;C0263428;C0439474;C1442488,true;false;false;true;false;false,2021/20013
role emotional,C0035820;C0013987;C0849912;C1705810;C3871154,true;true;false;false;false,2022/20013
baseline ( geometric mean,C0168634;C2986759;C1442488,true;false;false,2023/20013
pah classification,C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2024/20013
days without albuterol use,C0439228;C0001927;C0042153;C0457083;C1947944,false;true;true;false;false,2025/20013
simva ( % ),,,2026/20013
treatment with open - label perindopril,C3640652;C0136123,false;true,2027/20013
new diabetes — no . ( % ),C0205314;C0011847;C0011849,false;false;true,2028/20013
adjusted change from baseline mean ( s . e . ),C0456081;C0392747;C0168634;C0444504;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false;false;false,2029/20013
$ nmbrand,,,2030/20013
fpg ( range ) ( mmol / l ),C1514721;C1532563;C2348147;C3542016,false;false;false;false,2031/20013
arterial graft,C0450140,false,2032/20013
any established coronary artery disease,C0443211;C0010054;C0010068;C1956346;C1272684,false;true;true;true;false,2033/20013
time to treatment ( min ) t,C3494202;C0702093;C1524029;C3813700,true;false;false;false,2034/20013
serum potassium : < nmbr . nmbrmmol / l ( n = nmbr ),C0302353;C1532563;C0543465,false;false;false,2035/20013
hemoglobin concentration — g / liter,C1319312;C0086045;C0475211;C1446561;C3827302;C0019029;C0439267;C1314664;C1318517,false;true;false;false;false;false;false;false;false,2036/20013
clopidogrel + aspirin ( n = nmbr ),C0070166;C0004057,true;true,2037/20013
previous metformin use,C0205156;C0025598;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,2038/20013
current ( % ),C0521116;C1705970,false;false,2039/20013
ecg findings at baseline — no . ( % ),C0438154;C0168634;C1442488,false;true;false,2040/20013
concomitant therapies n ( % ),C1707479,false,2041/20013
baseline therapy,C0168634;C0039798;C0087111;C1363945;C1442488,true;true;true;false;false,2042/20013
hbanmbrc nmbr . nmbr to < nmbr . nmbr % ( nmbr - nmbr mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,2043/20013
history of recurrent venous thromboembolism,C0455533;C1455761;C0042449;C0348013;C2945760,false;false;true;false;false,2044/20013
magnetic resonance angiography,C0243032,true,2045/20013
free fatty acids — mmol / liter,C0015688;C0439190;C0475211,true;false;false,2046/20013
id genotype,C0009450;C0017431;C0600091;C1441613,true;true;false;false,2047/20013
major coronary,C0205082;C0018787;C0205164;C4318856;C4521762,false;true;false;false;false,2048/20013
cardiac rhythm disorders,C0264886,true,2049/20013
previous ischemic stroke,C0205156;C0948008;C1552607,false;false;false,2050/20013
apolipoprotein b tx difference vs pbo,C0003593;C0041403;C1705241;C1705242,true;true;false;false,2051/20013
history of macroalbuminuriat,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,2052/20013
high ( > nmbr risk factor ),C0332167;C1521761;C2827422;C3272283;C4050568;C4319571;C0205250;C0035648;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;true;false;false;false;false;false;false,2053/20013
psoriasis affecting > nmbr % of body - surface,C0033860;C0392760;C0489451;C1314939,true;false;false;false,2054/20013
asthma duration ( sd ),C0004096;C0449238;C2699239;C2926735;C2984299,true;false;false;false;false,2055/20013
glucose metabolism,C0596620,false,2056/20013
glycated hemoglobin,C0017853,true,2057/20013
fpi,,,2058/20013
secondary # nmbr,C0027627;C0175668;C0205436,true;false;false,2059/20013
nmbr . nmbr - nmbr . nmbr kg / mnmbr,C1532718,false,2060/20013
primary pci no .,C0205225;C4049621;C0439612;C0439631,false;false;false;false,2061/20013
rectum and sigmoid colon only,C0034896,true,2062/20013
radial access — no . / total no . ( % ),C0442038;C0920847,false;false,2063/20013
oral blood glucose - lowering,C0442027;C0005802;C0441994;C2003888;C4521986,false;true;false;false;false,2064/20013
age nmbr + yrs,C0001779,false,2065/20013
> nmbr . nmbr pmol / liter hscrp level,C0439192;C0475211;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false;false,2066/20013
other ischaemic heart disease ( non - infarction ),C0010054;C1518422;C0021308;C0151744,true;false;true;true,2067/20013
calcium supplements,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,2068/20013
country : argentina ( n = nmbr ),C0454664;C0003761;C1504311;C1511538,false;true;false;false,2069/20013
estimated gfr — no . ( % ) nmbr,C0750572;C0017654;C1424601,false;true;false,2070/20013
received > nmbr prior anti - tnf therapies,C1514756;C0332152;C0281481;C2826257,false;false;false;false,2071/20013
nmbr placebo ( n = nmbr nmbr ),C0032042;C1696465;C1706408,true;false;false,2072/20013
standard care n ( % ),C1442989;C1947933;C2828392,false;false;false,2073/20013
interval from clopidogrel loading,C1272706;C0070166;C1708715;C1552654;C1552713,false;true;false;false;false,2074/20013
severity of copd *,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,2075/20013
acr deciles,C1412134;C1515941,false;false,2076/20013
change at week nmbr,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,2077/20013
europe,C0015176,true,2078/20013
low density lipoprotein cholesterol - mg / dltt,C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2079/20013
other dmard use,C0242708;C0042153;C0457083;C1947944,true;true;false;false,2080/20013
duration of hypercholesterolemia ( yr ),C0449238;C0020443;C0439234;C1522133;C2926735,false;true;false;false;false,2081/20013
personal relationships,C1552027,false,2082/20013
heart failure or lvef < nmbr % associated with index acs event,C0018801;C0018802;C4554158,true;true;false,2083/20013
previous venous thromboembolism — no . ( % ),C0205156;C1861172;C1552607,false;true;false,2084/20013
prior biologic exposure,C0332152;C0005515;C0274281;C0332157;C0205460;C2826257,false;true;false;false;false;false,2085/20013
need for urgent coronary - artery bypass grafting,C0027552;C0439609;C0010055;C3272275;C0686904,true;false;true;false;false,2086/20013
egfr ( ml / min / nmbr - nmbr mz ),C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,2087/20013
egfr ( mdrd ),C1739039;C3839656;C3811844;C3812682,true;false;false;false,2088/20013
previous stroke,C0205156;C0038454;C4554100;C1552607,false;true;false;false,2089/20013
alpha nmbr blockers,C0001641,true,2090/20013
moderate dysfunction,C3274776,false,2091/20013
tnf - rnmbra ( ng / ml ),C1363984;C1706001,false;false,2092/20013
jejunum,C0022378,true,2093/20013
neither ace - i nor arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,2094/20013
history of vte * *,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2095/20013
d - dimer level,C0060323;C0441889;C0456079;C1547707;C2946261,true;false;false;false;false,2096/20013
gfr ( ml / min per nmbr . nmbr nr ),C0017654;C0439445;C0027496;C3844738;C1424601,true;false;true;false;false,2097/20013
diastolic fmmhff ' ),C0012000,true,2098/20013
diabetes duration,C0011847;C0449238;C2926735;C0011849,false;false;false;true,2099/20013
nmbr . nmbr ( nmbr nmbr . nmbr ),,,2100/20013
plaque score ( nmbr - nmbr ),C0429153,false,2101/20013
prior disease,C0332152;C0012634;C2826257,false;true;false,2102/20013
mean sd fpg,C0444504;C2699239;C2347634;C2348143,false;false;false;false,2103/20013
serum ctx ( ng / ml ),C0229671;C0010377;C0439275;C0631180;C3539598;C1546774;C1550100,true;true;false;true;false;false;false,2104/20013
baseline triglycerides in nmbr classes,C0168634;C0041004;C0456387;C1518526;C1705943;C4019422;C1442488,true;true;false;false;false;false;false,2105/20013
ff / vi nmbr mg / nmbr mg ( n = nmbr ),C4554348;C0205999;C1319635,false;true;false,2106/20013
previous anti - tnf therapy,C0205156;C0281481;C1552607,false;false;false,2107/20013
dronedarone ( n = nmbr ),C0766326,true,2108/20013
standard ( nmbr ),C1442989;C2828392,false;false,2109/20013
one or more copd exacerbations ( n / n [ % ] ),C0205447,false,2110/20013
peripheral embolism,C0205100;C0013922;C1704212,false;true;true,2111/20013
arterial blood pressure,C1272641,true,2112/20013
co - morbidities,C0009488,true,2113/20013
oral hypoglycemic drugs only,C0359086;C0205171;C1720467,false;false;false,2114/20013
p value ( on vs off omt ),C1709380,false,2115/20013
mucocutaneous,,,2116/20013
any new anti - hyperglycemic rx,C0205314;C1425688;C1521941;C2709207,false;false;false;false,2117/20013
metsyn with ldl > nmbr . nmbr mg / dl,C0439269,false,2118/20013
severe or worse airflow limitation,C0205082;C4050465;C4050466,false;false;false,2119/20013
periprocedural anticoagulant,C0003280;C0848112;C3536711,true;false;false,2120/20013
lsms difference ( nmbr % ci ) nmbr,C1705241;C0008107;C3259781;C1705242,false;true;false;false,2121/20013
blood eosinophil,C0014467,true,2122/20013
pah classification — no . ( % ),C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2123/20013
short - acting bnmbr - agonists,C1282927;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;true;false;false;false;false,2124/20013
fevnmbr reversibility,C3714541;C0449261,true;false,2125/20013
ischemia on cecg ( n = nmbr,C0022116;C4321499,true;false,2126/20013
ularitide n / n ( % ),C0077910,true,2127/20013
three of seven risk factors,C0205449;C0205453;C0035648;C1553898,false;false;true;false,2128/20013
moderately high risk without atherosclerotic vascular disease *,C0205081;C0332167;C0004153;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;true;false;false;false;false;false;false,2129/20013
randomised to canakinumab nmbr mg,,,2130/20013
ff nmbr pgod,C4554348,false,2131/20013
fevnmbr post - bronchodilator,C3714541,true,2132/20013
migraine — no . ( % ) $,C0149931,true,2133/20013
hypertension — no . / total no . ( % ),C0020538;C1963138,true;false,2134/20013
randomized to active yitamin e,C0034656;C0205177;C3853793;C3888249;C3815594,true;false;false;false;false,2135/20013
low risk and more symptoms ( group b ),C3272281;C3538919,false;false,2136/20013
high risk,C0332167;C3272283;C4050568;C4319571,false;false;false;false,2137/20013
carotid artery diseaset,C0007272;C0162859,true;true,2138/20013
cholesterol — mmol / liter,C0008377;C0439190;C0475211,true;false;false,2139/20013
daily activities,C0871707,false,2140/20013
extended - duration enoxaparin ( n = nmbr ),C0231448;C0449238;C0206460;C2926735;C0231449;C0439792,false;false;true;false;false;false,2141/20013
dasnmbr - nmbr ( esr ),C0051767;C3811131;C0057671,true;false;true,2142/20013
associated with corrected - congenital shunts,C0332281;C0205202;C0009678;C0232180;C0542331;C1442858;C1744681,false;false;true;false;false;false;false,2143/20013
traditional nsaid use,C3897349;C0003211;C3536840,false;true;false,2144/20013
baseline albumin : < nmbr,C0168634;C0001924;C1442488,true;true;false,2145/20013
high - risk cvd,C0332167;C0007222;C3272283;C4050568;C4319571,false;true;false;false;false,2146/20013
pro / pro homozygotes,C1120626;C0019904,true;true,2147/20013
sulfasalazine ( mean dose : nmbr . nmbr g / day ),C0036078;C0444504;C0178602;C0439417;C0869039;C1114758;C2347634;C2348143,true;false;false;false;false;false;false;false,2148/20013
> nmbr years eze / simva baseline ldl - c,C0439234;C0168634;C1442488,false;true;false,2149/20013
< nmbr % predicted arr ( n = nmbr,C0681842;C2170357;C4084934;C1882327,false;false;false;false,2150/20013
pe associated with dvt at diagnosis,C0070939;C1880476;C4284304,true;false;false,2151/20013
baseline hbanmbrc,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,2152/20013
renal function < nmbr egfr,C0232804;C1739039;C3811844;C3812682,false;true;false;false,2153/20013
blood eosinophil concentration,C0427728;C0014467;C0699870;C1313904;C0086045;C1446561;C3827302,false;true;false;false;true;false;false,2154/20013
less severenmbr,C0439092;C0205082;C4050465;C4050466;C0547044,false;false;false;false;false,2155/20013
cardiovascular risk,C0007226;C0035647;C4552904;C3887460,true;true;false;false,2156/20013
prehospital ticagrelor ( n = nmbr ),C1999375,true,2157/20013
symptoms of atrial fibrillation in the nmbr months before randomiza -,C0683368;C0004238;C0344434;C1963067;C1457887,true;true;false;false;false,2158/20013
perindopril,C0136123,true,2159/20013
tiotropium / olodaterol nmbr / nmbr mg ( n = nmbr ),C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2160/20013
symptom onset to hospital admission,C4086878;C0184666,false;false,2161/20013
ldl - c ( measured ) *,,,2162/20013
rerapamil - sr strategy ( n = nmbr ),C0753208;C0679199;C1709991;C3813610;C3890900;C3891546,true;false;false;false;false;false,2163/20013
valve surgery,C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;true;true;true;false;false;false,2164/20013
ticagrelor nmbr mg nmbr year km ( % ),C1999375;C0024671;C0439234;C3887676;C0439508;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,2165/20013
north america ( plus australia and new zealand ),C0028405;C0332287;C0004340,true;false;true,2166/20013
calcium antagonist — no . ( % ),C0006684,true,2167/20013
penetrating disease,C0205321;C0012634,false;true,2168/20013
non - drug - eluting stent,C1518422;C1322815,false;true,2169/20013
number of exacerbations in the past nmbr months,C0237753;C4086268;C0449788,false;false;false,2170/20013
potassium supplement,C0304475,false,2171/20013
age group,C0027362;C2348001,true;false,2172/20013
congestive heart failure ( chf ) ( in past nmbr weeks ),C0018802;C2987125,true;false,2173/20013
platelet count,C0032181;C1287267,true;false,2174/20013
other supraventricular tachycardia,C0039240;C1963244;C3815188,true;false;false,2175/20013
egfr ( ml / min / nmbr . nmbr mnmbr [mdrdequation] ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,2176/20013
* * * unstable angina,C0002965,true,2177/20013
rate ratio,C0871208;C0456603;C1547037;C1521828,false;false;false;false,2178/20013
recurrent vte ( statin use vs non - use ),C1455761;C0630906;C0360714;C0042153;C0457083;C1947944;C2945760,false;true;true;true;false;false;false,2179/20013
saxagliptin nmbr mg ( n = nmbr,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2180/20013
irregular or ulcerated ica p ) laque : [ :,C0205271,false,2181/20013
extreme tortuosity,C0205403;C0333076;C3641272;C4085555,false;false;false;false,2182/20013
angina status — no . ( % ),C0002962;C0449438,true;false,2183/20013
p value nmbr . nmbr,C1709380,false,2184/20013
nonaspirin antiplatelet,C0722138,false,2185/20013
antihyperglycemictherapies,,,2186/20013
geographic distribution - no . ( % ),C0681686,false,2187/20013
conventional synthetic dmard use at baseline,C0439858;C1883254;C0242708;C0042153;C0168634;C1442488;C0457083;C1947944,false;false;true;true;true;false;false;false,2188/20013
statins 一 no . ( % ),C0360714,true,2189/20013
at six weeks,C0205452;C0439230,false;false,2190/20013
angiographic data and treatment :,C0002978;C1511726;C3245479;C3714741,true;false;false;false,2191/20013
clinical indication at the index procedure,C0205210;C2315323;C0600653;C0918012;C1552854;C1637833;C2986546;C2347896,false;false;true;true;false;false;false;false,2192/20013
mean bdi focal score ( sd ),C3533236;C0006448;C0205234;C2699239;C0451022;C3714938;C3889415,false;true;false;false;false;false;false,2193/20013
cabg during index hospitalization,C0010055;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,2194/20013
pci for index event,C4049621;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,2195/20013
concomitant drug treatment,C0521115;C0150270;C3469597,false;false;false,2196/20013
third primary ( change in updrs score / wk,C0205437;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631,false;false;false;true;false;false;false;false;false,2197/20013
implanted pacemaker,C0848753,false,2198/20013
concomitant asthma medications,C0521115;C0004096;C0013227;C0802604;C2598133;C4284232;C2984299,false;true;true;false;false;false;false,2199/20013
hbanmbrc $ nmbr . nmbr % ( nmbr mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,2200/20013
uacr not available,,,2201/20013
ret / abx - facil . pci,C0389252;C4049621,true;false,2202/20013
claudication only,C0021775;C0205171;C1720467;C0311395;C1456822,true;false;false;false;false,2203/20013
mean % predicted dlco * ( sd ),C0444504;C2347634;C2348143,false;false;false,2204/20013
titre ( u / ml ) t,C0475208;C0439340;C1880521;C2945590,false;false;false;false,2205/20013
treatment before admission ( % ),C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,2206/20013
overall quality of life,C3641830,false,2207/20013
no baseline corticosteroids,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,2208/20013
high on - treatment platelet reactivity *,C0205250;C0039798;C0005821;C0443286;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,2209/20013
potassium ( meql ),C0032821;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false,2210/20013
all patients with opg n - nmbr,C0030705;C1262886;C1336645;C1412836;C1710303,true;false;false;false;false,2211/20013
urinary albumin : creatinine ratio ( pg / mg ),C0455271;C1627892;C1318330,false;false;false,2212/20013
cardiac rhythm disorder at baseline yes,C0264886;C0168634;C1549445;C1705108;C1710701;C1442488,true;true;false;false;false;false,2213/20013
islander,,,2214/20013
left circumflex coronary artery,C0226037,false,2215/20013
risk category ( points ),C0035647;C0683312;C3889287;C4552904,true;false;false;false,2216/20013
nihss at randomization,C1697238;C0034656,false;true,2217/20013
cilostazol,C0055729,true,2218/20013
creatinine clearance category,C0812399;C0683312;C3889287,false;false;false,2219/20013
tg > nmbr mg / dl,C0337445;C0439269,false;false,2220/20013
chf on losartan ( % ),C0018802;C0126174,true;true,2221/20013
comorbidities,C0009488,true,2222/20013
prior lipid - lowering agent use,C0332152;C0086440;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,2223/20013
iwqol - lite total score ( arbitrary units ) #,C2964552;C0439183,false;false,2224/20013
absolute change,C1549031,false,2225/20013
gusto moderate / severe,,,2226/20013
ls mean difference ( se ) vs placebo,C0023668;C0444504;C1705241;C0036919;C1705242;C2347634;C2348143,true;false;false;true;false;false;false,2227/20013
stent implanted — no . ( % ),C0522776,false,2228/20013
eze / simva ( „ = nmbr },,,2229/20013
low eosinophil subgroup (,C0205251;C0014467;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false,2230/20013
alaska native,C0682125,true,2231/20013
| interactior nmbr p,,,2232/20013
number ( s ) of features present,C0237753;C1521970;C1706388;C2346469;C2348519;C0449788,false;false;false;false;false;false,2233/20013
extent of disease — no . / total no . ( % ) § ^ |,C0449279;C4553144,false;false,2234/20013
eze / simva nmbr / nmbr mg n = nmbr,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,2235/20013
bivalirudin,C0168273,true,2236/20013
two arm,C0205448;C0446516;C3715044;C4553528,false;true;false;false,2237/20013
metreo modified intention - to - treat population §,C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737,false;true;true;true;true;false;false;false;false,2238/20013
any blood pressure medications ( % ),C0849164;C0033095;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;false;false;false;true;true;false;false;false;false;true,2239/20013
statin users ( n = nmbr ),C0360714;C1706077,true;false,2240/20013
simplified disease activity index score ( nmbr - nmbr ),C3869582;C0449820;C4050231,false;false;false,2241/20013
calcium channel,C0006685,true,2242/20013
level — no . ( % ),C0441889;C0456079;C1547707;C2946261,false;false;false;false,2243/20013
no regular consumption,C0205272;C0009830;C1947907,false;true;false,2244/20013
nmbr / nmbr,,,2245/20013
time from randomization to pci ( non - st - elevation mi ),C0040223;C0034656;C3541383,true;true;false,2246/20013
nmbre < nmbr %,,,2247/20013
prior pacemaker,C0332152;C0030163;C0810633;C1546728;C3275122;C3853703;C2826257,false;true;false;false;false;false;false,2248/20013
non - detectable / unknown,C1518422;C3830527;C0439673;C3541433;C4050014,false;false;false;false;false,2249/20013
individuals without diabetes,C0027361;C0011847;C0011849;C0237401,true;false;true;false,2250/20013
post - fibrinolysis angioplasty ( n = nmbr ),C0687676;C0016017;C0162577;C1548817;C1305868;C1704687;C3469826,false;true;true;false;false;false;false,2251/20013
aerobic activity,C0001701,true,2252/20013
pulse pressure,C0949236,true,2253/20013
laboratory measures,C0022877;C3244292;C4283904,true;false;false,2254/20013
deep - vein thrombosis ( % ),C0149871,true,2255/20013
cardiovascu lar subg roup,C1419115;C0276828;C3814448,false;false;false,2256/20013
greater than or equal to nmbr ml / min / nmbr . nmbrmnmbr,C0439093,false,2257/20013
statin,C0360714,true,2258/20013
location of infarction,C0450429;C0021308;C1515974;C4284930;C4284931,false;true;false;false;false,2259/20013
infliximab - experienced ( n = nmbr ),C0666743,true,2260/20013
time since first copd diagnosis ( years ),C0040223;C3541383,true;false,2261/20013
potassium — mmol / liter,C0032821;C0439190;C0475211;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false,2262/20013
rivaroxaban ( n = nmbr ),C1739768,true,2263/20013
investigator - determined myocardial infarction,C0035173,true,2264/20013
time from first eval,C0040223;C0205435;C1707957;C2698624;C1279901;C3541383,true;false;false;false;false;false,2265/20013
diagnosis of heterozygous familial hypercholester,C0011900;C0019425;C0015576;C0241888;C1704338;C1704656,true;true;true;false;true;false,2266/20013
baseline crp ( mg / dl ),C0168634;C3890735;C0439269;C4048285;C1442488,true;false;false;false;false,2267/20013
average of maximum far wall cimt ( mm ),C1510992;C0806909;C0205108;C0677535;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false,2268/20013
hispanic ethnicity,C0086409;C0015031;C0243103,true;true;true,2269/20013
other vasodilator,C0042402;C3537240,true;false,2270/20013
maintenance dose,C3714445,false,2271/20013
thienopyridine type,C1120149;C0332307;C1547052,true;false;false,2272/20013
perfusion defectsatinclusion,C0031001;C4281794,true;false,2273/20013
dasnmbr - esr remission,C0051767;C3811131;C0544452;C0687702;C0057671,true;false;false;false;true,2274/20013
no . of panents . total no . nmbr % ),,,2275/20013
disease activity outcomes ( itt population ) week nmbr,C1292728;C1274040;C0032659;C0332174;C0439230;C1257890;C0679250;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939;C3542417,false;false;true;false;false;true;false;false;false;false;false;false;false;false;false,2276/20013
fluticasone furoate and vilanterol ( n = nmbr ),C1948374,true,2277/20013
any infarct,C0021308,true,2278/20013
apolipoprotein a - i *,C0085201;C1677784,true;true,2279/20013
current smoking — no . / total no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,2280/20013
miami k antagonist received,C1551421;C0597277;C0231491;C1708601,false;false;false;false,2281/20013
rivastigmine,C0649350,true,2282/20013
europa ( n = nmbrlnmbr ),C0242751,true,2283/20013
lung function,C0035245,true,2284/20013
physician ' s global assessment of disease activity ( nmbr - nmbr mm vas ),C4050369;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,2285/20013
nmbr - nmbr ( very severe ),C3641272;C4050419,false;false,2286/20013
high - risk clinical features,C0332167;C0683325;C3272283;C4050568;C4319571,false;false;false;false;false,2287/20013
second primary composite outcome,C0205436;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false;false;false;false,2288/20013
baseline % predicted fevnmbr,C0168634;C1442488,true;false,2289/20013
treatment characteristics,C0039798;C1521970;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,2290/20013
digoxin at last follow - up,C0012265;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2291/20013
both impaired glucose tolerance and impaired fasting glucose tolerance — no .,C0271650,true,2292/20013
ez / simva < % >,C0206578,true,2293/20013
sbp indicates systolic blood pressure  dbp  diastolic blood pressure  aa  arachidonic acid  epa  eicosapentaenoic acid . values for age  bmi  total cholesterol  ldl cholesterol  hdl cholesterol  sbp  dbp  aa  epa  and epa / aa ratio represent the mean values represent the median ( interquartile range ) . p values are for the differences between the no epa and epa groups .,C0085805,true,2294/20013
# of prior bdmards,C0332152;C2826257,false;false,2295/20013
acute reaction,C0205178;C0443286,false;false,2296/20013
ulcers / gangrene,C0041582;C0017086,true;true,2297/20013
fasting plasma glucose ( mmol / l ),C0015663;C0202042;C1532563;C0455280,true;false;false;false,2298/20013
other teaes,,,2299/20013
alcohol intake,C0001948,true,2300/20013
change from baseline ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,2301/20013
ileum only,C0020885;C0205171;C1720467,true;false;false,2302/20013
anti - tnf - ir patients,C1448177;C0022065;C0030705;C0022071;C1448132,true;true;true;true;true,2303/20013
north america plus australia and new zealand,C0028405;C0332287;C0004340,true;false;true,2304/20013
medial - distal - diag,C0205098;C0205108;C0348026;C4522154,false;false;false;false,2305/20013
bw at nmbr weeks,C0005910;C0439230;C0006041;C2986891,true;false;true;false,2306/20013
haemoglobin ( mmol / l ),C0635222;C0439190;C0019046;C1532563,true;false;true;false,2307/20013
severity ofcopd ( goldnmbr ),C0439793;C0018026;C1304897;C0522510,false;true;false;false,2308/20013
prior stroke — no . ( % ),C0332152;C2826257,false;false,2309/20013
adalimumab ( n = nmbr ),C1122087,true,2310/20013
aliskiren dm = nmbr non - dm = nmbr,C1120110;C0011816;C3250443,true;true;false,2311/20013
previous cabg ( before index acs ) *,C0205156;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;true;true;true;false;true;false;false;false;false,2312/20013
number of patients ( % ) or mean 士 sd,C2360800,false,2313/20013
western friroce,C1705493,false,2314/20013
baseline lipids  mean ± sd ( mmol / nmbr ),C0168634;C0023779;C0444504;C2699239;C0439190;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,2315/20013
baseline calcium yes,C0168634;C0006675;C1549445;C1705108;C1710701;C0006726;C2936886;C3540037;C3714611;C1442488,true;true;false;false;false;true;false;false;false;false,2316/20013
cardiac mediations,C0018787;C0680727;C1522601,true;true;false,2317/20013
large vessel,C0225990,false,2318/20013
no . of treated vessels,C1522326;C0005847,false;true,2319/20013
sinus rhythm at baseline,C0232201;C0168634;C1442488,false;true;false,2320/20013
ipah / hpah,C0152171;C0340543;C0637939;C1150929,false;true;true;false,2321/20013
ccs class §,C1879987,false,2322/20013
antithrombotic and anticoagulant medications,,,2323/20013
ixeqnmbrw,,,2324/20013
warfarin group ( n = nmbr ),C0043031;C0441848,true;false,2325/20013
white - cell count — xnmbr_nmbr / liter,C0023508;C0475211;C0427512,true;false;false,2326/20013
mean % predicted fvc ( sd ),C0444504;C2347634;C2348143,false;false;false,2327/20013
only cerebrovascular disease,C0205171;C0007820;C1720467,false;true;false,2328/20013
three or more agents,C0205449,false,2329/20013
msfc timed nmbr - foot walk test,,,2330/20013
mean ( sd ) baseline scores,C0444504;C2699239;C0168634;C1442488;C2347634;C2348143,false;false;true;false;false;false,2331/20013
patients with > nmbr % ■ nmbr ml increase in fevnmbr post - bronchodilator ( % ),C0030705;C0439526;C0442805;C1705224;C3887665,true;false;false;false;false,2332/20013
meglitinide,C0065880,true,2333/20013
prior tobacco use,C0332152;C0040335;C0543414;C0841002;C3853727;C2826257,false;false;true;false;false;false,2334/20013
graft occlusionsa,C0181074;C0332835;C1961139,false;true;false,2335/20013
ascot - lla,C0718674,false,2336/20013
cortical only,C0001613;C0205171;C1720467;C0007776;C0022655,true;false;false;true;true,2337/20013
key : tc = triglyceride  hs - crp = ldl - c = low - density lipoprotein fc = fasting glucose  ncep atp * this category did not include ar to have > _ nmbr of the indicated char least - square means  except tc an note : all treatment by subgroup,C0039411;C0041004;C3890735;C0023823;C2983605;C0015663;C0017725;C2744579;C4552600;C4048285;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;false;true;false;true;true;true;false;false;true;true;true;false;false;false,2338/20013
prior disease - modifying drugs resulting in inadequate response — mean no . / patient,C0332152;C0012634;C0392747;C0013227;C3687832;C2826257,false;true;false;true;false;false,2339/20013
candesartan group ( n = nmbr ),C0717550;C0441848,true;false,2340/20013
rivaroxaban alone ( n = nmbr ),C1739768;C0205171;C0439044;C0679994,true;false;false;false,2341/20013
baseline antihyperglycemic medications,C0168634;C0020616;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;true;false;false;false;false,2342/20013
fasting lipid levels,C0015663;C0428460,true;false,2343/20013
proximal gastrointestinal tract,C0205107;C0017189;C0521362;C4489236,false;true;false;false,2344/20013
diabetes mellitus ( type nmbr or nmbr ),C1320657,false,2345/20013
heart failure ( hf ),C0018801;C0018488;C1313497;C1538440;C3273279;C0018802;C4554158,true;true;true;false;false;true;false,2346/20013
platelet,C0005821,true,2347/20013
hbanmbrc < nmbr % ( n - nmbr ),C0019016;C1825777;C3538758,true;false;false,2348/20013
spironolactone,C0037982,true,2349/20013
proteinurianmbr ( g / day ),C0033687;C0439417;C1962972;C4554346,true;false;false;false,2350/20013
elevated blood pressure,C0020538;C0497247,true;false,2351/20013
ldl - c ( mg / dl ) < nmbr,C0439269,false,2352/20013
laser or vitrectomy,C0023089;C0458142;C1023865;C1706315,true;false;false;false,2353/20013
total study population ( n = nmbr ),C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,2354/20013
presenting diagnosis,C0449450;C0011900;C1704338;C1704656,false;true;true;false,2355/20013
duration of type nmbr diabetes ( years ),C0449238;C1320657;C0439234;C2926735,false;false;false;false,2356/20013
alt ( units / l ),C1266129;C0439339;C4553172,false;false;false,2357/20013
severity of airflow limitation,C0439793;C0231999;C0443288;C0449295;C0522510,false;false;false;false;false,2358/20013
patient ' s global assessment of disease,C4054229;C0012634,false;true,2359/20013
daily dose nmbr - nmbr mg n = nmbr,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,2360/20013
in - stent restenosis of des,C3272317;C0011702;C4551552,false;true;true,2361/20013
predicted normal ( % ),C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327,false;false;false;false;false;false;false,2362/20013
killip class — no . ( % ) i,C1881332,false,2363/20013
prior ml or abnormal angiogram,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,2364/20013
placebo + mtx ( n = nmbr ),C0032042;C0025677;C1417487;C1696465;C1706408,true;true;false;false;false,2365/20013
baseline corticosteroid use ( mg ),C0168634;C0239126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;false;true;true;false;false;false;false;false;false,2366/20013
ind / gly nmbr / nmbr mg once daily ( n = nmbr,C4049864;C0017890;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523677,false;true;true;false;true;false;false;false;false;false;false,2367/20013
patients who received positive results on test for antibodies to infliximabt,C0030705,true,2368/20013
ptca < nmbr h,C2936173;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,2369/20013
verapamil - sr ( « = nmbr nmbr ),C1527129,false,2370/20013
simvastatin ( nmbr / nmbr mg / d ),C0074554;C0439422,true;false,2371/20013
insulin 一 no . ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,2372/20013
duration of type nmbr diabetes mellitus ( years ),C0449238;C1320657;C0439234;C2926735,false;false;false;false,2373/20013
central america and south america,C0007674,true,2374/20013
hip circumference — cm,C0562350,false,2375/20013
rnmbr + ezio ( n = nmbr ),C0687673,true,2376/20013
male sex — no . of patients ( % ),C0086582,true,2377/20013
stents per lesion,C0038257;C0221198;C1546698,true;false;false,2378/20013
infliximab ( n = nmbr ),C0666743,true,2379/20013
dose of rosuvastatin,C0178602;C0965129;C0869039;C1114758,false;true;false;false,2380/20013
lvef < nmbr %,C0428772;C0488728,false;false,2381/20013
n - terminal pro - brain natriuretic peptide,C3272900,false,2382/20013
bmi — mean ( sd ) ( kg / mnmbr ),C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,2383/20013
vorapaxar event rate ( n = nmbr ),C2974521;C0441471;C0871208;C1521828;C4019010,true;false;false;false;false,2384/20013
death or nmbrmwd decrease > nmbr m,C0011065;C1306577;C4082313;C4552775,true;false;false;false,2385/20013
associated with transient or reversible risk factor,C0332281;C0040704;C0205374,false;true;false,2386/20013
europe and australia,C0015176,true,2387/20013
all countries,C0454664,false,2388/20013
urinary protein : creatinine ratioa ( mg / mg ),C0042027;C0369901;C1319635;C0428627;C1524119,true;false;false;false;false,2389/20013
serum cholesterol,C0587184,false,2390/20013
intermediate risk ( ri = nmbr ),C3640764;C0035487;C1826843,false;true;false,2391/20013
baseline cdai score,C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,2392/20013
major bleeding events *,C0205082;C0019080;C0441471;C3541888;C0205164;C4318856;C4521762,false;true;false;false;false;false;false,2393/20013
baseline,C0168634;C1442488,true;false,2394/20013
white / caucasian,C0043157,true,2395/20013
body mass index  mean ± sd ( kg / mnmbr ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,2396/20013
recurrent ischemia,C1455761;C0022116;C4321499;C2945760,false;true;false;false,2397/20013
index event not confirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,2398/20013
non - hdl cholesterol ( mg / dl ),C0729627;C0439269;C1535899,false;false;false,2399/20013
comparison with placebo,C1707455;C0032042;C1696465;C1706408,false;true;false;false,2400/20013
current use of an ace inhibitor,C0521116;C1524063;C0003015;C4541021;C1705970,false;false;true;false;false,2401/20013
mean total serum ige ( sd ),C0444504;C0439175;C0229671;C2699239;C1546774;C1550100;C0439810;C2347634;C2348143,false;false;true;false;false;false;false;false;false,2402/20013
af or atrial flutter 卞,C0344434;C4049859,false;false,2403/20013
pain subscale,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,2404/20013
ejection fraction based on local reading,C0489482;C2700378,false;false,2405/20013
cardiac and echocardiography parameters,C0018787;C1522601,true;false,2406/20013
albuterol use ( sd ),C0001927;C0042153;C2699239;C0457083;C1947944,true;true;false;false;false,2407/20013
white race — number ( % ),C0007457;C0237753;C0449788;C0043157,true;false;false;true,2408/20013
stable angina ( n - nmbr,C0340288,true,2409/20013
long - term aspirin,C0443252;C0004057,false;true,2410/20013
moderately impaired,C0205081;C1881878;C4085643;C4321491,false;false;false;false,2411/20013
left side only,C3842976,false,2412/20013
past or never,C1444637;C4284302,false;false,2413/20013
gastroesophageal reflux disease,C0017168;C4553201,true;false,2414/20013
anticoagulant — no . ( % ),C0003280;C0848112;C3536711,true;false;false,2415/20013
region,C0017446;C0205147,true;false,2416/20013
arteriosclerosis,C0003850,true,2417/20013
fasting plasma glucose nmbr medan,C0015663;C0202042;C0455280,true;false;false,2418/20013
age mean ( yrs ± sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,2419/20013
chronic renal failure,C0022661;C1561643;C2316810,true;true;false,2420/20013
peripheral artery,C0489868,false,2421/20013
neither tnmbrdm nor mets,C2603360;C0011816;C3250443,false;true;false,2422/20013
time since first af diagnosis,C0040223;C3541383,true;false,2423/20013
anti - hypertensive therapy - no . ( % ),C0585941,false,2424/20013
pacemaker,C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,2425/20013
infarct ion w ithin previous nmbr day s,C0021308;C0022023;C0205156;C0332173;C0439228;C0439505;C1552607;C1700702,true;true;false;false;false;false;false;false,2426/20013
cardiac death,C0376297,true,2427/20013
interval between clinical evaluation and initiation oftreatment — no . ( % ),C1272706;C1261322;C4084924;C1552654;C1552713;C0205210;C2826267,false;false;false;false;false;false;false,2428/20013
apolipoprotein b,C0003593,true,2429/20013
no . of participants with events ( % ),C0679646,false,2430/20013
mean a ± sd,C0444504;C2347634;C2348143,false;false;false,2431/20013
homa - ir ( mu / l^mmol / l ),C0022065;C0439342;C0439190;C0022071;C1448132,true;false;false;true;true,2432/20013
> nmbr months ( n = nmbr,C0439231,false,2433/20013
elevated troponin ( > nmbr . nmbr mg / l ),C0205250;C0041199;C0439268;C3163633,false;true;false;false,2434/20013
mean weight ( sd ),C0444504;C0005910;C2699239;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;false;true;false;false;false;false,2435/20013
europe ( zone nmbr ),C0015176;C1710706,true;false,2436/20013
cox bsl onlyc,C1565830;C1549954,true;false,2437/20013
number resulting in ed visit,C0237753;C0449788,false;false,2438/20013
left ventricular systolic or diastolic dysfunction,C0225897;C0039155,true;true,2439/20013
any other llts ( other than statin ),,,2440/20013
other blood - pressure drug,C0003364,true,2441/20013
both ace inhibitor and arb,C0003015;C4541021,true;false,2442/20013
statin at last follow - up,C0360714;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2443/20013
p - value ( lnteraction ),C1709380,false,2444/20013
mild dysfunction or normal,C3274775,false,2445/20013
recurrent infections ( > nmbr per year ),C0239998;C0439234;C0439508,false;false;false,2446/20013
estimated glomerular filtration rate < nmbr ml / min per nmbr . nmbr mnmbr,C3811844;C0439445;C0369637;C0441923,false;false;false;false,2447/20013
median ( qnmbr : qnmbr ) duration of diabetes,C0549183;C0449238;C0011847;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false,2448/20013
nmbrlnmbrmmhg,C0439394;C0439475;C1706495;C3642217,false;false;false;false,2449/20013
chronic non - steroidal antiinflammatory drugs,C0205191;C0003211,false;true,2450/20013
european subcategories,C0239307;C1515010;C1535514,false;false;false,2451/20013
placebo + nmbr mg / d of simvastatin ( n = nmbr ),C0032042;C0439422;C0074554;C1696465;C1706408,true;false;true;false;false,2452/20013
median c - reactive protein — mg / dl^,C0549183;C0006560;C0439269;C1413716;C4048285;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,2453/20013
use of other medications — no . ( % ),C0240320,false,2454/20013
total - c : hdl - c,C0439175;C3715113;C0439810,false;false;false,2455/20013
pre - bronchodilator fevnmbr / fvc ( % ),C2599602;C3714541,false;true,2456/20013
reversibility ( % predicted fevnmbr ) *,C0449261,false,2457/20013
conversion to sinus rhythm in < nmbr days,C1321500,false,2458/20013
stent implanted,C0522776,false,2459/20013
median weight,C0549183;C0005910;C0043100;C1305866;C1705104;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false,2460/20013
saxagliptin ( % ),C1611934,true,2461/20013
salmeterol - fluticasone group ( n = nmbr ),C0939232;C0441848,true;false,2462/20013
abciximab,C0288672,true,2463/20013
vein bypass graft stented,C0398147,false,2464/20013
mean age ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,2465/20013
prior treatment,C1514463,false,2466/20013
bivalirudin used during pci,C0168273,true,2467/20013
mean ( s . d . ) ldl particle number,C0444504;C2612459;C0237753;C0449788;C2347634;C2348143,false;false;false;false;false;false,2468/20013
pad symptoms ( % ),C0182158;C0683368;C1457887;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2469/20013
number of treated lesions,C0449791;C1522326,false;false,2470/20013
infliximab ( combined nmbr mg / kg and nmbr mg / kg ),C0666743;C0205195;C0439272,true;false;false,2471/20013
high dose statin ( n = nmbr,C0444956;C0360714,false;true,2472/20013
any recurrent stroke,C2242682,false,2473/20013
distal one - third of radius,C0450168;C0205447;C0034627;C1306504;C0588207;C0205437,false;false;true;false;false;false,2474/20013
mean mayo score ( sd ),C3533236;C0454788;C2699239;C1077578,false;false;false;false,2475/20013
diagnosis at presentation,C0011900;C0449450;C1704338;C1704656,true;false;true;false,2476/20013
median disease duration — yr,C0549183;C0872146;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2477/20013
events / control group,C0441471;C0009932;C3541888,false;true;false,2478/20013
lowest tg tertile,C1708760;C0337445,false;false,2479/20013
other antihyperglycemic agents,C0020616,true,2480/20013
index stroke > nmbr days before randomization — no . ( % ),C0456712;C0439228;C0034656,false;false;true,2481/20013
renal fmclicn : creatntoe clearance,C0232813;C0699829,false;false,2482/20013
prior mi ( n - nmbr,C0332152;C3810814;C2826257,false;false;false,2483/20013
losartan plus placebo ( n = nmbr ),C0126174;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,2484/20013
anti - ccp positive ( > nmbr u / ml ),C4318437;C0439178;C0439340;C1880521;C2945590;C1446409;C1514241;C2825490;C3812269,true;false;false;false;false;false;false;false;false,2485/20013
total occlusion,C0439175;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0439810,false;false;true;false;false;false;false;false,2486/20013
male sex — no . ( % ) risk factors,C0086582,true,2487/20013
multiple tnfi and other bdmards §,C0439064,false,2488/20013
stiffness ( min ),C0427008;C0702093;C1524029;C3813700,false;false;false;false,2489/20013
rosuvastatin nmbr - nmbr mg ( n = nmbr ),C0965129;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2490/20013
randomization to angiography,C0034656;C0002978,true;true,2491/20013
thienopyridine n = nmbr,C1120149,true,2492/20013
absolute reversibility in fevnmbr,C0205344;C0449261;C3714541,false;false;true,2493/20013
time to treatment,C3494202,true,2494/20013
duration of initial anticoagulation,C0449238;C0205265;C0003281;C2917212;C2919015;C3537050;C1279901;C1555582;C1705685;C2926735,false;false;false;false;false;false;false;false;false;false,2495/20013
undetermined etiology,C0478157,false,2496/20013
ace inhibitors through hospital discharge or day nmbr — %,C0003015;C0586003,true;false,2497/20013
patient ' s global assessment ( vas ),C4054229;C0042815;C3536884;C3827561,false;true;true;false,2498/20013
triglycerides ( mg / dl ),C0041004;C0439269,true;false,2499/20013
qualifying type of atherosclerosis,C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,2500/20013
patient ' s preference not to take vka,C0376409,true,2501/20013
probable,C0033204;C0332148,true;false,2502/20013
at least two cardiovascular risk factors,C0205448;C0850624,false;false,2503/20013
surgical technique post - randomisation characteristic * *,C0683469;C0687676;C0034656;C1521970;C1704687;C3469826,false;false;true;false;false;false,2504/20013
disease location ( % ) *,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,2505/20013
previous oad ( % ),C0205156;C1552607,false;false,2506/20013
hdl cholesterol — mg / dl triglycerides — mg / dl,C0023822;C0024671;C3539687;C0041004;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0392885,true;true;false;true;true;false;false;false;false;false;false,2507/20013
< nmbr months in - nmbr kill,C0439231;C0162388;C0681205;C1550555,false;true;false;false,2508/20013
antialdosterone agents,C0450442;C1254351;C1521826,false;false;false,2509/20013
risk factors bmi ( kg / mnmbr ),C0035648;C0578022;C1532718;C1553898,true;false;false;false,2510/20013
ex - smoker / current,C0337671;C0521116;C1705970;C4555205,false;false;false;true,2511/20013
at goal,C0018017;C1571704,true;false,2512/20013
history of heart failure — no . ( % ),C0455531,false,2513/20013
diabetes duration subgroups,C0011847;C0449238;C1079230;C2926735;C0011849,false;false;false;false;true,2514/20013
western europe ( including south africa ),C0043129,true,2515/20013
randomization stratum,C0034656,true,2516/20013
clopidogrel / total no . of patients % %,C0070166;C0439175;C0439810,true;false;false,2517/20013
corticosteroid ( without imm ),C0001617;C0205470;C3536709,true;false;false,2518/20013
creatinine ratio nmbr - nmbr,C0010294;C0456603;C1547037;C1561535,true;false;false;false,2519/20013
overall pad,C0282416;C1561607,true;false,2520/20013
steroids ( other ),C0038317,true,2521/20013
mean ± s . d . weight,C0444504;C0005910;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;false,2522/20013
amlodipine ( n = nmbr ),C0051696,true,2523/20013
previous infliximab therapy — no . of patients ( % ) * *,C0205156;C4076075;C1552607,false;false;false,2524/20013
anti - tnf - naive,C1448177,true,2525/20013
previous acute hypersensitivity reaction to infliximab — no . of patients ( % ),C0205156;C0413234;C0666743;C1552607,false;false;true;false,2526/20013
non - elderly ( < nmbr years ),C1518422;C0001792;C0439234;C1999167,false;true;false;false,2527/20013
pravastatin ( n = nmbr >,C0085542,true,2528/20013
week nmbr ( mean,C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,2529/20013
factor v leiden ( % ),C0380964;C0584960;C1414509;C3542419,true;false;false;false,2530/20013
tender joint count ( nmbr - nmbr possible joints ),C0240094;C4554549;C4696258,false;false;false,2531/20013
male sex — no . / total no . ( % ),C0086582,true,2532/20013
insulin glargine n ( x ),C0907402,true,2533/20013
time since randomization,C0040223;C3541383,true;false,2534/20013
post - bronchodilator fevnmbr ( % predicted normal ) a,C2599594;C3714541,false;true,2535/20013
vessel size,C0005847;C0456389,true;false,2536/20013
hs - crp ( median,C3890735;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false,2537/20013
insulin - requiring,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2538/20013
homa . ir,C0022065;C0022071;C1448132,true;true;true,2539/20013
baseline short - acting anticholinergics,C0168634;C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002;C1442488,true;false;true;true;false;false;false;true;false;false;false;false;false,2540/20013
multivitamin use ( current ),C0301532;C0042153;C0521116;C1705970;C0457083;C1947944,false;true;false;false;false;false,2541/20013
apob : apoal,C0003593;C3252643,true;true,2542/20013
cardiac stretch,C0018787;C0600080;C1522601,true;false;false,2543/20013
hospitalization for heart failure within nmbr mo,C3898876,false,2544/20013
lv ejection fraction,C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,2545/20013
patients with event / patients analyzed,C0030705;C0441471;C4019010,true;false;false,2546/20013
mean ( sd ) periostin,C0444504;C2699239;C0219433;C1424662;C3812270;C2347634;C2348143,false;false;true;false;false;false;false,2547/20013
any blood transfusion,C0005841;C0281867,true;false,2548/20013
low molecular weight heparin,C0019139;C3536766,true;false,2549/20013
yes ( stopped for trial ),C1549445;C1705108;C1710701,false;false;false,2550/20013
previous chronic use of antiplatelet drugs,C0205156;C0205191;C1524063;C0085826;C2963157;C1552607,false;false;false;true;false;false,2551/20013
aspirin - erdp clopidogrel no . of patients / total no .,C0004057;C0070166,true;true,2552/20013
denosumab,C1690432,true,2553/20013
patients randomized,C0030705,true,2554/20013
days with asthma symptoms / week,C0677547;C0004096;C0683368;C1457887;C2984299,false;true;true;false;false,2555/20013
statin with fibrate,C0360714,true,2556/20013
delayed - start group ( n = nmbr ),C0205421;C0439659;C0441848;C1545665;C3272602,false;false;false;false;false,2557/20013
fevnmbr % predicted ( post salbutamol ),C3714541,true,2558/20013
intended durat - sm of antccagubficn,C1283828;C0036154;C4553627;C1551357,false;true;false;false,2559/20013
baseline dmard use,C0168634;C0242708;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,2560/20013
creatinine — mg / dl urinary albumin - to - creatinine ratio §,C0010294;C0439269;C2362049;C0456603;C1547037;C1561535,true;false;false;false;false;false,2561/20013
companion : wake - up stroke,C0031268;C1170730;C0038454;C4554100;C0335343;C0682323,true;false;true;false;true;false,2562/20013
placebo events / n ( % ),C0032042;C0441471;C3541888;C1696465;C1706408,true;false;false;false;false,2563/20013
cdai score < nmbr,C0683448;C1413248;C3273706,false;false;false,2564/20013
baseline ibdq total score,C0168634;C2964552;C1442488,true;false;false,2565/20013
positive for rheumatoid factor,C0439178;C0035448;C0201660;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false,2566/20013
current alcohol use,C0521116;C0001948;C1705970,false;true;false,2567/20013
cardiac medications at discharge,C0018787;C0806915;C1522601,true;false;false,2568/20013
medical management only,C0199168;C0001554;C0205171;C1720467;C0376636;C1273870;C3273539;C0205476,false;true;false;false;true;false;false;false,2569/20013
shoulder pain,C0037011,true,2570/20013
hbalc,,,2571/20013
nmbr . nmbr mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,2572/20013
pci during index hospitalization,C4049621;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,2573/20013
history of cv disease,C0683519;C3538987;C4048877;C4318503;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,2574/20013
complex lesions^,C0439855;C0221198;C1704241,false;false;false,2575/20013
level nmbr immobility^,C0441889;C0231441;C0456079;C1547707;C2946261,false;false;false;false;false,2576/20013
asia / pacific / other,C0003980,true,2577/20013
calcium,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,2578/20013
mtss cfb mean ± sd,C0009002;C0444504;C2699239;C2347634;C2348143;C1824728,true;false;false;false;false;false,2579/20013
study end concentration,C0557651;C0444930;C0086045;C1446561;C3827302;C2746065;C2603343,false;false;true;false;false;false;false,2580/20013
naive to antihyperglycemic agent therapy,C0020616;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826,true;false;true;true;false;false;false,2581/20013
swollen joint count,C0451521,false,2582/20013
hemispheric tia n = nmbr,C0205139;C0007787;C0917805;C1054154,false;true;true;false,2583/20013
c - peptide tx difference vs pbo,C0006558;C0041403;C1705241;C1705242,true;true;false;false,2584/20013
severity of airflow limitation ( gold nmbr ),C0439793;C0231999;C0443288;C0018026;C1304897;C0449295;C0522510,false;false;false;true;false;false;false,2585/20013
other atherosclerotic event,C0333482;C0441471;C4019010,false;false;false,2586/20013
retinopathy ( stage nmbr / nmbr / nmbr / nmbr ),C0035309;C0205390;C1300072;C1306673;C1962966,true;false;false;false;false,2587/20013
mean — ml / min / nmbr . nmbrmnmbr,C0444504;C0439445;C0369637;C0441923;C2347634;C2348143,false;false;false;false;false;false,2588/20013
fevnmbr ( % predicted normal ),C3714541,true,2589/20013
baseline total cholesterol,C0168634;C0201950;C0543421;C1442488,true;false;false;false,2590/20013
egfr category,C1739039;C0683312;C3889287;C3811844;C3812682,true;false;false;false;false,2591/20013
any other antihyperglycaemic drugs,,,2592/20013
any risk factor for stent thrombosis,C0035648;C3897493,true;false,2593/20013
copd severity : mild / moderate,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,2594/20013
medications taken at time of randomization statins,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2595/20013
neither n = nmbr,C0369718;C0441922,false;false,2596/20013
exercise at least weekly ( a ),C0015259;C1522704,true;false,2597/20013
patients with previous intolerance of infliximab,C0030705;C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,true;false;false;true;false;false;false,2598/20013
mayo clinic score §,C0454788;C0002424;C0449820;C4050231;C0442592;C1077578,false;true;false;false;false;false,2599/20013
nob systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,2600/20013
geographic region - other,C0017446,true,2601/20013
months since first ra symptom,C0439231,false,2602/20013
continuation ( n = nmbr ),,,2603/20013
timi - defined bleeding,,,2604/20013
glycosylated hemoglobin,C0017853,true,2605/20013
omeprazole,C0028978,true,2606/20013
in - hospital ticagrelor ( n = nmbr ),C0019994;C1999375;C1510665,true;true;false,2607/20013
mean bmi ( nmbr % ci ),C0444504;C0578022;C0008107;C3259781;C2347634;C2348143,false;false;true;false;false;false,2608/20013
physiological measures,C0205463;C0079809;C1879489,false;true;false,2609/20013
atrial fibrillation pattern,C0004238;C0449774;C0344434;C1963067,true;false;false;false,2610/20013
corticosteroid + imm,C0001617;C0205470;C3536709,true;false;false,2611/20013
thiazide at enrollment,C0541746;C1516879;C1696073;C3888021,true;false;false;false,2612/20013
nasopharyngitis,C0027441,true,2613/20013
established atherosclerotic,C0443211;C0333482;C1272684,false;false;false,2614/20013
overall effect,C0282416;C1280500;C1518681;C2348382;C1561607,true;false;false;false;false,2615/20013
omega - nmbr fa,C1719844,false,2616/20013
ejection fraction : < nmbr % ( n = nmbr ),C0489482;C2700378,false;false,2617/20013
< nmbr mm hg heart rate,C0439475;C0018810,false;true,2618/20013
lv ejection fraction ( % ),C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,2619/20013
cangrelor clopidogrel no . of events / total no . ( % ),C1121991;C0070166,true;true,2620/20013
killip at baseline,C0168634;C1442488,true;false,2621/20013
time since asthma diagnosis ( years ),C0040223;C3541383,true;false,2622/20013
nmbr placebo,C0032042;C1696465;C1706408,true;false;false,2623/20013
carbamazepine,C0006949;C0006950;C0682993,true;false;false,2624/20013
known duration of type nmbr diabetes ( years ),C0205309;C0449238;C1320657;C0439234;C2926735,false;false;false;false;false,2625/20013
beta - blocker at enrollment,C0001645;C1516879;C1696073;C3888021,true;false;false;false,2626/20013
number of exacerbations nmbr months before randomisation,C0237753;C4086268;C0439231;C0449788,false;false;false;false,2627/20013
week nmbr hbanmbrc,C0332174;C0019016;C1825777;C3538758;C0439230,false;true;false;false;false,2628/20013
tertile nmbr ( n = nmbr ),,,2629/20013
mean ( sd ) duration of copd,C0444504;C2699239;C0449238;C0024117;C1412502;C3714496;C2926735;C2347634;C2348143,false;false;false;true;false;false;false;false;false,2630/20013
ci - aki risk score,C0008107;C0022660;C0035647;C0449820;C4050231;C4552904;C0330978;C3259781,true;true;true;false;false;false;true;false,2631/20013
risk factors for stroke,C0035648;C0038454;C4554100;C1553898,true;true;false;false,2632/20013
esr ( mm / h ),C3811131;C0456680,false;false,2633/20013
units per week,C0560588,false,2634/20013
c - reactive protein — mg / literj,C0006560;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;true;false;false;false;false;false;false;false,2635/20013
non - u . s .,C1518422,false,2636/20013
acuity - defined bleeding,C0750509,false,2637/20013
vedolizumab,C2742797,true,2638/20013
other / multiracial,C1881928,false,2639/20013
time since qualifying event,C0040223;C3541383,true;false,2640/20013
> nmbr vessels treated,C0005847,true,2641/20013
statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,2642/20013
previous coronary - artery bypass grafting,C2144990,false,2643/20013
median ( min,C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,2644/20013
intensive control ( n = nmbr ) no . of patients ( percent ),C0162425;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,2645/20013
arterial hypertension,C0020538,true,2646/20013
ranolazine ( n = nmbr ) placebo ( n = nmbr ),C0073633;C0032042;C1696465;C1706408,true;true;false;false,2647/20013
large shunt,C0549177;C0232180;C0542331;C1442858,false;false;false;false,2648/20013
history of hypertension,C0455527,false,2649/20013
age y,C0001779,false,2650/20013
companion : nmbr - nmbr hours,C0031268;C0439227;C0335343;C0682323,true;false;true;false,2651/20013
nt - pro bnp,C0669479;C0754710,true;true,2652/20013
lipid difference ( mg / dl ),C0023779;C1705241;C0439269;C1705242,true;false;false;false,2653/20013
other determined etiology,C0521095;C0015127;C1314792;C1524003,false;true;true;false,2654/20013
baseline pasi score,C0168634;C4528685;C0449820;C4050231;C1442488,true;false;false;false;false,2655/20013
mean ( sd ) total asthma symptom scores,C0444504;C2699239;C3533163;C0004096;C2984299;C2347634;C2348143,false;false;false;true;false;false;false,2656/20013
time since pah diagnosisc ( years ),C0040223;C3541383,true;false,2657/20013
alpha receptor antagonist,C0439095;C4543207;C2003941;C2350010,false;false;false;false,2658/20013
esrd on losartan ( % ),C0022661;C0126174;C0035078;C2316810,true;true;true;false,2659/20013
stroke at entry ( vs transient ischemic attack ),C0038454;C1705654;C4554100,true;false;false,2660/20013
medical history and risk factors ( % ),C0262926;C1704706,false;false,2661/20013
placebo monthly ( n = nmbr ),C0032042;C0332177;C1696465;C1706408,true;false;false;false,2662/20013
intravenous inotropes or vasopressors ( % ),C0348016;C1258199,false;true,2663/20013
overall a phase population,C0282416;C1561607,true;false,2664/20013
symptom onset to first medical contact : ambulance or emergency department,C4086878;C0205435;C0199168;C0332158;C0002422;C3846685;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;false;true;false;false;false;false;false;false,2665/20013
any glucocorticoid *,C0017710,true,2666/20013
mean ( sd ) post - bronchodilator fevnmbr percentage predicted,C0444504;C2699239;C2599594;C3714541;C0439165;C1549488;C1561533;C2347634;C2348143,false;false;false;true;false;false;false;false;false,2667/20013
insulin ( mu / ml ),C0021641;C0439339;C1533581;C1579433;C3714501,true;false;false;false;false,2668/20013
creatinine clearance < nmbr ml / min,C0812399;C0439445,false;false,2669/20013
elevated serum potassium,C0553704,false,2670/20013
concordant stress test abnormalities,C4553529;C0015260;C0000768;C0000769;C3494508,false;true;true;true;true,2671/20013
eos serum k +,C1623465;C0302353;C1861303,false;false;true,2672/20013
duration of diabetes,C0449238;C0011847;C0011849;C2926735,false;false;true;false,2673/20013
arterial revascularization,C0003842;C0581603;C0221464,true;false;false,2674/20013
endpoint rate,C2349179;C0871208;C1521828;C2826544,false;false;false;false,2675/20013
highest tertile ( range  nmbr . nmbr - nmbr . nmbr mg / dl  mean ± sd  nmbr . nmbr ± nmbr . nmbr mg / dl ),C1522410;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false,2676/20013
p interaction women vs men,C0369773;C1704675;C0043210;C2603361,false;false;true;false,2677/20013
malaysia,C0024552,true,2678/20013
populations :,C0032659;C1257890,true;true,2679/20013
index pci performed,C0600653;C4049621;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,2680/20013
retinopathy,C0035309;C1962966,true;false,2681/20013
history of nicotine use,C0019664;C0028040;C1524063;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2682/20013
insulin glargine n ( % ) / nmbrpy,C0907402;C0030428;C3538810,true;true;false,2683/20013
no chd simva ( n = nmbr],C0280604;C3542407,false;false,2684/20013
treated with insulin,C0332293;C0021641;C1533581;C1579433;C3714501,false;true;false;false;false,2685/20013
previous ischemic stroke ortia,C0205156;C0948008;C1552607,false;false;false,2686/20013
iglarlixi,,,2687/20013
previous cabg surgery,C0205156;C0010055;C0038894;C0038895;C0543467;C1274039;C1552607,false;true;false;true;true;true;false,2688/20013
statin alone,C0360714,true,2689/20013
study drug loading days ( actual ) : nmbr ( n = nmbr ),C0013175;C1708715;C0439228;C0237400,true;false;false;false,2690/20013
lumbar epidural,C0581283,false,2691/20013
periprocedural medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2692/20013
group dif . ( nmbr ),C0441833;C0812246;C1710304;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;false;true;false;false;false,2693/20013
prior cardiac resynchronization therapy,C0332152;C1167956;C2826257,false;true;false,2694/20013
cardiac risk,C0018787;C0035647;C4552904;C1522601,true;true;false;false,2695/20013
albuterol use,C0001927;C0042153;C0457083;C1947944,true;true;false;false,2696/20013
no . of events / total,C0441471;C3541888,false;false,2697/20013
no . of participants per nmbr patient - yr,C0679646,false,2698/20013
estimated glomerular filtration rate < nmbr ml / min / nmbr . nmbr mnmbr — no . / total no . ( % ) §,C3811844;C0439445;C0369637;C0441923,false;false;false;false,2699/20013
established atherosclerotic disease,C0443211;C0333482;C0012634;C1272684,false;false;true;false,2700/20013
ukraine,C0041580,true,2701/20013
negative for helicobacter pylori — no . / total no . ( % ),C4688581,false,2702/20013
other medical history — no . / total no . ( % ),C0262926;C1704706,false;false,2703/20013
left atrial anteroposterior diameter — mm,C0225860;C1301886;C4330985;C4554674;C0225861,true;false;false;false;false,2704/20013
any established peripheral arterial disease,C0443211;C0085096;C1704436;C1272684,false;true;true;false,2705/20013
serum k + level and drug treatment,C0302353;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,2706/20013
chronic inflammatory disease,C1290886,false,2707/20013
randomization to arrival in catheterization laboratory,C0034656;C1555577;C1706079,true;false;false,2708/20013
rituximab,C0393022,true,2709/20013
high risk ( receiving treatment for ) :,C0332167;C1514756;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3272283;C4050568;C4319571,false;false;true;true;false;false;false;false;false;false;false;false,2710/20013
c - reactive protein,C0006560;C1413716;C4048285,true;false;false,2711/20013
anti - tnf - naive patients,C1448177;C0030705,true;true,2712/20013
lipids,C0023779,true,2713/20013
high - dose statin use at screening *,C0444956;C0360714;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,false;true;true;true;true;false;false;false;false;false;false;false,2714/20013
second primary ( estimated change in total updrs score from baseline to wk nmbr ),C0205436;C0205225;C0750572;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,2715/20013
abciximab no . / total ( % ),C0288672,true,2716/20013
no . of non - tnfi,C1518422,false,2717/20013
current cvd / diabetes,C0521116;C0007222;C0011847;C0011849;C1705970,false;true;false;true;false,2718/20013
cv mortality,C3538987;C0026565;C0026566;C4048877;C4318503,false;true;true;true;false,2719/20013
duration of dementia symptoms,C0436359;C0011265;C0497327,false;true;true,2720/20013
no pad baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2721/20013
pre ' rtous eptscde ( s } d dvt / pe,C0332152;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,2722/20013
prior coronary artery bypass surgery,C0332152;C0010055;C2826257,false;true;false,2723/20013
interaction p - valuenmbr,C1704675;C1709380,false;false,2724/20013
ipah,C0152171,false,2725/20013
< nmbr mg / dl simva ( n = nmbr],C0439269,false,2726/20013
location of disease,C0450429;C0012634;C1515974;C4284930;C4284931,false;true;false;false;false,2727/20013
mtx ( mean dose : nmbr . nmbr mg / wk ),C0366550;C0444504;C1881833;C2347634;C2348143,false;false;false;false;false,2728/20013
labs at the index acs event,C0587081;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,2729/20013
black race ( n = nmbr vs nmbr ),C0005680,true,2730/20013
treatment with any bp lowering drugs,C3469597;C0037623;C0441994;C2003888;C1415692;C1708288;C4318478,false;true;false;false;false;false;false,2731/20013
placebo nmbr / nmbr,C0032042;C1696465;C1706408,true;false;false,2732/20013
diagnosed,C0011900,true,2733/20013
peri - op statins : no ( n = nmbr ),C0347985;C0360714,false;true,2734/20013
copd disease severity,C0024117;C0521117;C1412502;C3714496,true;false;false;false,2735/20013
baseline dyslipidemia,C0168634;C0242339;C1442488,true;true;false,2736/20013
difference in ls means ( nmbr % ci ) nmbr,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,2737/20013
male gender,C0086582;C1706180,true;false,2738/20013
( nmbr - nmbr - cm vas ),C0042815;C3536884;C3827561,true;true;false,2739/20013
screening absolute reversibility fevnmbr,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,2740/20013
k - m %,C0597277;C0369637;C0441923;C1708601,false;false;false;false,2741/20013
type of surgery,C0332307;C0038894;C0038895;C0543467;C1274039;C1547052,false;false;true;true;true;false,2742/20013
hosp . worsening hf,C0332271;C0018488;C1313497;C1538440;C3273279;C1457868;C1546960,false;true;true;false;false;false;false,2743/20013
rest of the world,C0035253;C2700280;C1622890,true;false;false,2744/20013
placebo no . / total no .,C0032042;C1696465;C1706408,true;false;false,2745/20013
azathioprine / nmbr - mercaptopurine,C0004482;C0000618,true;true,2746/20013
cox - nmbr selective nsaid,C1565830;C0036576;C0003211;C3536840;C1707391,true;true;true;false;false,2747/20013
total ( n = nmbr,C0439175;C0439810,false;false,2748/20013
laboratory variables,C0022877;C0439828;C3244292;C4283904,true;false;false;false,2749/20013
baseline anti - hyperglycemic medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,2750/20013
ivabradine group ( n = nmbr ),C0257190;C0441848,true;false,2751/20013
undergoing major vascular surgery,,,2752/20013
< nmbr baseline killip class,C0168634;C1881332;C1442488,true;false;false,2753/20013
statin intensitynmbr * nmbr,C0360714;C0522510,true;false,2754/20013
multivitamin use,C0301532;C0042153;C0457083;C1947944,false;true;false;false,2755/20013
baseline body weight quartile,C1303013;C2828255,false;false,2756/20013
primary pci n = nmbr,C0205225;C4049621;C0439612;C0439631,false;false;false;false,2757/20013
prior tnfi treatment,C1514463,false,2758/20013
multiple ( > nmbr ) chd risk factors that confer a nmbr - year risk of chd > nmbr %,C0439064;C0280604;C0035648;C1553898;C3542407,false;false;true;false;false,2759/20013
pctindopnl - indapamide ( n = nmbr ),C0021186,true,2760/20013
history of impaired renal function,C0019664;C1565489;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2761/20013
stroke of any etiology,C0038454;C0015127;C1314792;C1524003;C4554100,true;true;true;false;false,2762/20013
fasting insulin ( pmol / l ),C0015663;C0021641;C0439284;C1533581;C1579433;C3714501,true;true;false;false;false;false,2763/20013
total body ( without head ),C0229960;C0018670;C1706305,false;true;false,2764/20013
fatty acid composition,C0015684;C0486616;C1555710,true;false;false,2765/20013
cerebral hemorrhage,C2937358,true,2766/20013
pasinmbr response },C4528685;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,2767/20013
nonglycemic cardiovascular risk factors systolic blood pressure — mmhg,C0850624;C0488055;C0439475;C0871470;C1306620,false;false;false;true;false,2768/20013
duration of diabetes ( months ),C0449238;C0011847;C0439231;C0011849;C2926735,false;false;false;true;false,2769/20013
alpha - glucosidase inhibitors,C1299007;C2756986;C3539108,true;false;false,2770/20013
anthropometry : mean ( sd ),C0003188;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,2771/20013
white ethnicity,C0007457;C0015031;C0243103;C0043157;C0220938,true;true;true;true;false,2772/20013
vascular history,C0005847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1558950;C1801960,true;true;true;false;false;false;false;false;false,2773/20013
time from qualifying myocardial infarction,C0040223;C1514624;C0027051;C0428953;C2926063;C3810814;C4552959;C3541383,true;false;true;false;false;false;false;false,2774/20013
nmbr — nmbr nlmw,,,2775/20013
postoperative glucocorticoid use post - randomisation characteristic * *,C0032790;C0017710;C0042153;C0687676;C0034656;C1521970;C1704687;C3469826;C0457083;C1947944,true;true;true;false;true;false;false;false;false;false,2776/20013
sinus rhythm,C0232201,false,2777/20013
united states or canada,C0041703,true,2778/20013
heparin,C0019134;C0770546,true;false,2779/20013
community hospital,C0020003,true,2780/20013
patient - reported outcome measures,C4277735,true,2781/20013
> nmbr . nmbr mg / liter antiplatelet agents,C0024671;C0475211;C0085826;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,2782/20013
ara functional class — no . ( % ),C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,2783/20013
restenotic vessel,C0333186;C0005847,false;true,2784/20013
mean nmbr - year cvd risk *,C0444504;C0439234;C0007222;C0035647;C4552904;C0439508;C2347634;C2348143,false;false;true;true;false;false;false;false,2785/20013
^median > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,2786/20013
ace inhibitors / sartans,C0003015;C1563745,true;true,2787/20013
history of pci — no . / total no . ( % ) : t,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,2788/20013
current cigarette smoker or within past year,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,2789/20013
time to randomization from symptom onset,C0040223;C0034656;C3541383,true;true;false,2790/20013
motor weakness,C1513492;C3714552;C1705994,false;false;false,2791/20013
hospitalization for hf previous year,C0019993;C0018488;C0205156;C0439234;C0439508;C1552607;C1313497;C1538440;C3273279,true;true;false;false;false;false;true;false;false,2792/20013
st - segment depression < nmbr . nmbr mv,C0520887;C1454484;C1705503;C4281602,false;true;false;false,2793/20013
ab / ff nmbr / nmbr pg ( n = nmbr ),C4554348;C0030827;C0072225;C1266240,false;true;true;false,2794/20013
severity of airflow obstruction,C0439793;C0231999;C0028778;C1882136;C0522510,false;false;false;false;false,2795/20013
tender - joint count ( of nmbr joints ),C0451530,false,2796/20013
tenecteplase,C0872913,true,2797/20013
median duration of symptoms ( range ),C0549183;C0436359;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,2798/20013
history of pci / ptca,C0019664;C4049621;C2936173;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,2799/20013
only dvt,C0205171;C0149871;C2926618;C3899446;C1720467,false;true;false;false;false,2800/20013
glucose - lowering drug,C0017725;C0441994;C0013227;C1254351;C2003888,true;false;true;false;false,2801/20013
age group ( years ),C1510829;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0027362;C0439234;C2348001,false;false;false;true;false;false;false;true;false;false,2802/20013
renal events,C0022646;C0441471;C3541888,true;false;false,2803/20013
blood leucocyte concentration ( nmbr cells per l ),C0023516;C0086045;C0347983;C1446561;C3827302;C0427728;C0699870;C1313904,true;true;false;false;false;false;false;false,2804/20013
baricitinib nmbr mg,C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2805/20013
etd ( % ) [nmbr % ci],C1180255;C0008107;C3259781,false;true;false,2806/20013
ranolazine ( n = nmbr ),C0073633,true,2807/20013
below - knee popliteal,C0542339;C0022742;C0442037;C0022745;C1963703;C1552829,false;true;false;true;false;false,2808/20013
uacr ( mg / g ),C1300563,false,2809/20013
geographic location,C0017446,true,2810/20013
albuminuria,C0001925,true,2811/20013
angina,C0002962,true,2812/20013
acrnmbr response,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,2813/20013
dyslipidemianmbr,C0242339,true,2814/20013
past or current,C1444637;C4284302,false;false,2815/20013
interval from randomization to angiography,C1272706;C0034656;C1552654;C1552713,false;true;false;false,2816/20013
enthesitis,C1282952,false,2817/20013
previous treatment,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,2818/20013
non - tnf inhibitors,C1518422;C1448177;C0243077,false;true;true,2819/20013
any blood - pressure - lowering drug 一 no . ( % ),C0003364,true,2820/20013
previous stroke — no . ( % ),C0205156;C1552607,false;false,2821/20013
proximal to the splenic flexure,C0205107;C0227387;C4489236,false;true;false,2822/20013
high eosinophil subgroup ( > nmbr / ml ) ( n = nmbr ),C0014457;C1079230;C0439526;C1705224;C3887665;C1515021,true;false;false;false;false;false,2823/20013
patients with egfr > nmbr ml / min / nmbr . nmbrmnmbr,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,2824/20013
slo days,C1416602;C0439228;C3539661,false;false;false,2825/20013
cardiovascular mortality,C0007226;C0026565;C0026566;C3887460,true;true;true;false,2826/20013
mnmbr subgroup,C0369637;C1079230;C1515021;C0441923,false;false;false;false,2827/20013
valsartan ( n = nmbr ),C0216784,true,2828/20013
japan n = nmbr,C0022341,true,2829/20013
modified se - adl scale,C0392747;C0036919;C0001288;C0175659;C0349674;C1947916;C1420005;C3889737,false;true;true;true;false;false;false;false,2830/20013
corticosteroids only,C0001617;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false;false;false,2831/20013
p - value interaction,C1709380;C1704675,false;false,2832/20013
undetermined,C0205258;C3536725;C4082977,false;false;false,2833/20013
percentage patients reaching target,C0439165;C0030705;C1549488;C1561533,false;true;false;false,2834/20013
modified has - bled,C0392747;C3889737,false;false,2835/20013
insulin alone,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2836/20013
statin only,C0360714;C0205171;C1720467,true;false;false,2837/20013
body - mass index categories — no . ( % ) : c,C0005893;C0683312;C0578022;C1305855,false;false;false;true,2838/20013
monocytes,C0026473,true,2839/20013
criteria for subcortical vad ( by mri ),C0243161;C0815275;C0077973,true;false;true,2840/20013
crp mean ( mg / dl ± sd ),C3890735;C0444504;C0439269;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,2841/20013
angiographic features,C0002978;C1521970;C1706388;C2346469;C2348519,true;false;false;false;false,2842/20013
> nmbr years to < nmbr years ( n = nmbr ),C0439234,false,2843/20013
pathologic q waves,C0429090,false,2844/20013
duration of metformin therapy ( months ),C0444917;C0025598;C0439231,false;true;false,2845/20013
baseline bmi > nmbr kg / mnmbr,C0168634;C0578022;C1532718;C1442488,true;false;false;false,2846/20013
lesion location,C0221198;C0450429;C1515974;C4284930;C4284931;C1546698,false;false;false;false;false;false,2847/20013
patients treated with statins ( n = nmbr ),C0030705,true,2848/20013
copd exacerbations during the previous year,C0740304;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,2849/20013
biasp nmbr,,,2850/20013
insulin — iu,C0021641;C0049272;C0439453;C0694756;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,2851/20013
subject characteristics,C0681884;C1519021;C1706465,false;false;false,2852/20013
primary composite outcome,C0205225;C0205199;C1274040;C1547335;C0439612;C0439631,false;false;false;false;false;false,2853/20013
category nmbr and nmbr,C0683312;C3889287,false;false,2854/20013
race or ethnic background — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,2855/20013
renal function subgroups,C0232804;C1079230,false;false,2856/20013
percent of patients,C0439165;C0030705,false;true,2857/20013
placebo / simvastatin,C0032042;C0074554;C1696465;C1706408,true;true;false;false,2858/20013
% of predicted normal value *,C0681842;C0086715;C1882327,false;true;false,2859/20013
body - mass index ( kg / mnmbr ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,2860/20013
rolofylline dose,C0166128;C0178602;C0869039;C1114758,true;false;false;false,2861/20013
canagliflozin dose,C2974540;C0178602;C0869039;C1114758,true;false;false;false,2862/20013
pbo + statin nmbr,C0031962;C0360714,true;true,2863/20013
orthopaedic,C0029355,true,2864/20013
geographic region — number ( % ),C0017446;C0237753;C0449788,true;false;false,2865/20013
black race — no . / total no . ( % ) f,C0005680;C0027567;C0085756;C0439541,true;true;true;false,2866/20013
versus olodaterol nmbr pg,,,2867/20013
antihypertensive agents,C0003364,true,2868/20013
alpha - blocker,C0001641,true,2869/20013
modified total sharp score * *,C0392747;C2964552;C1444775;C1539835;C3890003;C3889737,false;false;false;false;false;false,2870/20013
beta - blocker use at baseline,C0001645;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,2871/20013
all - cause,C0015127;C1524003,true;false,2872/20013
class nmbr or no symptoms,C0456387;C1518526;C1705943,false;false;false,2873/20013
laboratory variables at baseline,C0022877;C0439828;C0168634;C1442488;C3244292;C4283904,true;false;true;false;false;false,2874/20013
pneumonia in past year,C0032285;C4086728,true;false,2875/20013
chd men,C0280604;C0025266;C3542407,false;true;false,2876/20013
calcium antagonist strategy ( cas ) ( events / n ),C0006684;C0679199;C0441471;C3541888,true;false;false;false,2877/20013
muscle twitching,C0015644;C0231530,true;false,2878/20013
other medication usage,C0013227;C0457083;C3244316;C4284232,true;false;false;false,2879/20013
qvanmbr nmbr / nmbr | ig od n = nmbr,C0021027;C0229089;C0439164;C1512019;C3273373;C3665488;C0305052;C0360506,true;false;false;false;true;true;false;false,2880/20013
female sex — number ( % ),C0086287;C0237753;C0449788,true;false;false,2881/20013
mitral insufficiency,C0026266,true,2882/20013
from baseline ( nmbr % ci ),C0168634;C0008107;C3259781;C1442488,true;true;false;false,2883/20013
compression stockings,C0038348,true,2884/20013
baseline triglycerides < nmbr mg / dl,C0168634;C0041004;C0439269;C1442488,true;true;false;false,2885/20013
apo b / apo a - l,C1447574;C0003592;C0523508;C4553344;C4521365,true;true;false;false;false,2886/20013
beta - carotene ( n = nmbr,C0053396;C0696105,true;false,2887/20013
> nmbr years baseline ldl - c,C0439234;C0168634;C1442488,false;true;false,2888/20013
prevalence of each metabolic syndrome criterion,C0033105;C0524620;C0243161;C0220900,true;true;true;true,2889/20013
high - dose statin use,C0444956;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,2890/20013
fasting glucose ( mmol / l ),C0015663;C0017725;C1532563,true;true;false,2891/20013
fistula at baseline,C0016169;C0168634;C1442488,true;true;false,2892/20013
dizziness,C0012833;C0042571;C1963093;C4084788;C4085547;C4085548;C4085549;C4553830,true;true;false;false;false;false;false;false,2893/20013
coronary angiography — no . ( % ),C0085532;C1548829,true;false,2894/20013
presenting signs and symptoms,C0449450;C0220912;C0220913;C0311392,false;true;false;false,2895/20013
moderate copdb [n z nmbr],C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,2896/20013
planned conservative therapy subgroup,C1301732;C0459914;C1079230;C1515021,false;true;false;false,2897/20013
sonti amenca,,,2898/20013
methotrexate,C0025677,true,2899/20013
hs - crp ( mg / l,C3890735;C0439268;C4048285,false;false;false,2900/20013
previously taken dmards other than methotrexate,,,2901/20013
non - ischaemic ( n = nmbronmbr ),C1518422;C0475224,false;false,2902/20013
progestins,C0033306,true,2903/20013
fasting serum glucose ( mg / dl ),C0015663;C0202041;C0439269;C3534430,true;false;false;false,2904/20013
normalized,C1882115,false,2905/20013
time from hospital admission to pci,C0040223;C0019994;C1959907;C1510665;C3541383,true;true;false;false;false,2906/20013
known t ' rc - iitoji cccndilon,C0205309;C1167159;C1419366,false;false;false,2907/20013
ii or iii,,,2908/20013
left ventricular ejection,C2733342,false,2909/20013
left ventricular ejection fraction — no . / total no . ( % ),C0428772;C0488728,false;false,2910/20013
previous loss of response to and intolerance of infliximab,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,2911/20013
reported diabetes mellitus,C0684224;C0011849;C0700287;C4319718,true;true;false;false,2912/20013
other / missing,C1551393;C1705492;C3272743,false;false;false,2913/20013
severe or moderate,C0205082;C4050465;C4050466,false;false;false,2914/20013
coronary bypass,C0010055,true,2915/20013
new zealand,C0027978;C0324547,true;true,2916/20013
cox - nmbr selective nsaid use,C1565830;C0036576;C0003211;C0042153;C0457083;C1947944;C3536840;C1707391,true;true;true;true;false;false;false;false,2917/20013
heart failure cause,C0018801;C0015127;C1524003;C0018802;C4554158,true;true;false;true;false,2918/20013
sbp ( mmhg ) < nmbr,C0085805;C0439475,true;false,2919/20013
past smoker,C1444637;C0337664;C4284302,false;true;false,2920/20013
previous stroke — no . ( % ) concomitant treatment — no . ( % ),C0205156;C1552607,false;false,2921/20013
mean ( s . d . ) hdl cholesterol,C0444504;C0023822;C0392885;C2347634;C2348143,false;true;false;false;false,2922/20013
amiodarone ( n = nmbr ),C0002598,true,2923/20013
previous disease — no . ( % ) f,C0205156;C0012634;C1552607,false;true;false,2924/20013
esrd on placebo ( % ),C0022661;C0032042;C1696465;C1706408;C0035078;C2316810,true;true;false;false;true;false,2925/20013
acute respiratory insufficiency,C0865850,false,2926/20013
> nmbr % predicted arr ( n = nmbr ),C0681842;C2170357;C4084934;C1882327,false;false;false;false,2927/20013
associated with drug or toxin exposure,C0332281;C0013227;C1254351,false;true;false,2928/20013
ls mean change ± sea,C0023668;C0444504;C0392747;C0036493;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,2929/20013
reversible ( % ),C0205343,false,2930/20013
left atrial dimension,C3275097,false,2931/20013
aspirin alone ( n = nmbr ) nmbr . nmbr,C0004057;C0205171;C0439044;C0679994,true;false;false;false,2932/20013
diuretics ( % ),C0012798,true,2933/20013
ldl cholesterohhdl cholesterol ratio,C0023824;C0456603;C1547037;C0202117,true;false;false;false,2934/20013
renal insufficiencynmbr,C0035078;C1565489,true;true,2935/20013
> nmbr : nmbr hrs : min ( n = nmbr ),C1568891;C0702093;C1524029;C3813700,true;false;false;false,2936/20013
sr ii b nmbr - cjl nmbr,C0753208;C1710602;C4082587;C1709991;C3813610;C3890900;C3891546,true;false;false;false;false;false;false,2937/20013
csdmards + mtx ( n = nmbr ),C0025677;C1417487,true;false,2938/20013
uc duration,C0449238;C2926735,false;false,2939/20013
ejection fraction category,C0489482;C0683312;C3889287;C2700378,false;false;false;false,2940/20013
high - probability ventilation / perfusion lung scanning,C4699572;C0560738;C0024109,false;true;true,2941/20013
mmse nmbr - nmbr,C0451306,true,2942/20013
use oforal glucose - lowering agent — no . ( % ),C0042153;C0457083;C1947944,true;false;false,2943/20013
baseline sgrq total score,C0168634;C2964552;C1442488,true;false;false,2944/20013
min - max age,C0702093;C0001779;C1524029;C3813700,false;false;false;false,2945/20013
baseline gfr < nmbr ml / min per nmbr . nmbr mnmbr,C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,2946/20013
ischemic stroke,C0948008,false,2947/20013
medications at discharge,C0806915,false,2948/20013
multiracial,C1881928,false,2949/20013
qnmbr : nmbr . nmbr to < nmbr . nmbr kg ( n = nmbr vs nmbr ),C0022718;C0439209;C4054209,true;false;false,2950/20013
self - reported disease severity,C0681906;C0521117;C2700446,false;false;true,2951/20013
concomitant aedsa,C0521115,false,2952/20013
immunosuppressant use,C0021081;C0042153;C0457083;C1947944,true;true;false;false,2953/20013
moderately high risk,C0205081;C0332167;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;false;false;false;false;false;false,2954/20013
nmbr = some restrictions  no help needed,C0443288,false,2955/20013
nmbr or nmbr high - risk categories,,,2956/20013
calcium antagonist strategy ( n = nmbr nmbr ),C0006684;C0679199,true;false,2957/20013
time to balloon / needle,C0040223;C0336867;C0027551;C1882041;C0441144;C3541383,true;false;true;false;false;false,2958/20013
no - diuretics group ( n = nmbr ),C0012798;C0441848,true;false,2959/20013
egfr . nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,2960/20013
patients with any clinical,C0030705;C0205210,true;false,2961/20013
squamous cell carcinoma,C0007137;C1302853,true;false,2962/20013
( pg / mg ),C1627892,false,2963/20013
phosphodiesterase type nmbr inhibitors,C0031638;C0332307;C1547052;C1656262;C3539996,true;false;false;false;false,2964/20013
history of stroke ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2965/20013
age ^nmbr yrs,C0001779,false,2966/20013
cangrelor ( n = nmbr ),C1121991,true,2967/20013
previous cabg ( % total ),C0205156;C0010055;C0439175;C0439810;C1552607,false;true;false;false;false,2968/20013
baseline composite mayo clinic score,C0168634;C4055211;C0454788;C0002424;C0442592;C1077578;C1442488,true;false;false;true;false;false;false,2969/20013
ticlopidine after completion of study drug,C0040207;C2348557;C0013227;C1254351;C0205197;C0013175;C1554962,true;false;true;false;false;true;false,2970/20013
admission for hf in previous year,C0184666;C0018488;C1313497;C1538440;C3273279;C0809949,false;true;true;false;false;false,2971/20013
time since diagnosis — mo,C0040223;C3541383,true;false,2972/20013
left main coronary artery,C1261082,false,2973/20013
other llt at randomization,C2347090;C0034656,false;true,2974/20013
other anti - hypertensives,C0003364,true,2975/20013
a ngina > nmbr day s previously *,C0332173;C0439228;C0439505,false;false;false,2976/20013
% predicted,C0681842;C1882327,false;false,2977/20013
use of antihypertensive drugs,C1524063;C0003364,false;true,2978/20013
total cholesterol ( median,C0201950;C0549183;C0876920;C2347635;C2348144;C2939193;C0543421,false;false;false;false;false;false;false,2979/20013
hr ( nmbr % ci ) p   value,C0008107;C1709380;C3259781,true;false;false,2980/20013
loop or thiazide diuretic : ! :,C0445022,false,2981/20013
monitoring group ( n = nmbr ),C0150369;C0441848;C1283169,false;false;false,2982/20013
ischemic coronary artery disease,C0852149,false,2983/20013
blood eosinophil count > nmbr / mmnmbr at screening — no . ( % ),C1511226;C0200638;C4330985;C4554674;C0750879,false;false;false;false;false,2984/20013
no known frtrontxtfufoc cond aon,C0205309,false,2985/20013
mssbp / msdbp,,,2986/20013
devices for heart failure at screening visit,C0025078;C0018787;C2024216;C0231174;C0680095;C0025080;C0018801;C0018802;C4554158;C0220819;C0699733,true;true;false;false;false;true;true;true;false;true;true,2987/20013
interleukin nmbr ( pg / ml ),C0021764;C0439297;C1527200,true;false;false,2988/20013
priorvascular disease,C0012634,true,2989/20013
planned thienopyridine at enrollment,C1709561;C1120149,false;true,2990/20013
background csdmard category,C1706907;C0683312;C3889287,false;false;false,2991/20013
relative risk ( nmbr % ci ) ofprimary end point,C0242492;C0008107;C2349179;C2826544;C3259781,true;true;false;false;false,2992/20013
history of gi bleeding or ulcer — no . / total no . ( % ),C0019664;C0017181;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2993/20013
non - fibrin - specific,C0205370;C0015982,false;true,2994/20013
gly nmbr . nmbr mg b . i . d . n = nmbr,C1415124;C0024671;C0152277;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,2995/20013
previous coronary angioplasty,C2114427,false,2996/20013
mean ± sd egfr,C0444504;C2699239;C1739039;C3811844;C3812682;C2347634;C2348143,false;false;true;false;false;false;false,2997/20013
octave induction nmbr and nmbr,C0205263;C0857127,false;false,2998/20013
single vessel coronary artery diseasenmbr,C0581374,false,2999/20013
greater than or equal to nmbr %,C0439093,false,3000/20013
baseline nih stroke scale — no . ( % ) ^,C0168634;C1697238;C3484372;C1442488,true;false;false;false,3001/20013
history of stroke or tia — no . ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3002/20013
chd + cerebrovascular disease men nmbr / nmbr ( nmbr . nmbr ),C0280604;C0007820;C0025266;C3542407,false;true;true;false,3003/20013
albumin ( mg / dl ),C0001924;C0439269,true;false,3004/20013
lp ( a ) ( pmol / l ),C0065058;C0439284;C1439335;C4553379,true;false;false;false,3005/20013
st - segment depression,C0520887,false,3006/20013
statin — no . / total no . ( % ),C0360714,true,3007/20013
> nmbr episodes of atrial fibrillation in previous nmbr mo,C0332189;C0004238;C0344434;C1963067,false;true;false;false,3008/20013
ascvd as per protocol,C3665365;C1698058,false;false,3009/20013
oral antidiabetes combination therapy without insulina,C0442027;C0009429;C0556895;C4521986,false;true;false;false,3010/20013
interquartile range — yr,C1711350;C0439234,false;false,3011/20013
beta - blockers through hospital discharge or day nmbr — %,C0001645;C0586003,true;false,3012/20013
korea,C0022771,true,3013/20013
index event subtype,C0600653;C0441471;C0449560;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,3014/20013
residual perfusion defect > nmbr % on lung scan,C1609982;C1457869;C1518040,false;false;false,3015/20013
antiplatelet agent or anticoagulant,C0085826,true,3016/20013
atorvastatin monotherapy ( n = nmbr * ),C0286651,true,3017/20013
glycoprotein ilb / iiia inhibitor before pci],C0017968;C4697913;C1999216;C4049621,true;false;false;false,3018/20013
extensive disease other,C0849867,false,3019/20013
catheter access site,C0449652;C0444454;C1554204;C0085590;C0589360,false;false;false;true;false,3020/20013
number of individuals,C1549735,false,3021/20013
congenital heart disease,C0152021,false,3022/20013
ff nmbr gg ( n = nmbr,C4554348;C0017454;C0018370,false;true;true,3023/20013
time from event to randomization — days,C0040223;C0441471;C4019010;C3541383,true;false;false;false,3024/20013
clinical,C0205210,false,3025/20013
presence of mets ( % ) a,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,3026/20013
parental history of mii,C0030551;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3027/20013
fasting serum glucose,C0015663;C0202041;C3534430,true;false;false,3028/20013
treatment at randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,3029/20013
glomerular filtration rate ( ml / min / nmbr . nmbrma,C0017654;C0439445;C0024443;C3887485;C1561549,true;false;true;false;false,3030/20013
qrs duration > nmbr ms,C0429025;C2349943;C3539704;C3713294;C0488377,false;false;false;true;false,3031/20013
median time to first exacerbation ( months [nmbr % ci] ),C0549183;C0205435;C4086268;C0556969;C0008107;C3259781;C1279901;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false;false,3032/20013
fasting c - peptide ( nmol / l ) c,C0015663;C0006558;C0439282,true;true;false,3033/20013
tender joint count ( nmbr joints ),C0451530,false,3034/20013
all - cause hospitalization,C0015127;C0019993;C1524003,true;true;false,3035/20013
duration of full - dose warfarin therapy before enrollment ( mo ),C0444917;C0443225;C0366686,false;false;false,3036/20013
severe or very severe copd,C0205082;C4050465;C4050466,false;false;false,3037/20013
nmbrmg vs placebo,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3038/20013
nmbrmwd,,,3039/20013
proportion ( nmbr % ci ) adjusted for baseline hbanmbrc,C1709707;C0008107;C3259781,false;true;false,3040/20013
waist ( cm ),C0230097,false,3041/20013
qualifying diagnosis,C1514624;C0011900;C1704338;C1704656,false;true;true;false,3042/20013
mean disease duration,C0444504;C0872146;C2347634;C2348143,false;false;false;false,3043/20013
daily activities / social functioning,C0871707;C0037395,false;true,3044/20013
saxa nmbr . nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3045/20013
rosuva nmbr mg n = nmbr,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3046/20013
bmi group — no . ( % ),C0578022;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;true;false;false;false,3047/20013
lv mass,C0455825,false,3048/20013
hours from clopidogrel loading,C0439227;C0070166;C1708715,false;true;false,3049/20013
non - ischaemic,C1518422;C0475224,false;false,3050/20013
omega nmbr allocation,C1719844;C1706778,false;false,3051/20013
adjustednmbr risk reduction losartan vs placebo ( nmbr % cl ),C0456081;C1137094;C0126174,false;true;true,3052/20013
n - nmbr pufa,C0369718;C0032615;C0441922,false;true;false,3053/20013
combined ( n = nmbr ),C0205195,false,3054/20013
lamotrigine,C0064636;C0524166,true;false,3055/20013
maximal diameter stenosis,C0205289;C1301886;C0678234;C1261287;C2632116;C0806909;C4049713,false;false;false;true;false;false;false,3056/20013
hispanic ethnic group,C0086409;C0015031;C1879937,true;true;false,3057/20013
multivessel coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,3058/20013
history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3059/20013
patient ' s global assessment of disease activity ( nmbr - nmbr mm vas ),C4054228;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,3060/20013
prior cardiovascular event   '  ,C0332152;C1320716;C2826257,false;false;false,3061/20013
no . with event / total no . { % ),C0441471;C0439175;C0439810;C4019010,false;false;false;false,3062/20013
ras - aldosterone inhibitor^,C1514727;C0002006;C0034678;C0002007;C0525678,false;true;true;true;true,3063/20013
mean ( sd ) post - bronchodilator fevnmbr / fvc,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,3064/20013
non - hispanic white,C1518424;C0007457;C0043157;C0220938,false;true;true;false,3065/20013
ethacrynic acid,C0014963,true,3066/20013
aqlq ( s ) score,C4055434;C0449820;C4050231,false;false;false,3067/20013
patients who received negative results on test for antibodies to infliximabt,C0030705,true,3068/20013
non - hdl ( mg / dl ) < nmbr,C1518422;C3715113;C0439269,false;false;false,3069/20013
all completers,,,3070/20013
mean difference = seb,C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,false;false;true;true;false;false;false;false;false,3071/20013
> nmbr,,,3072/20013
prior use of $ nmbr systemic therapies,C1514463;C1524063;C0205373;C0332152;C1515119;C2826257,false;false;false;false;false;false,3073/20013
health assessment questionnaire ( nmbr - nmbr range ),C0451208;C1514721;C2348147;C3542016,false;false;false;false,3074/20013
low - molecular - weight heparin,C0019139;C3536766,true;false,3075/20013
non - hdl cholesterol ( mmol / l ),C0729627;C1532563;C1535899,false;false;false,3076/20013
previous medication for respiratory disease — no . ( % ),C0205156;C0418986;C0012634;C0013227;C0035204;C0035242;C3244316;C4284232;C1552607,false;false;true;true;true;true;false;false;false,3077/20013
characteristics of the index ml,C1521970;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,3078/20013
history of heart failure,C0455531,false,3079/20013
prior cardiovascular history,C0332152;C1880008;C2826257,false;false;false,3080/20013
metabolic syndromenmbr *,C0524620,true,3081/20013
consistency of effect,C0332529;C1280500;C1518681;C2348382;C1547017,false;false;false;false;false,3082/20013
fondaparinux,C1098510,true,3083/20013
other lipid - modifying drug 一 no . ( % ),C0023779;C0392747;C0013227;C1254351,true;false;true;false,3084/20013
initial timi flow,C0205265;C3272266;C1279901;C1555582;C1705685,false;false;false;false;false,3085/20013
overall nmbr,C0282416;C1561607,true;false,3086/20013
absolute decrease > nmbr %,C0205344;C0392756;C0547047,false;false;false,3087/20013
recurrent hf hospitalization,C1455761;C0018488;C0019993;C1313497;C1538440;C3273279;C2945760,false;true;true;true;false;false;false,3088/20013
intrathoracic or intraperitoneal surgery,C0595836,false,3089/20013
former or never diabetes,C0205156;C0750523,false;false,3090/20013
geographic site,C0017446,true,3091/20013
history of high cholesterol ( a ) nmbr,C0019664;C0020443;C1522133;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3092/20013
sco . ’ ita ' rojs dvt . ' pe,C2986561;C0022277;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446,false;true;true;true;false;false;false;false,3093/20013
general health vas,C0424575;C0042815;C3536884;C3827561;C4018875,false;true;true;false;false,3094/20013
placebo / open - label abatacept,C0032042;C1709323;C1619966;C1696465;C1706408,true;false;true;false;false,3095/20013
prior known stenosis > nmbr %,C0332152;C0205309;C0678234;C1261287;C2632116;C2826257,false;false;false;true;false;false,3096/20013
ras antagonist,C0034678;C0231491;C0525678,true;false;true,3097/20013
cancer medications,C0006826;C0013227;C0802604;C2598133;C4284232;C0998265;C1306459,true;true;false;false;false;false;false,3098/20013
current other ( predefined ) medical conditions,C0521116;C1705970,false;false,3099/20013
center location,C0205099,false,3100/20013
time from qualifying stroke to randomization,C0040223;C1514624;C0038454;C4554100;C3541383,true;false;true;false;false,3101/20013
geographical region,C0017446,true,3102/20013
priorbone disease,C0012634,true,3103/20013
laba - inhaled glucocorticoid use at screening,,,3104/20013
main concomitant treatments,C0205225;C0521115;C0087111;C1542147,false;false;true;false,3105/20013
use of rescue medication,C0240320,false,3106/20013
p vs placebo,C0369773;C2603361,false;false,3107/20013
cardiac troponin t level > nmbr . nmbr pg / l,C3538889;C0441889;C0439278;C0456079;C1547707;C2946261,false;false;false;false;false;false,3108/20013
aspirin < nmbr day,C0004057;C0332173;C0439228;C0439505,true;false;false;false,3109/20013
native coronary,C0302891;C0018787,false;true,3110/20013
arthralgia,C0003862;C4551938,true;false,3111/20013
other bdmards ( no tnfi taken ) t,,,3112/20013
hmgcoa rl,C0047420;C1419337;C3539667,true;false;false,3113/20013
egfrmdrd,,,3114/20013
prior angioplasty,C0332152;C0162577;C1548817;C2826257,false;true;false;false,3115/20013
anti - ccp antibody ( u /,C0003242;C1525410;C0439148;C1704514;C4318437;C0003241;C0021027;C1167408;C3665580,true;false;false;false;true;true;true;false;false,3116/20013
mean baseline ldl - c ( mmol / l ),C0444504;C0168634;C1532563;C1442488;C2347634;C2348143,false;true;false;false;false;false,3117/20013
composite events,C0205199;C0441471;C3541888;C1547335,false;false;false;false,3118/20013
foot fracture,C0272774,false,3119/20013
non - caucasian simva ( „ = nmbr },C1518422;C0007457;C0043157,false;true;true,3120/20013
tc,C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;false;false;false,3121/20013
high risk and fewer symptoms ( group c ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,3122/20013
type nmbr diabetes history,C1320657;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3123/20013
total cholesterol / hdl - c,C0201950;C3715113;C0543421;C0439175;C0023822;C0439810,false;false;false;false;true;false,3124/20013
hypertension absent,C0020538;C1963138,true;false,3125/20013
warfarin,C0043031,true,3126/20013
moderate,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3127/20013
urine acr ( mg / g ),C0042036;C1412134;C1300563;C1515941;C0042037;C2963137,true;false;false;false;true;false,3128/20013
baseline systolic blood pressure,C4274438,false,3129/20013
hrnmbr and nmbr % cl,,,3130/20013
ventricular tachyarrhythmias,C3827656,false,3131/20013
sulfonylurea based,C0038766;C3536898,true;false,3132/20013
medication use — no . ( % ) ^ |,C0013227;C3244316;C4284232,true;false;false,3133/20013
bivalirudin ( n = nmbr ),C0168273,true,3134/20013
p - blockers,C0369773;C2603361,false;false,3135/20013
acarbose 一 no . ( % ),C0050393,true,3136/20013
unfractionated heparin,C0019134;C2825026,true;false,3137/20013
all patients n = nmbr,C0030705,true,3138/20013
sitagliptin no . / total no .,C1565750,true,3139/20013
% anti - ccp + ( > nmbr units ),C4318437;C0439148;C1519795;C3853603,true;false;false;false,3140/20013
septal anomaly — no . ( % ),C0442004;C0332447;C1704258,false;false;false,3141/20013
intensified ( n 二 nmbr ),,,3142/20013
long - acting bnmbr - agonists,C0205166;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;true;false;false;false,3143/20013
bodily pain,C3890602,false,3144/20013
mmrc grade,C3826977;C0441800;C0919553;C3244287,false;false;false;false,3145/20013
alcohol consumption > once weekly,C0001948,true,3146/20013
p - value for trend *,C1709380;C1521798;C4554533,false;false;false,3147/20013
blood eosinophil count > nmbr / mmnmbr in nmbr months before screening — no . ( % ),C0014467;C0750480;C4330985;C0439231;C4554674;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664,true;false;false;false;false;false;true;false;false;true;false,3148/20013
at entry,C1705654,false,3149/20013
tiotropium group ( n = nmbr ),C0213771;C0441848,true;false,3150/20013
nmbr - nmbr months ( n = nmbr ),C0439231,false,3151/20013
dapagliflozin nmbr mg group ( n = nmbr ),C2353951;C0024671;C0441848;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,3152/20013
p value ( aged > nmbr vs . < nmbr years ),C1709380;C0001779;C0001792;C1999167,false;false;true;false,3153/20013
valvular disease,C3258293,false,3154/20013
prior angina,C0332152;C0002962;C2826257,false;true;false,3155/20013
japan and south korea,C0022341,true,3156/20013
postoperative nsaid or glucocorticoid use post - randomisation characteristic * *,C0032790;C0003211;C3536840,true;true;false,3157/20013
all randomized patients,C0034656;C0030705;C3815594,true;true;false,3158/20013
pack - years,C1277691,false,3159/20013
epa hr events ( % ),C0441471;C3541888,false;false,3160/20013
type of myocardial infarction — no . ( % ),C0332307;C0027051;C0428953;C2926063;C3810814;C4552959;C1547052,false;true;false;false;false;false;false,3161/20013
pciperformed for qualifying event,C1514624;C0441471;C4019010,false;false;false,3162/20013
nonsustained ventricular tachycardia — no . ( % ) - j -,C0750194;C2919575,false;false,3163/20013
ventricular tachycardia or fibrillation,C0042514;C0344428;C1963247;C4554446,true;false;false;false,3164/20013
percutaneous intervention,C0522523;C0184661;C0886296;C1273869,false;true;false;false,3165/20013
hazard ratio for cardiovascular death,C2985465;C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,false;true;true;false;false;false;false,3166/20013
hypercholesterolemia,C0020443;C1522133,true;false,3167/20013
diclofenac,C0012091,true,3168/20013
nmbr week to nmbr month,C0332174;C0332177;C0439231;C0439230,false;false;false;false,3169/20013
gp llb / llla inhibitors,C1705010;C0243077;C3811116,false;true;false,3170/20013
current,C0521116;C1705970,false;false,3171/20013
syndesmophyte present,C0221690,false,3172/20013
angiographic findings | |,C0002978;C2607943;C2926606;C3539655,true;true;false;false,3173/20013
bypass graft,C0185098,false,3174/20013
bmnmbr ( kg / mnmbr ),C0006416;C1532718,true;false,3175/20013
nmbr = no symptoms,C0683368;C1457887,true;false,3176/20013
prior brachytherapy,C0332152;C0006098;C2826257,false;true;false,3177/20013
time since cessation of full - dose warfarin therapy,C0040223;C3541383,true;false,3178/20013
history of or current cardiac disorders,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3179/20013
impaired glucose tolerance or impaired fasting glucose,C0271650,true,3180/20013
severe,C0205082;C4050465;C4050466,false;false;false,3181/20013
hospitalization for heart failure within previous nmbr mo — no . ( % ),C3898876,false,3182/20013
diuretics,C0012798,true,3183/20013
mmse ( points ),C0451306,true,3184/20013
apixaban ( n = nmbr ),C1831808,true,3185/20013
corticosteroid ( with or without immunosuppressants ),C0001617;C3536709,true;false,3186/20013
chf on placebo ( % ),C0018802;C0032042;C1696465;C1706408,true;true;false;false,3187/20013
overall hr ( nmbr % cl ),C0282416;C0596019;C1561607,true;false;false,3188/20013
hyperlipidemia — no . ( % ),C0020473;C0428465;C4555212,true;false;false,3189/20013
p value for trend across tertiles,C1709380;C1521798;C4554533,false;false;false,3190/20013
nmbr - nmbr drinks / wk,C0452428,false,3191/20013
> nmbr mg / dl — %,C0439269,false,3192/20013
diagnosis of allergic rhinitis,C0011900;C1334103;C2607914;C4552864;C1704338;C1704656,true;false;true;false;true;false,3193/20013
refractory to such therapy — no . ( % ),C0205269;C0039798;C0087111;C1363945,false;true;true;false,3194/20013
lymphocytes,C0024264;C4018897,true;false,3195/20013
adjusted * or ( nmbr % ci ) p value,C0456081,false,3196/20013
fevnmbr % pred . ( post - albuterol ),C3714541;C0032952;C0687676;C0001927;C1704687;C3469826;C0044955,true;true;false;true;false;false;true,3197/20013
known thrombophilia — no . ( % ),C0205309;C0398623,false;true,3198/20013
nmbr - nmbr ( mild ),C2945599,false,3199/20013
simvastatin,C0074554,true,3200/20013
copd exacerbation history,C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3201/20013
atio - pla,C0456170,false,3202/20013
cardiac troponin t level,C3538889;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,3203/20013
toast classification of qualifying stroke ( % ),C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,3204/20013
duration of diabetes by tertiles,C0449238;C0011847;C0011849;C2926735,false;false;true;false,3205/20013
on drug treatment ( % ),C0150270;C3469597,false;false,3206/20013
triglyceride ( median  mg / dl ) - nmbr [nmbr - nmbr percentile |,C0041004;C0549183;C0439269;C1264641;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false,3207/20013
pre - specified hr ( nmbr % cl ),C2826245,false,3208/20013
cardiac medications during indexhospitalization and / or discharge,C0018787;C0013227;C0802604;C2598133;C4284232;C1522601,true;true;false;false;false;false,3209/20013
neither corticosteroid nor immunosuppressant,C0001617;C3536709,true;false,3210/20013
albumin / creatinine ratio,C0486293;C1318293,false;false,3211/20013
score on modified rankin scale — median ( iqr ),C0449820;C2984908;C0549183;C0876920;C2347635;C2348144;C2939193;C3854213;C4050231,false;false;false;false;false;false;false;false;false,3212/20013
placebo group,C0032042;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,true;false;false;true;false;false;false;false;false,3213/20013
discontinuations due to ae,C0457454;C0678226;C3887670,false;false;false,3214/20013
creatinine clearance,C0812399,false,3215/20013
multi vessel ( or left main ),C0439064;C0005847;C3266262,false;true;true,3216/20013
infarct location,C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,3217/20013
elevated hscrp,C0205250;C3163633,false;false,3218/20013
laba + ics n = nmbr,C0815320;C4551720,false;true,3219/20013
renal function,C0232804,false,3220/20013
mean ± sd fasting insulin,C0444504;C2699239;C0015663;C0021641;C1533581;C1579433;C3714501;C2347634;C2348143,false;false;true;true;false;false;false;false;false,3221/20013
at least nmbr / mo,C0026544;C0332177,true;false,3222/20013
atrial fibrillation — no . / total no . ( % ),C0004238;C0344434;C1963067,true;false;false,3223/20013
ls - mean between - group difference ( nmbr % ci ),C0023668;C2347634;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,3224/20013
all others,C1955473;C3539125,false;false,3225/20013
median age ( nmbr %,C0549183;C0001779;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3226/20013
history of cerebrovascular disease,C0585890,false,3227/20013
laba or lama ’,,,3228/20013
metformin ( n = nmbr ),C0025598,true,3229/20013
prior cabg ( before index acs ),C0332152;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C2826257,false;true;true;true;false;true;false;false;false;false,3230/20013
anti - tnf - experienced patients,C1448177;C0030705,true;true,3231/20013
digoxin / digitalis glycoside,C0012265;C0012253,true;true,3232/20013
body mass index ( range ) ( kg / mnmbr ),C0005893;C1514721;C1532718;C2348147;C3542016;C0578022;C1305855,false;false;false;false;false;false;true,3233/20013
patients with previous loss of response to infliximab,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,3234/20013
treatment group,C0039798;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;true;false;false;false;false;false,3235/20013
haq - di,C3826998;C4321476,false;false,3236/20013
duration of copd ( years ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,3237/20013
carotid infarct,C0741968;C0021308,false;true,3238/20013
negative ( < nmbr . nmbr ),C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,3239/20013
endpoint week nmbr,C2349179;C0332174;C0439230;C2826544,false;false;false;false,3240/20013
lipid and lipoprotein values ( mg / dl ),C0023779,true,3241/20013
placebo no . of events / no .,C0032042;C1696465;C1706408,true;false;false,3242/20013
for treatment of index event,C0039798;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;true;false;false;false;true;false;false;false;false;false,3243/20013
mild ( > nmbr to < nmbr ),C2945599,false,3244/20013
heterogeneity p value,C0019409;C1709380;C0242960,false;false;true,3245/20013
number of stents ( per patient ),C0237753;C0038257;C0449788,false;true;false,3246/20013
preoperative serum creatinine > nmbr pmol / l,C0445204;C0201976;C0439284;C0600061,false;false;false;false,3247/20013
sacubitril / valsartan ( n = nmbr ),C4033631,true,3248/20013
mean ( s . d . ) apoc - ll nmbr,C0444504;C0003594;C2347634;C2348143,false;true;false;false,3249/20013
implanted cardioverter - defibrillator,C0021102;C0810516;C2828363,false;false;false,3250/20013
swollen joint count ( n / nmbr ),C0451521,false,3251/20013
postmenopausal ( % ),C0232970,false,3252/20013
coronary disease,C0010068;C1956346,true;true,3253/20013
prior lev treatment,C1514463;C0023556,false;true,3254/20013
rsg nmbr mg / day,C0439422,false,3255/20013
former or current smokers ( % ),C0205156;C0750523,false;false,3256/20013
topiramate,C0076829,true,3257/20013
hydrochlorothiazide,C0020261,true,3258/20013
class nmbr antiarrhythmic agents,C0456387;C0003195;C0301380;C1518526;C1705943,false;true;false;false;false,3259/20013
concomitant methotrexate,C0521115;C0025677,false;true,3260/20013
corticosteroids . immunosuppressants . and antimalarials,C0001617;C0021081;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3261/20013
bl mean,C0005918;C0444504;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;true;false;false,3262/20013
history of diabetes mellitus,C0455488,false,3263/20013
median ( iqr ) admission data,C0549183;C0184666;C1511726;C3245479;C3714741;C0809949;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,3264/20013
not provided,C1518422,false,3265/20013
current bone disease,C0521116;C0005940;C1705970,false;true;false,3266/20013
triglyceride ( median : mg / dl ) a [nmbr - nmbr percentile],C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,3267/20013
stent plus abciximab,C0038257;C0332287;C0288672,true;false;true,3268/20013
systolic blood pressure < nmbr mm hg and diastolic blood pressure < nmbr mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,3269/20013
vasoprotectives,C0304533,false,3270/20013
associatedproximaldeep - veinthrombosisatdiagnosis,,,3271/20013
discharge medication,C0012621;C0013227;C3244316;C4284232;C0030685;C2926602,false;true;false;false;true;false,3272/20013
other cardiac surgery,C0018821;C0524727,true;true,3273/20013
induction - trial group assignment — no . ( % ),C0205263;C1320290;C1516050;C0857127,false;false;false;false,3274/20013
bw,C0005910;C0006041;C2986891,true;true;false,3275/20013
first procedure,C0205435;C0184661;C2700391;C3274430;C3539779;C1279901,false;true;false;false;false;false,3276/20013
prior af ablation,C0332152;C0344434;C0547070;C1261381;C4049859;C2826257,false;false;false;false;false;false,3277/20013
fevnmbr reversibilityz ( pre / post salbutamol ),C3714541;C0332152;C0687676;C0001927;C1704687;C3469826;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false,3278/20013
second - generation stent,C0205436;C0079411;C0038257;C3146294;C0457385;C0565930;C1561503;C1705190,false;true;true;false;false;false;false;false,3279/20013
msasss,,,3280/20013
total cholesterohhdl cholesterol ratio,C0201950;C0456603;C1547037;C0543421,false;false;false;false,3281/20013
primary safety end point : severe / life - threatening,C2986535;C0036043;C0205082;C1546953;C2826244;C3537125;C4050465;C4050466;C1705187,false;true;false;false;false;false;false;false;false,3282/20013
nt - probnp ( pg / ml ) ( qnmbr - qnmbr ),C0669479;C0439297;C0754710,true;false;true,3283/20013
remodeling,,,3284/20013
smoking past,C0037369;C1444637;C4284302;C0453996;C1881674,true;false;false;true;false,3285/20013
cigarette smoking status,C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,3286/20013
use of concomitant lipid - lowering therapy - no . ( % ),C1524063;C0521115;C0585943,false;false;false,3287/20013
prior arrhythmias,C0332152;C0003811;C2826257,false;true;false,3288/20013
thienopyridine at enrollment,C1120149;C1516879;C1696073;C3888021,true;false;false;false,3289/20013
coronary risk factors — no . ( % ),C2024776,false,3290/20013
cardiovascular risk factors,C0850624,false,3291/20013
less than nmbr year,C0439092;C0439234;C0439508,false;false;false,3292/20013
anti - arthritic medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,3293/20013
some physical activity,C0015259;C0026606,true;true,3294/20013
first medical contact — no . ( % ) §,C0205435;C0199168;C0205476;C1279901,false;false;false;false,3295/20013
premature cad among family members,C0151526;C1504769;C0086282;C2239547;C3813548;C4284121;C0205252;C4018905,true;true;true;false;false;false;false;false,3296/20013
ppci in - nmbr,,,3297/20013
overall n = nmbr,C0282416;C1561607,true;false,3298/20013
fevnmbr % predicted,C3714541,true,3299/20013
medical therapy only,C0418981;C0205171;C1720467,false;false;false,3300/20013
aspirin and thienopyridine therapy,C0004057,true,3301/20013
non - hispanic black,C1518424;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,3302/20013
normal renal function,C0232805,false,3303/20013
renal parameters,C0022646;C0449381,true;false,3304/20013
fasting blood glucose — mmol / liter,C0428568;C0439190;C0475211;C1261430,false;false;false;false,3305/20013
glycoprotein iib / iiiareceptorinhibitor,C0017968,true,3306/20013
plaque ( n,C0011389;C0241148;C0332461;C0333463;C4316797,true;false;false;true;false,3307/20013
coronary angiography,C0085532;C1548829,true;false,3308/20013
evolocumab nmbr mg every nmbrweeks ( n = nmbr ),C3529352;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3309/20013
patients not receiving immunosuppressive agents at baseline,C0030705,true,3310/20013
no . ( % ) with event [incidence rate per nmbr patient - y],C0441471;C1708485;C0030705;C4019010,false;false;true;false,3311/20013
screening hbanmbrc ( % ),C0220908;C0019016;C1825777;C3538758;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;true;false;false;false;false;false,3312/20013
modified rankin scale — no . ( % ) |,C2984908;C3854213,false;false,3313/20013
previous cancer,C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,3314/20013
penetrating,C0205321,false,3315/20013
more than nmbr vessels stented,C0205172;C0005847,false;true,3316/20013
changes ( a ) in metabolic syndrome parameters hdl cholesterol,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3317/20013
baseline acq - nmbr score,C0168634;C2919686;C1442488,true;false;false,3318/20013
dm medication,C0011816;C0013227;C3244316;C4284232;C3250443,true;true;false;false;false,3319/20013
left main disease,C0205091;C0205225;C0012634;C1542147;C0443246;C1552822,false;false;true;false;false;false,3320/20013
> nmbr lesions per vessel,C0221198;C0005847,false;true,3321/20013
xanthinesnmbr,C0043318;C3541955,true;false,3322/20013
tg ( mmol / l,C0337445;C1532563,false;false,3323/20013
verapamil sr strategy ( n = nmbr,C1527129;C0679199,false;false,3324/20013
aspirin ( asa ) ( » = nmbr nmbr ),C0004057;C3853627,true;false,3325/20013
hispanic black,C0086409;C0005680;C0027567;C0085756;C0439541,true;true;true;true;false,3326/20013
atrial fibrillation or flutter — no . ( % ),C0004238;C0344434;C1963067,true;false;false,3327/20013
on - treatment,C4684449,false,3328/20013
killip class i — no . ( % ),C2697844,false,3329/20013
killip class ( interaction : p = nmbr . nmbr ),C1881332;C1704675,false;false,3330/20013
adjusted hr ( enl vs lcz ) ( nmbr % cl ),C0456081,false,3331/20013
total basdai,C0439175;C1998004;C0439810,false;false;false,3332/20013
placebo + statin ( n = nmbr,C0032042;C0360714;C1696465;C1706408,true;true;false;false,3333/20013
thrombus aspiration,C0087086;C0220787;C0349707;C0700198;C2712334;C2827071;C0302148;C3146237,true;false;false;false;false;false;false;false,3334/20013
marital status,C0024819;C1716536;C3172566,true;false;false,3335/20013
no . of days to randomization — median ( iqr ),C0439228,false,3336/20013
exacerbations in previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,3337/20013
pain ( nmbr mm vas ),C0042815;C4330985;C4554674,true;false;false,3338/20013
angiogenesis,C0302600;C1519670,false;false,3339/20013
non - fatal mi,C1518422;C1302234;C3810814;C1705232,false;false;false;false,3340/20013
who functional class — no . ( % ) : c,C0205245;C0456387;C1518526;C1705943;C0542341;C2700217,false;false;false;false;false;false,3341/20013
diabetic patients,C0241863;C0030705,false;true,3342/20013
type nmbr,C0332307;C1547052,false;false,3343/20013
abatacept nmbr / — nmbr mg / kg ( n = nmbr ),C1619966;C0439272,true;false,3344/20013
black race and ss < nmbr ( n = nmbr vs nmbr ) ■ -,C0005680,true,3345/20013
baseline treatments,C0168634;C0087111;C1442488,true;true;false,3346/20013
imm ( without corticosteroid ),C0205470;C0001617;C3536709,false;true;false,3347/20013
mean ( sd ) number of exacerbations *,C0444504;C2699239;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false;false,3348/20013
s . e .,C0565930;C2603362,false;false,3349/20013
spiralcomputedtomographyangiography,,,3350/20013
p ( losartan versus placebo ),C0369773;C0126174;C2603361,false;true;false,3351/20013
apo b / apo a - l ratio ( mean ),C1447574;C0003592;C0456603;C0444504;C2347634;C2348143;C1547037;C0523508;C4553344;C4521365,true;true;false;false;false;false;false;false;false;false,3352/20013
mean ( s . d . ) non - hdl cholesterol,C0444504;C0729627;C1535899;C2347634;C2348143,false;false;false;false;false,3353/20013
secukinumab nmbr mg,C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3354/20013
early - start group ( n = nmbr ),C1279919,false,3355/20013
p interaction ( rx arm * sex ),C0369773;C1704675;C1425688;C0446516;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C3715044;C4553528;C1521941;C2709207;C2603361,false;false;false;true;true;true;true;false;false;true;false;false;false;false;false,3356/20013
left ventricular hypertrophy,C0149721;C3484363,true;false,3357/20013
af pattern,C0344434;C0449774;C4049859,false;false;false,3358/20013
post - bronchodilator fev,C2599594;C3714541,false;true,3359/20013
body - mass index — no . ( % ) $,C0005893;C0578022;C1305855,false;false;true,3360/20013
waist - to - hip ratio,C0205682,true,3361/20013
nmbr years or older,C0439234,false,3362/20013
years since myocardial infarction,C0439234,false,3363/20013
with alogliptin nmbr mg ( n nmbr nmbr ),C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3364/20013
hoehn and yahr stage,C0205390;C1300072;C1306673,false;false;false,3365/20013
elevated cardiac markers — no . ( % ) : t,C0205250;C1271630;C3163633,false;false;false,3366/20013
scores for global and pain assessments §,C0449820;C0205246;C2348867,false;false;false,3367/20013
documented coronary artery disease,C1301725;C0010054;C0010068;C1956346;C1609436,false;true;true;true;false,3368/20013
large vessel atherosclerosis,C0225990;C0003850;C0004153,false;true;true,3369/20013
hbalc < nmbr % ( < nmbr mmol / mol ),C3829066,false,3370/20013
copd severity,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,3371/20013
geometric mean,C2986759,false,3372/20013
assoc,,,3373/20013
chronic kidney disease stage : egfr ( ml / min per nmbr . nmbr mnmbr ),C1561643;C1739039;C0439445;C0007591;C0456533;C3811844;C3812682;C4553188,true;true;false;true;false;false;false;false,3374/20013
haq - di ( nmbr - nmbr ),C3826998;C4321476,false;false,3375/20013
egfr crcl < nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C1846718;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,3376/20013
baseline weight,C1303013,false,3377/20013
bifurcation,C0184906;C3146289,false;false,3378/20013
pe ( with or without dvt ),C0070939;C1880476;C4284304,true;false;false,3379/20013
differencenmbr,C1705241;C1705242,false;false,3380/20013
dilatative,C0002940;C0012359;C0700124;C1322279,true;true;false;true,3381/20013
arterial access,C0003842;C0444454;C1554204;C0221464,true;false;false;false,3382/20013
serum cholesterol ( mg / l ) *,C0587184;C0439268,false;false,3383/20013
cerebral thrombosis,C0079102;C0151945;C0795687,true;false;false,3384/20013
rosuva nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3385/20013
dose of atorvastatin,C0178602;C0286651;C0869039;C1114758,false;true;false;false,3386/20013
mean ( sd ) weight,C0444504;C2699239;C0005910;C0043100;C1305866;C1705104;C2347634;C2348143,false;false;true;true;false;false;false;false,3387/20013
congestive heart failure — %,C0018802,true,3388/20013
no prior ms therapies,C1514463;C2349943;C3539704;C3713294,false;false;false;true,3389/20013
glucocorticoids only,C0017710;C0205171;C1720467;C3540777;C3540778,true;false;false;false;false,3390/20013
background aha therapy at screening,C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,3391/20013
established atherosclerotic cv disease §,C0443211;C0333482;C0007222;C1272684,false;false;true;false,3392/20013
angina symptoms^,C0858277,false,3393/20013
pain ( vas ),C0042815,true,3394/20013
stroke subtype,C0038454;C0449560;C4554100,true;false;false,3395/20013
with placebo,C0032042;C1696465;C1706408,true;false;false,3396/20013
relative risk ( nmbr % confidence interval ),C0242492;C0009667,true;true,3397/20013
r nmbr mg + fa ( « = nmbr ),C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,3398/20013
previous pci or cabg,C0205156;C4049621;C1552607,false;false;false,3399/20013
total pack - yrs,C0439175;C1968515;C2825051;C2828395;C0439810,false;false;false;false;false,3400/20013
baseline trl - c by quintiles,C0168634;C1508496;C1442488,true;false;false,3401/20013
mtx > nmbr and £ nmbr mg / week,C0025677;C1417487,true;false,3402/20013
ff / vi nmbr / nmbr | ig ( n = nmbr ),C4554348;C0205999;C0021027;C0305052;C0360506,false;true;true;false;false,3403/20013
corticosteroids and immunosuppressants only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,3404/20013
number of vessels treated,C0237753;C0005847;C0449788,false;true;false,3405/20013
mra ( spironolactone or eplerenone ),C0243032;C0037982;C1609165;C3891069,true;true;true;false,3406/20013
peripheral artery occlusive disease,C1306889,false,3407/20013
baseline value,C0168634;C1522609;C1442488,true;false;false,3408/20013
chronic cvd,C0205191;C0007222,false;true,3409/20013
established ( n = nmbr ),C0443211;C1272684,false;false,3410/20013
known thrombophilia,C0205309;C0398623,false;true,3411/20013
normal > nmbr - nmbr,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,3412/20013
estimated gfr renal function stage,C0750572;C0017654;C0232804;C0205390;C1300072;C1306673;C1424601,false;true;false;false;false;false;false,3413/20013
clinical characteristics,C0683325,false,3414/20013
interval after index event,C1272706;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C1552654;C1552713,false;true;false;false;true;false;false;false;false;false,3415/20013
country,C0454664;C1511538,false;false,3416/20013
fractures ( site not specified ),C0016658,true,3417/20013
number of previous dmards,C0237753;C0205156;C0242708;C1552607;C0449788,false;false;true;false;false,3418/20013
non - hispanic,C1518424,false,3419/20013
proportion of patients in corticosteroid - free clinical remission at week nmbr,C1709707;C0030705,false;true,3420/20013
pramlintide,C0537551,true,3421/20013
height,C0489786,false,3422/20013
ambulance,C0002422;C3846685,true;false,3423/20013
chd risk - no . ( % ),C0280604;C3542407,false;false,3424/20013
infusion administered — no . / total no . ( % ),C0574032;C1827465,false;false,3425/20013
non - hdl cholesterol ( week nmbr ),C0729627;C0332174;C0439230;C1535899,false;false;false;false,3426/20013
inhaled glucocorticoid use at screening,C0004048;C0017710;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;true;true;false;false;false;false;false;false;false,3427/20013
type of vessel involved,C1282017,false,3428/20013
oral blood glucose - lowering drug nmbr ( nmbr . nmbr ),C0442027;C0018938;C0017725;C0441994;C2003888;C0005802;C0013227;C1254351;C4521986,false;true;true;false;false;true;true;false;false,3429/20013
baseline pos frequency per nmbr days,C0168634;C1262869;C0585290;C3496112;C3496399;C1442488,true;true;false;false;false;false,3430/20013
mean ( sd ) mtx dose,C0444504;C2699239;C0366550;C2347634;C2348143,false;false;false;false;false,3431/20013
laboratory ae,C0022877;C3887670;C3244292;C4283904,true;false;false;false,3432/20013
use of concomitant lipid - lowering treatment,C1524063;C0521115;C0023779;C0441994;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888,false;false;true;false;true;true;false;false;false;false;false;false,3433/20013
age ( y ),C0001779,false,3434/20013
heart failure,C0018801;C0018802;C4554158,true;true;false,3435/20013
omalizumab ( lsm ),C0966225,true,3436/20013
baseline cv medications,C0168634;C3538987;C0013227;C0802604;C2598133;C4284232;C4048877;C4318503;C1442488,true;false;true;false;false;false;true;false;false,3437/20013
nmbr or nmbr high cardiovascular risk categories,,,3438/20013
pack - years smoked,C1277691,false,3439/20013
exenatide lar,C0167117,true,3440/20013
concomitant treatment,C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,3441/20013
score on the minnesota living with heart failure scaled,C0449820;C0026183;C0595998;C4520849;C4551704;C4050231,false;true;false;false;false;false,3442/20013
eosinophil count ( cells per pl ),C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;true;false;false;true;false,3443/20013
disease duration ( yr ),C0872146;C0439234,false;false,3444/20013
baseline total pcsknmbr level by median,C0168634;C0439175;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C0439810;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false,3445/20013
antiplatelet agents ( % ),C0085826,true,3446/20013
peripheral vascular disease,C0085096,true,3447/20013
duration of disease — yr : t,C0872146;C0439234,false;false,3448/20013
infarction nmbr - nmbr days,C0021308;C0439228,true;false,3449/20013
estimated difference ( nmbr % ci ),C0750572;C1705241;C0008107;C3259781;C1705242,false;false;true;false;false,3450/20013
non - st - elevation myocardial infarction,C1536221;C1536222;C3537184;C4255010,false;false;false;true,3451/20013
aspirin i clopidogrel ( n = nmbr,C0004057;C0021966;C0070166;C0221138,true;true;true;false,3452/20013
pulmonary disease — no . ( % ),C0024115,true,3453/20013
etn nmbr mg + mtx n = nmbr,C0014758;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0717758,true;true;true;false;true;false;false;false;false;false;true,3454/20013
all stroke,C0038454;C4554100,true;false,3455/20013
previous respiratory disease other than copd — no . ( % ),C0205156;C0035204;C0024117;C1412502;C3714496;C0035242;C1552607,false;true;true;false;false;true;false,3456/20013
history of stroke or transient ischemic attack,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3457/20013
pelvic fractures,C0149531,false,3458/20013
standard care allocation,C1442989;C1947933;C1706778;C2828392,false;false;false;false,3459/20013
ra duration ( months ) *,C3538806;C0449238;C0439231;C2926735;C4048756,false;false;false;false;false,3460/20013
other drugs — no . ( % ),C0013227;C3687832,true;false,3461/20013
atherosclerotic disease *,C0333482;C0012634,false;true,3462/20013
angiography and revascularization,C0002978,true,3463/20013
unfractionated heparin ( n = nmbr ),C0019134;C2825026,true;false,3464/20013
demographic and clinical characteristics,C0011298,true,3465/20013
mean lixi dose ± sd ( lg / day ),C0444504;C0178602;C2699239;C0023128;C0332173;C0439228;C0439505;C0694651;C0869039;C1114758;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,3466/20013
number ( % ),C0237753;C0449788,false;false,3467/20013
age subgroups,C0001779;C1079230,false;false,3468/20013
ind / gly nmbr / nmbr mg once daily ( n = nmbr ),C4049864;C0017890;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523677,false;true;true;false;true;false;false;false;false;false;false,3469/20013
no . of events / no . of patients,C0441471;C3541888,false;false,3470/20013
carotid artery intervention *,C0007272;C0184661;C0886296;C1273869;C0162859;C0741968;C0397581,true;true;false;false;true;false;false,3471/20013
hope patients with coronary - artery disease ( n = nmbr ),C0392347;C0030705;C0010054;C0010068;C1956346,true;true;true;true;true,3472/20013
linagliptin / metformin,C3264599,false,3473/20013
ultrasound carotid arteries,C0948945,false,3474/20013
pci or cabg surgery for index event,C4049621,false,3475/20013
dasnmbr - nmbr ( esr ) nmbr,C0051767;C3811131;C0057671,true;false;true,3476/20013
cardiac therapy §,C3654025,false,3477/20013
low - dose statin,C0445550;C0360714;C1708745,false;true;false,3478/20013
oral anticoagulant,C0354604,false,3479/20013
p - value for interaction nmbr . nmbr,C1709380;C1704675,false;false,3480/20013
> nmbr des type,C0011702;C0332307;C1547052;C4551552,true;false;false;true,3481/20013
placebo patients with events / total,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,3482/20013
average age ( year ),C1510992;C0001779;C0439234;C0439508;C2825518,false;false;false;false;false,3483/20013
placebo + nmbr mg / d of simvastatin,C0032042;C0439422;C0074554;C1696465;C1706408,true;false;true;false;false,3484/20013
baseline hb nmbrg i nmbr n = nmbr,C0168634;C0062408;C0086706;C1442488,true;true;true;false,3485/20013
type of end point,C0332307;C2349179;C2826544;C1547052,false;false;false;false,3486/20013
copd medication at study entry,C0024117;C0013175;C1705654;C1412502;C3714496,true;true;false;false;false,3487/20013
emphysema,C0013990;C0034067,true;true,3488/20013
mean ( sd ) esr,C0444504;C2699239;C3811131;C2347634;C2348143,false;false;false;false;false,3489/20013
vilanterol,C2935023,true,3490/20013
latin america ( n = nmbr ),C0023122,true,3491/20013
tnfi naive,,,3492/20013
continued thienopyridine ( n = nmbr ),C0549178;C1120149,false;true,3493/20013
total intravenous loop diuretic ( mg ) median,C0439175;C0348016;C0354100;C0024671;C0549183;C0876920;C2347635;C2348144;C2939193;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3536704;C0439810,false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false,3494/20013
mild to moderate,C1299392,false,3495/20013
median n - terminal probnp ( iqr ) — pg / ml,C0549183;C0669479;C0439297;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,3496/20013
degree of stenosis,C4034225,false,3497/20013
diagnostic angiography,C0002978,true,3498/20013
left ventricular hypertrophy on echo,C0149721;C0058928;C1655045;C3484363,true;true;false;false,3499/20013
abatacept plus mtx ( n = nmbr ),C1619966;C0025677;C1417487,true;true;false,3500/20013
baseline measurements,C0168634;C0242485;C1442488,true;false;false,3501/20013
non - compliance,C0376405;C0457432,true;false,3502/20013
duration of pre - randomization anticoagulant therapy,C2711563;C0332152;C0034656;C0740175;C2257086;C3669034,false;false;true;false;false;false,3503/20013
bmi at baseline ( kg / mnmbr ),C0578022;C0168634;C1532718;C1442488,false;true;false;false,3504/20013
average maximum common and bifurcation cimt ( mm ),C1510992;C0806909;C1552615;C2826546;C2825518,false;false;false;false;false,3505/20013
location,C0450429;C1515974;C4284930;C4284931,false;false;false;false,3506/20013
kheeatne index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3507/20013
osteitis,C0029400,true,3508/20013
nmbr - nmbr months fn = nmbr . nmbr ),C0439231;C1570610,false;true,3509/20013
glinide 一 no . ( % ),C2266929,false,3510/20013
below - knee popliteal crural,C0542339;C0022742;C0442037;C0023216;C1140621;C0022745;C1963703;C1552829,false;true;false;true;true;true;false;false,3511/20013
pre - enrollment antihyperglycemic therapy,C1882440;C1516879;C0020616;C1696073;C3888021,false;false;true;false;false,3512/20013
symptom duration,C1457887;C0449238;C2926735;C3854129,false;false;false;false,3513/20013
% patients with no progression,C0030705;C0242656;C0449258,true;true;false,3514/20013
measured at clinic visit with automated device §,C0444706;C0008952;C3541902,false;true;false,3515/20013
previous episode of heart failure,C0205156;C0332189;C0018801;C0018802;C4554158;C1552607,false;false;true;true;false;false,3516/20013
liraglutide ( n = nmbr ),C1456408,true,3517/20013
post - bronchodilator fevnmbr — liters,C2599594;C3714541;C0475211,false;true;false,3518/20013
renal insufficiency,C0035078;C1565489,true;true,3519/20013
lvef within nmbr mo,C0428772;C0026544;C0332177;C0488728,false;true;false;false,3520/20013
ldl cholesterol,C0023824;C0202117,true;false,3521/20013
history of hypertension for nmbr mo or more,C0455527,false,3522/20013
fish oil ( n = nmbr ),C0016157,true,3523/20013
digitalis glycoside,C0012253,true,3524/20013
baseline mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,3525/20013
no previous dmard therapy,C0205156;C0242708;C0039798;C0087111;C1363945;C1552607,false;true;true;true;false;false,3526/20013
hbanmbrc at nmbr weeks *,C0019016;C0439230;C1825777;C3538758,true;false;false;false,3527/20013
elevated fasting glucose,C0205250;C3163633,false;false,3528/20013
no adk / e cancer,C1412243;C0006826;C0998265;C1306459,false;true;false;false,3529/20013
indacaterol + tiotropium ( n[nmbr ),C1722260;C0213771,true;true,3530/20013
ras % target dose,C0034678;C1521840;C0178602;C0869039;C1114758;C2986546;C0525678,true;false;false;false;false;false;true,3531/20013
history of upper gastrointestinal event,C0019664;C3203348;C0441471;C4019010;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,3532/20013
ibdq score |,,,3533/20013
first primary ( change in updrs score / wk,C0205435;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631;C1279901,false;false;false;true;false;false;false;false;false;false,3534/20013
overweight ( nmbr to < nmbr kg / mnmbr ),C0497406;C1532718,true;false,3535/20013
symptom onset - to -,C4086878,false,3536/20013
median ( iqr ) cholesterol,C0549183;C0008377;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false,3537/20013
week nmbr mean ( se ),C0332174;C0444504;C0036919;C2347634;C2348143;C0439230,false;false;true;false;false;false,3538/20013
western europe,C0043129,true,3539/20013
imm + corticosteroid,C0205470;C0001617;C3536709,false;true;false,3540/20013
tnmbrdm duration,C2603360;C0011816;C0449238;C2926735;C3250443,false;true;false;false;false,3541/20013
previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,3542/20013
no . ( % ) of participants,C0679646,false,3543/20013
previous tnf antagonist exposure,C0205156;C1448177;C0231491;C0274281;C0332157;C1552607,false;true;false;false;false;false,3544/20013
pharmacotherapy,C0013216;C0013217,true;true,3545/20013
ulcerative colitis,C0009324,true,3546/20013
received nmbr prior anti - tnf therapy,C1514756;C0332152;C0281481;C2826257,false;false;false;false,3547/20013
placebo n ( rate ) *,C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,3548/20013
low - density lipoprotein,C0023823,true,3549/20013
family history^,C0241889,true,3550/20013
fvc ( % predicted ),C3714541,true,3551/20013
clinical ae,C0205210;C3887670,false;false,3552/20013
dietary epa - dha intake ( mg / day ) *,C1286104;C0142831;C0439422;C2348308,false;true;false;false,3553/20013
other llt use,C2347090;C0042153;C0457083;C1947944,false;true;false;false,3554/20013
ada nmbr / nmbr n[nmbr,C1060325;C3811629,false;false,3555/20013
serious adverse events,C1519255,false,3556/20013
change from baseline at week nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,3557/20013
medications at coronary angiography,C0013227;C0085532;C1548829;C0802604;C2598133;C4284232,true;true;false;false;false;false,3558/20013
nmbr nmbr years,C0439234,false,3559/20013
no . of subjects,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,3560/20013
sfc nmbr / nmbr mg twice daily ( n = nmbr,C4521536;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,3561/20013
geometric mean blood eosinophil count ( sd on a loge scale ) — cells / mmnmbr,C2986759;C0200638;C2699239;C2697934;C0175659;C4330985;C4554674;C0349674;C1947916,false;false;false;false;true;false;false;false;false,3562/20013
copd - placebo ( n = nmbr ),C0024117;C0032042;C1696465;C1706408;C1412502;C3714496,true;true;false;false;false;false,3563/20013
pga subscore,C0016410;C3541266;C4050369,true;false;false,3564/20013
mafcaiancy at randorrtzaton,,,3565/20013
nmbr . nmbr mg / dl triglycerides^,C0439269;C0041004,false;true,3566/20013
antiplatelet within nmbr mo before randomization,C0026544;C0332177,true;false,3567/20013
lesion characteristics,C1286326,false,3568/20013
handihaler and diskus,,,3569/20013
baseline dyspnea index score,C1511069;C0449820;C4050231,false;false;false,3570/20013
creatinine clearance — no . ( % ),C0812399,false,3571/20013
any oral hypoglycemic drug 一 no . ( % ),C0359086,false,3572/20013
sfcnmbr / nmbr pg b . i . d . n = nmbr,C4521536;C2827928;C0021966;C0221138;C0030827;C0152277;C0072225;C1266240,false;false;true;false;true;false;true;false,3573/20013
infarct related artery location,C0021308;C0439849;C0003842;C0450429;C1515974;C4284930;C4284931;C0226004;C0445223,true;false;true;false;false;false;false;false;false,3574/20013
pen - label empagliflozin nmbr mg ( baseline hbanmbrc > nmbr % ),C1424886;C0181496;C3490348;C0024671;C0168634;C0019016;C1825777;C3538758;C1442488;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2827499;C4522130;C4551445;C3273588;C4319659,false;false;true;true;true;true;false;false;false;true;false;false;false;false;false;false;false;false;false;false,3575/20013
other vasculars,,,3576/20013
patients who received indeterminate results on test for antibodies to infliximabt,C0030705,true,3577/20013
history of diabetes requiring drugs,C0019664;C0020616;C0019665;C0262512;C0262926;C1705255;C2004062;C0011847;C1553893;C0011849,true;true;true;false;false;false;false;false;false;true,3578/20013
coronary intervention,C0018787;C0184661;C0886296;C1273869,true;true;false;false,3579/20013
elevated at wk nmbr — no . ( % ) !,C0205250;C0332174;C0439230;C3163633,false;false;false;false,3580/20013
body mass index category,C0005893;C0683312;C3889287;C0578022;C1305855,false;false;false;false;true,3581/20013
liraglutide nmbr . nmbr mg mean ( n ),C1456408;C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,3582/20013
habnmbrc ( mean ± sem ),C0444504;C2347634;C2348143,false;false;false,3583/20013
low risk ( nmbr - nmbr ),C3272281;C3538919,false;false,3584/20013
gfr as assessed by mdrd,C0017654;C1424601,true;false,3585/20013
history of ischemic stroke,C0019664;C0948008;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3586/20013
nmbr - minute walk distance — m,C0439232;C0429886;C0369637;C0441923;C0700321;C0702093;C1282918;C2347166,false;false;false;false;false;false;false;false,3587/20013
male / female,C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429,true;true;true;false;false;false;false;false,3588/20013
current inhaler +,C0521116;C0021461;C1881212;C4319647;C1705970,false;true;false;false;false,3589/20013
phosphate ( mmol / l ),C0031603;C1532563;C0031701;C1601799,true;false;true;false,3590/20013
established cardiovascular disease,C0443211;C0007222;C1272684,false;true;false,3591/20013
smoker ( current / former ),C0337664;C0521116;C0205156;C0750523;C1705970,true;false;false;false;false,3592/20013
total cholesterol - to - hdl cholesterol ratio,C0428619,false,3593/20013
oral anticoagulant drugs,C0354604,false,3594/20013
definite,C0439544;C1704787,false;false,3595/20013
abciximab - facilitated pci ( n = nmbr ),C0288672;C4049621,true;false,3596/20013
computed tomographic angiography,C1536105,true,3597/20013
distribution — no . ( % ),C0520511;C1704711,false;true,3598/20013
intravenous heparin,C0354566,false,3599/20013
nmbr . nmbr to < nmbr . nmbr % ( nmbr to < nmbr mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,3600/20013
nmbr - month follow - up median ( iq range ),C0332177;C0589120;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1522577;C1704685;C3274571;C0439231,false;false;false;false;false;false;false;false;false;false;false;false;false;false,3601/20013
biventricular pacemaker,C1719274,false,3602/20013
warfarin group,C0043031;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,3603/20013
nmbr aspirin ( n = nmbr nmbr ),C0004057,true,3604/20013
short form nmbr ( sf - nmbr ),C2964478;C0037712,false;true,3605/20013
individual intended study duration — no . ( % ),C0027361;C1283828;C0489652;C1551357;C0237401,true;false;false;false;false,3606/20013
male nyha class,C0086582;C1882083;C1706180;C1706428;C1706429,true;false;false;false;false,3607/20013
metoprolol group ( n = nmbr ),C0025859;C0441848,true;false,3608/20013
fenofibric acid,C0060179,true,3609/20013
warfarin at enrollment,C0043031;C1516879;C1696073;C3888021,true;false;false;false,3610/20013
global ischemia,C0205246;C0022116;C4321499;C2348867,false;true;false;false,3611/20013
p value § ( < nmbr vs . > = nmbr years ),C1709380,false,3612/20013
hf or lvef < nmbr % associated with index event,C0018488;C1313497;C1538440;C3273279,true;true;false;false,3613/20013
subject completion status,C3891295;C0205197;C1554962;C2348577;C0449438;C0681850;C0805732;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false;false;false;false;false,3614/20013
egfr — ml / min / nmbr . nmbr m * *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3615/20013
coronary angioplasty or stenting,C0002997;C0190211,true;false,3616/20013
death from cardiovascular causes,C0007465;C0007226;C3887460,true;true;false,3617/20013
nmbr mg / dl ldl cholesterol | |,C0439269;C0023824;C0202117,false;true;false,3618/20013
femur fracture,C0015802,true,3619/20013
erythrocyte sedimentation rate,C1176468;C1619634,false;true,3620/20013
insulin sensitivity — % §,C0920563;C4049919,true;false,3621/20013
anti - tnf agent ( s ),C0221141;C1448177;C0450442;C1254351;C1521826;C0313162,false;true;false;false;false;false,3622/20013
medication after enrolment,C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,3623/20013
number insulin glargine,C0237753;C0907402;C0449788,false;true;false,3624/20013
asian ( nmbr . nmbr % ),C0078988,true,3625/20013
lifestyle modifications,C0870811;C2960841,false;false,3626/20013
change from,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3627/20013
% change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3628/20013
< nmbrnwrrtn,,,3629/20013
moderate renal impairment,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3630/20013
major diabetic eye disease,C0205082;C0342245;C0205164;C4318856;C4521762,false;false;false;false;false,3631/20013
all participants,C0679646,false,3632/20013
history of atrial fibrillation / flutter,C0729790;C0016385;C2242390;C1998417;C0232197,false;false;false;false;false,3633/20013
apixaban dose ( or matching placebo ),C1831808;C0178602;C0869039;C1114758,true;false;false;false,3634/20013
symptom onset,C4086878,false,3635/20013
prosthetic,,,3636/20013
disease hare . no . ( % ) i,C0012634,true,3637/20013
treatment by egfr stage,C0815181;C1739039;C3811844;C3812682,false;true;false;false,3638/20013
hormonal therapy — no . ( % ),C0279025,false,3639/20013
angina pectoris,C0002962,true,3640/20013
type of stent at index procedure,C0332307;C0038257;C1547052,false;true;false,3641/20013
blood pressure lowering medication use,C0005823;C0441994;C0240320;C2003888;C1271104;C1272641,true;false;false;false;false;true,3642/20013
gpi used during pci,C1415351,false,3643/20013
lowzmedium intensity,C0522510,false,3644/20013
antihypertensive therapy,C0585941,false,3645/20013
any medication,C0013227;C3244316;C4284232,true;false;false,3646/20013
mean — mm hg level — no . ( % ),C0444504;C0439475;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,3647/20013
chd simva nmbr = nmbr],C0280604;C3542407,false;false,3648/20013
diabetic history ( years ) x,C0241863;C0019664;C0439234;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;true;false;false;false;false,3649/20013
urine albumin / creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,3650/20013
extensive colitis or pancolitis,C0205231;C0009319;C1963084,false;true;false,3651/20013
moderate ckd at randomization,C0205081;C1561643;C0034656;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false,3652/20013
less than the median,C0439092;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3653/20013
qualifying cv event,C1514624;C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;false;true;false,3654/20013
peripheral artery occlusive disease ( stage nmbr / nmbr / nmbr / nmbr / nmbr ),C1306889;C0205390;C1300072;C1306673,false;false;false;false,3655/20013
or placebo treatment,,,3656/20013
diabetesnmbr ( % ),C0011847;C0011849,false;true,3657/20013
continued thienopyridine ( n nmbr nmbr ),C0549178;C1120149,false;true,3658/20013
saxagliptin nmbr . nmbr mg,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3659/20013
patients with ra,C0030705;C3538806;C4048756,true;false;false,3660/20013
chronic bronchitis ( % ),C0008677,true,3661/20013
reduction
 in risk
 ( nmbr % ci ) %,C1137094;C0008107;C3259781;C0035647;C0520870;C4552904,true;true;false;true;false;false,3662/20013
moderate disease activity : > nmbr . nmbr to < nmbr . nmbr,C1513375;C0012634;C3833417;C0205081;C1292728;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false;false;false,3663/20013
age nmbr years or more,C1510829,false,3664/20013
valsartan / hctz ( n = nmbr ),C0216784;C0020261,true;true,3665/20013
ics users,C0815320;C1706077;C4551720,false;false;true,3666/20013
since onset,,,3667/20013
diabetes at randomization,C0011847;C0034656;C0011849,false;true;true,3668/20013
treated with pci — no . / total no . ( % ),C0332293;C4049621,false;false,3669/20013
device group ( n = nmbr ),C0025080;C0441848;C0699733,true;false;true,3670/20013
statin use at study entry,C0360714;C0869040;C1705654,true;false;false,3671/20013
lipid disorder,C0154251,true,3672/20013
history of atrial fibrillation,C0729790,false,3673/20013
total diuretic dose ( iv + oral ) on day nmbr,C2986497;C0012798;C0022326;C4265176,false;true;true;false,3674/20013
immobazaton,,,3675/20013
digit symbol substitution,C0582802;C0679214;C1555721;C1706204;C1698987;C3241971,false;false;false;false;false;false,3676/20013
prior coronary revascularization ( pci or cabg ),C0332152;C0877341;C4049621;C2826257,false;false;false;false,3677/20013
fasting cholesterol — mg / dl,C0015663;C0008377;C0439269,true;true;false,3678/20013
idiopathic,C0332240,false,3679/20013
mean ( sd ) [range],C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,3680/20013
inhaled corticosteroids,C0004048;C0001617;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3681/20013
fasting insulin — pmol / liter,C0015663;C0021641;C0439192;C0475211;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,3682/20013
watchman ( n = nmbr ),C0335390,false,3683/20013
primary renal endpoint,C2986535;C0022646,false;true,3684/20013
hgb,C0019029;C0019046;C0518015;C1424337,false;true;false;false,3685/20013
normal ( > nmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,3686/20013
type of des at index procedure,C0332307;C0011702;C4551552;C1547052,false;true;true;false,3687/20013
nmbr vitamin e ( n = nmbr nmbr ),C0042874;C3714803,true;false,3688/20013
persistent wrf ( n = nmbr ),C0205322;C0332996,false;false,3689/20013
estonia,C0014908,true,3690/20013
score on modified rankin scale ( ' % / ',C0449820;C2984908;C3854213;C4050231,false;false;false;false,3691/20013
atrial fibrillation or flutter ( ecg ) §,C0004238;C0344434;C1963067,true;false;false,3692/20013
adcs - adl score *,C3641947;C0449820;C4050231,false;false;false,3693/20013
mean sfnmbr score ( nmbr % ci ),C3533236;C0037712;C0008107;C3259781,false;true;true;false,3694/20013
qrs > nmbr ms,C2349943;C3539704;C3713294,false;false;true,3695/20013
baseline high - sensitivity crp,C0168634;C1441604;C3890735;C4048285;C1442488,true;false;false;false;false,3696/20013
heart rates ( beats / minutes ),C0018810,true,3697/20013
insulin glargine allocation,C0907402;C1706778,true;false,3698/20013
left side of colon,C0227388,false,3699/20013
non - cortical,C1518422;C0001613;C0007776;C0022655,false;true;true;true,3700/20013
unsuccessful procedure,C1272705;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,3701/20013
previous angina,C0205156;C0002962;C1552607,false;true;false,3702/20013
nmbr . nmbr to nmbr . nmbr ( % ),C0040363;C0041260;C1883351,true;true;false,3703/20013
nt - pro - bnp — pmol / liter - j -,C0669479;C0439192;C0475211;C0754710,true;false;false;true,3704/20013
sirukumab nmbr mg qnmbrw,C3254570;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3705/20013
euroscore additive,C3164744;C0442796;C1550602,false;false;false,3706/20013
lev - naive,C0023556,true,3707/20013
clinical disease activity index score ( nmbr - nmbr ),C3869583;C0449820;C4050231,false;false;false,3708/20013
black / african - american ( nmbr . nmbr % ),C0085756,true,3709/20013
chronic coxnmbr inhibitors,C0205191;C0085387,false;true,3710/20013
no . of coronary vessels with > nmbr % diameter stenosis,C0010075,true,3711/20013
history of claudication,C2315493,false,3712/20013
seated sbp at nmbr weeks,C0277814;C0085805;C0439230;C1283233,true;true;false;false,3713/20013
ended > nmbr days before trial entry,C1272693;C0439228;C0008976;C1705654;C2746065,false;false;true;false;false,3714/20013
rope score * *,C1563164;C0449820;C4050231,false;false;false,3715/20013
inter p - value,C0205103;C1548610,false;false,3716/20013
risk factor profile index event,C0035648;C1979963;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C2003903,true;false;true;false;false;true;false;false;false;false,3717/20013
adverse eventy,,,3718/20013
discontinued,C1444662,false,3719/20013
duration of osteoarthritis symptoms — yr,C0436359;C0029408;C0439234,false;true;false,3720/20013
total cholesterol - mg / dl * *,C0201950;C0439269;C0543421,false;false;false,3721/20013
peripheral revascularization ( n = nmbr ),C0205100;C0581603,false;false,3722/20013
smoking in past yr,C0037369;C1444637;C0439234;C4284302;C0453996;C1881674,true;false;false;false;true;false,3723/20013
percentage of patients using ics or ics / laba on entry,C0439165;C0030705;C1549488;C1561533,false;true;false;false,3724/20013
mean change,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,3725/20013
neither ics nor laba,C0815320;C4551720,false;true,3726/20013
combination - facilitated pci ( n = nmbr ),C0205195;C1947911;C3811910,false;false;false,3727/20013
coronary heart disease death,C0010054;C0011065;C1306577;C4082313;C4552775;C0010068;C1956346,true;true;false;false;false;true;true,3728/20013
< nmbr mg / dl eze / simva ( n = nmbr },C0439269,false,3729/20013
a / v ( n = nmbr ) v ( n = nmbr ),C0560268;C1272460;C3887614,false;false;false,3730/20013
hypertrophic cardiomyopathy,C0007194;C4551472,true;true,3731/20013
median body mass index,C0549183;C0005893;C0578022;C1305855;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false,3732/20013
nmbr - year framingham chd risk ( % ) nmbr mean / sd ),C0439234;C3166866;C1282512;C0444504;C2699239;C2347634;C2348143;C0439508,false;false;false;false;false;false;false;false,3733/20013
ecrcl,,,3734/20013
time from longest event to randomisation,C0040223;C1522425;C0441471;C4019010;C3541383,true;false;false;false;false,3735/20013
no prior hf hospitalization,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,3736/20013
conservative,,,3737/20013
serum creatinine ( pmol / l ),C0201976;C0439284;C0600061,false;false;false,3738/20013
any cv history / risk factors,C3538987;C0019664;C0035648;C1553898;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503,false;true;true;false;true;false;false;false;false;true;false,3739/20013
vte at day nmbr +,C0630906;C0332173;C0439228;C0439505,true;false;false;false,3740/20013
age of completion of highest education,C0001779;C0205197;C1522410;C0013621;C0013622;C0013658;C0039401;C1554962,false;false;false;true;true;true;true;false,3741/20013
pfo + asa,C0004057;C3853627,true;false,3742/20013
nmbr mg / day - placebo,C0439422;C0032042;C1696465;C1706408,false;true;false;false,3743/20013
mtss cfb,C0009002;C1824728,true;false,3744/20013
mental component summary,C0229992;C0449432;C1552616;C1706244;C1705248,false;false;false;false;false,3745/20013
low - density lipoprotein cholesterol tx difference vs pbo,C0023824;C0041403;C1705241;C1705242,true;true;false;false,3746/20013
dihydropyridine calcium - channel blocker,C2945601,false,3747/20013
germany,C0017480,true,3748/20013
high sensitivity c - reactive protein ( mg / l ),C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,3749/20013
azathioprine,C0004482,true,3750/20013
high risk ( ri ≥ nmbr ),C0332167;C0035487;C1826843;C3272283;C4050568;C4319571,false;true;false;false;false;false,3751/20013
egfr ( ml / min per nmbr - nmbr m ' ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3752/20013
ez / simva nmbr mg,C0206578;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3753/20013
patients receiving immunosuppressive agents at baseline,C0030705,true,3754/20013
demographics age,C0011298;C0001779;C1704791,true;false;false,3755/20013
previous aorta - femoral or lower extremity bypass surgery,C0205156;C0003483;C1552607,false;true;false,3756/20013
fracture,C0016658,true,3757/20013
clopidogrel loading dose nmbr mg,C0070166;C3714444;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,3758/20013
renal insufficiency — no . ( % ),C0035078;C1565489,true;true,3759/20013
caucasian eze / simva ( „ = nmbr },C0007457;C0043157,true;true,3760/20013
tg mg / dl,C0337445;C0439269,false;false,3761/20013
locafon of index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3762/20013
baseline nihss,C0168634;C1697238;C1442488,true;false;false,3763/20013
clinical details,C0205210;C1522508,false;false,3764/20013
limited i -,C0439801;C0021966;C0221138;C2674459;C3542948;C4050251,false;true;false;false;false;false,3765/20013
intracranial disease of major artery 寸,C0524466;C0852949;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false;false,3766/20013
mean bp ( mmhg ),C0444504;C0037623;C0439475;C1415692;C1708288;C4318478;C2347634;C2348143,false;true;false;false;false;false;false;false,3767/20013
no chd eze / simva nmbr = nmbr },C0280604;C3542407,false;false,3768/20013
estimated glomerular filtration rate - no . ( % ) : :,C3811844,false,3769/20013
moderate n z nmbr,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3770/20013
central nervous system,C3540014;C3714787,false;true,3771/20013
drug - eluting stent implanted — no . ( % ),C1322815,true,3772/20013
elevated bnp ( nmbr pg / ml ),C0205250;C0054015;C0439297;C1095989;C1417808;C2982014;C3163633,false;true;false;false;false;false;false,3773/20013
verapamil - sr strategy,C1527129;C0679199,false;false,3774/20013
baseline steroids,C0168634;C0038317;C1442488,true;true;false,3775/20013
albumin measurements^^,C0201838,false,3776/20013
no hypertension ( n = nmbr ),C0020538;C1963138,true;false,3777/20013
history of other medical conditions,C0262926;C0012634;C0348080;C1705253;C3864998,false;true;false;false;false,3778/20013
placebo allocation,C0032042;C1706778;C1696465;C1706408,true;false;false;false,3779/20013
cyclosporin,C0010592;C0010594,true;true,3780/20013
symptom onset to hospital arrival,C4086878;C0019994;C1555577;C1706079;C1510665,false;true;false;false;false,3781/20013
before amendment,C0680532;C2346732,false;false,3782/20013
baseline erosion,C0168634;C0333307;C1880549;C1959609;C3887524;C1442488,true;false;false;false;false;false,3783/20013
minimal important change threshold ( improvement ) a,C3845594;C3898777;C0449864;C2986411;C4084912,false;false;false;false;false,3784/20013
digoxin,C0012265,true,3785/20013
new york heart association congestive heart failure class,C1882083;C0018802,false;true,3786/20013
haemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,3787/20013
peripheral arterial revascularization,C0205100;C0003842;C0581603;C0221464,false;true;false;false,3788/20013
median daily dose - iu ™,C0549183;C2348070;C0049272;C0439453;C0694756;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false,3789/20013
hla - bnmbr positive,C0019737;C0439178;C1446409;C1514241;C2825490;C3812269;C0550853;C1415561,true;false;false;false;false;false;false;false,3790/20013
renal function ( egfr,C0232804;C1739039;C3811844;C3812682,false;true;false;false,3791/20013
ldl particle numbers ( week nmbr ),C2612459;C0237753;C0332174;C0439230;C0449788,false;false;false;false;false,3792/20013
serum ldl cholesterol,C0428474,false,3793/20013
all grafts,,,3794/20013
stroke thought due to atherothrombotic disease,C0038454;C4554100,true;false,3795/20013
first hhf,C0205435;C1279901,false;false,3796/20013
primary angioplasty ( n = nmbr ),C0205225;C0162577;C1548817;C0439612;C0439631,false;true;false;false;false,3797/20013
atenolol strategy ( n = nmbr ),C0004147;C0679199,true;false,3798/20013
prothrombin mutation ( % ),C1610621,false,3799/20013
cardiovascular risk factors and medical history,C0850624,false,3800/20013
valsartan,C0216784,true,3801/20013
qrs > nmbr msec nmbr - min walk test,C0439223;C0702093;C4277740;C1524029;C3813700,false;false;true;false;false,3802/20013
immobilization at randomization,C0020944;C0034656;C4048292,true;true;false,3803/20013
difference,C1705241;C1705242,false;false,3804/20013
participants n,C0679646,false,3805/20013
associated with corrected,C0332281;C0205202,false;false,3806/20013
ckd ( egfr < nmbrb ),C1561643;C1739039;C3811844;C3812682,true;true;false;false,3807/20013
lowering drugs,C0441994;C0013227;C3687832;C2003888,false;true;false;false,3808/20013
concomitant cardiovascular therapy ( taken > nmbr days ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,3809/20013
post - bronchodilator fevnmbr / fvc ( % ) a,C2599594;C3714541,false;true,3810/20013
no . evenls,,,3811/20013
medical treatment,C0679624,false,3812/20013
previous angina pectoris,C0205156;C0002962;C1552607,false;true;false,3813/20013
indeterminate ! !,C0205258,false,3814/20013
select lipids and lipoproteins,C1707391,false,3815/20013
nmbr - year framingham chd risk,C0439234;C3166866;C1282512;C0439508,false;false;false;false,3816/20013
> qnmbr ( nmbr . nmbr ) - qnmbr ( nmbr ) — number / n ( % ),C0237753;C0449788,false;false,3817/20013
egfr ( ckd - epi,C1739039;C1561643;C0162734;C4281721;C3811844;C3812682,true;true;true;false;false;false,3818/20013
previous receipt of therapy against tnf - a — no . ( % ),C0205156;C0039798;C0087111;C1363945;C1552607,false;true;true;false;false,3819/20013
prior to index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,3820/20013
apo a - i,C0085201;C1677784,true;true,3821/20013
vessel treated,C0005847,true,3822/20013
non - smokers receiving lipid - lowering drugs,C0337672;C4554605,false;true,3823/20013
estrogen therapy,C0279494,false,3824/20013
haq - di total score,C3826998;C2964552;C4321476,false;false;false,3825/20013
high density lipoprotein cholesterol - mg / dl * *,C0023822;C0439269,true;false,3826/20013
systolic pulmonary arterial pressure,C0871470;C0024109;C2707265;C2709248;C4522268;C0039155;C1168098,true;true;false;false;false;true;false,3827/20013
> qnmbr ( nmbr ) - qnmbr ( nmbr . nmbr ) — number / n ( % ),C0237753;C0449788,false;false,3828/20013
das - nmbr ( crp ),C0051767;C3890735;C4048285;C0057671,true;false;false;true,3829/20013
blood transfusion,C0005841;C0281867,true;false,3830/20013
partial evolving to secondarily generalized ( ic ),C0728938;C0332253;C0205246;C0020750;C4554818;C1550516,false;false;false;true;false;false,3831/20013
hscrp > nmbr to < nmbr mg / l,C0439268,false,3832/20013
ra symptom duration < nmbr months — number ( % ),C3538806;C1457887;C0449238;C0439231;C0237753;C0449788;C2926735;C3854129;C4048756,false;false;false;false;false;false;false;false;false,3833/20013
ldl - c < nmbr mg / dl,C0439269,false,3834/20013
ace / arb medication ( % ),C1452534;C3888198;C0013227;C3244316;C4284232;C4284014,true;false;true;false;false;false,3835/20013
positive family history of type nmbr diabetes ( % ),C0439178;C1313937;C0332307;C1547052;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false;false;false,3836/20013
urinary albumimcreatinine ratio,C1273442,false,3837/20013
diabetes treatment,C0011847;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0011849,false;true;true;false;false;false;false;false;true,3838/20013
mucolytics,C0026698,true,3839/20013
pooled analysis,C1709595;C0002778;C0936012;C1524024;C2349200;C4522255,false;false;false;true;false;false,3840/20013
infliximab,C0666743,true,3841/20013
iduration of symptoms > nmbr min,C0683368;C0702093;C1524029;C3813700;C1457887,true;false;false;false;false,3842/20013
estrogens,C0014939;C3537250;C3541386;C3714615,true;false;false;false,3843/20013
nmbr mg twice daily n = nmbr,C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,3844/20013
major gastro - intestinal bleeding,C0205082;C0017181;C0205164;C4318856;C4521762,false;true;false;false;false,3845/20013
weight > nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,3846/20013
multiple diagnoses,C0439064;C0011900,false;true,3847/20013
cholecystitis chronic,C0008325;C1963083;C4553186,true;false;false,3848/20013
baseline % bsa involvement,C0168634;C1314939;C1442488,true;false;false,3849/20013
> nmbr corticosteroids or immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,3850/20013
history of atrial arrhythmia,C0019664;C0085611;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3851/20013
chronic pulmonary disease,C0746102,false,3852/20013
congestive heart failure ( definite ),C0018802,true,3853/20013
average dose ( mg / week ),C1510992;C0178602;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C2825518,false;false;true;false;false;true;false;false;false;false;false;false;false;false,3854/20013
urinary albumin : creatinine ratio *,C0455271;C1318330,false;false,3855/20013
previous pci ( % total ),C0205156;C4049621;C0439175;C0439810;C1552607,false;false;false;false;false,3856/20013
highest killip classiciation pre - pci,C1522410,false,3857/20013
edss stratification,C0451246;C1514983;C3887783,false;false;false,3858/20013
exenatide no . of events / total no . ( % ),C0167117,true,3859/20013
method used to diagnose the incident pulmonary embolism,C0025663;C0449851;C0871511,true;false;false,3860/20013
blood glucose,C0005802,true,3861/20013
rf or acpa positive,C0035448;C0201660;C0748398;C1547111,true;false;false;false,3862/20013
congestive heart failure — no . ( % ),C0018802,true,3863/20013
mean ucsd - sobq score * ( sd ),C3533236;C2699239,false;false,3864/20013
morphine use for index event / pci,C0242000;C0600653;C0441471;C4049621;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,3865/20013
albumin - to - creatinine ratio,C0486293;C1318293,false;false,3866/20013
medical therapy alone,C0418981,false,3867/20013
continuation,,,3868/20013
nmbr ( fevi nmbr - < nmbr % pred ),C0849974;C1561566;C4528367,false;false;false,3869/20013
anmbrs - hydroxy -,C0700307,false,3870/20013
qrs interval > nmbr msec — no . ( % ),C0520880;C0439223,false;false,3871/20013
streptokinase,C0038418,true,3872/20013
haq - di improvement > nmbr . nmbr,C3826998;C2986411;C4321476,false;false;false,3873/20013
baseline cv treatment,C0168634;C3538987;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4048877;C4318503;C1442488,true;false;true;true;false;false;false;false;false;true;false;false,3874/20013
adalimumab croup,C1122087;C0010380,true;true,3875/20013
apob ( week nmbr ),C0003593;C0332174;C0439230;C3252643,true;false;false;true,3876/20013
systemic arterial hypertension,C0020538,true,3877/20013
reversibility to salbutamol,C1271924,false,3878/20013
overall,C0282416;C1561607,true;false,3879/20013
nmbr p value,C1709380,false,3880/20013
evolocumab ( nmbr mg ),C3529352;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3881/20013
bifurcation lesion,C0184906;C0221198;C1546698;C3146289,false;false;false;false,3882/20013
time from onset of symptoms to randomization — days,C1320528,false,3883/20013
thiazide at last follow - up,C0541746;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,3884/20013
% change median baseline crp > nmbrmg / l,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3885/20013
blood pressure systolic,C0005823;C1271104;C1272641,true;false;true,3886/20013
hf hospitalizations,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,3887/20013
history of carotid artery disease,C0019664;C0007273;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3888/20013
prior treatment historynmbr,C1514463;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3889/20013
patients with bw decrease of $ nmbr % in patients with baseline bmi of $ nmbr kg / mnmbr +,C0030705;C0005910;C0392756;C0547047;C0006041;C2986891,true;true;false;false;true;false,3890/20013
interactionnmbr,C1704675,false,3891/20013
no history of migraine,C0455512,false,3892/20013
mild ( gold nmbr ),C2945599;C0018026;C1304897,false;true;false,3893/20013
iii : fevnmbr > nmbr % - < nmbr % predicted,C0439070;C3714541;C1705160,false;true;false,3894/20013
cat score category,C0007450;C0449820;C0683312;C3889287;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;false;false;true;false;false;false;false,3895/20013
drug therapy at admission 一 no . ( % ) aspirin,C0013216;C0184666;C0809949;C0013217,true;false;false;true,3896/20013
fatty acid profile,C0015684;C1979963;C2003903,true;false;false,3897/20013
residual deep - vein thrombosis,C1609982;C0149871,false;true,3898/20013
unstable angina,C0002965,true,3899/20013
completed trial,C0205197;C0008976;C3854010,false;true;false,3900/20013
duration of symptoms,C0436359,false,3901/20013
% predicted ” fev,C0681842;C3714541;C1882327,false;true;false,3902/20013
aspirin dose at randomization,C4696290;C0034656,false;true,3903/20013
normoglycemia^,C0580545,false,3904/20013
oral antidiabetic drugs,C0029167;C0935929;C0175795;C0304289;C0442027;C4521986,true;true;false;false;false;false,3905/20013
ef nmbr - nmbr % hfmref ( n = nmbr,,,3906/20013
cerebral embolism,C0007780,true,3907/20013
fevnmbr / fvc prebronchodilatort,C3714541,true,3908/20013
previous use of antiplatelet drugs,C0205156;C1524063;C0085826;C2963157;C1552607,false;false;true;false;false,3909/20013
laba non - users,C1518422;C1706077,false;false,3910/20013
thiazolidinedione based,C0289779;C1257987;C3537039,true;true;false,3911/20013
chronic respiratory failure,C0264492,false,3912/20013
coronary artery disease history,C0010054;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0010068;C1956346,true;true;true;false;false;false;false;true;true,3913/20013
current prescribed medications,C0521116;C3166216;C3202967;C1705970,false;false;false;false,3914/20013
current weekly alcohol use ( % ),C0521116;C0332174;C0001948;C1705970,false;false;true;false,3915/20013
calcium ( mmol / l ),C0006675;C1532563;C0006726;C2936886;C3540037;C3714611,true;false;true;false;false;false,3916/20013
region ( pooled ),C0017446;C0205147,true;false,3917/20013
bdmard - naive,,,3918/20013
general andthoracic epidural,C0205246;C0228134;C0812144;C3812897;C3891294;C4521767,false;true;false;false;false;false,3919/20013
first co - primary outcome,C0205435;C3245499;C0205225;C1274040;C0439612;C0439631;C1279901,false;true;false;false;false;false;false,3920/20013
cvd,C0007222,true,3921/20013
age at enrolment,C0001779;C1516879;C1696073;C3888021,false;false;false;false,3922/20013
not available,C0686905,false,3923/20013
use of antiplatelet agents^,C1524063;C0085826,false;true,3924/20013
aspirin or thienopyridines ( % ),C0004057,true,3925/20013
baseline trig > nmbr millycerides g / dl,C0168634;C0202236;C0439267;C1519533;C1442488,true;false;false;false;false,3926/20013
baseline anti - hypertensive usea,C0168634;C0003364;C1442488,true;true;false,3927/20013
intent - to - treat population,C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C1550453,true;true;true;true;false;false;false;false,3928/20013
dyslipidaemia and hypertension,C0242339,true,3929/20013
saxa nmbr . nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3930/20013
estimated response rate and odds ratio,C0750572;C0237629,false;false,3931/20013
first loading dose,C0205435;C3714444;C1279901,false;false;false,3932/20013
ex - smokers nmbr,C0337671;C4555205,false;true,3933/20013
atrial fibrillation ldl cholesterol level,C0004238;C0023824;C0441889;C0456079;C1547707;C2946261;C0202117;C0344434;C1963067,true;true;false;false;false;false;false;false;false,3934/20013
duration of,C0449238;C2926735,false;false,3935/20013
weight ab,C0005910;C0043100;C1305866;C1705104,true;true;false;false,3936/20013
race or ethnic group — no . / total no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,3937/20013
loop at enrollment,C0445022;C1516879;C1696073;C3888021,false;false;false;false,3938/20013
current cigarette use,C0521116;C0694535;C1705970,false;false;false,3939/20013
central europe,C0682369,false,3940/20013
atopic ( based on phadiatop test ),C0392707,false,3941/20013
kccq ( nmbr months ),C3476798;C0439231,false;false,3942/20013
mean eq - nmbrd response ( nmbr % ci ),C0444504;C0205163;C0871261;C0008107;C3259781;C1704632;C1706817;C2911692;C0439185;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,3943/20013
tp vs no tp,C0036183;C3541334,true;false,3944/20013
r nmbr mg + fa,C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,3945/20013
total study population,C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,3946/20013
subacute ( nmbr - nmbr days ),C0205365;C0439228,false;false,3947/20013
spinal fractures,C0080179;C0518450,true;false,3948/20013
multivessel disease,C0012634,true,3949/20013
normoalbuminuria or microalbuminuria,,,3950/20013
low ( no risk factor ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,3951/20013
hospitalisation for chf within nmbr years of randomisation,C0019993;C0018802,true;true,3952/20013
rec . ischemia due to ecg changes,C1424025;C0022116;C0678226;C1623258;C4321499;C2606415,false;true;false;true;false;true,3953/20013
event / patients ( nmbr / pt - y ),C0441471;C0030705;C0032743;C0699718;C4019010,false;true;true;false;false,3954/20013
calcium - channel antagonists,C0006684;C2757014,true;false,3955/20013
angiotensin receptor,C0034787;C1622222,true;true,3956/20013
dbp,C0536221;C3813197;C4281799,true;false;false,3957/20013
priorother ( predefined ) medical conditions,,,3958/20013
tnmbr lesion volume,C2603360;C0221198;C0449468;C1690016;C1705102;C2700258;C1546698,false;false;false;false;false;false;false,3959/20013
african - american / african heritage ( n = nmbr ),C0085756;C2986513,true;false,3960/20013
new anti - anginal therapy,C3242274;C1874267;C3537168,false;false;false,3961/20013
smoking : current smoker,C0037369;C0453996;C1881674,true;true;false,3962/20013
total cataract,C3665439,false,3963/20013
no . of patients ( % ),C0030705,true,3964/20013
ami nmbr mg n = nmbr,C4319936;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,3965/20013
baseline lvef,C0168634;C0428772;C0488728;C1442488,true;false;false;false,3966/20013
change from baseline stage nmbr ckd,C0168634;C0597205;C1561643;C0679846;C1442488,true;false;true;false;false,3967/20013
indacaterol group ( n = nmbr ),C1722260;C0441848,true;false,3968/20013
iv : fevnmbr < nmbr % predicted,C0022326;C3714541;C4265176,true;true;false,3969/20013
education nmbr - nmbr years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,3970/20013
waist circumference,C0455829,true,3971/20013
hispanic — no . ( % ),C0086409,true,3972/20013
> nmbr . nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,3973/20013
stroke,C0038454;C4554100,true;false,3974/20013
family history of premature,C0241889;C0151526;C0205252;C4018905,true;true;false;false,3975/20013
change in bp,C1268766,false,3976/20013
nonfatal ischemic stroke,C0948008,false,3977/20013
pci delay due to low risk,C4049621,false,3978/20013
oral anticoagulant agent,C0354604,false,3979/20013
alcohol intake ( a ),C0001948,true,3980/20013
hbanmbrc subgroups,C0019016;C1079230;C1825777;C3538758,true;false;false;false,3981/20013
history of atherosclerotic vascular disease — no . ( % ) §,C0683519;C0333482;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983,false;false;true;false;false;false;false;false,3982/20013
renal function : creatinine clearance,C0232804;C0812399,false;false,3983/20013
mercaptopurine,C0000618,true,3984/20013
transient monocular blindness,C0149793,true,3985/20013
nyha functional class,C1882083;C0205245;C0542341;C2700217,false;false;false;false,3986/20013
entire cohort gender,C0439751;C0009247;C0079399;C1522384;C0599755;C0444667,false;true;true;true;false;false,3987/20013
inhaled §,C0004048,true,3988/20013
patient global assessment of pain ( vas nmbr - nmbr mm ),C4054229;C0042815;C4330985;C4554674,false;true;false;false,3989/20013
rituximab ( nmbrxnmbr mg ) + mtx ( n = nmbr ),C0393022;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,3990/20013
peripheral artery revascularization without amputation,C0489868;C0581603;C0002688;C0332840;C1546539,false;false;true;false;false,3991/20013
other cause,C0015127;C1524003,true;false,3992/20013
immunosuppressants and antimalarials only,C0021081,true,3993/20013
* * positive stress test,C0439178;C0015260;C3494508;C1446409;C1514241;C2825490;C3812269,false;true;true;false;false;false;false,3994/20013
aspirin use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,3995/20013
randomisation scheme,C0034656;C1519193,true;false,3996/20013
ala carriers,C0523459;C0007294;C3888236,false;true;false,3997/20013
arterial hypertension — no . ( % ),C0020538,true,3998/20013
bmi ( median,C0578022;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3999/20013
alternative disability,C1523987;C0231170,false;false,4000/20013
non - hdl cholesterol / apob ( ratio ),C0729627;C0003593;C0456603;C1547037;C3252643;C1535899;C1518422;C2938854,false;true;false;false;true;false;false;false,4001/20013
other risk factors,C0035648;C1553898,true;false,4002/20013
hf hospitalization or cardiovascular death,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,4003/20013
no revascularization for index acs event,C0581603;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,4004/20013
p - value for variance,C1709380;C1711260;C2348152,false;false;false,4005/20013
apo b,C0003593;C3252643,true;true,4006/20013
at ldl - c ( bq ) goal * at baseline - no . ( % ),C0560038;C0018017;C0168634;C1442488;C1571704;C3541236,false;true;true;false;false;false,4007/20013
missing data initial diagnosis — no .,C4684714;C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;false;true;true;false;false;false;false,4008/20013
aspirin at enrollment,C0004057;C1516879;C1696073;C3888021,true;false;false;false,4009/20013
prespecified analysis,C0002778;C0936012;C1524024,false;false;true,4010/20013
k ( rate ),C0597277;C0871208;C1521828;C1708601,false;false;false;false,4011/20013
r | r ' ' ' ( nmbr % ci ),C0205090;C0008107;C3259781;C0684010;C2603358,false;true;false;true;false,4012/20013
glyburide dose duringthe study ( mg ),C0017628;C0178602;C0557651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2603343;C0869039;C1114758,true;false;false;true;true;false;false;false;false;false;false;false;false,4013/20013
ptca / cabg,C2936173;C0010055,true;true,4014/20013
score,C0449820;C4050231,false;false,4015/20013
biologic therapeutic failure,C0005515;C0087111;C0231174;C0680095;C0302350;C0205460,true;true;false;false;false;false,4016/20013
simva ( „ = nmbr },,,4017/20013
partial mayo score,C0728938;C0454788;C0449820;C4050231;C1077578;C1550516,false;false;false;false;false;false,4018/20013
selected clinical characteristics — no . / total no . ( % ),C1707391;C0683325,false;false,4019/20013
. nmbr . nmbr ml / s / mnmbr ( nmbr ml / min / nmbr . nmbr mnmbr ),C0439390;C1709500;C0702093;C1524029;C3813700,false;false;false;false;false,4020/20013
prior use of conventional dmards only ( biologic - nai ' ve ),C0332152;C1524063;C0439858;C0205171;C4055380;C3537218;C0042469;C3714652;C4321495;C1720467;C2826257,false;false;false;false;false;false;true;false;false;false;false,4021/20013
family history,C0241889,true,4022/20013
patients with diabetes mellitus,C0030705;C0011849,true;true,4023/20013
thiazolidinedione ( includes pioglitazone ),C0289779;C1257987;C3537039,true;true;false,4024/20013
corticosteroids and antimalarials only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4025/20013
total pack - years mean ( sd ),C0439175;C1277691;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,4026/20013
medications at study entry — no . / total no . ( % ),C0013175;C1705654,true;false,4027/20013
gold iii - iv,C0018026;C0439070;C0022326;C4265176;C1705160;C1304897,true;false;true;false;false;false,4028/20013
reason for enrollment in active a,C0392360;C1516879;C1696073;C3888021,false;false;false;false,4029/20013
asia / australia / new zealand,C0003980;C4289954,true;false,4030/20013
octave induction nmbr,C0205263;C0857127,false;false,4031/20013
tachyarrhythmias,C0080203,true,4032/20013
europe n z nmbr,C0015176,true,4033/20013
atrial fibrillation alone ) ,C0004238;C0344434;C1963067,true;false;false,4034/20013
supraventricular tachyarrhythmias ( incl . atrial,C1698480;C3853833,false;false,4035/20013
previous cerebrovascular event,C0205156;C1880018;C0441471;C4019010;C1552607,false;false;false;false;false,4036/20013
stroke — no . ( % ),C0038454;C4554100,true;false,4037/20013
bronchodilator response,C0006280;C0871261;C1704632;C1706817;C2911692,true;false;false;false;false,4038/20013
nmbr ( fevi ^nmbr % pred ),C0849974;C1561566;C4528367,false;false;false,4039/20013
mental component,C0229992;C0449432;C1705248,false;false;false,4040/20013
apo a - l ( g / l ),C0628062,true,4041/20013
veflonzumao,,,4042/20013
pfo with large shunt and atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4043/20013
classification of index venous thromboembolism — no . ( % ),C0008902;C0600653;C1997614;C0918012;C1552854;C1637833;C2986546;C0008903;C0678229,true;true;false;true;false;false;false;true;false,4044/20013
fevnmbr at baseline,C3714541;C0168634;C1442488,true;true;false,4045/20013
incidence rate per nmbr person - years,C1708485;C0027361;C0439234;C2347489,false;true;false;false,4046/20013
time of randomization ( interaction : p = nmbr . nmbr ),C0040223;C0034656;C1704675;C3541383,true;true;false;false,4047/20013
both deep - vein thrombosis and pulmonary embolism,C0149871,true,4048/20013
myocardial infarction without st - segment elevation — no . ( % ),C1536220,true,4049/20013
pooled eze / simva,C1709595;C2349200;C4522255,false;false;false,4050/20013
other sglt - nmbr inhibitor,C1999216,false,4051/20013
clavicle fracture,C0159658,false,4052/20013
ecg abnormality ( resting ),C1623258;C1704258,true;false,4053/20013
musculoskeletal stiffness,C0497254;C0427008;C2707260,false;false;false,4054/20013
psoriatic arthritis,C0003872,true,4055/20013
medication prior to admission,C0013227;C0332152;C0184666;C0809949;C3244316;C4284232,true;false;false;false;false;false,4056/20013
death / st,C0011065;C0036056;C3272372;C1306577;C4082313;C4552775,true;true;false;false;false;false,4057/20013
bdi focal score,C0006448;C0205234;C0449820;C4050231;C0451022;C3714938;C3889415,true;false;false;false;false;false;false,4058/20013
time to randomisation [hours] ( interaction : p = nmbr . nmbr ),C0040223;C0034656;C0439227;C1704675;C3541383,true;true;false;false;false,4059/20013
laboratory examination,C0260877,false,4060/20013
placebo patients with events,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,4061/20013
organ system involvement,C0460002;C1314939,false;false,4062/20013
enalapril lcznmbr ( n = nmbr ) ( n = nmbr ),C0014025,true,4063/20013
high - dose statin,C0444956;C0360714,false;true,4064/20013
peripheral,C0205100,false,4065/20013
ldl cholesicrol ( minol / l ),,,4066/20013
hispanic / latino ethnicity,C0086409;C0086528;C0015031;C0243103,true;true;true;true,4067/20013
nmbr - nmbr drinks,C0452428,false,4068/20013
aborted cardiac arrest,C1550015;C1609614;C4085625;C4318470,false;false;false;false,4069/20013
baseline crp < nmbrmg / l,C0168634;C3890735;C0439268;C4048285;C1442488,true;false;false;false;false,4070/20013
relative risk reduction ( nmbr % cl ) percent,C0242492;C0301630;C0596019;C0439165;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;false;false;false;false;false;true;true;false;false,4071/20013
unprotected left main stented,C0205091;C0205225;C0038257;C1542147;C0443246;C1552822,false;false;true;false;false;false,4072/20013
catheterization performed for qualifying event,C0007430,true,4073/20013
fraction ( % ),C1264633;C1554103,false;false,4074/20013
nmbr % ci for difference,C0008107;C1705241;C1705242;C3259781,true;false;false;false,4075/20013
index event to randomization,C0600653;C0441471;C0034656;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;true;false;true;false;false;false,4076/20013
inclusion criteria — no . ( % ),C1512693,false,4077/20013
normal hscrp,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,4078/20013
^nmbr - cell function — % §,C0007613,true,4079/20013
previous tnf - antagonist use,C0205156;C1448177;C0231491;C0042153;C0457083;C1947944;C1552607,false;true;false;true;false;false;false,4080/20013
depressed only,C0344315;C0549249,false;true,4081/20013
acute infection without septic shock,C0275518;C0036983,false;true,4082/20013
mtss units,C0439148;C1519795;C3853603,false;false;false,4083/20013
previous statin use,C0205156;C0360714;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,4084/20013
mean ( s . d . ) calculated ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,4085/20013
nmbr % confidence interval,C0009667,true,4086/20013
type of concomitant statin by daily dose,C0332307;C0521115;C0360714;C1547052,false;false;true;false,4087/20013
statin with ezetimibe,C0360714;C1142985,true;true,4088/20013
history of ml or ischemic stroke,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,4089/20013
within nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,4090/20013
placebo n = nmbr n ( % ),C0032042;C1696465;C1706408,true;false;false,4091/20013
nyha class not reported,C1882083,false,4092/20013
neither uh or lmw heparin,,,4093/20013
fpg tx difference vs pbo,C0041403;C1705241;C1705242,true;false;false,4094/20013
iglarlixi ( fixed - ratio combination ),C0443218;C0456603;C0205195;C1947911;C3811910;C1547037;C2827483;C3714578,false;false;false;false;false;false;false;false,4095/20013
previous congestive heart failure,C0205156;C0018802;C1552607,false;true;false,4096/20013
periostin ( ng / ml ),C0219433;C0439275;C1424662;C3812270,true;false;false;false,4097/20013
belimumab nmbr mg sc ( n nmbr ),C1723401;C0024671;C0282380;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,4098/20013
glycatedhemoglobin category,C0683312;C3889287,false;false,4099/20013
canvas - r,C3281223;C0205090;C0684010;C2603358,false;false;true;false,4100/20013
tg > nmbr . hdl < nmbr ( mg / dl ) ( / ? = nmbr ),C0337445;C3715113;C0439269,false;false;false,4101/20013
africa,C0001737,true,4102/20013
history of gestational diabetes mellitus — no . ( % of women ),C2183115,false,4103/20013
non - black race ( n = nmbr vs nmbr ),C1518422;C0005680,false;true,4104/20013
not - japan n = nmbr,C1518422;C0022341,false;true,4105/20013
stage > nmbr chronic kidney disease ( % ),C0205390;C1300072;C1306673,false;false;false,4106/20013
nmbr - hr plasma glucose — mg / dl,C0202042;C0439269;C0455280,false;false;false,4107/20013
not at goal,C1518422;C0018017;C1571704,false;true;false,4108/20013
concomitant aminosalicylates,C0521115;C0368663,false;false,4109/20013
baseline fecal caicrctectin,C0168634;C0015733;C1442488,true;true;false,4110/20013
hospitalization for unstable angina,C0019993;C0002965,true;true,4111/20013
patients having exacerbation,C0030705,true,4112/20013
regular alcohol consumption per week,C0205272;C0001948;C0332174;C0439230,false;true;false;false,4113/20013
improving anemia bsl hb < nmbrg i - nmbr  yr nmbr > nmbrg i - nmbr,C1272745;C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,false;true;false;true;false;true;false;false;false;false,4114/20013
qualifying peripheral arterial disease,C1514624,false,4115/20013
previous bypass surgery,C0205156;C1536078;C1552607,false;false;false,4116/20013
anthropometric characteristics,C0003188;C1521970,true;false,4117/20013
baseline fevnmbr,C0168634;C3714541;C1442488,true;true;false,4118/20013
nmbr - lead ecg heart rate,C0179504;C0018810,false;true,4119/20013
aspirin + dipyridamole ( n = nmbr ),C0732279,true,4120/20013
patients entering pt period n = nmbr,C0030705,true,4121/20013
surgical technique,C0683469,false,4122/20013
psoriatic arthropathy,C0003872,true,4123/20013
with alogliptin nmbr mg,C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4124/20013
revascularisation but no antiplatelets,C0581603,false,4125/20013
pfo with large shunt without atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4126/20013
clinical and patient - reported characteristics at baseline and randomization,C0205210,false,4127/20013
or ( unadjusted ),,,4128/20013
unknown or missing,C0439673;C3541433;C4050014,false;false;false,4129/20013
reported high cholesterol ' !,C0684224;C0020443;C1522133;C0700287;C4319718,true;true;false;false;false,4130/20013
syndecan - nmbr ( ng / ml ),C0075691;C0439275;C1419891,true;false;false,4131/20013
long - acting,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,4132/20013
use of antiarrhythmic agent,C1524063;C0003195;C0301380,false;true;false,4133/20013
egfr using cg / mdrd formulae,C1739039;C3811844;C3812682,true;false;false,4134/20013
baseline body mass index,C0168634;C0005893;C0578022;C1305855;C1442488,true;false;false;true;false,4135/20013
swollen - joint count ( of nmbr joints ),C0451521,false,4136/20013
> nmbr - nmbr mg / week,C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,4137/20013
hypertensionnmbr ( % ),C0020538;C1963138,true;false,4138/20013
psa - modified total shs,C3810537;C3813209,false;false,4139/20013
minor ischaemic stroke,C0026193;C0948008;C0205165,true;false;false,4140/20013
annualized rate ind / gly sfc,C0871208;C4049864;C0017890;C4521536;C0523677;C1521828,false;false;true;false;false;false,4141/20013
sulfasalazine,C0036078,true,4142/20013
mean change at week nmbr,C0444504;C0392747;C0332174;C0439230;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,4143/20013
acpa positive ( > nmbr iu / ml ),C1525410;C0439178;C0439458;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false;false,4144/20013
history of strokenmbr,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4145/20013
long - term warfarin ( n - nmbr ),C0443252;C0043031,false;true,4146/20013
obese ( > nmbr kg / mnmbr ),C0028754;C1532718,true;false,4147/20013
facit - fatigue . mean nmbrsd ( range nmbr - nmbr ),C3476791;C0015672;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C3463815;C4050243;C4554645,false;true;false;false;false;false;false;false;false;false;false;false,4148/20013
infarct location ( interactsn $ : p = nmbr . nmbr ),C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,4149/20013
not hospitalized for heart failure in the year prior to study enrollment,C1518422,false,4150/20013
calcification,C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,true;true;false;false;false;false,4151/20013
all ischemic stroke,C0948008,false,4152/20013
rosuvastatin,C0965129,true,4153/20013
hormone replacement therapy use,C0282402;C0042153;C0457083;C1947944,true;true;false;false,4154/20013
older than nmbr years,C0580836;C0439234,false;false,4155/20013
rolofylline,C0166128,true,4156/20013
apo a - nmbr,C0003592;C0523508;C4553344;C4553379,true;false;false;false,4157/20013
long - term antiplatelet therapy,C0443252;C1096021,false;false,4158/20013
prior bypass graft surgery,C0455610;C0185098,false;false,4159/20013
bone erosion ( judged by physician ),C0587240,false,4160/20013
triglyceride ( mm,C0041004;C4330985;C4554674,true;false;false,4161/20013
cigarettesmoking,,,4162/20013
pentraxin - nmbr ( ng / ml ),C0439275,false,4163/20013
tnfi exposed,,,4164/20013
asa or antiplatelet agent,C0004057;C3853627,true;false,4165/20013
ischemic stroke ( vs . tia ),C0948008,false,4166/20013
men : women ( % ),C0025266;C0043210,true;true,4167/20013
patients not treated with statins ( n = nmbr ),C0030705,true,4168/20013
severe renal impairment,C0205082;C1565489;C4050465;C4050466,false;true;false;false,4169/20013
om nmbr mg / aml nmbr mg / hctz nmbr mg,C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,4170/20013
corticosteroid use at baseline,C0239126;C0168634;C1442488,false;true;false,4171/20013
sedentary,C0205254,false,4172/20013
no . of patients ( indacaterol / placebo ),C0030705;C1722260;C0032042;C1696465;C1706408,true;true;true;false;false,4173/20013
insulin plus oral,C0021641;C0442027;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false,4174/20013
> nmbr . nmbr,,,4175/20013
ics use,C0815320;C4551720,false;true,4176/20013
age category ( years ),C1510829;C0683312;C3889287,false;false;false,4177/20013
atherosclerotic disease ( % ),C0333482;C0012634,false;true,4178/20013
copd duration,C0024117;C0449238;C2926735;C1412502;C3714496,true;false;false;false;false,4179/20013
thrombolytic therapy,C0040044,true,4180/20013
acei vs . non - acei,,,4181/20013
risk factors for atherosclerosis,C0035648;C0003850;C0004153;C1553898,true;true;true;false,4182/20013
bifurcation lesion with side branch $ nmbr . nmbr mm stented,C0184906;C0221198;C0441987;C0205384;C4330985;C4554674;C1253959;C1881507;C2700383;C2826234;C1546698;C3146289,false;false;false;false;false;false;false;false;false;false;false;false,4183/20013
heart rate at rest in the supine position ( beats / min ),C0018810;C0035253;C1622890,true;true;false,4184/20013
feno nmbr mg / eze nmbr mg ( n = nmbr ),C1319635,false,4185/20013
mean ( s . d . ) total pcsknmbr,C0444504;C0439175;C0439810;C2347634;C2348143,false;false;false;false;false,4186/20013
ambulance ( % ),C0002422;C3846685,true;false,4187/20013
estimated means and difference,C0750572;C1704970,false;false,4188/20013
concomitant medication ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4189/20013
qualifying atherosclerosis,C1514624;C0003850;C0004153,false;true;true,4190/20013
ada impaired fasting glucose,C1060325;C1272092;C3811629,false;false;false,4191/20013
stented vessels,C0183521,false,4192/20013
tender - joint count,C0451530,false,4193/20013
verapamil sr,C1527129,false,4194/20013
thiazolidinedione 一 no . ( % ),C0289779;C1257987;C3537039,true;true;false,4195/20013
edema,C0013604;C1717255,true;false,4196/20013
medications on admission,C0013227;C0802604;C2598133;C4284232,true;false;false;false,4197/20013
rf positive ( > nmbr iu / ml ),C0035448;C0439178;C0439458;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false;false,4198/20013
worsening heart failure,C0332271;C0018801;C0018802;C4554158;C1457868;C1546960,false;true;true;false;false;false,4199/20013
previous limb or foot amputation,C0205156;C0015385;C1552607,false;true;false,4200/20013
alcohol consumption ( % ),C0001948,true,4201/20013
om nmbr / aml nmbr /,C0028971;C0023465;C0023467;C1705272,true;true;true;false,4202/20013
hypertension history,C0020538;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1963138,true;true;true;false;false;false;false;false,4203/20013
swollen - joint count,C0451521,false,4204/20013
racial group,C0034510,true,4205/20013
nmbr to < nmbr ml per nmbr - nmbr mnmbr,C0439526;C0369637;C0441923;C1705224;C3887665,false;false;false;false;false,4206/20013
deep vein thrombosis only,C0149871;C0205171;C1720467,true;false;false,4207/20013
within last nmbr d,C1517741,false,4208/20013
egfr at baseline,C1739039;C0168634;C1442488;C3811844;C3812682,true;true;false;false;false,4209/20013
intermediate,C0205103;C1550465;C2827755;C3889971,false;false;false;false,4210/20013
duration of hypertension ( months ),C0449238;C0020538;C0439231;C1963138;C2926735,false;true;false;false;false,4211/20013
wapnmbrc ( ng / ml ),C0439275,false,4212/20013
ischaemic cause,C0475224;C0015127;C1524003,false;true;false,4213/20013
total cholesterol > nmbr mg / dl,C0201950;C0439269;C0543421,false;false;false,4214/20013
intention - to - treat,C0162425;C1283828,true;false,4215/20013
enoxaparin / vka n / n ( % ) nmbr / nmbr ( nmbr . nmbr ),C0206460,true,4216/20013
in - stent restenosis,C3272317,false,4217/20013
high risk without atherosclerotic vascular disease +,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,4218/20013
priorother ( not predefined ) medical conditions,,,4219/20013
reteplase / abciximab - facilitated pci ( n = nmbr ),C0256103;C0288672;C4049621,true;true;false,4220/20013
after amendment ( % ),C0680532;C2346732,false;false,4221/20013
antianginal medications,C1874267;C0013227;C0802604;C2598133;C4284232;C3537168,false;true;false;false;false;false,4222/20013
eular good response,C0205170;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,4223/20013
ls means difference ( nmbr % ci ) nmbr,C0023668;C1704970;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,4224/20013
prior stroke ( before index event ),C0332152;C0456712;C0441471;C4019010;C2826257,false;false;false;false;false,4225/20013
interval from onset of symptoms,C1272706;C4086878;C1552654;C1552713,false;false;false;false,4226/20013
low risk ( ri = nmbr - nmbr ),C3272281;C0035487;C1826843;C3538919,false;true;false;false,4227/20013
patients with prior copd - related,C0030705;C0332152;C0024117;C0439849;C0445223;C1412502;C3714496;C2826257,true;false;true;false;false;false;false;false,4228/20013
duration of ra,C0449238;C3538806;C4048756;C2926735,false;false;false;false,4229/20013
myocardial infarction / cabg / pci < nmbr years,C0027051;C0010055;C4049621;C0439234;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false;false,4230/20013
ncep atp iii risk factors,C2744579;C0439070;C0035648;C1553898;C1705160;C4552600,true;false;true;false;false;false,4231/20013
antiarrhythmic therapy,C0003195;C0039798;C0087111;C1363945;C3537142,true;true;true;false;false,4232/20013
mean ( sd ) tender joint count *,C0444504;C2699239;C0451530;C2347634;C2348143,false;false;false;false;false,4233/20013
• ? sd ml / min,C2699239;C0439445,false;false,4234/20013
first - recorded event  no . ( and % ) of patients,C0205435;C1279901,false;false,4235/20013
unknown ( none of the above ),C0439673;C3541433;C4050014,false;false;false,4236/20013
baseline creatinine clearance,C0168634;C0812399;C1442488,true;false;false,4237/20013
drug - eluting stent — no . ( % ),C1322815,true,4238/20013
spacer use during the study,C0221874;C0869040,false;false,4239/20013
non - end - stage renal dysfunction,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4240/20013
duration of epilepsy,C0449238;C0014544;C2926735,false;true;false,4241/20013
blood pressure control,C0005823;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1271104;C1272641,true;true;false;false;false;false;false;false;true,4242/20013
medications through day nmbr,C0013227;C0332173;C0439228;C0439505;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,4243/20013
nyha class ii ( n = nmbrlnmbr ),C1882085,false,4244/20013
nadroparin,C0206232,true,4245/20013
past smoking,C1444637;C0037369;C0453996;C1881674;C4284302,false;true;true;false;false,4246/20013
nmbr - min walk distance ( m ),C0702093;C0429886;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false;false,4247/20013
biologics user,C0005515;C1548600;C1706077;C0005522;C4553887,true;false;false;true;true,4248/20013
other medical history — no . ( % ),C0262926;C1704706,false;false,4249/20013
blood pressure ( % ),C0005823;C1271104;C1272641,true;false;true,4250/20013
sfc nmbr mg / nmbr mg,C4521536;C1319635,false;false,4251/20013
cardioversion in previous nmbr wk,C0013778;C0205156;C0332174;C0439230;C1552607,true;false;false;false;false,4252/20013
nmbr - nmbr ( low risk ),C3272281;C3538919,false;false,4253/20013
hypercholesterolemia ( > nmbr mg / dl ),C0020443;C0439269;C1522133,true;false;false,4254/20013
use of medication at baseline — no . ( % ),C1524063;C0013227;C3244316;C4284232,false;true;false;false,4255/20013
revascularization during index hospitalization,C0581603;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,4256/20013
brv dosage,C0155502;C0178602;C2986497,true;false;false,4257/20013
not rando . in na *,C1518422;C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,4258/20013
oral antidiabetic drugs / insulin ( % / % ),C0029167;C0935929;C0021641;C1533581;C1579433;C3714501;C0175795;C0304289;C0442027;C4521986,true;true;true;false;false;false;false;false;false;false,4259/20013
risk factors specified as inclusion criteria — no . ( % ) f,C0035648;C1553898,true;false,4260/20013
asian or pacific islander,C0078988,true,4261/20013
reversibility : > nmbr - < nmbr %,C0449261,false,4262/20013
average daily dose ( % of target ) *,C1510992;C2348070;C1521840;C2986546;C2825518,false;false;false;false;false,4263/20013
target - vessel revascularization,C0449618;C0581603,false;false,4264/20013
severity of copd — no . ( % ) f,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4265/20013
lvef,C0428772;C0488728,false;false,4266/20013
esrd saxa nmbr . nmbr mg ( n = nmbr ),C0022661;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0035078;C2316810,true;true;true;false;false;false;false;false;true;false,4267/20013
time since diagnosis of pah — yrf,C0040223;C3541383,true;false,4268/20013
right coronary artery,C1261316,false,4269/20013
younger patients ( agednmbr years ),C0332239;C0030705,false;true,4270/20013
fvc ( l ) proportion taking pulmonary medications ( % ) b,C3714541;C1709707,true;false,4271/20013
vein graft stented,C0042449;C0181074;C0332835;C1961139,true;false;true;false,4272/20013
qualifying stroke,C1514624;C0038454;C4554100,false;true;false,4273/20013
difference vs . pbof mean ( s . e . ) t,C1705241;C1705242,false;false,4274/20013
oral hypoglycaemics only,C0359086;C0205171;C1720467,false;false;false,4275/20013
baseline history of vascular disease ( % ),C0168634;C0683519;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983;C1442488,true;false;true;false;false;false;false;false;false,4276/20013
prednisone - equivalent dose — mg,C0032952;C0205163;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C0439185,true;false;false;true;true;false;false;false;false;false;false;false;false,4277/20013
aspirin alone group no of events / total n ( % ),C0004057;C2826346,true;false,4278/20013
known thrombophilic condition — no . ( % ),C0205309;C0398623;C0012634;C0348080;C1705253;C3864998,false;true;true;false;false;false,4279/20013
blood eosinophil proportion ( % ),C0014467;C1709707,true;false,4280/20013
( a ) demographics,C0011298;C1704791,true;false,4281/20013
cox bsl + yr nmbr hbd,C1565830;C1549954;C0439234,true;false;false,4282/20013
direct thrombin inhibitors,C0003440;C3541936,true;false,4283/20013
body - mass index - kg / mnmbr,C0005893;C1532718;C0578022;C1305855,false;false;false;true,4284/20013
acute coronary syndrome,C0948089,true,4285/20013
moderate impairment ( egfr nmbr - nmbr ),C0205081;C0221099;C1739039;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false,4286/20013
use of supplemental oxygen,C4067893;C4554557,false;false,4287/20013
unadjusted or ( nmbr % ci ) p value,C1439367,false,4288/20013
rarely / never,C4035880,false,4289/20013
st - elevation myocardial infarction,C1536220;C3538872,true;false,4290/20013
woscops,,,4291/20013
age ( yrs ),C0001779,false,4292/20013
non - ischaemic cardiomyopathy,C1518422;C0349782,false;false,4293/20013
history of myocardial infarction,C1275835,false,4294/20013
cardiac catheterization,C0018795,true,4295/20013
no aspirin or ppi,C0004057,true,4296/20013
inadequate response,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,4297/20013
drinking,C0001948;C0684271,true;true,4298/20013
non - ics +,C1518422;C0815320;C4551720,false;false;true,4299/20013
endovascular,C0524425,false,4300/20013
sbp ( mmhg ),C0085805;C0439475,true;false,4301/20013
hormone - refractory prostate carcinoma,C1328504,false,4302/20013
drug - eluting stent implanted ( at least one ),C1322815,true,4303/20013
pah origin / cause,C1418251;C0015127;C1524003,false;true;false,4304/20013
experience,C0237607;C0596545,false;false,4305/20013
chinese subgroup,C0008120;C1079230;C1515021;C0152035,false;false;false;true,4306/20013
history of cardiovascular events,C1880008;C0441471;C3541888;C0019664;C1320716;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;false;true;false;true;false;false;false;false,4307/20013
disease duration : < baseline mean,C0872146;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,4308/20013
physician ' s global assessment . mean nmbr sd,C4050369;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,4309/20013
glycated hemoglobin < median,C0017853;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,4310/20013
upper respiratory tract infection,C0041912,true,4311/20013
antibiotics * *,C0003232;C0003237;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710,true;true;false;false;false;false;false;false;false,4312/20013
normoalbuminuria — no . / total no . ( % ),,,4313/20013
aggressive ( nmbr ),C0001807;C0580822,true;false,4314/20013
patients with specific disease characteristics,C0030705;C0205369;C0599878;C1552740,true;false;false;false,4315/20013
work and school,C0043227,true,4316/20013
activity ( nmbr - nmbr vas ),C0205177;C0042815;C3536884;C3827561;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;true;true;false;false;false;false;false;false;false,4317/20013
age ( yrs ) nmbr - nmbr,C0001779,false,4318/20013
afcaps /,,,4319/20013
clinical presentation of vte at initial diagnosis — no . ( % ),C2708283;C0630906,false;true,4320/20013
aspirin < nmbr hours,C0004057;C0439227,true;false,4321/20013
glucosamine ( n = nmbr ),C0017718,true,4322/20013
neither ace inhibitor nor arb,C0003015;C4541021,true;false,4323/20013
previous coronary intervention,C0205156;C0018787;C0184661;C0886296;C1273869;C1552607,false;true;true;false;false;false,4324/20013
time since diagnosis of diabetes — no . ( % ),C0040223;C3541383,true;false,4325/20013
dyslipidaemia and hypertensiont,C0242339,true,4326/20013
presence of erosions,C0150312;C0333307;C1959609;C0392148;C3854307,false;false;false;false;false,4327/20013
sitting pulse,C0277814;C0232117;C0391850;C1947910;C2584297;C4050224,true;true;false;false;true;false,4328/20013
post - cabg,C0687676;C0010055;C1704687;C3469826,false;true;false;false,4329/20013
cigarette smoking,C0239059;C0700219,false;true,4330/20013
> nmbr - nmbr ( moderate risk ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,4331/20013
triglycerides tx difference vs pbo,C0041004;C0041403;C1705241;C1705242,true;true;false;false,4332/20013
nmbr - nmbr / nmbr - nmbr mm hg,C0439475,false,4333/20013
body mass indexa < median,C0518010;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4334/20013
dmard user,C0242708;C1548600;C1706077,true;false;false,4335/20013
duplex ultrasonography,C3825392,false,4336/20013
all of the colon,C0009368;C3888384,true;false,4337/20013
nmbr - nmbr - nmbr,,,4338/20013
coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,4339/20013
body mass index  mean + sd ( kg / m ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,4340/20013
> nmbr previous venous thromboembolisms ( % ),C0205156;C1997614;C1552607,false;false;false,4341/20013
remission at maintenance - trial entry — no . ( % ),C0544452;C0024501;C0008976;C1705654;C0687702,false;true;true;false;false,4342/20013
improved,C0184511;C0332272;C1561611;C4084203,false;false;false;false,4343/20013
treatment stratum^ :,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,4344/20013
red blood cell counting,C0014772;C1287262,true;false,4345/20013
nmbr - wk kaplan - meier rate,C0332174;C0871208;C1521828;C0439230,false;false;false;false,4346/20013
continuous variables,C0549178;C0439828,false;false,4347/20013
intensified nmbr months ( n - nmbr ),C0439231,false,4348/20013
elevated troponin,C0205250;C0041199;C3163633,false;true;false,4349/20013
smoking history : current smoker,C1519384;C3173209;C3241966,false;false;false,4350/20013
jbs - nmbr primary prevention onlynmbr,C0175692;C0033144;C0205171;C1720467;C0795841;C1416527,true;true;false;false;true;false,4351/20013
( se]tf hdl - c,C0036919;C4048299;C3715113;C4048587,true;false;false;false,4352/20013
baseline hs - crp tertiles ( mg / i],C0168634;C3890735;C0024671;C0021966;C0221138;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285;C1442488,true;false;true;true;false;true;false;false;false;false;false;false;false,4353/20013
not reported,C1518422,false,4354/20013
diabetes and currently on an oral hypoglycaemic agent orinsulin,C0011847;C0011849,false;true,4355/20013
standard care n ( % ) / nmbrpy,C1442989;C1947933;C0030428;C3538810;C2828392,false;false;true;false;false,4356/20013
apremilast,C1678805,true,4357/20013
anterior myocardial infarction — no . ( % ),C0340293,true,4358/20013
oxcarbazepine,C0069751,true,4359/20013
mildly impaired,C0750532;C2945599,false;false,4360/20013
incidence [n / n ( rate per nmbr person - years ) ],C1708485;C0027361;C0439234;C2347489,false;true;false;false,4361/20013
blood pressure at target level ( % ) §,C0005823;C1521840;C0441889;C0456079;C1547707;C2946261;C2986546;C1271104;C1272641,true;false;false;false;false;false;false;false;true,4362/20013
egfrmdrd ， ml - min - nmbr - nmbr . nmbr m_nmbr,C0439445;C0369637;C0441923,false;false;false,4363/20013
benign prostatic hyperplasia,C1704272,true,4364/20013
> nmbr erosion,C0333307;C1880549;C1959609;C3887524,false;false;false;false,4365/20013
body - mass index > nmbr,C0005893;C0578022;C1305855,false;false;true,4366/20013
alcohol consumption,C0001948,true,4367/20013
rhabdomyolysis or myopathy,C0035410;C4552660,true;false,4368/20013
treatment arm,C1522541,false,4369/20013
concomitant therapies at hospital discharge,C1707479;C0586003,false;false,4370/20013
hbanmbrc in patients with baseline hbanmbrc > nmbr % ( > nmbr mmol / mol ),C0019016;C0030705;C0168634;C3829066;C1442488;C1825777;C3538758,true;true;true;false;false;false;false,4371/20013
specific risk of bleeding^,C0205369;C3251812;C1552740,false;false;false,4372/20013
number resulting in emergency department visit,C0237753;C0449788,false;false,4373/20013
elevated troponin ( > nmbr . nmbr pg / l ),C0205250;C0041199;C0439278;C3163633,false;true;false;false,4374/20013
hi ) ah ( % ),C0018619;C1836672;C0239849;C1412082;C1412316;C1431594;C4552857,true;true;true;false;false;true;false,4375/20013
number of exacerbations,C0237753;C4086268;C0449788,false;false;false,4376/20013
cpk > nmbr times uln,C0040223;C1519815;C1632851,true;false;false,4377/20013
glucosamine + chondroitin sulfate ( n = nmbr ),C0017720;C0008454;C0876712;C0038720;C0474702;C0475337;C3536965;C0017718;C0008466,true;true;false;true;false;false;false;true;true,4378/20013
serum trap - nmbrb ( u / liter ),C0229671;C0184047;C0439148;C0475211;C1336677;C1566918;C1706005;C1710330;C3887583;C1546774;C1550100,true;false;false;false;false;true;false;false;false;false;false,4379/20013
sex ( male ) ethnic origin,C0086582;C0015031,true;true,4380/20013
no corticosteroids or immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4381/20013
lvef within nmbr months,C0428772;C0439231;C0488728,false;false;false,4382/20013
ls mean change from baselinenmbr,C0023668;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,4383/20013
uric acid ( mg / dl ) creatinine clearance ( ml / min per nmbr . nmbr mnmbr ),C0041980;C0439269;C0151280;C0369637;C0441923;C0024671;C3642208;C0026410;C1960952;C2346927;C4321396;C4521761,true;false;false;false;false;true;false;true;false;false;false;false,4384/20013
weight — kg ( median ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,4385/20013
non - black,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,4386/20013
myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,4387/20013
duration of assigned regimen before surgery,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,4388/20013
asian / black / white / hispanic / other ( % ) clinical parameters,C0078988;C1533017;C0007457;C0043157;C0220938;C1533018;C0005680;C1533020;C1533021;C0027567;C0085756;C0439541,true;false;true;true;false;false;true;false;false;true;true;false,4389/20013
> nmbr mg / dl eze / simva nmbr = nmbr },C0439269,false,4390/20013
risk factors for pad,C0035648;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C1553898,true;false;false;false;false;false;false;false,4391/20013
baseline hemoglobin,C0168634;C0019046;C1442488,true;true;false,4392/20013
insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,4393/20013
prior percutaneous coronary intervention — no . ( % ),C0332152;C1532338;C2826257,false;true;false,4394/20013
other bdmard §,,,4395/20013
icd therapy ( n =,C0021122;C0039798;C0087111;C1363945,true;true;true;false,4396/20013
apo a - l ( mg / dl ) - mean ± sd,C1447574;C0439269;C0444504;C2699239;C2347634;C2348143;C4521365,true;false;false;false;false;false;false,4397/20013
with alogliptin nmbr . nmbr mg ( n nmbr nmbr ),C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4398/20013
symptomatic pad of lower extremities *,C0231220;C0182158;C0023216;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;true;false;false;false;false;false,4399/20013
pfor heterogeneity,C1151635;C0019409;C0242960,false;false;true,4400/20013
severe impairment ( egfr < nmbr ),C0205082;C0221099;C1739039;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;false;false;false;false;false,4401/20013
previous use of amiodarone,C0205156;C1524063;C0002598;C1552607,false;false;true;false,4402/20013
levetiracetam,C0377265;C3693636,true;false,4403/20013
peri - op beta - blockers : no ( n = nmbr ),C0347985;C0001645,false;true,4404/20013
patient global assessment ( nmbr - nmbr mm vas ),C4054229;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,4405/20013
background treatment,C1706907;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,4406/20013
high titre ( > nmbr times of uln ),C0205250;C0475208;C0040223;C1519815;C1632851;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false,4407/20013
no corticosteroid,C0001617;C3536709,true;false,4408/20013
greater than or equal to nmbr mm hg,C0439093,false,4409/20013
antiarrhythmic agent,C0003195;C0301380,true;false,4410/20013
white not of hispanic origin,C0007457;C0043157;C0220938,true;true;false,4411/20013
cause of dvt or pe — no . ( % ),C0015127;C0149871;C2926618;C3899446;C1524003,true;true;false;false;false,4412/20013
sulfonylurea — no . ( % ),C0038766;C3536898,true;false,4413/20013
mean preoperative abpi of the index,C0444504;C0445204;C0600653;C0918012;C1552854;C1637833;C2986546;C2347634;C2348143,false;false;true;true;false;false;false;false;false,4414/20013
met criterion at finalt,C0428210;C0243161;C1550543;C4317104,false;true;false;false,4415/20013
orthopnea,C0085619,false,4416/20013
total mortality,C0439175;C0026565;C0026566;C0439810,false;true;true;false,4417/20013
pace,C0287990;C1552930;C4048252,true;false;false,4418/20013
non - caucasian simva,C1518422;C0007457;C0043157,false;true;true,4419/20013
high periostin subgroup ( > nmbr ng / ml ) ( n = nmbr ),C0205250;C0219433;C1079230;C0439275;C1515021;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false;false;false;false,4420/20013
overall population,C0282416;C0032659;C1257890;C1561607,true;true;true;false,4421/20013
all randomized women,C0034656;C0043210;C3815594,true;true;false,4422/20013
respiratory - related^,C0521346;C0439849;C0445223;C1546767,false;false;false;false,4423/20013
treated vessel - native coronary,C1522326;C0005847;C0302891;C0018787,false;true;false;true,4424/20013
< nmbr . nmbr mmol / liter estimated gfr,C0439190;C0475211,false;false,4425/20013
prior ms treatment with ifn - beta or,C1514463;C2349943;C0015980;C3539704;C3713294,false;false;true;false;true,4426/20013
no hemoconcentration hemoconcentration,C0549409;C0854379,false;false,4427/20013
body weight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,4428/20013
dasnmbr ( c - reactive protein ),C0051767;C0006560;C1413716;C4048285;C0057671,true;true;false;false;true,4429/20013
blood pressure  pbo y patients with diabe teristics ( ncep atp i,C0005823;C0031962;C0030705;C2744579;C0021966;C0221138;C4552600;C1271104;C1272641,true;true;true;true;true;false;false;false;true,4430/20013
patients with normoalbuminuria at baseline,C0030705,true,4431/20013
stenting plus medical therapy ( n = nmbr ),C0038257;C0418981;C2348535,true;false;false,4432/20013
mean - sd change in pre - bronchodilator fevnmbr,C0444504;C2699239;C0392747;C2599602;C3714541;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;true;false;false;false;false;false,4433/20013
change from baseline in % predicted fevnmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,4434/20013
patients with uncomplicated events ( p = o - nmbr 十 ),C0030705;C0443334;C0441471;C3541888,true;false;false;false,4435/20013
post - bronchodilator percent of predicted fevnmbr,C2599594;C1882327;C3714541,false;false;true,4436/20013
comparison with baseline,C1707455;C0168634;C1442488,false;true;false,4437/20013
previous ml ( interaction : p = nmbr . nmbr ),C0205156;C0439526;C1704675;C1705224;C3887665;C1552607,false;false;false;false;false;false,4438/20013
cardiac glycosides,C0007158,true,4439/20013
previously taken any other dmards,,,4440/20013
crp ( normal range : nmbr - nmbr . nmbr ),C3890735;C0086715;C4048285,false;true;false,4441/20013
modified rankin score,C0392747;C0449820;C4050231;C3889737,false;false;false;false,4442/20013
a a ( nmbr ( % ),,,4443/20013
mean involved bsa,C0444504;C2347634;C2348143,false;false;false,4444/20013
other defined,C1704788;C3539106,false;false,4445/20013
without ( n = nmbr nmbr ),C0369718;C0441922,false;false,4446/20013
treatment with drugeluting stent,C0039798;C1322815;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,4447/20013
nmbr - nmbr ( moderate ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4448/20013
angiography,C0002978,true,4449/20013
sbp / dbp $ nmbr / $ nmbr mmhg,C0085805;C0536221;C0439475;C3813197;C4281799,true;true;false;false;false,4450/20013
non - extensive,C1518422;C0205231,false;false,4451/20013
electrocardiographic findings — no . ( % ),C0438154,false,4452/20013
beta receptor antagonist,C0330390;C4543207;C0439096;C2004068,false;false;false;false,4453/20013
baseline triglycerides by quintiles,C0168634;C0041004;C1508496;C1442488,true;true;false;false,4454/20013
median albumin - to - creatinine ratio ( interquartile range ),C0549183;C0486293;C1711350;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4455/20013
< nmbr regardless of historical count,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,4456/20013
stent type,C0038257;C0332307;C1547052,true;false;false,4457/20013
nmbr vessel pci,C0005847;C4049621,true;false,4458/20013
body mass index subgroups,C0005893;C1079230;C0578022;C1305855,false;false;false;true,4459/20013
pioglitazone,C0071097,true,4460/20013
b - agonists ( long - acting ) a,C0243192;C2987634,true;false,4461/20013
tg ( mg / dl ),C0337445;C0439269,false;false,4462/20013
risk factors for recurrent vte — no . ( % ) f,C0035648;C1455761;C0630906;C2945760;C1553898,true;false;true;false;false,4463/20013
caucasian eze / simva,C0007457;C0043157,true;true,4464/20013
nmbr - < nmbr mvmin,,,4465/20013
pioglitazone ( n = nmbr,C0071097,true,4466/20013
time from onset to medication,C0449244,false,4467/20013
baseline insulin daily dose / kg,C0168634;C0366513;C0332173;C0022718;C0439209;C4054209;C0021641;C2348070;C1533581;C1579433;C3714501;C1442488,true;false;false;true;false;false;true;false;false;false;false;false,4468/20013
mean — ml / min / nmbr . nmbr mnmbr of body - surface area,C0444504;C0439445;C0369637;C0489451;C0017446;C0205146;C0441923;C2347634;C2348143,false;false;false;false;true;false;false;false;false,4469/20013
telmisartan group ( n = nmbr ),C0248719;C0441848,true;false,4470/20013
total cholesterol ( mmo nmbr / nmbr ),C0201950;C0543421,false;false,4471/20013
african - latin american,C0085756,true,4472/20013
more than nmbr lesions per vessel,C0205172,false,4473/20013
> = nmbr % and < nmbr % ( > = nmbrand < nmbr mmol / mol ),,,4474/20013
no . of events / total no . ( % ),C0441471;C3541888,false;false,4475/20013
ind nmbr mg q . d . n = nmbr,C4049864;C0439422,false;false,4476/20013
smoking history : ex - smoker,C1519384;C0337664,false;true,4477/20013
troponin level,C0041199;C0441889;C0456079;C1547707;C2946261,true;false;false;false;false,4478/20013
duration of copd — days^,C0449238;C0024117;C0439228;C1412502;C3714496;C2926735,false;true;false;false;false;false,4479/20013
other antiplatelet agents,C0085826,true,4480/20013
thienopyridine at randomization,C1120149;C0034656,true;true,4481/20013
bmi ( kg / mnmbr ) cardiovascular history,C0578022;C1532718;C1880008,false;false;false,4482/20013
controllednmbr — no . ( % ),C2587213;C2911690,false;false,4483/20013
sulfonylurea derivatives,C0038766,true,4484/20013
score nmbr - nmbr,C0449820;C4050231,false;false,4485/20013
radial access site,C0442038;C0589360;C0920847,false;false;false,4486/20013
use of parenteral antithrombotic agents — no . ( % ),C1524063;C0030547;C1704311;C4522267,false;true;true;false,4487/20013
immunosuppressant ( with or without corticosteroid ),C0021081,true,4488/20013
ml with st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,4489/20013
remission in overall population,C0544452;C0282416;C0032659;C1257890;C1561607;C0687702,false;true;true;true;false;false,4490/20013
v / hctz,C0020261,true,4491/20013
pulse ( beats / min ) cholesterol ( mmol / l ),C0232117;C0391850;C1947910,true;false;false,4492/20013
number of participants,C0237753;C0679646;C0449788,false;false;false,4493/20013
beta - carotene,C0053396;C0696105,true;false,4494/20013
hemispheric stroke n = nmbr,C0205139;C0038454;C4554100,false;true;false,4495/20013
pci for index mi ( % ),C4049621;C0600653;C3810814;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false,4496/20013
absolute fvc decrease > nmbr %,C0205344;C3714541;C0392756;C0547047,false;true;false;false,4497/20013
hemoglobin ( gl ' ),C0019046;C0018229;C1423073;C1427674,true;true;false;false,4498/20013
low ( nmbr - nmbr ) ( n = nmbr  nmbr  nmbr % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,4499/20013
> nmbr % and < nmbr % predicted arr ( n = nmbr,,,4500/20013
duration from hospital admission to pci,C0449238;C0019994;C1959907;C1510665;C2926735,false;true;false;false;false,4501/20013
prednisone,C0032952,true,4502/20013
enalapril dm = nmbr non - dm = nmbr,C0014025;C0011816;C3250443,true;true;false,4503/20013
entire cohort,C0439751;C0009247;C0599755;C0444667,false;true;false;false,4504/20013
intravenous loop diuretics !,C0348016;C0354100,false;true,4505/20013
peripheral revascularization,C0205100;C0581603,false;false,4506/20013
no ischemia ( n = nmbr,C0022116;C4321499,true;false,4507/20013
fp / sal nmbr / nmbr pg ( n = nmbr ),C0016704;C0036140;C0030827;C0072225;C1266240;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412,true;true;true;true;false;true;true;false;false;false;false,4508/20013
antithrombotic use,C0042153;C0457083;C1947944,true;false;false,4509/20013
p lace of randomization ( interaction : p = nmbr . nmbr ),C0369773;C0280109;C0034656;C1704675;C0453991;C2603361,false;false;true;false;false;false,4510/20013
km event rate ( % ),C3887676;C0441471;C0871208;C1521828;C4019010,false;false;false;false;false,4511/20013
revascularisation + antiplatelets + lipid - lowering agents + p blockers,C0581603;C0086440,false;true,4512/20013
betanmbr selective,C0330390;C0439096;C2004068,false;false;false,4513/20013
iii and iv ejection fraction,C0439070;C1705160,false;false,4514/20013
antiarrhythmic drug,C0003195;C0301380,true;false,4515/20013
median time since diagnosis * ( range ),C0549183;C0040223;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,4516/20013
bmi,C0578022,false,4517/20013
serum potassium ( mmol / l ),C0302353;C1532563;C0543465,false;false;false,4518/20013
gissi prevention nmbr / nmbr - nmbr / nmbr,C0199176;C1706420;C2700409,false;false;true,4519/20013
nyha class nmbr or higher,C1882083,false,4520/20013
concomitant medication — no . ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4521/20013
history of major cardiovascular disease,C0455539;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false,4522/20013
versus tiotropium nmbr pg,,,4523/20013
nyha functional class at screening,C1882083;C0205245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0542341;C2700217,false;false;true;true;false;false;false;false;false;false;false,4524/20013
time from most recent qualifying,C0040223;C0332185;C1514624;C3541383,true;false;false;false,4525/20013
use of loop diuretics,C1524063;C0354100,false;true,4526/20013
glycemia,C0005802,true,4527/20013
duration of asthma,C0449238;C0004096;C2984299;C2926735,false;true;false;false,4528/20013
bisphosphonates,C0012544;C3541401,true;false,4529/20013
cardiovascular disease history,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,4530/20013
no pci or cabg — no . ( % ),C4049621,false,4531/20013
any statin ( with / without llt ),C0360714,true,4532/20013
associated with drug / toxin,C0332281;C0013221,false;true,4533/20013
non - diabetic patients,C1829939;C0241863,false;false,4534/20013
baseline hbanmbrc in nmbr classes,C0168634;C0019016;C0456387;C1518526;C1705943;C4019422;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false,4535/20013
coronary artery disease — no . ( % ) : ! :,C0010054;C0010068;C1956346,true;true;true,4536/20013
patients with egfr nmbr > nmbr to < nmbr ml / min / nmbr . nmbrmnmbr,C0030705;C1739039;C3811844;C3812682,true;true;false;false,4537/20013
baseline corticosteroidst ( mean dose : nmbr . nmbr mg / day ),C0168634;C0444504;C0178602;C0439422;C0869039;C1114758;C2347634;C2348143;C1442488,true;false;false;false;false;false;false;false;false,4538/20013
vka,,,4539/20013
reported in ecrf,C0684224;C4551412;C0700287;C4319718,true;false;false;false,4540/20013
evidence or thombus,C3887511,false,4541/20013
prior aortocoronary bypass surgery 一 no . ( % ),C0455610;C0010055,false;true,4542/20013
regional anaesthesia,C0002911,true,4543/20013
events / n,C0441471;C3541888,false;false,4544/20013
anti - coagulants - no . ( % ),C0848112,false,4545/20013
other antihypertensive,C0003364,true,4546/20013
thrombus - containing lesion,C0087086;C0332256;C0221198;C1546698;C2700400;C0302148;C3146237,true;false;false;false;false;false;false,4547/20013
sgrq total score ( week,C2964552;C0332174;C0439230,false;false;false,4548/20013
americas ( n = nmbr ),C0002454;C0596070,true;false,4549/20013
placebo - adjusted mean difference in % hbanmbrc ( nmbr % ci  [ p value] ),C0032042;C1696465;C1706408,true;false;false,4550/20013
serum total cholesterol ( mmol / l ),C0587184;C1532563;C1287371,false;false;false,4551/20013
creatinine level,C0428279,false,4552/20013
cv death / mi / stroke / ucr,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,4553/20013
irbesartan,C0288171,true,4554/20013
time from acs to randomization,C0040223;C0742343;C4318612;C3541383,true;true;false;false,4555/20013
time intervals,C0872291,false,4556/20013
history of stroke or tia,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4557/20013
medications at timing of randomization,C2359859;C0034656,false;true,4558/20013
cv death or hf hospitalization n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,4559/20013
cvd events,C0007222;C0441471;C3541888,true;false;false,4560/20013
nmbr - point mace,C1552961;C2347617;C3714763,false;false;false,4561/20013
low - dose aspirin use,C2608320;C0042153;C0457083;C1947944,false;true;false;false,4562/20013
moderate / severe exacerbations  itt population  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4563/20013
lp ( a ) §,C0065058;C1439335;C4553379,true;false;false,4564/20013
hbanmbrc levels,C0019016;C0441889;C1825777;C3538758,true;false;false;false,4565/20013
weekly,C0332174,false,4566/20013
> nmbr ( high risk ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,4567/20013
percentage of time in therapeutic inr range,C0439165;C0040223;C3541383;C1549488;C1561533,false;true;false;false;false,4568/20013
> nmbr prior myocardial infarction — no . ( % ),C0155668,false,4569/20013
threatened abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,4570/20013
prior therapy,C1514463,false,4571/20013
duration of pci ( min ),C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,4572/20013
age > nmbr y,C0001779,false,4573/20013
van der heijde mtss,C0557775;C1511780,false;false,4574/20013
form / bud,C0348078;C2700462;C2945744;C0376315;C1522492;C4255237,false;false;false;true;false;false,4575/20013
no . of patients ind / gly sfc,C0030705;C4049864;C0017890;C4521536;C0523677,true;false;true;false;false,4576/20013
missing hb at yr nmbr,C1551393;C0019046;C0439234;C1705492;C3272743,false;true;false;false;false,4577/20013
within nmbr h after,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,4578/20013
left ventricular ejection fraction < nmbr %,C0428772;C0488728,false;false,4579/20013
mestizos,C0682082,false,4580/20013
ankle - brachial index < nmbr . nmbr,C1328319;C3888326,true;false,4581/20013
p - value ( anova ),C1709380;C0753802,false;true,4582/20013
patients with > nmbr exacerbations resulting in emergency department visit,C0030705;C4086268,true;false,4583/20013
difference in change,C1705241;C0392747;C0443172;C4319952;C1705242,false;false;false;false;false,4584/20013
established atherosclerotic cardiovascular disease,C0443211;C0004153;C1272684,false;true;false,4585/20013
other vascular disease,C0042373,true,4586/20013
black race and ss > nmbr ( n = nmbr vs nmbr ),C0005680,true,4587/20013
qualifying mi : stemi,C1514624;C3810814;C1536220;C3538872,false;false;true;false,4588/20013
history of a transient ischaemic attack,C0455536,false,4589/20013
known tiromtcch * c ccndifeon,C0205309,false,4590/20013
total patients,C0439175;C0030705;C0439810,false;true;false,4591/20013
swollen joint count ( nmbr - nmbr possible joints ),C0451521;C0332149;C1705910;C2362652,false;false;false;false,4592/20013
prior amputation,C0332152;C0002688;C0332840;C1546539;C2826257,false;true;false;false;false,4593/20013
arterial area ( mmnmbr ),C0003842;C0017446;C4330985;C4554674;C0205146;C0221464,true;true;false;false;false;false,4594/20013
statin + fibrate or,C0360714,true,4595/20013
presence of enthesitis,C0150312;C1282952;C0392148;C3854307,false;false;false;false,4596/20013
nyha class ( when patient was last in stable condition before admission ),C1882083,false,4597/20013
ischaemic ( n = nmbrlnmbr ),C0475224,false,4598/20013
sbp > nmbr mmhg and / or dbp > nmbr mmhg,C0085805;C0439475,true;false,4599/20013
caucasian,C0007457;C0043157,true;true,4600/20013
use of cardiac medication *,C1524063;C0018787;C0013227;C3244316;C4284232;C1522601,false;true;true;false;false;false,4601/20013
pioglitazone ( n = nmbr ),C0071097,true,4602/20013
hdl cholesterol < nmbr ( men ) or < nmbr mg / dl ( women ),C0023822;C0025266;C0392885,true;true;false,4603/20013
cardiac valvular disease,C0018824,true,4604/20013
randomized to receive vitamin e,C0034656;C3815594,true;false,4605/20013
indication for index procedure,C2315323;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,4606/20013
total c ( mmol / l,C0439175;C1532563;C0439810,false;false;false,4607/20013
left ventricular ejection fraction — %,C0428772;C0488728,false;false,4608/20013
non - reversible ( % ),C1518422;C0205343,false;false,4609/20013
peripheral neuropathy,C0031117,true,4610/20013
acuity major,C0750509,false,4611/20013
standard therapyy ( n = nmbr ),C1442989;C2828392,false;false,4612/20013
acqnmbr score,C2919686,false,4613/20013
baseline cardiovascular disease,C0168634;C0007222;C1442488,true;true;false,4614/20013
myalgia,C0231528;C4552646,true;false,4615/20013
time since as diagnosis,C0040223;C3541383,true;false,4616/20013
albumin / creatinine ratio - mg / mmol,C0486293;C0567349;C2348885;C1318293,false;false;false;false,4617/20013
change in dasnmbr - esr ( mean ) i physical function outcomes week nmbr,C0392747;C0051767;C3811131;C0444504;C0021966;C0516981;C1274040;C0332174;C0439230;C4049916;C0221138;C2347634;C2348143;C0057671;C0443172;C1705241;C4319952,false;true;false;false;true;false;false;false;false;false;false;false;false;true;false;false;false,4618/20013
venous insufficiency,C0042485,true,4619/20013
pdqol scale,C0175659;C0349674;C1947916,true;false;false,4620/20013
baseline nmbr - asa,C0168634;C0004057;C3853627;C1442488,true;true;false;false,4621/20013
current medication,C0746467,false,4622/20013
median ( range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4623/20013
mean ( sd ) aqlq,C0444504;C2699239;C4055434;C2347634;C2348143,false;false;false;false;false,4624/20013
humerus fracture,C0020162,true,4625/20013
high - density lipoprotein cholesterol tx difference vs pbo,C0023822;C0041403;C1705241;C1705242,true;true;false;false,4626/20013
clopidogrel pretreatment duration,C0070166;C1550147;C0449238;C2926735;C2709094;C3539075;C3539076,true;false;false;false;false;false;false,4627/20013
lower than normal range — % ^,C0441994;C0086715;C1548802;C2003888,false;true;false;false,4628/20013
months ( log - transformed ),C0439231,false,4629/20013
saba reversibility,C0449261,false,4630/20013
previous stroke or tia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,4631/20013
high disease activity : > nmbr . nmbr,C4699623;C0012634;C0205250;C1292728;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false,4632/20013
alcohol use ( % ),C0001948,true,4633/20013
americas,C0002454;C0596070,true;false,4634/20013
acitretin,C0050559,true,4635/20013
stratification variables,C1514983;C0439828,false;false,4636/20013
factor v leiden or prothrombin mutation,C0380964;C0584960;C1414509;C3542419,true;false;false;false,4637/20013
simplified disease activity index score,C3869582;C0449820;C4050231,false;false;false,4638/20013
diabetic kidney disease,C0011881,true,4639/20013
prior coronary artery disease yes,C0332152;C0010054;C1549445;C1705108;C1710701;C0010068;C1956346;C2826257,false;true;false;false;false;true;true;false,4640/20013
intravenous nitrates,C0348016;C0028125,false;true,4641/20013
toast classification,C1710306;C4521230,false;false,4642/20013
£ nmbr . nmbr % * *,,,4643/20013
yes previous revascularization,C1549445;C0205156;C0581603;C1552607;C1705108;C1710701,false;false;false;false;false;false,4644/20013
no . / nmbr person - yr,C0027361;C0439234;C2347489,true;false;false,4645/20013
p - blocker intake at randomisation ( n = nmbro ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,4646/20013
> l : nmbrhrs : min ( n = nmbr ),C0439393;C1568891,false;true,4647/20013
oral glucocorticoid use at baseline — no . ( % ) : t,C1527415;C0017710;C0168634;C1442488,false;true;true;false,4648/20013
adjusted mean change,C0456081;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false,4649/20013
age at completion of highest level of,C0001779;C0205197;C4321237;C1554962,false;false;false;false,4650/20013
age group 一 ％,C0027362;C2348001,true;false,4651/20013
combined macro + micro,C0205195;C2984010;C0085672;C1553035;C3811161;C4049106,false;false;false;false;false;false,4652/20013
race / ethnicity chinese,C0034510;C0015031;C0008120;C0152035;C0243103;C1706779;C3853635,true;true;false;true;true;false;false,4653/20013
history of more than nmbr prior mi ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,4654/20013
physical activity §,C0015259;C0026606,true;true,4655/20013
systolic blood pressure,C0488055;C0871470;C1306620,false;true;false,4656/20013
diagnoses / risk factors,C0011900;C0035648;C1553898,true;true;false,4657/20013
medication effects,C1319171,false,4658/20013
insulin glargine,C0907402,true,4659/20013
diuretic thiazide,C0012802,true,4660/20013
paclitaxel,C0144576,true,4661/20013
total back pain,C0439175;C0004604;C1963071;C4553945;C0439810,false;true;false;false;false,4662/20013
previous intolerance of infliximab,C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,false;false;true;false;false;false,4663/20013
uae ( p,C1519789,false,4664/20013
any statin versus no statin at randomization,C0360714,true,4665/20013
adalimumab group ( n = nmbr ) t,C1122087;C0036669,true;true,4666/20013
fracture during follow - up,C0016658;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,4667/20013
biguanides,C0005382;C0360396;C3540012,true;false;false,4668/20013
> nmbr . nmbr kg / mnmbr hypertension :,C1532718;C0020538;C1963138,false;true;false,4669/20013
values are expressed as percentages unless otherwise indicated . bmi  body mass index  cabg  coronary artery bypass ischemic attack  nsaids  nonsteroidal anti - inflammatory drugs  sbp  systolic bp  dbp  diastolic bp . * history of or currently taking antidiabetic or lipid - lowering medications .,C0042295,false,4670/20013
aminosalicylates,C0368663,false,4671/20013
prediabetes — no . ( % ) nmbr,C0362046,true,4672/20013
history of pci with stenting,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,4673/20013
brain volume,C1113695,false,4674/20013
swollen joint count ( nmbr - nmbr ),C0451521,false,4675/20013
no . of strokes ( % ),C0038454,true,4676/20013
demographic and medical variables,C0011298,true,4677/20013
australia / nz,C0004340;C0027978,true;true,4678/20013
no . of events / patients,C0441471;C0030705;C3541888,false;true;false,4679/20013
chd history,C0280604;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3542407,false;true;true;false;false;false;false;false,4680/20013
jsn score ( nmbr - nmbr ),C0449820;C4050231,false;false,4681/20013
ascvdor > nmbr cv risk factors,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,4682/20013
previous transient ischemic attack,C0205156;C0007787;C0917805;C1552607,false;true;true;false,4683/20013
number of stent = l or nmbr or nmbr,C0237753;C0038257;C0449788,false;true;false,4684/20013
ischemic stroke with hemnrrhnaic cnnversinn,C0948008,false,4685/20013
chronic stable angina,C0340288,true,4686/20013
fenofibric acid + low - dose statin,C0060179;C0445550;C0360714;C1708745,true;false;true;false,4687/20013
daily iglar dose at week nmbr ( u ),C2348070;C0560588,false;false,4688/20013
anticholinergic,C0242896;C3537004,true;false,4689/20013
contrast volume,C0009924;C0449468;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false,4690/20013
rituximab ( nmbrxnmbr mg ) + mtx,C0393022;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,4691/20013
> nmbr mg / dl simva nmbr = nmbr],C0439269,false,4692/20013
glucagon - like peptide - nmbr agonist,C0014361;C2987634,true;false,4693/20013
acrnmbr response at week nmbr,C1412134;C0871261;C0332174;C0439230;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false;false;false,4694/20013
alcohol intake ( + ) ( % ),C0001948,true,4695/20013
# of prior tnfi among non - tnfi naive,C0332152;C1518422;C2826257,false;false;false,4696/20013
triglycerides ( median,C0041004,true,4697/20013
total antihypertensive use,C0439175;C0003364;C0042153;C0457083;C1947944;C0439810,false;true;true;false;false;false,4698/20013
anmbrc distribution ( % ),C0520511;C1704711,false;true,4699/20013
middle third,C0442050,false,4700/20013
symptom score ( sd ),C3476546;C2699239,false;false,4701/20013
atorvastatin factorial study,C0286651;C2826344,true;false,4702/20013
former / non - drinker,C0205156;C0457801;C0750523,false;false;false,4703/20013
electrocardiographic findings at randomization,C0438154;C0034656,false;true,4704/20013
lumbar spine bmd t - score,C0024091;C0449820;C4050231;C3887615,true;false;false;false,4705/20013
multiple ( nmbr + ) chd risk,C0439064;C1282512,false;false,4706/20013
hyperlipidemia,C0020473;C0428465;C4555212,true;false;false,4707/20013
place of randomization,C0442504;C0034656;C1533810;C1704765;C1882509,false;true;false;false;false,4708/20013
beta - blocker % target dose,C0001645;C1521840;C0178602;C0869039;C1114758;C2986546,true;false;false;false;false;false,4709/20013
ranolazine vs . placebo km failure rate,C0073633,true,4710/20013
biomarker high ( periostin > nmbrng / ml or blood eosinophils > nmbrcells per pl ),C0005516;C0205250;C0219433;C0439275;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,true;false;true;false;false;false;false;false;false;false;false;false,4711/20013
at or above the median,,,4712/20013
indacaterol - glycopyrronium group ( n = nmbr ),C1722260;C3814772;C0441848,true;false;false,4713/20013
infarct on brain imaging 丰,C0751955,true,4714/20013
baseline laboratory values,C0168634;C0022877;C0042295;C3244292;C4283904;C1442488,true;true;false;false;false;false,4715/20013
timi major or minor bleeding,,,4716/20013
olodaterol nmbr mg ( n = nmbr ),C2934193;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4717/20013
race / ethnicity white,C0034510;C0015031;C0007457;C0043157;C0220938;C0243103;C1706779;C3853635,true;true;true;true;false;true;false;false,4718/20013
tnfi ( no other bdmard taken ) t,,,4719/20013
patients treated,C0030705,true,4720/20013
distribution time,C0520511;C0040223;C3541383;C1704711,false;true;false;true,4721/20013
previous treatment failure — no . ( % ) § * *,C0205156;C0162643;C0235828;C0521983;C1547544;C1552607,false;true;false;false;false;false,4722/20013
median body weight — kg,C3821165;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false;false,4723/20013
raas inhibitor use,C1999216;C0042153;C0457083;C1947944,false;true;false;false,4724/20013
previous cardiovascular event at randomization,C0205156;C1320716;C0034656;C1552607,false;false;true;false,4725/20013
aspirin alone ( n = nmbr ),C0004057;C0205171;C0439044;C0679994,true;false;false;false,4726/20013
wml load at baseline mri,C1550025;C0168634;C0024485;C1824234;C3890166;C1442488;C1704782;C1708715,false;true;true;false;false;false;false;false,4727/20013
clopidogrel plus aspirin,C0070166;C0332287;C0004057,true;false;true,4728/20013
alanine aminotransferase or aspartate aminotransferase > nmbrx upper limit of normal ( n = nmbr ),C0001899;C0057041;C1415274;C3887708,true;true;false;false,4729/20013
non - endstage renal dysfunction *,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4730/20013
active inflammatory bowel disease,C0205177;C0021390;C3853793;C3888249,false;true;false;false,4731/20013
current alcohol use — no . / total no . ( % ),C0521116;C0001962;C0001975;C1705970,false;true;true;false,4732/20013
complex partial ( ib ),C0439855;C0728938;C2744579;C3890035;C4283819;C1550516;C1704241,false;false;true;false;false;false;false,4733/20013
saxagliptin ( n = nmbr,C1611934,true,4734/20013
low subgroup,C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,4735/20013
high - dose statin pretreatment ( n = nmbr ),C0444956;C0360714;C1550147;C2709094;C3539075;C3539076,false;true;false;false;false;false,4736/20013
common study baseline,C0205214;C0557651;C0168634;C1442488;C2603343;C1522138;C3245511,false;false;true;false;false;false;false,4737/20013
lm bifurcation treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,4738/20013
renal impairment,C1565489,true,4739/20013
> nmbr failure,C0231174;C0680095,false;false,4740/20013
coronary revascularization procedure,C0877341,false,4741/20013
intensified baseline ( n - nmbr ),C0168634;C1442488,true;false,4742/20013
time from onset of qualifying stroke to randomization,C0449244;C1514624;C0038454;C4554100,false;false;true;false,4743/20013
statin non - users ( n = nmbr ),C0360714;C1518422;C1706077,true;false;false,4744/20013
barc nmbr - nmbr,,,4745/20013
laba use,C0042153;C0457083;C1947944,true;false;false,4746/20013
enoxaparin ( n = nmbr ),C0206460,true,4747/20013
who / idf impaired fasting glucose,C1272092,false,4748/20013
dip involvement,C3539618;C1314939,false;false,4749/20013
copd severity ( gold nmbr ),C0024117;C0439793;C0018026;C1304897;C0522510;C1412502;C3714496,true;false;true;false;false;false;false,4750/20013
erosion score ( nmbr - nmbr ),C0333307;C0449820;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false,4751/20013
st - segment depression > nmbr . nmbr mv,C0520887;C1454484;C1705503;C4281602,false;true;false;false,4752/20013
fasting tgs §,C0015663;C1156212;C1537574,true;false;false,4753/20013
total cataract extraction,C3665439;C0185115;C0684295;C0439175;C0007389;C0439810,false;false;false;false;true;false,4754/20013
nmbr mg / day early - start,C0439422,false,4755/20013
nmbr - nmbr with cv risk but not disease ( n = nmbr ),C3538987;C0035647;C4552904;C4048877;C4318503,false;true;false;true;false,4756/20013
oral treprostinil ( n = nmbr ),C0442027;C1145760;C4521986,false;true;false,4757/20013
acute ( < nmbr hr ),C0205178,false,4758/20013
total ldl - c *,C0439175;C0439810,false;false,4759/20013
obese patients,C0028754;C0030705,true;true,4760/20013
baseline aspirin dose < nmbr mg,C0168634;C4696290;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;false;true;true;false;false;false;false;false;false,4761/20013
immunologic,C0152036;C0205470,true;false,4762/20013
high - dose aspirin,C0444956;C0004057,false;true,4763/20013
a - glucosidase inhibitor,C1512211,false,4764/20013
history of stroke,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4765/20013
crusade bleeding score,C0019080;C0449820;C4050231,true;false;false,4766/20013
% with haq - di decrease > nmbr . nmbr,C3826998;C0392756;C0547047;C4321476,false;false;false;false,4767/20013
= nmbr ’ ),,,4768/20013
simple partial ( ia ),C0205352;C0728938;C0020980;C0694634;C1947960;C1550516,false;false;true;false;false;false,4769/20013
monitoring ( n = nmbr ),C0150369;C1283169,false;false,4770/20013
crp median ( se ),C3890735;C0549183;C0036919;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;true;false;false;false;false;false,4771/20013
no . of previous venous thromboembolic events,C0205156;C1861172;C1997614;C3160733;C1552607,false;true;false;false;false,4772/20013
d / mi / idr / st,C0073187;C3810814;C0036056;C3272372;C0332173;C4484261,true;false;true;false;false;false,4773/20013
smoking ( % ) laboratory parameters,C0037369;C0022877;C0449381;C3244292;C4283904;C0453996;C1881674,true;true;false;false;false;true;false,4774/20013
female sex,C0086287,true,4775/20013
hypertension,C0020538;C1963138,true;false,4776/20013
no . in the nmbr mo before screening,C0026544;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0332177,true;true;true;false;false;false;false;false;false,4777/20013
reduced ef,C0392756,false,4778/20013
absent ( < nmbr mg / dl ),C0332197;C0439269;C4285062,false;false;false,4779/20013
sgrq total score * *,C2964552,false,4780/20013
indication for index pci,C0392360;C0600653;C4049621;C0918012;C1552854;C1637833;C2986546;C3146298,false;true;false;true;false;false;false;false,4781/20013
forearm fracture,C1305215,false,4782/20013
clinical copd phenotype^,C0205210;C0024117;C0031437;C1285572;C1412502;C3714496,false;true;true;false;false;false,4783/20013
symptoms and feelings,C0683368;C1457887,true;false,4784/20013
extent of index event,C0439792;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,4785/20013
gold stage — no . ( % ) * *,C0018026;C1304897,true;false,4786/20013
stent plus medical therapy,C0038257;C0418981,true;false,4787/20013
significant worsening in kccq clinical score ( > nmbr ) at nmbr monthsnmbr,C0332271;C3476798;C2826293;C0449820;C4050231;C1457868;C1546960,false;false;false;false;false;false;false,4788/20013
diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,4789/20013
doubling of serum creatinine,C0205173;C0201976;C0600061;C1705764,false;false;false;false,4790/20013
before index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,4791/20013
global ischemia ( % ) * *,C0205246;C0022116;C4321499;C2348867,false;true;false;false,4792/20013
il - nmbr,C0020898;C0021764;C0022271,true;true;true,4793/20013
> nmbr . nmbr to < nmbr . nmbr mu / l $ mmol / l,C0439342;C0439190,false;false,4794/20013
glycoprotein llb / llla inhibitors,C0017968;C0243077,true;true,4795/20013
statin intolerancenmbr,C0360714;C0231199;C1744706;C2355652,true;false;false;false,4796/20013
ccsc at nmbr month before enrollment,C1516705;C0332177;C0439231,false;false;false,4797/20013
fevi aucnmbr - nmbrl,C0429706;C0376690;C0849974;C1561566;C4528367,false;true;false;false;false,4798/20013
total,C0439175;C0439810,false;false,4799/20013
indacaterol n = nmbr,C1722260,true,4800/20013
cv risk factors,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,4801/20013
% rf +,C0035448;C0201660;C0748398;C1547111,true;false;false;false,4802/20013
moderate or severe copd exacerbations,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4803/20013
beta - blocker use at randomization,C0001645;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,4804/20013
hscrp > nmbr mg / l,C0439268,false,4805/20013
exacerbation rate in the previous year ( range ),C4086268;C0871208;C0205156;C0439234;C1514721;C2348147;C3542016;C0439508;C1552607;C1521828,false;false;false;false;false;false;false;false;false;false,4806/20013
bdp / ff / g ( n = nmbr ),C0004906;C4554348;C0439267;C1422585;C1538710,true;false;false;false;false,4807/20013
high density lipoprotein ( mg / dl ),C0023821;C0439269,true;false,4808/20013
dose ( n ),C0178602;C0869039;C1114758,false;false;false,4809/20013
hormone replacement therapy,C0282402,true,4810/20013
europe ( eu ),C0015176;C0015179;C3665627,true;true;false,4811/20013
events / statin group,C0441471;C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888,false;true;false;false;true;false;false;false;false,4812/20013
site of disease — no . ( % ),C2945843;C0012634,false;true,4813/20013
proximal - mainleft,C0205107;C4489236,false;false,4814/20013
pharmaco - invasive n = nmbr,C0205281;C1334278,false;false,4815/20013
nmbr % c . i .,C1547546,false,4816/20013
metformin : no / yes,C0025598,true,4817/20013
laba or lamab n = nmbr,,,4818/20013
physical role,C0031809;C0035820;C1705810;C3871154;C0205485;C1509143,true;true;false;false;false;false,4819/20013
colorectal cancer,C0009402;C0346629;C1527249;C2984278;C3542412,true;false;true;false;false,4820/20013
estimated odds ratio,C0750572;C0028873,false;true,4821/20013
secukinumab intravenous nmbr mg ( n = nmbr ),C3179547;C0348016;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,4822/20013
clopidogrel dose,C0070166;C0178602;C0869039;C1114758,true;false;false;false,4823/20013
ex - smoker / smoker,C0337671;C4555205,false;true,4824/20013
moderate ( > nmbr to < nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4825/20013
stroke of undetermined cause,C0038454;C0015127;C1524003,true;true;false,4826/20013
screening visit,C0220908;C0545082;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;false,4827/20013
medications before admission,C0013227;C0184666;C0809949;C0802604;C2598133;C4284232,true;false;false;false;false;false,4828/20013
antiplatelet therapy dual,C1096021,false,4829/20013
fenofibric acid nmbr = nmbr,C0060179,true,4830/20013
asia / pacific ( % ),C0003980,true,4831/20013
number of patients with fractures,C2360800,false,4832/20013
before amendment ( % ),C0680532;C2346732,false;false,4833/20013
( haq - di,C3826998;C4321476,false;false,4834/20013
race or ethnic group — no . f,C0034510;C1706779;C3853635,true;false;false,4835/20013
loss of response : ! : : ! :,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,4836/20013
post - bronchodilator fevnmbr — % of predicted value,C2599594;C3714541;C0681842;C1522609;C1882327,false;true;false;false;false,4837/20013
medical history duration of heart failure ( years ) primary cause of heart failure,C0199168;C0455531;C0449238;C0439234;C0205225;C0015127;C1524003;C0439612;C0439631;C2926735;C0205476,false;false;false;false;false;true;false;false;false;false;false,4838/20013
major cardiovascular,C0205082;C0007226;C3887460;C0205164;C4318856;C4521762,false;true;false;false;false;false,4839/20013
bmi > nmbr ( % ),C0578022,false,4840/20013
high risk ( nmbr - nmbr ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,4841/20013
seronegative ( rf - ve and acpa - ve ) subgroup,C0521144;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,4842/20013
functional outcome ( mrs nmbr - nmbr ),C0205245;C1274040;C1522706;C2349188;C3714939;C3854213;C0542341;C2700217,false;false;false;false;false;false;false;false,4843/20013
mean number of exacerbations in previous nmbr months ( sd ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,4844/20013
duration from clopidogrel / placebo to pci,C0449238;C0070166;C0032042;C1696465;C1706408;C2926735,false;true;true;false;false;false,4845/20013
( ci ) b,C0008107;C3259781,true;false,4846/20013
hispanic ethnic group — no . / total no . ( % ) ‘ j ‘,C0086409;C0015031;C1879937,true;true;false,4847/20013
serum triglycerides,C0542495,false,4848/20013
post - acute ischemic stroke,C0687676;C0751956;C0475224;C0205178;C0948008;C1704687;C3469826,false;true;false;false;false;false;false,4849/20013
death / mi / idr / st / gusto - defined moderate or severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,4850/20013
use of rescue albuterol,C1524063;C0001927,false;true,4851/20013
intent of conservative strategy,C0162425;C0679199;C1283828;C1550453,true;false;false;false,4852/20013
> < nmbr . nmbr  < nmbr . nmbr  r < mmse = mini - mental ,C0205090;C0451306;C0684010;C2603358,false;true;true;false,4853/20013
stenosis > nmbr %,C0678234;C1261287;C2632116,false;true;false,4854/20013
nmbr - year rates in placebo groups,C0439234;C0871208;C0032042;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1696465;C1706408;C1521828;C0439508,false;false;true;false;false;true;false;false;false;false;false;false;false;false,4855/20013
previously on acei + arb,C3888198,false,4856/20013
peripheral artery disease details,C1704436;C4025272,true;false,4857/20013
egfr ( median,C1739039;C0549183;C0876920;C2347635;C2348144;C2939193;C3811844;C3812682,true;false;false;false;false;false;false;false,4858/20013
dipeptidyl peptidase - nmbr inhibitor,C0003015;C2757044;C3536837,true;false;false,4859/20013
body mass indexnmbr,C0005893;C0578022;C1305855,false;false;true,4860/20013
traditional nsaid,C0443324;C0003211;C3536840;C1548559,false;true;false;false,4861/20013
menopausal status and use of ht,C1513126,false,4862/20013
standard care,C1442989;C1947933;C2828392,false;false;false,4863/20013
non - european trial,C1518422;C0239307;C0008976;C1535514,false;false;true;false,4864/20013
patient ' s assessment of pain ( nmbr - nmbr vas ),C0679830;C0042815,false;true,4865/20013
tdi total score ( week nmbr,C0205976;C2964552;C0332174;C0439230;C2674784;C3714807,true;false;false;false;false;false,4866/20013
insulin only,C0021641;C0205171;C1720467;C1533581;C1579433;C3714501,true;false;false;false;false;false,4867/20013
catscorecategory,,,4868/20013
anacetrapib ( n = nmbr,C2604745,true,4869/20013
control nmbr months ( n - nmbr ),C0243148;C0439231;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false;false,4870/20013
no immomtedion,,,4871/20013
delayed reaction,C0205421;C0443286;C1545665;C3272602,false;false;false;false,4872/20013
disease site — no . of patients ( % ) |,C0012634;C0205145;C1515974;C2825164,true;false;false;false,4873/20013
nmbr . nmbr - < nmbr,,,4874/20013
sgrq total score ( units ) : ! :,C2964552;C0439148;C1519795;C3853603,false;false;false;false,4875/20013
qualifying myocardial infarction,C1514624,false,4876/20013
psoriasis,C0033860,true,4877/20013
no glucocorticoids or immunosuppressants,C0017710;C3540777;C3540778,true;false;false,4878/20013
mean ± s . d . hbanmbrc,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,4879/20013
time from last dose of pnmbrynmbr inhibitor,C0946444;C1999216,false;false,4880/20013
snmbr gallop,C0565930;C2603362,false;false,4881/20013
any condition,C0012634;C0348080;C1705253;C3864998,true;false;false;false,4882/20013
sitagliptin n = nmbr,C1565750,true,4883/20013
abciximab ( n = nmbr ),C0288672,true,4884/20013
antiplatelet — no . ( % ),,,4885/20013
ischemic heart disease indicator no ( n = nmbrl ),C0010054;C0021212;C1235732;C1522602;C0151744,true;true;false;false;true,4886/20013
ifg / prediabetes^,C1334085;C0362046;C1708411,false;true;false,4887/20013
no . of target vessels,C0449618,false,4888/20013
adjusted mean ± se ( nmbr % ci ),C0456081;C0444504;C0036919;C0008107;C3259781;C2347634;C2348143,false;false;true;true;false;false;false,4889/20013
albuminuria < nmbr gram / gram cr,C0001925;C1319635;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337,true;false;false;false;true;false;false;false,4890/20013
nyha lll - iv,C1275491;C1261077;C0022326;C4265176,false;false;true;false,4891/20013
chronic kidney disease,C1561643;C4553188,true;false,4892/20013
patients with fistulas at baseline,C0030705;C0016169,true;true,4893/20013
standard control,C1442989;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;false;false;false;false;false;false,4894/20013
white race,C0007457;C0043157,true;true,4895/20013
> nmbr / tmol / liter — no . ( % ),C0475211,false,4896/20013
renin inhibitors,C2917241;C3653375,false;false,4897/20013
not localized,C1518422,false,4898/20013
ischemic stroke without hemorrhagic conversior,C0948008;C0333275;C0475224;C0553692,false;false;false;true,4899/20013
constitutional,C1511487,false,4900/20013
smoking status,C1519386,false,4901/20013
crp ( mg / dl ) * *,C3890735;C0439269;C4048285,false;false;false,4902/20013
ularitide ( n = nmbr ),C0077910,true,4903/20013
vorapaxar placebo nmbr - yr . km %,C2974521;C0032042;C0439234;C3887676;C1696465;C1706408,true;true;false;false;false;false,4904/20013
prior anti - tnf therapy,C0332152;C0281481;C2826257,false;false;false,4905/20013
reinfarction,,,4906/20013
sgrq total score,C2964552,false,4907/20013
first primary composite outcome,C0205435;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C1279901,false;false;false;false;false;false;false;false,4908/20013
score on modified mini - mental state examination — median ( iqr ),C4304091;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4909/20013
hormone replacement,C0282402,true,4910/20013
composite endpoint of doubling of serum creatinine,C0205199;C2349179;C0205173;C0201976;C0600061;C1705764;C2826544;C1547335,false;false;false;false;false;false;false;false,4911/20013
exercise ( % ),C0015259;C1522704,true;false,4912/20013
history of ischemic heart disease — no . ( % ),C0683519;C0475224;C0018787;C0730226;C0850708;C0944983,false;false;true;false;false;false,4913/20013
statin therapy,C1278454,false,4914/20013
stratified analyses,C0205363;C0002778;C0936012;C1524024,false;false;false;true,4915/20013
former / current smoker,C0337671;C0521116;C1705970;C0205156;C3173209;C3241966;C0750523,false;false;false;false;false;false;false,4916/20013
( sd ),C2699239,false,4917/20013
primary trial end point,C2986535;C0008976,false;true,4918/20013
fasting blood glucose,C0428568;C1261430,false;false,4919/20013
number ( % ) reporting migraine on nmbr - month questionnaire,C0237753;C0700287;C0149931;C0332177;C0034394;C0439231;C0449788,false;false;true;false;true;false;false,4920/20013
elevated bun ( > nmbr . nmbr meq / l ),C0151539;C0439375,false;false,4921/20013
slowest third,C0439834;C0205437,false;false,4922/20013
clinical features of hf,C0683325;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,4923/20013
tertile nmbr index pci performed,C0600653;C4049621;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,4924/20013
risk factor ( predefined ) for falling at screening,C0035648,true,4925/20013
left ventricular dysfunction,C0242698,true,4926/20013
acs treatment,C0742343;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4318612,true;true;true;false;false;false;false;false;false,4927/20013
< nmbr ml / min / nmbr . nmbr mnmbr nt - pro - bnp,C0439445;C0369637;C0669479;C0754710;C0441923,false;false;true;true;false,4928/20013
prednisone use,C0032952;C0042153;C0457083;C1947944,true;true;false;false,4929/20013
actual treatment strategy,C0237400;C0039798;C0679199;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;true;false;false;false;false;false,4930/20013
other antiplatelet agent 一 no . ( % ),C0085826,true,4931/20013
% change from baseline ls means ( se ),C0392747;C0168634;C0023668;C1704970;C0036919;C1442488;C0443172;C1705241;C4319952,false;true;true;false;true;false;false;false;false,4932/20013
use of blood pressure lowering medication *,C1524063;C0020649;C0013227;C3244316;C4284232,false;true;true;false;false,4933/20013
multivessel disease 一 no . ( % ),C0012634,true,4934/20013
patients using concurrent tiotropium,C0030705,true,4935/20013
time since copd diagnosis ( yrs ),C0040223;C3541383,true;false,4936/20013
use of medications for pah — no . ( % ),C1524063;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,4937/20013
ace - i or arb use at baseline,C1452534;C0021966;C0221138;C4284014,true;true;false;false,4938/20013
medical history of diabetic retinopathy §,C0262926;C0011884,false;true,4939/20013
anmbr + ez n = nmbr anmbr n = nmbr,C0206578,true,4940/20013
anti - tnf - naive patientsnmbr,C1448177;C0030705,true;true,4941/20013
heterogeneity test,C0019409;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0242960,false;false;false;false;false;false;false;false;true,4942/20013
infarction,C0021308,true,4943/20013
rates per nmbr patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,4944/20013
% difference,C1705241;C1705242,false;false,4945/20013
tofacitinib nmbr mg bid,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4946/20013
smoking index — pack - yr §,C0037369;C0600653;C1968515;C0439234;C2825051;C2828395;C0918012;C1552854;C1637833;C2986546;C0453996;C1881674,true;true;false;false;false;false;true;false;false;false;true;false,4947/20013
non - frail,C1518422;C0871754,false;false,4948/20013
nmbr vitamin e,C0042874;C3714803,true;false,4949/20013
low potencyc,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,4950/20013
osteopontin ( ng / ml ),C0069676;C0439275;C1420369;C1505427;C4084879,true;false;false;true;false,4951/20013
pvaluefor any mi versus no mi,,,4952/20013
prerandomization statin therapy,C1278454,false,4953/20013
multivessel cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,4954/20013
glomerular filtration rate §,C0017654;C1561549,true;false,4955/20013
nmbr mg sirukumab every nmbr weeks ( n = nmbr ),C0024671;C3254570;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4956/20013
hypertension ( % ) : t,C0020538;C1963138,true;false,4957/20013
previous loss of response to infliximab,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,4958/20013
number of treated vessels,C0237753;C1522326;C0005847;C0449788,false;false;true;false,4959/20013
extracranial carotid stenosis,C0580586;C0007282,false;true,4960/20013
coronary artery disease,C0010054;C0010068;C1956346,true;true;true,4961/20013
telmisartan,C0248719,true,4962/20013
physician,C0031831;C0804815,true;false,4963/20013
black and other,C0005680;C0027567;C0085756;C0439541,true;true;true;false,4964/20013
diclofenac nmbr mg ( n nmbr nmbr ),C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4965/20013
smokers ( at baseline ),C0337664;C0168634;C1442488,true;true;false,4966/20013
baseline use of hormone therapy ( % ),C0168634;C1524063;C0279025;C1442488,true;false;false;false,4967/20013
high hdl - c ( for men ≥ nmbr   mg / dl / for women ≥ nmbr   mg / dl ),C0205250;C3715113;C0025266;C0439269;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false,4968/20013
myocardial infarction or angina,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,4969/20013
exposed ( n = nmbr ),C0332157,false,4970/20013
primary composite end point,C2986535;C0205199;C1547335,false;false;false,4971/20013
fasting insulin ( giu / ml ),C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,4972/20013
met criterion at final ( n [ % ] ),C0428210;C0243161;C0205088;C1546485;C3853528;C1550543;C4317104,false;true;false;false;false;false;false,4973/20013
mean ( sd ) bmi ( kg / mnmbr ),C0444504;C2699239;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false;false,4974/20013
mean body weight ( sd ),C0444504;C0005910;C2699239;C1305866;C2347634;C2348143,false;true;false;false;false;false,4975/20013
lean ( < nmbr kg / mnmbr ),C1532718,false,4976/20013
previous treatment with a laba and / or lama,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,4977/20013
new des ( n = nmbr ),C0205314;C0011702;C4551552,false;true;true,4978/20013
homa - ir index — median ( iqr ),C0022065;C0600653;C0549183;C0876920;C2347635;C2348144;C2939193;C0918012;C1552854;C1637833;C2986546;C0022071;C1448132,true;true;false;false;false;false;false;true;false;false;false;true;true,4979/20013
timi risk score ( interaction : p = nmbr . nmbr ),C0035647;C0449820;C1704675;C4050231;C4552904,true;false;false;false;false,4980/20013
prior use of systemic,C0332152;C1524063;C0205373;C2826257,false;false;false;false,4981/20013
all randomized,,,4982/20013
obesity ( % ) §,C0028754;C1963185,true;false,4983/20013
balloon angioplasty,C0002996;C0002997,true;true,4984/20013
ibdq domain scores,C1880389;C1883221;C3541951,false;false;false,4985/20013
rosiglitazone ( n = nmbr ),C0289313,true,4986/20013
smoking ( ever ),C0037369;C0453996;C1881674,true;true;false,4987/20013
patella fracture,C0159849,false,4988/20013
screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,4989/20013
medical history and risk factors,C0262926;C1704706,false;false,4990/20013
ineffective therapy,C3242229;C0039798;C0087111;C1363945,false;true;true;false,4991/20013
risk group,C0242444,true,4992/20013
hdl - c ( mg / dl ) - mean ± sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,4993/20013
very severe ( gold nmbr ),C3641272;C0018026;C1304897;C4050419,false;true;false;false,4994/20013
antihypertensive therapy — no . ( % ),C0585941,false,4995/20013
non - ischaemic cause,C1518422;C0475224;C0015127;C1524003,false;false;true;false,4996/20013
low periostin subgroup (,C0205251;C0219433;C1079230;C1515021;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false,4997/20013
infarct location — no . / total no . ( % ),C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,4998/20013
enrollment by region,C1516879;C0017446;C0205147;C1696073;C3888021,false;true;false;false;false,4999/20013
fixed triple ( n = nmbr ),C0443218;C0205174;C2827483;C3714578,false;false;false;false,5000/20013
multivessel stenting,C0038257;C2348535,true;false,5001/20013
estimated creatinine clearance < nmbr rmb ' mint,C0750572;C0812399;C0452249;C0522467;C1337213;C1576800;C3890003,false;false;false;true;false;false;false,5002/20013
event rate,C0441471;C0871208;C1521828;C4019010,false;false;false;false,5003/20013
gpifeellla inhibitor use before angography,C1999216;C0042153;C0457083;C1947944,false;true;false;false,5004/20013
latin america or south africa,C0023122,true,5005/20013
patients with complicated events ( p = nmbr - nmbr 十 ),C0030705;C0231242;C0441471;C3541888,true;false;false;false,5006/20013
triglycerides $ nmbr mg / dl ( nmbr . nmbr mmol / l ),C0041004;C0439269;C1532563,true;false;false,5007/20013
patients with > nmbr exacerbations resulting in ed visit,C0030705;C4086268,true;false,5008/20013
use of statins,C1524063;C0360714,false;true,5009/20013
time between cessation of full - dose warfarin therapy and enrollment ( mo ),C1880019;C0682295;C0366686;C0039798;C0087111;C1363945;C0178602;C4303340;C0869039;C1114758,false;false;false;true;true;false;false;false;false;false,5010/20013
egfr nmbr - nmbr,C1739039;C3811844;C3812682,true;false;false,5011/20013
egfr > = nmbrml / min / nmbr . nmbrmnmbr n = nmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,5012/20013
peri - op ace - inhibitors / arbs : no ( n = nmbr ),C0347985;C0003015;C3888198,false;true;false,5013/20013
cangrelor ( n = nmbr ) n / n ( % ),C1121991,true,5014/20013
baseline fevnmbr % predicted,C0168634;C3714541;C1442488,true;true;false,5015/20013
age ( range ) ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,5016/20013
mean — yr age group — no . ( % ),C0444504;C0439234;C0027362;C2348001;C2347634;C2348143,false;false;true;false;false;false,5017/20013
history of atrial fibrillation or flutter treatment at randomisation,C0729790,false,5018/20013
previous stenting ( % previous pci ),C0205156;C0038257;C4049621;C2348535;C1552607,false;true;false;false;false,5019/20013
bivalirudin only,C0168273;C0205171;C1720467,true;false;false,5020/20013
medical history ( % ),C0262926;C1704706,false;false,5021/20013
clopidogrel given before procedure,C0070166,true,5022/20013
ezetimibe + simvastatin ( n = nmbr,C1532737,true,5023/20013
aliskiren / valsartan ( n = nmbr ),C2733073,false,5024/20013
urinary protein - to - creatinine ratio | |,C1096054,false,5025/20013
cerebrovascular accident,C0038454,true,5026/20013
male sex — no . ( % ) weight — no . ( % ),C0086582,true,5027/20013
weight — no . ( % ),C0005910;C0043100;C1305866;C1705104,true;true;false;false,5028/20013
nmbr non - mtx,C1518422;C0025677;C1417487,false;true;false,5029/20013
fasting triglycerides — mg / dl,C0015663;C0041004;C0439269,true;true;false,5030/20013
concomitant csdmards other than methotrexate,C0521115;C0025677,false;true,5031/20013
( b ) concomitant respiratory medications [n ( % ) ],C0521115;C0418986,false;false,5032/20013
copd population ( n = nmbr ),C0024117;C0032659;C1257890;C1412502;C3714496,true;true;true;false;false,5033/20013
ibdq score,,,5034/20013
lifestyle,C0023676,true,5035/20013
disease location,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,5036/20013
cardiac pacemaker — no . ( % ),C0030163;C0037189,true;true,5037/20013
patient ' s preference not to take,C0376409,true,5038/20013
diet + pravastatin group,C0012155;C0085542;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0012159;C1519433;C2983588;C3668949,true;true;false;false;true;false;false;false;true;false;false;false,5039/20013
glycated hemoglobin level,C0202054,false,5040/20013
asthma population ( n = nmbr ),C0004096;C0032659;C1257890;C2984299,true;true;true;false,5041/20013
albumin creatinine ratio,C0486293;C1318293,false;false,5042/20013
apolipoproiein b ( mij / nmbr ),,,5043/20013
aliskiren ( dm - vs . dm + ),C1120110;C0011816;C3250443,true;true;false,5044/20013
regadenoson,C1698215,true,5045/20013
change in erosion score ( mean ),C0392747;C0333307;C3533236;C1880549;C1959609;C3887524;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,5046/20013
fecal calprotectin — pg / g * *,C0015733;C0950624;C1638318;C1335798;C1366582,true;true;false;false;false,5047/20013
infarction before age nmbr ( a ),C0021308;C0001779,true;false,5048/20013
patients,C0030705,true,5049/20013
prior biologic use,C0332152;C0005515;C0042153;C0457083;C1947944;C0205460;C2826257,false;true;true;false;false;false;false,5050/20013
time since diagnosis of type nmbr diabetes - no . ( % ),C0040223;C3541383,true;false,5051/20013
metabolic syndrome visit nmbr low - density lipoprotein cholesterol strata,C0524620,true,5052/20013
nonbiologic disease - modifying drug other than methotrexate : :,C0392747;C4036059;C0025677,false;false;true,5053/20013
moderate risk ( nmbr - nmbr ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,5054/20013
csf a ( nmbr ( pm ),C3540512;C3889436,false;false,5055/20013
combination - facilitated pci ( % ),C0205195;C4049621;C1947911;C3811910,false;false;false;false,5056/20013
time since psa diagnosis ( years ),C0040223;C3541383,true;false,5057/20013
deep - vein thrombosis,C0149871,true,5058/20013
> nmbr to < nmbr - nmbr mg / week,C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,5059/20013
aspirin alone ( n / n ),C0004057;C0205171;C0439044;C0679994,true;false;false;false,5060/20013
prior treatment — %,C1514463,false,5061/20013
homa - ir ( % ) b,C0022065;C0022071;C1448132,true;true;true,5062/20013
interquartile range height — cm,C1711350;C0489786,false;false,5063/20013
mild thrombocytopenia ( < nmbrx nmbr / l ),C1856453,false,5064/20013
reversibility ( anticholinergic ),C0449261,false,5065/20013
number of exacerbation in the previous nmbr months,C0237753;C4086268;C0449788,false;false;false,5066/20013
established cvd ( age > nmbr ),C0443211;C0007222;C0001779;C1272684,false;true;false;false,5067/20013
crci > nmbr - < nmbr,,,5068/20013
who functional class ii / iii,C0205245;C0441887;C1710602;C4082587;C2698969;C0441886;C0439070;C1705160;C2698968;C0542341;C2700217,false;false;false;false;false;false;false;false;false;false;false,5069/20013
( n nmbr nmbr ),C0369718;C0441922,false;false,5070/20013
cigarette smoking in the past year,C0239059;C4086728;C0700219,false;false;true,5071/20013
candesartan,C0717550,true,5072/20013
previous pci / cabg,C0205156;C4049621;C0010055;C1552607,false;false;true;false,5073/20013
coronary angiography during the index hospitalization,C0085532;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,5074/20013
baseline free pcsknmbr level by median,C0168634;C0332296;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C1880497;C1996904;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false;false,5075/20013
( se]tf total - c,C0036919;C4048299;C0439175;C0439810;C4048587,true;false;false;false;false,5076/20013
continued thienopyridine %,C0549178;C1120149,false;true,5077/20013
before pci,C4049621,false,5078/20013
glomerular filtration rate,C0017654;C1561549,true;false,5079/20013
elevated troponin t ( > nmbr . nmbr / xg / l ),C0205250;C0077404;C0017209;C1292284;C1421532;C1420827;C3163633,false;true;true;false;false;false;false,5080/20013
rivaroxaban,C1739768,true,5081/20013
prior history ml or stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,5082/20013
atorvastatin nmbr mg ( n = nmbr,C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5083/20013
alcohol,C0001962;C0001975,true;true,5084/20013
western europe and lebanon,C0043129,true,5085/20013
current smoker ( > nmbr cigarettes / day ) — no . ( % ),C3173209;C0677453;C0332173;C0439228;C0439505;C3241966,false;true;false;false;false;false,5086/20013
atorvastatin nmbr mg ( n = nmbr ),C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5087/20013
unstable angina > nmbr mo ago,C0002965;C0026544;C0332177,true;true;false,5088/20013
amlodipine / valsartan nmbr / nmbr vs nmbr / nmbr mg,C1962523,true,5089/20013
mean ( s . d . ) apob,C0444504;C0003593;C3252643;C2347634;C2348143,false;true;true;false;false,5090/20013
tobacco use — no . ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,5091/20013
previousdistaldeep - veinthrombosisorsuperficial - vein thrombosis,C0042487,true,5092/20013
dapagliflozin nmbr mg / day ( n = nmbr ),C2353951;C0439422,true;false,5093/20013
angina ( past nmbr weeks ),C0002962;C2987125,true;false,5094/20013
drug - eluting stent implanted,C1322815,true,5095/20013
rhabdomyolysis ( n = nmbr ),C0035410;C4552660,true;false,5096/20013
hospitalizations,C0019993,true,5097/20013
baseline heart failure severity amongthose with priorheartfailure,C0168634;C0018801;C0439793;C0522510;C0018802;C4554158;C1442488,true;true;false;false;true;false;false,5098/20013
patients with end point,C0030705;C2349179;C2826544,true;false;false,5099/20013
us resident,C1320928;C1549439;C2347958;C3835651,false;false;false;false,5100/20013
less than nmbr mm hg,C0439092;C0439475,false;false,5101/20013
p value for mra vs no mra,C1709380;C0243032;C1609165;C3891069,false;true;true;false,5102/20013
insulin - treated diabetes,C0021641;C1533581;C1579433;C3714501,true;false;false;false,5103/20013
nmbrrrmnl ),,,5104/20013
metastatic disease,C0027627;C2939419;C2939420,true;false;false,5105/20013
no stroke n = nmbr nmbr,C0038454;C4554100,true;false,5106/20013
physical component score ( pcs ),C4483112;C0449432;C1864389;C1882368;C1705248,false;false;false;true;false,5107/20013
bmi > nmbr — no . ( % ) f,C0578022,false,5108/20013
oral contraceptive pills — no . / total no . ( % ),C0009905;C0009906;C0029151,true;true;false,5109/20013
nmbr - yr risk of coronary heart disease ( % ) ^ |,C0439234;C1277690,false;false,5110/20013
llt other than statin at randomization,C2347090;C0360714,false;true,5111/20013
other antihypertensive agents,C0003364,true,5112/20013
ace inhibitor at enrollment,C0003015;C1516879;C1696073;C3888021;C4541021,true;false;false;false;false,5113/20013
b - agonists ( short - acting ) a,C0243192;C2987634,true;false,5114/20013
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr n = nmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,5115/20013
hemoglobin anmbrc,C0019020;C3889898,true;false,5116/20013
duration of ulcerative colitis,C0449238;C0009324;C2926735,false;true;false,5117/20013
positive for rheumatoid factor — no . ( % ) : t,C0439178;C0035448;C0201660;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false,5118/20013
euroscore logistic,C3164744,false,5119/20013
simvastatin nmbr mg plus fenofibrate nmbr mg ( n = nmbr /,C0074554;C1319635;C0332287;C0033228,true;false;false;true,5120/20013
age — mean ( sd ) ( years ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5121/20013
cerebrovascular or peripheral arterial disease,C1880018,false,5122/20013
low feno subgroup (,C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,5123/20013
blood - pressure medications at randomization — no . / total no . ( % ),C0849164;C0033095;C0034656;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;true;false;false;false;true;true;false;false;false;false;true,5124/20013
other or missing data,,,5125/20013
number of copd exacerbations in the previous year,C0237753;C0740304;C0449788,false;false;false,5126/20013
rivaroxaban plus aspirin ( n = nmbr ),C1739768;C0332287;C0004057,true;false;true,5127/20013
diuretics * *,C0012798,true,5128/20013
one vessel,C0205447;C0005847,false;true,5129/20013
intended duration of anticoagulation,C1283828;C0449238;C0003281;C2917212;C2919015;C3537050;C2926735;C1551357,false;false;false;false;false;false;false;false,5130/20013
non - stenotic vessels,C1518422;C0679403,false;false,5131/20013
gusto severe,,,5132/20013
> nmbr . nmbr bpm current smoker,C3173209;C3241966,false;false,5133/20013
patients with any clinical event,C0030705;C0205210;C0441471;C4019010,true;false;false;false,5134/20013
previous diabetes,C0205156;C0011847;C0011849;C1552607,false;false;true;false,5135/20013
mmrc dyspnea scale,C3826977;C0013404;C0175659;C0349674;C1947916;C1963100,false;true;true;false;false;false,5136/20013
brv nmbr mg / day ( n = nmbr ),C0155502;C0439422,true;false,5137/20013
urinary tract infection,C0042029;C0262655;C4554638,true;false;false,5138/20013
hospitalization for heart failure,C3898876,false,5139/20013
any history of congestive heart failure,C0455531;C0742742,false;false,5140/20013
time from study drug administration to coronary revascularization,C0040227;C0150270;C3469597;C0206209;C0013175;C2349982,true;false;false;true;true;false,5141/20013
heart failure ( class i — iii ),C0018801;C0441887;C0021966;C0221138;C2698969;C0441885;C0439070;C1705160;C1319793;C2698967;C0018802;C4554158,true;false;true;false;false;false;false;false;false;false;true;false,5142/20013
c - reactive protein — mg / liter * *,C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;false;true;false;false;false;false;false;false;false,5143/20013
liraglutide nmbr . nmbr mg,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5144/20013
placebo nmbr yr km %,C0032042;C0439234;C3887676;C1696465;C1706408,true;false;false;false;false,5145/20013
prebronchodilator fevnmbr ( % predicted normal ) t,C2599602;C3714541,false;true,5146/20013
rest of world,C0035253;C2700280;C1622890,true;false;false,5147/20013
low - molecular weight heparin or intravenous unfractionated heparin,C0019139;C3536766,true;false,5148/20013
nmbr early intervention ( n = nmbr ),C0242687;C1964029,true;false,5149/20013
no statin ( + / - llt ),C0360714;C2347090,true;false,5150/20013
treatment satisfaction,C3476649,false,5151/20013
pathologic q waves — no . ( % ),C0429090,false,5152/20013
total periventricular wml score,C2964552,false,5153/20013
laboratory values at admission ( median and iqr ),C0022877;C0042295;C0184666;C0549183;C0876920;C2347635;C2348144;C2939193;C0809949;C3244292;C4283904,true;false;false;false;false;false;false;false;false;false;false,5154/20013
corticosteroid use,C0239126,false,5155/20013
use of inhaled glucocorticoids at screening — no . ( % ),C1524063;C0004048;C0017710;C3540777;C3540778,false;true;true;false;false,5156/20013
comorbidity score,C0009488;C0449820;C4050231,true;false;false,5157/20013
non - smokers ( at baseline ),C0337672;C0168634;C1442488;C4554605,false;true;false;true,5158/20013
tender joint count ( n / nmbr ),C0451530,false,5159/20013
total intravenous loop diuretics,C0439175;C0348016;C0354100;C0439810,false;false;true;false,5160/20013
atorvastatin nmbr mg + ezetimibe nmbr mg ( n = nmbr ),C0286651;C1319635;C1142985,true;false;true,5161/20013
angiotensin ll - receptor antagonist — no . ( % ),C0003018;C4521302,true;false,5162/20013
mean serum glucose,C0444504;C0202041;C3534430;C2347634;C2348143,false;false;false;false;false,5163/20013
gold stage ( % ) f,C0018026;C0205390;C0016327;C1300072;C1306673;C1304897,true;false;true;false;false;false,5164/20013
non - hdl - c / hdl - c,C1518422;C3715113,false;false,5165/20013
multivessel ( two vessel,C4012475;C4037954,false;false,5166/20013
body weight index ( kg / mnmbr ),C0005910;C0600653;C1532718;C0918012;C1552854;C1637833;C2986546;C1305866,true;true;false;true;false;false;false;false,5167/20013
procalcitonin ( ng / ml ),C0072027;C0439275,true;false,5168/20013
fasting blood glucose > nmbr mg / dl,C0428568;C0439269;C1261430,false;false;false,5169/20013
category nmbr,C0683312;C3889287,false;false,5170/20013
type of event,C1561488,false,5171/20013
quality of life,C0034380;C0518214,true;false,5172/20013
diagnosis ( y ),C0011900;C1704338;C1704656,true;true;false,5173/20013
persistent or permanent immobilization,C0205322;C0332996,false;false,5174/20013
modified rankin scale at screening,C2984908;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3854213,false;true;true;false;false;false;false;false;false,5175/20013
placebo nmbr . nmbr pt yrs,C0032042;C0032743;C0699718;C1696465;C1706408,true;true;false;false;false,5176/20013
diet controlled or no,C0743195,false,5177/20013
body weight,C0005910;C1305866,true;false,5178/20013
no . of patients / no . of events,C0030705,true,5179/20013
intravenous study drug administered — no . ( % ),C0683092;C0557651;C2603343;C0348016;C0013175,false;false;false;false;true,5180/20013
number of females n ( % ),C0237753;C0086287;C0449788,false;true;false,5181/20013
> nmbr . nmbr % and ≤ nmbr . nmbr %,,,5182/20013
treatment with statins,C0039798;C0360714;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,5183/20013
prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,5184/20013
systemic symptoms,C0205373;C0683368;C1457887,false;true;false,5185/20013
persistent or paroxysmal,C0205322;C0332996,false;false,5186/20013
metabolic syndrome w / o tnmbrdm,C0524620;C0011816;C3250443,true;true;false,5187/20013
stroke — no . / total no . ( % ),C0038454;C4554100,true;false,5188/20013
nice primary prevention onlyb,C4087029;C0033144,false;true,5189/20013
change from pre - to,C0392747;C0332152;C0740175;C2257086;C3669034;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false,5190/20013
any lipid - lowering agent,C0086440,true,5191/20013
abatacept,C1619966,true,5192/20013
indacaterol - glycopyrronium group,C1722260;C3814772;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;false;true;false;false;false,5193/20013
warfarin naive,C0043031,true,5194/20013
prior or new diabetes,C0332152;C2826257,false;false,5195/20013
tender and swollen joints — mean no . : :,C0234234,false,5196/20013
systolic blood pressure > nmbr mm hg or diastolic blood pressure > nmbr mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,5197/20013
rolofylline ( n = nmbr,C0166128,true,5198/20013
total stent length ( mm ),C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,5199/20013
swollen joint count ( nmbr joints ),C0451521,false,5200/20013
mean nmbr sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5201/20013
previously taken methotrexate,,,5202/20013
gusto moderate,,,5203/20013
procedure * *,C0184661;C2700391;C3274430;C3539779,true;false;false;false,5204/20013
hormone replacement ! !,C0282402,true,5205/20013
other cardiovascular risk factors,C0850624,false,5206/20013
severe copdc [n z nmbr],C0205082;C4050465;C4050466,false;false;false,5207/20013
cardiac biomarker status !,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,5208/20013
nmbr - mercaptopurine,C0000618,true,5209/20013
patient presentation,C0030705;C0449450,true;false,5210/20013
baseline serum k +,C0168634;C0302353;C1442488,true;false;false,5211/20013
other sulfonylurea 一 no . ( % ),C0038766;C3536898,true;false,5212/20013
hctz * ( n = nmbr ),C0020261,true,5213/20013
cardiometabolic syndrome,C0039082,true,5214/20013
carotid artery — no . ( % ),C0007272;C0162859,true;true,5215/20013
cardiac valve surgery : no ( n = nmbr ),C0018821;C0184252;C1186983;C1704414;C3888056;C0524727;C0018826;C0038894;C0038895;C0543467;C1274039,true;false;false;false;false;true;true;false;true;true;true,5216/20013
beyond popliteal pedal,C0442037;C0016504;C0687080,false;true;false,5217/20013
> nmbr cv risk factors 咐 or established atherosclerotic cv disease,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,5218/20013
fracture history ( predefined ),C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,5219/20013
any coronary revascularization,C0877341,false,5220/20013
ex - / current smoker,C0337671;C0521116;C1705970;C4555205;C1704625;C3173209;C3241966,false;false;false;true;false;false;false,5221/20013
vorapaxar nmbr - y,C2974521,true,5222/20013
fluindione,C0117899,true,5223/20013
current n z nmbr,C0521116;C1705970,false;false,5224/20013
concomitant oral corticosteroids,C0521115;C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;false;true;false;false;false;false;false,5225/20013
anaesthesia / analgesia,C0002905,true,5226/20013
local eosinophil count ( cells per pl ) t,C0205276;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;false;true;false;false;true;false,5227/20013
age ( years ),C1510829,false,5228/20013
ethnic group ( % ),C0015031;C1879937,true;false,5229/20013
physician ' s global assessment ( vas ),C4050369;C0042815;C3536884;C3827561,false;true;true;false,5230/20013
antihypertensive drugs,C0003364,true,5231/20013
median age — yr §,C0549183;C0001779;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,5232/20013
cad and / or crvd ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5233/20013
chronic obstructive lung disease,C0024117,true,5234/20013
exercise category ( % ),C3669314,false,5235/20013
prior congestive heart failure yes,C0332152;C0018802;C1549445;C1705108;C1710701;C2826257,false;true;false;false;false;false,5236/20013
secondary prevention subgroup,C0679699;C1079230;C1515021,true;false;false,5237/20013
aspirin nmbr mg ( n = nmbr ),C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5238/20013
night - time awakenings / week,C0860510;C0332174;C0439230,false;false;false,5239/20013
non - hdl - c,C1518422;C3715113,false;false,5240/20013
laa closure ( n - nmbr ),C0185003;C1521802,false;false,5241/20013
p - value * ' ',C1709380,false,5242/20013
known prothrombotic genotype,C0205309;C0017431,false;true,5243/20013
> nmbr concomitant medication,C0521115;C0013227;C3244316;C4284232,false;true;false;false,5244/20013
function subscale,C0031843;C0542341;C0700205;C1705273,true;false;false;false,5245/20013
high risk and more symptoms ( group d ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,5246/20013
white ( nmbr . nmbr % ),C0007457;C0043157;C0220938,true;true;false,5247/20013
osteoarthritis,C0029408,true,5248/20013
history of microalbuminuria — no . ( % ),C3532606,false,5249/20013
nmbr mg / day delayed - start,C0439422,false,5250/20013
documented symptomatic chdb,C1301725;C0231220;C1609436,false;false;false,5251/20013
previous pneumonia,C0205156;C0032285;C1552607,false;true;false,5252/20013
budesonide — no . ( % ),C0054201,true,5253/20013
linagliptin,C2746078,true,5254/20013
middle tg tertile,C0444598;C0337445;C0549183;C1552826,false;false;false;false,5255/20013
density lipoprotein  csf =,C0178587;C0023820;C3540512;C3889436,false;true;false;false,5256/20013
hscrp,,,5257/20013
concomitant medication after randomisation,C0521115;C0013227;C0034656;C3244316;C4284232,false;true;true;false;false,5258/20013
non - black ( n = nmbr ),C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,5259/20013
dmard or corticosteroid,C0242708,true,5260/20013
non - epa number of <,C1518422;C0237753;C0449788,false;false;false,5261/20013
hbalc tx difference vs pbo,C0041403;C1705241;C1705242,true;false;false,5262/20013
trough fevi l,C0444506;C0429706;C0849974;C1561566;C4528367,false;false;false;false;false,5263/20013
eq - nmbrd ( visual analog score ),C0205163;C0234621;C0243071;C0449820;C4050231;C0439185,false;false;false;false;false;false,5264/20013
antihypertensive medication,C0003364,true,5265/20013
mer ’ s disease assessment,C0673013;C0012634;C1261322;C1516048;C3810521;C4281714,true;true;false;false;false;false,5266/20013
baseline ldl - c strata,C0168634;C1442488,true;false,5267/20013
with alogliptin nmbr . nmbr mg,C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5268/20013
anacetrapib ( n = nmbr ),C2604745,true,5269/20013
secondary dvt . ' fe,C0027627;C0149871;C3848561;C2926618;C3899446;C0175668;C0205436,true;true;false;false;false;false;false,5270/20013
with laba,,,5271/20013
basal insulin analogue dose * ( coefficient,C0650607;C0243071;C0178602;C1707429;C0869039;C1114758;C0205112;C0366513;C2825028,false;false;false;false;false;false;false;false;false,5272/20013
theophyllines,C0039771,true,5273/20013
angina class iii or iv — no . ( % ),C0264677,false,5274/20013
n ( nmbryr km event rate,C0369718;C0439234;C3887676;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false;false;false,5275/20013
age — year ( median ),C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0439508,false;false;false;false;false;false;false;false,5276/20013
tnt and ideal ( pooled ),,,5277/20013
cabg or ptca / pci,C0010055,true,5278/20013
ex - smoker ( n z nmbr ),C0337671;C4555205,false;true,5279/20013
event rate ( % ) of primary endpoints,C0441471;C0871208;C2986535;C1521828;C4019010,false;false;false;false;false,5280/20013
insulin - dependent diabetes,C0011854,true,5281/20013
malignancy at randomization,C0006826;C0034656;C1306459;C4282132,true;true;false;false,5282/20013
short - acting,C1282927;C0079613;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;false;true;false;false;false;false,5283/20013
serum potassium,C0302353;C0543465,false;false,5284/20013
rest of world n z nmbr,C0035253;C2700280;C1622890,true;false;false,5285/20013
never smoked,C2003901,false,5286/20013
seizure worry,C0036572;C0233481;C1959629;C4553401,true;false;false;false,5287/20013
placebo group ( n = nmbr nmbr ) ( nmbr nmbr person years ),C0032042;C0441848;C0027361;C0439234;C2347489;C1696465;C1706408,true;false;true;false;false;false;false,5288/20013
rest - of - world ( n = nmbr ),C0035253;C2700280;C1622890,true;false;false,5289/20013
no use ofdiabetes drugs — no . ( % ),C0240320,false,5290/20013
no estimate,C0750572,false,5291/20013
baseline ( n ),C0168634;C1442488,true;false,5292/20013
pci > nmbr month ago,C4049621;C0332177;C0439231,false;false;false,5293/20013
> nmbr years nmbr / nmbr ( nmbr . nmbr ),C0439234,false,5294/20013
time in therapeutic range before inclusion,C1554109;C0087111;C0302350;C0040223;C0460097;C3541383,false;true;false;true;false;false,5295/20013
initial diagnosis — no . ( % ),C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;true;true;false;false;false;false,5296/20013
angiotension converting enzyme - inhibitor,C0014432;C0919438;C4521603,true;false;false,5297/20013
xanthines,C0043318;C3541955,true;false,5298/20013
management distribution medical treatment,C0030677;C0520511;C0199168;C0205476;C1704711;C0001554;C0679624;C0376636;C1273870;C3273539,true;false;false;false;true;true;false;true;false;false,5299/20013
pharmaco - invasive ( n = nmbr ),C0205281;C1334278,false;false,5300/20013
estrogen - containing hormones,C0014939;C0332256;C0019932;C2700400;C2936882;C4542544,true;false;true;false;false;false,5301/20013
uac nmbr - nmbr mg / g,C1300563,false,5302/20013
nmbr % < hbanmbrc < = nmbr % ( n nmbr nmbr ),C0019016;C1825777;C3538758,true;false;false,5303/20013
mean ( s . d . ) measured ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,5304/20013
history of hypertension — no . ( % ),C0455527,false,5305/20013
prior cv history,C0332152;C3538987;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503;C2826257,false;false;true;true;false;false;false;false;true;false;false,5306/20013
time to end - of - study ivus,C0040227;C0444930;C1456025;C2746065,true;false;false;false,5307/20013
steroids ( inhaled ) a,C0038317,true,5308/20013
> qnmbr ( nmbr . nmbr ) - qnmbr ( nmbr . nmbr ) — number / n ( % ),C0237753;C0449788,false;false,5309/20013
previous angioplasty,C0205156;C0162577;C1548817;C1552607,false;true;false;false,5310/20013
time since diagnosis of diabetes,C0040223;C3541383,true;false,5311/20013
uric acid tertile nmbr ( nmbr . nmbr to < nmbr . nmbr mg / dl ),C0041980;C0439269,true;false,5312/20013
major hypoglycemia,C0205082;C0020615;C4553659;C0205164;C4318856;C4521762,false;true;false;false;false;false,5313/20013
prosper,,,5314/20013
dyspnea at rest ( nyha iv ),C0743330;C1275491;C0022326;C4265176,false;false;true;false,5315/20013
czech republic,C0206578,true,5316/20013
gusto moderate or severe bleeding,,,5317/20013
baseline cdai,C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,5318/20013
% change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,5319/20013
enalapril + aliskiren ( n = nmbr ),C0014025;C1120110,true;true,5320/20013
non - calcium antagonist strategy ( n = nmbr nmbr ),C1518422;C0006684;C0679199,false;true;false,5321/20013
ankle fracture,C0159877;C4552974,true;false,5322/20013
number standard care,C0237753;C1442989;C1947933;C2828392;C0449788,false;false;false;false;false,5323/20013
warfarin at last follow - up,C0043031;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,5324/20013
pci data,C4049621;C1511726;C3245479;C3714741,false;false;false;false,5325/20013
end of follow - up,C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,5326/20013
handihaler only,C0205171;C1720467,false;false,5327/20013
certolizumab pegol ( n = nmbr ),C1872109,true,5328/20013
mean — ml / min / nmbr . nmbr mnmbr level — no . ( % ),C0444504;C0439445;C0369637;C0441889;C0456079;C1547707;C2946261;C0441923;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,5329/20013
egfr via mdrd ( ml / min / nmbr . nmbrmnmbr ),C1739039;C3839656;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,5330/20013
core laboratory percent stenosis,C0444669;C0022877;C0439165;C0678234;C1261287;C2632116;C3244292;C4283904;C1167518;C1706352;C1882467;C3274653,false;true;false;false;true;false;false;false;false;false;false;false,5331/20013
native american / alaskan,C0682125;C0596070;C0282204;C0238611;C1515945,true;false;true;false;false,5332/20013
mean cdai score ( sd ),C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,5333/20013
insulin glargine vs standard care least - squares mean ( nmbr % cl ),C0907402,true,5334/20013
difference in ls meannmbr ( nmbr % cl ),C1705241;C0023668;C0444504;C0596019;C2347634;C2348143;C1705242,false;true;false;false;false;false;false,5335/20013
prior diagnosis - no . ( % ),C0332132,false,5336/20013
moderate - dose statin,C1709056;C0360714,false;true,5337/20013
tnf - alpha ( pg / ml ),C1448177;C0439297;C1456820;C1522669,true;false;true;false,5338/20013
antithrombotic drug use at time of event,C0013227;C1524063;C0040223;C0441471;C4019010;C3541383;C1254351,true;false;true;false;false;false;false,5339/20013
jbs - nmbr secondary prevention onlynmbr,C0175692;C0679699;C0205171;C1720467;C0795841;C1416527,true;true;false;false;true;false,5340/20013
full cohort,C0443225;C0009247;C0599755,false;true;false,5341/20013
immobilization,C0020944;C4048292,true;false,5342/20013
thienopyridine ( n = nmbr ),C1120149,true,5343/20013
etoricoxib,C0972314,true,5344/20013
previous coronary artery disease,C0205156;C0010054;C0010068;C1956346;C1552607,false;true;true;true;false,5345/20013
elevated cardiac markers,C0205250;C1271630;C3163633,false;false;false,5346/20013
ifx + aza ( n = nmbr ),C0020823;C0004482,true;true,5347/20013
open - label clopidogrel after completion of study drug,C1709323;C0070166;C0205197;C0013227;C1254351;C1554962,false;true;false;true;false;false,5348/20013
baseline low - density lipoprotein cholesterol ( mg / dl ),C0168634;C0023824;C0439269;C1442488,true;true;false;false,5349/20013
symptom onset to randomization,C4086878;C0034656,false;true,5350/20013
stricturing,C1261287,true,5351/20013
insulin tx difference vs pbo,C0021641;C0041403;C1705241;C1705242;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,5352/20013
duration of rheumatoid arthritis ( years ),C0449238;C0003873;C0439234;C2926735,false;true;false;false,5353/20013
beta - blocker — no . / total no . ( % ),C0001645,true,5354/20013
second loading dose,C0205436;C3714444;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,5355/20013
trochanter,C0162370,true,5356/20013
low perceived social support only,C0205251;C0030971;C0037438;C0205171;C1720467;C0748877;C1540833;C3669642;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;true;false;false;false;false;false;false;false,5357/20013
white / other,C0007457;C0043157;C0220938,true;true;false,5358/20013
treatment groups [n / nb ( % ) ],C0039798;C0441848;C0028101;C0919442;C1705347;C4553907;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;true;false;false;false;false;false,5359/20013
cardiovascular medication usage,C0007220;C0457083,true;false,5360/20013
non - calcium antagonist strategy ( ncas ) ( events / n ),C1518422;C0006684;C0679199;C1413309;C0441471;C3541888;C3813543,false;true;false;false;false;false;false,5361/20013
simvastatin ( nmbr / nmbr mg / d ) ( n = nmbr ),C0074554;C0439422,true;false,5362/20013
n / n nmbr / nmbr,C0369718;C0441922,false;false,5363/20013
not - japan,C1518422;C0022341,false;true,5364/20013
previous cardiovascular events,C0205156;C1320716;C1552607,false;false;false,5365/20013
trigl yeerides * ( m mol / l ),C0456616;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C0369637;C0347982;C0441923,false;true;true;false;false;false;false;false;false;false,5366/20013
total cholesterol : hdl - c ratio,C0439175;C0523558;C0439810,false;false;false,5367/20013
proadm ( ng / ml ),C0439275,false,5368/20013
interact !,,,5369/20013
older des ( n = nmbr ),C0580836;C0011702;C4551552,false;true;true,5370/20013
second co - primary outcome,C0205436;C3245499;C0205225;C1274040;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false;false;false;false;false,5371/20013
pe ± dvt,C0070939;C0149871;C2926618;C3899446;C1880476;C4284304,true;true;false;false;false;false,5372/20013
previous warfarin use,C0205156;C0043031;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,5373/20013
nice secondary prevention onlyb,C4087029;C0679699,false;true,5374/20013
ankle / brachial index,C1328319;C3888326,true;false,5375/20013
non - caucasian eze / simva,C1518422;C0007457;C0043157,false;true;true,5376/20013
use of compression stockings,C1524063;C0038348,false;true,5377/20013
prior angiography showing stenosis > nmbr %,C0332152;C0002978;C2826257,false;true;false,5378/20013
previous use of antiarrhythmic drugs,C0205156;C1524063;C0003195;C1552607,false;false;true;false,5379/20013
associated with ctd,C0332281;C1335071;C1442905,false;false;false,5380/20013
clopidogrel ( n = nmbr ) n / n ( % ),C0070166,true,5381/20013
physical exam oedema,C0031809;C0013604;C1717255,true;true;false,5382/20013
triglyceride ( mmol / l ) * blood pressure,C0041004;C1532563;C0005823;C1271104;C1272641,true;false;true;false;true,5383/20013
valproate,C0080356,true,5384/20013
ls - mean change from baseline ( nmbr % ci ),C0023668;C0444504;C0392747;C0168634;C0008107;C3259781;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false;false,5385/20013
median age ( iqr  years ),C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5386/20013
cardiac medications during index hospital stay and / or discharge,C0428776;C0013227;C3489408;C0802604;C2598133;C4284232,false;true;true;false;false;false,5387/20013
cardiac medications during index hospitalization,C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,5388/20013
no ipst ( n = nmbr,,,5389/20013
non high dose statin ( n = nmbr,C1518422;C0444956;C0360714,false;false;true,5390/20013
gall bladder adverse event ( n = nmbr ),C0016976;C0877248,true;false,5391/20013
elevated crp ( > ulnt ),C0742906,false,5392/20013
liraglutide,C1456408,true,5393/20013
type of drug - eluting stent,C0457591;C0038257;C0332307;C1322815;C1547052,false;true;false;true;false,5394/20013
ratio of fevnmbr to fvc,C0456603;C3714541;C1547037,false;true;false,5395/20013
infarct localization,C0021308;C0475264;C1744691,true;false;false,5396/20013
racial category *,C0034510;C0683312;C3889287;C1706779;C3669213;C3853635,true;false;false;false;false;false,5397/20013
inhaled jnmbr - agonist §,C0004048;C2987634,true;false,5398/20013
nonwhite race — no . ( % ) ejection fraction,,,5399/20013
theophylline use at screening,C0241361;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,5400/20013
history of omalizumab treatment,C0019664;C0966225;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;true;false;false;false;false;false;true;false;false;false;false,5401/20013
symptom onset to arrival in catheterization laboratory,C4086878;C1555577;C1706079,false;false;false,5402/20013
omega - nmbr fatty acid vs placebo least - squares mean ( nmbr % cl ),C1719844;C0015684,false;true,5403/20013
tnfi and other bdmardst,,,5404/20013
atenolol strategy ( n = nmbr,C0004147;C0679199,true;false,5405/20013
left atrial diameter : < nmbr mm ( n = nmbr ),C0225860;C1301886;C4330985;C4554674;C0225861,true;false;false;false;false,5406/20013
ethnic group,C0015031;C1879937,true;false,5407/20013
rf ( iu / ml ),C0035448;C0439458;C0201660;C0748398;C1547111,true;false;false;false;false,5408/20013
coronary heart disease risk equivalents,C1277690;C0439185;C4049980,false;false;false,5409/20013
medical history of hypertension,C0262926;C0020538;C1963138;C0199168;C0455527;C0205476,false;true;false;false;false;false,5410/20013
mepolizumab group,C0969324;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,5411/20013
microalbuminuria or macroalbuminuria,C0730345,false,5412/20013
baseline ldl - c > nmbr mg / dl,C0168634;C0439269;C1442488,true;false;false,5413/20013
combination therapy * *,C0009429;C0556895,true;false,5414/20013
uac > nmbr mg / g,C1300563,false,5415/20013
health assessment questionnaire score,C2960025,false,5416/20013
age at onset,C0206132;C3870509,true;false,5417/20013
antidiabetes drug usage [ % ( n ) ],C0242510,false,5418/20013
ibdq total score,C2964552,false,5419/20013
fenofibric,,,5420/20013
era and pdenmbr inhibitors,C1521863;C3495919,true;false,5421/20013
allogliptin,,,5422/20013
current smoker ( n = nmbr,C3173209;C3241966,false;false,5423/20013
weight ( kg ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,5424/20013
previous stroke or tia ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,5425/20013
average of maximum common carotid cimt ( mm ),C1510992;C0806909;C0205214;C0741968;C4330985;C4554674;C1522138;C3245511;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false;false;false,5426/20013
new or suspected thrombus,C0205314,false,5427/20013
lacosamide,C0893761,true,5428/20013
natalizumab ( n = nmbr ) f,C1172734;C0016327,true;true,5429/20013
family history of coronary disease,C0850707;C0018787,false;true,5430/20013
multivessel cad ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5431/20013
long - acting bronchodilator use at screening,C0205166;C0079613;C0006280;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;true;true;true;false;false;false;false;false;false;false;false;true;false;false;false,5432/20013
fevnmbr / fvc ratio,C3714541;C0456603;C1547037,true;false;false,5433/20013
mild impairment ( egfr nmbr - nmbr ),C2945599;C0221099;C1739039;C3811844;C3812682;C0684336,false;false;true;false;false;false,5434/20013
all randomly assigned,,,5435/20013
diet and exercise,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5436/20013
diabetesduration,,,5437/20013
median feno,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5438/20013
primary enrollment diagnoses,C0332137;C1516879;C1696073;C3888021;C0801658,false;false;false;false;false,5439/20013
low hdl - c ( for men < nmbr   mg / dl / for women < nmbr   mg / dl ),C0151691;C0025266;C0439269,false;true;false,5440/20013
mean body mass index ( sd ),C0444504;C0005893;C2699239;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,5441/20013
ace inhibitor or angiotensin ii receptor,C0003015;C4541021,true;false,5442/20013
diet diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,5443/20013
unspecified,C0205370;C1549663;C2983689;C4048188,false;false;false;false,5444/20013
atherosclerotic cardiovascular disease,C0004153,true,5445/20013
dilated cardiomyopathy,C0007193;C2984282,true;false,5446/20013
participation in phase a,C0679823;C0205390;C1710475,false;false;false,5447/20013
after amendment,C0680532;C2346732,false;false,5448/20013
laba + ics versus indzgly lsm difference ( nmbr % cl ),C0815320;C4551720,false;true,5449/20013
number of patients > nmbr years ( % ),C2360800;C0439234,false;false,5450/20013
hypoglycemia,C0020615;C4553659,true;false,5451/20013
gold stage [n ( % ) ],C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,5452/20013
not treated,C1518422,false,5453/20013
motor subscale ( range,C1513492;C1514721;C2348147;C3542016;C1705994,false;false;false;false;false,5454/20013
feno + eze,,,5455/20013
total group,C0439175;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0439810,false;false;false;true;false;false;false;false,5456/20013
asthma control test score at baseline,C2733224;C0168634;C1442488,false;true;false,5457/20013
lipid values,C0023779;C0042295,true;false,5458/20013
esr,C3811131,false,5459/20013
europe and canada,C0015176,true,5460/20013
total mayo score $ | |,C2964552;C0454788;C1077578,false;false;false,5461/20013
as - needed inhalations / day,C1879745;C0004048;C0332173;C0439228;C0439505;C0354922;C1883728,false;true;false;false;false;false;false,5462/20013
habitual fish intake : < nmbr servings / wk ( n = nmbr ),C0205353;C0556216;C1519269;C0332174;C0439230,false;false;false;false;false,5463/20013
number resulting in hospital admission,C0237753;C0449788,false;false,5464/20013
infarction > nmbr days previously,C0021308;C0439228,true;false,5465/20013
pasi score ( nmbr - nmbr ) t,C4528685;C0449820;C4050231,false;false;false,5466/20013
index mi ( n - nmbr,C0600653;C3810814;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,5467/20013
> nmbr % coronary stenosis,C0242231,true,5468/20013
mean ( s . d . ) egfr,C0444504;C1739039;C3811844;C3812682;C2347634;C2348143,false;true;false;false;false;false,5469/20013
losartan + lisinopril,C0126174;C0065374,true;true,5470/20013
male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,5471/20013
isolated deep - vein thrombosis,C0205409;C0149871;C1548221,false;true;false,5472/20013
esrd or death,C0022661;C0035078;C2316810,true;true;false,5473/20013
tiotropium nmbr . nmbr mg,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5474/20013
other major risk factors,C0205082;C0035648;C1553898;C0205164;C4318856;C4521762,false;true;false;false;false;false,5475/20013
csf lathosterol ( | jlg / cll ),C3540512;C0064673;C0023434;C3889436,false;true;true;false,5476/20013
diagnosis at presentation — no . ( % ),C0011900;C0449450;C1704338;C1704656,true;false;true;false,5477/20013
number of concomitant csdmards,C0237753;C0521115;C0449788,false;false;false,5478/20013
radiographic characteristics at baseline and randomization,C0444708;C4684572,false;false,5479/20013
probability   of event %,C0033204;C0441471;C4019010,true;false;false,5480/20013
d - dimer ( ng / ml ),C0060323;C0439275,true;false,5481/20013
cerebrovascular,C1880018,false,5482/20013
methotrexate use at randomisation,C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,5483/20013
method of identification ofstenosis ( % ),C1301921,false,5484/20013
treatment of the index ml,C0039798;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;true;false;false;false;true;false;false;false;false;false,5485/20013
saba puffs per day at baseline,C1533107;C0332173;C0439228;C0439505,false;false;false;false,5486/20013
joint space narrowing score,C1859695;C0449820;C4050231,false;false;false,5487/20013
evolocumab nmbr mg monthly ( n = nmbr ),C3529352;C0024671;C0332177;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,5488/20013
intent - to - treatb,C0162425;C1283828;C1550453,true;false;false,5489/20013
ace - i or angiotensin receptor blocker,C1452534;C0021966;C0221138;C4284014,true;true;false;false,5490/20013
body mass index > nmbr — no . ( % ) f,C0005893;C0578022;C1305855,false;false;true,5491/20013
prebronchodilator fevnmbr / fvc,C2599602;C3714541,false;true,5492/20013
less than nmbr ml / min / nmbr . nmbrmnmbr,C0439092;C0439445;C0369637;C0441923,false;false;false;false,5493/20013
previous tia or stroke,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,5494/20013
non - ischaemic aetiology,C1518422;C0475224;C0015127;C1314792;C1524003,false;false;true;true;false,5495/20013
stroke n = nmbr,C0038454;C4554100,true;false,5496/20013
crp concentration > nmbr mg / l,C3890735;C0086045;C0439268;C1446561;C3827302;C4048285,false;true;false;false;false;false,5497/20013
european quality of life - nmbr dimensions - nmbr level ( eq - nmbrd ),C0239307;C0034380;C0439534;C0441889;C0205163;C0439185;C0456079;C1547707;C2946261;C0518214;C1535514,false;true;false;false;false;false;false;false;false;false;false,5498/20013
major clinical response,C0205082;C4055223;C0205164;C4318856;C4521762,false;false;false;false;false,5499/20013
mean ham - d score ( nmbr % ci ),C3533236;C1570167;C0008107;C3259781;C3853311,false;true;true;false;false,5500/20013
bowel function,C0011135,true,5501/20013
laa ostium,C0444567,false,5502/20013
bnp o nmbr pg / ml or nt pro - bnp o nmbr pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,5503/20013
laa length,C1444754;C1706316,false;false,5504/20013
risk factors and immobility level,C0035648;C1553898,true;false,5505/20013
pasi score > nmbr *,C4528685;C0449820;C4050231,false;false;false,5506/20013
drug - eluting stent,C1322815,true,5507/20013
copd — no . ( % ) medication use,C0024117;C1412502;C3714496,true;false;false,5508/20013
interquartile range,C1711350,false,5509/20013
acute stroke of other determined cause,C0751956;C0521095;C0015127;C1524003,true;false;true;false,5510/20013
severe exacerbations  itt population  n ( % ),C0205082;C4086268;C0032659;C1257890;C4050465;C4050466,false;false;true;true;false;false,5511/20013
europe nmbr,C0015176,true,5512/20013
male gender ( % ),C0086582;C1706180,true;false,5513/20013
no . of vessels,C0005847,true,5514/20013
n - nmbr fatty acids - placebo lsm ( nmbr % cl ),C0369718;C0015684;C0032042;C0596019;C1696465;C1706408;C0441922,false;true;true;false;false;false;false,5515/20013
rheumatoid arthritis,C0003873,true,5516/20013
> nmbr % focal seizure frequency responders,C0751495;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775,true;true;false;false;false;false;false;false;false;false,5517/20013
medication within nmbr days before enrolment,C0013227;C0439228;C3244316;C4284232,true;false;false;false,5518/20013
sex ( male ) - no . ( % ),C0086582,true,5519/20013
worsened,C1457868;C4084902,false;false,5520/20013
digoxin at enrollment,C0012265;C1516879;C1696073;C3888021,true;false;false;false,5521/20013
prostate cancer,C0376358;C0600139;C2984325;C3541264,true;false;false;false,5522/20013
pre - bronchodilator fvc ( l ),C2599602;C3714541,false;true,5523/20013
no . of treated lesions,C1522326;C0221198,false;false,5524/20013
cholecystectomy ( n = nmbr ),C0008320,true,5525/20013
# of prior non - tnfi bdmards *,C0332152;C1518422;C2826257,false;false;false,5526/20013
immunosuppressive agents only,C0021081;C0205171;C1720467,true;false;false,5527/20013
enalapril ( n = nmbr ),C0014025,true,5528/20013
deep - vein thrombosis or pulmonary embolism — no . ( % ),C0149871,true,5529/20013
age - years,C1510829,false,5530/20013
total no . of patients,C0439175;C0439810,false;false,5531/20013
n - nmbr fatty acids ( n = nmbr ),C0369718;C0015684;C0441922,false;true;false,5532/20013
selena - sledai ( range u - nmbrunmbr ) t,C0451528;C1514721;C0439148;C2348147;C3542016,false;false;false;false;false,5533/20013
bnp > nmbr pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,5534/20013
ms & ng,C2349943;C0017887;C0028074;C3539704;C3713294,false;true;true;false;true,5535/20013
global assessment of disease status score,C0281858;C3176928;C0449820;C4050231,false;false;false;false,5536/20013
all patients ( n = nmbr ),C0030705,true,5537/20013
isolated impaired glucose tolerance — no .,C0205409;C1548221,false;false,5538/20013
angiographic extent of disease,C0002978;C0449279;C4553144,true;false;false,5539/20013
type of concomitant statin by daily dose - no . ( % ),C0332307;C0521115;C0360714;C1547052,false;false;true;false,5540/20013
postoperative nsaid or glucocorticoid use,C0032790;C0003211;C3536840,true;true;false,5541/20013
airflow reversibility — no . ( % ) |,C0231999;C0449261,false;false,5542/20013
devices,C0025080;C0220819;C0699733,true;true;true,5543/20013
age at enrollment ( years ),C1510829;C1516879;C1696073;C3888021,false;false;false;false,5544/20013
mean ( sd ) disease duration,C0444504;C2699239;C0872146;C2347634;C2348143,false;false;false;false;false,5545/20013
race - white ( n = nmbr,C0034510;C1706779;C3853635,true;false;false,5546/20013
fluticasone furoate,C1948374,true,5547/20013
aldosterone antagonists ( e . g . spironolactone ),C0002007;C2757004,true;false,5548/20013
pci duration in min ( median,C4049621;C0449238;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,5549/20013
age > nmbr years,C1510829,false,5550/20013
active cancer — no . ( % ),C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,5551/20013
insulina,,,5552/20013
skull,C0037303;C2951888,true;false,5553/20013
nmbr - aminosalicylates {,C0368663,false,5554/20013
hemorrhagic stroke,C0553692,true,5555/20013
immy ( without corticosteroid ),C0001617;C3536709,true;false,5556/20013
log rank p - value,C1708728;C0667477;C1709380;C0699794;C2986775,false;true;false;false;false,5557/20013
high - density lipoprotein,C0023821,true,5558/20013
antibodies to infliximab,C3533054,false,5559/20013
safety : non - cabg - related bleeding,C0036043;C1518422;C0010055;C1705187,true;false;true;false,5560/20013
diabetes mellitus — no . ( % ),C0011849,true,5561/20013
inspiratory capacity ( l ),C0021610;C0802663,true;false,5562/20013
hf,C0018488;C1313497;C1538440;C3273279,true;true;false;false,5563/20013
percent of predicted fevnmbr,C1882327;C3714541,false;true,5564/20013
ace inhibitor or angiotensin - receptor blocker — no . / total no . ( % ),C0003015;C4541021,true;false,5565/20013
diuretics group ( n = nmbr ),C0012798;C0441848,true;false,5566/20013
prior aortocoronary bypass surgery,C0455610;C0010055,false;true,5567/20013
neutrophils,C0027950,true,5568/20013
antiplatelet or anti - inflammatory drugs,,,5569/20013
presentation of index event,C0449450;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,5570/20013
statin at enrollment,C0360714;C1516879;C1696073;C3888021,true;false;false;false,5571/20013
ethnicitya hispanic or latino,C0086409,true,5572/20013
waist circumference snmbr ( men ) or > nmbr cm ( women ),C0455829;C0025266,true;true,5573/20013
baseline mssbp / msdbp,C0168634;C1442488,true;false,5574/20013
hispanic american,C0019576,true,5575/20013
hba]c ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,5576/20013
men / women,C0025266;C0043210,true;true,5577/20013
pbo ( nnmbr nmbr ),C0031962,true,5578/20013
creatinine clearance < nmbr ml / min ( % ),C0812399;C0439445,false;false,5579/20013
total comparators ( n = nmbr ),C0439175;C1707454;C4553389;C4553390;C0439810,false;false;false;false;false,5580/20013
high feno subgroup ( > nmbr . nmbr ppb ) ( n = nmbr ),C0205250;C1079230;C1415800;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false,5581/20013
hbanmbrc in patients with baseline hbanmbrc < nmbr % ( < nmbr mmol / l ),C0019016;C0030705;C0168634;C1532563;C1442488;C1825777;C3538758,true;true;true;false;false;false;false,5582/20013
overall event rate,C0282416;C0441471;C0871208;C1521828;C4019010;C1561607,true;false;false;false;false;false,5583/20013
prior biologic therapeutic failures,C0332152;C0005515;C0087111;C0231174;C0680095;C0302350;C0205460;C2826257,false;true;true;false;false;false;false;false,5584/20013
losartan plus lisinopril ( n = nmbr ),C0126174;C0332287;C0065374,true;false;true,5585/20013
us site of enrollment,C2945843;C1516879;C1696073;C3888021,false;false;false;false,5586/20013
killip class lll - iv,C2697847;C1261077,false;false,5587/20013
coronary artery osteochondrosis,C0205042;C0029376;C0029429;C0729346,true;true;true;false,5588/20013
subset of patients not on metformin,C1515021;C0030705,false;true,5589/20013
no persistent wrf ( n = nmbr,C0205322;C0332996,false;false,5590/20013
clopidogrel plus aspirin % / yr,C0070166;C0332287;C0004057;C0439234,true;false;true;false,5591/20013
percutaneous coronary revascularization,C1532338,true,5592/20013
plus metformin,C0332287;C0025598,false;true,5593/20013
calcium - channel inhibitor,C0006685;C1999216,true;false,5594/20013
cure trial,C1880198;C0008976,false;true,5595/20013
ratio ( nmbr % ci ) *,C0456603;C0008107;C3259781;C1547037,false;true;false;false,5596/20013
baseline pre - bronchodilator fevnmbr,C0168634;C2599602;C3714541;C1442488,true;false;true;false,5597/20013
physical component summary,C0031809;C0449432;C1552616;C1706244;C1705248;C0205485;C1509143,true;false;false;false;false;false;false,5598/20013
placebo croup,C0032042;C0010380;C1696465;C1706408,true;true;false;false,5599/20013
copd medication taken for at least nmbr months before st,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,5600/20013
st - segment - elevation myocardial infarction — no . ( % ),C1536220,true,5601/20013
ada nmbr / nmbr ( n[nmbr ),C1060325;C3811629,false;false,5602/20013
previous segmental resection — no . ( % ),C0205156;C2987624;C1552607,false;false;false,5603/20013
older patients ( aged > nmbr years ),C0580836;C0030705,false;true,5604/20013
pre - operative cardiac medications *,C2347660;C1882154;C0018787;C1522601,false;false;true;false,5605/20013
other forms of,C0348078;C0376315,false;true,5606/20013
number of ( % ) patients > nmbr years,C2360800;C0439234,false;false,5607/20013
ck - mb,C0010290,true,5608/20013
prior cardiovascular disease,C0332152;C0007222;C2826257,false;true;false,5609/20013
current / past smoker,C3173209;C1444637;C4284302;C3241966,false;false;false;false,5610/20013
on - pump time : < l : nmbrhrs : min ( n = nmbr ),C3842462;C0040223;C1568891;C0702093;C1524029;C3813700;C3541383,false;true;true;false;false;false;false,5611/20013
diuretic — no . ( % ) surgery,C0012798,true,5612/20013
< nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,5613/20013
types of fibrinolytic agent,C0332307;C0016018,false;true,5614/20013
u » c » ( mg / g ),C1532633;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2608091;C1638407;C0439267;C0439148;C1300563,false;true;true;false;false;false;false;false;false;false;false;false;false,5615/20013
anticoagulant group ( n = nmbr ),C0003280;C0441848;C0848112;C3536711,true;false;false;false,5616/20013
< nmbr yr of education — no . ( % ),C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,5617/20013
non - colorectal cancer,C1518422;C0009402;C0346629;C1527249;C2984278;C3542412,false;true;false;true;false;false,5618/20013
all bleeding,,,5619/20013
hbalc ( % ),,,5620/20013
simvastatin nmbr mg ( n = nmbr,C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5621/20013
losmapimod ( n = nmbr ),C3272847,true,5622/20013
number of e,C0237753;C0449788,false;false,5623/20013
hydochlorothiazide ( n = nmbr ),,,5624/20013
continued treatment study,C0549178;C3161471,false;false,5625/20013
death / q - wave mi / idr,C0011065;C0861151;C1306577;C4082313;C4552775,true;false;false;false;false,5626/20013
p value for trend,C1709380;C1521798;C4554533,false;false;false,5627/20013
time since diagnosis of heart failure,C0040223;C3541383,true;false,5628/20013
mean ( s . d . ) ldl particle size,C0444504;C3641256;C2347634;C2348143,false;false;false;false,5629/20013
single vessel pci,C0037179;C0005847;C4049621;C0087136;C0205171,true;true;false;true;false,5630/20013
pfo with mild - to - moderate shunt and atrial septal aneurysm,C1299392;C0232180;C0542331;C1442858,false;false;false;false,5631/20013
obesity ( bmi > nmbr kg / mnmbr ),C0028754;C0578022;C1532718;C1963185,true;false;false;false,5632/20013
colon only,C0009368;C0205171;C1720467;C3888384,true;false;false;false,5633/20013
lp ( a ) ( week nmbr ),C0065058;C0332174;C0439230;C1439335;C4553379,true;false;false;false;false,5634/20013
n - nmbr pufa events / patients ( % ),C0369718;C0032615;C0441471;C0030705;C3541888;C0441922,false;true;false;true;false;false,5635/20013
arthritis type *,C0003864;C0332307;C1547052;C4552845,true;false;false;false,5636/20013
aml / val,C0023465;C0042285;C0523975;C0023467,true;true;false;true,5637/20013
in emergency department before ambulance transfer,C0562508;C0002422;C0040671;C1705822;C4319192;C3846685,true;true;true;false;false;false,5638/20013
gold d,C0018026;C1304897,true;false,5639/20013
saaca,,,5640/20013
ecg,C1623258,true,5641/20013
之 nmbr,,,5642/20013
total ( n = nmbr ),C0439175;C0439810,false;false,5643/20013
race — no . ( % ) |,C0034510;C1706779;C3853635,true;false;false,5644/20013
% nmbr - nmbr,,,5645/20013
pbo,C0031962,true,5646/20013
male sex,C0086582,true,5647/20013
females,C0086287,true,5648/20013
< nmbr mm,C4330985;C4554674,false;false,5649/20013
snmbr %,C0565930;C2603362,false;false,5650/20013
age ' ^nmbr yrs,C0001779,false,5651/20013
atvnmbr mg ( n = nmbr ),C0210243;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;true;false;false;false;false;false;true;true;false,5652/20013
female,C0043210;C0086287;C1705497;C1705498,true;true;false;false,5653/20013
> nmbr mo,C0026544;C0332177,true;false,5654/20013
male sex — %,C0086582,true,5655/20013
lvh,C0149721,true,5656/20013
stent,C0038257,true,5657/20013
acrnmbr,C1412134;C1515941,false;false,5658/20013
diet,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5659/20013
cg / ld,C0043444;C0694649;C1567075;C3540479,true;false;true;false,5660/20013
age ( years ) *,C1510829,false,5661/20013
nonsmoker,C0337672;C0425293;C4554605,false;false;true,5662/20013
no ( % ),,,5663/20013
lips,C0023759,true,5664/20013
≤ nmbr,,,5665/20013
ocs,,,5666/20013
tg < = nmbr . nmbr,C0337445,false,5667/20013
rate * ( n ),C0871208;C1521828,false;false,5668/20013
statin ( n - nmbr ),C0360714,true,5669/20013
« snmbr - nmbr,C0565930;C2603362,false;false,5670/20013
nmbr to < nmbrmmhg,C0439475,false,5671/20013
males ( % ),C0086582,true,5672/20013
三 nmbr to < nmbr,C0040363;C0041260;C1883351,true;true;false,5673/20013
cough,C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,5674/20013
> median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5675/20013
smoking *,C0037369;C0453996;C1881674,true;true;false,5676/20013
etd ( nmbr % ci ),C1180255;C0008107;C3259781,false;true;false,5677/20013
% ( se ),C0036919,true,5678/20013
pm,C0030266;C4049155,true;false,5679/20013
n ( % ),C0369718;C0441922,false;false,5680/20013
> nmbr beds,C0004916,true,5681/20013
number,C0237753;C0449788,false;false,5682/20013
> nmbr years ( n = nmbr ),C0439234,false,5683/20013
femaleb,,,5684/20013
< nmbr hr,,,5685/20013
> nmbr to < nmbr mm hg,C0439475,false,5686/20013
deaths,C0011065;C1306577,true;false,5687/20013
uvb,C0454530;C0564461,false;false,5688/20013
asian ( n — nmbr ),C0078988,true,5689/20013
bms,,,5690/20013
p - int,C0369773;C3272375;C2603361,false;false;false,5691/20013
l ’ - value ’,C0439394;C1522609;C1706495;C3642217,false;false;false;false,5692/20013
abnormal,C0205161;C2347472;C2699333,false;false;false,5693/20013
crt,,,5694/20013
sex :,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,5695/20013
icd,C0021122,true,5696/20013
cabg,C0010055,true,5697/20013
≤ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5698/20013
nmbr - nmbr ft,C1881534;C3890579,false;false,5699/20013
lad,,,5700/20013
nmbr yrs,,,5701/20013
hs - crp,C3890735;C4048285,false;false,5702/20013
no prior llt,C0332152;C2347090;C2826257,false;false;false,5703/20013
range,C1514721;C2348147;C3542016,false;false;false,5704/20013
phi ( n = nmbr ),C1333690;C1704947;C1706536;C2975867;C4084801,false;false;false;true;false,5705/20013
> nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,5706/20013
women ( n = nmbr ),C0043210,true,5707/20013
> nmbr - < nmbr years,C0439234,false,5708/20013
men ( % ),C0025266,true,5709/20013
> nmbr ug / g,C0439272,false,5710/20013
cdai,C0683448;C1413248;C3273706,false;false;false,5711/20013
age nmbr,C0001779,false,5712/20013
age > = nmbr years,C1510829,false,5713/20013
hbalc < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5714/20013
arr ( nmbr % ci ),C2170357;C0008107;C3259781;C4084934,false;true;false;false,5715/20013
msdbp,,,5716/20013
ato nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5717/20013
redon,,,5718/20013
daily,C0332173,false,5719/20013
placebo n / n ( % ),C0032042;C1696465;C1706408,true;false;false,5720/20013
statin ( n = nmbr ),C0360714,true,5721/20013
blockers,,,5722/20013
idr,,,5723/20013
p - valuec,C0369773;C2603361,false;false,5724/20013
nmbr ( > nmbr % ),,,5725/20013
≥ nmbr . nmbr years,C0439234,false,5726/20013
anmbr n = nmbr,C0369718;C0441922,false;false,5727/20013
p valued,C0369773;C2603361,false;false,5728/20013
study,C0557651;C2603343,false;false,5729/20013
> nmbr % nmbr,,,5730/20013
no pci,C4049621,false,5731/20013
igm,,,5732/20013
ex - smoker,C0337671;C4555205,false;true,5733/20013
etn,C0014758;C0717758,true;true,5734/20013
rales,C0034642;C0240859,true;false,5735/20013
pooled,C1709595;C2349200;C4522255,false;false;false,5736/20013
female sex ( % ),C0086287,true,5737/20013
acs,C0742343;C4318612,true;false,5738/20013
nmbr . nmbr min,C0702093;C1524029;C3813700,false;false;false,5739/20013
motor,C1513492;C1705994,false;false,5740/20013
apo bt,,,5741/20013
asian,C0078988,true,5742/20013
age < nmbr yr,C0001779;C0439234,false;false,5743/20013
hr nmbr % cl,C0596019,false,5744/20013
sal nmbr mg,C0036140;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0037494;C0206136,true;true;true;false;false;false;false;false;true;true,5745/20013
frail,C0871754,false,5746/20013
> lnmbr years,C0439394;C0439234;C1706495;C3642217,false;false;false;false,5747/20013
iv ( n z nmbr ),C0022326;C4265176,true;false,5748/20013
( nmbr % cl ),C0596019,false,5749/20013
* p value,C1709380,false,5750/20013
arb,C3888198,false,5751/20013
oad,,,5752/20013
fema le,C0023190;C0439090;C1423767;C2697858,true;false;false;false,5753/20013
nmbr enmbr years,C0439234,false,5754/20013
black ( n = nmbr ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,5755/20013
missing,C1551393;C1705492;C3272743,false;false;false,5756/20013
single,C0037179;C0087136;C0205171,true;true;false,5757/20013
events ( % ),C0441471;C3541888,false;false,5758/20013
> nmbr kg,C0022718;C0439209;C4054209,true;false;false,5759/20013
s,C0565930;C2603362,false;false,5760/20013
< nmbr ng / ml,C0439275,false,5761/20013
rr ( nmbr % ci ),C4554402;C0008107;C3259781,false;true;false,5762/20013
result,C1274040;C1546471;C2825142,false;false;false,5763/20013
patients n,C0030705,true,5764/20013
placebo [n = nmbr |,C0032042;C1696465;C1706408,true;false;false,5765/20013
nmbr % cl,C0596019,false,5766/20013
nmbr nmbr,,,5767/20013
> nmbr %,,,5768/20013
hbak < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5769/20013
> nmbr yr sex,C0439234;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,false;true;true;true;false;false;true,5770/20013
< nmbr,,,5771/20013
> = nmbr years,C0439234,false,5772/20013
nmbr mg / g,C1300563,false,5773/20013
ascvd,C3665365,false,5774/20013
lgm ( n = nmbr ),,,5775/20013
mace,C0349381;C0949745;C1445339,false;true;false,5776/20013
neither,,,5777/20013
> = nmbrkg,C0022718;C0439209;C4054209,true;false;false,5778/20013
( se ) t *,C0036919,true,5779/20013
esrd,C0022661;C0035078;C2316810,true;true;false,5780/20013
placebo n[nmbr,C0032042;C1696465;C1706408,true;false;false,5781/20013
mtx,C0025677;C1417487,true;false,5782/20013
loop,C0445022,false,5783/20013
japanese,C0376247;C1556094,false;true,5784/20013
chda,,,5785/20013
> nmbr lb,,,5786/20013
age ( years ) +,C1510829,false,5787/20013
l ( % ),C0439394;C1706495;C3642217,false;false;false,5788/20013
chadsnmbr,C0007928;C1413373,true;false,5789/20013
( n = nmbr ),C0369718;C0441922,false;false,5790/20013
new om,C0205314;C0028971;C1705272,false;true;false,5791/20013
nmbr % nmbr,,,5792/20013
former,C0205156;C0750523,false;false,5793/20013
b lack,C0332268,false,5794/20013
median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5795/20013
nmbr — < nmbr years,C0439234,false,5796/20013
hdl - cd,C3715113;C0007928;C0034283;C4552032,false;true;true;false,5797/20013
low,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,5798/20013
> nmbr ( n — nmbr ),C0369718;C0441922,false;false,5799/20013
rr *,,,5800/20013
iii / iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,5801/20013
pla,C0456170,false,5802/20013
hr,,,5803/20013
bmi < nmbr,C0578022,false,5804/20013
nmbr . nmbr yrs,,,5805/20013
plac,C0048838,true,5806/20013
women,C0043210,true,5807/20013
other,,,5808/20013
lmwh,C0019139;C3536766,true;false,5809/20013
mexico,C0025885,true,5810/20013
lcznmbr ( n = nmbr ),,,5811/20013
nmbr % cit,C0008864;C0523573;C1427027;C4553421,true;false;false;false,5812/20013
black ( n — nmbr ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,5813/20013
< nmbr yr,C0439234,false,5814/20013
< nmbr » < nmbry,,,5815/20013
hba „ ( % ),C0019016;C1825777;C3538758,true;false;false,5816/20013
htn,C0020538,true,5817/20013
p for i,C0369773;C0021966;C0221138;C2603361,false;true;false;false,5818/20013
af,C0344434;C4049859,false;false,5819/20013
# nmbr year,C0439234;C0439508,false;false,5820/20013
beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,5821/20013
naive ( n = nmbr ),,,5822/20013
changenmbr,C0392747;C0443172;C1705241;C4319952,false;false;false;false,5823/20013
< lnmbr years,C0439394;C0439234;C1706495;C3642217,false;false;false;false,5824/20013
treated,C1522326,false,5825/20013
tnmbrd,C2603360,false,5826/20013
mtx n = nmbr,C0025677;C1417487,true;false,5827/20013
white ( n — nmbr ),C0007457;C0043157;C0220938,true;true;false,5828/20013
pasi *,C4528685,false,5829/20013
aged ^nmbr years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,5830/20013
> nmbr - < nmbr mmhg,C0439475,false,5831/20013
copd ( n = nmbr ),C0024117;C1412502;C3714496,true;false;false,5832/20013
nmbrto < nmbrmmhg,C0439475,false,5833/20013
nmbr +,,,5834/20013
< nmbrkg,C0022718;C0439209;C4054209,true;false;false,5835/20013
< nmbr ( n — nmbr ),C0369718;C0441922,false;false,5836/20013
bmi > nmbr,C0578022,false,5837/20013
lsm ( nmbr % ci ),C0008107;C3259781,true;false,5838/20013
dd,C3538867;C3814791,false;false,5839/20013
x / n,,,5840/20013
age yrs,C0001779,false,5841/20013
diet alone,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5842/20013
sfc ( n [nmbr ),C4521536,false,5843/20013
> nmbr / > nmbr mm hg,C0439475,false,5844/20013
< nmbr ft,C1881534;C3890579,false;false,5845/20013
■ nmbr years,C0439234,false,5846/20013
nmbr - nmbr years,C0439234,false,5847/20013
p value *,C1709380,false,5848/20013
beta blocker,C0001645,true,5849/20013
< nmbr years ( n = nmbr ),C0439234,false,5850/20013
beta - blocker,C0001645,true,5851/20013
race ( % ) $,C0034510;C1706779;C3853635,true;false;false,5852/20013
fibrate,,,5853/20013
primary pci,C0205225;C4049621;C0439612;C0439631,false;false;false;false,5854/20013
colon,C0009368;C3888384,true;false,5855/20013
n,C0369718;C0441922,false;false,5856/20013
aphasia,C0003537,true,5857/20013
low ’,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,5858/20013
f emale,C0016327,true,5859/20013
igm ( n = nmbr ),C1706005,false,5860/20013
> nmbr nmbr,,,5861/20013
< nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5862/20013
ics : yes,C0815320;C1549445;C1705108;C1710701;C4551720,false;false;false;false;true,5863/20013
< nmbr ml,C0439526;C1705224;C3887665,false;false;false,5864/20013
placebo ( n = nmbr,C0032042;C1696465;C1706408,true;false;false,5865/20013
unprovoked,,,5866/20013
strategy,C0679199,false,5867/20013
asia ( n = nmbr ),C0003980,true,5868/20013
cse] +,,,5869/20013
age > nmbr y * *,C0001779,false,5870/20013
i % nmbr,C0021966;C0221138,true;false,5871/20013
mca,C0149566,true,5872/20013
taci ( n = nmbr ),C0666480;C1425349;C4284230,true;false;false,5873/20013
hdl - c,C3715113,false,5874/20013
medium,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,5875/20013
placebo ( n = nmbr ),C0032042;C1696465;C1706408,true;false;false,5876/20013
women men,C0043210;C0025266,true;true,5877/20013
both,,,5878/20013
rca,,,5879/20013
italy,C0022277,true,5880/20013
,,,5881/20013
> nmbr - nmbr years,C0439234,false,5882/20013
snmbr,C0565930;C2603362,false;false,5883/20013
chf,C0018802,true,5884/20013
^ - blockers,,,5885/20013
nmbr ( n = nmbr ),C0369718;C0441922,false;false,5886/20013
ale,C0678386;C2632076,false;false,5887/20013
p valuea,C0369773;C2603361,false;false,5888/20013
≤ nmbr %,,,5889/20013
nmbrmg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5890/20013
placebo n = nmbr,C0032042;C1696465;C1706408,true;false;false,5891/20013
anemia,C0002871;C1000483;C4554633,true;false;false,5892/20013
eze,,,5893/20013
mean *,C0444504;C2347634;C2348143,false;false;false,5894/20013
atv nmbr mg,C0210243;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;true;false;false;false;false;false;true;true;false,5895/20013
ef nmbr - nmbr %,,,5896/20013
open — no . ( % ),C0175566,false,5897/20013
oriental,C0078988;C0699027,true;false,5898/20013
\nmbr %,,,5899/20013
anakinra,C0245109,true,5900/20013
of patients,C0030705,true,5901/20013
sedbp,,,5902/20013
£ nmbr kg,C0022718;C0439209;C4054209,true;false;false,5903/20013
japan,C0022341,true,5904/20013
> nmbr hrs,C1568891,true,5905/20013
female ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,5906/20013
hbak > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5907/20013
aspirin,C0004057,true,5908/20013
other — no . ( % ),,,5909/20013
male ( n z nmbr ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,5910/20013
dm absent,C0011816;C3250443,true;false,5911/20013
vora,,,5912/20013
* nmbr to < nmbry,,,5913/20013
never smoking,C2003901,false,5914/20013
female sex — no . ( % ),C0086287,true,5915/20013
( gm ),C0017480;C3854019,true;true,5916/20013
st +,C0036056;C3272372,true;false,5917/20013
≥ nmbr to < nmbr %,C0040363;C0041260;C1883351,true;true;false,5918/20013
aqe inmbr,C0021966;C0221138,true;false,5919/20013
n / pyr,C0369718;C0441922,false;false,5920/20013
< nmbr kg,C0022718;C0439209;C4054209,true;false;false,5921/20013
apobe,,,5922/20013
age : > nmbr years,C1510829,false,5923/20013
crci > nmbr,,,5924/20013
nmbr mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5925/20013
psa ( n = nmbr ),C3810537;C3813209,false;false,5926/20013
ldl *,,,5927/20013
pin /,C0175718;C1168556;C1704584,true;false;false,5928/20013
( se]tf,C0036919;C4048299;C4048587,true;false;false,5929/20013
oa,C0029408;C3887876,true;false,5930/20013
grade nmbr,C0441800;C0919553;C3244287,false;false;false,5931/20013
off omt,,,5932/20013
gold a,C0018026;C1304897,true;false,5933/20013
no ascvd,C3665365,false,5934/20013
serum,C0229671;C1546774;C1550100,true;false;false,5935/20013
othersc,,,5936/20013
eze nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5937/20013
crt - p,,,5938/20013
itherchdt,,,5939/20013
dm present,C0011816;C0150312;C0449450;C3250443,true;false;false;false,5940/20013
non - smoker,C0337672;C0425293;C4554605,false;false;true,5941/20013
> = nmbr - < nmbr mmhg,C0439475,false,5942/20013
nmbr or nmbr days,,,5943/20013
group d,C0441838,false,5944/20013
placebo pts / n ( % ),C0032042;C1419129;C2698747;C1696465;C1706408,true;false;false;false;false,5945/20013
= snmbr,C0565930;C2603362,false;false,5946/20013
nmbr - nmbr min,C0702093;C1524029;C3813700,false;false;false,5947/20013
ii ( n = nmbr ),C1710602;C4082587,false;false,5948/20013
rectum,C0034896,true,5949/20013
total *,C0439175;C0439810,false;false,5950/20013
< nmbr . nmbr %,,,5951/20013
cana nmbrmg ( n = nmbr ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,5952/20013
mae,C0286540;C4085238,true;false,5953/20013
nmbr % - nmbr %,,,5954/20013
^nmbr - nmbr,,,5955/20013
on omt,,,5956/20013
race — no . ( % ),C0034510;C1706779;C3853635,true;false;false,5957/20013
age : < nmbr years,C1510829,false,5958/20013
hdl - cy,C3715113;C0010622;C0332298;C2239193,false;true;false;false,5959/20013
≥ nmbr %,,,5960/20013
cardiac,C0018787;C1522601,true;false,5961/20013
feno nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5962/20013
pa,C0030428;C3541314,true;false,5963/20013
hr ( nmbr % ci ),C0008107;C3259781,true;false,5964/20013
nsaid,C0003211;C3536840,true;false,5965/20013
pe,C0070939;C1880476;C4284304,true;false;false,5966/20013
white ( n = nmbr ),C0007457;C0043157;C0220938,true;true;false,5967/20013
placebo n ( % ),C0032042;C1696465;C1706408,true;false;false,5968/20013
egfr > nmbr,C1739039;C3811844;C3812682,true;false;false,5969/20013
other *,,,5970/20013
> nmbr . nmbr yrs,,,5971/20013
past,C1444637;C4284302,false;false,5972/20013
< nmbr mm hg,C0439475,false,5973/20013
> nmbr % to < nmbr %,C0040363;C0041260;C1883351,true;true;false,5974/20013
known chd,C0205309;C0280604;C3542407,false;false;false,5975/20013
nnt,C1417750,false,5976/20013
all ( n = nmbrf ),C0369718;C0016327;C0441922,false;true;false,5977/20013
tia,C0007787;C0917805;C1054154,true;true;false,5978/20013
nmbr / nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,5979/20013
mmse < nmbr,C0451306,true,5980/20013
> nmbr - nmbr kg,C0022718;C0439209;C4054209,true;false;false,5981/20013
< nmbr . nmbr bpm,,,5982/20013
placebo ( n z nmbr ),C0032042;C1696465;C1706408,true;false;false,5983/20013
locf ),C2825507,false,5984/20013
< nmbr days,C0439228,false,5985/20013
erosion,C0333307;C1880549;C1959609;C3887524,false;false;false;false,5986/20013
smokers,C0337664,true,5987/20013
iiiv,,,5988/20013
( i - blocker,C0021966;C0221138,true;false,5989/20013
dasnmbr,C0051767;C0057671,true;true,5990/20013
all ( n = nmbr ),C0369718;C0441922,false;false,5991/20013
no htn,C0020538,true,5992/20013
race ( % ),C0034510;C1706779;C3853635,true;false;false,5993/20013
vitality,C0424589,false,5994/20013
us,,,5995/20013
pain,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,5996/20013
age — y £,C0001779,false,5997/20013
< nmbr week,C0332174;C0439230,false;false,5998/20013
open,C0175566,false,5999/20013
> nmbr y,,,6000/20013
avm ( n = nmbr ),C0003857;C0279476,true;false,6001/20013
mild,C2945599,false,6002/20013
ami nmbr mg,C4319936;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,6003/20013
nmbr mg / day,C0439422,false,6004/20013
ever - smoker,C3887636;C0337664,false;true,6005/20013
no . ( % ),,,6006/20013
lateral,C0205093,false,6007/20013
region — no . ( % ),C0017446;C0205147,true;false,6008/20013
age ^nmbr,C0001779,false,6009/20013
pvd,C0085096;C4521226,true;false,6010/20013
> nmbr mm hg,C0439475,false,6011/20013
romania,C0035826,true,6012/20013
nmbr < - nmbr,,,6013/20013
< nmbr mg / dl,C0439269,false,6014/20013
n / n ( % ),C0369718;C0441922,false;false,6015/20013
> = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6016/20013
> nmbr ( n = nmbr ),C0369718;C0441922,false;false,6017/20013
nmbr — nmbr years,C0439234,false,6018/20013
> nmbr % and < nmbr %,,,6019/20013
cancer,C0006826;C0998265;C1306459,true;false;false,6020/20013
macce,,,6021/20013
£ nmbr to < nmbr years,C0439234,false,6022/20013
or nmbr % ci,,,6023/20013
> i,C0021966;C0221138,true;false,6024/20013
any use,C0042153;C0457083;C1947944,true;false;false,6025/20013
never,C2003901,false,6026/20013
p - blocker,C0369773;C2603361,false;false,6027/20013
age > nmbr,C0001779,false,6028/20013
period i,C0439531;C0021966;C0221138;C1948053,false;true;false;false,6029/20013
nmbr to < nmbr hr,,,6030/20013
swollen,C0038999,false,6031/20013
rrr ( nmbr % cl ),C0596019,false,6032/20013
≤ nmbr . nmbr %,,,6033/20013
nmbr % ci,C0008107;C3259781,true;false,6034/20013
second ( n = nmbr ),C0205436;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false,6035/20013
chd death,C0280604;C0011065;C1306577;C4082313;C4552775;C3542407,false;true;false;false;false;false,6036/20013
pbo ( n = nmbr ),C0031962,true,6037/20013
mean — kg,C0444504;C0022718;C0439209;C4054209;C2347634;C2348143,false;true;false;false;false;false,6038/20013
ab nmbr pg ( n = nmbr ),C0030827;C0072225;C1266240,true;true;false,6039/20013
p +,C0369773;C2603361,false;false,6040/20013
yes *,C1549445;C1705108;C1710701,false;false;false,6041/20013
ageadj,,,6042/20013
aqc < nmbr,,,6043/20013
rr^ ( nmbr % ci ),C4554402;C0008107;C3259781,false;true;false,6044/20013
nmbr mmhg,C0439475,false,6045/20013
nmbr - nmbr mo,C0026544;C0332177,true;false,6046/20013
> nmbr mg / dl,C0439269,false,6047/20013
statin usage,C0360714;C0457083,true;false,6048/20013
age nmbr y,C0001779,false,6049/20013
race — no . ( % ) 卞,C0034510;C1706779;C3853635,true;false;false,6050/20013
> nmbr / day,C0332173;C0439228;C0439505,false;false;false,6051/20013
des,C0011702;C4551552,true;true,6052/20013
< median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6053/20013
nmbr - < nmbr yrs,,,6054/20013
taiwan,C0039260,true,6055/20013
nmbr - nmbr yrs,,,6056/20013
some,,,6057/20013
≥ nmbr years,C0439234,false,6058/20013
> nmbr to < nmbr years,C0439234,false,6059/20013
cabg — no . ( % ),C0010055,true,6060/20013
women - no . ( % ),C0043210,true,6061/20013
paci,C1165245,false,6062/20013
anmbrc,,,6063/20013
age :,C0001779,false,6064/20013
vldl,C0523560,false,6065/20013
nmbr - nmbr hr,,,6066/20013
mi,C3810814,false,6067/20013
ls mean,C0023668;C0444504;C2347634;C2348143,true;false;false;false,6068/20013
n *,C0369718;C0441922,false;false,6069/20013
ldl,,,6070/20013
risk *,C0035647;C4552904,true;false,6071/20013
present,C0150312;C0449450,false;false,6072/20013
bid,,,6073/20013
pci,C4049621,false,6074/20013
monthnmbr,C0332177;C0439231,false;false,6075/20013
primary,C0205225;C0439612;C0439631,false;false;false,6076/20013
placebo ( n = nmbro ),C0032042;C1696465;C1706408,true;false;false,6077/20013
< nmbr years,C0439234,false,6078/20013
niacini,,,6079/20013
dm,C0011816;C3250443,true;false,6080/20013
nmbr to < nmbr yr,C0439234,false,6081/20013
edge,C0205154;C2697523,false;false,6082/20013
spoke,,,6083/20013
bmi < = nmbr,C0578022,false,6084/20013
epa ( n = nmbr ),,,6085/20013
mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,6086/20013
cdmard,,,6087/20013
sd,C2699239,false,6088/20013
nmbr mo to nmbr yr,C0026544;C0439234;C0332177,true;false;false,6089/20013
pfor,C1151635,false,6090/20013
nmbr - < nmbr %,,,6091/20013
alert,C0239110;C2004580;C3665546;C3669039;C4084853;C4553014,false;false;false;false;false;false,6092/20013
$ nmbr,,,6093/20013
apo - b,C0003593;C3252643,true;true,6094/20013
cohort,C0009247;C0599755,true;false,6095/20013
ali,,,6096/20013
ace,C1452534;C4284014,true;false,6097/20013
woman,C0043210;C4281745,true;false,6098/20013
apob,C0003593;C3252643,true;true,6099/20013
nmbr to < nmbr mm hg,C0439475,false,6100/20013
£ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6101/20013
ckd,C1561643,true,6102/20013
or ( nmbr % cl ),,,6103/20013
af alone,C0344434;C4049859,false;false,6104/20013
nsclc,C0007131,true,6105/20013
other ( n,C0369718;C0441922,false;false,6106/20013
monthly,C0332177,false,6107/20013
beta - blockers,C0001645,true,6108/20013
australasia,C0282279;C1257882,true;true,6109/20013
fp nmbr mg,C0016704;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1419068;C1419906;C3541238;C3541412,true;true;true;false;false;false;false;false;false;false;false;false,6110/20013
mean ( se ),C0444504;C0036919;C2347634;C2348143,false;true;false;false,6111/20013
iii - iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6112/20013
nmbr or nmbr,,,6113/20013
or [nmbr % ci],,,6114/20013
itt,,,6115/20013
id ( n = nmbr ),C0009450;C0600091;C1441613,true;false;false,6116/20013
state,C1301808;C1442792;C3148680,false;false;false,6117/20013
anmbr,,,6118/20013
hub,C0063034;C1414372;C1708389,true;false;false,6119/20013
> nmbr hr,,,6120/20013
lsm ( nmbr % cl ),C0596019,false,6121/20013
no . ( % ) *,,,6122/20013
≥ nmbr to < nmbr years,C0439234,false,6123/20013
wssng,,,6124/20013
f,C0016327,true,6125/20013
fp ( n [nmbr ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,6126/20013
» nmbr yr,C0439234,false,6127/20013
mean — yr,C0444504;C0439234;C2347634;C2348143,false;false;false;false,6128/20013
prior dm,C0332152;C0011816;C3250443;C2826257,false;true;false;false,6129/20013
pre - h,C0332152;C0033727;C0369286;C0441932;C0564385;C4528284;C0740175;C2257086;C3669034,false;true;false;false;false;false;false;false;false,6130/20013
acid,C0001128;C0202406,true;false,6131/20013
hctz,C0020261,true,6132/20013
rnmbr,C0205090;C0684010;C2603358,false;true;false,6133/20013
korean,C1556095,true,6134/20013
placebo %,C0032042;C1696465;C1706408,true;false;false,6135/20013
. nmbr,,,6136/20013
age < median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,6137/20013
nste - acs,C0742343;C4318612,true;false,6138/20013
age £ nmbr,C0001779,false,6139/20013
w,,,6140/20013
p - value *,C1709380,false,6141/20013
stent ( n = nmbr ),C0038257,true,6142/20013
> nmbrh,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6143/20013
value *,C1522609,false,6144/20013
sso - nmbr,,,6145/20013
id,C0009450;C0600091;C1441613,true;false;false,6146/20013
iorii ( n z nmbr ),,,6147/20013
belgium,C0004950,true,6148/20013
hbalca median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6149/20013
use,C0042153;C0457083;C1947944,true;false;false,6150/20013
male sex ( % ),C0086582,true,6151/20013
> nmbr yrs sex :,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6152/20013
female ( n z nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6153/20013
pci ( % ),C4049621,false,6154/20013
or ( nmbr % ci ),,,6155/20013
( e - blocker,,,6156/20013
nsteacs,,,6157/20013
other ',,,6158/20013
bmi^,C0578022,false,6159/20013
smoking,C0037369;C0453996;C1881674,true;true;false,6160/20013
race n ( % ),C0034510;C1706779;C3853635,true;false;false,6161/20013
risk,C0035647;C4552904,true;false,6162/20013
homa,,,6163/20013
africa *,C0001737,true,6164/20013
sex ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6165/20013
jvp,,,6166/20013
rnmbr ( n = nmbr ),C0687673,true,6167/20013
py = nmbr ),C0030428;C3538810,true;false,6168/20013
a - blocker,,,6169/20013
p blocker,C0369773;C2603361,false;false,6170/20013
r nmbr mg,C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,6171/20013
> nmbr to < nmbr,C0040363;C0041260;C1883351,true;true;false,6172/20013
tion — no . ( % ),,,6173/20013
p trend,C0369773;C1521798;C4554533;C2603361,false;false;false;false,6174/20013
ada,C1060325;C3811629,false;false,6175/20013
macce ( % ),,,6176/20013
nonwhite,,,6177/20013
pt,C0032743;C0699718,true;false,6178/20013
apo b *,C0003593;C3252643,true;true,6179/20013
% ( nmbr % ci ),C0008107;C3259781,true;false,6180/20013
^ - blocker,,,6181/20013
no betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6182/20013
> nmbr type,C0332307;C1547052,false;false,6183/20013
us ( n = nmbr ),C0369718;C0441922,false;false,6184/20013
tzd,,,6185/20013
nmbr - < nmbr,,,6186/20013
peace ( n = nmbr ),C0680443,false,6187/20013
< nmbr lb,,,6188/20013
< nmbr mg / g,C1300563,false,6189/20013
non - mtx,C1518422;C0025677;C1417487,false;true;false,6190/20013
py *,C0030428;C3538810,true;false,6191/20013
feno,,,6192/20013
mental,C0229992,false,6193/20013
> nmbr ft,C1881534;C3890579,false;false,6194/20013
mssbp,,,6195/20013
uac =,,,6196/20013
acei,,,6197/20013
usa,C0041703,true,6198/20013
class > nmbr,C0456387;C1518526;C1705943,false;false;false,6199/20013
europe ii,C0015176;C1710602;C4082587,true;false;false,6200/20013
/ ’ - value  ,C1522609,false,6201/20013
sabaa,,,6202/20013
prior mi,C0332152;C3810814;C2826257,false;false;false,6203/20013
no statin,C0360714,true,6204/20013
age > = nmbr,C0001779,false,6205/20013
nmbr §,,,6206/20013
alone,C0205171;C0439044;C0679994,false;false;false,6207/20013
r,C0205090;C0684010;C2603358,false;true;false,6208/20013
ultra,C0728475,false,6209/20013
paci ( n = nmbr ),C1165245,false,6210/20013
age < nmbr,C0001779,false,6211/20013
stage nmbr,C0205390;C1300072;C1306673,false;false;false,6212/20013
laba alone,,,6213/20013
eze nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6214/20013
no prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,6215/20013
nmbr ( < nmbr % ),,,6216/20013
nnmbr yrs,C0369718;C0441922,false;false,6217/20013
male ( n = nmbr ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6218/20013
psa,C3810537;C3813209,false;false,6219/20013
region - no . ( % ),C0017446;C0205147,true;false,6220/20013
placebo ( n = nmbrl ),C0032042;C1696465;C1706408,true;false;false,6221/20013
otherz,,,6222/20013
nmbr years,C0439234,false,6223/20013
nmbr yr,C0439234,false,6224/20013
asp,C0206293;C0206298;C1332656;C1528298;C3541260;C3890396;C4048238;C4321307;C4553371,false;true;false;true;false;false;false;false;false,6225/20013
aqe < nmbr,,,6226/20013
n = nmbr,C0369718;C0441922,false;false,6227/20013
fh ii,C1854107,true,6228/20013
overallb,,,6229/20013
nitrate,C0028125;C0699857;C3848573,true;false;false,6230/20013
black,C0005680;C0027567;C0085756;C0439541,true;true;true;false,6231/20013
new dm,C0205314;C0011816;C3250443,false;true;false,6232/20013
< nmbr mon ( n = nmbr ),,,6233/20013
lower,C0441994;C1548802;C2003888,false;false;false,6234/20013
dvt,C0149871;C2926618;C3899446,true;false;false,6235/20013
m,C0369637;C0441923,false;false,6236/20013
nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6237/20013
< nmbr y ( n = nmbr ),,,6238/20013
placebo r %,C0032042;C0205090;C0684010;C2603358;C1696465;C1706408,true;false;true;false;false;false,6239/20013
mg / dl,C0439269,false,6240/20013
ml c,C0439526;C1705224;C3887665,false;false;false,6241/20013
tg +,C0337445,false,6242/20013
sotalol,C0037707,true,6243/20013
cdai < nmbrt,C0683448;C1413248;C3273706,false;false;false,6244/20013
nmbr ( nmbr % ),,,6245/20013
mmse > nmbr,C0451306,true,6246/20013
tg §,C0337445,false,6247/20013
v ( n = nmbr ),,,6248/20013
= nmbr,,,6249/20013
fa nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6250/20013
none,,,6251/20013
no smoking,C0037369;C0453996;C1881674,true;true;false,6252/20013
usa ( n = nmbr ),C0041703,true,6253/20013
rate *,C0871208;C1521828,false;false,6254/20013
male ( n - nmbr ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6255/20013
austria,C0004348,true,6256/20013
$ nmbr years,C0439234,false,6257/20013
fh nmbr,,,6258/20013
no ?,,,6259/20013
dd ( n = nmbr ),C3538867;C3814791,false;false,6260/20013
lu / kg,C0024171;C0022718;C0439209;C4054209;C0024176;C2697939,true;true;false;false;true;false,6261/20013
no ststm,,,6262/20013
st -,C0036056;C3272372,true;false,6263/20013
p - valuea,C0369773;C2603361,false;false,6264/20013
yes ( n = nmbr ),C1549445;C1705108;C1710701,false;false;false,6265/20013
abi < nmbr . nmbr,C1328319;C3888326,true;false,6266/20013
iv,C0022326;C4265176,true;false,6267/20013
sama,C1075468,false,6268/20013
latvia,C0023128,true,6269/20013
mra,C0243032;C1609165;C3891069,true;true;false,6270/20013
asian *,C0078988,true,6271/20013
bm i < nmbr,C0006416;C0021966;C0221138,true;true;false,6272/20013
age > nmbr yrs,C0001779,false,6273/20013
chf ( % ),C0018802,true,6274/20013
ef,,,6275/20013
vi nmbr mg ( n = nmbr ),C0205999;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,6276/20013
< nmbr % ( n = nmbr ),C0369718;C0441922,false;false,6277/20013
hbaic ( % ),,,6278/20013
tjc,,,6279/20013
> nmbr ml,C0439526;C1705224;C3887665,false;false;false,6280/20013
nmbr to < nmbr,C0040363;C0041260;C1883351,true;true;false,6281/20013
obese,C0028754,true,6282/20013
gold,C0018026;C1304897,true;false,6283/20013
age $ nmbr yrs,C0001779,false,6284/20013
placebo ( % ),C0032042;C1696465;C1706408,true;false;false,6285/20013
rr ( nmbr % cl ),C4554402;C0596019,false;false,6286/20013
« nmbr - nmbr,,,6287/20013
whitea,C1021495,false,6288/20013
age > : nmbr,C0001779,false,6289/20013
median ( iqr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6290/20013
sjc,,,6291/20013
< nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6292/20013
nmbr - nmbr yr,C0439234,false,6293/20013
< nmbr %,,,6294/20013
chadsnmbr^,C0007928;C1413373,true;false,6295/20013
p blockers,C0369773;C2603361,false;false,6296/20013
£ nmbr years,C0439234,false,6297/20013
> nmbr / week,C0332174;C0439230,false;false,6298/20013
nmbr - < nmbr y,,,6299/20013
non - c,C1518422,false,6300/20013
group a,C0441835;C4522145,false;false,6301/20013
< nmbr - nmbr,,,6302/20013
ldu - c,,,6303/20013
$ nmbr ( n = nmbr ),C0369718;C0441922,false;false,6304/20013
≥ nmbr mg / dl,C0439269,false,6305/20013
> nmbr % ( n = nmbr ),C0369718;C0441922,false;false,6306/20013
nyha ii,C1275491;C1710602;C4082587,false;false;false,6307/20013
nmbr . nmbr,,,6308/20013
£ nmbr yo ( n = nmbr ),C1413296,false,6309/20013
ni,C0028075;C2348274;C3869926;C3869927,true;false;false;false,6310/20013
noneh,,,6311/20013
» nmbry,,,6312/20013
saba §,,,6313/20013
nitrates,C0028125;C0699857;C3848573,true;false;false,6314/20013
sita nmbr,,,6315/20013
anmbr + eznmbr,C0206578,true,6316/20013
laaca,,,6317/20013
> nmbr mmhg,C0439475,false,6318/20013
age > nmbr yr,C0001779;C0439234,false;false,6319/20013
stemi ( % ),C1536220;C3538872,true;false,6320/20013
cabg ( % ),C0010055,true,6321/20013
european,C0239307;C1535514,false;false,6322/20013
pvalue,,,6323/20013
lll - iv,C1261077;C0022326;C4265176,false;true;false,6324/20013
bmi > = nmbr,C0578022,false,6325/20013
onmbr,C0483204,false,6326/20013
fp ( n = nmbr ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,6327/20013
crt - d,,,6328/20013
severity,C0439793;C0522510,false;false,6329/20013
normal,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,6330/20013
patients ( n ),C0030705,true,6331/20013
sdai < nmbr t,C3871128,false,6332/20013
no *,,,6333/20013
age years,C1510829,false,6334/20013
row,C1552840;C1552846,false;false,6335/20013
beta blockers,C0001645,true,6336/20013
lvmi ( nmbr,,,6337/20013
care,C1947933,false,6338/20013
egfr -,C1739039;C3811844;C3812682,true;false;false,6339/20013
prior om,C0332152;C0028971;C1705272;C2826257,false;true;false;false,6340/20013
n %,C0369718;C0441922,false;false,6341/20013
early ( n = nmbr ),C1279919,false,6342/20013
nmbr to < nmbr cells,C0007584;C0007634,true;true,6343/20013
mm hg,C0439475,false,6344/20013
any death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6345/20013
> nmbr < nmbr,,,6346/20013
cl nmbr %,C0596019,false,6347/20013
poci ( n = nmbr ),,,6348/20013
pbo n ( % ),C0031962,true,6349/20013
$ nmbr years ( n = nmbr ),C0439234,false,6350/20013
all patients,C0030705,true,6351/20013
laba ',,,6352/20013
< nmbr ( n = nmbr ),C0369718;C0441922,false;false,6353/20013
level nmbr,C0441889;C0456079;C1547707;C2946261,false;false;false;false,6354/20013
< nmbr mmhg,C0439475,false,6355/20013
no psa,C3810537;C3813209,false;false,6356/20013
nmbrenmbr,,,6357/20013
placebo [n z nmbr],C0032042;C1696465;C1706408,true;false;false,6358/20013
ls mean ( se ),C0023668;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,6359/20013
prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6360/20013
betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6361/20013
aml nmbr /,C0023465;C0023467,true;true,6362/20013
\nmbr,,,6363/20013
homa > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6364/20013
p - blocker yes,C0369773;C1549445;C1705108;C1710701;C2603361,false;false;false;false;false,6365/20013
> = nmbr mmhg,C0439475,false,6366/20013
no dm ( n = nmbr ),C0011816;C3250443,true;false,6367/20013
otherx,,,6368/20013
age — yrf,C0001779,false,6369/20013
fragile,C0302113,false,6370/20013
no beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6371/20013
n o,C0369718;C0441922,false;false,6372/20013
asa > nmbr mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3853627,true;true;true;false;false;false;false;false;false,6373/20013
india,C0021201;C2700456,true;false,6374/20013
gold nmbr,C0018026;C1304897,true;false,6375/20013
csf,C3540512;C3889436,false;false,6376/20013
nmbr mo,C0026544;C0332177,true;false,6377/20013
sites,C0205145,false,6378/20013
aspirin ( n = nmbr ),C0004057,true,6379/20013
< nmbr days ( n = nmbr ),C0439228,false,6380/20013
first ( n = nmbr ),C0205435;C1279901,false;false,6381/20013
sesbp,,,6382/20013
( se]t *,C0036919,true,6383/20013
value,C1522609,false,6384/20013
ics usage,C0815320;C0457083;C4551720,false;false;true,6385/20013
> nmbr to < nmbr yr,C0439234,false,6386/20013
< nmbr beds,C0004916,true,6387/20013
ptca,C2936173,true,6388/20013
≥ nmbr bpm ( n = nmbr ),,,6389/20013
no beta - blocker,C0001645,true,6390/20013
age < nmbr y,C0001779,false,6391/20013
fa nmbr mg ( « = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6392/20013
p value 十,C1709380,false,6393/20013
spinal,C0521329,false,6394/20013
arr,C2170357;C4084934,false;false,6395/20013
acm,C0001143;C1549040,true;false,6396/20013
age > nmbr yrs *,C0001779,false,6397/20013
orc ( nmbr % cl ),C1167125;C0596019,false;false,6398/20013
saba,,,6399/20013
in - h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6400/20013
males,C0086582,true,6401/20013
brachial,C0445456,false,6402/20013
month nmbr,C0332177;C0439231,false;false,6403/20013
nmbryr,C0439234,false,6404/20013
age ( yr ),C0001779;C0439234,false;false,6405/20013
italy ( n = nmbr ),C0022277,true,6406/20013
nmbr - nmbr,,,6407/20013
hiv,C0019682;C0019699,true;true,6408/20013
ale < nmbr,C0678386;C2632076,false;false,6409/20013
chd *,C0280604;C3542407,false;false,6410/20013
iglar,,,6411/20013
arbs,C3888198,false,6412/20013
age in years,C1510829,false,6413/20013
l / ll,C0439394;C1706495;C3642217,false;false;false,6414/20013
> nmbr yrs,,,6415/20013
tg ’,C0337445,false,6416/20013
age < nmbryrs,C0001779,false,6417/20013
ff nmbr pg ( n = nmbr ),C4554348;C0030827;C0072225;C1266240,false;true;true;false,6418/20013
pad,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,6419/20013
arr ( nmbr % cl ),C2170357;C0596019;C4084934,false;false;false,6420/20013
st,C0036056;C3272372,true;false,6421/20013
hctz *,C0020261,true,6422/20013
> nmbr . nmbr mm hg,C0439475,false,6423/20013
placebo ( n - nmbr ),C0032042;C1696465;C1706408,true;false;false,6424/20013
gold ii,C0018026;C1710602;C4082587;C1304897,true;false;false;false,6425/20013
lama,C0999593;C1416775,false;false,6426/20013
chd,C0280604;C3542407,false;false,6427/20013
cv death n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,6428/20013
p - value,C1709380,false,6429/20013
edge ii,C0205154;C1710602;C4082587;C2697523,false;false;false;false,6430/20013
nmbr kg,C0022718;C0439209;C4054209,true;false;false,6431/20013
both ( % ),,,6432/20013
ml,C0439526;C1705224;C3887665,false;false;false,6433/20013
cana nmbr mg ( n = nmbr ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,6434/20013
cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,6435/20013
all,,,6436/20013
sa,C0036243;C0038702;C1539696;C1825840;C3539736;C4521691,true;true;false;false;false;false,6437/20013
racea,,,6438/20013
others,C1955473;C3539125,false;false,6439/20013
reqion,,,6440/20013
m / f,C1306057,false,6441/20013
cat > nmbr,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,6442/20013
atv n ( % ),C0210243;C0674679;C1145759;C1334862,true;true;true;false,6443/20013
< nmbry,,,6444/20013
> nmbr days,C0439228,false,6445/20013
ebria,C1917247,false,6446/20013
no pa,C0030428;C3541314,true;false,6447/20013
poland,C0032356,true,6448/20013
prior pci,C0332152;C4049621;C2826257,false;false;false,6449/20013
b - blocker,,,6450/20013
( n = nmbr,C0369718;C0441922,false;false,6451/20013
abi # nmbr . nmbr,C1328319;C3888326,true;false,6452/20013
oradj ( nmbr % cl ),C0596019,false,6453/20013
labaa,,,6454/20013
hr nmbr % ci,C0008107;C3259781,true;false,6455/20013
minor,C0026193;C0205165,true;false,6456/20013
ufh,,,6457/20013
dm ( n = nmbr ),C0011816;C3250443,true;false,6458/20013
copd,C0024117;C1412502;C3714496,true;false;false,6459/20013
v total ( n = nmbr ),C0439175;C0439810,false;false,6460/20013
other !,,,6461/20013
hba < median,C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,6462/20013
event ( % ),C0441471;C4019010,false;false,6463/20013
general,C0205246;C3812897;C3891294;C4521767,false;false;false;false,6464/20013
≤ nmbr ug / g,C0439272,false,6465/20013
rr ( nmbr % ci ) *,C4554402;C0008107;C3259781,false;true;false,6466/20013
yes ( % ),C1549445;C1705108;C1710701,false;false;false,6467/20013
post - mi,C0856742,false,6468/20013
laba,,,6469/20013
sdai,C3871128,false,6470/20013
> nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6471/20013
p value,C1709380,false,6472/20013
stemi,C1536220;C3538872,true;false,6473/20013
< nmbr ( n z nmbr ),C0369718;C0441922,false;false,6474/20013
area,C0017446;C0205146,true;false,6475/20013
male sex — no . ( % ),C0086582,true,6476/20013
teaes,,,6477/20013
sex — no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6478/20013
male ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6479/20013
cvd death,C0007222;C0011065;C1306577;C4082313;C4552775,true;true;false;false;false,6480/20013
chinese,C0008120;C0152035,false;true,6481/20013
nstemi,C3537184;C4255010,false;true,6482/20013
qmi,,,6483/20013
nmbr - nmbrh,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6484/20013
> nmbr mm ( n = nmbr ),C4330985;C4554674,false;false,6485/20013
all n = nmbr,C0369718;C0441922,false;false,6486/20013
abi,C1328319;C3888326,true;false,6487/20013
any statin,C0360714,true,6488/20013
tg > nmbr . nmbr,C0337445,false,6489/20013
nmbry,,,6490/20013
race — no . ( % ) : c,C0034510;C1706779;C3853635,true;false;false,6491/20013
e,,,6492/20013
ns,C0038944;C1112705;C1705982,true;false;false,6493/20013
oretal,,,6494/20013
no smo king,C1311076;C1364142;C1423784,true;false;false,6495/20013
p value c,C1709380,false,6496/20013
mets,C0812270;C1705694;C2939420,false;false;false,6497/20013
pbo ( n = nmbr ) vs,C0031962,true,6498/20013
race — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,6499/20013
lipid,C0023779,true,6500/20013
nmbrmg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6501/20013
placebo [n = nmbr],C0032042;C1696465;C1706408,true;false;false,6502/20013
< nmbr mo,C0026544;C0332177,true;false,6503/20013
$ nmbr %,,,6504/20013
> = nmbr . nmbr,,,6505/20013
< nmbr min,C0702093;C1524029;C3813700,false;false;false,6506/20013
no .,,,6507/20013
hbaic — %,,,6508/20013
n .,C0369718;C0441922,false;false,6509/20013
russia,C0035970,true,6510/20013
race *,C0034510;C1706779;C3853635,true;false;false,6511/20013
< nmbr hrs,C1568891,true,6512/20013
hps,C0242994,true,6513/20013
patients ( ft ),C0030705,true,6514/20013
prior stent,C0332152;C0038257;C2826257,false;true;false,6515/20013
nmbr — < nmbr,,,6516/20013
all ( n = nmbr * ),C0369718;C0441922,false;false,6517/20013
asa < nmbr mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3853627,true;true;true;false;false;false;false;false;false,6518/20013
< nmbr year,C0439234;C0439508,false;false,6519/20013
stage nmbrb,C0441781,false,6520/20013
iv nitrates,C0022326;C4265176,true;false,6521/20013
pio nmbr,C0030800;C2347712,true;false,6522/20013
beta - blocker !,C0001645,true,6523/20013
femoral,C0015811,true,6524/20013
australia,C0004340,true,6525/20013
placeboa,,,6526/20013
pint,C0560012;C3811619;C3890014;C3890556,false;false;false;false,6527/20013
hdl,C3715113,false,6528/20013
> nmbr y ( n = nmbr ),,,6529/20013
phi ( n - nmbr ),C1333690;C1704947;C1706536;C2975867;C4084801,false;false;false;true;false,6530/20013
iii & iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6531/20013
aqe ^nmbr,,,6532/20013
region ( % ),C0017446;C0205147,true;false,6533/20013
nmbr to < nmbr kg,C0022718;C0439209;C4054209,true;false;false,6534/20013
< nmbr y,,,6535/20013
age # nmbr yrs,C0001779,false,6536/20013
placebo ( n nmbr ),C0032042;C1696465;C1706408,true;false;false,6537/20013
anemia ( % ),C0002871;C1000483;C4554633,true;false;false,6538/20013
pbo ( nnmbr ),C0031962,true,6539/20013
ckdc,,,6540/20013
provoked,C1444748,false,6541/20013
mtx ( n = nmbr ),C0025677;C1417487,true;false,6542/20013
> nmbr years,C0439234,false,6543/20013
upper,C1282910,false,6544/20013
mean a ± sdt,C0444504;C2347634;C2348143,false;false;false,6545/20013
no prior mi,C0332152;C3810814;C2826257,false;false;false,6546/20013
mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,6547/20013
female ( n — nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6548/20013
tics — no . ( % ),C0040188;C0278076;C2169806;C3889970,true;true;false;false,6549/20013
glipizide,C0017642,true,6550/20013
stage nmbra,C0205390;C1300072;C1306673,false;false;false,6551/20013
asian ( n = nmbr ),C0078988,true,6552/20013
ics alone,C0815320;C4551720,false;true,6553/20013
i / ii,C0021966;C1710602;C4082587;C0221138,true;false;false;false,6554/20013
%,,,6555/20013
lesions,C0221198,false,6556/20013
total c,C0439175;C0439810,false;false,6557/20013
> nmbr mon ( n = nmbr ),,,6558/20013
nstemi ( % ),C3537184;C4255010,false;true,6559/20013
ppci ( n = nmbr ),,,6560/20013
no ipst,,,6561/20013
( n = ms ),C0369718;C2349943;C3539704;C3713294;C0441922,false;false;false;true;false,6562/20013
uti,C0042029;C0077906;C1412376,true;true;false,6563/20013
obesityj,,,6564/20013
asia,C0003980,true,6565/20013
p [int],C0369773;C3272375;C2603361,false;false;false,6566/20013
rarely,C0522498,false,6567/20013
qd,C0332173,false,6568/20013
age ( year ),C0001779;C0439234;C0439508,false;false;false,6569/20013
> nmbr mm,C4330985;C4554674,false;false,6570/20013
≥ nmbr,,,6571/20013
nmbr min,C0702093;C1524029;C3813700,false;false;false,6572/20013
statins,C0360714,true,6573/20013
canvas,C3281223,false,6574/20013
niacin,C0027996;C1142562,true;false,6575/20013
study nmbr,C0557651;C2603343,false;false,6576/20013
graft,C0181074;C0332835;C1961139,false;true;false,6577/20013
c,,,6578/20013
ipst ( n = nmbr ),,,6579/20013
f * >,C0016327,true,6580/20013
high,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,6581/20013
ml ),C0439526;C1705224;C3887665,false;false;false,6582/20013
male sex 一 no . ( % ),C0086582,true,6583/20013
£ nmbr %,,,6584/20013
no po,C0032729;C0442027,true;false,6585/20013
y es,C0013754;C0205944,true;true,6586/20013
ff - blocker,C4554348,false,6587/20013
no prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6588/20013
< nmbr . nmbr years,C0439234,false,6589/20013
african,C0027567,true,6590/20013
fibrates,C1449704;C3540783,true;false,6591/20013
canada,C0006823,true,6592/20013
nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6593/20013
venous,C0042449;C0348013,true;false,6594/20013
nmbr - < nmbr ( % ),,,6595/20013
total n = nmbr,C0439175;C0439810,false;false,6596/20013
mate,C0682323;C1260875,false;false,6597/20013
i,C0021966;C0221138,true;false,6598/20013
met ( n = nmbr ),C0428210;C1550543;C4317104,false;false;false,6599/20013
nausea,C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767,true;false;false;false;false;false;false;false;false;false;false;false,6600/20013
other chd,C0280604;C3542407,false;false,6601/20013
lda,C4553195,false,6602/20013
ics : no,C0815320;C4551720,false;true,6603/20013
rrr,,,6604/20013
nmbr - nmbr days,C0439228,false,6605/20013
hr ( nmbr % cl ),C0596019,false,6606/20013
> nmbr and < nmbr %,,,6607/20013
male sex — no . ( % ) f,C0086582,true,6608/20013
n nmbr,C0369718;C0441922,false;false,6609/20013
ipst,,,6610/20013
age > = nmbr yrs,C0001779,false,6611/20013
m being,C0369637;C0441923,false;false,6612/20013
oral,C0442027;C4521986,false;false,6613/20013
> nmbr - < nmbr,,,6614/20013
tgt,C1421391;C1428265;C4321338,false;false;false,6615/20013
sfc ( n = nmbr ),C4521536,false,6616/20013
prior llt,C0332152;C2347090;C2826257,false;false;false,6617/20013
> = nmbr y,,,6618/20013
p - value  ,C1709380,false,6619/20013
non - white,C1518422;C0007457;C0043157;C0220938,false;true;true;false,6620/20013
ldl - c,,,6621/20013
( nmbr % ci]h,C0008107;C0033727;C0369286;C0441932;C0564385;C4528284;C3259781,true;true;false;false;false;false;false,6622/20013
gold b,C0018026;C1304897,true;false,6623/20013
never smoker,C0425293,false,6624/20013
≥ nmbr mg / g,C1300563,false,6625/20013
≥ nmbr ng / ml,C0439275,false,6626/20013
no psa ( n = nmbr ),C3810537;C3813209,false;false,6627/20013
nmbr - i,C0021966;C0221138,true;false,6628/20013
haq,C0102923;C0451208,true;false,6629/20013
urti,,,6630/20013
renal,C0022646,true,6631/20013
lama +,C0999593;C1416775,false;false,6632/20013
( sem ),,,6633/20013
primary *,C0205225;C0439612;C0439631,false;false;false,6634/20013
no mi,C3810814,false,6635/20013
age < nmbr yrs,C0001779,false,6636/20013
statini,,,6637/20013
n_,C0369718;C0441922,false;false,6638/20013
metsyn,,,6639/20013
< nmbr / < nmbr mm hg,C0439475,false,6640/20013
no use,C0042153;C0457083;C1947944,true;false;false,6641/20013
> nmbr . nmbr %,,,6642/20013
tvr,,,6643/20013
laa,,,6644/20013
om nmbr /,C0028971;C1705272,true;false,6645/20013
arm,C0446516;C3715044;C4553528,true;false;false,6646/20013
r nmbr mg ( « = nmbr ),C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,6647/20013
cancer §,C0006826;C0998265;C1306459,true;false;false,6648/20013
hbalc > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6649/20013
men ( n = nmbr ),C0025266,true,6650/20013
crcl < nmbr,C1846718,false,6651/20013
age — yr,C0001779;C0439234,false;false,6652/20013
gold c,C0018026;C1304897,true;false,6653/20013
mean = sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,6654/20013
avr,C0449217,false,6655/20013
epa,,,6656/20013
lnmbr,C0439394;C1706495;C3642217,false;false;false,6657/20013
treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,6658/20013
< nmbr yo ( n = nmbr ),C1413296,false,6659/20013
wegu,,,6660/20013
( se] +,C0036919,true,6661/20013
cards,C2930619;C3275277,true;false,6662/20013
nmbr mg / dl,C0439269,false,6663/20013
hdl *,C3715113,false,6664/20013
year nmbr,C0439234;C0439508,false;false,6665/20013
< nmbr yrs,,,6666/20013
( se]t,C0036919,true,6667/20013
no prior pci,C0332152;C4049621;C2826257,false;false;false,6668/20013
nmbr . nmbr %,,,6669/20013
diet ( n 二 nmbr ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,6670/20013
pnorpci,,,6671/20013
hr ( nmbr % cl ) *,C0596019,false,6672/20013
iu,C0049272;C0439453;C0694756,true;false;false,6673/20013
^median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6674/20013
> nmbr min,C0702093;C1524029;C3813700,false;false;false,6675/20013
nmbr to < nmbr mo,C0026544;C0332177,true;false,6676/20013
> = nmbr yea ' s,,,6677/20013
median — yr,C0549183;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,6678/20013
nnmbr,C0369718;C0441922,false;false,6679/20013
nmbr to < nmbr years,C0439234,false,6680/20013
no des,C0011702;C4551552,true;true,6681/20013
> nmbr mg / g,C1300563,false,6682/20013
hrqol,C4279947;C4300252,true;false,6683/20013
p values,C1709380,false,6684/20013
no acs,C0742343;C4318612,true;false,6685/20013
othernmbr,,,6686/20013
> nmbr to nmbr years,C0439234,false,6687/20013
cat < nmbr,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,6688/20013
age > nmbr yr 十,C0001779;C0439234,false;false,6689/20013
smoker,C0337664,true,6690/20013
oads,,,6691/20013
paod,,,6692/20013
nmbr or more,,,6693/20013
site,C0205145;C1515974;C2825164,false;false;false,6694/20013
> = nmbr years ( n = nmbr ),C0439234,false,6695/20013
ifg,C1334085;C1708411,false;false,6696/20013
cancer * *,C0006826;C0998265;C1306459,true;false;false,6697/20013
race — no . ( % ) ' (,C0034510;C1706779;C3853635,true;false;false,6698/20013
aged < nmbr years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,6699/20013
( ri = nmbr ),C0035487;C1826843,true;false,6700/20013
x / n *,,,6701/20013
s £ nmbr,C0565930;C2603362,false;false,6702/20013
aml,C0023465;C0023467,true;true,6703/20013
age ( years ) :,C1510829,false,6704/20013
htn hx,C0020538;C0262926;C3814444,true;false;false,6705/20013
lvef > nmbr %,C0428772;C0488728,false;false,6706/20013
non - dm,C1518422;C0011816;C3250443,false;true;false,6707/20013
group b,C4522078,false,6708/20013
total hip,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,6709/20013
obesity t,C0028754;C1963185,true;false,6710/20013
b,,,6711/20013
no,,,6712/20013
race - no . ( % ),C0034510;C1706779;C3853635,true;false;false,6713/20013
< nmbrh,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6714/20013
< nmbr . nmbr,,,6715/20013
r nmbr mg ( n = nmbr ),C0687673;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,6716/20013
ics # #,C0815320;C4551720,false;true,6717/20013
off pump,C1518543;C0182537,false;false,6718/20013
china,C0008115,true,6719/20013
abi > nmbr . nmbr,C1328319;C3888326,true;false,6720/20013
female ( n = nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6721/20013
adl,C0001288;C1420005,true;false,6722/20013
ii - iv,C1710602;C0022326;C4265176;C4082587,false;true;false;false,6723/20013
any,,,6724/20013
ff nmbr | ig ( n = nmbr ),C4554348;C0021027;C0305052;C0360506,false;true;false;false,6725/20013
nste - mi,C3537184;C4255010,false;true,6726/20013
n =,C0369718;C0441922,false;false,6727/20013
poba,,,6728/20013
no aspirin,C0004057,true,6729/20013
placebo nmbr,C0032042;C1696465;C1706408,true;false;false,6730/20013
no chd,C0280604;C3542407,false;false,6731/20013
sfc,C4521536,false,6732/20013
asthma,C0004096;C2984299,true;false,6733/20013
[nmbr % cl],C0596019,false,6734/20013
nmbr to < nmbr ( % ),C0040363;C0041260;C1883351,true;true;false,6735/20013
> = nmbr,,,6736/20013
ynmbr,,,6737/20013
age < nmbr years,C1510829,false,6738/20013
n / n,C0369718;C0441922,false;false,6739/20013
racenmbr,C0034510;C1706779;C3853635,true;false;false,6740/20013
placebo ( n[nmbr ),C0032042;C1696465;C1706408,true;false;false,6741/20013
vdhmtss,,,6742/20013
poci,,,6743/20013
> nmbr . nmbr min,C0702093;C1524029;C3813700,false;false;false,6744/20013
placebo ( n = nmbr * ),C0032042;C1696465;C1706408,true;false;false,6745/20013
aicd,C0972395;C2611803;C3537205;C3546309,false;false;false;false,6746/20013
hscrp §,,,6747/20013
major,C0205082;C0205164;C4318856;C4521762,false;false;false;false,6748/20013
prior,C0332152;C2826257,false;false,6749/20013
ccb,C0006684,true,6750/20013
male - no . ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6751/20013
b - blockers,,,6752/20013
placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,6753/20013
median — vr,C0549183;C3476815;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,6754/20013
ileum,C0020885,true,6755/20013
no ( n = nmbr ),C0369718;C0441922,false;false,6756/20013
> nmbr - nmbr,,,6757/20013
no statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,6758/20013
absent,C0332197;C4285062,false;false,6759/20013
age $ nmbr years § *,C1510829,false,6760/20013
laci,C1420705;C3273314;C4281721,false;false;false,6761/20013
< nmbr bpm ( n = nmbr ),,,6762/20013
% pred,C0032952;C0044955,true;true,6763/20013
prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,6764/20013
> nmbr yr,C0439234,false,6765/20013
on nmbr,,,6766/20013
> = nmbr kg,C0022718;C0439209;C4054209,true;false;false,6767/20013
on pump,C3842462,false,6768/20013
tnmbrdm,C2603360;C0011816;C3250443,false;true;false,6769/20013
mean,C0444504;C2347634;C2348143,false;false;false,6770/20013
hazard,C0598697,false,6771/20013
p valuey,C0369773;C2603361,false;false,6772/20013
cana nmbr mg,C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,6773/20013
( nmbr % ci ),C0008107;C3259781,true;false,6774/20013
age ( yij,C0001779,false,6775/20013
ssi - nmbr,,,6776/20013
« = nmbr,,,6777/20013
ucr,,,6778/20013
tender,C0234234,false,6779/20013
p *,C0369773;C2603361,false;false,6780/20013
iii ( n z nmbr ),C0439070;C1705160,false;false,6781/20013
cyclo,C1172566,true,6782/20013
hbalc < medan,,,6783/20013
non - hdl,C1518422;C3715113,false;false,6784/20013
sodium,C0037473;C0597484;C3541959;C3714642,true;false;false;false,6785/20013
£ nmbr,,,6786/20013
simva,,,6787/20013
laci ( n = nmbr ),C1420705;C3273314;C4281721,false;false;false,6788/20013
puva,C0853073;C1704892,false;false,6789/20013
icsa,,,6790/20013
ua,C0041580;C0042014,true;true,6791/20013
hr ( nmbr % ci ) “,C0008107;C3259781,true;false,6792/20013
asa,C0004057;C3853627,true;false,6793/20013
ng,C0017887;C0028074,true;true,6794/20013
patient,C0030705,true,6795/20013
rr,,,6796/20013
race ( % ) ) ',C0034510;C1706779;C3853635,true;false;false,6797/20013
> nmbr to nmbr,C0040363;C0041260;C1883351,true;true;false,6798/20013
ii,,,6799/20013
otherb,,,6800/20013
ldl - cz,C0206578,true,6801/20013
( a blocker,,,6802/20013
event,C0441471;C4019010,false;false,6803/20013
iii,C0439070;C1705160,false;false,6804/20013
^nmbr,,,6805/20013
ef < nmbr %,,,6806/20013
israel,C0022271,true,6807/20013
glinide,C2266929,false,6808/20013
brazil,C0006137,true,6809/20013
nmbr to < nmbrkg,C0022718;C0439209;C4054209,true;false;false,6810/20013
pasi^i,C4528685;C0021966;C0221138,false;true;false,6811/20013
indian,C1524069,false,6812/20013
europe i,C0015176;C0021966;C0221138,true;true;false,6813/20013
ifx ( n = nmbr ),C0020823,true,6814/20013
week nmbr,C0332174;C0439230,false;false,6815/20013
right,C0205090;C0444532,false;false,6816/20013
tg *,C0337445,false,6817/20013
samanmbr,C1075468,false,6818/20013
high *,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,6819/20013
hope ( n = nmbr ),C0392347,true,6820/20013
active ( n = nmbr ),C0205177;C3853793;C3888249,false;false;false,6821/20013
group c,C0441837,false,6822/20013
ex - smokers,C0337671;C4555205,false;true,6823/20013
with ( n = nmbr ),C0369718;C0441922,false;false,6824/20013
poor,C0032854;C0542537;C2700379,true;false;false,6825/20013
radial,C0442038;C0920847,false;false,6826/20013
nnmbr / nnmbr,C0369718;C0441922,false;false,6827/20013
ef > nmbr %,,,6828/20013
stalin,,,6829/20013
> = nmbr yr,C0439234,false,6830/20013
sfc ( n[nmbr ),C4521536,false,6831/20013
ra,C3538806;C4048756,false;false,6832/20013
sal nmbr pg ( n = nmbr ),C0036140;C0030827;C0072225;C1266240;C0037494;C0206136,true;true;true;false;true;true,6833/20013
pci — no . ( % ),C4049621,false,6834/20013
hrt,C0282402,true,6835/20013
fp ( n[nmbr ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,6836/20013
mtss,,,6837/20013
yes ',C1549445;C1705108;C1710701,false;false;false,6838/20013
ratio,C0456603;C1547037,false;false,6839/20013
sal ( n = nmbr ),C0036140;C0037494;C0206136,true;true;true,6840/20013
nyhaii,,,6841/20013
women — no . ( % ),C0043210,true,6842/20013
smoking status — no . ( % ),C1519386,false,6843/20013
systolic bp,C0871470,true,6844/20013
systolic bp ( mm hg ),C0871470;C0439475,true;false,6845/20013
diastolic ( mmhg ),C0012000;C0439475,true;false,6846/20013
systolic — mm hg,C0039155;C0439475,true;false,6847/20013
diastolic ( mm hg ),C0012000;C0439475,true;false,6848/20013
systolic bp ( mmhg ),C0871470;C0439475,true;false,6849/20013
systolic ( mm hg ),C0039155;C0439475,true;false,6850/20013
diastolic bp,C0428883,true,6851/20013
systolic ( mmhg ),C0039155;C0439475,true;false,6852/20013
diastolic bp ( mmhg ),C0428883;C0439475,true;false,6853/20013
diastolic — mm hg,C0012000;C0439475,true;false,6854/20013
diastolic bp ( mm hg ),C0428883;C0439475,true;false,6855/20013
dasnmbr - crp §,C0051767;C3890735;C4048285;C0057671,true;false;false;true,6856/20013
dasnmbr - hscrp,C0051767;C0057671,true;true,6857/20013
dasnmbr ( crp ),C0051767;C3890735;C4048285;C0057671,true;false;false;true,6858/20013
dasnmbr - crp,C0051767;C3890735;C4048285;C0057671,true;false;false;true,6859/20013
dasnmbr - esr,C0051767;C3811131;C0057671,true;false;true,6860/20013
unadjusted,C1439367,false,6861/20013
unadjusted hr,C1439367,false,6862/20013
unadjusted irr,C1439367;C4082285,false;true,6863/20013
adjusted,C0456081,false,6864/20013
unadjusted hr .,C1439367,false,6865/20013
apolipoprotein anmbr ( g / l ),C0003592;C0439294;C0456615;C0523508,true;false;false;false,6866/20013
apolipoprotein anmbr ( mg / dl ),C0003592;C0439269;C0523508,true;false;false,6867/20013
tg ( mmol / l ) c,C0337445;C1532563,false;false,6868/20013
na ( mmol / l ),C0597484;C1532563;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,6869/20013
k ( mmol / l ),C0597277;C1532563;C1708601,false;false;false,6870/20013
ldl ( mmol / l ),C1532563,false,6871/20013
bun,,,6872/20013
tc ( mmol / l ),C0039411;C1532563;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,6873/20013
tg ( mmol / l ),C0337445;C1532563,false;false,6874/20013
ffa ( mmol / l ),C0015688;C1532563,true;false,6875/20013
mdg ( mmol / l ),C0024443;C1532563;C1417239;C2986643,true;false;false;false,6876/20013
ppg,C1418888,false,6877/20013
hdl ( mmol / l ),C3715113;C1532563,false;false,6878/20013
dbp ( mmhg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,6879/20013
sbp ( mm hg ),C0085805;C0439475,true;false,6880/20013
sbp,C0085805,true,6881/20013
dbp ( mm hg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,6882/20013
map ( mmhg ),C0024779;C0439475;C1706473;C4050322,true;false;false;false,6883/20013
cvd subjects,C0007222,true,6884/20013
all subjects,,,6885/20013
mrf subjects,C0312443;C1412879,false;false,6886/20013
c - reactive protein ( mg / l ),C0006560;C0439268;C1413716;C4048285,true;false;false;false,6887/20013
c - reactive protein ( mg / dl ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,6888/20013
c - reactive protein ( mg / dl_ ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,6889/20013
body - mass index ( kg / mnmbr ) t,C0005893;C1532718;C0578022;C1305855,false;false;false;true,6890/20013
body mass index - kg / mnmbrt,C0005893;C1532718;C0578022;C1305855,false;false;false;true,6891/20013
body mass index ( kg / mnmbr ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,6892/20013
body mass index ( kg / nr ),C0005893;C0022718;C0027496;C3844738;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;false;true,6893/20013
bodymass index ( kg / mnmbr ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,6894/20013
body mass index ( kg / mnmbr ) * ',C0005893;C1532718;C0578022;C1305855,false;false;false;true,6895/20013
comorbidites,,,6896/20013
controls ( n = nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,6897/20013
control ( n z nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,6898/20013
control ( nznmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,6899/20013
control ( n = nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,6900/20013
control ( n - nmbr ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,6901/20013
african - american,C0085756,true,6902/20013
african american,C0085756,true,6903/20013
african americans,C0085756,true,6904/20013
african america,C0085756,true,6905/20013
history of hypertension ( n = nmbr ),C0455527,false,6906/20013
no history of hypertension ( n = nmbr ),C0455527,false,6907/20013
egfr ( ml / min ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,6908/20013
- ics / + laba n z nmbr,C0815320;C4551720,false;true,6909/20013
+ ics / + laba nz nmbr,C0815320;C0027978;C4551720,false;true;true,6910/20013
baseline mean ( se ),C0168634;C0444504;C0036919;C2347634;C2348143;C1442488,true;false;true;false;false;false,6911/20013
baseline ( mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,6912/20013
no current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,6913/20013
current smoker,C3173209;C3241966,false;false,6914/20013
current smokers,C3173209;C3241966,false;false,6915/20013
current smokers ( % ),C3173209;C3241966,false;false,6916/20013
current smoker ( % ),C3173209;C3241966,false;false,6917/20013
current non - smoker,C0425311,false,6918/20013
current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,6919/20013
current smokers *,C3173209;C3241966,false;false,6920/20013
current smoking *,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,6921/20013
current nonsmoker,C0521116;C0337672;C0425293;C4554605;C1705970,false;false;false;true;false,6922/20013
current smoker yes,C3173209;C1549445;C1705108;C1710701;C3241966,false;false;false;false;false,6923/20013
current nonsmokers,C0521116;C0337672;C4554605;C1705970,false;false;true;false,6924/20013
prior ptca or pci,C0332152;C2936173;C2826257,false;true;false,6925/20013
prior ptca / pci,C0332152;C2936173;C4049621;C2826257,false;true;false;false,6926/20013
interactior p - value,C1709380,false,6927/20013
interaction p - value,C1704675;C1709380,false;false,6928/20013
interaction p value 中,C1704675;C1709380,false;false,6929/20013
interaction p value §,C1704675;C1709380,false;false,6930/20013
interaction p value,C1704675;C1709380,false;false,6931/20013
duration of copd ( yr ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,6932/20013
duration of copd,C0449238;C0024117;C1412502;C3714496;C2926735,false;true;false;false;false,6933/20013
duration of copd — yr,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,6934/20013
duration of pd,C0449238;C4553228;C4553229;C2926735,false;false;false;false,6935/20013
multivariate p - value,C1709380,false,6936/20013
univariate p - value,C1709380,false,6937/20013
group b ( n = nmbr ),C0441848,false,6938/20013
group c ( n = nmbr ),C0441848,false,6939/20013
group a ( n = nmbr ),C0441848,false,6940/20013
rage ( ng / ml ),C0034634;C0439275;C3539760;C3815186,true;false;false;false,6941/20013
ltbr ( ng / ml ),C1416931;C0439275,false;false,6942/20013
pigr ( ng / ml ),C1418569;C0439275,false;false,6943/20013
vegfr ( ng / ml ),C1568520;C0439275,true;false,6944/20013
imt ( nmbr ),C0334121;C1704614;C4318736,true;false;false,6945/20013
imt ( mm ),C0334121;C4330985;C4554674;C1704614;C4318736,true;false;false;false;false,6946/20013
haq - di *,C3826998;C4321476,false;false,6947/20013
haq - di * *,C3826998;C4321476,false;false,6948/20013
non - fatal stroke,C1518422;C1302234;C0038454;C4554100;C1705232,false;false;true;false;false,6949/20013
nonfatal stroke,C0038454;C4554100,true;false,6950/20013
antiplatelet or anticoagulant,,,6951/20013
antiplatelets or anticoagulants,,,6952/20013
hypercholesterolemia — no . ( % ) *,C0020443;C1522133,true;false,6953/20013
hypercholesterolemia — no . ( % ),C0020443;C1522133,true;false,6954/20013
hypercholesterolemia 一 no . ( % ),C0020443;C1522133,true;false,6955/20013
pre - menopausal without hormone replacement,C0206158;C0282402,true;true,6956/20013
post - menopausal with hormone replacement,C0019930,true,6957/20013
pre - menopausal with hormone replacement,C0206158;C0282402,true;true,6958/20013
post - menopausal without hormone replacement,C0019930,true,6959/20013
bumetanide,C0006376,true,6960/20013
budesonide,C0054201,true,6961/20013
nmbr - hour madbp,C0439227;C0564385,false;false,6962/20013
nmbr - hour masbp,C0439227;C0564385,false;false,6963/20013
no prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,6964/20013
prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,6965/20013
no prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,6966/20013
nmbr to < nmbr ( n = nmbr ),C0369718;C0441922,false;false,6967/20013
$ nmbr to,C0040363;C0041260;C1883351,true;true;false,6968/20013
nmbr to < nmbr ( n z nmbr ),C0369718;C0441922,false;false,6969/20013
ace - i or arb,C1452534;C0021966;C0221138;C4284014,true;true;false;false,6970/20013
no ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,6971/20013
ace - lorarb,C1452534;C4284014,true;false,6972/20013
acei or arb,,,6973/20013
ace - l / arbs,C1452534;C3888198;C4284014,true;false;false,6974/20013
aceis / arbs,C3888198,false,6975/20013
acei / arb,C3888198,false,6976/20013
triglyceride a,C0041004,true,6977/20013
triglycerides *,C0041004,true,6978/20013
triglycerides * *,C0041004,true,6979/20013
triglyceride,C0041004,true,6980/20013
fluvastatin ( n = nmbr ),C0082608,true,6981/20013
simvastatin ( n = nmbr ),C0074554,true,6982/20013
rosuvastatin ( n = nmbr ),C0965129,true,6983/20013
diabetic yes,C0241863;C1549445;C1705108;C1710701,false;false;false;false,6984/20013
diabetes,C0011847;C0011849,false;true,6985/20013
antidiabetic,C0935929,true,6986/20013
diabetesnmbr,C0011847;C0011849,false;true,6987/20013
nondiabetic,,,6988/20013
prediabetes,C0362046,true,6989/20013
diabetic no,C0241863,false,6990/20013
non - diabetic,C1518422;C0241863,false;false,6991/20013
diabetes ( % ),C0011847;C0011849,false;true,6992/20013
diuretic use,C0012798;C0042153;C0457083;C1947944,true;true;false;false,6993/20013
diabeticnmbr,C0241863,false,6994/20013
diabetesf,,,6995/20013
prediabeticb,,,6996/20013
diureticff,,,6997/20013
n o diabetes,C0369718;C0011847;C0011849;C0441922,false;false;true;false,6998/20013
diabetes *,C0011847;C0011849,false;true,6999/20013
dabetes,,,7000/20013
non - diabetes,C1518422;C0011847;C0011849,false;false;true,7001/20013
non - diabetics,C1518422;C0241863,false;false,7002/20013
diabetics,C0241863,false,7003/20013
diuretic,C0012798,true,7004/20013
no diabetes,C0011847;C0011849,false;true,7005/20013
diurciic,,,7006/20013
diabetic,C0241863,false,7007/20013
diabeticb,,,7008/20013
stage nmbra : egfr > = nmbr and < nmbr ml / min per nmbr . nmbr mnmbr,C0205390;C1300072;C1306673,false;false;false,7009/20013
stage nmbrb : egfr > = nmbr and < nmbr ml / min per nmbr . nmbr mnmbr,C0441781;C1739039;C3811844;C3812682,false;true;false;false,7010/20013
pm pef ( sd ),C0030266;C0030771;C2699239;C1518922;C1542834;C4049155,true;true;false;false;false;false,7011/20013
am pef ( sd ),,,7012/20013
fevnmbr : fvc ratio,C3714541;C0456603;C1547037,true;false;false,7013/20013
fevnmbr : fvc ratio ,C3714541;C0456603;C1547037,true;false;false,7014/20013
fevnmbr / fvc ratio *,C3714541;C0456603;C1547037,true;false;false,7015/20013
egfr ( ml / min / nmbr . nmbrmnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7016/20013
egfr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7017/20013
egfr ( ml / min / nmbr . nmbr mnmbr ) §,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7018/20013
dyslipidaemiat,,,7019/20013
dyslipidaemia,C0242339,true,7020/20013
dyslipidaemia 本,C0242339,true,7021/20013
dyslipidemia,C0242339,true,7022/20013
nmbr st < nmbr . nmbr,C0036056;C3272372,true;false,7023/20013
nmbr / nmbr ( nmbr ),,,7024/20013
nmbr ( nmbr,,,7025/20013
nmbr ( nmbr . nmbr % ),,,7026/20013
nmbr ( nmbre < nmbr % ),,,7027/20013
> nmbr - nmbr - nmbr,,,7028/20013
nmbrrd > nmbr . nmbr,C0694666;C4553350,false;false,7029/20013
nmbr - nmbr . nmbr,,,7030/20013
nmbr ( nmbr . nmbr ),,,7031/20013
nmbr . nmbr % ( nmbr ),,,7032/20013
nmbr - < nmbr . nmbr,,,7033/20013
oral hypoglycemic,C0359086,false,7034/20013
oral hypoglycemics,C0359086,false,7035/20013
north america ( % ),C0028405,true,7036/20013
south america ( % ),C0037713,true,7037/20013
sitagliptin nmbr mg n = nmbr,C1565750;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7038/20013
sitagliptin nmbrmg n = nmbr,C1565750;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7039/20013
disease activity],C1292728,false,7040/20013
disease activity,C1292728,false,7041/20013
ease activity],C1331418;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false,7042/20013
class i,C0441885;C1319793;C2698967,false;false;false,7043/20013
class ia,C0456387;C0020980;C0694634;C1947960;C1518526;C1705943,false;true;false;false;false;false,7044/20013
class iii,C0441887;C2698969,false;false,7045/20013
class ii,C0441886;C2698968,false;false,7046/20013
class ib,C0456387;C2744579;C3890035;C4283819;C1518526;C1705943,false;true;false;false;false;false,7047/20013
class ic,C0456387;C0020750;C4554818;C1518526;C1705943,false;true;false;false;false,7048/20013
class iv,C0441888;C2698970,false;false,7049/20013
nt - probnp ( pg / ml ) h,C0669479;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C0754710,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;true,7050/20013
nt - probnp ( pg / ml ),C0669479;C0439297;C0754710,true;false;true,7051/20013
nt - probnp — pg / ml * *,C0669479;C0439297;C0754710,true;false;true,7052/20013
drug eluting stent,C1322815,true,7053/20013
race : non - white,C0034510;C1706779;C3853635,true;false;false,7054/20013
race - non - white,C0034510;C1706779;C3853635,true;false;false,7055/20013
race nonwhitet,C0034510;C1706779;C3853635,true;false;false,7056/20013
smoking status *,C1519386,false,7057/20013
smokinq status,C0449438,false,7058/20013
nyha iii or iv,C1275491;C0439070;C1705160,false;false;false,7059/20013
nyhaiiioriv,,,7060/20013
csf cholesterol,C3540512;C0008377;C3889436,false;true;false,7061/20013
hdl - cholesterol,C0023822;C0392885,true;false,7062/20013
vldl cholesterol,C0023826;C0523560,true;false,7063/20013
ldl cholesterolt,,,7064/20013
ldl - cholesterol (,C0023824;C0202117,true;false,7065/20013
hdl cholesterol §,C0023822;C0392885,true;false,7066/20013
tolal choleslerol,,,7067/20013
total cholesterol *,C0201950;C0543421,false;false,7068/20013
hdl cholesterol *,C0023822;C0392885,true;false,7069/20013
total cholesterol,C0201950;C0543421,false;false,7070/20013
hdl choleslerol,C3715113,false,7071/20013
ldl choleslerol,,,7072/20013
aldl cholesterol,C0008377,true,7073/20013
hdl cholesterol,C0023822;C0392885,true;false,7074/20013
ldl - cholesterol,C0023824;C0202117,true;false,7075/20013
medical therapy,C0418981,false,7076/20013
medical therapies,C0418981,false,7077/20013
topical therapy,C0332237;C0039798;C0087111;C1363945,false;true;true;false,7078/20013
hbanmbrc ( n ),C0019016;C1825777;C3538758,true;false;false,7079/20013
> nmbr days ( % ),C0439228,false,7080/20013
> nmbr ( % ),,,7081/20013
anmbrc ( % ),,,7082/20013
> nmbry,,,7083/20013
hbanmbrc ( % ),C0019016;C1825777;C3538758,true;false;false,7084/20013
> nmbr yr — no . ( % ),C0439234,false,7085/20013
< nmbr vr — no . ( % ),C3476815,false,7086/20013
< nmbr { % ),,,7087/20013
^nmbr y,,,7088/20013
aabnmbr ( % ),,,7089/20013
< nmbr yr — no . ( % ),C0439234,false,7090/20013
< nmbr ( % ),,,7091/20013
> = nmbr * ( % ),,,7092/20013
> nmbr yr ( % ),C0439234,false,7093/20013
> = nmbr ( % ),,,7094/20013
< nmbr days ( % ),C0439228,false,7095/20013
> nmbr y . n ( % ),,,7096/20013
£ median ( nmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7097/20013
> median ( nmbr % ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7098/20013
> median ( nmbr kg ),C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,7099/20013
> median ( nmbr mm ),C0549183;C4330985;C4554674;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7100/20013
> median ( nmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7101/20013
< median ( nmbr kg ),C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,7102/20013
women < nmbr years,C0043210;C0439234,true;false,7103/20013
women > nmbr years,C0043210;C0439234,true;false,7104/20013
diclofenac ( n = nmbr,C0012091,true,7105/20013
diclofenac ( n = nmbr nmbr ),C0012091,true,7106/20013
previous mi — no . ( % ),C0205156;C3810814;C1552607,false;false;false,7107/20013
previous vte — no . ( % ),C0205156;C0630906;C1552607,false;true;false,7108/20013
previous chf — no . ( % ),C0205156;C0018802;C1552607,false;true;false,7109/20013
bl h / y : bilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7110/20013
bl h / y : unilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7111/20013
diabetes status,C1317301,false,7112/20013
diabetic status,C0241863;C0449438,false;false,7113/20013
mean ( sd ) age in years,C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7114/20013
mean ( sd ) age,C0444504;C2699239;C0001779;C2347634;C2348143,false;false;false;false;false,7115/20013
mean ( sd ) age ( years ),C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7116/20013
no symptoms,C0683368;C1457887,true;false,7117/20013
symptoms,C0683368;C1457887,true;false,7118/20013
age at randomization,C0001779;C0034656,false;true,7119/20013
age at randomisation,C0001779;C0034656,false;true,7120/20013
vadas score *,,,7121/20013
mmse score *,C0451306;C0449820;C4050231,true;false;false,7122/20013
mean acrn,C0444504;C2347634;C2348143,false;false;false,7123/20013
rope score,C1563164;C0449820;C4050231,false;false;false,7124/20013
cat score,C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;true;false;false;false;false,7125/20013
sss score,C0037052;C0723181,true;false,7126/20013
gds score *,C0451184;C1149049;C1418244,false;false;false,7127/20013
mmse score,C0451306;C0449820;C4050231,true;false;false,7128/20013
edss score,C0451246;C3887783,false;false,7129/20013
chads score,C0007928;C1413373,true;false,7130/20013
mean score,C3533236,false,7131/20013
mhis score,C0449820;C4050231,false;false,7132/20013
cat scoreff,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,7133/20013
kccq score,C3476798,false,7134/20013
aqlq score,C4055434,false,7135/20013
accp score,C0449820;C4050231,false;false,7136/20013
baseline sbp ( mm hg ),C0168634;C0085805;C0439475;C1442488,true;true;false;false,7137/20013
baseline dbp ( mm hg ),C0168634;C0536221;C0439475;C3813197;C4281799;C1442488,true;true;false;false;false;false,7138/20013
itt population,C0032659;C1257890,true;true,7139/20013
mitt population,C0032659;C1257890,true;true,7140/20013
tiotropium + placebo ( n[nmbr ),C0213771;C0032042;C1696465;C1706408,true;true;false;false,7141/20013
tiotropium + placeb ( n[nmbr ),C0213771,true,7142/20013
sinusitis,C0037199;C4553555,true;false,7143/20013
synovitis,C0039103,true,7144/20013
no history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7145/20013
history of tia or stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7146/20013
history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7147/20013
heart rate ( beats per min ),C0018810,true,7148/20013
heart rate — beats / min,C0018810,true,7149/20013
heart rate ( beats / min ),C0018810,true,7150/20013
heart rate ( beats per minute ),C0018810,true,7151/20013
pga,C0016410;C3541266;C4050369,true;false;false,7152/20013
ptga,,,7153/20013
region latin american,C0017446;C0205147,true;false,7154/20013
calcium - channel blockers,C0006684;C2757014,true;false,7155/20013
calcium - channel blocker,C0006684;C3536851;C4521885,true;false;false,7156/20013
calcium channel blocker,C0006684;C3536851;C4521885,true;false;false,7157/20013
calcium - channel blockerf,C0006685,true,7158/20013
baseline median [mg / l],C0168634;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7159/20013
baseline median,C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false,7160/20013
baseline mean ( mg / dl],C0168634;C0444504;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false,7161/20013
baseline mean mtss,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,7162/20013
baseline mean 士 sd,C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7163/20013
glucocorticoids,C0017710;C3540777;C3540778,true;false;false,7164/20013
glucocorticoid,C0017710,true,7165/20013
glucocorticoids *,C0017710;C3540777;C3540778,true;false;false,7166/20013
esr — mm / hr,C3811131;C4330985;C4554674,false;false;false,7167/20013
esr ( mm / hour ) git config - - global user . name   your name  ,C3811131;C4330985;C0439227;C1418224;C2827597;C0205246;C1548600;C1706077;C2348867;C0564385;C4554674,false;false;false;false;false;false;false;false;false;false;false,7168/20013
ns cardiac cisease,C0038944;C0018787;C1522601;C1112705;C1705982,true;true;false;false;false,7169/20013
cardiac disease,C0018799,true,7170/20013
no cardiac disease,C0018799,true,7171/20013
education < nmbr years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,7172/20013
education > nmbr years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,7173/20013
triglyceride ( mmol / l ),C0041004;C1532563,true;false,7174/20013
triglyceride ( mmol / l ) t,C0041004;C1532563,true;false,7175/20013
triglycerides ( mmol / l ) :,C0041004;C1532563,true;false,7176/20013
triglycerides ( mmol / l ),C0041004;C1532563,true;false,7177/20013
triglycerides * ( mg / dl ),C0041004;C0439269,true;false,7178/20013
triglyceride ( mg / dl ) d,C0041004;C0439422;C3642216,true;false;false,7179/20013
triglycerides — mg / dl,C0041004;C0439269,true;false,7180/20013
triglyceride ( mg / dl ),C0041004;C0439269,true;false,7181/20013
patients without diabetesb,C0030705,true,7182/20013
patients with diabetesb,C0030705,true,7183/20013
no prior heart failure ( n = nmbr,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7184/20013
prior heart failure ( n = nmbr,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7185/20013
prior lev use,C0332152;C0023556;C2826257,false;true;false,7186/20013
prior asa use,C0332152;C0004057;C0042153;C0457083;C1947944;C3853627;C2826257,false;true;true;false;false;false;false,7187/20013
premenopausal,C0279752,false,7188/20013
hs - crp ( mg / l ),C3890735;C0439268;C4048285,false;false;false,7189/20013
bnp ( pg / ml ),C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,7190/20013
fpg ( mg / dl ),C0439269,false,7191/20013
crp — mg / l,C3890735;C0439268;C4048285,false;false;false,7192/20013
crp ( ng / ml ),C3890735;C0439275;C4048285,false;false;false,7193/20013
bun ( mg / dl ),C0439269,false,7194/20013
tgs ( mg / dl ),C1156212;C0439269;C1537574,false;false;false,7195/20013
hdl ( mg / dl ),C3715113;C0439269,false;false,7196/20013
apo b ( g / l ),C0003593;C0439294;C0456615;C3252643,true;false;false;true,7197/20013
crp ( mg / dl ),C3890735;C0439269;C4048285,false;false;false,7198/20013
apoal,,,7199/20013
mpo ( ng / ml ),C0439275,false,7200/20013
hscrp ( mg / l ),C0439268,false,7201/20013
hscrp ( mg / l ) c,C0439268,false,7202/20013
hscrp ( nmol / l ),C0439282,false,7203/20013
troy ( ng / ml ),C1420811;C0439275;C1883402,false;false;false,7204/20013
apob ( mg / dl ),C0003593;C0439269;C3252643,true;false;true,7205/20013
bnp ( pg / ml ) h,C0054015;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C1095989;C1417808;C2982014,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;false;false;false,7206/20013
triglycerides nmbr,C0041004,true,7207/20013
triglycerides nmbrst third,C0041004;C0036056;C0205437;C3272372,true;true;false;false,7208/20013
triglycerides nmbrnd third,C0041004;C0205437,true;false,7209/20013
no multivessel disease,C0012634,true,7210/20013
fastng plasma glucose < median,C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,false;false;false;false;false;false;false,7211/20013
fascng plasma glucose a medan,C0202042;C0455280,false;false,7212/20013
fasting plasma glucose < median,C0015663;C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,true;false;false;false;false;false;false;false,7213/20013
caucasian ( % ),C0007457;C0043157,true;true,7214/20013
caucasiana ( % ),,,7215/20013
concomitant cardiovascular therapies — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7216/20013
concomitant cardiovascular therapy — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7217/20013
dissatisfied with / stopped $ nmbr prior systemic therapies because of side effects,C0870433;C1272691;C1514463;C0205373;C0332152;C1515119;C2826257;C4085546,false;false;false;false;false;false;false;false,7218/20013
dissatisfied with / stopped $ nmbr prior systemic therapy because of side effects,C0870433;C1272691;C1514463;C0205373;C0332152;C1515119;C2826257;C4085546,false;false;false;false;false;false;false;false,7219/20013
linagliptin ( n z nmbr ),C2746078,true,7220/20013
vildagliptin ( n = nmbr ),C1570906,true,7221/20013
linagliptin ( n = nmbr ),C2746078,true,7222/20013
sitagliptin ( n = nmbr ),C1565750,true,7223/20013
smoking — current,C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,7224/20013
current smoking — no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7225/20013
current smoker 一 no . ( % ),C3173209;C3241966,false;false,7226/20013
current smoker — no . ( % ),C3173209;C3241966,false;false,7227/20013
without tnmbrdm n = nmbr,C2986835;C0011816;C3250443,false;true;false,7228/20013
with tnmbrdm n = nmbr,C2986835;C0011816;C3250443,false;true;false,7229/20013
val / hctz ( n = nmbr ),C0042285;C0020261;C0523975,true;true;false,7230/20013
v / hctz ( n = nmbr ),C0020261,true,7231/20013
aml / hctz ( n = nmbr ),C0023465;C0020261;C0023467,true;true;true,7232/20013
ind / gly,C4049864;C0017890;C0523677,false;true;false,7233/20013
indzgly,,,7234/20013
gdf - nmbr ( ng / ml ),C1418244;C0439275,false;false,7235/20013
mmp - nmbr ( ng / ml ),C0623362;C0439275;C0919336,true;false;false,7236/20013
st - nmbr ( ng / ml ),C0036056;C0439275;C3272372,true;false;false,7237/20013
mmp - nmbr ( ng / ml ) *,C0623362;C0439275;C0919336,true;false;false,7238/20013
il - nmbr ( pg / ml ),C0020898;C0439297;C0021764;C0022271,true;false;true;true,7239/20013
diabetes — no . ( % ),C0011847;C0011849,false;true,7240/20013
unstable angina — no . ( % ),C0002965,true,7241/20013
stable angina — no . ( % ),C0340288,true,7242/20013
anmbrc < nmbr . nmbr % ( median ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7243/20013
anmbr = nmbr . nmbr % ( median ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7244/20013
hazard ratio ( nmbr % cl ),C2985465;C0596019,false;false,7245/20013
hazard ratio ( nmbr % ci ) *,C2985465;C0008107;C3259781,false;true;false,7246/20013
hazard ratio ( nmbr % ci ),C2985465;C0008107;C3259781,false;true;false,7247/20013
hazard ratio * ( nmbr % ci ),C2985465;C0008107;C3259781,false;true;false,7248/20013
hazard ratiof ( nmbr % ci ),C0598697;C0008107;C3259781,false;true;false,7249/20013
lipid - lowering agent §,C0086440,true,7250/20013
lipid - lowering agents,C0086440,true,7251/20013
lipid - lowering agent,C0086440,true,7252/20013
zotarolimus,C1700035,true,7253/20013
zotarolimust,,,7254/20013
pci orcabg,C4049621,false,7255/20013
prior cabg,C0332152;C0010055;C2826257,false;true;false,7256/20013
no prior cabg,C0332152;C0010055;C2826257,false;true;false,7257/20013
pnorcabg,,,7258/20013
diastolic blood pressure,C0428883;C1305849,true;false,7259/20013
very severe,C3641272;C4050419,false;false,7260/20013
more severe^,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7261/20013
less severe,C0439092;C0205082;C4050465;C4050466;C0547044,false;false;false;false;false,7262/20013
more severe,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7263/20013
cholesterol ( mg / dl ),C0008377;C0439269,true;false,7264/20013
cholesterol — mg / dl,C0008377;C0439269,true;false,7265/20013
treatment difference ( nmbr % cl ),C0039798;C1705241;C0596019;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,7266/20013
treatment difference ( nmbr % ci ),C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;true;false;false;false;false;false,7267/20013
> median ( nmbr ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7268/20013
< median ( nmbr ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7269/20013
baseline mssbp ( mmhg ),C0168634;C0439475;C1442488,true;false;false,7270/20013
baseline msdbp ( mmhg ),C0168634;C0439475;C1442488,true;false;false,7271/20013
age range ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,7272/20013
age range,C0001779;C1514721;C2348147;C3542016,false;false;false;false,7273/20013
inflammation,C0021368,true,7274/20013
inflammatory,C0333348,false,7275/20013
hispanic or latino,C0086409,true,7276/20013
hispanic / latino,C0086409;C0086528,true;true,7277/20013
< nmbr cells / pl,C0007584;C3897966;C4049765;C0007634,true;false;false;true,7278/20013
> nmbr cells / pl,C0007584;C3897966;C4049765;C0007634,true;false;false;true,7279/20013
american indian,C0002460,true,7280/20013
american indian /,C0002460,true,7281/20013
with an sfua,,,7282/20013
without an sfua,,,7283/20013
sulphonylureas,C0038766,true,7284/20013
sulphonylurea,C0038766;C3536898,true;false,7285/20013
on sulfonylurea,C0038766;C3536898,true;false,7286/20013
sulfonylureaa,,,7287/20013
sulfonylurea,C0038766;C3536898,true;false,7288/20013
pbo + mtx,C0031962;C0025677;C1417487,true;true;false,7289/20013
czp + mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,7290/20013
caucasians,C0007457;C0043157,true;true,7291/20013
noncaucasian,,,7292/20013
non - caucasian,C1518422;C0007457;C0043157,false;true;true,7293/20013
ldl cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7294/20013
hdl cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7295/20013
previous or current use of im or cs : no,C0205156;C1552607,false;false,7296/20013
previous or current use of im and cs : no,C0205156;C1552607,false;false,7297/20013
nmbr to < nmbr ml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,7298/20013
nmbr to o nmbr ml / min / nmbr . nmbr mnmbr,C0483204;C0439445;C0369637;C0441923,false;false;false;false,7299/20013
nmbr to onmbr ml / min / nmbr . nmbr mnmbr,C0483204;C0439445;C0369637;C0441923,false;false;false;false,7300/20013
≥ nmbr to < nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,7301/20013
nmbr to < nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,7302/20013
without psoriasis ( zi = nmbr ),C0033860;C0043476,true;true,7303/20013
with psoriasis ( n = nmbr ),C0033860,true,7304/20013
with psoriasis ( zi = nmbr ),C0033860;C0043476,true;true,7305/20013
placebo events / patients ( % ),C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,7306/20013
ldl - cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7307/20013
ldl cholesterol — mg / dl,C0023824;C0439269;C0202117,true;false;false,7308/20013
i idl cholesterol ( mg / dl ),C0619865;C0523559;C0439269;C0021966;C0123167;C0221138,true;false;false;true;true;false,7309/20013
hdl cholesterol — mg / dl,C0023822;C0439269;C0392885,true;false;false,7310/20013
hdl - cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7311/20013
baseline ldl - c,C0168634;C1442488,true;false,7312/20013
baseline ldl - c :,C0168634;C1442488,true;false,7313/20013
who fc ii symptoms at baseline,C2983605;C1710602;C0683368;C0168634;C1442488;C1457887;C4082587,false;false;true;true;false;false;false,7314/20013
who fc iii symptoms at baseline,C2983605;C0439070;C0683368;C0168634;C1442488;C1457887;C1705160,false;false;true;true;false;false;false,7315/20013
nmbr . nmbr - < nmbr . nmbr,,,7316/20013
> nmbr - nmbr - nmbr - nmbr,,,7317/20013
nmbr - nmbr - nmbr - nmbr,,,7318/20013
nmbr . nmbr to nmbr . nmbr %,C0040363;C0041260;C1883351,true;true;false,7319/20013
> nmbr . nmbr - < nmbr . nmbr,,,7320/20013
nmbr . nmbr - nmbr . nmbr,,,7321/20013
nmbr . nmbr + nmbr . nmbr,,,7322/20013
nmbr nmbr ( nmbr . nmbr ),,,7323/20013
nmbr . nmbr - < nmbr . nmbr %,,,7324/20013
nmbr / nmbr ( nmbr . nmbr ),,,7325/20013
nmbr . nmbr to nmbr . nmbr,C0040363;C0041260;C1883351,true;true;false,7326/20013
> nmbr . nmbr to < nmbr . nmbr,C0040363;C0041260;C1883351,true;true;false,7327/20013
nmbr . nmbr ( nmbr . nmbr ),,,7328/20013
> nmbr . nmbrto < nmbr . nmbr %,C0040363;C0041260;C1883351,true;true;false,7329/20013
nmbr . nmbr % - nmbr . nmbr %,,,7330/20013
no mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7331/20013
mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7332/20013
ss at baseline,C2699257;C0168634;C1442488;C3891295;C4551874,false;true;false;false;false,7333/20013
mmrc at baseline,C3826977;C0168634;C1442488,false;true;false,7334/20013
pad at baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,7335/20013
nihss at baseline,C1697238;C0168634;C1442488,false;true;false,7336/20013
aspirin dose,C4696290,false,7337/20013
aspirin alone,C0004057,true,7338/20013
aspirin use,C0004057;C0042153;C0457083;C1947944,true;true;false;false,7339/20013
arrhythmia,C0003811,true,7340/20013
arrhythmia !,C0003811,true,7341/20013
arrhythmias,C0003811,true,7342/20013
hypertensive,C0857121,false,7343/20013
hypertensiont,,,7344/20013
hypertension 本,C0020538;C1963138,true;false,7345/20013
hypotension,C0020649;C3163620,true;false,7346/20013
hyper - tension,C0020538;C1963138,true;false,7347/20013
hypertension ( % ),C0020538;C1963138,true;false,7348/20013
no hypertension,C0020538;C1963138,true;false,7349/20013
hyperlension,,,7350/20013
hypertension *,C0020538;C1963138,true;false,7351/20013
hypertension §,C0020538;C1963138,true;false,7352/20013
hypertension !,C0020538;C1963138,true;false,7353/20013
unstable angina *,C0002965,true,7354/20013
unstable angina age,C0002965;C0001779,true;false,7355/20013
unstable angina §,C0002965,true,7356/20013
unstable anginad,C0443343;C1883468,false;false,7357/20013
unstableangina,,,7358/20013
stable angina,C0340288,true,7359/20013
unstable anginat,C0443343;C1883468,false;false,7360/20013
arb monotherapy,C3888198,false,7361/20013
era monotherapy,C1521863;C3495919,true;false,7362/20013
cardioembolism,,,7363/20013
cardioembolic,,,7364/20013
age category >,C0001779;C0683312;C3889287,false;false;false,7365/20013
bmi category,C0578022;C0683312;C3889287,false;false;false,7366/20013
age category,C0001779;C0683312;C3889287,false;false;false,7367/20013
aspirin or other antiplatelet agents,C0004057,true,7368/20013
aspirin or other antiplatelet agent,C0004057,true,7369/20013
mean ( sd ) pga vas *,C0444504;C2699239;C0016410;C0042815;C3536884;C3827561;C3541266;C4050369;C2347634;C2348143,false;false;true;true;true;false;false;false;false;false,7370/20013
mean ( sd ) ptga vas *,C0444504;C2699239;C0042815;C3536884;C3827561;C2347634;C2348143,false;false;true;true;false;false;false,7371/20013
mean ( sd ) pain vas *,C0444504;C2699239;C0042815;C2347634;C2348143,false;false;true;false;false,7372/20013
previous ml ( before index acs ),C0205156;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C1552607,false;false;true;true;false;true;false;false;false;false;false;false,7373/20013
previous pci ( before index acs ),C0205156;C4049621;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;false;true;true;false;true;false;false;false;false,7374/20013
fibula fracture,C0149699,false,7375/20013
tibia fracture,C0040185,true,7376/20013
weight in kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,7377/20013
serum creatinine ( gmol / ),C0201976;C0600061,false;false,7378/20013
serum creatinine ( mmol / l ),C0201976;C1532563;C0600061,false;false;false,7379/20013
> nmbr years eze / simva ( „ = nmbr },C0439234,false,7380/20013
< nmbr years eze / simva ( n = nmbr },C0439234,false,7381/20013
im use : no,,,7382/20013
cs use : no,C0010182;C0271160;C3540510;C4085345,true;false;false;false,7383/20013
stent diameter < nmbr mm,C0038257;C1301886;C4330985;C4554674,true;false;false;false,7384/20013
stent diameter $ nmbr mm,C0038257;C1301886;C4330985;C4554674,true;false;false;false,7385/20013
overall ( n = nmbr,C0282416;C1561607,true;false,7386/20013
overall ( n = nmbr vs nmbr ),C0282416;C1561607,true;false,7387/20013
leukotriene receptor antagonists,C0595726;C2757015;C3542962,true;false;false,7388/20013
leukotriene - receptor antagonist,C0595726;C3537183;C4521995,true;false;false,7389/20013
high - sensitivity c - reactive protein,C1441604;C0006560;C1413716;C4048285,false;true;false;false,7390/20013
high - sensitivityc - reactive protein,C0205250;C0205332;C0033684;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false,7391/20013
etn + mtx ( n = nmbr ),C0014758;C0025677;C1417487;C0717758,true;true;false;true,7392/20013
hcq + mtx ( n = nmbr ),C0020336;C0025677;C1417487,true;true;false,7393/20013
ssz + mtx ( n = nmbr ),C0025677;C1417487,true;false,7394/20013
lef + mtx ( n = nmbr ),C0025677;C1417487,true;false,7395/20013
> nmbr drinks,C0452428,false,7396/20013
nmbr drinks,C0452428,false,7397/20013
glucose ( mg / dl ),C0017725;C0439269,true;false,7398/20013
glucose — mg / dl,C0017725;C0439269,true;false,7399/20013
thienopyridine,C1120149,true,7400/20013
+ thienopyridine,C1120149,true,7401/20013
no thienopyridine,C1120149,true,7402/20013
- thienopyridine,C1120149,true,7403/20013
acholesterol ( % ),,,7404/20013
cholesterol ( % ),C0008377,true,7405/20013
< nmbr . nmbr mg / dl,C0439269,false,7406/20013
> nmbr . nmbr mg / mmol,C0567349;C2348885,false;false,7407/20013
> nmbr . nmbr - g / l,C0439294;C0456615,false;false,7408/20013
nmbr - nmbr mg / g,C1300563,false,7409/20013
nmbr nmbr mg / dl,C0439269,false,7410/20013
≥ nmbr to < nmbr mg / g,C1300563,false,7411/20013
> nmbr . nmbr mg / l,C0439268,false,7412/20013
> nmbr . nmbr mmol / l,C1532563,false,7413/20013
≥ nmbr to < nmbr mg / dl,C0439269,false,7414/20013
< nmbr . nmbr mmol / l,C1532563,false,7415/20013
< nmbr . nmbr mg / mmol,C0567349;C2348885,false;false,7416/20013
> nmbr & < nmbr mg / dl,C0439269,false,7417/20013
> nmbr and < nmbr mg / dl,,,7418/20013
> nmbr to nmbr mg / g,C1300563,false,7419/20013
> nmbr but < nmbr mg / dl,,,7420/20013
< nmbr . nmbr ng / ml,C0439275,false,7421/20013
> nmbr + nmbr mmol / l,C1532563,false,7422/20013
nmbr - nmbr mg / dl,C0439269,false,7423/20013
. nmbr . nmbr mg / mmol,C0567349;C2348885,false;false,7424/20013
< nmbr - nmbr mmol / l,C1532563,false,7425/20013
nmbr to nmbr mg / g,C1300563,false,7426/20013
nmbr to < nmbr mg / dl,C0439269,false,7427/20013
> nmbr . nmbr mg / dl,C0439269,false,7428/20013
< nmbr . nmbr l - g / l,C3539687;C0439267,false;false,7429/20013
> nmbr . nmbr ng / ml,C0439275,false,7430/20013
> nmbr ' nmbr mmol / l,C1532563,false,7431/20013
> nmbr - nmbr mmol / l,C1532563,false,7432/20013
< nmbr . nmbrmg / l,C0439268,false,7433/20013
cerebral vascular disease,C0007820,true,7434/20013
vildagliptin,C1570906,true,7435/20013
sitagliptin,C1565750,true,7436/20013
saxagliptin,C1611934,true,7437/20013
mean ( s . e . ),C0444504;C2347634;C2348143,false;false;false,7438/20013
mean ( s . e . ) t,C0444504;C2347634;C2348143,false;false;false,7439/20013
mean ( s . d . ),C0444504;C2347634;C2348143,false;false;false,7440/20013
mean bmi ( kg / mnmbr ) ( sd ),C0444504;C0578022;C1532718;C2699239;C2347634;C2348143,false;false;false;false;false;false,7441/20013
tiotropium ( nznmbr ),C0213771;C0027978,true;true,7442/20013
tiotropium ( n z nmbr ),C0213771,true,7443/20013
tiotropium ( n = nmbr ),C0213771,true,7444/20013
gastroduodenum,C0391900,false,7445/20013
gastroduodenal,C0450199,false,7446/20013
primary endpoint,C2986535,false,7447/20013
primary end point  ,C2986535,false,7448/20013
dyslipidemia — no . ( % ),C0242339,true,7449/20013
dyslipidemia — no . ( % ) |,C0242339,true,7450/20013
tjc ( nmbr - nmbr ),,,7451/20013
sjc ( nmbr - nmbr ),,,7452/20013
non cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,7453/20013
non - cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,7454/20013
patients with prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,7455/20013
patients without prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,7456/20013
mean ( s . d . ) age,C0444504;C0001779;C2347634;C2348143,false;false;false;false,7457/20013
mean ± s . d . age,C0444504;C0001779;C2347634;C2348143,false;false;false;false,7458/20013
nmbr mg / day early - start - delayed - start,C0439422,false,7459/20013
nmbr mg / day early - start - delayed start,C0439422,false,7460/20013
£ nmbr kg / mnmbr,C1532718,false,7461/20013
anmbr kg / mnmbr,C1532718,false,7462/20013
< nmbr kg / m nmbr,C1532718,false,7463/20013
> nmbrkg / mnmbr,C1532718,false,7464/20013
< nmbrkg / mnmbr,C1532718,false,7465/20013
snmbr kg / mnmbr,C0565930;C1532718;C2603362,false;false;false,7466/20013
< nmbr kg / mnmbr,C1532718,false,7467/20013
≥ nmbr kg / mnmbr,C1532718,false,7468/20013
> nmbr kg / mnmbr,C1532718,false,7469/20013
hypokalemia ‡   ( potassium < nmbr . nmbr mmol / l ),C0020621;C0032821;C1532563;C0202194;C0304475;C0597277;C3714637;C4553966,true;true;false;false;false;false;false;false,7470/20013
hyperkalemia ‡   ( potassium ≥ nmbr . nmbr mmol / l ),C0020461;C0032821;C1532563;C0202194;C0304475;C0597277;C3714637;C4552983,true;true;false;false;false;false;false;false,7471/20013
heparin only,C0019134;C0205171;C1720467;C0770546,true;false;false;false,7472/20013
aspirin only,C0004057;C0205171;C1720467,true;false;false,7473/20013
mitral regurgitation,C0026266,true,7474/20013
< nmbr years n z nmbr,C0439234,false,7475/20013
> nmbr years n z nmbr,C0439234,false,7476/20013
age < nmbr y ( n = nmbr ),C0001779,false,7477/20013
age ' nmbr y ( n nmbr ),C0001779,false,7478/20013
age > nmbr y ( n = nmbr ),C0001779,false,7479/20013
ace inhibitor,C0003015;C4541021,true;false,7480/20013
ace inhibitors,C0003015,true,7481/20013
tnf inhibitors,C1448177;C0243077,true;true,7482/20013
tnf inhibitor,C1448177;C1999216,true;false,7483/20013
ace inhibitor yes,C0003015;C1549445;C1705108;C1710701;C4541021,true;false;false;false;false,7484/20013
body - mass index : ! :,C0005893;C0578022;C1305855,false;false;true,7485/20013
body - mass index  ! ,C0005893;C0578022;C1305855,false;false;true,7486/20013
change from baseline to eos,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,7487/20013
r ight coronar y artery,C0205090;C0003842;C0226004;C0684010;C2603358,false;true;false;true;false,7488/20013
duration of tnmbrdm > nmbr years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,7489/20013
duration of tnmbrdm < nmbr years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,7490/20013
time to randomization,C0040223;C0034656;C3541383,true;true;false,7491/20013
time of randomization,C0040223;C0034656;C3541383,true;true;false,7492/20013
p value ( cangrelor versus clopidogrel in men ),C1709380;C1121991,false;true,7493/20013
p value ( cangrelor versus clopidogrel in women ),C1709380;C1121991,false;true,7494/20013
height — cm,C0489786,false,7495/20013
w eight ( k g ),C0205454;C0597277;C0439267;C1708601,false;false;false;false,7496/20013
weight 一 kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,7497/20013
height ( cm ),C0489786,false,7498/20013
weight — kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,7499/20013
weight - kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,7500/20013
body - mass index ) -,C0005893;C0578022;C1305855,false;false;true,7501/20013
body - mass indexj,C0518010,false,7502/20013
body - mass indexf,C0518010,false,7503/20013
body - mass index )  ,C0005893;C0578022;C1305855,false;false;true,7504/20013
body - mass index ),C0005893;C0578022;C1305855,false;false;true,7505/20013
body - mass index *,C0005893;C0578022;C1305855,false;false;true,7506/20013
body - mass index §,C0005893;C0578022;C1305855,false;false;true,7507/20013
body mass index *,C0005893;C0578022;C1305855,false;false;true,7508/20013
body - mass index $,C0005893;C0578022;C1305855,false;false;true,7509/20013
body mass indexc,C0518010,false,7510/20013
body mass index +,C0005893;C0578022;C1305855,false;false;true,7511/20013
body mass index :,C0005893;C0578022;C1305855,false;false;true,7512/20013
body - mass index,C0005893;C0578022;C1305855,false;false;true,7513/20013
family history of premature chd,C0241889;C0151526;C0280604;C3542407;C0205252;C4018905,true;true;false;false;false;false,7514/20013
family history of premature chdj,C0241889;C0151526;C0205252;C4018905,true;true;false;false,7515/20013
abatacept nmbr mg / kg ( n = nmbr ),C1619966;C0439272,true;false,7516/20013
abatacept ~ nmbr mg / kg ( n = nmbr ),C1619966;C0439272,true;false,7517/20013
prior tnf antagonist failure - no,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,7518/20013
prior tnf antagonist failure - yes,C0332152;C1448177;C0231491;C0231174;C1549445;C1705108;C1710701;C0680095;C2826257,false;true;false;false;false;false;false;false;false,7519/20013
previous cabg,C0205156;C0010055;C1552607,false;true;false,7520/20013
previous mi,C0205156;C3810814;C1552607,false;false;false,7521/20013
previous ptca,C0205156;C2936173;C1552607,false;true;false,7522/20013
previous pci,C0205156;C4049621;C1552607,false;false;false,7523/20013
previous hf,C0205156;C0018488;C1313497;C1538440;C3273279;C1552607,false;true;true;false;false;false,7524/20013
previous tia,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,7525/20013
previous ml,C0205156;C0439526;C1705224;C3887665;C1552607,false;false;false;false;false,7526/20013
previous chf,C0205156;C0018802;C1552607,false;true;false,7527/20013
previous cad,C0205156;C1504769;C2239547;C3813548;C4284121;C1552607,false;true;false;false;false;false,7528/20013
previous ami,C0205156;C4319936;C1552607,false;false;false,7529/20013
previously,,,7530/20013
previous,C0205156;C1552607,false;false,7531/20013
w event ( rate ),C0441471;C0871208;C1521828;C4019010,false;false;false;false,7532/20013
n event ( rate ),C0369718;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false,7533/20013
type nmbr diabetes ( n = nmbr,C1320657,false,7534/20013
no type nmbr diabetes ( n = nmbr,C1320657,false,7535/20013
family history of vte,C0241889;C0630906,true;true,7536/20013
family history of cad,C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,7537/20013
with p blockers,C0369773;C2603361,false;false,7538/20013
without p blockers,C0369773;C2603361,false;false,7539/20013
triglycerides < nmbr - nmbr mmol / l,C0041004;C1532563,true;false,7540/20013
triglycerides > nmbr - nmbr mmol / l,C0041004;C1532563,true;false,7541/20013
non - hdl - c ( mg / dl ),C1518422;C3715113;C0439269,false;false;false,7542/20013
lipid - lowering medications^,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,7543/20013
lipid - lowering medications,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,7544/20013
lipid - lowering medication,C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,7545/20013
history of cad,C0019664;C1504769;C2239547;C3813548;C4284121;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;true;false;false;false;false,7546/20013
no history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,7547/20013
history of pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,7548/20013
history of copd,C0019664;C0024117;C1412502;C3714496;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,7549/20013
history pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,7550/20013
history of mi,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,7551/20013
history of vte,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,7552/20013
history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,7553/20013
history of chd,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,7554/20013
history of cabg,C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,7555/20013
no history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,7556/20013
history of pad,C0019664;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;true;false;false;false;false,7557/20013
history of ml,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,7558/20013
history of hf,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,7559/20013
history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,7560/20013
lesion length $ nmbr mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,7561/20013
lesion length > nmbr mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,7562/20013
female gender,C0086287,true,7563/20013
ratio of hrs ( nmbr % cl ),C0456603;C1568891;C0596019;C1547037,false;true;false;false,7564/20013
ratio of hrs ( nmbr % ci ),C0456603;C1568891;C0008107;C3259781;C1547037,false;true;true;false;false,7565/20013
statins / ezetimibe,C0360714;C1142985,true;true,7566/20013
statin or ezetimibe,C0360714,true,7567/20013
> median ( nmbr . nmbr ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7568/20013
< median ( nmbr . nmbr ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7569/20013
renal impairmentt,C0022646,true,7570/20013
antiplatelet drugs,C0085826;C2963157,true;false,7571/20013
antiplatelet drug,C0085826,true,7572/20013
chanmbrdsnmbr - vasc $ nmbr,C1420648;C3714751,false;false,7573/20013
chanmbrdsnmbr - vasc # nmbr,C1420648;C3714751,false;false,7574/20013
chanmbrdsnmbr - vasc > nmbr,C1420648;C3714751,false;false,7575/20013
reversibility to,C0449261,false,7576/20013
reversibility ( % ) t,C0449261,false,7577/20013
reversibility *,C0449261,false,7578/20013
reversibility,C0449261,false,7579/20013
reversibility ( % ),C0449261,false,7580/20013
reversibility %,C0449261,false,7581/20013
present ( £ nmbr mg / dl ),C0150312;C0439269;C0449450,false;false;false,7582/20013
present ( > nmbr mg / dl ),C0150312;C0439269;C0449450,false;false;false,7583/20013
hbanmbrc < = nmbr %,C0019016;C1825777;C3538758,true;false;false,7584/20013
hbanmbrc < nmbr %,C0019016;C1825777;C3538758,true;false;false,7585/20013
hbanmbrc > nmbr %,C0019016;C1825777;C3538758,true;false;false,7586/20013
hbanmbrc > = nmbr %,C0019016;C1825777;C3538758,true;false;false,7587/20013
metformin 一 no . ( % ),C0025598,true,7588/20013
metformin — no . ( % ),C0025598,true,7589/20013
women / men [ % ],C0043210;C0025266,true;true,7590/20013
women / men,C0043210;C0025266,true;true,7591/20013
nmbr . nmbr to # nmbr . nmbr mg / mmol,C0567349;C2348885,false;false,7592/20013
nmbr . nmbr - < nmbr . nmbr mg / mmol,C0567349;C2348885,false;false,7593/20013
baseline tav - > = median ( n = nmbr,C0168634;C0279686;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7594/20013
baseline pav - > = median ( n = nmbr,C0168634;C0058890;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;false;false;false;false;false,7595/20013
baseline tav - < median ( n = nmbr,C0168634;C0279686;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7596/20013
baseline pav - < median ( n = nmbr,C0168634;C0058890;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;false;false;false;false;false,7597/20013
ifg / igt,C1334085;C1708411,false;false,7598/20013
ifg and igt,C1334085;C1708411,false;false,7599/20013
< nmbr % ( < nmbr mmol / mol ),C3829066,false,7600/20013
> nmbr % ( > nmbr mmol / mol ),C3829066,false,7601/20013
> = nmbr % ( nmbr mmol / mol ),C3829066,false,7602/20013
< nmbr % ( nmbr mmol / mol ),C3829066,false,7603/20013
no mi ( n - nmbr,C3810814,false,7604/20013
pad ( n - nmbr,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,7605/20013
no mvd ( n - nmbr,C1417507;C3272839,false;false,7606/20013
acs ( n - nmbr,C0742343;C4318612,true;false,7607/20013
mvd ( n - nmbr,C1417507;C3272839,false;false,7608/20013
any mi ( n - nmbr,C3810814,false,7609/20013
no pad ( n - nmbr,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,7610/20013
total cholesterol > nmbr - nmbr mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,7611/20013
total cholesterol < nmbr nmbr mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,7612/20013
total cholesterol < nmbr - nmbr mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,7613/20013
total cholesterol > nmbr ' nmbr mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,7614/20013
body massindex,C0242821;C0460148;C1268086;C4082212,true;false;false;false,7615/20013
change from baseline *,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,7616/20013
rectal bleeding subscore {,C0018932;C0267596,true;false,7617/20013
rectal bleeding subscore,C0018932;C0267596,true;false,7618/20013
ldl - c ( mmol / l ),C1532563,false,7619/20013
hdl - c ( mmol / l ),C3715113;C1532563,false;false,7620/20013
ldl - c * ( mmol / l ),C1532563,false,7621/20013
insulin - dependent,C0021641;C0429964;C0429986;C0851827;C1701901;C3244310;C4321395;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,7622/20013
insulin dependentc,C0021641;C1533581;C1579433;C3714501,true;false;false;false,7623/20013
anti - hypertensive therapy,C0585941,false,7624/20013
ace inhibitors or angiotensin - receptor blockers^,C0003015,true,7625/20013
ace inhibitor or angiotensin receptor blocker,C0003015;C4541021,true;false,7626/20013
ace inhibitor or angiotensin ii receptor blocker,C0003015;C4541021,true;false,7627/20013
ace inhibitors or angiotensin receptor blockers,C0003015,true,7628/20013
diabetes duration ( years ),C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,7629/20013
age ( years ) mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,7630/20013
age ( years ) mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,7631/20013
age ( years ) ( mean,C1510829;C0444504;C2347634;C2348143,false;false;false;false,7632/20013
ibdq,,,7633/20013
basfi,,,7634/20013
age ( years ) - mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,7635/20013
one of the above,C0205447,false,7636/20013
two of the above,C0205448,false,7637/20013
all of the above,C1282910;C1552828,false;false,7638/20013
none of the above,C1282910;C1552828,false;false,7639/20013
any of the above,C1282910;C1552828,false;false,7640/20013
asian or oriental,C0078988,true,7641/20013
asian / oriental,C0078988;C0699027,true;false,7642/20013
no . of stents,C0038257,true,7643/20013
no . of events,C0441471;C3541888,false;false,7644/20013
no . of patients,C0030705,true,7645/20013
serum creatinine — mg / dl §,C0201976;C0439269;C0600061,false;false;false,7646/20013
serum creatinine ( mg / dl ),C0201976;C0439269;C0600061,false;false;false,7647/20013
serum creatinine — mg / dl,C0201976;C0439269;C0600061,false;false;false,7648/20013
no diabetes ( n - nmbr,C0011847;C0011849,false;true,7649/20013
diabetes ( n - nmbr,C0011847;C0011849,false;true,7650/20013
final median,C0205088;C0549183;C0876920;C2347635;C2348144;C2939193;C1546485;C3853528,false;false;false;false;false;false;false;false,7651/20013
final mean,C0205088;C0444504;C2347634;C2348143;C1546485;C3853528,false;false;false;false;false;false,7652/20013
nonwhite race !,C0034510;C1706779;C3853635,true;false;false,7653/20013
nonwhite race,C0034510;C1706779;C3853635,true;false;false,7654/20013
non - white race,C1518422;C0007457;C0043157,false;true;true,7655/20013
non - white raceb,C1518422;C0007457;C0043157;C0220938,false;true;true;false,7656/20013
> nmbr egfr,C1739039;C3811844;C3812682,true;false;false,7657/20013
current cigarette smoker,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,7658/20013
current cigarette smoking,C0521116;C0239059;C0700219;C1705970,false;false;true;false,7659/20013
at home systolic pressure > nmbr mm hg,C4534363;C0871470;C0439475,false;true;false,7660/20013
at home diastolic pressure < nmbr mm hg,C4534363;C0428883;C0439475,false;true;false,7661/20013
at home diastolic pressure > nmbr mm hg,C4534363;C0428883;C0439475,false;true;false,7662/20013
at home systolic pressure < nmbr mm hg,C4534363;C0871470;C0439475,false;true;false,7663/20013
hx stroke / tia,C0262926;C0038454;C0007787;C0917805;C1054154;C4554100;C3814444,false;true;true;true;false;false;false,7664/20013
stroke or tia,C0038454;C4554100,true;false,7665/20013
stroke ortiab,C0038454;C4554100,true;false,7666/20013
stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,7667/20013
no stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,7668/20013
clinical history — no . ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,7669/20013
combination therapy ( n = nmbr ),C0009429;C0556895,true;false,7670/20013
combination therapy,C0009429;C0556895,true;false,7671/20013
anmbrc at baseline < nmbr . nmbr %,C0168634;C1442488,true;false,7672/20013
anmbrc at baseline ≥ nmbr . nmbr %,C0168634;C1442488,true;false,7673/20013
native american,C0282204;C1515945,true;false,7674/20013
latin american,C1553378,false,7675/20013
latin america,C0023122,true,7676/20013
medical history — no . ( % ),C0262926;C1704706,false;false,7677/20013
diabetes mellitus :,C0011849,true,7678/20013
diabetes mellitus,C0011849,true,7679/20013
no diabetes mellitus,C0011849,true,7680/20013
diabetes mellitus !,C0011849,true,7681/20013
diabetes mellitus ( % ),C0011849,true,7682/20013
since diagnosis,,,7683/20013
index diagnosis,C0600653;C0011900;C1704338;C1704656;C0918012;C1552854;C1637833;C2986546,true;true;true;false;true;false;false;false,7684/20013
> nmbr months,C0439231,false,7685/20013
placebo ( n = nmbr nmbr ),C0032042;C1696465;C1706408,true;false;false,7686/20013
placebo ( n - nmbr . nmbr ),C0032042;C1696465;C1706408,true;false;false,7687/20013
placebo ( n nmbr nmbr ),C0032042;C1696465;C1706408,true;false;false,7688/20013
second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,7689/20013
no second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,7690/20013
controlled,C2587213;C2911690,false;false,7691/20013
coronary,C0018787,true,7692/20013
controlld,,,7693/20013
uncontrolled,C0205318,false,7694/20013
control,C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7695/20013
ezetimibe nmbr mg ( n = nmbr * ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7696/20013
ezetimibe nmbr mg ( n = nmbr ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7697/20013
chadsnmbr score,C0007928;C1413373,true;false,7698/20013
chadsnmbr score *,C0007928;C1413373,true;false,7699/20013
chadsnmbr scoreb,C0007928;C1413373,true;false,7700/20013
aiirocumab ( n = nmbr ),,,7701/20013
alirocumab ( n = nmbr ),C3491162,true,7702/20013
< nmbr enroll,,,7703/20013
> nmbr enroll,,,7704/20013
anacetrapib nmbr mg ( n = nmbr ),C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7705/20013
anacetrapib nmbrmg ( n = nmbr ),C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7706/20013
anacetrapib nmbr mg ( n - nmbr ),C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7707/20013
currently,C0521116,false,7708/20013
total stent length - mm,C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,7709/20013
body mass index > nmbr kg / mnmbr *,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7710/20013
body mass index < nmbr kg / mnmbr,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7711/20013
p inleraclion,C0369773;C2603361,false;false,7712/20013
p nmbr interaction,C0369773;C1704675;C2603361,false;false;false,7713/20013
p for interaction,C0369773;C1704675;C2603361,false;false;false,7714/20013
pfor interaction,C1151635;C1704675,false;false,7715/20013
p interaction,C0369773;C1704675;C2603361,false;false;false,7716/20013
pinteraction,,,7717/20013
p for interaction *,C0369773;C1704675;C2603361,false;false;false,7718/20013
interaction p,C1704675,false,7719/20013
age - interaction,C0001779;C1704675,false;false,7720/20013
interaction - p,C1704675,false,7721/20013
p - interaction,C0369773;C1704675;C2603361,false;false;false,7722/20013
p . interaction,C0369773;C1704675;C2603361,false;false;false,7723/20013
p : interaction,C0369773;C1704675;C2603361,false;false;false,7724/20013
p - interactio n,C0369773;C2603361,false;false,7725/20013
angiotensin receptor blockers,C0521942;C0815017,true;true,7726/20013
angiotensin receptor blocker yes,C0034787;C1549445;C1705108;C1710701;C1622222,true;false;false;false;true,7727/20013
angiotensin ii receptor blocker,C0521942;C3536793,true;false,7728/20013
angiotensin - receptor blocker,C0034787;C1622222,true;true,7729/20013
angiotensin receptor blocker,C0034787;C1622222,true;true,7730/20013
angiotensin ll - receptor blocker,C0003018;C4521302,true;false,7731/20013
creatinine — mg / dl,C0010294;C0439269;C1561535,true;false;false,7732/20013
creatinine ( mg / dl ),C0010294;C0439269;C1561535,true;false;false,7733/20013
fevnmbr ( % predicted ),C3714541,true,7734/20013
fevnmbr ( l ),C3714541,true,7735/20013
mean sitting sbp ( mmhg ),C0444504;C0277814;C0085805;C0439475;C2584297;C4050224;C2347634;C2348143,false;true;true;false;true;false;false;false,7736/20013
mean sitting dbp ( mmhg ),C0444504;C0277814;C0536221;C0439475;C3813197;C4281799;C2584297;C4050224;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false,7737/20013
potassium ( mmol / l ),C0032821;C1532563;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,7738/20013
potassium ( meq / l ),C0032821;C0439375;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,7739/20013
£ nmbr ( men ) / £ nmbr ( women ),C0025266;C0043210,true;true,7740/20013
< nmbr ( men ) / < nmbr ( women ),C0025266;C0043210,true;true,7741/20013
creat clearance < nmbr ml / min,C0201975;C0449297;C0439445;C1382187;C2825073;C4554548,false;false;false;false;false;false,7742/20013
creat clearance > nmbr ml / min,C0201975;C0449297;C0439445;C1382187;C2825073;C4554548,false;false;false;false;false;false,7743/20013
pre - bronchodilator,C2599602,false,7744/20013
prebronchodilator,C2599602,false,7745/20013
post - bronchodilator,C2599594,false,7746/20013
postbronchodilator,C2599594,false,7747/20013
heritable,C0439660,false,7748/20013
variable,C0439828;C4553760,false;false,7749/20013
apolipoprotein b ( mg / dl ),C0003593;C0439269,true;false,7750/20013
apolipoprotein b ( g / l ),C0003593;C0439294;C0456615,true;false;false,7751/20013
tiotropiumc,,,7752/20013
tiotropium,C0213771,true,7753/20013
no prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,7754/20013
prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,7755/20013
nyha iv,C1275491;C0022326;C4265176,false;true;false,7756/20013
nyha iii,C1275491;C0439070;C1705160,false;false;false,7757/20013
metabolic syndrome,C0524620,true,7758/20013
metabolic syndrome *,C0524620,true,7759/20013
tiotropium nmbr mg,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7760/20013
tiotropium nmbrmg,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7761/20013
tiotropium nmbr m g,C0213771;C0456715,true;false,7762/20013
pitavastatin nmbr mg,C1101838;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7763/20013
pravastatin nmbr mg,C0085542;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7764/20013
rosuvastatin nmbr mg,C0965129;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7765/20013
simvastatin nmbr mg,C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7766/20013
atorvastatin nmbr mg,C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7767/20013
fluvastatin nmbr mg,C0082608;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7768/20013
lovastatin nmbr mg,C0024027;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7769/20013
stage nmbrb : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0441781;C0439445;C0369637;C0441923,false;false;false;false,7770/20013
stage nmbra : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0205390;C1300072;C1306673,false;false;false,7771/20013
stage nmbr : nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0456533;C0439445,false;false,7772/20013
readmission ( n = nmbr ),C1548168;C4489276,false;false,7773/20013
no readmission ( n = nmbr ),C1548168;C4489276,false;false,7774/20013
nyha class iii,C1882086,false,7775/20013
nyha class iv,C1882087,false,7776/20013
nyha class,C1882083,false,7777/20013
nyha class ii,C1882085,false,7778/20013
nyha class > ii,C1882085,false,7779/20013
nyha class i,C1882084,false,7780/20013
no prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,7781/20013
prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,7782/20013
prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,7783/20013
no prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,7784/20013
prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,7785/20013
major cv event,C0205082;C3538987;C0441471;C4019010;C4048877;C4318503;C0205164;C4318856;C4521762,false;false;false;false;true;false;false;false;false,7786/20013
no prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,7787/20013
prior peripheralarterialdisease,C0332152;C2826257,false;false,7788/20013
prior peripheral arterial disease,C0332152;C0085096;C1704436;C2826257,false;true;true;false,7789/20013
pre - bronchodilator fevnmbr ( l ),C2599602;C3714541,false;true,7790/20013
postbronchodilator fevnmbr,C2599594;C3714541,false;true,7791/20013
prebronchodilator fevnmbr ( l ) t,C2599602;C3714541,false;true,7792/20013
post - bronchodilator fevnmbr ( l ) a,C2599594;C3714541,false;true,7793/20013
post - bronchodilator fevnmbr ( l ) *,C2599594;C3714541,false;true,7794/20013
prebronchodilator fevnmbr ( l ),C2599602;C3714541,false;true,7795/20013
prebronchodilator fevnmbr,C2599602;C3714541,false;true,7796/20013
post - bronchodilator fevnmbr ( l ),C2599594;C3714541,false;true,7797/20013
pre - bronchodilator fevnmbr,C2599602;C3714541,false;true,7798/20013
amlodipine / valsartan nmbr / nmbr mg ( n = nmbr ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7799/20013
amlodipine / valsartan nmbr / nmbr mg ( n = nmbri ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7800/20013
noncardiovascular,,,7801/20013
cardiovascular,C0007226;C3887460,true;false,7802/20013
etoricoxib ( n = nmbr,C0972314,true,7803/20013
etoricoxib ( n = nmbr nmbr ),C0972314,true,7804/20013
no previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,7805/20013
previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,7806/20013
asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,7807/20013
ics use at baseline,C0815320;C4551720,false;true,7808/20013
ics users at baseline,C0815320;C1706077;C0168634;C1442488;C4551720,false;false;true;false;true,7809/20013
icsusers atbaseline,,,7810/20013
mean fvc ± sd,C0444504;C3714541;C2699239;C2347634;C2348143,false;true;false;false;false,7811/20013
mean dlco ± sd,C0444504;C1516251;C2699239;C2347634;C2348143,false;false;false;false;false,7812/20013
saphenous vein graft,C0729538,false,7813/20013
saphenous - vein graft,C0729538,false,7814/20013
hypercholesterolemia *,C0020443;C1522133,true;false,7815/20013
hypercholesterolemiat,,,7816/20013
hypercholesterolaemia,C0020443;C1522133,true;false,7817/20013
one tnfi and,C0205447,false,7818/20013
one tnfi *,C0205447,false,7819/20013
with stent^l,C0038257,true,7820/20013
with stent,C0038257,true,7821/20013
without stent,C0038257,true,7822/20013
postmenopausal and current hrt,C0232970,false,7823/20013
postmenopausal and current ht,C0232970,false,7824/20013
end point,C2349179;C2826544,false;false,7825/20013
endpoint,C2349179;C2826544,false;false,7826/20013
end points,C2349179,false,7827/20013
endpointc,,,7828/20013
telmisartan ( n = nmbr ),C0248719,true,7829/20013
irbesartan ( n = nmbr ),C0288171,true,7830/20013
olmesartan ( n = nmbr ),C1098320,true,7831/20013
duration of rheumatoid arthritis,C0449238;C0003873;C2926735,false;true;false,7832/20013
duration of rheumatoid arthritis — yr,C0449238;C0003873;C0439234;C2926735,false;true;false;false,7833/20013
heart failure nmbr mo before admission,C0018801;C0026544;C0184666;C0809949;C0332177;C0018802;C4554158,true;true;false;false;false;true;false,7834/20013
heart failure nmbr month before admission,C0018801;C0332177;C0184666;C0809949;C0439231;C0018802;C4554158,true;false;false;false;false;true;false,7835/20013
no anemia bsl hb > nmbrg i - nmbr  yr nmbr > nmbrg i - nmbr,C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,true;false;true;false;true;false;false;false;false,7836/20013
new anemia bsl hb > nmbrg i - nmbr  yr nmbr < nmbrg i - nmbr,C0205314;C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,false;true;false;true;false;true;false;false;false;false,7837/20013
no previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,7838/20013
peripheral artery disease,C1704436;C4025272,true;false,7839/20013
peripheral - artery disease,C1704436;C4025272,true;false,7840/20013
peripheral artery disease *,C1704436;C4025272,true;false,7841/20013
peripheral artery diseasef,C0489868,false,7842/20013
history of pvd,C4534349,false,7843/20013
history of tia,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7844/20013
white race — no . / total no . ( % ) $,C0007457;C0043157;C0220938,true;true;false,7845/20013
white race — no . / total no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,7846/20013
aspirin nmbr,C0004057,true,7847/20013
aspirin nmbr mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7848/20013
total cholesterol ( mmol / l ),C0201950;C1532563;C0543421,false;false;false,7849/20013
total cholesterol ( mmol / l ) :,C0201950;C1532563;C0543421,false;false;false,7850/20013
no myocardial infarction at presentation ( n = nmbr ),C0027051;C0449450;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false,7851/20013
myocardial infarction at presentation ( n = nmbr ),C0027051;C0449450;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false,7852/20013
< nmbr mmol / l,C1532563,false,7853/20013
> nmbr mmol / l,C1532563,false,7854/20013
black / african american,C0085756,true,7855/20013
black or african - american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,7856/20013
black / african - american,C0085756,true,7857/20013
black or african american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,7858/20013
black or african america,C0005680;C0027567;C0085756;C0439541,true;true;true;false,7859/20013
black / african american *,C0085756,true,7860/20013
saxagliptin nmbr . nmbr mg ( n = nmbr ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7861/20013
saxagliptin nmbr . nmbr mg ( n z nmbr ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7862/20013
bmi ( kg / mnmbr ),C0578022;C1532718,false;false,7863/20013
bmi ( kg / mnmbr ) mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,7864/20013
bmi in kg / mnmbr,C0578022;C1532718,false;false,7865/20013
bmi ( kg / mnmbr ) mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,7866/20013
hazard ratio or differencenmbr * ( nmbr % cl ) p - value,C2985465,false,7867/20013
hazard ratio or differencenmbr ( nmbr % cl ) p - value,C2985465,false,7868/20013
history of hypertension ( a ) c,C0455527,false,7869/20013
history of hypertension ( % ),C0455527,false,7870/20013
aldosterone antagonists,C0002007;C2757004,true;false,7871/20013
aldosterone antagonist,C0002007;C2757004;C3536833,true;false;false,7872/20013
diastolic blood pressure ( mm hg ),C0428883;C0439475;C1305849,true;false;false,7873/20013
systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,7874/20013
length of stent > median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7875/20013
length of stent < median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7876/20013
£ median ( nmbr . nmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7877/20013
< median ( nmbr . nmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7878/20013
> median ( nmbr . nmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7879/20013
with previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,7880/20013
without previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,7881/20013
corticosteroids,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,7882/20013
corticosteroidsa,,,7883/20013
corticosteroid,C0001617;C3536709,true;false,7884/20013
full population,C0443225;C0032659;C1257890,false;true;true,7885/20013
full po pulatio n,C0443225;C0946289,false;false,7886/20013
no epa group n = nmbr,C0441848,false,7887/20013
epa group n = nmbr,C0441848,false,7888/20013
coronary artery disease — %,C0010054;C0010068;C1956346,true;true;true,7889/20013
coronary artery disease ( % ),C0010054;C0010068;C1956346,true;true;true,7890/20013
olodaterol nmbr m g,C2934193;C0456715,true;false,7891/20013
olodaterol nmbr mg,C2934193;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7892/20013
baseline : > nmbr . nmbr meq / l eos : < nmbr . nmbr meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,7893/20013
baseline : > nmbr . nmbr meq / l eos : > nmbr . nmbr meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,7894/20013
vitamin k antagonists,C3653316,false,7895/20013
vitamin k antagonist,C1096489;C2267235,false;false,7896/20013
off omt ( n = nmbr ),,,7897/20013
on omt ( n = nmbr ),,,7898/20013
ticlopidine,C0040207,true,7899/20013
ticlopidin,,,7900/20013
laba use at screening,C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;false;false;false;false;false;false;false,7901/20013
lama use at screening,C0999593;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1416775,false;true;true;true;false;false;false;false;false;false;false;false,7902/20013
dasnmbr - nmbr ( esr ) < nmbr . nmbr *,C0051767;C3811131;C0057671,true;false;true,7903/20013
dasnmbr - nmbr ( esr ) < nmbr . nmbrt,C0051767;C3811131;C0057671,true;false;true,7904/20013
modified acc / aha lesion class bnmbr / c,C0392747;C0101856;C0050451;C0221198;C0456387;C1518526;C1705943;C1546698;C0772110;C3889737,false;true;true;false;false;false;false;false;false;false,7905/20013
modified acc - aha lesion class bnmbr or c,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,7906/20013
modified acc / aha lesion class bnmbr or cj,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,7907/20013
modified acc or aha lesion class bnmbr or c,C0392747;C0175754;C0282160;C3541413;C3889737,false;true;true;false;false,7908/20013
mtss ( nmbr - nmbr ),,,7909/20013
vas ( nmbr - nmbr ),C0042815;C3536884;C3827561,true;true;false,7910/20013
oad only,C0205171;C1720467,false;false,7911/20013
diet only,C0012155;C0205171;C1720467;C0012159;C1519433;C2983588;C3668949,true;false;false;true;false;false;false,7912/20013
past only,C1444637;C0205171;C1720467;C4284302,false;false;false;false,7913/20013
cabg only,C0010055;C0205171;C1720467,true;false;false,7914/20013
dvt only,C0149871;C0205171;C1720467;C2926618;C3899446,true;false;false;false;false,7915/20013
ptca only,C2936173;C0205171;C1720467,true;false;false,7916/20013
ics only,C0815320;C0205171;C1720467;C4551720,false;false;false;true,7917/20013
< nmbr ml / min per nmbr - nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,7918/20013
> nmbr ml / min per nmbr - nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,7919/20013
gold stage,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,7920/20013
gold stage ii,C0018026;C0441767;C1304897,true;false;false,7921/20013
gold stage iv,C0018026;C0205390;C0022326;C4265176;C1300072;C1306673;C1304897,true;false;true;false;false;false;false,7922/20013
gold stage iii,C0018026;C0441771;C1304897,true;false;false,7923/20013
gold stage #,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,7924/20013
austrafca and new zealand,,,7925/20013
australia / new zealand,C4289954,false,7926/20013
australia and new zealand,C0004340,true,7927/20013
pravastatin,C0085542,true,7928/20013
subjects $ nmbr years of age,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,7929/20013
subjects,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,7930/20013
nmbr - nmbr vr — no . ( % ),C3476815,false,7931/20013
nmbr - nmbr yr — no . ( % ),C0439234,false,7932/20013
nmbr = nmbr yr — no . ( % ),C0439234,false,7933/20013
hdl cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,7934/20013
ldl - cholesterol ( mmol / ),C0023824;C0439190;C0202117,true;false;false,7935/20013
hdl cholesterol ( mmol / l ) :,C0023822;C1532563;C0392885,true;false;false,7936/20013
kdl cholesterol ( mmol / ),C0008377;C0439190,true;false,7937/20013
ldl - cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,7938/20013
ldl cholesterol ( mmol / l ) :,C0023824;C1532563;C0202117,true;false;false,7939/20013
ldl cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,7940/20013
hdl - cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,7941/20013
no renal dysfunction,C1565489;C3279454,true;false,7942/20013
renal dysfunction,C1565489;C3279454,true;false,7943/20013
< qnmbr ( nmbr . nmbr ) — number / n ( % ),C0237753;C0449788,false;false,7944/20013
> qnmbr ( nmbr . nmbr ) — number / n ( % ),C0237753;C0449788,false;false,7945/20013
p valuenmbr,C1709380,false,7946/20013
p value * nmbr,C1709380,false,7947/20013
eze / simva - nmbryr km rale ( % ),C0439234;C3887676;C0034642,false;false;true,7948/20013
pbo / simva - nmbryr km rale ( % ),C0031962;C0439234;C3887676;C0034642,true;false;false;true,7949/20013
inter .,C0205103;C1548610,false;false,7950/20013
intense,C0522510,false,7951/20013
< nmbr . nmbr kg / mnmbr,C1532718,false,7952/20013
nmbr - nmbr kg / mnmbr,C1532718,false,7953/20013
> nmbr . nmbr kg / mnmbr,C1532718,false,7954/20013
thiazide,C0541746,true,7955/20013
thiazides,C0541746,true,7956/20013
antiplatelet agents,C0085826,true,7957/20013
antiplatelet agent,C0085826,true,7958/20013
haemoglobin ( g / l ),C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,7959/20013
hemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,7960/20013
hemoglobin ( gm / dl ),C0019046;C0017480;C3642216;C3854019,true;true;false;true,7961/20013
haemoglobin,C0019046,true,7962/20013
hemoglobin — g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,7963/20013
usual care ( n = nmbrla ),C3538928;C1947933;C0023031;C0023749;C0230347;C2346906;C4553351,false;false;true;true;false;false;false,7964/20013
usual care ( n = nmbra ),C3538928;C1947933,false;false,7965/20013
usual care ( n = nmbr ),C3538928;C1947933,false;false,7966/20013
ace - inhibitors,C0003015,true,7967/20013
total ho population ( n = nmbr ),C3258257;C0019905;C1832110;C3889614,false;true;false;false,7968/20013
total population ( n = nmbr ),C3258257,false,7969/20013
mean age ( years ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,7970/20013
mean age ( yrs ),C0444504;C0001779;C2347634;C2348143,false;false;false;false,7971/20013
mean age — yr,C0444504;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false,7972/20013
waist - to - hip,C0230097;C0019552;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false,7973/20013
at index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,7974/20013
index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,7975/20013
chronic bronchitis !,C0008677,true,7976/20013
chronic bronchitis,C0008677,true,7977/20013
post - bronchodilation fevnmbr,C0439576;C3714541,false;true,7978/20013
pre - bronchodilation fevnmbr,C0439566;C3714541,false;true,7979/20013
exetimibe / simvastatin,C0074554,true,7980/20013
ezetimibe / simvastatin,C1532737,true,7981/20013
proton pump inhibitors,C0358591;C1384478;C3540020,true;false;false,7982/20013
proton - pump inhibitors,C0358591;C1384478;C3540020,true;false;false,7983/20013
proton - pump inhibitor,C0358591;C3536754;C4521480,true;false;false,7984/20013
proton pump inhibitor use,C0358591;C0042153;C0457083;C1947944;C3536754;C4521480,true;true;false;false;false;false,7985/20013
duration of tnmbrdm ( years ),C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,7986/20013
duration of tnmbrd ( years ),C0449238;C0439234;C2926735,false;false;false,7987/20013
anti platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,7988/20013
anti - platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,7989/20013
no antiplatelet therapy,C1096021,false,7990/20013
antiplatelet therapy,C1096021,false,7991/20013
antiplatelet therapy §,C1096021,false,7992/20013
diastolic blood pressurea,C0012000;C0005767;C0005768;C0229664,true;true;true;false,7993/20013
systolic blood pressure — mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,7994/20013
systolic blood pressure ( mmhg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,7995/20013
diastolic blood pressure ( mm hg ) :,C0428883;C0439475;C1305849,true;false;false,7996/20013
systolic blood pressurea,C0039155;C0005767;C0005768;C0229664,true;true;true;false,7997/20013
diastolic blood pressure - mmhg,C0428883;C0439475;C1305849,true;false;false,7998/20013
diastolic blood pressure ( mmhg ),C0428883;C0439475;C1305849,true;false;false,7999/20013
systolic blood pressure - mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8000/20013
diastolic blood pressure — mm hg,C0428883;C0439475;C1305849,true;false;false,8001/20013
mineralocorticoid receptor antagonist,C1579268,true,8002/20013
mineralocorticoid receptor antagonists,C1373021;C1579268,false;true,8003/20013
diet group ( n = nmbr ),C0012155;C0441848;C0012159;C1519433;C2983588;C3668949,true;false;true;false;false;false,8004/20013
stent group ( n = nmbr ),C0038257;C0441848,true;false,8005/20013
haq - di scoreff,C3826998;C4321476,false;false,8006/20013
haq - di scored,C3826998;C4321476,false;false,8007/20013
haq - di score,C3826998;C0449820;C4050231;C4321476,false;false;false;false,8008/20013
sirolimus,C0072980,true,8009/20013
everolimus,C0541315,true,8010/20013
in ambulance,C0002422;C3846685,true;false,8011/20013
p value for heterogeneity,C1709380;C0019409;C0242960,false;false;true,8012/20013
pvalue for heterogeneity,C0019409;C0242960,false;true,8013/20013
racea white,C0007457;C0043157;C0220938,true;true;false,8014/20013
nmbr . nmbr - nmbr . nmbr mg / l,C0439268,false,8015/20013
nmbr . nmbr - nmbr . nmbr mmol / l,C1532563,false,8016/20013
macroalbuminuria,,,8017/20013
microalbuminuria,C0730345,false,8018/20013
womac score,C0449820;C4050231,false;false,8019/20013
total score,C2964552,false,8020/20013
lacunar,C0241970;C1459585,false;false,8021/20013
vascular,C0005847;C1558950;C1801960,true;false;false,8022/20013
mean dlqi score ( nmbr % ci ),C0444504;C3899393;C2347634;C2348143,false;false;false;false,8023/20013
mean pasi score ( nmbr % ci ),C3533236;C4528685;C0008107;C3259781,false;false;true;false,8024/20013
race / ethnicity n ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8025/20013
race or ethnicity,C0034510;C1706779;C3853635,true;false;false,8026/20013
arial flutter or fibrillation,C0016385;C2242390,false;false,8027/20013
atrial flutter / fibrillation,C0155709,false,8028/20013
current smoker ( n z nmbr ),C3173209;C3241966,false;false,8029/20013
current smoker ( n = nmbr ),C3173209;C3241966,false;false,8030/20013
empagliflozin,C3490348,true,8031/20013
dapagliflozint,,,8032/20013
canagliflozin,C2974540,true,8033/20013
coronary - artery bypass grafting,C0010055,true,8034/20013
coronary artery bypass grafting,C0010055,true,8035/20013
coronary artery bypass graft,C0010055;C1260596,true;false,8036/20013
sex : male,C0086582,true,8037/20013
sexa male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8038/20013
sex : female,C0086287,true,8039/20013
sex ( female ),C0086287,true,8040/20013
contrast volume ( ml ),C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,8041/20013
crp — mg / liter^,C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;true;false;true;false;false;false;false;false;false,8042/20013
hscrp — mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,8043/20013
omega - nmbr fa intake nmbrnd third,C1719844;C1512806;C0205437,false;false;false,8044/20013
omega - nmbr fa intake nmbrst third,C1719844;C1512806;C0036056;C0205437;C3272372,false;false;true;false;false,8045/20013
omega - nmbr fa intake nmbr,C1719844;C1512806,false;false,8046/20013
mean ( sd ) pre - bronchodilator,C0444504;C2699239;C2599602;C2347634;C2348143,false;false;false;false;false,8047/20013
mean ( sd ) post - bronchodilator,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8048/20013
former smoking,C0205156;C0037369;C0453996;C1881674;C0750523,false;true;true;false;false,8049/20013
egfr > nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8050/20013
egfr > nmbr ml / min / nmbr - nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8051/20013
egfr < nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8052/20013
egfr > nmbr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8053/20013
egfr < nmbr ml / min / nmbr - nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8054/20013
egfr > nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8055/20013
egfr < nmbr ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8056/20013
egfr < nmbr ml / min / nmbr . nmbr mnmbr *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8057/20013
egfr £ nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8058/20013
egfr < nmbr ml / min / nmbr . nmbr mnmbr §,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8059/20013
egfr < nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8060/20013
primary outcomes,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8061/20013
primary outcome !,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8062/20013
primary outcome,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8063/20013
nmbr vessel,C0005847,true,8064/20013
nmbr vessels,C0005847,true,8065/20013
non - st - segment elevation mi,C1518422;C0520886;C3810814,false;false;false,8066/20013
non - st - segment elevation acs,C1518422;C0520886;C0742343;C4318612,false;false;true;false,8067/20013
rate ratio ( nmbr % ci ),C0871208;C0456603;C0008107;C3259781;C1547037;C1521828,false;false;true;false;false;false,8068/20013
rate ratio ( nmbr % cl ),C0871208;C0456603;C0596019;C1547037;C1521828,false;false;false;false;false,8069/20013
extensive colitisy,C0205231,false,8070/20013
extensive colitis,C0205231;C0009319;C1963084,false;true;false,8071/20013
lipid - lowering therapy — no . ( % ),C0585943,false,8072/20013
lipid - lowering therapy - no . ( % ),C0585943,false,8073/20013
patients with at least one concomitant disease *,C0030705;C0205447;C0243087,true;false;true,8074/20013
patients with at least one concomitant disease | |,C0030705;C0205447;C0243087,true;false;true,8075/20013
hyperlipidemia ( % ) §,C0020473;C0428465;C4555212,true;false;false,8076/20013
hyperlipidaemia ( % ),C0020473;C0428465;C4555212,true;false;false,8077/20013
hyperlipidemia ( % ),C0020473;C0428465;C4555212,true;false;false,8078/20013
diagnosed diabetes ( n = nmbr ),C0011900;C0011847;C0011849,true;false;true,8079/20013
undiagnosed diabetes ( n = nmbr ),C1408353;C0011847;C0011849,false;false;true,8080/20013
salmeterol ( n[nmbr ),C0073992,true,8081/20013
salmeterol ( n [nmbr ),C0073992,true,8082/20013
physician ' s judgment that vka inappropriate],C0031831;C0022423;C0804815,true;true;false,8083/20013
physician ' s judgment that vka inappropriate,C0031831;C0022423;C0804815,true;true;false,8084/20013
female simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,8085/20013
male simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8086/20013
western europe ( n = nmbr ),C0043129,true,8087/20013
eastern europe ( n = nmbr ),C0015177,true,8088/20013
elevated creatine kinase - mb ( > nmbr u / l ),C0151576;C0024853;C0439339;C0205250;C0010290;C0523584;C3163633,false;true;false;false;true;false;false,8089/20013
elevated creatine kinase mb ( > nmbr u / l ),C0151576;C0024853;C0439339;C0205250;C0010290;C0523584;C3163633,false;true;false;false;true;false;false,8090/20013
current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8091/20013
no current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8092/20013
bare metal,C0025552,true,8093/20013
bare - metal,C0025552,true,8094/20013
corticosteroid or azathioprine / nmbr - mercaptopurine,C0001617;C3536709,true;false,8095/20013
corticosteroid - azathioprine / nmbr - mercaptopurine,C0001617;C0004482;C0000618;C3536709,true;true;true;false,8096/20013
dapagliflozin nmbr mg,C2353951;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8097/20013
dapagliflozin nmbrmg,C2353951;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8098/20013
empagliflozin nmbr mg,C3490348;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8099/20013
ertugliflozin nmbr mg,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8100/20013
ics / lama,C0815320;C0999593;C1416775;C4551720,false;false;false;true,8101/20013
ics / laba,C0815320;C4551720,false;true,8102/20013
ics + laba,C0815320;C4551720,false;true,8103/20013
duration of disease — yr,C0872146;C0439234,false;false,8104/20013
duration of disease — mo,C0872146;C0026544;C0332177,false;true;false,8105/20013
eze + statin,C0360714,true,8106/20013
pbo + statin,C0031962;C0360714,true;true,8107/20013
ze + statin,C0360714,true,8108/20013
coronary endpoint,C0018787;C2349179;C2826544,true;false;false,8109/20013
coronary end point,C0018787;C2349179;C2826544,true;false;false,8110/20013
patients with baseline crp concentration £ nmbr mg / l,C0030705;C0168634;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,true;true;false;true;false;false;false;false;false,8111/20013
patients with baseline crp concentration < nmbr mg / l,C0030705;C0168634;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,true;true;false;true;false;false;false;false;false,8112/20013
none 一 no . ( % ),,,8113/20013
score 一 no . ( % ),C0449820;C4050231,false;false,8114/20013
female simva ( „ = nmbr },C0043210;C0086287;C1705497;C1705498,true;true;false;false,8115/20013
male simva ( „ = nmbr },C0086582;C1706180;C1706428;C1706429,true;false;false;false,8116/20013
aspirin — no . ( % ),C0004057,true,8117/20013
aspirin 一 no . ( % ),C0004057,true,8118/20013
adas — cog score,C3539026;C0449820;C4050231,false;false;false,8119/20013
adas - cog score *,C3539026;C0449820;C4050231,false;false;false,8120/20013
troponin nmbr at baseline *,C0041199;C0168634;C1442488,true;true;false,8121/20013
troponin nmbr at baseline,C0041199;C0168634;C1442488,true;true;false,8122/20013
lower limb fracture,C0023216;C0016658;C0441994;C0596838;C1548802;C2003888,true;true;false;false;false;false,8123/20013
upper limb fractures,C1140618,true,8124/20013
upper limb fracture,C0178316,false,8125/20013
lower limb fractures,C0023216,true,8126/20013
inflix,C0666743,true,8127/20013
east europe,C1707877;C0015176,false;true,8128/20013
e . europe,C0015176,true,8129/20013
w . europe,C0015176,true,8130/20013
eastern europe,C0015177,true,8131/20013
w est europe,C3811127;C0015176;C3890902,false;true;false,8132/20013
eastern european,C0239309,false,8133/20013
general health,C0424575;C4018875,false;false,8134/20013
mental health,C0025353,true,8135/20013
canakinumab dose ( per mo ),C2718773;C0178602;C0026544;C0332177;C0869039;C1114758,true;false;true;false;false;false,8136/20013
canakinumab dose ( per month ),C2718773;C0178602;C0332177;C0439231;C0869039;C1114758,true;false;false;false;false;false,8137/20013
age ( years ) : < nmbr,C1510829,false,8138/20013
age ( years ) : > nmbr,C1510829,false,8139/20013
chd status §,C0280604;C0449438;C3542407,false;false;false,8140/20013
chd status,C0280604;C0449438;C3542407,false;false;false,8141/20013
rheumatoid factor positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8142/20013
rheumatoid factor - positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8143/20013
priorheartfailure,,,8144/20013
prior heart failure yes,C0332152;C0018801;C1549445;C1705108;C1710701;C0018802;C4554158;C2826257,false;true;false;false;false;true;false;false,8145/20013
gender male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,8146/20013
metabolic syndrome * n = nmbr,C0524620,true,8147/20013
metabolic syndrome ( n = nmbr ),C0524620,true,8148/20013
nonmetabolic syndrome ( n = nmbr ),C0039082,true,8149/20013
bmi ( kg / mnmbr ) *,C0578022;C1532718,false;false,8150/20013
baseline bmi < nmbr kg / mnmbr,C0168634;C0578022;C1532718;C1442488,true;false;false;false,8151/20013
duration of assigned regimen before surgery post - randomisation characteristic *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8152/20013
duration of assigned regimen before surgery post - randomisation characteristic * *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8153/20013
no asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8154/20013
female eze / simva ( „ = nmbr },C0043210;C0086287;C1705497;C1705498,true;true;false;false,8155/20013
male eze / simva ( „ = nmbr },C0086582;C1706180;C1706428;C1706429,true;false;false;false,8156/20013
abdominal obesity *,C0311277,true,8157/20013
abdominal obesity,C0311277,true,8158/20013
cohort nmbr ( n = nmbr ),C0009247;C0599755,true;false,8159/20013
cohort nmbr ( n = nmbr ) f,C0009247;C0016327;C0599755,true;true;false,8160/20013
baseline hbanmbrc ( % ),C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,8161/20013
no aminosalicylates,C0368663,false,8162/20013
aminosalicylates * *,C0368663,false,8163/20013
vildagliptin nmbr mg qd,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,8164/20013
vildagliptin nmbr mg bid,C1570906;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8165/20013
< nmbr kg / mnmbr ( n — nmbr ),C1532718,false,8166/20013
> nmbr kg / mnmbr ( n — nmbr ),C1532718,false,8167/20013
baseline ldl - c > nmbr . nmbr to < nmbr . nmbr mmol / lc,C0168634;C0439190;C1442488,true;false;false,8168/20013
baseline ldl - c nmbr . nmbr to < nmbr . nmbr mmol / lc,C0168634;C0439190;C1442488,true;false;false,8169/20013
methotrexate use,C0025677;C0042153;C0457083;C1947944,true;true;false;false,8170/20013
methotrexate user,C0025677;C1548600;C1706077,true;false;false,8171/20013
bare - metal stent,C2825200,false,8172/20013
other ( n = nmbr ),C0369718;C0441922,false;false,8173/20013
other ( n — nmbr ),C0369718;C0441922,false;false,8174/20013
amputationsa,,,8175/20013
amputation,C0002688;C0332840;C1546539,true;false;false,8176/20013
p — value for interaction,C1709380;C1704675,false;false,8177/20013
p - value for interaction *,C1709380;C1704675,false;false,8178/20013
p value for interactiont,C1709380,false,8179/20013
p value for interaction,C1709380;C1704675,false;false,8180/20013
p - value for interaction,C1709380;C1704675,false;false,8181/20013
p value for interaction^,C1709380;C1704675,false;false,8182/20013
p value fo interactio,C1709380,false,8183/20013
waisthip ratio,C0205682;C0456603;C1547037,true;false;false,8184/20013
waist - hip ratio,C0205682,true,8185/20013
tnglycendes < median,,,8186/20013
tngtycerides a median,,,8187/20013
tngtycendes a median,,,8188/20013
tngtycerides < median,,,8189/20013
furosemide,C0016860,true,8190/20013
torsemide,C0076840,true,8191/20013
drinker ( % ) a,C0556338,false,8192/20013
drinker ( % ),C0556338,false,8193/20013
uncertain,C0087130;C4085655,true;false,8194/20013
uncerlain,,,8195/20013
mean diastolic blood pressure,C0428886;C0012000;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;true;false;false;false,8196/20013
mean systolic blood pressure,C0428886;C0039155;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;true;false;false;false,8197/20013
maximum cimt < median,C0806909;C0549183;C0876920;C2347635;C2348144;C2939193;C1552615;C2826546,false;false;false;false;false;false;false;false,8198/20013
maximum cimt a med an,C0806909;C1552615;C2826546,false;false;false,8199/20013
at clinic diastolic pressure > nmbr mm hg,C0002424;C0428883;C0439475;C0442592,true;true;false;false,8200/20013
at clinic systolic pressure > nmbr mm hg,C0002424;C0871470;C0439475;C0442592,true;true;false;false,8201/20013
at clinic systolic pressure < nmbr mm hg,C0002424;C0871470;C0439475;C0442592,true;true;false;false,8202/20013
at clinic diastolic pressure < nmbr mm hg,C0002424;C0428883;C0439475;C0442592,true;true;false;false,8203/20013
thiazolidinediones,C1257987;C3541957,true;false,8204/20013
thiazolidinedioneb,,,8205/20013
thiazolidinedione no,C0289779;C1257987;C3537039,true;true;false,8206/20013
thiazolidinedione,C0289779;C1257987;C3537039,true;true;false,8207/20013
thiazolidinedione yes,C0289779;C1549445;C1705108;C1710701;C1257987;C3537039,true;false;false;false;true;false,8208/20013
crcl < nmbr ml / min,C1846718;C0439445,false;false,8209/20013
crcl > nmbr ml / min,C1846718;C0439445,false;false,8210/20013
ecrcl < nmbr ml / min,C0439445,false,8211/20013
stroke or transient ischemic attack,C0038454;C4554100,true;false,8212/20013
stroke / transient ischemic attack,C0038454;C4554100,true;false,8213/20013
disease duration > nmbr years ( n = nmbr ),C0872146;C0439234,false;false,8214/20013
disease duration b nmbr years ( n = nmbr ),C0872146;C0439234,false;false,8215/20013
bmi ( kg / rrr ),C0578022;C0022718;C0439209;C4054209,false;true;false;false,8216/20013
bmi ( kg / m ),C0578022;C1532718,false;false,8217/20013
anterior ( n,C0205094,false,8218/20013
inferior ( n,C0542339;C0678975,false;false,8219/20013
blood pressure — mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8220/20013
blood pressure — mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8221/20013
blood pressure ( mm hg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,8222/20013
blood pressure ( mmhg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,8223/20013
non - st - elevation mi,C1518422;C0520886;C3810814,false;false;false,8224/20013
non - st — elevation mi,C1518422;C0520886;C3810814,false;false;false,8225/20013
non - st - elevation ml,C1518422;C0520886;C0439526;C1705224;C3887665,false;false;false;false;false,8226/20013
nmbr - nmbr . nmbr : overweight,C0497406,true,8227/20013
intention - to - treat with st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,8228/20013
intention - to - treat without st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,8229/20013
no history of cancer,C0455471,false,8230/20013
history of cancer,C0455471,false,8231/20013
antidiabetic agent,C0935929,true,8232/20013
antidiabetic agents,C0935929,true,8233/20013
age > = nmbr years old,C1510829,false,8234/20013
age < nmbr years old,C1510829,false,8235/20013
ics use at baseline : no,C0815320;C4551720,false;true,8236/20013
ics use at baseline : yes,C0815320;C4551720,false;true,8237/20013
crp $ nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,8238/20013
crp < nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,8239/20013
stent thrombosis *,C3897493,false,8240/20013
stent thrombosis,C3897493,false,8241/20013
high - dosage ics plus laba with baseline blood eosinophils > nmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8242/20013
high - dosage ics plus laba with baseline blood eosinophils anmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8243/20013
high - dosage ics plus laba with baseline blood eosinophils < nmbr cells per pl ( n = nmbr ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8244/20013
not hispanic or latino ( n = nmbr ),C1518424,false,8245/20013
not hispanic or latino ( n — nmbr ),C1518424,false,8246/20013
< nmbr mg / dl simva,C0439269,false,8247/20013
> nmbr mg / dl simva,C0439269,false,8248/20013
cardiovasculardeath,,,8249/20013
cardiovascular death !,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,8250/20013
cardiovascular death,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,8251/20013
mean body - mass index,C0444504;C0005893;C0578022;C1305855;C2347634;C2348143,false;false;false;true;false;false,8252/20013
mean body mass index,C0444504;C0005893;C0578022;C1305855;C2347634;C2348143,false;false;false;true;false;false,8253/20013
mean body mass index ( kg / mnmbr ) *,C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,8254/20013
mean body mass index ( kg / mnmbr ),C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,8255/20013
anmbr + enmbr ( n = nmbr ),C1272460,false,8256/20013
anmbr / nmbr ( n = nmbr ),C0369718;C0441922,false;false,8257/20013
nmbr - nmbr ( n = nmbr ),C0369718;C0441922,false;false,8258/20013
mean sd nmbr - h asbp,C0444504;C2699239;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;false;true;false;false;false;false;false;false,8259/20013
mean ± sd nmbr - h adbp,C0444504;C2699239;C0033727;C0168370;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false,8260/20013
egfr nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8261/20013
egfr nmbr – nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8262/20013
egfr nmbr - nmbr ml / min / nmbr . nmbrmnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8263/20013
nmbr - nmbr / month,C0332177;C0439231,false;false,8264/20013
nmbr - nmbr months,C0439231,false,8265/20013
with corticosteroid treatment < nmbr,C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;false;false;false;false;false,8266/20013
with corticosteroid treatment > nmbr,C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;false;false;false;false;false,8267/20013
postmenopausal and no ht,C0232970,false,8268/20013
poslmenopausal,,,8269/20013
postmenopausal and no hrt,C0232970,false,8270/20013
depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,8271/20013
depression^,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,8272/20013
no depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,8273/20013
concomitant medications,C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,8274/20013
concomitant medication,C0521115;C0013227;C3244316;C4284232,false;true;false;false,8275/20013
nmbr blocker,,,8276/20013
( nmbr - blockers,,,8277/20013
nmbr blockers,,,8278/20013
( nmbr blocker,,,8279/20013
/ nmbr - blockers,,,8280/20013
no prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,8281/20013
prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,8282/20013
prior stroke or tia,C0332152;C0038454;C4554100;C2826257,false;true;false;false,8283/20013
cv entry criteria,C3538987;C1705654;C0243161;C4048877;C4318503,false;false;true;true;false,8284/20013
entry criteria,C1705654;C0243161,false;true,8285/20013
mayo < nmbr,C0454788;C1077578,false;false,8286/20013
mayo $ nmbr,C0454788;C1077578,false;false,8287/20013
prior myocardial infarction — no . ( % ),C0155668,false,8288/20013
prior myocardial infarction 一 no . ( % ),C0155668,false,8289/20013
baseline ics use : no,C0168634;C0815320;C4551720;C1442488,true;false;true;false,8290/20013
baseline ics use : yes,C0168634;C0815320;C4551720;C1442488,true;false;true;false,8291/20013
jsn,,,8292/20013
all - cause mortality or hf hospitalization,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,8293/20013
all - cause mortality or hf hospitalization^,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,8294/20013
fbs < nmbr mg / dl,C3812213;C0439269,false;false,8295/20013
fbs > = nmbr mg / dl,C3812213;C0439269,false;false,8296/20013
amlodipine / valsartan nmbr / nmbr mg,C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8297/20013
amlodipine / wlsartan inmbr / nmbr mg,C0051696;C0021966;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0221138,true;true;true;true;false;false;false;false;false;false,8298/20013
all - cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,8299/20013
all cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,8300/20013
renal insufficiency / failure,C0035078;C0231179;C1963154;C0231174;C0680095;C1565489,true;false;false;false;false;true,8301/20013
renal insufficiency or failure,C0035078;C1565489,true;true,8302/20013
anticoagulants,C0003280,true,8303/20013
anti - coagulants,C0848112,false,8304/20013
anticoagulant,C0003280;C0848112;C3536711,true;false;false,8305/20013
oral corticosteroids,C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;true;false;false;false;false;false,8306/20013
oral corticosteroid,C0442027;C0001617;C3536709;C4521986,false;true;false;false,8307/20013
prior lower gi clinical event,C0332152;C0441994;C1708130;C0205210;C0441471;C4019010;C3539617;C4050121;C1548802;C2003888;C2826257,false;false;false;false;false;false;false;false;false;false;false,8308/20013
prior upper gi clinical event,C0332152;C0203057;C0205210;C0441471;C4019010;C2826257,false;false;false;false;false;false,8309/20013
complex anatomy ( n - nmbr,C0439855;C0002808;C0700276;C1384516;C1704241,false;true;false;true;false,8310/20013
noncomplex anatomy ( n - nmbr,C0002808;C0700276;C1384516,true;false;true,8311/20013
all cana,C1418845,false,8312/20013
all cancer,C0006826;C0998265;C1306459,true;false;false,8313/20013
ace inhibitors / arb,C0003015,true,8314/20013
ace inhibitor or arb,C0003015;C4541021,true;false,8315/20013
ace inhibitors and arb,C0003015,true,8316/20013
ace inhibitors or arb,C0003015,true,8317/20013
ace inhibitors or arbs,C0003015,true,8318/20013
ace inhibitors / arbs,C0003015;C3888198,true;false,8319/20013
physician ' s global assessment,C4050369,false,8320/20013
physician ' s global assessment !,C4050369,false,8321/20013
previous or current im use : no,C0205156;C1552607,false;false,8322/20013
previous or current cs use : no,C0205156;C1552607,false;false,8323/20013
baseline heart rate ( beat / min ),C0168634;C0425583;C0871208;C0702093;C1524029;C3813700;C1521828;C1442488,true;false;false;false;false;false;false;false,8324/20013
baseline heart rate ( beats / min ),C0168634;C0018810;C1442488,true;true;false,8325/20013
concomitant medication | |,C0521115;C0013227;C3244316;C4284232,false;true;false;false,8326/20013
body weight — kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,8327/20013
bodyweight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,8328/20013
body weighta,C0242821;C0460148;C1268086;C4082212,true;false;false;false,8329/20013
fev_ ( l ) :,C3714541,true,8330/20013
fvc,C3714541,true,8331/20013
fvc ( l ) ,C3714541,true,8332/20013
fvc ( l ) *,C3714541,true,8333/20013
fvc ( l ),C3714541,true,8334/20013
no fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8335/20013
fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8336/20013
nmbr to < nmbr ml / min,C0439445,false,8337/20013
> nmbr to < nmbr ml / min,C0439445,false,8338/20013
nmbr - < nmbr ml / min,C0439445,false,8339/20013
nmbr - nmbr ml / min,C0439445,false,8340/20013
met criterion at blt ( n [ % ] ),C0428210;C0243161;C1563149;C1708627;C1550543;C4317104,false;true;false;false;false;false,8341/20013
met criterion at bl ( n [ % ] ),C0428210;C0243161;C0005918;C0006413;C1552663;C2827109;C1550543;C4317104,false;true;true;true;false;false;false;false,8342/20013
( % ) ( nmbr . nmbr ),,,8343/20013
( % ) ( nmbr - nmbr ),,,8344/20013
post - bronchodilator fevnmbr reversibility,C2599594;C3714541;C0449261,false;true;false,8345/20013
postbronchodilator fevnmbr reversibility,C2599594;C3714541;C0449261,false;true;false,8346/20013
cigarette smoker,C0337667,false,8347/20013
daily dose nmbr mg n = nmbr,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,8348/20013
daily dose > nmbr mg n = nmbr,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,8349/20013
female ( n = nmbr,C0043210;C0086287;C1705497;C1705498,true;true;false;false,8350/20013
male ( n = nmbr,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8351/20013
hemoglobin ( g rnmbr ),C1319312;C0205090;C0684010;C2603358,false;false;true;false,8352/20013
hemoglobin ( g nmbr ! ),C1319312,false,8353/20013
with lipid - lowering agents,C0086440,true,8354/20013
without lipid - lowering agents,C0086440,true,8355/20013
macroalbuminuriaf,,,8356/20013
macro - albuminuria,C2984010;C0001925,false;true,8357/20013
micro - albuminuria,C0085672;C0001925;C1553035;C3811161;C4049106,false;true;false;false;false,8358/20013
egfr ( ml / min per nmbr - nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8359/20013
egfr ( ml / min per nmbr - nmbr mnmbr ) t,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8360/20013
macroalbuminuria — no . / total no . ( % ),,,8361/20013
microalbuminuria — no . / total no . ( % ),C0730345,false,8362/20013
chd simva,C0280604;C3542407,false;false,8363/20013
no chd simva,C0280604;C3542407,false;false,8364/20013
> nmbr . nmbr mu / l $ mmol / l,C0439342;C0439190,false;false,8365/20013
< nmbr . nmbr mu / l $ mmol / l,C0439342;C0439190,false;false,8366/20013
stage nmbra : > = nmbr and < nmbr,C0205390;C1300072;C1306673,false;false;false,8367/20013
stage nmbrb : > = nmbr and < nmbr,C0441781,false,8368/20013
post - bronchodilator screening fevnmbr ml,C2599594;C0220908;C3714541;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;true;false;false;false;false;false,8369/20013
pre - bronchodilator screening fevnmbr ml,C2599602;C0220908;C3714541;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;true;false;false;false;false;false,8370/20013
duration of hypercholesterolaemia  mean ± sd ( year ),C0449238;C0020443;C0444504;C2699239;C0439234;C0439508;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false;false,8371/20013
duration of hypercholesterolemia  mean ± sd ( years ),C0449238;C0020443;C0444504;C2699239;C0439234;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false,8372/20013
< nmbr with no historical count > nmbr,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,8373/20013
< nmbr with historical count > nmbr,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,8374/20013
baseline hbalc > nmbr . nmbr % ( nmbr mmol / mol ) nmbr,C0168634;C3829066;C1442488,true;false;false,8375/20013
baseline hbalc < nmbr . nmbr % ( nmbr mmol / mol ) nmbr,C0168634;C3829066;C1442488,true;false;false,8376/20013
difference from placebo ( nmbr % ci ),C1705241;C0032042;C0008107;C3259781;C1696465;C1706408;C1705242,false;true;true;false;false;false;false,8377/20013
difference from placebo * ( nmbr % ci ),C1705241;C0032042;C0008107;C3259781;C1696465;C1706408;C1705242,false;true;true;false;false;false;false,8378/20013
central eosinophil count ( cells per pl ),C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,8379/20013
central eosinophil count ( cells per pl ) t,C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,8380/20013
other anti - platelet agents,C0040616;C0005821,true;true,8381/20013
other forms of atherosclerosis^,C0348078;C0003850;C0004153;C0376315,false;true;true;true,8382/20013
other forms of atherosclerosis ’,C0348078;C0003850;C0004153;C0376315,false;true;true;true,8383/20013
race or ethnic group — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,8384/20013
prior smoker,C0337671,false,8385/20013
prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,8386/20013
no prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,8387/20013
mean ± s . d . fpg,C0444504;C2347634;C2348143,false;false;false,8388/20013
mean ( s . d . ) fpg,C0444504;C2347634;C2348143,false;false;false,8389/20013
troponin i ( pg / ml ),C0077401;C0439297,true;false,8390/20013
troponin t ( pg / ml ),C0077404;C0439297;C1420827,true;false;false,8391/20013
> nmbr ml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,8392/20013
≥ nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,8393/20013
< nmbr ml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,8394/20013
> nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,8395/20013
ischemia - driven revascularization,C0022116;C4321499,true;false,8396/20013
ischemia driven revascularization,C0022116;C4321499,true;false,8397/20013
timi minor,,,8398/20013
timi major,,,8399/20013
history of major microvascular disease,C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,8400/20013
history of major macrovascular disease,C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,8401/20013
pre - bronchodilation fvc,C0439566;C3714541,false;true,8402/20013
post - bronchodilation fvc,C0439576;C3714541,false;true,8403/20013
nmbr . nmbr ( nmbr . nmbr – nmbr . nmbr ),,,8404/20013
nmbr . nmbr ( nmbr . nmbr - nmbr . nmbr ),,,8405/20013
nmbr . nmbr ( nmbr . nmbr . nmbr . nmbr ),,,8406/20013
history of macrovascular disease ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,8407/20013
history of microvascular disease ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,8408/20013
patient characteristics,C0815172,false,8409/20013
patients ' characteristics,C0815172,false,8410/20013
treatment with anti - platelet drugs,C0039798;C2963157;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,8411/20013
treatment with antiplatelet drugs,C3469597,false,8412/20013
one - vessel disease,C3275121,false,8413/20013
two - vessel disease,C0581375,false,8414/20013
ethnicity,C0015031;C0243103,true;true,8415/20013
ind / glyb n = nmbr,C4049864;C1415124,false;false,8416/20013
ind / gly n = nmbr,C4049864;C0017890;C0523677,false;true;false,8417/20013
non - hispanic / latino,C1518424;C0086528,false;true,8418/20013
not hispanic or latino,C1518424,false,8419/20013
not hispanic / latino,C1518424;C0086528,false;true,8420/20013
north american,C0425358;C2700615,false;false,8421/20013
north america,C0028405,true,8422/20013
south africa,C0037712,true,8423/20013
south american,C0425359,false,8424/20013
sou ti africa,C0039247;C0001737;C0040302;C1553045;C1704756,true;true;true;false;false,8425/20013
south america,C0037713,true,8426/20013
northamerica,,,8427/20013
bloodpressure,C0005823;C1271104;C1272641,true;false;true,8428/20013
tiotropium / olodaterol nmbr . nmbr / nmbr mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8429/20013
tiotropium + olodaterol nmbr . nmbr / nmbr mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8430/20013
tiotropium + olodaterol nmbr . nmbr / nmbr pg,C4032878;C0030827;C0072225;C1266240,true;true;true;false,8431/20013
postamendment,,,8432/20013
preamendment,C1548596,false,8433/20013
fasting glucose — mg / dl,C0015663;C0017725;C0439269,true;true;false,8434/20013
fasting glucose ( mg / dl ),C0015663;C0017725;C0439269,true;true;false,8435/20013
mean systolic bp,C0444504;C0871470;C2347634;C2348143,false;true;false;false,8436/20013
mean diastolic bp,C0444504;C0428883;C2347634;C2348143,false;true;false;false,8437/20013
number of prior aeds,C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,8438/20013
mean ( sd ) sdai *,C0444504;C2699239;C3871128;C2347634;C2348143,false;false;false;false;false,8439/20013
mean ( sd ) cdai *,C0444504;C2699239;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false;false,8440/20013
age > nmbr yearsnmbr,C1510829,false,8441/20013
age < nmbr yearsnmbr,C1510829,false,8442/20013
baseline systolic blood pressure ( mm hg ),C4274438;C0439475,false;false,8443/20013
baseline diastolic blood pressure ( mm hg ),C4274392;C0439475,false;false,8444/20013
adp antagonist,C0523452;C0231491,false;false,8445/20013
tnf antagonist,C1448177;C0231491,true;false,8446/20013
vildagliptin nmbr mg bid n = nmbr,C1570906;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8447/20013
vildagliptin nmbr mg qd n = nmbr,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,8448/20013
migraine with aura,C0154723,true,8449/20013
migraine without aura,C0338480,true,8450/20013
previous cancerc,C0205156;C1552607,false;false,8451/20013
lipid - lowering drugs,C0086440,true,8452/20013
lipid - lowerinq druq,C0023779,true,8453/20013
lipid - lowering drug,C0086440,true,8454/20013
des type,C0011702;C0332307;C1547052;C4551552,true;false;false;true,8455/20013
acs type,C0742343;C0332307;C1547052;C4318612,true;false;false;false,8456/20013
fevnmbr ( post - albuterol ),C3714541,true,8457/20013
fevnmbr ( pre - albuterol ),C3714541;C0332152;C0001927;C0740175;C2257086;C3669034,true;false;true;false;false;false,8458/20013
p blockers ( % ),C0369773;C2603361,false;false,8459/20013
p - blocker ( % ),C0369773;C2603361,false;false,8460/20013
severe or very severe,C0205082;C4050465;C4050466,false;false;false,8461/20013
severe / very severea,C0205082;C0442824;C2984081;C4050465;C4050466,false;false;false;false;false,8462/20013
difference ( nmbr % cl ),C1705241;C0596019;C1705242,false;false;false,8463/20013
difference ( nmbr % ci ) *,C1705241;C0008107;C3259781;C1705242,false;true;false;false,8464/20013
nmbr months,C0439231,false,8465/20013
nmbr mentis,,,8466/20013
nmbr mortis,,,8467/20013
nmbr montlts,,,8468/20013
seated sbp,C0277814;C0085805;C1283233,true;true;false,8469/20013
seated dbp,C0277814;C0536221;C3813197;C4281799;C1283233,true;true;false;false;false,8470/20013
alcohol abuse,C0085762;C4050601,true;false,8471/20013
alcohol use,C0001948,true,8472/20013
> nmbr microg / l,,,8473/20013
< nmbr microg / l,,,8474/20013
tobacco abuse,C0040336,true,8475/20013
tobacco use,C0040335;C0543414;C0841002;C3853727,false;true;false;false,8476/20013
hospital stay ( days ),C3489408;C0439228,true;false,8477/20013
hospital stay,C3489408,true,8478/20013
fevnmbr — % of predicted value,C3714541;C0681842;C1522609;C1882327,true;false;false;false,8479/20013
fevnmbr ( % of predicted value ),C3714541;C0681842;C1522609;C1882327,true;false;false;false,8480/20013
maternal history,C0559473,false,8481/20013
paternal history,C0424909,false,8482/20013
plp - c,C0034266;C1175541;C1257874;C1705623,true;true;true;false,8483/20013
nmbr drinks / wk,C0452428,false,8484/20013
> nmbr drinks / week,C0452428,false,8485/20013
nmbr + drinks / wk,C0452428,false,8486/20013
> nmbr drinks / wk,C0452428,false,8487/20013
prior hypertension yes,C0332152;C0020538;C1549445;C1705108;C1710701;C1963138;C2826257,false;true;false;false;false;false;false,8488/20013
prior hypertensiona yes,C0332152;C1549445;C1705108;C1710701;C2826257,false;false;false;false;false,8489/20013
drug - related ae *,C0013227;C0439849;C3887670;C0445223;C1254351,true;false;false;false;false,8490/20013
drug - related teaes *,C0013227;C0439849;C0445223;C1254351,true;false;false;false,8491/20013
subgroup p valuef,C1079230;C1515021,false;false,8492/20013
subgroup p value 本,C1079230;C1709380;C1515021,false;false;false,8493/20013
white ethnic origin,C0007457;C0015031;C0043157;C0220938,true;true;true;false,8494/20013
while ethnic origin,,,8495/20013
> nmbr yr since menopause,C0439234,false,8496/20013
< nmbr yr since menopause,C0439234,false,8497/20013
ls mean difference ( nmbr % ci ),C0023668;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,true;false;false;true;false;false;false;false,8498/20013
( mean difference,C0444504;C1705241;C1705242;C2347634;C2348143,false;false;false;false;false,8499/20013
( mean % difference,C0444504;C1705241;C1705242;C2347634;C2348143,false;false;false;false;false,8500/20013
reversibility : < nmbr %,C0449261,false,8501/20013
reversibility : > nmbr %,C0449261,false,8502/20013
male eze / simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8503/20013
all ez / simva,C0206578,true,8504/20013
female eze / simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,8505/20013
glycated hemoglobin - % ’,C0017853,true,8506/20013
glycated hemoglobin ( % ),C0017853,true,8507/20013
glycated hemoglobin — %,C0017853,true,8508/20013
glycated haemoglobin ( % ),C0017853,true,8509/20013
anmbrc ( mmol / mol ),C3829066,false,8510/20013
hbanmbrc ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,8511/20013
arterial hypertension *,C0020538,true,8512/20013
intervention,C0184661;C0886296;C1273869,true;false;false,8513/20013
interruption,C0332453;C1512900,false;false,8514/20013
waist circumference ( cm ),C0455829,true,8515/20013
waist circumference — cm,C0455829,true,8516/20013
total cholesterol — mg / dl,C0201950;C0439269;C0543421,false;false;false,8517/20013
toial cholcsierol ( mg / dl ),C0439269,false,8518/20013
no change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,8519/20013
> nmbr ml / min,C0439445,false,8520/20013
£ nmbr ml / min,C0439445,false,8521/20013
< nmbr ml / min,C0439445,false,8522/20013
smoking history ( pack - years ),C1519384;C1277691,false;false,8523/20013
smoking history ( pack - yr ),C1519384;C1968515;C0439234;C2825051;C2828395,false;false;false;false;false,8524/20013
dm + ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,8525/20013
dm - ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,8526/20013
without beta blocker,C0001645,true,8527/20013
with beta blocker,C0001645,true,8528/20013
timi risk score !,C0035647;C0449820;C4050231;C4552904,true;false;false;false,8529/20013
timi risk score,C0035647;C0449820;C4050231;C4552904,true;false;false;false,8530/20013
angiotensin - converting enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,8531/20013
angiotensin - converting - enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,8532/20013
total asthma symptom score,C3533163;C0004096;C2984299,false;true;false,8533/20013
total asthma symptom score :,C3533163;C0004096;C2984299,false;true;false,8534/20013
uric acid fertile nmbr ( > nmbr . nmbr mg / dl ),C0041980;C0015895;C0439269,true;true;false,8535/20013
uric acid tertile nmbr ( < nmbr . nmbr mg / dl ),C0041980;C0439269,true;false,8536/20013
uric acid tertile nmbr ( > nmbr . nmbr mg / dl ),C0041980;C0439269,true;false,8537/20013
> nmbr . nmbr mmol / liter,C0439190;C0475211,false;false,8538/20013
> nmbr . nmbr mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,8539/20013
< nmbr . nmbr mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,8540/20013
< nmbr . nmbr mmol / liter,C0439190;C0475211,false;false,8541/20013
< nmbr . nmbr pmol / liter,C0439192;C0475211,false;false,8542/20013
age ( years ) - < median ( n = nmbr,C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8543/20013
age ( years ) - > = median ( n = nmbr,C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8544/20013
macrovascular disease,C0012634,true,8545/20013
microvascular disease,C0443258;C0012634,false;true,8546/20013
vorapaxar ( n = nmbr . nmbr ),C2974521,true,8547/20013
vorapaxar ( n = nmbr nmbr ),C2974521,true,8548/20013
vorapaxar ( n = nmbr,C2974521,true,8549/20013
risk difference,C0035647;C1705241;C1705242;C4552904,true;false;false;false,8550/20013
lsm difference,C1705241;C1705242,false;false,8551/20013
aspirin ( n = nmbr,C0004057,true,8552/20013
aspirin ( n = nmbr nmbr ),C0004057,true,8553/20013
rosuvastatin +,C0965129,true,8554/20013
metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,8555/20013
no metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,8556/20013
prior revascularization,C0332152;C0581603;C2826257,false;false;false,8557/20013
pci revascularization,C4049621;C0581603,false;false,8558/20013
ldl - c : hdl - c,C3715113,false,8559/20013
ldl - c / hdl - c,C3715113,false,8560/20013
ldl - c / hdl - cx,C3715113,false,8561/20013
oral agents,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,8562/20013
two agents,C0205448;C0450442;C1254351;C1521826,false;false;false;false,8563/20013
ras agents,C0034678;C0450442;C1254351;C1521826;C0525678,true;false;false;false;true,8564/20013
mean ( sd ) fevnmbr ( l ) pre - bronchodilator,C0444504;C2699239;C3714541;C2599602;C2347634;C2348143,false;false;true;false;false;false,8565/20013
mean ( sd ) fevnmbr ( l ) post - bronchodilator,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,8566/20013
< nmbr years simva ( n = nmbr },C0439234,false,8567/20013
> nmbr years simva ( „ = nmbr },C0439234,false,8568/20013
bmi > nmbr kg / mnmbr,C0578022;C1532718,false;false,8569/20013
bmi < nmbr kg / mnmbr,C0578022;C1532718,false;false,8570/20013
bmi < nmbrkg / mnmbr,C0578022;C1532718,false;false,8571/20013
bmi > = nmbrkg / mnmbr,C0578022;C1532718,false;false,8572/20013
physical function,C0516981;C4049916,false;false,8573/20013
physical functioning,C0516981;C4049916,false;false,8574/20013
ldl - c ( mg / dl ),C0439269,false,8575/20013
hdl - c ( mg / dl ),C3715113;C0439269,false;false,8576/20013
regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,8577/20013
no regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,8578/20013
> nmbr beats / min,,,8579/20013
< nmbr beats / min,,,8580/20013
antiplatelets,,,8581/20013
antiplatelet,,,8582/20013
characteristics,C1521970,false,8583/20013
characteristic,C1521970,false,8584/20013
hypokalemia,C0020621;C4553966,true;false,8585/20013
hvookalemia,,,8586/20013
hyperkalemiab,,,8587/20013
hungary,C0020174,true,8588/20013
surgery,C0038894;C0038895;C0543467;C1274039,false;true;true;true,8589/20013
baseline uacr < nmbr mg / g,C0168634;C1300563;C1442488,true;false;false,8590/20013
baseline uacr > nmbr mg / g,C0168634;C1300563;C1442488,true;false;false,8591/20013
insulin plus nmbr oral agent,C0021641;C0442027;C0450442;C1254351;C1521826;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false,8592/20013
insulin plus > nmbr oral agent,C0021641;C0442027;C0450442;C1254351;C1521826;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false,8593/20013
long - acting nitrates,C0205166;C0079613;C0028125;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;true;false;false;false,8594/20013
long acting nitratef,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,8595/20013
long - acting nitrate,C0205166;C0079613;C0028125;C0699857;C3848573;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;false;true;false;false;false,8596/20013
ischaemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,8597/20013
hscrp < nmbr . nmbr mg / l,C0439268,false,8598/20013
hscrp > nmbr . nmbr mg / l,C0439268,false,8599/20013
hscrp > nmbr . nmbr mga .,C0065879,true,8600/20013
hs - crp > nmbr . nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,8601/20013
hs - crp < nmbr . nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,8602/20013
hs - crp < nmbr . nmbr g / l,C3890735;C0439294;C0456615;C4048285,false;false;false;false,8603/20013
creatine clearance,C0373595,false,8604/20013
creatinine clearance ( ml / min ),C0812399;C0439445,false;false,8605/20013
total cholesterolnmbr < nmbr mg / dl,C0201950;C0439269;C0543421,false;false;false,8606/20013
total cholesterolnmbr > nmbr mg / dl,C0201950;C0439269;C0543421,false;false;false,8607/20013
rosuvastatin n ( rate ) *,C0965129;C0871208;C1521828,true;false;false,8608/20013
rosuvastatin n ( rate ),C0965129;C0871208;C1521828,true;false;false,8609/20013
tiotropium / olodaterol nmbr / nmbr mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8610/20013
tiotropium + olodaterol nmbr / nmbr mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8611/20013
tiotropium + olodaterol nmbr / nmbr pg,C4032878;C0030827;C0072225;C1266240,true;true;true;false,8612/20013
cardiac failure *,C0018801;C0018802,true;true,8613/20013
cardiac failure §,C0018801;C0018802,true;true,8614/20013
major cardiovascular event,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,8615/20013
major cardiovascular event *,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,8616/20013
major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,8617/20013
no concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,8618/20013
concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,8619/20013
triglycerides - mg / dl * *,C0041004;C0439269,true;false,8620/20013
triglycerides ( mg / dl ) * *,C0041004;C0439269,true;false,8621/20013
nmbr - < nmbr months,C0439231,false,8622/20013
received nmbr prior biologic therapies,C1514756;C0278947,false;false,8623/20013
received nmbr prior biologic therapy,C1514756;C0278947,false;false,8624/20013
immunosuppressants onlyff,C0021081,true,8625/20013
immunosuppressants only,C0021081;C0205171;C1720467,true;false;false,8626/20013
mtx > nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,8627/20013
mtx £ nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,8628/20013
active smoking,C0205177;C0037369;C0453996;C1881674;C3853793;C3888249,false;true;true;false;false;false,8629/20013
active smoker,C0205177;C0337664;C3853793;C3888249,false;true;false;false,8630/20013
demographic,C0011298,true,8631/20013
demographics,C0011298;C1704791,true;false,8632/20013
demography,C0011298,true,8633/20013
no stroke ( n = nmbr ),C0038454;C4554100,true;false,8634/20013
any stroke ( n = nmbr ),C0038454;C4554100,true;false,8635/20013
left main,C0205091;C0205225;C1542147;C0443246;C1552822,false;false;false;false;false,8636/20013
back pain,C0004604;C1963071;C4553945,true;false;false,8637/20013
neck pain,C0007859;C1963180;C4553909,true;false;false,8638/20013
rest pain,C0234253,false,8639/20013
< nmbr mg / dl eze / simva,C0439269,false,8640/20013
> nmbr mg / dl eze / simva,C0439269,false,8641/20013
no st depression or elevation,C0520887,false,8642/20013
st depression or elevation,C0520887,false,8643/20013
medication use at baseline,C0240320;C0168634;C1442488,false;true;false,8644/20013
medications at baseline,C0013227;C0168634;C1442488;C0802604;C2598133;C4284232,true;true;false;false;false;false,8645/20013
history of atrial fibrillation or fl utter,C0729790,false,8646/20013
statin without other llt,C0360714;C2347090,true;false,8647/20013
statin with other llt,C0360714;C2347090,true;false,8648/20013
< qnmbr ( nmbr ) — number / n ( % ),C0237753;C0449788,false;false,8649/20013
> qnmbr ( nmbr ) — number / n ( % ),C0237753;C0449788,false;false,8650/20013
time from qualifying mi,C0040223;C1514624;C3810814;C3541383,true;false;false;false,8651/20013
prior history of ml or ischemic stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,8652/20013
prior history of mi or ischaemic stroke,C0332152;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;true;false;false;false;false;false,8653/20013
hazard ratio ( nmbr % confi dence interval ),C2985465;C1272706;C1552654;C1552713,false;false;false;false,8654/20013
hazard ratio ( nmbr % confidence interval ),C2985465;C0009667,false;true,8655/20013
hazard ratio ( nmbr % confidence interval ) *,C2985465;C0009667,false;true,8656/20013
with antiplatelets,,,8657/20013
without antiplatelets,,,8658/20013
range : min,C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,8659/20013
range ( min,C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,8660/20013
aml nmbr mg / hctz nmbr mg,C0023465;C1319635;C0020261;C0023467,true;false;true;true,8661/20013
om nmbr mg / hctz nmbr mg,C0028971;C1319635;C0020261;C1705272,true;false;true;false,8662/20013
insulin therapy,C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,true;true;true;false;false;false;false,8663/20013
noninsulin therapy,C0039798;C0087111;C1363945,true;true;false,8664/20013
mean ± sd ( yr ),C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false,8665/20013
mean ± sd ( n ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,8666/20013
stage nmbr : > nmbr ml / min / nmbr . nmbr mnmbr,C0456533;C0439445,false;false,8667/20013
stage nmbr : < nmbr ml / min / nmbr . nmbr mnmbr,C0456533;C0439445,false;false,8668/20013
median ( qnmbr,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,8669/20013
median ( qnmbr : qnmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,8670/20013
bmi category ( % ),C0578022;C0683312;C3889287,false;false;false,8671/20013
age category ( % ),C0001779;C0683312;C3889287,false;false;false,8672/20013
supplementary oxygen,C0030054,true,8673/20013
supplemental oxygen,C4534306,false,8674/20013
fvc ( liters ),C3714541;C0475211,true;false,8675/20013
fvc — liters,C3714541;C0475211,true;false,8676/20013
> nmbr years of age,C1510829,false,8677/20013
< nmbr years of age,C1510829,false,8678/20013
$ nmbr exacerbations,C4086268,false,8679/20013
nmbr exacerbation,C4086268,false,8680/20013
> nmbr exacerbations,C4086268,false,8681/20013
nmbr exacerbations,C4086268,false,8682/20013
history of mi ( n = nmbr,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8683/20013
no history of mi ( n = nmbr,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8684/20013
vka therapy,C0039798;C0087111;C1363945,true;true;false,8685/20013
dual therapy,C0205173;C0039798;C0087111;C1363945;C1554184,false;true;true;false;false,8686/20013
nt - probnp ， pmol / h,C0669479;C0439192;C0033727;C0369286;C0441932;C0564385;C4528284;C0754710,true;false;true;false;false;false;false;true,8687/20013
antihypertensives,C0003364,true,8688/20013
ldl - c ( mmol / l,C1532563,false,8689/20013
hdl - c ( mmol / l,C3715113;C1532563,false;false,8690/20013
all patients ( « = nmbr nmbr ),C0030705,true,8691/20013
all patients ( n = nmbr,C0030705,true,8692/20013
eastern europe ( % ),C0015177,true,8693/20013
western europe ( % ),C0043129,true,8694/20013
om nmbrmg / aml nmbr mg,C0028971;C1319635;C0023465;C0023467;C1705272,true;false;true;true;false,8695/20013
om nmbr mg / aml nmbr mg,C0028971;C1319635;C0023465;C0023467;C1705272,true;false;true;true;false,8696/20013
ischaemic heart disease,C0010054;C0151744,true;true,8697/20013
asia pacific,C0003980,true,8698/20013
asia - pacific,C0003980,true,8699/20013
asia / pacific,C0003980,true,8700/20013
previous coronary revascularization,C0205156;C0877341;C1552607,false;false;false,8701/20013
previous coronary revascularisation,C0205156;C0877341;C1552607,false;false;false,8702/20013
corticosteroid use at baseline - no,C0239126;C0168634;C1442488,false;true;false,8703/20013
corticosteroid use at baseline - yes,C0239126;C0168634;C1549445;C1705108;C1710701;C1442488,false;true;false;false;false;false,8704/20013
serum triglycerides — mmol / liter,C0542495;C0439190;C0475211,false;false;false,8705/20013
serum triglycerides — pmol / liter,C0542495;C0439192;C0475211,false;false;false,8706/20013
angina pectoris 本,C0002962,true,8707/20013
angina pectoris *,C0002962,true,8708/20013
angina pectorisf,C0002962,true,8709/20013
alc > = nmbr . nmbr %,C1424945;C3811058,false;false,8710/20013
alc < nmbr . nmbr %,C1424945;C3811058,false;false,8711/20013
major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,8712/20013
minor bleeding,C0026193;C0019080;C0205165,true;true;false,8713/20013
a from baselineb,,,8714/20013
a from baseline,C0168634;C1442488,true;false,8715/20013
bmi : < nmbr . nmbr kg / mnmbr,C0578022;C1532718,false;false,8716/20013
bmi : > nmbr . nmbr kg / mnmbr,C0578022;C1532718,false;false,8717/20013
mayo score,C0454788;C0449820;C4050231;C1077578,false;false;false;false,8718/20013
mayo score ( mean ± sd ),C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578,false;false;false;false;false;false;false;false,8719/20013
total ( n = nmbr nmbr ),C0439175;C0439810,false;false,8720/20013
> median ( nmbr . nmbr years ) — number / n ( % ),C0549183;C0439234;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,8721/20013
< median ( nmbr . nmbr years ) — number / n ( % ),C0549183;C0439234;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,8722/20013
difference vs placebo * *,C1705241;C1705242,false;false,8723/20013
difference vs placebo ',C1705241;C1705242,false;false,8724/20013
difference vs . placebo,C1705241;C1705242,false;false,8725/20013
avm % △ ( se ),C0003857;C0036919;C0279476,true;true;false,8726/20013
met % △ ( se ),C0428210;C0036919;C1550543;C4317104,false;true;false;false,8727/20013
chronic kidney diseased,C2364010,false,8728/20013
estimated difference %,C0750572;C1705241;C1705242,false;false;false,8729/20013
estimated difference,C0750572;C1705241;C1705242,false;false;false,8730/20013
u . s . site,C0041703;C0205145;C1515974;C2825164,true;false;false;false,8731/20013
u . s . sites,C0041703;C0205145,true;false,8732/20013
history of diabetes ( n = nmbr ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,8733/20013
no history of diabetes ( n = nmbr ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,8734/20013
posterior circulation,C0205095;C0005775;C1516559,false;true;false,8735/20013
anterior circulation,C0205094;C0005775;C1516559,false;true;false,8736/20013
insulin yes,C0021641;C1549445;C1705108;C1710701;C1533581;C1579433;C3714501,true;false;false;false;false;false;false,8737/20013
insulin use,C0240016,false,8738/20013
insulin based,C0021641;C1533581;C1579433;C3714501,true;false;false;false,8739/20013
non - black race and ss > nmbr ( n = nmbr vs nmbr ),C1518422;C0005680,false;true,8740/20013
non - black race and ss < nmbr ( n = nmbr vs nmbr ),C1518422;C0005680,false;true,8741/20013
family history of diabetes ( % ) *,C1313937,false,8742/20013
family history of diabetes ( - ),C1313937,false,8743/20013
family history of diabetes ( + ),C1313937,false,8744/20013
duration ofdiabetes — yr,C0449238;C0439234;C2926735,false;false;false,8745/20013
duration of diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,8746/20013
duration of diabetes — yr,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,8747/20013
duration of diabetes ( y ),C0449238;C0011847;C0011849;C2926735,false;false;true;false,8748/20013
duration of diabetes ( years ) t,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,8749/20013
duration diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,8750/20013
at index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,8751/20013
moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,8752/20013
moderate ’,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,8753/20013
moderatey,,,8754/20013
no moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,8755/20013
weight < nmbr . nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8756/20013
history of microvascular disease,C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,8757/20013
history of macrovascular disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,8758/20013
disease duration ( years ),C0872146;C0439234,false;false,8759/20013
baseline characteristics,C4684572,false,8760/20013
baseline characteristic,C0168634;C1442488,true;false,8761/20013
patients without chronic,C0030705;C0205191,true;false,8762/20013
patients with chronic,C0030705;C0205191,true;false,8763/20013
baseline egfr < nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,8764/20013
baseline egfr < nmbr ml / min / nmbr . nmbr mnmbrc,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,8765/20013
baseline egfr > nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,8766/20013
tchdl - c,,,8767/20013
symptomatic pad,C0231220;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false;false,8768/20013
symptomatic padt,C0231220,false,8769/20013
statin during admission,C0360714;C0184666;C0809949,true;false;false,8770/20013
no statin during admission,C0360714;C0184666;C0809949,true;false;false,8771/20013
rosuvastatin events / patients ( % ),C0965129;C0441471;C0030705;C3541888,true;false;true;false,8772/20013
average weekly mtx dose ( mg / week ),C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,8773/20013
average weekly mtx dose ( mg / week ) t,C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,8774/20013
all teaes *,,,8775/20013
all teaes,,,8776/20013
mild teaes,C2945599,false,8777/20013
death ( all - cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,8778/20013
death ( all cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,8779/20013
qnmbr : > nmbr . nmbr kg ( n = nmbrvsnmbr ),C0022718;C0439209;C4054209,true;false;false,8780/20013
qnmbr : < nmbr . nmbr kg ( n = nmbrvsnmbr ),C0022718;C0439209;C4054209,true;false;false,8781/20013
> = nmbr years ( placebo n = nmbr  nmbr  saxagliptin n = nmbr  nmbr ),C0439234;C0032042;C1611934;C1696465;C1706408,false;true;true;false;false,8782/20013
< nmbr years ( placebo n = nmbr  nmbr  saxagliptin n = nmbr  nmbr ),C0439234;C0032042;C1611934;C1696465;C1706408,false;true;true;false;false,8783/20013
without psoriasis ( zi = nmbr,C0033860;C0043476,true;true,8784/20013
without psoriasis ( n = nmbr,C0033860,true,8785/20013
heart rate > nmbr bpm,C0018810,true,8786/20013
heart rate < nmbr bpm,C0018810,true,8787/20013
inferior,C0542339;C0678975,false;false,8788/20013
non - anterior,C1518422;C0205094,false;false,8789/20013
nonanterior,,,8790/20013
not anterior,C1518422;C0205094,false;false,8791/20013
anterior,C0205094,false,8792/20013
hyperlipidaemia,C0020473;C0428465;C4555212,true;false;false,8793/20013
hyperlipidemia^,C0020473;C0428465;C4555212,true;false;false,8794/20013
left - sided colitisz,C0205091;C0443246,false;false,8795/20013
left sided colitis,C2887821,false,8796/20013
left - sided colitis,C2887821,false,8797/20013
nadroparin ( n = nmbr ),C0206232,true,8798/20013
no nadroparin ( n = nmbr ),C0206232,true,8799/20013
social functioning,C0037395,true,8800/20013
social function,C0037395,true,8801/20013
eze / simva,,,8802/20013
ez / simva,C0206578,true,8803/20013
aniagonisi,,,8804/20013
antagonist,C0231491,false,8805/20013
all - cause death n,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,8806/20013
all - cause death,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,8807/20013
family history of cancera,C0241889,true,8808/20013
family history of cancerf,C0241889,true,8809/20013
indacaterol nmbr mg,C1722260;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8810/20013
indacaterol nmbr pg,C1722260;C0030827;C0072225;C1266240,true;true;true;false,8811/20013
liraglutide nmbr . nmbr mg n = nmbr,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8812/20013
liraglutide nmbr - nmbr mg ( n = nmbr ),C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8813/20013
liraglutide nmbr . nmbr mg ( n = nmbr ),C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8814/20013
fevnmbr pre - bronchodilator,C3714541;C2599602,true;false,8815/20013
ace - inhibitors / arbs,C0003015;C3888198,true;false,8816/20013
increase creatinine,C0442805;C0010294;C1561535,false;true;false,8817/20013
> nmbr . nmbr ( % ),,,8818/20013
< nmbr . nmbr ( % ),,,8819/20013
baseline lipid and lipoprotein values,C0168634;C0023779;C1442488,true;true;false,8820/20013
baseline lipid / lipoprotem values,C0168634;C0023779;C0042295;C1442488,true;true;false;false,8821/20013
baseline lipid / lipoprotein values,C0168634;C0443602;C0042295;C1442488,true;false;false;false,8822/20013
previous stroke *,C0205156;C0038454;C4554100;C1552607,false;true;false;false,8823/20013
hypertension — no . ( % ),C0020538;C1963138,true;false,8824/20013
hypertension — no . ( % ) |,C0020538;C1963138,true;false,8825/20013
overall ( n = unmbr ),C0282416;C0439148;C1561607,true;false;false,8826/20013
overall ( n = nmbr ),C0282416;C1561607,true;false,8827/20013
history of diabetes :,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,8828/20013
history of diabetes,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,8829/20013
history of hypertension *,C0455527,false,8830/20013
patients receiving enl,C0030705,true,8831/20013
patients receiving lcz,C0030705,true,8832/20013
urinary albumin : creatinine ratioa ( mg / g ),C0455271;C1300563;C1318330,false;false;false,8833/20013
urinary albumin : creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,8834/20013
indian ( american ) or alaska native,C1524069;C0596070,false;false,8835/20013
indian ( american ) or alaskan native,C1524069;C0596070,false;false,8836/20013
saxagliptin nmbr mg,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8837/20013
saxagliptin nmbrmg,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8838/20013
mssbp < nmbrmmhg,C0439475,false,8839/20013
mssbp > nmbrmmhg,C0439475,false,8840/20013
infarct localisation,C0021308;C0475264;C1744691,true;false;false,8841/20013
placebo group ( n = nmbr ),C0032042;C0441848;C1696465;C1706408,true;false;false;false,8842/20013
placebo group ( n = nmbr ) f,C0032042;C0441848;C0016327;C1696465;C1706408,true;false;true;false;false,8843/20013
sjc ( nmbr joints ),C0022417;C0392905,true;false,8844/20013
sjc ( / nmbr joints ),C0022417;C0392905,true;false,8845/20013
tjc ( / nmbr joints ),C0022417;C0392905,true;false,8846/20013
tjc ( nmbr joints ),C0022417;C0392905,true;false,8847/20013
oral anticoagulants,C0354604,false,8848/20013
ischemia,C0022116;C4321499,true;false,8849/20013
disease characteristics,C0599878,false,8850/20013
disease characteristics *,C0599878,false,8851/20013
ara functional class,C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,8852/20013
teaes ( > nmbr % in any treatment group ) *,C0374505,false,8853/20013
teaes ( > nmbr % in any treatment group ),C0374505,false,8854/20013
history myocardial infarction,C0155668;C1275835,false;false,8855/20013
acq - nmbr score *,C2919686,false,8856/20013
npi - nmbr score *,C1412208;C1549728;C3539727,false;false;false,8857/20013
acq - nmbr scoret,C2919686,false,8858/20013
nmbr - h ppg ( mmol / l ),C2827804;C1418888,false;false,8859/20013
nmbr - h ppg ( mmol / l ) *,C2827804;C1418888,false;false,8860/20013
nmbr - h pg ( mmol / l ),C2827798;C0439190;C2827804;C0030827;C0072225;C1266240,false;false;false;true;true;false,8861/20013
fvc post - bronchodilator,C3714541,true,8862/20013
fvc pre - bronchodilator,C3714541;C2599602,true;false,8863/20013
baseline su dose < nmbr / nmbr maximal,C0168634;C0038642;C0178602;C0869039;C1114758;C1705534;C1442488,true;true;false;false;false;false;false,8864/20013
baseline su dose > nmbr / nmbr maximal,C0168634;C0038642;C0178602;C0869039;C1114758;C1705534;C1442488,true;true;false;false;false;false;false,8865/20013
mean sd ldl - c,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8866/20013
mean sd hdl - c,C0444504;C2699239;C3715113;C2347634;C2348143,false;false;false;false;false,8867/20013
laa closure,C0185003;C1521802,false;false,8868/20013
pfo closure,C0185003;C1521802,false;false,8869/20013
cdai < nmbr . nmbr *,C0683448;C1413248;C3273706,false;false;false,8870/20013
sdai < nmbr . nmbr *,C3871128,false,8871/20013
nyha class — no . ( % ) $,C1882083,false,8872/20013
nyha class — no . ( % ),C1882083,false,8873/20013
drug - eluting,C0013227;C1254351,true;false,8874/20013
drug eluting,C0013227;C1254351,true;false,8875/20013
homa - p,,,8876/20013
no . of patients with psa,C0030705,true,8877/20013
no . of patients with ra,C0030705,true,8878/20013
no . of patients with as,C0030705,true,8879/20013
ng ( n = nmbr,C0017887;C0028074,true;true,8880/20013
no ( n = nmbr,C0369718;C0441922,false;false,8881/20013
nmbr ( n = nmbr,C0369718;C0441922,false;false,8882/20013
sf - nmbrvnmbr mcs,C0037712,true,8883/20013
sf - nmbrvnmbr pcs,C0037712;C1864389;C1882368,true;false;true,8884/20013
regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,8885/20013
no regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,8886/20013
hospitalization for acs,C0019993;C0742343;C4318612,true;true;false,8887/20013
hospitalization for,C0019993,true,8888/20013
hospitalization for hf,C0019993;C0018488;C1313497;C1538440;C3273279,true;true;true;false;false,8889/20013
pbo + mtx to mtx,C0031962;C0025677;C1417487,true;true;false,8890/20013
czp + mtx to mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,8891/20013
aiirocumab,,,8892/20013
alirocumab,C3491162,true,8893/20013
hispanic or latino ethnic groupf,C0086409,true,8894/20013
hispanic or latino ethnic group !,C0086409,true,8895/20013
hispanic or latino ethnic groupb,C0086409,true,8896/20013
hispanic or latino ethnic group *,C0086409,true,8897/20013
prior aspirin,C0332152;C0004057;C2826257,false;true;false,8898/20013
no prior aspirin,C0332152;C0004057;C2826257,false;true;false,8899/20013
medication,C0013227;C3244316;C4284232,true;false;false,8900/20013
medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,8901/20013
medication — no . ( % ),C0013227;C3244316;C4284232,true;false;false,8902/20013
medications . no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,8903/20013
eze + statin n = nmbr,C0360714,true,8904/20013
pbo + statin n = nmbr,C0031962;C0360714,true;true,8905/20013
incidence *,C0021149;C0220856,true;true,8906/20013
incidence,C0021149;C0220856,true;true,8907/20013
incidencea,,,8908/20013
asia pacific or other,C0003980,true,8909/20013
asia pacific and other,C0003980,true,8910/20013
apo b : apo a - i ratio,C0003593;C0085201;C0456603;C1547037;C1677784;C3252643,true;true;false;false;true;true,8911/20013
apob : apoal ratio,C0003593;C0456603;C1547037;C3252643,true;false;false;true,8912/20013
apob : apoa - l ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,8913/20013
saxa + met n = nmbr,,,8914/20013
dapa + met n = nmbr,,,8915/20013
patients with uncomplicated events,C0030705;C0443334;C0441471;C3541888,true;false;false;false,8916/20013
patients with complicated events,C0030705;C0231242;C0441471;C3541888,true;false;false;false,8917/20013
sf - nmbr mcs,C0037712,true,8918/20013
sf - nmbr pcs,C0037712;C1864389;C1882368,true;false;true,8919/20013
systolic blood pressure subgroups,C0488055;C1079230;C0871470;C1306620,false;false;true;false,8920/20013
diastolic blood pressure subgroups,C0428883;C1079230;C1305849,true;false;false,8921/20013
losartan,C0126174,true,8922/20013
persistent,C0205322;C0332996,false;false,8923/20013
persistent af,C0205322;C0344434;C4049859;C0332996,false;false;false;false,8924/20013
ukpds nmbr - year risk score < nmbr %,C0439234;C0035647;C0449820;C4050231;C4552904;C0439508,false;true;false;false;false;false,8925/20013
ukpds nmbr - year risk score > nmbr %,C0439234;C0035647;C0449820;C4050231;C4552904;C0439508,false;true;false;false;false;false,8926/20013
sirolimus - eluting,C0072980,true,8927/20013
everolimus - eluting,C0541315,true,8928/20013
immunosuppressants,C0021081,true,8929/20013
immunosuppressant^^,C0021081,true,8930/20013
medication use,C0240320,false,8931/20013
education *,C0013621;C0013622;C0013658;C0039401,true;true;true;true,8932/20013
medications *,C0013227;C0802604;C2598133;C4284232,true;false;false;false,8933/20013
sgrq total score * ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,8934/20013
sgrq total score ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,8935/20013
total no .,C0439175;C0439810,false;false,8936/20013
total body,C0229960,false,8937/20013
ind / gly ( n = nmbr ),C4049864;C0017890;C0523677,false;true;false,8938/20013
ind + pbo ( n = nmbr ),C4049864;C0031962,false;true,8939/20013
ind + gly ( n = nmbr ),C4049864;C0017890;C0523677,false;true;false,8940/20013
score of $ nmbr,C0449820;C4050231,false;false,8941/20013
score of # nmbr,C0449820;C4050231,false;false,8942/20013
body - mass index ( kg / m ' ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,8943/20013
body - mass index ( kg / m - ) !,C0005893;C1532718;C0578022;C1305855,false;false;false;true,8944/20013
body - mass index ( kg / m - ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,8945/20013
time to treatment initiation ( min ,C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,8946/20013
time to treatment initiation ( min ),C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,8947/20013
patients with microalbuminuria at baseline,C0030705;C0730345,true;false,8948/20013
patients with macroalbuminuria at baseline,C0030705,true,8949/20013
atrial fibrillation !,C0004238;C0344434;C1963067,true;false;false,8950/20013
atrial fibrillation ( % ),C0004238;C0344434;C1963067,true;false;false,8951/20013
prior tnf antagonist treatment - no,C1514463;C1448177;C0231491,false;true;false,8952/20013
prior tnf antagonist treatment - yes,C1514463;C1448177;C0231491;C1549445;C1705108;C1710701,false;true;false;false;false;false,8953/20013
pt baseline ( week nmbr ),C0032743;C0168634;C0332174;C0439230;C1442488;C0699718,true;true;false;false;false;false,8954/20013
db baseline ( week nmbr ),C1418892;C0168634;C0332174;C0439230;C1442488,false;true;false;false;false,8955/20013
odds ratio ( nmbr % ci ),C0028873;C0008107;C3259781,true;true;false,8956/20013
odds ratio ( nmbr % cl ),C0028873;C0596019,true;false,8957/20013
ethnicity - no . ( % ),C0015031;C0243103,true;true,8958/20013
physical examination,C0031809;C1744699,true;false,8959/20013
physical examinations,C0031809,true,8960/20013
ileum and colon,C0020885,true,8961/20013
ileum or colon,C0020885,true,8962/20013
killip class > ii ( % ),C2697845,false,8963/20013
qrs < nmbr msec,C0439223,false,8964/20013
qrs > nmbr ms *,C2349943;C3539704;C3713294,false;false;true,8965/20013
< nmbr % blood eosinophils at baseline,C0014467;C0168634;C1442488,true;true;false,8966/20013
> nmbr % blood eosinophils at baseline,C0014467;C0168634;C1442488,true;true;false,8967/20013
czp nmbr mg ( n nmbr ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,8968/20013
czp nmbr mg ( nnmbr ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,8969/20013
age ( median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8970/20013
atrial fibrillation or flutter,C0004238;C0344434;C1963067,true;false;false,8971/20013
metformin,C0025598,true,8972/20013
no metformin,C0025598,true,8973/20013
q wave,C0429089;C1305738,false;false,8974/20013
q wave mi,C0861151,false,8975/20013
q - wave mi,C0861151,false,8976/20013
hand fracture,C0435632,false,8977/20013
hip fracture,C0019557;C0149531;C4552776,true;false;false,8978/20013
canagliflozin ( n = nmbr ),C2974540,true,8979/20013
empagliflozin ( n = nmbr ),C3490348,true,8980/20013
post - bronchodilator fevnmbr / fvc,C2599594;C3714541,false;true,8981/20013
postbronchodilator fevnmbr / fvc,C2599594;C3714541,false;true,8982/20013
smoker ( % ),C0337664,true,8983/20013
smoker ( % ) a,C0337664,true,8984/20013
ast,C1415181;C3891303,false;false,8985/20013
non - hdl - c ( mmol / l ),C1518422;C3715113;C1532563,false;false;false,8986/20013
menopause and ht,C0025320;C0567312,true;false,8987/20013
menopause and hrt,C0025320;C0567312,true;false,8988/20013
minimum - maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,8989/20013
minimum : maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,8990/20013
patients < nmbr %,C0030705,true,8991/20013
patients > nmbr %,C0030705,true,8992/20013
women ( n = nmbr vs nmbr ),C0043210,true,8993/20013
men ( n = nmbr vs nmbr ),C0025266,true,8994/20013
men ( n = nmbr nmbr ),C0025266,true,8995/20013
diastolic — mean ( sd ) ( mm hg ),C0012000;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8996/20013
systolic — mean ( sd ) ( mm hg ),C0039155;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8997/20013
active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,8998/20013
no active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,8999/20013
ac tve cancer,C0001246;C0006826;C0998265;C1306459;C0003354;C1412573;C2000891;C3539770,true;true;false;false;true;false;true;false,9000/20013
physical activity,C0015259;C0026606,true;true,9001/20013
loop or thiazide diuretic,C0445022,false,9002/20013
loop or thiazide diuretic #,C0445022,false,9003/20013
total population,C3258257,false,9004/20013
total population n,C3258257,false,9005/20013
interruption ( n = nmbr ),C0332453;C1512900,false;false,9006/20013
intervention ( n = nmbr ),C0184661;C0886296;C1273869,true;false;false,9007/20013
non - st - segment elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9008/20013
non — st - segment — elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9009/20013
% risk reduction ( nmbr % ci ),C1137094;C0008107;C3259781,true;true;false,9010/20013
risk reduction ( nmbr % cl ),C1137094;C0596019,true;false,9011/20013
use of beta - blocker,C1524063;C0001645,false;true,9012/20013
use of beta - blockers,C1524063;C0001645,false;true,9013/20013
hf hospitalization,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,9014/20013
hf hospitalization n,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,9015/20013
hospitalization,C0019993,true,9016/20013
r elative risk ( nmbr % ci ),C0205090;C0233492;C0035647;C0008107;C3259781;C4552904;C0684010;C2603358,false;false;true;true;false;false;true;false,9017/20013
relative risk ( nmbr % ci ),C0242492;C0008107;C3259781,true;true;false,9018/20013
relative risk ( nmbr % cl ),C0242492;C0596019,true;false,9019/20013
> nmbr . nmbr ( n — nmbr ),C0369718;C0441922,false;false,9020/20013
< nmbr . nmbr ( n — nmbr ),C0369718;C0441922,false;false,9021/20013
mi > nmbr months *,C3810814;C0439231,false;false,9022/20013
mi < nmbr months *,C3810814;C0439231,false;false,9023/20013
> nmbr months — number / n ( % ),C0439231;C0237753;C0449788,false;false;false,9024/20013
< nmbr months — number / n ( % ),C0439231;C0237753;C0449788,false;false;false,9025/20013
all n = nmbr nmbr,C0369718;C0441922,false;false,9026/20013
any clinical or lesion rf for st,C0205210,false,9027/20013
no clinical or lesion rfs for st,C0205210,false,9028/20013
neuropathy,C0442874,false,9029/20013
nephropathy,C0022658,true,9030/20013
hbanmbrc > nmbr % ( n nmbr nmbr ),C0019016;C1825777;C3538758,true;false;false,9031/20013
hbanmbrc < = nmbr % ( n nmbr nmbr ),C0019016;C1825777;C3538758,true;false;false,9032/20013
am △ 士 s . e .,C3813124;C3890196;C4520798,false;false;false,9033/20013
ama 士 s . e .,C0002461;C0279755;C2825862,true;false;false,9034/20013
im or cs use : no,,,9035/20013
im and cs use : no,,,9036/20013
hdlnmbr - c,C3715113,false,9037/20013
ldlnmbr - c,,,9038/20013
at randomization,C0034656,true,9039/20013
randomization,C0034656,true,9040/20013
to randomization,C0034656,true,9041/20013
> nmbr years simva,C0439234,false,9042/20013
< nmbr years simva,C0439234,false,9043/20013
simvastatin nmbr mg ( n = nmbr ) *,C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9044/20013
simvastatin nmbr mg ( n = nmbr ),C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9045/20013
hispanic or latino ( n — nmbr ),C0086409,true,9046/20013
hispanic or latino ( n = nmbr ),C0086409,true,9047/20013
copd exacerbation : yes,C0740304;C1549445;C1705108;C1710701,false;false;false;false,9048/20013
copd exacerbation : no,C0740304,false,9049/20013
hdl cholesterol > nmbr - nmbr mmol / l,C0023822;C1532563;C0392885,true;false;false,9050/20013
ldl cholesterol < nmbr - nmbr mmol / l,C0023824;C1532563;C0202117,true;false;false,9051/20013
ldl cholesterol > nmbr - nmbr mmol / l,C0023824;C1532563;C0202117,true;false;false,9052/20013
hdl cholesterol < nmbr - nmbr mmol / l,C0023822;C1532563;C0392885,true;false;false,9053/20013
sex ( male ),C0086582,true,9054/20013
adjusted p - value for interaction,C0456081;C1709380;C1704675,false;false;false,9055/20013
unadjusted p - value for interaction,C1439367;C1709380;C1704675,false;false;false,9056/20013
no chd eze / simva,C0280604;C3542407,false;false,9057/20013
chd eze / simva,C0280604;C3542407,false;false,9058/20013
aspirin use ( p = nmbr - nmbrt ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,9059/20013
aspirin use ( p = nmbr - nmbr 十 ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,9060/20013
dapagliflozin nmbr mg ( n = nmbr ),C2353951;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9061/20013
ertugliflozin nmbr mg ( n = nmbr ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9062/20013
empagliflozin nmbr mg ( n = nmbr ),C3490348;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9063/20013
prior coronary artery bypass grafting,C0332152;C0010055;C2826257,false;true;false,9064/20013
prior coronary artery bypass graft,C0332152;C0010055;C1260596;C2826257,false;true;false;false,9065/20013
cholesterol ( mmol / l ),C0008377;C1532563,true;false,9066/20013
insulin ( pmol / l ),C0021641;C0439284;C1533581;C1579433;C3714501,true;false;false;false;false,9067/20013
proprotein convertase subtil / kexin typnmbr ( ng / ml ) - baseline - < median ( n = nmbr,C1100660;C0165249;C1414185;C0439275;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488;C3811813,true;true;false;false;true;false;false;false;false;false;false;false,9068/20013
proprotein convertase subtil / kexin typnmbr ( ng / ml ) - baseline - > = median ( n = nmbr,C1100660;C0165249;C1414185;C0439275;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488;C3811813,true;true;false;false;true;false;false;false;false;false;false;false,9069/20013
( mmol / l],C1532563,false,9070/20013
mmol / mol,C3829066,false,9071/20013
mmol / l,C1532563,false,9072/20013
wc ( cm ),C0013123;C2825512,true;false,9073/20013
rr ( cl ),C4554402;C0596019,false;false,9074/20013
patient ' s global assessment,C4054229,false,9075/20013
patient ' s global assessment !,C4054229,false,9076/20013
patient ' s global assessment of,C4054229,false,9077/20013
no epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,9078/20013
epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,9079/20013
cox hr ( nmbr % ci ),C1565830;C0008107;C3259781,true;true;false,9080/20013
cmh rr ( nmbr % ci ),C4554402;C0008107;C3259781,false;true;false,9081/20013
coronary revascularization,C0877341,false,9082/20013
coronary revascularisation,C0877341,false,9083/20013
n - nmbr pufa ( n = nmbr ),C0369718;C0032615;C0441922,false;true;false,9084/20013
n - nmbr - pufa ( n = nmbr ),C0369718;C0032615;C0441922,false;true;false,9085/20013
antihypertensive agents *,C0003364,true,9086/20013
mean ( sd ) bmi,C0444504;C2699239;C0578022;C2347634;C2348143,false;false;false;false;false,9087/20013
non - high density lipoprotein ( mg / dl ) - baseline - > = median ( n = nmbr,C1535899;C0439269;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;false;false;false;false;false,9088/20013
non - high density lipoprotein ( mg / dl ) - baseline - < median ( n = nmbr,C1535899;C0439269;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;false;false;false;false;false,9089/20013
aldosterone blockers,C0002006,true,9090/20013
adjusted hr ( nmbr % ci ),C0456081;C0008107;C3259781,false;true;false,9091/20013
adjusted hr ( nmbr % cl ),C0456081;C0596019,false;false,9092/20013
cohort nmbr ( uacr < nmbr . nmbr mg / g ),C0009247;C1300563;C0599755,true;false;false,9093/20013
cohort nmbr ( uacr > nmbr . nmbr mg / g ),C0009247;C1300563;C0599755,true;false;false,9094/20013
no extensive colitis,C0205231;C0009319;C1963084,false;true;false,9095/20013
prior migraine,C0332152;C0149931;C2826257,false;true;false,9096/20013
prior migraine *,C0332152;C0149931;C2826257,false;true;false,9097/20013
primary endpoint death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,9098/20013
primary end point : death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,9099/20013
difference from placebo,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,9100/20013
difference from placeboa,C1705241;C1705242,false;false,9101/20013
difference from placebo ¥,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,9102/20013
standing after nmbr minute change from baseline,C0231472;C0439232;C0392747;C0443172;C1705241;C4319952;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false;false;false;false;false,9103/20013
standing after nmbr minutes change from baseline,C0231472;C0439232;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false,9104/20013
american indian or alaskan native,C0002460,true,9105/20013
american indian / alaska native,C0002460,true,9106/20013
american indian or alaska native,C0002460,true,9107/20013
multi - racial,C0439064;C0034510;C1706779;C3669213;C3853635;C3266262,false;true;false;false;false;true,9108/20013
aqlq ( s ) + nmbr scored,C4055434,false,9109/20013
aqlq ( s ) + nmbr scorets,C4055434,false,9110/20013
antiarrhythmic,C0003195;C3537142,true;false,9111/20013
anti arrhythmic,C0003195;C3537142,true;false,9112/20013
ct findings,C0007673;C2607943;C2926606;C3539655;C3540513;C3813556;C3888140,true;true;false;false;false;false;false,9113/20013
ecg findings,C0438154,false,9114/20013
lipoprotein ( a ) ( nmol / l ),C0065058;C0439282;C0125953;C1096202;C1439335,true;false;true;false;false,9115/20013
lipoprotein ( a ) ( mmol / l ),C0065058;C1532563;C0125953;C1096202;C1439335,true;false;true;false;false,9116/20013
baseline . mean _ sd,C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,9117/20013
baseline . mean _ sd . mg / mg,C0168634;C0444504;C2699239;C1319635;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,9118/20013
baseline . mean _ sd . mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,9119/20013
≤ nmbr u / kg / day,C1532634,false,9120/20013
> nmbr u / kg / day,C1532634,false,9121/20013
bosentan,C0252643,true,9122/20013
history of stroke *,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,9123/20013
patients without syndesmophytes at baseline,C0030705;C0221690,true;false,9124/20013
patients with syndesmophytes at baseline,C0030705;C0221690,true;false,9125/20013
lipid - lowering,C0023779;C0441994;C2003888,true;false;false,9126/20013
lipid lowering,C0023779;C0441994;C2003888,true;false;false,9127/20013
stratum ii,C1710602;C4082587,false;false,9128/20013
stratum i,C0021966;C0221138,true;false,9129/20013
aaponmbr at rest,C0035253;C1622890,true;false,9130/20013
paonmbr at rest,C0232555;C0035253;C1622890;C1423784;C1427155;C4318615,false;true;false;false;false;false,9131/20013
mean ( s . d . ) systolic blood pressure,C0428886;C0039155;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;true;false;false;false,9132/20013
mean ( s . d . ) diastolic blood pressure,C0428886;C0012000;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;true;false;false;false,9133/20013
> nmbr to < nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,9134/20013
nmbr to < nmbr h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,9135/20013
coronary artery disease^,C0010054;C0010068;C1956346,true;true;true,9136/20013
coronaiy artery disease,C0852949,false,9137/20013
> o - nmbr - i - i,C0483204;C0021966;C0221138,false;true;false,9138/20013
> o - nmbr - ii,C0483204;C1710602;C4082587,false;false;false,9139/20013
baseline fevnmbr #,C0168634;C3714541;C1442488,true;true;false,9140/20013
nmbr ( n nmbr nmbr ),C0369718;C0441922,false;false,9141/20013
nmbr mg ( n nmbr nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9142/20013
respiratory rate,C0231832;C0489258,true;false,9143/20013
respiratory rate ( breaths / min ),C0231832;C0439386;C0489258,true;false;false,9144/20013
karnofsky score < nmbr,C0206065,true,9145/20013
karnofsky score 竺 nmbr,C0206065,true,9146/20013
ldl - csmedian,,,9147/20013
ldl - c > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9148/20013
non - hdl - c *,C1518422;C3715113,false;false,9149/20013
duration of pci — min,C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,9150/20013
duration of pci,C0449238;C4049621;C2926735,false;false;false,9151/20013
mean ( s . d . ) bmi,C0444504;C0578022;C2347634;C2348143,false;false;false;false,9152/20013
mean ± s . d . bmi,C0444504;C0578022;C2347634;C2348143,false;false;false;false,9153/20013
baselinec,,,9154/20013
( baseline ),C0168634;C1442488,true;false,9155/20013
baselineb,,,9156/20013
< nmbr . nmbr % ( nmbr mmol / mol ),C3829066,false,9157/20013
≥ nmbr . nmbr % ( ≥ nmbr mmol / mol ),C3829066,false,9158/20013
inferior ( % ),C0542339;C0678975,false;false,9159/20013
anterior { % ),C0205094,false,9160/20013
qualifying mi < nmbr yrs prior,C1514624;C3810814,false;false,9161/20013
qualifying mi $ nmbr yrs prior,C1514624;C3810814,false;false,9162/20013
hawaiian / pacific islander,C0337920;C0242191,true;true,9163/20013
hawaiian pacific islander,C0337920;C0242191,true;true,9164/20013
bl mean ( mmhg ),C0005918;C0444504;C0439475;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;false;true;false;false,9165/20013
bl mean ( cm ),C0005918;C0444504;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;true;false;false,9166/20013
no or unknown,,,9167/20013
no / unknown,C0439673;C3541433;C4050014,false;false;false,9168/20013
loop diuretic,C0354100;C3536704,true;false,9169/20013
loop diuretics,C0354100,true,9170/20013
non diuretics,C1518422;C0012798,false;true,9171/20013
esam ( ng / ml ),C1424976;C0439275,false;false,9172/20013
ngal ( ng / ml ),C0215955;C0439275;C1416806;C2346625,true;false;false;false,9173/20013
fevnmbr / fvc %,C3714541,true,9174/20013
history of diabetes ( a ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9175/20013
history of diabetes ( % ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9176/20013
age : < nmbr years ( n = nmbr ),C1510829,false,9177/20013
age < nmbr years ( n = nmbr ),C1510829,false,9178/20013
metabolic syndrome ( % ) b,C0524620,true,9179/20013
metabolic syndrome ( % ),C0524620,true,9180/20013
peripheral artery disease — no . ( % ),C1704436;C4025272,true;false,9181/20013
peripheral - artery disease — no . ( % ),C1704436;C4025272,true;false,9182/20013
aiorvasiaiin,,,9183/20013
epa ( mol % ),C0027960;C0324740;C0439189;C1456781;C1824986;C3665593,true;true;false;false;false;false,9184/20013
aa,C0282379;C1235746;C1882141;C4554792,true;false;false;false,9185/20013
cardiovasculardeath / myocardial infarction / stroke,C0027051;C0038454;C4554100;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false,9186/20013
cardiovascular death / myocardial infarction / stroke,C0027051;C0011065;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775,true;true;false;false;false;false;false;false;false,9187/20013
m o nito ring treatment,C0369637;C0521164;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1260969;C1882954;C0441923,false;false;true;true;false;false;false;false;false;false;false;false,9188/20013
monitoring treatment,C0150369;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1283169,false;true;true;false;false;false;false;false;false,9189/20013
baseline focal seizure frequency / nmbr days,C0168634;C0751495;C0376249;C0439228;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1442488,true;true;true;false;false;false;false;false;false;false;false;false;false,9190/20013
thiazide diuretics,C0012802,true,9191/20013
thiazide diuretic,C0012802;C3536861,true;false,9192/20013
diabetes present nmbr ( nmbr . nmbr ),C0011847;C0150312;C0449450;C0011849,false;false;false;true,9193/20013
diabetes absent nmbr ( nmbr . nmbr ),C0011847;C0011849,false;true,9194/20013
baseline medication,C0168634;C0013227;C3244316;C4284232;C1442488,true;true;false;false;false,9195/20013
baseline medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,9196/20013
calcium aniagonisi,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,9197/20013
calcium antagonist,C0006684,true,9198/20013
at qualifying event,C1514624;C0441471;C4019010,false;false;false,9199/20013
qualifying event,C1514624;C0441471;C4019010,false;false;false,9200/20013
nmbr - nmbr . nmbr : obese class ii,C3853263,false,9201/20013
nmbr - nmbr . nmbr : obese class i,C3853264,false,9202/20013
white race — no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,9203/20013
white race — no . ( % ) : t,C0007457;C0043157;C0220938,true;true;false,9204/20013
white race — no . ( % ) :,C0007457;C0043157;C0220938,true;true;false,9205/20013
ileocolon,,,9206/20013
lleocolon,,,9207/20013
tiotropium nmbrmg ( n = nmbr,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9208/20013
tiotropium nmbr mg ( n = nmbr ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9209/20013
multi - vessel coronary artery disease,C1299432,false,9210/20013
multivessel coronary artery disease,C0010054;C0010068;C1956346,true;true;true,9211/20013
mean ± sd msdbp,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9212/20013
mean sd mssbp,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9213/20013
mean age ( y ) ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,9214/20013
age in nmbr classes,C0001779;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false,9215/20013
egfr in nmbr classes,C1739039;C0456387;C1518526;C1705943;C4019422;C3811844;C3812682,true;false;false;false;false;false;false,9216/20013
heart rate — bpm,C0018810,true,9217/20013
heart rate ( bpm ),C0018810,true,9218/20013
biguanide ( metformin ),C0005382;C0025598;C3537187;C4317165,true;true;false;false,9219/20013
biguanides ( metformin ),C0005382;C0025598;C0360396;C3540012,true;true;false;false,9220/20013
naive : no,,,9221/20013
naive : yes,C1549445;C1705108;C1710701,false;false;false,9222/20013
no steroids ( n = nmbr vs nmbr ),C0038317,true,9223/20013
steroids ( n = nmbr vs nmbr ),C0038317,true,9224/20013
secondary ' outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,9225/20013
secondary outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,9226/20013
clopiodogrel,,,9227/20013
antiplatelet - onl group ( n = nmbr ),C0441848,false,9228/20013
antiplatelet - only group ( n = nmbr ),C0205171;C0441848;C1720467,false;false;false,9229/20013
myopathyt,,,9230/20013
myopathy,C0026848,true,9231/20013
baseline hdl - c in nmbr classes,C0168634;C3715113;C0456387;C1518526;C1705943;C4019422;C1442488,true;false;false;false;false;false;false,9232/20013
baseline trl - c in nmbr classes,C0168634;C0456387;C1518526;C1705943;C4019422;C1442488,true;false;false;false;false;false,9233/20013
with diabetes,C0011847;C0011849,false;true,9234/20013
without diabetes,C0011847;C0011849,false;true,9235/20013
treated vessel,C1522326;C0005847,false;true,9236/20013
treated vessel !,C1522326;C0005847,false;true,9237/20013
estimated glomerular filtration rate - ml / min / nmbr . nmbrmnmbrtt,C3811844;C0439445;C0369637;C1452561;C4554543;C0441923,false;false;false;true;false;false,9238/20013
estimated glomerular filtration rate ( ml / min / nmbr . nmbrmnmbr ),C3811844;C0439445;C0369637;C0441923,false;false;false;false,9239/20013
inferior or posterior,C0542339;C0678975,false;false,9240/20013
inferior / posterior,C0542339;C0205095;C0678975,false;false;false,9241/20013
weight < nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,9242/20013
systolic ( mean,C0039155;C0444504;C2347634;C2348143,true;false;false;false,9243/20013
diastolic ( mean,C0012000;C0444504;C2347634;C2348143,true;false;false;false,9244/20013
tertile nmbr ( > nmbr . nmbr pg / ml ) n - nmbr,C0439297,false,9245/20013
tertile nmbr ( < nmbr . nmbr ng / ml ) n - nmbr,C0439275,false,9246/20013
patients with egfr > nmbr ml / min / nmbr . nmbrmnmbr at baseline,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,9247/20013
patients with egfr < nmbr ml / min / nmbr . nmbrmnmbr at baseline,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,9248/20013
baseline hbanmbrc > nmbr . nmbr %,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,9249/20013
baseline hbanmbrc < nmbr . nmbr %,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,9250/20013
nmbr . nmbr - nmbr . nmbr % f,C0016327,true,9251/20013
nmbr . nmbr - nmbr . nmbr % t,C2603360,false,9252/20013
number of stents,C0237753;C0038257;C0449788,false;true;false,9253/20013
number of patients,C2360800,false,9254/20013
all other,,,9255/20013
secondary *,C0027627;C0175668;C0205436,true;false;false,9256/20013
secondary pci,C0027627;C4049621;C0175668;C0205436,true;false;false;false,9257/20013
no . of prior aeds,C0332152;C0180309;C2826257,false;true;false,9258/20013
( mean change,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,9259/20013
( mean % change,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,9260/20013
hazard ratiof,C0598697,false,9261/20013
hazard ratio,C2985465,false,9262/20013
prior myocardial infarction yes,C0155668;C1549445;C1705108;C1710701,false;false;false;false,9263/20013
dpp - nmbr inhibitor,C1414174;C1999216,false;false,9264/20013
dpp - nmbr inhibitors,C1414174;C0243077,false;true,9265/20013
ldl - c / hdl - c ratio,C0428621,false,9266/20013
ldl - c : hdl - c ratio,C0428621,false,9267/20013
modified has - bled $ nmbr,C0392747;C3889737,false;false,9268/20013
modified has - bled < nmbr,C0392747;C3889737,false;false,9269/20013
subgroup,C1079230;C1515021,false;false,9270/20013
subgroups,C1079230,false,9271/20013
old stroke *,C1536121,false,9272/20013
new stroke *,C0205314;C0038454;C4554100,false;true;false,9273/20013
low risk,C3272281;C3538919,false;false,9274/20013
lower risk,C3272281;C3538919,false;false,9275/20013
high - intensity statin,C4081854;C0360714,false;true,9276/20013
high - intensity statin *,C4081854;C0360714,false;true,9277/20013
no high - intensity statin,C4081854;C0360714,false;true,9278/20013
ics use yes / no,C0815320;C4551720,false;true,9279/20013
present smokerc,C0150312;C0449450,false;false,9280/20013
present smoker,C0150312;C0337664;C0449450,false;true;false,9281/20013
p - value ( int ),C1709380;C3272375,false;false,9282/20013
p value ( int ),C1709380;C3272375,false;false,9283/20013
alteplase,C0032143,true,9284/20013
reteplase,C0256103,true,9285/20013
western europe / australia,C0043128;C0015176;C0043129;C0004340,true;true;true;true,9286/20013
western europe and australia,C0043129,true,9287/20013
tiotropium nmbr mg respimat ® ( n z nmbr ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9288/20013
tiotropium nmbr mg respimat ® ( n = nmbr ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9289/20013
body mass index > nmbr,C0005893;C0578022;C1305855,false;false;true,9290/20013
pbo + mtx n = nmbr,C0031962;C0025677;C1417487,true;true;false,9291/20013
czp + mtx n = nmbr,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,9292/20013
ef < nmbr % hfref ( n = nmbr,,,9293/20013
ef > nmbr % hfpef ( n = nmbr,,,9294/20013
macroalbuminuria at baseline ( nmbr % of patients treated ),C0168634;C0030705;C1442488,true;true;false,9295/20013
microalbuminuria at baseline ( nmbr % of patients treated ),C0730345;C0168634;C0030705;C1442488,false;true;true;false,9296/20013
any coronary artery disease,C0010054;C0010068;C1956346,true;true;true,9297/20013
only coronary artery disease,C0205171;C0010054;C0010068;C1956346;C1720467,false;true;true;true;false,9298/20013
estimated gfr < nmbr ml / min / nmbr . nmbr mnmbr,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,9299/20013
estimated gfr > nmbr ml / min / nmbr . nmbr mnmbr,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,9300/20013
female patients,C0150905,false,9301/20013
male patients,C0150904,false,9302/20013
history ( pack - years ),C0019664;C1277691;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,9303/20013
duration of diabetes > nmbr years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9304/20013
duration of diabetes < nmbr years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9305/20013
structural heart disease §,C1290384,false,9306/20013
structural heart disease,C1290384,false,9307/20013
no family history of chd ( n = nmbr,C0241889;C0280604;C3542407,true;false;false,9308/20013
family history of chd ( n = nmbr,C0241889;C0280604;C3542407,true;false;false,9309/20013
subcortical wml load diameter,C0815275;C1550025;C1301886;C1704782;C1708715,false;false;false;false;false,9310/20013
etoricoxib nmbr mg ( n nmbr nmbr ),C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9311/20013
glycoprotein iib / iiia inhibitor,C0016011;C1999216,true;false,9312/20013
glycoprotein iib / iiia inhibitors,C0016011;C0243077,true;true,9313/20013
with acei / arb,C3888198,false,9314/20013
without acei / arb,C3888198,false,9315/20013
corticosteroid or immunosuppressant,C0001617;C3536709,true;false,9316/20013
corticosteroids and immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,9317/20013
corticosteroid and immunosuppressant,C0001617;C3536709,true;false,9318/20013
egfr < nmbr ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,9319/20013
egfr > nmbr ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,9320/20013
st - segment — elevation myocardial infarction,C1536220,true,9321/20013
st - segment elevation myocardial infarction,C1536220,true,9322/20013
patients with psoriasis ( n = nmbr ),C0030705;C0033860,true;true,9323/20013
patients without psoriasis ( n = nmbr ),C0030705;C0033860,true;true,9324/20013
egfr < nmbr ml / min / nmbr . nmbr mz,C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,9325/20013
egfr > nmbr ml / min / nmbr . nmbr mz,C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,9326/20013
age > nmbr years ( median ),C1510829,false,9327/20013
age < nmbr years ( median ),C1510829,false,9328/20013
no . pts,C1419129;C2698747,false;false,9329/20013
no . men,C0025266,true,9330/20013
nmbr mg qw nmbr . nmbr pt yrs,C0024671;C0043011;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,9331/20013
nmbr mg biw nmbr . nmbr pt yrs,C0024671;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,9332/20013
fasting plasma glucose ( mg / dl ),C0015663;C0202042;C0439269;C0455280,true;false;false;false,9333/20013
fasting plasma glucose — mg / dl,C0015663;C0202042;C0439269;C0455280,true;false;false;false,9334/20013
antidiabetic medications,C0935929,true,9335/20013
antidiabetic medication,C0935929,true,9336/20013
ldl - c ( median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9337/20013
hdl - c ( median,C3715113;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9338/20013
nonischemic cardiomyopathy,C0878544,true,9339/20013
ischaemic cardiomyopathy,C0349782,false,9340/20013
ischemic cardiomyopathy,C0349782,false,9341/20013
no ilb / iiia inhibitors,C4697913;C0243077,false;true,9342/20013
ilb / iiia inhibitors,C4697913;C0243077,false;true,9343/20013
nontatal ml,C0439526;C1705224;C3887665,false;false;false,9344/20013
nonfatal ml,C0439526;C1705224;C3887665,false;false;false,9345/20013
no of events women men *,C0441471;C0043210;C0025266;C3541888,false;true;true;false,9346/20013
no of events womenmen *,C0441471;C3541888,false;false,9347/20013
demographic features,C0683970,false,9348/20013
demographic feature,C0683970,false,9349/20013
non - epa ( n = nmbr ),C1518422,false,9350/20013
non - us ( n = nmbr ),C1518422,false,9351/20013
heart failure *,C0018801;C0018802;C4554158,true;true;false,9352/20013
heart failurea,C0018787,true,9353/20013
acetylsalicylic acid,C0004057,true,9354/20013
acetyl - salicylic acid,C0004057,true,9355/20013
difference ( % ),C1705241;C1705242,false;false,9356/20013
difference ( se ),C1705241;C0036919;C1705242,false;true;false,9357/20013
exercise > once weekly,C0015259;C1522704,true;false,9358/20013
exercise > once weekly ?,C0015259;C1522704,true;false,9359/20013
nmbr - nmbr days ( % ),C0439228,false,9360/20013
nmbr - nmbr yr ( % ),C0439234,false,9361/20013
number stent > nmbr,C0237753;C0038257;C0449788,false;true;false,9362/20013
number ste   t > nmbr,C0237753;C1420459;C3811127;C0449788,false;false;false;false,9363/20013
most common concomitant aeds,C0205393;C0205214;C0521115;C0180309;C1522138;C3245511,false;false;false;true;false;false,9364/20013
> nmbr % to < nmbr % ( > nmbr to nmbr mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,9365/20013
> nmbr % to < nmbr % ( > nmbr to < nmbr mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,9366/20013
baricitinib nmbr mg ( n = nmbr ),C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9367/20013
baricitinib nmbr mg qd ( n = nmbr ),C4044947;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,9368/20013
alcohol consumption !,C0001948,true,9369/20013
sri response,C1420401;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,9370/20013
acr response,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,9371/20013
endpoint / baseline,C2349179;C0168634;C1442488;C2826544,false;true;false;false,9372/20013
endpoint / baselinec,C2349179;C2826544,false;false,9373/20013
ranozaline,,,9374/20013
left anterior descending coronary artery,C0226032,false,9375/20013
l eft anterior descending coronary artery,C0439394;C0451214;C0226032;C1706495;C3642217,false;false;false;false;false,9376/20013
renal subgroup,C0022646;C1079230;C1515021,true;false;false,9377/20013
female subgroup,C0043210;C1079230;C1515021;C0086287;C1705497;C1705498,true;false;false;true;false;false,9378/20013
ss < nmbr ( n = nmbrvsnmbr ),C2699257;C3891295;C4551874,false;false;false,9379/20013
ss > nmbr ( n = nmbrvs nmbr ),C2699257;C3891295;C4551874,false;false;false,9380/20013
transient ischemic attack,C0007787;C0917805,true;true,9381/20013
transient ischaemic attack,C0007787;C0917805,true;true,9382/20013
nmbr mg ew n = nmbr,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9383/20013
nmbr mg eow n = nmbr,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9384/20013
phgada ( mm ),C4330985;C4554674,false;false,9385/20013
ptgada ( mm ),C4330985;C4554674,false;false,9386/20013
patient ' s assessment of pain !,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,9387/20013
patient ' s assessment of pain,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,9388/20013
lama ( only monotherapy ),C0999593;C0205171;C1720467;C1416775,false;false;false;false,9389/20013
laba ( only monotherapy ),C0205171;C1720467,false;false,9390/20013
insulin glargine ( n = nmbr ),C0907402,true,9391/20013
insulin glargine ( n = nmbrll ),C0907402,true,9392/20013
secukinumab nmbr mg ( n = nmbr ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9393/20013
paroxysmal,C0205311,false,9394/20013
paroxysmal af,C0235480,true,9395/20013
history of major microvascular disease — no . ( % ),C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,9396/20013
history of major macrovascular disease — no . ( % ),C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,9397/20013
non - hdl cholesterol,C0729627;C1535899,false;false,9398/20013
non - hdl choleslerol,C1518422;C3715113,false;false,9399/20013
insulin treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,9400/20013
insulin - treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,9401/20013
no prior statin ( n = nmbr,C0332152;C0360714;C2826257,false;true;false,9402/20013
prior statin ( n = nmbr,C0332152;C0360714;C2826257,false;true;false,9403/20013
fevnmbr ( liters ),C3714541;C0475211,true;false,9404/20013
fevnmbr — liters,C3714541;C0475211,true;false,9405/20013
systolic,C0039155,true,9406/20013
diastolic,C0012000,true,9407/20013
czp + mtx^mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,9408/20013
pbo + mtx^mtx,C0031962;C0025677;C1417487,true;true;false,9409/20013
history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9410/20013
no history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9411/20013
stage nmbr : > = nmbr,C0205390;C1300072;C1306673,false;false;false,9412/20013
stage nmbr : < nmbr,C0205390;C1300072;C1306673,false;false;false,9413/20013
ato nmbr mg and sim nmbr^nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9414/20013
ato nmbr mg and sim nmbr - nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9415/20013
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - week nmbr - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -,C0332174;C0439230,false;false,9416/20013
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - week nmbr - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -,C0332174;C0439230,false;false,9417/20013
- - - - - - - - - - - - - week nmbr - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -,C0332174;C0439230,false;false,9418/20013
- - - - - - - - - - - - week nmbr - - - - - - - - - - - - - - - - -,C0332174;C0439230,false;false,9419/20013
- < — ■ bb — - ►,C0004739;C0332297,true;false,9420/20013
- hdl cholesterol,C0023822;C0392885,true;false,9421/20013
- ldl cholesterol,C0023824;C0202117,true;false,9422/20013
- median fasting serum glucose ( mg / dl ) ( iqr ),C0549183;C0015663;C0202041;C0439269;C3534430;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,9423/20013
- median pulse pressure ( mm hg ) ( iqr ),C0549183;C0949236;C0439475;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,9424/20013
- median tg ( iqr ),C0549183;C0337445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9425/20013
- median urine acr ( mg / g ) ( iqr ),C0549183;C0042036;C1412134;C1300563;C1515941;C0042037;C2963137;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;true;false;false;false;false;false,9426/20013
- recurrent vte during overall study period,C1455761;C0630906;C0282416;C0557651;C0439531;C1948053;C2603343;C1561607;C2945760,false;true;true;false;false;false;false;false;false,9427/20013
- triglycerides,C0041004,true,9428/20013
- [the null hypothesis is that there are no differences among subgroups  for age and time since randomization  the inter -,C4684719,false,9429/20013
- ° - nmbr  wom -,,,9430/20013
- nmbr - nmbr ( - nmbr - nmbrtoo nmbr ),,,9431/20013
- nmbr - nmbr ( nmbr % cl - nmbr - nmbr to - nmbr - nmbr ),C0596019,false,9432/20013
- nmbr . nmbr ( nmbr % ci : - nmbr . nmbr,C0008107;C3259781,true;false,9433/20013
- nmbr placebo,C0032042;C1696465;C1706408,true;false;false,9434/20013
- nmbr < flex fn f - score,C1570610;C0016327;C0449820;C4050231,true;true;false;false,9435/20013
- nmbr . nmbr < ls t - score,C0023668;C0449820;C4050231,true;false;false,9436/20013
- nmbr . nmbr ( - nmbr . nmbr,,,9437/20013
- nmbr . nmbr < flex fn f - score < - nmbr,C1570610;C0016327;C0449820;C4050231,true;true;false;false,9438/20013
- nmbr . nmbr < ls t - score < — nmbr . nmbr,C0023668;C0449820;C4050231,true;false;false,9439/20013
- nmbr . nmbr ( nmbr . nmbr ) * ll,,,9440/20013
- nmbr . nmbr ± lno^,,,9441/20013
- nmbr . nmbr ± nmbr . nmbr § ti,C0039247;C0040302;C1553045;C1704756,true;true;false;false,9442/20013
- nmbr . nmbr to - nmbr cm,,,9443/20013
- nmbr - nmbr ( nmbr % cl - nmbr - nmbr to nmbr - nmbr ),C0596019,false,9444/20013
- b - i -,C0021966;C0221138,true;false,9445/20013
- b - i —,C0021966;C0221138,true;false,9446/20013
- bi -,,,9447/20013
- fnmbr . nmbr ( - i - nmbr . nmbr ),C0016327;C0021966;C0221138,true;true;false,9448/20013
- major bleed,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,9449/20013
- o - oonmbr ( - nmbr - nmbr to nmbr - nmbr ),C0483204,false,9450/20013
- o . os,C2673162,false,9451/20013
- onmbro ( - nmbr - loto - nmbr - nmbr ),C0483204,false,9452/20013
- oil,C0028908;C0032085;C1517288;C3541397,true;true;false;false,9453/20013
— no . ( % ),,,9454/20013
— nmbr . nmbr < fn t - score,C1570610;C0449820;C4050231,true;false;false,9455/20013
— nmbr . nmbr < fn t - score < — nmbr . nmbr,C1570610;C0449820;C4050231,true;false;false,9456/20013
— b - h —,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,9457/20013
! amlodipine,C0051696,true,9458/20013
# pts,C1419129;C2698747,false;false,9459/20013
# nmbr kg,C0022718;C0439209;C4054209,true;false;false,9460/20013
$ race was determined by the investigator during the patient ' s interview .,C0034510;C1706779;C3853635,true;false;false,9461/20013
% - point difference ( nmbr % ci ) c,C1552961;C1705241;C0008107;C3259781;C1705242;C2347617;C3714763,false;false;true;false;false;false;false,9462/20013
% \mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9463/20013
% asthma control days {,C0004096;C0243148;C0439228;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;false;false;false;false;false;false,9464/20013
% bronchial reversibility ( sd ),C0205039;C0449261;C2699239;C1442216,false;false;false;false,9465/20013
% change ( mean ± se ),C0392747;C0444504;C0036919;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false,9466/20013
% change ( meanlse ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,9467/20013
% change ( meantse ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,9468/20013
% change ( median  qnmbr  qnmbr ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,9469/20013
% change from baseline to week nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,9470/20013
% fhg,,,9471/20013
% hbanmbrc ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,9472/20013
% improvement in dactylitis score at week nmbr,C2986411;C0239161;C0449820;C4050231,false;false;false;false,9473/20013
% improvement in enthesitis score at week nmbr,C2986411;C1282952;C0449820;C4050231,false;false;false;false,9474/20013
% of patients nmbr . nmbr nmbr . nmbr,C0030705,true,9475/20013
% of predicted,C0681842;C1882327,false;false,9476/20013
% patients,C0030705,true,9477/20013
% phg,,,9478/20013
% predicted fev,C0681842;C3714541;C1882327,false;true;false,9479/20013
% predicted fev^,C0681842;C3714541;C1882327,false;true;false,9480/20013
% predicted fevnmbr,C0681842;C3714541;C1882327,false;true;false,9481/20013
% predicted post - bronchodilator fev,C0681842;C1882327,false;false,9482/20013
% predicted post - bronchodilator fevnmbr,C0681842;C1882327,false;false,9483/20013
% predicted pre - bd,C0681842;C0332152;C0005126;C2344255;C4050145;C0740175;C2257086;C3669034;C1882327,false;false;true;false;false;false;false;false;false,9484/20013
% predicted prebronchodilator fevnmbr,C0681842;C2599602;C3714541;C1882327,false;false;true;false,9485/20013
% predicted value ( sd ),C0681842;C1522609;C2699239;C1882327,false;false;false;false,9486/20013
% reduction,C0301630;C0392756;C1293152;C4551656,false;false;false;false,9487/20013
% reversibility,C0449261,false,9488/20013
% reversibility in fev^ at,C0449261;C3714541,false;true,9489/20013
% risk reduction ( nmbr % cl ),C1137094;C0596019,true;false,9490/20013
% stenosis ( core lab ),C0678234;C4684837;C1261287;C2632116,false;false;true;false,9491/20013
% stenosis ( investigator ),C0678234;C0035173;C1261287;C2632116,false;true;true;false,9492/20013
% to goal,C0018017;C1571704,true;false,9493/20013
% / year,C0439234;C0439508,false;false,9494/20013
% / yr,C0439234,false,9495/20013
& median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9496/20013
( $ nmbr ml / min per nmbr . nmbr mnmbr ),C0439445;C0369637;C0441923,false;false;false,9497/20013
( % of group ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,9498/20013
( % of target ) ∗,C1521840;C2986546,false;false,9499/20013
( % ),,,9500/20013
(,,,9501/20013
( : > blockers,,,9502/20013
( _ > nmbr . nmbr mmol / l ) hdl - c women : < nmbr mg / dl ( < nmbr . nmbr mmol / l ) men : < nmbr mg / dl,C3898312;C3715113;C0043210;C3539687;C0025266,false;false;true;false;true,9503/20013
( < nmbr . nmbr mmol / l ),C1532563,false,9504/20013
( < nmbr mg / l ),C0439268,false,9505/20013
( < nmbr ml / minute ) *,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,9506/20013
( ≥ nmbr mg / l ),C0439268,false,9507/20013
( nmbr patients ),C0030705,true,9508/20013
( nmbr subjects ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,9509/20013
( nmbr - blocker,,,9510/20013
( nmbr - sitosterol ( p . mol / l ),C0037215;C0347982;C0220914,true;false;true,9511/20013
( nmbr - nmbr ml / min per nmbr . nmbr mnmbr ),C0439445;C0369637;C0441923,false;false;false,9512/20013
( nmbr . nmbr % )  values were not collected for nmbr patients ( nmbr . nmbr % ) who were enrolled,C0042295,false,9513/20013
( nmbr % ci ) ,C0008107;C3259781,true;false,9514/20013
( nmbr % ci ) a,C0008107;C3259781,true;false,9515/20013
( nmbr % ci ) b,C0008107;C3259781,true;false,9516/20013
( nmbr % ci ) c,C0008107;C3259781,true;false,9517/20013
( a ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,9518/20013
( a ) bmi subgroups,C0578022;C1079230,false;false,9519/20013
( b ) age subgroups,C1304659;C0001779,false;false,9520/20013
( b ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,9521/20013
( c ) ' ' kza treatment ( ref ),C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,9522/20013
( cells per pl ) t,C0007584;C3897966;C4049765;C0007634,true;false;false;true,9523/20013
( cm ),,,9524/20013
( composite endpoint ),C0205199;C2349179;C2826544;C1547335,false;false;false;false,9525/20013
( d ) aza treatment ( ref ),C0073187;C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0332173;C4484261,true;true;true;false;true;false;false;false;false;false;false;false,9526/20013
( e ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,9527/20013
( fxs ),C0016667,true,9528/20013
( id,C0009450;C0600091;C1441613,true;false;false,9529/20013
( incl . uncertain ),C0268281;C1418854,true;false,9530/20013
( including hypertension ),C0332257,false,9531/20013
( interquartile range ) ( mm ),C1711350;C4330985;C4554674,false;false;false,9532/20013
( iqr ),,,9533/20013
( iqr ) — days,C0439228,false,9534/20013
( l ) t,C0439394;C1706495;C3642217,false;false;false,9535/20013
( mean + . sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9536/20013
( mean ± sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9537/20013
( median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9538/20013
( mg / dl ± sd ),C0439269;C2699239,false;false,9539/20013
( mg / dl ),C0439269,false,9540/20013
( min ) *,C0702093;C1524029;C3813700,false;false;false,9541/20013
( minimum - maximum ) focal seizure fre - quency / nmbr days at baseline,C1524031;C0806909;C0751495;C1414819;C0439228;C0168634;C1442488;C1552615;C2826546;C1552614;C2826545,false;false;true;false;false;true;false;false;false;false;false,9542/20013
( mmol / l ),C1532563,false,9543/20013
( mu / l $ mmol / l ) b,C0439342;C0439190,false;false,9544/20013
( n = nmbr ) ( n = nmbr ),C0369718;C0441922,false;false,9545/20013
( n = nmbr )   ' ( n = nmbr ),C0369718;C0441922,false;false,9546/20013
( n = nmbrlnmbr ),C0369718;C0441922,false;false,9547/20013
( n = lnmbr ),C0369718;C0441922,false;false,9548/20013
( ne,C0027608;C0028219;C3538705,true;true;false,9549/20013
( ngml ' ' ) total mean ipss score,C2964552;C0444504;C1019118;C1998280;C2827405;C3811063;C2347634;C2348143;C0439175;C3533236;C0439810,false;false;false;false;false;false;false;false;false;false;false,9550/20013
( nyha grade iii or iv ),C1275491;C0205617;C0450094;C0475271;C0687697;C3889290;C4050000;C4283820;C4283821;C4283822,false;false;false;false;false;false;false;false;false;false,9551/20013
( ofl ),,,9552/20013
( phase nmbr dose - finding trial ),C0205390;C0178602;C0037088;C0008976;C0243095;C2825141;C0869039;C1114758;C1710475,false;false;true;true;false;false;false;false;false,9553/20013
( points ),C1552961;C2347617;C3714763,false;false;false,9554/20013
( range ),C1514721;C2348147;C3542016,false;false;false,9555/20013
( ref ),C1425988,false,9556/20013
( scale diabetes ),C0175659;C0011847;C0011849;C0349674;C1947916,true;false;true;false;false,9557/20013
( scale obesity and prediabetes ),C0175659;C0028754;C1963185;C0349674;C1947916,true;true;false;false;false,9558/20013
( sd ) l / min acq - nmbr score,C2699239;C0702093;C2919686;C1524029;C3813700,false;false;false;false;false,9559/20013
( se ),C0036919,true,9560/20013
( subgroup ),C1079230;C1515021,false;false,9561/20013
( tiotropium n = nmbr,C0213771,true,9562/20013
( tiotropium n = nmbr  placebo n =,C0213771;C0032042;C1696465;C1706408,true;true;false;false,9563/20013
( tiotropium n = nmbr non - tiotropium n = nmbr ),C0213771;C1518422,true;false,9564/20013
( tiotropium n = nmbr non - tiotropium n = nmbr nmbr,C0213771;C1518422,true;false,9565/20013
( total ses - cd score at,C2964552;C0007928;C0034283;C4552032,false;true;true;false,9566/20013
( week ),C0332174;C0439230,false;false,9567/20013
( women only ),C0043210;C0205171;C1720467,true;false;false,9568/20013
( years ),C0439234,false,9569/20013
( yes / no ),C1512698,false,9570/20013
* data are expr,C1511726;C3245479;C3714741,false;false;false,9571/20013
* eligibility risk factors,C0013893;C0035648;C1553898;C1548635,true;true;false;false,9572/20013
* hypercholesterolemia was defined as a low - density lipoprotein cholesterol level at enrollment of more than nmbr mg per deciliter ( nmbr . nmbr mmol per liter ) after an overnight fast . † nonsustained ventricular tachycardia was defined as nmbr or more consecutive ventricular beats at a heart rate of more than nmbr beats per minute . ‡ to convert weight to kilograms  divide by nmbr . nmbr . § to convert values for creatinine to micromoles per liter  multiply by nmbr . nmbr . ¶ data for follow - up medication were available for nmbr patients ( amiodarone  nmbr  placebo  nmbr  and icd  nmbr ) . ace de - notes angiotensin - converting enzyme  and arb angiotensin ii – receptor blocker . ¿ p < nmbr . nmbr for the comparison among the groups,C0020443;C1522133,true;false,9573/20013
* non - black *,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,9574/20013
* nonfatal ml,C0439526;C1705224;C3887665,false;false;false,9575/20013
* patient characterization data are reproduced from morrow et al . ( nmbr ) .,C2707520;C1880022,false;false,9576/20013
* plus - minus values are means 士 sd . race or ethnic group was self - determined . the body - mass index is the weight in kilograms divided by,C0332288;C0042295,false;false,9577/20013
* plus - minus values are means ± sd . there were no significant differences ( at,C0332288;C0042295,false;false,9578/20013
* plus – minus values are means ± sd . percentages may not total nmbr because of rounding . the body - mass index is the weight in kilograms divided by the square of the height in meters . to convert the values for creatinine to micromoles per liter,C0332288;C0042295,false;false,9579/20013
* the p ‐ value is from the test statistic for testing the interaction between the treatment group and diabetes group .,C1709380,false,9580/20013
* atherosclerotic coronary heart disease,C0010054;C0018787;C0333482;C0010068;C1956346,true;true;false;true;true,9581/20013
* ci denotes confidence interval .,C0008107;C3259781,true;false,9582/20013
* data are expressed as median ± sd,C1511726;C3245479;C3714741,false;false;false,9583/20013
* data are given as percentage of subjects unless otherwise specified . ptca indicates percutaneous transluminal coronary angioplasty  cabg  coronary artery bypass graft  ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by square of height in meters )  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  fpg  fasting plasma glucose  and fpi  fasting plasma insulin . tto convert cholesterol values to micromoles per liter  multiply by nmbr . nmbr . to convert triglycerides to micromoles per liter  multiply by nmbr . nmbr . to convert fpg to micromoles per liter  multiply by nmbr . nmbr . to convert fpi to picomoles per liter  multiply by nmbr . nmbr .,C1511726;C3245479;C3714741,false;false;false,9584/20013
* data reported as n ( % ) or median ( quartiles nmbr,C1511726;C3245479;C3714741,false;false;false,9585/20013
* determined by investigator to be possibly  probably or definitely related to study drug tmyopathy defined as cpk > nmbr x uln with associated muscle symptoms with no other plausible etiology ^consecutive defined as two or more measurements at least one week apart or one measurement < nmbr days after the last dose of study drug ( presumed consecutive ) § two patients had incomplete data to assess chd status simva = simvastatin  eze = ezetimibe  ae = adverse event  alt = alanine aminotransferase  ast = aspartate aminotransferase  cpk = creatine phosphokinase  uln = upper limit of normal,C0521095;C0035173,false;true,9586/20013
* interquartile range,C1711350,false,9587/20013
* other - europe ( n = nmbr ),C0015176,true,9588/20013
* p < nmbr . nmbr for eze / simva ( pooled across doses ) vs . simva ( pooled across doses ) for the entire cohort data are presented as least squares mean ± standard error ( † median ± se for tg ) for the entire cohort and also for each selected subgroup simva = simvastatin  eze = ezetimibe  tc = total cholesterol  tg = triglycerides  hdl - c = high - density lipoprotein - cholesterol  non - hdl - c = non - high - density lipoprotein cholesterol  apo = apolipoprotein,C0369773;C2603361,false;false,9589/20013
* p < nmbr . nmbr for between - treatment difference with same dose of simvastatin for entire cohort data are expressed as least squares mean ± standard error simva = simvastatin  eze = ezetimibe  chd = coronary heart disease,C0369773;C2603361,false;false,9590/20013
* p for heterogeneity of treatment effect between tertiles > nmbr . nmbr .,C0369773;C0019409;C1518681;C0242960;C2603361,false;false;false;true;false,9591/20013
* per nmbr participant years . composite of first occurrence death ( all cause ),C0679646;C0439234;C0205199;C0205435;C0243132;C0011065;C1306577;C4082313;C4552775;C1554210;C2745955;C1279901;C1547335;C2698741;C4554048,false;false;false;false;true;true;false;false;false;false;false;false;false;false;false,9592/20013
* rate is number of events per nmbr patient - years of follow - up . fthe p value for number of patients from log - rank,C0871208;C1521828,false;false,9593/20013
* reported by physicians . † data are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .,C1709908;C0031831;C1511726;C3245479;C3714741,false;true;false;false;false,9594/20013
* risk reduction  nmbr percent confidence interval ( ci )  and p value are derived from cox models . for risk reductions  negative numbers indicate an increase in risk . † diabetes and hypertension were defined by clinical history . ‡ a family history was defined as having one or more first - degree relatives with either myocardial infarction or sudden death before the age of nmbr . § hdl cholesterol levels are shown according to the median value ( nmbr . nmbr mg per deciliter [nmbr . nmbr mmol per liter] ) . ¶ triglyceride levels are shown according to the median value ( nmbr mg per deciliter [nmbr . nmbr mmol per liter] ) . ¿ ldl cholesterol levels are shown according to the median value ( nmbr mg per deciliter [nmbr . nmbr mmol per liter] ) and according to the values that divide the subjects into three equal groups ( < nmbr  nmbr to nmbr  and > nmbr mg per deciliter [ < nmbr . nmbr  nmbr . nmbr to nmbr . nmbr  and > nmbr . nmbr mmol per liter] ) .,C1137094;C0439165;C0009667;C0008107;C3259781,true;false;true;true;false,9595/20013
* subgroups were defined on the basis of variables assessed before randomization . the lipid levels represent the averages of the values measured four weeks before randomization and those measured at randomization . to convert values for cholesterol to millimoles per liter  multiply by nmbr . nmbr  to convert values for triglycerides to millimoles per liter  multiply by nmbr . nmbr . ci denotes confidence interval  ldl low - density lipoprotein  and hdl high - density lipoprotein . tests for heterogeneity of treatment effect were undertaken across each of the subgroups . in addition  we performed tests for interaction between treatment and the following continuous base - line variables : age  total  ldl  and hdl cholesterol  and triglyceride levels . there was no evidence of significant heterogeneity of treat - ment effect in any prespecified subgroup ( p » nmbr . nmbr ) . † data were missing for three patients  two in the placebo group and one in the pravastatin group .,C1079230,false,9596/20013
* the nmbr substrata with baseline ( bl ) ldl cholesterol nmbr to nmbr mg / dl and nmbr to nmbr mg / dl were combined to make nmbr group with bl ldl cholesterol nmbr to nmbr mg / dl because of small numbers of patients included in the substrata with nmbr to nmbr mg / dl . † bl hdl cholesterol cutoffs were nmbr or nmbr mg / dl for men and nmbr or nmbr mg / dl for women . bars indicate se . bmi body mass index  e ezetimibe nmbr mg  hdl - c hdl cholesterol  ldl - c ldl cholesterol  tg triglycerides,C0168634;C0005918;C0023824;C0202117;C0006413;C1552663;C2827109;C1442488,true;true;true;false;true;false;false;false,9597/20013
. nmbr kg,C0022718;C0439209;C4054209,true;false;false,9598/20013
. nmbr kg mtx use,C0022718;C0025677;C0042153;C0457083;C1947944;C1417487;C0439209;C4054209,true;true;true;false;false;false;false;false,9599/20013
. nmbr step or incident vitrectomy or photocoagulation,C1261552;C1704379;C1705117;C2825408;C3814463,false;false;false;false;false,9600/20013
/ \ge category,C1292300;C0683312;C3889287;C3538705,false;false;false;false,9601/20013
/ ’ interaction,C1704675,false,9602/20013
/ nmbr - blocker,,,9603/20013
/ pl nmbr nmbr,C3897966;C4049765,false;false,9604/20013
: mi,C3810814,false,9605/20013
? f ? n,C0016327,true,9606/20013
[ } ifrerence vs . placebo,,,9607/20013
[nmbr . nmbr mmol / l] ),C1532563,false,9608/20013
[nmbr % ci] *,C0008107;C3259781,true;false,9609/20013
[cm ( female ) / cm ( male ) ],C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,9610/20013
[cm { female ) / cm { male ) ],C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,9611/20013
[kg / m^],C1532718,false,9612/20013
[min,C0702093;C1524029;C3813700,false;false;false,9613/20013
[no / yes] ( % ),C1549445;C1705108;C1710701,false;false;false,9614/20013
[sd],C2699239,false,9615/20013
[zi = nmbr] nmbr ( nmbr . nmbr ),C0043476,true,9616/20013
\bl - sc n / n,C0005918;C0282380;C0006413;C1552663;C2827109,true;true;true;false;false,9617/20013
^ ≥ nmbr % incidence in any treatment group in the overall safety population .,C0021149;C0374505;C0220856,true;false;true,9618/20013
^nmbr days,C0439228,false,9619/20013
^nmbr months,C0439231,false,9620/20013
^nmbr mm hg,C0439475,false,9621/20013
^nmbr mg / g,C1300563,false,9622/20013
^nmbr hrs,C1568891,true,9623/20013
^nmbr ml / min,C0439445,false,9624/20013
^numbers do not always sum to group totals due to missing information for some variables . fbody mass index was calculated as weight in kilograms divided by the square of height in meters . ^hypertension was defined as a self - reported systolic blood pressure > nmbr mm hg,C0237753;C0449788,false;false,9625/20013
| : s blocker,C0565930;C2603362,false;false,9626/20013
| ? > - blocker ( n,,,9627/20013
“ off ”,,,9628/20013
“ on ” with troublesome dyskinesia,C0013384,true,9629/20013
“ on ” without troublesome dyskinesia,C0013384,true,9630/20013
“ relative risk of outcome in acei group iw control group . bbaseline variables for models included : logarithm of age,C0242492;C1274040,true;false,9631/20013
£ nmbr min,C0702093;C1524029;C3813700,false;false;false,9632/20013
£ nmbr . nmbr yrs,,,9633/20013
£ nmbr . nmbr min,C0702093;C1524029;C3813700,false;false;false,9634/20013
£ nmbr . nmbr mmol / l,C1532563,false,9635/20013
£ nmbr mg / dl,C0439269,false,9636/20013
£ nmbr % bsa psoriasis,C0033860,true,9637/20013
£ nmbr yr,C0439234,false,9638/20013
£ nmbr m b ' m in,C1709500,false,9639/20013
£ nmbr ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,9640/20013
£ l nmbr kg,C1637390,false,9641/20013
+ ics / + laba n z nmbr,C0815320;C4551720,false;true,9642/20013
< - nmbr . nmbr - vfx,,,9643/20013
< - nmbr . nmbr + vfx,,,9644/20013
< - nmbr . nmbr cm,,,9645/20013
< nmbr . nmbr tng > cll,C0023434,true,9646/20013
< nmbr cells / ul nmbr nmbr,C0439378,false,9647/20013
< nmbr mg / dl eze / simva ( n = nmbr ),C0439269,false,9648/20013
< nmbr mg / dl simva ( n = nmbr ),C0439269,false,9649/20013
< nmbrst quartile,C0036056;C2828255;C3272372,true;false;false,9650/20013
< nmbr mgday p . eq .,C0205163;C0439185,false;false,9651/20013
< nmbr month n = nmbr,C0332177;C0439231,false;false,9652/20013
< nmbr l / min,C0439393,false,9653/20013
< nmbr . nmbr yrs,,,9654/20013
< nmbr years ( % ),C0439234,false,9655/20013
< nmbr years eze / simva ( n = nmbr ),C0439234,false,9656/20013
< nmbr years simva ( n = nmbr ),C0439234,false,9657/20013
< nmbr . nmbr min,C0702093;C1524029;C3813700,false;false;false,9658/20013
< median nmbr . nmbr,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9659/20013
< = nmbr yr,C0439234,false,9660/20013
< = € nmbr kg,C0022718;C0439209;C4054209,true;false;false,9661/20013
< = nmbr year,C0439234;C0439508,false;false,9662/20013
< = nmbr kg,C0022718;C0439209;C4054209,true;false;false,9663/20013
< nmbr . nmbr ld,C0694649,false,9664/20013
< nmbr mg / l ( n = nmbr ),C0439268,false,9665/20013
< nmbr . nmbr ng / ml ( n = nmbr ),C0439275,false,9666/20013
< nmbr . nmbr ng / l ( n = nmbr ) n ( % ),C0439297,false,9667/20013
< nmbr . nmbr ng / l ( n = nmbr ),C0439297,false,9668/20013
< nmbr mg / dl *,C0439269,false,9669/20013
< nmbr . nmbr mm hg,C0439475,false,9670/20013
< nmbr mm hg — no . ( % ),C0439475,false,9671/20013
< nmbr / nmbr mm hg +,C0439475,false,9672/20013
< nmbr / nmbr mmhg,C0439475,false,9673/20013
< nmbr / nmbr mm hg,C0439475,false,9674/20013
< nmbr ml / s,C0439390,false,9675/20013
< nmbr cells / mm^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,9676/20013
< nmbryear,C0439234;C0439508,false;false,9677/20013
< nmbr and no moderate or severe deformity ( n = nmbr ),,,9678/20013
< nmbr mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,9679/20013
< nmbr mg / d peq,C0439422,false,9680/20013
< nmbr mg / day,C0439422,false,9681/20013
< nmbr — no . { % ),,,9682/20013
< nmbr kg / mnmbr ( n = nmbr ),C1532718,false,9683/20013
< nmbr ppb,C1415800,false,9684/20013
< nmbrxuln,,,9685/20013
< nmbr — no . ( % ),,,9686/20013
< nmbr no . ( % ),,,9687/20013
< nmbr crcl,C1846718,false,9688/20013
< nmbr kg / m^,C1532718,false,9689/20013
< nmbr kg / manmbr,C0022718;C0024443;C3887485;C0439209;C4054209,true;true;false;false;false,9690/20013
< nmbr ky / nr,,,9691/20013
< nmbr mg dl ( reference ),C0439269;C1514811;C1706462,false;false;false,9692/20013
< nmbr ml / min / nmbr . nmbrni -,C0439445;C0028075;C2348274;C3869926;C3869927,false;true;false;false;false,9693/20013
< nmbr ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,9694/20013
< nmbr % predicted,C0681842;C1882327,false;false,9695/20013
< nmbrmlmin ) nmbr,,,9696/20013
< nmbr meters,C0441074,false,9697/20013
< nmbrmo,C0026544;C0332177,true;false,9698/20013
< nmbr . nmbr mu / l - mmol / l,C0439342;C0439190,false;false,9699/20013
< nmbr mg / dl ( < nmbr . nmbr mmol / l ),C0439269;C1532563,false;false,9700/20013
< nmbr ml / min / nmbr,C0439445,false,9701/20013
< nmbr ml / min — %,C0439445,false,9702/20013
< nmbr ml / min ( n = nmbr ),C0439445,false,9703/20013
< nmbr mg / l,C0439268,false,9704/20013
< nmbr weeks,C0439230,false,9705/20013
< nmbr kg ' i ',C0022718;C0021966;C0221138;C0439209;C4054209,true;true;false;false;false,9706/20013
< nmbr mi / min,C3810814;C0702093;C1524029;C3813700,false;false;false;false,9707/20013
< nmbr ml min ’ nmbr nmbr . nmbr m   nmbr,C0439445;C0369637;C0441923,false;false;false,9708/20013
< nmbr ml / min per nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,9709/20013
< nmbr ml / min / nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,9710/20013
< nmbr ml / min / nmbr . nmbr m^ — no . { % ),C0439445;C0369637;C0441923,false;false;false,9711/20013
< nmbr mlymin,,,9712/20013
< nmbr yr — no . { % ),C0439234,false,9713/20013
< nmbr y ( n = nmbr,,,9714/20013
< nmbr y ears,C0013443;C0521421,true;false,9715/20013
< nmbr yr ( n = nmbr ),C0439234,false,9716/20013
< nmbr yrs of age ( n = nmbr,C0001779,false,9717/20013
< nmbr yea ' s,,,9718/20013
< nmbr . nmbr kg,C0022718;C0439209;C4054209,true;false;false,9719/20013
< nmbr . nmbr % ( < nmbr mmol / mol ),C3829066,false,9720/20013
< nmbr ml / minute ),C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,9721/20013
< nmbr cm,,,9722/20013
< mean,C0444504;C2347634;C2348143,false;false;false,9723/20013
< median ( nmbr year - old ),C0549183;C0439234;C0580836;C0439508;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9724/20013
< median ( nmbr days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9725/20013
< median { nmbr days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9726/20013
< median prednisone dose,C0549183;C0032952;C0178602;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,9727/20013
★ reported by physicians . tdata are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .,C1709908;C0031831,false;true,9728/20013
卞 at discharge .,C0012621;C0030685;C2926602,false;true;false,9729/20013
赛 nmbr years,C0439234,false,9730/20013
= calcium channel blocker  bmi = body,C0006684;C0578022;C0242821;C0460148;C1268086;C4082212;C3536851;C4521885,true;false;true;false;false;false;false;false,9731/20013
= cerebrospinal fluid .,C0007806;C0007807,true;true,9732/20013
= ezetimibe  tc = triglycerides  hdl - c = lg / dl l > nmbr . nmbr mmol / l] ) . to qualify as having,C1142985;C0039411;C0062152;C0023128;C3642216;C0439190;C0694651;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;false;false;false;true;true;true;false;false;false,9733/20013
= international prostate symptom score ,C1998280,false,9734/20013
= placebo  eze : tes ( fc j > nmbr rr nmbr definition ) .,C0032042;C0076172;C2983605;C4554402;C1550452;C1704788;C3539107;C3888054;C1422793;C1696465;C1706408,true;true;false;false;false;false;false;false;false;false;false,9735/20013
= placebo  eze = ezetimibe  erol  apo = apolipoprotein  metabolic syndrome  patients were eans and percentage changes are,C0032042;C1142985;C0003591;C0524620;C0030705;C1696465;C1706408,true;true;true;true;true;false;false,9736/20013
≤   nmbr   mmol / mol ( nmbr . nmbr % ),C3829066,false,9737/20013
≥   nmbr   mmol / mol ( nmbr . nmbr % ),C3829066,false,9738/20013
≥ nmbr ae,C3887670,false,9739/20013
≥ nmbr sae,C1519255;C1622657;C4553214,false;false;false,9740/20013
≥ nmbr teae,,,9741/20013
≤ nmbr   year,C0439234;C0439508,false;false,9742/20013
≤ nmbr years,C0439234,false,9743/20013
≤ nmbr mg / l,C0439268,false,9744/20013
≥ nmbr . nmbr % and < nmbr . nmbr %,,,9745/20013
≥ nmbr yearsa,,,9746/20013
≥ nmbra ( n = nmbr ),C0369718;C0441922,false;false,9747/20013
≥ nmbr ml / min,C0439445,false,9748/20013
≥ nmbr . nmbr % and ≤ nmbr . nmbr %,,,9749/20013
= sia,C1225105;C1551538,false;false,9750/20013
> - nmbr . nmbr - vfx,,,9751/20013
> - nmbr . nmbr + vfx,,,9752/20013
> - nmbr . nmbr and < - nmbr . nmbr,,,9753/20013
> - nmbr cm,,,9754/20013
> nmbr med at baseline cardiac disorder *,C4321267;C0168634;C0018799;C1442488,false;true;true;false,9755/20013
> nmbr years vs .   ≤   nmbr years,C0439234,false,9756/20013
> nmbr mg / dl eze / simva ( „ = nmbr ),C0439269,false,9757/20013
> nmbr mg / dl simva ( „ = nmbr ),C0439269,false,9758/20013
> nmbrst and < nmbrnd quartile,C0036056;C3272372,true;false,9759/20013
> nmbr to   ≤   nmbr years vs .   ≤   nmbr years,C0439234,false,9760/20013
> nmbrnd and < nmbrrd quartile,,,9761/20013
> nmbr . nmbr   vs . nmbr . nmbr to   ≤   nmbr . nmbr,,,9762/20013
> nmbr kg / mnmbr smokers,C1532718;C0337664,false;true,9763/20013
> nmbr cells / ul,C0439378,false,9764/20013
> nmbrrd quartile,C0694666;C2828255;C4553350,false;false;false,9765/20013
> nmbr and   ≤   nmbr   vs .   ≤   nmbr,,,9766/20013
> nmbr to   ≤   nmbr   vs .   ≤   nmbr,,,9767/20013
> nmbr and < nmbr years,,,9768/20013
> nmbr to s nmbr yrs,C0040363;C0041260;C1883351,true;true;false,9769/20013
> nmbr month n = nmbr,C0332177;C0439231,false;false,9770/20013
> nmbr and   ≤   nmbr   vs   ≤   nmbr,,,9771/20013
> nmbr years ( % ),C0439234,false,9772/20013
> nmbr years eze / simva ( n = nmbr ),C0439234,false,9773/20013
> nmbr years old,C0439234,false,9774/20013
> nmbr years simva ( n = nmbr ),C0439234,false,9775/20013
> nmbr years bmi,C0439234;C0578022,false;false,9776/20013
> nmbr ml min ) nmbr,C0439445,false,9777/20013
> nmbr   vs .   ≤   nmbr,,,9778/20013
> is years,,,9779/20013
> median nmbr . nmbr,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9780/20013
>   nmbr – <   nmbr   mmol / mol ( nmbr . nmbr – nmbr . nmbr % ),C3829066,false,9781/20013
> = nmbr kg / mnmbr,C1532718,false,9782/20013
> = nmbr l / min,C0439393,false,9783/20013
> = nmbr l_ / min,C0439393,false,9784/20013
> = nmbr ml / mln,C0439526;C1417190;C3815103;C1705224;C3887665,false;false;false;false;false,9785/20013
> = nmbr . nmbr to < nmbr ng / l ( n = nmbr ) n ( % ),C0439297,false,9786/20013
> = nmbr day s initial heparin treatment duration,C0332173;C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685;C0439228;C0439505,false;false;true;false;false;false;false;false;false;false;false,9787/20013
> = nmbr days,C0439228,false,9788/20013
> = nmbr to < nmbr ng / l ( n = nmbr ) n ( % ),C0439297,false,9789/20013
> = nmbr mmhq,,,9790/20013
> = nmbr ng / l ( n = nmbr ) n ( % ),C0439297,false,9791/20013
> = nmbr ng / l ( n = nmbr ),C0439297,false,9792/20013
> = nmbr kg / manmbr,C0022718;C0024443;C3887485;C0439209;C4054209,true;true;false;false;false,9793/20013
> = nmbr mg / g,C1300563,false,9794/20013
> = nmbr meters,C0441074,false,9795/20013
> = nmbr years and < nmbr years,C0439234,false,9796/20013
> = nmbr^ initial heparin treatment duration,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,9797/20013
> = nmbr . nmbr % ( > = nmbr mmol / mol ),C3829066,false,9798/20013
> = nmbr ml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,9799/20013
> = medan ( nmbr year - old ),C0439234;C0580836;C0439508,false;false;false,9800/20013
> = median ( nmbr days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9801/20013
> = medion ( nmbr days ),C0439228,false,9802/20013
> nmbr aes,C1412268;C2699274,false;false,9803/20013
> nmbr aes leading to discontinuation,C1412268;C2699274,false;false,9804/20013
> nmbr antihypertensive medication,C0003364,true,9805/20013
> nmbr drug - related,C0013227;C0439849;C0445223;C1254351,true;false;false;false,9806/20013
> nmbr drug - related aes *,C0013227;C0439849;C1412268;C2699274;C0445223;C1254351,true;false;false;false;false;false,9807/20013
> nmbr exacerbation in prev nmbr m ( n = nmbr ),C4086268;C1552852;C0369637;C0441923,false;false;false;false,9808/20013
> nmbr glucose - lowering medication . no . ( % ),C0017725;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,9809/20013
> nmbr oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,9810/20013
> nmbr serious aes,C0205404;C1412268;C2699274,false;false;false,9811/20013
> nmbr to < = nmbr years,C0439234,false,9812/20013
> nmbr to nmbr   years,C0439234,false,9813/20013
> nmbr year,C0439234;C0439508,false;false,9814/20013
> nmbr . nmbr ng / ml ( n = nmbr ),C0439275,false,9815/20013
> nmbr / nmbr lung fields,C0225759,false,9816/20013
> nmbr da of capillary nonperfusion in the eyec,C0011318;C0006901;C0935624;C3668815,true;true;false;false,9817/20013
> nmbr years to < nmbr years,C0439234,false,9818/20013
> nmbr   years,C0439234,false,9819/20013
> nmbr ng / l,C0439297,false,9820/20013
> nmbrb ( nmbrb to nmbra ),,,9821/20013
> nmbr cm,,,9822/20013
> nmbrmonths,C0439231,false,9823/20013
> nmbr . nmbr mm,C4330985;C4554674,false;false,9824/20013
> nmbr ^mol / liter — no . ( % ),C0347982,false,9825/20013
〉 nmbr ml / min per nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,9826/20013
> nmbr mm hg — no . ( % ),C0439475,false,9827/20013
> nmbr ml / s,C0439390,false,9828/20013
> nmbr at screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,9829/20013
> nmbr per pl at screening,C3897966;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4049765,false;true;true;false;false;false;false;false;false,9830/20013
> nmbr to < nmbr cells / mm^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,9831/20013
> nmbr to < nmbr cells / mm ’,C0007584;C4330985;C4554674;C0007634,true;false;false;true,9832/20013
> nmbr and < nmbr,,,9833/20013
> nmbr and / or > nmbr moderate or severe deformity,,,9834/20013
> nmbr antihypertensive medications,C0003364,true,9835/20013
> nmbr chd risk factors,C0280604;C0035648;C1553898;C3542407,false;true;false;false,9836/20013
> nmbr cv risk factors^ or established atherosclerotic cv disease,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,9837/20013
> nmbr mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,9838/20013
> nmbr oads,,,9839/20013
> nmbr symptom days per week,C1457887;C0677547;C3854129,false;false;false,9840/20013
〉 nmbr years,C0439234,false,9841/20013
> nmbr ( nmbr ) drinks / day if male ( female ),C0452428,false,9842/20013
> nmbr ( n = nmbrlnmbr ),C0369718;C0441922,false;false,9843/20013
> nmbr mg / d peq,C0439422,false,9844/20013
> nmbr mg / day,C0439422,false,9845/20013
> nmbr - ^nmbr kg / m ’,C1532718,false,9846/20013
> nmbr - snmbr kg / m ’,C0565930;C1532718;C2603362,false;false;false,9847/20013
> nmbr - < nmbrkg / mnmbr ( n = nmbr ),C1532718,false,9848/20013
> nmbr - < snmbr kg / m ’,C0565930;C1532718;C2603362,false;false;false,9849/20013
> nmbr to < nmbr ppb,C1415800,false,9850/20013
> nmbr . nmbr pmol / liter,C0439192;C0475211,false;false,9851/20013
> nmbrto < nmbr uln,C0040363;C1519815;C0041260;C1883351,true;false;true;false,9852/20013
> nmbr diseased vessels,C0005847,true,9853/20013
> nmbr drinks / dav,C0452428,false,9854/20013
> nmbr mg / l ( n = nmbr ),C0439268,false,9855/20013
> nmbr . nmbr   vs .   >   nmbr . nmbr and   ≤   nmbr . nmbr,,,9856/20013
> nmbr — no . { % ),,,9857/20013
> nmbr ( moderate or high bleeding risk ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,9858/20013
> nmbr days to nmbr year ( n = nmbr ),C0556972,false,9859/20013
> nmbr kg nr,C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,9860/20013
> nmbr kg / m^,C1532718,false,9861/20013
> nmbr kg / m^ ( obesity ),C1532718;C0028754;C1963185,false;true;false,9862/20013
> nmbr kg / m ’,C1532718,false,9863/20013
> nmbr kg / mnmbr ( n = nmbr ),C1532718,false,9864/20013
> nmbr ky / nr,,,9865/20013
> nmbr to < nmbr ml / min / lnmbrnr,C1635169;C0702093;C0027496;C3844738;C1524029;C3813700,false;false;true;false;false;false,9866/20013
> nmbr to < nmbr mg dl,C0439269,false,9867/20013
> nmbr to < nmbrml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,9868/20013
> nmbr to < nmbr iu / l,C0439457,false,9869/20013
> nmbr % predicted to < nmbr % predicted,C0681842;C1882327,false;false,9870/20013
> nmbr cells / mm^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,9871/20013
> nmbr in previous,C0205156;C1552607,false;false,9872/20013
> nmbr per pl in nmbr months before screening,C3897966;C0439231;C4049765,false;false;false,9873/20013
> nmbr kg / nr,C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,9874/20013
> nmbr y pathogenesis,C0543483;C0699748,true;false,9875/20013
> nmbr . nmbr to < nmbr . nmbr mu / l - mmol / l,C0439342;C0439190,false;false,9876/20013
> nmbr - nmbr yr,C0439234,false,9877/20013
> nmbr ppb,C1415800,false,9878/20013
> nmbr % predicted,C0681842;C1882327,false;false,9879/20013
> nmbr % responder rate,C0871208;C1521828,false;false,9880/20013
> nmbr % stenosis of major artery,C0038449;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false,9881/20013
> nmbruln,C1519815,false,9882/20013
> nmbryearstos is years,,,9883/20013
> nmbr mg / l,C0439268,false,9884/20013
> nmbr weeks,C0439230,false,9885/20013
> nmbr crcl,C1846718,false,9886/20013
> nmbr kg body weight at randomization,C0022718;C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212;C0439209;C4054209,true;true;true;false;true;false;false;false;false;false;false,9887/20013
> nmbr mg / dl ( > nmbr . nmbr mmol / l ) + +,C0439269;C1532563,false;false,9888/20013
> nmbr mi / min,C3810814;C0702093;C1524029;C3813700,false;false;false;false,9889/20013
> nmbr ml / min / nmbr . nmbr mnmbr — no . ( % ),C0439445;C0369637;C0441923,false;false;false,9890/20013
> nmbr ml / niin / lnmbrni -,C1635169;C0028075;C2348274;C3869926;C3869927,false;true;false;false;false,9891/20013
> nmbr mlymin,,,9892/20013
> nmbr to < nmbr ml / min / nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,9893/20013
> nmbr to < nmbriiil / iiim / nmbr . nmbr mnmbr,C0369637;C0441923,false;false,9894/20013
> nmbr yr ( n = nmbr ),C0439234,false,9895/20013
> nmbr yr from the united states,C0439234;C0041703,false;true,9896/20013
> nmbr yrs of age ( n = nmbr,C0001779,false,9897/20013
> nmbr to < nmbr mg / dl,C0439269,false,9898/20013
> nmbr . nmbr mg / day,C0439422,false,9899/20013
> nmbr yr — no . { % ),C0439234,false,9900/20013
> nmbr iu / l,C0439457,false,9901/20013
> nmbr ( n,C0369718;C0441922,false;false,9902/20013
> nmbr y ( n = nmbr,,,9903/20013
> nmbr years or < nmbr crcl,C0439234,false,9904/20013
> nmbr yr — %,C0439234,false,9905/20013
> nmbr . nmbr bpm,,,9906/20013
> nmbr bpm ( n = nmbr ),,,9907/20013
> nmbr . nmbr mu / l - mmol / l,C0439342;C0439190,false;false,9908/20013
> nmbr kg — no . ( % ),C0022718;C0439209;C4054209,true;false;false,9909/20013
> nmbr ml / min ( n = nmbr ),C0439445,false,9910/20013
> nmbrkg,C0022718;C0439209;C4054209,true;false;false,9911/20013
> nmbr . nmbr - nmbr . nmbr kg,C0022718;C0439209;C4054209,true;false;false,9912/20013
> nmbr mg / dl baseline high - sensitivity crp,C0439269;C0168634;C1441604;C3890735;C4048285;C1442488,false;true;false;false;false;false,9913/20013
> nmbr bpm ( n = nmbrlnmbr ),,,9914/20013
> nmbr mg dl,C0439269,false,9915/20013
> nmbr ml min - nmbr nmbr . nmbr m ' nmbr,C0439445;C0369637;C0441923,false;false;false,9916/20013
> nmbr ml / min per nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,9917/20013
> nmbr ml / min / nmbr . nmbr,C0439445,false,9918/20013
> nmbr ml / min / nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,9919/20013
> nmbrml / min / nmbr . nmbr,C0439445,false,9920/20013
> nmbr . nmbr kg,C0022718;C0439209;C4054209,true;false;false,9921/20013
> nmbr - nmbr cm,,,9922/20013
> ii,,,9923/20013
> lto £ nmbr symptom days per week,C1457887;C0677547;C3854129,false;false;false,9924/20013
> lto < nmbr ( n = nmbr ),,,9925/20013
> mean,C0444504;C2347634;C2348143,false;false;false,9926/20013
> ulnand < nmbr ng / l,C0439297,false,9927/20013
> year nmbr,C0439234;C0439508,false;false,9928/20013
± sd .,C2699239,false,9929/20013
± standard deviation . triglyceride,C0871420;C0041004,false;true,9930/20013
« nmbr kg,C0022718;C0439209;C4054209,true;false;false,9931/20013
» nmbr years,C0439234,false,9932/20013
§ classes on the canadian cardiovascular society ( ccs ) scale range from i to iv,C0238884;C0007226;C0037455;C1879987;C0175659;C1514721;C2348147;C3542016;C0349674;C1947916;C3887460,false;true;true;false;true;false;false;false;false;false;false,9933/20013
† includes patients originally randomized to placebo who were switched to secukinumab per the study designs . ‡ aes that occurred in at least nmbr . nmbr % of the patients in the any secukinumab group during the nmbr ‐ week placebo ‐ controlled period and events with an eair of at least nmbr . nmbr cases per nmbr patient ‐ years in the any secukinumab group during the entire treatment period . events listed according to preferred term in the medical dictionary for regulatory activities ( meddra version nmbr . nmbr )  sorted in descending order of eair in the any secukinumab group for the entire treatment period . the entire treatment period for safety data was from baseline to week nmbr visit of the last patient enrolled in these studies . ae  adverse event  as  ankylosing spondylitis  eair  exposure adjusted incidence rates n  number of randomized patients  sae  serious adverse event  urti  upper respiratory tract infection .,C0332257;C1552866;C2700399,false;false;false,9934/20013
• nmbr : death from any cause,C0007465,true,9935/20013
• any mi,C3810814,false,9936/20013
• any stroke,C0038454;C4554100,true;false,9937/20013
• death from any cause,C0007465,true,9938/20013
• death from coronary heart disease,C0011065;C0010054;C0010068;C1956346;C1306577;C4082313;C4552775,true;true;true;true;false;false;false,9939/20013
• death from cv causes,C0011065;C3538987;C4048877;C4318503;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,9940/20013
• hemorrhagic stroke,C0553692,true,9941/20013
• hospitalization for unstable angina,C0019993;C0002965,true;true,9942/20013
• ii : death from coronary heart disease,C1710602;C0011065;C0010054;C0010068;C1956346;C1306577;C4082313;C4552775;C4082587,false;true;true;true;true;false;false;false;false,9943/20013
• iii : death from cv causes,C0439070;C0011065;C3538987;C4048877;C4318503;C1306577;C4082313;C4552775;C1705160,false;true;false;true;false;false;false;false;false,9944/20013
• ischemic stroke,C0948008,false,9945/20013
• ml with st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,9946/20013
• ml without st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,9947/20013
• unstable angina,C0002965,true,9948/20013
• urgent coronaiy revascularization > nmbr days,C0439609;C0581603;C0439228;C3272275,false;false;false;false,9949/20013
• j . the body - mass index is the weight in kilograms divided by the square of the,,,9950/20013
nmbr - nmbr hours,C0439227,false,9951/20013
nmbr - nmbr ( onmbr - o - nmbr ),C0483204,false,9952/20013
nmbr - nmbr ( nmbr % cl nmbr - nmbr to nmbr - nmbr ),C0596019,false,9953/20013
nmbr - nmbr ( o - nmbr - o - nmbr ),C0483204,false,9954/20013
nmbr - nmbr mm,C4330985;C4554674,false;false,9955/20013
nmbr - nmbr ( o - nmbro - o - nmbr ),C0483204,false,9956/20013
nmbr - nmbr ( o - nmbr - i - nmbr ),C0483204;C0021966;C0221138,false;true;false,9957/20013
nmbr - nmbr ( o - nmbr - i - onmbr ),C0483204;C0021966;C0221138,false;true;false,9958/20013
nmbr - nmbr fo - nmbr nmbr - nmbr^,,,9959/20013
nmbr - nmbr ( o - nmbrs - o - nmbr ),C0483204,false,9960/20013
nmbr - nmbr ( o - nmbr - o - nmbro ),C0483204,false,9961/20013
nmbr - nmbr ( o - nmbri - o - nmbr ),C0483204;C0021966;C0221138,false;true;false,9962/20013
nmbr - nmbr ( o - nmbr - nmbr - oo ),C0483204,false,9963/20013
nmbr - nmbr fo - nmbr - o - q^i,C0021966;C0221138,true;false,9964/20013
nmbr - nmbr { o - nmbr - nmbr - onmbr ),C0483204,false,9965/20013
nmbr - nmbr ( onmbro - i - inmbr ),C0483204;C0021966;C0221138,false;true;false,9966/20013
nmbr - nmbr ( snmbr - nmbr ) t,C0718146,false,9967/20013
nmbr - nmbr ( o - nmbrs - i - nmbr ),C0483204;C0021966;C0221138,false;true;false,9968/20013
nmbr - blocker,,,9969/20013
nmbr — nmbr days,C0439228,false,9970/20013
nmbr ( or nmbr,,,9971/20013
nmbr nmbr fo nmbr - nmbr nmbr ),,,9972/20013
nmbr nmbr ( o - nmbr - i - onmbr ),C0483204;C0021966;C0221138,false;true;false,9973/20013
nmbr or nmbr — no . / total no . ( % ),,,9974/20013
nmbr to nmbr symptom days per week,C1457887;C0677547;C3854129,false;false;false,9975/20013
nmbr . nmbr ( nmbr . nmbr - nmbr . inmbri ),C0021966;C0221138,true;false,9976/20013
nmbr . nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9977/20013
nmbr . nmbr ( nmbr . nmbr,,,9978/20013
nmbr . nmbr vs nmbr . nmbr,,,9979/20013
nmbr . nmbr nmbr % ci : nmbr . nmbr - nmbr . nmbr p = nmbr . nmbr,C0008107;C3259781,true;false,9980/20013
nmbr . nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,9981/20013
nmbr . nmbr { nmbr . nmbr,,,9982/20013
nmbr . nmbr ( nmbr . nmbr - l . l ),C3539687,false,9983/20013
nmbr . nmbr ( nmbr % ci nmbr . nmbr to nmbr . nmbr ) p = nmbr . nmbr,C0008107;C3259781,true;false,9984/20013
nmbr . nmbr ( nmbr % ci nmbr . nmbr to nmbr . nmbr ),C0008107;C3259781,true;false,9985/20013
nmbr . nmbr ( nmbr % cl nmbr . nmbr to nmbr . nmbr ) p = nmbr . nmbr,C0596019,false,9986/20013
nmbr . nmbr ( nmbr . nmbr - nmbr . os ),C0229090;C0230028;C0262950;C0393706;C1561953,false;false;true;false;false,9987/20013
nmbr . nmbrto . nmbr . i . iot,C0021966;C0006196;C0221138,true;true;false,9988/20013
nmbr . inmbr ( nmbr . nmbri - nmbr . nmbr ),C0021966;C0221138,true;false,9989/20013
nmbr ( o - onmbr - o - nmbr ),C0483204,false,9990/20013
nmbr ( oonmbr - o . nmbr ),,,9991/20013
nmbr ( o - nmbr - o - nmbr ),C0483204,false,9992/20013
nmbr ix,C0015491,true,9993/20013
nmbrtob nmbr months,C1420851;C0439231,false;false,9994/20013
nmbrtol ( n = nmbr ),,,9995/20013
nmbr - nmbr drinks / dav,C0452428,false,9996/20013
nmbr - nmbr / week ( n = nmbr ),C0332174;C0439230,false;false,9997/20013
nmbr - nmbr / day,C0332173;C0439228;C0439505,false;false;false,9998/20013
nmbr — — bh — i,C0004684;C0021966;C0221138;C0004952;C1412800;C2986890;C4284594;C4321407,true;true;false;true;false;false;false;false,9999/20013
nmbr — e - h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,10000/20013
nmbr — em,,,10001/20013
nmbr ( $ nmbr ml / min ),C0439445,false,10002/20013
nmbr ( nmbr si,,,10003/20013
nmbr ( except for female alone ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,10004/20013
nmbr ( ref ),C1425988,false,10005/20013
nmbr abciximab ( n = nmbr ),C0288672,true,10006/20013
nmbr amlodipine - chlorthalidone,C0051696;C0008294,true;true,10007/20013
nmbr antihypertensive medication,C0003364,true,10008/20013
nmbr baricitinib nmbr mg ■ baricitinib nmbr mg,C4044947;C1319635,true;false,10009/20013
nmbr chlorthalidone,C0008294,true,10010/20013
nmbr chlorthalidone ( n = nmbr ),C0008294,true,10011/20013
nmbr chlorthalidone amlodipine,C0008294;C0051696,true;true,10012/20013
nmbr cl ),C0596019,false,10013/20013
nmbr day l,C0332173;C0439228;C0439505,false;false;false,10014/20013
nmbr event,C0441471;C4019010,false;false,10015/20013
nmbr exacerbation in prev nmbr m ( n = nmbr ),C4086268;C1552852;C0369637;C0441923,false;false;false;false,10016/20013
nmbr is ( nmbr . nmbr ),,,10017/20013
nmbr lisinopril,C0065374,true,10018/20013
nmbr lisinopril - chlorthalidone,C0065374;C0008294,true;true,10019/20013
nmbr low ( n = nmbr ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,10020/20013
nmbr med at baseline,C4321267;C0168634;C1442488,false;true;false,10021/20013
nmbr mg ( nmbr,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10022/20013
nmbr mg a,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10023/20013
nmbr month l,C0332177;C0439231,false;false,10024/20013
nmbr n qi,C0369718;C0376586;C0441922,false;true;false,10025/20013
nmbr n / n,C0369718;C0441922,false;false,10026/20013
nmbr oad,,,10027/20013
nmbr oam,,,10028/20013
nmbr oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,10029/20013
nmbr parameter,C0549193;C1704769;C2350001,false;false;false,10030/20013
nmbr prior tnf antagonist failure,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,10031/20013
nmbr standard ( n = nmbr ),C1442989;C2828392,false;false,10032/20013
nmbr t i,C2603360;C0021966;C0221138,false;true;false,10033/20013
nmbr to nmbr years,C0439234,false,10034/20013
nmbr to nmbr mg / l ( n = nmbr ),C0439268,false,10035/20013
nmbr year mean change from baseline,C0439234;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C0439508,false;false;false;true;false;false;false;false;false;false;false,10036/20013
nmbr . nmbr ( reference ),C1514811;C1706462,false;false,10037/20013
nmbr . nmbr ( referent ),C1706462,false,10038/20013
nmbr . nmbr ( ref . ),C1425988,false,10039/20013
nmbr . nmbrfnmbr . nmbr,C0016327,true,10040/20013
nmbr . nmbr ( fi . nmbr ),C4050619,false,10041/20013
nmbr . nmbr % vs . nmbr . nmbr %,,,10042/20013
nmbr . nmbr - < nmbr ng / l ( n = nmbr ),C0439297,false,10043/20013
nmbr - < nmbr ng / l ( n = nmbr ),C0439297,false,10044/20013
nmbr - year risk for chd,C0439234;C1282512;C0439508,false;false;false,10045/20013
nmbr - year risk of chd,C0439234;C1282512;C0439508,false;false;false,10046/20013
nmbr - yr rate / nmbr participants,C0439234;C0871208;C0679646;C1521828,false;false;false;false,10047/20013
nmbr μ g ( n = nmbr ),C0439267,false,10048/20013
nmbr mg empagliflozin,C0024671;C3490348;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10049/20013
nmbr mg / d ( n = nmbr ),C0439422,false,10050/20013
nmbr mg / kg,C0439272,false,10051/20013
nmbr ml / min,C0439445,false,10052/20013
nmbr years or more,C0439234,false,10053/20013
nmbr % ( - ito nmbr ),C0022283,true,10054/20013
nmbr % ( oto nmbr ),,,10055/20013
nmbr % participants,C0679646,false,10056/20013
nmbr . nmbr per nmbr py,C0030428;C3538810,true;false,10057/20013
nmbr - nmbr mg / dl *,C0439269,false,10058/20013
nmbr mg + mtx,C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,10059/20013
nmbr mg / nmbr mgb,C0024671;C0373680;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10060/20013
nmbr ml ( nmbr to nmbr ) ( n = nmbr / nmbr ),C0439526;C1705224;C3887665,false;false;false,10061/20013
nmbr / nmbr mga ( n = nmbr ),C0065879,true,10062/20013
nmbr ( mono ),C1551432;C1551969,false;false,10063/20013
nmbr % ( ito nmbr ),C0022283,true,10064/20013
nmbr mg dabigatran,C0024671;C2348066;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10065/20013
nmbr mg dabigatran ( n = nmbr ),C0024671;C2348066;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10066/20013
nmbr ( nmbr % cl nmbr to nmbr ),C0596019,false,10067/20013
nmbr < sbp < nmbrmmhg n = nmbr,C0085805;C0439475,true;false,10068/20013
nmbrb ( nmbrb to > nmbra ),,,10069/20013
nmbr carotid artery sites,C0007272;C0205145;C0162859,true;false;true,10070/20013
nmbr ml ( nmbr to nmbr ) ( n - nmbr / nmbr ),C0439526;C1705224;C3887665,false;false;false,10071/20013
nmbr ml ( nmbr to nmbr ) ( n = nmbr / nmbr ) §,C0439526;C1705224;C3887665,false;false;false,10072/20013
nmbr to nmbr mm hg,C0439475,false,10073/20013
nmbr < sbp < nmbr mmhg n = nmbr,C0085805;C0439475,true;false,10074/20013
nmbr to < nmbr mm hg — no . { % ),C0439475,false,10075/20013
nmbr events,C0441471;C3541888,false;false,10076/20013
nmbr . nmbr to < nmbr . nmbr mmhg,C0439475,false,10077/20013
nmbro - inmbr mm hg,C0483204;C0021966;C0439475;C0221138,false;true;false;false,10078/20013
nmbr . nmbr per nmbr pyr,,,10079/20013
nmbr [nmbr - nmbrjs,C1552154,false,10080/20013
nmbr fnmbrq % ),C0016327,true,10081/20013
nmbr . nmbr ( nmbr % ci : nmbr . nmbr,C0008107;C3259781,true;false,10082/20013
nmbr . nmbr to < nmbr . nmbr mm hg,C0439475,false,10083/20013
nmbr - year predicted risk ( % ) of,C0439234;C0439508,false;false,10084/20013
nmbr min / time ),C0702093;C0040223;C3541383;C1524029;C3813700,false;true;false;false;false,10085/20013
nmbr to < nmbr cel,C0208736;C0346421;C0439237;C1413336,true;true;false;false,10086/20013
nmbr   mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10087/20013
nmbr . nmbrinmbr . nmbr ( n = nmbr ),C0021966;C0221138,true;false,10088/20013
nmbr . nmbr per nmbr nmbr . nmbr per nmbr pyr pyr,,,10089/20013
nmbr ( nmbr . nmbr ) ( continued ),C0549178,false,10090/20013
nmbr ( only nmbr distal ),C0205171;C0205108;C4522154;C1720467,false;false;false;false,10091/20013
nmbro / nmbronmbr ( nmbr - nmbr % ),C0483204,false,10092/20013
nmbr fnmbrl % nmbr,C0016327,true,10093/20013
nmbr ( nmbrs . s ),C0565930;C2603362,false;false,10094/20013
nmbr < nmbrs ) n nmbr ( nmbr . nmbr ),C2986823,true,10095/20013
nmbr - < nmbr years,C0439234,false,10096/20013
nmbr nmbr . nmbr ( nmbr . nmbr ) [nmbr ( nmbr . nmbr ) ] - nmbr . nmbr ( - nmbr . nmbr to - nmbr . nmbr ) [ - nmbr . nmbr ( - nmbr . nmbr to - nmbr . nmbr ) ] - nmbr . nmbr ( nmbr . nmbr ) [ - nmbr . nmbr ( nmbr . nmbr ) ],C0040363;C0041260;C1883351,true;true;false,10097/20013
nmbrb ( nmbrb to nmbra ),,,10098/20013
nmbrst tertile ( < = nmbr mg / dl [ < = nmbr . nmbr mmol / l] ) b,C0036056;C0439269;C1532563;C3272372,true;false;false;false,10099/20013
nmbrst : nmbr - nmbr . nmbr pmol / l,C0036056;C0439284;C3272372,true;false;false,10100/20013
nmbr - gi,C1708130;C3539617;C4050121,false;false;false,10101/20013
nmbr - h pmg ( mmol / l ),C2827804,false,10102/20013
nmbr - h pmg,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,10103/20013
nmbr - h postprandial c - peptide ( ng / ml ),C2827809;C0376674;C0006558,false;true;true,10104/20013
nmbr - h postprandial insulin ( miu / ml ),C0033727;C0376674;C0021641;C0439457;C1533581;C1579433;C3714501;C0369286;C0441932;C0564385;C4528284,true;true;true;false;false;false;false;false;false;false;false,10105/20013
nmbr - h postprandial proinsulin ( pmol / l ),C2827799;C0376674;C0033362;C3813208,false;true;true;false,10106/20013
nmbr - hour postload glucose,C0439227;C0017725;C0564385,false;true;false,10107/20013
nmbr - hour ppg,C0439227;C1418888;C0564385,false;false;false,10108/20013
nmbr - y kaplan - meier rate ( nmbr % ci ),C0871208;C0008107;C3259781;C1521828,false;true;false;false,10109/20013
nmbr — no . / total no . ( % ),C0439175;C0439810,false;false,10110/20013
nmbr ( nmbr to < nmbr ml / min ),C0439445,false,10111/20013
nmbr nmbr to < nmbr kg / mnmbr,C1532718,false,10112/20013
nmbr hr after glucose challenge,C3840385,false,10113/20013
nmbr oads,,,10114/20013
nmbr or nmbr d / mo,,,10115/20013
nmbr or nmbr d / wk,,,10116/20013
nmbr or nmbr step,,,10117/20013
nmbr prior tnf antagonist failures,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,10118/20013
nmbr yr . km rate,C0439234;C3887676;C0871208;C1521828,false;false;false;false,10119/20013
nmbr . nmbr ( ne,C0027608;C0028219;C3538705,true;true;false,10120/20013
nmbr . nmbr range nmbr - nmbr,C1514721;C2348147;C3542016,false;false;false,10121/20013
nmbr . nmbrmg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10122/20013
nmbr . nmbr % vi . nmbr . nmbr %,C0205999,true,10123/20013
nmbr nmbr . nmbr ( nmbr . nmbr ) [nmbr ( nmbr . nmbr ) ] nmbr . nmbr ( - nmbr . nmbr to nmbr . nmbr ) [nmbr . nmbr ( - nmbr . nmbr to nmbr . nmbr ) ],C0040363;C0041260;C1883351,true;true;false,10124/20013
nmbr i - nmbr - nmbrai,C0021966;C0003504;C4551710;C0221138,true;true;false;false,10125/20013
nmbr . nmbr ( ll . nmbr ),,,10126/20013
nmbr / nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10127/20013
nmbr mgrdl,,,10128/20013
nmbr - nmbr mmol / l,C1532563,false,10129/20013
nmbr mm hg,C0439475,false,10130/20013
nmbr kg / mnmbr,C1532718,false,10131/20013
nmbr . nmbr % vi,C0205999,true,10132/20013
nmbr - < nmbr kg / mnmbr,C1532718,false,10133/20013
nmbr ( oh ) vitamin d ( ng / ml ),C0220853;C0014695;C0439275;C0042866;C2936842;C3537249;C3714503,true;true;false;true;false;false;false,10134/20013
nmbr μ g bid ( n = nmbr ),C0439267,false,10135/20013
nmbr to < nmbr — no . { % ),,,10136/20013
nmbr < bmi < nmbr,C0578022,false,10137/20013
nmbr ( io - nmbr % ),C1046794;C3146236,false;false,10138/20013
nmbrth — nmbrth percentiles,C0039725;C1264641;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,10139/20013
nmbr c . t,,,10140/20013
nmbr a . g,C0439267,false,10141/20013
nmbrhr prandial glucose ' * ’,C1998602;C0017725;C4553624,true;true;false,10142/20013
nmbrinmbr ( nmbri . nmbr ),C0021966;C0221138,true;false,10143/20013
nmbrl . nmbr ( lnmbr . nmbrl ),C3539687,false,10144/20013
nmbrnd tertile ( > nmbr to < = nmbr mg / dl [ > nmbr . nmbr to < = nmbr . nmbr mmol / l] ) c,C0439269,false,10145/20013
nmbrnd : nmbr . nmbr - nmbr . nmbr pmol / l,C0439284,false,10146/20013
nmbrornmbr,,,10147/20013
nmbrs . nmbr ± s . nmbr,C0565930;C2603362,false;false,10148/20013
nmbr - < nmbrmo,C0026544;C0332177,true;false,10149/20013
nmbr - nmbr — no . / total no . ( % ),C0439175;C0439810,false;false,10150/20013
nmbr - polnt mace,C0349381;C0949745;C1445339,false;true;false,10151/20013
nmbr - yr km mortality rate,C0439234;C3887676;C0026565;C0205848,false;false;true;true,10152/20013
nmbr - yr %,C0439234,false,10153/20013
nmbr – nmbr months,C0439231,false,10154/20013
nmbr ( moderate disease ),C0205081;C0012634;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,10155/20013
nmbr blocker before admission,C0184666;C0809949,false;false,10156/20013
nmbr coenzyme qnmbr subgroups for time to first hospitalization ( number of patients variable ) .,C0041536;C1079230;C0040223;C3541383,true;false;true;false,10157/20013
nmbr mo - nmbr y,C0026544;C0332177,true;false,10158/20013
nmbr . nmbr ( lo - nmbr . nmbr ),C0206579;C1232424,true;false,10159/20013
nmbr − nmbr mg / g,C1300563,false,10160/20013
nmbr - nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,10161/20013
nmbr - nmbr ml min ) nmbr,C0439445,false,10162/20013
nmbr - nmbr ml / rain,C0439526;C0034640;C1705224;C3887665,false;true;false;false,10163/20013
nmbr - nmbr crcl,C1846718,false,10164/20013
nmbr – ≤ nmbr ml / min,C0439445,false,10165/20013
nmbr days composite of death / new mi / urgent revascularization and definite st,C0205199;C0011065;C4689466;C3810814;C0439609;C0581603;C3272275;C1306577;C4082313;C4552775;C1547335,false;true;false;false;false;false;false;false;false;false;false,10166/20013
nmbr days definite st,C0439228;C0439544;C0036056;C3272372;C1704787,false;false;true;false;false,10167/20013
nmbr days new mi,C0439228;C0205314;C3810814,false;false;false,10168/20013
nmbr days new mi or definite acute st,C0439228;C0205314;C3810814,false;false;false,10169/20013
nmbr days stroke ( ischemic ),C0439228,false,10170/20013
nmbr days until end of study ( landmark analysis ),C0444930;C2826182;C0002778;C0936012;C1524024;C2746065,false;false;false;false;true;false,10171/20013
nmbr days urgent revascularization,C0439228;C0439609;C0581603;C3272275,false;false;false;false,10172/20013
nmbr kg / mnmbr or more,C1532718,false,10173/20013
nmbr mg qd ( n = nmbr ),C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10174/20013
nmbr to < nmbr mumin,,,10175/20013
nmbr to < nmbr ml / min per nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,10176/20013
nmbr to < nmbr ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,10177/20013
nmbr to less than nmbr,C0040363;C0041260;C1883351,true;true;false,10178/20013
nmbr wk,C0332174;C0439230,false;false,10179/20013
nmbr mg ld,C0024671;C0694649;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10180/20013
nmbr mg qnmbrw,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10181/20013
nmbrqnmbrw ( n = nmbr ),,,10182/20013
nmbr events[nmbr . nmbr],C0441471;C3541888,false;false,10183/20013
nmbr . l ( nmbr . l ),C3539687,false,10184/20013
nmbrs fnmbr ),C0565930;C0016327;C2603362,false;true;false,10185/20013
nmbrms score †,C2349943;C0449820;C4050231;C3539704;C3713294,false;false;false;false;true,10186/20013
nmbrrd tertile ( > nmbr mg / dl [ > nmbr . nmbr mmol / l] ) d,C0694666;C0567349;C3642216;C2348885;C0439269;C0439190;C4553350,false;false;false;false;false;false;false,10187/20013
nmbrrd : nmbr . nmbr - nmbr . nmbr pmol / l,C0694666;C0439284;C4553350,false;false;false,10188/20013
nmbr - nmbr ( < nmbr ml / min ),C0439445,false,10189/20013
nmbr - nmbr — no . ( % ),,,10190/20013
nmbr - point mace ( nmbr - point mace plus hospitalization for unstable angina ),C1552961;C2347617;C3714763,false;false;false,10191/20013
nmbr ‐ point reduction in selena – sledai score,C1552961;C0301630;C0451528;C0392756;C1293152;C4551656;C2347617;C3714763,false;false;false;false;false;false;false;false,10192/20013
nmbr - year cumulative incidence,C0439234;C1511559;C0021149;C0220856;C0439508,false;false;true;true;false,10193/20013
nmbr ( severe disease ),C1836348,false,10194/20013
nmbr tcz + mtx,C0025677;C1417487,true;false,10195/20013
nmbr tcz + mtx mtx,C0025677;C1417487,true;false,10196/20013
nmbr week,C0332174;C0439230,false;false,10197/20013
nmbr yrs l,,,10198/20013
nmbr . nmbr ± nmbr . lf,C1416933;C2986618;C4554443,false;false;false,10199/20013
nmbr / week ( n = nmbr ),C0332174;C0439230,false;false,10200/20013
nmbr nmbr . nmbr ( nmbr . nmbr ) [nmbr ( nmbr . nmbr ) ] - nmbr . nmbr ( - nmbr . nmbr to - nmbr . nmbr ) [ - nmbr . nmbr ( - nmbr . nmbr to - nmbr . nmbr ) ],C0040363;C0041260;C1883351,true;true;false,10201/20013
nmbr / day,C0332173;C0439228;C0439505,false;false;false,10202/20013
nmbr min twice / week,C0702093;C1720725;C0332174;C0439230;C1948050;C1524029;C3813700,false;false;false;false;false;false;false,10203/20013
nmbr . nmbr ± ii . nmbr,,,10204/20013
nmbr - nmbr ( men ),C0025266,true,10205/20013
nmbr to < nmbr ml / min / nmbr,C0439445,false,10206/20013
nmbr . i ± ii . nmbr,C0021966;C1710602;C4082587;C0221138,true;false;false;false,10207/20013
nmbr nmbr . nmbr ( nmbr . nmbr ) [nmbr ( nmbr . nmbr ) ] - nmbr . nmbr ( - nmbr . nmbr to nmbr . nmbr ) [ - nmbr . nmbr ( - nmbr . nmbr to nmbr . nmbr ) ],C0040363;C0041260;C1883351,true;true;false,10208/20013
nmbr ( nmbr cl ),C0596019,false,10209/20013
nmbr . nmbr ( io . i ),C1046794;C0021966;C0221138;C3146236,false;true;false;false,10210/20013
nmbrs = scandinavian simvastatin survival study . nmbr woscops = west of scotland coronary prevention study . nmbr care = cholesterol and recurrent events . nmbr post - cabg = post - coronary artery bypass graft . nmbr afcaps / texcaps = air force / texas coronary atherosclerosis prevention study . nmbr lipid = long - term intervention with pravastatin in ischaemic disease . nmbr gissi prevention = gruppo italiano per lo studio della sopravvivenza nell ’ infarto miocardico . nmbr lips = lescol intervention prevention study . nmbr hps = heart protection study . nmbr prosper = prospective study of pravastatin in the elderly at risk . nmbr allhat - llt = antihypertensive and lipid - lowering treatment to prevent heart attack trial . nmbr ascot - lla = anglo - scandinavian cardiac outcomes trial - lipid lowering arm . nmbr alert = assessment of lescol in renal transplantation . nmbr cards = collaborative atorvastatin diabetes study . nmbr s = simvastatin . l = lovastatin . p = pravastatin . f = ﬂ uvastatin . a = atorvastatin . * mean duration of follow - up based on survival times within each trial . overall mean is weighted by trial - speci ﬁ c variances of logrank ( o – e ) for major vascular events . † all trials included dietary intervention : woscops  gissi prevention  lipid  nmbrs  lips  and hps provided dietary advice  afcaps / texcaps  post - cabg  care  allhat  alert  cards  and prosper used american heart association ( aha ) step nmbr diet and care intensi ﬁ ed to step nmbr diet if ldl cholesterol nmbr · nmbr mmol / l ( nmbr mg / dl ) . ‡ other chd includes patients with a history of other symptomatic chd but excludes those with a history of mi ( as already counted in mi column ) . § other vascular includes history of intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  and peripheral artery disease . ¶ none includes individuals without a history of mi  symptomatic chd  intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  or peripheral artery disease,C0565930;C0240951;C0074554;C0038952;C1705493;C0036453;C0489835;C1706420;C1947933;C0008377;C0557651;C0150158;C2603343;C0220921;C2603362,false;false;true;true;false;true;false;false;false;true;false;false;false;true;false,10211/20013
nmbrth : nmbr . nmbr - nmbr pmol / l,C0039725;C0439284;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,10212/20013
nmbr - nmbr / week ( n = nmbr ) nmbr - nmbr / week ( n = nmbr ),C0332174;C0439230,false;false,10213/20013
nmbr - asa compounds,C0004057;C0205198;C1706082;C3853627,true;false;false;false,10214/20013
nmbr . nmbr ( nmbr . o - nmbr . o ),C0483204,false,10215/20013
nmbr . nmbr ± l . l,C3539687,false,10216/20013
nmbr . nmbr - nmbr . nmbr mm,C4330985;C4554674,false;false,10217/20013
nmbr . nmbr or more,,,10218/20013
nmbr - nmbr ml min   nmbr,C0439445,false,10219/20013
nmbr - nmbr kg,C0022718;C0439209;C4054209,true;false;false,10220/20013
nmbr – < nmbr ml / min,C0439445,false,10221/20013
nmbr - < nmbr kg,C0022718;C0439209;C4054209,true;false;false,10222/20013
nmbr - < nmbrml / min,C0439445,false,10223/20013
nmbr to < nmbr m um in,C0369637;C0441923,false;false,10224/20013
nmbr to < nmbr ml / min ( n = nmbr nmbr ),C0439445,false,10225/20013
nmbr to nmbr y,,,10226/20013
nmbr % decrease in womac pain score,C0392756;C0582148;C0547047,false;false;false,10227/20013
nmbr . nmbr ± b . b,,,10228/20013
nmbrmg / nmbr mgc,C0024671;C3888239;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10229/20013
nmbr kg / m ’,C1532718,false,10230/20013
nmbr - nmbr ( women ),C0043210,true,10231/20013
nmbr . nmbr ( inmbr . s ),C0021966;C0221138,true;false,10232/20013
nmbr %,,,10233/20013
nmbr . nmbr ( nmbr l . l ),C3539687,false,10234/20013
nmbr ( nmbr . nmbr ) / nmbrz ( nmbrze ),,,10235/20013
nmbr tq - fi ' i,C3555502;C4050619;C0021966;C0221138,true;false;true;false,10236/20013
nmbrfe black *,C3848561;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,10237/20013
nmbrii ( nmbr . nmbr ),,,10238/20013
nmbrl ( lnmbr ),C3539687,false,10239/20013
nmbrl . nmbr ( lnmbr . nmbr ),C3539687,false,10240/20013
nmbr - mercaptopurine / azathioprine,C0000618;C0004482,true;true,10241/20013
nmbr - min walk distance m,C0702093;C0429886;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false;false,10242/20013
nmbr - min walk distance,C0702093;C0429886;C1524029;C3813700,false;false;false;false,10243/20013
nmbr - up and / or aza at baseline,,,10244/20013
nmbr - y incidence rate ( se ) per nmbr participants,C1708485;C0036919;C0679646,false;true;false,10245/20013
nmbr - y rate per nmbr persons ( se ),C0871208;C0027361;C0036919;C1521828,false;true;true;false,10246/20013
nmbr - year km %,C0439234;C3887676;C0439508,false;false;false,10247/20013
nmbr days,C0439228,false,10248/20013
nmbr mg / kgf ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10249/20013
nmbr mq / kq *,C0024853,true,10250/20013
nmbr . nmbr ( g . l ),C0439294;C0456615,false;false,10251/20013
nmbr - nmbr ml / min / nmbr . nmbrmnmbr,C0439445;C0369637;C0441923,false;false;false,10252/20013
nmbr to < nmbr yr — no . { % ),C0439234,false,10253/20013
nmbr to < nmbr ml min ’ nmbr nmbr . nmbr m ' nmbr,C0439445;C0369637;C0441923,false;false;false,10254/20013
nmbr to < nmbr ml / min / nmbr - nmbr,C0439445,false,10255/20013
nmbr to < nmbr ml / min / nmbr . nmbr m^,C0439445;C0369637;C0441923,false;false;false,10256/20013
nmbr to nmbr ml / min per nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,10257/20013
nmbr . nmbr ( lo . i ),C0206579;C0021966;C0221138;C1232424,true;true;false;false,10258/20013
nmbr ( nmbri . i ),C0021966;C0221138,true;false,10259/20013
nmbr to < nmbr yr — no . ( % ),C0439234,false,10260/20013
nmbr to nmbr y ( n = nmbr,,,10261/20013
nmbr to nmbr yr,C0439234,false,10262/20013
nmbr yrs or more,,,10263/20013
nmbrmo,C0026544;C0332177,true;false,10264/20013
nmbrmoto < nmbr yr,C0439234,false,10265/20013
nmbrmw distance,C0024548;C0012751;C0026385;C0556966,true;false;true;false,10266/20013
nmbrmwt ( m ),C0369637;C0441923,false;false,10267/20013
nmbr . nmbr % or more,,,10268/20013
nmbr to < nmbr bpm ( n = nmbr ),C0040363;C0041260;C1883351,true;true;false,10269/20013
nmbr / nmbr ( nmbr . nmbr ) ( continued ),C0549178,false,10270/20013
nmbr - nmbr y,,,10271/20013
nmbr years ( n = nmbr ),C0439234,false,10272/20013
nmbr ( nmbrj ) znmbr ( nmbr . e,,,10273/20013
nmbr . nmbr ± o . lt,C0483204;C0023376;C0230426;C3887647;C4521399,false;true;false;false;false,10274/20013
nmbr ± ll,,,10275/20013
nmbr . nmbr ± l . ot,C0439394;C1318464;C1418208;C1705587;C1706495;C3642217,false;true;false;false;false;false,10276/20013
nmbr nil,C0442734,false,10277/20013
nmbr . l ( nmbrl . nmbr ),C3539687,false,10278/20013
nmbrtcz,,,10279/20013
nmbr - nmbr . nmbr mm,C4330985;C4554674,false;false,10280/20013
nmbr . ' ^ / nmbrtnmbrc } u,C2603360;C0439148,false;false,10281/20013
nmbr - day cce,C0332173;C0439228;C0439505,false;false;false,10282/20013
nmbr - day mortality,C0332173;C0026565;C0026566;C0439228;C0439505,false;true;true;false;false,10283/20013
nmbr mg / nmbr wk ( n = nmbr ),C1881833,false,10284/20013
nmbr or greater,,,10285/20013
nmbr % ci nmbr . nmbr - nmbr . nmbr,C0008107;C3259781,true;false,10286/20013
nmbr % cinmbr,C0008107;C3259781,true;false,10287/20013
nmbr % clf,C3540486;C4553190,false;false,10288/20013
nmbr . nmbrinmbr . nmbr ( n = nmbr ) a,C0021966;C0221138,true;false,10289/20013
a,,,10290/20013
a - blockers,,,10291/20013
α - glucosidase inhibitor,C1512211,false,10292/20013
a - glucosidase inhibitors,C1512211,false,10293/20013
a - glucosidase inhibitors ' nmbr,C1512211,false,10294/20013
a nmbr years,C0439234,false,10295/20013
a cardiovascular death or hospitalization for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,10296/20013
a compared w,C1707455,false,10297/20013
a compared wi,C1707455;C0043193;C1520135,false;true;false,10298/20013
a decrease of > nmbr points in the cdai score,C0392756;C2924612;C0547047,false;false;false,10299/20013
a excludes two randomized patients with unknown diabetes status at baseline .,,,10300/20013
a median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10301/20013
a new vertebral fractures ( mfas ),C0205314;C0080179;C1549796;C1549980,false;true;false;false,10302/20013
a prebronchodilator fevl ( % predicted ),C2599602,false,10303/20013
a reslizumab nmbr . nmbr mg / kg n / n,C1869620;C0439272,true;false,10304/20013
a severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,10305/20013
a stroke,C0038454;C4554100,true;false,10306/20013
a vs . c,,,10307/20013
a ) those receiving no inhaled pre - treatment maintenance medication,,,10308/20013
a . acr nmbr,C1412134;C1515941,false;false,10309/20013
a . beuralizuinab nmbr ing qnmbrw,,,10310/20013
a . overall and subgroups bv statin potency - -,C0282416;C1561607,true;false,10311/20013
a . primary composite outcome,C0205225;C0205199;C1274040;C1547335;C0439612;C0439631,false;false;false;false;false;false,10312/20013
a / aml ( n = nmbr ),C0023465;C0023467,true;true,10313/20013
a / c,,,10314/20013
a / ga,C0016993,true,10315/20013
a : worldwide black and non - black patients,C0005680;C0027567;C0085756;C0439541,true;true;true;false,10316/20013
anmbr vs placebo,,,10317/20013
anmbrc [n ( % ) ],C1272460,false,10318/20013
anmbrc < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10319/20013
anmbrc < nmbr . nmbr %,,,10320/20013
anmbrc > = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10321/20013
anmbrc > nmbr . nmbr - nmbr . nmbr %,,,10322/20013
anmbrc > nmbr . nmbr %,,,10323/20013
anmbrc > s . nmbr - s . nmbr %,,,10324/20013
anmbr . nmbr ± nmbra . nmbr,,,10325/20013
aa / g,C0282379;C0439267;C1235746;C1882141;C4554792,true;false;false;false;false,10326/20013
abaloparatide - sc,C4042342;C0282380,true;true,10327/20013
abatacept nmbr / nmbr ( n = nmbr ),C1619966,true,10328/20013
abatacept ‡,C1619966,true,10329/20013
abbreviations : ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by height in meters squared )  dm  diabetes mellitus  hbanmbrc  hemoglobin anmbrc  hmg - coa  nmbr - hydroxy - nmbr - methylglutaryl coenzyme a . asome subjects took more than nmbr oral anti - dm drug in addition to metformin  and thus the total number of concomitant oral anti - dm drugs in the columns exceed the “ n ” values in the colesevelam hydrochloride and placebo group headings . bsulfonylureas include chlorpropamide  glibenclamide  glimepiride  glipizide  and tolazamide . cthiazolidinediones include pioglitazone  pioglitazone hydrochloride  rosiglitazone  and rosiglitazone maleate . d - glucosidase inhibitors include acarbose or miglitol .,C0000723;C0022709;C1305855,true;true;true,10330/20013
abbreviations : ace  angiotensin - converting enzyme  iqr  interquartile range  ml  myocardial infarction . si conversion : to convert creatinine clearance to ml / s  multiply by nmbr . nmbr . * data are expressed as no . / total ( % ) unless otherwise specified . festimated using cockroft - gault equation . tthe timi risk score was used to categorize patients at low ( nmbr - nmbr )  intermediate ( nmbr - nmbr )  and high ( nmbr - nmbr ) risk . nmbr,C0000723;C0022709;C1711350;C0439526;C0027051;C0439836;C0428953;C2926063;C3810814;C4552959;C1705224;C3887665,true;true;false;false;true;false;false;false;false;false;false;false,10331/20013
abbreviations : acei  angiotensin - converting enzyme inhibitor  arb  angiotensin receptor blocker  bpm  beats per minute  ccb  calcium channel blocker  msdbp  mean sitting diastolic blood pressure  mssbp  mean sitting systolic blood pressure . values are no . ( % ) unless otherwise indicated . amean ± sd . bmore severe  > nmbr and < nmbr mm hg / > nmbr and < nmbr mm hg  less severe  > nmbr and < nmbr mm hg / > nmbr and < nmbr mm hg . blood pressure at baseline is with monotherapy ( ie  before switch to amlodipine / valsar - tan therapy ) .,C0000723;C0003015;C3888198;C0597357;C2757044;C3536837;C4541021,true;true;false;false;false;false;false,10332/20013
abbreviations : bmi  body mass index  cabg  coronary artery bypass graft  nsaids  nonsteroidal anti - inflammatory drugs  pci  percutaneous coronary interventions . * values expressed as number ( percentage ) unless otherwise indicated . percentages may not equal nmbr due to rounding . fhistory of or currently taking antidiabetic or lipid - lowering medications . ^history of or currently have elevated serum creatinine level but less than nmbr mg / dl_ ( < nmbr pmol / l ) . § patients with a history of skin  prostate  and other cancers with long survival expectancy were not excluded . | | lnsulin and / or oral hypoglycemics . ildata for women only ( n = nmbr for calcium antagonist strategy and n = nmbr for non - calcium antagonist strategy ) .,C0000723;C1305855;C0010055;C0003211;C1532338;C0042295;C3536840,true;true;true;true;true;false;false,10333/20013
abbreviations : chd  coronary heart disease  cl  confidence interval  ml  myocardial infarction  rr  relative risk . ^defined as a composite end point comprising the first of any of these events : nonfatal ml  nonfatal stroke  or cardiovascular death . tp value for interaction < . nmbr for major cardiovascular event . no other interactions are significant . ^calculated as weight in kilograms divided by the square of height in meters . § hypertension was defined as a self - reported systolic blood pressure > nmbr mm hg  a diastolic blood pressure > nmbr mm hg  or physician - diagnosed hypertension . | | hyperlipidemia was defined as a self - reported total cholesterol > nmbr mg / dl_ ( nmbr . nmbr mmol / l ) or physician - diagnosed high cholesterol . ^diabetes defined by self - report . # calculated using the framingham risk score among nmbr nmbr women who provided a blood sample at baseline .,C0000723;C0010068;C0596019;C0009667;C0439526;C0027051;C4554402;C0242492;C0428953;C2926063;C3810814;C4552959;C1705224;C3887665,true;true;false;true;false;true;false;true;false;false;false;false;false;false,10334/20013
abbreviations : da  disc area  e - etdrs  electronic early treatment diabetic retinopathy study  iop  intraocular pressure  oct  optical coherence tomography .,C0000723;C0011318;C0180459;C0017446;C0013850;C3161471;C0011884;C0021888;C0920367;C1547561;C4281784;C0205146;C1556138;C1705370;C2348299;C3668815,true;true;false;true;false;false;true;true;true;false;true;false;false;false;false;false,10335/20013
abbreviations : egfr = estimated glomerular filtration rate  imt = intimal medial thickness  lv = left ventricular . * two - sample comparison t - tests were calculated based on log - transformed variables . * * geometric mean with nmbr % confidence interval in parenthesis .,C0000723;C1739039;C3811844;C0334121;C0162864;C0205098;C1280412;C0023128;C0225897;C0205448;C0370003;C1707455;C0871472;C2347026;C0731033;C1881413;C1256463;C1704614;C4318736;C3812682,true;true;false;true;true;false;false;true;true;false;false;false;false;false;true;false;false;false;false;false,10336/20013
abbreviations :   teae  treatment - emergent adverse event  gly  glycopyrrolate inhalation solution  bid  twice daily .,C0000723;C4684800;C0017890;C0017970;C1154181;C0585361;C0523677,true;false;true;true;false;false;false,10337/20013
abciximab - facilitated pci,C0288672;C4049621,true;false,10338/20013
abciximab vs . primary,C0288672,true,10339/20013
abl - sc mean,C0023139;C0282380;C0444504;C2347634;C2348143;C1704928;C3890208,true;true;false;false;false;false;false,10340/20013
abl - sc n / n,C0023139;C0282380;C1704928;C3890208,true;true;false;false,10341/20013
about nmbr mg / l or more,C0439268,false,10342/20013
about nmbr mg / l,C0439268,false,10343/20013
absence,C0332197;C1689985,false;false,10344/20013
absolute ( l ),C0205344,false,10345/20013
absolute decline in fvc > nmbr % predicted,C0205344;C3714541,false;true,10346/20013
absolute decline in fvc > nmbr % predicted or death,C0205344;C3714541,false;true,10347/20013
absolute difference estimate vs placebo ( nmbr % ci ),C1549031;C0750572,false;false,10348/20013
absolute risk difference ( nmbr % cl ),C1549031;C0035647;C0596019;C4552904;C1519101;C1705241;C1705242,false;true;false;false;false;false;false,10349/20013
absolute risk reduction ( nmbr % ci ),C3179139;C0008107;C3259781,true;true;false,10350/20013
absolute risk reduction ( nmbr % cl ) *,C3179139;C0596019,true;false,10351/20013
absolute risk reductions,C3179139,true,10352/20013
absolute time spent “ on ” with troublesome dyskinesia,C0439546,false,10353/20013
absolute time spent “ on ” without troublesome dyskinesia,C0439546,false,10354/20013
absolute time spent “ on ”,C0439546,false,10355/20013
absolutedifferenceestimate vs placebo ( nmbr % ci ),,,10356/20013
access site,C0589360,false,10357/20013
accord acr < nmbr - nmbr,C0680240;C1412134;C1515941,false;false;false,10358/20013
accord acr > nmbr - nmbr,C0680240;C1412134;C1515941,false;false;false,10359/20013
accord primary,C0680240,false,10360/20013
acd,C4554601,false,10361/20013
ace - i ( n,C1452534;C0021966;C0221138;C4284014,true;true;false;false,10362/20013
ace ‐ i or arb,C1452534;C0021966;C0221138;C4284014,true;true;false;false,10363/20013
ace - inhibitor or arb ( % ),C0003015;C4541021,true;false,10364/20013
ace = angiotensin - converting enzyme  cabg = coronary artery bypass graft  ccsc = canadian cardiovascular society classification  mi = myocardial infarction  pci = percutaneous coronary,C0022709;C0010055;C0545743;C0189695;C3640258;C0027051,true;true;false;false;false;true,10365/20013
ace inhibitor / arb,C0003015;C3888198;C4541021,true;false;false,10366/20013
ace inhibitor and / or arb,C0003015;C4541021,true;false,10367/20013
ace inhibitor or arb use,C0003015;C4541021,true;false,10368/20013
ace inhibitor treatment,C0003015;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4541021,true;true;true;false;false;false;false;false;false,10369/20013
ace inhibitor use ( % ),C0003015;C0042153;C0457083;C1947944;C4541021,true;true;false;false;false,10370/20013
ace inhibitor / arb therapy,C1444755;C3888198,false;false,10371/20013
ace inhibitors or angiotensin - receptor blockers,C0003015,true,10372/20013
ace or arb,C1452534;C4284014,true;false,10373/20013
ace / arb,C1452534;C3888198;C4284014,true;false;false,10374/20013
ace / arb use,C1452534;C3888198;C4284014,true;false;false,10375/20013
ace / arb users,C1452534;C3888198;C1706077;C4284014,true;false;false;false,10376/20013
ace = angiotensin - converting enzyme . arb = angiotensin receptor blockers .,C0022709;C3888198;C0597357,true;false;false,10377/20013
acei and / or arb,,,10378/20013
acei / arb therapy,C3888198;C0039798;C0087111;C1363945,false;true;true;false,10379/20013
aceis,,,10380/20013
aceis  angiotensin - converting enzyme inhibitors  c  candesartan  des  drug - eluting stent  egfr  estimated glomerular filtration rate  hdl  high - density lipoprotein  ldl  low - density lipoprotein  nc  non - candesartan .,C0003015;C0717550;C0011702;C1322815;C1739039;C3811844;C3812682;C4551552;C2757044,true;true;true;true;true;false;false;true;false,10381/20013
acetaminophen,C0000970;C2917659,true;false,10382/20013
aclidinium nmbr pg,C2699757;C0030827;C0072225;C1266240,false;true;true;false,10383/20013
aclidinium nmbr pg vs placebo,C2699757;C0030827;C0072225;C1266240,false;true;true;false,10384/20013
aclidinium nmbr   μ g ( n   =   nmbr ) a,C2699757;C0439267,false;false,10385/20013
aclidinium nmbr   μ g ( n   =   nmbr ) b,C2699757;C0439267,false;false,10386/20013
aclidinium nmbr   μ g ( n   =   nmbr ),C2699757;C0439267,false;false,10387/20013
aclidinium nmbr   μ g bid ( n   =   nmbr ),C2699757;C0439267,false;false,10388/20013
aclidinium / formoterol nmbr / nmbr pg twice daily,C2699757;C0060657;C0030827;C0585361;C0072225;C1266240,false;true;true;false;true;false,10389/20013
acq - nmbr score,C2919686,false,10390/20013
acq - nmbr score ' ! ',C2919686,false,10391/20013
acq - nmbr score 本,C2919686,false,10392/20013
acq - nmbr total score ∗,C2919686;C2964552,false;false,10393/20013
acq score,C2919686,false,10394/20013
acr ( mg / g ),C1412134;C1300563;C1515941,false;false;false,10395/20013
acr > nmbr mg / g,C1412134;C1300563;C1515941,false;false;false,10396/20013
acr functional class,C1412134;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C1515941,false;false;false;false;false;false;false;false,10397/20013
acr response by baseline mtx use,C1412134;C0871261;C0168634;C0025677;C0042153;C0457083;C1947944;C1417487;C1442488;C1704632;C1706817;C2911692;C1515941,false;false;true;true;true;false;false;false;false;false;false;false;false,10398/20013
acr response by baseline weight,C1412134;C0871261;C1303013;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false;false,10399/20013
acrnmbr week nmbr responders,C1412134;C0332174;C0439230;C1515941,false;false;false;false,10400/20013
acs ( n = nmbr,C0742343;C4318612,true;false,10401/20013
acs event,C0742343;C0441471;C4019010;C4318612,true;false;false;false,10402/20013
acs management,C0742343;C0001554;C0376636;C1273870;C3273539;C4318612,true;true;true;false;false;false,10403/20013
acs presentation,C0742343;C0449450;C4318612,true;false;false,10404/20013
act - nmbr,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,10405/20013
act total score ≥   nmbr,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,10406/20013
act total score   ≥   nmbr and / or improvement from baseline   ≥   nmbr,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,10407/20013
act . nmbr,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,10408/20013
action tested is between the continuous variable and treatment .,C0441472;C3266814,false;false,10409/20013
active,C0205177;C3853793;C3888249,false;false;false,10410/20013
active - control study,C2347179;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1706449;C0557651;C2603343,false;true;false;false;false;false;false;false;false;false,10411/20013
active canakinumab ( n   =   nmbr,C0205177;C2718773;C3853793;C3888249,false;true;false;false,10412/20013
active cancer at any timeb,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,10413/20013
active cancer at baseline,C0205177;C0006826;C0168634;C1442488;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false;false,10414/20013
active cancer at randomisation,C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,10415/20013
active comparatorb,C0205177;C3853793;C3888249,false;false;false,10416/20013
active pso winmbr bsa > nmbr %,C0205177;C0043193;C1520135;C3853793;C3888249,false;true;false;false;false,10417/20013
active smokers,C0205177;C0337664;C3853793;C3888249,false;true;false;false,10418/20013
active treatment,C1704532,false,10419/20013
active vs placebo,C0205177;C3853793;C3888249,false;false;false,10420/20013
active   versus   placebo,C0205177;C3853793;C3888249,false;false;false,10421/20013
activities of daily living updrs subscore ( baseline ),C0001288;C3639721;C0168634;C1442488;C4050548,true;true;true;false;false,10422/20013
activity,C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false,10423/20013
activity ( range nmbr - nmbr ),C0205177;C1514721;C2348147;C3542016;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false;false;false,10424/20013
activity limitation,C0205177;C0443288;C0449295;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false;false,10425/20013
actual ( l ),C0237400,false,10426/20013
actual or estimated weight,C0237400,false,10427/20013
acuity - bleeding major / minor,C0750509,false,10428/20013
acuity major or,C0750509,false,10429/20013
acuity minor,C0750509,false,10430/20013
acute increase in serum creatinine,C1546542;C0442805;C0010294;C1561535;C0205178;C0201976;C0600061,false;false;true;false;false;false;false,10431/20013
acute medication intake ( days / month ),C0205178;C0013227;C1512806;C0556971;C3244316;C4284232,false;true;false;false;false;false,10432/20013
acute reperfusion,C0205178;C0035124;C0684253,false;true;false,10433/20013
acute stent thrombosis ( definite or probable ),C0205178;C3897493,false;false,10434/20013
adalimumab,C1122087,true,10435/20013
adamantane derivatives,C3653470,false,10436/20013
add - on to met,C1883712;C0428210;C1550543;C4317104,false;false;false;false,10437/20013
add - on to met + sunmbr,C1883712;C0428210;C0038642;C1705534;C1550543;C4317104,false;false;true;false;false;false,10438/20013
add - on to met + su,C1883712;C0428210;C0038642;C1705534;C1550543;C4317104,false;false;true;false;false;false,10439/20013
add - on to metnmbr,C1883712;C0428210;C1550543;C4317104,false;false;false;false,10440/20013
additional angiography,C1524062;C0002978,false;true,10441/20013
additional antihypertensive subgroup,C1524062;C0003364;C1079230;C1515021,false;true;false;false,10442/20013
additional endpoints,C1524062;C2349179,false;false,10443/20013
additional heparin,C1524062;C0019134;C0770546,false;true;false,10444/20013
additional radiographic findings at week nmbr,C1524062;C0444708;C2607943;C0332174;C0439230;C2926606;C3539655,false;false;true;false;false;false;false,10445/20013
additional subgroup analyses,C1524062;C2986480,false;false,10446/20013
adhere,C3714578,false,10447/20013
adherence > nmbr %,C1510802,false,10448/20013
adherence to study regimen — no . ( % ),C1510802,false,10449/20013
adherence to study regimen — no . ( % ) ff,C1510802,false,10450/20013
adiusted hazard ratio *,C2985465,false,10451/20013
adj . hr ( nmbr % cl ) a,C0001552;C0596019;C2826286,true;false;false,10452/20013
adjudicated macenmbr,C0349381;C0949745;C1445339,false;true;false,10453/20013
adjusted nmbr or ( nmbr % cl ),C0456081,false,10454/20013
adjusted change from baseline,C0456081;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,10455/20013
adjusted exacerbation rate ( per patient peryear ),C0456081;C4086268;C0871208;C0030705;C1521828,false;false;false;true;false,10456/20013
adjusted exacerbation rate { per patient peryear ),C0456081;C4086268;C0871208;C0030705;C1521828,false;false;false;true;false,10457/20013
adjusted for all baseline variables and interaction between acei and baseline upb,C0456081;C0168634;C0439828;C1442488,false;true;false;false,10458/20013
adjusted for all baseline variables,C0456081;C0168634;C0439828;C1442488,false;true;false;false,10459/20013
adjusted for all baseline variablesnmbr,C0456081;C0168634;C0439828;C1442488,false;true;false;false,10460/20013
adjusted hazard ratio ( nmbr % ci ) †,C0456081;C2985465;C0008107;C3259781,false;false;true;false,10461/20013
adjusted hazard ratio ( nmbr % cl ) *,C0456081;C2985465;C0596019,false;false;false,10462/20013
adjusted hazard ratio ≠ ( nmbr % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,10463/20013
adjusted hazard ratio *,C0456081;C2985465,false;false,10464/20013
adjusted hazard ratio § ( nmbr % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,10465/20013
adjusted hazard ratio ‡ ( nmbr % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,10466/20013
adjusted hr ( nmbr % ci ) * compared with no diabetes at bl or at year nmbr,C0456081;C0008107;C3259781,false;true;false,10467/20013
adjusted hr ( nmbr % ci ) * comparing idm with bl,C0456081;C0008107;C1707455;C0270221;C0005918;C0006413;C1552663;C2827109;C3259781,false;true;false;false;true;true;false;false;false,10468/20013
adjusted hr losartan vs atenolol *,C0456081;C0126174,false;true,10469/20013
adjusted hr * ( nmbr % ci ),C0456081;C0008107;C3259781,false;true;false,10470/20013
adjusted hr * ( nmbr % cl ) pvalue,C0456081;C0596019,false;false,10471/20013
adjusted hr  nmbr % ci,C0456081;C0008107;C3259781,false;true;false,10472/20013
adjusted mean ( se ),C0456081;C0444504;C0036919;C2347634;C2348143,false;false;true;false;false,10473/20013
adjusted mean ( se ) fevi auco_nmbr,C0456081;C0444504;C0036919;C0429706;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;true;false;false;false;false;false;false,10474/20013
adjusted mean ( se ) trough fevi,C0456081;C0444504;C0036919;C0444506;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;true;false;false;false;false;false;false,10475/20013
adjusted mean _ se change from baseline,C0456081;C0444504;C0036919;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;true;false;false;false;false;false;false,10476/20013
adjusted mean ± se change from baseline,C0456081;C0444504;C0036919;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;true;false;false;false;false;false;false,10477/20013
adjusted mean change ( kg ),C0456081;C0444504;C0392747;C0022718;C0439209;C4054209;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,10478/20013
adjusted mean change from baseline,C0456081;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,10479/20013
adjusted mean change from baseline ( se ),C0456081;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;true;false;false;false;false;false;false,10480/20013
adjusted mean difference ( nmbr % ci ),C0456081;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,false;false;false;true;false;false;false;false,10481/20013
adjusted modelc hr,C0456081,false,10482/20013
adjusted or ( nmbr % ci ) b,C0456081,false,10483/20013
adjusted or ( nmbr % ci ) c,C0456081,false,10484/20013
adjusted or ( nmbr % cl ),C0456081,false,10485/20013
adjusted rate of fevnmbr   decline ( se ),C0456081;C0871208;C3714541;C0036919;C1521828,false;false;true;true;false,10486/20013
adjusted rate of hospitalized pneumonia events ( per patient - year ),C0456081;C0871208;C0701159;C0032285;C0441471;C3541888;C1521828,false;false;false;true;false;false;false,10487/20013
adjusted rate of pneumonia events ( per patient - year ),C0456081;C0871208;C0032285;C0441471;C3541888;C1521828,false;false;true;false;false;false,10488/20013
adjusted *   hr,C0456081,false,10489/20013
adjusted ∗   mean ( se ) ( ml ),C0456081;C0444504;C0036919;C0439526;C1705224;C3887665;C2347634;C2348143,false;false;true;false;false;false;false;false,10490/20013
adjusted ∗   mean of difference ( se ) ( ml ),C0456081;C0444504;C1705241;C0036919;C0439526;C1705224;C3887665;C1705242;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,10491/20013
adjusted ⁎ hazard ratio ( nmbr % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,10492/20013
adjustedahr,,,10493/20013
adjustedaor,,,10494/20013
adjustedb,,,10495/20013
administration of study - drug bolus — no . / total no . ( % ),C3161471;C0013227;C1186706;C1511237;C1705509;C3812160;C1254351;C0001554;C0013175;C1533734;C0557651;C0150270;C0262754;C3469597;C2603343,false;true;false;false;false;false;false;true;true;false;false;false;false;false;false,10496/20013
administration of study drug ( % ),C3161471;C0013227;C1254351;C0001554;C0013175;C1533734;C0557651;C0150270;C0262754;C3469597;C2603343,false;true;false;true;true;false;false;false;false;false;false,10497/20013
admission grace score,C0184666;C0809949,false;false,10498/20013
adolescents ( aged nmbr - nmbr y ),C0205653,true,10499/20013
adults ( aged   ≥ nmbr y ),C0001675,true,10500/20013
advanced,C0205179,false,10501/20013
adverse event,C0877248,false,10502/20013
adverse events ( any grade ),C0877248;C1705413,false;false,10503/20013
adverse events leading to premature treatment discontinuation,C0877248;C1705413,false;false,10504/20013
ae ' ( per cm / s ),C3887670;C0439392,false;false,10505/20013
ae / a ratio ( per nmbr . nmbr unit ),C3887670,false,10506/20013
ae / e ' ratio ( per nmbr unit ),C3887670;C0456603;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C1547037,false;false;false;false;false;false;false;false;false;false,10507/20013
aed inducer status,C0887457;C3898767;C0449438,true;false;false,10508/20013
aerobic exercise,C0001701,true,10509/20013
aes in ≥ nmbr japanese patients in a study arm,C1412268;C0376247;C0030705;C1556094;C2699274,false;false;true;true;false,10510/20013
aes leading to,C1412268;C2699274,false;false,10511/20013
aes leading to discontinuation of study drugb,C1412268;C2699274,false;false,10512/20013
aes leading to dose reduction of study drugb,C1412268;C2699274,false;false,10513/20013
aes related to,C1412268;C2699274,false;false,10514/20013
aes *,C1412268;C2699274,false;false,10515/20013
aetiology of pah,C0015127;C0030123;C3203102;C4284467;C1314792;C1524003,true;true;true;false;true;false,10516/20013
af alone refers to atrial fi - brillation without coexisting cardiovascular conditions but with left atrial dilatation . ace denotes angiotensin - con - verting enzyme,C0344434;C4049859,false;false,10517/20013
af duration,C0344434;C0449238;C2926735;C4049859,false;false;false;false,10518/20013
af first diagnosis > nmbr years,C0344434;C0205435;C0011900;C0439234;C1704338;C1704656;C1279901;C4049859,false;false;true;false;true;false;false;false,10519/20013
af on baseline ecg,C0344434;C0168634;C1623258;C1442488;C4049859,false;true;true;false;false,10520/20013
af or atrial flutter !,C0344434;C4049859,false;false,10521/20013
af type,C0344434;C0332307;C1547052;C4049859,false;false;false;false,10522/20013
af type — no . ( % ),C0344434;C0332307;C1547052;C4049859,false;false;false;false,10523/20013
affected body - surface area > nmbr % — no . { % ),C1879646;C0205148;C0392760;C0005902;C1314939,false;false;false;true;false,10524/20013
africa ! near east,C0001737;C1707877,true;false,10525/20013
africa or near east,C0001737,true,10526/20013
african american n = nmbr,C0085756,true,10527/20013
african american / black,C0085756;C0005680;C0027567;C0439541,true;true;true;false,10528/20013
african descent,C0027567,true,10529/20013
after bronchodilator use,C0006280;C0042153;C0457083;C1947944,true;true;false;false,10530/20013
ag,C0002037;C0051080;C0152305;C3888235,true;true;true;false,10531/20013
ag + gg,C0002037;C0017454;C0018370;C0051080;C0152305;C3888235,true;true;true;true;true;false,10532/20013
aga group,C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10533/20013
age - mean ( sd ) years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,10534/20013
age — y,C0001779,false,10535/20013
age — yr age group — no . ( % ),C0027362;C0439234;C2348001,true;false;false,10536/20013
age — yr race — no . ( % ) f,C0001779;C0439234,false;false,10537/20013
age & nmbr,C0001779,false,10538/20013
age ( median [iqr] ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10539/20013
age ( p = o - nmbr ),C0001779,false,10540/20013
age ( per nmbr years ),C1510829,false,10541/20013
age ( sd ),C0001779;C2699239,false;false,10542/20013
age ( y ) [mean - sd],C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,10543/20013
age ( y ) ∗,C0001779,false,10544/20013
age ( years ( s . d . ) ),C1510829,false,10545/20013
age ( years ) ( mean ± sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,10546/20013
age ( years ) : mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,10547/20013
age ( years ) a,C1510829,false,10548/20013
age ( years  sd ),C1510829;C2699239,false;false,10549/20013
age ( yr ) *,C0001779;C0439234,false;false,10550/20013
age [year],C0001779;C0439234;C0439508,false;false;false,10551/20013
age [years],C1510829,false,10552/20013
age £ nmbr years ( itt ) ( n = nmbr ),C1510829,false,10553/20013
age < nmbr gd lesion > nmbr n = nmbr,C0001779;C0221198;C1546698,false;false;false,10554/20013
age < nmbr gd lesion = nmbr n = nmbr,C0001779;C0221198;C1546698,false;false;false,10555/20013
age < nmbr years and bmi < nmbr kg / mnmbr,C1510829,false,10556/20013
age < nmbr years and bmi ≥ nmbr kg / mnmbr,C1510829,false,10557/20013
age < nmbr vears n = nmbr,C0001779,false,10558/20013
age < nmbr years ( itt ) ( n = nmbr ),C1510829,false,10559/20013
age < nmbr years ( n = nmbr,C1510829,false,10560/20013
age < nmbr yr or > nmbr yr,C0001779;C0439234,false;false,10561/20013
age < nmbr : qvainmbr - sfc,C0001779;C4521536,false;false,10562/20013
age < nmbryears,C1510829,false,10563/20013
age < nmbr years ( n =,C1510829,false,10564/20013
age ≥ nmbr years and bmi < nmbr kg / mnmbr,C1510829,false,10565/20013
age ≥ nmbr years and bmi ≥ nmbr kg / mnmbr,C1510829,false,10566/20013
age ≥ nmbr years,C1510829,false,10567/20013
age ≥ nmbr yearsa,C0001779,false,10568/20013
age >,C0001779,false,10569/20013
age > - median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10570/20013
age > nmbr gd lesion > nmbr n = nmbr,C0001779;C0221198;C1546698,false;false;false,10571/20013
age > nmbr gd lesion = nmbr n = nmbr,C0001779;C0221198;C1546698,false;false;false,10572/20013
age > nmbr yr ( % ),C0001779;C0439234,false;false,10573/20013
age > nmbr yr and elevated biomarkers,C0001779;C0439234,false;false,10574/20013
age > nmbr yr and st - segment changes,C0001779;C0439234,false;false,10575/20013
age > nmbr ( years ) t,C1510829,false,10576/20013
age > nmbr vears n = nmbr,C0001779,false,10577/20013
age > nmbr y ( % ),C0001779,false,10578/20013
age > nmbr y *,C0001779,false,10579/20013
age > nmbr yr — no . ( % ),C0001779;C0439234,false;false,10580/20013
age > nmbr : qvainmbr - sfc,C0001779;C4521536,false;false,10581/20013
age > nmbr years ( itt ) ( n = nmbr ),C1510829,false,10582/20013
age > nmbr years ( n = nmbr ),C1510829,false,10583/20013
age ± sd ( yrs ),C0001779;C2699239,false;false,10584/20013
age nmbr nmbr y,C0001779,false,10585/20013
age nmbryears,C1510829,false,10586/20013
age nmbr years ( n = nmbr ),C1510829,false,10587/20013
age nmbr * nmbr yr,C0001779;C0439234,false;false,10588/20013
age nmbr - nmbr yr,C0001779;C0439234,false;false,10589/20013
age nmbr - nmbr y ( n = nmbr ),C0001779,false,10590/20013
age nmbr - nmbr,C0001779,false,10591/20013
age nmbr - nmbr years ( itt ) ( n = nmbr ),C1510829,false,10592/20013
age nmbr - nmbr years ( n = nmbr ),C1510829,false,10593/20013
age nmbr +,C0001779,false,10594/20013
age nmbr + y,C0001779,false,10595/20013
age nmbr + years,C1510829,false,10596/20013
age a nmbr,C0001779,false,10597/20013
age at asthma diagnosis years,C1828181;C0004096;C0439234;C2984299;C3173302,false;true;false;false;false,10598/20013
age at baseline ( years ),C1510829;C0168634;C1442488,false;true;false,10599/20013
age at baseline in years,C0001779;C0168634;C1442488,false;true;false,10600/20013
age at diagnosis < nmbr years,C1828181;C0439234;C3173302,false;false;false,10601/20013
age at diagnosis of ln,C1828181;C0861352;C1428884;C3714709;C3173302,false;false;false;false;false,10602/20013
age at diagnosis of sle,C1828181;C0024141;C3173302,false;true;false,10603/20013
age at diagnosis snmbr years,C1828181;C0439234;C3173302,false;false;false,10604/20013
age at disease onset,C0206132;C0012634;C3870509,true;true;false,10605/20013
age at entry ( years ),C1510829;C1705654,false;false,10606/20013
age at lipid randomization ( y ),C0001779;C0065033;C0034656,false;true;true,10607/20013
age at menopause ( yr ),C1625754;C0439234;C1629609,false;false;false,10608/20013
age at time of first seizure,C0001779;C0040223;C0205435;C0036572;C1959629;C4553401;C1279901;C3541383,false;true;false;true;false;false;false;false,10609/20013
age bnmbr y ( n = nmbr ),C0001779,false,10610/20013
age categories,C2916832,false,10611/20013
age categories ( y ),C2916832,false,10612/20013
age cohort,C2348001,false,10613/20013
age distribution,C0001782,true,10614/20013
age groiro : < nmbr years,C1510829,false,10615/20013
age group — no . ( % ),C0027362;C2348001,true;false,10616/20013
age group ( ≥ nmbr years ) — no . ( % ),C1510829;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0027362;C0439234;C2348001,false;false;false;true;false;false;false;true;false;false,10617/20013
age group ( ≥ nmbr ) — no . ( % ),C0027362;C2348001,true;false,10618/20013
age group ( y ),C0001779;C0441858,false;false,10619/20013
age group nmbr,C0027362;C2348001,true;false,10620/20013
age groups,C0027362,true,10621/20013
age is > nmbr vrs,C0001779,false,10622/20013
age mean age,C0001779;C0444504;C2347634;C2348143,false;false;false;false,10623/20013
age of asthma onset,C0206132;C0004096;C2984299;C3175530,true;true;false;false,10624/20013
age of onset,C0206132;C3175530,true;false,10625/20013
age of onset < nmbr years ( n = nmbr ),C0206132;C0439234;C3175530,true;false;false,10626/20013
age of onset nmbr years ( n = nmbr ),C0206132;C0439234;C3175530,true;false;false,10627/20013
age s * nmbr yr,C0001779;C0439234,false;false,10628/20013
age snmbr years ( n = nmbr,C1510829,false,10629/20013
age snmbr,C0001779,false,10630/20013
age subgroup,C0001779;C1079230;C1515021,false;false;false,10631/20013
age when diabetes first diagnosed ( years ),C0001779,false,10632/20013
age years geographic region,C1510829;C0017446,false;true,10633/20013
age yr,C0001779;C0439234,false;false,10634/20013
age *,C0001779,false,10635/20013
age  y  median ( qnmbr – qnmbr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10636/20013
age  years  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,10637/20013
age . y,C0001779,false,10638/20013
age . years,C1510829,false,10639/20013
age . . . . . . . . y ( n = nmbr ),C0001779,false,10640/20013
age / gd lesion,C0001779;C0221198;C1546698,false;false;false,10641/20013
age\\yr,C0001779;C0439234,false;false,10642/20013
age   ≥ nmbr   y,C0001779,false,10643/20013
agea,,,10644/20013
aged ≥ nmbr years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,10645/20013
aged nmbr y or older,C0001779;C0001792;C1999167,false;true;false,10646/20013
aged a nmbr years,C0001779;C0001792;C1999167,false;true;false,10647/20013
aget,,,10648/20013
agi,C1299007,true,10649/20013
aha status at screeningb,C0050451;C0449438;C0772110,true;false;false,10650/20013
ainmbr,C0003504;C4551710,true;false,10651/20013
aii participants ( n = nmbr ),C1424250;C0679646;C2698414,false;false;false,10652/20013
aii patients ( n = nmbr ),C1424250;C0030705;C2698414,false;true;false,10653/20013
ain,C0347129,false,10654/20013
air ( n = nmbr ),C0001861;C3536832,true;false,10655/20013
air + ig ( n = nmbr ),C0001861;C0021027;C0305052;C0360506;C3536832,true;true;false;false;false,10656/20013
airway compromise,C4055482,false,10657/20013
airway reversibility,C0178987;C0449261;C0458827,false;false;false,10658/20013
alanine aminotransferase increased,C0001899;C0057041;C1415274;C3887708,true;true;false;false,10659/20013
alanine aminotransferase,C0001899;C0057041;C1415274;C3887708,true;true;false;false,10660/20013
alav ( per ml ),C0439526;C1705224;C3887665,false;false;false,10661/20013
albiglutide ( n = nmbr ),C2607479,true,10662/20013
albiglutide events / patients ( %,C2607479;C0441471;C0030705;C3541888,true;false;true;false,10663/20013
albumin - to - creatinine ratio ' i   /,C0486293;C0021966;C0221138;C1318293,false;true;false;false,10664/20013
albumin - to - creatinine ratio ( acr ),C0486293;C1412134;C1515941;C1318293,false;false;false;false,10665/20013
albumin,C0001924,true,10666/20013
albuminuria ( acr > nmbr m . g / g ) at baseline to normoalbuminuria,C0001925;C1412134;C0369637;C1319635;C0168634;C1442488;C0441923;C1515941,true;false;false;false;true;false;false;false,10667/20013
albuminuria and previous maerovaseular disease plus established renal disease ( egfr nmbr - nmbr ml / min / lnmbr in - with an uacr > nmbr mg / g or egfr nmbr - < nmbr ml / inin / lnmbr in - with any uacr mg / g ),C0001925,true,10668/20013
albuminuria and previous maerovaseular disease without established renal disease,C0001925,true,10669/20013
albuminuria progression,C0001925;C0242656;C0449258,true;true;false,10670/20013
albuminuria_p_interaction,C0001925;C1704675,true;false,10671/20013
alc ( % ),C1424945;C3811058,false;false,10672/20013
alc ( mmol / mol ),C1424945;C3829066;C3811058,false;false;false,10673/20013
alc < nmbr . nmbr % at baseline,C1424945;C0168634;C1442488;C3811058,false;true;false;false,10674/20013
alc > nmbr . nmbr - nmbr . nmbr %,C1424945;C3811058,false;false,10675/20013
alc at week nmbr ( % ),C1424945;C0332174;C0439230;C3811058,false;false;false;false,10676/20013
alc at weeko ( % ),C1424945;C3811058,false;false,10677/20013
alc group ( % ),C1424945;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3811058,false;false;false;true;false;false;false;false,10678/20013
alcohol < = nmbr / wk,C0001962;C0332174;C0439230;C0001975,true;false;false;true,10679/20013
alcohol > nmbr / wk,C0001962;C0332174;C0439230;C0001975,true;false;false;true,10680/20013
alcohol > nmbr drinks per week,C0556297;C0332174;C0439230,false;false;false,10681/20013
alcohol consumption ( % ) < nmbr drink / dav,C0556297;C0009830;C1947907;C0001948;C0452428,false;true;false;true;false,10682/20013
alcohol consumption ( yes ) ( n ),C0001948;C1549445;C1705108;C1710701,true;false;false;false,10683/20013
alcohol consumption at baseline,C0001948;C0168634;C1442488,true;true;false,10684/20013
alcohol consumption *,C0001948,true,10685/20013
alcohol drinker,C0001962;C0556338;C0001975,true;false;true,10686/20013
alcohol intake never / rarely,C0001948;C2003901;C0522498,true;false;false,10687/20013
alcohol use ( %,C0001948,true,10688/20013
alcohol useb,C0001962;C0001975,true;true,10689/20013
alcohol usef,C0001962;C0001975,true;true,10690/20013
alcohol users,C0556297,false,10691/20013
alcohol^,C0001962;C0001975,true;true,10692/20013
aldosterone receptor antagonists,C1579268,true,10693/20013
aldosterone use,C0002006;C0042153;C0457083;C1947944,true;true;false;false,10694/20013
alendronate,C0102118,true,10695/20013
alendronate ( n = nmbr ),C0102118,true,10696/20013
algorithm nmbr,C0002045;C1553907,true;false,10697/20013
alirocumab nmbr mg qnmbrw,C3491162;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10698/20013
alirocumab nmbr / nmbr mg,C3491162;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10699/20013
alirocumab n = nmbr,C3491162,true,10700/20013
alive ( n = nmbr ),C2584946;C4551704,false;false,10701/20013
all - baricitinib ra ( n = nmbr ) *,C4044947;C3538806;C4048756,true;false;false,10702/20013
all - causa mortality,C3903827;C0026565;C0026566,false;true;true,10703/20013
all - cause death / stroke / see,C0015127;C0011065;C0038454;C4554100;C1306577;C4082313;C4552775;C1524003,true;true;true;false;false;false;false;false,10704/20013
all - cause mortalitv,C0015127;C1524003,true;false,10705/20013
all - cause mortality ( n = nmbr ),C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,10706/20013
all - cause mortality ( no . of events ),C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,10707/20013
all - cause mortality ( per nmbr person - years ),C0444868;C0015127;C0026565;C0027361;C0439234;C2347489;C0026566;C1524003;C3539085,false;true;true;true;false;false;true;false;false,10708/20013
all - cause mortality at nmbr year,C0444868;C0015127;C0026565;C0439234;C0439508;C0026566;C1524003;C3539085,false;true;true;false;false;true;false;false,10709/20013
all ( n = nmbr,C0369718;C0441922,false;false,10710/20013
all ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0369718;C0441922,false;false,10711/20013
all bleed,,,10712/20013
all canakinumab,C2718773,true,10713/20013
all cause mortality or hosp . for worsening hf hs - crp < nmbr . nmbr mg / l,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,10714/20013
all death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,10715/20013
all diabetesd,,,10716/20013
all doses,C0178602,false,10717/20013
all doses ( n = nmbr ),C0178602,false,10718/20013
all dulaglutide nmbr . nmbr mg + insulin lispro / insulin glargine ( n = nmbr ),C3179549;C0024671;C0907402;C0293359;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;true;false;false;false;false;false,10719/20013
all itt sutajects,,,10720/20013
all major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,10721/20013
all men,C0025266,true,10722/20013
all mis,C0687670;C1333208;C1412384;C3538735,false;false;false;false,10723/20013
all mis *,C0687670;C1333208;C1412384;C3538735,false;false;false;false,10724/20013
all mn - na ï ve patients,C0026327;C0597484;C0042469;C0030705;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882;C0026405;C4285072,true;false;true;true;false;false;false;false;false;false;false;true;false,10725/20013
all non - mn,C1518422;C0026327;C0026405;C4285072,false;true;true;false,10726/20013
all noncompleters,,,10727/20013
all others eteed for nmbr mg edoxaban dose at,C1955473;C4086581;C2975435;C3539125,false;false;true;false,10728/20013
all participants ( n = nmbr ),C0679646,false,10729/20013
all participants history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,10730/20013
all participants * ( n = nmbr / nmbr ),C0679646,false,10731/20013
all participants^^ ( n = nmbr / nmbr ),C0679646,false,10732/20013
all participantsa,,,10733/20013
all participantst ( n = nmbr / nmbr ),,,10734/20013
all patients ( n nmbr nmbr ),C0030705,true,10735/20013
all patients ( n   =   nmbr ) b,C0030705,true,10736/20013
all patients ( p < nmbr . nmbr ),C0030705,true,10737/20013
all patients ( p = nmbr . nmbr ),C0030705,true,10738/20013
all patients n = nmbr nmbr,C0030705,true,10739/20013
all patients on maximally tolerated statin ± other llt,C0030705;C0360714,true;true,10740/20013
all patientsb,,,10741/20013
all randomized all - cause mortality,,,10742/20013
all randomized all - cause mortality or hospitalization for worsening hf^,,,10743/20013
all randomized coronary end point,C0034656;C0018787;C2349179;C2826544;C3815594,true;true;false;false;false,10744/20013
all recurrent strokes,C1836785,false,10745/20013
all responders,,,10746/20013
all strokes,,,10747/20013
all strokes *,,,10748/20013
all subjects - n,,,10749/20013
all treatments,C0087111,true,10750/20013
all trials,C0008976,true,10751/20013
all with diabetes ( n = nmbr ),C0011847;C0011849,false;true,10752/20013
all without diabetes ( n = nmbr ),C0011847;C0011849,false;true,10753/20013
all women,C0043210,true,10754/20013
alleles,C0002085,true,10755/20013
allergic disease by historyb,C0020517;C0851444,true;false,10756/20013
allergic rhinitis,C1334103;C2607914;C4552864,false;true;false,10757/20013
allergic rhinitis — no . ( % ),C1334103;C2607914;C4552864,false;true;false,10758/20013
allergic rhinitis duration,C1334103;C0449238;C2926735;C2607914;C4552864,false;false;false;true;false,10759/20013
allopurinol,C0002144,true,10760/20013
allopurinol nmbr / nmbr mg daily n = nmbr,C0002144;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,10761/20013
allopurinol nmbr / nmbr mg n = nmbr,C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10762/20013
allopurinol nmbr mg ( n = nmbr ) +,C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10763/20013
allopurinolt,,,10764/20013
alogliptin,C1958126,true,10765/20013
alogliptin ( n = nmbr ),C1958126,true,10766/20013
alogliptin nmbr . nmbr mg + pioglitazone ( n = nmbr ),C3535925;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,10767/20013
alogliptin nmbr mg + pioglitazone ( n = nmbr ),C3535925;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,10768/20013
alpha - blocker / other vasodilator,C0001641,true,10769/20013
alpha - blockers,C0001641,true,10770/20013
alpha blockers,C0001641,true,10771/20013
alpha glucosidase inhibitors,C1299007;C2756986;C3539108,true;false;false,10772/20013
alpha reductase inhibitors,C0439095;C0597153;C1655741;C2003941;C2350010,false;false;false;false;false,10773/20013
alprostadil ( n = nmbr ),C0002335,true,10774/20013
alprostadil n / n,C0002335,true,10775/20013
alprostadil n / n %,C0002335,true,10776/20013
alt > nmbrx uln on two consecutive visits,C1266129;C1519815;C0205448;C1707491;C0545082;C1512346;C4553172,false;false;false;false;false;false;false,10777/20013
alt increased,C1266129;C4553172,false;false,10778/20013
alt or ast > nmbr x ulnnmbr,C1266129;C4553172,false;false,10779/20013
alvedv ( per ml ),C0439526;C1705224;C3887665,false;false;false,10780/20013
alvef ( per nmbr % ),,,10781/20013
alvesv ( per ml ),C0439526;C1705224;C3887665,false;false;false,10782/20013
alvmi ( per g / mnmbr ),C0456715,false,10783/20013
am_ % delta,,,10784/20013
am_delta,,,10785/20013
amann whitney u test / wilcoxon sum rank test .,C0439148;C0683443;C1515051;C0667477;C0699794,false;false;false;true;false,10786/20013
ambition,C0870128,false,10787/20013
ambulatory sbp,C0439841;C0085805,false;true,10788/20013
amended dabigatran protocol,C1691222;C2348066;C0442711;C1507394;C1522729;C2348563;C2599718;C3715209;C4282383,false;true;false;false;false;false;true;false;false,10789/20013
america,C0002454,true,10790/20013
american,C0596070,false,10791/20013
american ‐ indian / alaska native,C0002460,true,10792/20013
american hispanic ( n   = nmbr ),C0596070;C0086409,false;true,10793/20013
american indian or,C0002460,true,10794/20013
american indian or alaska native   :,C0002460,true,10795/20013
american indian or alaskan,C0002460,true,10796/20013
american indian / alaskan native,C0002460;C0238611,true;false,10797/20013
american indian / native alaskan,C0002460;C0682125,true;true,10798/20013
americas * *,C0002454;C0596070,true;false,10799/20013
aminosalicylate,C0368663;C2825094,false;false,10800/20013
amiodarone ( n,C0002598,true,10801/20013
amiodarone ote at baseline,C0002598;C0168634;C1442488,true;true;false,10802/20013
amiodarone use at baseline,C0002598;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,10803/20013
amiodarone use at baseline yes nmbr,C0002598;C0042153;C0168634;C1549445;C1705108;C1710701;C1442488;C0457083;C1947944,true;true;true;false;false;false;false;false;false,10804/20013
amiodarone vs . placebo,C0002598,true,10805/20013
aml ( n = nmbr ),C0023465;C0023467,true;true,10806/20013
aml nmbr mg + hctz nmbr mg,C0023465;C1319635;C0020261;C0023467,true;false;true;true,10807/20013
aml nmbr mg + hctz nmbr mg ( n = nmbr ),C0023465;C1319635;C0020261;C0023467,true;false;true;true,10808/20013
aml vs . chl,C0023465;C0023467,true;true,10809/20013
aml vs . lis,C0023465;C0023467,true;true,10810/20013
amlodipine,C0051696,true,10811/20013
amlodipine nmbrtonmbrmg ( n = nmbr ),C0051696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10812/20013
amlodipine and valsartan,C0051696,true,10813/20013
amlodipine vs chlorthalidone normal,C0051696,true,10814/20013
amlodipine vs chlorthalidone obese,C0051696,true,10815/20013
amlodipine vs chlorthalidone overweight,C0051696,true,10816/20013
amlodipine / chlorthalidone,C0051696;C0008294,true;true,10817/20013
amlodipine / lisinopril nmbr,C0051696;C0065374,true;true,10818/20013
amlodipine / lisinopril / chlorthalidone comparison,C0051696;C0065374;C0008294;C1707455,true;true;true;false,10819/20013
amlodipine / valsartan nmbr to nmbr / nmbr mg ( n = nmbr ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10820/20013
ampdnmbr,,,10821/20013
amputation — no . ( % ),C0002688;C0332840;C1546539,true;false;false,10822/20013
amputation due to diabetes — no . ( % ),C0678226;C0598284,false;false,10823/20013
amputations,C0002688,true,10824/20013
anacetrapib nmbr mg,C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10825/20013
analgesic medication,C0002771,true,10826/20013
analysis,C0002778;C0936012;C1524024,false;false;true,10827/20013
analysis compared with the pretreatment condition ( baseline )  n  ldl = low - density lipoprotein  csf = cerebrospinal fluid .,C0002778;C0936012;C1524024,false;false;true,10828/20013
anatomic extent of qualifying event,C0220784;C0439792;C1514624;C0441471;C4019010,false;false;false;false;false,10829/20013
anatomical extent of qualifying event — no . ( % ) : t,C0220784;C0439792;C1514624;C0441471;C4019010,false;false;false;false;false,10830/20013
anatomy,C0002808;C0700276;C1384516,true;false;true,10831/20013
ancova result,C0814908;C1274040;C1546471;C2825142,false;false;false;false,10832/20013
and after pci,C4049621,false,10833/20013
and either an ace inhibitor or angiotension receptor blocker,,,10834/20013
and infusion,,,10835/20013
and microalbuminuria or macroalbuminuria,,,10836/20013
and physical examination,,,10837/20013
and vfx status,,,10838/20013
and / or aza at baseline,,,10839/20013
and / or discharge,,,10840/20013
anesthesiad,,,10841/20013
angina class iii or iv prior,C0264677,false,10842/20013
angina or acute mi,C0002962,true,10843/20013
angina or positive stress test,C0002962,true,10844/20013
angina with documented ischemia,C0002962;C1301725;C0022116;C4321499;C1609436,true;false;true;false;false,10845/20013
angina .,C0002962,true,10846/20013
angioedema ( adjudicated ),C0002994,true,10847/20013
angioedema present,C0002994;C0150312;C0449450,true;false;false,10848/20013
angiographic characteristics,C0002978;C1521970,true;false,10849/20013
angioplasty,C0162577;C1548817,true;false,10850/20013
angiotensin -,C0003018;C4521302,true;false,10851/20013
angiotensin - converting - enzyme inhibitor or angiotensin -,C0003015;C2757044;C3536837;C4541021,true;false;false;false,10852/20013
angiotensin - converting enzyme inhibitor or angiotensin receptor blocker use ( mitt population ),C0003015;C2757044;C3536837;C4541021,true;false;false;false,10853/20013
angiotensin - converting enzyme inhibitor / angiotensin receptor blocker,C0003015;C0597357;C2757044;C3536837;C4541021,true;false;false;false;false,10854/20013
angiotensin - converting enzyme inhibitors,C0003015;C2757044,true;false,10855/20013
angiotensin - converting enzyme inhibitors^,C0003015;C2757044,true;false,10856/20013
angiotensin - eonverting enzyme inhibitors,C0003018;C0014432;C1152555;C2756995;C4521302,true;true;false;false;false,10857/20013
angiotensin - eonverting enzyme inhibitors / angiotensin reeeptor bloekers,C0003018;C0014432;C1152555;C2756995;C4521302,true;true;false;false;false,10858/20013
angiotensin - receptor,C0034787;C1622222,true;true,10859/20013
angiotensin ii antagonists,C0003009;C0243076;C1366631;C3714928,true;true;false;false,10860/20013
angiotensin ii receptor blockers,C0521942;C2757003,true;false,10861/20013
angiotensin il - receptor blocker,C0034787;C0020898;C0021764;C0022271;C1622222;C0003018;C1149183;C4521302,true;true;true;true;true;true;false;false,10862/20013
angiotensin receptive blocker,C0003018;C0544683;C4521302,true;false;false,10863/20013
ankle - brachial index £ nmbr . nmbr,C1328319;C3888326,true;false,10864/20013
ankle edema,C0235439,false,10865/20013
annanginal drugs ( nmbr / l / s » nmbr ) ^,C0013227;C3687832,true;false,10866/20013
annual asthma exacerbation rates,C0332181;C0349790;C0871208;C1521828,false;false;false;false,10867/20013
annual exacerbation rate,C0332181;C4086268;C0871208;C1521828,false;false;false;false,10868/20013
anorexigen use,C0042153;C0457083;C1947944,true;false;false,10869/20013
anterior infarct location,C0340293;C0450429;C1515974;C4284930;C4284931;C2349195,true;false;false;false;false;true,10870/20013
anterior mi,C3536746,false,10871/20013
anterior myocardial infarction — no . / total no . ( % ),C0340293,true,10872/20013
anterior or non - anterior ml,C0205094,false,10873/20013
anthropometrics,,,10874/20013
anti - anaemics,C0857322,false,10875/20013
anti - ccp antibodies *,C1624602;C1525410;C1704514;C4318437;C0003241,true;false;false;true;true,10876/20013
anti - ccp antibody - positive,C4318437;C0741132,true;false,10877/20013
anti - ccp positive,C4318437;C0439178;C1446409;C1514241;C2825490;C3812269,true;false;false;false;false;false,10878/20013
anti - dsdna ( > nmbr iu / ml ),C0741099;C0439458,false;false,10879/20013
anti - dsdna positive,C0741099;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,10880/20013
anti - gad negative,C0270549;C0205160;C1513916;C2825415;C2825491;C3853545;C1414925,false;false;false;false;false;false;false,10881/20013
anti - gad negative ( n = nmbr ),C0432633;C0270549;C0205160;C1513916;C2825415;C2825491;C3853545;C1414925,false;false;false;false;false;false;false;false,10882/20013
anti - gad positive,C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false,10883/20013
anti - gad positive ( n = nmbr ),C0432633;C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false;false,10884/20013
anti - histamines,C0019590,true,10885/20013
anti ‐ hyperglycaemic agent,C1321567,false,10886/20013
anti - hypertensive,C0003364,true,10887/20013
anti - hypertensive treatment history,C0003364;C0039798;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;true;false;false;false;false;true;false;false;false;false;false,10888/20013
anti - hypertensives,C0003364,true,10889/20013
anti - pnmbr,,,10890/20013
anti ‐ platelet agents,C0040616;C0005821,true;true,10891/20013
anti - thrombotics,C0087086,true,10892/20013
anti - tnf,C1448177,true,10893/20013
anti ‐ tnf ‐ na ï ve,C1448177;C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,true;false;true;false;false;false;false;false;false;false,10894/20013
anti - tnf ir,C1448177;C0022065;C0022071;C1448132,true;true;true;true,10895/20013
antiarrhythmic drugs,C0003195,true,10896/20013
antiarrhythmics,C0003195,true,10897/20013
antibody binding level at baseline,C0428536;C1145667;C0168634;C1442488;C1167622;C1149306;C0441889;C0456079;C1547707;C2946261,false;false;true;false;false;false;false;false;false;false,10898/20013
anticholinergic drug,C0242896,true,10899/20013
anticholinergic use,C0242896;C0042153;C0457083;C1947944;C3537004,true;true;false;false;false,10900/20013
anticholinergics,C0242896;C3537307;C3540711,true;false;false,10901/20013
antidepressant,C0003289,true,10902/20013
antidiabetic drug,C0935929,true,10903/20013
antidiabetic drug ‘ i “ j ‘,C0935929;C0021966;C0221138,true;true;false,10904/20013
antihyperglycaemic medication at baseline,C0020616;C0013227;C0168634;C1442488;C3244316;C4284232,true;true;true;false;false;false,10905/20013
antihyperglycemic medications,C0020616;C0013227;C0802604;C2598133;C4284232,true;true;false;false;false,10906/20013
antihypertensive agent use,C0003364;C0042153;C0457083;C1947944,true;true;false;false,10907/20013
antihypertensive agents ( n per patient ),C0003364;C0030705,true;true,10908/20013
antihypertensive medication use,C0003364;C0042153;C0457083;C1947944,true;true;false;false,10909/20013
antihypertensive medication ),C0003364,true,10910/20013
antihypertensive medicationnmbr ',C0003364,true,10911/20013
antihypertensive randomization,C0003364;C0034656,true;true,10912/20013
antihypertensive treatments,C0003364;C0087111,true;true,10913/20013
antihypertensive use,C0003364;C0042153;C0457083;C1947944,true;true;false;false,10914/20013
antihypertensives ' *,C0003364,true,10915/20013
antimalarial,C0003374;C3536844;C4552582,true;false;false,10916/20013
antiplatelet agent n ( % ),C0085826,true,10917/20013
antiplatelet at randomization,C0034656,true,10918/20013
antiplatelet use,C0042153;C0457083;C1947944,true;false;false,10919/20013
antiplatelets agents,C0085826,true,10920/20013
antiplateletsa,,,10921/20013
antithrombin,C0003438;C0003440;C4521254,true;true;false,10922/20013
antithrombotic,,,10923/20013
antithrombotic medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,10924/20013
antithrombotic use before enrollment,C0042153;C1516879;C1696073;C3888021;C0457083;C1947944,true;false;false;false;false;false,10925/20013
antithrombotic ! i,C0021966;C0221138,true;false,10926/20013
any ( including corticosteroid ),,,10927/20013
any acuity bleeding,C0333276,false,10928/20013
any adverse event ( ae ),C0877248;C3887670,false;false,10929/20013
any adverse event leading to study drug discontinuation,C0877248,false,10930/20013
any ae,C3887670,false,10931/20013
any ae leading to discontinuation,C3887670,false,10932/20013
any albuminuria,C0001925,true,10933/20013
any anti - hypertensive agent,C0003364,true,10934/20013
any antianginal drug !,C1874267;C0013227;C1254351;C3537168,false;true;false;false,10935/20013
any anticoagulant,C0003280;C0848112;C3536711,true;false;false,10936/20013
any antihypertensive agent,C0003364,true,10937/20013
any antihypertensive drug,C0003364,true,10938/20013
any bleeding,,,10939/20013
any blood,C0005767;C0005768;C0229664,true;true;false,10940/20013
any blood product transfusion,C0005841;C1514468;C1704444;C0281867;C0456388;C0199960;C1879316;C1547007,true;false;false;false;false;false;false;false,10941/20013
any bp - lowering agents^,C0037623;C0441994;C0450442;C1254351;C1521826;C2003888;C1415692;C1708288;C4318478,true;false;false;false;false;false;false;false;false,10942/20013
any cardiovascular disease,C0007222,true,10943/20013
any cardiovascular diseased,C0007226;C3887460,true;false,10944/20013
any cause,C0015127;C1524003,true;false,10945/20013
any copd medication,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,10946/20013
any cough,C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,10947/20013
any cvd history ( % ),C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,10948/20013
any drug - related ae,C0013227;C0439849;C3887670;C0445223;C1254351,true;false;false;false;false,10949/20013
any dynamic st - segment shift,C0729333;C0429029;C0333051;C2347509,false;false;false;false,10950/20013
any early adverse event,C1279919;C0877248,false;false,10951/20013
any electrocardiographic abnormality — no . ( % ),C0522055,false,10952/20013
any glycoprotein iib / iiia inhibitor use,C0016011;C1999216;C0042153;C0457083;C1947944,true;false;true;false;false,10953/20013
any gusto bleeding,C0019080,true,10954/20013
any hbanmbrc,C0019016;C1825777;C3538758,true;false;false,10955/20013
any lipid - lowering agent use,C0086440;C0042153;C0457083;C1947944,true;true;false;false,10956/20013
any llt other than nutraceuticals,C2347090;C1518478,false;true,10957/20013
any llt other than statins,C2347090;C0360714,false;true,10958/20013
any mi,C3810814,false,10959/20013
any other lipid ‐ lowering therapy,,,10960/20013
any overt bleed,C0019080,true,10961/20013
any peripheral revascularization,C0205100;C0581603,false;false,10962/20013
any placebo,C0032042;C1696465;C1706408,true;false;false,10963/20013
any prerandomization failure of an antiarrhythmic drug — no . ( % ),C0231174;C0003195;C0301380;C0680095,false;true;false;false,10964/20013
any revascularization,C0581603,false,10965/20013
any sae,C1519255;C1622657;C4553214,false;false;false,10966/20013
any secukinumab ( n   = nmbr ),C3179547,true,10967/20013
any serious ae,C0205404;C3887670,false;false,10968/20013
any serious teaes,C0205404,false,10969/20013
any severity,C0439793;C0522510,false;false,10970/20013
any site,C0205145;C1515974;C2825164,false;false;false,10971/20013
any stroke,C0038454;C4554100,true;false,10972/20013
any sulfonylurea,C0038766;C3536898,true;false,10973/20013
any teae,,,10974/20013
any teaes,,,10975/20013
any therapy — no . ( % ),C0039798;C0087111;C1363945,true;true;false,10976/20013
any thiazide diuretic,C0012802;C3536861,true;false,10977/20013
any thiazolidinedione,C0289779;C1257987;C3537039,true;true;false,10978/20013
any timi bleeding,,,10979/20013
any treatment - emergent ae,C0039798;C0750573;C3887670;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,10980/20013
any ulcerative colitis medication,C0009324;C0013227;C3244316;C4284232,true;true;false;false,10981/20013
any vascular diasease,C0005847;C1558950;C1801960,true;false;false,10982/20013
any vascular disease,C0042373,true,10983/20013
any vascular *   efficacy,C0005847;C1280519;C1707887;C1558950;C1801960,true;false;false;false;false,10984/20013
any vte - related death,C0630906;C0425043,true;false,10985/20013
any vte or vte - related death — no . ( % ),C0630906,true,10986/20013
aortic,C0003483,true,10987/20013
aortic - valve replacement,C0003506,false,10988/20013
aortic valve disease ( n = nmbr nmbr ),C1260873;C4553103,false;false,10989/20013
ap - value from an ancova with corresponding baseline lipid value as the covariate and with a effect for treatment group .,C0002680;C1522609;C0814908;C3887950,true;false;false;false,10990/20013
ap = nmbr . nmbr  bp nmbr . nmbr  cp = nmbr . nmbr . * the study - speci ﬁ c bp targets were sbp nmbr mm hg and dbp nmbr mm hg ( or sbp nmbr mm hg and dbp nmbr mm hg in those with dm ) . the ldl - c target was nmbr mg / dl or nmbr mg / dl  depending on risk factor status at baseline in accordance with ncep atp iii guidelines . odds ratio and p value calculated based on generalized linear mixed model with generalized estimating equations method that includes compound symmetry covariance matrix for subjects from the same site . an interaction between treatment effect and dm status was observed for bp goal attainment ( p = nmbr . nmbr ) and dual bp / ldl - c goal attainment ( p = nmbr . nmbr ) among patients with or without dm calculated based on a mixed - effects linear model ( not adjusted for differences in baseline values ) .
 
 abbreviations : bp  blood pressure  dbp  diastolic blood pressure  dm  diabetes mellitus  ldl - c  low - density lipoprotein cholesterol  ncep atp iii  national cholesterol education program – adult treatment panel iii  or  odds ratio  sbp  systolic blood pressure,C0002680;C0037623;C0006938;C4050020;C1415692;C1708288;C4318478;C3887950,true;true;true;false;false;false;false;false,10991/20013
apasp ( per mmhg ),C0439475,false,10992/20013
apixaban nmbr . nmbr mg bid,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10993/20013
apixaban nmbr mg bid,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10994/20013
aplxaban nmbr . nmbr mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10995/20013
apo a - i ( mg / dl ) *,C0085201;C0439269;C1677784,true;false;true,10996/20013
apo anmbr ( mg / dl ),C0003592;C0439269;C0523508;C4553344;C4553379,true;false;false;false;false,10997/20013
apo anmbr,C0003592;C0523508;C4553344;C4553379,true;false;false;false,10998/20013
apo b ( mg / dl ),C0003593;C0439269;C3252643,true;false;true,10999/20013
apo b ( mg / dl ) * *,C0003593;C0439269;C3252643,true;false;true,11000/20013
apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol ,C0003594;C0003591;C0011849;C3715113;C0392885;C0008377;C0023824;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0428471,true;true;true;false;false;true;true;true;true;true;true;false;false;false;false,11001/20013
apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol  tg  triglycerides . * includes agents acting on the renin - angiotensin system  beta blocking agents  calcium channel blockers  and diuretics . † median values [standard deviation for medians calculated by ( qnmbr qnmbr ) / nmbr . nmbr] . § includes cardiac glycosides  antiarrhythmics class i and iii  vasodilators used in cardiac diseases and other cardiac preparations . ‡ expressed as g / l .,C0003594;C0003591;C0011849;C0392885;C0008377;C0023824;C0039411;C0041004;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0428471,true;true;true;false;true;true;true;true;true;true;true;false;false;false;false,11002/20013
apoa - i,C0085201;C1677784,true;true,11003/20013
apoanmbr,C0003592;C0523508;C4553344;C4553379,true;false;false;false,11004/20013
apoal ( mg / dl ) *,C0439269,false,11005/20013
apob : apoa - i,C0003593;C0085201;C1677784;C3252643,true;true;true;true,11006/20013
apob : apoa - i ratio,C0003593;C0085201;C0456603;C1547037;C1677784;C3252643,true;true;false;false;true;true,11007/20013
apob : apoanmbr,C0003593;C0003592;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;true,11008/20013
apob : apoanmbr ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,11009/20013
apobnmbr,C0003593;C3252643,true;true,11010/20013
apoe enmbr carriers,C0003595;C0007294;C0523511;C1412481,true;true;false;false,11011/20013
apoe   ε nmbr carrier,C0003595;C0007294;C0560175;C1325398;C1706209;C3273162;C0523511;C1412481,true;true;true;false;false;false;false;false,11012/20013
apolipoprotein,C0003591,true,11013/20013
apolipoprotein b nmbr,C0003593,true,11014/20013
aqlq ( s ) + nmbr score,C4055434;C0449820;C4050231,false;false;false,11015/20013
aqlq ( s ) + nmbr score : §,C4055434;C0449820;C4050231,false;false;false,11016/20013
aqlq ( si + nmbr score ’,C4055434;C0449820;C4050231,false;false;false,11017/20013
arb ( n,C3888198,false,11018/20013
arb + ccb ( n = nmbr ),C3888198;C0006684,false;true,11019/20013
arb = angiotensin ii receptor blocker  ccb,C3888198;C0521942;C0006684;C3536793,false;true;true;false,11020/20013
arb or ace inhibitor,C3888198,false,11021/20013
arbs or ace inhibitors,C3888198,false,11022/20013
ard ( nmbr % cl ) per nmbr patient - years,C1817569;C0596019;C0030705;C0439234;C1826411,false;false;true;false;false,11023/20013
ard per nmbr nmbr patient - years ( nmbr % ci ),C1817569;C0030705;C0439234;C0008107;C3259781;C1826411,false;true;false;true;false;false,11024/20013
area of fluorescein leakage within the grid,C0017446;C4476700;C0205146,true;false;false,11025/20013
area of retinal hemorrhage within the grid,C0017446;C0035317;C0205146,true;true;false,11026/20013
area of retinal thickening within the grid,C0017446;C1302690;C0205146,true;false;false,11027/20013
areas,C0205146;C4319729,false;false,11028/20013
arr ( % ),C2170357;C4084934,false;false,11029/20013
arteriai access,,,11030/20013
arthritis characteristics,C0003864;C1521970;C4552845,true;false;false,11031/20013
arthritis mutilans,C0702102,false,11032/20013
arvfac ( per nmbr % ),,,11033/20013
as,,,11034/20013
as duration,C0449238;C2926735,false;false,11035/20013
as major component — no . ( % ),C0205082;C0449432;C1705248;C0205164;C4318856;C4521762,false;false;false;false;false;false,11036/20013
asas nmbr / nmbr,C0004057;C3853627,true;false,11037/20013
asas partial remission,C0004057;C1521726;C4552913;C4552914;C3853627,true;false;false;false;false,11038/20013
asasnmbr,C0004057;C3853627,true;false,11039/20013
ascvd no prior ml,C3665365,false,11040/20013
ascvd  ,C3665365,false,11041/20013
ascvd * . n ( % ),C3665365,false,11042/20013
asdas - crp δ   ≥   nmbr . nmbr,C3890735;C4048285,false;false,11043/20013
asdas - crp *,C3890735;C4048285,false;false,11044/20013
asdas - crp   <   nmbr . nmbr,C3890735;C4048285,false;false,11045/20013
asdas inactive disease,C0544452,false,11046/20013
asia - pacific and south africa,C0003980,true,11047/20013
asia - pacific region and south africa,C0003980;C0017446;C0205147,true;true;false,11048/20013
asia ( excluding japan ),C0003980;C0332196;C0022341;C2828389,true;false;true;false,11049/20013
asia ( n = nmbr,C0003980,true,11050/20013
asia and pacific islands,C0003980,true,11051/20013
asia pacific ( n = nmbr ),C0003980,true,11052/20013
asia pacific and africa,C0003980,true,11053/20013
asia pacific and south africa,C0003980,true,11054/20013
asia #,C0003980,true,11055/20013
asian ( n   = nmbr ),C0078988,true,11056/20013
asian ( n = nmbr,C0078988,true,11057/20013
asian itt population by treatment group,C0078988;C1257890;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0032659;C0374505,true;true;true;true;false;false;false;false;false;true;false,11058/20013
asian itt population total ( n = nmbr ),C0078988;C0032659;C0439175;C0439810;C1257890,true;true;false;false;true,11059/20013
asian / pacific islander,C0078988;C0242191,true;true,11060/20013
asians ( n = nmbr ),C0078988,true,11061/20013
aslan,,,11062/20013
aspartate aminotransferase increased,C0004002,true,11063/20013
aspartate aminotransferase,C0004002,true,11064/20013
aspirin ( % ),C0004057,true,11065/20013
aspirin ( any dose ),C0004057,true,11066/20013
aspirin ( n,C0004057,true,11067/20013
aspirin ( n = nmbr ) no . of participants with events ( % ),C0004057,true,11068/20013
aspirin alone ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0004057;C0205171;C0439044;C0679994,true;false;false;false,11069/20013
aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,11070/20013
aspirin before admission,C0004057;C0184666;C0809949,true;false;false,11071/20013
aspirin dose at baseline,C4696290;C0168634;C1442488,false;true;false,11072/20013
aspirin group ( n = nmbr ),C0004057;C0441848,true;false,11073/20013
aspirin or other antiplatelet drug,C0004057,true,11074/20013
aspirin or other antiplatelet or anticoagulant agent,C0004057,true,11075/20013
aspirin orother antiplatelet drug,C0004057;C0013227;C1254351;C0085826,true;true;false;true,11076/20013
aspirin plus clopidogrel ( n = nmbr ),C0004057;C0332287;C0070166,true;false;true,11077/20013
aspirin plus placebo ( n = nmbr ),C0004057;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,11078/20013
aspirin use ( % ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,11079/20013
aspirin use ( p = nmbr . nmbrt ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,11080/20013
aspirin use at randomization,C0004057;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,11081/20013
aspirin use at randomization - n ( % ),C0004057;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,11082/20013
aspirin use before screening — no . { % ),C0004057;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;true;false;false;false;false;false;false;false,11083/20013
aspirin use n ( % ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,11084/20013
aspirin / antiplatelet medication,C0004057;C0013227;C3244316;C4284232;C0085826,true;true;false;false;true,11085/20013
aspirin + dipyridamole,C0732279,true,11086/20013
aspirin + thienopyridine,C0004057;C1120149,true;true,11087/20013
asqol,,,11088/20013
assessment of physical function ( nmbr - nmbr,C0031809;C0031843;C0542341;C0700205;C1705273;C1261322;C0516981;C4049916;C1516048,true;true;false;false;false;false;false;false;false,11089/20013
assigned to placebo,C1516050;C0032042;C1696465;C1706408;C1552601,false;true;false;false;false,11090/20013
assigned to topiramate,C1516050;C1552601,false;false,11091/20013
assigned treatment by sex interaction,C1516050;C0039798;C0009253;C1704675;C0036864;C0079399;C0804628;C1314687;C1522384;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552601,false;true;true;false;true;true;false;false;true;true;false;false;false;false;false;false,11092/20013
associated with an atrial septal defect,C0332281;C0018817,false;true,11093/20013
ast > nmbrx uln on two consecutive visits,C1415181;C1519815;C0205448;C1707491;C0545082;C1512346;C3891303,false;false;false;false;false;false;false,11094/20013
ast increased,C1415181;C3891303,false;false,11095/20013
asteria i / ii,C1093020;C0021966;C1710602;C4082587;C0221138,true;true;false;false;false,11096/20013
asthma - control status at randomization — no . ( % ),C0004096;C0243148;C0449438;C0034656;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;true;false;false;false;false;false;false,11097/20013
asthma - related health -,C0004096;C2984299,true;false,11098/20013
asthma exacerbations,C0349790,false,11099/20013
asthma symptoms in the past nmbr weeks,C0004096;C0683368;C2987125;C1457887;C2984299,true;true;false;false;false,11100/20013
asubset of the ≥ nmbr years subgroup .,C0439234;C1079230;C1515021,false;false;false,11101/20013
asui score,,,11102/20013
asymmetric peripheral arthritis,C0332514;C0238694,false;false,11103/20013
at,,,11104/20013
at nmbr years,C0439234,false,11105/20013
at any time,C0040223;C3541383,true;false,11106/20013
at baseline,C0168634;C1442488,true;false,11107/20013
at baseline — no . ( % ),C0168634;C1442488,true;false,11108/20013
at c change ( % ) *,C0392747;C0443172;C1705241;C4319952,false;false;false;false,11109/20013
at c data,C1511726;C3245479;C3714741,false;false;false,11110/20013
at end of follow - up,C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,11111/20013
at end of follow - up — no . ( % ),C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,11112/20013
at end of follow - up — no . / total no . ( % ),C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,11113/20013
at femoral neck,C0015815,true,11114/20013
at increased fall risk ( n - nmbr ),C4699158;C0085639;C0238715;C4553726;C0205217;C1268740;C0442805,false;false;false;false;false;false;false,11115/20013
at index event : no . ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,11116/20013
at or above median,,,11117/20013
at screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,11118/20013
at week nmbr,C0332174;C0439230,false;false,11119/20013
at weeks nmbr and nmbr,C0439230,false,11120/20013
atenoioi ( n = nmbr ),,,11121/20013
atenolol,C0004147,true,11122/20013
atenolol ( n = nmbr ),C0004147,true,11123/20013
atenolol ( n = nmbr,C0004147,true,11124/20013
atenolol ( no . = nmbr ),C0004147,true,11125/20013
atenolol use at nmbr month,C0004147;C0042153;C0332177;C0439231;C0457083;C1947944,true;true;false;false;false;false,11126/20013
atherectomy,C0162513,true,11127/20013
atherosclerosis,C0003850;C0004153,true;true,11128/20013
atherosclerotic cardiovascular disease *,C0004153,true,11129/20013
atherosclerotic cvd,C0333482;C0007222,false;true,11130/20013
atherosclerotic cvd §,C0333482;C0007222,false;true,11131/20013
atherosclerotic cvdj,C0333482,false,11132/20013
atherosclerotic vascular disease — no .,C0004153,true,11133/20013
atherosclerotic vascular disease history,C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,11134/20013
atherosclerotic vascular disease history †,C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,11135/20013
atherosclerotic vascular disease,C0004153,true,11136/20013
atherothrombotic infarction,C0021308,true,11137/20013
atherothrombotic stroke,C0038454;C4554100,true;false,11138/20013
atients with event,C0441471;C4019010,false;false,11139/20013
atm - locm,C3711796,true,11140/20013
atm - locus,C3711796;C1708726,true;false,11141/20013
atonic,C0541791,false,11142/20013
atopic,C0392707,false,11143/20013
atopic at baseline : yes,C0392707;C0168634;C1549445;C1705108;C1710701;C1442488,false;true;false;false;false;false,11144/20013
atopy ( n = nmbr,C0392707;C3539705,false;false,11145/20013
atopy ( specific ige ) c,C0392707;C0205369;C1552740;C3539705,false;false;false;false,11146/20013
atopy by phadiatop test,C0392707;C1441070;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C3539705,false;false;false;false;false;false;false;false;false;false,11147/20013
atorvastatin ( n = nmbr,C0286651,true,11148/20013
atorvastatin { n = nmbr,C0286651,true,11149/20013
atorvastatin nmbr mg and simvastatin nmbr - nmbr mg ( zi = nmbr ),C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11150/20013
atorvastatin nmbr mg ( zi = nmbr ),C0286651;C0024671;C0043476;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,11151/20013
atorvastatinb,,,11152/20013
atrial fibrillation — no . ( % ),C0004238;C0344434;C1963067,true;false;false,11153/20013
atrial fibrillation on baseline ecg,C0344434;C0168634;C1442488,false;true;false,11154/20013
atrial fibrillation type,C0004238;C0332307;C1547052;C0344434;C1963067,true;false;false;false;false,11155/20013
atrial fibrillation . no . ( % ),C0004238;C0344434;C1963067,true;false;false,11156/20013
attack ( % ),C0277793;C1261512;C1304680,false;false;false,11157/20013
attain,,,11158/20013
atv  atorvastatin  ldl - c  low - density lipoprotein cholesterol . * p - values pertain to treatment - by - stratum interaction test for stratum or treatment - by - subgroup interaction test for subgroups . ' multiplicity adjustments were not applied to this predefined subgroup analysis of ldl - c goal attainment    [expressed as number of patients reaching ldl - c goal at week nmbr / number of patients above goal at baseline  ^treatment stratum was defined by intake of atv nmbr or nmbr mg .,C0210243;C0286651;C0023824;C1709380;C0674679;C1145759;C1334862,true;true;true;false;true;true;false,11159/20013
atwo ‐ sample t ‐ test .,C0370003;C0871472;C2347026,false;false;false,11160/20013
atypical absence,C0595948,false,11161/20013
augment copd,C0205217,false,11162/20013
aunivariate logistic regression .,C0206031,true,11163/20013
austral ia / new zealand,C0020980;C0027978;C0324547;C0694634;C1947960,true;true;true;false;false,11164/20013
australia / new zealand / south africa,C4289954;C0037712,false;true,11165/20013
autonomic neuropathy,C0259749,false,11166/20013
available data,C0470187;C1511726;C3245479;C3714741,false;false;false;false,11167/20013
average daily dose,C1510992;C2348070;C2825518,false;false;false,11168/20013
avp pg / ml,C1098706;C0439297;C1568204;C1708407,true;false;true;false,11169/20013
aza ( n = nmbr ),C0004482,true,11170/20013
azathioprine monotherapy,C0004482,true,11171/20013
azl - m,C0369637;C0441923,false;false,11172/20013
azl - m + hctz ( n = nmbr ),C0369637;C0020261;C0441923,false;true;false,11173/20013
azl - m nmbr mg ( n = nmbr ),C0369637;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0441923,false;true;true;false;false;false;false;false;false,11174/20013
azl - m nmbr mg + cld nmbr mg,C0369637;C1319635;C0441923,false;false;false,11175/20013
azl - m nmbr mg nmbr - cld nmbr mg ( n = lnmbr ),C0369637;C2827881;C0441923,false;false;false,11176/20013
azl - m / cld ( n = nmbr ),C0369637;C0441923,false;false,11177/20013
azl - m + cldb,C0369637;C0441923,false;false,11178/20013
azl - ma,C0024443;C3887485,true;false,11179/20013
b - blockers at baseline,C0168634;C1442488,true;false,11180/20013
b - natriuretic peptide . pg / ml,C0070338;C0597421;C0439297,true;false;false,11181/20013
b includes both ex - smokers and nonsmokers .,,,11182/20013
b mace,C0349381;C0949745;C1445339,false;true;false,11183/20013
b major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,11184/20013
b nonsevere hypoglycemia,C0020615;C4553659,true;false,11185/20013
b pooled new and worsened vertebral fractures ( mfas ),,,11186/20013
b postbronchodilator fevl ( % predicted ),C2599594,false,11187/20013
b reslizumab nmbr . nmbr mg / kg n / n,C1869620;C0439272,true;false,11188/20013
b ) those on inhaled corticosteroids and long - acting bronchodilators as previous treatment use .,,,11189/20013
b . acr nmbr,C1412134;C1515941,false;false,11190/20013
b . benralizumab nmbr mg qnmbrw  ,C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11191/20013
b . i . d .  twice daily  cat  copd assessment test  copd  chronic obstructive pulmonary disease  fevnmbr    forced expiratory volume in nmbr   s  fvc  forced vital capacity  gold  global initiative for chronic obstructive lung disease  ics  inhaled corticosteroid  mcid  minimum clinically important difference  mmrc  modified medical research council  o . d .  once daily  sd  standard deviation  sgrq - c  st . george ’ s respiratory questionnaire for copd,C0152277;C0585361;C0007450;C0024117;C0178628;C0231958;C0018026;C0205246;C0424093;C2348867;C1304897;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,false;false;true;true;false;false;true;false;false;false;false;false;true;false;false;false;false,11192/20013
b . myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,11193/20013
b : u . s . black and non - black patients,C0041703;C0005680;C0027567;C0085756;C0439541,true;true;true;true;false,11194/20013
b + a ( n = nmbr ),,,11195/20013
b + h ( n = nmbr ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,11196/20013
background laba use,C1706907;C0042153;C0457083;C1947944,false;true;false;false,11197/20013
background laba use - yes,C1706907;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,11198/20013
background lipid - lowering therapy,C1706907;C0585943,false;false,11199/20013
background lipid therapy per acc / aha definition,C1706907;C0023779;C0039798;C4072694;C1550452;C1704788;C3539107;C3888054;C0087111;C1363945,false;true;true;false;false;false;false;false;true;false,11200/20013
background therapy,C1706907;C0039798;C0087111;C1363945,false;true;true;false,11201/20013
bacterial pneumonia,C0004626,true,11202/20013
bail ‐ out use of glycoprotein iib / iiia inhibitors,C0175673,false,11203/20013
barc types nmbr,C0332307,false,11204/20013
baricitinib nmbr / nmbr mg,C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11205/20013
baricitinib nmbr mg qd,C4044947;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,11206/20013
basal,C0205112,false,11207/20013
basal alone,C0205112;C0205171;C0439044;C0679994,false;false;false;false,11208/20013
basal insulin,C0650607,false,11209/20013
basal insulin doset,C0650607,false,11210/20013
basal only,C0205112;C0205171;C1720467,false;false;false,11211/20013
basal plus bolus,C0205112;C0332287;C1186706;C1511237;C1705509;C3812160,false;false;false;false;false;false,11212/20013
basdai question nmbr score ( nmbr - nmbr ),C1998004,false,11213/20013
basdai responses at week nmbr,C1998004;C0871261;C0332174;C0439230,false;false;false;false,11214/20013
basdai score ( nmbr - nmbr ),C1998004,false,11215/20013
basdai score,C1998004,false,11216/20013
basdai,C1998004,false,11217/20013
basdai ⁎ ⁎,C1998004,false,11218/20013
basdainmbr,C1998004,false,11219/20013
base,C0002055;C0178499;C1880279,true;false;false,11220/20013
baseiine acei / arb,C3888198,false,11221/20013
baseiine aspirin,C0004057,true,11222/20013
baseiine ccb,C0006684,true,11223/20013
baseiine diuretic,,,11224/20013
baseiine statin,C0360714,true,11225/20013
baseline - adjusted hr,C0168634;C1442488,true;false,11226/20013
baseline - - mdrd,C0168634;C3839656;C1442488,true;false;false,11227/20013
baseline - ckd - epi,C0168634;C1561643;C0162734;C4281721;C1442488,true;true;true;false;false,11228/20013
baseline ( mmol / l ),C0168634;C1532563;C1442488,true;false;false,11229/20013
baseline ( sd ),C0168634;C2699239;C1442488,true;false;false,11230/20013
baseline ^ste,C0168634;C1420459;C3811127;C1442488,true;false;false;false,11231/20013
baseline £ std,C0168634;C1442488,true;false,11232/20013
baseline nmbr - hour mean sbp,C0168634;C0439227;C0444504;C0085805;C2347634;C2348143;C0564385;C1442488,true;false;false;true;false;false;false;false,11233/20013
baseline nmbr - mlnute walk distance :,C0168634;C0429886;C1442488,true;false;false,11234/20013
baseline anmbrc ( % ),C0168634;C1442488,true;false,11235/20013
baseline anmbrc ( % ) [lsm ( se ) ],C0168634;C0036919;C1442488,true;true;false,11236/20013
baseline abi,C0168634;C1328319;C3888326;C1442488,true;true;false;false,11237/20013
baseline adas - cog nmbr,C0168634;C3539026;C1442488,true;false;false,11238/20013
baseline age,C0168634;C0001779;C1442488,true;false;false,11239/20013
baseline albuminuria,C0168634;C0001925;C1442488,true;true;false,11240/20013
baseline alc < nmbr . nmbr %,C0168634;C1424945;C3811058;C1442488,true;false;false;false,11241/20013
baseline alc category,C0168634;C1424945;C0683312;C3889287;C3811058;C1442488,true;false;false;false;false;false,11242/20013
baseline asdas - crp,C0168634;C3890735;C4048285;C1442488,true;false;false;false,11243/20013
baseline aspirin use,C0168634;C0004057;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,11244/20013
baseline aspirin use strata,C0168634;C0004057;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,11245/20013
baseline basdai,C0168634;C1998004;C1442488,true;false;false,11246/20013
baseline basfi,C0168634;C1442488,true;false,11247/20013
baseline bii,C0168634;C1413059;C1442488,true;false;false,11248/20013
baseline bmi,C0168634;C0578022;C1442488,true;false;false,11249/20013
baseline bmi ( kg / m^ ),C0168634;C0578022;C1532718;C1442488,true;false;false;false,11250/20013
baseline bmi ( kg / mnmbr ),C0168634;C0578022;C1532718;C1442488,true;false;false;false,11251/20013
baseline bnp concentration ( pg / ml ),C0168634;C0054015;C0086045;C0439297;C1446561;C3827302;C1095989;C1417808;C2982014;C1442488,true;true;true;false;false;false;false;false;false;false,11252/20013
baseline bp,C0168634;C0037623;C1415692;C1708288;C4318478;C1442488,true;true;false;false;false;false,11253/20013
baseline bsa,C0168634;C1442488,true;false,11254/20013
baseline cardiovascular assessment,C4684571;C0007226;C3887460;C0168634;C0846600;C1442488,false;true;false;true;false;false,11255/20013
baseline cardiovascular medications,C0168634;C0007220;C1442488,true;true;false,11256/20013
baseline cdr - sb ( n   = nmbr + nmbr ),C0168634;C4521843;C0038111;C3811240;C1442488,true;false;true;false;false,11257/20013
baseline chanmbrdsnmbr - vascb,C0168634;C1420648;C3714751;C1442488,true;false;false;false,11258/20013
baseline chadsnmbra,C0168634;C0007928;C1413373;C1442488,true;true;false;false,11259/20013
baseline ckd egfr < nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1561643;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false;false,11260/20013
baseline ckd egfr > nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C1561643;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false;false,11261/20013
baseline concentration,C0168634;C0086045;C1446561;C3827302;C1442488,true;true;false;false;false,11262/20013
baseline concomitant cardiovascular medications,C0168634;C0521115;C0007220;C1442488,true;false;true;false,11263/20013
baseline crcl,C0168634;C1846718;C1442488,true;false;false,11264/20013
baseline creatinine,C0168634;C0010294;C1561535;C1442488,true;true;false;false,11265/20013
baseline crohn ' s disease medications,C0168634;C0010346;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;true;false;false;false;false,11266/20013
baseline crp,C0168634;C3890735;C4048285;C1442488,true;false;false;false,11267/20013
baseline crp category ( mg / l ),C0168634;C3890735;C0683312;C0439268;C3889287;C4048285;C1442488,true;false;false;false;false;false;false,11268/20013
baseline crp levels < nmbr mg / l,C0168634;C3890735;C0441889;C0439268;C4048285;C1442488,true;false;false;false;false;false,11269/20013
baseline crp levels ≥ nmbr mg / l,C0168634;C3890735;C0441889;C0439268;C4048285;C1442488,true;false;false;false;false;false,11270/20013
baseline dad ( n   = nmbr + nmbr ),C0168634;C3641946;C1442488,true;false;false,11271/20013
baseline dasnmbr,C0168634;C0051767;C0057671;C1442488,true;true;true;false,11272/20013
baseline data,C0168634;C1511726;C3245479;C3714741;C1442488,true;false;false;false;false,11273/20013
baseline daytime nasal symptoms score,C0168634;C0332169;C0231918;C1442488,true;false;false;false,11274/20013
baseline dbp,C0168634;C0536221;C3813197;C4281799;C1442488,true;true;false;false;false,11275/20013
baseline demographics,C0168634;C0011298;C1704791;C1442488,true;true;false;false,11276/20013
baseline diabetes mellitus therapy,C0168634;C0948092;C1442488,true;false;false,11277/20013
baseline diastolic blood,C0168634;C0012000;C0005767;C0005768;C0229664;C1442488,true;true;true;true;false;false,11278/20013
baseline diastolic blood pressure,C4274392,false,11279/20013
baseline dipeptidyl peptidase nmbr,C0168634;C0022709;C1442488,true;true;false,11280/20013
baseline dlqi,C0168634;C3899393;C1442488,true;false;false,11281/20013
baseline ecg with lvh,C0168634;C0232306;C1442488,true;false;false,11282/20013
baseline ecrcl nmbr nmbr ml / min,C0168634;C0439445;C1442488,true;false;false,11283/20013
baseline ecrcl k nmbr to < nmbr ml / min,C0168634;C0597277;C0439445;C1708601;C1442488,true;false;false;false;false,11284/20013
baseline ecro < nmbr mumin,C0168634;C1442488,true;false,11285/20013
baseline ecrq nmbr nmbr to < nmbr ml / min,C0168634;C0439445;C1442488,true;false;false,11286/20013
baseline ed severity * * :,C0168634;C3538926;C0439793;C0522510;C1442488,true;false;false;false;false,11287/20013
baseline egfr ( ml / min per nmbr « nmbr m ’ ),C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,11288/20013
baseline egfr < nmbr,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,11289/20013
baseline egfr ≥ nmbr to < nmbr,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,11290/20013
baseline egfr,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,11291/20013
baseline eosinophil < nmbr cells / pl,C0168634;C0682547;C3897966;C4049765;C1442488,true;false;false;false;false,11292/20013
baseline eosinophil nmbr cells / pl,C0168634;C0682547;C3897966;C4049765;C1442488,true;false;false;false;false,11293/20013
baseline estimated gfr,C0168634;C1442488,true;false,11294/20013
baseline factor,C0168634;C1521761;C2827422;C1442488,true;false;false;false,11295/20013
baseline fasting plasma glucose,C0168634;C0015663;C0202042;C0455280;C1442488,true;true;false;false;false,11296/20013
baseline fasting tgs,C0168634;C0015663;C1156212;C1537574;C1442488,true;true;false;false;false,11297/20013
baseline fc - ldl - c,C0168634;C2983605;C1442488,true;false;false,11298/20013
baseline feature,C0168634;C1521970;C1706388;C2346469;C2348519;C1442488,true;false;false;false;false;false,11299/20013
baseline free pcsknmbr level,C0168634;C0332296;C0441889;C0456079;C1547707;C2946261;C1880497;C1996904;C1442488,true;false;false;false;false;false;false;false;false,11300/20013
baseline geometric mean ( nmbr ® / l ),C0168634;C2986759;C1442488,true;false;false,11301/20013
baseline gfr < nmbr ml / min / nmbr . nmbrmnmbr,C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,11302/20013
baseline glycated,C0168634;C1442488,true;false,11303/20013
baseline glycated hemoglobin ( % ),C0168634;C0017853;C1442488,true;true;false,11304/20013
baseline glycemic control,C0168634;C0005802;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1442488,true;true;true;false;false;false;false;false;false,11305/20013
baseline haq mean ( s . e . ),C0168634;C0102923;C0444504;C2347634;C2348143;C0451208;C1442488,true;true;false;false;false;false;false,11306/20013
baseline hba^c,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,11307/20013
baseline hbanmbrc < nmbr . nmbr % ( nmbr mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,11308/20013
baseline hbanmbrc ≤ median nmbr . nmbr % ( nmbr mmol / mol ),C0168634;C0019016;C0549183;C3829066;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false;false;false,11309/20013
baseline hbanmbrc ≥ nmbr mmol / mol ( ≥ nmbr . nmbr % ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,11310/20013
baseline hbanmbrc ≥ nmbr . nmbr % to < nmbr . nmbr % ( nmbr – nmbr mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,11311/20013
baseline hbanmbrc ≥ nmbr . nmbr % ( nmbr mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,11312/20013
baseline hbanmbrc > median nmbr . nmbr % ( nmbr mmol / mol ),C0168634;C0019016;C0549183;C3829066;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false;false;false,11313/20013
baseline hbanmbrc concentration,C0168634;C0019016;C0086045;C1446561;C3827302;C1825777;C3538758;C1442488,true;true;true;false;false;false;false;false,11314/20013
baseline hbanmbrc subgroup,C0168634;C0019016;C1079230;C1515021;C1825777;C3538758;C1442488,true;true;false;false;false;false;false,11315/20013
baseline hbanmbrc^,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,11316/20013
baseline hbalc,C0168634;C1442488,true;false,11317/20013
baseline hbalc < nmbr %,C0168634;C1442488,true;false,11318/20013
baseline hbalc > nmbr mmol / mol ( > nmbr . nmbr % ),C0168634;C3829066;C1442488,true;false;false,11319/20013
baseline hbalc > nmbr % to < nmbr %,C0168634;C1442488,true;false,11320/20013
baseline hbalc > nmbr %,C0168634;C1442488,true;false,11321/20013
baseline hbalc^,C0168634;C1442488,true;false,11322/20013
baseline hbalc ’,C0168634;C1442488,true;false,11323/20013
baseline hbi,C0168634;C1442488,true;false,11324/20013
baseline hdl - c,C0168634;C3715113;C1442488,true;false;false,11325/20013
baseline hdl - c level ( n = nmbr » nmbr ) > nmbr . nmbr mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,11326/20013
baseline hdl - c level ( n = nmbr . nmbr ) > nmbr . nmbr mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,11327/20013
baseline hdl - c level ( n = nmbr,C0168634;C3715113;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,11328/20013
baseline hdl - c level ( n = snmbr,C0168634;C3715113;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,11329/20013
baseline hdl ‐ c,C0168634;C3715113;C1442488,true;false;false,11330/20013
baseline height ( cm ),C0168634;C0489786;C1442488,true;false;false,11331/20013
baseline hemoglobin aj^ values,C0168634;C0019046;C0004486;C0042295;C0230613;C1442488,true;true;true;false;true;false,11332/20013
baseline high - density lipoprotein cholesterol ( mg / dl ),C0168634;C0023822;C0439269;C1442488,true;true;false;false,11333/20013
baseline hstni,C0168634;C1442488,true;false,11334/20013
baseline ics,C0168634;C0815320;C4551720;C1442488,true;false;true;false,11335/20013
baseline ics > nmbr pg per day ( fluticasone propionate dpi or equivalent ) and laba,C0168634;C0815320;C2827928;C0117996;C4551720;C1442488,true;false;false;true;true;false,11336/20013
baseline ics dose,C0168634;C0815320;C0178602;C0869039;C1114758;C4551720;C1442488,true;false;false;false;false;true;false,11337/20013
baseline if have nmbr yr follow - up *,C0168634;C1442488,true;false,11338/20013
baseline ifg ( fpg nmbr . nmbr - nmbr . nmbr mmol / l ) - n,C0168634;C1334085;C1532563;C1708411;C1442488,true;false;false;false;false,11339/20013
baseline in - check * ’ pifr ( l / min ),C0168634;C1283174;C0702093;C1524029;C3813700;C1555524;C4321547;C1442488,true;false;false;false;false;false;false;false,11340/20013
baseline inflammation markers,C0168634;C0021368;C0005516;C1442488,true;true;true;false,11341/20013
baseline insulin,C0168634;C0021641;C1533581;C1579433;C3714501;C1442488,true;true;false;false;false;false,11342/20013
baseline insulin dose ( u = kg ) [lsm ( se ) ],C0168634;C0366513;C1300561;C0036919;C1442488,true;false;false;true;false,11343/20013
baseline ldl ‐ c,C0168634;C1442488,true;false,11344/20013
baseline ldl ( mg % ),C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;true;true;false;false;false;false;false;false,11345/20013
baseline ldl cholesterol ( derived ),C0168634;C0023824;C0202117;C1442488,true;true;false;false,11346/20013
baseline ldlc level ( n = nmbr,C0168634;C1416822;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,11347/20013
baseline ldlc level ( n = nmbr . nmbr ) > nmbr . nmbr mg / dl,C0168634;C1416822;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,11348/20013
baseline lipid and apolipoprotein levels,C0168634;C0023779;C1442488,true;true;false,11349/20013
baseline lipid parameters,C0168634;C0023779;C0449381;C1442488,true;true;false;false,11350/20013
baseline lipid profile,C0168634;C0023779;C1979963;C2003903;C1442488,true;true;false;false;false,11351/20013
baseline lipid therapy,C0168634;C0023779;C0039798;C0087111;C1363945;C1442488,true;true;true;true;false;false,11352/20013
baseline lipids,C0168634;C0023779;C1442488,true;true;false,11353/20013
baseline lipoprotein ( a ) ( nmol / l ),C0168634;C0065058;C0439282;C0125953;C1096202;C1439335;C1442488,true;true;false;true;false;false;false,11354/20013
baseline los angeles grade of eo,C0168634;C0024015;C1442488,true;true;false,11355/20013
baseline lp ( a ),C0168634;C0065058;C1439335;C4553379;C1442488,true;true;false;false;false,11356/20013
baseline luts severity * :,C0168634;C0574785;C0439793;C0522510;C1442488,true;true;false;false;false,11357/20013
baseline luts severity,C0168634;C0574785;C0439793;C0522510;C1442488,true;true;false;false;false,11358/20013
baseline mayo score,C0168634;C0454788;C0449820;C4050231;C1077578;C1442488,true;false;false;false;false;false,11359/20013
baseline mdrd egfr < nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;false;true;false;false;false;false;false;false,11360/20013
baseline mdrd egfr > nmbr ml / min / nmbr . nmbr mnmbr,C0168634;C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;false;true;false;false;false;false;false;false,11361/20013
baseline mean ambulatory sbp,C0168634;C0444504;C0439841;C0085805;C2347634;C2348143;C1442488,true;false;false;true;false;false;false,11362/20013
baseline mean fevnmbr ( sd ),C0168634;C0444504;C3714541;C2699239;C2347634;C2348143;C1442488,true;false;true;false;false;false;false,11363/20013
baseline mean seated sbp,C0168634;C0444504;C0277814;C0085805;C1283233;C2347634;C2348143;C1442488,true;false;true;true;false;false;false;false,11364/20013
baseline mean serum uric acid,C0168634;C0444504;C0455272;C0700634;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,11365/20013
baseline medications ( % ),C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,11366/20013
baseline metformin,C0168634;C0025598;C1442488,true;true;false,11367/20013
baseline microalbumin : < nmbr,C0168634;C0201838;C2362049;C1442488,true;false;false;false,11368/20013
baseline monthly pos seizure rate,C0168634;C0332177;C1262869;C0036572;C0871208;C1521828;C1959629;C4553401;C3496112;C3496399;C1442488,true;false;true;true;false;false;false;false;false;false;false,11369/20013
baseline mtss subgroup,C0168634;C1079230;C1515021;C1442488,true;false;false;false,11370/20013
baseline mwd,C0168634;C1442488,true;false,11371/20013
baseline nbp,C0168634;C1442488,true;false,11372/20013
baseline non - hdl - ca,C0168634;C1518422;C3715113;C3887642;C1442488,true;false;false;true;false,11373/20013
baseline normoglycaemia ( fpg < nmbr . nmbr mmol / l ) - n,C0168634;C0580545;C1532563;C1442488,true;false;false;false,11374/20013
baseline normoglycemia,C0168634;C0580545;C1442488,true;false;false,11375/20013
baseline numberf of adm classes,C0168634;C0215825;C0456387;C1518526;C1705943;C4019422;C4521767;C1442488,true;true;false;false;false;false;false;false,11376/20013
baseline ocs use : yes,C0168634;C1442488,true;false,11377/20013
baseline of induction,C0168634;C0205263;C0857127;C1442488,true;false;false;false,11378/20013
baseline of induction ),C0168634;C0205263;C0857127;C1442488,true;false;false;false,11379/20013
baseline outcomes,C0168634;C1274040;C1442488,true;false;false,11380/20013
baseline parameter,C0168634;C0549193;C1704769;C2350001;C1442488,true;false;false;false;false,11381/20013
baseline pasi,C0168634;C4528685;C1442488,true;false;false,11382/20013
baseline pava,C0168634;C0135567;C1442488,true;true;false,11383/20013
baseline pcsi < nmbra,C0168634;C1442488,true;false,11384/20013
baseline pfd,C0168634;C0016065;C1839454;C2827389;C3889643;C1442488,true;true;true;false;false;false,11385/20013
baseline post - bronchodilator fevnmbr   ( sd ),C0168634;C2599594;C3714541;C2699239;C1442488,true;false;true;false;false,11386/20013
baseline ppasi score,C0168634;C1442488,true;false,11387/20013
baseline prediabetes,C0168634;C0362046;C1442488,true;true;false,11388/20013
baseline prednisone or oral prednisone equivalent daily dose,C0168634;C0032952;C1442488,true;true;false,11389/20013
baseline presence of nasal polyps,C0168634;C0150312;C0027430;C0392148;C3854307;C1442488,true;false;true;false;false;false,11390/20013
baseline procedure,C0168634;C0184661;C2700391;C3274430;C3539779;C1442488,true;true;false;false;false;false,11391/20013
baseline pssi score,C0168634;C1442488,true;false,11392/20013
baseline ptga,C0168634;C1442488,true;false,11393/20013
baseline pulmonary medications,C0168634;C0024109;C0013227;C0802604;C2598133;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false;false,11394/20013
baseline renal function ( eclcr ),C0168634;C0232804;C1442488,true;false;false,11395/20013
baseline risk factors,C0168634;C0035648;C1553898;C1442488,true;true;false;false,11396/20013
baseline rst - segment,C0168634;C1425219;C0441635;C1442488,true;false;false;false,11397/20013
baseline rst - segment elevation,C0168634;C1425219;C0441635;C0439775;C0702240;C1442488,true;false;false;false;false;false,11398/20013
baseline sbp,C0168634;C0085805;C1442488,true;true;false,11399/20013
baseline sbp ( mm ),C0168634;C0085805;C4330985;C4554674;C1442488,true;true;false;false;false,11400/20013
baseline sbp { p = o - nmbr ),C0168634;C0085805;C1442488,true;true;false,11401/20013
baseline sedbp,C0168634;C1442488,true;false,11402/20013
baseline serum calcium level,C0168634;C0036785;C0728876;C1442488,true;false;false;false,11403/20013
baseline serum mg < nmbr . nmbr mmol / l,C0168634;C0229671;C0439268;C0439190;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100;C1442488,true;true;false;false;true;false;true;false;false;false;false;false;false;false;false,11404/20013
baseline serum mg > = nmbr . nmbr mmol / l,C0168634;C0229671;C0439268;C0439190;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100;C1442488,true;true;false;false;true;false;true;false;false;false;false;false;false;false;false,11405/20013
baseline serum urate ( mg / dl ) a,C0168634;C0455272;C0439269;C1442488,true;false;false;false,11406/20013
baseline sesbp,C0168634;C1442488,true;false,11407/20013
baseline shs ( nmbr - nmbr ),C0168634;C1442488,true;false,11408/20013
baseline sildenafil dose mg,C0168634;C0529793;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C1442488,true;true;false;true;true;false;false;false;false;false;false;false;false,11409/20013
baseline sitosterol / cholesterol,C0168634;C0037215;C0008377;C0220914;C1442488,true;true;true;true;false,11410/20013
baseline sitosterol / lathosterol,C0168634;C0037215;C0064673;C0220914;C1442488,true;true;true;true;false,11411/20013
baseline sitting dbp,C0168634;C0277814;C0536221;C3813197;C4281799;C2584297;C4050224;C1442488,true;true;true;false;false;true;false;false,11412/20013
baseline sitting sbp,C0168634;C0277814;C0085805;C2584297;C4050224;C1442488,true;true;true;true;false;false,11413/20013
baseline sjc,C0168634;C1442488,true;false,11414/20013
baseline skin pain vas,C0168634;C0241136;C0042815;C3536884;C3827561;C1963195;C0444099;C1123023;C4520765;C1442488,true;false;true;true;false;false;false;true;false;false,11415/20013
baseline smoking status,C0168634;C1519386;C1442488,true;false;false,11416/20013
baseline spga,C0168634;C1442488,true;false,11417/20013
baseline spirometry,C0168634;C0037981;C1442488,true;true;false,11418/20013
baseline statin,C0168634;C0360714;C1442488,true;true;false,11419/20013
baseline statin intensity,C0168634;C0360714;C0522510;C1442488,true;true;false;false,11420/20013
baseline statin use,C0168634;C0360714;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,11421/20013
baseline ste in worst lead,C0168634;C1420459;C1522166;C3811127;C1442488,true;false;false;false;false,11422/20013
baseline sua,C0168634;C1442488,true;false,11423/20013
baseline subgroup,C0168634;C1079230;C1515021;C1442488,true;false;false;false,11424/20013
baseline sulfonylurea yes,C0168634;C0038766;C1549445;C1705108;C1710701;C3536898;C1442488,true;true;false;false;false;false;false,11425/20013
baseline symptom days perweek,C0168634;C1457887;C0439228;C3854129;C1442488,true;false;false;false;false,11426/20013
baseline t - score at femoral neck,C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,11427/20013
baseline tava,C0168634;C1442488,true;false,11428/20013
baseline tbp,C0168634;C1442488,true;false,11429/20013
baseline tc,C0168634;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C1442488,true;true;true;true;true;false;false;false;false,11430/20013
baseline tg,C0168634;C0337445;C1442488,true;false;false,11431/20013
baseline tg < nmbr . nmbr mmol / l,C0168634;C0337445;C1532563;C1442488,true;false;false;false,11432/20013
baseline tg > nmbr . nmbr mmol / l,C0168634;C0337445;C1532563;C1442488,true;false;false;false,11433/20013
baseline tg level ( n = nmbr,C0168634;C0337445;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,11434/20013
baseline tg level ( n = nmbr . nmbr ) > nmbr . nmbr mg / dl,C0168634;C0337445;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,11435/20013
baseline tg level { n = nmbr,C0168634;C0337445;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,11436/20013
baseline tjc,C0168634;C1442488,true;false,11437/20013
baseline to eom placebo ( n = nmbr ),C0168634;C0241886;C0032042;C1696465;C1706408;C1442488,true;false;true;false;false;false,11438/20013
baseline to year nmbr,C0168634;C0439234;C0439508;C1442488,true;false;false;false,11439/20013
baseline tophusa,C0168634;C1442488,true;false,11440/20013
baseline total ipss,C0168634;C0439175;C1019118;C1998280;C2827405;C3811063;C0439810;C1442488,true;false;false;false;false;false;false;false,11441/20013
baseline total pcsknmbr level,C0168634;C0439175;C0441889;C0456079;C1547707;C2946261;C0439810;C1442488,true;false;false;false;false;false;false;false,11442/20013
baseline triglycerides,C0168634;C0041004;C1442488,true;true;false,11443/20013
baseline triglycerides > nmbr mg / dl and,C0168634;C0041004;C0439269;C1442488,true;true;false;false,11444/20013
baseline uasnmbr,C0168634;C1442488,true;false,11445/20013
baseline upgr > nmbr gm / gm ( nmbr mg / mmole ),C0168634;C0017480;C0567349;C2348885;C3854019;C1442488,true;true;false;false;true;false,11446/20013
baseline upgr,C0168634;C1442488,true;false,11447/20013
baseline use of adm,C0168634;C1524063;C0215825;C4521767;C1442488,true;false;true;false;false,11448/20013
baseline variable,C0168634;C0439828;C4553760;C1442488,true;false;false;false,11449/20013
baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,11450/20013
baseline vfx,C0168634;C1442488,true;false,11451/20013
baseline vitamin - d,C0168634;C0014695;C0042866;C2936842;C3537249;C3714503;C1442488,true;true;true;false;false;false;false,11452/20013
baseline weekly iss,C0168634;C0332174;C1740819;C1845118;C1442488,true;false;false;false;false,11453/20013
baseline who function class,C0168634;C1442488,true;false,11454/20013
basfi *,,,11455/20013
batellna c - reective protein,C0033684,true,11456/20013
bb,C0004739;C0332297,true;false,11457/20013
bdi focal scorenmbr,C0006448;C0205234;C0449820;C4050231;C0451022;C3714938;C3889415,true;false;false;false;false;false;false,11458/20013
beam values ( mg / dl ),C0338248;C0042295;C0439269;C2347880;C4521565,false;false;false;false;false,11459/20013
beam   <   nmbr   mg / dl at week nmbr,C0338248;C0439269;C0332174;C0439230;C2347880;C4521565,false;false;false;false;false;false,11460/20013
because of ae,C3887670,false,11461/20013
because of drug ‐ relateda   ae,C0013227;C3887670;C1254351,true;false;false,11462/20013
because of drug ‐ relateda   sae,C0013227;C1519255;C1622657;C4553214;C1254351,true;false;false;false;false,11463/20013
because of sae,C1519255;C1622657;C4553214,false;false;false,11464/20013
before a change to the enrollment form was implemented in august nmbr . bnp,C0392747;C1516879;C0348078;C0376315;C1522492;C4255237;C1696073;C3888021;C0443172;C1705241;C4319952,false;false;false;true;false;false;false;false;false;false;false,11465/20013
before admission ),C0184666;C0809949,false;false,11466/20013
before bronchodilation — liters §,C1371299;C0475211;C3537072,false;false;false,11467/20013
before bronchodilator use,C0006280;C0042153;C0457083;C1947944,true;true;false;false,11468/20013
below median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,11469/20013
bempedoic,,,11470/20013
bempedoic acid ( n = nmbr ),C3659310,true,11471/20013
benazepril - amlodipine group ( n = nmbr ),C0053091;C0051696;C0441848,true;true;false,11472/20013
benazepril - hydrochlorothiazide group ( n = nmbr ),C0717481;C0441848,false;false,11473/20013
benralizumab,C2982078,true,11474/20013
benralizumab nmbr mg qnmbrw,C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11475/20013
benralizumab qnmbrw ( n - nmbr ),C2982078,true,11476/20013
benralizumab qnmbrw ( n = nmbr ),C2982078,true,11477/20013
benzodiazepine or bzra ‡,C0005064;C3536850;C4048284,true;false;true,11478/20013
beta - blocker n ( % ),C0001645,true,11479/20013
beta blocker use ( % ),C0001645;C0042153;C0457083;C1947944,true;true;false;false,11480/20013
beta blocker users,C0001645;C1706077,true;false,11481/20013
beta bloekers,C0330390;C0439096;C2004068,false;false;false,11482/20013
betablocker,C0001645,true,11483/20013
between - treatment comparison of percentage change from baseline in total hip bmd,C1299575;C1707455;C0439165;C1549488;C1561533,false;false;false;false;false,11484/20013
bi ( nmbr . nmbr ),,,11485/20013
biack,,,11486/20013
biack hispanic,C0086409,true,11487/20013
biack non - hispanic,,,11488/20013
biasp nmbr bid,,,11489/20013
bifurcation lesion with side branch ≥ nmbr . nmbr mm stented,C0184906;C0221198;C0441987;C0205384;C4330985;C4554674;C1253959;C1881507;C2700383;C2826234;C1546698;C3146289,false;false;false;false;false;false;false;false;false;false;false;false,11490/20013
bifurcation per lesion ‡,C0184906;C0221198;C1546698;C3146289,false;false;false;false,11491/20013
biguanide,C0005382;C3537187;C4317165,true;false;false,11492/20013
biguanide use at baseline,C0005382;C0042153;C0168634;C1442488;C0457083;C1947944;C3537187;C4317165,true;true;true;false;false;false;false;false,11493/20013
biguanides ¶,C0005382;C0360396;C3540012,true;false;false,11494/20013
bii ( mean ± sd ),C1413059;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11495/20013
bii score,C1413059,false,11496/20013
bilag a,,,11497/20013
biochemical events,C0205474;C0441471;C3541888,false;false;false,11498/20013
biochemical measures,C0205474;C0079809;C1879489,false;true;false,11499/20013
biochemical parameters at randomization,C0205474;C0449381;C0034656,false;false;true,11500/20013
biolimus anmbr - eluting stent ¶,,,11501/20013
biologic,C0005515;C0205460,true;false,11502/20013
biological,C0005532;C0205460,true;false,11503/20013
biomarker high,C0005516,true,11504/20013
biomarker high ( periostin > nmbr ng / ml or blood eosinophils > nmbr cells per pl ) t,C0005516;C0205250;C0219433;C0439275;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,true;false;true;false;false;false;false;false;false;false;false;false,11505/20013
biomarker levels,C0005516;C0441889,true;false,11506/20013
biomarker low,C0005516,true,11507/20013
biomarkers at baseline,C0005516;C0168634;C1442488,true;true;false,11508/20013
biometric parameters,C0005544;C0449381;C2718322,true;false;false,11509/20013
bivalirudin ( n = nmbr,C0168273,true,11510/20013
bivalirudin alone ( n = nmbr ),C0168273;C0205171;C0439044;C0679994,true;false;false;false,11511/20013
bivalirudin plus glycoprotein iib / iiia inhibitors ( n = nmbr ),C0168273;C0016011;C0243077,true;true;true,11512/20013
bivalirudin used,C0168273,true,11513/20013
bl,C0005918;C0006413;C1552663;C2827109,true;true;false;false,11514/20013
bl alc < nmbr . nmbr %,C0005918;C1424945;C3811058;C0006413;C1552663;C2827109,true;false;false;true;false;false,11515/20013
bl bmnmbr < nmbr kg / m^,C0005918;C0006416;C1532718;C0006413;C1552663;C2827109,true;true;false;true;false;false,11516/20013
bl bmioo kg / m^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,11517/20013
bl bml < nmbr kg / m^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,11518/20013
bl bml > nmbr kg / m^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,11519/20013
bl bml > nmbr ke / m^,C0005918;C0022558;C0369637;C0441923;C0006413;C1552663;C2827109,true;true;false;false;true;false;false,11520/20013
black ( n   = nmbr ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,11521/20013
black ( n = nmbr )  adjusted hazard ratio *,C0005680;C0456081;C2985465;C0027567;C0085756;C0439541,true;false;false;true;true;false,11522/20013
black hispanic,C1533017;C1533018,false;false,11523/20013
black hispanic - n ( % ),C1533017;C1533018,false;false,11524/20013
black non - hispanic,C1533017;C1518422;C1533018;C0005680;C1518424;C0027567;C0085756;C0439541,false;false;false;true;false;true;true;false,11525/20013
black non - hispanic - n ( % ),C1533017;C1518422;C1533018;C0005680;C1518424;C0027567;C0085756;C0439541,false;false;false;true;false;true;true;false,11526/20013
black or african,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11527/20013
black or african ‐ american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11528/20013
black or african heritage,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11529/20013
black or asian,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11530/20013
black participants,C0005680;C0679646;C0027567;C0085756;C0439541,true;false;true;true;false,11531/20013
black region or country ( % ),C0005680;C0017446;C0205147;C0027567;C0085756;C0439541,true;true;false;true;true;false,11532/20013
black *,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11533/20013
black /,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11534/20013
black / af rican american,C0085756;C0344434;C4049859,true;false;false,11535/20013
black / african,C0337824,false,11536/20013
black / non - black,C0005680;C1518422;C0027567;C0085756;C0439541,true;false;true;true;false,11537/20013
bladder,C0005682;C4319531,true;false,11538/20013
blaek,,,11539/20013
blaek / afriean - ameriean,,,11540/20013
blaic < nmbr . nmbr %,,,11541/20013
blaic > nmbr . nmbr %,,,11542/20013
bleeding,C0019080,true,11543/20013
bleeding end points,C0019080;C2349179,true;false,11544/20013
bleeding events during first nmbr days of treatmen,C0019080;C0441471;C0205435;C0439228;C1279901;C3541888,true;false;false;false;false;false,11545/20013
bleeding events during the entire study,C0019080;C0441471;C0439751;C0557651;C2603343;C0444667;C3541888,true;false;false;false;false;false;false,11546/20013
bleeding outcomes,C0019080;C1274040,true;false,11547/20013
blisibimod ( n = nmbr ),C3713826,true,11548/20013
blocker,,,11549/20013
blood - glucose control,C3267174,false,11550/20013
blood bilirubin increased,C0005767;C0005437;C0005768;C0229664,true;true;true;false,11551/20013
blood eosinophil count — cells / mm ’,C0005773;C0200638;C4330985;C4554674;C0750879,true;false;false;false;false,11552/20013
blood eosinophil count cells / mmnmbr no .,C0005773;C0200638;C4330985;C4554674;C0750879,true;false;false;false;false,11553/20013
blood eosinophil count,C0014467;C0750480;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664,true;false;false;true;false;false;true;false,11554/20013
blood eosinophils,C0014467,true,11555/20013
blood glucose - lowering drugs,C0018938;C0017725;C0441994;C2003888;C0005802;C0013227;C3687832,true;true;false;false;true;true;false,11556/20013
blood glucose - lowering treatments,C0596197;C0017725;C0441994;C2003888;C0005802;C0087111,false;true;false;false;true;true,11557/20013
blood glucose lowering treatment,C0596197;C0017725;C0441994;C2003888;C0005802;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;true;true;true;false;false;false;false;false,11558/20013
blood pressure ( mm hg ) systolic,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11559/20013
blood pressure ( mm hg ) *,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11560/20013
blood pressure < nmbr / nmbr mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11561/20013
blood pressure < nmbr mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11562/20013
blood pressure > nmbr mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11563/20013
blood pressure at baseline :,C0005823;C0168634;C1442488;C1271104;C1272641;C0005767;C0443150;C0005768;C0229664,true;true;false;false;true;true;false;true;false,11564/20013
blood pressure at entry ( mm   hg ),C0005823;C1705654;C0439475;C1271104;C1272641,true;false;false;false;true,11565/20013
blood pressure control *,C0005823;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1271104;C1272641,true;true;false;false;false;false;false;false;true,11566/20013
blood pressure eontrolt,C0005823;C1271104;C1272641,true;false;true,11567/20013
blood pressure in mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,11568/20013
blood pressure while seated — mm hg,C0005823;C1271104;C1272641,true;false;true,11569/20013
blood pressure : systolic / diastolic ( mm hg ) ( mean,C2704328;C0439475;C0444504;C2347634;C2348143,false;false;false;false;false,11570/20013
blood urea nitrogen,C0005845;C0600137,true;false,11571/20013
bmnmbr,C0006416,true,11572/20013
bmi - kg / mnmbr,C0578022;C1532718,false;false,11573/20013
bmi ( . kg / m - ) *,C0578022;C1532718,false;false,11574/20013
bmi ( kg / m nmbr ),C0578022;C1532718,false;false,11575/20013
bmi ( kg / ( m ) nmbr ),C0578022;C1532718,false;false,11576/20013
bmi ( kg / m^ ),C0578022;C1532718,false;false,11577/20013
bmi ( kg / m ’ ),C0578022;C1532718,false;false,11578/20013
bmi ( kg / mnmbr ) ( mean ± sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,11579/20013
bmi ( kg / mnmbr ) ( sd ),C0578022;C1532718;C2699239,false;false;false,11580/20013
bmi ( kg / mnmbr ) [mean - sd],C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,11581/20013
bmi ( kg / mnmbr ) : mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,11582/20013
bmi ( kg / mnmbr ) a,C0578022;C1532718,false;false,11583/20013
bmi ( kg = mnmbr ),C0578022;C1532718,false;false,11584/20013
bmi ( sd ),C0578022;C2699239,false;false,11585/20013
bmi [kg / mnmbr],C0578022;C1532718,false;false,11586/20013
bmi £ nmbr kg / m * ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11587/20013
bmi < nmbr kg / m   ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11588/20013
bmi < nmbr kg / m * ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11589/20013
bmi < nmbr kg / m^ ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11590/20013
bmi < nmbr kg / mnmbr ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11591/20013
bmi = body mass index  bnp = brain natriuretic peptide  dbp = diastolic blood pressure  gfr = glomerular filtration rate  hr = heart rate  iqr = interquartile range  kccq = kansas city cardiomyopathy questionnaire  n = number  nt = n - terminal  nyha = new york heart association  sbp = systolic blood pressure,C1305855;C0054015;C0428883;C0017654;C0018810;C1711350;C3476798;C3476086;C0332126;C0205088;C1275491;C0459867;C0085805;C0488055;C0871470;C1306620;C1705314;C1705315;C1449832;C3889152;C4050156;C4283901;C4284038;C1561549;C1424601;C1095989;C1417808;C2982014,true;true;true;true;true;false;false;false;false;false;false;false;true;false;true;false;false;false;true;false;false;false;false;false;false;false;false;false,11592/20013
bmi > nmbrkg / mnmbr,C0578022;C1532718,false;false,11593/20013
bmi > = nmbr kg / mnmbr population ( n = nmbr ),C0578022;C1532718;C0032659;C1257890,false;false;true;true,11594/20013
bmi > nmbr — no . { % ) $,C0578022,false,11595/20013
bmi > nmbr kg / m^ ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11596/20013
bmi > nmbr kg / mnmbr *,C0578022;C1532718,false;false,11597/20013
bmi > nmbr obese,C0578022,false,11598/20013
bmi ¼ body mass index  hctz ¼ hydrochlorothiazide  msdbp ¼ mean sitting diastolic blood pressure  mssbp ¼ mean sitting systolic blood pressure  sd ¼ standard deviation,C1305855;C0020261;C0444504;C1319894;C2347634;C2348143,true;true;false;false;false;false,11599/20013
bmi nmbr - < nmbr kg / m - ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11600/20013
bmi nmbr - < nmbr kg / m   ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11601/20013
bmi nmbr - < nmbr kg / m * ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11602/20013
bmi nmbr - < nmbr kg / m^ ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11603/20013
bmi nmbr - < nmbr kg / ni - ( n = nmbr / nmbr ),C0578022;C0022718;C0028075;C2348274;C3869926;C3869927;C0439209;C4054209,false;true;true;false;false;false;false;false,11604/20013
bmi nmbr – nmbr overweight,C0578022;C0497406,false;true,11605/20013
bmi nmbr - nmbr - nmbr - nmbr,C0578022,false,11606/20013
bmi nmbr nmbr - nmbr nmbr,C0578022,false,11607/20013
bmi nmbr - nmbr - nmbr nmbr,C0578022,false,11608/20013
bmi nmbr,C0578022,false,11609/20013
bmi anmbr,C0578022,false,11610/20013
bmi categories,C0578022;C0683312,false;false,11611/20013
bmi category ( kg / mnmbr ),C0578022;C0683312;C1532718;C3889287,false;false;false;false,11612/20013
bmi distribution,C0578022;C0520511;C1704711,false;false;true,11613/20013
bmi group ( kg / m^ ),C0578022;C0441847;C0022718;C0439209;C4054209;C0441833;C1532718;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false;false;false;true;false;false;false,11614/20013
bmi indicates body mass index  sbp  systolic blood pressure  dbp  lipoprotein ( a ) . ldl - c was calculated with the friedewald formula . ' hypertension and diabetes were based on physician diagnosis . ! smoker includes current and past smokers .,C0578022,false,11615/20013
bmi kg · m − nmbr,C0578022;C1532718,false;false,11616/20013
bmi onmbr kg / mnmbr,C0578022;C1532718,false;false,11617/20013
bmi   kg · m − nmbr,C0578022;C1532718,false;false,11618/20013
bmi # kg - m “ nmbr,C0578022;C1532718,false;false,11619/20013
bmi * ( kg / mnmbr ),C0578022;C1532718,false;false,11620/20013
bmi  body mass index  hrt  hormone replacement therapy  lvh  left ventricular hypertrophy  nsaids  nonsteroidal anti - inflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ahistory of and / or currently taking lipid - lowering or antidiabetic medications . bp < nmbr . nmbr for verapamil sustained - release ( sr ) vs . atenolol . chistory of or currently have elevated serum creatinine but less than nmbr mg / dl . dblood pressure control defined as < nmbr / nmbr or < nmbr / nmbr in patients with diabetes or a history of renal insufficiency .,C1305855;C0282402;C0149721;C0003211;C0085096;C0007787;C3536840,true;true;true;true;true;true;false,11621/20013
bmi  kg / mnmbr  median ( iqr ),C0578022;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,11622/20013
bmi : < nmbr kg / nr,C0578022;C0022718;C0027496;C3844738;C0439209;C4054209,false;true;true;false;false;false,11623/20013
bmi : body mass index  dbp : diastolic blood pressure  gm : geometric mean  sbp : systolic blood pressure . the analysis was based on observed data without imputation on missing values . asubgroup of patients in whom nmbr h urine was collected ( see materials and methods section ) .,C1305855;C0428883;C0017480;C2986759;C0085805;C0488055;C0871470;C1306620;C3854019,true;true;true;false;true;false;true;false;true,11624/20013
bmi > nmbrkg / m * ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11625/20013
bmi > nmbrkg / mnmbr ( n = nmbr / nmbr ),C0578022;C1532718,false;false,11626/20013
bmia,,,11627/20013
bmij,,,11628/20013
bmit,,,11629/20013
bmp kg - m “ nmbr,C0053932;C1532718;C0279266;C4281808,true;false;false;false,11630/20013
bmultivariate logistic regression with variables forced in the modela,C0206031;C0439828,true;false,11631/20013
bnp — pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,11632/20013
bnp — pg / ml  i ,C0054015;C0439297;C0021966;C0221138;C0030827;C0023806;C0072225;C1266240;C1095989;C1417808;C2982014,true;false;true;false;true;true;true;false;false;false;false,11633/20013
bnp ( n = nmbr ),C0054015;C1095989;C1417808;C2982014,true;false;false;false,11634/20013
bnp < nmbr pg / ml n = nmbr,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,11635/20013
bnp > nmbr pg / ml or nt pro - bnp > nmbr pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,11636/20013
bnp > nmbr pg / ml n = nmbr,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,11637/20013
bnp indicates brain natriuretic peptide  and nyha  new york heart association .,C0054015;C1095989;C1417808;C2982014,true;false;false;false,11638/20013
bnp / nt - probnp,C0054015;C0669479;C0754710;C1095989;C1417808;C2982014,true;true;true;false;false;false,11639/20013
bnp / ntbnp ( n = nmbr ),C0054015;C1095989;C1417808;C2982014,true;false;false;false,11640/20013
bocf - iike imputation ( random . ) ( n = nmbr ),C2984917;C2699638;C0034656;C0439605,false;false;true;false,11641/20013
body - mass index - ! ',C0005893;C0578022;C1305855,false;false;true,11642/20013
body - mass index — no . ( % ) : i :,C0005893;C0578022;C1305855,false;false;true,11643/20013
body - mass index ( kg / cmnmbr ),C0005893;C4054689;C0578022;C1305855,false;false;false;true,11644/20013
body - mass index ( kg / m   nmbr ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,11645/20013
body - mass index ( kg / m ’ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,11646/20013
body - mass index ( kg / mnmbr ) ( mean,C0005893;C1532718;C0444504;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,11647/20013
body - mass index ( kg / mnmbr ) *,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11648/20013
body - mass index ( kg / mq,C0005893;C0022718;C0024853;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;true,11649/20013
body - mass index \ kg / mnmbr,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11650/20013
body - mass index > nmbr kg / nrn,C0005893;C0022718;C1425210;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;true,11651/20013
body - mass index ) ',C0005893;C0578022;C1305855,false;false;true,11652/20013
body - mass index : ! : blood pressure — mm hg,C0005893;C0005823;C0439475;C1271104;C1272641;C0578022;C1305855,false;true;false;false;true;false;true,11653/20013
body - mass index^,C0005893;C0578022;C1305855,false;false;true,11654/20013
body - mass index^ :,C0005893;C0578022;C1305855,false;false;true,11655/20013
body - mass index^ ,C0005893;C0578022;C1305855,false;false;true,11656/20013
body - mass index ”,C0005893;C0578022;C1305855,false;false;true,11657/20013
body height ( cm ),C0005890;C0487985,true;false,11658/20013
body mass index - mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,11659/20013
body mass index ( bmi  kg / mnmbr )  n ( % ) < nmbr kg / mnmbr,C0005893;C0578022;C0022718;C1709500;C0439209;C4054209;C1305855,false;false;true;false;false;false;true,11660/20013
body mass index ( kg / m ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,11661/20013
body mass index ( kg / m^ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,11662/20013
body mass index ( kg / m^ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11663/20013
body mass index ( kg / m ’ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11664/20013
body mass index ( kg / m “ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11665/20013
body mass index ( kg / mnmbr ) baseline systolic blood,C0005893;C1532718;C0168634;C0039155;C0005767;C0005768;C0229664;C1442488;C0578022;C1305855,false;false;true;true;true;true;false;false;false;true,11666/20013
body mass index ( kg / mnmbr ) ∗,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11667/20013
body mass index ( kg / ma ),C0005893;C0022718;C0024443;C3887485;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;false;true,11668/20013
body mass index ( kgm _nmbr ),C0005893;C0578022;C1305855,false;false;true,11669/20013
body mass index ( median,C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,11670/20013
body mass index ( mg / mnmbr ),C0005893;C0024671;C0369637;C0441923;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0578022;C1305855,false;true;false;false;true;false;false;false;false;false;false;true,11671/20013
body mass index [kg / mnmbr],C0005893;C1532718;C0578022;C1305855,false;false;false;true,11672/20013
body mass index > nmbr kg / m,C0005893;C1532718;C0578022;C1305855,false;false;false;true,11673/20013
body mass index > nmbrt,C0005893;C0578022;C1305855,false;false;true,11674/20013
body mass index blood pressure — mmhg,C0005893;C0005823;C0439475;C1271104;C1272641;C0578022;C1305855,false;true;false;false;true;false;true,11675/20013
body mass index group ( ≥ nmbr kg / mnmbr ) — no . ( % ),C0005893;C0441847;C0022718;C0439209;C4054209;C0441833;C1532718;C0687744;C1257890;C1519504;C1705428;C1705429;C0578022;C1305855,false;false;true;false;false;false;false;false;true;false;false;false;false;true,11676/20013
body mass index group ( kg / mnmbr ) ≥ nmbr kg / mnmbr — no . ( % ),C0005893;C0441833;C0022718;C1709500;C0439209;C4054209;C0687744;C1257890;C1519504;C1705428;C1705429;C0578022;C1305855,false;false;true;false;false;false;false;true;false;false;false;false;true,11677/20013
body mass index mean kg / mnmbr ( sd ),C0005893;C0444504;C1532718;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,11678/20013
body mass index / mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,11679/20013
body mass index^,C0005893;C0578022;C1305855,false;false;true,11680/20013
body mass indexa,C0518010,false,11681/20013
body mass indexb,C0518010,false,11682/20013
body mass indexf,C0518010,false,11683/20013
body mass indexf  < nmbr,C0518010,false,11684/20013
body mass indext,C0518010,false,11685/20013
body weight ( change from baseline ),C0005911;C0168634;C1442488;C0392747;C1303013;C0443172;C1705241;C4319952,true;true;false;false;false;false;false;false,11686/20013
body weight ( kg ) *,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,11687/20013
body weight at randomization,C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212,true;true;false;true;false;false;false;false,11688/20013
body weight at randonization { ixrs ),C0005910;C1305866,true;false,11689/20013
body weight reduction > nmbr %,C0005910;C0301630;C0392756;C1293152;C4551656;C1305866;C0242821;C1262477;C0460148;C1268086;C4082212,true;false;false;false;false;false;true;true;false;false;false,11690/20013
body weight *,C0005910;C1305866,true;false,11691/20013
body weiqht,C0242821;C0460148;C1268086;C4082212,true;false;false;false,11692/20013
bodyweight,C0005910;C1305866,true;false,11693/20013
bolus,C1186706;C1511237;C1705509;C3812160,false;false;false;false,11694/20013
bolus alone,C1186706;C1511237;C1705509;C3812160,false;false;false;false,11695/20013
bolus and corrections,C1186706;C1511237;C1705509;C3812160,false;false;false;false,11696/20013
bolus and infusion,C1186706;C1511237;C1705509;C3812160,false;false;false;false,11697/20013
bolus insulin doseh,C1186706;C0021641;C1533581;C1579433;C3714501;C1511237;C1705509;C3812160,false;true;false;false;false;false;false;false,11698/20013
bolus of heparin given,C1186706;C0019134;C0770546;C1511237;C1705509;C3812160,false;true;false;false;false;false,11699/20013
bone erosion score,C0587240;C0449820;C4050231,false;false;false,11700/20013
bone fracture,C0016658,true,11701/20013
bone fracture due to fall,C0016658;C0678226;C0085639;C0238715;C4553726,true;false;false;false;false,11702/20013
bone mineral density ( g / cmnmbr ),C0005938;C0439267;C0177804,true;false;false,11703/20013
bonferroni - adjusted p value,C1879894;C1709380,false;false,11704/20013
boost intensify all ( pan - asian patient population ),C1511253;C1874596,false;false,11705/20013
boost intensify premix i ( global patient population ),C1511253;C1874596,false;false,11706/20013
borg dyspnea score who functional class,C0013404;C0449820;C4050231;C1963100,true;false;false;false,11707/20013
bosentan use :,C0252643;C0042153;C0457083;C1947944,true;true;false;false,11708/20013
both adalimumab groups ( n = nmbr ),C1122087,true,11709/20013
both adalimumab groups ( n = nmbr ) no baseline cd - related antibiotic use,C1122087,true,11710/20013
both adalimumab groups ( n = nmbr ) baseline immunosuppressant use,C1122087,true,11711/20013
both adalimumab groups ( n = nmbr ) baseline cd - related antibiotic use,C1122087,true,11712/20013
both iv vasodilator and inotrope,C0022326;C0042402;C3537240;C4265176,true;true;false;false,11713/20013
both unfractionated heparin and low - molecular - weight heparin,C0019134;C2825026,true;false,11714/20013
bowel stricturing,C0267465,false,11715/20013
bp - lowering treatment ( n = nmbr ),C0037623;C0441994;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888;C1415692;C1708288;C4318478,true;false;true;true;false;false;false;false;false;false;false;false;false,11716/20013
bp - lowering treatments,C0037623;C0441994;C0087111;C2003888;C1415692;C1708288;C4318478,true;false;true;false;false;false;false,11717/20013
bp < nmbr / nmbr,C0037623;C1415692;C1708288;C4318478,true;false;false;false,11718/20013
bp = blood pressure  egfr = estimated glomerular filtration rate ( men : nmbr en : nmbr x cr nmbr . nmbr x age nmbr . nmbr x nmbr . nmbr )  hdl = high - density lipoprotein .,C0005823;C1739039;C3811844;C3812682,true;true;false;false,11719/20013
bp and fasting glucose results,C0037623;C1415692;C1708288;C4318478,true;false;false;false,11720/20013
bp component ( mm hg ),C0037623;C0449432;C0439475;C1705248;C1415692;C1708288;C4318478,true;false;false;false;false;false;false,11721/20013
bp control,C0037623;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1415692;C1708288;C4318478,true;true;false;false;false;false;false;false;false;false,11722/20013
bp goal attainment,C0037623;C0680230;C1415692;C1708288;C4318478,true;false;false;false;false,11723/20013
bp goal,C0037623;C0018017;C1571704;C1415692;C1708288;C4318478,true;true;false;false;false;false,11724/20013
bp in pre - treated patients,C0037623;C1415692;C1708288;C4318478,true;false;false;false,11725/20013
bp variable,C0037623;C0439828;C4553760;C1415692;C1708288;C4318478,true;false;false;false;false;false,11726/20013
bp : blood pressure  ci : confidence interval  esrd : end - stage renal disease  hr  hazard ratio .
 
 all patients ( except patients with other race ) were included with missing covariates imputed .
 
 event : no . of patients with esrd  rate : event rate per nmbr years of follow - up  pre - specified : a cox model with treatment group and region as covariates and baseline proteinuria level ( o or xnmbr g / g ) as strata  adjusted : a multivariate cox model with treatment group  time - varying systolic and diastolic bp as covariates .
 
 pre - specified analysis and adjusted for time - varying bp,C0005823;C0008107;C0009667;C0022661;C2985465;C3259781,true;true;true;true;false;false,11727/20013
bpearson ' s chi ‐ square test .,C0008041,true,11728/20013
bph - luts severity,C0005001;C0574785;C0439793;C0522510;C1704272,true;true;false;false;true,11729/20013
bph - related health status,C0005001;C1704272,true;true,11730/20013
brandomization was stratified by diabetic status .,,,11731/20013
breakfastb,,,11732/20013
bronchial reversibility %,C0205039;C0449261;C1442216,false;false;false,11733/20013
brv > nmbr mg / day,C0155502;C0439422,true;false,11734/20013
brv nmbr   mg / day,C0155502;C0439422,true;false,11735/20013
brv nmbr mg / day ( n =,C0155502;C0439422,true;false,11736/20013
brv overall,C0155502,true,11737/20013
brv overall ( n = nmbr ),C0155502;C0282416;C1561607,true;true;false,11738/20013
brv overalla ( n = nmbr ),C0155502,true,11739/20013
bsa ( % ),,,11740/20013
bsa involved,,,11741/20013
bsl hb,C1549954;C0019046,false;true,11742/20013
bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  hr  hazard ratio  k ( rate )  # of events per nmbr patient - years of follow - up  yr  year . multivariate cox model with hemoglobin category and baseline urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates .,C0168634;C0009667;C0022661;C0205088;C0699829;C0026538;C0019046;C2985465;C0441471;C3541888;C0035078;C2316810;C1442488,true;true;true;false;false;true;true;false;false;false;true;false;false,11743/20013
bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  k ( rate )  # of events per nmbr patient - years of follow - up  rrr  relative risk reduction  yr  year . ^treatment effect of losartan versus placebo . interaction test between treatment group and hemoglobin group ( < nmbr or > nmbrg i - nmbr ) . cmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates . dmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin and change in hemoglobin at year nmbr as covariates .,C0168634;C0596019;C0009667;C0022661;C0019046;C0871208;C0441471;C3541888;C1521828;C1442488,true;false;true;true;true;false;false;false;false;false,11744/20013
bud nmbr ptg n = nmbr,C2700462;C0039512;C1418830;C2945744,false;true;false;false,11745/20013
bud / fm nmbr / nmbr atg n = ^nmbr,C2700462;C3540627;C3815109;C2945744,false;false;false;false,11746/20013
budesonide - formoterol ( n = nmbr ),C1276807,false,11747/20013
budesonide - formoterol nmbr ^g + nmbr . nmbr ^g ( n = nmbr ),C1276807;C1319635,false;false,11748/20013
budesonide - formoterol nmbr + nmbr . nmbr ^g ( n = nmbr ),C1276807;C0439267,false;false,11749/20013
budesonide ( n = nmbr ),C0054201,true,11750/20013
budesonide ( symptom days a week ),C0054201;C1457887;C0439228;C3854129,true;false;false;false,11751/20013
budesonide { symptom days a week ),C0054201;C1457887;C0439228;C3854129,true;false;false;false,11752/20013
budesonide nmbr ^g ( n = nmbr ),C0054201;C0439267,true;false,11753/20013
budesonide mmx nmbr mg,C0054201;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11754/20013
budesonide / formoterol fdc,C1276807;C0340427;C1413520;C3539652,false;true;false;false,11755/20013
bundle branch block,C0006384;C1879286,true;true,11756/20013
by baseline diabetic status,C0168634;C0241863;C0449438;C1442488,true;false;false;false,11757/20013
by cause of death,C0007465;C4050444,true;false,11758/20013
by genotyping,C1285573,false,11759/20013
by gfr stratum for all participants,C0017654;C0679646;C1424601,true;false;false,11760/20013
by gfr stratum for diabetic participants,C0017654;C0241863;C0679646;C1424601,true;false;false;false,11761/20013
by gfr stratum tor all participants,C0017654;C0076836;C1199517;C1419603;C3539732;C1424601,true;true;false;false;false;false,11762/20013
by gfr stratum tor diabetic participants,C0017654;C0076836;C0241863;C0679646;C1199517;C1419603;C3539732;C1424601,true;true;false;false;false;false;false;false,11763/20013
by treatment arm,C1522541,false,11764/20013
by who / simon broome criteria,C0443058;C0243161,false;true,11765/20013
bypass graft §,C0185098,false,11766/20013
c - reactive protein ( high - sensitivity assay )  mitt = modified intent - to - treat  pbo cholesterol  cl = confidence intervals  hdl - c = high - density lipoprotein cholest = national cholesterol education program adult treatment panel y patients with diabetes ( fc > _ nmbr mg / dl [ > nmbr . nmbr mmol / l] ) . to qualify as having acteristics described in methods ( ncep atp iii definition )  + baseline values are rr d hs - crr for which medians are presented  * * p < nmbr . nmbr  § p = nmbr . nmbr  * p = nmbr . nmbr . nteractions were not statistically significant ( p > nmbr . nmbr ) .,C0006560;C1441604;C0005507;C0243073;C1510438;C1413716;C4048285,true;false;true;true;false;false;false,11767/20013
c - reactive protein concentration ( mg / l ),C0006560;C0086045;C0439268;C1446561;C3827302;C1413716;C4048285,true;true;false;false;false;false;false,11768/20013
c - reactive proteinc,C0205332,false,11769/20013
c clinical fractures ( fas ),C0205210;C0016658,false;true,11770/20013
c group ( n = nmbr ),C0441848,false,11771/20013
c peptide,C0006558,true,11772/20013
c . dasnmbr - crp < nmbr . nmbr,C0051767;C3890735;C4048285;C0057671,true;false;false;true,11773/20013
cnmbr ml decrease in trough fevnmbr,C0439526;C0392756;C0444506;C3714541;C0547047;C1705224;C3887665,false;false;false;true;false;false;false,11774/20013
cnmbr - unit sgrq total score increase,C0439148;C2964552;C0442805;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603,false;false;false;false;false;false;false;false;false,11775/20013
cnmbrenmbr fab bolus,C1186706;C1511237;C1705509;C3812160,false;false;false;false,11776/20013
cnmbrenmbr fab bolus ( n = nmbr ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,11777/20013
cnmbrenmbr fab bolus and infusion ( n = nmbr ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,11778/20013
ca - channel blockers,C3887642;C0870261,true;false,11779/20013
cabg — no . { % ),C0010055,true,11780/20013
cabg history,C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,11781/20013
cabg or angioplasty,C0010055,true,11782/20013
cabg or ptca ( % ),C0010055,true,11783/20013
cabg or valve,C0010055,true,11784/20013
cabg performed during index hospitalization,C0010055,true,11785/20013
cabg surgery by no . of vessels nmbr,C0010055;C0042381;C3714645,true;true;false,11786/20013
cabg :,C0010055,true,11787/20013
cad death,C1504769;C0011065;C1306577;C4082313;C4552775;C2239547;C3813548;C4284121,true;true;false;false;false;false;false;false,11788/20013
cad *,C1504769;C2239547;C3813548;C4284121,true;false;false;false,11789/20013
caffeine,C0006644;C0236734,true;false,11790/20013
caffeine consumption ( yes ) ( n ),C0948365;C1549445;C1705108;C1710701,false;false;false;false,11791/20013
caffeine consumption *,C0948365,false,11792/20013
caffeine user,C3532939,false,11793/20013
caffeine users,C3532939,false,11794/20013
calcitonin,C0006668;C0770558;C1704385;C2825090;C4520796,true;false;false;false;false,11795/20013
calcium - channel blocker *,C0006684;C3536851;C4521885,true;false;false,11796/20013
calcium - channel blockersubgroup,C0006685,true,11797/20013
calcium channel blocker ( % ),C0006684;C3536851;C4521885,true;false;false,11798/20013
calcium channelantagonist,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,11799/20013
calcium level,C0201925;C0428302,false;false,11800/20013
calculated annual decline,C0444686;C0332181;C1441506,false;false;false,11801/20013
caleitonin,,,11802/20013
caleium ehannel bloekers ( ccb ),C0006684,true,11803/20013
calima japan ( n = nmbr ),C0022341,true,11804/20013
calima japandhigh - dosage ics / laba and baseline blood eosinophils > nmbr cells / ml ( n = nmbr ) y,C0178602;C0815320;C4551720;C2986497,false;false;true;false,11805/20013
calima overall ( n = nmbr ),C0282416;C1561607,true;false,11806/20013
calima overalldhigh - dosage ics / laba and baseline blood eosinophils > nmbr cells / ml ( n = nmbr ),C0178602;C0815320;C4551720;C2986497,false;false;true;false,11807/20013
cana,C1418845,false,11808/20013
cana nmbr mg ( n nmbr nmbr ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,11809/20013
cana nmbr mg ( n - nmbr ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,11810/20013
cana nmbr mg ( n = nmbr ) *,C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,11811/20013
cananmbr ( n = nmbr ),C1418845,false,11812/20013
cananmbr / met ( n = nmbr ),C1418845,false,11813/20013
canada or united states,C0006823,true,11814/20013
canagiiflozin,,,11815/20013
canagliflozin nmbr mg vs sitagliptin nmbr mg,C2974540;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11816/20013
canakinumab nmbr mg,C2718773;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11817/20013
canakinumab dose,C2718773;C0178602;C0869039;C1114758,true;false;false;false,11818/20013
cancer — no . ( % ),C0006826;C0998265;C1306459,true;false;false,11819/20013
cancer n ( % ),C0006826;C0998265;C1306459,true;false;false,11820/20013
cancer surgery,C0920424,false,11821/20013
cancer *,C0006826;C0998265;C1306459,true;false;false,11822/20013
cancert,,,11823/20013
cangrelor dyspnoea vs no dyspnoea *,C1121991;C0013404;C1963100,true;true;false,11824/20013
cangrelor n / n ( % ),C1121991,true,11825/20013
canrenone ( n z nmbr ),C0006882,true,11826/20013
canvas ( n = nmbr ) : placebo ( n = nmbr )  cana nmbr mg ( n = nmbr )  cana nmbr mg ( n = nmbr ),C3281223;C0032042;C1418845;C1319635;C1696465;C1706408,false;true;false;false;false;false,11827/20013
cardiac - biomarker status 一 no . / total no . ( % ) $,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,11828/20013
cardiac arrhythmia,C0003811;C0264886;C1560249,true;true;false,11829/20013
cardiac biomarker elevation,C1271630;C0439775;C0702240,false;false;false,11830/20013
cardiac biomarker,C1271630,false,11831/20013
cardiac catheterisation or pci for index event,C0018795,true,11832/20013
cardiac diseasec,C0018787;C1522601,true;false,11833/20013
cardiac disorder,C0018799,true,11834/20013
cardiac disorders ( soc ),C0018799,true,11835/20013
cardiac enzyates raised,C0018787;C1522601,true;false,11836/20013
cardiac failure —,C0018801;C0018802,true;true,11837/20013
cardiac failurec,C0018787;C1522601,true;false,11838/20013
cardiac index,C0428776,false,11839/20013
cardiac medications during index hospitalization — no . ( % ),C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,11840/20013
cardiac parameters,C0018787;C0449381;C1522601,true;false;false,11841/20013
cardiac procedure :,C1279986,false,11842/20013
cardiac resynchronization therapy n ( % ),C1167956,true,11843/20013
cardiac rhythm disorder at baseline no,C0264886;C0168634;C1442488,true;true;false,11844/20013
cardio - renal risk,C0018787;C0022646;C0035647;C4552904,true;true;true;false,11845/20013
cardioembolic infarction,C0021308,true,11846/20013
cardiogenic shock during first nmbr hr after randomization,C0036980;C0205435;C1279901,true;false;false,11847/20013
cardiomyopathy,C0878544,true,11848/20013
cardiothoracic ratio > nmbr . nmbr,C4055270;C0456603;C1547037,false;false;false,11849/20013
cardiovascuiar mortaiity,,,11850/20013
cardiovascular and oral hypoglycemic drugs - no . ( % ),C0007226;C3887460,true;false,11851/20013
cardiovascular death ( n = nmbr ),C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11852/20013
cardiovascular death and hospital admission for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11853/20013
cardiovascular death or heart failure hospitalization,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11854/20013
cardiovascular death or hospitalization for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11855/20013
cardiovascular death or hospitalized hf,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11856/20013
cardiovascular death or nonfatal myocardial infarction,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11857/20013
cardiovascular death *,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11858/20013
cardiovascular death / hospitalization for heart failure,C0007226;C0011065;C3898876;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false;false,11859/20013
cardiovascular death ®,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11860/20013
cardiovascular disease ( n = nmbr ),C0007222,true,11861/20013
cardiovascular disease history ‡,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,11862/20013
cardiovascular disease n ( % ),C0007222,true,11863/20013
cardiovascular disease risk category,C1113685;C0683312;C3889287,false;false;false,11864/20013
cardiovascular disease *,C0007222,true,11865/20013
cardiovascular disorder,C0007222,true,11866/20013
cardiovascular events,C1320716,false,11867/20013
cardiovascular history — no . ( % ),C1880008,false,11868/20013
cardiovascular hospitalisation §,C0007226;C0019993;C3887460,true;true;false,11869/20013
cardiovascular metabolic syndrome risk lactors,C0007226;C0524620;C0035647;C4552904;C3887460,true;true;true;false;false,11870/20013
cardiovascular mortality ( per nmbr person - years ),C0007226;C0026565;C0027361;C0439234;C2347489;C0026566;C3887460,true;true;true;false;false;true;false,11871/20013
cardiovascular mortality or mi,C0007226;C0026565;C0026566;C3887460,true;true;true;false,11872/20013
cardiovascular risk factor — no . { % ),C0850624,false,11873/20013
cardiovascular risk factors — no . { % ),C0850624,false,11874/20013
cardiovascular risk factors alone ( n = nmbr ),C0850624;C0205171;C0439044;C0679994,false;false;false;false,11875/20013
cardiovascular risk factors and history,C0850624,false,11876/20013
cardiovascular risk factors and history — no . ( % ),C0850624,false,11877/20013
cardiovascular risk factors and history ( % ),C0850624,false,11878/20013
cardiovascular therapies — no . { % ),C0587038,false,11879/20013
care use,C1947933;C0042153;C0457083;C1947944,false;true;false;false,11880/20013
caribbean,C0043122;C0206155;C1331005,true;true;false,11881/20013
carisbamate nmbr,C1871983,true,11882/20013
carisbamate nmbr mg ( n = nmbr ),C1871983;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11883/20013
carotid artery disease,C0007273,true,11884/20013
carotid artery stenosis,C0007282,true,11885/20013
carotid bulb sites,C0007281;C0205145,true;false,11886/20013
carotid endarterectomy,C0014099,true,11887/20013
carotid imt,C0741968;C0334121;C1704614;C4318736,false;true;false;false,11888/20013
carrier ( n = nmbr ),C0007294;C0560175;C1325398;C1706209;C3273162,true;true;false;false;false,11889/20013
carvedilol,C0054836,true,11890/20013
cases,C0868928;C1533148,false;false,11891/20013
casual plasma glucose ( mg / dl ),C0202042;C0439269;C0455280,false;false;false,11892/20013
cat > = nmbr ( n = nmbr,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,11893/20013
cat > = nmbr,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,11894/20013
cat total scorenmbr,C0007450;C2964552;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;true;false;false;false;false,11895/20013
cat . nmbr n / n ( % ),C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,11896/20013
cataract,C0086543;C4555209,true;false,11897/20013
cataract removal,C0007389,true,11898/20013
catecholamines or corticosteroids without hospitalization,C0007412,true,11899/20013
categorical variables,C0683312;C0439828;C3889287,false;false;false,11900/20013
categorical variables . no . ( % ) * ’,C0683312;C0439828;C3889287,false;false;false,11901/20013
categories of urinary acr,C0683312;C0042027;C1412134;C1515941;C1524119,false;true;false;false;false,11902/20013
category,C0683312;C3889287,false;false,11903/20013
category — no . / total no . ( % ),C0683312;C3889287,false;false,11904/20013
catheter site — femoral,C0449652,false,11905/20013
catheterization laboratory in,C0007430;C0022877;C3244292;C4283904,true;true;false;false,11906/20013
catheterization laboratory in center,C0007430;C0022877;C0205099;C4534362;C3244292;C4283904,true;true;false;false;false;false,11907/20013
caucasian nmbr,C0007457;C0043157,true;true,11908/20013
caucasian eze / simva ( n = nmbr ),C0007457;C0043157,true;true,11909/20013
caucasian n = nmbr,C0007457;C0043157,true;true,11910/20013
caucasian race,C0007457,true,11911/20013
caucasian race ( % ),C0007457,true,11912/20013
caucasian simva ( n = nmbr ),C0007457;C0043157,true;true,11913/20013
caucasians ( n = nmbr ),C0007457;C0043157,true;true,11914/20013
causaslan,,,11915/20013
cause of death unknown,C0007465;C4050444,true;false,11916/20013
causes of dvt or pe — no . ( % ) ^ |,C0015127;C0149871;C2926618;C3899446;C1314792,true;true;false;false;true,11917/20013
causes of dvt or pe,C0015127;C0149871;C2926618;C3899446;C1314792,true;true;false;false;true,11918/20013
cbz - exposed,C0006949,true,11919/20013
cbz - naive,C0006949,true,11920/20013
cc,C0008318;C3538933,true;false,11921/20013
cclear < nmbr,,,11922/20013
cclear nmbr - nmbr,,,11923/20013
cclear nmbr +,,,11924/20013
ccq total score,C2964552,false,11925/20013
cd [gemini nmbr] * ’,C0007928;C0034283;C4552032,true;true;false,11926/20013
cd complications,C0007928;C0009566;C1171258;C0034283;C4552032,true;false;true;true;false,11927/20013
cd duration,C0007928;C0449238;C2926735;C0034283;C4552032,true;false;false;true;false,11928/20013
cdai ( nmbr - nmbr ),C0683448;C1413248;C3273706,false;false;false,11929/20013
cdai > nmbr,C0683448;C1413248;C3273706,false;false;false,11930/20013
cdai score,C0683448;C1413248;C3273706,false;false;false,11931/20013
cdai §,C0683448;C1413248;C3273706,false;false;false,11932/20013
cdmard experience,C0237607;C0596545,false;false,11933/20013
celecoxib,C0538927,true,11934/20013
center,C0205099;C3810851,false;false,11935/20013
center - level ihr percent time in therapeutic range for warfarin subjects,C0205099;C0441889;C0439165;C1554109;C0087111;C0302350;C0040223;C0460097;C3541383;C0456079;C1547707;C2946261;C3810851,false;false;false;false;true;false;true;false;false;false;false;false;false,11936/20013
center level ttr,C0205099;C0441889;C0032923;C1421224;C0456079;C1547707;C2946261;C3810851,false;false;true;false;false;false;false;false,11937/20013
central and eastern europe,C0205099;C1879652,false;false,11938/20013
central and south america,C0205099;C1879652,false;false,11939/20013
central and south america and mexico,C0205099;C1879652,false;false,11940/20013
central eosinophil count,C0205099;C0200638;C0750879;C1879652,false;false;false;false,11941/20013
central or south america,C0205099;C1879652,false;false,11942/20013
central / eastern,C0205099;C1707877;C1879652,false;false;false,11943/20013
central / south,C0205099;C1710133;C1879652,false;false;false,11944/20013
central / south america,C0007674;C1710133;C0205099;C0037713;C1879652,true;false;false;true;false,11945/20013
central / south america and mexico,C0007674;C1710133;C0205099;C0037713;C1879652,true;false;false;true;false,11946/20013
centrally acting sympathomimetics,C3653511,false,11947/20013
centre,C0205099;C3810851,false;false,11948/20013
centrilobular emphysema,C0221227,true,11949/20013
cerebral,,,11950/20013
cerebral infarction,C0007785,true,11951/20013
cerebral ischemia,C0007785;C0917798,true;true,11952/20013
cerebrovascuiar disease,C0012634,true,11953/20013
cerebrovascular accident / tia,C0038454;C0007787;C0917805;C1054154,true;true;true;false,11954/20013
cerebrovascular disease n ( % ),C0007820,true,11955/20013
certolizumab group,C1872109;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,11956/20013
cfb at week nmbr,C0009002;C0332174;C0439230;C1824728,true;false;false;false,11957/20013
cfisher ' s exact test .,C2828393;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4050514,false;false;false;false;false;false;false;false;false,11958/20013
cgfr,,,11959/20013
cgfrby ckd - epi,C1561643;C0162734;C4281721,true;true;false,11960/20013
cgi - s,C4526016,false,11961/20013
cgm use,C0042153;C0457083;C1947944,true;false;false,11962/20013
chanmbrsnmbr score,C1420648;C0449820;C4050231,false;false;false,11963/20013
chanmbrdsnmbr - vasc < nmbr,C1420648;C3714751,false;false,11964/20013
chanmbrdsnmbr - vasc nmbr - nmbr,C1420648;C3714751,false;false,11965/20013
chanmbrdsnmbr - vasc nmbr nmbr,C1420648;C3714751,false;false,11966/20013
chanmbrdsnmbr - vasc score,C1420648;C3714751;C0449820;C4050231,false;false;false;false,11967/20013
chanmbrdsnmbrvasc score,C1420648;C3714751;C0449820;C4050231,false;false;false;false,11968/20013
chanmbrdsnmbrvasc score ( % ),C1420648;C3714751;C0449820;C4050231,false;false;false;false,11969/20013
chadnmbr > nmbr,C0007928;C1413373,true;false,11970/20013
chads - nmbr score,C0007928;C1413373,true;false,11971/20013
chadsnmbr risk factors,C0007928;C0035648;C1553898;C1413373,true;true;false;false,11972/20013
chadsnmbr score > nmbr,C0007928;C1413373,true;false,11973/20013
chadsnmbr score nmbr,C0007928;C1413373,true;false,11974/20013
chadsnmbr score nmbr - nmbr,C0007928;C1413373,true;false,11975/20013
chadsnmbr score per outcome stroke or systemic embolism,C0007928;C1413373,true;false,11976/20013
chadsnmbr scoret,C0007928;C1413373,true;false,11977/20013
chadsnmbr   score,C0007928;C1413373,true;false,11978/20013
chadsnmbr < nmbr,C0007928;C1413373,true;false,11979/20013
chadsnmbrcomponents,C0007928;C0449432;C1413373,true;false;false,11980/20013
chadsnmbrscoref,C0007928;C1413373,true;false,11981/20013
chadsa < nmbr,,,11982/20013
chadsj < nmbr,,,11983/20013
chadsj > nmbr,,,11984/20013
chajdsa - vasc nmbr - nmbr,,,11985/20013
chajdsj - vasc > nmbr,,,11986/20013
chajdsj - vasc nmbr - nmbr,,,11987/20013
chajdsrvasc nmbr - nmbr,,,11988/20013
change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,11989/20013
change from baseline in,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11990/20013
change from baseline in acq - nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11991/20013
change from baseline in acq - nmbr score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11992/20013
change from baseline in aqlq { s ) score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11993/20013
change from baseline in fevj ( mb ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11994/20013
change from baseline in mean nmbr - h dbp,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11995/20013
change from baseline in mean nmbr - h sbp,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11996/20013
change from baseline in morning pef during weeks nmbr - nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11997/20013
change from baseline in post - bd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11998/20013
change from baseline in pre - bd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,11999/20013
change from baseline in rescue medication use ( puffs per day ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12000/20013
change from baseline in sgrq,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12001/20013
change from baseline to final apbm,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12002/20013
change from baseline to week nmbr in dlqi scorez,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12003/20013
change from baseline to week nmbr in uasnmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12004/20013
change from baseline to week nmbr in weekly iss,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12005/20013
change from baseline to week nmbr in weekly no . of hives score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12006/20013
change from baseline to week nmbr in weekly size of largest hive score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12007/20013
change from baseline to week nmbr,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,12008/20013
change in dasnmbr > nmbr . nmbr,C0392747;C0051767;C0057671;C0443172;C1705241;C4319952,false;true;true;false;false;false,12009/20013
change in femoral neck bmd from fit baseline to flex baseline,C0392747;C0015815;C0443172;C1705241;C4319952,false;true;false;false;false,12010/20013
change in fpg nmbr to month nmbr ( mg / dl ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,12011/20013
change in hbanmbrc nmbr to month nmbr ( % ),C0392747;C0019016;C1825777;C3538758;C0443172;C1705241;C4319952,false;true;false;false;false;false;false,12012/20013
change in hbalc after nmbr weeks etd ( nmbr % cl ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,12013/20013
change in hdl ‐ c,C0392747;C3715113;C0443172;C1705241;C4319952,false;false;false;false;false,12014/20013
change in ldl ‐ c,C0392747;C0443172;C1705241;C4319952,false;false;false;false,12015/20013
change in lp ( a ),C0392747;C0065058;C1439335;C4553379;C0443172;C1705241;C4319952,false;true;false;false;false;false;false,12016/20013
change in nt - probnp at nmbr,C0392747;C0669479;C0754710;C0443172;C1705241;C4319952,false;true;true;false;false;false,12017/20013
change in pav,C0392747;C0058890;C0443172;C1705241;C4319952,false;true;false;false;false,12018/20013
change in psa ‐ modified shs,C0392747;C3810537;C3889737;C3813209;C0443172;C1705241;C4319952,false;false;false;false;false;false;false,12019/20013
change in retinal pathology,C0392747;C0035298;C0030664;C0205469;C0677042;C0443172;C1705241;C4319952,false;true;true;true;false;false;false;false,12020/20013
change in sbp,C0392747;C0085805;C0443172;C1705241;C4319952,false;true;false;false;false,12021/20013
change in sedbp,C0392747;C0443172;C1705241;C4319952,false;false;false;false,12022/20013
change in sesbp,C0392747;C0443172;C1705241;C4319952,false;false;false;false,12023/20013
change in tc,C0392747;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0443172;C1705241;C4319952,false;true;true;true;true;false;false;false;false;false;false,12024/20013
change in tg,C0392747;C0337445;C0443172;C1705241;C4319952,false;false;false;false;false,12025/20013
change to week nmbr,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,12026/20013
change to week nmbr *,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,12027/20013
change to week nmbr * ’ ’,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,12028/20013
change to   week nmbr,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,12029/20013
changes at baseline,C0392747;C0168634;C1442488;C0443172,false;true;false;false,12030/20013
changes from baseline in mssbp and msdbp are shown as least - squares mean sem . * p nmbr . nmbr vs nmbr y .,C0392747;C0168634;C1442488;C0443172,false;true;false;false,12031/20013
changes in serum creatinine,C0392747;C0201976;C0600061;C0443172,false;false;false;false,12032/20013
changes in shs,C0392747;C0443172,false;false,12033/20013
characteristic ( a ),C1521970,false,12034/20013
characteristic age,C1521970;C0001779,false;false,12035/20013
characteristic age — yr,C1521970;C0001779;C0439234,false;false;false,12036/20013
characteristic age mean ± sd — yr,C1521970;C0001779;C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false;false;false,12037/20013
characteristic and treatment,C1521970,false,12038/20013
characteristic at baseline,C1521970;C0168634;C1442488,false;true;false,12039/20013
characteristic *,C1521970,false,12040/20013
characteristic / outcome,C1521970;C1274040,false;false,12041/20013
characteristic^,C1521970,false,12042/20013
characteristic_level,C1521970;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,12043/20013
characteristic_name,C1521970;C0027365;C1547383;C4522128,false;true;false;false,12044/20013
characteristic †,C1521970,false,12045/20013
characteristica,,,12046/20013
characteristics no . of participants,C1521970,false,12047/20013
characteristics *,C1521970,false,12048/20013
characteristicsa,,,12049/20013
charlson,,,12050/20013
charlson comobility score,C0449820;C4050231,false;false,12051/20013
charlson comorbidity index,C4546361,false,12052/20013
charlson index ( % ),C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,12053/20013
charm,C0849759,false,12054/20013
chd ( nonfatal mi + fatal chd ),C0280604;C3810814;C1302234;C1705232;C3542407,false;false;false;false;false,12055/20013
chd ( primary outcome ),C0280604;C0205225;C1274040;C0439612;C0439631;C3542407,false;false;false;false;false;false,12056/20013
chd + cl all,C0280604;C0596019;C3542407,false;false;false,12057/20013
chd at baseline,C0280604;C0168634;C1442488;C3542407,false;true;false;false,12058/20013
chd deaths,C0280604;C0011065;C1306577;C3542407,false;true;false;false,12059/20013
chd disease death,C0280604;C0012634;C0011065;C1306577;C4082313;C4552775;C3542407,false;true;true;false;false;false;false,12060/20013
chd eze / simva ( „ = nmbr ),C0280604;C3542407,false;false,12061/20013
chd plus cerebral infarction,C0280604;C0007785;C3542407,false;true;false,12062/20013
chd risk factors #,C0280604;C0035648;C1553898;C3542407,false;true;false;false,12063/20013
chd simva ( „ = nmbr ),C0280604;C3542407,false;false,12064/20013
chd  coronary heart disease  eze / simva  ezetimibe / simvastatin combination tablet  fpg  fasting plasma glucose  pvd  peripheral vascular disease ,C0010068;C1532737;C0039225;C0015663;C0202042;C0085096;C0455280;C1705223;C4319774;C0074554,true;true;true;true;false;true;false;false;false;true,12065/20013
chest discomfort,C0235710,false,12066/20013
chest x - ray,C0039985,false,12067/20013
chf score ( u ),C0018802;C0449820;C0439148;C4050231,true;false;false;false,12068/20013
chi - square p value,C1552646;C1709380,false;false,12069/20013
china / japan,C0008115;C0022341,true;true,12070/20013
china / tjapan,C0008115,true,12071/20013
chl,C0019829,true,12072/20013
chlor,C0308648,false,12073/20013
chloroquine,C0008269,true,12074/20013
chlorthalidone,C0008294,true,12075/20013
chlorthalidone ( n = nmbr ),C0008294,true,12076/20013
chlorthalidone nmbr,C0008294,true,12077/20013
chlorthalidone group,C0008294;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,12078/20013
chlorthalidone vs amlodipine,C0008294,true,12079/20013
chlorthalidone vs doxazosin,C0008294,true,12080/20013
chlorthalidone vs lisinopril,C0008294,true,12081/20013
cholesterol - mean ( sd,C0008377;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,12082/20013
cholesterol ( ng / ml ),C0008377;C0439275,true;false,12083/20013
cholesterol ( nmol / l ),C0008377;C0439282,true;false,12084/20013
cholinesterase inhibitor use at baseline,C0008425;C0042153;C0168634;C1442488;C0457083;C1947944;C3536756;C4521309,true;true;true;false;false;false;false;false,12085/20013
chondroitin,C0008454,true,12086/20013
chondroitin sulfate,C0008466,true,12087/20013
chronic bronchitis ( itt ) ( n = nmbr ),C0008677,true,12088/20013
chronic bronchitis ( n = nmbr ),C0008677,true,12089/20013
chronic bronchitist,C0205191,false,12090/20013
chronic cardiovascular disease,C1290380,false,12091/20013
chronic kidney disease ( % ),C1561643;C4553188,true;false,12092/20013
chronic kidney disease †,C1561643;C4553188,true;false,12093/20013
chronic obstructive pulmonary,C0205191;C0549186;C0024109;C2707265;C2709248;C4522268,false;false;true;false;false;false,12094/20013
chronic obstructive pulmonary disease — no . ( % ),C0024117,true,12095/20013
chronic renal disease,C0022661;C1561643,true;true,12096/20013
chronic renal disease — no . ( % ),C0022661;C1561643,true;true,12097/20013
chronic renal insufficiency,C0403447;C1561643,true;true,12098/20013
chronic sinusitis + nasal polypsd,C0149516;C0028429;C4520890,false;true;false,12099/20013
chronic treatment with aspirin,C0205191;C0039798;C0004057;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;false;false;false;false;false,12100/20013
chylomicron cholesterol,C0008731;C0008377;C1325761,true;true;false,12101/20013
chylomicron triglycerides,C0008731;C0041004;C1325761,true;true;false,12102/20013
ci = confidence interval  na = not applicable or not analyzed .,C0008107;C0009667;C0597484;C1272460;C1546968;C1879645;C4049872;C4552882;C3259781,true;true;false;false;false;false;false;false;false,12103/20013
ci  confidence interval  esrd  end - stage renal disease  n / n  number of patients who had an event / total number of patients . aadjusted with terms including treatment ( losartan or placebo )  geographic region  genotype  and the treatment  genotype interaction . bp value for treatment  genotype interaction ( i . e .  comparison of the losartan treatment effect between the nmbr genotype groups ) .,C0008107;C0009667;C0022661;C2360800;C3259781,true;true;true;false;false,12104/20013
ciass i,C0021966;C0221138,true;false,12105/20013
ciass ll - iv,,,12106/20013
cigarette - smoking status — no . ( % ),C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,12107/20013
cigarette - smoking status ( % ),C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,12108/20013
cigarette smoker *,C0337667,false,12109/20013
ck > nmbr x ulnnmbr,C0009212;C1519815;C0010287;C1872855,true;false;true;true,12110/20013
ck > nmbrxuln,C0009212;C0010287;C1872855,true;true;true,12111/20013
ckd ( egfr < nmbr ),C1561643;C1739039;C3811844;C3812682,true;true;false;false,12112/20013
ckd n,C1561643,true,12113/20013
ckd prognosis by kdigo ' ',C1561643;C0033325;C3854082,true;true;false,12114/20013
ckd rate ( # events ),C1561643;C0871208;C0441471;C3541888;C1521828,true;false;false;false;false,12115/20013
ckd stage nmbr,C1561643;C0205390;C1300072;C1306673,true;false;false;false,12116/20013
ckd stage nmbr ( % ),C1561643;C0205390;C1300072;C1306673,true;false;false;false,12117/20013
ckd stages,C1561643;C1306673,true;false,12118/20013
ckd *,C1561643,true,12119/20013
cl - nmbr],C0596019,false,12120/20013
class > ii,C0441886;C2698968,false;false,12121/20013
class nmbr,C0456387;C1518526;C1705943,false;false;false,12122/20013
class i or no symptoms,C0441885;C1319793;C2698967,false;false;false,12123/20013
class ii ( b - blockers ),C0441886;C2698968,false;false,12124/20013
class iii / iii - v,C0457166;C0439070;C1705160;C1880098,false;false;false;false,12125/20013
class iv glomerulonephritis,C0441888;C0017658;C2698970,false;true;false,12126/20013
class iv only,C0441888;C0205171;C1720467;C2698970,false;false;false;false,12127/20013
class iv / iv - v,C0457166;C0022326;C4265176;C1880098,false;true;false;false,12128/20013
class ll - iv,C0456387;C1518526;C1705943,false;false;false,12129/20013
class v only,C0457166;C0205171;C1720467;C1880098,false;false;false;false,12130/20013
classification of epilepsy type,C0008902;C0014544;C0332307;C1547052;C0008903;C0678229,true;true;false;false;true;false,12131/20013
cld nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,12132/20013
cld nmbr mg ( n = lnmbr ),C0439268,false,12133/20013
clean,C1947930,false,12134/20013
clinic research experience,C0008972;C0237607;C0596545,true;false;false,12135/20013
clinical and patient reported outcomes,C0205210,false,12136/20013
clinical atherosclerotic disease *,C0205210;C0333482;C0012634,false;false;true,12137/20013
clinical characteristics ( % ),C0683325,false,12138/20013
clinical dementia rating sum of boxes,C0451074;C1515051;C0179400;C1638312,true;false;false;false,12139/20013
clinical disease activity index,C3869583,false,12140/20013
clinical efficacy at week nmbr,C0087113;C0332174;C0439230,true;false;false,12141/20013
clinical endpoint,C2347784,false,12142/20013
clinical fracture,C0205210;C0016658,false;true,12143/20013
clinical or lesion rf for st,C0205210,false,12144/20013
clinical outcome,C0205210;C1274040,false;false,12145/20013
clinical remissione,C0205210,false,12146/20013
clinical responsed,C0205210,false,12147/20013
clinical variables,C0205210;C0439828,false;false,12148/20013
clinically relevant non,C2347946;C1518422,false;false,12149/20013
clonic,,,12150/20013
clopidogrel %,C0070166,true,12151/20013
clopidogrel ( n = nmbr nmbr ),C0070166,true,12152/20013
clopidogrel dyspnoea vs no dyspnoea *,C0070166;C0013404;C1963100,true;true;false,12153/20013
clopidogrel n / n ( % ),C0070166,true,12154/20013
clopidogrel n / n { % ),C0070166,true,12155/20013
clopidogrel or ticlopidine,C0070166,true,12156/20013
closure,C0185003;C1521802,false;false,12157/20013
clow - potency stratum : simvastatin nmbrmg  pravastatin nmbr mg  fluvastatin nmbr mg  atorvastatin nmbr mg  high - potency stratum : simvastatin nmbr mg  atorvastatin,C2985073;C3245505;C0074554;C1319635;C0085542;C0082608;C0286651;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;true;true;true;false;false;false;false;false;false;false,12158/20013
cluster nmbr : diuretic ( n = nmbr ),C1555715;C1704332,false;false,12159/20013
cluster nmbr : reversible,C1555715;C1704332,false;false,12160/20013
cluster nmbr : not reversible,C1555715;C1704332,false;false,12161/20013
cluster seizures,C1555715;C0036572;C1704332,false;true;false,12162/20013
cm,,,12163/20013
cmann whitney u test / wilcoxon sum rank test .,C0439148;C0683443;C1515051;C0667477;C0699794,false;false;false;true;false,12164/20013
cns systemic embolism,C3714787;C0205373;C0013922;C1704212,true;false;true;true,12165/20013
cochranemantelehaenszel ( repeated nmbr . nmbr % ci ) c,C0205341;C0008107;C3259781,false;true;false,12166/20013
coefficient,C1707429,false,12167/20013
coenzyme qnmbr p,C0041536,true,12168/20013
cognitive,C1516691,false,12169/20013
cognitive subscale on alzheimer ' s disease assessment scale,C1516691;C0450989,false;false,12170/20013
coiticosieroids at baseline,C0168634;C1442488,true;false,12171/20013
colchicine ( n = nmbr ),C0009262,true,12172/20013
colectomy ( partial or total ),C0009274,true,12173/20013
colesevelam ( n = nmbr ),C0541155,true,12174/20013
colesevelam hydrochloride group ( n = nmbr ),C0541154;C0441848,true;false,12175/20013
college degree or higher,C0557806;C0441889;C0449286;C0542560;C2348088,false;false;false;false;false,12176/20013
college graduate or more,C0682187,false,12177/20013
colombia,C3245499,true,12178/20013
colon ' ses - cd score,C0009368;C0007928;C0449820;C4050231;C0034283;C4552032;C3888384,true;true;false;false;true;false;false,12179/20013
colon or rectum,C0009368;C3888384,true;false,12180/20013
colonic area involved,C0009368;C0017446;C0205146,true;true;false,12181/20013
colonoscopy,C0009378;C1548837,true;false,12182/20013
combination,C0205195;C1947911;C3811910,false;false;false,12183/20013
combination ( n = nmbr ),C0205195;C1947911;C3811910,false;false;false,12184/20013
combination treatment ifx + aza,C0205195;C0039798;C0020823;C0004482;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1947911;C3811910,false;true;true;true;true;false;false;false;false;false;false;false,12185/20013
combinationf,,,12186/20013
combinations of aspirin and ppi use ( p = nmbr . nmbrt ),C0453882;C0004057;C3539181;C3539182;C3539954;C3539955;C3539956;C3539957;C3539959;C3539960;C3539961;C3539962;C3539963;C3539964;C3539965;C3539966;C3539967;C3539968;C3539969;C3539970;C3539971;C3539972;C3539973;C3539974;C3539975;C3539976;C3539977;C3539978;C3539979;C3540026;C3540027;C3540028;C3540030;C3540031;C3540719;C3540720;C3540721;C3540722;C3540723;C3540724;C3540740;C3854036,false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,12187/20013
combined,C0205195,false,12188/20013
combined ( dutasteride / ta msu losi n ),C0205195;C0754659;C0039297;C0024776;C1412759;C1506978;C1705538;C3272501;C4553364,false;true;true;true;false;false;false;false;false,12189/20013
combined cardiac failure,C0205195;C0018801;C0018802,false;true;true,12190/20013
combined chd,C0205195;C0280604;C3542407,false;false;false,12191/20013
combined cvd,C0205195;C0007222,false;true,12192/20013
combined end point,C0205195;C2349179;C2826544,false;false;false,12193/20013
combined end poir,C0205195;C0444930;C2746065,false;false;false,12194/20013
combined fatal / nonfatal outcomes,C0205195;C0206277,false;true,12195/20013
combined golimumab groups,C0205195;C2353893,false;true,12196/20013
combined infliximab,C0205195;C0666743,false;true,12197/20013
combined insulin / oral hypoglycaemic agent use,C0205195;C0240016;C0359086,false;false;false,12198/20013
combined ischaemic heart disease and / or cerebrovascular disorder *,C0205195;C0010054;C0151744,false;true;true,12199/20013
combined major macrovascular events,C0205195;C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false;false,12200/20013
combined major macrovascular events .,C0205195;C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false;false,12201/20013
combined statin and other lipid - lowering agent use,C0205195;C0360714,false;true,12202/20013
combined therapy ( / v = nmbr ),C0033972,true,12203/20013
combined therapy vsdutasteride,C0033972,true,12204/20013
combined therapy vsta msu iosin,C0033972;C0024776;C1412759,true;true;false,12205/20013
combo - facilitated pci,C4049621,false,12206/20013
combo vs . primary,,,12207/20013
commercially available fondaparinux,C0470187;C1098510,false;true,12208/20013
common carotid artery sites,C0007272;C0205145;C0162859,true;false;true,12209/20013
comorbid conditionsb,C0009488,true,12210/20013
comorbid illnesses,C0009488;C0221423,true;false,12211/20013
comorbidities ( % ),C0009488,true,12212/20013
comorbidities and concomitant medications,C0009488,true,12213/20013
comorbidities / concomitant medications,C0009488;C0521115;C0013227;C0802604;C2598133;C4284232,true;false;true;false;false;false,12214/20013
comorbidity,C0009488,true,12215/20013
comparator,C1707454;C4553389;C4553390,false;false;false,12216/20013
comparison,C1707455,false,12217/20013
comparison : cat . nmbr vs . cat . nmbr,C1707455;C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,false;true;false;true;false;false;false;false,12218/20013
complete healinga,C0205197;C0725685;C3853530;C4283785,false;false;false;false,12219/20013
complete mayo clinic score,C0205197;C0454788;C0002424;C0449820;C4050231;C0442592;C1077578;C0725685;C3853530;C4283785,false;false;true;false;false;false;false;false;false;false,12220/20013
completed previous febuxostat study,C2348557;C0205156;C0249529;C1552607,false;false;true;false,12221/20013
completed prior febuxostat studya,C0205197;C0332152;C0249529;C2826257;C3854010,false;false;true;false;false,12222/20013
component . for all instruments,C0449432;C4551823;C1705248,false;true;false,12223/20013
components,C0449432,false,12224/20013
components of primary composite end point — secondary end points,C1882460;C0205199;C4528314;C1547335,false;false;false;false,12225/20013
components of the first cid,C0449432;C0205435;C1707433;C1279901,false;false;false;false,12226/20013
composite,C0205199;C1547335,false;false,12227/20013
composite endpoint,C0205199;C2349179;C2826544;C1547335,false;false;false;false,12228/20013
composite endpoint ( anmbrc < nmbr . nmbr %,C0205199;C2349179;C2826544;C1547335,false;false;false;false,12229/20013
composite index of insulin sensitivity ( isi ),C0205199;C0600653;C0920563;C4049919;C0918012;C1552854;C1637833;C2986546;C1547335,false;true;true;false;true;false;false;false;false,12230/20013
composite microvascular end point *,C0205199;C0443258;C2349179;C2826544;C1547335,false;false;false;false;false,12231/20013
composite ocular end point^,C0205199;C0015392;C2349179;C2826544;C0042789;C0700042;C1299003;C4521296;C1547335,false;true;false;false;true;false;false;false;false,12232/20013
composite of nmbr % reduction in egfr,C0205199;C0301630;C0392756;C1293152;C4551656;C1547335,false;false;false;false;false;false,12233/20013
composite of death / mi / stro ke / urgent revasc / definit e acute stent thrombosis,C0205199;C0011065;C0022558;C0439609;C0378365;C0155626;C3897493;C3272275;C1306577;C4082313;C4552775;C1547335,false;true;true;false;true;false;false;false;false;false;false;false,12234/20013
composite of death / mi / urg ent revasc,C0205199;C0011065;C3810814;C0919420;C3889152;C0378365;C1367721;C1705448;C1306577;C4082313;C4552775;C1547335,false;true;false;false;false;true;false;false;false;false;false;false,12235/20013
composite of doubling of serum creatinine,C0205199;C0205173;C0201976;C0600061;C1705764;C1547335,false;false;false;false;false;false,12236/20013
composite physiologic index §,C0205199;C0205463;C0600653;C0918012;C1552854;C1637833;C2986546;C1547335,false;false;true;true;false;false;false;false,12237/20013
composite vascular endpoint,C0205199;C0005847;C2349179;C2826544;C1558950;C1801960;C1547335,false;true;false;false;false;false;false,12238/20013
concentrations at baseline,C0086045;C0168634;C1442488,true;true;false,12239/20013
concern,C2699424,false,12240/20013
concomitant,C0521115,false,12241/20013
concomitant aeds,C0521115;C0180309,false;true,12242/20013
concomitant aedsb,C0521115,false,12243/20013
concomitant antibiotic use,C0521115;C0003232;C0042153;C0457083;C1947944,false;true;true;false;false,12244/20013
concomitant anticoagulant,C0521115;C0003280;C0848112;C3536711,false;true;false;false,12245/20013
concomitant antiplatelet,C0521115,false,12246/20013
concomitant aspirin use,C0521115;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,12247/20013
concomitant cardiovascular therapy,C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,12248/20013
concomitant drug therapies,C0521115;C0013216,false;true,12249/20013
concomitant drug therapy at discharge,C1707479;C0013227;C0012621;C0030685;C2926602;C1254351;C0521115;C0013216;C0013217;C3850077;C0039798;C0087111;C1363945,false;true;false;true;false;false;false;true;true;true;true;true;false,12250/20013
concomitant dvt — no . ( % ) baseline nt - probnp — no . ( % ),C0521115;C0149871;C2926618;C3899446,false;true;false;false,12251/20013
concomitant dvt,C0521115;C0149871;C2926618;C3899446,false;true;false;false,12252/20013
concomitant lipid - lowering therapy ( any ),C0521115;C0585943,false;false,12253/20013
concomitant lipid - modifying therapy — no . { % ),C1707479;C0023779;C0392747,false;true;false,12254/20013
concomitant medication — no . { % ) | ace inhibitor,C0521115;C0013227;C3244316;C4284232,false;true;false;false,12255/20013
concomitant medication ( > nmbr % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,12256/20013
concomitant medication use,C0521115;C0240320,false;false,12257/20013
concomitant medications — no . ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,12258/20013
concomitant medications ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,12259/20013
concomitant medications ( yes ),C0521115;C0013227;C1549445;C1705108;C1710701;C0802604;C2598133;C4284232,false;true;false;false;false;false;false;false,12260/20013
concomitant medications after randomization,C0521115;C0013227;C0034656;C0802604;C2598133;C4284232,false;true;true;false;false;false,12261/20013
concomitant medications at baseline,C0521115;C0013227;C0168634;C1442488;C0802604;C2598133;C4284232,false;true;true;false;false;false;false,12262/20013
concomitant medications in > nmbr % of subjects,C0521115;C0013227;C0681850;C1550501;C1706203;C2349001;C2697811;C0802604;C2598133;C4284232,false;true;false;false;false;false;false;false;false;false,12263/20013
concomitant methotrexate use,C0521115;C0025677;C0042153;C0457083;C1947944,false;true;true;false;false,12264/20013
concomitant oads,C0521115,false,12265/20013
concomitant oral anti - dm drugs,C0521115;C0029167;C0011816;C3250443;C0175795;C0304289,false;true;true;false;false;false,12266/20013
concomitant oral glucose - lowering agents,C2347852;C0442027;C0017725;C0441994;C2003888;C4521986,false;false;true;false;false;false,12267/20013
concomitant pd medications at baseline,C0521115;C4553228;C0013227;C0168634;C1442488;C0802604;C2598133;C4284232;C4553229,false;false;true;true;false;false;false;false;false,12268/20013
concomitant treatment 一 no . ( % ),C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,12269/20013
concomitant treatments at randomization,C0521115;C0087111;C0034656,false;true;true,12270/20013
concomitant use of bosentan,C0521115;C1524063;C0252643,false;false;true,12271/20013
concomitant use of conventional synthetic dmard up to nmbr mo — no . { % ) methotrexate,C0521115;C1524063;C0439858;C1883254;C0242708,false;false;false;false;true,12272/20013
concomitant use of corticosteroids,C0521115;C1524063;C0001617;C3539185;C3540725;C3540726;C3540727,false;false;true;false;false;false;false,12273/20013
concomitant use of mtx to week nmbr,C0521115;C1524063;C0025677;C1417487,false;false;true;false,12274/20013
concomitant use of nsaids to week nmbr,C0521115;C1524063;C0003211,false;false;true,12275/20013
concurrent illness,C0205420;C0221423,false;false,12276/20013
concurrent medications,C0205420;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,12277/20013
concurrent prednisolone,C0205420;C0032950,false;true,12278/20013
concurrent treatment at study entry — no . ( % ) * *,C0009247;C0039798;C1705654;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205420;C0679827;C0557651;C2603343;C1521826;C3161471,true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,12279/20013
condition nmbr ( nmbr . nmbr ),C0012634;C0348080;C1705253;C3864998,true;false;false;false,12280/20013
congestion *,C0700148;C2826600,false;false,12281/20013
congestive heart,C0742742;C0018787,false;true,12282/20013
congestive heart failure — no . ( % ) |,C0018802,true,12283/20013
congestive heart failure at randomisation,C0018802;C0034656,true;true,12284/20013
congestive heart failure §,C0018802,true,12285/20013
congestive heart failure †,C0018802,true,12286/20013
congestive hf,C0742742;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,12287/20013
conieosieroids and / or nmbr - mp,,,12288/20013
connective - tissue disease,C0009782,true,12289/20013
connective tissue disease,C0009782,true,12290/20013
conservative strategy ( n = nmbr,C0679199,false,12291/20013
constipation,C0009806;C1963087;C3641755;C4084722;C4084723;C4084724,true;false;false;false;false;false,12292/20013
continue thienopyridine n = nmbr,C0549178,false,12293/20013
continued use of gpa,C0549178;C1524063;C3495801;C4553145,false;false;true;false,12294/20013
continuous,C0549178,false,12295/20013
continuous lvef nmbr treatment interaction,C0549178;C0428772;C0039798;C1704675;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0488728,false;false;true;false;true;false;false;false;false;false;false,12296/20013
contrast angiography,C0009924;C0002978;C1979874,true;true;false,12297/20013
contrast used ( ml ) *,C0009924;C1979874,true;false,12298/20013
contrast volume > nmbr ( ml ),C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,12299/20013
contrast volume > nmbr ml,C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,12300/20013
control = warfarin,C0243148;C0043031;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false,12301/20013
control group,C0009932,true,12302/20013
control n = nmbr,C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,12303/20013
controlled : acq - nmbr < nmbr . nmbr,C2587213;C2919686;C2911690,false;false;false,12304/20013
controllertreatment before entry *,C1705654,false,12305/20013
contusion,C0009938,true,12306/20013
conventional agents *,C0439858;C0450442;C1254351;C1521826,false;false;false;false,12307/20013
converting enzyme inhibitor,C0014432;C0919438;C4521603,true;false;false,12308/20013
convulsion,C0036572;C4048158,true;true,12309/20013
copd - placebo ( nmbr pt ) n . ( % ),C0024117;C0032042;C0032743;C0699718;C1696465;C1706408;C1412502;C3714496,true;true;true;false;false;false;false;false,12310/20013
copd - rosuvastatin ( nmbr pt ) n . ( % ),C0024117;C0965129;C0032743;C0699718;C1412502;C3714496,true;true;true;false;false;false,12311/20013
copd ( % ),C0024117;C1412502;C3714496,true;false;false,12312/20013
copd exacerbation history in the previous year,C0740304;C0019664;C0205156;C0439234;C0439508;C1552607;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;false;true;false;false;false;false,12313/20013
copd history yrs,C0024117;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1412502;C3714496,true;true;true;false;false;false;false;false;false,12314/20013
copd medication taken for at least nmbr months before study entry,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,12315/20013
copd severity stage ( gold ),C0024117;C0439793;C0205390;C0018026;C1304897;C1300072;C1306673;C0522510;C1412502;C3714496,true;false;false;true;false;false;false;false;false;false,12316/20013
copd severitya,C0024117;C1412502;C3714496,true;false;false,12317/20013
copd severityy,C0024117;C1412502;C3714496,true;false;false,12318/20013
copd type,C0024117;C0332307;C1547052;C1412502;C3714496,true;false;false;false;false,12319/20013
copd worsening,C0024117;C0332271;C1457868;C1546960;C1412502;C3714496,true;false;false;false;false;false,12320/20013
coping,C0009967,true,12321/20013
core cardiovascular endpoint,C0444669;C0007226;C2349179;C2826544;C3887460;C1167518;C1706352;C1882467;C3274653,false;true;false;false;false;false;false;false;false,12322/20013
core study to first infusion,C0444669;C0557651;C0205435;C0574032;C1827465;C1279901;C2603343;C1167518;C1706352;C1882467;C3274653,false;false;false;false;false;false;false;false;false;false;false,12323/20013
corneii product,C1514468;C1704444,false;false,12324/20013
cornell index,C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,12325/20013
cornell voltage - duration product ( mmxmsec ) *,C0598352;C0449238;C1514468;C1704444;C2926735,false;false;false;false;false,12326/20013
cornell voltage - duration product,C0598352;C0449238;C1514468;C1704444;C2926735,false;false;false;false;false,12327/20013
cornell voltage duration ( mv × ms ),C0598352;C0449238;C1454484;C2349943;C3539704;C3713294;C1705503;C4281602;C2926735,false;false;true;false;false;true;false;false;false,12328/20013
cornell voltage x duration product,C0598352;C0449238;C1514468;C1704444;C2926735,false;false;false;false;false,12329/20013
coronar y - artery bypass grafting,C0450140;C0741847,false;false,12330/20013
coronar y artery disease,C0852949,false,12331/20013
coronarv arterv disease,C0012634,true,12332/20013
coronary - artery bypass grafting §,C0010055,true,12333/20013
coronary artery,C0205042,true,12334/20013
coronary artery bypass,C0010055,true,12335/20013
coronary artery bypass graft — no . ( % ),C0010055;C1260596,true;false,12336/20013
coronary artery bypass grafting n ( % ),C0010055,true,12337/20013
coronary artery disease — no . ( % ),C0010054;C0010068;C1956346,true;true;true,12338/20013
coronary artery disease — no . ( % ) : c,C0010054;C0010068;C1956346,true;true;true,12339/20013
coronary artery disease ( n = nmbr nmbr ),C0010054;C0010068;C1956346,true;true;true,12340/20013
coronary artery disease *,C0010054;C0010068;C1956346,true;true;true,12341/20013
coronary artery disease §,C0010054;C0010068;C1956346,true;true;true,12342/20013
coronary artery stenosis > nmbr %,C0242231,true,12343/20013
coronary artery treated,C0205042,true,12344/20013
coronary bypass surgery,C0010055,true,12345/20013
coronary eventsnmbr,C0741923,false,12346/20013
coronary heart disease — no . ( % ),C0010054;C0010068;C1956346,true;true;true,12347/20013
coronary procedure ( % of group ),C0018821;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1279986;C0018787;C2986530,true;false;false;true;false;false;false;false;true;false,12348/20013
coronary revascularisation §,C0877341,false,12349/20013
coronary syndrome . ci = confidence interval  hr = hazard ratio .,C0018787;C0039082;C0008107;C0009667;C2985465;C3259781,true;true;true;true;false;false,12350/20013
corticosteroid - free remissioni,C0001617;C0332296;C1880497;C1996904;C3536709,true;false;false;false;false,12351/20013
corticosteroid dose ( prednisone,C0001617;C0178602;C0032952;C0869039;C1114758;C3536709,true;false;true;false;false;false,12352/20013
corticosteroid use at randomization,C0239126;C0034656,false;true,12353/20013
corticosteroids ' nmbr,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,12354/20013
corticosteroids ( excluding budesonide ),C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,12355/20013
cortteosterom relrsclory status,C0449438,false,12356/20013
cough ( investigator reported ),C0010200;C0035173;C1961131;C3274924;C4084725;C4084726;C4084727,true;true;false;false;false;false;false,12357/20013
cough ( leading to study drug discontinuation ),C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,12358/20013
covariate,,,12359/20013
covariates,,,12360/20013
cox - nmbr selective inhibitor use,C0085387;C0036576;C0042153;C0457083;C1947944;C1707391,true;true;true;false;false;false,12361/20013
cr + crpnorr,C0201975;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;true;false;false;false,12362/20013
cr + mh,C0201975;C0026514;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337,false;true;true;false;true;false;false;false,12363/20013
cr + mh + crpnorr,C0201975;C0026514;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337,false;true;true;false;true;false;false;false,12364/20013
cr imputation ( random . ) ( n = nmbr ),C0201975;C2699638;C0034656;C0439605;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;true;false;false;true;false;false;false,12365/20013
crcl ( ml / min ),C1846718;C0439445,false;false,12366/20013
crcl ( ml / min ) at randomization,C1846718;C0439445;C0034656,false;false;true,12367/20013
crcl ( sd ) ml / min,C1846718;C2699239;C0439445,false;false;false,12368/20013
crcl < nmbrml / min,C1846718;C0439445,false;false,12369/20013
crcl > nmbr - < nmbrml / min,C1846718;C0439445,false;false,12370/20013
crcl > nmbrml / min,C1846718;C0439445,false;false,12371/20013
crcl nmbr - nmbr,C1846718,false,12372/20013
crcl at baseline,C1846718;C0168634;C1442488,false;true;false,12373/20013
crcl at randomization - ml / min,C1846718;C0034656;C0439445,false;true;false,12374/20013
crcl at randomization,C1846718;C0034656,false;true,12375/20013
crcl of nmbr - nmbr ml min ',C1846718;C0439445,false;false,12376/20013
crcl,C1846718,false,12377/20013
creatine clearance category,C0373595;C0683312;C3889287,false;false;false,12378/20013
creatine clearance category nmbr to < nmbr ml / min nmbr / nmbr,C0373595;C0683312;C0439445;C3889287,false;false;false;false,12379/20013
creatinine ( ^mol / l ) ( median,C0010294;C0347982;C0549183;C0876920;C2347635;C2348144;C2939193;C1561535,true;false;false;false;false;false;false;false,12380/20013
creatinine ( µ mol / l ),C0010294;C0347982;C1561535,true;false;false,12381/20013
creatinine ( p,C0010294;C1561535,true;false,12382/20013
creatinine > nmbr . nmbrx baseline and above uln,C0010294;C0168634;C1442488;C1561535,true;true;false;false,12383/20013
creatinine > nmbr x baseline,C0010294;C0168634;C1442488;C1561535,true;true;false;false,12384/20013
creatinine nmbr . nmbr mg / dl medications,C0010294;C0439269;C0013227;C0802604;C2598133;C4284232;C1561535,true;false;true;false;false;false;false,12385/20013
creatinine ciearance,C0010294;C1561535,true;false,12386/20013
creatinine clearance — ml / min,C0812399;C0439445,false;false,12387/20013
creatinine clearance < nmbr ml / min — no . ( % ) weight < nmbr kg — no . ( % ),C0812399;C0439445,false;false,12388/20013
creatinine clearance > nmbr to < nmbr ml / min — no . ( % ) f,C0151280,false,12389/20013
creatinine clearance at randomization,C0812399;C0034656,false;true,12390/20013
creatinine clearance at randomization ( ixrs ),C0812399;C0034656,false;true,12391/20013
creatinine clearance category [ml / min],C0812399;C0683312;C0439445;C3889287,false;false;false;false,12392/20013
creatinine clearanceb,C0010294;C1561535,true;false,12393/20013
creatinine ratio,C0010294;C0456603;C1547037;C1561535,true;false;false;false,12394/20013
criterion,C0243161,true,12395/20013
criterion reached first,C0243161,true,12396/20013
critical site,C1511545;C0205145;C1515974;C2825164,false;false;false;false,12397/20013
crj,,,12398/20013
crohn ' s disease duration,C0010346;C0449238;C2926735,true;false;false,12399/20013
cromoglicate,C0010347,true,12400/20013
cross - clamp,C2828360;C0175721;C1883710;C3810601,false;false;false;false,12401/20013
crosuvastatin + fenofibric acid vs . rosuvastatin monotherapy .,C0060179,true,12402/20013
crp ( mg / dl  per unit ),C3890735;C0439269;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C3642216;C1638407;C0024671;C1532632;C0026410;C1960952;C2346927;C4321396;C4521761;C4048285,false;false;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false,12403/20013
crp ( mg / l ) ( cv ),C3890735;C0439268;C3538987;C4048877;C4318503;C4048285,false;false;false;true;false;false,12404/20013
crp ( mg / l ) [b],C3890735;C0439268;C4048285,false;false;false,12405/20013
crp ( normal < nmbr . nmbr mg / dl ),C3890735;C0205307;C0439269;C0231683;C0439166;C2347086;C4553972;C4048285,false;false;false;false;false;false;false;false,12406/20013
crp [mg / l],C3890735;C0439268;C4048285,false;false;false,12407/20013
crp > nmbr . nmbr mg / dl,C3890735;C0439269;C4048285,false;false;false,12408/20013
crp > nmbr mg / nmbr,C3890735;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;true;true;false;false;false;false;false;false,12409/20013
crp level,C3890735;C0441889;C0456079;C1547707;C2946261;C4048285,false;false;false;false;false;false,12410/20013
crp   ≤   uln,C3890735;C1519815;C4048285,false;false;false,12411/20013
crp   >   uln,C3890735;C1519815;C4048285,false;false;false,12412/20013
crpnonr ?,,,12413/20013
crt - p + d,,,12414/20013
crude,,,12415/20013
crude model hr ( nmbr % ci ),C3161035;C0008107;C3259781;C3274659;C3714583;C3853906,false;true;false;false;false;false,12416/20013
crude rate,C0871208;C1521828,false;false,12417/20013
crusade score,C0449820;C4050231,false;false,12418/20013
cryptogenic,C0332240,false,12419/20013
cryptogenic localization - related,C0332240;C0475264;C1744691,false;false;false,12420/20013
cs,C0010182;C0271160;C3540510;C4085345,true;false;false;false,12421/20013
cs and im,C0010182;C0271160;C3540510;C4085345,true;false;false;false,12422/20013
cs and imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,12423/20013
cs and is,C0010182;C0271160;C3540510;C4085345,true;false;false;false,12424/20013
cs only,C0010182;C0205171;C1720467;C0271160;C3540510;C4085345,true;false;false;false;false;false,12425/20013
csdmard otherthan methotrexate,C0025677,true,12426/20013
csdmard use at baseline^,C0042153;C0168634;C1442488;C0457083;C1947944,true;true;false;false;false,12427/20013
csii,,,12428/20013
ct,C0007673;C3540513;C3813556;C3888140,true;false;false;false,12429/20013
ct ratio ( % ),C0007673;C0456603;C1547037;C3540513;C3813556;C3888140,true;false;false;false;false;false,12430/20013
ct ratio > nmbr . nmbr,C0007673;C0456603;C1547037;C3540513;C3813556;C3888140,true;false;false;false;false;false,12431/20013
ct  calcitonin  cv  cardiovascular  egfr  estimated glomerular filtration rate  hbalc  glycated hemoglobin  hnmbr  histamine nmbr  iqr  interquartile range  n  number of patients  sd  standard deviation .,C0006668;C3538987;C0007226;C1739039;C3811844;C3812682;C3887460;C4048877;C4318503,true;false;true;true;false;false;false;true;false,12432/20013
ct + tt,C0007673;C1452561;C4554543;C3540513;C3813556;C3888140,true;true;false;false;false;false,12433/20013
ctd population subgroup,C1335071;C0032659;C1079230;C1515021;C1257890;C1442905,false;true;false;false;true;false,12434/20013
ctn - i,C0917591;C0021966;C0221138,true;true;false,12435/20013
cu index test,C1177210;C0600653;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0918012;C1552854;C1637833;C2986546;C2347872,false;true;false;false;false;false;false;false;false;true;false;false;false;false,12436/20013
cuban,C1553379,false,12437/20013
culprit vessel,C0005847,true,12438/20013
cumulative events,C1511559;C0441471;C3541888,false;false;false,12439/20013
cumulative incidence nmbr years,C1511559;C0021149;C0439234;C0220856,false;true;false;true,12440/20013
cumulative incidence nmbryears,C1511559;C0021149;C0439234;C0220856,false;true;false;true,12441/20013
cumulative incidence lyear,C1511559;C0021149;C0220856,false;true;true,12442/20013
cumulative nsaid score,C1511559;C0003211;C0449820;C4050231;C3536840,false;true;false;false;false,12443/20013
current ( n   = nmbr,C0521116;C1705970,false;false,12444/20013
current alcohol drinking,C0521116;C0001948;C0556297;C1705970,false;true;false;false,12445/20013
current alcohol,C0521116;C0001962;C0001975;C1705970,false;true;true;false,12446/20013
current alendronate use,C0521116;C0102118;C0042153;C0457083;C1947944;C1705970,false;true;true;false;false;false,12447/20013
current angina,C0521116;C0002962;C1705970,false;true;false,12448/20013
current angina ( % ),C0521116;C0002962;C1705970,false;true;false,12449/20013
current cigarette,C0521116;C0677453;C1704760;C3890423;C1705970,false;true;false;false;false,12450/20013
current corticosteroid use,C0521116;C0239126;C1705970,false;false;false,12451/20013
current dactylitis,C0521116;C0239161;C1705970,false;false;false,12452/20013
current enthesitis,C0521116;C1282952;C1705970,false;false;false,12453/20013
current inhaled corticosteroid use,C0521116;C0004048;C0239126;C1705970,false;true;false;false,12454/20013
current laba use,C0521116;C0042153;C0457083;C1947944;C1705970,false;true;false;false;false,12455/20013
current lama use,C0521116;C0999593;C0042153;C0457083;C1947944;C1416775;C1705970,false;false;true;false;false;false;false,12456/20013
current lra use,C0521116;C1705970,false;false,12457/20013
current medication use,C0746467;C0042153;C0457083;C1947944;C0521116;C0240320;C1705970,false;true;false;false;false;false;false,12458/20013
current or former smoker,C0521116;C1705970,false;false,12459/20013
current or prior smoking,C0521116;C1705970,false;false,12460/20013
current oral corticosteroid use,C0521116;C1527415;C0001617;C3536709;C0442027;C0239126;C4521986;C1705970,false;false;true;false;false;false;false;false,12461/20013
current smoker — no . { % ),C3173209;C3241966,false;false,12462/20013
current smoker — no . ( % ) blood pressure — mm hg,C3173209;C3241966,false;false,12463/20013
current smoker — no . / total no . ( % ),C3173209;C3241966,false;false,12464/20013
current smoker »,C3173209;C3241966,false;false,12465/20013
current smoker at baseline,C3173209;C0168634;C1442488;C3241966,false;true;false;false,12466/20013
current smoker at screening,C3173209;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3241966,false;true;true;false;false;false;false;false;false,12467/20013
current smoker at screeninga,C3173209;C3241966,false;false,12468/20013
current smokers ( itt ) ( n = nmbr ),C3173209;C3241966,false;false,12469/20013
current smokers ( n = nmbr ),C3173209;C3241966,false;false,12470/20013
current smoking ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,12471/20013
current tobacco smoker,C3173209;C0040329;C0086707;C0740009;C3241966;C0521116;C4505217;C1705970,false;true;true;true;false;false;true;false,12472/20013
current tobacco smoker ( % ) qualifying event ( % ),C3173209;C0040329;C1514624;C0441471;C4019010;C0086707;C0740009;C3241966;C0521116;C4505217;C1705970,false;true;false;false;false;true;true;false;false;true;false,12473/20013
current use of hormone therapy,C2827774;C1524063;C0019932;C4521914;C0521116;C0279025;C1705970,false;false;true;false;false;false;false,12474/20013
current xanthine derivative use,C0521116;C0043314;C1527240;C0042153;C0457083;C1947944;C0043318;C1705970,false;true;false;true;false;false;true;false,12475/20013
currentd,,,12476/20013
currently on aha therapy,C0521116;C0050451;C0039798;C0087111;C1363945;C0772110,false;true;true;true;false;false,12477/20013
currently smoker,C0521116;C0337664,false;true,12478/20013
currently smokes,C0521116,false,12479/20013
cutoffs,C1442160,false,12480/20013
cv,C3538987;C4048877;C4318503,false;true;false,12481/20013
cv death or hf hosp .,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,12482/20013
cv death or hhf,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,12483/20013
cv death or ml,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,12484/20013
cv disease,C0007222,true,12485/20013
cv disease history,C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3538987;C0683519;C4048877;C4318503,true;true;true;false;false;false;false;false;false;true;false,12486/20013
cv endpoints n ( % ),C3538987;C2349179;C4048877;C4318503,false;false;true;false,12487/20013
cv historya,C3538987;C4048877;C4318503,false;true;false,12488/20013
cv risk factors and history,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,12489/20013
cvd deaths,C0007222;C0011065;C1306577,true;true;false,12490/20013
cvd mortality,C0007222;C0026565;C0026566,true;true;true,12491/20013
cvd risk factors ( age > nmbr ) ^ “ ^,C0007222;C0035648;C0001779;C1553898;C0035647;C0001783;C4552904,true;true;false;false;true;true;false,12492/20013
cvd without mi or stroke ( n = nmbr ),C0007222;C3810814,true;false,12493/20013
cvd without miatroke,C0007222,true,12494/20013
cvd without ml / stroke,C0007222;C0439526;C0038454;C4554100;C1705224;C3887665,true;false;true;false;false;false,12495/20013
cvd without ml^troke,C0007222;C0439526;C1705224;C3887665,true;false;false;false,12496/20013
cvd / mi / stroke,C0007222;C3810814;C0038454;C4554100,true;false;true;false,12497/20013
cvd / mi / stroke / revascularization / urgent vascular hospitalization,C0007222;C3810814;C0038454;C0581603;C0439609;C0005847;C0019993;C1558950;C1801960;C3272275;C4554100,true;false;true;false;false;true;true;false;false;false;false,12498/20013
cvd / mi / stroke / urgent coronary revascularization,C0007222;C3810814,true;false,12499/20013
cvd / mi / stroke / urgent vascular hospitalization,C0007222;C3810814,true;false,12500/20013
cvd / stroke / see,C0007222;C0038454;C4554100,true;true;false,12501/20013
cvdeath,,,12502/20013
cwt,,,12503/20013
cypnmbranmbr,C1418793;C2634343,false;false,12504/20013
cypnmbranmbr inhibitors,C1418793;C0243077;C2634343,false;true;false,12505/20013
cystitis,C0010692;C0600041;C1963088,true;false;false,12506/20013
cystoscopic procedure,C0560573;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,12507/20013
czech repumc,C0337799,false,12508/20013
czp nmbr mg ( n = nmbr ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,12509/20013
czp nmbr mg ( n = lll ),C0054841;C0024671;C1261077;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;false;true;false;false;false;false;false;true;true,12510/20013
czp nmbr mg every nmbr weeks ( n = nmbr ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,12511/20013
czp nmbr mg qnmbrw,C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,12512/20013
czp baseline,C0054841;C0168634;C1442488;C1861828;C1872109,true;true;false;true;true,12513/20013
czp combined arms ( n = nmbr ),C0054841;C0205195;C0206655;C0446516;C2681631;C3715044;C4553528;C1861828;C1872109,true;false;true;true;false;false;false;true;true,12514/20013
d,C0073187;C0332173;C4484261,true;false;false,12515/20013
d - value,C1522609,false,12516/20013
d ( nmbr % ci ),C0073187;C0008107;C3259781;C0332173;C4484261,true;true;false;false;false,12517/20013
d nmbr mg vs . warfarin,C0073187;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0332173;C4484261,true;true;true;false;false;false;false;false;false;false,12518/20013
d includes cardiac glycosides,C0073187;C0332173;C4484261,true;false;false,12519/20013
d non - vertebral fragility fractures ( fas ),C0073187;C1518422;C0549207;C0302113;C0332173;C4484261,true;false;true;false;false;false,12520/20013
d population,C0073187;C0032659;C1257890;C0332173;C4484261,true;true;true;false;false,12521/20013
d / mi / idfvst,C0073187;C3810814;C0332173;C4484261,true;false;false;false,12522/20013
dnmbr % ( n / n ),C0073187;C0332173;C4484261,true;false;false,12523/20013
dnmbr vs warfarin,C0073187;C0332173;C4484261,true;false;false,12524/20013
dnmbr vs warfarin rr ( nmbr % ci,C0073187;C0332173;C4484261,true;false;false,12525/20013
dabigatran,C2348066,true,12526/20013
dabigatran ( n = nmbr ),C2348066,true,12527/20013
dabigatran nmbr mg,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12528/20013
dabigatran nmbr mg ( n = nmbr ),C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12529/20013
dabigatran nmbr mg nmbr mg % per yr,C2348066;C1319635;C0439234,true;false;false,12530/20013
dabigatran nmbr mg bid,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12531/20013
dabigatran nmbr mg bid ( n = nmbr ),C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12532/20013
dabigatran nmbr mg bid events / n ( % / y ),C2348066;C0024671;C0441471;C3541888;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;true;false;false;false;false;false,12533/20013
dabigatran nmbr mg bid vs warfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12534/20013
dabigatran nmbr mg versus warfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12535/20013
dabigatran nmbr   mg b . i . d .,C2348066;C0439422;C0021966;C0221138;C0024671;C0152277;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;true;false;true;false;false;false;false;false,12536/20013
dabigatran nmbr mg versu swarfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12537/20013
dabigatran nmbr vs dabigatran nmbr mg bid,C2348066,true,12538/20013
dabigatran nmbrmg bid,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12539/20013
dabigatran nmbr mg ( n = nmbr,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12540/20013
dabigatran group,C2348066;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,12541/20013
dabigatrannmbr vs . warfarin p ( inter ),C2348066,true,12542/20013
dactylitis in > nmbr digit,C3863761,false,12543/20013
dactylitis score,C0239161;C0449820;C4050231,false;false;false,12544/20013
dactylitis score ( nmbr - nmbr ),C0239161;C0449820;C4050231,false;false;false,12545/20013
dactylitis score ( nmbr – nmbr scale ),C0239161;C0449820;C0175659;C0349674;C1947916;C4050231,false;false;true;false;false;false,12546/20013
dactylitis score at baseline,C0239161;C0449820;C0168634;C1442488;C4050231,false;false;true;false;false,12547/20013
dactylitis severity score ) score > nmbr — no . { % ),C0239161;C0457451,false;false,12548/20013
daily “ off ” time,C0332173;C0040223;C3541383,false;true;false,12549/20013
daily bowel movements,C0332173;C0011135,false;true,12550/20013
daily dose of inhaled glucocorticoid — no . ( % ) §,C2348070;C0004048;C0017710,false;true;true,12551/20013
daily dose of study medication prescribed,C2348070;C0013175,false;true,12552/20013
daily dose of vitamin d ( iu / day ),C2348070;C0014695;C0439465;C0042866;C2936842;C3537249;C3714503,false;true;false;true;false;false;false,12553/20013
daily exercise ( % ),C0332173,false,12554/20013
daily total dose of insulin — lu / kg,C2348070;C0021641;C0024171;C0022718;C0439209;C4054209;C0024176;C2697939;C1533581;C1579433;C3714501,false;true;true;true;false;false;true;false;false;false;false,12555/20013
dalteparin ( n = nmbr ),C0206461,true,12556/20013
dapaglifloiin,,,12557/20013
dapaglifloz . in,,,12558/20013
dapagliflozin,C2353951,true,12559/20013
dapagliflozin ( n = nmbr ),C2353951,true,12560/20013
dapagliflozin nmbr mg + insulin ( n   = nmbr ),C2353951;C0024671;C0021641;C1533581;C1579433;C3714501;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;true;false;false;false;false;false,12561/20013
dapagliflozin nmbr mg + insulin ( n = nmbr ),C2353951;C0024671;C0021641;C1533581;C1579433;C3714501;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;true;false;false;false;false;false,12562/20013
dapagliflozin placebo no . of events / no . of patients,C2353951;C0032042;C1696465;C1706408,true;true;false;false,12563/20013
dasnmbr ‐ crp,C0051767;C3890735;C4048285;C0057671,true;false;false;true,12564/20013
dasnmbr score,C0051767;C0057671,true;true,12565/20013
data are expressed as n / total ( % ) unless otherwise speci ﬁ ed . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by nmbr . nmbr . * estimated with cockroft - gault equation  † at discharge .
 
 ace angiotensin - converting enzyme  cabg coronary artery bypass graft  ccsc canadian cardiovascular society classi ﬁ cation  mi myocardial infarction  pci percutaneous coronary intervention .,C1511726;C3245479;C3714741,false;false;false,12566/20013
data are expressed as n / total ( % ) unless otherwise specified . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by nmbr . nmbr . * estimated with cockroft - gault equation ,C1511726;C3245479;C3714741,false;false;false,12567/20013
data are mean ( sd ) or n ( % ) . ace = angiotensin - converting enzyme  arb = angiotensin - receptor blocker .
 
 chf = congestive heart failure . * any use in nmbr h before surgery except for aspirin which only required any use in the nmbr days before surgery .,C1511726;C3245479;C3714741,false;false;false,12568/20013
data are mean ( sd ) or number ( % ) . bmi = body - mass index . sbp = systolic blood pressure . dbp = diastolic blood pressure . lvef = left ventricular ejection fraction .
 
 hf = heart failure . ami = acute myocardial infarction . cabg = coronary artery bypass graft . pci = percutaneous coronary intervention . icd = implantable cardioverter de ﬁ brillator . copd = chronic obstructive pulmonary disease . ace = angiotensin - converting enzyme . arbs = angiotensin receptor blockers . * available for nmbr patients ( nmbr rosuvastatin  nmbr placebo ) .,C1511726;C3245479;C3714741,false;false;false,12569/20013
data are mean ( sd ) or number ( % ) . pufa = polyunsaturated fatty acids,C1511726;C3245479;C3714741,false;false;false,12570/20013
data are mean ± standard deviation for continuous variables and number ( % ) for categoric variables . p,C1511726;C3245479;C3714741,false;false;false,12571/20013
data are number of patients ( % ) or hazard ratio ( nmbr % cl ),C1511726;C3245479;C3714741,false;false;false,12572/20013
data are number of patients ( % ) or mean ( sd ),C1511726;C3245479;C3714741,false;false;false,12573/20013
data are presented as mean sd . * n nmbr for ldl cholesterol .
 
 †
 
 n nmbr for ldl cholesterol .
 
 ‡
 
 signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p nmbr . nmbr .
 
 §
 
 signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p nmbr . nmbr .
 
 ¶
 
 signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p nmbr . nmbr .,C1511726;C3245479;C3714741,false;false;false,12574/20013
data are reported as n ( % ) . event rates in parentheses are kaplan - meier estimates ( % ) at nmbr year . * cardiovascular ( cv ) death,C1511726;C3245479;C3714741,false;false;false,12575/20013
data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . * p < nmbr . nmbr vs . ng . † p < nmbr . nmbr vs . ng .,C1511726;C3245479;C3714741,false;false;false,12576/20013
data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . ‡ p < nmbr . nmbr vs . non - epa . § p < nmbr . nmbr vs . non - epa,C1511726;C3245479;C3714741,false;false;false,12577/20013
data presented as mean   ±   sd  unless otherwise specified    acopd severity is based on the gold nmbr criteria [nmbr]  gold nmbr [nmbr]    bon a scale of nmbr – nmbr  with higher scores indicating worse health status  the mcid is a change of nmbr   units  on a scale of nmbr – nmbr  with higher scores indicating more severe dyspnea  on a scale of nmbr – nmbr  with higher scores indicating worse health status,C1511726;C3245479;C3714741,false;false;false,12578/20013
data represent number of patients ( % ) or mean ( standard deviation )  unless otherwise indicated . a self - reported information . bc physician - diagnosed diabetes or fasting plasma glucose ≥ nmbr mg / dl or hemoglobin anmbrc ≥ nmbr . nmbr % . d physician - diagnosed hypertension or systolic blood pressure ≥ nmbr mmhg or diastolic blood pressure ≥ nmbr mmhg .
 
 median ( interquartile range ) . ldl  low - density lipoprotein  hdl  high - density lipoprotein  tg  triglyceride .,C1511726;C3245479;C3714741,false;false;false,12579/20013
data,C1511726;C3245479;C3714741,false;false;false,12580/20013
dates of recruitment,C0011008;C2949735;C2348077,true;false;true,12581/20013
day nmbr oral glucocorticoid use — no . { % ),C0332173;C0442027;C0017710;C4521986;C0439228;C0439505,false;false;true;false;false;false,12582/20013
days between acs and rand,C0439228;C0742343;C4318612,false;true;false,12583/20013
days from acs to randomization,C0439228;C0742343;C4318612,false;true;false,12584/20013
days with heartburna ( days ),C0439228,false,12585/20013
daytime mean dbp ( abpm ) at week nmbr,C0332169;C0444504;C0536221;C0332174;C0439230;C3813197;C4281799;C2347634;C2348143,false;false;true;false;false;false;false;false;false,12586/20013
daytime mean sbp ( abpm ) at week nmbr,C0332169;C0444504;C0085805;C0332174;C0439230;C2347634;C2348143,false;false;true;false;false;false;false,12587/20013
daytime nasal symptoms score change from baseline,C0332169;C0231918,false;false,12588/20013
daytime symptoms more than twice per week,C0332169;C0683368;C1720725;C1948050;C1457887,false;true;false;false;false,12589/20013
dbp ( mean over nmbr h ),C0536221;C0444504;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143;C3813197;C4281799,true;false;true;false;false;false;false;false;false;false;false,12590/20013
dbp ( mmghg ),C0536221;C3813197;C4281799,true;false;false,12591/20013
dbp ( office measurement ),C0536221;C0442603;C0242485;C3813197;C4281799,true;false;false;false;false,12592/20013
dbp ( sd ),C0536221;C2699239;C3813197;C4281799,true;false;false;false,12593/20013
dbp < nmbr mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,12594/20013
dbp ≥ nmbr mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,12595/20013
dbp > nmbr or sbp > nmbr mm hg laboratory determinations,C0536221;C3813197;C4281799,true;false;false,12596/20013
dbp nmbr . nmbr ( nmbr . nmbr ) baseline lipid profile,C0536221;C0168634;C0023779;C1979963;C2003903;C1442488;C3813197;C4281799,true;true;true;false;false;false;false;false,12597/20013
dbp at visit nmbr,C0536221;C0545082;C1512346;C2826704;C3813197;C4281799,true;false;false;false;false;false,12598/20013
dbp during the follow - up period ( mmhg ),C0536221;C0589120;C0439531;C0439475;C1948053;C1522577;C1704685;C3274571;C3813197;C4281799,true;false;false;false;false;false;false;false;false;false,12599/20013
dbp mm hg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,12600/20013
dbp . mean ( sd ) mm hg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,12601/20013
dcct anmbrc,,,12602/20013
de,C0011198;C0017480;C3541240,true;true;false,12603/20013
de ( n = nmbr ),C0011198;C0017480;C3541240,true;true;false,12604/20013
de nmbr mg bid ( n - nmbr,C0011198;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0017480;C3541240,true;true;true;false;false;false;false;false;true;false,12605/20013
denmbr n = nmbr,C0011198;C0017480;C3541240,true;true;false,12606/20013
dead ( n = nmbr ),C0011065,true,12607/20013
death due to renal failure or sustained esrd,C0011065;C0678226;C0035078;C1963154;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,12608/20013
death due to renal failure ®,C0011065;C0678226;C0035078;C1963154;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,12609/20013
death from,C0011065;C1306577;C4082313;C4552775,true;false;false;false,12610/20013
death or disabling stroke,C0011065;C1306577;C4082313;C4552775,true;false;false;false,12611/20013
death or ich,C0011065;C1306577;C4082313;C4552775,true;false;false;false,12612/20013
death *,C0011065;C1306577;C4082313;C4552775,true;false;false;false,12613/20013
death / mi / idr / st,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,12614/20013
death / q - ml / stent thrombosis,C0011065;C0439526;C3897493;C1705224;C3887665;C1306577;C4082313;C4552775,true;false;false;false;false;false;false;false,12615/20013
death / q - mi / idr,C0011065;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false,12616/20013
death / udmi / idr,C0011065;C1306577;C4082313;C4552775,true;false;false;false,12617/20013
deathsb,,,12618/20013
decline #   ml · yr − nmbr,C0439526;C0439234;C1705224;C3887665,false;false;false;false,12619/20013
deep - vein thrombosis only,C0149871;C0205171;C1720467,true;false;false,12620/20013
definite acute stent thrombosis,C0439544;C0205178;C3897493;C1704787,false;false;false;false,12621/20013
definite stent thrombosis,C0439544;C3897493;C1704787,false;false;false,12622/20013
definite / probable stent thrombosis,C0439544;C0033204;C3897493;C0332148;C1704787,false;true;false;false;false,12623/20013
delayed,C0205421;C1545665;C3272602,false;false;false,12624/20013
delayed - eptifibatide group ( n = nmbr ),C0205421;C0253563;C0441848;C1545665;C3272602,false;true;false;false;false,12625/20013
delayed eptifibatide,C0205421;C0253563;C1545665;C3272602,false;true;false;false,12626/20013
delighted,C3830544,false,12627/20013
demographic nmbr . nmbr ( nmbr . nmbr ),C0011298,true,12628/20013
demographic and clinical,C0011298,true,12629/20013
demographic characteristic,C0011298;C1521970,true;false,12630/20013
demographic data,C4684639,false,12631/20013
demographic factors,C0011292;C0011298,true;true,12632/20013
demographic variable,C0011298;C0439828;C4553760,true;false;false,12633/20013
demographic / disease characteristics at baseline,C0683970;C0012634;C0168634;C1442488;C0011298;C0599878;C4684572,false;true;true;false;true;false;false,12634/20013
demographics age ( years ),C0011298;C1510829;C1704791,true;false;false,12635/20013
demographics and clinical characteristics,C0011298;C1704791,true;false,12636/20013
denosumab ( n = nmbr ) n ( % ),C1690432,true,12637/20013
denotes angiotensin - converting enzyme .,,,12638/20013
dense calcium,C0439794;C0006675;C0006726;C2936886;C3540037;C3714611,false;true;true;false;false;false,12639/20013
dental procedure,C0011331,true,12640/20013
depression ®,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,12641/20013
dermal,C0221928;C1522447,false;false,12642/20013
dermatitis atopic,C0011603,true,12643/20013
des implantation for restenosis,C0011702;C0021107;C0333186;C0029976;C4551552,true;false;false;true;true,12644/20013
des type at index procedure,C0011702;C0600653;C0455713;C0918012;C1552854;C1637833;C2986546;C4551552,true;true;false;true;false;false;false;true,12645/20013
descent,C0205386;C0680043,false;false,12646/20013
detected during tumor evaluation,C0442726;C0027651;C0220825;C1261322;C1578706;C3273930;C1511790,false;true;false;false;false;false;false,12647/20013
deterioration in renal function ( investigator reported ),C0868945;C0232804;C0035173,false;false;true,12648/20013
deviation,C0012727;C0205419;C1705236,false;false;false,12649/20013
deviation  tg  triglyceride .,C0012727;C0041004;C0205419;C1705236,false;true;false;false,12650/20013
device = watchman filter,C0180860;C0335390,false;false,12651/20013
dexlansoprazole mr,C2348248;C0024485;C1417249;C2347167;C3254418;C4050513,true;true;false;false;true;false,12652/20013
dexlansoprazole mr ( n = nmbr ),C2348248;C0024485;C1417249;C2347167;C3254418;C4050513,true;true;false;false;true;false,12653/20013
dexlansoprazole mr nmbr mg,C2348248;C0024485;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417249;C2347167;C3254418;C4050513,true;true;true;true;false;false;false;false;false;false;false;true;false,12654/20013
dexlansoprazole mr nmbr mg qd,C2348248;C0024485;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417249;C2347167;C3254418;C4050513,true;true;true;false;true;false;false;false;false;false;false;false;true;false,12655/20013
dfisher ' s exact test .,C2828393;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4050514,false;false;false;false;false;false;false;false;false,12656/20013
dha ( n = nmbr ),C0142831;C2348308,true;false,12657/20013
dha intake on food frequency questionnaire,C0142831;C1286336;C0034394;C1512806;C2986698;C2348308,true;false;true;false;false;false,12658/20013
diabetes - related medication use,C0011847;C0439849;C0240320;C0445223;C0011849,false;false;false;false;true,12659/20013
diabetes ( n [ % ] ) *,C0011847;C0011849,false;true,12660/20013
diabetes ( n = nmbr ),C0011847;C0011849,false;true,12661/20013
diabetes ( p = . nmbr ),C0011847;C0011849,false;true,12662/20013
diabetes ( p = . onmbr ),C0011847;C0011849,false;true,12663/20013
diabetes ( p = . oonmbr ),C0011847;C0011849,false;true,12664/20013
diabetes at baseline,C0011847;C0168634;C1442488;C0011849,false;true;false;true,12665/20013
diabetes bl,C0011847;C0005918;C0006413;C1552663;C2827109;C0011849,false;true;true;false;false;true,12666/20013
diabetes classificationa,C0011847;C0011849,false;true,12667/20013
diabetes duration ( y ),C0011847;C0449238;C2926735;C0011849,false;false;false;true,12668/20013
diabetes duration ( years ) *,C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,12669/20013
diabetes duration at baseline,C0011847;C0449238;C0168634;C1442488;C2926735;C0011849,false;false;true;false;false;true,12670/20013
diabetes duration mean ± sd,C0011847;C0449238;C0444504;C2699239;C2347634;C2348143;C2926735;C0011849,false;false;false;false;false;false;false;true,12671/20013
diabetes etiology,C0011847;C0015127;C1314792;C1524003;C0011849,false;true;true;false;true,12672/20013
diabetes history,C0011847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0011849,false;true;true;false;false;false;false;true,12673/20013
diabetes medication,C0011847;C0013227;C3244316;C4284232;C0011849,false;true;false;false;true,12674/20013
diabetes melitus,C0011847;C0011849,false;true,12675/20013
diabetes mellitus — no . / total no . ( % ),C0011849,true,12676/20013
diabetes mellitus ( type nmbr ),C1320657,false,12677/20013
diabetes mellitus [n ( % ) ],C0011849,true,12678/20013
diabetes mellitus 一 no . ( % ),C0011849,true,12679/20013
diabetes mellitus classification,C0011849;C0008902;C0008903;C0678229,true;true;true;false,12680/20013
diabetes mellitus duration ( sd ),C0011849;C0449238;C2699239;C2926735,true;false;false;false,12681/20013
diabetes mellitus duration,C0011849;C0449238;C2926735,true;false;false,12682/20013
diabetes mellitus n = nmbr,C0011849,true,12683/20013
diabetes mellitus yes ( n,C0011849;C1549445;C1705108;C1710701,true;false;false;false,12684/20013
diabetes mellitust,C0011847;C0011849,false;true,12685/20013
diabetes n ( % ),C0011847;C0011849,false;true,12686/20013
diabetes t,C0011847;C0011849,false;true,12687/20013
diabetes therapy at baseline ( alone or in combination ),C3274787;C0168634;C1442488;C3539002,false;true;false;false,12688/20013
diabetes type ii,C0011860,true,12689/20013
diabetes with no use of diabetes drugs,C0020616;C1524063,true;false,12690/20013
diabetes with use of oral diabetes drugs,C0020616;C1524063;C0442027;C4521986;C0011847;C0029167;C0175795;C0304289;C0011849,true;false;false;false;false;true;false;false;true,12691/20013
diabetes^,C0011847;C0011849,false;true,12692/20013
diabetes | |,C0011847;C0011849,false;true,12693/20013
diabetes | | yes,C0011847;C1549445;C1705108;C1710701;C0011849,false;false;false;false;true,12694/20013
diabetesc,,,12695/20013
diabetese,,,12696/20013
diabetesh yes,C1549445;C1705108;C1710701,false;false;false,12697/20013
diabetesz,,,12698/20013
diabetic ( no ),C0241863,false,12699/20013
diabetic ( yes ),C0241863;C1549445;C1705108;C1710701,false;false;false;false,12700/20013
diabetic eye disease,C0342245,false,12701/20013
diabetic participants,C0241863;C0679646,false;false,12702/20013
diabetic participants !,C0241863;C0679646,false;false,12703/20013
diabetic subjects,C0241863;C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false,12704/20013
diabetic therapy use,C0241863;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,false;true;true;false;false;true;false,12705/20013
diabetics - no ( n = nmbr,C0241863,false,12706/20013
diabetics - yes ( n = nmbr,C0241863;C1549445;C1705108;C1710701,false;false;false;false,12707/20013
diabetics ( n = nmbr ),C0241863,false,12708/20013
diabetics • no ( n = nmbr,C0241863,false,12709/20013
diagnosis — yr,C0011900;C0439234;C1704338;C1704656,true;false;true;false,12710/20013
diagnosis ( years ),C0011900;C0439234;C1704338;C1704656,true;false;true;false,12711/20013
diagnosis at study entry — no . ( % ),C1704656;C1705654;C4068481,false;false;false,12712/20013
diagnosis of diabetes,C0011900;C0011847;C0011849;C1704338;C1704656,true;false;true;true;false,12713/20013
diagnosis of hefh,C0011900;C1704338;C1704656,true;true;false,12714/20013
diagnostic catheterization,C0596429,false,12715/20013
diarrhoea,C0011991;C1963091;C3641756;C4084784;C4084802;C4085317,true;false;false;false;false;false,12716/20013
diary variables,C0376660;C0439828,true;false,12717/20013
diastoiic biood pressure,C0033095;C0460139;C1306345;C4284008,true;false;false;false,12718/20013
diastolic blood pressure > nmbr mm hg,C0428883;C0439475;C1305849,true;false;false,12719/20013
diastolic blood pressure mmhg,C0428883;C0439475;C1305849,true;false;false,12720/20013
diastolic blood pressure  and lp ( a ) ,C0428883;C1305849,true;false,12721/20013
diastolic bp ( mmhg ) *,C0428883;C0439475,true;false,12722/20013
diastolic pressure,C0428883,true,12723/20013
diclofenac ( n = nmbr ),C0012091,true,12724/20013
diclofenac nmbr mg ( n = nmbr ) n ( % ),C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12725/20013
diclofenac nmbr mg,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12726/20013
diclofenac group ( n = nmbr nmbr ),C0012091;C0441848,true;false,12727/20013
did not enrol into osler,,,12728/20013
did not meet atopy and igenmbr - nmbrku / lcriteriaa ( n = nmbr,,,12729/20013
diet - controlled ( % ),C0743195,false,12730/20013
diet - i - pravastatin ( n = nmbr ),C0012155;C0021966;C0085542;C0221138;C0012159;C1519433;C2983588;C3668949,true;true;true;false;true;false;false;false,12731/20013
diet diet + pravastatin event / patients ( nmbrooo / pt - y ),C0012155;C0085542;C0441471;C0030705;C0032743;C0699718;C4019010;C0012159;C1519433;C2983588;C3668949,true;true;false;true;true;false;false;true;false;false;false,12732/20013
diet ( n = nmbr ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,12733/20013
diet nmbr / nmbr ( nmbr . nmbr ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,12734/20013
diet group,C0012155;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0012159;C1519433;C2983588;C3668949,true;false;false;true;false;false;false;true;false;false;false,12735/20013
diet + pravastatin nmbr / nmbr ( nmbr . nmbr ),C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,12736/20013
dietary calcium intake,C0489458,false,12737/20013
diff_measure,,,12738/20013
diff_measure ( dm added this as table had multiple headings ),C0079809;C0011816;C3250443;C0242485,true;true;false;false,12739/20013
difference ( nmbr % ci  p value ),C1705241;C0008107;C1709380;C3259781;C1705242,false;true;false;false;false,12740/20013
difference ( glargine - standard care ) lsm ± se ( mm / year ),C1705241;C0907402;C1442989;C1947933;C0036919;C4330985;C0439234;C0439508;C4554674;C2828392;C1705242,false;true;false;false;true;false;false;false;false;false;false,12741/20013
difference ( n - nmbr fa - placebo ) lsm ± se ( mm / year ),C1705241;C0032042;C0036919;C4330985;C0439234;C0439508;C4554674;C1696465;C1706408;C1705242,false;true;true;false;false;false;false;false;false;false,12742/20013
difference nmbr years - baseline,C1705241;C0439234;C0168634;C1442488;C1705242,false;false;true;false;false,12743/20013
difference nmbr years - baseline *,C1705241;C0439234;C0168634;C1442488;C1705242,false;false;true;false;false,12744/20013
difference ff / vi versus uc,C1705241;C4554348;C0205999;C1705242,false;false;true;false,12745/20013
difference from placebo ( nmbr % cl ),C1705241;C0032042;C0596019;C1696465;C1706408;C1705242,false;true;false;false;false;false,12746/20013
difference in ls mean vs placebo ( nmbr % ci ),C1705241;C0023668;C0444504;C2347634;C2348143;C1705242,false;true;false;false;false;false,12747/20013
difference in ls means ( nmbr % ci ),C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,12748/20013
difference in ls means ( nmbr % ci ) versus placebo,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,12749/20013
difference in ls means ( nmbr % ci ) a,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,12750/20013
difference in means,C1705241;C1704970;C1705242,false;false;false,12751/20013
difference in means ( nmbr % cl ),C1705241;C1704970;C0596019;C1705242,false;false;false;false,12752/20013
difference in sbp between treatment,C1705241;C0085805;C1705242,false;true;false,12753/20013
difference mepo - pbo ( nmbr % ci ),C1705241;C0031962;C0008107;C3259781;C1705242,false;true;true;false;false,12754/20013
difference vs ff nmbr pg ( nmbr % ci ),C1705241;C1705242,false;false,12755/20013
difference vs pbo,C1705241;C1705242,false;false,12756/20013
difference vs pbo ( nmbr % ci ),C1705241;C1705242,false;false,12757/20013
difference vs placebo ( nmbr % ci ),C1705241;C1705242,false;false,12758/20013
differences between indacaterol + tiotropium versus tiotropium + placebo,C1705241;C1722260;C0213771;C1705242,false;true;true;false,12759/20013
differencevs . pbof,,,12760/20013
diffusion capacity of the lung for carbon monoxide,C0231971,false,12761/20013
digoxin n ( % ),C0012265,true,12762/20013
digoxin n = nmbr ( nmbr % ),C0012265,true,12763/20013
digoxin or digitalis glycoside,C0012265,true,12764/20013
digoxin or digitalis preparation,C0012265,true,12765/20013
digoxin or digitalis preparations,C0012265,true,12766/20013
digoxin scd,C0012265,true,12767/20013
dihydropyridine ccbs,C0012315;C0006684;C0220821,true;true;true,12768/20013
dip joint arthritis,C0932510;C0003864;C4552845,false;true;false,12769/20013
dipeptidyl peptidase nmbr inhibitor,C0003015;C2757044;C3536837,true;false;false,12770/20013
dipeptidyl peptidase nmbr inhibitors,C0003015,true,12771/20013
dipyridamole alone,C0012582,true,12772/20013
direct stenting per lesion ‡,C0439851;C0038257;C0221198;C1546698;C2348535;C1947931,false;true;false;false;false;false,12773/20013
direction of hr,C0449738,false,12774/20013
disabling or fatal,,,12775/20013
disabling or fatal stroke,,,12776/20013
disabling stroke,C0038454;C4554100,true;false,12777/20013
discontinu - ation,,,12778/20013
discontinuation of ics / laba prior to baseline,C0457454;C0815320;C4551720;C1444662;C4552847,false;false;true;false;false,12779/20013
discontinuation of lama prior to baseline,C0457454;C0999593;C1416775;C1444662;C4552847,false;false;false;false;false,12780/20013
disease activity ( n ( % ) ),C1292728,false,12781/20013
disease characteristics duration of psoriatic arthritis — yr,C0872146;C1521970;C0003872;C0439234;C0599878;C0449238;C2926735,false;false;true;false;false;false;false,12782/20013
disease duration ( y ),C0872146,false,12783/20013
disease duration [year],C0872146;C0439234;C0439508,false;false;false,12784/20013
disease duration > nmbr years,C0872146;C0439234,false;false,12785/20013
disease extent,C0012634;C0439792,true;false,12786/20013
disease history,C0683519,false,12787/20013
disease localization ' ’,C0012634;C0475264;C1744691,true;false;false,12788/20013
disease localization,C0012634;C0475264;C1744691,true;false;false,12789/20013
disease severity,C0521117,false,12790/20013
disease site — no . ( % ) ^,C0012634;C0205145;C1515974;C2825164,true;false;false;false,12791/20013
disease site,C0012634;C0205145;C1515974;C2825164,true;false;false;false,12792/20013
disorders ( soc ),C0012634,true,12793/20013
disposition index,C0743223;C0600653;C0918012;C1552854;C1637833;C2986546;C1705555,false;true;true;false;false;false;false,12794/20013
disseminated tuberculosis,C0152915,false,12795/20013
distal,C0205108;C4522154,false;false,12796/20013
distal forearm,C0588203,false,12797/20013
distal lower,C0205108;C0441994;C1548802;C2003888;C4522154,false;false;false;false;false,12798/20013
distance to ldl - c goal,C0012751;C0018017;C1571704,false;true;false,12799/20013
distribution — no . { % ),C0520511;C1704711,false;true,12800/20013
distribution of metformin dose at randomization,C0520511;C0025598;C0178602;C0869039;C1114758;C1704711,false;true;false;false;false;true,12801/20013
diuretic ( any ),C0012798,true,12802/20013
diuretic agents,C0012798;C0450442;C1254351;C1521826,true;false;false;false,12803/20013
diuretic agents ( excluding antialdosterone ),C0012798;C0450442;C1254351;C1521826,true;false;false;false,12804/20013
diuretic n ( % ),C0012798,true,12805/20013
diuretic subgroup,C0012798;C1079230;C1515021,true;false;false,12806/20013
diuretic therapy,C0948575,false,12807/20013
diuretic use at baseline,C0012798;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,12808/20013
diuretics^,C0012798,true,12809/20013
diureties,,,12810/20013
dlqi ( nmbr - nmbr ),C3899393,false,12811/20013
dlqi ( patients with £ nmbr % bsa psoriasis ),C3899393;C0030705;C0033860,false;true;true,12812/20013
dlqi improvement from baseline to week nmbr,C3899393;C2986411;C0168634;C1442488,false;false;true;false,12813/20013
dlqi score,C3899393,false,12814/20013
dlqi §,C3899393,false,12815/20013
dm ( n = nmbr,C0011816;C3250443,true;false,12816/20013
dm duration,C0011816;C0449238;C2926735;C3250443,true;false;false;false,12817/20013
dm or ckd *,C0011816;C3250443,true;false,12818/20013
dm or diabetic complications,C0011816;C3250443,true;false,12819/20013
dmab ( n = nmbr ),C0012411,true,12820/20013
dmard − ( n   =   nmbr ),C0242708,true,12821/20013
dmard - biologic ir,C0242708;C0005515;C0022065;C0022071;C1448132;C0205460,true;true;true;true;true;false,12822/20013
dmard - ir,C0242708;C0022065;C0022071;C1448132,true;true;true;true,12823/20013
dmard - ir / anti - tnf - ir,C0242708;C0022065;C1448177;C0022071;C1448132,true;true;true;true;true,12824/20013
dmard at baseline,C0242708;C0168634;C1442488,true;true;false,12825/20013
dmard + ( n   =   nmbr ),C0242708,true,12826/20013
documented hypoglycaemiac,C1301725;C1609436,false;false,12827/20013
documented mi,C1301725;C3810814;C1609436,false;false;false,12828/20013
door - to - balloon time — hr,C4296144,false,12829/20013
dopa and dopa derivativese,C0013023,true,12830/20013
dopamine agonist use,C0178601;C0042153;C0457083;C1947944;C3536925,true;true;false;false;false,12831/20013
dose ( iu ),C0178602;C0049272;C0439453;C0694756;C0869039;C1114758,false;true;false;false;false;false,12832/20013
dose ( mg / day ),C0178602;C0439422;C0869039;C1114758,false;false;false;false,12833/20013
dose ( mg / week ),C0178602;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,false;true;false;false;true;false;false;false;false;false;false;false,12834/20013
dose adjusted,C0178602;C0869039;C1114758,false;false;false,12835/20013
dose adjustment n ( % ),C2826232,false,12836/20013
dose adjustment reason < nmbr kg,C2826286;C0022718;C0439209;C4054209,false;true;false;false,12837/20013
dose equivalent,C0178602;C0205163;C0439185;C0869039;C1114758,false;false;false;false;false,12838/20013
dose ratio at week nmbr ( nmbr % cl ),C0178602;C0456603;C0332174;C0596019;C0439230;C1547037;C0869039;C1114758,false;false;false;false;false;false;false;false,12839/20013
dose reduced at randomization *,C0178602;C0869039;C1114758,false;false;false,12840/20013
dose reduction at randomization,C0178602;C0301630;C0034656;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;true;false;false;false;false;false,12841/20013
dose reduction at randomization — no . ( % )  i ,C0178602;C0301630;C0034656;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;true;false;false;false;false;false,12842/20013
dose reduction,C0178602;C0301630;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;false;false;false;false;false,12843/20013
dose,C0178602;C0869039;C1114758,false;false;false,12844/20013
dose / weight ( iu / kg ),C0178602;C0005910;C0439463;C0043100;C1305866;C1705104;C0869039;C1114758,false;true;false;true;false;false;false;false,12845/20013
dosing,,,12846/20013
double - dummy phase * *,C4684647;C0205390;C1710475,false;false;false,12847/20013
doubling of baseline serum creatinine or esrd rr ( ci ) “,C0205173;C0168634;C0201976;C0600061;C1442488;C1705764,false;true;false;false;false;false,12848/20013
doubling of creatinine,C0205173;C0010294;C1561535;C1705764,false;true;false;false,12849/20013
doubling of creatinine level,C0205173;C0428279;C1705764,false;false;false,12850/20013
doubling statin dose,C0205173;C0360714;C0178602;C0869039;C1114758;C1705764,false;true;false;false;false;false,12851/20013
doxazosin,C0114873,true,12852/20013
doxazosin group,C0114873;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,12853/20013
dpp - nmbr,C1414174,false,12854/20013
dpp ‐ nmbr inhibitors,C1414174;C0243077,false;true,12855/20013
draining fistulae,C0544791,false,12856/20013
drinker ( nmbr - nmbr drinks / week ),C0556338,false,12857/20013
drinker ( nmbr to nmbr drinks / week ),C0556338;C0452428;C0332174;C0439230,false;false;false;false,12858/20013
drinker,C0556338,false,12859/20013
dronedarone,C0766326,true,12860/20013
dronedarone ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0766326,true,12861/20013
drosuvastatin + fenofibric acid vs . fenofibric acid monotherapy .,C0060179,true,12862/20013
drug - related saes,C0013227;C0439849;C1519255;C1622657;C4553214;C0445223;C1254351,true;false;false;false;false;false;false,12863/20013
drug - related teaes,C0013227;C0439849;C0445223;C1254351,true;false;false;false,12864/20013
drug ‐ relateda,C0013227;C1254351,true;false,12865/20013
drug - relateda,C0013227;C1254351,true;false,12866/20013
drug and insulint,C0013227;C1254351,true;false,12867/20013
drug naive,C0013227;C1254351,true;false,12868/20013
drug therapy,C0013216;C0013217,true;true,12869/20013
drug therapy at admission — no . ( % ) aspirin,C0013216;C0184666;C0809949;C0013217,true;false;false;true,12870/20013
drugs and toxins,C0013227;C3687832,true;false,12871/20013
dual antiplatelet therapy,C0205173;C1096021;C1554184,false;false;false,12872/20013
dual bp / ldl - c goal attainment,C0205173;C0037623;C0680230;C1415692;C1708288;C4318478;C1554184,false;true;false;false;false;false;false,12873/20013
dual i extension,C0205173;C0021966;C0231448;C1880641;C0221138;C1554184,false;true;false;false;false;false,12874/20013
dual ii,C0205173;C1710602;C4082587;C1554184,false;false;false;false,12875/20013
dual iv,C0205173;C0022326;C4265176;C1554184,false;true;false;false,12876/20013
due to ae,C3887670,false,12877/20013
due to drug - relateda ae,C0013227;C3887670;C1254351,true;false;false,12878/20013
due to drug - relateda sae,C0013227;C1519255;C1622657;C4553214;C1254351,true;false;false;false;false,12879/20013
due to ecg changes,C1623258,true,12880/20013
due to sae,C1519255;C1622657;C4553214,false;false;false,12881/20013
due worsening angina,C0678226;C0002965;C3146286,false;true;false,12882/20013
dulaglutide nmbr . nmbr mg,C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12883/20013
dulaglutide nmbr . nmbr mg ( n = nmbr ),C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12884/20013
dulaglutide nmbr . nmbr mgf,C3179549;C1366394;C3712803;C3887684,true;true;true;false,12885/20013
dulaglutide nmbr · nmbr mg ( n = nmbr ),C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12886/20013
dulaglutide nmbr . nmbr mg *,C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12887/20013
dupiiumab,,,12888/20013
dupilumab nmbr,C3660996,true,12889/20013
durable clinical remissionh,C0205210,false,12890/20013
durable clinical responseg,C0205210,false,12891/20013
duration — yr,C0449238;C0439234;C2926735,false;false;false,12892/20013
duration < nmbr year,C0449238;C0439234;C0439508;C2926735,false;false;false;false,12893/20013
duration > nmbr to < nmbr years,C0449238;C0439234;C2926735,false;false;false,12894/20013
duration > nmbr years,C0449238;C0439234;C2926735,false;false;false,12895/20013
duration alendronate use,C0449238;C0102118;C0042153;C0457083;C1947944;C2926735,false;true;true;false;false;false,12896/20013
duration antiplatelet use as % of study duration ( sd ),C1881378;C0557651;C2699239;C2603343;C2826775,false;false;false;false;false,12897/20013
duration dm in dm ( years ),C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,12898/20013
duration of alendronate use,C1881378;C0102118;C2826775,false;true;false,12899/20013
duration of as,C0449238;C2926735,false;false,12900/20013
duration of asthma — yr,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,12901/20013
duration of asthma ( years ),C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,12902/20013
duration of asthma > nmbr years,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,12903/20013
duration of chf ( months ),C0449238;C0018802;C0439231;C2926735,false;true;false;false,12904/20013
duration of chronic kidney disease * ( years ),C0449238;C0205191;C0022658;C0439234;C2926735,false;false;true;false;false,12905/20013
duration of clopidogrel pretreatment — hr median,C0449238;C0070166;C1550147;C0549183;C0876920;C2347635;C2348144;C2939193;C2709094;C3539075;C3539076;C2926735,false;true;false;false;false;false;false;false;false;false;false;false,12906/20013
duration of copd ( yr ) f,C0449238;C0024117;C0439234;C0016327;C1412502;C3714496;C2926735,false;true;false;true;false;false;false,12907/20013
duration of crohn ’ s disease ( yrs ),C0449238;C0010346;C2926735,false;true;false,12908/20013
duration of current flare,C0449238;C0521116;C1517205;C3540542;C1705970;C2926735,false;false;false;false;false;false,12909/20013
duration of diabetes — yr^,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,12910/20013
duration of diabetes < nmbr yrs,C0449238;C0011847;C0011849;C2926735,false;false;true;false,12911/20013
duration of diabetes in years,C0449238;C0011847;C0011849;C2926735,false;false;true;false,12912/20013
duration of diabetes microvascular disease — no . ( % ),C0011847;C0443258;C0872146;C0011849,false;false;false;true,12913/20013
duration of disease — yr^ mean,C0872146;C0439234;C0444504;C2347634;C2348143,false;false;false;false;false,12914/20013
duration of disease ( y ),C0872146,false,12915/20013
duration of disease ( years ),C0872146;C0439234,false;false,12916/20013
duration of disease ( yr ),C0872146;C0439234,false;false,12917/20013
duration of disease before baseline,C0872146,false,12918/20013
duration of disease since,C0872146,false,12919/20013
duration of dm - years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,12920/20013
duration of heart failure ( years ),C0449238;C0018801;C0439234;C0018802;C4554158;C2926735,false;true;false;true;false;false,12921/20013
duration of hf,C0449238;C0018488;C1313497;C1538440;C3273279;C2926735,false;true;true;false;false;false,12922/20013
duration of infusion after pci — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,12923/20013
duration of infusion before cabg — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,12924/20013
duration of infusion before pci — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,12925/20013
duration of infusion during medical management — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,12926/20013
duration of macular edema,C0449238;C0024440;C0271051;C2926735,false;true;true;false,12927/20013
duration of oral antidiabetic treatment,C0444921;C0442027;C0935929;C4521986,false;false;true;false,12928/20013
duration of paod ( years ),C0449238;C0439234;C2926735,false;false;false,12929/20013
duration of previous use of vka,C1881378;C0205156;C1552607;C2826775,false;false;false;false,12930/20013
duration of prior alendronate use,C1881378;C0332152;C0102118;C2826257;C2826775,false;false;true;false;false,12931/20013
duration of prior statin therapy^,C0444917;C0332152;C0360714;C2826257,false;false;true;false,12932/20013
duration of procedure,C2346509,false,12933/20013
duration of psoriasis ( years ),C0449238;C0033860;C0439234;C2926735,false;true;false;false,12934/20013
duration of qualifying atrial fibrillation » nmbr days — no . ( % ),C0449238;C1514624;C0004238;C0439228;C0344434;C1963067;C2926735,false;false;true;false;false;false;false,12935/20013
duration of rat,C0449238;C0034693;C0034721;C2926735,false;true;true;false,12936/20013
duration of study - drug administration — hr,C2348354;C0013175,false;true,12937/20013
duration of sulphonylurea use ( months ),C1881378;C0038766;C0439231;C3536898;C2826775,false;true;false;false;false,12938/20013
duration of symptoms > nmbr min,C0436359;C0702093;C1524029;C3813700,false;false;false;false,12939/20013
duration of tnmbrd,C0449238;C2926735,false;false,12940/20013
duration of total exposure to study treatment,C0439175;C2826870;C0439810,false;false;false,12941/20013
duration of treatment in the healing study,C0444921,false,12942/20013
duration of type nmbr diabetes,C0449238;C1320657;C2926735,false;false;false,12943/20013
duration of type nmbr diabetes categories,C1547660;C1320657,false;false,12944/20013
duration of type nmbr diabetes mellitus,C0449238;C1320657;C2926735,false;false;false,12945/20013
duration since diagnosis ( years ),C0449238;C2926735,false;false,12946/20013
during overall study period,C0282416;C0557651;C0439531;C1948053;C2603343;C1561607,true;false;false;false;false;false,12947/20013
dutasteride,C0754659,true,12948/20013
dutasteride ( n = nmbr ),C0754659,true,12949/20013
dutasteride ( w = nmbr ),C0754659,true,12950/20013
dynamic measure of β - cell function ( ϕ s ) ( change from baseline ) – assessed for mmtt subset only,C0729333;C0079809;C0007613;C0392747;C0443172;C1705241;C4319952;C0242485,false;true;true;false;false;false;false;false,12951/20013
dysfunction  ef = erectile function  iief = i,C0031847;C0030847;C0031843;C3641331;C0021966;C0221138;C0542341;C0700205;C1705273;C0277785;C3887504;C3887505,true;true;true;false;true;false;false;false;false;false;false;false,12952/20013
dysglycaemia or mets,C1960636,false,12953/20013
dysglycemic categories,C1960636;C0683312,false;false,12954/20013
dyslipidaemia — no . ( % ),C0242339,true,12955/20013
dyslipidaemia including hypercholesterol — no . ( % ),C0242339,true,12956/20013
dyslipidaemiaj,,,12957/20013
dyslipidemia — no . { % ),C0242339,true,12958/20013
dyspnea,C0013404;C1963100,true;false,12959/20013
dyspnea – mmrc grade,C0013404;C3826977;C0441800;C0919553;C3244287;C1963100,true;false;false;false;false;false,12960/20013
dyspnea t,C0013404;C1963100,true;false,12961/20013
dyspnoea ( n = nmbr ),C0013404;C1963100,true;false,12962/20013
e - rs total scoreb,C0035970;C0439175;C0439810;C3714753;C3813325,true;false;false;false;false,12963/20013
e ( characteristic n,C1521970,false,12964/20013
e europe,C0015176,true,12965/20013
e major non - vertebral fragility fractures ( fas ),C0205082;C1518422;C0549207;C0302113;C0205164;C4318856;C4521762,false;false;true;false;false;false;false,12966/20013
e / a ratio,C0456603;C1547037,false;false,12967/20013
e / e ' ( septal ),,,12968/20013
enmbr + anmbr,,,12969/20013
enmbr ( n = nmbr ),,,12970/20013
enmbr / snmbr ( n = nmbr ),C3846405,false,12971/20013
enmbr / snmbr vs enmbr,C3846405,false,12972/20013
enmbr / snmbr vs snmbr,C3846405,false,12973/20013
eacit - e total score ) |,C2964552,false,12974/20013
early,C1279919,false,12975/20013
early - eptifibatide group ( n = nmbr ),C1279919;C0253563;C0441848,false;true;false,12976/20013
early clopidogrel intended,C1279919;C0070166,false;true,12977/20013
early crohn ' s disease *,C1279919;C0010346,false;true,12978/20013
early death,C1836407,false,12979/20013
early eptifibatide,C1279919;C0253563,false;true,12980/20013
early ichaem ic stroke,C1279919;C0020750;C0038454;C4554100;C4554818,false;true;true;false;false,12981/20013
early invasive strategy ( n = nmbr,C1279919;C0205281;C0679199;C1334278,false;false;false;false,12982/20013
early invasive *,C1279919;C0205281;C1334278,false;false;false,12983/20013
early invasivenmbr  ,C1279919;C0205281;C1334278,false;false;false,12984/20013
early load,C1279919,false,12985/20013
early routine,C1279919;C0205547,false;false,12986/20013
early use intended,C1279919,false,12987/20013
ease - nmbr,C1331418,false,12988/20013
east asia,C0015631,true,12989/20013
east asian,C1707877;C0078988,false;true,12990/20013
eastern and central europe,C1707877,false,12991/20013
eastern europe ( n   = nmbr,C0015177,true,12992/20013
eastern europe and africa,C0015177,true,12993/20013
ecfr ( ml / min per nmbr - nmbr m ’ ),C0439445;C0369637;C0441923,false;false;false,12994/20013
ecfr,,,12995/20013
ecg - lvh ( cornell ),C0232306,false,12996/20013
ecg - lvh ( sokolow - lyon ),C0232306,false,12997/20013
ecg abnormality at entry,C0522055;C1705654,false;false,12998/20013
ecg and imaging data,C1623258,true,12999/20013
ecg at time of qualifying symptoms,C1623258;C0040223;C1514624;C0683368;C1457887;C3541383,true;true;false;true;false;false,13000/20013
ecg atrial fibrillation,C1623258;C0004238;C0344434;C1963067,true;true;false;false,13001/20013
ecg changes ( % ) t,C1623258,true,13002/20013
ecg left ventricular,C1623258,true,13003/20013
eczema,C0013595;C4553957,true;false,13004/20013
ed > nmbr yr,C3538926;C0439234,false;false,13005/20013
ed characteristics,C3538926;C1521970,false;false,13006/20013
ed duration,C3538926;C0449238;C2926735,false;false;false,13007/20013
ed duration > nmbr yr,C3538926;C0449238;C0439234;C2926735,false;false;false;false,13008/20013
ed etiology,C3538926;C0015127;C1314792;C1524003,false;true;true;false,13009/20013
ed history,C3538926;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,13010/20013
ed severity * *,C3538926;C0439793;C0522510,false;false;false,13011/20013
ed severity,C3538926;C0439793;C0522510,false;false;false,13012/20013
ed therapy,C3538926;C0039798;C0087111;C1363945,false;true;true;false,13013/20013
ed visit related to exacerbation,C3538926;C0545082;C1512346;C2826704,false;false;false;false,13014/20013
eda,C0162359;C1539327;C3539920;C3887494,true;false;false;false,13015/20013
edema peripheral,C0013604;C1717255,true;false,13016/20013
edo,,,13017/20013
edoxaban,C2975435,true,13018/20013
edoxaban ( n = nmbr ),C2975435,true,13019/20013
edoxaban at randomization,C2975435;C0034656,true;true,13020/20013
edoxaban dose adjusted at randomisation,C2975435;C0178602;C0869039;C1114758,true;false;false;false,13021/20013
edoxaban higher dose vs warfarin,C2975435;C0444956,true;false,13022/20013
edoxaban lower dose vs warfarin,C2975435,true,13023/20013
edoxaban n = nmbr,C2975435,true,13024/20013
edoxaban n = nmbr n / n ( % ),C2975435,true,13025/20013
edoxaban n / n  rate ( % ),C2975435;C0871208;C1521828,true;false;false,13026/20013
edoxaban vs . warfarin,C2975435,true,13027/20013
edoxaban warfarin,C2975435;C0043031,true;true,13028/20013
edss stratification . no . ( % ),C0451246;C1514983;C3887783,false;false;false,13029/20013
educ > nmbry,,,13030/20013
educ nmbr - nmbry,,,13031/20013
educ ssy,,,13032/20013
education — no . ( % ),C0013621;C0013622;C0013658;C0039401,true;true;true;true,13033/20013
education ( % ),C0013621;C0013622;C0013658;C0039401,true;true;true;true,13034/20013
education ( years ),C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,13035/20013
education < nmbr y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,13036/20013
education > nmbr y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,13037/20013
education > nmbr yr ( % ),C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,13038/20013
education nmbr to nmbr y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,13039/20013
education in years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,13040/20013
education level,C0013621;C0013658,true;true,13041/20013
eduglinozin nmbr mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13042/20013
ef ( % ),,,13043/20013
ef < nmbr % ( n nmbr nmbr ),,,13044/20013
ef < nmbr % ( n = nmbr,,,13045/20013
ef < nmbr % n = nmbr,,,13046/20013
ef > nmbr % ( n = nmbr,,,13047/20013
ef > nmbr % n = nmbr,,,13048/20013
ef > nmbr % ( n nmbr nmbr ),,,13049/20013
ef nmbr - nmbr . nmbr % ( n nmbr nmbr ),,,13050/20013
ef b nmbr %,,,13051/20013
ef domain,C1880389;C1883221;C3541951,false;false;false,13052/20013
effect estimate,C1280500;C0750572;C1518681;C2348382,false;false;false;false,13053/20013
effect of covariates on slopes,C1280500;C1518681;C2348382,false;false;false,13054/20013
effect of ranolazine compared with placebo on angina and recurrent ischemia,C1280500;C0073633;C1518681;C2348382,false;true;false;false,13055/20013
effect size !,C0814843,false,13056/20013
effect size^,C0814843,false,13057/20013
efficacy end points,C1280519;C2349179;C1707887,false;false;false,13058/20013
efficacy endpoint,C1280519;C2349179;C2826544;C1707887,false;false;false;false,13059/20013
efficacy endpoints *,C1280519;C2349179;C1707887,false;false;false,13060/20013
efficacy measures,C1280519;C1707887,false;false,13061/20013
efficacy parameter,C1280519;C0549193;C1704769;C2350001;C1707887,false;false;false;false;false,13062/20013
efficacy variable,C1280519;C0439828;C4553760;C1707887,false;false;false;false,13063/20013
egfr — mean ( sd,C1739039;C0444504;C2699239;C2347634;C2348143;C3811844;C3812682,true;false;false;false;false;false;false,13064/20013
egfr — ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13065/20013
egfr — ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13066/20013
egfr ( ml / min per nmbr - nmbr kg / m^ ),C1739039;C0439402;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13067/20013
egfr ( ml / min per nmbr - nmbr m^ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13068/20013
egfr ( ml / min per nmbr - nmbr m ’ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13069/20013
egfr ( ml / min per nmbr . nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13070/20013
egfr ( ml / min per nmbr^nmbr m ' ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13071/20013
egfr ( ml / min per nmbr + nmbr m ”,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13072/20013
egfr ( ml / min per nmbr · nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13073/20013
egfr < nmbr ml / min / nmbr . nmbr,C1739039;C0439445;C3811844;C3812682,true;false;false;false,13074/20013
egfr < nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13075/20013
egfr < nmbr . nmbr ( vs egfr > nmbr ),C1739039;C3811844;C3812682,true;false;false,13076/20013
egfr < nmbr ml / min per nmbr^nmbr m ',C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13077/20013
egfr < nmbr ml / min per nmbr · nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13078/20013
egfr < nmbr ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13079/20013
egfr ≥ nmbr ml / min per nmbr · nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13080/20013
egfr ≥ nmbr ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13081/20013
egfr ≥ nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13082/20013
egfr > nmbr ml / min per nmbr^nmbr m ',C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13083/20013
egfr > nmbr ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13084/20013
egfr nmbr ml / min / nmbr . nmbr,C1739039;C0439445;C3811844;C3812682,true;false;false;false,13085/20013
egfr nmbr to < nmbr ml / min / nmbr . nmbr,C1739039;C0439445;C3811844;C3812682,true;false;false;false,13086/20013
egfr nmbr to < nmbr ml / min / nmbr . nmbr m *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13087/20013
egfr nmbr to < nmbr ml / min / nmbr . nmbr mnmbr ( n = nmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13088/20013
egfr nmbr . nmbr - nmbr . nmbr ( vs egfr > nmbr ),C1739039;C3811844;C3812682,true;false;false,13089/20013
egfr nmbr to < nmbr ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,13090/20013
egfr nmbr ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13091/20013
egfr nmbr to < nmbr ml / min / nmbr . nmbr m ’,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13092/20013
egfr nmbr to < nmbr ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13093/20013
egfr and albuminuria,C1739039;C3811844;C3812682,true;false;false,13094/20013
egfr by creatinine ( ml / min per nmbr · nmbr mnmbr ),C1739039;C0010294;C0439445;C1561535;C3811844;C3812682,true;true;false;false;false;false,13095/20013
egfr by creatinine ( ml / min per nmbr · nmbr mnmbr,C1739039;C0010294;C0439445;C1561535;C3811844;C3812682,true;true;false;false;false;false,13096/20013
egfr by cystatin c ( ml / min per nmbr · nmbrmnmbr,C1739039;C0071744;C0439445;C1413772;C3811844;C3812682,true;true;false;false;false;false,13097/20013
egfr category ( ml / min / nmbr . nmbr mnmbr ),C1739039;C0683312;C0439445;C0369637;C0441923;C3889287;C3811844;C3812682,true;false;false;false;false;false;false;false,13098/20013
egfr crcl ml · min − nmbr · nmbr . nmbr m − nmbr,C1739039;C1846718;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,13099/20013
egfr from the mdrd equation ( sd ),C1739039;C3839656;C0552449;C2699239;C3811844;C3812682,true;false;false;false;false;false,13100/20013
egfr in ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13101/20013
egfr snmbr ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13102/20013
egfr snmbro ml / min / nmbr . nmbr m^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13103/20013
egfr   < nmbr   ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13104/20013
egfr   ≥ nmbr   ml / min / nmbr . nmbr mnmbr,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13105/20013
egfr_p_interaction,C1739039;C1704675;C3811844;C3812682,true;false;false;false,13106/20013
egfr +,C1739039;C3811844;C3812682,true;false;false,13107/20013
egfr ‡ ( ml / min per nmbr · nmbr mnmbr ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,13108/20013
either ocs use,C3844638,false,13109/20013
ejection fraction — mean ± sd,C0489482;C0444504;C2699239;C2347634;C2348143;C2700378,false;false;false;false;false;false,13110/20013
ejection fraction ( % ),C0489482;C2700378,false;false,13111/20013
ejection fraction ( mean ),C0489482;C0444504;C2347634;C2348143;C2700378,false;false;false;false;false,13112/20013
ejection fraction group,C0489482;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2700378,false;false;false;true;false;false;false;false,13113/20013
ejection fraction *,C0489482;C2700378,false;false,13114/20013
el,C1416870;C1447747;C1823249;C3811107;C3811848;C3815598,false;true;false;false;false;false,13115/20013
elderly,C0001792;C1999167,true;false,13116/20013
elderly patients ( n — nmbr ),C0870602,false,13117/20013
elective peripheral revascularization,C0206058;C0205100;C0581603;C0439608,true;false;false;false,13118/20013
elective procedure,C0747973,false,13119/20013
elective surgery,C0206058,true,13120/20013
electrocardiogram,C0013798;C1547122;C1623258,true;false;true,13121/20013
electrocardiograph results,C0013798;C0180600;C1623258,true;true;true,13122/20013
electrocardiography,C0013798;C1623258,true;true,13123/20013
elevated baseline crp,C0742906;C0168634;C1442488,false;true;false,13124/20013
elevated biomarkers and st - segment changes,C0205250;C0005516;C3163633,false;true;false,13125/20013
elevated bnp,C0205250;C0054015;C1095989;C1417808;C2982014;C3163633,false;true;false;false;false;false,13126/20013
elevated cholesterol,C0020443,true,13127/20013
elevated crp,C0742906,false,13128/20013
elevated high - sensitivity crp — no . { % ) * *,C0742906;C1441604,false;false,13129/20013
elevated natriuretic peptide level ( n = nmbr ),C0205250;C1144709;C0441889;C0456079;C1547707;C2946261;C2709270;C3537020;C3163633,false;true;false;false;false;false;false;false;false,13130/20013
elevated natriuretic peptides in previous nmbr days — no . ( % ) $,C0205250;C1144709;C0205156;C0439228;C1552607;C3163633,false;true;false;false;false;false,13131/20013
elevated natriuretic peptides in previous nmbr days — no . ( % ) : ! :,C0205250;C1144709;C0205156;C0439228;C1552607;C3163633,false;true;false;false;false;false,13132/20013
elevated non - hdl cholesterol,C0205250;C0729627;C1535899;C3163633,false;false;false;false,13133/20013
elevated serum creatinine ( > nmbr . nmbr mg / dl_ ),C0700225;C0439269,false;false,13134/20013
elevated serum creatinine,C0700225,false,13135/20013
elevated symptomatic serum creatinine,C0700225;C0231220,false;false,13136/20013
elevated troponin — %,C0205250;C0041199;C3163633,false;true;false,13137/20013
elevated vs normalb,C0205250;C3163633,false;false,13138/20013
elevated vs . normalb,C0205250;C3163633,false;false,13139/20013
elevated vs . normalc,C0205250;C3163633,false;false,13140/20013
elevation of cardiac biomarker levels — no . / total no . ( % ),C0439775;C1271630;C0441889;C0702240,false;false;false;false,13141/20013
elevation of cardiac biomarker levels or st - seg - ment deviation > nmbr mm — no . / total no . ( % ),C0439775;C1271630;C0441889;C0702240,false;false;false;false,13142/20013
elevation of troponin levels — no . / total no . ( % ),C0439775;C0041199;C0441889;C0702240,false;true;false;false,13143/20013
eligibility risk factors,C0013893;C0035648;C1553898;C1548635,true;true;false;false,13144/20013
eligibility risk factors — n ( % ) :,C0013893;C0035648;C1553898;C1548635,true;true;false;false,13145/20013
eligibility risk factors !,C0013893;C0035648;C1553898;C1548635,true;true;false;false,13146/20013
eligibility risk factors /,C0013893;C0035648;C1553898;C1548635,true;true;false;false,13147/20013
eligibility risk factors :,C0013893;C0035648;C1553898;C1548635,true;true;false;false,13148/20013
eligibility risk factors ’ ),C0013893;C0035648;C1553898;C1548635,true;true;false;false,13149/20013
eligibility risk factorsa,C0013893;C0035647;C4552904;C1548635,true;true;false;false,13150/20013
eligibility strata,C0013893;C1548635,true;false,13151/20013
eligibility stratum,C0013893;C1548635,true;false,13152/20013
elms,C0330531;C2980688,true;false,13153/20013
embolism,C0013922;C1704212,true;true,13154/20013
emotional function,C0013987;C0031843;C0542341;C0700205;C1705273;C0849912,true;true;false;false;false;false,13155/20013
empa,C2699863,false,13156/20013
empagiiflozin nmbr mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13157/20013
empaglifiozin nmbr mg ( w = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13158/20013
empaglifiozin nmbr . nmbr mg ( w = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13159/20013
empagliflozin ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C3490348,true,13160/20013
empagliflozin ( n   =   nmbr ),C3490348,true,13161/20013
empagliflozin nmbr mg / day ( n = nmbr ),C3490348;C0439422,true;false,13162/20013
empagliflozin n with event / n,C3490348;C0441471;C4019010,true;false;false,13163/20013
empagliflozin pooled ( n = nmbr ),C3490348;C1709595;C2349200;C4522255,true;false;false;false,13164/20013
empagllflozin,,,13165/20013
empagllflozln,,,13166/20013
emphysema ( itt ) ( n = nmbr ),C0013990;C0034067,true;true,13167/20013
emphysema ( n = nmbr ),C0013990;C0034067,true;true,13168/20013
empty,C1880497,false,13169/20013
end - point ( sd ),C2349179;C2699239;C2826544,false;false;false,13170/20013
end - stage renal disease,C0022661;C2316810,true;false,13171/20013
end of trial,C0444930;C0008976;C2746065,false;true;false,13172/20013
endoscopic disease severity,C0014245;C0521117;C0442418,true;false;false,13173/20013
endpoint *,C2349179;C2826544,false;false,13174/20013
endpoints,C2349179,false,13175/20013
enox,C3147679,false,13176/20013
enoxaparin ( n = nmbr,C0206460,true,13177/20013
enoxaparin nmbr mg ( n = nmbr,C0206460;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13178/20013
enoxaparin only,C0206460;C0205171;C1720467,true;false;false,13179/20013
enrolled from re - cover ii study — no . ( % ),C4684790,false,13180/20013
enrolled from re - cover study — no . ( % ),C4684790,false,13181/20013
enrolled in russia or georgia,C4684790;C0035970,false;true,13182/20013
enrolled in the americas,C4684790;C0002454;C0596070,false;true;false,13183/20013
enrolled into osler,C4684790,false,13184/20013
enrollment in lmwh substudy,C1516879;C0019139;C3536766;C1696073;C3888021,false;true;false;false;false,13185/20013
enrollment strata : prior hospitalization,C1516879;C0332152;C0019993;C2826257;C1696073;C3888021,false;false;true;false;false;false,13186/20013
enrollment to randomization,C1516879;C0034656;C1696073;C3888021,false;true;false;false,13187/20013
enrolment through hf,C1516879;C0018488;C1313497;C1538440;C3273279;C1696073;C3888021,false;true;true;false;false;false;false,13188/20013
enrope + sonth afriea,,,13189/20013
entacapone,C0165921,true,13190/20013
enthesitis score ( mases,C1282952;C0449820;C4050231,false;false;false,13191/20013
enthesitis score at baseline,C1282952;C0449820;C0168634;C1442488;C4050231,false;false;true;false;false,13192/20013
enthesitis score *,C1282952;C0449820;C4050231,false;false;false,13193/20013
entire evaluable cohort,C0439751;C1516986;C0009247;C0599755;C0444667,false;false;true;false;false,13194/20013
entocort ec ( n = nmbr ),C1170256,false,13195/20013
entry category,C1705654;C0683312;C3889287,false;false;false,13196/20013
entry criteria ( % ),C1705654;C0243161,false;true,13197/20013
entry hip fracture location,C1705654;C3260017,false;false,13198/20013
environmental stimuli,C0450025,false,13199/20013
eo,C0332120,false,13200/20013
eo severity by la classification at baseline ( baseline of the healing study ),C0332120;C0439793;C1881447;C0522510,false;false;false;false,13201/20013
eos count ( cells / pl ),C1623465;C0750480;C0007584;C3897966;C4049765;C0007634;C1705566;C1861303,false;false;true;false;false;true;false;true,13202/20013
eosinoohil count,C0750480;C1705566,false;false,13203/20013
eosinophil counf cells pl ',C0682547;C3897966;C4049765,false;false;false,13204/20013
eosinophil count,C0200638;C0750879,false;false,13205/20013
eosinophil count ( cells / pl ),C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;true;false;false;true;false,13206/20013
eosinophil high,C0014467,true,13207/20013
eosinophil low,C0014467,true,13208/20013
eosinophils,C0014467;C0200638,true;false,13209/20013
eosinophils ( cells / ll ) inclusion criteria,C0682547,false,13210/20013
eosinophils £ nmbr % ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13211/20013
eosinophils £ nmbr % ( n = nmbr ),C0014467;C0200638,true;false,13212/20013
eosinophils < nmbr nmbrxnmbr * nmbr / l ( n = nmbr ),C0014467;C0200638,true;false,13213/20013
eosinophils < nmbr . nmbrxnmbr ' ' nmbr ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13214/20013
eosinophils < nmbr . nmbrxnmbr ' ' nmbr ( n = nmbr ),C0014467;C0200638,true;false,13215/20013
eosinophils < nmbr . nmbrxnmbr * nmbr ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13216/20013
eosinophils < nmbr . nmbrxnmbr * nmbr ( n = nmbr ),C0014467;C0200638,true;false,13217/20013
eosinophils < nmbr % ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13218/20013
eosinophils < nmbr % ( n = nmbr ),C0014467;C0200638,true;false,13219/20013
eosinophils > nmbr nmbrxnmbr * nmbr / nmbr ( n = nmbr ),C0014467;C0200638,true;false,13220/20013
eosinophils > nmbr . nmbrxnmbr ' ' nmbr ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13221/20013
eosinophils > nmbr . nmbrxnmbr ' ^ ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13222/20013
eosinophils > nmbr . nmbrxnmbr * nmbr ( n = nmbr ),C0014467;C0200638,true;false,13223/20013
eosinophils > nmbr . nmbrxnmbr^^ ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13224/20013
eosinophils > nmbr % ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13225/20013
eosinophils > nmbr % ( n = nmbr ),C0014467;C0200638,true;false,13226/20013
eosinophils nmbr . nmbrxnmbr ' ' nmbr ( n = nmbr ),C0014467;C0200638,true;false,13227/20013
eosinophils nmbr % ( itt ) ( n = nmbr ),C0014467;C0200638,true;false,13228/20013
eosinophils nmbr % ( n - nmbr ),C0014467;C0200638,true;false,13229/20013
epilepsy drug,C0014544;C0013227;C1254351,true;true;false,13230/20013
epilepsy with grand mal seizures on awakening,C0014549;C0494475,true;true,13231/20013
epistaxis,C0014591;C4554627,true;false,13232/20013
eplerenone ( n   = nmbr ),C0961485,true,13233/20013
eq - nmbrd - nmbr   l,C0205163;C0439185,false;false,13234/20013
eq - nmbrd mobility,C0205163;C0080078;C0425245;C0449580;C4318935;C0439185,false;true;false;false;false;false,13235/20013
eq - nmbrdprofile - mobility,C0205163;C0080078;C0425245;C0449580;C4318935;C0439185,false;true;false;false;false;false,13236/20013
eqnmbrda health index status score,C0205163;C0011318;C0018759;C0600653;C0449820;C4050231;C0918012;C1552854;C1637833;C2986546;C3668815;C0439185,false;true;true;true;false;false;true;false;false;false;false;false,13237/20013
er visit,C3810541;C0545082;C1512346;C2826704;C3811131,false;false;false;false;false,13238/20013
era,C1521863;C3495919,true;false,13239/20013
era and pde - nmbri,C1521863;C3495919,true;false,13240/20013
erd *,,,13241/20013
erectile dysfunction,C0242350;C1961100,true;false,13242/20013
erectile function  ipss,C0030847;C0031843;C1019118;C1998280;C2827405;C3811063;C0542341;C0700205;C1705273,true;true;false;false;false;false;false;false;false,13243/20013
erlugliflozin nmbr mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13244/20013
erosion score ( nmbr – nmbr scale ),C0333307;C0449820;C0175659;C0349674;C1947916;C4050231;C1880549;C1959609;C3887524,false;false;true;false;false;false;false;false;false,13245/20013
ertuglifldzin nmbr mg vs placebo / glinepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13246/20013
ertugliflozin,C4079805,true,13247/20013
ertugliflozin nmbr mg ( n nmbr nmbr ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13248/20013
ertugliflozin nmbr mg vs placebo / giimepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13249/20013
ertugliflozin nmbr mg vs placebo / glimepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13250/20013
ertugliflozin nmbr mg vs placebo / glirneplride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13251/20013
ertugliflozin nmbr   mg,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13252/20013
ertugliflozin nmbr   mg ( n   =   nmbr ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13253/20013
ertugliflozin nmbr mg ( n   =   nmbr ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13254/20013
ertugliflozin nmbr mg vs placebo / glinepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13255/20013
ertugliflozin nmbrmg,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13256/20013
ertuglrflozin nmbr mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13257/20013
erysipelas,C0014733,true,13258/20013
erythrocyte sedimentation rate ( mm / h ),C1176468;C0456680;C1619634,false;false;true,13259/20013
esophageal hiatal hernia *,C3489393,true,13260/20013
esr ( mm / hour ),C3811131;C4330985;C0439227;C0564385;C4554674,false;false;false;false;false,13261/20013
esr ( mm / hour  per unit ),C3811131;C4330985;C0456685;C4554674,false;false;false;false,13262/20013
esrd ',C0022661;C0035078;C2316810,true;true;false,13263/20013
esrd only rr ( ci ) “,C0022661;C0205171;C4554402;C0008107;C3259781;C1720467;C0035078;C2316810,true;false;false;true;false;false;true;false,13264/20013
esrd or nmbr % decline in gfr,C0022661;C0035078;C2316810,true;true;false,13265/20013
esrd or nmbr % dedine in gfr,C0022661;C0035078;C2316810,true;true;false,13266/20013
esrd *,C0022661;C0035078;C2316810,true;true;false,13267/20013
established atherosclerotic cardiovascular disease — no . { % ),C0443211;C0004153;C1272684,false;true;false,13268/20013
established atherosclerotic disease — no . { % ),C0443211;C0333482;C0012634;C1272684,false;false;true;false,13269/20013
established cvd / chronic kidney disease ( age > nmbr ) ^ * ’,C0443211;C0007222;C1561643;C0001779;C4553188;C1272684,false;true;true;false;false;false,13270/20013
established maerovaseular disease and albuminuria,C0443211;C0012634;C1272684,false;true;false,13271/20013
established renal disease ( egfr nmbr - < nmbr ml / min / nmbr . nmbr m^ with any uacr mg / g or egfr > nmbr - nmbr ml / inin / lnmbr mnmbr with an uacr > nmbr mg / g ) without previous maerovaseular and albuminuria disease,C0443211;C0022658;C1739039;C3829050;C0369637;C0441923;C3811844;C3812682;C1272684,false;true;true;false;false;false;false;false;false,13272/20013
established renal disease *,C0443211;C0022658;C1272684,false;true;false,13273/20013
estimate,C0750572,false,13274/20013
estimate ( nmbr % ci ),C0750572;C0008107;C3259781,false;true;false,13275/20013
estimate ( nmbr % cl ),C0750572;C0596019,false;false,13276/20013
estimated creatinine clearance — ml / min  i ,C0750572;C0812399;C0023806;C0702093;C1524029;C3813700;C0439445;C0021966;C0221138,false;false;true;false;false;false;false;true;false,13277/20013
estimated creatinine clearance — ml / min §,C0750572;C0812399;C0439445,false;false;false,13278/20013
estimated creatinine clearance ( ml / min ),C0750572;C0812399;C0439445,false;false;false,13279/20013
estimated creatinine clearance < nmbr ml / mint,C0750572;C0812399;C0439526;C0452249;C0522467;C1337213;C1576800;C3890003;C1705224;C3887665,false;false;false;false;true;false;false;false;false;false,13280/20013
estimated creatinine clearance   !  ,C0750572;C0812399,false;false,13281/20013
estimated creatinine clearancet,C0750572;C0010294;C1561535,false;true;false,13282/20013
estimated cv risk at baseline,C3538987;C1519101;C0168634;C1442488;C4048877;C4318503,false;false;true;false;true;false,13283/20013
estimated gfr — ml / min / nmbr . nmbr m^ |,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13284/20013
estimated gfr — ml / min / nmbr . nmbr mnmbr,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13285/20013
estimated gfr — no . ( % ) ^ |,C0750572;C0017654;C1424601,false;true;false,13286/20013
estimated gfr ( ml / min per nmbr . nmbr mnmbr ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13287/20013
estimated gfr ( ml / min / nmbr . nmbr mnmbr ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13288/20013
estimated gfr ( ml / min / nmbr . nmbr mnmbr ) lipid baseline lipid profile,C0750572;C0017654;C0439445;C0369637;C0023779;C0168634;C1979963;C2003903;C1442488;C0441923;C1424601,false;true;false;false;true;true;false;false;false;false;false,13289/20013
estimated gfr ( ml / min / nmbr . nmbrmnmbr ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13290/20013
estimated gfr < nmbr ml / min / nmbr . nmbr m^ — no . ( % ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,13291/20013
estimated gfr at baseline,C0750572;C0017654;C0168634;C1442488;C1424601,false;true;true;false;false,13292/20013
estimated gfr^,C0750572;C0017654;C1424601,false;true;false,13293/20013
estimated glomerular filtration rate — ml / min / nmbr . nmbr m^,C3811844;C0439445;C0369637;C0441923,false;false;false;false,13294/20013
estimated glomerular filtration rate — ml / min / nmbr . nmbr mnmbr,C3811844;C0439445;C0369637;C0441923,false;false;false;false,13295/20013
estimated glomerular filtration rate — ml / min / nmbr . nmbr mnmbr of body - surface area §,C3811844;C0439445;C0369637;C0489451;C0017446;C0205146;C0441923,false;false;false;false;true;false;false,13296/20013
estimated glomerular filtration rate — no . ( % ),C3811844,false,13297/20013
estimated glomerular filtration rate < nmbr,C3811844,false,13298/20013
estimated glomerular filtration rate^,C3811844,false,13299/20013
estimated glomerular filtration rate | |,C3811844,false,13300/20013
estimated glomerular filtration rate §,C3811844,false,13301/20013
estimated mean,C0750572;C0444504;C2347634;C2348143,false;false;false;false,13302/20013
estimated mean nmbr % cl,C0750572;C0444504;C0596019;C2347634;C2348143,false;false;false;false;false,13303/20013
estimated means and treatment differences ( % ),C0750572;C1704970,false;false,13304/20013
estimated number of pack - years,C0750572;C0237753;C1277691;C0449788,false;false;false;false,13305/20013
estimated proportions ( % ) and odds ratios,C0750572;C1709707,false;false,13306/20013
estimated treatment difference ( % ),C0750572;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;true;false;false;false;false;false,13307/20013
estradiol ( enmbr ) ( pmol / l ),C0014912;C0439284,true;false,13308/20013
estradiol ( pmol / l ),C0014912;C0439284,true;false,13309/20013
estradiol quartiles,C0014912;C2828255,true;false,13310/20013
estrogen,C0014939;C2936882;C4542544,true;false;false,13311/20013
estrogen ( ' % ? ),C0014939;C2936882;C4542544,true;false;false,13312/20013
estrogen supplementation,C0014939;C0242297;C2936882;C4542544,true;false;false;false,13313/20013
estrogen supplementation -,C0014939;C0242297;C2936882;C4542544,true;false;false;false,13314/20013
etd : − nmbr . nmbr [ − nmbr . nmbr  nmbr . nmbr]nmbr % ci  p     =   nmbr . nmbr,C1180255;C0008107;C3259781,false;true;false,13315/20013
etd : − nmbr . nmbr [ − nmbr . nmbr  − nmbr . nmbr]nmbr % ci  p     <   nmbr . nmbr,C1180255;C0008107;C3259781,false;true;false,13316/20013
etd : − nmbr . nmbr [ − nmbr . nmbr  − nmbr . nmbr]nmbr % ci  p     <   nmbr . nmbr,C1180255;C0008107;C3259781,false;true;false,13317/20013
ethnic background,C0015031,true,13318/20013
ethnic minority group — no . ( % ),C0015031;C0026192;C1879937;C0680174,true;true;false;false,13319/20013
ethnic origin white,C0015031;C0007457;C0043157;C0220938,true;true;true;false,13320/20013
ethnic origin *,C0015031,true,13321/20013
ethnicity - - hispanic or latino,C0015031;C0086409;C0243103,true;true;true,13322/20013
ethnicity t,C0015031;C0243103,true;true,13323/20013
ethnicitynmbr ',C0015031;C0243103,true;true,13324/20013
ethnieity,,,13325/20013
etiology,C0015127;C1314792;C1524003,true;true;false,13326/20013
etiology ( % ),C0015127;C1314792;C1524003,true;true;false,13327/20013
etoricoxib ( n = nmbr ),C0972314,true,13328/20013
etoricoxib nmbr mg,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13329/20013
etoricoxib group ( n = nmbr nmbr ),C0972314;C0441848,true;false,13330/20013
etr : nmbr . nmbr [nmbr . nmbr  nmbr . nmbr]nmbr % ci  p     =   nmbr . nmbr,C0008107;C3259781,true;false,13331/20013
eu,C0015179;C3665627,true;false,13332/20013
europe ( including south africa ),C0015176,true,13333/20013
europe ( plus south africa ),C0015176;C0332287;C0037712,true;false;true,13334/20013
europe nmbr ( n = nmbr,C0015176,true,13335/20013
europe nmbr ¶,C0015176,true,13336/20013
europe nmbr +,C0015176,true,13337/20013
europe and russia,C0015176,true,13338/20013
europenmbr,C0015176,true,13339/20013
european or arab,C0239307;C1535514,false;false,13340/20013
evening,C0587117,false,13341/20013
evening mealb,C0587117,false,13342/20013
event ( p = nmbr . nmbro + ),C0441471;C4019010,false;false,13343/20013
event during on -,C0441471;C4019010,false;false,13344/20013
event during overall,C0441471;C0282416;C1561607;C4019010,false;true;false;false,13345/20013
event incidence / n,C0441471;C0021149;C0220856;C4019010,false;true;true;false,13346/20013
event number,C0441471;C0237753;C0449788;C4019010,false;false;false;false,13347/20013
event rate ( per nmbr,C0441471;C0871208;C1521828;C4019010,false;false;false;false,13348/20013
event rate ( % / vr ),C0441471;C0871208;C3476815;C1521828;C4019010,false;false;false;false;false,13349/20013
event rate ( % / year ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,13350/20013
event rate ( per nmbr person - years ),C0441471;C0871208;C0027361;C0439234;C2347489;C1521828;C4019010,false;false;true;false;false;false;false,13351/20013
event rate ( per nmbr person years ),C0441471;C0871208;C0027361;C0439234;C2347489;C1521828;C4019010,false;false;true;false;false;false;false,13352/20013
event rates per nmbr patient - years ( nmbr % ci ),C0441471;C0871208;C0030705;C0439234;C0008107;C3259781;C1521828;C4019010,false;false;true;false;true;false;false;false,13353/20013
event / patients in group ( incidence / nmbr person - year ),C0441471;C0030705;C0441833;C0021149;C0027361;C0439234;C0439508;C2347489;C0220856;C0687744;C1257890;C1519504;C1705428;C1705429;C4019010,false;true;false;true;true;false;false;false;true;false;true;false;false;false;false,13354/20013
event { n ( % ),C0441471;C4019010,false;false,13355/20013
events consistent with genital infection,C0441471;C3541888,false;false,13356/20013
events consistent with uti,C0441471;C3541888,false;false,13357/20013
events consistent with volume depletion,C0441471;C3541888,false;false,13358/20013
events requiring assistance,C0441471;C3541888,false;false,13359/20013
events / patient - year ( n ),C0441471;C0030705;C0439234;C0439508;C3541888,false;true;false;false;false,13360/20013
ever,,,13361/20013
ever been on a vka,,,13362/20013
every day,C0332173;C0439228;C0439505,false;false;false,13363/20013
evolocumab,C3529352,true,13364/20013
evolocumab ( n = nmbr ),C3529352,true,13365/20013
evolocumab + soc ( n = nmbr ),C3529352,true,13366/20013
evomab,,,13367/20013
evomab + soc,,,13368/20013
ex - drinker,C0337679,false,13369/20013
ex - smokers ( itt ) ( n = nmbr ),C0337671;C4555205,false;true,13370/20013
ex - smokers ( n = nmbr ),C0337671;C4555205,false;true,13371/20013
ex - smokers : qvainmbr - sfc,C0337671;C4521536;C4555205,false;false;true,13372/20013
exacerbation historyh,C4086268,false,13373/20013
exacerbation in previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,13374/20013
exacerbation rate per year,C4086268;C0871208;C0439234;C0439508;C1521828,false;false;false;false;false,13375/20013
exacerbation within nmbr mo,C4086268;C0026544;C0332177,false;true;false,13376/20013
exacerbation within previous nmbr mo,C4086268;C0205156;C0026544;C0332177;C1552607,false;false;true;false;false,13377/20013
exacerbations in past nmbr mo — no . ( % ),C4086268;C1444637;C0026544;C0332177;C4284302,false;false;true;false;false,13378/20013
exacerbations in previous nmbr mo ( n ),C4086268;C0205156;C0026544;C0332177;C1552607,false;false;true;false;false,13379/20013
exacerbations in previous year requiring hospitalization and / or ed visit,C4086268;C0205156;C0439234;C0019993;C0439508;C1552607,false;false;false;true;false;false,13380/20013
exacerbations in previous year requiring hospitalization,C4086268;C0205156;C0439234;C0019993;C0439508;C1552607,false;false;false;true;false;false,13381/20013
exacerbations in the past nmbr months n,C4086268;C4331910,false;false,13382/20013
exacerbations in the prev . year : nmbr,C4086268;C1552852;C0439234;C0439508,false;false;false;false,13383/20013
exacerbations in the year before study,C4086268;C0439234;C0439508,false;false;false,13384/20013
exacerbations requiring hospitalisation ( past year ) ( % ),C4086268,false,13385/20013
exacerbations requiring oral steroids / antibiotics ( past year ) ( % ),C4086268,false,13386/20013
exact - pro total score,C2828393;C0033382;C2964552;C0523852;C2987124;C4050514,false;true;false;false;true;false,13387/20013
exact ( b ),C2828393;C4050514,false;false,13388/20013
exenatide ± oad,C0167117,true,13389/20013
exenatide er,C0167117;C3810541;C3811131,true;false;false,13390/20013
exercise status,C0015259;C0449438;C1522704,true;false;false,13391/20013
exlertl ot disease,C1318464;C0012634;C1418208;C1705587,true;true;false;false,13392/20013
expanded cv endpoint,C0205229;C3538987;C2349179;C2826544;C4048877;C4318503,false;false;false;false;true;false,13393/20013
expanded mace,C0205229;C0349381;C0949745;C1445339,false;false;true;false,13394/20013
experience ( n,C0237607;C0596545,false;false,13395/20013
experienced,C0237607;C0596545,false;false,13396/20013
experimental intervention group ( n = nmbr ),C1517586;C0184661;C0441848;C0886296;C1273869,false;true;false;false;false,13397/20013
experimental treatment group,C0949266;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2585119,true;false;false;true;false;false;false;false,13398/20013
exploratory cardiovascular and death outcomes,C0007226;C3887460,true;false,13399/20013
exploratory kidney and microvascular outcomes,C0022646;C0227665,true;false,13400/20013
exposed,C0332157,false,13401/20013
exposure to study drug — days,C0332157;C0013175;C0439228,false;true;false,13402/20013
exsmoker,C0337671;C4555205,false;true,13403/20013
extended - release niacin plus statin ( n = nmbr ),C1707968;C0027996;C0332287;C0360714;C1142562,false;true;false;true;false,13404/20013
extended cardiovascular endpoint,C0231448;C0007226;C2349179;C2826544;C3887460;C0231449;C0439792,false;true;false;false;false;false;false,13405/20013
extensive / pancolitis,C0205231;C0868908,false;false,13406/20013
extenswe,,,13407/20013
extent of index dvt ' ( n,C0439792;C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;true;false;false;false,13408/20013
extent of index pe ' ( n,C0439792;C0600653;C0070939;C1880476;C4284304;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;true;false;false;false,13409/20013
extracranial,C0580586,false,13410/20013
ez / simva nmbr / nmbr mg,C0206578;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13411/20013
eze = ezetimibe nmbr mg  pooled sinva = simvastatin pooled across doses  pooled eze / sinva = ezetimibe / simvastatin tablet pooled across doses  bni = body mass index  ldl - c = low - density lipoprotein cholesterol  t g = triglycerides  t c = total cholesterol  hdl - c = high - density lipoprotein cholesterol  apo — apolipoprotein  c rp — c - neactive protein  rlp - c = remnant - like particle - cholesterol .,C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13412/20013
eze / simva ( n = nmbr ),,,13413/20013
ezetimibe nmbr mg ( n — nmbr ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13414/20013
ezetimibe / simvastatin group,C1532737;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,13415/20013
f - plasma glucose,C0016327;C0202042;C0455280,true;false;false,13416/20013
fnmbr vs placebo,C0016327,true,13417/20013
facial psoriasis,C1276112,false,13418/20013
facilitated pci ( n = nmbr ),C4049621,false,13419/20013
facit - f,C3272505,false,13420/20013
facit - f score,C3272505;C0449820;C4050231,false;false;false,13421/20013
factor,C1521761;C2827422,false;false,13422/20013
factor absent,C1521761;C2827422,false;false,13423/20013
factor at baseline,C1521761;C0168634;C1442488;C2827422,false;true;false;false,13424/20013
factor present,C1521761;C0150312;C0449450;C2827422,false;false;false;false,13425/20013
factor *,C1521761;C2827422,false;false,13426/20013
factors dabigatran,C1521761;C2348066;C2827422,false;true;false,13427/20013
factors dabigatran event incidence / n,C1521761;C2348066;C0441471;C0021149;C0220856;C4019010;C2827422,false;true;false;true;true;false;false,13428/20013
factors that confer a,C1521761;C2827422,false;false,13429/20013
failure,C0231174;C0680095,false;false,13430/20013
fair control ( nmbr - nmbr . nmbr ),C2911689;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,false;true;false;false;false;false;false,13431/20013
fair or poor,C2911689,false,13432/20013
fair / poor,C2911689;C0032854;C0542537;C2700379,false;true;false;false,13433/20013
fall in last nmbr mo,C0085639;C0026544;C0332177;C0238715;C4553726,false;true;false;false;false,13434/20013
fall in last nmbr months ( % ),C0085639;C0439231;C0238715;C4553726,false;false;false;false,13435/20013
familial,C0015576;C0241888,true;false,13436/20013
familv historv of cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,13437/20013
family history of diabetes mellitus — no . ( % ),C0260526;C1313937,false;false,13438/20013
family history of diabetes mellitus — no . { % ),C0260526;C1313937,false;false,13439/20013
family history of myocardial infarction prior to age nmbr,C0455406,false,13440/20013
family history of premature chd * *,C0241889;C0151526;C0280604;C3542407;C0205252;C4018905,true;true;false;false;false;false,13441/20013
family history of premature coronary heart disease,C0260520;C0151526;C0205252;C4018905;C1313980;C2317524,false;true;false;false;false;false,13442/20013
family history of premature heart disease,C0850707;C0151526;C0018787;C0205252;C4018905,false;true;true;false;false,13443/20013
family history ot chd,C0241889;C1318464;C0280604;C3542407;C1418208;C1705587,true;true;false;false;false;false,13444/20013
famotidine nmbr mg ( n = nmbr ),C0015620;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13445/20013
fas,,,13446/20013
faster aspart,C0015663;C0123677;C0456962;C2985769,true;false;false;false,13447/20013
faster aspart ( mealtime ),C0015663;C0123677;C0587119;C0456962;C2985769,true;false;true;false;false,13448/20013
faster aspart   +   basal,C0015663;C0123677;C0205112;C0456962;C2985769,true;false;false;false;false,13449/20013
fasting,C0015663,true,13450/20013
fasting blood glucose > nmbr mg / dl ( > nmbr . nmbr mmol / l ),C0428568;C0439269;C1532563;C1261430,false;false;false;false,13451/20013
fasting c - peptide ( ng / ml ),C0015663;C0006558;C0439275,true;true;false,13452/20013
fasting glucose > nmbr mg / dl,C0015663;C0017725;C0439269,true;true;false,13453/20013
fasting glucose > nmbr mg / dl *,C0015663;C0017725;C0439269,true;true;false,13454/20013
fasting glucose level,C0202045,false,13455/20013
fasting glucose mg / dl diabetes classification,C0015663;C0017725;C0439269;C0011847;C0008902;C0008903;C0678229;C0011849,true;true;false;false;true;true;false;true,13456/20013
fasting glucose *,C0015663;C0017725,true;true,13457/20013
fasting indices,C0015663;C4033634,true;false,13458/20013
fasting insulin ( miu / ml ),C0015663;C0021641;C0439457;C1533581;C1579433;C3714501,true;true;false;false;false;false,13459/20013
fasting lipids ( mmol / nmbr ),C0015663;C0023779;C0439190,true;true;false,13460/20013
fasting plasma glucose — mmol / liter,C0015663;C0202042;C0439190;C0475211;C0455280,true;false;false;false;false,13461/20013
fasting plasma glucose ( change from baseline ),C0583513;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,13462/20013
fasting plasma glucose ( mg / dl ) nmbr,C0015663;C0202042;C0439269;C0455280,true;false;false;false,13463/20013
fasting plasma glucose ( mmol / l ) nmbr,C0015663;C0202042;C1532563;C0455280,true;false;false;false,13464/20013
fasting plasma glucose categories,C0015663;C0202042;C0683312;C0455280,true;false;false;false,13465/20013
fasting plasma glucose in mmol / l ( median ( qnmbr,C0583513;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,13466/20013
fasting plasma glucose *,C0015663;C0202042;C0455280,true;false;false,13467/20013
fasting proinsulin ( pmol / l ),C0015663;C0033362;C0439284;C3813208,true;true;false;false,13468/20013
fasting serum glucose — mg / dl * *,C0015663;C0202041;C0439269;C3534430,true;false;false;false,13469/20013
fasting serum glucose level,C0202045;C0229671;C1546774;C1550100;C0015663;C0583332,false;true;false;false;true;false,13470/20013
fasting tgs,C0015663;C1156212;C1537574,true;false;false,13471/20013
fasting triglyceride level,C0015663;C0428475,true;false,13472/20013
fasting triglycerides,C0015663;C0041004,true;true,13473/20013
fasting triglycerides > nmbr mg / dl *,C0015663;C0041004;C0439269,true;true;false,13474/20013
fatal,C1302234;C1705232,false;false,13475/20013
fatal & nonfatal ccvd,C1302234;C1705232,false;false,13476/20013
fatal & nonfatal hospitalized heart failure,C1302234;C0701159;C0018801;C0018802;C4554158;C1705232,false;false;true;true;false;false,13477/20013
fatal & nonfatal hospitalized stroke,C1302234;C0701159;C0038454;C4554100;C1705232,false;false;true;false;false,13478/20013
fatal aes,C1302234;C1412268;C2699274;C1705232,false;false;false;false,13479/20013
fatal bleed,C1302234;C0019080;C1705232,false;true;false,13480/20013
fatal bleeding,C1302234;C0019080;C1705232,false;true;false,13481/20013
fatal chd + nonfatal ml,C1302234;C0280604;C0439526;C1705224;C3887665;C3542407;C1705232,false;false;false;false;false;false;false,13482/20013
fatal chd and nonfatal mia,C1302234;C0280604;C3542407;C1705232,false;false;false;false,13483/20013
fatal myocardial infarction,C1302234;C0027051;C0428953;C2926063;C3810814;C4552959;C1705232,false;true;false;false;false;false;false,13484/20013
fatal or non - fatal myocardial infarction,C1302234;C1705232,false;false,13485/20013
fatal or non - fatal stroke,C1302234;C1705232,false;false,13486/20013
fatal or nonfatal myocardial infarction,C1302234;C1705232,false;false,13487/20013
fatal or nonfatal stroke,C1302234;C1705232,false;false,13488/20013
fatal or nonlatal myocardial inlarctlon,C1302234;C1705232,false;false,13489/20013
fatal or nonlatal stroke,C1302234;C1705232,false;false,13490/20013
fatal stroke,C1302234;C0038454;C4554100;C1705232,false;true;false;false,13491/20013
fatal / nonfatal mi,C1302234;C3810814;C1705232,false;false;false,13492/20013
fatal / nonfatal ml,C1302234;C0439526;C1705224;C3887665;C1705232,false;false;false;false;false,13493/20013
fatal / nonfatal stroke,C1302234;C0038454;C4554100;C1705232,false;true;false;false,13494/20013
fatigue ( range nmbr - nmbr ),C0015672;C1514721;C2348147;C3542016;C3463815;C4050243;C4554645,true;false;false;false;false;false;false,13495/20013
fatty acid group ( n = nmbr ),C0015684;C0441848,true;false,13496/20013
favors favors amlodipine chlorthalidone,C0309049,false,13497/20013
favors favors lisinopril chlorthalidone,C0309049,false,13498/20013
favors amlodipine favors chlorthalidone,C0309049;C0051696;C0008294,false;true;true,13499/20013
favors comparator,C0309049;C1707454;C4553389;C4553390,false;false;false;false,13500/20013
favors dabigatran,C0309049;C2348066,false;true,13501/20013
favors ff / vi favors placebo,C0309049;C4554348;C0205999,false;false;true,13502/20013
favors ffa / i favors placebo,C0309049;C0015688;C0021966;C0032042;C1696465;C1706408;C0221138,false;true;true;true;false;false;false,13503/20013
favors lisinopril favors chlorthalidone,C0309049;C0065374;C0008294,false;true;true,13504/20013
fbg ( mg / dl ),C0439269,false,13505/20013
fbg ( mmol / l ),C1532563,false,13506/20013
fbg baseline,C0168634;C1442488,true;false,13507/20013
fbg,,,13508/20013
fc > nmbr mg / dl ( > _ nmbr . nmbr mmol / l ) or history of diabetes,C2983605;C0439269;C1532563,false;false;false,13509/20013
fcal,,,13510/20013
fdc nmbr / nmbr pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,13511/20013
fdc nmbr / nmbr pg vs aclidinium nmbr pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,13512/20013
fdc nmbr / nmbr pg vs formoterol nmbr pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,13513/20013
fdc nmbr / nmbr pg vs placebo,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,13514/20013
fdc nmbr / nmbr   μ g ( n   =   nmbr ),C0340427;C0439267;C1413520;C3539652,true;false;false;false,13515/20013
feature,C1521970;C1706388;C2346469;C2348519,false;false;false;false,13516/20013
febuxostat,C0249529,true,13517/20013
febuxostat nmbr mg,C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13518/20013
febuxostat nmbr mg ( n = nmbr ),C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13519/20013
febuxostat nmbr mg daily n = nmbr,C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,13520/20013
febuxostat nmbr mg n = nmbr,C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13521/20013
febuxostat nmbr mg daily n = nmbr % ( n / n ),C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,13522/20013
febuxostat nmbr mg daily n = nmbr n ( % ),C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,13523/20013
feet,C0016504;C0347981,true;false,13524/20013
femaie,,,13525/20013
female - n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13526/20013
female — no . ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13527/20013
female ( n   = nmbr,C0043210;C0086287;C1705497;C1705498,true;true;false;false,13528/20013
female ( n = lllnmbr ),C0043210;C1261077;C0086287;C1705497;C1705498,true;false;true;false;false,13529/20013
female nmbr,C0043210;C0086287;C1705497;C1705498,true;true;false;false,13530/20013
female acr definition,C0043210;C1412134;C1550452;C1704788;C3539107;C3888054;C1515941;C0086287;C1705497;C1705498,true;false;false;false;false;false;false;true;false;false,13531/20013
female eze / simva ( n = nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13532/20013
female gender ( % ),C0086287,true,13533/20013
female gender n ( % ),C0086287,true,13534/20013
female n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13535/20013
female participants who are ≥ nmbr years postmenopausal,C0043210;C0679646;C0086287;C1705497;C1705498,true;false;true;false;false,13536/20013
female patients^,C0150905,false,13537/20013
female race white,C0043210;C0034510;C0007457;C0043157;C0220938;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;true;true;false;false;false;true;false;false,13538/20013
female sex — no . { % ),C0086287,true,13539/20013
female sex — %,C0086287,true,13540/20013
female sex — no . ( % ) race — no . ( % ) f,C0086287,true,13541/20013
female simva ( n = nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13542/20013
female subjects ( n = nmbr ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,13543/20013
female / male ( % ),C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,13544/20013
female : ≥ nmbr years postmenopausal,C0043210;C0439234;C0086287;C1705497;C1705498,true;false;true;false;false,13545/20013
female : perimenopausal or < nmbr years postmenopausal,C0043210;C0086287;C1705497;C1705498,true;true;false;false,13546/20013
female : premenopausal,C0043210;C0086287;C1705497;C1705498,true;true;false;false,13547/20013
femalenmbr,C0043210;C0086287;C1705497;C1705498,true;true;false;false,13548/20013
females ( itt ) ( n = nmbr ),C0086287,true,13549/20013
females ( n = nmbr ),C0086287,true,13550/20013
females only,C0086287;C0205171;C1720467,true;false;false,13551/20013
femalesex,,,13552/20013
femoral access,C0015811;C0444454;C1554204,true;false;false,13553/20013
femoral neck ( n = nmbr,C0015815,true,13554/20013
femoral neck bmd ( g / cmnmbr ),C0015815;C0439267,true;false,13555/20013
femoral neck bmd t - score,C0015815;C0449820;C4050231,true;false;false,13556/20013
femoral neck f - score at flex baseline,C0015815;C0016327;C0449820;C0168634;C1442488;C4050231,true;true;false;true;false;false,13557/20013
femoral neck t - score,C0015815;C0449820;C4050231,true;false;false,13558/20013
femoral neck t - score ( mean = sd ),C0015815;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,true;false;false;false;false;false;false,13559/20013
femoral neckc,C0015811,true,13560/20013
femoralneck t - scorebybaselinevfxstatus,,,13561/20013
feno — ppb,C1415800,false,13562/20013
fenofibrate ( n = nmbr ),C0033228,true,13563/20013
fenofibric acid - nmbr - low - dose statin,C0060179;C0445550;C0360714;C1708745,true;false;true;false,13564/20013
fenofibric acid - i - moderate - dose statin,C0060179;C0021966;C1709056;C0360714;C0221138,true;true;false;true;false,13565/20013
fenofibric acid - i - low - dose statin,C0060179;C0021966;C0445550;C0360714;C1708745;C0221138,true;true;false;true;false;false,13566/20013
fenofibric acid   n   =   nmbr,C0060179,true,13567/20013
fev auc i nmbrh,C3714541;C0376690;C0021966;C0033727;C0369286;C0441932;C0564385;C4528284;C0221138,true;true;true;true;false;false;false;false;false,13568/20013
fevnmbr % predicted at baseline,C3714541,true,13569/20013
fevnmbr % predicted normal,C3714541,true,13570/20013
fevnmbr ( l ) pre - bronchodilator,C3714541;C2599602,true;false,13571/20013
fevnmbr at week nmbr,C3714541;C0332174;C0439230,true;false;false,13572/20013
fevnmbr aucnmbrminenmbrh,C3714541;C0376690,true;true,13573/20013
fevnmbr pre - bronchodilator ( % predicted normal ),C3714541;C2599602,true;false,13574/20013
fevnmbr pre - bronchodilator ( l ),C3714541;C2599602,true;false,13575/20013
fevnmbr prebronchodilator [ % pn],C3714541;C2599602;C0219433;C1549735;C3541307;C4049640;C4049767,true;false;true;false;false;false;false,13576/20013
fevnmbr prebronchodilator [l],C3714541;C2599602,true;false,13577/20013
fevnmbr   % of predicted normal post - bronchodilator,C0520835;C0681842;C2599594;C1882327,false;false;false;false,13578/20013
fevnmbr   at baseline ( randomization ) ∗,C3714541;C0168634;C0034656;C1442488,true;true;true;false,13579/20013
fevnmbr   at screening ∗,C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;true;false;false;false;false;false,13580/20013
fevnmbr % predicted ( sd ),C3714541;C0681842;C2699239;C1882327,true;false;false;false,13581/20013
fevnmbr % predicted < nmbr %,C3714541,true,13582/20013
fevnmbr % predicted ≥ nmbr %,C3714541,true,13583/20013
fevnmbr % reversibility ( sd ),C3714541;C0449261;C2699239,true;false;false,13584/20013
fevnmbr / fvc at baseline ( randomization ) ( % ) ∗,C3714541;C0168634;C0034656;C1442488,true;true;true;false,13585/20013
fevnmbr / fvc prebronchodilator,C3714541;C2599602,true;false,13586/20013
fevi percent predicted ( % ),C0429706;C0439165;C0849974;C1561566;C4528367,false;false;false;false;false,13587/20013
fevi reversibility — %,C3830088,false,13588/20013
fevi / fvc ( % ),C0802741;C3815113,false;false,13589/20013
fevinmbr l,C0429706;C0849974;C1561566;C4528367,false;false;false;false,13590/20013
fevj % predicted !,,,13591/20013
fevt : fvc ratio — % |,C0016529;C3714541;C0456603;C1547037,true;true;false;false,13592/20013
ff - nmbr % ( - nmbr %,C4554348,false,13593/20013
ff – nmbr % ( nmbr % ci – nmbr – nmbr % ),C4554348;C0008107;C3259781,false;true;false,13594/20013
ff nmbr % ( - nmbr %,C4554348,false,13595/20013
ff nmbr   µ g,C4554348;C0439267,false;false,13596/20013
ff nmbr % ( nmbr % ci – nmbr – nmbr % ),C4554348;C0008107;C3259781,false;true;false,13597/20013
ff mdi,C4554348;C0993596;C1839839;C4049613,false;true;true;false,13598/20013
ff / vi,C4554348;C0205999,false;true,13599/20013
ff / vi – nmbr % ( nmbr % ci – nmbr – nmbr % ),C4554348;C0205999;C0008107;C3259781,false;true;true;false,13600/20013
ff / vi ( n   =   nmbr ),C4554348;C0205999,false;true,13601/20013
ff / vi nmbr . nmbr,C4554348;C0205999,false;true,13602/20013
ff / vi nmbr % ( - nmbr %,C4554348;C0205999,false;true,13603/20013
ff / vi nmbr / nmbr   µ g,C4554348;C0205999;C0439267,false;true;false,13604/20013
ff / vi nmbr % ( nmbr % ci nmbr – nmbr % ),C4554348;C0205999;C0008107;C3259781,false;true;true;false,13605/20013
ff / vi nmbr % ( nmbr %,C4554348;C0205999,false;true,13606/20013
ffa / i,C0015688;C0021966;C0221138,true;true;false,13607/20013
fg > nmbr,C0016703;C0439214;C2348814,true;false;false,13608/20013
fgf - nmbr high / < nmbr elevated biomarkers,C0016026;C0205250;C0005516;C3163633;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false,13609/20013
fgf - nmbr high / > nmbr elevated biomarkers,C0016026;C0205250;C0005516;C3163633;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false,13610/20013
fgf - nmbr high / egfr < nmbr,C0016026;C0205250;C1739039;C3811844;C3812682;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false;false,13611/20013
fgf - nmbr high / egfr > nmbr,C0016026;C0205250;C1739039;C3811844;C3812682;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false;false,13612/20013
fgf - nmbr low / < nmbr elevated biomarkers,C0016026;C0205251;C0205250;C0005516;C3163633;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;false;true;false;false;false;false;false;false;false,13613/20013
fgf - nmbr low / > nmbr elevated biomarkers,C0016026;C0205251;C0205250;C0005516;C3163633;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;false;true;false;false;false;false;false;false;false,13614/20013
fgf - nmbr low / egfr < nmbr,C0016026;C0205251;C1739039;C3811844;C3812682;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;true;false;false;false;false;false;false;false;false,13615/20013
fgf - nmbr low / egfr > nmbr,C0016026;C0205251;C1739039;C3811844;C3812682;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;true;false;false;false;false;false;false;false;false,13616/20013
fibrate or other lipid - lowering agent,,,13617/20013
fibrillation / flutter ),C0232197;C0016385;C2242390,false;false;false,13618/20013
fibrin - specilic,C0015982,true,13619/20013
fibrinolysist,,,13620/20013
fibrinolytic,C0040044,true,13621/20013
fibrinolytic agent — no . ( % ) : t,C0016018,true,13622/20013
fibrinolytic agent before randomisation,C0016018;C0034656,true;true,13623/20013
fibrinolytic agents before or after entry,C0016018,true,13624/20013
fibrinolytic therapy — no . ( % ),C0040044,true,13625/20013
fibrinolytics,C0040044,true,13626/20013
fibrofatty,,,13627/20013
fibrous,C0016059;C0439709,true;false,13628/20013
figure nmbr least squares ( ls ) mean differences between ro ﬂ umilast and placebo in ( a ) pre - and ( b ) postbronchodilator fevnmbr in the itt population and subpopulations . copd  chronic obstructive pulmonary disease  fevnmbr  forced expiratory volume in nmbr s  ics  inhaled corticosteroid  itt  intent to treat  laba  long - acting bnmbr - agonist .,,,13629/20013
final,C0205088;C1546485;C3853528,false;false;false,13630/20013
final ( mg / dl ),C0205088;C0439269;C1546485;C3853528,false;false;false;false,13631/20013
final anmbrc ( % ),C0205088;C1546485;C3853528,false;false;false,13632/20013
final analysis ( all patients ),C0205088;C0002778;C0936012;C1524024;C1546485;C3853528,false;false;false;true;false;false,13633/20013
final timi flow grade < nmbr,C0205088;C3272266;C0441800;C0919553;C3244287;C1546485;C3853528,false;false;false;false;false;false;false,13634/20013
first co - primary,C0205435;C3245499;C1279901,false;true;false,13635/20013
first cv hospitalization,C0205435;C3538987;C0019993;C4048877;C4318503;C1279901,false;false;true;true;false;false,13636/20013
first diagnosed,C0205435;C1279901,false;false,13637/20013
first disease - progression outcome to occur §,C0205435;C0679250;C0242656;C0449258;C3542417;C1274040;C1335499;C1947900;C4552808;C1279901,false;false;true;false;false;false;false;false;false;false,13638/20013
first dose admin . nmbr - nmbrh / nmbr - nmbrh post onset of symptoms,C0205435;C4084955;C0033727;C0439568;C4086878;C0369286;C0441932;C0564385;C4528284;C1279901,false;false;true;false;false;false;false;false;false;false,13639/20013
first episode of atrial fibrillation ( vs . recurrent episode ) — no . ( % ) f,C0205435;C0332189;C0004238;C0344434;C1963067;C1279901,false;false;true;false;false;false,13640/20013
first hospitalization for chf or cv death,C0205435;C0019993;C0018802;C1279901,false;true;true;false,13641/20013
first medical contact in ambulance,C0205435;C0199168;C0332158;C0002422;C3846685;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;true;false;false;false;false;false;false,13642/20013
first serum creatinine,C0205435;C0201976;C0600061;C1279901,false;false;false;false,13643/20013
first year *,C0205435;C0439234;C0439508;C1279901,false;false;false;false,13644/20013
fistula,C0016169,true,13645/20013
fl ( nmbr . nmbr ),C1300812;C1708024,false;false,13646/20013
fl ( nmbrb ),C1300812;C1708024,false;false,13647/20013
flecainide,C0016229,true,13648/20013
flex ain ' ’,C0347129,false,13649/20013
flex aln^,C0729594;C2681220,false;false,13650/20013
flex baseline bmd t - score at femoral neck ( meanisd ),C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,13651/20013
flex baseline bmd t - score at lumbar spine ( meanisd ),C0168634;C0449820;C0024091;C3887615;C4050231;C1442488,true;false;true;false;false;false,13652/20013
flex baseline bmd t score,C0168634;C0449820;C4050231;C1442488,true;false;false;false,13653/20013
flex baseline bmd,C0168634;C1442488,true;false,13654/20013
flex fn f - score < - nmbr . nmbr,C1570610;C0016327;C0449820;C4050231,true;true;false;false,13655/20013
flex pbo ®,C0031962,true,13656/20013
fluticasone - salmeterol ( n = nmbr ),C0939232,true,13657/20013
fluticasone alone ( n = nmbr ),C0082607;C0205171;C0439044;C0679994,true;false;false;false,13658/20013
fluticasone propionate / salmeterol fdc,C1622832;C0340427;C1413520;C3539652,true;true;false;false,13659/20013
fn t - score < — nmbr . nmbr,C1570610;C0449820;C4050231,true;false;false,13660/20013
fn t - score < = - nmbr . nmbr ( % ),C1570610;C0449820;C4050231,true;false;false,13661/20013
focal,C0205234,false,13662/20013
follow - up,C0589120;C1522577;C1704685;C3274571,false;false;false;false,13663/20013
follow - up in - trial at nmbr yr,C0589120;C0008976;C0439234;C1522577;C1704685;C3274571,false;true;false;false;false;false,13664/20013
fondaparinux — no . ( % ),C1098510,true,13665/20013
fondaparinux ( n = nmbr,C1098510,true,13666/20013
fondaparinux ( n = nmbr ),C1098510,true,13667/20013
for baseline hemoglobin nmbr g nmbr ’,C0168634;C1319312;C1442488,true;false;false,13668/20013
for baseline hemoglobin < nmbr g nmbr ',C0168634;C1319312;C1442488,true;false;false,13669/20013
for combined hemoglobin groups,C0205195;C0019046,false;true,13670/20013
for patients not using personal cgm,C0030705,true,13671/20013
for patients using personal cgm,C0030705,true,13672/20013
forearm,C0016536,true,13673/20013
former ( n   = nmbr,C0205156;C0750523,false;false,13674/20013
former smoker — no . ( % ),C0337671,false,13675/20013
former smoker — no . { % ),C0337671,false,13676/20013
former smoker ( n = nmbr,C0337671,false,13677/20013
former smokers,C0337671,false,13678/20013
former / current smoker ( n = nmbr nmbr ),C0337671;C0521116;C1705970;C0205156;C3173209;C3241966;C0750523,false;false;false;false;false;false;false,13679/20013
formoterol nmbr gg ( n = nmbr ),C0060657;C0017454;C0018370,true;true;true,13680/20013
formoterol nmbr pg,C0060657;C0030827;C0072225;C1266240,true;true;true;false,13681/20013
formoterol nmbr pg vs placebo,C0060657;C0030827;C0072225;C1266240,true;true;true;false,13682/20013
formoterol nmbr   μ g ( n   =   nmbr ),C0060657;C0439267,true;false,13683/20013
formoterol tiotropium n = nmbr non - tiotropium n = nmbr,C0060657;C0213771;C1518422,true;true;false,13684/20013
fp,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,13685/20013
fp ( n   = nmbr,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,13686/20013
fp versus no ics,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,13687/20013
fp versus other ics,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,13688/20013
fpci vs . ppci in men,,,13689/20013
fpci vs . ppci in women,,,13690/20013
fpg ( mmol / nmbr ),C0439190,false,13691/20013
fpg change ( mg / dl ) *,C0392747;C0439269;C0443172;C1705241;C4319952,false;false;false;false;false,13692/20013
fpg data ',C1511726;C3245479;C3714741,false;false;false,13693/20013
fpg month nmbr ( mg / dl ),C0332177;C0439269;C0439231,false;false;false,13694/20013
fpg ( mg / dl ) x,C0439269,false,13695/20013
fracture status prevalent vertebral fractured,C0016658;C0449438;C0033105;C0549207;C4554413;C0220900,true;false;true;true;false;true,13696/20013
fractures,C0016658,true,13697/20013
framingham risk score,C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,13698/20013
framingham risk score ( % ),C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,13699/20013
framingham risk score *,C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,13700/20013
freedom from gtc seizures,C1299590,false,13701/20013
freqency of events,C0441471;C3541888,false;false,13702/20013
frequency of events,C0376249;C0441471;C3541888;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352,true;false;false;false;false;false;false;false;false,13703/20013
frequent exacerbator,C0332183,false,13704/20013
frequent or continuous,C0332183,false,13705/20013
fsg ( mg / dl ),C0439269,false,13706/20013
fsg,,,13707/20013
fsn score,C0449820;C4050231,false;false,13708/20013
furosemide equivalent,C0016860;C0205163;C0439185,true;false;false,13709/20013
fvc % predicted !,C3714541,true,13710/20013
fvc < nmbr % predicted,C3714541,true,13711/20013
fvc > nmbr % predicted,C3714541,true,13712/20013
fvc change,C3714541;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,13713/20013
fvc ∗,C3714541,true,13714/20013
g,C0439267,false,13715/20013
g - blockers,C0439267,false,13716/20013
g + c,C0439267,false,13717/20013
ga,C0016993,true,13718/20013
ga / a,C0016993,true,13719/20013
gained bmd,C1517378,false,13720/20013
gait,C0016928,true,13721/20013
gamma glutamyltransferase,C0017040,true,13722/20013
gastroenteritis,C0017160,true,13723/20013
gastrointestinal ( gi ) disorders,C0017178;C1708130;C3539617;C4050121,true;false;false;false,13724/20013
gastrointestinal area involved,C0521362;C0017446;C0205146,false;true;false,13725/20013
gastrointestinal bleeding,C0017181,true,13726/20013
gastrointestinal disorders,C0017178,true,13727/20013
gastrointestinal event,C0521362;C0441471;C4019010,false;false;false,13728/20013
gastrointestinal major bleed,C0017181;C0205082;C0205164;C4318856;C4521762,true;false;false;false;false,13729/20013
gaviscon da ( n = nmbr ),C0061146;C0011318;C3668815,true;true;false,13730/20013
gemfibrozil ( n = nmbr,C0017245,true,13731/20013
gendar,,,13732/20013
gender - male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,13733/20013
gender - n ( % ),C0079399;C1522384,true;true,13734/20013
gender ( female : male,C0079399;C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;false;true;false;false;true,13735/20013
gender ( m / f ),C0079399;C1306057;C1522384,true;false;true,13736/20013
gender ( male ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,13737/20013
gender ( male / female ) ( number ),C0079399;C0086582;C0043210;C0237753;C0449788;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;false;false;true;false;false;false;false;false;true,13738/20013
gender [n ( % ) ],C0079399;C1522384,true;true,13739/20013
gender female,C0079399;C0043210;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;true,13740/20013
gender n ( % ),C0079399;C1522384,true;true,13741/20013
gender :,C0079399;C1522384,true;true,13742/20013
gender : male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,13743/20013
gene,C0017337,true,13744/20013
gene / chr / snp,C0017337;C0043459;C0752046;C1527094;C1861559;C3890034;C4050175,true;true;true;false;true;false;false,13745/20013
general allergic events,C0205246;C0700624;C0441471;C3541888;C3812897;C3891294;C4521767,false;false;false;false;false;false;false,13746/20013
general alone,C0205246;C0205171;C0439044;C0679994;C3812897;C3891294;C4521767,false;false;false;false;false;false;false,13747/20013
general anaesthesia,C0002915;C2930406,true;false,13748/20013
general health ( self - reported ),C0424575;C4018875,false;false,13749/20013
generalized,C0205246,false,13750/20013
genetic subgroup,C0017296;C1079230;C1515021;C0314603,true;false;false;false,13751/20013
genital mycotic infections malenmbr,C0740330;C0086582;C1706180;C1706428;C1706429,false;true;false;false;false,13752/20013
genotype,C0017431,true,13753/20013
genotype - by - treatment interaction p values *,C0017431;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;true;false;false;false;false;false,13754/20013
genotype - specific treatment effect hazard ratio ( nmbr % ci ),C0017431;C0205369;C1518681;C2985465;C0008107;C3259781;C1552740,true;false;false;false;true;false;false,13755/20013
gentype,,,13756/20013
geo graphic region : asia,C0017454;C0017446;C0003980;C0205147,true;true;true;false,13757/20013
geographic region ?,C0017446,true,13758/20013
geographic region^,C0017446,true,13759/20013
geographical location,C4545686,false,13760/20013
geometric anti - dsdna antibody binding level,C0449829;C2355607;C1145667;C0441889;C0456079;C1547707;C2946261;C1167622;C2746079,false;false;false;false;false;false;false;false;false,13761/20013
geometric cnmbr concentration,C0449829;C0086045;C1446561;C3827302,false;true;false;false,13762/20013
geometric mean blood eosinophil count on loge scale — cells / ^ljj,C2986759;C0200638;C2697934;C0175659;C0349674;C1947916,false;false;false;true;false;false,13763/20013
geometric mean ige on loge scale — u / ml,C2986759;C2697934;C0175659;C0439340;C1880521;C2945590;C0349674;C1947916,false;false;true;false;false;false;false;false,13764/20013
geometric mean ofcrp — mg / liter ( range ),C2986759;C0024671;C0475211;C1514721;C2348147;C3542016;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;false;false;true;false;false;false;false;false,13765/20013
geometric mean uacr,C2986759,false,13766/20013
gertder,,,13767/20013
getgoal - l - asia,C0003980,true,13768/20013
getgoal - s,,,13769/20013
gff mdi,C0993596;C1839839;C4049613,true;true;false,13770/20013
gfr ( ckd - epi ),C0017654;C1561643;C0162734;C4281721;C1424601,true;true;true;false;false,13771/20013
gfr < nmbrml / min / nmbr . nmbr mnmbr,C0017654;C0439445;C0369637;C0441923;C1424601,true;false;false;false;false,13772/20013
gfr < nmbr,C0017654;C1424601,true;false,13773/20013
gfr > nmbr,C0017654;C1424601,true;false,13774/20013
gfr nmbr nmbr,C0017654;C1424601,true;false,13775/20013
gfr nmbr - nmbr,C0017654;C1424601,true;false,13776/20013
gg,C0017454;C0018370,true;true,13777/20013
ggt increased,C1415053,false,13778/20013
gi bleed,C1708130;C3539617;C4050121,false;false;false,13779/20013
gi major bleeding,C0017181;C0205082;C0205164;C4318856;C4521762,true;false;false;false;false,13780/20013
giargine,,,13781/20013
giimepiride ± oad,,,13782/20013
glacialnmbr,,,13783/20013
glargine nmbr,C0907402,true,13784/20013
glargine allocation,C0907402;C1706778,true;false,13785/20013
glargine n ( n / loopy ),C0907402,true,13786/20013
glatiramer acetate,C0289884,true,13787/20013
glimepiride,C0061323,true,13788/20013
glipizide ( n = nmbr ),C0017642,true,13789/20013
global trial population,C0205246;C0008976;C0032659;C1257890;C2348867,false;true;true;true;false,13790/20013
glp - nmbr analogue,C0018301;C0243071;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,13791/20013
glp - nmbr receptor agonist,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,13792/20013
glp - nmbr receptor agonists,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,13793/20013
glunmbrasp g . t,C0125690;C0439267,true;false,13794/20013
glucagon - like peptide - nmbr receptor agonist,C0014361;C4543206,true;false,13795/20013
glucocorticoid],C0017710,true,13796/20013
glucocorticoids at baseline,C0017710;C0168634;C1442488;C3540777;C3540778,true;true;false;false;false,13797/20013
glucocorticoids combined with immunosuppressive agents,C0017710;C3540777;C3540778,true;false;false,13798/20013
glucosamine,C0017718,true,13799/20013
glucosamine + chondroitin sulfate,C0017720;C0008454;C0876712;C0038720;C0474702;C0475337;C3536965;C0017718;C0008466,true;true;false;true;false;false;false;true;true,13800/20013
glucose - lowering medication,C0017725;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,13801/20013
glucose - lowering medications,C0017725;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,13802/20013
glucose - lowering therapies — no . { % ),C0017725;C0441994;C0087111;C2003888,true;false;true;false,13803/20013
glucose - lowering therapy,C0017725;C0441994;C0039798;C0087111;C1363945;C2003888,true;false;true;true;false;false,13804/20013
glucose - lowering therapy - no . ( % ),C0017725;C0441994;C0039798;C0087111;C1363945;C2003888,true;false;true;true;false;false,13805/20013
glucose — mmol / liter,C0017725;C0439190;C0475211,true;false;false,13806/20013
glucose in urine,C0004076,false,13807/20013
glulisine + oad,,,13808/20013
glulisine monotherapy,,,13809/20013
gly,C0017890;C0523677,true;false,13810/20013
gly ( nmbr . nmbr pg b . i . d . ) n = nmbr,C1415124;C0030827;C0152277;C0072225;C1266240,false;true;false;true;false,13811/20013
gly nmbr μ g bid,C0017890;C0439267;C0523677,true;false;false,13812/20013
glycaemic control ( hbanmbrc ),C0005802;C0243148;C0019016;C1825777;C3538758;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;true;false;false;false;false;false;false;false,13813/20013
glycaemic control group,C0005802;C0009932,true;true,13814/20013
glycaemic parameters,C0005802;C0449381,true;false,13815/20013
glycated haemoglobin,C0017853,true,13816/20013
glycated hemoglobin — % -,C0017853,true,13817/20013
glycated hemoglobin | |,C0017853,true,13818/20013
glycemic characteristics,C0005802;C1521970,true;false,13819/20013
glycemic indexes,C1136206,true,13820/20013
glycemic status,C1320980,false,13821/20013
glycemic status f,C1320980;C0016327,false;true,13822/20013
glycemic variability,C0005802;C2827666,true;false,13823/20013
glyceryl trinitrate infusion,C0017887;C0574032;C1827465,true;false;false,13824/20013
glycohemoglobin,C0202054;C0696092,false;false,13825/20013
glycoprotein iib / iiia inhibitor use before angiography,C0016011;C1999216;C0042153;C0002978;C0457083;C1947944,true;false;true;true;false;false,13826/20013
glycoprotein iib / iiia inhibitort,C0016011,true,13827/20013
glycoprotein llb / illa inhibitor,C0017968;C1999216,true;false,13828/20013
glycoprotein llb / llia inhibitor,C0017968;C1999216,true;false,13829/20013
glycoprotein llb / llla receptor inhibitor,C0017968;C0597357;C1999216,true;false;false,13830/20013
glycopyrrolate / glycopyrrolate / eflow cs nmbr meg eflow cs nmbr meg ( n = nmbr ) ( n = nmbr ),C0017970;C0010182;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345,true;true;true;true;true;false;false;false,13831/20013
glycopyrrolate / eflow cs nmbr meg ( n = nmbr ),C0017970;C0010182;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345,true;true;true;true;true;false;false;false,13832/20013
glyeated haemoglobin,C0019046,true,13833/20013
gm,C0017480;C3854019,true;true,13834/20013
gm  geometric mean  gmr  geometric mean ratio over baseline  uacr  urinary albumimcreatinine ratio . % reduction : nmbr x ( nmbr — ratio of gmr for losartan versus gmr for placebo ) . amean of change  with change calculated as difference between time indicated and baseline as measured for each participant  difference of changes between treatment groups . cp - values compare differences from no change .,C0017480;C2986759;C1522544;C0456603;C0168634;C0042027;C0301630;C0392756;C1293152;C4551656;C1524119;C1442488;C1547037;C1704695;C3854019,true;false;true;false;true;true;false;false;false;false;false;false;false;false;true,13835/20013
gmi ( men ),C0025266,true,13836/20013
gmi ( women ),C0043210,true,13837/20013
gmr,C1522544;C1704695,true;false,13838/20013
goal,C0018017;C1571704,true;false,13839/20013
gold nmbr ( « = nmbr ),C0018026;C1304897,true;false,13840/20013
gold nmbr - nmbr,C0018026;C1304897,true;false,13841/20013
gold nmbr - nmbr ( « = nmbr ),C0018026;C1304897,true;false,13842/20013
gold nmbr - nmbr ( n = nmbr ),C0018026;C1304897,true;false,13843/20013
gold classification,C0018026;C0008902;C0008903;C0678229;C1304897,true;true;true;false;false,13844/20013
gold grade nmbr,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,13845/20013
gold grade nmbr and ics non - users at screening,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,13846/20013
gold grade nmbr and ics users at screening,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,13847/20013
gold grades nmbr - nmbr ( percent - predicted fev ( ),C0018026;C1304897,true;false,13848/20013
gold group,C0018026;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1304897,true;false;false;true;false;false;false;false,13849/20013
gold group a,C0018026;C0441835;C4522145;C1304897,true;false;false;false,13850/20013
gold group b,C0018026;C4522078;C1304897,true;false;false,13851/20013
gold group c,C0018026;C0441837;C1304897,true;false;false,13852/20013
gold group d,C0018026;C0441838;C1304897,true;false;false,13853/20013
gold groups a - d using mmrcb,C0018026;C1304897,true;false,13854/20013
gold stage ( % ) : c,C0018026;C0441785;C1304897,true;false;false,13855/20013
golden - nmbr and - nmbr,,,13856/20013
golden - nmbr,,,13857/20013
golimumab,C2353893,true,13858/20013
golimumab nmbr mg ( n = nmbr ),C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13859/20013
golimumab nmbr mg / kg + mtx,C2353893;C0439272;C0025677;C1417487,true;false;true;false,13860/20013
golimumab nmbr / nmbr mg,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13861/20013
golimumab nmbr mg ( n = nmbr ) †,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13862/20013
golimumab nmbr mg / nmbr mgt,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13863/20013
golimumab combined ( n = nmbr ),C2353893;C0205195,true;false,13864/20013
goncomitant treatment with age inhibitors / angiotensin,C0039798;C0001779;C0243077;C0003018;C4521302;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;true;false;true;false;false;false;false;false,13865/20013
good,C0205170,false,13866/20013
good control ( < nmbr ),C0205170;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,false;true;false;false;false;false;false,13867/20013
good / moderate response,C0205170;C4085643,false;false,13868/20013
gout history,C0018099;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,13869/20013
gp iib / iiia inhibitor before pci — no . ( % ),C0016011;C1999216;C4049621,true;false;false,13870/20013
gp iib / iiia inhibitor used,C0016011;C1999216,true;false,13871/20013
gp iib / iiia inhibitors,C0016011;C0243077,true;true,13872/20013
gp mdi,C1705010;C0993596;C1839839;C4049613;C3811116,false;true;true;false;false,13873/20013
gpifo ' llia inhibitor use before angography,C1999216;C0042153;C0457083;C1947944,false;true;false;false,13874/20013
gpiib - iiia inhibitors,C0016011;C0243077,true;true,13875/20013
grade > nmbr,C0441800;C0919553;C3244287,false;false;false,13876/20013
grade nmbr ( moderate copd ),C0441800;C0919553;C3244287,false;false;false,13877/20013
grade nmbr ( severe copd ),C0441800;C0919553;C3244287,false;false;false,13878/20013
grade of hypertension,C0441800;C0020538;C1963138;C0919553;C3244287,false;true;false;false;false,13879/20013
graft  pci  percutaneous coronary intervention  tia  transient,C0181074;C1532338;C0007787;C0917805;C1054154;C0332835;C1961139,false;true;true;true;false;true;false,13880/20013
granulating,,,13881/20013
grip strength < meidan,C0429271;C2598165,false;false,13882/20013
grip strength > = median,C0429271;C0549183;C0876920;C2347635;C2348144;C2939193;C2598165,false;false;false;false;false;false;false,13883/20013
group,C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,13884/20013
group b ( low risk,C4522078;C3272281;C3538919,false;false;false,13885/20013
group d ( high risk,C0441838,false,13886/20013
group difference,C0441833;C1705241;C1705242;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;false;true;false;false;false,13887/20013
groups,C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429,false;false;true;false;false;false;false,13888/20013
grs,C1412761;C3539564,false;false,13889/20013
gt,C1435727;C1704693;C2697657,true;false;false,13890/20013
gt + tt,C1435727;C1452561;C4554543;C1704693;C2697657,true;true;false;false;false,13891/20013
gusto - bleeding severe / moderate,,,13892/20013
gusto moderate bleeding / ich,C0205081;C0019080;C0019191;C3272597;C3281105;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false;false,13893/20013
gusto moderate or severe,,,13894/20013
gusto moderate / severe bleed,,,13895/20013
gusto moderate / severe bleeding,,,13896/20013
gusto severe bleed,C0205082;C0019080;C4050465;C4050466,false;true;false;false,13897/20013
gusto severe or,,,13898/20013
gusto severe / moderate,C1299393,false,13899/20013
h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,13900/20013
h dl cholesterol < nmbr mg / dl,C0033727;C3539687;C0008377;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0369286;C0441932;C0564385;C4528284,true;false;true;true;true;false;false;false;false;false;false;false;false;false,13901/20013
h pylori serology *,C0079488;C0036745;C0220911;C0455278,true;true;false;false,13902/20013
h . pylori status,C0079488;C0449438,true;false,13903/20013
hnmbr - receptor antagonist,C0033727;C4543207;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,13904/20013
hnmbr blocker ( n,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,13905/20013
hnmbr receptor antagonist,C0033727;C4543207;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,13906/20013
haematological,C0018943;C0200627,true;false,13907/20013
haemoglobin ( mg / dl ),C0019046;C0439269,true;false,13908/20013
haemorrhagic stroke,C0553692,true,13909/20013
haemorrhagic stroke — no . ( % ),C0553692,true,13910/20013
hale,,,13911/20013
hand,C0018563;C1552914,true;false,13912/20013
hands,C0018563;C1552914,true;false,13913/20013
haplotype,C0018591,true,13914/20013
haq - di ( range nmbr - nmbr ),C3826998;C1514721;C2348147;C3542016;C4321476,false;false;false;false;false,13915/20013
haq - di improvement from baseline to week nmbr,C3826998;C2986411;C0168634;C1442488;C4321476,false;false;true;false;false,13916/20013
haq - di mcide,C3826998;C4321476,false;false,13917/20013
haq alternative disability score,C0102923;C1523987;C0231170;C0449820;C4050231;C0451208,true;false;false;false;false;false,13918/20013
haq di,C3826998;C4321476,false;false,13919/20013
haq di ( range nmbr - nmbr ),C3826998;C1514721;C2348147;C3542016;C4321476,false;false;false;false;false,13920/20013
haq di score ( nmbr - nmbr ),C3826998;C0449820;C4050231;C4321476,false;false;false;false,13921/20013
haq di score ( range nmbr - nmbr ),C3826998;C0449820;C1514721;C2348147;C3542016;C4050231;C4321476,false;false;false;false;false;false;false,13922/20013
haq pain scale,C0102923;C1504479;C0451208,true;false;false,13923/20013
haq pain score,C0102923;C0582148;C0451208,true;false;false,13924/20013
haq score,C0102923;C0451208,true;false,13925/20013
haq score ( nmbr – nmbr scale ),C0102923;C0449820;C0175659;C0349674;C1947916;C4050231;C0451208,true;false;true;false;false;false;false,13926/20013
hard mace,C0018599;C0349381;C0949745;C1445339,true;false;true;false,13927/20013
harzar ratio ( nmbr % ci ),C0456603;C0008107;C3259781;C1547037,false;true;false;false,13928/20013
harzard ratio ( nmbr % ci ),C0456603;C0008107;C3259781;C1547037,false;true;false;false,13929/20013
has - bled > nmbr,,,13930/20013
has - bled nmbr - nmbr,,,13931/20013
has - bled score,,,13932/20013
has - bled score > nmbr,,,13933/20013
has - bled score ’,,,13934/20013
has - blednmbr - nmbr,,,13935/20013
has - bledo,,,13936/20013
hazard inleraction,C0598697,false,13937/20013
hazard interaction,C0598697;C1704675,false;false,13938/20013
hazard ratio ( nmbr % c,C2985465,false,13939/20013
hazard ratio ( nmbr % ci ) - j -,C2985465;C0008107;C3259781,false;true;false,13940/20013
hazard ratio ( nmbr % ci ) for adjudicated type nmbr diabetes,C2985465;C0008107;C1320657;C3259781,false;true;false;false,13941/20013
hazard ratio ( nmbr % ci ) vs . placebo,C2985465;C0008107;C3259781,false;true;false,13942/20013
hazard ratio ( nmbr % ci ) nmbr with vs . without psoriasis,C2985465;C0008107;C3259781,false;true;false,13943/20013
hazard ratio ( nmbr % cl ) nateglinide vs . placebo,C2985465;C0596019;C0903898,false;false;true,13944/20013
hazard ratio ( nmbr % cl ) valsartan vs . placebo,C2985465;C0596019;C0216784,false;false;true,13945/20013
hazard ratio ( nmbr % cl )  ,C2985465;C0596019,false;false,13946/20013
hazard ratio ( nmbr % cl ) *,C2985465;C0596019,false;false,13947/20013
hazard ratio ( nmbr % cl],C2985465;C0596019,false;false,13948/20013
hazard ratio [nmbr % cl],C2985465;C0596019,false;false,13949/20013
hazard ratio [nmbr % ci],C2985465;C0008107;C3259781,false;true;false,13950/20013
hazard ratio nmbr ),C2985465,false,13951/20013
hazard ratio and nmbr % confidence interval,C2985465,false,13952/20013
hazard ratio glp - nmbr analogue vs placebo [nmbr % cl],C2985465;C0018301;C0243071;C1422069;C1425391;C1539338;C2350813,false;true;false;false;false;false;true,13953/20013
hazard ratio vs . placebo,C2985465,false,13954/20013
hazard ratio with,C2985465,false,13955/20013
hazard ratio with dabigatran,C2985465;C2348066,false;true,13956/20013
hazard ratio with high ( nmbr % cl ),C2985465;C0205250;C0596019;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,13957/20013
hazard ratio with low ( nmbr % cl ),C2985465;C0205251;C0596019;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,13958/20013
hazard ratio * ( and nmbr % ci ),C2985465,false,13959/20013
hazard rationmbr,C2985465,false,13960/20013
hazard . ratio . ( nmbr % ci ) . . . . . . . . . .,C2985465;C0008107;C3259781,false;true;false,13961/20013
hb decrease ≥ nmbr g / dl,C3843510;C0392756;C3642216;C0547047;C0019046;C0439267,false;false;false;false;true;false,13962/20013
hb,C0019046,true,13963/20013
hbanmbrc — % cholesterol — mmol / l,C0019016;C0008377;C1532563;C1825777;C3538758,true;true;false;false;false,13964/20013
hbanmbrc % ( range ),C0019016;C1514721;C2348147;C3542016;C1825777;C3538758,true;false;false;false;false;false,13965/20013
hbanmbrc ( % patients < nmbr . nmbr % ),C0019016;C0030705;C1825777;C3538758,true;true;false;false,13966/20013
hbanmbrc ( % ) *,C0019016;C1825777;C3538758,true;false;false,13967/20013
hbanmbrc ( change from baseline ),C0019016;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1825777;C3538758,true;false;true;false;false;false;false;false;false,13968/20013
hbanmbrc ( mmol / mol [se] ),C0019016;C3829066;C0036919;C1825777;C3538758,true;false;true;false;false,13969/20013
hbanmbrc ( sd ),C0019016;C2699239;C1825777;C3538758,true;false;false;false,13970/20013
hbanmbrc \n ,C0019016;C1825777;C3538758,true;false;false,13971/20013
hbanmbrc < nmbr . nmbr %,C0019016;C1825777;C3538758,true;false;false,13972/20013
hbanmbrc < nmbr % level,C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758,true;false;false;false;false;false;false,13973/20013
hbanmbrc ≤ nmbr . nmbr %,C0019016;C1825777;C3538758,true;false;false,13974/20013
hbanmbrc ≤ nmbr . nmbr % without gi adverse reactions,C0019016;C1708130;C0559546;C3539617;C4050121;C1825777;C3538758,true;false;false;false;false;false;false,13975/20013
hbanmbrc > nmbr . nmbr %,C0019016;C1825777;C3538758,true;false;false,13976/20013
hbanmbrc > nmbr % level,C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758,true;false;false;false;false;false;false,13977/20013
hbanmbrc > nmbr · nmbr %,C0019016;C1825777;C3538758,true;false;false,13978/20013
hbanmbrc nmbr weeks,C0019016;C0439230;C1825777;C3538758,true;false;false;false,13979/20013
hbanmbrc at baseline :,C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,13980/20013
hbanmbrc categories,C0019016;C0683312;C1825777;C3538758,true;false;false;false,13981/20013
hbanmbrc in % ( median ( qnmbr,C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,13982/20013
hbanmbrc month nmbr ( % ),C0019016;C0332177;C0439231;C1825777;C3538758,true;false;false;false;false,13983/20013
hbanmbrc strata,C0019016;C1825777;C3538758,true;false;false,13984/20013
hbanmbrc tx difference vs pbo,C0019016;C0041403;C1705241;C1705242;C1825777;C3538758,true;true;false;false;false;false,13985/20013
hbanmbrc   ( % ),C0019016;C1825777;C3538758,true;false;false,13986/20013
hbanmbrc   ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,13987/20013
hbanmbrc   at randomization,C0019016;C0034656;C1825777;C3538758,true;true;false;false,13988/20013
hbanmbrc   baseline ( % ),C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,13989/20013
hbanmbrc ( % ) ( median ( iqr ),C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,13990/20013
hbai,,,13991/20013
hbaic group ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,13992/20013
hbaie ( % ),,,13993/20013
hbaie ( % ) mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,13994/20013
hbaie,,,13995/20013
hbaj ( - ( %  mmol / mol ),C3829066,false,13996/20013
hbajc ( mmol / mol ) mean ± sd,C3829066;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,13997/20013
hbalc ( mmol / mol ),C3829066,false,13998/20013
hbalc £ nmbr mmol / mol ( £ nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,13999/20013
hbalc £ nmbr mmol / mol ( < nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14000/20013
hbalc £ nmbr mmol / mol ( > nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14001/20013
hbalc < nmbr mmol / mol ( < nmbr . nmbr % ) at week nmbr,C3829066;C0332174;C0439230,false;false;false,14002/20013
hbalc < nmbr % ( nmbr mmol / mol ),C3829066,false,14003/20013
hbalc < nmbr mmol / mol ( £ nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14004/20013
hbalc < nmbr mmol / mol ( < nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14005/20013
hbalc < nmbr %,,,14006/20013
hbalc > nmbr - < nmbr mmol / mol ( > nmbr . nmbr - < nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14007/20013
hbalc > nmbr mmol / mol ( > nmbr . nmbr % ) ( n = nmbr / nmbr ),C3829066,false,14008/20013
hbalc > nmbr %,,,14009/20013
hbalc anmbr mmol / mol ( > nmbr . nmbr % ) ( n = nmbr / nmbr ),,,14010/20013
hbalc in %,,,14011/20013
hbau  %  ,,,14012/20013
hc,C0020268;C0262499;C1413512,true;false;false,14013/20013
hcru ( a ),,,14014/20013
hctz - hydrochlorothiazide . * data were missing for some patients .,C0020261;C1511726;C3245479;C3714741,true;false;false;false,14015/20013
hctz = hydrochlorothiazide . * based on a ' / _nmbr test,C0020261,true,14016/20013
hd ( n = nmbr ),,,14017/20013
hd edoxaban vs warfarin,C2975435,true,14018/20013
hder *,C3898895,false,14019/20013
hdl - c ( mg / dl ) *,C3715113;C0439269,false;false,14020/20013
hdl - c < nmbr mg / dl,C3715113;C0439269,false;false,14021/20013
hdl - c < nmbr mg / dl_,C3715113;C0439269,false;false,14022/20013
hdl - c > nmbr mg / dl ( nmbr . nmbr mmol / l ),C3715113;C0439269;C1532563,false;false;false,14023/20013
hdl - c at baseline .,C3715113;C0168634;C1442488,false;true;false,14024/20013
hdl - c level,C3715113;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,14025/20013
hdl - c   high - density lipoprotein cholesterol    ldl - c   low - density lipoprotein cholesterol    sestandard error    tg   triglycerides .,C0023822;C0858892;C0743559;C0337445;C1608199,true;false;false;false;false,14026/20013
hdl - c < nmbrmg / dl . n ( % ),C3715113;C0439269,false;false,14027/20013
hdl — female,C3715113;C0043210;C0086287;C1705497;C1705498,false;true;true;false;false,14028/20013
hdl — male,C3715113;C0086582;C1706180;C1706428;C1706429,false;true;false;false;false,14029/20013
hdl < nmbr mg / dl,C3715113;C0439269,false;false,14030/20013
hdl cholesterol ( mmol / l ) ( median,C0023822;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193;C0392885,true;false;false;false;false;false;false;false,14031/20013
hdl cholesterol ( sd ),C0023822;C2699239;C0392885,true;false;false,14032/20013
hdl cholesterol < nmbr mg / dl *,C0023822;C0439269;C0392885,true;false;false,14033/20013
hdl cholesterol level,C0023822;C0441889;C0456079;C1547707;C2946261;C0392885;C3715113;C0201950;C0428466,true;false;false;false;false;false;false;false;false,14034/20013
hdl cholesterol mean,C0023822;C0444504;C2347634;C2348143;C0392885,true;false;false;false;false,14035/20013
hdl cholesterol^ :,C0023822;C0392885,true;false,14036/20013
hdlnmbr,C3715113,false,14037/20013
hdlcholesterol,,,14038/20013
hdm n = nmbr,,,14039/20013
health - care use rate ( peryear ),C0814514;C0871208;C1521828,false;false;false,14040/20013
health practices,C0018684,true,14041/20013
healthy weight,C3898900;C0005910;C0043100;C1305866;C1705104,false;true;true;false;false,14042/20013
heart - rate group at baseline,C0018810;C0441833;C0168634;C1442488;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;true;false;false;true;false;false;false,14043/20013
heart failure — no . / total no . ( % ),C0018801;C0018802;C4554158,true;true;false,14044/20013
heart failure ( nyha ii ‐ iii ),C0018801;C1275491;C1710602;C0439070;C1705160;C4082587;C0018802;C4554158,true;false;false;false;false;false;true;false,14045/20013
heart failure ( treated / hospitalized / fatal ),C0018801;C0018802;C4554158,true;true;false,14046/20013
heart failure nmbr yr before admission,C0018801;C0439234;C0184666;C0809949;C0018802;C4554158,true;false;false;false;true;false,14047/20013
heart failure at entry,C0018801;C1705654;C0018802;C4554158,true;false;true;false,14048/20013
heart failure history,C0018801;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0018802;C4554158,true;true;true;false;false;false;false;true;false,14049/20013
heart failure hospitalisation or cv death,C3898876,false,14050/20013
heart failure hospitalizations,C3898876,false,14051/20013
heart failure  ci  confidence interval .,C0018801;C0008107;C0009667;C3259781;C0018802;C4554158,true;true;true;false;true;false,14052/20013
heart failure ‡,C0018801;C0018802;C4554158,true;true;false,14053/20013
heart rate ( bpm ) *,C0018810,true,14054/20013
heart rate ( bpmnmbr ) *,C0018810,true,14055/20013
heart rate ( median nmbr . nmbr },C0018810;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,14056/20013
heart rate ( min − nmbr ),C0018810;C0702093;C1524029;C3813700,true;false;false;false,14057/20013
heart rate ( sd ),C0018810;C2699239,true;false,14058/20013
heart rate 一 beats / min,C0018810,true,14059/20013
heart rate at baseline ( bpm,C0018810;C0168634;C1442488,true;true;false,14060/20013
heart rate at baseline,C0018810;C0168634;C1442488,true;true;false,14061/20013
heart rate at rest — beats / min,C0018810;C0035253;C1622890,true;true;false,14062/20013
heartburn severity during the run - in periodt,C0018834;C0439793;C3274438;C0522510,true;false;false;false,14063/20013
heat failure,C0018837;C0231174;C0680095,true;false;false,14064/20013
height ',C0489786,false,14065/20013
height ( cm ) ( mean ± sd ),C0489786;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14066/20013
height in meters .,C0489786;C0441074,false;false,14067/20013
height loss,C0424641,false,14068/20013
height loss ( cm ),C0424641,false,14069/20013
helicobacter pylori - negative,C4688581,false,14070/20013
helicobacter pylori infection ( + ) ( n ),C0850666,false,14071/20013
hematocrit,C0018935;C0518014,true;false,14072/20013
hemodynamic parameters at baseline in the patients enrolled in the hemodynamic substudy,C0019010;C0449381;C0168634;C1442488;C4281788,true;false;true;false;false,14073/20013
hemoglobin - anmbrc ( % ) ' • ■ * *,C0019020;C3889898,true;false,14074/20013
hemoglobin level,C0019029;C1314664,false;false,14075/20013
hemoglobin ( < nmbr men,C0019046;C0025266,true;true,14076/20013
hemoglobin ( g / l ),C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,14077/20013
hemoglobin 一 g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,14078/20013
hemoglobin a,C0019016,true,14079/20013
hemoglobin a^c,C0019020;C3889898,true;false,14080/20013
hemoglobin anmbrc ( % ),C0019020;C3889898,true;false,14081/20013
hemoglobin aj^ ( % ),C0019046;C0004486;C0230613,true;true;true,14082/20013
hemoglobin ale *,C0019046;C0678386;C2632076,true;false;false,14083/20013
hemoglobin ale,C0019046;C0678386;C2632076,true;false;false,14084/20013
hemoglobin category,C0019046;C0683312;C3889287,true;false;false,14085/20013
hemorrhagic,C0333275,false,14086/20013
heparin + tirofiban ( n = nmbr ),C0019134;C0247025;C0770546,true;true;false,14087/20013
heparin ± tirofiban ( n = nmbr ),C0019134;C0247025;C0770546,true;true;false,14088/20013
heparin alone ( n = nmbr ),C0019134;C0205171;C0439044;C0679994;C0770546,true;false;false;false;false,14089/20013
heparin at randomization,C0019134;C0034656;C0770546,true;true;false,14090/20013
heparin dose regimen,C0019134;C2348331;C0770546,true;false;false,14091/20013
heparin plus a gpi ( n = nmbr ),C0019134;C1415351;C0770546,true;false;false,14092/20013
heparin plus gpi ( n = nmbr,C0019134;C0332287;C1415351;C0770546,true;false;false;false,14093/20013
heparin plus tirofiban ( n = nmbr ),C0019134;C0332287;C0247025;C0770546,true;false;true;false,14094/20013
heparin use,C0239945,false,14095/20013
heparins and fondaparinux,C0019134,true,14096/20013
hepatic disorders,C0023895,true,14097/20013
heterogeneity or trend p vaiue,C0019409;C0242960,false;true,14098/20013
heterogeneity or trend p value,C0019409;C0242960,false;true,14099/20013
heterozygous familial hypercholesterolemia,C0342882,false,14100/20013
heterozygous familial hypercholesterolemia †,C0342882,false,14101/20013
hf ' without known reduced ef,C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,14102/20013
hf cause,C0018488;C0015127;C1524003;C1313497;C1538440;C3273279,true;true;false;true;false;false,14103/20013
hf duration,C0018488;C0449238;C2926735;C1313497;C1538440;C3273279,true;false;false;true;false;false,14104/20013
hf hosp .,C0018488;C1313497;C1538440;C3273279,true;true;false;false,14105/20013
hf hospitalisation,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,14106/20013
hf signs and symptoms,C0018488;C0220912;C0220913;C0311392;C1313497;C1538440;C3273279,true;true;false;false;true;false;false,14107/20013
hf symptoms and signs,C0018488;C0683368;C1457887;C1313497;C1538440;C3273279,true;true;false;true;false;false,14108/20013
hf without known reduced ef,C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,14109/20013
hf without known reduced ef ( n = nmbr ),C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,14110/20013
hfref,,,14111/20013
hfref ( n = nmbr ),,,14112/20013
hhf ( n = nmbr ),,,14113/20013
hiatal hernia ( yes ) ( n ),C3489393;C1549445;C1705108;C1710701,true;false;false;false,14114/20013
high - density lipoprotein cholesterol — mg / dl,C0023822;C0439269,true;false,14115/20013
high - density lipoprotein cholesterol metabolic syndrome,C0023822;C0524620,true;true,14116/20013
high - density lipoprotein],C0023821,true,14117/20013
high - dose arb ( n = nmbr ),C0444956;C3888198,false;false,14118/20013
high - dose edoxaban,C0444956;C2975435,false;true,14119/20013
high - dose edoxaban ( n = nmbr ),C0444956;C2975435,false;true,14120/20013
high - dose edoxaban vs warfarin,C0444956;C2975435,false;true,14121/20013
high - intensity statin use,C4081854;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,14122/20013
high ‐ intensity statins ‡,C4081854;C0360714,false;true,14123/20013
high - risk,C0332167;C3272283;C4050568;C4319571,false;false;false;false,14124/20013
high - school graduate,C0870649;C1549971,false;false,14125/20013
high - school graduate or ged,C0870649;C1549971,false;false,14126/20013
high - sensitivity c - reactive protein — mg / liter |,C1441604;C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,false;true;true;false;true;false;false;false;false;false;false;false,14127/20013
high - sensitivity c - reactive protein ( mg / l ),C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,14128/20013
high - sensitivity c - reactive protein stratification,C1441604;C0006560;C1514983;C1413716;C4048285,false;true;false;false;false,14129/20013
high ( >   uln and   ≤   nmbrxuln ) ( n   =   nmbr ),C0205250;C1519815;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,14130/20013
high ( > nmbr % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14131/20013
high ( > nmbr ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14132/20013
high ( > nmbr kg / m^ ) baseline bmi,C0205250;C1532718;C0168634;C0578022;C1442488;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false,14133/20013
high ( > nmbr . nmbr u / ml ),C0205250;C0439340;C1880521;C2945590;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false,14134/20013
high ( > nmbr % ) baseline hbalc,C0205250;C0168634;C1442488;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false,14135/20013
high ( > uln ),C0205250;C1519815;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,14136/20013
high ( nmbr % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14137/20013
high ( nmbr - nmbr ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14138/20013
high ( inmbr kg / mnmbr ) baseline bmi,C0205250;C0021966;C1532718;C0168634;C0578022;C1442488;C0221138;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;true;false;false;false;false;false;false;false;false;false,14139/20013
high ( inmbr % ) baseline hbanmbrc,C0205250;C0021966;C0168634;C0019016;C1825777;C3538758;C1442488;C0221138;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;true;false;false;false;false;false;false;false;false;false;false,14140/20013
high ( n = nmbr ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14141/20013
high blood pressure,C0020538;C2926615,true;false,14142/20013
high cardiovascular risk,C0332167;C0007226;C3887460;C3272283;C4050568;C4319571,false;true;false;false;false;false,14143/20013
high crp and esr,C0205250;C3890735;C4048285;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,14144/20013
high crp or esr,C0205250;C3890735;C4048285;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,14145/20013
high cv risk,C0332167;C3538987;C4048877;C4318503;C3272283;C4050568;C4319571,false;false;true;false;false;false;false,14146/20013
high dose,C0444956,false,14147/20013
high fracture risk stratum,C0332167;C0016658;C3272283;C4050568;C4319571,false;true;false;false;false,14148/20013
high microalbuminuria to macroalbuminuria ( n = nmbr ),C0205250;C0730345;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,14149/20013
high nafld fibrosis score ( nfs > nmbr . nmbr ),C0205250;C0400966;C1954436;C1555018;C1954437;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false;false,14150/20013
high nfs nfs > nmbr . nmbr ( n = nmbr ),C0205250;C1513839;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,14151/20013
high normal ( n = nmbr ),C0205250;C0205307;C0231683;C0439166;C2347086;C4553972;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false;false;false,14152/20013
high risk ( - ics ),C0332167;C0815320;C4551720;C3272283;C4050568;C4319571,false;false;true;false;false;false,14153/20013
high risk ( ? ics ),C0332167;C0815320;C4551720;C3272283;C4050568;C4319571,false;false;true;false;false;false,14154/20013
high risk ( > nmbr ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,14155/20013
high risk ( n nmbr nmbr ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,14156/20013
high risk for diabetes *,C0332167;C0011847;C0011849;C3272283;C4050568;C4319571;C0205250;C1171304;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false;false;false;false,14157/20013
high risk of diabetes,C0332167;C0011847;C0011849,false;false;true,14158/20013
high risk of diabetes  ,C0332167;C0011847;C0011849,false;false;true,14159/20013
high risk *,C0332167;C3272283;C4050568;C4319571,false;false;false;false,14160/20013
high trs : nmbr - nmbr ( n = nmbr,C0205250;C0266427;C0968917;C1150746;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;false;false;false;false;false;false,14161/20013
high tt > nmbr . nmbr ( n = nmbr ),C0205250;C1452561;C4554543;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false,14162/20013
high vs . normalb,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14163/20013
high vs . normalc,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,14164/20013
higher - dose,C0444956,false,14165/20013
higher - dose edoxaban ( n = nmbr ),C0444956;C2975435,false;true,14166/20013
higher - dose edoxaban vs warfarin,C0444956;C2975435,false;true,14167/20013
higher - target group ( n = nmbr ),C0205250;C1521840;C0441848;C2986546,false;false;false;false,14168/20013
higher dose,C0444956,false,14169/20013
higher dose edoxaban regimen,C0205250;C2348331;C2975435,false;false;true,14170/20013
higher risk ( n = nmbr ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,14171/20013
highest,C1522410,false,14172/20013
highjj,,,14173/20013
highly sensitive,C0439822,false,14174/20013
highly sensitive responder ( n = nmbr ),C0439822,false,14175/20013
highly sensitive responders ( n = nmbr ),C0439822,false,14176/20013
hip,C0019552;C0022122;C1505163;C3538851;C4284725,true;true;true;false;false,14177/20013
hip + nmbr vertebral fractures,C0019557;C0549207;C0019552;C0080179;C0022122;C1505163;C3538851;C4284725,true;true;true;true;true;true;false;false,14178/20013
hip + nonvertebral + vertebral,C0019552;C0549207;C0022122;C1505163;C3538851;C4284725,true;true;true;true;false;false,14179/20013
hip + other nonvertebral fractures,C0019552;C0022122;C1505163;C3538851;C4284725,true;true;true;false;false,14180/20013
hip fracture + > nmbr,C0019557;C0149531;C4552776,true;false;false,14181/20013
hip fracture only,C0019557;C0205171;C1720467;C0149531;C4552776,true;false;false;false;false,14182/20013
hispanic ( n = nmbrlnmbr ),C0086409,true,14183/20013
hispanic ethnic group — no . { % ) ’ i ',C0086409;C0015031;C1879937,true;true;false,14184/20013
hispanic ethnic group — no . ( % ) : t,C0086409;C0015031;C1879937,true;true;false,14185/20013
hispanic or non - hispanic ethnic group — no . ( % ) f,C0086409,true,14186/20013
hispanic / latino ( n = nmbr ),C0086409;C0086528,true;true,14187/20013
hispanic / non - hispanic,C0086409;C1518422,true;false,14188/20013
hispanie / latino,C0086528,true,14189/20013
histamine - nmbr - receptor antagonist,C0019590;C4521896,true;false,14190/20013
histor y of congestive heart failure — no . ( % ),C0018802,true,14191/20013
histor y of heart failure,C0018801;C0018802;C4554158,true;true;false,14192/20013
histor y of myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,14193/20013
histor y of stable angina,C0340288,true,14194/20013
histor y of unstable angina,C0002965,true,14195/20013
history chd,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,14196/20013
history congestive heart failure,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14197/20013
history coronary,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,14198/20013
history coronary revascularization,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14199/20013
history mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14200/20013
history of ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,14201/20013
history of > nmbr previous vte ( excluding index event ),C0019664;C0205156;C0630906;C0332196;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C2828389;C1552607;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;true;false;false;false;false;false;true;false;false;false;false,14202/20013
history of asthma - related intubation — no . ( % ),C0455544,false,14203/20013
history of atrial fibrillation and / or flutter,C0729790,false,14204/20013
history of atrial fibrillation or flutter,C0729790,false,14205/20013
history of bowel resection ( ref ),C0019664;C0741614;C1425988;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,14206/20013
history of bowel resections,C0019664;C0741614;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14207/20013
history of cad / mi,C0019664;C1504769;C3810814;C2239547;C3813548;C4284121;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,14208/20013
history of cardiovascular disease — no . ( % ),C0455539,false,14209/20013
history of cardiovascular disease — no . { % ),C0455539,false,14210/20013
history of carotid disease - n ( % ),C0683519;C0741968;C0730226;C0850708;C0944983,false;false;false;false;false,14211/20013
history of cerebrovascular disease — no . { % ),C0585890,false,14212/20013
history of chd at baseline,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,14213/20013
history of chd at baseline d,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,14214/20013
history of chd at baseline §,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,14215/20013
history of chf - n ( % ),C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14216/20013
history of chf before index event,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14217/20013
history of clinical fracture ( > nmbr years old ),C1272071;C0205210;C0439234,false;false;false,14218/20013
history of clinical fracture ( > nmbr years ),C1272071;C0205210;C0439234,false;false;false,14219/20013
history of coronary,C0019664;C0018787;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14220/20013
history of coronary arteiy disease,C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,14221/20013
history of coronary artery disease,C1881055,false,14222/20013
history of coronary artery disease - n ( % ),C1881055,false,14223/20013
history of coronary artery disease — no . { % ),C1881055,false,14224/20013
history of coronary heart disease at,C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,14225/20013
history of coronary heart disease,C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,14226/20013
history of coronary revascularization d,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14227/20013
history of crohn ' s disease surgery,C0455610;C0010346,false;true,14228/20013
history of cvd,C0019664;C0007222;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14229/20013
history of cvd and of cv risk factors - no . ( % ),C0019664;C0007222;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14230/20013
history of diabetes - n ( % ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,14231/20013
history of diabetes { p = nmbr * nmbr ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,14232/20013
history of diabetes mellitus ( n = nmbr ),C0455488,false,14233/20013
history of diabetes nyha class,C0019664;C0011847;C1882083;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;true;false;false;false;false,14234/20013
history of diagnosed hypertension n ( % ),C0455527;C0011900,false;true,14235/20013
history of diagnosed hypertension prior to randomization,C0455527;C0011900,false;true,14236/20013
history of disease refractory to treatment with tnf antagonist — no . ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,14237/20013
history of dyslipidaemia,C0019664;C0242339;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14238/20013
history of dyslipidemia,C0019664;C0242339;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14239/20013
history of elms,C0019664;C0330531;C2980688;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14240/20013
history of extra - intestinal manifestations of ibd,C0019664;C1883702;C0021853;C1280464;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,14241/20013
history of falls,C1561668;C2919132,false;false,14242/20013
history of falls in year before randomization,C1561668;C2919132,false;false,14243/20013
history of fistulising disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,14244/20013
history of fistulizing disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,14245/20013
history of fistullzing disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,14246/20013
history of h pylori eradication *,C0019664;C0079488;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14247/20013
history of heart failure — no . { % ),C0455531,false,14248/20013
history of heart failure at baseline,C0455531,false,14249/20013
history of hf hospitalization,C0551577;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,14250/20013
history of hf or lvef bnmbr % with index event,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,14251/20013
history of htn,C0019664;C0020538;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14252/20013
history of hypertension - n ( % ),C0455527,false,14253/20013
history of hypertension . no . ( % ),C0455527,false,14254/20013
history of hypertension^,C0455527,false,14255/20013
history of lvh on echocardiogram,C0019664;C0149721;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14256/20013
history of lvh on electrocardiogram,C0019664;C0149721;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,14257/20013
history of macrovascular disease at baseline,C0683519;C0730226;C0850708;C0944983,false;false;false;false,14258/20013
history of mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14259/20013
history of mi or stroke d,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14260/20013
history of mi or stroke history of coronary,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14261/20013
history of ml at baseline,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,14262/20013
history of ml before index event,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,14263/20013
history of ml or stroke,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,14264/20013
history of non - hemor - rhagic stroke,C0019664;C1518422;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,14265/20013
history of omalizumab treatment :,C0019664;C0966225;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;true;false;false;false;false;false;true;false;false;false;false,14266/20013
history of osteoporotic fracture,C4075937,false,14267/20013
history of oxygen use - yes,C0019664;C0030054;C1524063;C1549445;C1705108;C1710701;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,14268/20013
history of parental myocardial,C0019664;C0030551;C0027061;C1522564;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,14269/20013
history of pci or cabg before index event,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14270/20013
history of peripheral arterial disease,C0683519;C0205100;C0003842;C0221464;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,14271/20013
history of peripheral artery disease — no . { % ),C0683519;C0489868;C0730226;C0850708;C0944983,false;false;false;false;false,14272/20013
history of postmenopausal fracture *,C1272071;C0232970,false;false,14273/20013
history of smoking,C1519384,false,14274/20013
history of stroke at baseline,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14275/20013
history of stroke or tia - n ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14276/20013
history of stroke * *,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14277/20013
history of stroke / see / tia,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14278/20013
history of stroke †,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14279/20013
history of strokea,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,14280/20013
history of thyroid disease,C0683519;C0040132;C3540038;C0730226;C0850708;C0944983,false;true;false;false;false;false,14281/20013
history of tnf antagonist treatment failure — no . ( % ) * *,C0019664;C1448177;C0231491;C0162643;C0235828;C0521983;C1547544;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;true;false;false;false;false,14282/20013
history of upper,C0019664;C1282910;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14283/20013
history of upper gi events ( perforations,C0019664;C0203057;C0441471;C0549099;C3541888;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;true;false;false;false;false,14284/20013
history of upper gl events ( perforations,C0019664;C1282910;C0018229;C0441471;C0549099;C3541888;C1423073;C1427674;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false;false;true;false;false;false;false,14285/20013
history of venous,C0019664;C0042449;C0348013;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,14286/20013
history ol chd at baselines,C0019664;C0280604;C0168634;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,14287/20013
history ol coronary revascularization *,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14288/20013
history ol mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,14289/20013
history ot chd,C0019664;C1318464;C0280604;C3542407;C1418208;C1705587;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,14290/20013
history / presence of tophi,C0019664;C0150312;C0221248;C0392148;C3854307;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;true;false;false;false;false,14291/20013
hit - nmbr score,C0272285;C0449820;C4050231;C0332159;C1708373,false;false;false;false;false,14292/20013
hl 土 nmbr . nmbr,C1453952;C4085347,true;false,14293/20013
hla - bnmbr,C0019737;C0550853;C1415561,true;false;false,14294/20013
hla - bnmbr positive at baseline,C0019737;C0439178;C0168634;C1442488;C1446409;C1514241;C2825490;C3812269;C0550853;C1415561,true;false;true;false;false;false;false;false;false;false,14295/20013
hla ‐ bnmbr positive,C0019737;C0439178;C1446409;C1514241;C2825490;C3812269;C0550853;C1415561,true;false;false;false;false;false;false;false,14296/20013
hmg - coa reductase inhibitors,C0360714;C2756999;C3539119,true;false;false,14297/20013
ho,C0019905;C1832110;C3889614,true;false;false,14298/20013
ho active cancer,C0019905;C0205177;C0006826;C0998265;C1306459;C3853793;C3888249;C1832110;C3889614,true;false;true;false;false;false;false;false;false,14299/20013
hoehn & yahr stage,C0205390;C1300072;C1306673,false;false;false,14300/20013
hoehn & yahr stage ( “ off ” ),C0205390;C1300072;C1306673,false;false;false,14301/20013
hoehn & yahr stage ( “ on ” ),C0205390;C1300072;C1306673,false;false;false,14302/20013
hoehn and yahr stage ( baseline ),C0205390;C0168634;C1442488;C1300072;C1306673,false;true;false;false;false,14303/20013
homa - b,,,14304/20013
homa - ir index,C0022065;C0600653;C0918012;C1552854;C1637833;C2986546;C0022071;C1448132,true;true;true;false;false;false;true;true,14305/20013
homa - ir score,C0022065;C0449820;C4050231;C0022071;C1448132,true;false;false;true;true,14306/20013
homa_ % b,,,14307/20013
homa_ir tx difference vs pbo,C0022065;C0041403;C1705241;C1705242;C0022071;C1448132,true;true;false;false;true;true,14308/20013
homa_ir,C0022065;C0022071;C1448132,true;true;true,14309/20013
hong kong,C0019907;C2987742,true;false,14310/20013
hordic,,,14311/20013
hormone therapy use,C0279025;C0042153;C0457083;C1947944,false;true;false;false,14312/20013
hormones,C0019932,true,14313/20013
hospitaiization for angina,C0002962,true,14314/20013
hospitaiization for heart faiiure,C0018787,true,14315/20013
hospital admission for heart failure,C0184666;C0018801;C0018802;C4554158,false;true;true;false,14316/20013
hospitalisation,C0019993,true,14317/20013
hospitalisation for heart failure,C3898876,false,14318/20013
hospitalisation related to exacerbation,C0019993,true,14319/20013
hospitalization for acute limb ischemia,C0019993;C0205178;C2945695,true;false;false,14320/20013
hospitalization for heart failure n ( % ),C3898876,false,14321/20013
hospitalization for heart failure or cv,C3898876,false,14322/20013
hospitalization for heart failure or cv death,C3898876,false,14323/20013
hospitalization for unstable ap,C0019993;C0443343;C0002680;C3887950;C1883468,true;false;true;false;false,14324/20013
hospitalization for / due to,C0019993,true,14325/20013
hospitalization in previous year with management of heart failure,C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,14326/20013
hospitalization in previous year with management of heart failure as major component — no . ( % ),C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,14327/20013
hospitalization in the past nmbr months prior to baseline,C0019993;C4331910,true;false,14328/20013
hospitalization stratum,C0019993,true,14329/20013
hospitalization to enrollment,C0019993;C1516879;C1696073;C3888021,true;false;false;false,14330/20013
hospitalized,C0701159,false,14331/20013
hospitalized angina,C0701159;C0002962,false;true,14332/20013
hospitalized exacerbation rates,C0701159;C4086268;C0871208;C1521828,false;false;false;false,14333/20013
hospitalized for an exacerbation,C0701159;C4086268,false;false,14334/20013
hospitalized heart failure,C0701159;C0018801;C0018802;C4554158,false;true;true;false,14335/20013
hospitalized hf,C0701159;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,14336/20013
hospitalized hf !,C0701159;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,14337/20013
hospitalized pneumonia events,C0701159;C0032285;C0441471;C3541888,false;true;false;false,14338/20013
hospitalized without airway compromise,C0701159;C4055482,false;false,14339/20013
hospitalized !,C0701159,false,14340/20013
hospitalized / fatal heart failure,C0701159;C1302234;C0018801;C0018802;C4554158;C1705232,false;false;true;true;false;false,14341/20013
hot climate subset,C0178683;C1515021,false;false,14342/20013
hr ( nmbr % c ! ),,,14343/20013
hr ( nmbr % ci ) *,C0008107;C3259781,true;false,14344/20013
hr ( nmbr % cl ) = nmbr nmbr ( nmbr . nmbr . nmbr,C0596019,false,14345/20013
hr ( nmbr % cl ) = nmbr . nmbrb ( nmbr,C0596019,false,14346/20013
hr ( nmbr % cl ) = nmbr . nmbr ( nmbr . nmbr,C0596019,false,14347/20013
hr ( nmbr % cl ) = nmbr . nmbr ( nmbr nmbr,C0596019,false,14348/20013
hr ( nmbr % cl ) pvalue,C0596019,false,14349/20013
hr ( nmbrs % a ),,,14350/20013
hr ( nmbrs % ci ),C0008107;C3259781,true;false,14351/20013
hr ( adjusteda ),,,14352/20013
hr ( b . p . m . ),C0369637;C0441923,false;false,14353/20013
hr ( bpm ),,,14354/20013
hr [nmbr % ci ),C0008107;C3259781,true;false,14355/20013
hr nmbr - nmbr ( nmbr % cl nmbr - nmbr - nmbr ),C0596019,false,14356/20013
hr nmbr - nmbr ( nmbr % cl nmbr - nmbr - nmbr - nmbr ),C0596019,false,14357/20013
hr nmbr . nmbr,,,14358/20013
hr nmbr . nmbr ( nmbr % cl nmbr . nmbr,C0596019,false,14359/20013
hr and nmbr % ci *,,,14360/20013
hr is < nmbr if pravastatin is better than diet alone,,,14361/20013
hr vs control ( nmbr % cl ) *,,,14362/20013
hr vs placebo ( nmbr % ci ),,,14363/20013
hr vs . warfarin ( nmbr % ci ),,,14364/20013
hr with edoxaban ( nmbr % ci ),C2975435;C0008107;C3259781,true;true;false,14365/20013
hr * or rr †,,,14366/20013
hr * or rr † ( nmbr % ci ) ,,,14367/20013
hr : nmbr . nmbr
 
 ( nmbr % cl : nmbr . nmbr - nmbr . nmbr )
 
 p = nmbr . nmbr,C0596019,false,14368/20013
hr : nmbr . nmbr
 
 ( nmbr % cl : nmbr . nmbr - nmbr . nmbr ) p = nmbr . nmbr,C0596019,false,14369/20013
hr ‡,,,14370/20013
hradj ( nmbr % ci ),C0008107;C3259781,true;false,14371/20013
hradjusted ( nmbr % ci ) b,C0008107;C3259781,true;false,14372/20013
hrg,C1437978;C1705020,true;false,14373/20013
hrql mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,14374/20013
hrt use,C0282402;C0042153;C0457083;C1947944,true;true;false;false,14375/20013
hs - crp mg / l,C3890735;C0439268;C4048285,false;false;false,14376/20013
hs - crp _ = nmbr . nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,14377/20013
hs - crp < nmbr . nmbr nlg l,C3890735;C4048285,false;false,14378/20013
hs - crp jnmbr . nmbr mg / l,C3890735;C0439268;C4048285,false;false;false,14379/20013
hs - crp jnmbr . nmbrmg / l,C3890735;C0439268;C4048285,false;false;false,14380/20013
hs graduate / ged,C0588053;C1880947;C1547183,false;false;false,14381/20013
hscrp ( post - baseline / baseline ratio ),C0687676;C0168634;C0456603;C1547037;C1442488;C1704687;C3469826,false;true;false;false;false;false;false,14382/20013
hscrp at baseline,C0168634;C1442488,true;false,14383/20013
hscrp level,C0441889;C0456079;C1547707;C2946261,false;false;false;false,14384/20013
hscrp range,C1514721;C2348147;C3542016,false;false;false,14385/20013
hvpercholesterolemia,,,14386/20013
hvpertension,,,14387/20013
hx cabg,C0262926;C0010055;C3814444,false;true;false,14388/20013
hx mi or stroke,C0262926;C3810814;C3814444,false;false;false,14389/20013
hx of diabetes,C0262926;C0011847;C0011849;C3814444,false;false;true;false,14390/20013
hydroxychloroquine,C0020336,true,14391/20013
hydroxychloroquine treatment §,C0020336;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,14392/20013
hypercholesterolaemia ( % ),C0020443;C1522133,true;false,14393/20013
hypercholesterolemia ( % ),C0020443;C1522133,true;false,14394/20013
hyperkalaemia,C0020461;C4552983,true;false,14395/20013
hyperkalaemia ( investigator reported ),C0020461;C0035173;C4552983,true;true;false,14396/20013
hyperkalaemia ( serum potassium > nmbr . nmbr mmol / l ),C0020461;C0302353;C1532563;C0543465;C4552983,true;false;false;false;false,14397/20013
hyperkalemia * ’,C0020461;C4552983,true;false,14398/20013
hyperkalemia,C0020461;C4552983,true;false,14399/20013
hyperlipidaemia therapy use,C0020473;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945;C0428465;C4555212,true;true;true;false;false;true;false;false;false,14400/20013
hyperlipidemia — no . / total no . ( % ),C0020473;C0428465;C4555212,true;false;false,14401/20013
hyperlipidemia | |,C0020473;C0428465;C4555212,true;false;false,14402/20013
hyperlipidemia | | yes,C0020473;C1549445;C1705108;C1710701;C0428465;C4555212,true;false;false;false;false;false,14403/20013
hyperlipidemia §,C0020473;C0428465;C4555212,true;false;false,14404/20013
hyperlipidemia § yes,C0020473;C1549445;C1705108;C1710701;C0428465;C4555212,true;false;false;false;false;false,14405/20013
hyperlipidmemia,,,14406/20013
hypersensitivity,C0020517;C0520946,true;false,14407/20013
hypertension ( > nmbr / nmbr mm hg or taking,C0020538;C0439475;C1963138,true;false;false,14408/20013
hypertension ( bp > nmbr / nmbr mmhg or using antihypertensive medication ),C0020538;C0037623;C0439475;C1415692;C1708288;C4318478;C1963138,true;true;false;false;false;false;false,14409/20013
hypertension 一 no . ( % ),C0020538;C1963138,true;false,14410/20013
hypertension at baseline,C0020538;C0168634;C1442488;C1963138,true;true;false;false,14411/20013
hypertension n ( % ),C0020538;C1963138,true;false,14412/20013
hypertension requiring medical treatment,C0020538;C1963138,true;false,14413/20013
hypertension requiring treatment,C0578998,false,14414/20013
hypertension severity at baseline,C4013784;C0168634;C1442488,false;true;false,14415/20013
hypertension / yes,C0020538;C1549445;C1705108;C1710701;C1963138,true;false;false;false;false,14416/20013
hypertension^,C0020538;C1963138,true;false,14417/20013
hypertension § yes,C0020538;C1549445;C1705108;C1710701;C1963138,true;false;false;false;false,14418/20013
hypertrophy per ecg ( n = nmbr nmbr ),C0020564;C1623258,true;true,14419/20013
hypertrophy,C0020564,true,14420/20013
hypoglycaemiad,,,14421/20013
hypoglycaemic therapy,C0020616;C0039798;C0087111;C1363945,true;true;true;false,14422/20013
hypoglycemia^,C0020615;C4553659,true;false,14423/20013
hypoglycemiat,,,14424/20013
hypoglycemic agent,C0020616,true,14425/20013
hypokalaemia,C0020621;C4553966,true;false,14426/20013
hyponatremia,C0020625;C4553967,true;false,14427/20013
hyponatremic ( < nmbr meq / l ) at baseline,C0857122;C0439375;C0168634;C1442488,false;false;true;false,14428/20013
hypovolaemia,C0546884,true,14429/20013
hzard ratio,C0456603;C1547037,false;false,14430/20013
i - nmbr mg / d ( n = nmbr ),C0152277;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0021966;C0439422;C0221138,false;true;true;false;false;false;false;false;true;false;false,14431/20013
i - ^w « - i - nmbr,C0021966;C0221138,true;false,14432/20013
i - h,C0021966;C0033727;C0369286;C0441932;C0564385;C4528284;C0221138,true;true;false;false;false;false;false,14433/20013
i ( nmbr . i ),C0021966;C0221138,true;false,14434/20013
i nmbr . nmbr vs nmbr . nmbr,C0021966;C0221138,true;false,14435/20013
i amiodarone,C0021966;C0002598;C0221138,true;true;false,14436/20013
i intensive  nmbr mg of atorvastatin ( n = nmbr ),C0021966;C0162425;C0024671;C0286651;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0522510;C1283828;C1550453;C0221138,true;true;true;true;true;false;false;false;false;false;false;false;false;false,14437/20013
i lisinopril ( n = nmbr ),C0021966;C0065374;C0221138,true;true;false,14438/20013
i moderate  nmbr mg of pravastatin ( n = nmbr ),C0021966;C0205081;C0024671;C0085542;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1881878;C4049705;C4049706;C4085643;C4321335;C0221138,true;false;true;true;true;false;false;false;false;false;false;false;false;false;false;false,14439/20013
i no . of events,C0021966;C0221138,true;false,14440/20013
i or ii,C0021966;C0221138,true;false,14441/20013
i placebo,C0021966;C0032042;C1696465;C1706408;C0221138,true;true;false;false;false,14442/20013
i placebo ( n = nmbr ),C0021966;C0032042;C1696465;C1706408;C0221138,true;true;false;false;false,14443/20013
i rosuvastatin ( n = nmbr ),C0021966;C0965129;C0221138,true;true;false,14444/20013
i u - uj,C0021966;C0439148;C0221138,true;false;false,14445/20013
i vitamin e,C0683454;C0042890;C0021966;C0042874;C3714803;C0221138,false;true;true;true;false;false,14446/20013
i vitamin e ( n = nmbr ),C0683454;C0042890;C0021966;C0042874;C3714803;C0221138,false;true;true;true;false;false,14447/20013
i with mets ( n = nmbr ),C0021966;C0812270;C1705694;C2939420;C0221138,true;false;false;false;false,14448/20013
i without mets ( n = nmbr ),C0021966;C0812270;C1705694;C2939420;C0221138,true;false;false;false;false,14449/20013
i . nmbr ( nmbr . nmbr - i . nmbr ),C0021966;C0221138,true;false,14450/20013
i . nmbri ( nmbr . nmbr - i . nmbr ),C0021966;C0221138,true;false,14451/20013
inmbr ( inmbr . nmbr ),C0021966;C0221138,true;false,14452/20013
inmbr ( inmbr . i ),C0021966;C0221138,true;false,14453/20013
inmbrinmbr ± nmbr,C0021966;C0221138,true;false,14454/20013
inmbr ± nmbri,C0021966;C0221138,true;false,14455/20013
inmbr ± nmbrii,C0021966;C1710602;C4082587;C0221138,true;false;false;false,14456/20013
inmbri ( inmbr . nmbr ),C0021966;C0221138,true;false,14457/20013
inmbr ± inmbr,C0021966;C0221138,true;false,14458/20013
inmbr years of age,C0021966;C1510829;C0221138,true;false;false,14459/20013
inmbri ± inmbr,C0021966;C0221138,true;false,14460/20013
inmbri,C0021966;C0221138,true;false,14461/20013
ib ( nmbr . nmbr ),C2744579;C3890035;C4283819,true;false;false,14462/20013
ibs ( nmbr . nmbr ),C0022104;C0432306,true;true,14463/20013
ibuprofen,C0020740,true,14464/20013
ica stenosis nmbr % - nmbr % f,C0201519;C0678234;C0016327;C1261287;C2632116,false;false;true;true;false,14465/20013
icd or crt - d,C0021122,true,14466/20013
icd vs . placebo,C0021122,true,14467/20013
icd / crt - d,C0021122,true,14468/20013
ich,C0019191;C3272597;C3281105,true;false;false,14469/20013
icosapent ethyl ( events / n ( % ) ),C0058978;C0441471;C3541888,true;false;false,14470/20013
ics ( tiotropium n = nmbr,C0815320;C0213771;C4551720,false;true;true,14471/20013
ics ? laba ( free or fdc ),C0815320;C4551720,false;true,14472/20013
ics dose of stable maintenance treatment ( μ g ) ∗,C0815320;C0178602;C0205360;C0814469;C0439267;C1547311;C0869039;C1114758;C3714445;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4551720,false;false;false;false;false;false;false;false;false;true;true;false;false;false;false;false;true,14473/20013
ics no laba,C0815320;C4551720,false;true,14474/20013
ics non - users,C0815320;C1518422;C1706077;C4551720,false;false;false;true,14475/20013
ics non - users at screening,C0815320;C1518422;C1706077;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4551720,false;false;false;true;true;false;false;false;false;false;true,14476/20013
ics non - users : qvainmbr - sfc,C0815320;C1518422;C1706077;C4521536;C4551720,false;false;false;false;true,14477/20013
ics nonusers,C0815320;C4551720,false;true,14478/20013
ics plus laba,C0815320;C4551720,false;true,14479/20013
ics subset,C0815320;C1515021;C4551720,false;false;true,14480/20013
ics use at enrollment,C0815320;C4551720,false;true,14481/20013
ics use at screeningg,C0815320;C4551720,false;true,14482/20013
ics use no,C0815320;C4551720,false;true,14483/20013
ics use yes,C0815320;C4551720,false;true,14484/20013
ics users at screening,C0815320;C1706077;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4551720,false;false;true;true;false;false;false;false;false;true,14485/20013
ics users : qvainmbr - sfc,C0815320;C1706077;C4521536;C4551720,false;false;false;true,14486/20013
ics / laba subset,C0815320;C1515021;C4551720,false;false;true,14487/20013
ics / laba therapy,C0815320;C0039798;C0087111;C1363945;C4551720,false;true;true;false;true,14488/20013
ics / labd,C0815320;C0396059;C4551720,false;true;true,14489/20013
ics  no laba ( tiotropium n = nmbr  placebo n = nmbr ),C0815320;C4551720,false;true,14490/20013
icsa plus laba,C0332287,false,14491/20013
icsf,,,14492/20013
ideg,,,14493/20013
idegasp – biasp nmbr,,,14494/20013
idegasp bid,,,14495/20013
ideglira,C4308663,true,14496/20013
idiopathic / familial,C0332240;C0015576;C0241888,false;true;false,14497/20013
idiopathica,,,14498/20013
idm,C0270221,false,14499/20013
iee at baseline : < nmbriu / l,C0168634;C0439457;C1442488,true;false;false,14500/20013
ifg pbo ( n = nmbr ) vs evomab ( n = nmbr ),C1334085;C0031962;C1708411,false;true;false,14501/20013
ifx treatment,C0020823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,14502/20013
ig ( n = nmbr ),C0021027;C0305052;C0360506,true;false;false,14503/20013
iga nmbr / nmbr,C2825347,false,14504/20013
iga mod nmbr score,C2825347;C0011860;C0449820;C4050231,false;true;false;false,14505/20013
ige ( ku / l ),C0439340,false,14506/20013
ige high ( > nmbr ku / l  n = nmbr  nmbr ),C0205250;C0439340;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,14507/20013
igehigh ( > inmbrku / l  n = i  nmbr ),C0021966;C0439340;C0221138,true;false;false,14508/20013
igelow ( < nmbrku / l  n = nmbr  nmbr ),C0439340,false,14509/20013
igelow ( < inmbrku / l  n = i  nmbr ),C0021966;C0439340;C0221138,true;false;false,14510/20013
igelow ( n = nmbr,,,14511/20013
igg ( > nmbr . nmbr g / l ),C0439294;C0456615,false;false,14512/20013
igl ( n = nmbr ),C0021037;C0314619;C2247518,true;false;false,14513/20013
iglar ( n   =   nmbr ),,,14514/20013
iglarlixi ( n   =   nmbr ),,,14515/20013
igt or ifg,,,14516/20013
igt / ifg,C1334085;C1708411,false;false,14517/20013
ihd,C0151744,true,14518/20013
ii nmbr amlodipine - lisinopril - chlorthalidone chlorthalidone,C1710602;C0051696;C0065374;C0008294;C4082587,false;true;true;true;false,14519/20013
ii ( nmbr ),,,14520/20013
ii = nmbr,,,14521/20013
ii chiorthaiidone amiodipine,C1710602;C4082587,false;false,14522/20013
ii lisinopril,C1710602;C0065374;C4082587,false;true;false,14523/20013
ii lisinopril i,C1710602;C0065374;C0021966;C0221138;C4082587,false;true;true;false;false,14524/20013
ii . nmbr ( nmbr . nmbr ) nmbr,,,14525/20013
ii / iii,C1710602;C0439070;C1705160;C4082587,false;false;false;false,14526/20013
iinmbr ( inmbr . nmbr ),C1710602;C0021966;C0221138;C4082587,false;true;false;false,14527/20013
iinmbr ( ii . nmbr ),C1710602;C4082587,false;false,14528/20013
iinmbr ± nmbr,,,14529/20013
iief - ef domain score,C3641331;C1880389;C0449820;C4050231;C1883221;C3541951,false;false;false;false;false;false,14530/20013
iii ( nmbr ),C0439070;C1705160,false;false,14531/20013
iii and iv,C0439070;C1705160,false;false,14532/20013
iii or iv,C0439070;C1705160,false;false,14533/20013
ijb^,,,14534/20013
il - nmbr range,C0020898;C1514721;C2348147;C3542016;C0021764;C0022271,true;false;false;false;true;true,14535/20013
ileocolonic ( both ileum and colon ),,,14536/20013
ileum ses - cd score,C0020885;C0007928;C0449820;C4050231;C0034283;C4552032,true;true;false;false;true;false,14537/20013
ill -,C0231218,false,14538/20013
im - uniti,,,14539/20013
im on]y,,,14540/20013
image only,C1704254;C0205171;C1720467;C1704922;C3542466,false;false;false;false;false,14541/20013
imaged artery,C1704254;C0003842;C0226004;C1704922;C3542466,false;true;false;false;false,14542/20013
imaging data,C0011923;C1511726;C3245479;C3714741;C0079595,true;false;false;false;false,14543/20013
imm,C0205470,false,14544/20013
imm only,C0205470;C0205171;C1720467,false;false;false,14545/20013
immobilization — no . ( % ),C0020944;C4048292,true;false,14546/20013
immunomodulators,C0001551;C0005525;C1527392,true;true;true,14547/20013
immunomodulatory drugs,C0013227;C3687832,true;false,14548/20013
immunosuppressant^,C0021081,true,14549/20013
immunosuppressive agents at baseline,C0021081;C0168634;C1442488,true;true;false,14550/20013
immunosuppressive use,C0021081;C0042153;C0457083;C1947944,true;true;false;false,14551/20013
impacts,C1825598;C4049986,false;false,14552/20013
impaired cognitive,C0338656,true,14553/20013
impaired cognitive function ( spmsq > nmbr ) . n - nmbr n ( % ) participants with the event of interest,C0221099;C0009240;C0679646;C0441471;C0543488;C4019010;C0392335;C4050130,false;true;false;false;false;false;false;false,14554/20013
impaired fasting giucose levei ( n = nmbr ),C0221099,false,14555/20013
impaired fasting glucose,C1272092,false,14556/20013
impaired fasting glucose ( > nmbr mg / dl ) ( % ),C1272092;C0439269,false;false,14557/20013
impaired fasting glucose §,C1272092,false,14558/20013
impaired fasting glucosex,C0221099,false,14559/20013
impaired renal function §,C1565489,true,14560/20013
impaired renal function †,C1565489,true,14561/20013
implantable cardioverter - defibrillator n ( % ),C0162589;C2825184,true;false,14562/20013
implanted cardioverter defibrillator,C0021102;C0810516;C2828363,false;false;false,14563/20013
improvement from baseline ≥   nmbr,C2986411;C0168634;C1442488,false;true;false,14564/20013
imputed,C2699638,false,14565/20013
in,,,14566/20013
in - clinic uasnmbr,C0150312;C0002424;C0442592;C0332285;C1707101,false;true;false;false;false,14567/20013
in - clinic uask,C0150312;C0002424;C0442592;C0332285;C1707101,false;true;false;false;false,14568/20013
in - hospital medication,C0019994;C0013227;C3244316;C4284232;C1510665,true;true;false;false;false,14569/20013
in - trial nmbr - year rates per nmbr ( se ) total events / number at risk,C0150312;C0008976;C0439234;C1264674;C0036919;C0439175;C0441471;C3541888;C0439810;C0871208;C4288115;C1521828;C0439508;C0332285;C1707101,false;true;false;false;true;false;false;false;false;false;false;false;false;false;false,14570/20013
in - trial and post - trial nmbr - year rates per nmbr ( se ) total events / number at risk,C0150312;C0008976;C0332285;C1707101,false;true;false;false,14571/20013
in - trial nonfatal or fatal stroke n = nmbr,C0150312;C0008976;C0332285;C1707101,false;true;false;false,14572/20013
in extension study,C0231448;C0557651;C2603343;C1880641,false;false;false;false,14573/20013
in hospital ticagrelor,C0019994;C1999375;C1510665,true;true;false,14574/20013
in patients with a history of chronic angina who have presented with an acute,C0679831;C0205191;C0002962,false;false;true,14575/20013
in previous year,C0205156;C0439234;C0439508;C1552607,false;false;false;false,14576/20013
in remission at maintenance study baseline,C0544452;C0024501;C0557651;C0168634;C1442488;C2603343;C0687702,false;true;false;true;false;false;false,14577/20013
in the spironolactone group and nmbr patients in the placebo group .,C0037982;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,14578/20013
in therapeutic range for warfarin subjects,C0460097;C0043031,false;true,14579/20013
in thirds,,,14580/20013
inadequate response ' ^,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,14581/20013
inadequate response ' ’ ',C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,14582/20013
inadequate response ( > nmbr months mmf / ggs ),C0205412;C0871261;C0439231;C0083765;C0209368;C3848524;C1704632;C1706817;C2911692;C0439856,false;false;false;true;true;true;false;false;false;false,14583/20013
inadequate response or intolerance to > nmbr anti - tnfdrug,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,14584/20013
inappropriate,C1548788;C3537135;C3542467,false;false;false,14585/20013
incidence of each outcome,C0021149;C1274040;C0220856,true;false;true,14586/20013
incidence rate ( n ),C1708485,false,14587/20013
incidence rate ( n ) a,C1708485,false,14588/20013
incidence rate ( per nmbr person - yr ),C1708485;C0027361;C0439234;C2347489,false;true;false;false,14589/20013
incidence rate difference,C1708485;C1705241;C1705242,false;false;false,14590/20013
incidence rate no . ( / nmbrperson - years ),C1708485,false,14591/20013
incidence rate of cv events,C1708485;C3538987;C0441471;C3541888;C4048877;C4318503,false;false;false;false;true;false,14592/20013
incidence rate per nmbr person years,C1708485;C0027361;C0439234;C2347489,false;true;false;false,14593/20013
incidence rate *,C1708485,false,14594/20013
incidence^,C0021149;C0220856,true;true,14595/20013
incident dm or change in,C1551358;C0011816;C3250443,false;true;false,14596/20013
incident or worsening nephropathy,C1551358,false,14597/20013
included in analysis,C0332257;C0002778;C0936012;C1524024,false;false;false;true,14598/20013
included in this study ( n = nmbr ),C0332257;C0557651;C2603343,false;false;false,14599/20013
inclusion criteria,C1512693,false,14600/20013
inclusion findings ( % ),C0007637;C2607943;C2926606;C3539655;C1512693,true;true;false;false;false,14601/20013
inconsistent fao ( n [ nmbr ),C0442809;C0016457,false;false,14602/20013
incontinence episodes / nmbrh,C0021167;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,false;false;true;false;false;false;false,14603/20013
increase in serum creatinine,C0442805;C0201976;C0600061,false;false;false,14604/20013
increased - risk for thrombotic cardiovascular,C4699158;C0087086;C0007226;C3887460,false;true;true;false,14605/20013
increased risk for falls,C4699158;C0000921;C0085639;C1849142;C0035647;C4552904,false;true;false;false;true;false,14606/20013
increased risk for thrombotic cardiovascular event^,C0205217;C0087086;C1273410;C0442805,false;true;false;false,14607/20013
indacaterol / glycopyrronium nmbr / nmbr   μ g o . d .,C1722260;C3814772;C0439417,true;false;false,14608/20013
indeterminate nfs - nmbr . nmbr < nfs < nmbr . nmbr ! n = nmbr ),C0205258;C1513839,false;false,14609/20013
index acs — no . ( % ),C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;true;false;false;false,14610/20013
index acs ( % ),C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;true;false;false;false,14611/20013
index acute coronary syndrome — no . { % ),C0600653;C0948089;C0918012;C1552854;C1637833;C2986546,true;true;true;false;false;false,14612/20013
index event information,C0600653;C0441471;C1533716;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,14613/20013
index events,C0600653;C0441471;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,14614/20013
index events : dvt n ( % ),C0600653;C0441471;C0149871;C2926618;C3899446;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false;true;false;false;false,14615/20013
index events : pe ± dvt n ( % ),C0600653;C0441471;C0070939;C0149871;C2926618;C3899446;C1880476;C4284304;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;true;true;false;false;false;false;false;true;false;false;false,14616/20013
index inclusion acute coronary syndrome,C0600653;C0007637;C0948089;C1512693;C0918012;C1552854;C1637833;C2986546,true;true;true;false;true;false;false;false,14617/20013
index pe : event during,C0600653;C0070939;C0441471;C4019010;C1880476;C4284304;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;false;true;false;false;false,14618/20013
index percutaneous coronary intervention,C0600653;C1532338;C0918012;C1552854;C1637833;C2986546,true;true;true;false;false;false,14619/20013
indian subpopulation,C1524069;C1257890,false;true,14620/20013
indication,C0392360;C3146298,false;false,14621/20013
individual endpoints,C0027361;C2349179;C0237401,true;false;false,14622/20013
individuals with normoglycaemia,C0027361;C0580545;C0237401,true;false;false,14623/20013
individuals with pre - diabetes,C0027361;C0362046;C0237401,true;true;false,14624/20013
individuals with prediabetes,C0027361;C0362046;C0237401,true;true;false,14625/20013
individuals with tnmbrdm ( scale diabetes ),C0027361;C0011816;C0175659;C0011847;C0011849;C0349674;C1947916;C3250443;C0237401,true;true;true;false;true;false;false;false;false,14626/20013
individuals with type nmbr diabetes,C0027361;C1320657;C0237401,true;false;false,14627/20013
indomethacin,C0021246,true,14628/20013
inducing,C0205263,false,14629/20013
induction study treatment,C4049995;C0557651;C2603343;C0205263;C1521826;C0857127,false;false;false;false;false;false,14630/20013
infarct - related vessel ( % ),C0021308,true,14631/20013
infarct location anterior,C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,14632/20013
infarct on brain imaging^,C0751955,true,14633/20013
infarct size,C0021308;C0456389,true;false,14634/20013
infarct territory ( % ),C0021308;C1301808;C2983136,true;false;false,14635/20013
infarction ( yr ) history of congestive heart failure ( % ),C0021308;C0439234;C0455531;C0742742,true;false;false;false,14636/20013
infected,C0439663,false,14637/20013
infections,C3714514,true,14638/20013
infections and infestations,C3714514,true,14639/20013
inferior mi *,C0340305;C3542426,true;false,14640/20013
inflammatory bowel disease,C0021390,true,14641/20013
infliiimab i,C0021966;C0221138,true;false,14642/20013
infliximab combination therapy,C4076075;C0205195;C1947911;C3811910;C0666743;C0009429;C0556895,false;false;false;false;true;true;false,14643/20013
infliximab monotherapy,C0666743,true,14644/20013
inflotmas io mgluj versus piecew,C1046794;C3146236,false;false,14645/20013
influenza,C0021400;C0021403,true;true,14646/20013
infrequent exacerbator,C0521114,false,14647/20013
inguinal hernia repair,C0021446,false,14648/20013
inhaled corticosteroid,C0004048;C0001617;C3536709,true;true;false,14649/20013
inhaled corticosteroid - yes,C0004048;C0001617;C1549445;C1705108;C1710701;C3536709,true;true;false;false;false;false,14650/20013
inhaled^,C0004048,true,14651/20013
inhaledb,,,14652/20013
inhibitor,C1999216,false,14653/20013
inhibitors — no . { % ) se - nmbr physical functioning score^^,C0243077,true,14654/20013
inhixanab nmbr mgikg versus piacom,,,14655/20013
initial heparin — no . ( % ) §,C0205265;C0019134;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false,14656/20013
initial heparin treatment duration,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,14657/20013
initial heparin treatment duration on or after randomization,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,14658/20013
initial symptomatic pe,C0205265;C0231220;C0070939;C1880476;C4284304;C1279901;C1555582;C1705685,false;false;true;false;false;false;false;false,14659/20013
initial timi flow grade nmbr,C0205265;C3272266;C0441800;C0919553;C3244287;C1279901;C1555582;C1705685,false;false;false;false;false;false;false;false,14660/20013
initial treatment randomization,C0205265;C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1279901;C1555582;C1705685,false;true;true;true;false;false;false;false;false;false;false;false,14661/20013
initial type of heparin treatment received,C0205265;C0019134;C0455708;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false,14662/20013
initiated use during double - blind treatment period,C1548602;C0042153;C0013072;C0039798;C0439531;C1948053;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0457083;C1947944;C1704686,false;true;true;true;false;false;true;false;false;false;false;false;false;false;false,14663/20013
injectable anti ‐ hyperglycaemic,C1272883,false,14664/20013
injection - site reaction,C0151735;C4551923,true;false,14665/20013
inotropic agent,C0304509,false,14666/20013
insufficient,C0205412;C0231180;C0439856,false;false;false,14667/20013
insuiin giargine ± oad,,,14668/20013
insulin - dependent diabetes mellitus,C0011854,true,14669/20013
insulin - naive,C0021641;C1533581;C1579433;C3714501,true;false;false;false,14670/20013
insulin - requiring diabetes,C0021641;C0011847;C0011849;C1533581;C1579433;C3714501,true;false;true;false;false;false,14671/20013
insulin - treated dm,C0021641;C1533581;C1579433;C3714501,true;false;false;false,14672/20013
insulin — / tu / ml,C0021641;C0041400;C0439526;C1705224;C3887665;C1532464;C2700314;C3811255;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false;false;false;false,14673/20013
insulin ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,14674/20013
insulin + metformin,C0021641;C0025598;C1533581;C1579433;C3714501,true;true;false;false;false,14675/20013
insulin + oral antidiabetic medication ( s ),C0021641;C0175795;C0935929;C0442027;C4521986;C1533581;C1579433;C3714501,true;false;true;false;false;false;false;false,14676/20013
insulin administration,C0199782,false,14677/20013
insulin aspart,C0123677;C1708521,false;true,14678/20013
insulin aspart ( mealtime ),C0123677;C0587119;C1708521,false;true;true,14679/20013
insulin at baseline,C0021641;C0168634;C1442488;C1533581;C1579433;C3714501,true;true;false;false;false;false,14680/20013
insulin detemir,C0537270,true,14681/20013
insulin dose — lu / day,C0366513;C0024171;C0332173;C0439228;C0439505;C0024176;C2697939,false;true;false;false;false;true;false,14682/20013
insulin dose ( iu / day ),C0366513;C0439465,false;false,14683/20013
insulin dose ( lu / day ),C0366513;C0024171;C0332173;C0439228;C0439505;C0024176;C2697939,false;true;false;false;false;true;false,14684/20013
insulin dose ( u ),C0366513;C0439148,false;false,14685/20013
insulin dose,C0366513,false,14686/20013
insulin glargin arm,C0021641;C0446516;C3715044;C4553528;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,14687/20013
insulin glargine + insulin lispro ( award - nmbr  n = nmbr ),C0293359;C0907402;C0004446,true;true;true,14688/20013
insulin glargine dose at screening visit,C0366513;C0907402;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0178602;C0869039;C1114758,false;true;true;true;false;false;false;false;false;false;false;false,14689/20013
insulin glargine slope lsm ± se ( mm / year ),C0907402;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674,true;false;true;false;false;false;false,14690/20013
insulin glargine   ±   oad,C0907402,true,14691/20013
insulin glargine   ±   oad   +   > bd prandial,C0907402;C0005126;C2344255;C4050145,true;true;false;false,14692/20013
insulin glargine   ±   oad   +   bd prandial,C0907402;C0005126;C2344255;C4050145,true;true;false;false,14693/20013
insulin glargine   ±   oad   +   od prandial,C0907402;C0229089;C0439164;C1512019;C3273373;C3665488,true;false;false;false;true;true,14694/20013
insulin lispro mix nmbr,C0293359;C0205430;C1421951;C1720722;C4553942,true;false;false;false;false,14695/20013
insulin secretagogue,C0021641;C4704833;C1533581;C1579433;C3714501,true;true;false;false;false,14696/20013
insulin treatment,C0745343,false,14697/20013
insulin type,C0457592,false,14698/20013
insulin use at baseline,C0240016;C0168634;C1442488,false;true;false,14699/20013
insulin + metformin + sulphonylureas,C0021641;C0025598;C0038766;C1533581;C1579433;C3714501,true;true;true;false;false;false,14700/20013
insulin + sulphonylureas,C0021641;C0038766;C1533581;C1579433;C3714501,true;true;false;false;false,14701/20013
insulinogenic index ( dinsulino_nmbro min / dglucoseo - nmbro min ),C0600653;C0702093;C1524029;C3813700;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,14702/20013
insulins,C0021641;C3537244;C4049919,true;true;false,14703/20013
insulins and analogs,C0021641;C3537244;C4049919,true;true;false,14704/20013
integrated analysis set ( n = nmbr ),C1158478;C0002778;C0936012;C1524024;C1705422,false;false;false;true;false,14705/20013
intensification of antianginal therapy,C1511484;C1874267;C3537168,false;false;false,14706/20013
intensity of rest pain ( mmvas ),C0522510;C0234253;C0035253;C1320357;C4085211;C1622890,false;false;true;false;false;false,14707/20013
intensity of statin therapy,C0522510;C1278454,false;false,14708/20013
intensity of statin therapy at baseline — no . { % ),C0522510;C1278454,false;false,14709/20013
intensitynmbr,C0522510,false,14710/20013
intensive ( n = nmbr ),C0162425;C0522510;C1283828;C1550453,true;false;false;false,14711/20013
intensive blood glucose control,C0162425;C3267174;C0522510;C1283828;C1550453,true;false;false;false;false,14712/20013
intensive bp lowering,C0162425;C0037623;C0441994;C2003888;C1415692;C1708288;C4318478;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,14713/20013
intensive glycemia lowering,C0162425;C0005802;C0441994;C2003888;C0522510;C1283828;C1550453,true;true;false;false;false;false;false,14714/20013
intensive therapy ( n = nmbr ),C0162425;C0039798;C0087111;C1363945;C0522510;C1283828;C1550453,true;true;true;false;false;false;false,14715/20013
intent to use direct thrombin,C0162425;C1283828;C1550453,true;false;false,14716/20013
intent to use glycoprotein iib / iiia inhibitor,C0162425;C1283828;C1550453,true;false;false,14717/20013
intention to treat,C0162425;C1283828,true;false,14718/20013
inter . p - value,C0205103;C1548610,false;false,14719/20013
interaction,C1704675,false,14720/20013
interaction between treatment and baseline bmi category,C1704675;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,14721/20013
interaction jnmbr - valuet,C1704675,false,14722/20013
interaction p - vaiue,C1704675,false,14723/20013
interaction p - value *,C1704675;C1709380,false;false,14724/20013
interaction p - valuef,C1704675,false,14725/20013
interaction p = nmbr . nmbr,C1704675,false,14726/20013
interaction p vaiue,C1704675,false,14727/20013
interaction p value nmbr . nmbr,C1704675;C1709380,false;false,14728/20013
interaction p value !,C1704675;C1709380,false;false,14729/20013
interaction p value ∗,C1704675;C1709380,false;false,14730/20013
interaction p value *,C1704675;C1709380,false;false,14731/20013
interaction p values are as follows : amlodipine vs . chlorthalidone : age  p = nmbr . nmbr  gender  p = nmbr . nmbr  race  p = nmbr . nmbr  history of chd  p = nmbr . nmbr  history of diabetes  p = nmbr . nmbr . lisinopril vs . chlorthalidone : age  p = nmbr . nmbr  gender  p = nmbr . nmbr  race  p = nmbr . nmbr  history of chd  p = nmbr . nmbr  history of diabetes  p = nmbr . nmbr . peripheral arterial disease refers to in - trial hospitalization or lower extremity revascularization procedure .,C1704675;C1709380,false;false,14732/20013
interaction pf,C1704675;C3815179,false;false,14733/20013
interaction : treatment by psoriasis p valueb,C1704675;C3258078,false;false,14734/20013
intercourse satisfac -,C0009253,true,14735/20013
interim analysis,C4684691,false,14736/20013
interim analysis ( all patients ),C4684691,false,14737/20013
intermediate - acting,C0205103;C1550465;C2827755;C3889971,false;false;false;false,14738/20013
intermediate ( nmbr ),C0205103;C1550465;C2827755;C3889971,false;false;false;false,14739/20013
intermediate ( nmbr - nmbr ),C0205103;C1550465;C2827755;C3889971,false;false;false;false,14740/20013
intermediate / long - acting + fast - acting,C0205103;C0205166;C0079613;C0015663;C0456962;C2985769;C1704930;C1869853;C3890007;C4048375;C1706317;C1550465;C2827755;C3889971,false;false;true;true;false;false;false;true;false;false;false;false;false;false,14741/20013
internal carotid artery sites,C0007276;C0205145,true;false,14742/20013
interquartile range — ml / min,C1711350;C0439445,false;false,14743/20013
intertrochanteric,C0745355,false,14744/20013
interval between clinical evaluation and initiation of treatment — no . ( % ),C1272706;C1261322;C4084924;C1552654;C1552713;C0205210;C2826267,false;false;false;false;false;false;false,14745/20013
interval from symptom onset to qualifying ecg obtained in the er — hr,C1272706;C4086878;C1552654;C1552713,false;false;false;false,14746/20013
interval of > nmbr yr since diagnosis of type nmbr diabetes — no . ( % ),C1272706;C0439234;C1552654;C1552713,false;false;false;false,14747/20013
intervention .,C0184661;C0886296;C1273869,true;false;false,14748/20013
interventional or surgical procedures,C0184661;C3274035,true;false,14749/20013
intestinal area involved — no . ( % ),C0021853;C0017446;C0205146,true;true;false,14750/20013
intolerance,C0231199;C1744706;C2355652,false;false;false,14751/20013
intolerance ',C0231199;C1744706;C2355652,false;false;false,14752/20013
intolerance ®,C0231199;C1744706;C2355652,false;false;false,14753/20013
intra - abdominal abscess ( past ),C0243001;C1444637;C4284302,true;false;false,14754/20013
intracerebral,C0442111,false,14755/20013
intracranial,C0524466,false,14756/20013
intracranial bleed,C0151699,true,14757/20013
intracranial bleeding,C0151699,true,14758/20013
intracranial disease of major artery disease t,C0752138;C0012634;C0205082;C0205164;C4318856;C4521762,true;true;false;false;false;false,14759/20013
intracranial hemorrhage,C0151699;C4554169,true;false,14760/20013
intracranial hemorrhage †,C0151699;C4554169,true;false,14761/20013
intravenous ( n = nmbr ),C0348016,false,14762/20013
intravenous anticoagulant during hospitalisation *,C0348016;C0003280;C0019993;C0848112;C3536711,false;true;true;false;false,14763/20013
intravenous anticoagulant prior to pre - pci angiography,C0348016;C0003280;C0332152;C4049621;C0002978;C0740175;C2257086;C3669034;C0848112;C3536711,false;true;false;false;true;false;false;false;false;false,14764/20013
intravenous vasoactive drugs,C0683092;C1980011,false;false,14765/20013
inversion,C0021943;C0021945;C1705687;C2349984,true;false;false;false,14766/20013
investigations,C1261322,false,14767/20013
investigator - defined drug - related aes,C0035173,true,14768/20013
investigator - reported aes,C0035173;C0684224;C1412268;C2699274;C0700287;C4319718,true;true;false;false;false;false,14769/20013
involved gastrointestinal,C1314939;C0521362,false;false,14770/20013
involved gl areas,C1879646;C0018229;C1423073;C1427674,false;true;false;false,14771/20013
iop - lowering medication,C0578862;C0441994;C0013227;C3244316;C4284232;C2003888,false;false;true;false;false;false,14772/20013
iop,C0578862,false,14773/20013
ipeated - measures state examinatioi,C0079809;C1879489,true;false,14774/20013
ipf,C0034069;C1800706,true;true,14775/20013
ipss,C1019118;C1998280;C2827405;C3811063,false;false;false;false,14776/20013
ipss - s,C1019118;C1998280;C2827405;C3811063,false;false;false;false,14777/20013
ipss - v,C1019118;C1998280;C2827405;C3811063,false;false;false;false,14778/20013
ipss ( ls mean ± se ),C1019118;C0023668;C0444504;C0036919;C2347634;C2348143;C1998280;C2827405;C3811063,false;true;false;true;false;false;false;false;false,14779/20013
ipss ( mean ± sd ),C1019118;C0444504;C2699239;C2347634;C2348143;C1998280;C2827405;C3811063,false;false;false;false;false;false;false;false,14780/20013
ipss ( unit ),C1019118;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C1998280;C2827405;C3811063,false;false;false;false;false;false;false;false;false;false;false,14781/20013
ipss categories,C1019118;C0683312;C1998280;C2827405;C3811063,false;false;false;false;false,14782/20013
ipss hrql,C1019118;C1998280;C2827405;C3811063,false;false;false;false,14783/20013
ipss qol,C1019118;C0518214;C1998280;C2827405;C3811063,false;false;false;false;false,14784/20013
ipss qol ( ls,C1019118;C0518214;C0023668;C1998280;C2827405;C3811063,false;false;true;false;false;false,14785/20013
ipss storage subscore,C1019118;C0337174;C1698986;C1753314;C1998280;C2827405;C3811063,false;false;false;false;false;false;false,14786/20013
ipss total score,C1019118;C2964552;C1998280;C2827405;C3811063,false;false;false;false;false,14787/20013
ipss voiding subscore,C1019118;C1998280;C2827405;C3811063,false;false;false;false,14788/20013
iqr,,,14789/20013
irr = nmbr . nmbr ( nmbr . nmbr – nmbr . nmbr ) nmbr . nmbr,C4082285,true,14790/20013
irregular or ulcerated ica plaquef,C0205271,false,14791/20013
irritative subscore,C0441723;C1706307;C2700617,false;false;false,14792/20013
is domain luts severity ( % ),,,14793/20013
is only,,,14794/20013
ischaemic ( n = nmbr ),C0475224,false,14795/20013
ischaemic dilated cardiomyopathy,C1960867,false,14796/20013
ischaemic etiology n ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,14797/20013
ischaemic heart disease or cerebrovascular disorder,C0010054;C0151744,true;true,14798/20013
ischaemic or unknown stroke,C0475224,false,14799/20013
ischaemic skin lesions,C0475224;C0037284,false;false,14800/20013
ischaemic stroke,C0948008,false,14801/20013
ischemia on cecg ( % ),C0022116;C4321499,true;false,14802/20013
ischemic,C0475224,false,14803/20013
ischemic cause,C0475224;C0015127;C1524003,false;true;false,14804/20013
ischemic etiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,14805/20013
ischemic etiology ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,14806/20013
ischemic heart disease ( % ),C0010054;C0151744,true;true,14807/20013
ischemic heart disease *,C0010054;C0151744,true;true,14808/20013
ischemic heart failure etiology,C0475224;C0018801;C0015127;C1314792;C1524003;C0018802;C4554158,false;true;true;true;false;true;false,14809/20013
ischemic hf etiology,C0475224;C0018488;C0015127;C1314792;C1524003;C1313497;C1538440;C3273279,false;true;true;true;false;true;false;false,14810/20013
ischemic hf,C0475224;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,14811/20013
ischemic outcomes,C0475224;C1274040,false;false,14812/20013
ischemic stroke ( % ),C0948008,false,14813/20013
ischemic stroke ( incl . uncertain ),C0948008,false,14814/20013
ischemic stroke or see,C0948008,false,14815/20013
ischemic stroke subtype,C0948008;C0449560,false;false,14816/20013
isehemie heart disease,C0018799,true,14817/20013
ish,,,14818/20013
ish status,C0449438,false,14819/20013
isoiated systoiic hypertension *,C0020538;C1963138,true;false,14820/20013
isolated systolic hypertension^,C0745133,false,14821/20013
isolated systolic hypertension ⁎,C0745133,false,14822/20013
isolated upper gastrointestinal disease behavior,C0205409;C0810300;C0004927;C2707008;C1548221,false;false;true;false;false,14823/20013
it nmbr . nmbr,,,14824/20013
itca nmbr nmbr mg / day ( n = nmbr ),C0165330;C0439422,true;false,14825/20013
itch nrs,C0033774;C2240043;C4050142;C1422257,true;false;false;false,14826/20013
itch nrs nmbr ( v = nmbr ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,14827/20013
itch nrs nmbr - nmbr ( at = nmbr ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,14828/20013
itch nrs nmbr - nmbr ( v = nmbr ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,14829/20013
itch nrs nmbr - nmbr ( . \ ' = nmbr ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,14830/20013
itch nrs nmbr - nmbr ( a ' = nmbr ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,14831/20013
item,C1551338;C4554251,false;false,14832/20013
ith vs . without ),,,14833/20013
itt cohort,C0009247;C0599755,true;false,14834/20013
itt patients,C0030705,true,14835/20013
iuss score,C0439453,false,14836/20013
iv - nmbr mg,C0022326;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4265176,true;true;true;false;false;false;false;false;false,14837/20013
iv ( nmbr ),C0022326;C4265176,true;false,14838/20013
iv inotropic drug,C1971835,false,14839/20013
iv vasodilator,C0022326;C0042402;C3537240;C4265176,true;true;false;false,14840/20013
ivabradine,C0257190,true,14841/20013
ivc ( n = nmbr ),C4085887,false,14842/20013
ixekizumab every nmbr weeks ( n = nmbr ),C3489764,true,14843/20013
ization — no . ( % ),,,14844/20013
jnmbr - blocker,,,14845/20013
jnmbr coefficient,C1707429,false,14846/20013
japanese subgroup ( n = nmbr ),C0376247;C1079230;C1515021;C1556094,false;false;false;true,14847/20013
japanese subpopulation,C0376247;C1257890;C1556094,false;true;true,14848/20013
jsnmbr - agonists,C1552154;C0243192;C2987634,false;true;false,14849/20013
jsn score ( nmbr – nmbr scale ),C0449820;C0175659;C0349674;C1947916;C4050231,false;true;false;false;false,14850/20013
jugular venous distension,C0425687,false,14851/20013
jugular venous distention > nmbr cm,C0425687,false,14852/20013
juvenile myoclonic epilepsy,C0270853,true,14853/20013
jvd $ nmbr cm hnmbro,C0425687;C0455483,false;false,14854/20013
jvp $ nmbr cm hnmbro,C0455483,false,14855/20013
jvp ( 〉 nmbr cm ),,,14856/20013
k - m % n,C0597277;C0369637;C0441923;C1708601,false;false;false;false,14857/20013
k,C0597277;C1708601,false;false,14858/20013
kaplan - meier rates,C0871208;C1521828,false;false,14859/20013
key secondary end points,C0027627;C2349179;C0175668;C0205436,true;false;false;false,14860/20013
key : fc = fasting glucose  bp = * this category did not include ar have nmbr of the indicated charac,C2983605;C0015663;C0017725;C0037623;C1415692;C1708288;C4318478,false;true;true;true;false;false;false,14861/20013
kg,C0022718;C0439209;C4054209,true;false;false,14862/20013
kg / mnmbr,C1532718,false,14863/20013
kg / mnmbr ),C1532718,false,14864/20013
kidney disease ( usrds ),C0022658,true,14865/20013
killip ciass,,,14866/20013
killip class — no . / total no . ( % ) i,C1881332,false,14867/20013
killip class > nmbr,C1881332,false,14868/20013
killip class > i,C2697844,false,14869/20013
killip class nmbr,C1881332,false,14870/20013
killip class nmbr / nmbr,C1881332,false,14871/20013
killip class ii - iv,C2697847;C1710602;C4082587;C2697845;C0022326;C4265176,false;false;false;false;true;false,14872/20013
killip class ii,C2697845,false,14873/20013
killip class iv at randomization,C2697847;C0034656,false;true,14874/20013
killip class *,C1881332,false,14875/20013
kl nmbr ( % ),C1366480;C1416656;C1704887,false;false;false,14876/20013
km event ( % ) at nmbr y,C3887676;C0441471;C4019010,false;false;false,14877/20013
km rate ( % ),C3887676;C0871208;C1521828,false;false;false,14878/20013
km rates { % ) e / s,C3887676;C0871208;C1521828,false;false;false,14879/20013
km rates { % ) p / s,C3887676;C0871208;C0234833;C0722388;C1521828,false;false;false;false;false,14880/20013
knee,C0022742;C0022745;C1963703,true;true;false,14881/20013
knees ( n ),C0022742,true,14882/20013
known duration,C0205309;C0449238;C2926735,false;false;false,14883/20013
known duration of tnmbrdm,C0205309;C0449238;C0011816;C3250443;C2926735,false;false;true;false;false,14884/20013
known duration of type nmbr diabetes,C0205309;C0449238;C1320657;C2926735,false;false;false;false,14885/20013
l,C0439394;C1706495;C3642217,false;false;false,14886/20013
l ( < l ),C3539687,false,14887/20013
l compared wi,C0439394;C1707455;C0043193;C1520135;C1706495;C3642217,false;false;true;false;false;false,14888/20013
l compared wit,C0439394;C1706495;C3642217,false;false;false,14889/20013
l eft anterior descending,C0439394;C0451214;C0205094;C0205386;C1547177;C1706495;C3642217,false;false;false;false;false;false;false,14890/20013
l vs . c,C0439394;C1706495;C3642217,false;false;false,14891/20013
l . i ( nmbr . nmbr ),C0439394;C0021966;C0221138;C1706495;C3642217,false;true;false;false;false,14892/20013
l . l ± nmbr . nmbr,C3539687,false,14893/20013
l / c,C0439394;C1706495;C3642217,false;false;false,14894/20013
lnmbr - nmbr vs placebo,C0439394;C1706495;C3642217,false;false;false,14895/20013
lnmbr - nmbr vs lnmbr - nmbr - nmbr,C0439394;C1706495;C3642217,false;false;false,14896/20013
la diameter,C0023031;C1301886;C0023749;C0230347;C2346906;C4553351,true;false;true;false;false;false,14897/20013
la grade a,C0023031;C0023749;C0230347;C2346906;C4553351,true;true;false;false;false,14898/20013
la grade b,C1881342,false,14899/20013
laa closure ( n = nmbr ),C0185003;C1521802,false;false,14900/20013
laba ( inhaled ),,,14901/20013
laba ( tiotropium n = nmbr  placebo n = nmbr ),C0213771;C0032042;C1696465;C1706408,true;true;false;false,14902/20013
laba or lama,,,14903/20013
laba plus ics ( tiotropium n = nmbr,C0332287;C0815320;C0213771;C4551720,false;false;true;true,14904/20013
laba plus ics,C0815320;C4551720,false;true,14905/20013
laba use at enrolment,C0042153;C1516879;C1696073;C3888021;C0457083;C1947944,true;false;false;false;false;false,14906/20013
laba / ics #,C0815320;C4551720,false;true,14907/20013
laba / lama / ics,C0999593;C0815320;C4551720;C1416775,false;false;true;false,14908/20013
laba   +   ics,C0815320;C4551720,false;true,14909/20013
labd alone,C0396059,true,14910/20013
laboratory determinations,C0022877;C0680730;C3244292;C4283904,true;false;false;false,14911/20013
laboratory evaluations,C0022877;C0220825;C3244292;C4283904,true;false;false;false,14912/20013
laboratory investigations,C0022877;C1261322;C3244292;C4283904,true;false;false;false,14913/20013
laboratory parameters,C0022877;C0449381;C3244292;C4283904,true;false;false;false,14914/20013
laboratory testing,C0022885,false,14915/20013
laboratory tests,C0022885,false,14916/20013
laboratory values in patients with history of diabetes,C0022877;C0042295;C0030705;C3244292;C4283904,true;false;true;false;false,14917/20013
labs at randomization,C0587081;C0034656,false;true,14918/20013
lack of effectiveness,C0235828,false,14919/20013
lack of efficacy,C0235828,false,14920/20013
lack of efficacy with > nmbr anti - interleukin nmbr,C0235828,false,14921/20013
lack of efficacy with > nmbr bdmard,C0235828,false,14922/20013
lacunar infarction,C0333559,true,14923/20013
lad artery,C0003842;C0226004,true;false,14924/20013
lama ( tiotropium ),C0999593;C0213771;C1416775,false;true;false,14925/20013
lama use,C0999593;C0042153;C0457083;C1947944;C1416775,false;true;false;false;false,14926/20013
lamad,,,14927/20013
lansoprazole ( n = nmbr ),C0050940,true,14928/20013
lansoprazole nmbr mg qd,C0050940;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,14929/20013
laparoscopic cholecystectomy,C0162522,true,14930/20013
large / very large,C0549177;C0442824;C2984081,false;false;false,14931/20013
last infusion in the horizon - pft,C1517741;C0574032;C0024119;C0053122;C0279232;C1827465,false;false;true;true;false;false,14932/20013
last study visit,C1517741,false,14933/20013
late load,C0205087,false,14934/20013
lathosterol ( jimol / l ),C0064673,true,14935/20013
lathosterol / total c ( | imol / mmol ),C0064673;C0439175;C0439190;C0439810,true;false;false;false,14936/20013
latin,,,14937/20013
latin american subgroup,C1553378;C1079230;C1515021,false;false;false,14938/20013
latin ameriea,,,14939/20013
latino,C0086528,true,14940/20013
lav ( ml ),C0019682;C0439526;C1705224;C3887665,true;false;false;false,14941/20013
lavolta nmbr,,,14942/20013
lavolta ii,C1710602;C4082587,false;false,14943/20013
lb,,,14944/20013
lc,,,14945/20013
lce — l - dopa / carbidopa / entacapone  lc — l - dopa / carbidopa  pd — parkinson disease  updrs — rating scale  adl — activities of daily living  pdq - nmbr — parkinson disease questionnaire .,C1423759;C0353697;C0165921;C0030567;C3639721;C0681889;C0001288;C0441655;C1420005;C3273355,false;true;true;true;true;false;true;false;false;false,14946/20013
lce,C1423759;C3273355,false;false,14947/20013
lcl,C3658298,true,14948/20013
lcznmbr,,,14949/20013
lcznmbr treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,14950/20013
ld,C0694649,false,14951/20013
ld edoxaban vs warfarin,C0694649;C2975435,false;true,14952/20013
ldi - b > nmbr ( n = nmbr ),,,14953/20013
ldi,,,14954/20013
ldinmbr,,,14955/20013
ldl - c ( calculated ),,,14956/20013
ldl - c ( measured ),,,14957/20013
ldl - c ( mg / dl ) * *,C0439269,false,14958/20013
ldl - c < nmbr mg / dl ( nmbr . nmbr mmol / l ),C0439269;C1532563,false;false,14959/20013
ldl - c > nmbr mg / dl,C0439269,false,14960/20013
ldl - c nmbr - nmbr mg / dl,C0439269,false,14961/20013
ldl - c at baseline :,C0168634;C1442488,true;false,14962/20013
ldl - c goal attainment,C0680230,false,14963/20013
ldl - c in mmol / l ( baseline : mean ( sd ) [n]  wk nmbr and change : mean ( se ) [n] ),C1532563;C0168634;C0444504;C2699239;C0332174;C0439230;C2347634;C2348143;C1442488,false;true;false;false;false;false;false;false;false,14964/20013
ldl - c in mmol / l ( mean ± sd for baseline [n]  mean ± se for week nmbr [n] ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14965/20013
ldl - c level,C0441889;C0456079;C1547707;C2946261,false;false;false;false,14966/20013
ldl - c   *   ( mmol / l ),C1532563,false,14967/20013
ldl - c < nmbrmg / dl,C0439269,false,14968/20013
ldl - to - hdl cholesterol ratio,C0428621;C0008377;C1171408,false;true;false,14969/20013
ldl cholesterol - lowering therapy,C0023824;C0441994;C0039798;C0087111;C1363945;C2003888;C0202117,true;false;true;true;false;false;false,14970/20013
ldl cholesterol ( mmol / l ) ( median,C0023824;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193;C0202117,true;false;false;false;false;false;false;false,14971/20013
ldl cholesterol ( sd ),C0023824;C2699239;C0202117,true;false;false,14972/20013
ldl cholesterol level,C0023824;C0441889;C0456079;C1547707;C2946261;C0201950;C0202117;C0428466,true;false;false;false;false;false;false;false,14973/20013
ldl cholesterol mean,C0023824;C0444504;C2347634;C2348143;C0202117,true;false;false;false;false,14974/20013
ldl cholesterol^ :,C0023824;C0202117,true;false,14975/20013
ldl / hdl cholesterol ratio,C2938854,false,14976/20013
ldl : hdl ratio,C0428621,false,14977/20013
ldlc,C1416822,false,14978/20013
ldlc : hdlc,C1416822;C1704429,false;true,14979/20013
leader,,,14980/20013
leading to death,C0332152;C0011065;C1306577;C4082313;C4552775;C1522538,false;true;false;false;false;false,14981/20013
leading to discontinuation,C0332152;C0457454;C1444662;C4552847;C1522538,false;false;false;false;false,14982/20013
leading to study drug discontinuation,C0332152;C1522538,false;false,14983/20013
leading to study withdrawal,C0332152;C1522538,false;false,14984/20013
least - squares mean difference ( nmbr % ci ) *,C0023189;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,true;false;false;true;false;false;false;false,14985/20013
least - squares mean difference ( nmbr % cl ),C0023189;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,14986/20013
least squares mean between - treatment difference ( nmbr % ci ),C0023189;C0444504;C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,true;false;true;false;true;false;false;true;false;false;false;false;false;false;false,14987/20013
lebrikizumab nmbr mg,C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14988/20013
lebrikizumab nmbr mg ( n = nmbr ),C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14989/20013
lebrikizumab nmbr - nmbr mg,C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14990/20013
lebrikizumab nmbr - nmbr mg ( n = nmbr ),C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14991/20013
leeds dactylitis index - basic,C0239161;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,14992/20013
leeds enthesitis index,C0451148,false,14993/20013
leeds enthesitis index^ score > nmbr — no . { % ),C0451148,false,14994/20013
leflunomide,C0063041,true,14995/20013
left,C0205091;C0443246;C1552822,false;false;false,14996/20013
left main coronary artery bifurcation,C3898614,false,14997/20013
left main treated,C0205091;C0205225;C1522326;C1542147;C0443246;C1552822,false;false;false;false;false;false,14998/20013
left shoulder,C0524469,false,14999/20013
left side,C0205091,false,15000/20013
left ventricular ejection fraction — % §,C0428772;C0488728,false;false,15001/20013
left ventricular ejection fraction ( % ),C0428772;C0488728,false;false,15002/20013
left ventricular ejection fraction within previous nmbr mo — no . / total no . ( % ) nmbr,C0428772;C0205156;C0026544;C0332177;C1552607;C0488728,false;false;true;false;false;false,15003/20013
left ventricular hypertrophy * *,C0149721;C3484363,true;false,15004/20013
left ventricular systolic dysfunction,C1277187;C1963159;C4553199,false;false;false,15005/20013
legend,C2729544,false,15006/20013
legs only,C1140621;C0205171;C1720467,true;false;false,15007/20013
lei > nmbr ( n = nmbr ),C0023401;C0428209,true;false,15008/20013
lei,C0023401;C0428209,true;false,15009/20013
leinmbr,C0023401;C0428209,true;false,15010/20013
lelt ventricular hypertrophy *,C0340279,false,15011/20013
lesion length ≥ nmbr mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,15012/20013
lesion ( s ),C0221198;C1546698,false;false,15013/20013
lesions treated per patient,C0221198,false,15014/20013
less severe oa symptoms at baseline,C0439092;C0436345;C0029408;C0168634;C1442488;C3887876;C0547044,false;false;true;true;false;false;false,15015/20013
less than nmbr y ears,C0439092;C0013443;C0521421,false;true;false,15016/20013
less than nmbr,C0439092,false,15017/20013
less than nmbr kg / mnmbr,C0439092;C1532718,false;false,15018/20013
less than nmbr . nmbr %,C0439092,false,15019/20013
less than high school,C0439092;C0599395;C0683862;C0870649,false;false;false;false,15020/20013
less than median,C0439092;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15021/20013
leukopenia,C0023530;C0750394,true;false,15022/20013
leukotriene modifier,C0023545;C0205349;C1514623;C1516451;C3542952,true;false;false;false;false,15023/20013
lev - exposed,C0023556,true,15024/20013
lev ( n   =   nmbr ),C0023556,true,15025/20013
level of renal impairment ',C0441889;C1565489;C0456079;C1547707;C2946261,false;true;false;false;false,15026/20013
level of thyroperoxidase antibody at baseline,C0441889;C0487652;C1318460;C0456079;C1547707;C2946261;C0021965;C0428536;C1364508;C1429427;C3272921,false;false;false;false;false;false;true;false;false;true;false,15027/20013
levodopa dose,C0023570;C0178602;C0869039;C1114758,true;false;false;false,15028/20013
levosimendan ( n   = nmbr ),C0246904,true,15029/20013
li nmbr ( nmbr . nmbr ),C0023617;C3495095,true;false,15030/20013
lieum only,C0205171;C1720467,false;false,15031/20013
life - threatening,C1546953;C2826244;C3537125,false;false;false,15032/20013
life - threatening bleed,C1546953;C0019080;C2826244;C3537125,false;true;false;false,15033/20013
life - threatening bleeding,C1546953;C0019080;C2826244;C3537125,false;true;false;false,15034/20013
lifestyle behaviors,C0023676;C0004927;C0677505,true;true;false,15035/20013
lifestyle behaviours,C0023676;C0004927;C0677505,true;true;false,15036/20013
likelihood test,C0033204;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,true;false;false;false;false;false;false;false,15037/20013
limb,C0015385,true,15038/20013
limb amputation,C0002689,false,15039/20013
limited,C0439801;C2674459;C3542948;C4050251,false;false;false;false,15040/20013
limited to left side of colon,C0439801;C0227388;C2674459;C3542948;C4050251,false;false;false;false;false,15041/20013
linagliptin ( n = nmbr ) ',C2746078,true,15042/20013
linear regression,C0023733;C2346679,true;false,15043/20013
lioid trial participants,C1997894;C2242969,false;false,15044/20013
lipc,C1416867,false,15045/20013
lipid - lowering drug * *,C0086440,true,15046/20013
lipid ‐ lowering therapies,C0585943,false,15047/20013
lipid - modulating drug,C0023779;C0443264;C0013227;C1254351,true;false;true;false,15048/20013
lipid concentrations,C0023779;C0086045,true;true,15049/20013
lipid concentrations total cholesterol ( mmol / l ),C0023779;C0086045;C0201950;C1532563;C0543421,true;true;false;false;false,15050/20013
lipid levels — mg / dlj total cholesterol,C0428460;C0024671;C0201950;C0543421;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,15051/20013
lipid lowering agent n ( % ),C0086440,true,15052/20013
lipid lowering agents,C0086440,true,15053/20013
lipid lowering drugs,C0086440,true,15054/20013
lipid lowering therapy,C0585943,false,15055/20013
lipid measure *,C0023779;C0079809;C0242485,true;true;false,15056/20013
lipid measures at baseline — mg / dl,C0023779,true,15057/20013
lipid medication,C0023779;C0013227;C3244316;C4284232,true;true;false;false,15058/20013
lipid modifiers,C0023779;C4284280,true;false,15059/20013
lipid parameters,C0023779;C0449381,true;false,15060/20013
lipid treatment,C0023779;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,15061/20013
lipid trial participants,C0023779;C1997894;C2242969,true;false;false,15062/20013
lipid trial participants - n ( % ),C0023779;C1997894;C2242969,true;false;false,15063/20013
lipid trial participants #,C0023779;C1997894;C2242969,true;false;false,15064/20013
lipid trial participantsk,C0023779;C0008976,true;true,15065/20013
lipid trial participantss,C0023779;C0008976,true;true,15066/20013
lipids — mg / dl,C0023779;C0439269,true;false,15067/20013
lipids medications,C0023779;C0013227;C0802604;C2598133;C4284232,true;true;false;false;false,15068/20013
lira,C1555441,false,15069/20013
liraglutide ( « = nmbr ),C1456408,true,15070/20013
liraglutide ( nmbr . nmbr mg ) ± oad,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15071/20013
liraglutide nmbr - nmbr mg mean ( n ),C1456408;C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,15072/20013
liraglutide n ( % ),C1456408,true,15073/20013
lis,C2247545,false,15074/20013
lisinopril,C0065374,true,15075/20013
lisinopril ( n = nmbr ),C0065374,true,15076/20013
lisinopril cvd total,C0065374;C0007222;C0439175;C0439810,true;true;false;false,15077/20013
lisinopril vs amlodipineb,C0065374,true,15078/20013
lisinopril vs chlorthalidone,C0065374,true,15079/20013
lisinopril vs chlorthalidone normal,C0065374,true,15080/20013
lisinopril vs chlorthalidone obese,C0065374,true,15081/20013
lisinopril vs chlorthalidone overweight,C0065374,true,15082/20013
lisinopril / chlorthalidone,C0065374;C0008294,true;true,15083/20013
lisrs,,,15084/20013
lithe,,,15085/20013
lived alone,C1548795;C0205171;C0439044;C0679994;C1634625;C2982691,false;false;false;false;false;false,15086/20013
liver disorder,C0023895,true,15087/20013
lixi,,,15088/20013
lixisenatide,C2973895,true,15089/20013
lixisenatide ( n = nmbr ),C2973895,true,15090/20013
lixisenatide ( n = nmbro ),C2973895,true,15091/20013
ll ( nmbr ),,,15092/20013
ll,,,15093/20013
llnmbr ( nmbr ),,,15094/20013
lll / iv,C1261077;C0022326;C4265176,false;true;false,15095/20013
llpasi nmbr,,,15096/20013
llraglutide nmbr - nmbr mg mean ( n ),C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;false;true;false;false;false;false;false,15097/20013
lmnmbr nmbr,C1261082;C1551056,false;false,15098/20013
lmnmbr bid ( n = nmbr ),C1261082;C1551056,false;false,15099/20013
lmwh within nmbr days before randomization — no . / total no . ( % ),C0019139;C0439228;C3536766,true;false;false,15100/20013
lo ( lo - lo ),C0206579;C1232424,true;false,15101/20013
loading dose of clopidogrel or ticlopidine,C3714444;C0070166,false;true,15102/20013
local eosinophil count,C0205276;C0200638;C0750879,false;false;false,15103/20013
local eosinophil count [cells / µ l],C0205276;C0200638;C0347983;C0750879,false;false;false;false,15104/20013
local eosinophil count [cells / ml],C0205276;C0200638;C2699156;C0750879,false;false;false;false,15105/20013
locally advanced,C1517927,false,15106/20013
location of infarction — no . ( % ) §,C0450429;C0021308;C1515974;C4284930;C4284931,false;true;false;false;false,15107/20013
log - rank,C1708728;C0667477;C0699794;C2986775,false;true;false;false,15108/20013
log - rank p value,C1708728;C0667477;C1709380;C0699794;C2986775,false;true;false;false;false,15109/20013
logistic regression,C0206031,true,15110/20013
lone atrial fibrillation — no . ( % ) §,C0340489,false,15111/20013
long - acting nitrate agents,C0205166;C0079613;C0028125;C0450442;C1254351;C1521826;C0699857;C3848573;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;false;false;false;false;true;false;false;false,15112/20013
long - acting^,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,15113/20013
long - standing persistent,C0205166;C0231472;C0205322;C0332996;C1706317,false;true;false;false;false,15114/20013
long - term treatment with aspirin — no . / total no . ( % ),C0023977;C0004057,true;true,15115/20013
long - term vitamin k antagonist,C0443252;C1096489;C2267235,false;false;false,15116/20013
long - term vka therapy,C0443252;C0039798;C0087111;C1363945,false;true;true;false,15117/20013
long - term warfarin ( n = nmbr ),C0443252;C0043031,false;true,15118/20013
long ( > nmbr years ) duration of diabetes,C0439591;C0439234;C0011847;C0011849,false;false;false;true,15119/20013
long ( > nmbrmm ) stenting yes ( n = nmbr ),C0205166;C4330985;C0038257;C1549445;C1705108;C1710701;C2348535;C4554674;C1706317,false;false;true;false;false;false;false;false;false,15120/20013
long ( inmbr years ) duration of diabetes,C0439591;C0021966;C0439234;C0011847;C0011849;C0221138,false;true;false;false;true;false,15121/20013
long term ( n = nmbr ) +,C0443252,false,15122/20013
long term vka therapy,C0443252;C0039798;C0087111;C1363945,false;true;true;false,15123/20013
long term *,C0443252,false,15124/20013
loop diuretic use,C0354100;C0042153;C0457083;C1947944;C3536704,true;true;false;false;false,15125/20013
loop diureties,C0445022,false,15126/20013
loop or thiazide diuretic^,C0445022,false,15127/20013
lor ii,C1416897;C1710602;C4082587;C1416899;C2986770,false;false;false;false;false,15128/20013
losartan ( n = nmbr,C0126174,true,15129/20013
losartan ( n = nmbr ),C0126174,true,15130/20013
loss of response,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,15131/20013
loss of response ‘ s,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,15132/20013
loss of response ®,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,15133/20013
lost bmd,C0745777;C3815882,false;false,15134/20013
low - ceiling diuretic,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15135/20013
low - density lipoprotein choles -,C0023823,true,15136/20013
low - density lipoprotein cholesterol — mg / dlf,C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15137/20013
low - density lipoprotein^,C0023823,true,15138/20013
low - dose aspirin use at baseline,C2608320;C0042153;C0168634;C1442488;C0457083;C1947944,false;true;true;false;false;false,15139/20013
low - dose aspirin use strata * n ( % ),C2608320;C0042153;C0457083;C1947944,false;true;false;false,15140/20013
low - dose aspirin use . strata *,C2608320;C0042153;C0457083;C1947944,false;true;false;false,15141/20013
low - dose edoxaban,C0445550;C2975435;C1708745,false;true;false,15142/20013
low - dose edoxaban ( n = nmbr ),C0445550;C2975435;C1708745,false;true;false,15143/20013
low - dose edoxaban vs warfarin,C0445550;C2975435;C1708745,false;true;false,15144/20013
low - medium microalbuminuria ( n = nmbr ),C0205251;C0009458;C0730345;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false;false;false,15145/20013
low - molecular - weight heparin — no . ( % ),C0019139;C3536766,true;false,15146/20013
low - molecular - weight heparin only,C0019139;C0205171;C1720467;C3536766,true;false;false;false,15147/20013
low - molecular - weight only,C0041667;C1521991;C0205171;C1720467;C0205251;C0026385;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;false;false;true;false;false;false;false;false,15148/20013
low - trauma fracture since age nmbr,C0521170,true,15149/20013
low ( < nmbr kg / m^ ) baseline bmi,C0205251;C1532718;C0168634;C0578022;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;true;false;false;false;false;false;false;false,15150/20013
low ( < nmbr kg / mnmbr ) baseline bmi,C0205251;C1532718;C0168634;C0578022;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;true;false;false;false;false;false;false;false,15151/20013
low ( < nmbr % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15152/20013
low ( < nmbr % ) baseline hbanmbrc,C0205251;C0168634;C0019016;C1825777;C3538758;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;false;false;false;false;false;false,15153/20013
low ( < nmbr % ) baseline hbalc,C0205251;C0168634;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false,15154/20013
low ( > nmbr . nmbr and < nmbr ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15155/20013
low ( nmbr - nmbr ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15156/20013
low ( n = nmbr ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15157/20013
low { < nmbr % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15158/20013
low body weight ( < nmbr kg ),C0041667;C0022718;C0439209;C4054209,true;true;false;false,15159/20013
low cnmbr ( < nmbr . nmbr g / l ),C0205251;C0439294;C0456615;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,15160/20013
low cnmbr ( < nmbr mg / dl ),C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false,15161/20013
low cnmbr / cnmbr and anti - dsdna,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15162/20013
low complement / anti - dsdna positive ( n = nmbr ),C3897137;C0432633;C0012854;C0439178;C1446409;C1514241;C2825490;C3812269;C0311474,false;false;true;false;false;false;false;false;true,15163/20013
low dose,C0445550;C1708745,false;false,15164/20013
low dose combination therapy,C0445550;C0009429;C0556895;C1708745,false;true;false;false,15165/20013
low hdl - c,C0151691,false,15166/20013
low hdl cholesterol * |,C0151691,false,15167/20013
low nafld fibrosis score ( nfs < - nmbr . nmbr ),C0205251;C0400966;C1954436;C1555018;C1954437;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false,15168/20013
low nfs nfs < - nmbr . nmbr ( n = nmbr ),C0205251;C1513839;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false,15169/20013
low normal ( n = nmbr ),C0205251;C0205307;C0231683;C0439166;C2347086;C4553972;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false;false;false;false,15170/20013
low or moderate,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,15171/20013
low renin ( pra < nmbr . nmbr ng / ml / h ) ( n = nmbr ),C0855389;C0633231;C1533072;C4050009;C1141951;C1419788;C3274822;C3669212;C4283900,false;true;false;false;false;false;false;false;false,15172/20013
low risk ( - ics ),C3272281;C0815320;C4551720;C3538919,false;false;true;false,15173/20013
low risk ( ? ics ),C3272281;C0815320;C4551720;C3538919,false;false;true;false,15174/20013
low risk ( n nmbr nmbr ),C3272281;C3538919,false;false,15175/20013
low to medium microalbuminuria ( n = nmbr ),C0205251;C0009458;C0730345;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false;false;false,15176/20013
low trs : nmbr - nmbr ( n = nmbr,C0205251;C0266427;C0968917;C1150746;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;false;false;false;false,15177/20013
low tt < nmbr . nmbr ( n = nmbr ),C0205251;C1452561;C4554543;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false,15178/20013
lower - dose,C0445550;C1708745,false;false,15179/20013
lower - limb angioplasty or bypass surgery,C0745788,false,15180/20013
lower - target group ( n = nmbr ),C0441994;C1521840;C0441848;C2986546;C1548802;C2003888,false;false;false;false;false;false,15181/20013
lower dose,C0445550;C1708745,false;false,15182/20013
lower dose edoxaban regimen,C0441994;C2348331;C2975435;C1548802;C2003888,false;false;true;false;false,15183/20013
lower limbs,C0023216,true,15184/20013
lower risk ( n = nmbr ),C3272281;C3538919,false;false,15185/20013
lower tertile : b nmbr . nmbr,C0441994;C1548802;C2003888,false;false;false,15186/20013
lowest,C1708760,false,15187/20013
lowest activated clotting,C1708760;C1879547;C0005778;C1328723,false;false;true;false,15188/20013
lowest normal ( n = nmbr ),C1708760;C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,15189/20013
lowest tertile ( range  nmbr . nmbr - nmbr . nmbr mg / dl  mean ± sd  nmbr . nmbr ± nmbr . nmbr mg / dl ),C1708760;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false,15190/20013
lp ( a ) ( μ mol / l ),C0065058;C0347982;C1439335;C4553379,true;false;false;false,15191/20013
lpa,C1096202;C1439335;C3539666;C4049711;C4553379,false;false;false;false;false,15192/20013
lrg,C1428862,false,15193/20013
ls - mean difference between treatment groups ( nmbr % ci ),C0023668;C0444504;C1705241;C0374505;C0008107;C3259781;C1705242;C0039798;C2347634;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2348143,true;false;false;false;true;false;false;true;false;true;false;false;false;false;false;false,15194/20013
ls - mean difference ® ( nmbr % cl ),C0023668;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,15195/20013
ls mean ( nmbr % ci ),C0023668;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,15196/20013
ls mean ( nmbr % ci ) a,C0023668;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,15197/20013
ls mean [nmbr % ci] treatment difference vs placebo,C0023668;C0444504;C0008107;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3259781;C2347634;C2348143,true;false;true;true;false;false;true;false;false;false;false;false;false;false;false,15198/20013
ls mean ± se,C0023668;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,15199/20013
ls mean change,C0023668;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false,15200/20013
ls mean change ( se ),C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,15201/20013
ls mean change from baseline,C0023668;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,15202/20013
ls mean change from baseline ( se ),C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,15203/20013
ls mean difference ( nmbr % cl ),C0023668;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,15204/20013
ls mean difference ( se ),C0023668;C0444504;C1705241;C0036919;C1705242;C2347634;C2348143,true;false;false;true;false;false;false,15205/20013
ls mean difference vs placebo ( nmbr % ci ),C0023668;C0444504;C1705241;C1705242;C2347634;C2348143,true;false;false;false;false;false,15206/20013
ls mean treatment difference ( nmbr % ci ),C0023668;C0444504;C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,true;false;true;false;true;false;false;true;false;false;false;false;false;false;false,15207/20013
ls means difference ( nmbr % ci ) a,C0023668;C1704970;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,15208/20013
ls t - score < — nmbr . nmbr,C0023668;C0449820;C4050231,true;false;false,15209/20013
ls / ul nmbr nmbr,C0023668;C1300557,true;false,15210/20013
lsm difference ( nmbr % cl ),C1705241;C0596019;C1705242,false;false;false,15211/20013
lta ( max response to nmbr pm adp ) defined hpr ( % patients ),C2611142;C0030266;C0523452;C4049155,false;true;false;false,15212/20013
ltg - exposed,C1420817;C4521367;C4521846,false;false;false,15213/20013
ltg - naive,C1420817;C4521367;C4521846,false;false;false,15214/20013
ltg subgroup,C1420817;C1079230;C1515021;C4521367;C4521846,false;false;false;false;false,15215/20013
ltt other than statin,C0360714,true,15216/20013
lue for interaction,C1704675,false,15217/20013
lumbar,C0024090,true,15218/20013
lumbar spine bmd t -,C0024091;C3887615,true;false,15219/20013
lunchb,,,15220/20013
lung,C0024109,true,15221/20013
lung infection,C0876973;C4552950,false;false,15222/20013
lung neoplasm malignant,C0024121,true,15223/20013
luts = lower urinary tract symptoms  is =,C0574785,true,15224/20013
luts severity,C0574785;C0439793;C0522510,true;false;false,15225/20013
luts / bph characteristics,C0574785;C0005001;C1521970;C1704272,true;true;false;true,15226/20013
lv diastolic dysfunction,C0023128;C0520863;C0731033;C1881413,true;false;true;false,15227/20013
lv ejection fraction > nmbr % and < nmbr %,C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,15228/20013
lv ejection fractionb,C0023128;C0302131;C0336969;C0812388;C0731033;C1881413,true;false;false;false;true;false,15229/20013
lv function,C0023128;C0031843;C0542341;C0700205;C1705273;C0731033;C1881413,true;true;false;false;false;true;false,15230/20013
lv function > nmbr . nmbr and < nmbr . nmbr,C0023128;C0031843;C0542341;C0700205;C1705273;C0731033;C1881413,true;true;false;false;false;true;false,15231/20013
lv heart structure,C0023128;C0018787;C0731033;C1881413,true;true;true;false,15232/20013
lv hypertrophy per ecg,C0232306,false,15233/20013
lv mass index ( mg / mnmbr ),C0455825;C0600653;C0024671;C0369637;C0441923;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;true;false;false;false;false;false;true;false;false;false,15234/20013
lv systolic dysfunction,C0023128;C0749225;C0731033;C1881413,true;false;true;false,15235/20013
lvedv ( ml ),C0439526;C1705224;C3887665,false;false;false,15236/20013
lvef — no . ( % )  i ,C0428772;C0488728,false;false,15237/20013
lvef ( mean ± sd ),C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,15238/20013
lvef ( u ),C0428772;C0439148;C0488728,false;false;false,15239/20013
lvef < nmbr . nmbr,C0428772;C0488728,false;false,15240/20013
lvef ≤ nmbr %,C0428772;C0488728,false;false,15241/20013
lvef^nmbr . nmbr and nyha class ii,C0428772;C0488728,false;false,15242/20013
lvesv ( ml ),C0439526;C1705224;C3887665,false;false;false,15243/20013
lvh - n = nmbr,C0149721,true,15244/20013
lvh ( from echocardiogram ),C0149721;C0013516;C2243117,true;true;false,15245/20013
lvh ( from electrocardiogram ),C0149721;C0013798;C1547122;C1623258,true;true;false;true,15246/20013
lvh + n = nmbr,C0149721,true,15247/20013
lvh by ecg,C0232306,false,15248/20013
lvh by ecg ( minnesota code ),C0232306;C0026183;C0009219;C0805701;C3889831,false;true;true;false;false,15249/20013
lvh by ecg or echo . n ( % ),C0232306,false,15250/20013
lvh by ecg or echocardiography,C0232306,false,15251/20013
lvh by ecg or echocardiographyd,C0232306,false,15252/20013
lvh by ecg / echo,C0232306;C0058928;C1655045,false;true;false,15253/20013
lvh by ecgt blood pressure,C0149721;C0005823;C1271104;C1272641,true;true;false;true,15254/20013
lvh by echo or ecg,C0149721;C0058928;C1655045,true;true;false,15255/20013
lvh by echocardiogram,C0149721;C0013516;C2243117,true;true;false,15256/20013
lvh by echocardiography,C0149721;C0013516,true;true,15257/20013
lvh by electrocardiogram,C0149721;C0013798;C1547122;C1623258,true;true;false;true,15258/20013
lvh by minnesota code,C0149721;C0026183;C0009219;C0805701;C3889831,true;true;true;false;false,15259/20013
lvh on ecg,C0232306,false,15260/20013
lyear mean change from baseline,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,15261/20013
lymphadenopathy,C0497156;C4282165,true;false,15262/20013
mnmbrs,C0439493;C1513009,false;false,15263/20013
mab,C0003250;C0369637,true;false,15264/20013
macce ( % ) abciximab placebo,C0288672;C0032042;C1696465;C1706408,true;true;false;false,15265/20013
macce ( death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,15266/20013
mace category,C0349381;C0683312;C3889287;C0949745;C1445339,false;false;false;true;false,15267/20013
mace +,C0349381;C0949745;C1445339,false;true;false,15268/20013
macroalbuminuria — no . ( % ) drug therapy — no . ( % ),,,15269/20013
macroalbuminuria ( uacr > nmbr ),,,15270/20013
maf,,,15271/20013
main effect baseline hormone,C0205225;C1280500;C0168634;C0019932;C4521914;C1442488;C1518681;C2348382;C1542147,false;false;true;true;false;false;false;false;false,15272/20013
main etiology of heart failure,C0205225;C0015127;C0018801;C0018802;C4554158;C1314792;C1524003;C1542147,false;true;true;true;false;true;false;false,15273/20013
maintenance ocs use,C0024501,true,15274/20013
maintenance use — no . ( % ),C0024501,true,15275/20013
major adverse cardiovascular events,C0205082;C0877248;C0007226;C3887460;C1705413;C0205164;C4318856;C4521762,false;false;true;false;false;false;false;false,15276/20013
major amputationsb,C0205082;C0205164;C4318856;C4521762,false;false;false;false,15277/20013
major and crnm bleeds,C0205082;C0205164;C4318856;C4521762,false;false;false;false,15278/20013
major bleed,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,15279/20013
major bleeding ( mb ),C0205082;C0019080;C0024853;C0205164;C4318856;C4521762,false;true;true;false;false;false,15280/20013
major bleeding nmbr to nmbr,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,15281/20013
major coronary disease event ( fatal / non - fatal mi ),C0205082;C0741923;C0012634;C1302234;C1518422;C3810814;C1705232;C0010068;C0441471;C4019010;C1956346;C0205164;C4318856;C4521762,false;false;true;false;false;false;false;true;false;false;true;false;false;false,15282/20013
major coronary event,C0205082;C0741923;C0205164;C4318856;C4521762,false;false;false;false;false,15283/20013
major gl bleeding,C0205082;C0018229;C0019080;C1423073;C1427674;C0205164;C4318856;C4521762,false;true;true;false;false;false;false;false,15284/20013
major macrovascular events,C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false,15285/20013
major or clinically relevant non - major bleed,C0205082;C0205164;C4318856;C4521762,false;false;false;false,15286/20013
major or clinically relevant non - major bleeding,C0205082;C0205164;C4318856;C4521762,false;false;false;false,15287/20013
major secondary end pointf,C0205082;C0027627;C0444930;C2746065;C0175668;C0205436;C0205164;C4318856;C4521762,false;true;false;false;false;false;false;false;false,15288/20013
major st depression or,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,15289/20013
major st depression or t - wave,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,15290/20013
major st depression or t - wave inversion,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,15291/20013
major surgery,C0679637,false,15292/20013
major / crnm bleed,C0205082;C0205164;C4318856;C4521762,false;false;false;false,15293/20013
male ( n   = nmbr,C0086582;C1706180;C1706428;C1706429,true;false;false;false,15294/20013
male acr definition,C0086582;C1412134;C1550452;C1704788;C3539107;C3888054;C1515941;C1706180;C1706428;C1706429,true;false;false;false;false;false;false;false;false;false,15295/20013
male eze / simva ( n = nmbr ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,15296/20013
male patients *,C0150904,false,15297/20013
male sex — no . { % ),C0086582,true,15298/20013
male sex — no . ( % ) medical history — no . / total no . ( % ),C0086582,true,15299/20013
male sex ( % ) race or ethnic group ( % ) f,C0086582;C0034510;C1706779;C3853635,true;true;false;false,15300/20013
male sex \ no . ( % ),C0086582,true,15301/20013
male sex^,C0086582,true,15302/20013
male simva ( n = nmbr ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,15303/20013
male subjects ( n = nmbr,C0086582;C1706180;C1706428;C1706429,true;false;false;false,15304/20013
male vs . female,C0086582;C1706180;C1706428;C1706429,true;false;false;false,15305/20013
male *,C0086582;C1706180;C1706428;C1706429,true;false;false;false,15306/20013
males ( itt ) ( n = nmbr ),C0086582,true,15307/20013
males ( n = nmbr ),C0086582,true,15308/20013
males [n ( % ) ],C0086582,true,15309/20013
malignancy death,C0006826;C0011065;C1306577;C4082313;C4552775;C1306459;C4282132,true;true;false;false;false;false;false,15310/20013
management distribution,C0001554;C0520511;C1704711;C0376636;C1273870;C3273539,true;false;true;true;false;false,15311/20013
mar ( itt ) ( n = nmbr ),C3829202;C4255469,false;false,15312/20013
mar imputation ( random . ) ( n = nmbr ),C3829202;C2699638;C0034656;C0439605;C4255469,false;false;true;false;false,15313/20013
married,C0024841;C0555047,true;false,15314/20013
mass index ,C0577559;C0600653;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905,false;true;true;false;false;false;false;true;false;false;false;false,15315/20013
mate !,C0682323;C1260875,false;false,15316/20013
maximum,C0806909;C1552615;C2826546,false;false;false,15317/20013
mayo clinic score,C0454788;C0002424;C0449820;C4050231;C0442592;C1077578,false;true;false;false;false;false,15318/20013
mayo clinic scoreb,C0454788;C0002424;C0442592;C1077578,false;true;false;false,15319/20013
mayo score ( nmbr - nmbr ),C0454788;C0449820;C4050231;C1077578,false;false;false;false,15320/20013
mbes / crbesb,,,15321/20013
mbes / crbesc,,,15322/20013
mbesb,,,15323/20013
mbesc,,,15324/20013
mcs score,,,15325/20013
mcs score ( nmbr – nmbr scale ),,,15326/20013
mdi,C0993596;C1839839;C4049613,true;true;false,15327/20013
mdrd - egfr ( ml / min per nmbr . nmbr mnmbr ),C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,false;true;false;false;false;false;false,15328/20013
mdrd egfr geometric mean ( cv % ),C3839656;C1739039;C2986759;C3538987;C4048877;C4318503;C3811844;C3812682,false;true;false;false;true;false;false;false,15329/20013
mdrd egfr,C3839656;C1739039;C3811844;C3812682,false;true;false;false,15330/20013
mean — %,C0444504;C2347634;C2348143,false;false;false,15331/20013
mean — mg / dl,C0444504;C0439269;C2347634;C2348143,false;false;false;false,15332/20013
mean — ml / min,C0444504;C0439445;C2347634;C2348143,false;false;false;false,15333/20013
mean — ml / min / nmbr . nmbr m^,C0444504;C0439445;C0369637;C0441923;C2347634;C2348143,false;false;false;false;false;false,15334/20013
mean — ml / min / nmbr . nmbr mnmbr,C0444504;C0439445;C0369637;C0441923;C2347634;C2348143,false;false;false;false;false;false,15335/20013
mean — mm hg,C0444504;C0439475;C2347634;C2348143,false;false;false;false,15336/20013
mean % change in fn bmd,C0444504;C0392747;C1570610;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,15337/20013
mean % predicted value prebronchodilation,C0444504;C2347634;C2348143,false;false;false,15338/20013
mean ( = sd ) days since,C0444504;C2699239;C0439228;C2347634;C2348143,false;false;false;false;false,15339/20013
mean ( ± s . d . ),C0444504;C2347634;C2348143,false;false;false,15340/20013
mean ( ± sd ) baseline score,C3533236;C2699239;C0168634;C1442488,false;false;true;false,15341/20013
mean ( ± sd ) change from,C0444504;C2699239;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false,15342/20013
mean ( nmbrth tonmbrthquartile ) bnp ( pg / ml ),C0444504;C0039725;C0054015;C0439297;C1095989;C1417808;C2982014;C0039738;C1420718;C4282123;C4285344;C2347634;C2348143,false;true;true;false;false;false;false;true;false;false;false;false;false,15343/20013
mean ( nmbr % ci ) change from nmbr . nmbr to nmbr . nmbr mg,C0444504;C0008107;C0392747;C0443172;C1705241;C4319952;C3259781;C2347634;C2348143,false;true;false;false;false;false;false;false;false,15344/20013
mean ( median ) mtx dose,C0444504;C0549183;C0366550;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15345/20013
mean ( s . d . ) baseline fpg,C0444504;C0168634;C1442488;C2347634;C2348143,false;true;false;false;false,15346/20013
mean ( s . d . ) baseline hbanmbrc,C0444504;C0168634;C0019016;C1825777;C3538758;C1442488;C2347634;C2348143,false;true;true;false;false;false;false;false,15347/20013
mean ( s . d . ) duration of tnmbrdm,C0444504;C0449238;C0011816;C3250443;C2926735;C2347634;C2348143,false;false;true;false;false;false;false,15348/20013
mean ( s . d . ) metformin dose †,C0444504;C0025598;C0178602;C0869039;C1114758;C2347634;C2348143,false;true;false;false;false;false;false,15349/20013
mean ( s . d . ) weight,C0444504;C0005910;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;false,15350/20013
mean ( sd on loge scale ) u / ml,C0444504;C2699239;C2697934;C0175659;C0439340;C1880521;C2945590;C0349674;C1947916;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,15351/20013
mean ( sd ) % of predicted normal eevi,C0444504;C2699239;C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false,15352/20013
mean ( sd ) % of predicted normal fevnmbr,C0444504;C2699239;C0681842;C0520835;C1882327;C2347634;C2348143,false;false;false;false;false;false;false,15353/20013
mean ( sd ) % of predicted normal fevi,C0444504;C2699239;C0681842;C0205307;C0429706;C0849974;C1561566;C4528367;C0231683;C0439166;C2347086;C4553972;C1882327;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,15354/20013
mean ( sd ) % reversibility fevnmbr at,C0444504;C2699239;C0449261;C3714541;C2347634;C2348143,false;false;false;true;false;false,15355/20013
mean ( sd ) ( years ),C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false,15356/20013
mean ( sd ) [range] duration of epilepsy,C0444504;C2699239;C1514721;C0449238;C0014544;C2926735;C2348147;C3542016;C2347634;C2348143,false;false;false;false;true;false;false;false;false;false,15357/20013
mean ( sd ) nmbr . nmbr ( nmbr . nmbr ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,15358/20013
mean ( sd ) anthropometry,C0444504;C2699239;C0003188;C2347634;C2348143,false;false;true;false;false,15359/20013
mean ( sd ) baseline,C0444504;C2699239;C0168634;C1442488;C2347634;C2348143,false;false;true;false;false;false,15360/20013
mean ( sd ) bmd in g / cmnmbr,C0444504;C2699239;C0439267;C2347634;C2348143,false;false;false;false;false,15361/20013
mean ( sd ) calcium intake in mg daily,C0444504;C2699239;C0489458;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;false;true;false;true;false;false;false;false;false;false;false,15362/20013
mean ( sd ) change from pre - to post - bronchodilator fevnmbr,C0444504;C2699239;C0392747;C2599602;C0687676;C3714541;C1704687;C3469826;C0332152;C2599594;C0740175;C2257086;C3669034;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,15363/20013
mean ( sd ) change from pre - to post - bronchodilator fevi,C0444504;C2699239;C2599602;C0687676;C3481639;C1704687;C3469826;C0332152;C2599594;C0740175;C2257086;C3669034;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false;false;false,15364/20013
mean ( sd ) duration of tnmbrdm,C0444504;C2699239;C0449238;C0011816;C3250443;C2926735;C2347634;C2348143,false;false;false;true;false;false;false;false,15365/20013
mean ( sd ) e - etdrs visual acuity letter score ( snellen equivalent ),C3533236;C2699239;C0042812;C1096774;C0183370;C0205163;C0439185;C2360551,false;false;true;true;false;false;false;false,15366/20013
mean ( sd ) eevi,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15367/20013
mean ( sd ) egfr,C0444504;C2699239;C1739039;C3811844;C3812682;C2347634;C2348143,false;false;true;false;false;false;false,15368/20013
mean ( sd ) fev nmbr,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,15369/20013
mean ( sd ) fev nmbr / fvc,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,15370/20013
mean ( sd ) fevnmbr postbronchodilator,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,15371/20013
mean ( sd ) fevnmbr,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,15372/20013
mean ( sd ) fevnmbr / fvc,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,15373/20013
mean ( sd ) fevi,C0444504;C2699239;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;false;false;false;false;false,15374/20013
mean ( sd ) fevi / evc,C0444504;C2699239;C0429706;C0013903;C0429711;C1414479;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,15375/20013
mean ( sd ) fevi / fvc,C0444504;C2699239;C0802741;C3815113;C2347634;C2348143,false;false;false;false;false;false,15376/20013
mean ( sd ) hbanmbrc level,C0444504;C2699239;C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false;false,15377/20013
mean ( sd ) hbanmbrc,C0444504;C2699239;C0019016;C1825777;C3538758;C2347634;C2348143,false;false;true;false;false;false;false,15378/20013
mean ( sd ) improvement from baseline to week nmbr in basdai,C0444504;C2699239;C2986411;C0168634;C1442488;C2347634;C2348143,false;false;false;true;false;false;false,15379/20013
mean ( sd ) improvement from baseline to week nmbr in basdai questions *,C0444504;C2699239;C2986411;C0168634;C1442488;C2347634;C2348143,false;false;false;true;false;false;false,15380/20013
mean ( sd ) nonstudy eye e - etdrs visual acuity letter score,C3533236;C2699239;C0015392;C0042812;C1096774;C2360551;C0700042,false;false;true;true;true;false;false,15381/20013
mean ( sd ) postbronchodilator fevnmbr % predicted,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,15382/20013
mean ( sd ) postbronchodilator fevnmbr reversibility,C0444504;C2699239;C2599594;C3714541;C0449261;C2347634;C2348143,false;false;false;true;false;false;false,15383/20013
mean ( sd ) postbronchodilator fevnmbr / fvc,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,15384/20013
mean ( sd ) values are presented for all variables,C0444504;C2699239;C0042295;C2347634;C2348143,false;false;false;false;false,15385/20013
mean ( sd ) years daily ocs use,C0444504;C2699239;C0439234;C0332173;C2347634;C2348143,false;false;false;false;false;false,15386/20013
mean ( sd ) % predicted normal fevnmbr,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15387/20013
mean ( sd ) d,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15388/20013
mean ( se ) nmbr - year rates per nmbr population,C0036919;C0439234;C0871208;C2347634;C1521828;C0439508,true;false;false;false;false;false,15389/20013
mean ( se ) auc^p l,C0444504;C0036919;C0376690;C2347634;C2348143,false;true;true;false;false,15390/20013
mean ( se ) aucnmbr - nmbr,C0444504;C0036919;C0376690;C2347634;C2348143,false;true;true;false;false,15391/20013
mean ( se ) trough l,C0444504;C0036919;C0444506;C2347634;C2348143,false;true;false;false;false,15392/20013
mean ( se ) trough,C0444504;C0036919;C0444506;C2347634;C2348143,false;true;false;false;false,15393/20013
mean ± s . d .,C0444504;C2347634;C2348143,false;false;false,15394/20013
mean ± sd age ( y ) mean bmi category ( % ),C0444504;C2699239;C0001779;C0578022;C0683312;C3889287;C2347634;C2348143,false;false;false;false;false;false;false;false,15395/20013
mean ± sd mg ( n = nmbr,C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,15396/20013
mean ± sd unless otherwise indicated,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15397/20013
mean ± se,C0444504;C0036919;C2347634;C2348143,false;true;false;false,15398/20013
mean ± se ) bii ( ls mean ± se ),C0444504;C0036919;C1413059;C0023668;C2347634;C2348143,false;true;false;true;false;false,15399/20013
mean ±   sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15400/20013
mean nmbr - h dbp +,C0444504;C0033727;C0536221;C3813197;C4281799;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;true;true;false;false;false;false;false;false;false;false,15401/20013
mean nmbr - h sbp *,C0444504;C0033727;C0085805;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;true;true;false;false;false;false;false;false,15402/20013
mean acq - nmbr score at randomization  ! ,C0444504;C2919686;C2347634;C2348143,false;false;false;false,15403/20013
mean acq - nmbr scores,C0444504;C2919686;C2347634;C2348143,false;false;false;false,15404/20013
mean age — yr ( range ),C0444504;C0001779;C0439234;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,15405/20013
mean age ( range ) — yr,C0444504;C0001779;C1514721;C0439234;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,15406/20013
mean age ( y ),C0444504;C0001779;C2347634;C2348143,false;false;false;false,15407/20013
mean age ( years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,15408/20013
mean age ( yr ),C0444504;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false,15409/20013
mean age 士 s . d .,C0444504;C0001779;C2347634;C2348143,false;false;false;false,15410/20013
mean age ± s . d .,C0444504;C0001779;C2347634;C2348143,false;false;false;false,15411/20013
mean age ± sd ( years ),C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,15412/20013
mean alc,C0444504;C1424945;C3811058;C2347634;C2348143,false;false;false;false;false,15413/20013
mean aqlq total score t,C3533236;C4055434;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,15414/20013
mean arterial pressure,C0428886,true,15415/20013
mean asui scored,C0444504;C2347634;C2348143,false;false;false,15416/20013
mean baseline ( n ),C0444504;C0168634;C1442488;C2347634;C2348143,false;true;false;false;false,15417/20013
mean baseline bmi,C0444504;C0168634;C0578022;C1442488;C2347634;C2348143,false;true;false;false;false;false,15418/20013
mean baseline ei score,C0444504;C0168634;C0022067;C1414370;C2348481;C1442488;C2347634;C2348143,false;true;true;false;false;false;false;false,15419/20013
mean baseline nasal congestion score,C3533236;C0168634;C0027424;C4554631;C1442488,false;true;false;false;false,15420/20013
mean baseline ucdai score,C0444504;C0168634;C1442488;C2347634;C2348143,false;true;false;false;false,15421/20013
mean blood eosinophil count ( cells per pl ),C0444504;C0200638;C3897966;C4049765;C2347634;C2348143,false;false;false;false;false;false,15422/20013
mean blood pressure at screening visit ( mm hg ),C0428886;C0220908;C0545082;C0439475;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0488053,true;true;false;false;false;false;true;false;false;false;false;false;false,15423/20013
mean bmnmbr ± s . d .,C0444504;C0006416;C2347634;C2348143,false;true;false;false,15424/20013
mean bmd ( = sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,15425/20013
mean bmi ( sd ),C0444504;C0578022;C2699239;C2347634;C2348143,false;false;false;false;false,15426/20013
mean bmi ± s . d .,C0444504;C0578022;C2347634;C2348143,false;false;false;false,15427/20013
mean bmi ± sd ( kg / mnmbr ),C0444504;C0578022;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,15428/20013
mean bmii 士 s . d .,C0444504;C2347634;C2348143,false;false;false,15429/20013
mean body - mass index ( = sd ),C0444504;C0005893;C2699239;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,15430/20013
mean body - mass index ( kg / mq,C0444504;C0005893;C0022718;C0024853;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;true;false;false;false;true;false;false,15431/20013
mean body - mass indexj,C0444504;C0518010;C2347634;C2348143,false;false;false;false,15432/20013
mean body weight,C0444504;C0005910;C1305866;C2347634;C2348143,false;true;false;false;false,15433/20013
mean change from baseline in acq overall score ( sd ) *,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,15434/20013
mean change from baseline in fevnmbr % predicted,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,15435/20013
mean change from baseline in the number of,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,15436/20013
mean change from baseline,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,15437/20013
mean change in acq score,C3533236;C0392747;C2919686;C0443172;C1705241;C4319952,false;false;false;false;false;false,15438/20013
mean change in dbp from baseline,C0444504;C0392747;C0536221;C3813197;C4281799;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,15439/20013
mean change in fevnmbr,C0444504;C0392747;C3714541;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,15440/20013
mean change in radiographic end points shs,C0444504;C0392747;C0444708;C2349179;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15441/20013
mean change in sbp from baseline,C0444504;C0392747;C0085805;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,15442/20013
mean change in sgrq,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,15443/20013
mean change in total updrs scores adjusted according to baseline updrs,C3533236;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0444504;C2964552;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,15444/20013
mean change ‘ s in fasting blood glucose [mg / dl ( mmol / l ) ],C0444504;C0392747;C0428568;C2827883;C3642216;C1532563;C1261430;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false,15445/20013
mean copd duration,C0444504;C0024117;C0449238;C2926735;C1412502;C3714496;C2347634;C2348143,false;true;false;false;false;false;false;false,15446/20013
mean crp level,C0444504;C3890735;C0441889;C0456079;C1547707;C2946261;C4048285;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15447/20013
mean daily dose ( range ) — mg  i ,C0444504;C2348070;C1514721;C0024671;C0021966;C0221138;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016;C2347634;C2348143,false;false;false;true;true;false;true;false;false;false;false;false;false;false;false;false,15448/20013
mean diastolic blood pressure ( sd ),C0428886;C0012000;C2699239;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;true;false;false;false,15449/20013
mean difference ( nmbr % cl ),C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,false;false;false;false;false;false,15450/20013
mean dose ' ’,C0444504;C0178602;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false,15451/20013
mean dose ( sd ) ( mg / day ),C0444504;C0178602;C2699239;C0439422;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false;false;false,15452/20013
mean dose ( sd ) ( mg / week ),C0444504;C0178602;C2699239;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C2347634;C2348143,false;false;false;true;false;false;true;false;false;false;false;false;false;false;false;false,15453/20013
mean doseb,C0444504;C2347634;C2348143,false;false;false,15454/20013
mean duration of pd,C0444504;C0449238;C4553228;C4553229;C2926735;C2347634;C2348143,false;false;false;false;false;false;false,15455/20013
mean duration of surgery ± sd,C0444504;C0449238;C0038894;C2699239;C0038895;C0543467;C1274039;C2926735;C2347634;C2348143,false;false;false;false;true;true;true;false;false;false,15456/20013
mean duration offollow - up ( years ) *,C0444504;C0449238;C0439234;C2926735;C2347634;C2348143,false;false;false;false;false;false,15457/20013
mean fecal calprotectin level,C0444504;C0015733;C0950624;C0441889;C0456079;C1547707;C2946261;C1335798;C1366582;C2347634;C2348143,false;true;true;false;false;false;false;false;false;false;false,15458/20013
mean femoral neck t score,C3533236;C0015815,false;true,15459/20013
mean fpg,C0444504;C2347634;C2348143,false;false;false,15460/20013
mean glycated hemoglobin reduction during characteristic follow - up ( nmbr % ci ) percent,C0444504;C0017853;C1521970;C0589120;C0520870;C0439165;C1522577;C1704685;C3274571;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false,15461/20013
mean hbanmbrc ± s . d .,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,15462/20013
mean hbanmbrc,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,15463/20013
mean hbaic = • = s . d .,C0444504;C2347634;C2348143,false;false;false,15464/20013
mean ics ( fluticasone propionate dpi or equivalent  pg per day ),C0444504;C0815320;C0117996;C4551720;C2347634;C2348143,false;false;true;true;false;false,15465/20013
mean ics use at enrolment ( pg ) *,C0444504;C0815320;C4551720;C2347634;C2348143,false;false;true;false;false,15466/20013
mean iief ef score mean iief domain score by bmi ( < nmbr / < nmbr to < nmbr / < nmbr kg / mnmbr ),C3533236;C3641331;C1880389;C0578022;C1883221;C3541951,false;false;false;false;false;false,15467/20013
mean ipss qol ( sd ),C0444504;C1019118;C0518214;C2699239;C1998280;C2827405;C3811063;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15468/20013
mean ipss,C0444504;C1019118;C1998280;C2827405;C3811063;C2347634;C2348143,false;false;false;false;false;false;false,15469/20013
mean lipid difference ( mg / dl ) hdl - c,C0444504;C0023779;C1705241;C0439269;C3715113;C1705242;C2347634;C2348143,false;true;false;false;false;false;false;false,15470/20013
mean lumbar spine t score,C3533236;C0024091;C3887615,false;true;false,15471/20013
mean lvef,C0444504;C0428772;C0488728;C2347634;C2348143,false;false;false;false;false,15472/20013
mean mmrc grade,C0444504;C3826977;C0441800;C0919553;C3244287;C2347634;C2348143,false;false;false;false;false;false;false,15473/20013
mean mmse score,C3533236;C0451306,false;true,15474/20013
mean no . agents ( sd ) other medications,C0444504;C2347634;C2348143,false;false;false,15475/20013
mean number of antihypertensive medication at last visit   ‡,C0444504;C0237753;C0003364;C0449788;C2347634;C2348143,false;false;true;false;false;false,15476/20013
mean number of antihypertensive medications at nmbr year   *,C0444504;C1718138;C0003364;C2347634;C2348143,false;false;true;false;false,15477/20013
mean number of caes in past nmbr months ( number per patient ) ] |,C0444504;C0237753;C0449788;C2347634;C2348143,false;false;false;false;false,15478/20013
mean number of clinically significant asthma exacerbations †,C0444504;C0237753;C0237881;C0349790;C0750502;C1546944;C0449788;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15479/20013
mean number of combined visits / hospitalizations †,C0444504;C4086639;C0205195;C0545082;C1512346;C2347634;C2348143,false;false;false;false;false;false;false,15480/20013
mean number of exacerbations in previous y ( sd ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,15481/20013
mean number of puffs per day,C0444504;C0237753;C1533107;C0449788;C2347634;C2348143,false;false;false;false;false;false,15482/20013
mean of jsw ( mm ),C0444504;C4330985;C4554674;C2347634;C2348143,false;false;false;false;false,15483/20013
mean of maximum cimt,C0444504;C0806909;C1552615;C2826546;C2347634;C2348143,false;false;false;false;false;false,15484/20013
mean of mean cimt,C0444504;C2347634;C2348143,false;false;false,15485/20013
mean or n,C0444504;C2347634;C2348143,false;false;false,15486/20013
mean percentage change from baseline to final visit,C0444504;C0439165;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1549488;C1561533;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,15487/20013
mean pga score ± sd,C3533236;C0016410;C2699239;C3541266;C4050369,false;true;false;false;false,15488/20013
mean postbronchodilatora fevnmbr,C0444504;C3714541;C2347634;C2348143,false;true;false;false,15489/20013
mean prebronchodilation ( l ),C0444504;C2347634;C2348143,false;false;false,15490/20013
mean proportion ( % ),C0444504;C1709707;C2347634;C2348143,false;false;false;false,15491/20013
mean pulmonary artery pressure,C3854605,false,15492/20013
mean qmax score by bmi ( < nmbr / < nmbr to < nmbr / < nmbr kg / mnmbr ),C3533236;C0578022,false;false,15493/20013
mean reversibility ( % ),C0444504;C0449261;C2347634;C2348143,false;false;false;false,15494/20013
mean score ( min,C3533236;C0702093;C1524029;C3813700,false;false;false;false,15495/20013
mean selena - sledai score ± sd,C0444504;C0451528;C2347634;C2348143,false;false;false;false,15496/20013
mean serum cholesterol,C0444504;C0587184;C2347634;C2348143,false;false;false;false,15497/20013
mean serum creatinine,C0444504;C0201976;C0600061;C2347634;C2348143,false;false;false;false;false,15498/20013
mean serum potassium,C0444504;C0302353;C0543465;C2347634;C2348143,false;false;false;false;false,15499/20013
mean sgrq total score,C3533236;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false,15500/20013
mean sitting diastolic blood pressure,C0444504;C1319894;C2347634;C2348143,false;false;false;false,15501/20013
mean sitting systolic blood pressure,C0444504;C2347634;C2348143,false;false;false,15502/20013
mean slicc damage index score ± sd,C3533236;C0010957;C0600653;C2699239;C0918012;C1552854;C1637833;C2986546;C1883709,false;false;true;false;true;false;false;false;false,15503/20013
mean stent diameter per lesion,C0038257;C0552409;C0221198;C1546698,true;false;false;false,15504/20013
mean stents per lesion ( sd ) ‡,C0444504;C0038257;C0221198;C2699239;C1546698;C2347634;C2348143,false;true;false;false;false;false;false,15505/20013
mean systolic blood pressure ( sd ),C0428886;C0039155;C2699239;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,15506/20013
mean systolic pressure gradient,C4687744;C0039155,false;true,15507/20013
mean time since as diagnosis,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,15508/20013
mean time since asthma,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,15509/20013
mean time since diagnosis ( years ),C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,15510/20013
mean time since diagnosis,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,15511/20013
mean time to first oral dose postsurgeryh,C0444504;C0040223;C0205435;C0442027;C0178602;C0869039;C1114758;C4521986;C1279901;C3541383;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false;false,15512/20013
mean time to first subcutaneous injectiong,C0444504;C0040223;C0205435;C0443315;C1279901;C3541383;C2347634;C2348143,false;true;false;false;false;false;false;false,15513/20013
mean total ipss ( sd ),C0444504;C0439175;C1019118;C2699239;C1998280;C2827405;C3811063;C0439810;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,15514/20013
mean total ipss mean ipss by bmi ( < nmbr / < nmbr to < nmbr / < nmbr kg / mnmbr ),C0444504;C0439175;C1019118;C0578022;C1998280;C2827405;C3811063;C0439810;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,15515/20013
mean total serum psa,C0444504;C2986589;C0229671;C1546774;C1550100;C2347634;C2348143,false;false;true;false;false;false;false,15516/20013
mean total stent length per lesion,C0444504;C0439175;C0038257;C1444754;C0221198;C1546698;C1706316;C0439810;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,15517/20013
mean treatment exposure,C0444504;C0039798;C0274281;C0332157;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,false;true;false;false;true;false;false;false;false;false;false;false,15518/20013
mean wall thickness ( cm ),C4054557;C0677535,false;false,15519/20013
mean years since menopause,C0444504;C0439234;C2347634;C2348143,false;false;false;false,15520/20013
mean   ±   sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15521/20013
mean_delta,C0444504;C0439097;C1705241;C3146239;C3538806;C3540585;C3815527;C2347634;C2348143,false;false;false;false;false;false;false;false;false,15522/20013
mean 土 sd ( n ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,15523/20013
measure,C0079809;C0242485,true;false,15524/20013
measures,C0079809;C1879489,true;false,15525/20013
measures ( % ),C0079809;C1879489,true;false,15526/20013
measures ( mmol / l ),C0079809;C0242485;C1879489,true;false;false,15527/20013
measures of lung function,C0079809;C0035245;C1879489,true;true;false,15528/20013
medal,C0524670,true,15529/20013
meddra smq,C1140263,false,15530/20013
median — ml / min,C0549183;C0439445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15531/20013
median — ml / min / nmbr . nmbr mnmbr,C0549183;C0439445;C0369637;C0441923;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,15532/20013
median ( nmbrth,C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false,15533/20013
median ( nmbr % ci ) time to weekly iss mid response up to week nmbr ( wk ) f,C0549183;C0008107;C0332174;C1740819;C0034746;C1845118;C3259781;C0876920;C2347635;C2348144;C2939193,false;true;false;false;true;false;false;false;false;false;false,15534/20013
median ( interquartile range ),C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15535/20013
median ( interquartile range ) — yr,C0549183;C1711350;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,15536/20013
median ( iq range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,15537/20013
median ( iqr ) — yr,C0549183;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15538/20013
median ( iqr ) change from baseline to week nmbr in psa - modified total shs score,C0549183;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false,15539/20013
median ( iqr ) meannmbrsdchange from baseline to week nmbr by weight group and mtx use : weight,C0549183;C0444504;C0168634;C1442488;C2347634;C2348143;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,15540/20013
median ( minimum – maximum ) focal seizure frequency / nmbr   days at baseline,C0549183;C1524031;C0806909;C0751495;C0376249;C0439228;C0168634;C1442488;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1552615;C2826546;C1552614;C2826545;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,15541/20013
median ( qnmbr – qnmbr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,15542/20013
median ( range ) duration of asthma ( y ),C0549183;C1514721;C0449238;C0004096;C2984299;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false,15543/20013
median ( range ) duration of asthma ( years ),C0549183;C1514721;C0449238;C0004096;C0439234;C2984299;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false;false,15544/20013
median ( range ) duration of hospital stayi,C0549183;C1514721;C0449238;C0019994;C1510665;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false,15545/20013
median ( range ) total ige level ( iuml ~ ’ ) nmbr,C0549183;C1514721;C0439175;C0441889;C0456079;C1547707;C2946261;C0439810;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false;false;false;false,15546/20013
median ( range ) treatment duration,C0549183;C1514721;C0444921;C3259042;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,15547/20013
median age — yr,C0549183;C0001779;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,15548/20013
median age [interquartile range] — yr,C0549183;C0001779;C1711350;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,15549/20013
median age,C0549183;C0001779;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15550/20013
median blood eosinophil count ( cells per pl ) t,C0549183;C0200638;C3897966;C4049765;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,15551/20013
median bnp ( iqr ) – pg / ml,C0549183;C0054015;C0439297;C1095989;C1417808;C2982014;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,15552/20013
median body weight ( kg ),C3821165;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false;false,15553/20013
median c - reactive protein — mg / liter,C0549183;C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285;C0876920;C2347635;C2348144;C2939193,false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,15554/20013
median cardiac troponin t ( iqr ) 一 pg / ml,C0549183;C3538889;C0439297;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,15555/20013
median crcl — ml / min,C0549183;C1846718;C0439445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,15556/20013
median crohn ' s disease duration,C0549183;C0010346;C0449238;C2926735;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,15557/20013
median delay ( h ) §,C0549183;C0205421;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false,15558/20013
median dose ( range ) ' ’,C0549183;C0178602;C1514721;C2348147;C3542016;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false,15559/20013
median dose ( range ) b,C0549183;C0178602;C1514721;C2348147;C3542016;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false,15560/20013
median duration of chf — mo,C0549183;C0449238;C0018802;C0026544;C0332177;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;true;true;false;false;false;false;false;false,15561/20013
median duration of diabetes ( yr ),C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,15562/20013
median duration of study - drug administration ( iqr ) — days,C0549183;C2348354;C0013175;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false,15563/20013
median duration oftype nmbr diabetes ( iqr ) — yr,C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,15564/20013
median egfr ( interquartile range ),C0549183;C1739039;C1711350;C3811844;C3812682;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,15565/20013
median fecal calprotectin — mg / kg gi areas involved — no . ( % ),C0549183;C0015733;C0950624;C0439272;C1708130;C0205146;C4319729;C3539617;C4050121;C1335798;C1366582;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false;false;false;false;false;false,15566/20013
median feno ( ppb ) f,C0549183;C1415800;C0016327;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false,15567/20013
median infusions — no . ( range ),C0549183;C0574032;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15568/20013
median m / kgnmbr ( iqr ),C0549183;C0369637;C0022718;C0439209;C4054209;C0441923;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,15569/20013
median nt - probnp ( iqr ) – pg / ml,C0549183;C0669479;C0439297;C0754710;C0876920;C2347635;C2348144;C2939193,false;true;false;true;false;false;false;false,15570/20013
median of jsw,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,15571/20013
median pasi score { range ) ' i   i ',C0549183;C4528685;C0449820;C1514721;C0021966;C0221138;C2348147;C3542016;C4050231;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false;false;false;false,15572/20013
median seconds,C0549183;C0457385;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15573/20013
median serum periostin ( ng / ml ) t,C0549183;C0229671;C0219433;C0439275;C1424662;C3812270;C1546774;C1550100;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false;false;false,15574/20013
median time delay ( interquartile range ) — min,C0549183;C0522486;C1711350;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,15575/20013
median time from index acute coronary syndrome to randomization ( iqr ) — mo,C0549183;C0040223;C0600653;C0948089;C0918012;C1552854;C1637833;C2986546;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;true;true;true;false;false;false;false;false;false;false;false,15576/20013
median time in therapeutic range for warfarin recipients,C0549183;C1554109;C0087111;C0302350;C0040223;C0460097;C3541383;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false,15577/20013
median time to event ( weeks ),C0549183;C0040223;C0441471;C0439230;C4019010;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,15578/20013
median triglyceride ( mg / dl ),C0549183;C0041004;C0439269;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,15579/20013
median §,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,15580/20013
medians ( iqr ),C0549183,false,15581/20013
medical and lifestyle history,C0199168;C0205476,false;false,15582/20013
medical historv,C0199168;C0205476,false;false,15583/20013
medical history — %,C0262926;C1704706,false;false,15584/20013
medical history at randomization — no . ( % ),C0262926;C0034656;C1704706,false;true;false,15585/20013
medical history before index acute coronary syndrome — no . { % ),C0262926;C0600653;C0948089;C0918012;C1552854;C1637833;C2986546;C1704706,false;true;true;true;false;false;false;false,15586/20013
medical history of cv disease or heart failure,C0262926;C0007222,false;true,15587/20013
medical history . no . ( % ),C0262926;C1704706,false;false,15588/20013
medical history : cancer,C0262926;C0006826;C0998265;C1306459;C1704706,false;true;false;false;false,15589/20013
medical management only — no . { % ),C0199168;C0001554;C0205171;C1720467;C0376636;C1273870;C3273539;C0205476,false;true;false;false;true;false;false;false,15590/20013
medical therapy before admission,C0418981;C0184666;C0809949,false;false;false,15591/20013
medical therapy before randomization — no . / total no . ( % ),C0418981;C0034656,false;true,15592/20013
medical therapy during index hospitalization — %,C0418981;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,15593/20013
medication nmbr ( nmbr . nmbr ),C0013227;C3244316;C4284232,true;false;false,15594/20013
medication at entry ( % ),C0013227;C1705654;C3244316;C4284232,true;false;false;false,15595/20013
medication at randomization,C0013227;C0034656;C3244316;C4284232,true;true;false;false,15596/20013
medication at time of randomization,C0013227;C0040223;C0034656;C3541383;C3244316;C4284232,true;true;true;false;false;false,15597/20013
medication at time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C3244316;C4284232,true;true;true;false;false;false,15598/20013
medication continued into double - blind treatment period,C0013227;C3244316;C4284232,true;false;false,15599/20013
medication in use at the baseline,C0013227;C3244316;C4284232,true;false;false,15600/20013
medication use — no . { % ),C0013227;C3244316;C4284232,true;false;false,15601/20013
medication use ( % ),C0240320,false,15602/20013
medication use ( % ) aspirin,C0240320;C0004057,false;true,15603/20013
medication use at baseline - n ( % ),C0240320;C0168634;C1442488,false;true;false,15604/20013
medication use at entry ( % ),C0240320;C1705654,false;false,15605/20013
medication use before enrollment,C0240320;C1516879;C1696073;C3888021,false;false;false;false,15606/20013
medication useb,C0013227;C3244316;C4284232,true;false;false,15607/20013
medications — no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,15608/20013
medications — no . { % ) * *,C0013227;C0802604;C2598133;C4284232,true;false;false;false,15609/20013
medications ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,15610/20013
medications antihypertensive drugs,C0013227;C0003364;C0802604;C2598133;C4284232,true;true;false;false;false,15611/20013
medications at baselinet,C0013227;C0802604;C2598133;C4284232,true;false;false;false,15612/20013
medications at enrollment,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,15613/20013
medications at enrolment,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,15614/20013
medications at the time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C0802604;C2598133;C4284232,true;true;true;false;false;false;false,15615/20013
medications at time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C0802604;C2598133;C4284232,true;true;true;false;false;false;false,15616/20013
medications during hospitalization or at discharge,C0013227;C0019993;C0802604;C2598133;C4284232,true;true;false;false;false,15617/20013
medications for crohn ' s disease taken at baseline — no . ( % ),C0013227;C0010346;C0802604;C2598133;C4284232,true;true;false;false;false,15618/20013
medications in the hospital after randomization — no . ( % ),C0013227;C0019994;C1510665;C0802604;C2598133;C4284232,true;true;false;false;false;false,15619/20013
medications in use at baseline — no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,15620/20013
medications in use at baseline — no . / total no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,15621/20013
medications in use at baseline,C0013227;C0802604;C2598133;C4284232,true;false;false;false,15622/20013
medium normal ( n = nmbr ),C0009458;C0205307;C0231683;C0439166;C2347086;C4553972;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false;false;false;false;false;false,15623/20013
meglitinides ( glinides ),C0065880;C3537178;C1579432,true;false;false,15624/20013
meloxicam,C0083381,true,15625/20013
memantine use at baseline,C0025242;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,15626/20013
men ( n [ % ] ),C0025266,true,15627/20013
men ( n 二 nmbr ),C0025266,true,15628/20013
men ( n,C0025266,true,15629/20013
men with ed ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0025266;C3538926,true;false,15630/20013
men without ed ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0025266;C3538926,true;false,15631/20013
men : < nmbr mg / dl ( < nmbr . nmbr mmol / l ),C0025266;C0439269;C1532563,true;false;false,15632/20013
men : qvainmbr - sfc,C0025266;C4521536,true;false,15633/20013
menopausal status and hormone therapy use,C1513126,false,15634/20013
menopausal status and hormone therapy use premenopausal,C1513126,false,15635/20013
mensa,,,15636/20013
ment,C0084844;C1538994,true;false,15637/20013
mental activities updrs subscore ( baseline ),C0229992;C0441655;C3639721;C0168634;C1442488,false;false;true;true;false,15638/20013
mental status,C0278060,false,15639/20013
mental status ( baseline spmsq scores ),C0278060;C0168634;C1442488,false;true;false,15640/20013
mepo ( n = nmbr ),,,15641/20013
mepolizumab nmbr mg ( n = nmbr ),C0969324;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15642/20013
merformin,,,15643/20013
mesalamine use,C0127615;C0042153;C0457083;C1947944,true;true;false;false,15644/20013
met atopy and ige nmbr - nmbr ku / l criteria   ( n = nmbr ),C0428210;C0392707;C3539705;C1550543;C4317104,false;false;false;false;false,15645/20013
met / su / tzd,C0428210;C0038642;C1705534;C1550543;C4317104,false;true;false;false;false,15646/20013
met / tzd,C0428210;C1550543;C4317104,false;false;false,15647/20013
metabolic syndrome — no . ( % ) !,C0524620,true,15648/20013
metabolic syndrome — no . ( % ) ^,C0524620,true,15649/20013
metabolic syndrome — no . ( % ) nmbr,C0524620,true,15650/20013
metabolic syndromeb,C0311400;C1524026;C2707259,false;false;false,15651/20013
metabolism and nutrition,C0025519;C0025520,true;true,15652/20013
metastatic,C0036525;C1522484;C4085632,false;true;false,15653/20013
metformin - dose,C0025598;C0178602;C0869039;C1114758,true;false;false;false,15654/20013
metformin ( hdm ),C0025598,true,15655/20013
metformin ( n nmbr nmbr ),C0025598,true,15656/20013
metformin ? pioglitazone,C1635037,false,15657/20013
metformin ? su,C0025598;C0038642;C1705534,true;true;false,15658/20013
metformin + su,C0025598;C0038642;C1705534,true;true;false,15659/20013
metformin + su + tzd,C0025598;C0038642;C1705534,true;true;false,15660/20013
metformin ± other oral anti - dm drugs,C0025598,true,15661/20013
metformin • pioglitazone,C1635037,false,15662/20013
metformin alone,C0025598,true,15663/20013
metformin monotherapy,C0025598,true,15664/20013
metformin only,C0025598;C0205171;C1720467,true;false;false,15665/20013
metformin open - label *,C0025598,true,15666/20013
metformin + sulphonylureas,C0025598;C0038766,true;true,15667/20013
metforminmonotherapy,,,15668/20013
method of assessing ejection fraction,C0025663;C1516048;C0302131;C1264633;C0336969;C0812388;C0449851;C0871511,true;false;false;false;false;false;false;false,15669/20013
method of insulin administration,C0025663;C0199782;C0449851;C0871511,true;false;false;false,15670/20013
methotrexate alone^,C0025677,true,15671/20013
methotrexate dose on day nmbr — mg per wl < nmbr,C0025677;C0178602;C0439422;C0869039;C1114758;C0332173;C4086581;C0439228;C0439505,true;false;false;false;false;false;false;false;false,15672/20013
methotrexate dose | |,C0025677;C0178602;C0869039;C1114758,true;false;false;false,15673/20013
methotrexate plus other csdmardfl,C0025677,true,15674/20013
methotrexate treatment !,C0746573,false,15675/20013
methotrexate use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,15676/20013
methotrexate use at randomization,C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,15677/20013
methylxanthines,C0066447,true,15678/20013
metoprolol ( n = nmbr nmbr ),C0025859,true,15679/20013
mets pbo ( n = nmbr ) vs evomab ( n = nmbr ),C0812270;C0031962;C1705694;C2939420,false;true;false;false,15680/20013
mexican,C0240339,false,15681/20013
mfns ( n = nmbr ),,,15682/20013
mg daily ),C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,15683/20013
mg / day,C0439422,false,15684/20013
mg / dl fpg ( mmol / l ),C0439269;C1532563,false;false,15685/20013
mg / g,C1300563,false,15686/20013
mg / mmol,C0567349;C2348885,false;false,15687/20013
mh + crpnorr,C0026514;C2930980,true;true,15688/20013
mhi,,,15689/20013
mi — no . ( % ),C3810814,false,15690/20013
mi ( fatal / nonfatal ),C3810814;C1302234;C1705232,false;false;false,15691/20013
mi *,C3810814,false,15692/20013
micral test result,C0456984;C0587081,false;false,15693/20013
micro - or macroalbuminuria,C0085672;C1553035;C3811161;C4049106,false;false;false;false,15694/20013
micro / macroaibuminuria,C0085672;C1553035;C3811161;C4049106,false;false;false;false,15695/20013
micro / macroalbuminuria,C0085672;C1553035;C3811161;C4049106,false;false;false;false,15696/20013
microalbuminuria — no . ( % ),C0730345,false,15697/20013
microalbuminuria ( uacr nmbr – nmbr ),C0730345,false,15698/20013
microalbuminuria or macroalbuminuria §,C0730345,false,15699/20013
microvascular complicationsb,C0443258,false,15700/20013
microvascular disease history,C0443258;C0683519,false;false,15701/20013
microvascular disease *,C0443258;C0012634,false;true,15702/20013
microvascular outcome,C0443258;C1274040,false;false,15703/20013
micturitions / nmbrh,C0042034;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,15704/20013
midas score,C1309950;C1423498;C4049617,true;false;false,15705/20013
middle,C0444598;C0549183;C1552826,false;false;false,15706/20013
middle east,C0026068,true,15707/20013
middle tertile : > nmbr . nmbr to b nmbr . nmbr,C0444598;C0549183;C1552826,false;false;false,15708/20013
migraine duration ( h ),C0149931;C0449238;C0033727;C0369286;C0441932;C0564385;C4528284;C2926735,true;false;true;false;false;false;false;false,15709/20013
migraine occurrence ( days / month ),C0149931;C0243132;C0556971;C1554210;C2745955,true;true;false;false;false,15710/20013
migraine severity score,C0149931;C0457451,true;false,15711/20013
mild - to - moderate ( ipss < nmbr ),C1299392;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,15712/20013
mild ( < nmbr ),C2945599,false,15713/20013
mild ( nmbr - nmbr ),C2945599,false,15714/20013
mild ( nmbr – nmbr ml · min − nmbr · nmbr . nmbr m − nmbr ),C2945599;C0439445;C0369637;C0441923,false;false;false;false,15715/20013
mild ( fev,C2945599;C3714541,false;true,15716/20013
mild ( iief - ef nmbr - nmbr ),C2945599;C3641331,false;false,15717/20013
mild ( ipss < nmbr ),C2945599;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,15718/20013
mild ( n = nmbr ),C2945599,false,15719/20013
mild ( nnmbr = nmbr ) nmbr,C2945599,false,15720/20013
mild decrease ( nmbr - < nmbr ml / min per nmbr . nmbr mnmbr ),C2945599;C0392756;C0439445;C0369637;C0441923;C0547047,false;false;false;false;false;false,15721/20013
mild decrease in gfr ( nmbr - nmbr ml / mln per nmbr . nmbr m^ ),C2945599;C0392756;C0017654;C0439526;C1417190;C3815103;C1705224;C3887665;C1424601;C0547047,false;false;true;false;false;false;false;false;false;false,15722/20013
mild dysfunction ( crcl > nmbr - nmbr ml / min  n = nmbr [nmbr . nmbr % ] ),C3274775;C1846718;C0439445,false;false;false,15723/20013
mild ed,C2945599;C3538926,false;false,15724/20013
mild ed severe ed,C2945599;C3538926;C0205082;C4050465;C4050466,false;false;false;false;false,15725/20013
mild impairment,C2945599;C0221099;C0684336,false;false;false,15726/20013
mild impairment ( £ nmbr to,C2945599;C0221099;C0684336,false;false;false,15727/20013
mild impairment ( nmbr tonmbrml / min ),C2945599;C0221099;C0439445;C0684336,false;false;false;false,15728/20013
mild impairment ( egfr nmbr - nmbr ml / min / m^ ),C2945599;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336,false;false;true;false;false;false;false;false;false,15729/20013
mild impairment ( egfr nmbr – nmbr ),C2945599;C0221099;C1739039;C3811844;C3812682;C0684336,false;false;true;false;false;false,15730/20013
mild or no dysfunction ( crcl > nmbr ml / min  n = nmbr nmbr  [nmbr . nmbr % ] ),C2945599,false,15731/20013
mild reduction in egfr,C2945599;C0301630;C1739039;C3811844;C3812682;C0392756;C1293152;C4551656,false;false;true;false;false;false;false;false,15732/20013
mild to moderate renal impairment *,C1299392;C1565489,false;true,15733/20013
mild / moderate ( ipss < nmbr ),C1299392;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,15734/20013
mildlydecreased baseline gfr ( nmbr - nmbr ml / min / nmbr . nmbrmnmbr ),C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,15735/20013
min - ’,C0702093;C1524029;C3813700,false;false;false,15736/20013
min - max,C0702093;C1524029;C3813700,false;false;false,15737/20013
min – max,C0702093;C1524029;C3813700,false;false;false,15738/20013
min per nmbr . nmbr mnmbr,C0702093;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false,15739/20013
mineralcorticoid receptor antagonist,C4543207,false,15740/20013
mineralocorticoid receptor antagonist n ( % ),C1579268,true,15741/20013
minimum,C1524031;C1552614;C2826545,false;false;false,15742/20013
minimum — maxim um,C1524031;C0024968;C1552614;C2826545,false;true;false;false,15743/20013
minimum — maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,15744/20013
minimum / maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,15745/20013
minor bleed,C0026193;C0019080;C0205165,true;true;false,15746/20013
minor surgery,C0038904,true,15747/20013
minor / major,C0026193;C0205082;C0205164;C4318856;C4521762;C0205165,true;false;false;false;false;false,15748/20013
minority,C0026192,true,15749/20013
minutes from pre - pci angiography to post - pci angiography,C0439232;C0332152;C4049621;C0002978;C0740175;C2257086;C3669034;C0700321;C0702093;C1282918;C2347166,false;false;false;true;false;false;false;false;false;false;false,15750/20013
minutes from prehospital ecg to pci,C0439232;C1623258;C0700321;C0702093;C1282918;C2347166,false;true;false;false;false;false,15751/20013
minutes from symptom onset to prehospital ecg,C0439232;C4086878;C0700321;C0702093;C1282918;C2347166,false;false;false;false;false;false,15752/20013
missing ed duration ( y ),C1551393;C3538926;C0449238;C2926735;C1705492;C3272743,false;false;false;false;false;false,15753/20013
missing *,C1551393;C1705492;C3272743,false;false;false,15754/20013
mitral valve disease ( n = nmbr nmbr ),C0026265;C4553832,false;false,15755/20013
mitt population ( n = nmbr ),C0032659;C1257890,true;true,15756/20013
mixed,C0205430;C3160715,false;false,15757/20013
mixed ( itt ) ( n = nmbr ),C0205430;C3160715,false;false,15758/20013
mixed ( n = nmbr ),C0205430;C3160715,false;false,15759/20013
mixed hispanic,C0205430;C0086409;C3160715,false;true;false,15760/20013
mmf ( n = nmbr ),C0083765;C0209368;C3848524,true;true;true,15761/20013
mmol / l [n],C1532563,false,15762/20013
mmol / l ),C1532563,false,15763/20013
mmp - nmbr,C0623362;C0919336,true;false,15764/20013
mmrc dyspnea scale score : t : t,C3826977;C0013404;C4049715;C1963100,false;true;false;false,15765/20013
mmrm estimates,,,15766/20013
mmse = mini - mental state examination  adas — cog = alzhei -,C0451306;C3539026,true;false,15767/20013
mn - na ï ve population,C0026327;C0597484;C0042469;C0032659;C1257890;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882;C0026405;C4285072,true;false;true;true;true;false;false;false;false;false;false;false;true;false,15768/20013
mn population,C0026327;C0032659;C1257890;C0026405;C4285072,true;true;true;true;false,15769/20013
mnapsi,,,15770/20013
mod / sev exacerbation rate,C0011860;C0439793;C4086268;C0871208;C1521828;C0458216;C2983285,true;false;false;false;false;false;false,15771/20013
mod / sev exacerbation rates,C0011860;C0439793;C4086268;C0871208;C1521828;C0458216;C2983285,true;false;false;false;false;false;false,15772/20013
model,C3161035;C3274659;C3714583;C3853906,false;false;false;false,15773/20013
model nmbr,C3161035;C3274659;C3714583;C3853906,false;false;false;false,15774/20013
model nmbr +,C3161035;C3274659;C3714583;C3853906,false;false;false;false,15775/20013
model nmbrt,C3161035;C3274659;C3714583;C3853906,false;false;false;false,15776/20013
model nmbr §,C3161035;C3274659;C3714583;C3853906,false;false;false;false,15777/20013
moderate - intensity statin,C4081855;C0360714,false;true,15778/20013
moderate - intensity statin use,C4081855;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,15779/20013
moderate - to -,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15780/20013
moderate - to - severe copd exacerbation,C1299393;C0740304,false;false,15781/20013
moderate severe ( n = nmbr ) ( n = nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15782/20013
moderate ( > nmbr and < nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15783/20013
moderate ( > nmbr % . < nmbr % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15784/20013
moderate ( nmbr % . < nmbr % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15785/20013
moderate ( nmbr – nmbr ml · min − nmbr · nmbr . nmbr m − nmbr ),C0205081;C0439445;C0369637;C0441923;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false,15786/20013
moderate ( nmbr % < fev,C0205081;C3714541;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,15787/20013
moderate ( nmbr - nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15788/20013
moderate ( nmbr < ipss < nmbr ),C0205081;C1019118;C1998280;C2827405;C3811063;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,15789/20013
moderate ( iief - ef nmbr - nmbr ),C0205081;C3641331;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false,15790/20013
moderate ( ipss < nmbr ) ( n = nmbr ),C0205081;C1019118;C1998280;C2827405;C3811063;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,15791/20013
moderate ( n = nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15792/20013
moderate ( nnmbr = nmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15793/20013
moderate ( snmbr % . < nmbr % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15794/20013
moderate chronic kidney disease,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15795/20013
moderate copd,C0205081;C0024117;C1412502;C3714496;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false;false,15796/20013
moderate cord * : qvanmbr - sfc,C0205081;C1550235;C4521536;C1706500;C3489532;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;true;false;false;false;false;false,15797/20013
moderate decrease ( nmbr - < nmbr mlymin per nmbr . nmbr mnmbr ),C0205081;C0392756;C0369637;C0441923;C0547047;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,15798/20013
moderate disease,C0205081;C0012634;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,15799/20013
moderate dysfunction ( crcl nmbr - nmbr ml / min  n = nmbr [nmbr . nmbr % ] ),C3274776;C1846718;C0439445,false;false;false,15800/20013
moderate impairment,C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,15801/20013
moderate impairment ( nmbr tonmbrml / min ),C0205081;C0221099;C0439445;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false,15802/20013
moderate impairment ( egfr nmbr - nmbr ml / min / m^ ),C0205081;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false;false;false;false,15803/20013
moderate impairment ( egfr nmbr – nmbr ),C0205081;C0221099;C1739039;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false,15804/20013
moderate or severe decrease in gfr ( < nmbr ml / min / nmbr . nmbr mnmbr ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15805/20013
moderate or severe decrease in gfr { < nmbr ml / mln per nmbr . nmbr m^ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15806/20013
moderate or severe impairment,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15807/20013
moderate or severe renal disease,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15808/20013
moderate risk ( > nmbr - nmbr ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,15809/20013
moderate severity,C0205081;C0439793;C0522510;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,15810/20013
moderate trs : nmbr - nmbr ( n = nmbr,C0205081;C0266427;C0968917;C1150746;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false,15811/20013
moderate / low,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15812/20013
moderate / severe exacerbation,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15813/20013
moderate / severe exacerbations  patient subgroups  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15814/20013
moderate / severe reduction in egfr,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,15815/20013
moderatex,,,15816/20013
moderatez,,,15817/20013
modi fied la grade *,C0342276;C0023031;C0441800;C0919553;C3244287;C0023749;C0230347;C2346906;C4553351,true;true;false;false;false;true;false;false;false,15818/20013
modified hachinski ischemia scale,C0392747;C0022116;C0175659;C0349674;C1947916;C4321499;C3889737,false;true;true;false;false;false;false,15819/20013
modified has - bled > nmbr,C0392747;C3889737,false;false,15820/20013
modified has - bled score,C0392747;C3889737,false;false,15821/20013
modified total sharp score,C0392747;C2964552;C1444775;C1539835;C3890003;C3889737,false;false;false;false;false;false,15822/20013
monoamine oxidase b inhibitors,C2917290;C3653412,false;false,15823/20013
monotherapynmbr,,,15824/20013
monteiukast,,,15825/20013
monteiukast ( n = nmbr ),,,15826/20013
monteiukast vs placebo,,,15827/20013
month nmbr subgroup x treatment interaction p - value,C0332177;C1079230;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021;C0439231,false;false;true;false;false;true;false;false;false;false;false;false;false,15828/20013
months from qualifying stroke *   ( % ),C0439231;C1514624;C0038454;C4554100,false;false;true;false,15829/20013
morning,C0332170,false,15830/20013
morning peak expiratory flow — liters / min,C0332170;C1518922;C0475211;C0702093;C1524029;C3813700,false;false;false;false;false;false,15831/20013
morning stiffness duration,C0457086;C0449238;C2926735,false;false;false,15832/20013
morning stiffness severity,C0457086;C0439793;C0522510,false;false;false,15833/20013
morphometric vertebral,C0200760;C0549207,false;true,15834/20013
mortality,C0026565;C0026566,true;true,15835/20013
mortality outcomes,C0026565;C1274040;C0026566,true;false;true,15836/20013
most common aes in any group,C0205393;C0205214;C1412268;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2699274;C1522138;C3245511,false;false;false;false;false;true;false;false;false;false;false;false,15837/20013
most common aes ‡,C0205393;C0205214;C1412268;C2699274;C1522138;C3245511,false;false;false;false;false;false,15838/20013
most frequent aesa,C0205393;C0332183,false;false,15839/20013
most frequent gi disorders,C0205393;C0332183;C1708130;C0012634;C3539617;C4050121,false;false;false;true;false;false,15840/20013
most frequent infections,C0205393;C0239998,false;false,15841/20013
most frequent non - infectious teaesb,C0205393;C0239998;C1518422,false;false;false,15842/20013
most frequent serious teaes,C0205393;C0332183;C0205404,false;false;false,15843/20013
mostly dissatisfied,C0205393;C0750554,false;false,15844/20013
mostly satisfied,C0205393;C0750554,false;false,15845/20013
motor updrs subscore ( baseline ),C1513492;C3639721;C0168634;C1442488;C1705994,false;true;true;false;false,15846/20013
mouth ulceration,C0149745,true,15847/20013
mra regimen ( n - nmbr ),C0243032;C0040808;C2945654;C1609165;C3891069,true;true;false;true;false,15848/20013
mra use,C0243032;C1609165;C3891069,true;true;false,15849/20013
mras,C1335594;C1367476,true;false,15850/20013
mrf,C0312443;C1412879,false;false,15851/20013
ms < nmbr,C2349943;C3539704;C3713294,false;false;true,15852/20013
ms nmbr - nmbr,C2349943;C3539704;C3713294,false;false;true,15853/20013
ms,C2349943;C3539704;C3713294,false;false;true,15854/20013
msdbp ( mm hg ),C0439475,false,15855/20013
msdbp ± sd,C2699239,false,15856/20013
msfc timed nmbr - foot walk test .,,,15857/20013
mssbp ( mm hg ),C0439475,false,15858/20013
mssbp < nmbr mmhg,C0439475,false,15859/20013
mssbp > nmbr mmhg,C0439475,false,15860/20013
mssbp ± sd,C2699239,false,15861/20013
mtss at,,,15862/20013
mtss at baseline observed case,C0168634;C1442488,true;false,15863/20013
mtx - ir,C0025677;C0022065;C0022071;C1448132;C1417487,true;true;true;true;false,15864/20013
mtx ( n ),C0025677;C1417487,true;false,15865/20013
mtx + other csdmards,C0025677;C1417487,true;false,15866/20013
mtx + other csomards,C0025677;C1417487,true;false,15867/20013
mtx + othetcsdmards,C0025677;C1417487,true;false,15868/20013
mtx < nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,15869/20013
mtx ≤ nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,15870/20013
mtx ≥ nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,15871/20013
mtx > nmbr – nmbr mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,15872/20013
mtx > nmbr and si nmbr mg / week,C0025677;C1417487,true;false,15873/20013
mtx at baseline,C0025677;C0168634;C1442488;C1417487,true;true;false;false,15874/20013
mtx average weekly dose,C0366550;C1510992;C0332174;C2825518,false;false;false;false,15875/20013
mtx dose > nmbr mg / week,C0366550;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,15876/20013
mtx ir,C0025677;C0022065;C0022071;C1448132;C1417487,true;true;true;true;false,15877/20013
mtx naive or free,C0025677;C1417487,true;false,15878/20013
mtx only,C0025677;C0205171;C1720467;C1417487,true;false;false;false,15879/20013
mtx plus infliximab,C0025677;C0332287;C0666743;C1417487,true;false;true;false,15880/20013
mtx plus placebo,C0025677;C0332287;C0032042;C1696465;C1706408;C1417487,true;false;true;false;false;false,15881/20013
mtx sio mg / week,C0025677;C1039355;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;false;true;false;false;true;false;false;false;false;false;false,15882/20013
mtx use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944;C1417487,true;true;true;false;false;false;false,15883/20013
mtx use at randomization,C0025677;C0042153;C0034656;C0457083;C1947944;C1417487,true;true;true;false;false;false,15884/20013
mucosal healingc n / n ( % ),C0026724,true,15885/20013
mucosal healingf,C0026724,true,15886/20013
multiple risk factors,C0439064;C0035648;C1553898,false;true;false,15887/20013
multiracial or other,C1881928,false,15888/20013
multivariable,,,15889/20013
multivariable adjusted hr ( nmbr % ci ),C0456081;C0008107;C3259781,false;true;false,15890/20013
multivariable adjusted model hr ( nmbr % ci ),C0456081;C3161035;C0008107;C3259781;C3274659;C3714583;C3853906,false;false;true;false;false;false;false,15891/20013
multivariable or ( nmbr % ci ),,,15892/20013
multivariate logistic modelb,C0242415,true,15893/20013
multivessel coronary - artery bypass grafting,C0010055,true,15894/20013
multivessel disease — no . ( % ),C0012634,true,15895/20013
multivitamin use yes,C0301532;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,15896/20013
multivitamins,C0301532;C3714835,false;false,15897/20013
mycophenolate ( any derivative ),C0883242,false,15898/20013
myocardiai infarction,C0021308,true,15899/20013
myocardial infarction ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,15900/20013
myocardial infarction before index acs — no . ( % ),C0027051;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C0428953;C2926063;C3810814;C4552959,true;true;true;false;true;false;false;false;false;false;false;false,15901/20013
myocardial infarction n ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,15902/20013
myocardial infarction / cabg / pci,C0027051;C0010055;C4049621;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false,15903/20013
myocardial infarction :,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,15904/20013
myocardial infarction §,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,15905/20013
myoclonic,,,15906/20013
n - nmbr allocation,C0369718;C1706778;C0441922,false;false;false,15907/20013
n - nmbr fatty acids,C0369718;C0015684;C0441922,false;true;false,15908/20013
n - nmbr fatty acids slope lsm ± se ( mm / year ),C0369718;C0015684;C0441922,false;true;false,15909/20013
n - nmbr fatty acit,C0369718;C0441922,false;false,15910/20013
n - terminal pro - bnp — pg / ml §,C0669479;C0439297,true;false,15911/20013
n ( % of patients ),C0369718;C0030705;C0441922,false;true;false,15912/20013
n ( % ) blood pressure - mean ( sd ) mm hg,C0369718;C0428886;C2699239;C0439475;C0441922,false;true;false;false;false,15913/20013
n ( % ) liraglutide nmbr placebo,C0369718;C1456408;C0032042;C1696465;C1706408;C0441922,false;true;true;false;false;false,15914/20013
n ( % ) patients with risk faetors for cv disease aged > nmbr,C0369718;C0030705;C0035647;C4552904;C0441922,false;true;true;false;false,15915/20013
n ( % ) responders,C0369718;C0441922,false;false,15916/20013
n ( % ) unless otherwise specified,C0369718;C0441922,false;false,15917/20013
n ( iqr ),C0369718;C0441922,false;false,15918/20013
n ( lesions ),C0369718;C0441922,false;false,15919/20013
n ( stented lesions ),C0369718;C0441922,false;false,15920/20013
n = nmbrt,C0369718;C0441922,false;false,15921/20013
n america,C0369718;C0002454;C0441922,false;true;false,15922/20013
n events ( % ),C0369718;C0441471;C3541888;C0441922,false;false;false;false,15923/20013
n events / n subjects,C0369718;C0441471;C3541888;C0441922,false;false;false;false,15924/20013
n events / n at risk,C0369718;C0441471;C3541888;C0441922,false;false;false;false,15925/20013
n nt,C0369718;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038;C0441922,false;false;true;false;false;false;false;false,15926/20013
n observed,C0369718;C0441922,false;false,15927/20013
n participants,C0369718;C0679646;C0441922,false;false;false,15928/20013
n t % ),C0369718;C0441922,false;false,15929/20013
n . a .,C1272460,false,15930/20013
n / a,C1272460,false,15931/20013
n / n   ( % ),C0369718;C0441922,false;false,15932/20013
n / n ( % / yr ),C0369718;C0439234;C0441922,false;false;false,15933/20013
n / r,C0369718;C0205090;C0684010;C2603358;C0441922,false;false;true;false;false,15934/20013
n + v ( n = nmbr ),C0369718;C0441922,false;false,15935/20013
n = nmbr lesions,C0369718;C0441922,false;false,15936/20013
na,C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false,15937/20013
nail involvement,C0027342;C1314939;C1432728;C3538766,true;false;true;false,15938/20013
naire can range from nmbr to nmbr for the alternative disability portion and from nmbr to nmbr for the pain portion . scores for the medical outcomes,,,15939/20013
naive,,,15940/20013
naive ( no treatment for current flare ),,,15941/20013
nap,C0870935;C1423800;C4283878,false;false;false,15942/20013
naproxen,C0027396,true,15943/20013
napsi score ( nmbr - nmbr ) of target fingernail,,,15944/20013
napsit,,,15945/20013
nasal polyposis or chronic rhinosinusitis — no . { % ),C0027430,true,15946/20013
nasal polyps at baseline : yes,C0027430;C0168634;C1549445;C1705108;C1710701;C1442488,true;true;false;false;false;false,15947/20013
nateglinide ( n = nmbr ),C0903898,true,15948/20013
nateglinide and repaglinide,C0903898,true,15949/20013
nateglinide n / n,C0903898,true,15950/20013
native american or alaska native,C0282204;C1515945,true;false,15951/20013
native american or alaskan native,C0282204;C1515945,true;false,15952/20013
native hawaiian or,C0337920,true,15953/20013
native hawaiian or other pacific,C0337920,true,15954/20013
native hawaiian / pacific islander,C0337920;C0242191,true;true,15955/20013
nausea and / or vomiting adverse events,C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767,true;false;false;false;false;false;false;false;false;false;false;false,15956/20013
nbp,,,15957/20013
nc,C0027964;C0028407;C0067895;C0265987,true;true;true;false,15958/20013
nc group ( n = nmbr ),C0027964;C0441848;C0028407;C0067895;C0265987,true;false;true;true;false,15959/20013
ncep atp - iii metabolic syndrome features,C2744579;C0439070;C0524620;C1705160;C4552600,true;false;true;false;false,15960/20013
nctnmbr,,,15961/20013
nd,,,15962/20013
nd not due to swelling or ich,,,15963/20013
ne,C0027608;C0028219;C3538705,true;true;false,15964/20013
nebivolol ( n = nmbr ),C0068475,true,15965/20013
necessitating hospitalization in previous year — no . ( % ),C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,15966/20013
necrosis,C0027540;C1334928,true;false,15967/20013
necrotic core,C0027540;C0444669;C1167518;C1706352;C1882467;C3274653,true;false;false;false;false;false,15968/20013
need for nmbr ng edoxaban dose at,C0027552;C0017887;C2975435;C0178602;C0869039;C1114758;C0028074;C0686904,true;true;true;false;false;false;true;false,15969/20013
negative ctnl ( n = nmbr,C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,15970/20013
neither cs nor imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,15971/20013
neither deep - vein thrombosis nor pulmonary embolism^,C0149871,true,15972/20013
neither deep - vein thrombosis nor pulmonary embolism §,C0149871,true,15973/20013
neither pe nor dvt,C0070939;C1880476;C4284304,true;false;false,15974/20013
neither unfractionated heparin nor low - molecular - weight heparin,C0019134;C2825026,true;false,15975/20013
neohrodathv . and all - cause mortalitv,,,15976/20013
nerd,,,15977/20013
nesiritide ( n = nmbr ),C0054015,true,15978/20013
nesiritide,C0054015,true,15979/20013
net clinical benefit *,C1456447;C4684590;C3853572;C3887809;C3890893,true;false;false;false;false,15980/20013
net clinical benefit : cv death,C1456447;C4684590;C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503;C3853572;C3887809;C3890893,true;false;false;true;false;false;false;true;false;false;false;false,15981/20013
net clinical benefit : on - treatment vte or major bleeding,C1456447;C1516635;C0814225;C0630906;C4684590;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3853572;C3887809;C3890893,true;false;false;true;false;true;true;false;false;false;false;false;false;false;false,15982/20013
net composite,C1456447;C0205199;C1547335;C3853572;C3887809;C3890893,true;false;false;false;false;false,15983/20013
net ep nmbr,C1456447;C1880476;C4321526;C3853572;C3887809;C3890893,true;false;false;false;false;false,15984/20013
network,C0150775;C1513822;C1705739;C1882071,true;false;false;false,15985/20013
neuraxial alonee,C3714787,true,15986/20013
neuraxial anaesthesia,C3714787;C0002903;C0002912;C0002930;C4049933,true;true;true;true;false,15987/20013
neurocognitive disorders,C0029227;C4041080,true;true,15988/20013
neurologicai events,C0441471;C3541888,false;false,15989/20013
neuropathy — no . ( % ),C0442874,false,15990/20013
neutropenia,C0023530;C0027947;C0853697,true;true;false,15991/20013
never been on a vka,C2003901,false,15992/20013
never drink,C2003901,false,15993/20013
never nsaid,C2003901;C0003211;C3536840,false;true;false,15994/20013
never or past,C2003901,false,15995/20013
never smoked — no . ( % ),C2003901,false,15996/20013
never took alendronate,C2003901,false,15997/20013
new - onset atrial fibrillation,C0741281,false,15998/20013
new - onset diabetes,C0746890;C0011847;C0011849,false;false;true,15999/20013
new - onset diabetes §,C0746890;C0011847;C0011849,false;false;true,16000/20013
new diabetes,C0205314;C0011847;C0011849,false;false;true,16001/20013
new hf medication,C0205314;C0018488;C0013227;C3244316;C4284232;C1313497;C1538440;C3273279,false;true;true;false;false;true;false;false,16002/20013
new or worsenina neohrodathv,C0205314,false,16003/20013
new or worsentna neohrodathv,C0205314,false,16004/20013
new use of gpa,C0205314;C1524063;C3495801;C4553145,false;false;true;false,16005/20013
new york heart association class,C1882083,false,16006/20013
newly diagnosed asthma ( n ),C0750546;C0011900;C0004096;C2984299,false;true;true;false,16007/20013
nfs < - nmbr . nmbr ( low ),C1555018,false,16008/20013
nfs > nmbr . nmbr ( high ),C1555018,false,16009/20013
niacin ( n = nmbr ),C0027996;C1142562,true;false,16010/20013
niacin + statin,C0027996;C0360714;C1142562,true;true;false,16011/20013
nice classification of copd severity of obstruction,C4087029;C0008902;C0024117;C0439793;C0028778;C1882136;C0522510;C1412502;C3714496;C0008903;C0678229,false;true;true;false;false;false;false;false;false;true;false,16012/20013
night - time awakenings in past nmbr weeks ( sd ) *,C0860510;C2987125;C2699239,false;false;false,16013/20013
night - time awakenings in past nmbr weeks prior to baseline,C0860510;C2987125,false;false,16014/20013
nighttime mean dbp ( abpm ) at week nmbr,C0240526;C0444504;C0536221;C0332174;C0439230;C3813197;C4281799;C2347634;C2348143,false;false;true;false;false;false;false;false;false,16015/20013
nighttime mean sbp ( abpm ) at week nmbr,C0240526;C0444504;C0085805;C0332174;C0439230;C2347634;C2348143,false;false;true;false;false;false;false,16016/20013
nih stroke scale,C1697238;C3484372,false;false,16017/20013
nihss score,C1697238,false,16018/20013
nilvadipine,C0132512,true,16019/20013
nintedanib ( n   =   nmbr ),C2930789,true,16020/20013
nintedanib ( n = nmbr ),C2930789,true,16021/20013
nitrate ( oral or intravenous ),C0028125;C0699857;C3848573,true;false;false,16022/20013
nitrate ( oral or topical ),C0028125;C0699857;C3848573,true;false;false,16023/20013
nitrates ( % ),C0028125;C0699857;C3848573,true;false;false,16024/20013
nitratesf,,,16025/20013
nkf stage,,,16026/20013
no - ckd intensive ( n = nmbr ),C1561643;C0162425;C0522510;C1283828;C1550453,true;true;false;false;false,16027/20013
no - ckd standard ( n = nmbr ),C1561643;C1442989;C2828392,true;false;false,16028/20013
no nmbr,,,16029/20013
no ( nmbr . nmbr ),,,16030/20013
no ( reference ),C1514811;C1706462,false;false,16031/20013
no ace inhibitor / arb,C0003015;C3888198;C4541021,true;false;false,16032/20013
no active cancer center - level inr percent time,C0205177;C1513817;C0441889;C0525032;C0439165;C0040223;C3541383;C1704538;C0456079;C1547707;C2946261;C3853793;C3888249,false;false;false;true;false;true;false;false;false;false;false;false;false,16033/20013
no alcohol consumption,C0001948,true,16034/20013
no amiodarone,C0002598,true,16035/20013
no antihypertensive medication,C0003364,true,16036/20013
no apparent heart disease,C0750489;C0018799,false;true,16037/20013
no asa,C0004057;C3853627,true;false,16038/20013
no aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,16039/20013
no atopy ( n = nmbr ),C0392707;C3539705,false;false,16040/20013
no atrial fibrillation,C0004238;C0344434;C1963067,true;false;false,16041/20013
no baseline characteristics,C4684572,false,16042/20013
no baseline immunosuppressant use,C0168634;C0021081;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,16043/20013
no body weight at randomization ( ixrs ),C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212,true;true;false;true;false;false;false;false,16044/20013
no cad / mi,C1504769;C3810814;C2239547;C3813548;C4284121,true;false;false;false;false,16045/20013
no cardiovascular disease ( n = nmbr ),C0007222,true,16046/20013
no cardiovascular disordernmbr ',C0007222,true,16047/20013
no cases,C0868928;C1533148,false;false,16048/20013
no chd at baseline,C0280604;C0168634;C1442488;C3542407,false;true;false;false,16049/20013
no chd eze / simva ( n = nmbr ),C0280604;C3542407,false;false,16050/20013
no chd simva ( „ = nmbr ),C0280604;C3542407,false;false,16051/20013
no ckd,C1561643,true,16052/20013
no ckd ( % ),C1561643,true,16053/20013
no ckd n,C1561643,true,16054/20013
no ckd rate ( # events ),C1561643;C0871208;C0441471;C3541888;C1521828,true;false;false;false;false,16055/20013
no colchicine ( n = nmbr ),C0009262,true,16056/20013
no concomitant antiplatelet,C0521115,false,16057/20013
no cs and imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,16058/20013
no cs and is,C0010182;C0271160;C3540510;C4085345,true;false;false;false,16059/20013
no culprit vessel identified,C0005847,true,16060/20013
no cv event ( n = nmbr,C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;true;false,16061/20013
no cvd,C0007222,true,16062/20013
no diabetes ( n = nmbr,C0011847;C0011849,false;true,16063/20013
no diabetes ( p = . nmbr ),C0011847;C0011849,false;true,16064/20013
no diabetes ( p = . onmbr ),C0011847;C0011849,false;true,16065/20013
no digoxin n = nmbr nmbr ( nmbr % ),C0012265,true,16066/20013
no digoxin scd,C0012265,true,16067/20013
no diuretic therapy,C0948575,false,16068/20013
no dm,C0011816;C3250443,true;false,16069/20013
no dm ( n = nmbr,C0011816;C3250443,true;false,16070/20013
no draining fistulas *,C0544791,false,16071/20013
no dysglycaemia or mets pbo ( n = nmbr ) vs evomab ( n = nmbr ),C1960636,false,16072/20013
no dyspnoea ( n = nmbr ),C0013404;C1963100,true;false,16073/20013
no ef data | |,C1511726;C3245479;C3714741,false;false;false,16074/20013
no estrogen,C0014939;C2936882;C4542544,true;false;false,16075/20013
no gi bleed,C1708130;C3539617;C4050121,false;false;false,16076/20013
no glucocorticoids at baseline,C0017710;C0168634;C1442488;C3540777;C3540778,true;true;false;false;false,16077/20013
no glucose lowering drugs,C0017725;C0441994;C0013227;C3687832;C2003888,true;false;true;false;false,16078/20013
no heart failure,C0018801;C0018802;C4554158,true;true;false,16079/20013
no history of bowel resections,C0019664;C0741614;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16080/20013
no history of extra - intestinal manifestations of ibd ( ref ),C0019664;C1883702;C0021853;C1280464;C1425988;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;true;false;false;false;false,16081/20013
no history of heart failure at baseline,C0455531,false,16082/20013
no history of hf,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,16083/20013
no history of tnf antagonist treatment — no . ( % ),C0019664;C1448177;C0231491;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;true;false;false;false;false;false;true;false;false;false;false,16084/20013
no hospitalization in the past nmbr months prior to baseline ( ref ),C0019993;C4331910,true;false,16085/20013
no hx of hf ( n = nmbr ),C0262926;C0018488;C1313497;C1538440;C3273279;C3814444,false;true;true;false;false;false,16086/20013
no ics,C0815320;C4551720,false;true,16087/20013
no immunosuppressive agents at baseline,C0021081;C0168634;C1442488,true;true;false,16088/20013
no in - trial stroke n = nmbr,C0150312;C0008976;C0038454;C4554100;C0332285;C1707101,false;true;true;false;false;false,16089/20013
no incident dm or change in fg > nmbr,C1551358;C0011816;C3250443,false;true;false,16090/20013
no increased risk for falls,C4699158;C0000921;C0085639;C1849142;C0035647;C4552904,false;true;false;false;true;false,16091/20013
no inducer at core study entry,C3898767;C0444669;C0557651;C1705654;C2603343;C1167518;C1706352;C1882467;C3274653,false;false;false;false;false;false;false;false;false,16092/20013
no infarct visible,C0021308,true,16093/20013
no laba,,,16094/20013
no laba  no ics ( tiotropium n = nmbr  placebo n = nmbr ),,,16095/20013
no longer met study criteria,C0205166;C0428210;C0557651;C0243161;C2603343;C1550543;C4317104;C1706317,false;false;false;true;false;false;false;false,16096/20013
no metabolic syndrome,C0524620,true,16097/20013
no methotrexate,C0025677,true,16098/20013
no mtx at baseline,C0025677;C0168634;C1442488;C1417487,true;true;false;false,16099/20013
no mtx use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944;C1417487,true;true;true;false;false;false;false,16100/20013
no nasal polyps,C0027430,true,16101/20013
no new a or and no more than nmbr new bilag b domain score,C0205314,false,16102/20013
no new erosions among patients with ≥ nmbr uninvolved joint at baseline ¶,C0205314;C0333307;C0030705;C1959609,false;false;true;false,16103/20013
no new jsn among patients with ≥ nmbr uninvolved joint at baseline ¶,C0205314;C0030705,false;true,16104/20013
no nonsevere hypoglycemia,C0020615;C4553659,true;false,16105/20013
no oam,,,16106/20013
no ocs,,,16107/20013
no ocs use,,,16108/20013
no of events / total n ( % ),C0441471;C0439175;C0439810;C3541888,false;false;false;false,16109/20013
no op,,,16110/20013
no oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,16111/20013
no p value for ischemia ischemia hr ( nmbr % ci ) interaction,C1709380;C0022116;C0008107;C1704675;C3259781;C4321499,false;true;true;false;false;false,16112/20013
no pah - specific therapy,C0030123;C0205369;C0039798;C0087111;C1363945;C1552740;C3203102;C4284467,true;false;true;true;false;false;true;false,16113/20013
no polyvascular disease ( n = nmbr nmbr ),C0012634,true,16114/20013
no polyvascular disease * ( n = nmbr nmbr ),C0012634,true,16115/20013
no ppi,C0358591;C0871125;C3811894,true;true;false,16116/20013
no pretreatment,C1550147;C2709094;C3539075;C3539076,false;false;false;false,16117/20013
no previous cd related surgerynmbr,C0205156;C0007928;C0034283;C4552032;C1552607,false;true;true;false;false,16118/20013
no previous copd medication,C0205156;C0024117;C0013227;C3244316;C4284232;C1412502;C3714496;C1552607,false;true;true;false;false;false;false;false,16119/20013
no previous diagnosis of diabetes mellitus,C0332132;C0011849,false;true,16120/20013
no previous ischemic stroke / tia ( n = nmbr nmbr  nmbr . nmbr % ),C0205156;C0948008;C0007787;C0917805;C1054154;C1552607,false;false;true;true;false;false,16121/20013
no previous myocardial infarction nmbr / nmbr,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,16122/20013
no previous stroke or tia ( n = nmbr ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,16123/20013
no previous stroke ortia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,16124/20013
no previous stroke / tia,C0205156;C0038454;C0007787;C0917805;C1054154;C4554100;C1552607,false;true;true;true;false;false;false,16125/20013
no previous treatment with infliximab,C0205156;C0039798;C0666743;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,16126/20013
no prior admc,C0332152;C2826257,false;false,16127/20013
no prior angina ( n = nmbr,C0332152;C0002962;C2826257,false;true;false,16128/20013
no prior cvd,C0332152;C0007222;C2826257,false;true;false,16129/20013
no prior dm,C0332152;C0011816;C3250443;C2826257,false;true;false;false,16130/20013
no prior hf ( n = nmbr,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,16131/20013
no prior hf hospitalization ( n   = nmbr,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,16132/20013
no prior hf n = nmbr,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,16133/20013
no prior htn ( n = nmbr,C0332152;C0020538;C2826257,false;true;false,16134/20013
no prior mi ( n = nmbr,C0332152;C3810814;C2826257,false;false;false,16135/20013
no prior mi n = nmbr,C0332152;C3810814;C2826257,false;false;false,16136/20013
no prior oma use,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,16137/20013
no prior oma use ( n = nmbr ),C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,16138/20013
no prior revascularization ( n = nmbr,C0332152;C0581603;C2826257,false;false;false,16139/20013
no prior stroke ( n = nmbr ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,16140/20013
no prior tnf inhibitor exposure,C0332152;C1448177;C1999216;C0274281;C0332157;C2826257,false;true;false;false;false;false,16141/20013
no reperfusion,C0035124;C0684253,true;false,16142/20013
no resistant htn n = nmbr,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,16143/20013
no revascularisation,C0581603,false,16144/20013
no severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,16145/20013
no statin group,C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,16146/20013
no steroid use at baseline ( ref ),C0281991;C0168634;C1425988;C1442488,false;true;false;false,16147/20013
no stsd > nmbr mm on admission ( n = nmbr,C4330985;C0184666;C0809949;C4554674,false;false;false;false,16148/20013
no treatment or antihistamines only,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,16149/20013
no vhd,,,16150/20013
no vhd event rate / year ( n ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,16151/20013
no vka at randomization,C0034656,true,16152/20013
no worsening in pga,C0332271;C0016410;C3541266;C4050369;C1457868;C1546960,false;true;false;false;false;false,16153/20013
no . ( % ) ',,,16154/20013
no . ( % ) nmbr ( nmbr ),,,16155/20013
no . ( % ) of individuals *,C0027361;C0237401,true;false,16156/20013
no . ( % ) of patients with ≥ nmbr % bsa affected,C0030705,true,16157/20013
no . ( % ) of patients with atrial tachyarrhythmia,C0030705,true,16158/20013
no . ( % ) of patients with fingernail involvement,C0030705,true,16159/20013
no . ( % ) of patients with stroke,C0030705,true,16160/20013
no . *,,,16161/20013
no . copies glynmbr - glunmbr - nmbrc,C1948062;C0068000,false;true,16162/20013
no . fingernails,C0222001,true,16163/20013
no . japanese,C0376247;C1556094,false;true,16164/20013
no . needed to treat ( nmbr % cl ) *,,,16165/20013
no . of,,,16166/20013
no . of ' signs or symptoms of chff,C0220912;C0220913;C0311392,true;false;false,16167/20013
no . of nmbr - mg tablets of acetaminophen,C0024671;C1243102;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,16168/20013
no . of agents,C0450442;C1254351;C1521826,false;false;false,16169/20013
no . of background glucose - lowering therapies,C1706907;C0017725;C0441994;C0087111;C2003888,false;true;false;true;false,16170/20013
no . of cardiovascular events ( cardiovascular events / nmbr person - years ),C1320716;C0027361;C0439234;C2347489,false;true;false;false,16171/20013
no . of deaths,C0011065;C1306577,true;false,16172/20013
no . of diseased vessels ( % of group ),C0005847;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,16173/20013
no . of drugs,C0013227;C3687832,true;false,16174/20013
no . of events ( rate ),C0441471;C0871208;C1521828;C3541888,false;false;false;false,16175/20013
no . of events / patients % / yr,C0441471;C0030705;C0439234;C3541888,false;true;false;false,16176/20013
no . of events / sample size,C0441471;C3541888,false;false,16177/20013
no . of events / sample size i i,C0441471;C3541888,false;false,16178/20013
no . of events / total no . nmbr % ),C0441471;C3541888,false;false,16179/20013
no . of events / totol no . ( % ),C0441471;C3541888,false;false,16180/20013
no . of exacerbations in past year,C4086268,false,16181/20013
no . of hospitalised patients,C0030705,true,16182/20013
no . of infusions,C0574032,false,16183/20013
no . of moderate or severe exacerbations in previous,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,16184/20013
no . of pack - yr,C1968515;C0439234;C2825051;C2828395,false;false;false;false,16185/20013
no . of participants,C0679646,false,16186/20013
no . of participants ( % ),C0679646,false,16187/20013
no . of patients with events ( % ),C0030705,true,16188/20013
no . of patients / no . of events ( % ) nmbr / nmbr ( nmbr ) nmbr / nmbr ( nmbr ),C0030705,true,16189/20013
no . of previous biologic dmards — no . ( % ),C0205156;C4055380;C1552607,false;false;false,16190/20013
no . of previous ciu / csu medications,C0205156;C0578870;C0013227;C0802604;C2598133;C4284232;C1552607,false;false;true;false;false;false;false,16191/20013
no . of previous csdmards,C0205156;C1552607,false;false,16192/20013
no . of previous tne inhibitors,C0205156;C3896585;C0243077;C1552607,false;false;true;false,16193/20013
no . of prior aedsd,C0332152;C2826257,false;false,16194/20013
no . of risk factors for venous thromboembolism,C0035648;C1553898,true;false,16195/20013
no . of strokes / no . of patients in category ( and % ),C0038454,true,16196/20013
no . of vessels treated,C0005847,true,16197/20013
no . of vessels with > nmbr % stenosis,C0005847,true,16198/20013
no . patients ( % ),C0030705,true,16199/20013
no . patients with,C0030705,true,16200/20013
no . previous alpha - blocker use,C0205156;C0001641;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,16201/20013
no . previous dmard,C0205156;C0242708;C1552607,false;true;false,16202/20013
no . randomized,C0034656;C3815594,true;false,16203/20013
no . with visit,C0545082;C1512346;C2826704,false;false;false,16204/20013
no . women,C0043210,true,16205/20013
no . / total,C0439175;C0439810,false;false,16206/20013
no . / total no . ( % ),C0439175;C0439810,false;false,16207/20013
no . / total no . ( % ) t,C0439175;C0439810,false;false,16208/20013
no . / total 	 no . ( % ),C0439175;C0439810,false;false,16209/20013
no . a,,,16210/20013
nocad / mi,C3810814,false,16211/20013
nocturia episodes / nmbrh,C0028734;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,true;false;true;false;false;false;false,16212/20013
nocturnal back pain,C1970122,false,16213/20013
nocturnal symptoms in past week,C0240526;C0683368;C2987125;C1457887,false;true;false;false,16214/20013
noirecerving,,,16215/20013
noliecervrig,,,16216/20013
nominal change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,16217/20013
nominal p vs placebo,,,16218/20013
non - / ex - drinker,C0457801,false,16219/20013
non - / ex - tobacco user,C1518422;C3853727,false;false,16220/20013
non - asian,C1518422;C0078988,false;true,16221/20013
non - asian ( n = nmbr nmbr ),C1518422;C0078988,false;true,16222/20013
non - biological systemic,C0445097;C0205373,false;false,16223/20013
non - black participants,C1518422;C0005680;C0679646;C0027567;C0085756;C0439541,false;true;false;true;true;false,16224/20013
non - cabg related bleeding at nmbr h,C1518422;C0010055,false;true,16225/20013
non - cana ( n = nmbr ),C1518422;C1418845,false;false,16226/20013
non - cardiovascular mortality,C1518422;C0007226;C0026565;C0026566;C3887460,false;true;true;true;false,16227/20013
non - carrier ( n = nmbr ),C2986416,false,16228/20013
non - caucasian eze / simva ( n = nmbr ),C1518422;C0007457;C0043157,false;true;true,16229/20013
non - caucasian simva ( n = nmbr ),C1518422;C0007457;C0043157,false;true;true,16230/20013
non - cvd deaths,C1518422;C0007222;C0011065;C1306577,false;true;true;false,16231/20013
non - cvd mortality,C1518422;C0007222;C0026565;C0026566,false;true;true;true,16232/20013
non - diabetic ( n = nmbr ),C1518422;C0241863,false;false,16233/20013
non - diabetic subjects,C1518422;C0241863;C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,16234/20013
non - diabetics ( n = nmbr ),C1518422;C0241863,false;false,16235/20013
non - dihydropyridine ccbs,C1518422;C0012315;C0006684;C0220821,false;true;true;true,16236/20013
non - early crohn ' s disease,C1518422;C1279919;C0010346,false;false;true,16237/20013
non - east asian §,C1518422;C1707877;C0078988,false;false;true,16238/20013
non - east asianf,C1518422;C1707877,false;false,16239/20013
non ‐ elderly,C1518422;C0001792;C1999167,false;true;false,16240/20013
non - fatal ml,C1518422;C1302234;C0439526;C1705224;C3887665;C1705232,false;false;false;false;false;false,16241/20013
non ‐ haemorrhagic stroke — no . ( % ),C1518422;C0333275,false;false,16242/20013
non - hdl - c ( mg / dl ) * *,C1518422;C3715113;C0439269,false;false;false,16243/20013
non ‐ hdl cholesterol,C0729627;C1535899,false;false,16244/20013
non - hdl cholesterol j,C0729627;C1535899,false;false,16245/20013
non - hdlc,C1518422;C1704429,false;true,16246/20013
non - hishnic,C1518422,false,16247/20013
non - hispanic and latino,C1518424,false,16248/20013
non - hispanic black or african - american,C1518424;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,16249/20013
non - hispanic or latino,C1518424,false,16250/20013
non - hispanicwhite,C1518422,false,16251/20013
non - inhaled steroid use,C1518422;C0586793,false;false,16252/20013
non - insulin treated dm,C1518422;C0021641;C1522326;C0011816;C3250443;C1533581;C1579433;C3714501,false;true;false;true;false;false;false;false,16253/20013
non - ischaemic ( n = nmbr ),C1518422;C0475224,false;false,16254/20013
non - ischaemic dilated cardiomyopathy,C1518422;C1960867,false;false,16255/20013
non - ischemic,C1518422;C0475224,false;false,16256/20013
non - lad artery,C1518422;C0003842;C0226004,false;true;false,16257/20013
non - mets,C1518422;C0812270;C1705694;C2939420,false;false;false;false,16258/20013
non - mtx csdmards,C1518422;C0025677;C1417487,false;true;false,16259/20013
non - pci intravenous unfractionated heparin,C1518422;C4049621;C0354566,false;false;false,16260/20013
non - q - wave myocardial infarction,C0542269;C3537181,false;false,16261/20013
non - rheumatic valvular heart disease,C1518422;C0264757,false;false,16262/20013
non - rollover,C1518422;C0517067;C0543436,false;false;false,16263/20013
non - severe hypoglycaemia,C1518422;C0205082;C0020615;C4553659;C4050465;C4050466,false;false;true;false;false;false,16264/20013
non - smokers receiving lipid lowering drugs,C0337672;C4554605,false;true,16265/20013
non - spondylitis,C1518422;C0038012,false;true,16266/20013
non - st - segment elevation,C1518422;C0520886,false;false,16267/20013
non - statin ( n = nmbr ),C1518422;C0360714,false;true,16268/20013
non - steroidal anti - inflammatory drugs,C0003211,true,16269/20013
non - tiotropium,C1518422;C0213771,false;true,16270/20013
non - transient risk factors for recurrent vte,C0439597;C0040704;C0035648;C0630906;C1553898;C0205374,false;true;true;true;false;false,16271/20013
non - trial antiplatelet,C1518422;C0008976,false;true,16272/20013
non - trial p blocker,C1518422;C0008976,false;true,16273/20013
non - trial treatment during hospital stay,C1518422;C0008976;C0039798;C3489408;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;true;false;false;false;false;false,16274/20013
non - united states,C1518422;C0041703,false;true,16275/20013
non - us,C1518422,false,16276/20013
non - user nmbr,C1518422;C1548600;C1706077,false;false;false,16277/20013
non cns embolism,C1518422;C3714787;C0013922;C1704212,false;true;true;true,16278/20013
non stent thrombosis - related mi,C1518422;C3897493,false;false,16279/20013
non usa,C1518422;C0041703,false;true,16280/20013
non white,C1518422;C0007457;C0043157;C0220938,false;true;true;false,16281/20013
nonblack,,,16282/20013
nonblack ( n = nmbr ),,,16283/20013
nonblack ( n = nmbr )  adjusted hazard ratio *,C0456081;C2985465,false;false,16284/20013
nonblack participants,C0679646,false,16285/20013
nonblack race — no . ( % ) f,,,16286/20013
noncardiac death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,16287/20013
noncardiovascular death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,16288/20013
noncompliant,C0457432,false,16289/20013
noncurrent smoker,C0337664,true,16290/20013
nondiabetes,,,16291/20013
nondiabetic participants !,C0679646,false,16292/20013
nondisabling,,,16293/20013
none ( n = nmbr ),C0369718;C0441922,false;false,16294/20013
none at baseline,C0168634;C1442488,true;false,16295/20013
none or diet,,,16296/20013
none or seldom,,,16297/20013
nonfatai myocardiai infarction,C0021308,true,16298/20013
nonfatal,,,16299/20013
nonfatal mi ( n = nmbr ),C3810814,false,16300/20013
nonfatal mi + fatal chdt,C3810814;C1302234;C1705232,false;false;false,16301/20013
nonfatal myocardiail infarction,C0021308,true,16302/20013
nonfatal myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,16303/20013
nonfatal myocardial infarction ®,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,16304/20013
nonfatal stroke ( n = nmbr ),C0038454;C4554100,true;false,16305/20013
nonfatal stroke ®,C0038454;C4554100,true;false,16306/20013
nonglycemic cardiovascular risk factors,C0850624,false,16307/20013
noninducing,,,16308/20013
nonischemic,,,16309/20013
nonischemic cardiomyopathy — no . ( % ),C0878544,true,16310/20013
nonobese ( < nmbr kg / nr ),C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,16311/20013
nonreversible,,,16312/20013
nonsevere hypoglycemia,C0020615;C4553659,true;false,16313/20013
nontraumatic leg or foot amputation,C0023216;C1140621,true;true,16314/20013
nonuser,,,16315/20013
nonvertebral,,,16316/20013
noppi,,,16317/20013
nordic,C0331873,false,16318/20013
nordic countries,C0036273,true,16319/20013
normai fasting giucose levei ( n = nmbr ),,,16320/20013
normal - high renin ( pra > nmbr . nmbr ng / ml / h ) ( n = nmbr ),C0205307;C0855390;C0633231;C1533072;C4050009;C1141951;C1419788;C3274822;C3669212;C4283900;C0231683;C0439166;C2347086;C4553972,false;false;true;false;false;false;false;false;false;false;false;false;false;false,16321/20013
normal ( £ nmbr ml / minute ),C0205307;C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false;false;false;false;false,16322/20013
normal ( < nmbr . nmbr u / ml ),C0205307;C0439340;C1880521;C2945590;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false,16323/20013
normal ( ≤   uln ) n   =   nmbr,C0205307;C1519815;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,16324/20013
normal ( ≥ nmbr ml · min − nmbr · nmbr . nmbr m − nmbr ),C0205307;C0439445;C0369637;C0441923;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false,16325/20013
normal ( > nmbr ml / min ),C0205307;C0439445;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,16326/20013
normal ( > nmbr mlvmin per nmbr . nmbr mnmbr ),C0205307;C0369637;C0441923;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,16327/20013
normal ( bmi < nmbr ),C4229017,false,16328/20013
normal ( egfr ≥ nmbr ),C0205307;C1739039;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,16329/20013
normal acr ( < nmbr mg / mg ) at baseline to albuminuria ( acr > nmbr mg / g ),C0205307;C1412134;C1319635;C0168634;C1442488;C1515941;C0231683;C0439166;C2347086;C4553972,false;false;false;true;false;false;false;false;false;false,16330/20013
normal albuminuria ( uacr < nmbr ),C0205307;C0001925;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false,16331/20013
normal baseline crp,C0205307;C0168634;C3890735;C4048285;C1442488;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false,16332/20013
normal bnp,C0205307;C0054015;C1095989;C1417808;C2982014;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false,16333/20013
normal cognitive,C2712133,false,16334/20013
normal cognitive function ( spmsq < nmbr ) . n - nmbr . nmbr n ( % ) participants with the event of interest,C1276356;C0009240;C0679646;C0441471;C4019010;C0392335;C4050130,false;true;false;false;false;false;false,16335/20013
normal coronary angiography,C0853522,false,16336/20013
normal crp and,C0205307;C3890735;C4048285;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,16337/20013
normal egfr ( nmbr < egfr < nmbr ml / min per nmbr . nmbr mnmbr ) at baseline to high egfr ( > nmbr ml / min per nmbr . nmbr mnmbr ),C0205307;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false;false;false,16338/20013
normal function ( crcl > nmbr ml / min  n = nmbr [nmbr . nmbr % ] ),C4296962;C1846718;C0439445,false;false;false,16339/20013
normal function or mild impairment,C4296962,false,16340/20013
normal hbanmbrc,C0205307;C0019016;C1825777;C3538758;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,16341/20013
normal left ventricular ejection fraction — no . ( % ) j,C1535947;C0205091;C0443246;C1552822;C0205307;C0428772;C0488728;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false;false;false,16342/20013
normal or high egfr ( > nmbr ml / min per nmbr . nmbr mnmbr ) at baseline to low egfr ( < nmbr ml / min per nmbr . nmbr mnmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16343/20013
normal or increased baseline gfr ( > nmbr ml / min / nmbr . nmbr mnmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16344/20013
normal or increased egfr,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16345/20013
normal or increased gfr ( > nmbr ml / mln per nmbr . nmbr m^ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16346/20013
normal or mild ( iief - ef nmbr - nmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16347/20013
normal responder,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16348/20013
normal responder ( n = nmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16349/20013
normal responders ( n = nmbr ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,16350/20013
normal study termination,C0205307;C0557651;C1549081;C1692758;C2603343;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false,16351/20013
normal weight ( bmi < nmbr ),C4229017;C0005910;C0043100;C1305866;C1705104;C2712185;C0578022,false;true;true;false;false;false;false,16352/20013
normalfunction or mild impairment,,,16353/20013
normalized volume measures,C1882115;C0449468;C1690016;C1705102;C2700258,false;false;false;false;false,16354/20013
normalized womac score,C1882115;C0449820;C4050231,false;false;false,16355/20013
normoalbuminuria,,,16356/20013
normoalbuminuria — no . ( % ),,,16357/20013
normoalbuminuria ( uacr < nmbr mg / g ),C1300563,false,16358/20013
normoalbuminuria §,,,16359/20013
normoglycaemic individuals,C0580545;C0027361;C0237401,false;true;false,16360/20013
normoglycemia,C0580545,false,16361/20013
normoglycemic,C0580545,false,16362/20013
normoglycemic^,C0580545,false,16363/20013
normoglycemic {,C0580545,false,16364/20013
normonatremic ( > nmbr meq / l ) at baseline,C0439375;C0168634;C1442488,false;true;false,16365/20013
normotensive ( n = nmbr ),C2712122,false,16366/20013
north,C1709269,false,16367/20013
north america ( n = nmbr ),C0028405,true,16368/20013
north america ( plus america and new zealand ),C0028405;C0332287,true;false,16369/20013
north america *,C0028405,true,16370/20013
north america / oceania,C0028405;C0282279;C4085681,true;true;false,16371/20013
north ameriea,C1709269,false,16372/20013
nosnmbr nmbr c . t,C0326287;C1518425,false;false,16373/20013
nosnmbr nmbr a . g,C0326287;C1518425,false;false,16374/20013
nosnmbr glunmbrasp g . t,C0326287;C0125690;C0439267;C1518425,false;true;false;false,16375/20013
not assessable,C1883425,false,16376/20013
not collected^,C1518422,false,16377/20013
not estimable,C1518422,false,16378/20013
not hispanic,C1518424,false,16379/20013
not hispanic / latino ( n = nmbr,C1518424;C0086528,false;true,16380/20013
not hispanie / latino,C1518422;C0086528,false;true,16381/20013
not on an aha,C1518422;C0050451;C0772110,false;true;false,16382/20013
not on metformin,C1518422;C0025598,false;true,16383/20013
not perfused,C1518422,false,16384/20013
not present at screening,C1518422,false,16385/20013
not receiving,C1518422,false,16386/20013
not severe,C4316743,false,16387/20013
not tested,C1518422,false,16388/20013
notatincreased fall risk ( n - nmbr,C1268740,false,16389/20013
notes :,C1317574,false,16390/20013
nothfref,,,16391/20013
np tercile nmbr ( bnp < nmbr pg / ml,C0065827;C0054015;C0439297;C1095989;C1417808;C2982014;C1706141;C3887659,true;true;false;false;false;false;false;false,16392/20013
np tercile nmbr ( bnp > nmbr pg / ml,C0065827;C0054015;C0439297;C1095989;C1417808;C2982014;C1706141;C3887659,true;true;false;false;false;false;false;false,16393/20013
nph,C0020258;C0027442,true;true,16394/20013
nptercilenmbr ( bnpnmbr - nmbr pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,16395/20013
nsaid   at   least   once,C0003211;C3536840,true;false,16396/20013
nste acs,C0742343;C4318612,true;false,16397/20013
nstemi ( n = nmbr,C3537184;C4255010,false;true,16398/20013
nt - pro - bnp,C0669479;C0754710,true;true,16399/20013
nt - pro - bnp — pmol / literf,C0669479;C0439192;C0754710,true;false;true,16400/20013
nt - probnp — pg / ml,C0669479;C0439297;C0754710,true;false;true,16401/20013
nt - probnp values were reported in nmbr of nmbr patients enrolled in this stratum,C0669479;C0042295;C0754710,true;false;true,16402/20013
nt - probnpnmbr pmol - l - nmbr,C0669479;C0439284;C0754710,true;false;true,16403/20013
nt estimated,C0332126;C1449832;C3889152;C4050156;C4283901;C4284038,false;true;false;false;false;false,16404/20013
nt probnp > nmbr ng / ml n ( % ) §,C4284038;C1317554;C0439275;C2825907,false;false;false;false,16405/20013
ntbnp ( n = nmbr ),,,16406/20013
nteraction p value,C1709380,false,16407/20013
nternational index of,C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,16408/20013
ntprobnp ( pg / ml ),C0669479;C0439297;C0754710,true;false;true,16409/20013
numab,,,16410/20013
number ( % ) of patients,C2360800,false,16411/20013
number and % of participants with events,C0237753;C0449788,false;false,16412/20013
number of “ off ” periods,C0237753;C0449788,false;false,16413/20013
number of agents,C0237753;C0450442;C1254351;C1521826;C0449788,false;false;false;false;false,16414/20013
number of antihypertensive agent reported,C0237753;C0003364;C0449788,false;true;false,16415/20013
number of antihypertensive medications at study entry,C1718138;C0003364,false;true,16416/20013
number of antihypertensive medications used,C1718138;C0003364,false;true,16417/20013
number of antihypertensive medications,C1718138;C0003364,false;true,16418/20013
number of arterial beds involved,C0237753;C0003842;C0004916;C0221464;C0449788,false;true;true;false;false,16419/20013
number of clinically significant asthma exacerbations in last year prior to baseline,C0237753;C0237881;C0349790;C0750502;C1546944;C0449788,false;false;false;false;false;false,16420/20013
number of co - aeds,C0237753;C3245499;C0180309;C0449788,false;true;true;false,16421/20013
number of concomitant aedsc,C0237753;C0521115;C0449788,false;false;false,16422/20013
number of copd exacerbations within nmbr months,C0237753;C0740304;C0449788,false;false;false,16423/20013
number of diseased vessels,C0237753;C0005847;C0449788,false;true;false,16424/20013
number of draining fistulae per patient,C0237753;C0544791;C0449788,false;false;false,16425/20013
number of er visits in last year prior to baseline,C0237753;C3810541;C3811131;C0449788,false;false;false;false,16426/20013
number of events,C4330837,false,16427/20013
number of events ( annualised rate [ % ] ),C4330837,false,16428/20013
number of exacerbations in previous nmbr months,C0237753;C4086268;C0449788,false;false;false,16429/20013
number of exacerbations in previous nmbr   months,C0237753;C4086268;C0449788,false;false;false,16430/20013
number of exacerbations in previous year,C0237753;C4086268;C0449788,false;false;false,16431/20013
number of exacerbations in the nmbr months before screening,C0237753;C4086268;C0449788,false;false;false,16432/20013
number of exacerbations in the last nmbr months,C0237753;C4086268;C0449788,false;false;false,16433/20013
number of hospitalizations in last year prior to baseline,C4086639,false,16434/20013
number of implanted stents,C0237753;C0522776;C0449788,false;false;false,16435/20013
number of lesions,C0449791,false,16436/20013
number of medications,C1718138,false,16437/20013
number of pack years,C0237753;C1277691;C0449788,false;false;false,16438/20013
number of participants with an event,C0237753;C0679646;C0449788,false;false;false,16439/20013
number of patients ( % ) or mean ± sd,C2360800,false,16440/20013
number of patients randomized,C2360800,false,16441/20013
number of patients with available data,C2360800,false,16442/20013
number of patients with dose available,C2360800,false,16443/20013
number of patients with events,C2360800,false,16444/20013
number of patients with exacerbations in the previous nmbr months,C2360800,false,16445/20013
number of people ( n ),C0237753;C0027361;C0449788,false;true;false,16446/20013
number of prevalent vertebral fractures,C0237753;C0033105;C0080179;C0220900;C0449788,false;true;true;true;false,16447/20013
number of previous anti - tnf treatments for psa,C0237753;C0205156;C1448177;C0087111;C1552607;C0449788,false;false;true;true;false;false,16448/20013
number of previous reported aeds,C0237753;C0205156;C0684224;C0180309;C0700287;C4319718;C1552607;C0449788,false;false;true;true;false;false;false;false,16449/20013
number of previous tnfa inhibitors,C0237753;C0205156;C1448177;C0243077;C1710304;C1552607;C0449788,false;false;true;true;false;false;false,16450/20013
number of subjects in analysis,C0237753;C0681850;C1550501;C1706203;C2349001;C2697811;C0449788,false;false;false;false;false;false;false,16451/20013
number of swollen joints ( nmbr - nmbr ),C0449813;C0038999,false;false,16452/20013
number of swollen joints ( nmbr assessed ),C0449813;C0038999,false;false,16453/20013
number of target vessels,C0237753;C0449618;C0449788,false;false;false,16454/20013
number of tender joints ( nmbr - nmbr ),C0449813;C0234234,false;false,16455/20013
number of tender joints ( nmbr assessed ),C0449813;C0234234,false;false,16456/20013
number of treated lesions ( per patient ),C0449791;C1522326,false;false,16457/20013
number of treated patients,C2360800;C1522326,false;false,16458/20013
number of visits,C1549755,false,16459/20013
number ol ( % ) patients > nmbr years,C0237753;C0030705;C0439234;C0449788,false;true;false;false,16460/20013
number randomized,C0237753;C0449788,false;false,16461/20013
numbera,,,16462/20013
numbers of events ( % ) :,C4330837,false,16463/20013
nutraceuticals,C1518478,true,16464/20013
nvf at flex baseline - nmbr < flex fn t - score,C0168634;C1570610;C0449820;C4050231;C1442488,true;true;false;false;false,16465/20013
nx *,C0445085,false,16466/20013
nyha,C1275491,false,16467/20013
nyha chf class,C1882083;C0018802,false;true,16468/20013
nyha class ( when patient was last in stable condition,C1882083,false,16469/20013
nyha class ii ( n = nmbr ),C1882085,false,16470/20013
nyha class iii or iv,C1882086,false,16471/20013
nyha class iii / iv,C0278962,false,16472/20013
nyha classes iii - iv,C0278962,false,16473/20013
nyha functional class ( % ),C1882083;C0205245;C0542341;C2700217,false;false;false;false,16474/20013
nyha functional class nmbr,C1882083;C0205245;C0542341;C2700217,false;false;false;false,16475/20013
nyha functional class at randomization,C1882083;C0205245;C0034656;C0542341;C2700217,false;false;true;false;false,16476/20013
nyha functional class i,C1882084;C0205245;C0542341;C2700217,false;false;false;false,16477/20013
nyha functional class iii,C1882086;C0205245;C0542341;C2700217,false;false;false;false,16478/20013
nyha functional class iii ( % ),C1882086;C0205245;C0542341;C2700217,false;false;false;false,16479/20013
nyha functional classification — no . ( % ),C1275491;C0205245;C0542341;C2700217,false;false;false;false,16480/20013
nyha functional classification — no . ( % ) i,C1275491;C0205245;C0542341;C2700217,false;false;false;false,16481/20013
nyha iii or iv § ( n = nmbr nmbr ),C1275491;C0439070;C1705160,false;false;false,16482/20013
nyha ll / lll patients with lvef < nmbr . nmbr at baseline,C1275491,false,16483/20013
nyha_class,C1882083,false,16484/20013
o,C0483204,false,16485/20013
o - oinmbr ( - nmbr - nmbr to nmbr - nmbr ),C0483204;C0029118;C0029434,false;true;true,16486/20013
o - oonmbr ( - nmbr - nmbr to nmbr - nmbr ),C0483204,false,16487/20013
onmbro ( oonmbr - o - nmbro ),C0483204,false,16488/20013
onmbr kg,C0483204;C0022718;C0439209;C4054209,false;true;false;false,16489/20013
oab - q score,C3641332;C0449820;C4050231,false;false;false,16490/20013
oab therapy,C0039798;C0087111;C1363945,true;true;false,16491/20013
oac experienced,,,16492/20013
oad at screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,16493/20013
oad history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,16494/20013
oad use,C0042153;C0457083;C1947944,true;false;false,16495/20013
oam,,,16496/20013
oam use [n ( % ) ],C0042153;C0457083;C1947944,true;false;false,16497/20013
oascvd,,,16498/20013
oat,C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,16499/20013
oat ( n   =   nmbr ),C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,16500/20013
obese ( > nmbr kg / m^nmbr ),C0028754;C1532718,true;false,16501/20013
obese ( > nmbr kg / mnmbr ) b,C0028754;C1532718,true;false,16502/20013
obese ( bmi £ nmbr ),C0028754;C0578022,true;false,16503/20013
obese ( bmi > nmbrkg / mnmbr ),C0028754;C0578022;C1532718,true;false;false,16504/20013
obesity ( bmi £ nmbr kg / mnmbr ),C0028754;C0578022;C1532718;C1963185,true;false;false;false,16505/20013
obesity *,C0028754;C1963185,true;false,16506/20013
obesity * ( bmnmbr > nmbr kg / mnmbr ),C0028754;C0006416;C1532718;C1963185,true;true;false;false,16507/20013
observation,C0302523;C0700325;C1964257;C3889687,true;true;false;false,16508/20013
observed,C1441672,false,16509/20013
observed case,C1441672;C0868928;C1706255;C1706256,false;false;false;false,16510/20013
obstructive subscore,C0549186,false,16511/20013
ocn,C1412791;C2347392,false;false,16512/20013
ocs at baseline,C0168634;C1442488,true;false,16513/20013
ocs dose *,C0178602;C0869039;C1114758,false;false;false,16514/20013
ocs maintained / increased,,,16515/20013
ocs reduced / stopped,,,16516/20013
ocs use,,,16517/20013
oct center point thickness,C3828732;C0205099;C1552961;C1280412;C2347617;C3714763;C3810851,false;false;false;false;false;false;false,16518/20013
octi,,,16519/20013
octi & matenmbr,C0682323;C1260875,false;false,16520/20013
odds ‐ ratio ( nmbr % ci ),C0028873;C0008107;C3259781,true;true;false,16521/20013
odds ratio and nmbr % cl,C0028873,true,16522/20013
odds ratios ( nmbr % ci ),C0028873;C0008107;C3259781,true;true;false,16523/20013
of patients meeting criterion / total no . of patients,C0030705,true,16524/20013
of tnmbrdm ( years ),C2603360;C0011816;C0439234;C3250443,false;true;false;false,16525/20013
of variation ),C0205419,false,16526/20013
off - pump,C1518543;C0182537,false;false,16527/20013
ohs graduate,C0268353;C1861455,true;true,16528/20013
oil,C0028908;C0032085;C1517288;C3541397,true;true;false;false,16529/20013
ol / l ),,,16530/20013
olaemia,,,16531/20013
older subjects ( aged > nmbr years ',C0580836,false,16532/20013
olmesartan along with ccb ( n - nmbr ),C1098320;C0006684,true;true,16533/20013
olmesartan along with diuretic ( n - nmbr ),C1098320;C0012798,true;true,16534/20013
olmesartan medoxomil nmbr mg ( n = nmbr ),C0386393;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16535/20013
olmesartan medoxomil nmbrmg / hctznmbr . nmbrmg ( n = nmbr ),C0386393;C1319635;C0020261,true;false;true,16536/20013
olodaterol,C2934193,true,16537/20013
olodaterol nmbr nmbr | ig tiotropium n = nmbr non - tiotropium n = nmbr,C4032878;C0021027;C1518422;C0305052;C0360506,true;true;false;false;false,16538/20013
olodaterol nmbr gg ( n = nmbr ),C2934193;C0017454;C0018370,true;true;true,16539/20013
olodaterol nmbr jig,C2934193,true,16540/20013
olodaterol nmbr | ig tiotropium n = nmbr non - tiotropium n = nmbr,C4032878;C0021027;C1518422;C0305052;C0360506,true;true;false;false;false,16541/20013
olodaterol nmbrpg,C2934193;C0030827;C0072225;C1266240,true;true;true;false,16542/20013
olodaterol sgg,C2934193,true,16543/20013
om nmbr mg + aml nmbr mg + hctz nmbr mg,C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,16544/20013
om nmbr mg + aml nmbr mg + hctz nmbr mg ( n = nmbr ),C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,16545/20013
om nmbr mg / aml nmbr mg ( n = nmbr ),C0028971;C1319635;C0023465;C0023467;C1705272,true;false;true;true;false,16546/20013
om nmbr mg / hctz nmbr mg ( n = nmbr ),C0028971;C1319635;C0020261;C1705272,true;false;true;false,16547/20013
om nmbr / aml nmbr / hctz nmbr . nmbr mg,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,16548/20013
om nmbr / aml nmbr / hctz nmbr mg,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,16549/20013
om nmbr / aml nmbr / hctz nmbr . nmbr mg *,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,16550/20013
oma / oat,C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,16551/20013
oma / oat ( n   =   nmbr ),C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,16552/20013
omalizumab,C0966225,true,16553/20013
omalizumab nmbr mg ( n [ nmbr ),C0966225;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16554/20013
omega - nmbr fa ( n = nmbr ),C1719844,false,16555/20013
omega - nmbr fatty acids,C1719844;C0015684,false;true,16556/20013
omeract - oarsi response,C0871261;C1704632;C1706817;C2911692,false;false;false;false,16557/20013
on - pump,C3842462,false,16558/20013
on antihypertensive medication at baseline,C0003364;C0168634;C1442488,true;true;false,16559/20013
on antihypertensive treatment,C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,16560/20013
on aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,16561/20013
on bp medication,C0037623;C0013227;C3244316;C4284232;C1415692;C1708288;C4318478,true;true;false;false;false;false;false,16562/20013
on maximum tolerated medications ( % ) median ( nmbrth to nmbrth quartile ) sua ( mg / dl ),C0806909;C0013227;C0549183;C0039725;C2828255;C0439269;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193;C0802604;C2598133;C4284232;C1552615;C2826546,false;true;false;true;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,16563/20013
on metformin ir or metformin xr nmbr   mg / d,C0025598;C0022065;C0022071;C1448132,true;true;true;true,16564/20013
on non ‐ metformin aha,C1518422;C0025598;C0050451;C0772110,false;true;true;false,16565/20013
on oac at time of randomisation,C0040223;C0034656;C3541383,true;true;false,16566/20013
on or after e^andomization,,,16567/20013
on statins at baseline,C0360714;C0168634;C1442488,true;true;false,16568/20013
on step - nmbr drug,C1261552;C0013227;C1254351;C1704379;C1705117;C2825408;C3814463,false;true;false;false;false;false;false,16569/20013
on steroid at baseline,C0038317;C0168634;C1442488,true;true;false,16570/20013
one antihypertensive medication,C0205447;C0003364,false;true,16571/20013
one at baseline,C0205447;C0168634;C1442488,false;true;false,16572/20013
one lesion,C0205447;C0221198;C1546698,false;false;false,16573/20013
one or more exacerbations,C0205447,false,16574/20013
one or more medications,C0205447,false,16575/20013
ongoing atopic or allergic condition — no . { % ),C0549178;C0392707,false;false,16576/20013
onset nmbr [nmbr],C0206132;C0332162,true;false,16577/20013
ontario and mcmaster universities osteoarthritis index ( womac ) can range from nmbr to nmbr for the pain subscale,C0029040,true,16578/20013
op concomitant medications ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,16579/20013
op,,,16580/20013
opaqb physical function score,C4483112;C0031843;C0542341;C0700205;C1705273;C0516981;C0449820;C4050231;C4049916,false;true;false;false;false;false;false;false;false,16581/20013
open - label phase ( baseline = week nmbr ),C1709323;C0205390;C0168634;C0332174;C0439230;C1442488;C1710475,false;false;true;false;false;false;false,16582/20013
open - label population,C1709323;C0032659;C1257890,false;true;true,16583/20013
operative procedure,C0543467;C0677612,true;false,16584/20013
ophthalmologic events,C0029087;C0441471;C3541888;C0205481,true;false;false;false,16585/20013
option,C1518601;C1550456,false;false,16586/20013
or,,,16587/20013
or ( nmbr % ci ) a,,,16588/20013
or ( nmbr % cl ) = nmbr nmbr ( nmbr . nmbr,,,16589/20013
or ( nmbr % cl ) = nmbr . nmbr ( nmbr nmbr . nmbr . nmbr ),,,16590/20013
or ( nmbr % cl ) = nmbr . nmbr ( nmbr . nmbr . nmbr . nmbr ),,,16591/20013
or ( nmbr % cl ) = nmbr nmbr ( nmbr . nmbr . nmbr nmbr ),,,16592/20013
or ( itt ) ( n = nmbr ),,,16593/20013
or [nmbr % cl],,,16594/20013
or death,,,16595/20013
or esrd,,,16596/20013
or for cana vs pbo ( nmbr % ci ) | |,C1418845,false,16597/20013
or for cana vs pbo ( nmbr % ci ) §,C1418845,false,16598/20013
or morbidity and mortality,,,16599/20013
or no microalbuminuria or macroalbuminuria,,,16600/20013
or per unit for continuous variables,C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603,false;false;false;false;false;false;false,16601/20013
or primary outcome,,,16602/20013
or raloxifene,,,16603/20013
or severe,,,16604/20013
or taking antihypertensive medication,,,16605/20013
or ulcerations,,,16606/20013
or : nmbr . nmbr ( nmbr . nmbr  nmbr . nmbr )  p = nmbr . nmbr,,,16607/20013
or 、 ( nmbr % ci ),,,16608/20013
or = nmbr . nmbr ( nmbr . nmbr – nmbr . nmbr ) < nmbr . nmbr,,,16609/20013
or = nmbr . nmbr ( nmbr . nmbr – nmbr . nmbr ) nmbr . nmbr,,,16610/20013
oradj ( nmbr % ci ),C0008107;C3259781,true;false,16611/20013
oral ( % ),C0442027;C4521986,false;false,16612/20013
oral agent,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,16613/20013
oral agent and / or insulin therapy,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,16614/20013
oral anti - dm drug status,C0029167;C0011816;C0449438;C3250443;C0175795;C0304289,true;true;false;false;false;false,16615/20013
oral anticoagulant n ( % ),C0354604,false,16616/20013
oral antihyperglycaemic,C0359086,false,16617/20013
oral corticosteroid dose ( mg / day ),C0442027;C0001617;C0178602;C0439422;C0869039;C1114758;C3536709;C4521986,false;true;false;false;false;false;false;false,16618/20013
oral corticosteroid use at baseline,C1527415;C0001617;C0168634;C1442488;C3536709;C0442027;C0239126;C4521986,false;true;true;false;false;false;false;false,16619/20013
oral corticosteroid use at enrolmentt,C1527415;C0001617;C3536709;C0442027;C0239126;C4521986,false;true;false;false;false;false,16620/20013
oral corticosteroid use,C1527415;C0001617;C3536709;C0442027;C0239126;C4521986,false;true;false;false;false;false,16621/20013
oral diabetic agent,C0442027;C0241863;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false;false,16622/20013
oral fi - blockers,C0442027;C4050619;C4521986,false;false;false,16623/20013
oral glucocorticoid dose,C0442027;C0017710;C0178602;C0869039;C1114758;C4521986,false;true;false;false;false;false,16624/20013
oral glucocorticoid use,C1527415;C0017710,false;true,16625/20013
oral hypoglycemic agents,C0359086,false,16626/20013
oral hypoglycemic agentsj,C0359086,false,16627/20013
oral hypoglycemics hormone replacement,C0359086;C0282402,false;true,16628/20013
oral or other systemic corticosteroid,C0442027;C4521986,false;false,16629/20013
oral β - adrenergics,C0442027;C0001637;C4521986,false;true;false,16630/20013
oralb,,,16631/20013
organic,C0747055,false,16632/20013
origin [n ( % ) ],C0079946;C0439659;C1550512,false;false;false,16633/20013
original dabigatran protocol,C0205313;C2348066;C0442711;C1507394;C1522729;C2348563;C2599718;C3715209;C4282383;C2347409,false;true;false;false;false;false;true;false;false;false,16634/20013
oropharyngeal pain,C2363731;C4554669,false;false,16635/20013
ors ( nmbr % cis ) :,C0069590;C1963718,true;false,16636/20013
orthostatic test *,C0231472;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,true;false;false;false;false;false;false;false,16637/20013
os domain,C0229090;C1880389;C1883221;C3541951;C0230028;C0262950;C0393706;C1561953,false;false;false;false;false;true;false;false,16638/20013
osmotic diuresis - related aes,C0232823;C0439849;C1412268;C2699274;C0445223,false;false;false;false;false,16639/20013
osteoporosis drug,C0029456;C0013227;C1254351;C4554622,true;true;false;false,16640/20013
osteoprotegerin decreased,C0538161;C1308614;C1336645,true;true;false,16641/20013
other ' i ',C0021966;C0221138,true;false,16642/20013
other ( % ) diabetes ( interaction : p = nmbr . nmbr ),C0011847;C1704675;C0011849,false;false;true,16643/20013
other ( n   = nmbr ),C0369718;C0441922,false;false,16644/20013
other ( n = nmbr,C0369718;C0441922,false;false,16645/20013
other { n = nmbr ),C0369718;C0441922,false;false,16646/20013
other anti - hypertensive,C0003364,true,16647/20013
other antihypertensive drug,C0003364,true,16648/20013
other antihypertensive medications,C0003364,true,16649/20013
other antithrombotic medication for index event — no . ( % ),C0013227;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C3244316;C4284232,true;true;false;false;true;false;false;false;false;false,16650/20013
other ascvd,C3665365,false,16651/20013
other atherosclerotic,C0333482,false,16652/20013
other atherosclerotic cvd,C0333482;C0007222,false;true,16653/20013
other atherosclerotic cvd st depression on,C0333482;C0007222;C0520887,false;true;false,16654/20013
other atherosclerotic cvd * *,C0333482;C0007222,false;true,16655/20013
other atherosclerotic cvdd,C0333482;C1859330,false;true,16656/20013
other blood glucose - lowering agents,C0005802;C0441994;C0450442;C1254351;C1521826;C2003888,true;false;false;false;false;false,16657/20013
other blood pressure - lowering drugs,C0003364,true,16658/20013
other bp drug,C0037623;C0013227;C1254351;C1415692;C1708288;C4318478,true;true;false;false;false;false,16659/20013
other bph - luts therapy,C0005001;C0574785;C0039798;C0087111;C1363945;C1704272,true;true;true;true;false;true,16660/20013
other climate subset,C0008946;C1515021,true;false,16661/20013
other clinical characteristics,C0683325,false,16662/20013
other combination,C0205195;C1947911;C3811910,false;false;false,16663/20013
other diagnostic procedure *,C0430022;C1546908,false;false,16664/20013
other diuretic,C0012798,true,16665/20013
other dmards,C0242708,true,16666/20013
other drug therapy,C0013216;C0013217,true;true,16667/20013
other end points,C2349179,false,16668/20013
other glucose - lowering drugs,C0017725;C0441994;C0013227;C3687832;C2003888,true;false;true;false;false,16669/20013
other glucose status,C0017725;C0449438,true;false,16670/20013
other hypoglycemic agent,C0020616,true,16671/20013
other ics,C0815320;C4551720,false;true,16672/20013
other ics versus no ics,C0815320;C4551720,false;true,16673/20013
other individual and exploratory end points,C0027361;C0237401,true;false,16674/20013
other lipid - lowering medication,C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,16675/20013
other lipid lowering drugs,C0086440,true,16676/20013
other medical history,C0262926;C1704706,false;false,16677/20013
other medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,16678/20013
other medications at enrollment,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,16679/20013
other n ( % ),C0369718;C0441922,false;false,16680/20013
other osteoporosis medication,C0029456;C0013227;C3244316;C4284232;C4554622,true;true;false;false;false,16681/20013
other outcomes,C1274040,false,16682/20013
other pacific islander,C0242191,true,16683/20013
other plain vitamin preparations,C0042890,true,16684/20013
other prespecified end points,C2349179,false,16685/20013
other race,C0034510;C1706779;C3853635,true;false;false,16686/20013
other selected aes,C1707391;C1412268;C2699274,false;false;false,16687/20013
other stent,C0038257,true,16688/20013
other steroids,C0038317,true,16689/20013
other treatment assignment,C0039798;C1516050;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,16690/20013
other uc - related gi surgical procedure,,,16691/20013
other vascular disease ( cvd or pad ),C0042373;C0007222,true;true,16692/20013
other vasodilators §,C0042402,true,16693/20013
other * ( n = nmbr ),C0369718;C0441922,false;false,16694/20013
other * ’,,,16695/20013
other / mixed ( n = nmbr ),C0205430;C3160715,false;false,16696/20013
other / multiple,C0439064,false,16697/20013
other : :,,,16698/20013
other^,,,16699/20013
other ® region — no . ( % ),C0017446;C0205147,true;false,16700/20013
other †,,,16701/20013
othera,,,16702/20013
otherc,,,16703/20013
otherd,,,16704/20013
otherf,,,16705/20013
otherj^ :,,,16706/20013
othert,,,16707/20013
othery ethnicity,C0015031;C0243103,true;true,16708/20013
outcome - variant,C1274040;C0205419,false;false,16709/20013
outcome ( n,C1274040,false,16710/20013
outcome according to no . of risk factors for vte,C1274040;C0680240;C0035648;C1553898,false;false;true;false,16711/20013
outcome according to primary cancer site — no . / total no . ( % ),C1274040;C0680240;C0872338,false;false;false,16712/20013
outcome according to renal function level ( in ml / min ),C1274040;C0680240;C0232804;C0441889;C0456079;C1547707;C2946261;C0022646;C0935587,false;false;false;false;false;false;false;true;false,16713/20013
outcome according to stage of cancer — no . / total no . ( % ),C1274040;C0680240;C0027646,false;false;true,16714/20013
outcome and metabolizer phenotype,C1274040,false,16715/20013
outcome measure,C0086749,true,16716/20013
outcome severity,C1274040;C0439793;C0522510,false;false;false,16717/20013
outcome type,C1274040;C0332307;C1547052,false;false;false,16718/20013
outcome_subgroup,C1274040;C1079230;C1515021,false;false;false,16719/20013
outcomes,C1274040,false,16720/20013
outcomes by treatment ( spironolactone vs placebo ),C0085415;C0037982,true;true,16721/20013
outcomes during accord,C1274040;C0680240,false;false,16722/20013
ovary,C0029939;C0227898,true;false,16723/20013
over past nmbr years,C4086728,false,16724/20013
overaii,,,16725/20013
overaii ( n = nmbr ),,,16726/20013
overal event rate,C0441471;C0871208;C1521828;C4019010,false;false;false;false,16727/20013
overall ( nmbr,C0282416;C1561607,true;false,16728/20013
overall ( itt ) ( n = nmbr ),C0282416;C1561607,true;false,16729/20013
overall ( per protocol ) ( n = nmbr ),C0282416;C1698058;C1561607,true;false;false,16730/20013
overall ( pp ) ( n = nmbr ),C0282416;C0030375;C0063017;C4319755;C1561607,true;true;true;false;false,16731/20013
overall ( w = nmbr ),C0282416;C1561607,true;false,16732/20013
overall analysis,C0282416;C0002778;C0936012;C1524024;C1561607,true;false;false;true;false,16733/20013
overall cohort ( post hoc analysis excluding metformin users ),C0282416;C0086027;C0687676;C0332196;C0025598;C1706077;C2828389;C1704687;C3469826;C1561607,true;true;false;false;true;false;false;false;false;false,16734/20013
overall cohort ( primary analysis ),C0282416;C0086027;C0205225;C0439612;C0439631;C1561607,true;true;false;false;false;false,16735/20013
overall ctd,C0282416;C1335071;C1442905;C1561607,true;false;false;false,16736/20013
overall dlqi score,C0282416;C3899393;C1561607,true;false;false,16737/20013
overall dlqi scorenmbr,C0282416;C3899393;C1561607,true;false;false,16738/20013
overall early - morning copd symptom severity scorec,C0282416;C1279919;C0332170;C0024117;C1319166;C1412502;C3714496;C1561607,true;false;false;true;false;false;false;false,16739/20013
overall efficacy,C0282416;C1280519;C1707887;C1561607,true;false;false;false,16740/20013
overall freedom population ( n = nmbr ),C0282416;C0016694;C0032659;C1257890;C1561607,true;true;true;true;false,16741/20013
overall mortality,C0282416;C0026565;C0026566;C1561607,true;true;true;false,16742/20013
overall n ( n / loopy ),C0282416;C1561607,true;false,16743/20013
overall night - time copd symptom severity scorec,C0282416;C0240526;C0024117;C1319166;C1412502;C3714496;C1561607,true;false;true;false;false;false;false,16744/20013
overall pea population,C0282416;C0030738;C0032659;C1257890;C0069964;C0070939;C1262903;C3257529;C1561607,true;true;true;true;true;true;true;false;false,16745/20013
overall population ( n - nmbr ),C0282416;C0032659;C1257890;C1561607,true;true;true;false,16746/20013
overall population ( n = nmbr nmbr ) : non - cana ( n = nmbr )  cana nmbr mg ( n = nmbr )  cana nmbr mg ( n = nmbr ),C0282416;C0032659;C1518422;C1418845;C1319635;C1257890;C1561607,true;true;false;false;false;true;false,16747/20013
overall population ( n = nmbr ),C0282416;C0032659;C1257890;C1561607,true;true;true;false,16748/20013
overall study period,C0282416;C1561607,true;false,16749/20013
overall study population,C0282416;C2348561;C1561607,true;false;false,16750/20013
overall treatment effect,C0282416;C1518681;C1561607,true;false;false,16751/20013
overall vero population,C0282416;C0032659;C1257890;C1561607,true;true;true;false,16752/20013
overall  qvainmbr - sfc,C0282416;C4521536;C1561607,true;false;false,16753/20013
overall ® nmbr . nmbr,C0282416;C1561607,true;false,16754/20013
overally,,,16755/20013
overweight,C0497406,true,16756/20013
overweight ( bmi £ nmbr to < nmbr ),C0497406;C0578022,true;false,16757/20013
overweight ( bmi = nmbr - nmbr . nmbr ),C0497406;C0578022,true;false,16758/20013
oxypurinol ( n = nmbr ),C0030086,true,16759/20013
p ' value,C1709380,false,16760/20013
p - blocker intake at randomisation ( n = nmbr ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,16761/20013
p - blocker use,C0369773;C0042153;C0457083;C1947944;C2603361,false;true;false;false;false,16762/20013
p - blockers ( % ),C0369773;C2603361,false;false,16763/20013
p - blocking agents,C0369773;C0233660;C0450442;C1254351;C1521826;C0332206;C2603361,false;false;false;false;false;false;false,16764/20013
p - for interaetion,C0369773;C2603361,false;false,16765/20013
p - gp inhibitor,C3898062,false,16766/20013
p - gp use,C0369773;C1705010;C0042153;C0457083;C1947944;C3811116;C2603361,false;false;true;false;false;false;false,16767/20013
p - heterogeneity,C0369773;C0019409;C0242960;C2603361,false;false;true;false,16768/20013
p - int .,C0369773;C3272375;C2603361,false;false;false,16769/20013
p - inte faction,C0369773;C2603361,false;false,16770/20013
p - inter,C0369773;C2603361,false;false,16771/20013
p - sitosterol / lathosterol,C0369773;C0037215;C0064673;C0220914;C2603361,false;true;true;true;false,16772/20013
p - sitosterol / total c ( | imol / mmol ),C0369773;C0037215;C0439175;C0439190;C0439810;C0220914;C2603361,false;true;false;false;false;true;false,16773/20013
p ‐ value,C1709380,false,16774/20013
p - value ( ■ nt ),C1709380;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038,false;false;true;false;false;false;false,16775/20013
p - value ( ancova treatment difference ) a,C1709380;C0814908;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;false;true;false;false;true;false;false;false;false;false,16776/20013
p - value ( interaction ) ≠,C1709380;C1704675,false;false,16777/20013
p - value ( overall ),C1709380;C0282416;C1561607,false;true;false,16778/20013
p - value ( trend ),C1709380;C1521798;C4554533,false;false;false,16779/20013
p - value ( vs placebo ),C1709380,false,16780/20013
p - value d nmbr mg vs . warfarin,C1709380;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,16781/20013
p - value for,C1709380,false,16782/20013
p - value for east asian versus non - east asian *,C1709380;C1707877;C0078988,false;false;true,16783/20013
p - value for interactionnmbr :,C1709380;C1704675,false;false,16784/20013
p - value for trend across categories,C1709380;C1521798;C4554533,false;false;false,16785/20013
p - value low vs . high nfs^,C1709380,false,16786/20013
p - value n / n ( % ),C1709380,false,16787/20013
p - value vs . placebo,C1709380,false,16788/20013
p ‐ value *,C1709380,false,16789/20013
p - value },C1709380,false,16790/20013
p - value ‘ ’,C1709380,false,16791/20013
p - value ¶,C1709380,false,16792/20013
p - valuenmbr,C1709380,false,16793/20013
p - valueb,C0369773;C2603361,false;false,16794/20013
p ( nmbr % cl ),C0369773;C0596019;C2603361,false;false;false,16795/20013
p ( inter - action ),C0369773;C0205103;C0441472;C3266814;C1548610;C2603361,false;false;false;false;false;false,16796/20013
p ( women vs men ),C0369773;C0043210;C2603361,false;true;false,16797/20013
p . b * int,C1539794;C3272375,false;false,16798/20013
p . b “ int,C1539794;C3272375,false;false,16799/20013
p nmbr interaction women vs men,C0369773;C1704675;C0043210;C2603361,false;false;true;false,16800/20013
p between age groups,C0369773;C0027362;C2603361;C0001779;C0441849;C1959644,false;true;false;false;false;false,16801/20013
p blocker before admission,C0369773;C0184666;C0809949;C2603361,false;false;false;false,16802/20013
p blocker *,C0369773;C2603361,false;false,16803/20013
p blockersubgroup,C0369773;C2603361,false;false,16804/20013
p for inter - act,C0369773;C2603361,false;false,16805/20013
p for interaction between rhtn and no rhtn and treatmenta,C0369773;C1704675;C2603361,false;false;false,16806/20013
p for trend,C0369773;C1521798;C4554533;C2603361,false;false;false;false,16807/20013
p for trend -,C0369773;C1521798;C4554533;C2603361,false;false;false;false,16808/20013
p int . f,C0369773;C3272375;C0016327;C2603361,false;false;true;false,16809/20013
p inter,C0369773;C2603361,false;false,16810/20013
p interaction = nmbr . nmbr,C0369773;C1704675;C2603361,false;false;false,16811/20013
p j nmbr * trend,C1518835;C1521798;C4554533,false;false;false,16812/20013
p vaiue,C0369773;C2603361,false;false,16813/20013
p vaiue ( interaction ),C0369773;C1704675;C2603361,false;false;false,16814/20013
p value ( inter ),C1709380,false,16815/20013
p value ( interaction ),C1709380;C1704675,false;false,16816/20013
p value ( nominal ),C1709380,false,16817/20013
p value ( vs . previous time point ),C1709380,false,16818/20013
p value between groups,C1709380;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1522609;C0441849,false;false;false;true;false;false;false;false;false;false,16819/20013
p value by gt,C1709380;C1435727;C1704693;C2697657,false;true;false;false,16820/20013
p value f,C1709380;C0016327,false;true,16821/20013
p value for,C1709380,false,16822/20013
p value for dm vs . no dm,C4086240,false,16823/20013
p value for heterogeneity （ rosiglitazone versus glyburide ）,C1709380;C0019409;C0289313;C0242960,false;false;true;true,16824/20013
p value for heterogeneity （ rosiglitazone versus metformin ）,C1709380;C0019409;C0289313;C0242960,false;false;true;true,16825/20013
p value for interaction - dosage with dabigatran,C1709380;C1704675;C0178602;C2986497,false;false;false;false,16826/20013
p value for interaction ( age continuous ),C1709380;C1704675;C0001779,false;false;false,16827/20013
p value for interaction ( age groups ) *,C1709380;C1704675;C0027362,false;false;true,16828/20013
p value for interaction by region,C1709380;C1704675,false;false,16829/20013
p value for interaction ®,C1709380;C1704675,false;false,16830/20013
p value for interaction ® vertebral fracture at flex baseline :,C1709380;C1704675;C0080179,false;false;true,16831/20013
p value for trend *,C1709380;C1521798;C4554533,false;false;false,16832/20013
p value heart failure vs no heart failure,C1709380;C0018801;C0018802;C4554158,false;true;true;false,16833/20013
p value interaction,C1709380;C1704675,false;false,16834/20013
p value within category,C1709380;C0683312;C3889287,false;false;false,16835/20013
p value ∥,C1709380,false,16836/20013
p value § ® ( w,C1709380,false,16837/20013
p valueb,C0369773;C2603361,false;false,16838/20013
p valuec,C0369773;C2603361,false;false,16839/20013
p valuej ',C0369773;C2603361,false;false,16840/20013
p valuer,C0369773;C0401806;C2603361,false;false;false,16841/20013
p   value,C1709380,false,16842/20013
p   value for interaction,C1709380;C1704675,false;false,16843/20013
p   values for interaction,C1709380;C1704675,false;false,16844/20013
p   values of interaction,C1709380;C1704675,false;false,16845/20013
p   vs . placebo,C0369773;C2603361,false;false,16846/20013
p ( inter ),C0369773;C2603361,false;false,16847/20013
p ) atients with > nmbr exacerbations resulting in emergency department visit,C0369773;C4086268;C2603361,false;false;false,16848/20013
p . o ),C0369773;C2603361,false;false,16849/20013
p / interaction,C0369773;C1704675;C2603361,false;false;false,16850/20013
p < nmbr . nmbr ) between the study groups in any of the baseline characteristics . ace,C0369773;C0681848;C2603361;C0557651;C0441849;C1959644;C2603343,false;false;false;false;false;false;false,16851/20013
pnmbr vs no treatment nmbr,C0369773;C2603361,false;false,16852/20013
pnmbrynmbr antagonist,C0369773;C0231491;C2603361,false;false;false,16853/20013
pnmbrynmbr antagonists,C0369773;C0243076;C2603361,false;true;false,16854/20013
pnmbr min twice / week,C0369773;C0702093;C1720725;C0332174;C0439230;C1948050;C1524029;C3813700;C2603361,false;false;false;false;false;false;false;false;false,16855/20013
pnmbrznmbr ( n = nmbr ),C0369773;C2603361,false;false,16856/20013
pnmbr vs placebo,C0369773;C2603361,false;false,16857/20013
pnmbr vs usual care,C0369773;C2603361,false;false,16858/20013
pacemaker — no . ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,16859/20013
pacemaker or icd,C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,16860/20013
pacific,,,16861/20013
pack - years ( iqr ),C1277691,false,16862/20013
pack years,C1277691,false,16863/20013
paclitaxel - eluting stent use,C0144576;C0038257;C0042153;C0457083;C1947944,true;true;true;false;false,16864/20013
pad details,C0182158;C1522508;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false;false,16865/20013
pah - ctd,C0030123;C1335071;C1442905;C3203102;C4284467,true;false;false;true;false,16866/20013
pah - mctd / ctd - other,C0030123;C0026272;C1335071;C1442905;C3203102;C4284467,true;true;false;false;true;false,16867/20013
pah - sle,C0030123;C0024141;C3203102;C4284467,true;true;true;false,16868/20013
pah - ssc,C0030123;C3897657;C3203102;C4284467,true;false;true;false,16869/20013
pah etiology,C0030123;C0015127;C1314792;C1524003;C3203102;C4284467,true;true;true;false;true;false,16870/20013
pah etiology :,C0030123;C0015127;C1314792;C1524003;C3203102;C4284467,true;true;true;false;true;false,16871/20013
pah therapy at baseline,C0030123;C0039798;C0168634;C1442488;C0087111;C1363945;C3203102;C4284467,true;true;true;false;true;false;true;false,16872/20013
pain vas ( range nmbr - nmbr ),C0042815;C1514721;C2348147;C3542016,true;false;false;false,16873/20013
pairwise comparison,C1707455,false,16874/20013
pancreas,C0030274,true,16875/20013
panel a,C0441833;C1706365;C1999270,false;false;false,16876/20013
panel b,C0441833;C1706365;C1999270,false;false;false,16877/20013
parameter ( mg / dl ),C0549193;C0439269;C1704769;C2350001,false;false;false;false,16878/20013
parameter at baseline,C0549193;C0168634;C1442488;C1704769;C2350001,false;true;false;false;false,16879/20013
parameter mean ± s . d .,C0549193;C0444504;C2347634;C2348143;C1704769;C2350001,false;false;false;false;false;false,16880/20013
parameter statistics,C0681933,false,16881/20013
parameter / variable,C0549193;C0439828;C4553760;C1704769;C2350001,false;false;false;false;false,16882/20013
parameters,C0449381,false,16883/20013
parameters at baseline,C0449381;C0168634;C1442488,false;true;false,16884/20013
parental history of mi before age nmbr y,C0030551;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16885/20013
parental history of ml before age nmbr y yes,C0030551;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;true;false;false;false;false,16886/20013
parental history of myocardial infarction before age nmbr y,C0030551;C1275835,true;false,16887/20013
parental history of myocardial infarction before age nmbr y yes,C0030551;C1275835,true;false,16888/20013
parenteral anticoagulation,C0030547;C0003281;C2917212;C2919015;C3537050;C4522267,true;false;false;false;false;false,16889/20013
paresthesia,C0030554;C4553220,true;false,16890/20013
paroxysmal ( n,C0205311,false,16891/20013
paroxysmal atrial fibrillation — no . ( % ),C0235480;C4050122,true;false,16892/20013
paroxysmal nocturnal dyspnea,C1956415,true,16893/20013
paroxysmal !,C0205311,false,16894/20013
participant - reported hypertension — no . { % ),C0679646;C2698741;C4554048,false;false;false,16895/20013
participants,C0679646,false,16896/20013
participants at baseline,C0679646;C0168634;C1442488,false;true;false,16897/20013
participants randomized,C0679646,false,16898/20013
participants taking insulin,C0679646,false,16899/20013
participants with a history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,16900/20013
participants with an event per nmbr patient - years,C0679646;C0441471;C4019010,false;false;false,16901/20013
participants with heart failure,C0679646;C0018801;C0018802;C4554158,false;true;true;false,16902/20013
participants with hf at baseline,C0679646;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,16903/20013
participants with metabolic syndrome,C0679646;C0524620,false;true,16904/20013
participants without a history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,16905/20013
participants without heart failure,C0679646;C0018801;C0018802;C4554158,false;true;true;false,16906/20013
participants without hf at baseline,C0679646;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,16907/20013
participants without metabolic syndrome,C0679646;C0524620,false;true,16908/20013
participated in a previous febuxostat studyb,C0205156;C0249529;C1552607,false;true;false,16909/20013
partner,C0682323;C3887537,false;false,16910/20013
pasi,C4528685,false,16911/20013
pasi # nmbr at week nmbr,C4528685;C0332174;C0439230,false;false;false,16912/20013
pasi [c],C4528685,false,16913/20013
pasi nmbr,C4528685,false,16914/20013
pasi response by baseline mtx use,C4528685;C0871261;C0168634;C0025677;C0042153;C0457083;C1947944;C1417487;C1442488;C1704632;C1706817;C2911692,false;false;true;true;true;false;false;false;false;false;false;false,16915/20013
pasi response by baseline weight,C4528685;C0871261;C1303013;C1704632;C1706817;C2911692,false;false;false;false;false;false,16916/20013
pasi score ( nmbr - nmbr ),C4528685;C0449820;C4050231,false;false;false,16917/20013
pasi score ( nmbr - nmbr ) d,C4528685;C0449820;C4050231,false;false;false,16918/20013
pasi score ( nmbr – nmbr scale ),C4528685;C0449820;C0175659;C0349674;C1947916;C4050231,false;false;true;false;false;false,16919/20013
pasi scorenmbr,C4528685;C0449820;C4050231,false;false;false,16920/20013
pasinmbra,C4528685,false,16921/20013
pasinmbr,C4528685,false,16922/20013
pasia,,,16923/20013
passive smoker,C0425309,false,16924/20013
past cardiovascular history,C0332119;C0007226;C3887460;C1444637;C1880008;C4284302,false;true;false;false;false;false,16925/20013
past or nonsmoker ( n = nmbr ),C1444637;C4284302,false;false,16926/20013
past treatment for paod,C2945691,false,16927/20013
patient ' s ga,C0030705;C0016993,true;true,16928/20013
patient ' s global assessment of disease status score,C4054229;C3176928;C0449820;C4050231,false;false;false;false,16929/20013
patient ' s global assessment of response to therapy score,C4054229;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,16930/20013
patient ' s history of :,C0679831;C1369882,false;false,16931/20013
patient - reported hypertension — no . { % ),C0030705,true,16932/20013
patient - reported outcomes,C2987124,true,16933/20013
patient - years ) hr ( unadjusted ),C0030705;C0439234,true;false,16934/20013
patient assessment of arthritis pain,C0679830;C4317006,false;false,16935/20013
patient assessment of disease activity,C0679830;C1292728,false;false,16936/20013
patient assessment of pain ( nmbr - nmbr cm,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,16937/20013
patient assessment of pain ( nmbr - nmbr mm ),C0679830;C0030193;C4330985;C4554674;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;false;false;true;true,16938/20013
patient characteristic,C0030705,true,16939/20013
patient characteristics at randomization,C0815172;C0034656,false;true,16940/20013
patient classification,C0030705;C0008902;C0008903;C0678229,true;true;true;false,16941/20013
patient demographics age — yr,C4698447;C0011298;C0439234;C1704791,false;true;false;false,16942/20013
patient global assessment of disease,C4054229;C0012634,false;true,16943/20013
patient global assessment of disease activity ( nmbr - nmbr cm,C4054228,false,16944/20013
patient global assessment of disease activity,C4054228,false,16945/20013
patient population,C0030705;C0032659;C1257890,true;true;true,16946/20013
patient status after wake - up,C0449437;C1170730,false;false,16947/20013
patient years,C0030705;C0439234,true;false,16948/20013
patients ( full analysis sety ),C0030705;C0443225;C0002778;C0936012;C1524024,true;false;false;false;true,16949/20013
patients ( treated set * ),C0030705,true,16950/20013
patients < nmbr y,C0030705,true,16951/20013
patients < nmbr y *,C0030705,true,16952/20013
patients > nmbr y,C0030705,true,16953/20013
patients > nmbr y *,C0030705,true,16954/20013
patients aged > nmbr y,C0030705,true,16955/20013
patients analyzed,C0030705,true,16956/20013
patients assessed,C0030705,true,16957/20013
patients in analysis,C0030705;C0002778;C0936012;C1524024,true;false;false;true,16958/20013
patients in the placebo group  nt - probnp values were reported for nmbr patients,C0030705;C0032042;C0441833;C0669479;C0042295;C0754710;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,true;true;false;true;false;true;false;true;false;false;false;false;false,16959/20013
patients included in analysis,C0030705,true,16960/20013
patients meeting the criteria to receive nmbr mg of,C0030705,true,16961/20013
patients not receiving mtx,C0030705,true,16962/20013
patients not receiving statin,C0030705,true,16963/20013
patients on antihypertensive medications,C0030705;C0003364,true;true,16964/20013
patients on atorvastatin,C0030705;C0286651,true;true,16965/20013
patients per nmbr patient - years,C0030705;C0439234,true;false,16966/20013
patients randomised,C0030705,true,16967/20013
patients randomly assigned,C0030705,true,16968/20013
patients receiving nmbr mg of edoxaban at randomization — no . ( % ) f,C0030705,true,16969/20013
patients receiving any uc medication,C0030705,true,16970/20013
patients receiving immunotherapy,C0030705,true,16971/20013
patients receiving mtx,C0030705,true,16972/20013
patients receiving statin,C0030705,true,16973/20013
patients taking mtx,C0030705,true,16974/20013
patients taking oral corticosteroids at baseline,C0030705,true,16975/20013
patients total no .,C0030705,true,16976/20013
patients treated and operated,C0030705,true,16977/20013
patients treated with atenoloi ( n = nmbr ),C0030705,true,16978/20013
patients treated with losartan ( n = nmbr ),C0030705,true,16979/20013
patients who did not use insulin pump,C0030705,true,16980/20013
patients who had ulcerations at,C0030705,true,16981/20013
patients who received nmbr drug,C0030705,true,16982/20013
patients who received nmbr or nmbr drugs,C0030705,true,16983/20013
patients who used insulin pump,C0030705,true,16984/20013
patients with $ nmbr dactylitis digit at week nmbr enthesitis,C0030705;C3863761,true;false,16985/20013
patients with $ nmbr % bsa at baseline,C0030705,true,16986/20013
patients with > nmbr exacerbation in previous nmbr months,C0030705;C4086268,true;false,16987/20013
patients with > nmbr exacerbation requiring admission to hospital in the nmbr months before screening,C4086268;C0030673,false;true,16988/20013
patients with > nmbr exacerbation requiring er visit or admission to hospital in the nmbr months before screening,C1512346;C4086268;C3810541;C3811131,false;false;false;false,16989/20013
patients with > nmbr co - aeds,C0030705;C3245499;C0180309,true;true;true,16990/20013
patients with > nmbr % bsa,C0030705,true,16991/20013
patients with > nmbr % bsa psoriasis skin involvement,C0030705;C0033860;C0444099;C1314939;C1123023;C4520765,true;true;false;false;true;false,16992/20013
patients with nmbr co - aed,C0030705;C3245499;C0887457,true;true;true,16993/20013
patients with nmbr co - aeds,C0030705;C3245499;C0180309,true;true;true,16994/20013
patients with a prior mi or stroke at baseline,C0030705;C0332152;C3810814;C2826257,true;false;false;false,16995/20013
patients with an event per nmbr patient - years,C0030705;C0441471;C4019010,true;false;false,16996/20013
patients with ascvd but no prior ml hr ( nmbr % cl ),C0030705;C3665365,true;false,16997/20013
patients with bp $ nmbr / nmbr mmhg ( abpm ) at baseline,C0030705;C0037623;C0439475;C1415692;C1708288;C4318478,true;true;false;false;false;false,16998/20013
patients with cardiac disorders,C0741926;C0012634;C0030705;C0018799,false;true;true;true,16999/20013
patients with change from baseline in psa - modified total shs score # nmbr,C0030705;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,17000/20013
patients with change from baseline in total psa ‐ modified shs ≤ nmbr,C0030705;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,17001/20013
patients with clinically evident vascular disease,C0030705;C3887511;C0042373,true;false;true,17002/20013
patients with dactylitis,C0030705;C0239161,true;false,17003/20013
patients with dactylitis at baseline,C0030705;C0239161,true;false,17004/20013
patients with dactylitis at week nmbr,C0030705;C0239161,true;false,17005/20013
patients with dactylitisa,C0030705,true,17006/20013
patients with deep - vein thrombosis only,C0030705;C0149871;C0205171;C1720467,true;true;false;false,17007/20013
patients with diabetes,C0030705;C0011847;C0011849,true;false;true,17008/20013
patients with diabetes mellitus ( n = nmbr ),C0030705;C0011849,true;true,17009/20013
patients with digits with dactylitis,C0030705;C0582802,true;false,17010/20013
patients with dm ( n = nmbr ),C0030705;C0011816;C3250443,true;true;false,17011/20013
patients with dm vs . patients without dm,C0030705;C0011816;C3250443,true;true;false,17012/20013
patients with draining fistulae at baseline[n = nmbr],C0030705;C0544791,true;false,17013/20013
patients with early cd ( n = nmbr ),C0030705;C1279919;C0007928;C0034283;C4552032,true;false;true;true;false,17014/20013
patients with eligible ses - cd score,C0030705;C1548635;C0007928;C0449820;C4050231;C0034283;C4552032,true;false;true;false;false;true;false,17015/20013
patients with endpoin t,C0030705,true,17016/20013
patients with enthesitis,C0030705;C1282952,true;false,17017/20013
patients with enthesitis ( lei > nmbr ),C0030705;C1282952;C0023401;C0428209,true;false;true;false,17018/20013
patients with enthesitis at baseline,C0030705;C1282952,true;false,17019/20013
patients with enthesitis at week nmbr radiographic progression § change from baseline to week nmbr in psa - modified total shs score,C0030705;C1282952,true;false,17020/20013
patients with enthesitis at week nmbr,C0030705;C1282952,true;false,17021/20013
patients with eot data,C2707520,false,17022/20013
patients with established cv disease aged > nmbr years .,C0030705;C0443211;C0007222;C1510829;C1272684,true;false;true;false;false,17023/20013
patients with evaluable endoscopy,C2986511;C0014245,false;true,17024/20013
patients with event ( n,C0030705;C0441471;C4019010,true;false;false,17025/20013
patients with event / patients analysed,C0030705;C0441471;C4019010,true;false;false,17026/20013
patients with event / analyzed,C0030705;C0441471;C4019010,true;false;false,17027/20013
patients with fingernail involvement,C0030705;C0222001;C1314939,true;true;false,17028/20013
patients with glycated hemoglobin < nmbr . nmbr % and no severe hypoglycemia or diabetic ketoacidosis,C0030705;C0017853,true;true,17029/20013
patients with glycated hemoglobin > nmbr . nmbr % and > nmbr episode of severe hypoglycemia *,C0030705;C0017853,true;true,17030/20013
patients with glycated hemoglobin > nmbr . nmbr % and > nmbr episode ofdiabetic ketoacidosis *,C0030705;C0017853,true;true,17031/20013
patients with hospitalized pneumonia events,C0870668;C0032285;C0441471;C3541888,false;true;false;false,17032/20013
patients with improvement $ nmbr . nmbr,C0030705;C2986411,true;false,17033/20013
patients with level > nmbr pg / ml,C0030705;C0441889;C0439297;C0456079;C1547707;C2946261,true;false;false;false;false;false,17034/20013
patients with low ( < nmbr mg / dl ) cnmbr,C0030705;C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;false;false;false;false;false,17035/20013
patients with measurement,C0030705;C0242485,true;false,17036/20013
patients with microvascular complications,C0030705;C0443258;C0009566;C1171258,true;false;false;true,17037/20013
patients with mild pain ( womac pain score,C0030705;C0278138;C0449820;C4050231;C4522280;C2945599;C0582148,true;false;false;false;false;false;false,17038/20013
patients with moderate - to - severe pain ( womac pain score,C0030705;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,true;false;false;false;false;false;false,17039/20013
patients with nail psoriasis ( mnapsi > nmbr ),C0030705;C0406322,true;false,17040/20013
patients with negative anti - dsdna,C0030705;C0205160;C0741099;C1513916;C2825415;C2825491;C3853545,true;false;false;false;false;false;false,17041/20013
patients with no prior cvd ( primary,C0030705;C0332152;C0007222;C2826257,true;false;true;false,17042/20013
patients with only mrf hr ( nmbr % cl ),C0030705;C0205171;C0312443;C0596019;C1412879;C1720467,true;false;false;false;false;false,17043/20013
patients with perianal fistulae,C0030705;C0267561,true;false,17044/20013
patients with pneumonia event,C0030705;C0032285;C0441471;C4019010,true;true;false;false,17045/20013
patients with pneumonia events,C0030705;C0032285;C0441471;C3541888,true;true;false;false,17046/20013
patients with pneumonia resulting in death,C0030705;C0032285,true;true,17047/20013
patients with possible new dm at randomization ( fpg > nmbr - nmbr ),C0030705;C0332149;C0205314;C0011816;C3250443;C1705910;C2362652,true;false;false;true;false;false;false,17048/20013
patients with possible new dm at randomization ( hbanmbrc > nmbr . nmbr - nmbr % ),C0030705;C0332149;C0205314;C0011816;C3250443;C1705910;C2362652,true;false;false;true;false;false;false,17049/20013
patients with prior dmard use,C0030705;C0332152;C0242708;C0042153;C0457083;C1947944;C2826257,true;false;true;true;false;false;false,17050/20013
patients with prior ml hr ( nmbr % cl ),C0030705;C0332152;C0439526;C0596019;C1705224;C3887665;C2826257,true;false;false;false;false;false;false,17051/20013
patients with psoriasis ( bsa ≥   nmbr % ),C0030705;C0033860,true;true,17052/20013
patients with psoriasis > nmbr % of body surface area,C0030705;C0033860;C0489451;C0017446;C0205146,true;true;false;true;false,17053/20013
patients with pulmonary embolism,C0030705;C0034065,true;true,17054/20013
patients with radiographic erosion,C0030705;C0444708;C0333307;C1880549;C1959609;C3887524,true;false;false;false;false;false,17055/20013
patients with remission,C1277626,false,17056/20013
patients with serum nmbr ( oh ) d ≥   nmbr . nmbr and <   nmbr   ng / ml,C0030705;C0229671;C0220853;C1546774;C1550100,true;true;true;false;false,17057/20013
patients with specific disease characteris -,C0683521;C0205369;C1552740,false;false;false,17058/20013
patients with supplemental vitamin d dose of nmbr iu / day starting at screeningc,C0030705;C0420176;C0178602;C0439465;C0439659;C0869039;C1114758;C3541352,true;false;false;false;false;false;false;false,17059/20013
patients with weekly iss mid response,C0030705;C0332174;C1740819;C0871261;C1704632;C1706817;C2911692;C1845118,true;false;false;false;false;false;false;false,17060/20013
patients without,C0030705,true,17061/20013
patients without a prior mi or stroke at baseline,C0030705;C0332152;C3810814;C2826257,true;false;false;false,17062/20013
patients without clinically evident vascular disease,C0030705;C3887511;C0042373,true;false;true,17063/20013
patients without diabetes,C0030705;C0011847;C0011849,true;false;true,17064/20013
patients without diabetes mellitus ( n = nmbr ),C0030705;C0011849,true;true,17065/20013
patients without dm ( n = nmbr,C0030705;C0011816;C3250443,true;true;false,17066/20013
patients without dm ( n = nmbr ),C0030705;C0011816;C3250443,true;true;false,17067/20013
patients without draining fistulae at baseline[n = nmbr],C0030705;C0544791,true;false,17068/20013
patients / events n,C0030705;C0441471;C3541888,true;false;false,17069/20013
patientswith bp $ nmbr / nmbr mmhg ( abpm ) at baseline,C0037623;C0439475;C0168634;C1442488;C1415692;C1708288;C4318478,true;false;true;false;false;false;false,17070/20013
patientswith bp,C0037623;C1415692;C1708288;C4318478,true;false;false;false,17071/20013
pb,C1415801;C3819255,false;false,17072/20013
pbo - adjusted ls mean change,C0031962;C0456081;C0023668;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;true;false;false;false;false;false;false;false,17073/20013
pbo - adjusted ls mean change ( se ),C0031962;C0456081;C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;true;false;false;true;false;false;false;false;false,17074/20013
pbo - sc every other week ( n = nmbr ),C0031962;C0282380,true;true,17075/20013
pbo ( n - nmbr ),C0031962,true,17076/20013
pbo ( n nmbr nmbr ),C0031962,true,17077/20013
pbo ( n   =   nmbr ),C0031962,true,17078/20013
pbo czp nmbr mg qnmbrw week nmbr ( n = nmbr ),C0031962;C0054841;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;true;false;false;false;false;false;true;true,17079/20013
pbo n = nmbr,C0031962,true,17080/20013
pbo to czp week nmbr dose combined,C0031962;C0054841;C0332174;C0178602;C0869039;C1114758;C0439230;C1861828;C1872109,true;true;false;false;false;false;false;true;true,17081/20013
pci — no . { % ),C4049621,false,17082/20013
pci alone ( n = nmbr ),C4049621;C0205171;C0439044;C0679994,false;false;false;false,17083/20013
pci duration,C4049621;C0449238;C2926735,false;false;false,17084/20013
pci history,C4049621;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,17085/20013
pci indication,C4049621;C0392360;C3146298,false;false;false,17086/20013
pci performed,C4049621,false,17087/20013
pci postindex event,C4049621;C0441471;C4019010,false;false;false,17088/20013
pci / thrombolysis at randomization,C4049621;C0520997;C0034656,false;false;true,17089/20013
pci :,C4049621,false,17090/20013
pci = percutaneous coronary intervention . cabg = coronary - artery bypass graft . for hope > nmbr mg / l  for europa > nmbr mg / l or on a lipid - lowering treatment  for peace  data are mean ( sd ) . data are mean ( sd ) unless otherwise indicated .,C4049621;C0522523;C0545743;C0184661;C0010055;C0189695;C0392347;C0439268;C0886296;C1273869,false;false;false;true;true;false;true;false;false;false,17091/20013
pcr after acs,C0032520;C0742343;C4318612;C3853643;C4050242,true;true;false;false;false,17092/20013
pcs score,C1864389;C1882368,false;true,17093/20013
pcs score ( nmbr – nmbr scale ),C1864389;C1882368,false;true,17094/20013
pde - nmbri,C0021966;C0221138,true;false,17095/20013
pde - nmbri monotherapy,C0021966;C0221138,true;false,17096/20013
pdenmbr inhibitors,C0031638,true,17097/20013
pdq - nmbr,,,17098/20013
pe and dvt,C0070939;C1880476;C4284304,true;false;false,17099/20013
pe only,C0070939;C0205171;C1720467;C1880476;C4284304,true;false;false;false;false,17100/20013
pe with / without dvt,C0070939;C1880476;C4284304,true;false;false,17101/20013
peak fevnmbr ( nmbr - nmbrh )   response,C0444505;C3714541;C0033727;C0871261;C1704632;C1706817;C2911692;C0369286;C0441932;C0564385;C4528284,false;true;true;false;false;false;false;false;false;false;false,17102/20013
peak systolic pressure gradient,C4687747;C0039155,false;true,17103/20013
pedal edema,C0574002,false,17104/20013
pef at baseline,C0030771;C0168634;C1442488;C1518922;C1542834,true;true;false;false;false,17105/20013
pef !,C0030771;C1518922;C1542834,true;false;false,17106/20013
pefam   ( l / min ) ∗,C0702093;C1524029;C3813700,false;false;false,17107/20013
pefpm   ( l / min ) ∗,C0702093;C1524029;C3813700,false;false;false,17108/20013
penetrating no . of resections,C0205321,false,17109/20013
people with diabetes n = nmbr,C0027361;C0011847;C0011849,true;false;true,17110/20013
people without diabetes n = nmbr,C0027361;C0011847;C0011849,true;false;true,17111/20013
pepsinogen i / ii ratio,C0030915;C0456603;C1547037;C0523817,true;false;false;false,17112/20013
per body weight,C0005910;C1305866,true;false,17113/20013
percent activity impairment due to asthma,C0439167;C0221099;C0678226;C0004096;C2984299;C0684336,false;false;false;true;false;false,17114/20013
percent atheroma volume at baseline,C1690016;C0264956;C0168634;C1442488;C3887614,false;true;true;false;false,17115/20013
percent change from baseline at week nmbr,C3272907,false,17116/20013
percent change from baseline to week nmbr in auc ( mean,C3272907,false,17117/20013
percent impairment while working due to asthma,C0439165;C0221099;C0684336,false;false;false,17118/20013
percent improvement,C0439165;C2986411,false;false,17119/20013
percent of predicted normal value,C1882327;C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,17120/20013
percent of predicted value before bronchodilation^,C1882327,false,17121/20013
percent of the time that inr was in the therapeutic range,C0439165;C0040223;C3541383,false;true;false,17122/20013
percent overall work impairment due to asthma,C0439165,false,17123/20013
percent stenosis [core lab],C0439165;C0678234;C4684837;C1261287;C2632116,false;false;false;true;false,17124/20013
percent stenosis [investigator],C0439165;C0678234;C0035173;C1261287;C2632116,false;false;true;true;false,17125/20013
percent work time missed due to asthma,C0439165;C0043227;C0040223;C3541383,false;true;true;false,17126/20013
percentage,C0439165;C1549488;C1561533,false;false;false,17127/20013
percentage of bsa involved,C0439165;C1549488;C1561533,false;false;false,17128/20013
percentage of females,C0439165;C0086287;C1549488;C1561533,false;true;false;false,17129/20013
percentage of fevj reversibility,C0439165;C0449261;C1549488;C1561533,false;false;false;false,17130/20013
percentage of p,C0439165;C1549488;C1561533,false;false;false,17131/20013
percentage of patients receiving dose adjustment,C0439165;C0030705;C1549488;C1561533,false;true;false;false,17132/20013
percentage of patients with event,C0439165;C0030705;C1549488;C1561533,false;true;false;false,17133/20013
percentage of predicted pre - bronchodilator fev^,C0439165;C0681842;C2599602;C3714541;C1882327;C1549488;C1561533,false;false;false;true;false;false;false,17134/20013
percentage points,C0439165;C1549488;C1561533,false;false;false,17135/20013
percentage unless otherwise noted . cabg indicates coronary artery bypass graft  lvh  left ventricular hypertrophy  nsaids  nonsteroidal antiinflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ‘ history of hypercholesterolemia or reporting use of lipid - lowering medications at baseline . thistory of or currently have elevated serum creatinine level < nmbr mg / dl . tbased on participant history or review of chart .,C0439165;C1549488;C1561533,false;false;false,17136/20013
percentages,C0439165;C1549488;C1561533,false;false;false,17137/20013
percentages of patients with event,C0439165;C0030705;C1549488;C1561533,false;true;false;false,17138/20013
percutaneous coronary intervention done *,C1532338,true,17139/20013
percutaneous coronary intervention n ( % ),C1532338,true,17140/20013
percutaneous coronary intervention or coronary - artery bypass grafting for index acute coronary syndrome — no . { % ),C1532338,true,17141/20013
percutaneous coronary intervention §,C1532338,true,17142/20013
percutaneous transluminal coronary angioplasty,C2936173,true,17143/20013
peri - operative cabg participants :,C0347985;C1882154;C0010055;C0679646,false;false;true;false,17144/20013
perianal gi tract,C0442158;C0017189,false;true,17145/20013
perianal,C0442158,false,17146/20013
perindopril - indapamide,C1273169,true,17147/20013
period ii,C0439531;C1710602;C4082587;C1948053,false;false;false;false,17148/20013
periostin,C0219433;C1424662;C3812270,true;false;false,17149/20013
periostin high,C0219433;C1424662;C3812270,true;false;false,17150/20013
periostin low,C0219433;C1424662;C3812270,true;false;false,17151/20013
peripherai arteriai disease,C0012634,true,17152/20013
peripheral - artery stenosis,C4025272,false,17153/20013
peripheral angioplasty,C0205100;C0162577;C1548817,false;true;false,17154/20013
peripheral arterial disease — no . ( % ),C0085096;C1704436,true;true,17155/20013
peripheral arterial disease ( n = nmbr nmbr ),C0085096;C1704436,true;true,17156/20013
peripheral arterial disease §,C0085096;C1704436,true;true,17157/20013
peripheral arterial stenosis,C4025272,false,17158/20013
peripheral artery disease - -,C1704436;C4025272,true;false,17159/20013
peripheral artery disease 一 no . ( % ),C1704436;C4025272,true;false,17160/20013
peripheral artery diseaseb,C0489868,false,17161/20013
peripheral limb vascular efficacy,C0150936;C0015385;C1280519;C1707887;C0947487,false;true;false;false;false,17162/20013
peripheral revascularisation,C0205100;C0581603,false;false,17163/20013
peripheral sensory neuropathy,C0151313;C4554142,false;false,17164/20013
permanent ( n,C0205355,false,17165/20013
permanent af,C0205355;C0344434;C4049859,false;false;false,17166/20013
permanent users,C0205355;C1706077,false;false,17167/20013
persisent,,,17168/20013
persistent ( n,C0205322;C0332996,false;false,17169/20013
persistent faod ( n [ nmbr ),C0205322;C0332996,false;false,17170/20013
persistent faol ( n [ nmbr ),C0205322;C0332996,false;false,17171/20013
persistent *,C0205322;C0332996,false;false,17172/20013
persistent / permanent,C0205322;C0205355;C0332996,false;false;false,17173/20013
person - years,C0027361;C0439234;C2347489,true;false;false,17174/20013
pervious cerebrovascular event,C0205326;C1880018;C0441471;C4019010,false;false;false;false,17175/20013
pfor trend,C1151635;C1521798;C4554533,false;false;false,17176/20013
pga score ( range ),C0016410;C0449820;C1514721;C2348147;C3542016;C4050231;C3541266;C4050369,true;false;false;false;false;false;false;false,17177/20013
pga score,C0016410;C0449820;C4050231;C3541266;C4050369,true;false;false;false;false,17178/20013
pgi - s,C0523816;C1333690;C1412792;C1704947;C2975867;C3810522;C4522133,false;false;false;false;true;false;false,17179/20013
phakic,,,17180/20013
pharmacological therapy for hf,C0013217;C0018488;C1313497;C1538440;C3273279,true;true;true;false;false,17181/20013
pharyngitis,C0031350;C4553308,true;false,17182/20013
phenobarbital,C0031412,true,17183/20013
phosphatase,C0031678;C1149880;C4522024,true;false;false,17184/20013
phototherapy,C0031765,true,17185/20013
phototherapy previous systemic treatment,C0031765;C0205156;C0678812;C1552607,true;false;false;false,17186/20013
physical activity ( hours walking / wk ),C0015259;C0439227;C0026606,true;false;true,17187/20013
physical characteristics,C0031809;C1521970;C0205485;C1509143,true;false;false;false,17188/20013
physician ' s assessment of disease activity ( vas ),C0031831;C1261322;C1292728;C0042815;C3536884;C3827561;C1516048;C0804815,true;false;false;true;true;false;false;false,17189/20013
physician ' s ga,C0031831;C0016993;C0804815,true;true;false,17190/20013
physician ' s global assessment of disease status score,C4050369;C3176928;C0449820;C4050231,false;false;false;false,17191/20013
physician global assessment of disease,C4050369;C0012634,false;true,17192/20013
physician global assessment of disease activity ( nmbr - nmbr cm,C4050369,false,17193/20013
physician global assessment of disease activity,C4050369,false,17194/20013
pi,C0122626;C0429863;C3537219;C3539772,true;false;false;false,17195/20013
piacebo,,,17196/20013
piacebo ( n = nmbr ) no . of participants with events ( % ),,,17197/20013
pifr l / min,C0702093;C1524029;C3813700,false;false;false,17198/20013
pinteraction for treatment and history of heart failure,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,17199/20013
pinteraction = nmbr . nmbr,,,17200/20013
pioglitazone dose,C0071097;C0178602;C0869039;C1114758,true;false;false;false,17201/20013
pioglitazone group ( n = nmbr ),C0071097;C0441848,true;false,17202/20013
pioglitazone only,C0071097;C0205171;C1720467,true;false;false,17203/20013
piroxicam,C0031990,true,17204/20013
pla « = nmbr,C0456170,false,17205/20013
pla n = nmbr,C0456170,false,17206/20013
place !,C0442504;C1533810;C1704765;C1882509,false;false;false;false,17207/20013
placebo - control study,C0683952,false,17208/20013
placebo ‐ controlled period,C1706408;C0439531;C1948053,false;false;false,17209/20013
placebo |,C0032042;C1696465;C1706408,true;false;false,17210/20013
placebo nmbronmbr,C0032042;C1696465;C1706408,true;false;false,17211/20013
placebo   ( n = nmbr ),C0032042;C1696465;C1706408,true;false;false,17212/20013
placebo ( « = nmbr ),C0032042;C1696465;C1706408,true;false;false,17213/20013
placebo ( » = nmbr ),C0032042;C1696465;C1706408,true;false;false,17214/20013
placebo ( nmbr = nmbr ),C0032042;C1696465;C1706408,true;false;false,17215/20013
placebo ( nmbr,C0032042;C1696465;C1706408,true;false;false,17216/20013
placebo ( events / n ( % ) ),C0032042;C0441471;C3541888;C1696465;C1706408,true;false;false;false;false,17217/20013
placebo ( n — nmbr ),C0032042;C1696465;C1706408,true;false;false,17218/20013
placebo ( n : nmbr ),C0032042;C1696465;C1706408,true;false;false,17219/20013
placebo ( n [ nmbr ),C0032042;C1696465;C1706408,true;false;false,17220/20013
placebo ( n = nmbr ) †,C0032042;C1696465;C1706408,true;false;false,17221/20013
placebo ( n = nmbr ) i -,C0032042;C1696465;C1706408,true;false;false,17222/20013
placebo ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C0032042;C1696465;C1706408,true;false;false,17223/20013
placebo ( n = nmbr ) ',C0032042;C1696465;C1706408,true;false;false,17224/20013
placebo ( n = nmbr ) n ( % ),C0032042;C1696465;C1706408,true;false;false,17225/20013
placebo ( n = nmbrinmbr ),C0032042;C1696465;C1706408,true;false;false,17226/20013
placebo ( n nmbr nmbr,C0032042;C1696465;C1706408,true;false;false,17227/20013
placebo ( n   = nmbr,C0032042;C1696465;C1706408,true;false;false,17228/20013
placebo ( n   = nmbr ),C0032042;C1696465;C1706408,true;false;false,17229/20013
placebo ( n   =   nmbr ),C0032042;C1696465;C1706408,true;false;false,17230/20013
placebo ( n   =   nmbr,C0032042;C1696465;C1706408,true;false;false,17231/20013
placebo ( n   =   nmbr ),C0032042;C1696465;C1706408,true;false;false,17232/20013
placebo ( n   =   nmbr ) a,C0032042;C1696465;C1706408,true;false;false,17233/20013
placebo ( n   =   nmbr ) b,C0032042;C1696465;C1706408,true;false;false,17234/20013
placebo ( n = lnmbr ),C0032042;C1696465;C1706408,true;false;false,17235/20013
placebo ( symptom days a week ),C0032042;C1457887;C0439228;C3854129;C1696465;C1706408,true;false;false;false;false;false,17236/20013
placebo ( w = nmbr ),C0032042;C1696465;C1706408,true;false;false,17237/20013
placebo + glimepiride,C0032042;C0061323;C1696465;C1706408,true;true;false;false,17238/20013
placebo + insulin ( n   = nmbr ),C0032042;C0021641;C1533581;C1579433;C3714501;C1696465;C1706408,true;true;false;false;false;false;false,17239/20013
placebo + insulin ( n = nmbr ),C0032042;C0021641;C1533581;C1579433;C3714501;C1696465;C1706408,true;true;false;false;false;false;false,17240/20013
placebo + insulin glargine ( award - nmbr  n = nmbr ),C0032042;C0907402;C0004446;C1696465;C1706408,true;true;true;false;false,17241/20013
placebo + pioglitazone ( n = nmbr ),C0032042;C0071097;C1696465;C1706408,true;true;false;false,17242/20013
placebo nmbr . nmbr,C0032042;C1696465;C1706408,true;false;false,17243/20013
placebo analysed ( % ),C0032042;C1696465;C1706408,true;false;false,17244/20013
placebo arm,C0032042;C0446516;C3715044;C4553528;C1696465;C1706408,true;true;false;false;false;false,17245/20013
placebo diabetes n = nmbr,C0032042;C0011847;C0011849;C1696465;C1706408,true;false;true;false;false,17246/20013
placebo dn = nmbr ),C0032042;C1333964;C1707618;C1696465;C1706408,true;false;false;false;false,17247/20013
placebo dr = nmbr ),C0032042;C0013014;C0031831;C1707664;C2348314;C3540849;C1696465;C1706408,true;true;true;false;false;false;false;false,17248/20013
placebo events / patients (,C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,17249/20013
placebo group ( n = nmbr ) ’ j ',C0032042;C0441844;C1696465;C1706408,true;false;false;false,17250/20013
placebo km %,C0032042;C3887676;C1696465;C1706408,true;false;false;false,17251/20013
placebo mdi,C0032042;C0993596;C1839839;C4049613;C1696465;C1706408,true;true;true;false;false;false,17252/20013
placebo mean,C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false,17253/20013
placebo mean change ( sd ),C0032042;C0444504;C0392747;C2699239;C0443172;C1705241;C4319952;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false;false;false;false;false;false,17254/20013
placebo mortality rate,C0032042;C0026565;C0205848;C1696465;C1706408,true;true;true;false;false,17255/20013
placebo n,C0032042;C1696465;C1706408,true;false;false,17256/20013
placebo n ( rate ) nmbr,C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,17257/20013
placebo n / n,C0032042;C1696465;C1706408,true;false;false,17258/20013
placebo no diabetes n = nmbr,C0032042;C1696465;C1706408,true;false;false,17259/20013
placebo no . ( nmbr - y km % ),C0032042;C1696465;C1706408,true;false;false,17260/20013
placebo patients / events n,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,17261/20013
placebo plus statin ( n = nmbr ),C0032042;C0332287;C0360714;C1696465;C1706408,true;false;true;false;false,17262/20013
placebo slope lsm ± se ( mm / year ),C0032042;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674;C1696465;C1706408,true;false;true;false;false;false;false;false;false,17263/20013
placebo tiotropium n = nmbr non - tiotropium n = nmbr,C0032042;C0213771;C1518422;C1696465;C1706408,true;true;false;false;false,17264/20013
placebo to ustekinumab nmbr mgt,C0032042;C1608841;C1696465;C1706408,true;true;false;false,17265/20013
placebo tolvaptan ( nmbr mg ) ( n nmbr nmbr ) ( n nmbr nmbr ),C0032042;C1176308;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;false;false;false;false;false;false;false,17266/20013
placebo * ( add on to basal insulin ),C0032042;C1883712;C0650607;C1696465;C1706408,true;false;false;false;false,17267/20013
placebo /,C0032042;C1696465;C1706408,true;false;false,17268/20013
placebo / rosu vastatin,C0032042;C1099881;C1696465;C1706408,true;true;false;false,17269/20013
placebo / simva,C0032042;C1696465;C1706408,true;false;false,17270/20013
placebo + statin,C0032042;C0360714;C1696465;C1706408,true;true;false;false,17271/20013
placebo → golimumab nmbr mg / nmbr mga,C0032042;C2353893;C0024671;C0065879;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;true;false;false;false;false;false;false;false,17272/20013
placebo §,C0032042;C1696465;C1706408,true;false;false,17273/20013
placebofigolimumab nmbr mg / nmbr mgt,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,17274/20013
plaeebo,,,17275/20013
plasma cholesterol — mg / dl,C0858034;C0439269,false;false,17276/20013
plasma creatine,C0032105;C0010286;C1550098;C4521445,true;true;false;false,17277/20013
plasma dha,C0032105;C0142831;C2348308;C1550098;C4521445,true;true;false;false;false,17278/20013
plasma glucose — mmol per liter,C0202042;C0439190;C0475211;C0455280,false;false;false;false,17279/20013
plasma glucose nmbr hr after glucose load — mmol / liter,C0202042;C1550025;C0439190;C0475211;C1704782;C1708715;C0455280,false;false;false;false;false;false;false,17280/20013
plasma lipids ( mg / dl ) nmbr total cholesterol mean,C0858034;C0023779;C0439269;C0444504;C2347634;C2348143,false;true;false;false;false;false,17281/20013
plasma lipoproteins,C0032105;C0023820;C1550098;C4521445,true;true;false;false,17282/20013
plasma triglyceride — mg / dl,C0032105;C0041004;C0439269;C1550098;C4521445,true;true;false;false;false,17283/20013
platelet aggregation inhibitors excluding heparin,C0032177,true,17284/20013
platelet aggregation inhibitors,C0032177,true,17285/20013
platelets xlooo / mm^,C0005821;C4330985;C4554674;C0443116;C1963076,true;false;false;false;false,17286/20013
pleased,C3829994;C4264468,false;false,17287/20013
plus – minus values are means ± sd . cabg denotes coronary - artery by - pass graft  ptca percutaneous transluminal coronary angioplasty  and ace angiotensin - converting enzyme . hypertension and diabetes were de - fined by clinical history . a more complete list of base - line characteristics is given in rubins et al . nmbr † nitrates includes all preparations except as - needed nitroglycerin . ‡ any antianginal drug includes any nitrate ( as defined above )  calcium - channel blocker  or beta - blocker . § the body - mass index is the weight in kilograms divided by the square of the height in meters . ¶ to convert values for cholesterol to millimoles per liter  multiply by nmbr . nmbr . to convert values for triglycerides to millimoles per liter  multiply by nmbr . nmbr .,C0332288;C0042295,false;false,17288/20013
pnd,C1417807;C1956415;C4552608,false;true;false,17289/20013
pneumonia,C0032285,true,17290/20013
pneumonia events,C0032285;C0441471;C3541888,true;false;false,17291/20013
pollen exposure,C0032385;C0274281;C0332157;C0795585;C1320238,true;false;false;false;false,17292/20013
pollent < nmbr,,,17293/20013
pollent s nmbr,,,17294/20013
polyarticular arthritis,C0162323,true,17295/20013
polyvascular disease ( n = nmbr ),C0012634,true,17296/20013
polyvascular disease and no type nmbr diabetes ( n = nmbr ),C0012634,true,17297/20013
polyvascular disease and type nmbr diabetes ( n = nmbr ),C0012634,true,17298/20013
polyvascular disease * ( n = nmbr ),C0012634,true,17299/20013
polyvascular disease * and type nmbr diabetes status,C0012634,true,17300/20013
polyvascular disease * status,C3176928,false,17301/20013
pool of fh i and ii studies,C0337051;C1260386;C1509144;C2349200,false;true;false;false,17302/20013
pool of long term ( hefh patients only ) and high fh,C0337051;C0443252;C0030705;C0205171;C1720467;C1509144;C2349200,false;false;true;false;false;false;false,17303/20013
pooled analysis of sustain nmbr — nmbr trials,C1709595;C0002778;C0936012;C1524024;C2349200;C4522255,false;false;false;true;false;false,17304/20013
pooled analysis sample,C1709595;C0002778;C0936012;C1524024;C1303103;C2349200;C4522255,false;false;false;true;false;false;false,17305/20013
pooled itt,C1709595;C2349200;C4522255,false;false;false,17306/20013
pooled non - canvas studies ( n = nmbr ) : non - cana ( n = nmbr )  cana nmbr mg ( n = nmbr )  cana nmbr mg ( n = nmbr ),C1709595;C1518422;C3281223;C2349200;C4522255,false;false;false;false;false,17307/20013
pooled pah - mctd and pah,C1709595;C0030123;C0026272;C3203102;C4284467;C2349200;C4522255,false;true;true;true;false;false;false,17308/20013
pooled placebo,C1709595;C0032042;C1696465;C1706408;C2349200;C4522255,false;true;false;false;false;false,17309/20013
pooled secukinumab,C1709595;C3179547;C2349200;C4522255,false;true;false;false,17310/20013
pooled trials * n = nmbr,C1709595;C0008976;C2349200;C4522255,false;true;false;false,17311/20013
poor compliance / noncompliance,C0032646;C0376405;C0457432,false;true;false,17312/20013
poor outcome at nmbr months,C3806166;C0439231,false;false,17313/20013
population,C0032659;C1257890,true;true,17314/20013
positive atopic status,C0439178;C0392707;C0449438;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false;false,17315/20013
positive ctnl ( n = nmbr ),C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,17316/20013
positive cu index test,C0439178;C1177210;C0600653;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0918012;C1552854;C1637833;C2986546;C2347872;C1446409;C1514241;C2825490;C3812269,false;false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false,17317/20013
positive for hla - bnmbr,C0439178;C0019737;C0550853;C1415561;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false;false,17318/20013
positive hla - bnmbr status,C0439178;C0019737;C0449438;C0550853;C1415561;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false;false;false,17319/20013
positive orthostatic test },C0439178;C0231472;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false;false;false;false;false;false;false,17320/20013
positive troponin i or t,C0439178;C0077401;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false,17321/20013
positive troponin or ck - mb,C0439178;C0041199;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false,17322/20013
positive vs . negative,C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,17323/20013
post - albuterol % predicted fevnmbr mean ( sd ) e,C0687676;C0001927;C1704687;C3469826,false;true;false;false,17324/20013
post - bronchodilator fev i reversibility,C2599594;C3714541;C0021966;C0449261;C0221138,false;true;true;false;false,17325/20013
post - bronchodilator fevnmbr at screening,C2599594;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,17326/20013
post - bronchodilator fevnmbr ml,C2599594;C3714541;C0439526;C1705224;C3887665,false;true;false;false;false,17327/20013
post - bronchodilator fevnmbr % predictedb,C2599594;C3714541,false;true,17328/20013
post - bronchodilator fevnmbr / fvc ratio,C2599594;C3714541;C0456603;C1547037,false;true;false;false,17329/20013
post - bronchodilator fevnmbr  % predicted,C2599594;C3714541,false;true,17330/20013
post - bronchodilator fevi,C2599594;C0849974;C1561566;C4528367,false;false;false;false,17331/20013
post - bronchodilator fevinmbr % predicted,C2599594;C0849974;C1561566;C4528367,false;false;false;false,17332/20013
post - bronchodilator fevx ( l ),C2599594,false,17333/20013
post - bronchodilator screening,C2599594;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,17334/20013
post - dose,C0439568,false,17335/20013
post - procedure,C3272301,false,17336/20013
post - salbutamol fevnmbr ( l ) b,C0687676;C0001927;C3714541;C1704687;C3469826,false;true;true;false;false,17337/20013
post - salbutamol fevnmbr / fvcb,C0687676;C0001927;C3714541;C1704687;C3469826,false;true;true;false;false,17338/20013
post erior - anterior spine,C0687676;C0205094;C0037949;C2752558;C1704687;C3469826,false;false;true;false;false;false,17339/20013
post fevnmbr,C0687676;C3714541;C1704687;C3469826,false;true;false;false,17340/20013
post fevnmbr   % pred,C0687676;C3714541;C1704687;C3469826,false;true;false;false,17341/20013
post fvc,C0687676;C3714541;C1704687;C3469826,false;true;false;false,17342/20013
post fvc % pred,C0687676;C3714541;C1704687;C3469826,false;true;false;false,17343/20013
post hoc analysis,C0687676;C0002778;C0936012;C1524024;C1704687;C3469826,false;false;false;true;false;false,17344/20013
post svc,C0687676;C0231957;C1704687;C3469826,false;false;false;false,17345/20013
postbaseline binding antibodies,C1145667;C0003241;C1167622,false;true;false,17346/20013
postbaseline new - onset diabetes - n ( % ),C0746890;C0011847;C0011849,false;false;true,17347/20013
postbronchodilator nmbr . nmbr ( nmbr . nmbr ),C2599594,false,17348/20013
postbronchodilator fevj ( % predicted ),C2599594,false,17349/20013
postdose fev / fvc at screening,C0439568;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,17350/20013
postoperative use of p - blocker,C0032790;C1524063,true;false,17351/20013
postprandial indices,C0376674;C4033634,true;false,17352/20013
potassium - sparing diuretic,C0304490;C3536751,true;false,17353/20013
potassium — mg / dl,C0032821;C0439269;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,17354/20013
potassium ( mg / dl ),C0032821;C0439269;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,17355/20013
potassium at admission,C0032821;C0184666;C0809949;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false,17356/20013
potent phosphorylated glycoprotein inhibitor use,C3245505;C0017968;C1999216;C0042153;C0457083;C1947944,false;true;false;true;false;false,17357/20013
potential injection site reactions,C3245505;C0151735,false;true,17358/20013
potential predictor,C3245505;C2698872,false;false,17359/20013
ppbc score,C0449820;C4050231,false;false,17360/20013
ppci,,,17361/20013
ppg post - meal test,C1418888;C0376674;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;true;false;false;false;false;false;false;false,17362/20013
ppi,C0358591;C0871125;C3811894,true;true;false,17363/20013
ppi or hnmbr receptor antagonist,C0358591;C0871125;C3811894,true;true;false,17364/20013
ppi use,C0358591;C0871125;C3811894,true;true;false,17365/20013
ppi use ( p = nmbr . nmbrt ),C0358591;C0871125;C3811894,true;true;false,17366/20013
ppi use at baseline,C0358591;C0871125;C3811894,true;true;false,17367/20013
ppi use within nmbr months of randomization,C0358591;C0871125;C3811894,true;true;false,17368/20013
pr / virgin islands,C0279759;C0042752;C0279766;C1418864;C3538934;C3538935;C3889640;C4048189;C4082178;C4082184;C4085573;C4552913;C4552914,false;true;false;false;false;false;false;false;false;false;false;false;false,17369/20013
pra,C0633231;C1141951;C1419788;C3274822;C3669212;C4283900,true;false;false;false;false;false,17370/20013
pravastatin ( n = nmbr ),C0085542,true,17371/20013
pravastatin n = nmbr,C0085542,true,17372/20013
pravastatin sodium,C0700474,true,17373/20013
pravastatin vs usual care,C0085542,true,17374/20013
pre - bd fvc < nmbr % of predicted,C0332152;C0005126;C3714541;C0681842;C1882327;C2344255;C4050145;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,17375/20013
pre - bd fvc snmbr % of predicted,C0332152;C0005126;C3714541;C0681842;C1882327;C2344255;C4050145;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,17376/20013
pre - bronchodilator fefnmbr . nmbr ( ml / s ) baseline blood eosinophil count,C2599602;C0439390;C0168634;C0014467;C0750480;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664;C1442488,false;false;true;true;false;false;true;false;false;true;false;false,17377/20013
pre - bronchodilator fev i ( l ),C2599602;C3714541;C0021966;C0221138,false;true;true;false,17378/20013
pre - bronchodilator fev,C2599602;C3714541,false;true,17379/20013
pre - bronchodilator fev^ ( l ),C2599602;C3714541,false;true,17380/20013
pre - bronchodilator fevi change,C2599602;C0849974;C1561566;C4528367,false;false;false;false,17381/20013
pre - bronchodilator fevi / fvc   %,C2599602;C0802741;C3815113,false;false;false,17382/20013
pre - bronchodilator fevj,C2599602,false,17383/20013
pre - bronchodilator fevr % pred,C2599602;C1708033,false;false,17384/20013
pre - bronchodilator fevr l,C2599602;C1708033,false;false,17385/20013
pre - bronchodilator fvc ’ % pred,C2599602;C3714541,false;true,17386/20013
pre - bronchodilator mean ( sd ) fevnmbr,C2599602;C0444504;C2699239;C3714541;C2347634;C2348143,false;false;false;true;false;false,17387/20013
pre - bronchodilator screening,C2599602;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,17388/20013
pre - dose,C0439565;C3812758,false;false,17389/20013
pre - hospital ticagrelor ( n = nmbr ),C0332152;C0019994;C1999375;C1510665;C0740175;C2257086;C3669034,false;true;true;false;false;false;false,17390/20013
pre - procedure,C3272300,false,17391/20013
pre - specified trial endpoints,C2826245,false,17392/20013
pre - treatedforhypertension [n ( % ) ],C0332152;C0740175;C2257086;C3669034,false;false;false;false,17393/20013
pre - treatment[n ( % ) ]c,C1550147;C2709094;C3539075;C3539076,false;false;false;false,17394/20013
pre – diabetes mellitus,C0362046,true,17395/20013
pre fevnmbr,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,17396/20013
pre fevnmbr   % pred,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,17397/20013
pre fvc,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,17398/20013
pre fvc % pred,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,17399/20013
pre hospital ticagrelor,C0332152;C0019994;C1999375;C1510665;C0740175;C2257086;C3669034,false;true;true;false;false;false;false,17400/20013
pre svc,C0332152;C0231957;C0740175;C2257086;C3669034,false;false;false;false;false,17401/20013
prebronchodilator fevnmbr ( %,C2599602;C3714541,false;true,17402/20013
prebronchodilator fevi — liters,C2599602;C0429706;C0475211;C0849974;C1561566;C4528367,false;false;false;false;false;false,17403/20013
prebronchodilator fevi ( % predicted ),C2599602;C0849974;C1561566;C4528367,false;false;false;false,17404/20013
prebronchodilator fevj ( % predicted ),C2599602,false,17405/20013
prediabetese,,,17406/20013
predicted normal ) t,C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327,false;false;false;false;false;false;false,17407/20013
predictive factor,C0683956,false,17408/20013
prednisone - equivalent dose,C0032952;C0205163;C0178602;C0869039;C1114758;C0439185,true;false;false;false;false;false,17409/20013
prednisone or equivalent dose ( mg / day ),C0032952,true,17410/20013
predominant cardiac diagnosis — no . ( % ),C1542147;C0018787;C0011900;C1704338;C1704656;C1522601,false;true;true;true;false;false,17411/20013
predose fev -,C0439565;C3714541;C3812758,false;true;false,17412/20013
predose fev / fvc,C0439565;C3714541;C3812758,false;true;false,17413/20013
predose fev^ at screening,C0439565;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3812758,false;true;true;true;false;false;false;false;false;false,17414/20013
predose fevnmbr ( l ) *,C0439565;C3714541;C3812758,false;true;false,17415/20013
predose fvc ( l ),C0439565;C3714541;C3812758,false;true;false,17416/20013
predose fvc ( l ) *,C0439565;C3714541;C3812758,false;true;false,17417/20013
preferred term,C1709637;C2347664,false;false,17418/20013
pregnancy,C0032961,true,17419/20013
premature discontinuation,C0151526;C0457454;C1444662;C4552847;C0205252;C4018905,true;false;false;false;false;false,17420/20013
premature treatment discontinuation,C0151526;C0039798;C0457454;C1444662;C4552847;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205252;C4018905,true;true;false;false;false;true;false;false;false;false;false;false;false,17421/20013
premixed insulin only ( % ),C0021641;C0205171;C1720467;C1533581;C1579433;C3714501,true;false;false;false;false;false,17422/20013
premixed insulin with oads ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,17423/20013
preoperative p - blocker use yes,C0445204;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,17424/20013
preoperative use p - blocker,C0445204;C0042153;C0457083;C1947944,false;true;false;false,17425/20013
prerandomization pci,C4049621,false,17426/20013
presence of angioedema at baseline,C0150312;C0002994;C0392148;C3854307,false;true;false;false,17427/20013
presence of tophi,C0150312;C0221248;C0392148;C3854307,false;false;false;false,17428/20013
present at screening,C0150312;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0449450,false;true;true;false;false;false;false;false;false,17429/20013
presentation to tertiary care hospital — %,C0449450;C0337954,false;false,17430/20013
presentation *,C0449450,false,17431/20013
presenting condition,C0449450;C0012634;C0348080;C1705253;C3864998,false;true;false;false;false,17432/20013
presenting history or diagnosis — no . ( % ),C0449450;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,17433/20013
prespecified medical conditions,C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,17434/20013
prespecified subgroup analyses,C2986480,false,17435/20013
prespecified subgroups,C1079230,false,17436/20013
pressure ( mm hg ),C0033095;C0439475;C0460139;C1306345;C4284008,true;false;false;false;false,17437/20013
pressure,C0033095;C0460139;C1306345;C4284008,true;false;false;false,17438/20013
prestudy treatment ( % ) a,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,17439/20013
prestudy treatment status,C0749659,false,17440/20013
pretreatment hdl - c,C1550147;C3715113;C2709094;C3539075;C3539076,false;false;false;false;false,17441/20013
pretreatment triglycerides,C1550147;C0041004;C2709094;C3539075;C3539076,false;true;false;false;false,17442/20013
prevalent cvd,C0033105;C0007222;C0220900,true;true;true,17443/20013
prevalent kidney disease ( egfr < nmbr ml / min / usm^ or maeroalbuminuria uacr > nmbr mg / g ),C0033105;C0022658;C1739039;C0439445;C3811844;C3812682;C0220900,true;true;true;false;false;false;true,17444/20013
prevalent vertebral fracture,C0033105;C0080179;C0220900,true;true;true,17445/20013
prevalent vertebral fracture status,C0033105;C0080179;C0449438;C0220900,true;true;false;true,17446/20013
prevention ),C0199176;C1706420;C2700409,false;false;true,17447/20013
previous nmbr - ari use ( % ),C0205156;C1412533;C4521376;C1552607,false;false;false;false,17448/20013
previous nmbrari use,C0205156;C1412533;C4521376;C1552607,false;false;false;false,17449/20013
previous a - blocker,C0205156;C1552607,false;false,17450/20013
previous a - blocker use,C0205156;C1552607,false;false,17451/20013
previous af,C0205156;C0344434;C4049859;C1552607,false;false;false;false,17452/20013
previous analgesic products n ( % ),C0205156;C0002771;C1552607,false;true;false,17453/20013
previous anti - inflammatory / antirheumatic products n ( % ),C0205156;C0432633;C0333348;C0003191;C1514468;C1552607,false;false;false;true;false;false,17454/20013
previous antihypertensive treatment,C0205156;C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,17455/20013
previous antihypertensive treatment — no . ( % ),C0205156;C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,17456/20013
previous antiparkinson medication,C0205156;C0003405;C1552607,false;true;false,17457/20013
previous bdmard received,C0205156;C1552607,false;false,17458/20013
previous cancer — no . ( % ),C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,17459/20013
previous cardiovascular event — no . ( % ),C0205156;C1320716;C1552607,false;false;false,17460/20013
previous cardiovascular event ( % ),C0205156;C1320716;C1552607,false;false;false,17461/20013
previous cd related surgery ( ref ) a,C0205156;C0007928;C0034283;C4552032;C1552607,false;true;true;false;false,17462/20013
previous chronic kidney disease,C0205156;C1561643;C4553188;C1552607,false;true;false;false,17463/20013
previous clinical stroke or tia,C0205156;C0205210;C0038454;C4554100;C1552607,false;false;true;false;false,17464/20013
previous clinical stroke or transient ischemic attack ( % ),C0205156;C0205210;C0038454;C4554100;C1552607,false;false;true;false;false,17465/20013
previous congestive heart failure — no . ( % ),C0205156;C0018802;C1552607,false;true;false,17466/20013
previous congestive heart failure ( % ),C0205156;C0018802;C1552607,false;true;false,17467/20013
previous coronary artery bypass graft,C2144990,false,17468/20013
previous coronary artery bypass grafting,C2144990,false,17469/20013
previous coronary artery bypass surgery,C2144990,false,17470/20013
previous coronary heart disease,C0205156;C0010054;C0010068;C1956346;C1552607,false;true;true;true;false,17471/20013
previous coronary procedure ( % of group ),C0205156;C0018821;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1279986;C0018787;C2986530;C1552607,false;true;false;false;true;false;false;false;false;true;false;false,17472/20013
previous cv events,C0205156;C3538987;C0441471;C3541888;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,17473/20013
previous cvd^,C0205156;C0007222;C1552607,false;true;false,17474/20013
previous diabetes mellitus,C0205156;C0011849;C1552607,false;true;false,17475/20013
previous diagnosis,C0332132,false,17476/20013
previous digoxin use,C0205156;C0012265;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,17477/20013
previous digoxin use ( % ),C0205156;C0012265;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,17478/20013
previous disease and drug use,C0205156;C0012634;C1552607,false;true;false,17479/20013
previous dm,C0205156;C0011816;C3250443;C1552607,false;true;false;false,17480/20013
previous dmards,C0205156;C0242708;C1552607,false;true;false,17481/20013
previous events,C0205156;C0441471;C3541888;C1552607,false;false;false;false,17482/20013
previous exposure to a vitamin k antagonist — no . ( % ) current or former never,C0205156;C0332157;C0042839;C0597277;C0231491;C1708601;C0087161;C2825076;C3714656;C1552607,false;false;true;false;false;false;true;false;false;false,17483/20013
previous exposure to biologic systemic psoriasis therapyb ( yes ),C0205156;C0332157;C0005515;C0205373;C0033860;C1549445;C1705108;C1710701;C0205460;C1552607,false;false;true;false;true;false;false;false;false;false,17484/20013
previous exposure to non - biologic systemic psoriasis therapyb ( yes ),C0205156;C0332157;C1518422;C0005515;C0205373;C0033860;C1549445;C1705108;C1710701;C0205460;C1552607,false;false;false;true;false;true;false;false;false;false;false,17485/20013
previous exposure to systemic psoriasis therapyb ( yes ),C0205156;C0332157;C0205373;C0033860;C1549445;C1705108;C1710701;C1552607,false;false;false;true;false;false;false;false,17486/20013
previous heart failure — no . ( % ),C0205156;C0018801;C0018802;C4554158;C1552607,false;true;true;false;false,17487/20013
previous history of cardiovascular events,C2004062;C0007226;C3887460,false;true;false,17488/20013
previous hospital admission for heart failure,C0205156;C0184666;C0018801;C0018802;C4554158;C1552607,false;false;true;true;false;false,17489/20013
previous hospitalization for heart failure,C0205156;C3898876;C1552607,false;false;false,17490/20013
previous hospitalization for unstable angina,C0205156;C0019993;C0002965;C1552607,false;true;true;false,17491/20013
previous htn,C0205156;C0020538;C1552607,false;true;false,17492/20013
previous hypersensitivity reaction — no . ( % ),C0205156;C0020517;C1552607,false;true;false,17493/20013
previous ics alone,C0205156;C0815320;C4551720;C1552607,false;false;true;false,17494/20013
previous ics only,C0205156;C0815320;C0205171;C1720467;C4551720;C1552607,false;false;false;false;true;false,17495/20013
previous ics / labd,C0205156;C0815320;C0396059;C4551720;C1552607,false;false;true;true;false,17496/20013
previous infarction,C0205156;C0021308;C1552607,false;true;false,17497/20013
previous infarction ( % of group ),C0205156;C0021308;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1552607,false;true;false;false;true;false;false;false;false,17498/20013
previous infliximab therapy | |,C0205156;C4076075;C1552607,false;false;false,17499/20013
previous intervention ( % ),C0205156;C0184661;C0886296;C1273869;C1552607,false;true;false;false;false,17500/20013
previous ischemic heart disease — no . ( % ),C0205156;C0010054;C0151744;C1552607,false;true;true;false,17501/20013
previous ischemic stroke / tia ( n = nmbr  nmbr . nmbr % ),C0205156;C0948008;C0007787;C0917805;C1054154;C1552607,false;false;true;true;false;false,17502/20013
previous labd alone,C0205156;C0396059;C1552607,false;true;false,17503/20013
previous labd only,C0205156;C0396059;C0205171;C1720467;C1552607,false;true;false;false;false,17504/20013
previous lev only,C0205156;C0023556;C0205171;C1720467;C1552607,false;true;false;false;false,17505/20013
previous mi ( % ),C0205156;C3810814;C1552607,false;false;false,17506/20013
previous ml or abnormal angiogram,C0205156;C0439526;C1705224;C3887665;C1552607,false;false;false;false;false,17507/20013
previous myocardiaunfarction,C0205156;C1552607,false;false,17508/20013
previous number of ciu / csu medications,C0205156;C1718138;C0578870;C1552607,false;false;false;false,17509/20013
previous oral antidiabetic medication use,C0205156;C1527415;C0935929;C1552607,false;false;true;false,17510/20013
previous pdenmbr - i therapy,C0205156;C0021966;C0039798;C0087111;C1363945;C0221138;C1552607,false;true;true;true;false;false;false,17511/20013
previous pdenmbr inhibitors,C0205156;C0031638;C1552607,false;true;false,17512/20013
previous renal disease,C0205156;C0022658;C1552607,false;true;false,17513/20013
previous revascularization,C0205156;C0581603;C1552607,false;false;false,17514/20013
previous segments resection ( s ) *,C0205156;C2987624;C1552607,false;false;false,17515/20013
previous smoker,C0337671,false,17516/20013
previous smokers,C0337671,false,17517/20013
previous stroke 一 no . ( % ),C0205156;C1552607,false;false,17518/20013
previous stroke or tia ( n = nmbr ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,17519/20013
previous stroke or tl a,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17520/20013
previous stroke or tl a nmbr - nmbr,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17521/20013
previous stroke or transient ischemic attack — no . / total,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17522/20013
previous stroke or transient ischemic attack,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17523/20013
previous stroke ortia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17524/20013
previous stroke ortia nmbr - nmbr,C0205156;C0038454;C4554100;C1552607,false;true;false;false,17525/20013
previous stroke yes ( n,C0205156;C3841753;C1552607,false;false;false,17526/20013
previous stroke / tia,C0205156;C0038454;C0007787;C0917805;C1054154;C4554100;C1552607,false;true;true;true;false;false;false,17527/20013
previous systemic treatment,C0205156;C0678812;C1552607,false;false;false,17528/20013
previous therapies,C0205156;C0087111;C1552607,false;true;false,17529/20013
previous therapy,C0205156;C0039798;C0087111;C1363945;C1552607,false;true;true;false;false,17530/20013
previous treatment in the healing study,C0205156;C0043240;C1521826;C3161471;C0205249;C1552607,false;true;false;false;false;false,17531/20013
previous treatment with infliximab,C0205156;C0039798;C0666743;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,17532/20013
previous treatment ?,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,17533/20013
previous use of biologic systemic therapy,C0205156;C1524063;C0005527;C0205373;C0005515;C1515119;C0205460;C1552607,false;false;true;false;true;false;false;false,17534/20013
previous use of niacin or niaspan §,C0205156;C1524063;C0027996;C1142562;C1552607,false;false;true;false;false,17535/20013
previous use of nonbiologic systemic therapy,C0205156;C1524063;C1515119;C1552607,false;false;false;false,17536/20013
previous use of other biologic agents in addition to tne,C0205156;C1524063;C0005515;C1552607,false;false;true;false,17537/20013
previous use of systemic steroids for ciu / csu,C0205156;C0281991;C0205373;C1552607,false;false;false;false,17538/20013
previous use of systemic steroids,C0205156;C0281991;C0205373;C1552607,false;false;false;false,17539/20013
previous use of vitamin k antagonist for > nmbr days — no . ( % ),C0205156;C1524063;C1096489;C2267235;C1552607,false;false;false;false;false,17540/20013
previous vka use,C0205156;C0042153;C0457083;C1947944;C1552607,false;true;false;false;false,17541/20013
previous vka use ( stratified randomization ),C0205156;C0042153;C4687737;C0457083;C1947944;C1552607,false;true;false;false;false;false,17542/20013
previous vte,C0205156;C0630906;C1552607,false;true;false,17543/20013
previous vte n ( % ),C0205156;C0630906;C1552607,false;true;false,17544/20013
previously failed anti - tnf treatment,,,17545/20013
previously untreated isolated systolic hypertension,C0332155;C0745133,false;false,17546/20013
primary - prevention cohort,C0033144;C0009247;C0599755,true;true;false,17547/20013
primary analysis,C0205225;C0002778;C0936012;C1524024;C0439612;C0439631,false;false;false;true;false;false,17548/20013
primary and secondary prevention subgroups  adjusted for age  gender  hypertension  diabetes mellitus  and smoking . hr indicates hazard ratio  nmbr % cl  nmbr % confidence interval  tia  transient ischemic attack .,C0205225;C0439612;C0439631,false;false;false,17549/20013
primary cardiovascular endpoint,C2986535;C0007226;C3887460,false;true;false,17550/20013
primary cause of chf,C0205225;C0015127;C0018802;C1524003;C0439612;C0439631,false;true;true;false;false;false,17551/20013
primary cause of heart failure,C0205225;C0015127;C0018801;C0018802;C4554158;C1524003;C0439612;C0439631,false;true;true;true;false;false;false;false,17552/20013
primary composite end point ‡,C2986535;C0205199;C1547335,false;false;false,17553/20013
primary composite end points,C0205225;C0205199;C2349179;C1547335;C0439612;C0439631,false;false;false;false;false;false,17554/20013
primary composite endpoint ‡,C2986535;C0205199;C1547335,false;false;false,17555/20013
primary composite^,C0205225;C0205199;C1547335;C0439612;C0439631,false;false;false;false;false,17556/20013
primary cv endpoint,C2986535;C3538987;C4048877;C4318503,false;false;true;false,17557/20013
primary efficacy outcome,C0205225;C1280519;C1274040;C1707887;C0439612;C0439631,false;false;false;false;false;false,17558/20013
primary end - point,C2986535,false,17559/20013
primary end point |,C2986535,false,17560/20013
primary end point *,C2986535,false,17561/20013
primary end points,C0205225;C2349179;C0439612;C0439631,false;false;false;false,17562/20013
primary endpoint :,C2986535,false,17563/20013
primary endpoint^,C2986535,false,17564/20013
primary endpoint ’,C2986535,false,17565/20013
primary endpointnmbr,C2986535,false,17566/20013
primary hemorrhagic stroke,C0205225;C0553692;C0439612;C0439631,false;true;false;false,17567/20013
primary indication,C1549995,false,17568/20013
primary ischemic stroke,C0205225;C0948008;C0439612;C0439631,false;false;false;false,17569/20013
primary mace endpoint,C2986535;C0349381;C0949745;C1445339,false;false;true;false,17570/20013
primary nonresponse,C0205225;C0439612;C0439631,false;false;false,17571/20013
primary outcome ( nmbr - point mace ),C0205225;C1274040;C1552961;C0349381;C0949745;C1445339;C2347617;C3714763;C0439612;C0439631,false;false;false;false;true;false;false;false;false;false,17572/20013
primary outcome plus revascularization or nonfatal hf,C0205225;C1274040;C0332287;C0581603;C0439612;C0439631,false;false;false;false;false;false,17573/20013
primary outcome ! ( n = nmbr ),C0205225;C1274040;C0439612;C0439631,false;false;false;false,17574/20013
primary outcome : nmbr % decrease in womac pain score,C0205225;C1274040;C0392756;C0582148;C0547047;C0439612;C0439631,false;false;false;false;false;false;false,17575/20013
primary pcit,C0205225;C0439612;C0439631,false;false;false,17576/20013
primary safety outcome -,C0205225;C0036043;C1274040;C1705187;C0439612;C0439631,false;true;false;false;false;false,17577/20013
primary study joint,C0205225;C0557651;C0022417;C0392905;C1706309;C2603343;C0439612;C0439631,false;false;true;false;false;false;false;false,17578/20013
primary target vessel ( % ),C0205225;C0449618;C0439612;C0439631,false;false;false;false,17579/20013
primary / key efficacy endpoint,C1709665;C1280519;C2349179;C2826544;C1707887,false;false;false;false;false,17580/20013
prior a - blocker use,C0332152;C2826257,false;false,17581/20013
prior acbi or arb use,C0332152;C2826257,false;false,17582/20013
prior admb,C0332152;C2826257,false;false,17583/20013
prior aeds,C0332152;C0180309;C2826257,false;true;false,17584/20013
prior analgesic products,C0332152;C0002771;C2826257,false;true;false,17585/20013
prior angina ( n = nmbr,C0332152;C0002962;C2826257,false;true;false,17586/20013
prior angina pectoris,C0332152;C0002962;C2826257,false;true;false,17587/20013
prior angina pectoris — no . / total no . ( % ),C0332152;C0002962;C2826257,false;true;false,17588/20013
prior angiography showing stenosis ≥ nmbr %,C0332152;C0002978;C2826257,false;true;false,17589/20013
prior anti - tnf exposure,C0332152;C1448177;C0274281;C0332157;C2826257,false;true;false;false;false,17590/20013
prior anti - tnf failure,C0332152;C1448177;C0231174;C0680095;C2826257,false;true;false;false;false,17591/20013
prior anti - tnf treatment,C1514463;C1448177,false;true,17592/20013
prior antiinflammatory / antirheumatic products,C0332152;C0003209;C0003191;C1514468;C1515999;C2826257,false;true;true;false;false;false,17593/20013
prior aortocoronary bypass surgery — no . ( % ),C0455610;C0010055,false;true,17594/20013
prior aspirin use,C0332152;C0004057;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,17595/20013
prior bb plus acbi plus arb use,C0332152;C0004739;C0332287;C3888198;C0042153;C0457083;C1947944;C0332297;C2826257,false;true;false;false;true;false;false;false;false,17596/20013
prior bisphosphonate usage,C0332152;C0012544;C0457083;C2267018;C2826257,false;true;false;false;false,17597/20013
prior bp use,C0332152;C0037623;C0042153;C0457083;C1947944;C1415692;C1708288;C4318478;C2826257,false;true;true;false;false;false;false;false;false,17598/20013
prior cabg surgery,C0455610;C0010055,false;true,17599/20013
prior cad,C0332152;C1504769;C2239547;C3813548;C4284121;C2826257,false;true;false;false;false;false,17600/20013
prior cardiovascular event,C0332152;C1320716;C2826257,false;false;false,17601/20013
prior chf,C0332152;C0018802;C2826257,false;true;false,17602/20013
prior clinical fracture ( since age nmbr ),C0332152;C0205210;C0016658;C2826257,false;false;true;false,17603/20013
prior conventional synthetic dmards,C0332152;C0439858;C1883254;C0242708;C2826257,false;false;false;true;false,17604/20013
prior copd medication,C0332152;C0024117;C0013227;C3244316;C4284232;C1412502;C3714496;C2826257,false;true;true;false;false;false;false;false,17605/20013
prior copd medicationa,C0332152;C0024117;C1412502;C3714496;C2826257,false;true;false;false;false,17606/20013
prior coronary intervention or coronary artery bypass grafting,C0332152;C0018787;C0184661;C0886296;C1273869;C2826257,false;true;true;false;false;false,17607/20013
prior coronary revascularization — no . { % ),C0332152;C0877341;C2826257,false;false;false,17608/20013
prior corticosteroid treatment,C1514463;C0001617;C3536709,false;true;false,17609/20013
prior cvd,C0332152;C0007222;C2826257,false;true;false,17610/20013
prior ed therapy,C1514463;C3538926,false;false,17611/20013
prior electrical cardioversion for af ( n = nmbr nmbr ),C0332152;C0013778;C0344434;C4049859;C0542380;C2826257,false;true;false;false;false;false,17612/20013
prior gestational diabetes,C0332152;C0085207;C2826257,false;true;false,17613/20013
prior heart failure — no . { % ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,17614/20013
prior hf ( n = nmbr,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,17615/20013
prior hf hospitalization,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,17616/20013
prior hf hospitalization ( n = nmbr ),C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,17617/20013
prior hf n = nmbr,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,17618/20013
prior history of bleeding on oac,C0332152;C0019664;C0019080;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;true;true;false;false;false;false;false,17619/20013
prior hospitalization for hf,C0332152;C0019993;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,17620/20013
prior hospitalizations,C0332152;C0019993;C2826257,false;true;false,17621/20013
prior htn ( n = nmbr,C0332152;C0020538;C2826257,false;true;false,17622/20013
prior hypertension,C0332152;C0020538;C1963138;C2826257,false;true;false;false,17623/20013
prior immunosuppressant failure,C0332152;C0021081;C0231174;C0680095;C2826257,false;true;false;false;false,17624/20013
prior immunosuppressant failure  ,C0332152;C0021081;C0231174;C0680095;C2826257,false;true;false;false;false,17625/20013
prior immunosuppressant failurec,C0332152;C0021081;C2826257,false;true;false,17626/20013
prior immunosuppressive exposure,C0332152;C0021081;C0274281;C0332157;C2826257,false;true;false;false;false,17627/20013
prior infarction,C0332152;C0021308;C2826257,false;true;false,17628/20013
prior insulin use ( years ),C0332152;C0240016;C0439234;C2826257,false;false;false;false,17629/20013
prior lev,C0332152;C0023556;C2826257,false;true;false,17630/20013
prior medication use,C0332152;C0240320;C2826257,false;false;false,17631/20013
prior mesalazine use *,C0332152;C0127615;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,17632/20013
prior mi ( n = nmbr,C0332152;C3810814;C2826257,false;false;false,17633/20013
prior mi diagnosis :,C0332132;C3810814,false;false,17634/20013
prior mi n = nmbr,C0332152;C3810814;C2826257,false;false;false,17635/20013
prior mi within nmbr y,C0332152;C3810814;C2826257,false;false;false,17636/20013
prior ml or stroke at baseline,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,17637/20013
prior ml / stroke,C0332152;C0439526;C0038454;C4554100;C1705224;C3887665;C2826257,false;false;true;false;false;false;false,17638/20013
prior ms treatment with ifn - beta or glatiramer acetate . no . ( % ),C1514463;C2349943;C0015980;C3539704;C3713294,false;false;true;false;true,17639/20013
prior myocardial infarction — no . { % ),C0155668,false,17640/20013
prior myocardial infarction — no . / total no . ( % ),C0155668,false,17641/20013
prior myocardial infarction ( % ),C0155668,false,17642/20013
prior myocardial intarction,C0332152;C0027061;C1522564;C2826257,false;true;false;false,17643/20013
prior non - cns se,C0332152;C1518422;C3714787;C0036919;C2826257,false;false;true;true;false,17644/20013
prior non - haemorrhagic stroke,C0332152;C1518422;C0553692;C2826257,false;false;true;false,17645/20013
prior nonvertebral fracture,C0332152;C0016658;C2826257,false;true;false,17646/20013
prior nonvertebral fracture at age > nmbr years,C0332152;C0016658;C1510829;C2826257,false;true;false;false,17647/20013
prior nsaid use,C0332152;C0003211;C0042153;C0457083;C1947944;C3536840;C2826257,false;true;true;false;false;false;false,17648/20013
prior nsaid,C0332152;C0003211;C3536840;C2826257,false;true;false;false,17649/20013
prior oabg surgery,C0455610,false,17650/20013
prior oac,C0332152;C2826257,false;false,17651/20013
prior oad :,C0332152;C2826257,false;false,17652/20013
prior oma use,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,17653/20013
prior oma use ( n = nmbr ),C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,17654/20013
prior pad,C0332152;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C2826257,false;false;false;false;false;false;false;false,17655/20013
prior pci or cabg,C0332152;C4049621;C2826257,false;false;false,17656/20013
prior percutaneous coronary intervention — no . / total no . ( % ),C0332152;C1532338;C2826257,false;true;false,17657/20013
prior ptca or cabg,C0332152;C2936173;C2826257,false;true;false,17658/20013
prior revascularization ( % ),C0332152;C0581603;C2826257,false;false;false,17659/20013
prior revascularization ( n = nmbr,C0332152;C0581603;C2826257,false;false;false,17660/20013
prior statin use ( n = nmbr ),C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,17661/20013
prior stroke ( % ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,17662/20013
prior stroke ( n = nmbr ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,17663/20013
prior stroke or tza,C0332152;C0038454;C4554100;C2826257,false;true;false;false,17664/20013
prior stroke / mi,C0332152;C0038454;C3810814;C4554100;C2826257,false;true;false;false;false,17665/20013
prior sulfasalazine use *,C0332152;C0036078;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,17666/20013
prior surgery for cd,C0455610;C0007928;C0034283;C4552032,false;true;true;false,17667/20013
prior therapy with omalizumab : yes,C1514463;C0966225;C1549445;C1705108;C1710701,false;true;false;false;false,17668/20013
prior thienopyridine ( - ),C0332152;C1120149;C2826257,false;true;false,17669/20013
prior thienopyridine ( + ),C0332152;C1120149;C2826257,false;true;false,17670/20013
prior tia,C0332152;C0007787;C0917805;C1054154;C2826257,false;true;true;false;false,17671/20013
prior tnf antagonist failure,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,17672/20013
prior tnf antagonist,C0332152;C1448177;C0231491;C2826257,false;true;false;false,17673/20013
prior tnf inhibitor exposure,C0332152;C1448177;C1999216;C0274281;C0332157;C2826257,false;true;false;false;false;false,17674/20013
prior transient ischaemic,C0332152;C0040704;C0475224;C0205374;C2826257,false;true;false;false;false,17675/20013
prior transient ischemic attack,C0332152;C0007787;C0917805;C2826257,false;true;true;false,17676/20013
prior treatment — no . ( % ),C1514463,false,17677/20013
prior urate lowering therapies,C1514463;C0729829;C0441994;C2003888;C0935936,false;false;false;false;true,17678/20013
prior use of osteoporosis medications,C0332152;C1524063;C0029456;C0013227;C0802604;C2598133;C4284232;C4554622;C2826257,false;false;true;true;false;false;false;false;false,17679/20013
prior use of synthetic dmards,C0332152;C1524063;C1883254;C0242708;C2826257,false;false;false;true;false,17680/20013
prior vka experience,C0332152;C0237607;C0596545;C2826257,false;false;false;false,17681/20013
prior vka use for > nmbr d,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,17682/20013
pro - active intervention,C0033382;C0205177;C0184661;C0886296;C1273869;C3853793;C3888249;C0523852;C2987124,true;false;true;false;false;false;false;false;true,17683/20013
probable stent thrombosis,C0033204;C3897493;C0332148,true;false;false,17684/20013
probenecid,C0033209,true,17685/20013
procedures after discharge — no . ( % ),C0025664;C0012621;C0030685;C2926602;C0184661;C2700391;C3538935,true;false;true;false;true;false;false,17686/20013
procedures in the hospital — no . ( % ),C0025664;C0019994;C1510665;C0184661;C2700391;C3538935,true;true;false;true;false;false,17687/20013
progression of albuminuria,C0242656;C0001925;C0449258,true;true;false,17688/20013
progression to diabetes,C1735364,false,17689/20013
propafenone,C0033429,true,17690/20013
propionic acid derivatives,C0033482;C0695274;C3540752,true;false;false,17691/20013
proportion,C1709707,false,17692/20013
proportion ( % ) of individuals • control alirocumab,C1709707;C0027361;C0237401,false;true;false,17693/20013
proportion ( % ) of individuals a alirocumab • placebo,C1709707;C0027361;C0237401,false;true;false,17694/20013
proportion of angioedema - free days from week nmbr to week nmbrx,C1709707;C0002994;C0332296;C0439228;C1880497;C1996904,false;true;false;false;false;false,17695/20013
proportion of patients who achieved acrnmbr n / n ( % ),C1709707;C0030705,false;true,17696/20013
proportion of patients with trough fevi > nmbr ml above baseline,C1709707;C0030705,false;true,17697/20013
proportion of responders n / n ( % ),C1709707,false,17698/20013
proportion taking pulmonary medications ( % ) b,C1709707,false,17699/20013
proportions,C1709707,false,17700/20013
prostate biopsy,C0194804,false,17701/20013
prostate volume ( cmnmbr ),C1441416,false,17702/20013
prostate volume ( ml ),C1441416;C0439526;C1705224;C3887665,false;false;false;false,17703/20013
protein in urine,C0033687,true,17704/20013
proteinuria ( > nmbr g / nmbr h ),C0033687;C0560020;C1962972;C4554346,true;false;false;false,17705/20013
proton pump inhibitor,C0358591;C3536754;C4521480,true;false;false,17706/20013
proton pump inhibitor ( n,C0358591;C3536754;C4521480,true;false;false,17707/20013
proximal,C0205107;C4489236,false;false,17708/20013
proximal gi tract,C0205107;C0017189;C4489236,false;true;false,17709/20013
proximal gl tract,C0205107;C0018229;C1185740;C1423073;C1427674;C4489236,false;true;false;false;false;false,17710/20013
psa - modified mases score ( nmbr - nmbr ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,17711/20013
psa ‐ modified mases score ( nmbr – nmbr scale ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,17712/20013
psa - modified shs of hands & feetnmbr ( nmbr - nmbr ),C3810537;C0392747;C0018563;C0016504;C0347981;C1552914;C3889737;C3813209,false;false;true;true;false;false;false;false,17713/20013
psa ‐ modified shs of hands and feet,C3810537;C0392747;C0018563;C1552914;C3889737;C3813209,false;false;true;false;false;false,17714/20013
psa - modified shs ( nmbr - nmbr ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,17715/20013
psa ( ng / ml ),C3810537;C0439275;C3813209,false;false;false,17716/20013
psa duration ( years ),C3810537;C0449238;C0439234;C2926735;C3813209,false;false;false;false;false,17717/20013
psa level,C4086720,false,17718/20013
psa pain ( vas ),C3810537;C0042815;C3813209,false;true;false,17719/20013
psa reported,C3810537;C3813209,false;false,17720/20013
psa subtypes,C3810537;C0449560;C3813209,false;false;false,17721/20013
psaqol,,,17722/20013
psoriasis ( n =,C0033860,true,17723/20013
psoriasis > nmbr % of bsa,C0033860,true,17724/20013
psoriasis bsa > nmbr %,C0033860,true,17725/20013
psoriasis characteristics,C0033860;C1521970,true;false,17726/20013
psoriasis duration ( years ),C0033860;C0449238;C0439234;C2926735,true;false;false;false,17727/20013
psychoactivesd,,,17728/20013
psychogenic,C0458006,false,17729/20013
psycholeptics,C3653516,false,17730/20013
pt . years = nmbr,C0032743;C0439234;C0699718,true;false;false,17731/20013
ptga ( nmbr - nmbr cm vas ),C0042815;C3536884;C3827561,true;true;false,17732/20013
ptga of disease activity ( nmbr ‒ nmbr mm ),C1292728;C4330985;C4554674,false;false;false,17733/20013
ptga ⁎ ⁎ ⁎,,,17734/20013
ptrend across doses,C0178602,false,17735/20013
pts,C1419129;C2698747,false;false,17736/20013
ptxnmbr ( ng / ml ),C0030899;C0439275,true;false,17737/20013
puerto rican,C0034043,true,17738/20013
pulmonary congestion ( cxr ),C0242073;C0006888;C0039985,false;true;false,17739/20013
pulmonary embolism only,C0034065;C0205171;C1720467,true;false;false,17740/20013
pulmonary embolisma,C0024109;C2707265;C2709248;C4522268,true;false;false;false,17741/20013
pulmonary embolismb,C0024109;C2707265;C2709248;C4522268,true;false;false;false,17742/20013
pulmonary function tests ( post - bronchodilator ),C0024119;C2598152,true;false,17743/20013
pulmonary medication during baseline ! ',C0024109;C0013227;C0168634;C1442488;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;true;false;false;false;false;false;false,17744/20013
pulmonary medications ( % ),C0024109;C0013227;C0802604;C2598133;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false;false,17745/20013
pulmonary vascular resistance,C0456261;C0488644,true;false,17746/20013
pulse — beats / min,C0232117;C0391850;C1947910,true;false;false,17747/20013
pulse in beats / minute,C0232117;C0439385;C0391850;C1947910,true;false;false;false,17748/20013
pulse pressure ( median nmbr . nmbr],C0949236;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,17749/20013
pulse pressure ( mm hg ),C0949236;C0439475,true;false,17750/20013
pulse pressure ( mmhg ),C0949236;C0439475,true;false,17751/20013
pulse rate ( mean nmbr h ),C0232117;C0444504;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,true;false;true;false;false;false;false;false;false,17752/20013
pulse rate,C0232117,true,17753/20013
pulse,C0232117;C0391850;C1947910,true;false;false,17754/20013
pump,C0182537,false,17755/20013
pure motor hemiparesis,C2247561;C1513492;C0018989;C1705994,false;false;true;false,17756/20013
pure sensory stroke,C2247561;C0445254;C0038454;C4554100,false;false;true;false,17757/20013
pv,C0030840;C0032463,true;true,17758/20013
pvalue ∗,,,17759/20013
pvaluefor interaction nmbr - nmbr,C1704675,false,17760/20013
pvaluefor trend,C1521798;C4554533,false;false,17761/20013
pvr volume,C0242852;C0449468;C1690016;C1705102;C2700258;C0456261;C1419141,true;false;false;false;false;true;false,17762/20013
pvr,C0242852;C0456261;C1419141,true;true;false,17763/20013
pyrexia,C0015967,true,17764/20013
q ( q nmbr\,,,17765/20013
q wave in the infarct territory at baseline *,C0429089;C0021308;C1301808;C2983136;C1305738,false;true;false;false;false,17766/20013
q waves in the infarct territory at baseline *,C0429089;C0021308;C1301808;C2983136;C1305738,false;true;false;false;false,17767/20013
qnmbr - qnmbr,,,17768/20013
qnmbr ( n   = nmbr ),,,17769/20013
qnmbrw ( n nmbr nmbr ),,,17770/20013
qnmbrw ( n = nmbr ),,,17771/20013
qids - srnmbr,C4331197,false,17772/20013
qmax ( ml / s ),C0439390,false,17773/20013
qmax category,C0683312;C3889287,false;false,17774/20013
qmax,,,17775/20013
qmaxi rn l / s,C2827110;C3540639;C4281819,false;false;false,17776/20013
qol,C0518214,false,17777/20013
qol due to urinary symptoms,C0518214;C0678226;C0426359,false;false;false,17778/20013
qrs $ nmbr ms ( nmbr % cl ) ( n - nmbr ),C2349943;C0596019;C3539704;C3713294,false;false;false;true,17779/20013
qrs < nmbr ms ( nmbr % cl ) ( n - nmbr,C2349943;C0596019;C3539704;C3713294,false;false;false;true,17780/20013
qrs duration,C0429025;C0488377,false;false,17781/20013
qrs width,C0487742,false,17782/20013
qtc > nmbr n = nmbr,,,17783/20013
qtc < nmbr n = nmbr,,,17784/20013
qualifying acs event — no . ( % ),C1514624;C0742343;C0441471;C4019010;C4318612,false;true;false;false;false,17785/20013
qualifying events,C1514624;C0441471;C3541888,false;false;false,17786/20013
qualifying high - risk features — %,C1514624,false,17787/20013
qualifying index event as pe,C1514624;C0600653;C0441471;C0070939;C1880476;C4284304;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false;true;false;false;false,17788/20013
qualifying risk factor,C1514624;C0035648,false;true,17789/20013
qualifying risk factor — no . ( % ),C1514624;C0035648,false;true,17790/20013
qualifying risk factors — no . ( % ),C1514624;C0035648;C1553898,false;true;false,17791/20013
qualifying symptomatic event,C1514624,false,17792/20013
quartiles of fgf - nmbr ( ru / ml ),C2828255;C0016026;C0035970;C0439526;C1705224;C3887665;C1425796;C0919505,false;true;true;false;false;false;false;false,17793/20013
question nmbr ( fatigue / tiredness ),C1522634;C0015672;C4553152;C3463815;C4050243;C4554645,false;true;false;false;false;false,17794/20013
question nmbr ( neck / back / hip pain ),C1522634;C0007859;C0004600;C0019552;C0022122;C1505163;C3538851;C4284725;C0205095;C0460009;C1995000;C1963180;C4553909;C0027530;C0004604;C1963071;C4553945;C0019559;C4551516;C3159206,false;true;true;true;true;true;false;false;false;false;false;false;false;true;true;false;false;false;false;false,17795/20013
question nmbr ( pain / swelling in joints other than neck / back / hips ),C1522634;C0003862;C0013604;C0038999,false;true;true;false,17796/20013
question nmbr ( discomfort from any areas tender to touch / pressure ),C1522634;C2364135;C0205146;C0234234;C0152054;C0439815;C0702221;C4319729,false;false;false;false;true;false;true;false,17797/20013
question nmbr ( morning stiffness since arising ),C1522634;C0457086,false;false,17798/20013
question nmbr ( length of morning stiffness since arising ),C1522634;C1444754;C0457086;C1706316,false;false;false;false,17799/20013
quintile ( n ),C1508496,false,17800/20013
quintile nmbr ( nmbr . nmbr % - nmbr . nmbr % ) ( n = nmbr ),C1508496,false,17801/20013
quintile,C1508496,false,17802/20013
qvanmbr / nmbr pg once daily ( n = nmbr ),C0030827;C0332173;C0072225;C1266240,true;false;true;false,17803/20013
qveral,,,17804/20013
r - tpa,C0032143,true,17805/20013
r ight coronary,C0205090;C0684010;C2603358,false;true;false,17806/20013
r wave in avl ( mm ),C0429091;C0449216;C4330985;C4554674,false;false;false;false,17807/20013
ra - beam,C3538806;C0338248;C2347880;C4521565;C4048756,false;false;false;false;false,17808/20013
ra duration ( years ),C3538806;C0449238;C0439234;C2926735;C4048756,false;false;false;false;false,17809/20013
ra ndosii zat ion,C3538806;C0022023;C1700702;C4048756,false;true;false;false,17810/20013
raas inhibitor,C1999216,false,17811/20013
raas inhibitors,C0243077,true,17812/20013
race - nonwhite,C0034510;C1706779;C3853635,true;false;false,17813/20013
race - n ( % ),C0034510;C1706779;C3853635,true;false;false,17814/20013
race — no . ( % ) : t,C0034510;C1706779;C3853635,true;false;false,17815/20013
race — no . { % ) ' i ',C0034510;C1706779;C3853635,true;false;false,17816/20013
race — no . { % ) - i -,C0034510;C1706779;C3853635,true;false;false,17817/20013
race — no . / total no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,17818/20013
race ( % white ),C0034510;C1706779;C3853635,true;false;false,17819/20013
race ( % ) white,C0034510;C1706779;C3853635,true;false;false,17820/20013
race ( % ) *,C0034510;C1706779;C3853635,true;false;false,17821/20013
race ( non - white ) ( % ),C0034510;C1706779;C3853635,true;false;false,17822/20013
race ( p = o - nmbr ),C0034510;C1706779;C3853635,true;false;false,17823/20013
race ( white,C0034510;C1706779;C3853635,true;false;false,17824/20013
race or ethnic group — no . ( % ) : t,C0034510;C1706779;C3853635,true;false;false,17825/20013
race or ethnic group — no . { % ) ■ ' ( white,C0034510;C1706779;C3853635,true;false;false,17826/20013
race or ethnic group ( % ) f,C0034510;C1706779;C3853635,true;false;false,17827/20013
race or ethnic origin,C0034510;C1706779;C3853635,true;false;false,17828/20013
race white,C0034510;C1706779;C3853635,true;false;false,17829/20013
race :,C0034510;C1706779;C3853635,true;false;false,17830/20013
race : white,C0034510;C1706779;C3853635,true;false;false,17831/20013
race_white,C0034510;C1706779;C3853635,true;false;false,17832/20013
race §,C0034510;C1706779;C3853635,true;false;false,17833/20013
racec,C4287599,false,17834/20013
racey,,,17835/20013
racial category,C0034510;C0683312;C3889287;C1706779;C3669213;C3853635,true;false;false;false;false;false,17836/20013
radiate,C0332301,false,17837/20013
radiographic progression based on change from baseline > sdc,C0444708;C0242656;C0449258,false;true;false,17838/20013
radionuclide ventriculography,C0017200;C0034610,true;true,17839/20013
raee,,,17840/20013
ramus,C3538818,false,17841/20013
randomised patients ( n ),C0030705,true,17842/20013
randomised patients with > nmbr % bsa psoriasis skin involvement at baseline,C0030705;C0033860;C0444099;C1314939;C1123023;C4520765,true;true;false;false;true;false,17843/20013
randomised patients with basdai assessment at baseline and week nmbr,C1998004;C0679830,false;false,17844/20013
randomised patients with dactylitis at baseline,C0030705;C0239161,true;false,17845/20013
randomised patients with enthesitis at baselinet,C0030705;C1282952,true;false,17846/20013
randomised patients with spondylitis at baseline,C0030705;C0038012,true;true,17847/20013
randomization - to - angiography,C0034656;C0002978,true;true,17848/20013
randomization - to - angiography distribution time,C0034656;C0002978;C0681683,true;true;false,17849/20013
randomization group,C0034656;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,17850/20013
randomization to,C0034656,true,17851/20013
randomization to end of study,C0034656,true,17852/20013
randomization to first balloon inflation,C0034656;C0205435;C0336867;C0021398;C1318493;C0441144;C1279901,true;false;false;true;false;false;false,17853/20013
randomization ),C0034656,true,17854/20013
randomize,,,17855/20013
randomized < nmbr hr after presentation — %,C0034656;C0449450;C3815594,true;false;false,17856/20013
randomized group by subgroup interaction,C0034656;C0441833;C1079230;C1704675;C1515021;C0687744;C1257890;C1519504;C1705428;C1705429;C3815594,true;false;false;false;false;false;true;false;false;false;false,17857/20013
randomized patients,C0034656;C0030705;C3815594,true;true;false,17858/20013
randomized to canakinumab nmbr mg,C0034656;C3815594,true;false,17859/20013
randomized to receive aspirin yes,C0034656;C3815594,true;false,17860/20013
randomized to receiveaspirin,C0034656;C3815594,true;false,17861/20013
randomized treatment,C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3815594,true;true;true;false;false;false;false;false;false,17862/20013
randomized treatments,C0034656;C0087111;C3815594,true;true;false,17863/20013
randomly assigned to ace,,,17864/20013
randomly assigned to calcium channel blocker,,,17865/20013
randomly assigned to diuretic,,,17866/20013
range ed etiology ( n ),C1514721;C3538926;C0015127;C1314792;C1524003;C2348147;C3542016,false;false;true;true;false;false;false,17867/20013
range iga modified nmbr score,C1514721;C2825347;C2348147;C3542016,false;false;false;false,17868/20013
range of sbp,C1514721;C0085805;C2348147;C3542016,false;true;false;false,17869/20013
range race,C1514721;C0034510;C1706779;C3853635;C2348147;C3542016,false;true;false;false;false;false,17870/20013
rank based on treatment   =   placebo,C0667477;C0699794,true;false,17871/20013
rankin scale ≥ nmbr,C0451405,false,17872/20013
ranolazine ( n nmbr nmbr ),C0073633,true,17873/20013
ranolazine n = nmbr,C0073633,true,17874/20013
ranotazine vs . placebo km failure rate,,,17875/20013
rash,C0015230,true,17876/20013
rate,C0871208;C1521828,false;false,17877/20013
rate - control group ( n = nmbr ),C0489879;C0441848,false;false,17878/20013
rate ( % per year ),C0871208;C0439234;C0439508;C1521828,false;false;false;false,17879/20013
rate ( ml / min / nmbr . nmbrmnmbr ),C0871208;C0439445;C0369637;C0441923;C1521828,false;false;false;false;false,17880/20013
rate difference ( events / year ),C0871208;C1705241;C0441471;C0439234;C0439508;C3541888;C1705242;C1521828,false;false;false;false;false;false;false;false,17881/20013
rate difference ( lebrikizumab - placebo ),C0871208;C1705241;C2981360;C0032042;C1696465;C1706408;C1705242;C1521828,false;false;true;true;false;false;false;false,17882/20013
rate estimate ( nmbr % ci ),C0871208;C0750572;C0008107;C3259781;C1521828,false;false;true;false;false,17883/20013
rate in all participants,C0871208;C0679646;C1521828,false;false;false,17884/20013
rate of non - progression ( defined as cfb in mtss £ nmbr ),C0871208;C3839460;C1521828,false;false;false,17885/20013
rate of non - progression ( defined as cfb in mtss £ nmbr . nmbr ),C0871208;C3839460;C1521828,false;false;false,17886/20013
rate of oral or systemic corticosteroid,C0871208;C0442027;C4521986;C1521828,false;false;false;false,17887/20013
rate of sares,C0871208;C1521828,false;false,17888/20013
rate per nmbr - patient - years ( control vs alirocumab ) *,C0871208;C0030705;C0439234;C1521828,false;true;false;false,17889/20013
rate per nmbr - patient - years ( control vs alirocumab ) i,C0871208;C0030705;C0439234;C1521828,false;true;false;false,17890/20013
rate per nmbr patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,17891/20013
rate ratio ( lebrikizumab vs placebo,C0871208;C0456603;C2981360;C1547037;C1521828,false;false;true;false;false,17892/20013
rate ratio { nmbr % cl ),C0871208;C0456603;C0596019;C1547037;C1521828,false;false;false;false;false,17893/20013
rate ratio mepo / pbo ( nmbr % ci ),C0871208;C0456603;C0031962;C0008107;C3259781;C1547037;C1521828,false;false;true;true;false;false;false,17894/20013
rate ratio vs placebo ( nmbr % ci ),C0871208;C0456603;C1547037;C1521828,false;false;false;false,17895/20013
rate reduction ( % ),C0871208;C0301630;C0392756;C1293152;C4551656;C1521828,false;false;false;false;false;false,17896/20013
rate ( % / year ),C0871208;C0439234;C0439508;C1521828,false;false;false;false,17897/20013
rate / nmbr pyo,C0871208;C0033809;C1521828,false;true;false,17898/20013
rate †,C0871208;C1521828,false;false,17899/20013
rate ‡,C0871208;C1521828,false;false,17900/20013
rates,C0871208;C1521828,false;false,17901/20013
ratet,,,17902/20013
ratet n ( % ),,,17903/20013
ratio mepo / pbo ( nmbr % ci ),C0456603;C0031962;C0008107;C3259781;C1547037,false;true;true;false;false,17904/20013
ratio of fevnmbrto fvc ( % ),C0456603;C3714541;C1547037,false;true;false,17905/20013
ratio of ldl to hdl cholesterol,C0456603;C1547037,false;false,17906/20013
ratio of urinary albumin ( mg ) to creatinine ( g ),C0456603;C2362049;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1547037,false;false;true;true;false;false;false;false;false;false,17907/20013
ratio of urinary albumin ( mg ) to creatinine ( g ) median,C0456603;C2362049;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1547037,false;false;true;true;false;false;false;false;false;false,17908/20013
ratio to baseline in eosinophil count at week nmbr,C0456603;C0168634;C1442488;C1547037,false;true;false;false,17909/20013
ratio to baseline in total ige at week nmbr,C0456603;C0168634;C1442488;C1547037,false;true;false;false,17910/20013
re - cover nmbr dabigatran,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,17911/20013
re - cover nmbr warfarin,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,17912/20013
re - cover ii,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,17913/20013
re - cover / re - cover ii,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,17914/20013
re - medy,C0556581;C2986904,false;false,17915/20013
reason for discontinuation of previous tnfa inhibitor,C0392360;C0457454;C0205156;C1448177;C1999216;C1710304;C1552607;C1444662;C4552847,false;false;false;true;false;false;false;false;false,17916/20013
rec . ischemia,C1424025;C0022116;C4321499;C2606415,false;true;false;true,17917/20013
rec . ischemia leading to hosp,C1424025;C0022116;C4321499;C2606415,false;true;false;true,17918/20013
received antihypertensive within last nmbr days,C1514756;C0003364;C0439228,false;true;false,17919/20013
received drug - eluting stent,C1514756;C1322815,false;true,17920/20013
received first loading dose,C1514756;C0205435;C3714444;C1279901,false;false;false;false,17921/20013
receiving antihypertensive,C1514756,false,17922/20013
receiving antihypertensive treatment -,C1514756,false,17923/20013
receiving antihypertensive treatment,C1514756,false,17924/20013
recent cardiovascular eventf,C0332185;C0007226;C3887460,false;true;false,17925/20013
recent cardioversion ( within nmbr days before randomization ) — no . ( % ),C0332185;C0013778;C0439228,false;true;false,17926/20013
recent treatment ( < nmbr months mmf / ggs ),C0332185;C0039798;C0439231;C0083765;C0209368;C3848524;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;true;true;true;true;false;false;false;false;false,17927/20013
recent use of allopurinol ( within nmbr days of,C0332185;C1524063;C0002144,false;false;true,17928/20013
receptor blocker,C0597357,false,17929/20013
recervini },,,17930/20013
recervng,,,17931/20013
recurrent hf,C1455761;C0018488;C1313497;C1538440;C3273279;C2945760,false;true;true;false;false;false,17932/20013
reduced hdl cholesterol,C0151691,false,17933/20013
reduction in odds %,C0301630;C0392756;C1293152;C4551656,false;false;false;false,17934/20013
reduction in risk % ( nmbr % ci ),C1137094;C0008107;C3259781;C0035647;C0520870;C4552904,true;true;false;true;false;false,17935/20013
reduction of hbanmbrc from baseline ≥ nmbr . nmbr %,C0301630;C0019016;C1825777;C3538758;C0392756;C1293152;C4551656,false;true;false;false;false;false;false,17936/20013
reduction in risk ( nmbr % ci ) %,C1137094;C0008107;C3259781;C0035647;C0520870;C4552904,true;true;false;true;false;false,17937/20013
ref .,C1425988,false,17938/20013
ref §,C1425988,false,17939/20013
reference,C1514811;C1706462,false;false,17940/20013
referent,C1706462,false,17941/20013
refractory to corticosteroids,C0205269;C0001617;C3539185;C3540725;C3540726;C3540727,false;true;false;false;false;false,17942/20013
regadenoson ( n = nmbr ),C1698215,true,17943/20013
region - north america,C0017446;C0028405;C0205147,true;true;false,17944/20013
region - n ( % ),C0017446;C0205147,true;false,17945/20013
region — no . { % ),C0017446;C0205147,true;false,17946/20013
region north america,C0017446;C0028405;C0205147,true;true;false,17947/20013
region ( us ),C0017446;C0205147,true;false,17948/20013
region 一 no . ( % ),C0017446;C0205147,true;false,17949/20013
region n ( % ),C0017446;C0205147,true;false,17950/20013
region of enrollment — no . ( % ),C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,17951/20013
region of residence ( p = nmbr nmbr ),C0017446;C0237096;C0205147,true;false;false,17952/20013
region of the world,C0017446;C2700280;C0205147,true;false;false,17953/20013
region of world — no . ( % ),C0017446;C2700280;C0205147,true;false;false,17954/20013
region ofenrollment — %,C0017446;C0205147,true;false,17955/20013
region ofthe world,C0017446;C2700280;C0205147,true;false;false,17956/20013
region united states,C0017446;C0041703;C0205147,true;true;false,17957/20013
region *,C0017446;C0205147,true;false,17958/20013
region :,C0017446;C0205147,true;false,17959/20013
regions,C0017446;C0205147,true;false,17960/20013
regiont,,,17961/20013
related to study druga,C0439849;C0445223,false;false,17962/20013
relative risk ( nmbr % cl ) comparing icd therapy and placebo using a linear interaction term in the model ( shfmxicd ) *,C0242492;C0596019;C1707455;C0021122;C0039798;C0087111;C1363945,true;false;false;true;true;true;false,17963/20013
relative risk { nmbr % ci ),C0242492;C0008107;C3259781,true;true;false,17964/20013
relative risk comparing icd therapy and placebo,C0242492;C1707455;C0021122;C0039798;C0087111;C1363945,true;false;true;true;true;false,17965/20013
relative risk vs . placebo ( nmbr % cl ),C0242492,true,17966/20013
relative risk * ( nmbr % cl ),C0242492;C0596019,true;false,17967/20013
relative risk ® ' ( nmbr % cl ),C0242492;C0596019,true;false,17968/20013
relative risk ® ( nmbr % cl ),C0242492;C0596019,true;false,17969/20013
relative wall thickness,C0080103;C0677535;C1280412;C0205345;C1547039,true;false;false;false;false,17970/20013
remaining patients,C1527428;C0030705,false;true,17971/20013
remission by : baseline duration of steroid,C0814126;C0168634;C0038317;C1442488,false;true;true;false,17972/20013
remission by : baseline steroid doses,C0544452;C0168634;C0038317;C0178602;C1442488;C0687702,false;true;true;false;false;false,17973/20013
remission component of variable,C0544452;C0449432;C0439828;C4553760;C1705248;C0687702,false;false;false;false;false;false,17974/20013
renal biopsy class,C0194073;C0456387;C1518526;C1705943,false;false;false;false,17975/20013
renal composite *,C0022646;C0205199;C1547335,true;false;false,17976/20013
renal disease,C0022658,true,17977/20013
renal disease ),C0022658,true,17978/20013
renal failure,C0035078;C1963154,true;false,17979/20013
renal function ( egfr ) according to mdrd,C0232804;C1739039;C0680240;C3839656;C3811844;C3812682,false;true;false;false;false;false,17980/20013
renal function ( ml / min ),C0232804;C0439445,false;false,17981/20013
renal function at randomization,C0232804;C0034656,false;true,17982/20013
renal function *,C0232804,false,17983/20013
renal function : ! : n ( % ),C0232804,false,17984/20013
renal functiona,C0022646,true,17985/20013
renal functionb,C0022646,true,17986/20013
renal functionc,C0022646,true,17987/20013
renal impairment ( crcl < nmbr ml / min ),C1565489;C1846718;C0439445,true;false;false,17988/20013
renal impairment *,C1565489,true,17989/20013
renal impairmentf,C0022646,true,17990/20013
renal insufficiency *,C0035078;C1565489,true;true,17991/20013
renin - angiotensin - aldosterone system blocker,C0086907,true,17992/20013
renin - angiotensin system inhibitor use,C0035096;C1999216;C0042153;C0457083;C1947944;C2984247,true;false;true;false;false;false,17993/20013
renin – angiotensin system inhibitor,C0035096;C1999216;C2984247,true;false;false,17994/20013
renin inhibitor,C1960108;C3537174;C4521920,false;false;false,17995/20013
repaired congenital shunts,C0205340;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,17996/20013
repaired s - p shunts,C0205340,false,17997/20013
required corticosteroid and / or antibiotic ( without hospitalization ),C1514873;C0001617;C3536709,false;true;false,17998/20013
required hospitalization,C1708385,false,17999/20013
requiring assistance,C0018896;C1269765,true;false,18000/20013
rescue medication use,C0240320,false,18001/20013
rescue use : mean no . of inhalations / d,C0042153;C0444504;C2347634;C2348143;C0457083;C1947944,true;false;false;false;false;false,18002/20013
resection performed — no . { % ),C0015252;C0728940,false;false,18003/20013
residence in asia,C0237096;C0003980,false;true,18004/20013
resistant htn n = nmbr,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,18005/20013
resistant htn : placebo n = nmbr,C0332325;C0020538;C0032042;C1696465;C1706408;C1514892;C1550464;C2827757,false;true;true;false;false;false;false;false,18006/20013
resistant htn : spiro n = nmbr,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,18007/20013
reslizumab,C1869620,true,18008/20013
reslizumab ( n = nmbr ),C1869620,true,18009/20013
reslizumab nmbr . nmbr   mg / kg ( n   = nmbr ),C1869620;C0439272,true;false,18010/20013
reslizumab nmbr . nmbr mg / kg ( n = nmbr ),C1869620;C0439272,true;false,18011/20013
resllzumab,,,18012/20013
respiratory medication taken at baseline,C0418986,false,18013/20013
responder analyses ( achieving alc < nmbr . nmbr % ),C0002778;C0936012;C1524024,false;false;true,18014/20013
rest angina but not past nmbr h,C0002965;C0152172,true;false,18015/20013
rest angina past nmbr h,C0002965;C1444637;C0033727;C0369286;C0441932;C0564385;C4528284;C4284302;C0152172,true;false;true;false;false;false;false;false;false,18016/20013
rest ofthe world,C0035253;C2700280;C1622890,true;false;false,18017/20013
rest ofworld,C0035253;C1622890,true;false,18018/20013
restriction in normal activities in the past nmbr weeks,C0443288;C4697852,false;false,18019/20013
retinopathy — no . ( % ),C0035309;C1962966,true;false,18020/20013
revascularisation,C0581603,false,18021/20013
revascularization history,C0581603;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,18022/20013
revascularization in nmbr days,C0581603;C0439228,false;false,18023/20013
reversibility — %,C0449261,false,18024/20013
reversibility [ % ],C0449261,false,18025/20013
reversibility < nmbr % ( itt ) ( n = nmbr ),C0449261,false,18026/20013
reversibility < nmbr % ( n = nmbr ),C0449261,false,18027/20013
reversibility > nmbr % ( itt ) ( n = nmbr ),C0449261,false,18028/20013
reversibility > nmbr % ( n = nmbr ),C0449261,false,18029/20013
reversibility snmbr % ( itt ) ( n = nmbr ),C0449261,false,18030/20013
reversibility stratum *,C0449261,false,18031/20013
reversibility to salbutamolc,C0449261,false,18032/20013
reversibility ’ ' %,C0449261,false,18033/20013
reversible,C0205343,false,18034/20013
reversible to albuterolc,C0205343,false,18035/20013
reversible to bronchodilator,C0205343;C0006280,false;true,18036/20013
revive i,,,18037/20013
revive ii,,,18038/20013
rf - positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,18039/20013
rf ( mg / dl ),C0035448;C0439269;C0201660;C0748398;C1547111,true;false;false;false;false,18040/20013
rf ( mg / dl  per unit ),C0035448;C0439269;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C3642216;C1638407;C0024671;C1532632;C0026410;C1960952;C2346927;C4321396;C4521761;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false;false;false,18041/20013
rf and acpa negative,C0035448;C0201660;C0748398;C1547111,true;false;false;false,18042/20013
rf and acpa positive,C0035448;C0201660;C0748398;C1547111,true;false;false;false,18043/20013
rf negative and acpa positive,C0035448;C0205160;C1513916;C2825415;C2825491;C3853545;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,18044/20013
rf positive and acpa negative,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,18045/20013
rf,C0035448;C0201660;C0748398;C1547111,true;false;false;false,18046/20013
rheumatoid factor and acpa positive,C0035448;C0201660,true;false,18047/20013
rheumatoid factor or acpa positive,C0035448;C0201660,true;false,18048/20013
rheumatoid factor !,C0035448;C0201660,true;false,18049/20013
rhinitis,C0035455,true,18050/20013
rhythm - control group ( n = nmbr ),C0871269;C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389;C1523018;C3828331,false;true;false;false;false;false;false;false;false;false,18051/20013
rib,C0035561,true,18052/20013
right ventricular dysfunction — no . / total no . ( % ) §,C0242707;C1556315,true;false,18053/20013
right ventricular dysfunction,C0242707;C1556315,true;false,18054/20013
risedronate ( n   =   nmbr ),C0246719,true,18055/20013
risedronate ( n = nmbr ),C0246719,true,18056/20013
risedronate n / n ( % ),C0246719,true,18057/20013
risk ratio [nmbr % cl],C0028873;C0596019;C0242492,true;false;true,18058/20013
risk at,C0035647;C4552904,true;false,18059/20013
risk categories,C0035647;C0683312;C4552904,true;false;false,18060/20013
risk factor,C0035648,true,18061/20013
risk factor for venous thromboembolism,C3495424;C1521761;C2827422;C3496592,false;false;false;false,18062/20013
risk factors — no . ( % ),C0035648;C1553898,true;false,18063/20013
risk factors ( % of group ),C0035648;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1553898,true;false;false;true;false;false;false;false,18064/20013
risk factors ( % ),C0035648;C1553898,true;false,18065/20013
risk factors and diabetes status ( % ),C0035648;C1553898,true;false,18066/20013
risk factors and medical history,C0035648;C1553898,true;false,18067/20013
risk level at admission,C2923839;C0184666;C0809949,false;false;false,18068/20013
risk marker and model,C1519104,false,18069/20013
risk model endpoint,C0035647;C3161035;C2349179;C2826544;C3274659;C3714583;C3853906;C4552904,true;false;false;false;false;false;false;false,18070/20013
risk of moderate / severe exacerbations,C0332166;C0205082;C4086268;C4050465;C4050466,false;false;false;false;false,18071/20013
risk stratum,C0035647;C4552904,true;false,18072/20013
rivaroxaban ( n   = nmbr ),C1739768,true,18073/20013
rivaroxaban nmbr . nmbr mg bid + aspirin nmbr mg od,C1739768;C1319635;C0004057;C0229089;C0439164;C1512019;C3273373;C3665488,true;false;true;false;false;false;true;true,18074/20013
rivaroxaban alone ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C1739768;C0205171;C0439044;C0679994,true;false;false;false,18075/20013
rivaroxaban plus,C1739768,true,18076/20013
rivaroxaban plus aspirin ( nmbr % cl ),C1739768;C0332287;C0004057;C0596019,true;false;true;false,18077/20013
rivaroxaban plus aspirin ( n = nmbr ) nmbr . nmbr ± nmbr . nmbr,C1739768;C0332287;C0004057,true;false;true,18078/20013
rivaroxaban +,C1739768,true,18079/20013
rofecoxib,C0762662,true,18080/20013
roflumilast ( n = nmbr,C0965618,true,18081/20013
rolofylline ( n = nmbr ),C0166128,true,18082/20013
rolofylline nmbr mg ( n = nmbr ),C0166128;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18083/20013
rolofylline n,C0166128,true,18084/20013
rolofylline rx,C0166128;C1425688;C1521941;C2709207,true;false;false;false,18085/20013
rosigiitazone ± oad,,,18086/20013
rosiglitazone nmbr mg daik,C0289313;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18087/20013
rosiglitazone nmbr mg daily,C0289313;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,18088/20013
rosiglitazone versus glyburide,C0289313,true,18089/20013
rosiglitazone versus metformin,C0289313,true,18090/20013
rosuva  rosuvastatin  sd  standard deviation  tnmbrdm  type nmbr diabetes mellitus .,C0965129;C2699239;C0871420;C0011849;C0332307;C1547052;C0011816;C1320657;C3250443,true;false;false;true;false;false;true;false;false,18091/20013
rosuvastain + fenofibric acid   n   =   nmbr,C0060179,true,18092/20013
rosuvastatin ( n = nmbr,C0965129,true,18093/20013
rosuvastatin ( n = nmbr . nmbr ),C0965129,true,18094/20013
rosuvastatin + fenofibric acid,C0965129;C0060179,true;true,18095/20013
rosuvastatin n ( rate ) nmbr,C0965129;C0871208;C1521828,true;false;false,18096/20013
rosuvastatin   n   =   nmbr,C0965129,true,18097/20013
rotablator use,C1260867;C0042153;C0457083;C1947944,false;true;false;false,18098/20013
rotigotine ( n = nmbr ),C1700683;C4318637,true;true,18099/20013
rotigotine n = nmbr,C1700683;C4318637,true;true,18100/20013
row * n = nmbr,C1552840;C1552846,false;false,18101/20013
row §,C1552840;C1552846,false;false,18102/20013
rr ( nmbr % ci ) c,C4554402;C0008107;C3259781,false;true;false,18103/20013
rr ( nmbr % cl ) p value,C4554402;C0596019;C1709380,false;false;false,18104/20013
rr ( nmbr % cl ) [ / ’ value],C4554402;C0596019;C1522609,false;false;false,18105/20013
rr nmbr - nmbr ( nmbr . nmbr,,,18106/20013
rr nmbr . nmbr ( nmbr . nmbr,,,18107/20013
rr nmbr . nmbr < nmbr . nmbr,,,18108/20013
rr nmbr . nmbr ( nmbr . nmbr . nmbr . nmbr ),,,18109/20013
rr nmbr . nmbr,,,18110/20013
rr reduction,C4554402;C0301630;C0392756;C1293152;C4551656,false;false;false;false;false,18111/20013
rr ( nmbraci ) [p value],C4554402;C0814206;C1709380;C1510682;C2346870;C4050575,false;false;false;false;false;false,18112/20013
rrnmbr . nmbr ( nmbr - nmbr . nmbr . nmbr ) *,,,18113/20013
rrnmbr . nmbr ( nmbr . nmbr . nmbr . nmbr ),,,18114/20013
rrnmbr . nmbr ( nmbr - nmbr,,,18115/20013
rro . nmbr ( nmbr . nmbr . nmbr . nmbr ),,,18116/20013
rronmbr ( nmbr . nmbr,,,18117/20013
rs - breathlessnessb,C0035970;C3714753;C3813325,true;false;false,18118/20013
rs - chest symptomsd,C0035970;C0817096;C1527391;C3714753;C3813325,true;true;false;false;false,18119/20013
rs - cough & sputumc,C0035970;C0010200;C1961131;C3274924;C4084725;C4084726;C4084727;C3714753;C3813325,true;true;false;false;false;false;false;false;false,18120/20013
rs - totala,C0035970;C3714753;C3813325,true;false;false,18121/20013
rsnmbr,C0035970;C3714753;C3813325,true;false;false,18122/20013
rsnmbr & rsnmbr,C0035970;C3714753;C3813325,true;false;false,18123/20013
rsnmbr ( aa ) & rsnmbr,C0035970;C0282379;C1235746;C1882141;C4554792;C3714753;C3813325,true;true;false;false;false;false;false,18124/20013
rsnmbr ( ac ) & rsnmbr,C0035970;C0001246;C0003354;C1412573;C2000891;C3539770;C3714753;C3813325,true;true;true;false;true;false;false;false,18125/20013
rsnmbr ( cc ) & rsnmbr,C0035970;C0008318;C3538933;C3714753;C3813325,true;true;false;false;false,18126/20013
ruled out non - fatal pe with or,C1446409,false,18127/20013
russia and georgia,C0035970,true,18128/20013
russia / georgia,C0035970;C0017452;C0017454,true;true;true,18129/20013
rv and pulmonary vascular,C0035190;C3889272,true;false,18130/20013
rvalue,,,18131/20013
rvalue for interaction,C1704675,false,18132/20013
rvfac ( % ),,,18133/20013
rvw,,,18134/20013
s - asa compounds at baseline,C0010139;C0004057;C0168634;C1442488;C3853627;C0043474,true;true;true;false;false;true,18135/20013
s ( snmbr,C0565930;C2603362,false;false,18136/20013
s nmbr mmhg,C0565930;C0439475;C2603362,false;false;false,18137/20013
s nmbr yrs,C0565930;C2603362,false;false,18138/20013
s arm,C0565930;C0446516;C3715044;C4553528;C2603362,false;true;false;false;false,18139/20013
s fs nmbr,C0565930;C1517317;C3814419;C2603362,false;false;false;false,18140/20013
s median,C0565930;C0549183;C0876920;C2347635;C2348144;C2939193;C2603362,false;false;false;false;false;false;false,18141/20013
s wave in vnmbr ( mm ),C4301968;C0456681,false;false,18142/20013
s / se,C0565930;C0036919;C2603362,false;true;false,18143/20013
snmbr ( n = nmbr ),C2986823,true,18144/20013
snmbr mg / mmol,C0565930;C0567349;C2348885;C2603362,false;false;false;false,18145/20013
snmbr - nmbr vs placebo,C0565930;C0032042;C1696465;C1706408;C2603362,false;true;false;false;false,18146/20013
snmbr kg / m^,C0565930;C1532718;C2603362,false;false;false,18147/20013
snmbr exacerbations,C0565930;C4086268;C2603362,false;false;false,18148/20013
snmbr vs placebo,C0565930;C0032042;C1696465;C1706408;C2603362,false;true;false;false;false,18149/20013
snmbr . nmbr mg / mmol,C0565930;C0567349;C2348885;C2603362,false;false;false;false,18150/20013
snmbr years ( n = nmbr ),C2986823;C0439234,true;false,18151/20013
snmbr years,C0565930;C0439234;C2603362,false;false;false,18152/20013
snmbr ml / min,C0565930;C0439445;C2603362,false;false;false,18153/20013
snmbr ( nmbr . s ),C0565930;C2603362,false;false,18154/20013
snmbr - nmbr - snmbr . nmbr %,C0565930;C2603362,false;false,18155/20013
snmbr months,C0565930;C0439231;C2603362,false;false;false,18156/20013
sa acs,C0036243;C0742343;C4318612;C0038702;C1539696;C1825840;C3539736;C4521691,true;true;false;true;false;false;false;false,18157/20013
saba ( inhaled ),,,18158/20013
saba use in past nmbr days,C0042153;C1444637;C0439228;C4284302;C0457083;C1947944,true;false;false;false;false;false,18159/20013
saba use,C0042153;C0457083;C1947944,true;false;false,18160/20013
sabae,,,18161/20013
sack,,,18162/20013
sacral and / or lumbar,C0036037,true,18163/20013
saes,C1519255;C1622657;C4553214,false;false;false,18164/20013
safety variable,C0036043;C0439828;C4553760;C1705187,true;false;false;false,18165/20013
safety,C0036043;C1705187,true;false,18166/20013
sal ( n   = nmbr,C0036140;C0037494;C0206136,true;true;true,18167/20013
salbutamol,C0001927,true,18168/20013
salmeterol,C0073992,true,18169/20013
salmeterol ( n = nmbr ),C0073992,true,18170/20013
salmeterol / fluticasone nmbr / nmbr pg twice daily,C0939232;C0030827;C0585361;C0072225;C1266240,true;true;false;true;false,18171/20013
salmeterol / fluticasone nmbr / nmbr   μ g b . i . d .,C0939232;C0086706,true;true,18172/20013
samac,,,18173/20013
sample size,C0242618,true,18174/20013
sample size ( n ),C0242618,true,18175/20013
sample sizea,C0370003;C2347026,false;false,18176/20013
sample statistics,C2348149,false,18177/20013
saudi arabia,C0036243,true,18178/20013
saxa nmbr mg ( n nmbr nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,18179/20013
saxa nmbr mg nmbr metformin ( n nmbr nmbr ),C0024671;C0025598;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18180/20013
saxagiiptin,,,18181/20013
saxagliptin ( n = nmbr ),C1611934,true,18182/20013
sbp ( mean over nmbr h ),C0085805;C0444504;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,true;false;true;false;false;false;false;false;false,18183/20013
sbp ( mmghg ),C0085805,true,18184/20013
sbp ( mmhg ) *,C0085805;C0439475,true;false,18185/20013
sbp ( office measurement ),C0085805;C0442603;C0242485,true;false;false,18186/20013
sbp ( sd ),C0085805;C2699239,true;false,18187/20013
sbp < nmbrmm hg,C0085805;C0439475,true;false,18188/20013
sbp < nmbr mmhg,C0085805;C0439475,true;false,18189/20013
sbp < nmbr mm hg and dbp < nmbr mm hg nmbr / nmbr,C0085805;C0439475,true;false,18190/20013
sbp ≥ nmbr mmhg,C0085805;C0439475,true;false,18191/20013
sbp > nmbrmmhg n = nmbr,C0085805;C0439475,true;false,18192/20013
sbp > nmbr mm hg and / or dbp > nmbr mm hg nmbr / nmbr,C0085805;C0439475,true;false,18193/20013
sbp > nmbr mmhg,C0085805;C0439475,true;false,18194/20013
sbp > nmbr mmhg or dbp > nmbr mmhg,C0085805;C0439475,true;false,18195/20013
sbp at baseline,C0085805;C0168634;C1442488,true;true;false,18196/20013
sbp at visit nmbr,C0085805;C0545082;C1512346;C2826704,true;false;false;false,18197/20013
sbp during the follow - up period ( mmhg ),C0085805;C0589120;C0439531;C0439475;C1948053;C1522577;C1704685;C3274571,true;false;false;false;false;false;false;false,18198/20013
sbp  systolic blood pressure  sd  standard deviation  dbp  diastolic blood pressure  b . p . m .  beats per minute  mi  myocardial infarction  tia  transient ischaemic attack .,C0085805;C0488055;C2699239;C0871420;C0428883;C0369637;C0441923;C0871470;C1306620,true;false;false;false;true;false;false;true;false,18199/20013
sbp . mean ( sd ) mm hg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,18200/20013
sbp / dbp ( mmhg ),C0085805;C0536221;C0439475;C3813197;C4281799,true;true;false;false;false,18201/20013
sbp / dbp mean,C0085805;C0536221;C0444504;C2347634;C2348143;C3813197;C4281799,true;true;false;false;false;false;false,18202/20013
sbp < nmbrmmhg n = nmbr,C0085805;C0439475,true;false,18203/20013
sbp < nmbrmmhg,C0085805;C0439475,true;false,18204/20013
sbp < median ( n = nmbronmbr ),C0085805;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,18205/20013
sbp > median ( n = nmbr ),C0085805;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,18206/20013
sbp > nmbrmm hg,C0085805;C0439475,true;false,18207/20013
sbp > nmbrmmhg,C0085805;C0439475,true;false,18208/20013
sbp > nmbrmnn hg,C0085805;C0025424;C0428257;C2347108;C2347109;C2348272,true;true;false;false;false;false,18209/20013
sc belimumab nmbr mg ( n = nmbr ),C0282380;C1723401;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,18210/20013
scale — cognitive portion  ldl — low -,C0175659;C1516691;C0449719;C0349674;C1947916,true;false;false;false;false,18211/20013
scalp psoriasis,C0406326,false,18212/20013
scarring on renal biopsy,C1700247;C0005558;C0220797;C0008767;C0194073;C2004491,false;true;true;true;false;true,18213/20013
scd ( % ),,,18214/20013
scdbp,,,18215/20013
schwab & england score,C0014282,true,18216/20013
score ( > nmbr ) at nmbr monthsb unadjusted or,C0449820;C4050231,false;false,18217/20013
score > nmbr . nmbr,C0449820;C4050231,false;false,18218/20013
score nmbr . nmbr,C0449820;C4050231,false;false,18219/20013
score at week nmbr,C0449820;C0332174;C0439230;C4050231,false;false;false;false,18220/20013
score distribution :,C0449820;C0520511;C1704711;C4050231,false;false;true;false,18221/20013
score improvement,C0449820;C2986411;C4050231,false;false;false,18222/20013
score on asthma control questionnaire * *,C4706265,false,18223/20013
score on st . george ' s respiratory questionnaire^^,C3472502,false,18224/20013
screening ( visit nmbr ),C0220908;C0545082;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;false,18225/20013
screening and baseline lung function characteristics,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,18226/20013
screening fevnmbr   % predicted,C0220908;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;true;false;false;false;false;false,18227/20013
scsbp,,,18228/20013
sd = standard deviation  bmi = body mass index  ed = erectile,C2699239;C0871420;C1305855;C3538926,false;false;true;false,18229/20013
sd of sbp,C2699239;C0085805,false;true,18230/20013
sd or %,C2699239,false,18231/20013
sdai ( nmbr - nmbr ),C3871128,false,18232/20013
sdc ( nmbr . nmbr - nmbr . nmbr ng / ml ),C1419891;C0439275;C3273112,false;false;false,18233/20013
sdc ( ng / ml ),C1419891;C0439275;C3273112,false;false;false,18234/20013
se,C0036919,true,18235/20013
second co - primary,C0205436;C3245499;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false,18236/20013
second serum creatinine,C0205436;C0201976;C0600061;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false,18237/20013
second year !,C0205436;C0439234;C0439508;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false,18238/20013
secondary - prevention cohort,C0679699;C0009247;C0599755,true;true;false,18239/20013
secondary cardiovascular endpoint,C4528314;C0007226;C3887460,false;true;false,18240/20013
secondary end points,C0027627;C2349179;C0175668;C0205436,true;false;false;false,18241/20013
secondary end points nmbr,C0027627;C2349179;C0175668;C0205436,true;false;false;false,18242/20013
secondary end points ii,C0027627;C2349179;C1710602;C4082587;C0175668;C0205436,true;false;false;false;false;false,18243/20013
secondary end points iii,C0027627;C2349179;C0439070;C1705160;C0175668;C0205436,true;false;false;false;false;false,18244/20013
secondary endpoints :,C4528314,false,18245/20013
secondary iii *,C0027627;C0439070;C1705160;C0175668;C0205436,true;false;false;false;false,18246/20013
secondary ip,C0027627;C1308226;C4049997;C0175668;C0205436,true;true;false;false;false,18247/20013
secondary kidney composite outcome,C0027627;C0022646;C0205199;C1274040;C1547335;C0227665;C0175668;C0205436,true;true;false;false;false;false;false;false,18248/20013
secondary mace endpoint,C4528314;C0349381;C0949745;C1445339,false;false;true;false,18249/20013
secondary nonresponse,C0027627;C0175668;C0205436,true;false;false,18250/20013
secondary outcome,C0027627;C1274040;C0175668;C0205436,true;false;false;false,18251/20013
secondary p,C0027627;C0175668;C0205436,true;false;false,18252/20013
section nmbra,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,18253/20013
section nmbrb,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,18254/20013
section nmbrc,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,18255/20013
secukinumab nmbr mg ( n nmbr nmbr ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18256/20013
secukinumab nmbr   mg,C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18257/20013
secukinumab nmbr   mg ( n   =   nmbr ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18258/20013
secukinumab nmbr   mg no load ( n   =   nmbr ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18259/20013
secukinumab pooled †   ( n   = nmbr ),C3179547;C1709595;C2349200;C4522255,true;false;false;false,18260/20013
sedbp ( mmhg ) [mean _sd]d,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18261/20013
sedbp ( mmhg ) [mean_ sd]a,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18262/20013
seizure frequency during nmbr ‐ week baseline,C0149775;C0332174;C0168634;C1442488;C0439230,false;false;true;false;false,18263/20013
seizure history,C0036572;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1959629;C4553401,true;true;true;false;false;false;false;false;false,18264/20013
seizure types reported during baselinee,C0036572;C0332307;C1959629;C4553401,true;false;false;false,18265/20013
selected key secondary efficacy endpoints,C1707391;C4528314;C1280519;C1707887,false;false;false;false,18266/20013
selective vascular history,C0036576;C0005847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1558950;C1801960;C1707391,true;true;true;true;false;false;false;false;false;false;false,18267/20013
selena - sledai > nmbr,C0451528,false,18268/20013
selena - sledai activity,C0451528;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false,18269/20013
selena - sledai mean score ( sd ),C0451528;C3533236;C2699239,false;false;false,18270/20013
selena - sledai total score,C0451528;C2964552,false;false,18271/20013
selexipag patients / events n,C2000145;C0030705;C0441471;C3541888,true;true;false;false,18272/20013
selexipag vs placebo hazard ratio ( nmbr % cl ),C2000145,true,18273/20013
self - rated health status,C0036588;C0871208;C0018759;C1551994,true;false;true;false,18274/20013
self - reported descent,C0681906;C2700446,false;true,18275/20013
semaglutide,C3885068,true,18276/20013
semaglutide ( n = nmbr ),C3885068,true,18277/20013
semaglutide nmbr . nmbr mg,C3885068;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18278/20013
semaglutide exposure,C3885068;C0274281;C0332157,true;false;false,18279/20013
semuloparin ( n = nmbr ),C2700104,true,18280/20013
sensitive,C0020517;C0332324;C1522640,true;false;false,18281/20013
sensitive responder ( n = nmbr ),C0020517;C0332324;C1522640,true;false;false,18282/20013
sensitive responders ( n = nmbr ),C0020517;C0332324;C1522640,true;false;false,18283/20013
sensitivity analyses,C0020517;C0002778;C0936012;C1524024;C0036667;C0312418;C0427965;C1511883;C1522640;C2346484;C2349185,true;false;false;true;true;false;false;false;false;false;false,18284/20013
sensorimotor stroke,C0038454;C4554100,true;false,18285/20013
serious,C0205404,false,18286/20013
serious aes,C0205404;C1412268;C2699274,false;false;false,18287/20013
serious decline in kidney function *,C0205404;C0232804,false;false,18288/20013
serious decline in kidney functionnmbr,C0205404;C0232804,false;false,18289/20013
serious gi disorder,C0205404;C1708130;C0012634;C3539617;C4050121,false;false;true;false;false,18290/20013
serious infections,C0205404;C3714514,false;true,18291/20013
serious teaes,C0205404,false,18292/20013
serms,C0732611,true,18293/20013
seropositivity status,C0521143;C0449438,false;false,18294/20013
sertraline,C0074393;C0524265,true;false,18295/20013
serum nmbr - hydroxyvitamin d,C0229671;C0020337;C1546774;C1550100,true;true;false;false,18296/20013
serum nmbr ( oh ) d concentrations,C0683149;C0220853,false;true,18297/20013
serum albumin - adjusted calcium ( mg / dl ),C0036773;C0728877,true;false,18298/20013
serum albumin concentration,C0683149;C0001924;C0036773;C0086045;C1446561;C3827302;C0728877;C0229671;C0486291;C1546774;C1550100,false;true;true;true;false;false;false;true;false;false;false,18299/20013
serum biochemistry potassium,C0302353;C0005477;C0543465,false;true;false,18300/20013
serum bone - specific alkaline,C0229671;C0262950;C0205369;C1979842;C1552740;C1546774;C1550100,true;true;false;false;false;false;false,18301/20013
serum c - terminal telopeptide of,C0229671;C1707271;C1546774;C1550100,true;false;false;false,18302/20013
serum calcium,C0036785;C0728876,false;false,18303/20013
serum creatinine - mean ( sd,C0201976;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false,18304/20013
serum creatinine — mg / dl | |,C0201976;C0439269;C0600061,false;false;false,18305/20013
serum creatinine > nmbr / xmol / l,C0201976;C0600061,false;false,18306/20013
serum creatinine concentration and randomization to losartan,C0683149;C0010294;C1561535;C0201976;C0086045;C1446561;C3827302;C0600061,false;true;false;false;true;false;false;false,18307/20013
serum creatinine level,C0600061,false,18308/20013
serum creatinine . mg / dl,C0201976;C0439269;C0600061,false;false;false,18309/20013
serum ctx - nmbr,C0229671;C0010377;C0631180;C3539598;C1546774;C1550100,true;true;true;false;false;false,18310/20013
serum ctx i ( ng / ml ),C0229671;C0631180;C0439275;C1546774;C1550100,true;true;false;false;false,18311/20013
serum fg,C0229671;C0016703;C0439214;C2348814;C1546774;C1550100,true;true;false;false;false;false,18312/20013
serum gastrint,C0229671;C1546774;C1550100,true;false;false,18313/20013
serum glucose ( mmol / l ),C0202041;C1532563;C3534430,false;false;false,18314/20013
serum glucose ( mg / dl ),C0202041;C0439269;C3534430,false;false;false,18315/20013
serum mg < nmbr . nmbr mmol / l ( hypomagnesemia ),C0229671;C0439268;C0439190;C0151723;C4552839;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100,true;false;false;false;false;true;false;true;false;false;false;false;false;false;false,18316/20013
serum mg > nmbr . nmbr mmol / l ( normal mg / hvpermagnesemia ),C0229671;C2827881;C0439190;C0205307;C0231683;C0439166;C2347086;C4553972;C1546774;C1550100,true;false;false;false;false;false;false;false;false;false,18317/20013
serum n - propeptide of type nmbr collagen,C0229671;C1709708;C0332307;C0009325;C1547052;C1875696;C1546774;C1550100,true;false;false;true;false;false;false;false,18318/20013
serum pepsinogen i / iit,C0229671;C0077923;C0523816;C1546774;C1550100,true;true;false;false;false,18319/20013
serum phosphate,C0036820,false,18320/20013
serum potassium 一 mmol / liter,C0302353;C0439190;C0475211;C0543465,false;false;false;false,18321/20013
serum potassium level,C0302353;C0543465,false;false,18322/20013
serum sodium — mmol / liter,C0523891;C0439190;C0475211,false;false;false,18323/20013
serum sodium,C0523891,false,18324/20013
serum sodium . meq / l,C0523891;C0439375,false;false,18325/20013
serum total ige,C1441420,false,18326/20013
serum urate ( mg / dl ),C0455272;C0439269,false;false,18327/20013
serum urea nitrogen,C0856666;C0028158;C1550581;C0229671;C0600137;C1291218;C3683557;C1546774;C1550100,false;true;false;true;false;false;false;false;false,18328/20013
serum uric acid,C0455272;C0700634,false;false,18329/20013
serum values,C0229671;C0042295;C1546774;C1550100,true;false;false;false,18330/20013
serum values^,C0229671;C0042295;C1546774;C1550100,true;false;false;false,18331/20013
serum vitamin d ( nmol / l ),C0229671;C0014695;C0439282;C0042866;C2936842;C3537249;C3714503;C1546774;C1550100,true;true;false;true;false;false;false;false;false,18332/20013
ses - cd,C0007928;C0034283;C4552032,true;true;false,18333/20013
sesbp ( mmhg ) [mean - sd]d,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18334/20013
sesbp ( mmhg ) [mean _sd]a,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18335/20013
severe ( < nmbr ml · min − nmbr · nmbr . nmbr m − nmbr ),C0205082;C0439445;C0369637;C0441923;C4050465;C4050466,false;false;false;false;false;false,18336/20013
severe ( > nmbr ),C0205082;C4050465;C4050466,false;false;false,18337/20013
severe ( fev,C0205082;C3714541;C4050465;C4050466,false;true;false;false,18338/20013
severe ( iief - ef < nmbr ),C0205082;C3641331;C4050465;C4050466,false;false;false;false,18339/20013
severe ( iief - ef nmbr - nmbr ),C0205082;C3641331;C4050465;C4050466,false;false;false;false,18340/20013
severe ( ipss > nmbr ),C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;false;false;false;false;false,18341/20013
severe ( ipss > nmbr ) age group,C0205082;C1019118;C0027362;C2348001;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;true;false;false;false;false;false;false,18342/20013
severe ( ipss > nmbr ) ( n = nmbr ),C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;false;false;false;false;false,18343/20013
severe ( itt ) ( n = nmbr ),C0205082;C4050465;C4050466,false;false;false,18344/20013
severe ( nnmbr = nmbr ),C0205082;C4050465;C4050466,false;false;false,18345/20013
severe aes,C0205082;C1412268;C2699274;C4050465;C4050466,false;false;false;false;false,18346/20013
severe copd,C0205082;C0024117;C1412502;C3714496;C4050465;C4050466,false;true;false;false;false;false,18347/20013
severe cord * : qvainmbr - sfc,C0205082;C1550235;C4521536;C1706500;C3489532;C4050465;C4050466,false;false;false;false;true;false;false,18348/20013
severe disease,C1836348,false,18349/20013
severe ed,C0205082;C3538926;C4050465;C4050466,false;false;false;false,18350/20013
severe episodes in previous year — no . / patient,C0205082;C0332189;C0205156;C0439234;C0439508;C1552607;C4050465;C4050466,false;false;false;false;false;false;false;false,18351/20013
severe exacerbations,C0205082;C4086268;C4050465;C4050466,false;false;false;false,18352/20013
severe hyperkalemia ' s,C0205082;C0020461;C4552983;C4050465;C4050466,false;true;false;false;false,18353/20013
severe hyperkalemia ‘ s,C0205082;C0020461;C4552983;C4050465;C4050466,false;true;false;false;false,18354/20013
severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,18355/20013
severe impairment ( egfr < nmbr ml / min / m^ ),C0205082;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;false;false;false;false;false;false;false;false,18356/20013
severe oa symptoms at baselined,C0436345;C0029408;C3887876,false;true;false,18357/20013
severe oab subgroup,C0205082;C1079230;C1515021;C4050465;C4050466,false;false;false;false;false,18358/20013
severe or very severe smoking status,C0205082;C4050465;C4050466,false;false;false,18359/20013
severe recurrent ischemia,C0205082;C1455761;C0022116;C4321499;C2945760;C4050465;C4050466,false;false;true;false;false;false;false,18360/20013
severe to end - stage impairment ( nmbr ml / min ),C0205082;C0205088;C0221099;C0439445;C0684336;C4050465;C4050466,false;false;false;false;false;false;false,18361/20013
severe / life threatening,C0205082;C1546953;C2826244;C3537125;C4050465;C4050466,false;false;false;false;false;false,18362/20013
severe / life ttireatening,C0205082;C0376558;C4050465;C4050466,false;true;false;false,18363/20013
severe / lite threatening,C0205082;C4050465;C4050466,false;false;false,18364/20013
severe / moderate,C1299393,false,18365/20013
severity of copda,C0439793;C0522510,false;false,18366/20013
severity of heartburnb,C0439793;C0522510,false;false,18367/20013
severity ofhypertension [n ( % ) ]b,C0439793;C0522510,false;false,18368/20013
severitya,,,18369/20013
sex — no . / total no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,18370/20013
sex ( male,C0086582,true,18371/20013
sex ( male / female ),C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,18372/20013
sex ( male / female ) ( n ),C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,18373/20013
sex ( men / women ),C0009253;C0025266;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;true;false;false;true,18374/20013
sex ( no . ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,18375/20013
sex ( p = nmbr ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,18376/20013
sex ( women,C0009253;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;false;false;true,18377/20013
sex m / f,C0009253;C1306057;C0036864;C0079399;C0804628;C1314687;C1522384,true;false;true;true;false;false;true,18378/20013
sexually active,C0241028,false,18379/20013
sexually active with female,C0241028;C0043210;C0086287;C1705497;C1705498,false;true;true;false;false,18380/20013
sexually activenmbr ( % ),C0241028,false,18381/20013
sexy,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,18382/20013
sf - nmbr mcs score,C0037712,true,18383/20013
sf - nmbr pcs score,C0037712;C1864389;C1882368,true;false;true,18384/20013
sf - nmbr bodily pain,C0037712;C3890602,true;false,18385/20013
sf ‐ nmbr health survey,C0037712;C0018762,true;true,18386/20013
sf ‐ nmbr pcs,C0037712;C1864389;C1882368,true;false;true,18387/20013
sf - nmbr summary scores,C0037712;C1552616;C1706244,true;false;false,18388/20013
sfc ( n   = nmbr,C4521536,false,18389/20013
sfc nmbr / nmbr pg twice daily ( n = nmbr ),C4521536;C0030827;C0585361;C0072225;C1266240,false;true;false;true;false,18390/20013
sgrq - c total scoreb,C3826872;C0439175;C0439810,false;false;false,18391/20013
sgrq responder ( % ),,,18392/20013
sgrq score,,,18393/20013
sgrq scores,,,18394/20013
sgrq total scorenmbr,C2964552,false,18395/20013
shared epitope,C0237876;C0003316;C1522138,false;true;false,18396/20013
shfm annual mortality,C0332181;C0026565;C0026566,false;true;true,18397/20013
short ( < nmbr years ) duration of diabetes,C0439593;C0439234;C0011847;C0011849,false;false;false;true,18398/20013
short term ( n = nmbr ) +,C0443303,false,18399/20013
short term^,C0443303,false,18400/20013
shs ( nmbr - nmbr  per nmbr score ),C0449820;C4050231,false;false,18401/20013
si . gni . fi . canr ecg changes,C4050619;C1623258,false;true,18402/20013
significant worsening in kccq clinical,C0237881;C0332271;C3476798;C1457868;C1546960;C0750502;C1546944,false;false;false;false;false;false;false,18403/20013
significant worsening in kccq clinical score ( ≥ nmbr ) at nmbr mo †,C0332271;C3476798;C2826293;C0449820;C4050231;C1457868;C1546960,false;false;false;false;false;false;false,18404/20013
sildenafil ( n = nmbr ),C0529793,true,18405/20013
silodosin nmbr mg ( n = nmbr ),C1870115;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18406/20013
simva ( n = nmbr ),,,18407/20013
simvastatin ( n = nmbr . nmbr ),C0074554,true,18408/20013
simvastatin ( n = nmbr,C0074554,true,18409/20013
single vessel coronary artery disease †,C0581374,false,18410/20013
single vessel coronary artery diseasea,C0265903;C0005847,false;true,18411/20013
sinus tracts / perforation,C0854572;C1185740;C0544791;C0549099;C1881710,false;false;false;false;false,18412/20013
sirius,,,18413/20013
sirolimus - eluting stent use,C0072980;C0038257;C0042153;C0457083;C1947944,true;true;true;false;false,18414/20013
sita nmbr mg ( n = nmbr ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,18415/20013
sitagliptin nmbr,C1565750,true,18416/20013
sitagliptin nmbr nmbr . nmbr 士 nmbr . nmbr nmbr - h postprandial plasma glucose ( ppg ) ( mmol / l ),C1565750;C2827804;C0376674;C0202042;C1418888;C0455280,true;false;true;false;false;false,18417/20013
sitagliptin nmbr nmbr . nmbr 士 nmbr . nmbr fasting plasma glucose ( fpg ) ( mmol / l ),C1565750;C0015663;C0202042;C1532563;C0455280,true;true;false;false;false,18418/20013
sitagliptin ± oad,C1565750,true,18419/20013
sitting blood pressure — mmhg,C0580946;C0439475,false;false,18420/20013
sitting diastolic blood pressure ( mm hg ),C1319894;C0439475,false;false,18421/20013
sitting systolic blood pressure ( mm hg ),C0277814;C2584297;C4050224,true;true;false,18422/20013
six - minute walk distance,C3900196;C0012751,false;false,18423/20013
six - study placebo - controlled set,C0205452;C0557651;C1706408;C0036849;C1442518;C1705195;C2603343,false;false;false;true;false;false;false,18424/20013
size ( cmnmbr ) ( mean ± standard deviation ),C0456389;C1828170;C1442989;C2828392;C0444504;C0871420;C2347634;C2348143,false;false;false;false;false;false;false;false,18425/20013
size of left atrium normal — no . ( % ) £,C0456389;C0225860,false;true,18426/20013
sk . nmbr,,,18427/20013
slnmbr mm hg,C0439475,false,18428/20013
sle markers,C0024141;C0005516,true;true,18429/20013
sleep,C0037313,true,18430/20013
sleeping problems in the past nmbr weeks ( % ),C0700201;C2987125,true;false,18431/20013
small / medium,C0700321;C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,false;true;false;false;false;false;false;false,18432/20013
smedian prednisone dose,C0032952;C0178602;C0869039;C1114758,true;false;false;false,18433/20013
smi :,,,18434/20013
smmse,,,18435/20013
smmse < nmbr,,,18436/20013
smoker at baseline,C0337664;C0168634;C1442488,true;true;false,18437/20013
smoker or ex - smoker,C0337664,true,18438/20013
smokers : qvanmbr - nmbrfc,C0337664;C2983605,true;false,18439/20013
smoking ' ! ',C0037369;C0453996;C1881674,true;true;false,18440/20013
smoking ( % ),C0037369;C0453996;C1881674,true;true;false,18441/20013
smoking ( current ),C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,18442/20013
smoking ( during the previous month ),C2114448;C0332177;C0439231,false;false;false,18443/20013
smoking classification,C0037369;C0008902;C0008903;C0678229;C0453996;C1881674,true;true;true;false;true;false,18444/20013
smoking consumption pack - years,C0425291;C1277691,false;false,18445/20013
smoking history ( pack - years ) ∗,C1519384;C1277691,false;false,18446/20013
smoking pack - yearsa,C0037369;C1968515;C2825051;C2828395;C0453996;C1881674,true;false;false;false;true;false,18447/20013
smoking pack - yearsb,C0037369;C1968515;C2825051;C2828395;C0453996;C1881674,true;false;false;false;true;false,18448/20013
smoking pack year ( years ) ^,C0037369;C1277691;C0439234;C0439508;C0453996;C1881674,true;false;false;false;true;false,18449/20013
smoking status — no . { % ),C1519386,false,18450/20013
smoking status ( ongoing ) ( n ),C1519386;C0549178,false;false,18451/20013
smoking status ( previous ) ( n ),C1519386;C0205156;C1552607,false;false;false,18452/20013
smoking status current,C1519386;C0521116;C1705970,false;false;false,18453/20013
smoking status current smoker ( n = nmbr ),C1519386;C3173209;C3241966,false;false;false,18454/20013
smoking status . no . ( % ),C1519386,false,18455/20013
smoking * ( > nmbr pack - years ),C0037369;C1277691;C0453996;C1881674,true;false;true;false,18456/20013
smokingb,,,18457/20013
snp,C0752046;C1527094,true;false,18458/20013
so,C0037640,true,18459/20013
so nmbr %,C0037640,true,18460/20013
soc,,,18461/20013
socalone ( n = nmbr ),,,18462/20013
social interaction,C0037420,true,18463/20013
sodium - glucose cotransporter nmbr inhibitor,C0037473;C0017725;C1999216;C0597484;C3541959;C3714642,true;true;false;false;false;false,18464/20013
sokoiow - lyon voitage,,,18465/20013
sokolow - lyon ( mm ) *,C4330985;C4554674,false;false,18466/20013
sokolow - lyon voltage,C0598352,false,18467/20013
sokolow - lyon,,,18468/20013
sokolow – lyon voltage ( mv ),C0598352;C1454484;C1705503;C4281602,false;true;false;false,18469/20013
solifenacin ( n = nmbr ),C1099677,true,18470/20013
some college,C0557806,false,18471/20013
some college / tech,C0557806;C1826596,false;false,18472/20013
some walking,,,18473/20013
somnolence,C0013144;C2830004;C4553740,false;true;false,18474/20013
sotagliflozin,C3896939,true,18475/20013
sotagliflozin ( n = nmbr ),C3896939,true,18476/20013
sotagliflozin nmbr mg ( n = nmbr ),C3896939;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18477/20013
source,C0449416;C1705919;C4521696,false;false;false,18478/20013
south africa / south america,C0037713;C0001737;C0037712;C0002454,true;true;true;true,18479/20013
south america ( n = nmbr ),C0037713,true,18480/20013
south asia,C0037723;C1519427,true;false,18481/20013
south or central america,C1710133,false,18482/20013
south or central american,C1710133,false,18483/20013
south ! central america,C0037713;C0205099;C1879652;C1710133;C0007674,true;false;false;false;true,18484/20013
south,C1710133,false,18485/20013
southern europe,C0037724,true,18486/20013
southern hemisphere,C1710133;C0205139,false;false,18487/20013
spain,C0037747,true,18488/20013
spain ( n = nmbr ),C0037747,true,18489/20013
special interest categories,C0205555;C0543488;C0683312,false;false;false,18490/20013
specific syndromes,C0205369;C0039082;C1558916;C1552740,false;true;false;false,18491/20013
spga > nmbr,,,18492/20013
spine,C0037949;C2752558,true;false,18493/20013
spine *,C0037949;C2752558,true;false,18494/20013
spirometric values at baseline,C0037981;C0042295;C0168634;C1442488;C0183441,true;false;true;false;false,18495/20013
spirometry,C0037981,true,18496/20013
spirometry after bronchodilation §,C0037981;C1371299;C3537072,true;false;false,18497/20013
spirono ( n = nmbr ),,,18498/20013
spondylitis,C0038012,true,18499/20013
spondylitis with peripheral arthritis,C0038012;C0238694,true;false,18500/20013
sprint acr < nmbr - nmbr,C1412134;C1515941,false;false,18501/20013
sprint acr > nmbr - nmbr,C1412134;C1515941,false;false,18502/20013
sri ‐ nmbr response rate,C1420401;C0237629,false;false,18503/20013
β - blocker,,,18504/20013
β ‐ blocker,,,18505/20013
β - blockers,,,18506/20013
β blocker,,,18507/20013
β blockers,,,18508/20013
ss years,C2699257;C0439234;C3891295;C4551874,false;false;false;false,18509/20013
ssed as ls means,C0023668;C1704970,true;false,18510/20013
ssomgdayp . eq .,C0205163;C0439185,false;false,18511/20013
st - depression and t - wave inversion,C0520887,false,18512/20013
st - depression only,C0520887;C0205171;C1720467,false;false;false,18513/20013
st - segment depression > nmbr mm,C0520887;C4330985;C4554674,false;false;false,18514/20013
st - segment depression > nmbr mm — no . ( % ),C0520887;C4330985;C4554674,false;false;false,18515/20013
st - segment depression or t - wave inversion on ecg,C0520887,false,18516/20013
st - segment deviation > nmbr mm — no . / total no . ( % ),C1114722;C0441635;C4330985;C4554674;C1116089;C0429029;C0012727;C0205419;C1705236;C0036056;C0429066;C3272372,false;false;false;false;false;false;false;false;false;true;false;false,18517/20013
st - segment deviation timi risk score,C1114722;C0441635;C0035647;C0449820;C4050231;C4552904;C1116089;C0429029;C0012727;C0205419;C1705236;C0036056;C0429066;C3272372,false;false;true;false;false;false;false;false;false;false;false;true;false;false,18518/20013
st - segment elevation,C0520886,false,18519/20013
st ‐ str ≥ nmbr % post pci,C0036056;C0687676;C4049621;C1704687;C3469826;C3272372,true;false;false;false;false;false,18520/20013
st ‐ str ≥ nmbr % pre ‐ ci,C0036056;C0332152;C0008107;C3259781;C0740175;C2257086;C3669034;C3272372,true;false;true;false;false;false;false;false,18521/20013
st - t wave,C0036056;C0429103;C3272372,true;false;false,18522/20013
st - t wave abnormality d,C0036056;C1839341;C3272372,true;false;false,18523/20013
st - t wave changes,C0036056;C0429103;C3272372,true;false;false,18524/20013
st - t waveft,C0036056;C3272372,true;false,18525/20013
st - t wavett,C0036056;C3272372,true;false,18526/20013
st depression ( without st elevation ),C0520887;C0439775;C0702240;C0011570;C0520886;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,false;false;false;true;false;true;false;false;false;false;false;false,18527/20013
st depression > nmbr mm,C0520887;C4330985;C4554674,false;false;false,18528/20013
st elevation,C0520886,false,18529/20013
st george ' s respiratory questionnaire total score !,C3472502;C0439175;C0439810,false;false;false,18530/20013
st segment depression,C0520887,false,18531/20013
st segment elevation,C0520886,false,18532/20013
st / t wave,C0036056;C0429103;C3272372,true;false;false,18533/20013
stable angina ( n = nmbr,C0340288,true,18534/20013
stable coronary artery disease,C0205360;C0010054;C0010068;C1956346;C1547311,false;true;true;true;false,18535/20013
stage nmbr ckd egfr > nmbr ml / ( n = nmbr ),C0205390;C1300072;C1306673,false;false;false,18536/20013
stage nmbr ckd egfr nmbr to nmbr ml / min ( n = nmbr ),C0205390;C1300072;C1306673,false;false;false,18537/20013
stage nmbra ckd cohort ( post hoc analysis excluding metformin users ),C0205390;C1300072;C1306673,false;false;false,18538/20013
stage nmbra ckd cohort ( secondary analysis ),C0205390;C1300072;C1306673,false;false;false,18539/20013
stage i ( gfr > nmbr ml / min per nmbr . nmbr mnmbr ) and stage v ( gfr < nmbr ml / min per nmbr . nmbr mnmbr ) were not considered because they included only nmbr and nmbr patient,C0441766;C0017654;C0439445;C0369637;C0441923;C1424601;C0023806;C0702093;C0007591;C0456533;C1524029;C3813700;C0021966;C0221138,false;true;false;false;false;false;true;false;true;false;false;false;true;false,18540/20013
stage ii,C0441767,false,18541/20013
stage iii,C0441771,false,18542/20013
stage iv,C0205390;C1300072;C1306673,false;false;false,18543/20013
stage of pda,C0205390;C0013274;C0226047;C4282128;C1300072;C1306673,false;true;false;false;false;false,18544/20013
standard,C1442989;C2828392,false;false,18545/20013
standard allocation,C1442989;C1706778;C2828392,false;false;false,18546/20013
standard bp lowering,C1442989;C0037623;C0441994;C2003888;C1415692;C1708288;C4318478;C2828392,false;true;false;false;false;false;false;false,18547/20013
standard care slope lsm ± se ( mm / year ),C1442989;C1947933;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674;C2828392,false;false;false;true;false;false;false;false;false,18548/20013
standard therapy ( n = nmbr ),C2936643,true,18549/20013
standard treatment ( n - nmbr ),C4684780,false,18550/20013
standardized mean difference,C0444504;C1705241;C1705242;C2347634;C2348143,false;false;false;false;false,18551/20013
standardized total hip bmd ( g / cmnmbr ),C0439175;C0019552;C0439267;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;false;true;true;false;false;false,18552/20013
statin ( % ),C0360714,true,18553/20013
statin + ezetimibe ( n = nmbr . nmbr ),C0360714;C1142985,true;true,18554/20013
statin + ezetimibe { n = nmbr,C0360714;C1142985,true;true,18555/20013
statin + fibrate or niacin,C0360714,true,18556/20013
statin and / or ezetimibe,C0360714,true,18557/20013
statin and / or other lipid - lowering agent therapy,C0360714,true,18558/20013
statin group,C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,18559/20013
statin intensity per acc / ahac,C0360714;C0522510;C0175754;C0282160;C3541413,true;false;true;true;false,18560/20013
statin intolerant *,C0360714;C0231200,true;false,18561/20013
statin medication,C0360714;C0013227;C3244316;C4284232,true;true;false;false,18562/20013
statin only ( n = nmbr,C0360714;C0205171;C1720467,true;false;false,18563/20013
statin potency medium ( n = nmbr ),C0360714;C3245505;C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;true;false;false;false;false;false;false,18564/20013
statin use — no . { % ),C0360714,true,18565/20013
statin use ( % ),C0360714;C0042153;C0457083;C1947944,true;true;false;false,18566/20013
statin use at baseline :,C0360714;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,18567/20013
statin users,C0360714;C1706077,true;false,18568/20013
statin ( s ),C0360714,true,18569/20013
statin + er niacin ( n = nmbr ),C0360714;C3810541;C0027996;C1142562;C3811131,true;false;true;false;false,18570/20013
statin + placebo ( n = nmbr ),C0360714;C0032042;C1696465;C1706408,true;true;false;false,18571/20013
stating,C1301808;C1442792;C3148680,false;false;false,18572/20013
statins used during follow - up,C0360714,true,18573/20013
statistic * *,C2348149;C2828391,false;false,18574/20013
statisticd,,,18575/20013
statistics,C0038215;C0600673,false;true,18576/20013
status ( spmsq < nmbr,C0449438,false,18577/20013
status ( spmsq > nmbr,C0449438,false,18578/20013
std n ( n / loopy ),,,18579/20013
stent thrombosis - related mi,C3897493,false,18580/20013
stent thrombosis arc definite / probable,C3897493;C0439544;C0033204;C0332148;C1704787,false;false;true;false;false,18581/20013
stent thrombosis or mi,C3897493,false,18582/20013
stented lesions,C0038257;C0221198,true;false,18583/20013
stented vessel,C0183521,false,18584/20013
steroid - free cr - nmbr,C0038317;C0332296;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337;C1880497;C1996904,true;false;false;false;true;false;false;false;false;false,18585/20013
steroid - free remission,C0038317;C0332296;C0544452;C0687702;C1880497;C1996904,true;false;false;false;false;false,18586/20013
steroid - sparing remission *,C0038317;C0544452;C0687702,true;false;false,18587/20013
steroid use at baseline ( mg / day ),C0281991;C0168634;C0439422;C1442488,false;true;false;false,18588/20013
steroid use,C0281991,false,18589/20013
steroids,C0038317,true,18590/20013
still taking alendronate at study entry,,,18591/20013
stomach,C0038351;C3714551,true;false,18592/20013
storage subscore,C0337174;C1698986;C1753314,false;false;false,18593/20013
strain ( % ),C0080194;C0456178;C1518614;C2987481,true;false;false;false,18594/20013
strata modelb hr,,,18595/20013
stratification factor : menopausal status,C1514984;C1513126,false;false,18596/20013
stratification factors,C1514984,false,18597/20013
stratified by,C0205363,false,18598/20013
stratified hazard ratio ( nmbr % ci ),C0205363;C2985465;C0008107;C3259781,false;false;true;false,18599/20013
stratified log - rank p value,C0205363;C1708728;C0667477;C1709380;C0699794;C2986775,false;false;true;false;false;false,18600/20013
stratified log - rank   p   value,C0205363;C1708728;C0667477;C1709380;C0699794;C2986775,false;false;true;false;false;false,18601/20013
stratum,,,18602/20013
stratum nmbr : inadequate response or intolerance to nmbr - nmbr bdmards of same moa,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,18603/20013
stratum nmbr : inadequate response or intolerance to > nmbr bdmards of same moa or > nmbr of multiple moa,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,18604/20013
stratum *,,,18605/20013
stroke ( fatal / nonfatal ),C0038454;C4554100,true;false,18606/20013
stroke and tia,C0038454;C4554100,true;false,18607/20013
stroke any,C0038454;C4554100,true;false,18608/20013
stroke at entry,C0038454;C1705654;C4554100,true;false;false,18609/20013
stroke deaths,C0038454;C0011065;C1306577;C4554100,true;true;false;false,18610/20013
stroke n ( % ),C0038454;C4554100,true;false,18611/20013
stroke non - fatal,C0038454;C4554100,true;false,18612/20013
stroke of atherosclerotic origin,C0038454;C0333482;C0079946;C0439659;C1550512;C4554100,true;false;false;false;false;false,18613/20013
stroke or,C0038454;C4554100,true;false,18614/20013
stroke or cerebrovascular disease,C0038454;C4554100,true;false,18615/20013
stroke or se ( s / se ),C0038454;C4554100,true;false,18616/20013
stroke or see,C0038454;C4554100,true;false,18617/20013
stroke or systemic,C0038454;C4554100,true;false,18618/20013
stroke or systemic embolism,C0038454;C4554100,true;false,18619/20013
stroke ortia,C0038454;C4554100,true;false,18620/20013
stroke / embolism,C0038454;C0013922;C1704212;C4554100,true;true;true;false,18621/20013
stroke / m nmbr,C0038454;C0369637;C0441923;C4554100,true;false;false;false,18622/20013
stroke / m l / hf hospitalization,C0038454;C0456616;C0018488;C0019993;C1313497;C1538440;C3273279;C4554100,true;false;true;true;true;false;false;false,18623/20013
stroke / non -,C0038454;C4554100,true;false,18624/20013
stroke / se,C0038454;C0036919;C4554100,true;true;false,18625/20013
stroke / see,C0038454;C4554100,true;false,18626/20013
strokezsee,,,18627/20013
structural,C0678594,false,18628/20013
structural heart disease — no . ( % ) f,C1290384,false,18629/20013
stsd > nmbr mm on admission ( n = nmbr,C4330985;C0184666;C0809949;C4554674,false;false;false;false,18630/20013
study nmbr . nmbr,C0557651;C2603343,false;false,18631/20013
study nmbr - item short - form general health survey ( sf - nmbr ) can range from nmbr to nmbr for the physical component and from nmbr to nmbr for the mental,C0557651;C1551338;C1282927;C0348078;C3481509;C0037712;C0376315;C1522492;C4255237;C1806781;C2350002;C4554251;C2603343,false;false;false;false;false;true;true;false;false;false;false;false;false,18632/20013
study drug,C0013175,true,18633/20013
study druga,C0557651;C2603343,false;false,18634/20013
study eye characteristics,C1568011;C0015392;C0700042,true;true;false,18635/20013
study medication,C0557651;C0013227;C3244316;C4284232;C2603343,false;true;false;false;false,18636/20013
study period fatal pe,C0557651;C0439531;C1302234;C0070939;C1880476;C4284304;C1705232;C1948053;C2603343,false;false;false;true;false;false;false;false;false,18637/20013
study population,C2348561,false,18638/20013
study treatment,C1521826,false,18639/20013
study treatment — no . / total no . ( % ),C1521826,false,18640/20013
su,C0038642;C1705534,true;false,18641/20013
su monotherapy,C0038642;C1705534,true;false,18642/20013
su / met,C0038642;C1705534,true;false,18643/20013
su / tzd,C0038642;C1705534,true;false,18644/20013
sua < nmbr . nmbr,,,18645/20013
subcutaneous ( n = nmbr ),C0443315,false,18646/20013
subcutaneous injections,C0021499,true,18647/20013
subcutaneous unfractionated heparin,C0353681,false,18648/20013
subdural / epidural,C0038541;C0228134;C0812144,true;true;false,18649/20013
subgoup_name,C0027365;C1547383;C4522128,true;false;false,18650/20013
subgroup nmbr,C1079230;C1515021,false;false,18651/20013
subgroup analyses,C2986480,false,18652/20013
subgroup analysis : change from baseline in hbanmbrc at week nmbr per baseline hbanmbrc category,C2986480;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,18653/20013
subgroup based on :,C1079230;C1515021,false;false,18654/20013
subgroup level,C1079230;C0441889;C0456079;C1547707;C2946261;C1515021,false;false;false;false;false;false,18655/20013
subgroup levels,C1079230;C0441889;C1515021,false;false;false,18656/20013
subgroup name / level,C1079230;C0027365;C0441889;C0456079;C1547707;C2946261;C1547383;C4522128;C1515021,false;true;false;false;false;false;false;false;false,18657/20013
subgroup no .,C1079230;C1515021,false;false,18658/20013
subgroup overall,C1079230;C0282416;C1561607;C1515021,false;true;false;false,18659/20013
subgroup p - valuenmbr,C1079230;C1709380;C1515021,false;false;false,18660/20013
subgroup p value !,C1079230;C1709380;C1515021,false;false;false,18661/20013
subgroup sex,C1079230;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1515021,false;true;true;true;false;false;true;false,18662/20013
subgroup statistics,C1079230;C0038215;C0600673;C1515021,false;false;true;false,18663/20013
subgroup treatment,C1079230;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021,false;true;true;false;false;false;false;false;false,18664/20013
subgroup w . r . t . re - cover,C1079230;C0232024;C0556581;C0180153;C1999244;C3888055;C2986904;C1515021,false;false;false;false;false;false;false;false,18665/20013
subgroup_level,C1079230;C0441889;C0456079;C1547707;C2946261;C1515021,false;false;false;false;false;false,18666/20013
subgroupt,,,18667/20013
subject disposition,C0681850;C0743223;C1705555;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,18668/20013
subject group,C0681850;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1550501;C1706203;C2349001;C2697811,false;false;false;true;false;false;false;false;false;false;false,18669/20013
subjects ( n ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,18670/20013
subjects n,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,18671/20013
subjects stratified by baseline pra,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,18672/20013
subjects who did not receive labd prior to the study,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,18673/20013
subjects who did receive labd prior to the study,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,18674/20013
subjects with imputed value for end ‐ of ‐ treatment body weight,C0681850;C2699638;C1522609;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,18675/20013
subjects with prevalent vertebral fracture,C0681850;C0033105;C0080179;C0220900;C1550501;C1706203;C2349001;C2697811,false;true;true;true;false;false;false;false,18676/20013
subpopulation,C1257890,true,18677/20013
subpopulation analyses according to baseline hbanmbrc,C0441837;C0002778;C0680240;C0168634;C0019016;C1825777;C3538758;C1442488;C0936012;C1524024,false;false;false;true;true;false;false;false;false;true,18678/20013
subpopulation analyses according to bmi,C1514228;C0680240;C0578022,false;false;false,18679/20013
subscale  and nmbr to nmbr for the function subscale  normalized scores can range from nmbr to nmbr . scores for the health assessment question -,,,18680/20013
subsets,C1515021,false,18681/20013
subtrochanteric,,,18682/20013
sudden cardiac death §,C0085298,true,18683/20013
sudden death,C0011071;C1964022;C4554103,true;false;false,18684/20013
sufficient,C0205410,false,18685/20013
suit index,C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,18686/20013
suit quartile nmbr ( b nmbr . nmbr nmol / mmol ) ( n = nmbr ),C2828255;C1532564;C1533073,false;false;false,18687/20013
suit quartile nmbr ( > nmbr . nmbr - < nmbr . nmbr nmol / mmol ) ( n = nmbr ),C2828255;C1532564;C1533073,false;false;false,18688/20013
suit quartile nmbr ( > nmbr . nmbr nmol / mmol ) ( n = nmbr ),C2828255;C1532564;C1533073,false;false;false,18689/20013
sulfasalazine treatment,C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,18690/20013
sulfasalazine use at randomization,C0036078;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,18691/20013
sulfonylurea use at baseline,C0038766;C0042153;C0168634;C1442488;C0457083;C1947944;C3536898,true;true;true;false;false;false;false,18692/20013
sulfonylureas,C0038766;C3653359,true;false,18693/20013
sulfonylureasb,,,18694/20013
sulphonamides,C0038760,true,18695/20013
sulphonylureas only,C0038766;C0205171;C1720467,true;false;false,18696/20013
sun - nmbr ( nmbr ),C0038817;C0376223,true;true,18697/20013
supplementary table nmbr . change from baseline in urine albumin - to - creatinine ratio by hbanmbrc at baseline in patients with normoalbuminuria microalbuminuria and macroalbuminuria .,C0039224;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1706074,false;false;true;false;false;false;false;true,18698/20013
surgical repair of vsd or pda > nmbr - year duration,C0374711;C0018818,false;true,18699/20013
suspected myocardial infarction,C0332147;C0027051;C0428953;C2926063;C3810814;C4552959;C0750491,false;true;false;false;false;false;false,18700/20013
sustain,C0443318;C2732140,false;false,18701/20013
sustain nmbr,C0443318;C2732140,false;false,18702/20013
sustain nmbr : semaglutide vs . placebo,C0443318;C2732140,false;false,18703/20013
sustain nmbr : semaglutide vs . sitagliptin nmbr mg,C0443318;C2732140,false;false,18704/20013
sustain nmbr : semaglutide vs . exenatide er nmbr . nmbr mg,C0443318;C2732140,false;false,18705/20013
sustain nmbr : semaglutide vs . iglar,C0443318;C2732140,false;false,18706/20013
sustain nmbr : semaglutide add ‐ on to insulin vs . placebo,C0443318;C2732140,false;false,18707/20013
sustained decrease of > nmbr % in egfr ®,C0443318;C0392756;C0547047,false;false;false,18708/20013
sustained esrd,C0443318;C0022661;C0035078;C2316810,false;true;true;false,18709/20013
sustained mucosal healingc,C0443318;C0026724,false;true,18710/20013
sustained mucosal healingc n / n ( % ),C0443318;C0026724,false;true,18711/20013
swollen - joint count ( of nmbr joints assessed ) — no .,C0451521,false,18712/20013
swollen joint count ( nmbr - nmbr joints ),C0451521,false,18713/20013
swollen joint count ( nmbr – nmbr joints ),C0451521,false,18714/20013
swollen joint count ( nmbr — nmbr  per swollen joint ),C0451521,false,18715/20013
swollen joint count ( nmbr ),C0451521,false,18716/20013
swollen joint count ( range nmbr - nmbr joints ),C0451521;C1514721;C2348147;C3542016,false;false;false;false,18717/20013
swollen joint count of nmbr joints,C0451521,false,18718/20013
swollen joints ( nmbr - joint count ),C0451521,false,18719/20013
swollen joints > nmbr,C0152031,false,18720/20013
symmetric t - wave inversions,C0332516;C0520888;C2699744,false;false;false,18721/20013
symmetric t wave inversions,C0332516;C0520888;C2699744,false;false;false,18722/20013
symptom - free days in the past nmbr weeks ( % ),C1457887;C0332296;C0677547;C1444637;C4284302;C0439228;C2987125;C1880497;C1996904;C3854129,false;false;false;false;false;false;false;false;false;false,18723/20013
symptom bother,C1457887;C3854129,false;false,18724/20013
symptom onset - to - randomization,C4086878;C0034656,false;true,18725/20013
symptom onset to enrollment,C4086878;C1516879;C1696073;C3888021,false;false;false;false,18726/20013
symptom onset to hospitalization,C4086878;C0019993,false;true,18727/20013
symptom onset to pci,C4086878;C4049621,false;false,18728/20013
symptomatic,C0231220,false,18729/20013
symptomatic deep - vein thrombosis,C0231220;C0149871,false;true,18730/20013
symptomatic heart fail,C0231220;C0018787,false;true,18731/20013
symptomatic hypoglycaemia,C0231220;C0020615;C4553659,false;true;false,18732/20013
symptomatic hypotension,C0231220;C0020649;C3163620,false;true;false,18733/20013
symptomatic hypotension ( sbp < nmbr mmhg ),C0231220;C0020649;C0085805;C0439475;C3163620,false;true;true;false;false,18734/20013
symptomatic hypotension with sbp < nmbr mm   hg,C0231220;C0020649;C0085805;C0439475;C3163620,false;true;true;false;false,18735/20013
symptomatic ich,C0231220;C0019191;C3272597;C3281105,false;true;false;false,18736/20013
symptomatic infarct swelling,C0231220;C0021308;C0013604;C0038999,false;true;true;false,18737/20013
symptomatic localization - related,C0231220;C0475264;C1744691,false;false;false,18738/20013
symptomatic pe,C0231220;C0070939;C1880476;C4284304,false;true;false;false,18739/20013
symptomatic remissionb n / n ( % ),C0231220,false,18740/20013
symptomaticb,,,18741/20013
symptoms mean ( sd ),C0683368;C0444504;C2699239;C2347634;C2348143;C1457887,true;false;false;false;false;false,18742/20013
symptoms of atrial fibrillation in the nmbr months before randomization — no . ( % ),C0683368;C0004238;C0344434;C1963067;C1457887,true;true;false;false;false,18743/20013
symptoms onset to first balloon inflation,C4086878;C0205435;C0336867;C0021398;C1318493;C0441144;C1279901,false;false;false;true;false;false;false,18744/20013
syncope,C0039070;C3541349;C4554644,true;false;false,18745/20013
syndrome,C0039082,true,18746/20013
sys : ns dia : < nmbr . nmbr,C1425041;C0038944;C1706546;C1112705;C1705982,false;true;false;false;false,18747/20013
systemic corticosteroids — no . ( % ),C4053960,false,18748/20013
systemic embolism,C0205373;C0013922;C1704212,false;true;true,18749/20013
systemic glucocorticoid use at randomization,C0205373;C0017710;C0042153;C0034656;C0457083;C1947944,false;true;true;true;false;false,18750/20013
systemic hypertension,C0020538,true,18751/20013
systemic sle medications,C0205373;C0024141;C0013227;C0802604;C2598133;C4284232,false;true;true;false;false;false,18752/20013
systoiic biood pressure,C0033095;C0460139;C1306345;C4284008,true;false;false;false,18753/20013
systolic blood pressure — mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,18754/20013
systolic blood pressure ( change from baseline ),C0392747;C4274438;C0443172;C1705241;C4319952,false;false;false;false;false,18755/20013
systolic blood pressure ( median nmbr . nmbr ),C0488055;C0549183;C0876920;C2347635;C2348144;C2939193;C0871470;C1306620,false;false;false;false;false;false;true;false,18756/20013
systolic blood pressure < nmbr mm hg and diastolic,C0488055;C0439475;C0871470;C1306620,false;false;true;false,18757/20013
systolic blood pressure > nmbr mm hg — no . ( % ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,18758/20013
systolic blood pressure > nmbr mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,18759/20013
systolic blood pressure > nmbr mm hg or diastolic,C0488055;C0439475;C0871470;C1306620,false;false;true;false,18760/20013
systolic blood pressure mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,18761/20013
systolic blood pressure^,C0488055;C0871470;C1306620,false;true;false,18762/20013
systolic bp ( mmhg ) *,C0871470;C0439475,true;false,18763/20013
systolic bp at baseline :,C0871470;C0168634;C1442488,true;true;false,18764/20013
systolic pressure — mm hg,C0871470;C0439475,true;false,18765/20013
systolic pressure at ankle level ( mmhg ),C0871470;C0003086;C0441889;C0439475;C0456079;C1547707;C2946261;C0003087,true;true;false;false;false;false;false;true,18766/20013
systolic pressure,C0871470,true,18767/20013
t,C2603360,false,18768/20013
t - jj ( nmbr - nmbr ),C2603360,false,18769/20013
t - score at femoral neck,C3854607;C0015815,false;true,18770/20013
t - score categories lumbar spineb,C3854607;C0683312;C0024090,false;false;true,18771/20013
t - wave inversion,C0520888,false,18772/20013
t - wave inversion only,C0520888;C0205171;C1720467,false;false;false,18773/20013
t ( n = nmbr,C2986835,false,18774/20013
t nmbr . nmbr mg,C2603360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,18775/20013
t wave inversion,C0520888,false,18776/20013
tnmbr ( nmbr . nmbr - nmbr . nmbr ng / ml ),C2603360;C0439275,false;false,18777/20013
tnmbrd duration,C2603360;C0449238;C2926735,false;false;false,18778/20013
ta,C0039297;C1506978;C1705538;C3272501;C4553364,true;false;false;false;false,18779/20013
ta ( n = nmbr ),C0039297;C1506978;C1705538;C3272501;C4553364,true;false;false;false;false,18780/20013
table nmbr baseline characteristics of total study sample and stratified by treatment assignment and testosterone levela,C0039224;C4684572;C0947343;C0370003;C2347026;C0168634;C1315074;C1442488;C1706074,false;false;false;false;false;true;false;false;true,18781/20013
table nmbr . characteristics of patients treated with losartan and atenolol *,C0039224;C0815172;C1706074,false;false;true,18782/20013
table nmbr . characteristics of the patients at baseline . *,C0039224;C0815172;C1706074,false;false;true,18783/20013
table nmbr . selected baseline characteristics of the study patients . *,C0039224;C1706074,false;true,18784/20013
table_group,C0039224;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1706074,false;false;false;true;false;false;false;true,18785/20013
taci,C0666480;C1425349;C4284230,true;false;false,18786/20013
tadalafil,C1176316,true,18787/20013
tadalafil nmbr mg n = nmbr,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18788/20013
tadalafil nmbr . nmbr mg,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18789/20013
tadalafil nmbr . nmbr mg ( n = nmbr ),C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18790/20013
tadalafil nmbr . nmbr mg n = nmbr,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18791/20013
tadalafil nmbr mg,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18792/20013
tadalafil nmbr mg ( n = nmbr ),C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18793/20013
tadalafil nmbr mg mean change ( sd ),C1176316;C0024671;C0444504;C0392747;C2699239;C0443172;C1705241;C4319952;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false;false;false;false;true;false;false;false;false;false,18794/20013
tah ( n = nmbr ),C0404079,false,18795/20013
taking antihypertensive medication at baseline,C1515187,false,18796/20013
taking antihypertensive treatment at,C1515187,false,18797/20013
taking calcium supplements at baseline,C1515187;C0006675;C0006726;C2936886;C3540037;C3714611,false;true;true;false;false;false,18798/20013
taking statins,C1515187;C0360714,false;true,18799/20013
tamong those enrolling via bnp stratum . the study - qualifying bnp or,,,18800/20013
tamsulosin,C0257343,true,18801/20013
tamsulosin ( n = nmbr ),C0257343,true,18802/20013
tamsulosin ( w = nmbr ),C0257343,true,18803/20013
tamsulosin nmbr . nmbr mg ( n = nmbr ),C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18804/20013
tamsulosin nmbr . nmbr mg vs . placebo,C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18805/20013
tamsulosin nmbr . nmbrmg vs . nmbr . nmbrmg,C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18806/20013
tanezumab ( all doses combined ),C2346819,true,18807/20013
tanezumab ( all doses combined ) + nsaida,C2346819,true,18808/20013
tanezumab nmbr mg,C2346819;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18809/20013
tanezumab nmbr mg + nsaid,C2346819;C0024671;C0003211;C3536840;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,18810/20013
tanezumab nmbr . nmbr mg,C2346819;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18811/20013
tanezumab nmbr . nmbr mg + nsaid,C2346819;C0024671;C0003211;C3536840;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,18812/20013
target nail napsi score ( nmbr – nmbr scale ),C1521840;C0027342;C1432728;C3538766;C2986546,false;true;true;false;false,18813/20013
target vessel,C0449618,false,18814/20013
tass ’,C0559483,true,18815/20013
tbp,,,18816/20013
tc ( mg / dl ),C0039411;C0439269;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,18817/20013
tc level,C0039411;C0441889;C0456079;C1547707;C2946261;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;true;true;true;false;false;false,18818/20013
tc : hdlc,C0039411;C1704429;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;true;false;false;false,18819/20013
tcomparison of proportion of patients with nyha class lll / iv heart failure .,C1709707;C0030705,false;true,18820/20013
tcz - sc nmbr mg every other week ( n = nmbr ),C0282380;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18821/20013
tcz nmbr mg / kg n = nmbr,C0439272,false,18822/20013
tcz + mtx ( n ),C0025677;C1417487,true;false,18823/20013
tdi e ' ( septal ) ( cm / sec ),C0205976;C0442004;C0439392;C2674784;C3714807,true;false;false;false;false,18824/20013
teaes in anmbr % of individuals,C0027361;C0237401,true;false,18825/20013
teaes leading to discontinuation of study drug,,,18826/20013
teaes of special interest,C0205555;C0543488,false;false,18827/20013
teaes reported by ≥ nmbr % patients in the overall brv group,,,18828/20013
temporal data and management strategy,C0442043;C1511726;C3245479;C3714741;C2362314,false;false;false;false;false,18829/20013
temporary factors,C0205374;C1521761;C2827422;C1548539;C3245481,false;false;false;false;false,18830/20013
temporary risk factor,C0205374;C0035648;C1548539;C3245481,false;true;false;false,18831/20013
tender - or painful - joint count ( of nmbr joints assessed ) — no .,C0234234,false,18832/20013
tender joint count ( nmbr - nmbr  per tender joint ),C0451530,false,18833/20013
tender joint count ( nmbr - nmbr joints ),C0451530,false,18834/20013
tender joint count ( nmbr – nmbr joints ),C0451530,false,18835/20013
tender joint count ( nmbr ),C0451530,false,18836/20013
tender joint count ( range nmbr - nmbr joints ),C0451530;C1514721;C2348147;C3542016,false;false;false;false,18837/20013
tender joint count of nmbr joints,C0451530,false,18838/20013
tender joints ( nmbr - joint count ),C0451530,false,18839/20013
tenecteplase and pci ( n = nmbr ),C0872913,true,18840/20013
teriparatide ( n   =   nmbr ),C0070093,true,18841/20013
teriparatide n / n ( % ),C0070093,true,18842/20013
terlile nmbr,,,18843/20013
terrible,C3827840,false,18844/20013
tertiary,C0205372,false,18845/20013
tertiary amines,C3653356,false,18846/20013
tertiary end points,C0205372;C2349179,false;false,18847/20013
tertiary endpoints :,C0205372;C2349179,false;false,18848/20013
tertile nmbr : nmbr . nmbr ( nmbr . nmbr ),,,18849/20013
tertile of total cholesterol at baseline,C0201950;C0543421,false;false,18850/20013
test for interaction,C0022885;C1704675;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false,18851/20013
test for interaction ( p value ),C0022885;C1704675;C1709380;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false,18852/20013
test for interaction between treatment and race,C0022885;C1704675;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false,18853/20013
test for trend,C0022885;C1521798;C4554533;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false,18854/20013
testing order,C0039593;C1705175;C1705176;C1705177;C1705178;C1882348;C3889825;C4284072;C0392366,false;false;false;false;false;false;false;false;false,18855/20013
testosterone ( nmol / l ),C0039601;C0439282,true;false,18856/20013
testosterone ( tt ) ( nmol / l ),C0039601;C1452561;C0439282;C4554543,true;true;false;false,18857/20013
testosterone level ( nmol / l ),C0428412;C0439282;C0523912,false;false;false,18858/20013
tests for categoric,C0589061,false,18859/20013
texcaps,,,18860/20013
th ( nmbr % ),C0039725;C0039738;C1420718;C4282123;C4285344,true;true;false;false;false,18861/20013
th c,C0039725;C0039738;C1420718;C4282123;C4285344,true;true;false;false;false,18862/20013
the american college of rheumatology ) .,C0596070;C0557806;C0035452,false;false;true,18863/20013
the metabolic syndrome^,C0524620,true,18864/20013
the netherlands,C0027778,true,18865/20013
the plot shows hazard ratios and nmbr % confidence intervals for the primary outcome,,,18866/20013
the square of the height in meters . patient ' s and physician ' s global assessment scores can range from nmbr to nmbr . scores for the western,C0205120;C0489786;C1552595,false;false;false,18867/20013
the test for heterogeneity ( interaction ) indicates whether the treatment effect varied significantly among the sub - groups . the hochberg method was applied to each of the two comparisons of the treatment groups . bmi denotes body - mass index ( the weight in kilograms divided by the square of the height in meters ) .,C0022885;C0019409;C1704675;C0242960;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;true;false;false;false;false;false;false,18868/20013
therapies,C0087111,true,18869/20013
therapy,C0039798;C0087111;C1363945,true;true;false,18870/20013
therapy - fatigue ( facit - f,C0039798;C0015672;C3272505;C3463815;C4050243;C4554645;C0087111;C1363945,true;true;false;false;false;false;true;false,18871/20013
therapy use,C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,true;true;false;false;true;false,18872/20013
thiazide diuretic *,C0012802;C3536861,true;false,18873/20013
thiazide users,C0541746;C1706077,true;false,18874/20013
thiazolidinedione use at baseline,C0289779;C0042153;C0168634;C1442488;C0457083;C1947944;C1257987;C3537039,true;true;true;false;false;false;true;false,18875/20013
thiazolidinediones *,C1257987;C3541957,true;false,18876/20013
thiazolidinedionesc,,,18877/20013
thienopyridine alone,C1120149,true,18878/20013
thienopyridine at baseline,C1120149;C0168634;C1442488,true;true;false,18879/20013
thienopyridine at discharge,C1120149;C0012621;C0030685;C2926602,true;false;true;false,18880/20013
thienopyridine + dipyridamole,C1120149;C0012582,true;true,18881/20013
third yeart,C0205437,false,18882/20013
this study,C0557651;C2603343,false;false,18883/20013
three - point mace,C0205449;C1552961;C0349381;C0949745;C1445339;C2347617;C3714763,false;false;false;true;false;false;false,18884/20013
three or more lesions,C0205449,false,18885/20013
thromboaspiration,,,18886/20013
thromboembolism,C0040038,true,18887/20013
thrombolysis,C0520997,false,18888/20013
thrombolytic agents,C0016018,true,18889/20013
thrombus aspiration done per lesion †,C0087086;C0220787;C0349707;C0700198;C2712334;C2827071;C0302148;C3146237,true;false;false;false;false;false;false;false,18890/20013
thyroid disease,C0040128,true,18891/20013
thyroid hormone,C0040135;C4522017,true;false,18892/20013
ticagrelor nmbr mg,C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18893/20013
ticagrelor nmbr mg diabetes n = nmbr,C1999375;C0024671;C0011847;C0011849;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;true;false;false;false;false;false,18894/20013
ticagrelor nmbr mg km %,C1999375;C0024671;C3887676;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,18895/20013
ticagrelor nmbr mg no diabetes n = nmbr,C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18896/20013
ticagrelor in ‐ hosp ( n = nmbr ),C1999375,true,18897/20013
ticagrelor pre ‐ hosp ( n = nmbr ),C1999375;C0332152;C0740175;C2257086;C3669034,true;false;false;false;false,18898/20013
tier nmbr aes,C1412268;C2699274,false;false,18899/20013
tier nmbraes,C1412268;C2699274,false;false,18900/20013
time - to - first - infusion from hip surgery ( days ),C0040223;C0205435;C0574032;C1827465;C1279901;C3541383,true;false;false;false;false;false,18901/20013
time - to - first infusion,C0040223;C0205435;C0574032;C1827465;C1279901;C3541383,true;false;false;false;false;false,18902/20013
time ( sec ) *,C0040223;C0565930;C3541383,true;false;false,18903/20013
time between index acs and randomization — days,C0040223;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;true;false;false;false;false,18904/20013
time between index acs and randomization ( days ),C0040223;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;true;false;false;false;false,18905/20013
time from acute coronary syndrome to randomization ( days ),C0040223;C0948089;C3541383,true;true;false,18906/20013
time from end of fit,C1522314;C0036572;C2349186;C4048158;C4553125,false;true;false;true;false,18907/20013
time from fibrinolytic therapy to study - drug administration — no . / total no . ( % ),C0206209;C0040044;C0013175;C0040223;C0557651;C0013216;C1611232;C3665478;C2603343;C3541383;C0040227;C0150270;C3469597;C2349982,true;true;true;true;false;true;true;false;false;false;true;false;false;false,18908/20013
time from hospital admission to enrollment,C0040223;C0019994;C1959907;C1510665;C3541383,true;true;false;false;false,18909/20013
time from hospitalization to randomization — hr,C0040223;C0019993;C3541383,true;true;false,18910/20013
time from index acs event to randomisation ( days ),C0040223;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;false;false;true;false;false;false;false,18911/20013
time from ld to pci  min  median ( qnmbr – qnmbr ),C0040223;C0694649;C3541383,true;false;false,18912/20013
time from onset of pain to randomization — hr,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,18913/20013
time from onset of symptoms to presentation — hr,C1320528,false,18914/20013
time from onset of symptoms to start of fibrinolytic therapy — hr,C1320528,false,18915/20013
time from pah diagnosis months,C0030123;C0011900;C0556969;C1704338;C1704656;C3203102;C4284467,true;true;false;true;false;true;false,18916/20013
time from parkinson ’ s disease diagnosis in months,C0040223;C0030567;C0011900;C1704338;C1704656;C3541383,true;true;true;true;false;false,18917/20013
time from presentation to randomization — hr,C0040223;C0449450;C3541383,true;false;false,18918/20013
time from psoriatic arthritis diagnosis [a],C0040223;C0003872;C0011900;C1704338;C1704656;C3541383,true;true;true;true;false;false,18919/20013
time from qualifying ecg to balloon inflation,C0040223;C1514624;C1623258;C3541383,true;false;true;false,18920/20013
time from ra diagnosis,C0040223;C3538806;C0011900;C1704338;C1704656;C4048756;C3541383,true;false;true;true;false;false;false,18921/20013
time from randomization to cabg — hr,C0040223;C0034656;C3541383,true;true;false,18922/20013
time from randomization to coronary angiography — hr,C0040223;C0034656;C3541383,true;true;false,18923/20013
time from randomization to pci — hr,C0040223;C0034656;C3541383,true;true;false,18924/20013
time from randomization to study - drug administration — hr,C0206209;C0034656;C0013175;C0040227;C0150270;C3469597;C2349982,true;true;true;true;false;false;false,18925/20013
time from randomization to study - drug initiation — hr,C0040223;C0034656;C0013175;C0589507;C1158830;C1704686;C3541383;C0040227;C0013227;C1254351;C2349982,true;true;true;false;false;false;false;true;true;false;false,18926/20013
time from sx onset to baseline ecg,C1519428;C0449244;C3539997;C3815196,false;false;true;false,18927/20013
time from symptom onset of ra,C1320528;C3538806;C4048756,false;false;false,18928/20013
time from symptom onset to balloon inflation,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,18929/20013
time from symptom onset to enrollment,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,18930/20013
time from symptom onset to start of fibrinolytic therapy — hr,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,18931/20013
time from symptoms to randomization,C0040223;C0683368;C1457887;C3541383,true;true;false;false,18932/20013
time from,C0040223;C3541383,true;false,18933/20013
time in therapeutic range,C1554109;C0087111;C0302350;C0040223;C0460097;C3541383,false;true;false;true;false;false,18934/20013
time in trial,C0040223;C3541383,true;false,18935/20013
time point,C2348792,false,18936/20013
time sample drawn ( h ),C0040223;C3541383,true;false,18937/20013
time since as diagnosis ( years ),C0040223;C3541383,true;false,18938/20013
time since asthma,C0040223;C3541383,true;false,18939/20013
time since asthma diagnosis [years],C0040223;C3541383,true;false,18940/20013
time since asthma diagnosis years,C0040223;C3541383,true;false,18941/20013
time since bph diagnosis ( years ),C0040223;C3541383,true;false,18942/20013
time since cabg,C0040223;C3541383,true;false,18943/20013
time since diagnosis of ciu / csu ( years ) nmbr,C0040223;C3541383,true;false,18944/20013
time since diagnosis of ciu / csuf ( y ),C0040223;C3541383,true;false,18945/20013
time since diagnosis of copd,C0040223;C3541383,true;false,18946/20013
time since diagnosis of diabetes ( years ) ( median,C0040223;C3541383,true;false,18947/20013
time since diagnosis of ln,C0040223;C3541383,true;false,18948/20013
time since diagnosis of pah years #,C0040223;C3541383,true;false,18949/20013
time since diagnosis of psa ( years ),C0040223;C3541383,true;false,18950/20013
time since diagnosis of sle,C0040223;C3541383,true;false,18951/20013
time since diagnosis of tnmbrdm,C0040223;C3541383,true;false,18952/20013
time since diagnosis of type nmbr diabetes mellitus,C0040223;C3541383,true;false,18953/20013
time since diagnosis,C0040223;C3541383,true;false,18954/20013
time since end of fit,C0040223;C3541383,true;false,18955/20013
time since epilepsy diagnosis ( years ),C0040223;C3541383,true;false,18956/20013
time since first luts ( years ),C0040223;C3541383,true;false,18957/20013
time since first psoriasis diagnosis ( y ),C0040223;C3541383,true;false,18958/20013
time since ipf diagnosisa,C0040223;C3541383,true;false,18959/20013
time since last dose of,C0946444,false,18960/20013
time since most recent myocardial,C0040223;C3541383,true;false,18961/20013
time since onset ( h ),C0040223;C3541383,true;false,18962/20013
time since pd diagnosis,C0040223;C3541383,true;false,18963/20013
time since primary diagnosis,C0040223;C3541383,true;false,18964/20013
time since prior alendronate use,C0040223;C3541383,true;false,18965/20013
time since psa onset,C0040223;C3541383,true;false,18966/20013
time since psoriasis diagnosis,C0040223;C3541383,true;false,18967/20013
time since rheumatoid arthritis diagnosis,C0040223;C3541383,true;false,18968/20013
time since start insulin ( years ),C0040223;C3541383,true;false,18969/20013
time since start of fit,C0040223;C3541383,true;false,18970/20013
time to all - cause death up to end of the study,C0040223;C0007465;C3541383;C0015127;C1301931;C1524003,true;true;false;true;false;false,18971/20013
time to angiography — hr,C0040223;C0002978;C3541383,true;true;false,18972/20013
time to death due to pah or hospitalization due to pah up to the end of the treatment periodd,C1301931,false,18973/20013
time to first cv hospitalization or death from any cause,C0040223;C0205435;C3538987;C0019993;C4048877;C4318503;C1279901;C3541383,true;false;false;true;true;false;false;false,18974/20013
time to first exacerbation,C0040223;C0205435;C4086268;C1279901;C3541383,true;false;false;false;false,18975/20013
time to first inhaled corticosteroid ( % ),C0040223;C0205435;C0004048;C0001617;C3536709;C1279901;C3541383,true;false;true;true;false;false;false,18976/20013
time to first morbidity / mortality event up to the end of the treatment periodd,C0040223;C0205435;C0026538;C0026565;C0441471;C4019010;C0026566;C0220880;C1279901;C3541383,true;false;true;true;false;false;true;true;false;false,18977/20013
time to first oral or systemic corticosteroid ( % ),C0040223;C0205435;C0442027;C4521986;C1279901;C3541383,true;false;false;false;false;false,18978/20013
time to first sare * ( % ),C0040223;C0205435;C1279901;C3541383,true;false;false;false,18979/20013
time to randomization ( h ),C0040223;C0034656;C0033727;C0369286;C0441932;C0564385;C4528284;C3541383,true;true;true;false;false;false;false;false,18980/20013
time to rx,C0040223;C1425688;C1521941;C2709207;C3541383,true;false;false;false;false,18981/20013
time,C0040223;C3541383,true;false,18982/20013
timi - bleeding major / minor,,,18983/20013
timi ≥ nmbr,,,18984/20013
timi ≥ nmbr and spoke,,,18985/20013
timi ≥ nmbr and spoke and time ≤ nmbr h,,,18986/20013
timi clinically significant,,,18987/20013
timi flow grade nmbr of mi culprit vessel post ‐ pci,C3272266;C0441800;C0005847;C0856742;C4049621;C0919553;C3244287,false;false;true;false;false;false;false,18988/20013
timi flow grade nmbr of mi culprit vessel pre ‐ pci,C3272266;C0441800;C3810814;C0005847;C0919553;C3244287,false;false;false;true;false;false,18989/20013
timi flow ‡,C3272266,false,18990/20013
timi major or,,,18991/20013
timi major / minor bleeding,C4441842;C0019080,false;true,18992/20013
timi minor bleeding,C0026193;C0019080;C0205165,true;true;false,18993/20013
timi non - cabg major,C1518422;C0010055,false;true,18994/20013
timi risk score — %,C0035647;C0449820;C4050231;C4552904,true;false;false;false,18995/20013
timi risk score — no . / total no . ( % ) : c,C0035647;C0449820;C4050231;C4552904,true;false;false;false,18996/20013
timi risk score — no . / total no . ( % ) f,C0035647;C0449820;C4050231;C4552904,true;false;false;false,18997/20013
timi risk score > nmbr,C0035647;C0449820;C4050231;C4552904,true;false;false;false,18998/20013
timi risk score category — no . ( % ),C0035647;C0449820;C0683312;C3889287;C4050231;C4552904,true;false;false;false;false;false,18999/20013
timi risk score *,C0035647;C0449820;C4050231;C4552904,true;false;false;false,19000/20013
timi risk scoret,,,19001/20013
tio,,,19002/20013
tio ( n nmbr nmbr ),,,19003/20013
tio nmbr | ig ( n = nmbr ),C0021027;C0305052;C0360506,true;false;false,19004/20013
tio inmbr mcg ( n = nmbr ),C0021966;C0439211;C3463985;C0221138,true;false;false;false,19005/20013
tion  os = overall satisfaction  qmax = maximal urinary flow rate .,C0229090;C4086680;C0429784;C0230028;C0262950;C0393706;C1561953,false;false;false;false;true;false;false,19006/20013
tiotropium + olodaterol nmbr / nmbr,C4032878,true,19007/20013
tiotropium nmbr meg ( n = nmbr ),C0213771;C0024489;C0025175;C0072225,true;true;true;true,19008/20013
tiotropium nmbr . nmbr μ g ( n   = nmbr ),C0213771;C0439267,true;false,19009/20013
tiotropium nmbr . nmbr pg,C0213771;C0030827;C0072225;C1266240,true;true;true;false,19010/20013
tiotropium nmbr . nmbr   μ g ( n   =   nmbr ),C0213771;C0439267,true;false,19011/20013
tiotropium nmbr pg,C0213771;C0030827;C0072225;C1266240,true;true;true;false,19012/20013
tiotropium nmbr   μ g ( n   =   nmbr ),C0213771;C0439267,true;false,19013/20013
tiotropium salmeterol no . of patients / total no .,C0213771;C0073992,true;true,19014/20013
tiotropium vs . salmeterol,C0213771,true,19015/20013
tj ( nmbr - nmbr ),C0039247,true,19016/20013
tj ( nmbr % ),C0039247,true,19017/20013
tk,C0041405;C0220928;C4050092,true;true;false,19018/20013
tlmi risk score,C0035647;C0449820;C4050231;C4552904,true;false;false;false,19019/20013
tnf - failure patientsa,C1448177;C0231174;C0680095,true;false;false,19020/20013
tnf - failurea,C1448177,true,19021/20013
tnf - ir,C1448177;C0022065;C0022071;C1448132,true;true;true;true,19022/20013
tnf - na ï ve,C1448177;C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,true;false;true;false;false;false;false;false;false;false,19023/20013
tnf - naive patientsa,C1448177,true,19024/20013
tnf - naivea,C1448177,true,19025/20013
tnf antagonist - exposed,C1448177;C0231491,true;false,19026/20013
tnf antagonist - failure population ( n - nmbr ),C1448177;C0231491;C0231174;C0032659;C1257890;C0680095,true;false;false;true;true;false,19027/20013
tnf antagonist - naive ' ’,C1448177;C0231491,true;false,19028/20013
tnf antagonist - naive subgroup ( n - nmbr ),C1448177;C0231491;C1079230;C1515021,true;false;false;false,19029/20013
tnf antagonist - naive ®,C1448177;C0231491,true;false,19030/20013
tnfi - exposed †,,,19031/20013
tnfi - ir,C0022065;C0022071;C1448132,true;true;true,19032/20013
tnfi - naive,,,19033/20013
tnfi - na ï ve,C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;false;false;false;false;false;false,19034/20013
tni ultrapositive ≥ nmbr . nmbr µ g / l,C0077401;C0439294;C0456615,true;false;false,19035/20013
tni ultrapositive,C0077401,true,19036/20013
tobacco user,C3853727,false,19037/20013
tofacitinib nmbr mg bid ( n = nmbr ),C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,19038/20013
tofacitinib nmbr mg bid ( n   = nmbr ),C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,19039/20013
tolvaptan,C1176308,true,19040/20013
tolvaptan ( n = nmbr ),C1176308,true,19041/20013
tonic,C3543842,false,19042/20013
tonic – clonic,C3543842,false,19043/20013
took prior antihyperglycemic agent ( any ),C1515187,false,19044/20013
tophi present,C0221248,false,19045/20013
topical,C0332237,false,19046/20013
topical non - prescription,C0332237;C1518422;C0033080;C1521941,false;false;true;false,19047/20013
topical prescription,C0332237;C0033080;C1521941,false;true;false,19048/20013
toricoxib nmbr mg n = nmbr ) ( % ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,19049/20013
totai mortaiity,,,19050/20013
total - c,C0439175;C0439810,false;false,19051/20013
total - hip bmd t - score,C2964552;C0019552;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false,19052/20013
total ( n [ nmbr ),C0439175;C0439810,false;false,19053/20013
total ( n nmbr nmbr ),C0439175;C0439810,false;false,19054/20013
total ( n   = nmbr ),C0439175;C0439810,false;false,19055/20013
total ( n ),C0439175;C0439810,false;false,19056/20013
total ( n   =   nmbr ),C0439175;C0439810,false;false,19057/20013
total ( v = nmbr,C0439175;C0439810,false;false,19058/20013
total > atients,C0439175;C0439810,false;false,19059/20013
total nmbr,C0439175;C0439810,false;false,19060/20013
total aim ‐ high study,C0439175;C1947946;C0205250;C0557651;C2603343;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C2744535;C2948600;C3540471;C3540472;C3890193;C0439810,false;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;false,19061/20013
total back pain score ( nmbr – nmbr   mm scale ),C2964552;C0004604;C4330985;C0175659;C0349674;C1947916;C4554674;C1963071;C4553945,false;true;false;true;false;false;false;false;false,19062/20013
total basdai score,C0439175;C1998004;C0439810,false;false;false,19063/20013
total baseline insulin dose,C2986497;C0168634;C0021641;C1533581;C1579433;C3714501;C1442488;C0439175;C0366513;C0439810,false;true;true;false;false;false;false;false;false;false,19064/20013
total bilirubin > nmbr x ulnnmbr,C0005437;C1519815;C0368753,true;false;false,19065/20013
total bilirubin,C0005437;C0368753,true;false,19066/20013
total bleeding,C0232100,true,19067/20013
total bleeds,C0232100,true,19068/20013
total by treatment,C0439175;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0439810,false;true;true;false;false;false;false;false;false,19069/20013
total c ( mg / dl ) *,C0439175;C0439269;C0439810,false;false;false,19070/20013
total c / hdl - c ratio * *,C0439175;C3715113;C0456603;C1547037;C0439810,false;false;false;false;false,19071/20013
total carmelina population,C3258257,false,19072/20013
total cholesterol ( sd ),C0201950;C2699239;C0543421,false;false;false,19073/20013
total cholesterol level,C0878805;C1445957,false;false,19074/20013
total cholesterol  mg / dl   ^,C0201950;C0439269;C0543421,false;false;false,19075/20013
total cholesterol^,C0201950;C0543421,false;false,19076/20013
total cigarette pack - years,C0439175;C1303175;C0439810,false;false;false,19077/20013
total cohort,C0439175;C0009247;C0599755;C0439810,false;true;false;false,19078/20013
total daily dose of ics,C2348070;C0815320;C4551720,false;false;true,19079/20013
total daily insulin dose ( lu / kg ),C2348070;C0021641;C0024171;C0022718;C0439209;C4054209;C0024176;C2697939;C1533581;C1579433;C3714501,false;true;true;true;false;false;true;false;false;false;false,19080/20013
total daily insulin dose ( u / day ),C2348070;C0021641;C0456683;C1533581;C1579433;C3714501,false;true;false;false;false;false,19081/20013
total daily insulin dose,C2348070;C0021641;C1533581;C1579433;C3714501,false;true;false;false;false,19082/20013
total death,C0439175;C0011065;C1306577;C4082313;C4552775;C0439810,false;true;false;false;false;false,19083/20013
total deaths,C0439175;C0011065;C1306577;C0439810,false;true;false;false,19084/20013
total events,C0439175;C0441471;C3541888;C0439810,false;false;false;false,19085/20013
total feet score,C2964552;C0016504;C0347981,false;true;false,19086/20013
total gadolinium - enhancing lesion count . no . ( % ),C0439175;C1333400;C0439810,false;false;false,19087/20013
total glucose mg / dl,C0439175;C0017725;C0439269;C0439810,false;true;false;false,19088/20013
total hands score,C0439175;C0018563;C1552914;C0439810,false;true;false;false,19089/20013
total hip ( n = nmbr,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,19090/20013
total hip bmd ( g / cmnmbr ),C0439175;C0019552;C0439267;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;false;true;true;false;false;false,19091/20013
total hip bmd t - score,C2964552;C0019552;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false,19092/20013
total hip bmi ) t - score,C2964552;C0019552;C0578022;C0022122;C1505163;C3538851;C4284725,false;true;false;true;true;false;false,19093/20013
total hip or knee replacement,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,19094/20013
total hipc,C0439175;C0439810,false;false,19095/20013
total ics dose at entry,C2986497;C0815320;C1705654;C4551720,false;false;false;true,19096/20013
total ige — lu / ml,C0439175;C2697941;C0439810,false;false;false,19097/20013
total ige levelx ( iu / ml ),C0439175;C0439458;C0439810,false;false;false,19098/20013
total ige,C0439175;C0439810,false;false,19099/20013
total included in combined analysis,C0439175;C0439810,false;false,19100/20013
total ipss,C0439175;C1019118;C1998280;C2827405;C3811063;C0439810,false;false;false;false;false;false,19101/20013
total length of implanted stents,C0439175;C0449462;C0021102;C2828363;C0439810,false;false;false;false;false,19102/20013
total macular volume,C0449468;C0332574,false;false,19103/20013
total mayo score,C2964552;C0454788;C1077578,false;false;false,19104/20013
total mortality all,C0439175;C0026565;C0026566;C0439810,false;true;true;false,19105/20013
total n,C0439175;C0439810,false;false,19106/20013
total n   =   nmbr,C0439175;C0439810,false;false,19107/20013
total nnmbr,C0439175;C0439810,false;false,19108/20013
total no . nmbr,C0439175;C0439810,false;false,19109/20013
total no . of events ( % of participants ) / total no . of participants,C0439175;C0439810,false;false,19110/20013
total no . of events / total no . of participants,C0439175;C0439810,false;false,19111/20013
total no . of events / participants,C0439175;C0439810,false;false,19112/20013
total number of events / participants,C0439175;C4330837;C0679646;C0439810,false;false;false;false,19113/20013
total number of patients,C0439175;C2360800;C0439810,false;false;false,19114/20013
total phase nmbr pooled ( n = nmbr ),C0439175;C0205390;C1710475;C0439810,false;false;false;false,19115/20013
total psa ‐ modified shs,C2986589;C0392747;C3889737,false;false;false,19116/20013
total randomised ( n ),C0439175;C0439810,false;false,19117/20013
total randomized,C0439175;C0439810,false;false,19118/20013
total resolution of dactylitisb,C0439175;C1514893;C1706463;C2699488;C0439810,false;false;false;false;false,19119/20013
total resolution of enthesitisc,C0439175;C1514893;C1706463;C2699488;C0439810,false;false;false;false;false,19120/20013
total resolution of nail psoriasisd,C0439175;C1514893;C0027342;C1432728;C3538766;C1706463;C2699488;C0439810,false;false;true;true;false;false;false;false,19121/20013
total sample = nmbr ( % ),C0439175;C0370003;C2347026;C0439810,false;false;false;false,19122/20013
total score ( nmbr – nmbr scale ),C2964552;C0175659;C0349674;C1947916,false;true;false;false,19123/20013
total score < nmbr,C2964552,false,19124/20013
total score > nmbr,C2964552,false,19125/20013
total score §,C2964552,false,19126/20013
total scores ( total score range : nmbr - nmbr ),C2964552;C1514721;C2348147;C3542016,false;false;false;false,19127/20013
total sgrq mean total score ( sd ),C2964552;C0444504;C2699239;C2347634;C2348143;C0439175;C3533236;C0439810,false;false;false;false;false;false;false;false,19128/20013
total sgrq score,C0439175;C0439810,false;false,19129/20013
total study itt population ( n = nmbr ),C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,19130/20013
total subjects,C0439175;C0681850;C1550501;C1706203;C2349001;C2697811;C0439810,false;false;false;false;false;false;false,19131/20013
total time of fondaparinux treatment before,C0439175;C0040223;C1098510;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3541383;C0439810,false;true;true;true;true;false;false;false;false;false;false;false,19132/20013
total updrs score ( baseline ),C0439175;C3639721;C0439810,false;true;false,19133/20013
total vdh - s score,C2964552,false,19134/20013
total vdh - s score ( nmbr - nmbr ) ( n ),C2964552,false,19135/20013
total !,C0439175;C0439810,false;false,19136/20013
total ! by baseline diabetic status,C0439175;C0168634;C0241863;C0449438;C1442488;C0439810,false;true;false;false;false;false,19137/20013
totalhdl cholesterol ratio,C0008377;C0456603;C1547037,true;false;false,19138/20013
toward,,,19139/20013
tpasi nmbr,,,19140/20013
tpm - exposed,C0076829,true,19141/20013
tpm - naive,C0076829,true,19142/20013
tpm subgroup,C0076829;C1079230;C1515021,true;false;false,19143/20013
tr jet velocity ( m / sec ),C0108801;C0336862;C0439830;C0439493;C1547053;C1539482;C1705610;C1872943;C3811249;C3811250;C3814152,true;false;false;false;false;false;false;true;false;false;false,19144/20013
trait,C0599883,false,19145/20013
trandolapril,C0076891,true,19146/20013
trandolapril ( n = nmbr ),C0076891,true,19147/20013
transaminases increased,C0002594;C0919834,true;false,19148/20013
transfemoral,,,19149/20013
transfusion,C0005841;C0199960;C1879316,true;false;false,19150/20013
transfusion ≥ nmbr units rbcs or whole blood,C0005841;C0439148;C0014792;C1519795;C3853603;C0199960;C1879316,true;false;true;false;false;false;false,19151/20013
transfusions,C0005841;C0199960;C1879316,true;false;false,19152/20013
transient,C0040704;C0205374,true;false,19153/20013
transient ischaemic attack — no . ( % ),C0007787;C0917805,true;true,19154/20013
transient ischemic attack ( % ) type of lacunar syndrome ( % ),C0007787;C0332307;C3178801;C1547052;C0917805,true;false;true;false;true,19155/20013
transient st elevation,C0040704;C0520886;C0205374,true;false;false,19156/20013
transradial,,,19157/20013
treated at baseline,C1522326;C0168634;C1442488,false;true;false,19158/20013
treated for hypertension,C1522326;C0020538;C1963138,false;true;false,19159/20013
treated lesions ‡,C1522326;C0221198,false;false,19160/20013
treated patients with baseline and nmbr post - baseline ef ﬁ cacy measurement  bp value for treatment group comparison ( proactive intervention vs usual care ) was calculated based on a nmbr - sample t test for continuous variables and chi - square test for categorical variables cbp values were measured at baseline ( week nmbr )  whereas information on all of the other variables listed was collected during screening . abbreviations : bmi  body mass index  bp  blood pressure  chd  coronary heart disease  crucial  cluster randomized usual care vs caduet investigation assessing long - term - risk  dbp  diastolic blood pressure  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  sd  standard deviation  sbp  systolic blood pressure  tc  total cholesterol  tg  triglyceride .,C0332293;C0030705;C0168634;C1442488,false;true;true;false,19161/20013
treated vessel ( s ),C1522326;C0005847,false;true,19162/20013
treated with atenolol ( n = nmbr ),C0332293;C0004147,false;true,19163/20013
treated with laba,C0332293,false,19164/20013
treated with losartan ( n = nmbr ),C0332293;C0126174,false;true,19165/20013
treatment - by - subgroup interaction,C0039798;C1079230;C1704675;C1515021;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,19166/20013
treatment ( de vs warfarin ) by thrombophilia interaction,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19167/20013
treatment after randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19168/20013
treatment and parameter,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19169/20013
treatment arm ( zoledronate ) ( % ),C1522541;C0392938,false;true,19170/20013
treatment at baseline,C0039798;C0168634;C1442488;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,19171/20013
treatment at randomisation,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19172/20013
treatment before catheterization,C0039798;C0007430;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19173/20013
treatment before randomization — days,C0039798;C0034656;C0439228;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,19174/20013
treatment before randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19175/20013
treatment by subgroup interaction,C0039798;C1079230;C1704675;C1515021;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,19176/20013
treatment comparison,C0039798;C1707455;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,19177/20013
treatment comparison ( mg / day ) t,C0039798;C1707455;C0439422;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,19178/20013
treatment diff . vs tio ( nmbr % ci ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19179/20013
treatment difference % ( nmbr % cl ),C0039798;C1705241;C0596019;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,19180/20013
treatment duration before randomization — days,C0444921;C0034656;C0439228;C3259042,false;true;false;false,19181/20013
treatment duration mean ( sd ),C0444921;C0444504;C2699239;C2347634;C2348143;C3259042,false;false;false;false;false;false,19182/20013
treatment during or after catheterization,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19183/20013
treatment effect ( hr ),C1518681,false,19184/20013
treatment for latent tuberculosis^,C0039798;C1609538;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205275;C0749724,true;true;true;false;false;false;false;false;false;false,19185/20013
treatment glargine,C0039798;C0907402;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19186/20013
treatment groups,C0039798;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;true;false;false;false;false;false,19187/20013
treatment period index dvt : event,C0039798;C0439531;C0600653;C0149871;C0441471;C4019010;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546;C1948053;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;true;false;false;false;false;true;false;false;false;false;true;false;false;false;false;false,19188/20013
treatment randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,19189/20013
treatment throughout study,C1521826;C3161471,false;false,19190/20013
treatment with any blood - pressure -,C0596197;C0033095;C0460139;C1306345;C4284008;C0039798;C0005823;C1271104;C1272641;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;false;true;true;false;true;true;false;false;false;false;false,19191/20013
treatment with sulphonylurea + biguanide,C0039798;C0038766;C0005382;C3537187;C4317165;C3536898;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;true;false;false;false;false;false,19192/20013
treatment with sulphonylurea,C0039798;C0038766;C3536898;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,19193/20013
treatment   ×   lipid interaction,C0039798;C0023779;C1704675;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,19194/20013
treatments at randomisation,C0087111;C0034656,true;true,19195/20013
triacylglycerol,C0041004,true,19196/20013
trial,C0008976,true,19197/20013
trial nmbr,C0008976,true,19198/20013
trial completers,C0008976,true,19199/20013
triglyceride ( mg / dl ) nmbr,C0041004;C0439269,true;false,19200/20013
triglyceride level,C0428475,false,19201/20013
triglycerides — mg / dl^,C0041004;C0439269,true;false,19202/20013
triglycerides — mg / dl | |,C0041004;C0439269,true;false,19203/20013
triglycerides — mmol / l,C0041004;C1532563,true;false,19204/20013
triglycerides ( mmol / l ) ( median,C0041004;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,19205/20013
triglycerides ( sd ),C0041004;C2699239,true;false,19206/20013
triglycerides > nmbr mg / dl ( > nmbr . nmbr mmol / l ),C0041004;C0439269;C1532563,true;false;false,19207/20013
triglycerides at baseline,C0041004;C0168634;C1442488,true;true;false,19208/20013
triglycerides level,C0428475,false,19209/20013
triglycerides mean,C0041004;C0444504;C2347634;C2348143,true;false;false;false,19210/20013
troponin,C0041199,true,19211/20013
troponin ( - ),C0041199,true,19212/20013
troponin ( + ),C0041199,true,19213/20013
troponin negative ( n = nmbr ),C0041199;C0205160;C1513916;C2825415;C2825491;C3853545,true;false;false;false;false;false,19214/20013
troponin positive ( n = nmbr ),C0041199;C0439178;C1446409;C1514241;C2825490;C3812269,true;false;false;false;false;false,19215/20013
trough fev,C0444506;C3714541,false;true,19216/20013
trough fev | response ( l ),C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,19217/20013
trough fevnmbr,C0444506;C3714541,false;true,19218/20013
trough fevnmbr   response,C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,19219/20013
trough fvc response ( l ),C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,19220/20013
trough fvc response ( l ) !,C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,19221/20013
trough seated dbp ( mmhg ) a,C0444506;C0277814;C0536221;C0439475;C3813197;C4281799;C1283233,false;true;true;false;false;false;false,19222/20013
trough seated hr ( bpm ) a,C0444506;C0277814;C1283233,false;true;false,19223/20013
trough seated sbp ( mmhg ) a,C0444506;C0277814;C0085805;C0439475;C1283233,false;true;true;false;false,19224/20013
tt,C1452561;C4554543,true;false,19225/20013
ttf - fv,C1332112;C1705840;C4087167,false;false;false,19226/20013
ttr ( warfarin arm only ),C0032923;C0043031;C0446516;C0205171;C1720467;C3715044;C4553528;C1421224,true;true;true;false;false;false;false;false,19227/20013
two - dimensional echocardiography,C0013524,true,19228/20013
two - sided p - value for hetero - geneity,C0205448;C0441987;C1709380,false;false;false,19229/20013
two lesions,C0205448;C0221198,false;false,19230/20013
two or more,C0205448,false,19231/20013
two or more antihypertensive medications,C0205448,false,19232/20013
two or more at baseline,C0205448,false,19233/20013
type,C0332307;C1547052,false;false,19234/20013
type nmbr collagen,C0332307;C0009325;C1547052,false;true;false,19235/20013
type nmbr diabetes — no . ( % ),C1320657,false,19236/20013
type nmbr diabetes — no . ( % ) §,C1320657,false,19237/20013
type nmbr diabetes — no . { % ) §,C1320657,false,19238/20013
type nmbr diabetes meiiitus,C1320657,false,19239/20013
type nmbr diabetes mellitus,C1320657,false,19240/20013
type nmbr diabetes mellitus ' nmbr ',C1320657,false,19241/20013
type nmbr diabetes mellitusa,C1320657,false,19242/20013
type nmbr diabetes pbo ( n = nmbr ) vs evomab ( n = nmbr ),C1320657;C0031962,false;true,19243/20013
type nmbr diabetes *,C1320657,false,19244/20013
type nmbr diabetes . n ( % ),C1320657,false,19245/20013
type bnmbr / c lesions,C4264484,false,19246/20013
type ia,C0332307;C0020980;C0694634;C1947960;C1547052,false;true;false;false;false,19247/20013
type ib,C0332307;C2744579;C3890035;C4283819;C1547052,false;true;false;false;false,19248/20013
type ic,C0332307;C0020750;C4554818;C1547052,false;true;false;false,19249/20013
type ii diabetes,C0011860,true,19250/20013
type of af,C0332307;C0344434;C4049859;C1547052,false;false;false;false,19251/20013
type of antihypertensive medication use among patients using antihypertensive medications,C0332307;C0003364;C1524063;C1547052,false;true;false;false,19252/20013
type of atrial fibrillation,C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,19253/20013
type of atrial fibrillation - n ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,19254/20013
type of atrial fibrillation — no . / total no . ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,19255/20013
type of atrial fibrillation ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,19256/20013
type of atrial fibrillation ( n = nmbr nmbr ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,19257/20013
type of basal insulin,C0332307;C0650607;C1547052;C0205112;C0457592,false;false;false;false;false,19258/20013
type of event :,C1561488,false,19259/20013
type of hospital care,C0332307;C0259945;C1547052,false;false;false,19260/20013
type of hospitalization,C3177060,false,19261/20013
type of index event — no . ( % ),C1561488;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,19262/20013
type of insulin,C0457592,false,19263/20013
type of insulin therapy — no . ( % ) nmbr,C0457592;C0039798;C0087111;C1363945,false;true;true;false,19264/20013
type of intervention,C3274412,false,19265/20013
type of lipid - lowering regimen,C0332307;C0023779;C0441994;C0040808;C2945654;C2003888;C1547052,false;true;false;true;false;false;false,19266/20013
type of ml,C0332307;C0439526;C1705224;C3887665;C1547052,false;false;false;false;false,19267/20013
type of reference treatment strategy,C1514811;C0455708;C0679199;C1706462,false;false;false;false,19268/20013
type of surgery cabg,C0332307;C0038894;C0010055;C0038895;C0543467;C1274039;C1547052,false;false;true;true;true;true;false,19269/20013
type of surgery cabg only,C0332307;C0038894;C0010055;C0205171;C1720467;C0038895;C0543467;C1274039;C1547052,false;false;true;false;false;true;true;true;false,19270/20013
type of tnf antagonist failure,C0332307;C1448177;C0231491;C0231174;C0680095;C1547052,false;true;false;false;false;false,19271/20013
type of tnf failure,C0332307;C1448177;C0231174;C0680095;C1547052,false;true;false;false;false,19272/20013
type / no . of valves repaired / replaced mitral,C0332307;C1547052,false;false,19273/20013
types of antihypertensive medications at nmbr year   †,C0332307;C0003364,false;true,19274/20013
types of antihypertensive medications at last visit   §,C0332307;C0003364,false;true,19275/20013
u . s . black patients,C0041703;C0005680;C0030705;C0027567;C0085756;C0439541,true;true;true;true;true;false,19276/20013
u . s . non - black patients,C0041703;C1829939;C0005680;C0027567;C0085756;C0439541,true;false;true;true;true;false,19277/20013
ua ( n = nmbr ),C0041580;C0042014,true;true,19278/20013
uacr — mg / g,C1300563,false,19279/20013
uacr ( mg / g,C1300563,false,19280/20013
uacr   < nmbr   mg / mmol ∗,C0567349;C2348885,false;false,19281/20013
uacr   ≥ nmbr   mg / mmol ∗,C0567349;C2348885,false;false,19282/20013
uacr *  mg / g ( qnmbr  qnmbr ),C1300563,false,19283/20013
uasnmbr {,,,19284/20013
uasnmbr,,,19285/20013
uc,,,19286/20013
uc ( n   =   nmbr ),,,19287/20013
uc [gemini nmbr] ‘,,,19288/20013
uc disease duration ( y ),C0872146,false,19289/20013
uc disease durslion,C0012634,true,19290/20013
uc history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,19291/20013
ucl,,,19292/20013
udy entry,C1705654,false,19293/20013
ufh only,C0205171;C1720467,false;false,19294/20013
ugt induction status : as randomizeda,C1420188;C0205263;C0449438;C0857127;C4284131,false;false;false;false;false,19295/20013
ugt induction status : per aeda,C1420188;C0205263;C0449438;C0857127;C4284131,false;false;false;false;false,19296/20013
uistekinumab,,,19297/20013
ulcer,C0041582;C3887532,true;false,19298/20013
ulpasi nmbr,,,19299/20013
umec nmbr . nmbr | ig ( n = nmbr ),C0021027;C0305052;C0360506,true;false;false,19300/20013
umec nmbr . nmbr mcg ( n = nmbr ),C0439211;C3463985,false;false,19301/20013
umec / vi nmbr . nmbr / nmbr,C0205999,true,19302/20013
umec / vi nmbr . nmbr / nmbr ( n nmbr nmbr ),C0205999,true,19303/20013
umied,,,19304/20013
unacceptable side effects,C1883420;C0001688;C0877248;C0879626,false;true;false;false,19305/20013
unadjusted nmbr - y risk per nmbr population = se ( adjusted rate ),C1439367;C0242444;C0036919;C0456081;C0871208;C1521828;C2987720,false;true;true;false;false;false;false,19306/20013
unadjusted hazard ratio ( nmbr % ci ),C1439367;C2985465;C0008107;C3259781,false;false;true;false,19307/20013
unadjusted hazard ratio ( nmbr % cl ),C1439367;C2985465;C0596019,false;false;false,19308/20013
unadjusted hr ( nmbr % ci ) for nmbr sd increment,C1439367;C0008107;C2699239;C1705117;C3259781,false;true;false;false;false,19309/20013
unadjusted hr ( nmbr % ci ) for nmbr standard deviation increment,C1439367;C0008107;C0871420;C1705117;C3259781,false;true;false;false;false,19310/20013
unadjusted hr ( nmbr % ci ) a,C1439367;C0008107;C3259781,false;true;false,19311/20013
unadjusted model hr,C1439367;C3161035;C3274659;C3714583;C3853906,false;false;false;false;false,19312/20013
unadjusted p value,C1439367;C1709380,false;false,19313/20013
unadjusteda beta ( se ),C0330390;C0036919;C0439096;C2004068,false;true;false;false,19314/20013
unclassified,C0205426;C1546437;C2347854;C4085229,false;false;false;false,19315/20013
uncontrolled on basal insulin,C0205318;C0650607,false;false,19316/20013
uncontrolled on oad ( s ),C0205318,false,19317/20013
uncontrolled : acq - nmbr > nmbr . nmbr,C0205318;C2919686,false;false,19318/20013
uncover - nmbr,,,19319/20013
underlying disease,C4067746;C0012634,false;true,19320/20013
undeterminedc,,,19321/20013
undiagnosed diabetes mellitus,C1408353;C0011849,false;true,19322/20013
unfractionated heparin — no . ( % ),C0019134;C2825026,true;false,19323/20013
unfractionated heparin ( n = nmbr,C0019134;C2825026,true;false,19324/20013
unfractionated heparin only,C0019134;C0205171;C1720467;C2825026,true;false;false;false,19325/20013
unfractionated heparin or enoxaparin plus glycoprotein iib / iiia inhibitors ( n = nmbr ),C0019134;C2825026,true;false,19326/20013
unfractionated heparin within nmbr hr before randomization — no . / total no . ( % ),C0019134;C2825026,true;false,19327/20013
unfractionated only,C0205171;C1720467,false;false,19328/20013
unhappy,C1688635,false,19329/20013
unified parkinson disease,C1548174;C0030567;C1521736;C1706076,false;true;false;false,19330/20013
united states ( n   = nmbr,C0041703,true,19331/20013
united states and canada,C0041703,true,19332/20013
uniti - nmbr,,,19333/20013
uniti - nmbr and uniti - nmbr im - uniti,,,19334/20013
univariable,,,19335/20013
univariable or ( nmbr % ci ),,,19336/20013
univariate logistic modela,C0242415,true,19337/20013
unknown — no . { % ),C0439673;C3541433;C4050014,false;false;false,19338/20013
unknown ( % ),C0439673;C3541433;C4050014,false;false;false,19339/20013
unknown / missing,C0439673;C3541433;C4050014,false;false;false,19340/20013
unprovoked vte n ( % ),C0630906,true,19341/20013
unrelated to effectiveness,C0445356;C1280519;C4553491;C1704623,false;false;false;false,19342/20013
unstable,C0443343;C1883468,false;false,19343/20013
unstable angina ( n = nmbr,C0002965,true,19344/20013
unstable angina requiring hospitalization,C0002965;C0019993,true;true,19345/20013
unstable but no rest angina,C0443343;C1883468,false;false,19346/20013
untreated,C0332155,false,19347/20013
untreated at baseline,C0332155;C0168634;C1442488,false;true;false,19348/20013
upa nmbrmg qd,C0042071;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1706177,true;true;false;true;false;false;false;false;false;false,19349/20013
upa nmbr mg qd,C0042071;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1706177,true;true;false;true;false;false;false;false;false;false,19350/20013
upadacitinib nmbr mg ( n = lnmbr ),C0439268,false,19351/20013
upcr,,,19352/20013
updrs iii ( motor ),C3639721;C0439070;C1513492;C1705994;C1705160,true;false;false;false;false,19353/20013
updrs score,C3639721,true,19354/20013
updrs total ( ii + iii ),C3639721;C0439175;C1710602;C0439070;C1705160;C4082587;C0439810,true;false;false;false;false;false;false,19355/20013
updrs,C3639721,true,19356/20013
uplift ® population,C0032659;C1257890,true;true,19357/20013
upper abdominal pain,C0232492,false,19358/20013
upper gastrointestinal tract,C3203348,true,19359/20013
upper limb,C1140618,true,19360/20013
upper limbs,C1140618,true,19361/20013
upper respiratory tract inflammation,C0877266,false,19362/20013
upper tertile : > nmbr . nmbr,C1282910,false,19363/20013
ups score,C0334463;C3542434,true;false,19364/20013
ure,,,19365/20013
urgency episodes / nmbrh,C0439609;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,false;false;true;false;false;false;false,19366/20013
urgent peripheral revascularization,C0439609;C0205100;C0581603;C3272275,false;false;false;false,19367/20013
urgent revascularisation due to unstable angina,C0439609;C0581603;C0678226;C0002965;C3272275,false;false;false;true;false,19368/20013
urgent revascularizati on,C0439609;C3272275,false;false,19369/20013
urgent revascularization because of unstable angina,C0439609;C0581603;C0002965;C3272275,false;false;true;false,19370/20013
urgent surgery,C2188405,false,19371/20013
urgent vascular hospitalization,C0439609;C0005847;C0019993;C1558950;C1801960;C3272275,false;true;true;false;false;false,19372/20013
urinary acr,C0042027;C1412134;C1515941;C1524119,true;false;false;false,19373/20013
urinary acr ( mg / mmol ),C0042027;C1412134;C0567349;C2348885;C1515941;C1524119,true;false;false;false;false;false,19374/20013
urinary albumin - to - creatinine ratio — no . ( % ) §,C0455271;C1318330,false;false,19375/20013
urinary albumin - to - creatinine ratio §,C0455271;C1318330,false;false,19376/20013
urinary albumin : creatinine ratio^,C0455271;C1318330,false;false,19377/20013
urine acr ( mg / mmol ),C0042036;C1412134;C0567349;C2348885;C1515941;C0042037;C2963137,true;false;false;false;false;true;false,19378/20013
urine acr < median,C0042036;C1412134;C0549183;C0876920;C2347635;C2348144;C2939193;C1515941;C0042037;C2963137,true;false;false;false;false;false;false;false;true;false,19379/20013
urine acr > = median,C0042036;C1412134;C0549183;C0876920;C2347635;C2348144;C2939193;C1515941;C0042037;C2963137,true;false;false;false;false;false;false;false;true;false,19380/20013
urine acr geometric mean ( cv % ),C0042036;C1412134;C2986759;C3538987;C4048877;C4318503;C1515941;C0042037;C2963137,true;false;false;false;true;false;false;true;false,19381/20013
urine albumin - to - ereatinine ratio,C1273442;C0001924;C0042038;C0456603;C1547037;C0587185;C2362049,false;true;false;false;false;false;false,19382/20013
urine albumin / creatinine ( mg / mmol ),C0455271;C0567349;C2348885;C1318330,false;false;false;false,19383/20013
urine albumin / creatinine ratio,C0455271;C1318330,false;false,19384/20013
urine p / cr,C0042036;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337;C0042037;C2963137,true;false;false;true;false;false;false;true;false,19385/20013
urine qmax,C0042036;C0042037;C2963137,true;true;false,19386/20013
urticaria,C0042109;C1559188,true;false,19387/20013
us n = nmbr,C0369718;C0441922,false;false,19388/20013
us site,C0205145;C1515974;C2825164,false;false;false,19389/20013
us w = nmbr,,,19390/20013
usa ( n = nmbr,C0041703,true,19391/20013
usa / canada,C0041703;C0006823,true;true,19392/20013
use ( % ),C0042153;C0457083;C1947944,true;false;false,19393/20013
use at baseline,C0042153;C0168634;C1442488;C0457083;C1947944,true;true;false;false;false,19394/20013
use of ace inhibitors / arbs,C1524063;C0003015;C3888198,false;true;false,19395/20013
use of anti - hypertensive agents,C1524063;C0003364,false;true,19396/20013
use of antiplatelet agents — no . / total no . ( % ),C1524063;C0085826,false;true,19397/20013
use of antiplatelet agents,C1524063;C0085826,false;true,19398/20013
use of aspirin at time of qualifying event ( % ),C1524063;C0004057,false;true,19399/20013
use of cgm ( yes ),C1524063;C1549445;C1705108;C1710701,false;false;false;false,19400/20013
use of cgm interaction test p - value^ =,C1524063;C1704675;C0022885;C1709380;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false;false,19401/20013
use of clopidogrel,C1524063;C0070166,false;true,19402/20013
use of diuretics,C1524063;C0012798,false;true,19403/20013
use of hnmbr bloekers,C1524063;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,19404/20013
use of high - dose inhaled glucocorticoid — no . { % ),C1524063;C0444956,false;false,19405/20013
use of ics at baseline,C1524063;C0815320;C4551720,false;false;true,19406/20013
use of inhaled glucocorticoids at baseline,C1524063;C0004048;C0017710;C3540777;C3540778,false;true;true;false;false,19407/20013
use of low - dose aspirin ( < nmbr,C1524063;C2608320,false;false,19408/20013
use of low - dose aspirin ( < nmbr mg daily ),C1524063;C2608320;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;false;true;false;true;false;false;false;false;false,19409/20013
use of medication for pah,C1524063;C0013227;C3244316;C4284232,false;true;false;false,19410/20013
use of medication from randomization through nmbr hr — no . / total no . ( % ),C1524063;C0013227;C3244316;C4284232,false;true;false;false,19411/20013
use of methotrexate at randomization —,C1524063;C0025677,false;true,19412/20013
use of oral glucocorticoids,C1524063;C0442027;C0017710;C3540777;C3540778;C4521986,false;false;true;false;false;false,19413/20013
use of pci or thrombolysis within one day of randomization,C1524063;C4049621,false;false,19414/20013
use of proton inhibitors,C1524063;C0033727;C0243077,false;true;true,19415/20013
use of statin at any follow - up visit ( % ),C1524063;C0360714,false;true,19416/20013
use of systemic glucocorticoid at random -,C1524063;C0205373;C0017710,false;false;true,19417/20013
use of ticagrelor,C1524063;C1999375,false;true,19418/20013
use of verapamil or quinidine,C1524063;C0042523,false;true,19419/20013
used,C1273517,false,19420/20013
user,C1548600;C1706077,false;false,19421/20013
using alendronate at baseline ( % ),C1524063,false,19422/20013
using hrt or raloxifene at baseline ( % ),C1524063,false,19423/20013
usteki,,,19424/20013
ustekinu,,,19425/20013
ustekinumab,C1608841,true,19426/20013
ustekinumab ' ’ ( n = nmbr ),C1608841,true,19427/20013
ustekinumab nmbr mg ( n = nmbr ),C1608841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,19428/20013
ustekinumab combined,C1608841,true,19429/20013
ustekinumab ® ( n = nmbr ),C1608841,true,19430/20013
usual care,C3538928;C1947933,false;false,19431/20013
utis,C0042029,true,19432/20013
uveitis,C0042164;C1963266,true;false,19433/20013
vnmbr ( n = nmbr,,,19434/20013
valdecoxib,C0913246,true,19435/20013
valsartan n / n,C0216784,true,19436/20013
value for nteraction,C1522609,false,19437/20013
values are mean ± sd  median [quartile range]  or % . ace indicates angiotensin - converting enzyme  arb  angiotensin receptor blocker  bnp  b - type natriuretic peptide  bp  blood pressure  bun  blood urea nitrogen  lvef  left ventricular ejection fraction  and nt - probnp  n - terminal pro - b - type natriuretic peptide .,C0042295,false,19438/20013
values are presented as mean sd unless stated otherwise . data shown are for the randomized population . * body mass index values were missing from nmbr patients in the aliskiren group and nmbr patients in the hydrochlorothiazide group . † obesity was defined as body mass index nmbr kg / mnmbr . ‡ metabolic syndrome was defined according to the third report of the national cholesterol education program expert panel on detection  evaluation  and treatment of high blood cholesterol in adults ( adult treatment panel iii ) criterianmbr as any nmbr of the following : waist circumference nmbr cm for men or nmbr cm for women  triglycerides nmbr mg / dl  high - density lipoprotein cholesterol nmbr mg / dl for men or nmbr mg / dl for women  mssbp nmbr mm hg or msdbp nmbr mm hg  fasting glucose nmbr mg / dl . § by medical history . aliskiren  n nmbr  hydrochlorothiazide  n nmbr .,C0042295,false,19439/20013
values expressed as mean sd or number ( percent ) . * two patients were missing values for body mass index . † other forms of atherosclerosis are peripheral arterial disease  abdom - inal aortic aneurysm  symptomatic carotid artery disease  transient isch - emic attack  and stroke . ‡ family history of premature chd de ﬁ ned as chd in male ﬁ rst - degree relative aged nmbr years or female ﬁ rst - degree relative nmbr years . § blood pressure nmbr / nmbr mm hg  on antihypertensive medication  or diagnosis of hypertension based on medical history . n number of randomly assigned patients  ncep atp national cholesterol education program adult treatment panel .,C0042295,false,19440/20013
values were calculated using t tests for continuous variables and chi - square,C0042295,false,19441/20013
values were reported for nmbr patients in the spironolactone group and nmbr,C0042295,false,19442/20013
valve repair / replacement only,C0184252;C0043240;C0035139;C0205171;C1720467;C0559956;C1555302;C4553149;C0374711;C4319951;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false;false;false,19443/20013
valve repair / replacement with or without cabg,C0184252;C0043240;C0035139;C0559956;C1555302;C4553149;C0374711;C4319951;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false,19444/20013
valve replacement / repair with or without cabg,C0184252;C0035139;C0043240;C0374711;C4319951;C0559956;C1555302;C4553149;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false,19445/20013
valvular heart disease,C0018824;C1963123,true;false,19446/20013
valvular heart disease — no . ( % ),C0018824;C1963123,true;false,19447/20013
varespladib,C2713485,true,19448/20013
variable ' ! ',C0439828;C4553760,false;false,19449/20013
variable demographic characteristics,C0439828;C0683970;C4553760,false;false;false,19450/20013
variable_level,C0439828;C0441889;C0456079;C1547707;C2946261;C4553760,false;false;false;false;false;false,19451/20013
variables,C0439828,false,19452/20013
variables *,C0439828,false,19453/20013
variables .,C0439828,false,19454/20013
variablesnmbr,C0439828,false,19455/20013
vascular access site †,C0750138;C0205145;C1515974;C2825164;C0005847;C0589360;C1558950;C1801960,false;false;false;false;true;false;false;false,19456/20013
vascular accidents,C0005847;C0000924;C1558950;C1801960,true;true;false;false,19457/20013
vascular death,C0005847;C0011065;C1306577;C4082313;C4552775;C1558950;C1801960,true;true;false;false;false;false;false,19458/20013
vascular disease,C0042373,true,19459/20013
vascular disease ( % of group ),C0042373;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,19460/20013
vascular risk score — no . { % ) ^,C0005847;C0035647;C4552904;C1558950;C1801960,true;true;false;false;false,19461/20013
vascular risk score |,C0005847;C0035647;C0449820;C4050231;C4552904;C1558950;C1801960,true;true;false;false;false;false;false,19462/20013
vascular risk score *,C0005847;C0035647;C0449820;C4050231;C4552904;C1558950;C1801960,true;true;false;false;false;false;false,19463/20013
vasodilator,C0042402;C3537240,true;false,19464/20013
vasodilator therapy,C0042402;C0039798;C0087111;C1363945;C3537240,true;true;true;false;false,19465/20013
vasp pri - defined hpr ( % patients ),C0255567;C0034044;C1826843;C3539761;C3539762;C1421428,true;true;false;false;false;false,19466/20013
vdz n = \nmbr,,,19467/20013
vdz n = nmbr,,,19468/20013
vdz / pbo [n = nmbr],C0031962,true,19469/20013
vdz / pla n = nmbr,C0456170,false,19470/20013
vdz / vdz [n = nmbr],,,19471/20013
vedolizumab cohort nmbr ( n = nmbr ),C2742797;C0009247;C0599755,true;true;false,19472/20013
vedolizumab n = nmbr,C2742797,true,19473/20013
vein bypass stented,C0042449;C0741847,true;false,19474/20013
verapamil ( n,C0042523,true,19475/20013
verapamil sr ( no . = nmbr ),C1527129,false,19476/20013
verifynow pru - defined hpr ( % patients ),C1704788;C1337105;C0030705;C3539106,false;false;true;false,19477/20013
versus tiotropium nmbr pg tiotropium + olodaterol nmbr - nmbr / nmbr pg,,,19478/20013
versus tiotropium nmbr pg tiotropium + olodaterol nmbr . nmbr / nmbr pg,,,19479/20013
vertebral fracture and / or t score - nmbr . nmbr,C0080179,true,19480/20013
vertebral fracture and / or t score s - nmbr . nmbr,C0080179,true,19481/20013
vertebral fractures at baseline,C0080179;C0168634;C1442488,true;true;false,19482/20013
very elderly patients ( n - nmbr ),C0442824;C0870602;C2984081,false;false;false,19483/20013
very g ood / ex cellent,C0442824;C0439267;C4267693;C2984081,false;false;false;false,19484/20013
very good or excellent,C3641222,false,19485/20013
very high,C0442804;C4321397,false;false,19486/20013
very high ( >   nmbrxuln ) n   =   nmbr,C0442804;C4321397,false;false,19487/20013
very high vs . normal,C0442804;C4321397,false;false,19488/20013
very high vs . normalb,C0442804;C4321397,false;false,19489/20013
very severe ( itt ) ( n = nmbr ),C3641272;C4050419,false;false,19490/20013
very severe copd,C3641272;C0024117;C1412502;C3714496;C4050419,false;true;false;false;false,19491/20013
vhd,,,19492/20013
vhd event rate / year ( n ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,19493/20013
vi - nmbr % ( - nmbr %,C0205999,true,19494/20013
vi – nmbr % ( nmbr % ci – nmbr – nmbr % ),C0205999;C0008107;C3259781,true;true;false,19495/20013
vi nmbr % ( - nmbr %,C0205999,true,19496/20013
vi nmbr % ( nmbr % ci – nmbr – nmbr % ),C0205999;C0008107;C3259781,true;true;false,19497/20013
vi nmbr % ( nmbr % ci nmbr – nmbr % ),C0205999;C0008107;C3259781,true;true;false,19498/20013
vi nmbr   µ g,C0205999;C0439267,true;false,19499/20013
viidagliptin nmbr mg daily + glimepiride,C0024671;C0332173;C0061323;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,19500/20013
vildagliptin + metformin ( vldm ),C1570906;C0025598,true;true,19501/20013
vildagliptin nmbr mg daily,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,19502/20013
vildagliptin nmbr mg daily + glimepiride,C1570906;C0024671;C0332173;C0061323;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;true;false;false;false;false;false,19503/20013
visit,C0545082;C1512346;C2826704,false;false;false,19504/20013
visit nmbr blood pressures :,C0545082;C1272641;C1512346;C2826704,false;true;false;false,19505/20013
visit nmbr dbp,C0545082;C0536221;C3813197;C4281799;C1512346;C2826704,false;true;false;false;false;false,19506/20013
visit nmbr sbp,C0545082;C0085805;C1512346;C2826704,false;true;false;false,19507/20013
vital signs,C0150404;C0518766,false;true,19508/20013
vitamin c,C0003968;C2349136;C3714687;C4522080,true;false;false;false,19509/20013
vitamin d §,C0014695;C0042866;C2936842;C3537249;C3714503,true;true;false;false;false,19510/20013
vitamin k antagonist experienced,C1096489;C2267235,false;false,19511/20013
vitamin k antagonist experiencedk ( n = nmbr nmbr ),C1096489;C2267235,false;false,19512/20013
vitamin k antagonist naive,C1096489;C2267235,false;false,19513/20013
vitamins,C0042890;C3540032;C3714649,true;false;false,19514/20013
vka ( n   = nmbr ),,,19515/20013
vka at randomization,C0034656,true,19516/20013
vka experienced,,,19517/20013
vka naive,,,19518/20013
vka naxve,,,19519/20013
vldl - c,C0523560,false,19520/20013
vldm n = nmbr,,,19521/20013
voided volume,C0042034;C0449468;C1690016;C1705102;C2700258;C1552835,true;false;false;false;false;false,19522/20013
voiding subscore,C0042034;C4067975,true;false,19523/20013
volume change,C0449468;C0392747;C0443172;C1705241;C4319952;C1690016;C1705102;C2700258,false;false;false;false;false;false;false;false,19524/20013
volume depletion - related aes,C0546884;C0439849;C1412268;C2699274;C0445223,true;false;false;false;false,19525/20013
volumetric bmd by qct,C0445383;C0412669,false;false,19526/20013
voluntary,C0439656;C3543419,false;false,19527/20013
vonoprazan nmbr mg n = nmbr,C4080009;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,19528/20013
vorapaxar,C2974521,true,19529/20013
vorapaxar ( n = nmbr ),C2974521,true,19530/20013
vorapaxar no . ( nmbr - y km % ),C2974521,true,19531/20013
vorapaxar placebo,C2974521;C0032042;C1696465;C1706408,true;true;false;false,19532/20013
vs . placebo,,,19533/20013
vs . warfarin,,,19534/20013
vte / vte - related deathsa,C0630906;C0439849;C0445223,true;false;false,19535/20013
vte / vte - related deathsb,C0630906;C0439849;C0445223,true;false;false,19536/20013
w europe,C0015176,true,19537/20013
w hite,,,19538/20013
wafarin,,,19539/20013
wafarin event incidence / n,C0441471;C0021149;C0220856;C4019010,false;true;true;false,19540/20013
waist circumference — cmj,C0455829,true,19541/20013
waist circumference ( cm ) : mean ± sd,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,19542/20013
waist circumference women : > nmbr in ( nmbr cm ) men : > nmbr in ( nmbr cm ) tc nmbrc nmbr mg / dl,C0455829;C0043210;C0025266,true;true;true,19543/20013
waist circumference .,C0455829,true,19544/20013
waist / hip < median,C0230097;C0019552;C0549183;C0876920;C2347635;C2348144;C2939193;C0022122;C1505163;C3538851;C4284725,false;true;false;false;false;false;false;true;true;false;false,19545/20013
waist : hip ratio,C0205682,true,19546/20013
waisvhip > = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,19547/20013
walk for exercise,C0080331;C0015259;C1522704,true;true;false,19548/20013
walk for exercise ( % ),C0080331;C0015259;C1522704,true;true;false,19549/20013
walking,C0080331;C4283795;C4321241;C4321242,true;false;false;false,19550/20013
war,C0043027,true,19551/20013
warf,C0043031,true,19552/20013
warfarin % ( n / n ),C0043031,true,19553/20013
warfarin ( % ),C0043031,true,19554/20013
warfarin ( n - nmbr,C0043031,true,19555/20013
warfarin ( snmbr % cl ),C0043031;C0596019,true;false,19556/20013
warfarin events / n ( % / y ),C0043031;C0441471;C3541888,true;false;false,19557/20013
warfarin n = nmbr,C0043031,true,19558/20013
warfarin n = nmbr n / n ( % ),C0043031,true,19559/20013
warfarin n / n  rate ( % ),C0043031;C0871208;C1521828,true;false;false,19560/20013
we recorded no significant interactions for any subgroup analysis . nyha = new york heart association . lvef = left ventricular ejection fraction . ' nmbr % cl was calculated by cox proportional hazards model . tmedian value . data for total cholesterol were available for nmbr patients ( nmbr rosuvastatin,,,19561/20013
we recorded no significant interactions for any subgroup analysis . pufa = polyunsaturated fatty acids . nyha = new york heart association . lvef = left ventricular ejection fraction . * nmbr % cl was calculated with a cox proportional hazards model . tmedian value . data for total cholesterol were available for nmbr patients ( nmbr n - nmbr pufa,,,19562/20013
week,C0332174;C0439230,false;false,19563/20013
week - nmbr changea,C0332174;C4349366;C0439230,false;false;false,19564/20013
week nmbr — mg / liter,C0332174;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;false;true;false;false;false;false;false;false,19565/20013
week nmbr czp nmbr mg qnmbrw,C0332174;C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109;C0439230,false;true;true;true;false;false;false;false;false;true;true;false,19566/20013
week nmbr czp nmbr mg qnmbrw ( n = nmbr ),C0332174;C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109;C0439230,false;true;true;true;false;false;false;false;false;true;true;false,19567/20013
week nmbr czp dose combined,C0332174;C0054841;C0178602;C0869039;C1114758;C1861828;C1872109;C0439230,false;true;false;false;false;true;true;false,19568/20013
week nmbr czp dose combined ( n   =   nmbr ),C0332174;C0054841;C0178602;C0869039;C1114758;C1861828;C1872109;C0439230,false;true;false;false;false;true;true;false,19569/20013
week nmbr mayo endoscopy subscorea,C0332174;C0454788;C0014245;C1077578;C0439230,false;false;true;false;false,19570/20013
week nmbr mean ± sem,C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,19571/20013
week nmbr - baseline,C0332174;C0168634;C1442488;C0439230,false;true;false;false,19572/20013
week nmbr — mg / liter^,C0332174;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;false;true;false;false;false;false;false;false,19573/20013
week nmbr mean + sem,C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,19574/20013
week nmbr outcome,C0332174;C1274040;C0439230,false;false;false,19575/20013
week nmbr outcomes,C0332174;C1274040;C0439230,false;false;false,19576/20013
week nmbr overall population,C0332174;C0282416;C0032659;C1257890;C1561607;C0439230,false;true;true;true;false;false,19577/20013
week nmbr responders,C0332174;C0439230,false;false,19578/20013
week nmbr ( before ee ),C0332174;C0439230,false;false,19579/20013
week nmbr crp,C0332174;C3890735;C4048285;C0439230,false;false;false;false,19580/20013
week nmbr ( non - ee responders ),C0332174;C1518422;C0439230,false;false;false,19581/20013
week nmbr mean ( sd ),C0332174;C0444504;C2699239;C2347634;C2348143;C0439230,false;false;false;false;false;false,19582/20013
week nmbr % of patients,C0332174;C0030705;C0439230,false;true;false,19583/20013
week nmbr ( mmol / l ),C0332174;C1532563;C0439230,false;false;false,19584/20013
week nmbr ertugliflozin nmbr mg vs placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,19585/20013
week nmbr ertugliflozin nmbr   mg vs . placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,19586/20013
week nmbr ertugliflozin nmbr mg vs . placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,19587/20013
week nmbr  % ( n )    ,C0332174;C0439230,false;false,19588/20013
week nmbr *,C0332174;C0439230,false;false,19589/20013
week nmbr * ’ ’,C0332174;C0439230,false;false,19590/20013
week nmbr / et,C0332174;C0439230,false;false,19591/20013
week nmbra,C0332174;C0439230,false;false,19592/20013
week and,C0332174;C0439230,false;false,19593/20013
week o ( baseline ) mean 士 sd,C0332174;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C0439230,false;true;false;false;false;false;false;false,19594/20013
week   nmbr,C0332174;C0439230,false;false,19595/20013
weekly iss {,C0332174;C1740819;C1845118,false;false;false,19596/20013
weekly issnmbr,C0332174;C1740819;C1845118,false;false;false,19597/20013
weekly number of hives score {,C0332174;C0237753;C0042109;C0449788,false;false;true;false,19598/20013
weekly number of hives scorenmbr,C0332174;C0237753;C0042109;C0449788,false;false;true;false,19599/20013
weekly size of largest hives score {,C0332174;C0456389;C0443228;C0042109,false;false;false;true,19600/20013
weeko mean + sem,C0444504;C2347634;C2348143,false;false;false,19601/20013
weeks,C0439230,false,19602/20013
weeks_measured,C0439230,false,19603/20013
weight — kg cardiovascular history — no . ( % ),C0005910;C0022718;C1880008;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;true;false;false,19604/20013
weight # nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19605/20013
weight ( kg ) ( mean ± sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,19606/20013
weight ( kg ) bmi ( kg / mnmbr ),C0005910;C1319635;C0578022;C0369637;C0441923;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,19607/20013
weight ( kg ) *,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19608/20013
weight ( kg ) 十,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19609/20013
weight ( kg ) a,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19610/20013
weight ( kg },C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19611/20013
weight ( median [iqr] ),C0005910;C0549183;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;false;false;false;true;false;false,19612/20013
weight [kg],C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19613/20013
weight nmbr +,C0005910;C0043100;C1305866;C1705104,true;true;false;false,19614/20013
weight nmbr - nmbr,C0005910;C0043100;C1305866;C1705104,true;true;false;false,19615/20013
weight at baseline,C1303013,false,19616/20013
weight at randomization ( kg ),C2985844;C0022718;C0439209;C4054209,false;true;false;false,19617/20013
weight category,C0005910;C0683312;C3889287;C0043100;C1305866;C1705104,true;false;false;true;false;false,19618/20013
weight group,C0005910;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;true;false;false,19619/20013
weight in kg ( baseline : mean ( sd ) [n]  wk nmbr and change : mean ( se ) [n] ),C0022718;C1303013;C0444504;C2699239;C0332174;C0439230;C2347634;C2348143;C0439209;C4054209,true;false;false;false;false;false;false;false;false;false,19620/20013
weight of < nmbr kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,19621/20013
weight^ ,C0005910;C0043100;C1305866;C1705104,true;true;false;false,19622/20013
weight < nmbr,C0005910;C0043100;C1305866;C1705104,true;true;false;false,19623/20013
west europe,C1705493;C0015176,false;true,19624/20013
western,C1705493,false,19625/20013
western europe ( n   = nmbr,C0043129,true,19626/20013
western europe plus other,C0043129,true,19627/20013
while,,,19628/20013
white ( n   = nmbr,C0007457;C0043157;C0220938,true;true;false,19629/20013
white ( n = nmbr,C0007457;C0043157;C0220938,true;true;false,19630/20013
white blood cell count,C0023508;C0427512,true;false,19631/20013
white hispanic,C1533020;C1533021,false;false,19632/20013
white hispanic - n ( % ),C1533020;C1533021,false;false,19633/20013
white mtx ( n ),C0007457;C0025677;C1417487;C0043157;C0220938,true;true;false;true;false,19634/20013
white non - hispanic,C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938,false;false;false;true;false;true;false,19635/20013
white non - hispanic - n ( % ),C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938,false;false;false;true;false;true;false,19636/20013
white or caucasian,C0007457;C0043157;C0220938,true;true;false,19637/20013
white race — no . ( % ) y left ventricular ejection fraction — %,C0007457;C0043157;C0220938,true;true;false,19638/20013
white race — no . { % ) ' i ',C0007457;C0043157;C0220938,true;true;false,19639/20013
white race — no . { % ) - i -,C0007457;C0043157;C0220938,true;true;false,19640/20013
white race — no . { % ) $,C0007457;C0043157;C0220938,true;true;false,19641/20013
white race — no . { % ) t,C0007457;C0043157;C0220938,true;true;false,19642/20013
white race ( n = nmbr nmbr ),C0007457;C0043157,true;true,19643/20013
white tcz + mtx ( n ),C0007457;C0025677;C1417487;C0043157;C0220938,true;true;false;true;false,19644/20013
whiteb,,,19645/20013
who fc ii symptoms at baselinenmbr,C2983605;C1710602;C0683368;C0168634;C1442488;C1457887;C4082587,false;false;true;true;false;false;false,19646/20013
who fc ii symptoms at baselinef,C2983605;C1710602;C0683368;C1457887;C4082587,false;false;true;false;false,19647/20013
who functional class,C0205245;C0456387;C1518526;C1705943;C0542341;C2700217,false;false;false;false;false;false,19648/20013
whole cohort,C0444667;C0009247;C0599755,false;true;false,19649/20013
with any stent,C0038257,true,19650/20013
with aspirin ( n = nmbr,C0004057,true,19651/20013
with baseline crp level of > nmbr mg / liter,C0168634;C3890735;C0441889;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0456079;C1547707;C2946261;C4048285;C1442488,true;false;false;true;false;true;false;false;false;false;false;false;false;false;false;false,19652/20013
with baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,19653/20013
with cerebrovascular disease,C0007820,true,19654/20013
with ckd ( nmbr ),C1561643,true,19655/20013
with ckd intensive ( n = nmbr ),C1561643;C0162425;C0522510;C1283828;C1550453,true;true;false;false;false,19656/20013
with ckd standard ( n = nmbr ),C1561643;C1442989;C2828392,true;false;false,19657/20013
with concomitant ics,C0521115;C0815320;C4551720,false;false;true,19658/20013
with des,C0011702;C4551552,true;true,19659/20013
with dm,C0011816;C3250443,true;false,19660/20013
with dm ( n proactive intervention ( n = nmbra ),C0011816;C0184661;C0886296;C1273869;C3250443,true;true;false;false;false,19661/20013
with dyspnoea,C0013404;C1963100,true;false,19662/20013
with events ( % ),C0441471;C3541888,false;false,19663/20013
with higher classes indicating greater limitations on physical activity owing to,C0205250;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false,19664/20013
with highest bwa,C1522410;C0006041,false;true,19665/20013
with highest hbanmbrcc,C1522410;C0019016;C0008318;C3538933;C1825777;C3538758,false;true;true;false;false;false,19666/20013
with ics,C0815320;C4551720,false;true,19667/20013
with long - acting jnmbr - agonists,C0205166;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;true;false;false;false,19668/20013
with lowest bwb,C1708760,false,19669/20013
with lowest hbanmbrcd,C1708760;C0019016;C0007928;C0034283;C4552032;C1825777;C3538758,false;true;true;true;false;false;false,19670/20013
with metabolic syndrome,C0524620,true,19671/20013
with mets,C0812270;C1705694;C2939420,false;false;false,19672/20013
with prior mi / stroke ( n = nmbr ),C0332152;C3810814;C0038454;C4554100;C2826257,false;false;true;false;false,19673/20013
with rehospitalization,,,19674/20013
with tamsulosin,C0257343,true,19675/20013
with tiotropium,C0213771,true,19676/20013
with treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19677/20013
withdrawals,C1710677;C2349954;C2825032;C3812880;C4049634,false;false;false;false;false,19678/20013
withdrew consent,C2349954,false,19679/20013
within nmbr h after first procedure,C0033727;C0205435;C0184661;C2700391;C3274430;C3539779;C1279901;C0369286;C0441932;C0564385;C4528284,true;false;true;false;false;false;false;false;false;false;false,19680/20013
without aspirin ( n = nmbr,C0004057,true,19681/20013
without baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,19682/20013
without cerebrovascular disease,C0007820,true,19683/20013
without ckd ( nmbr ),C1561643,true,19684/20013
without concomitant ics,C0521115;C0815320;C4551720,false;false;true,19685/20013
without dm,C0011816;C3250443,true;false,19686/20013
without dvt dvt alone,C0149871;C2926618;C3899446,true;false;false,19687/20013
without dyspnoea,C0013404;C1963100,true;false,19688/20013
without hx of hf,C0262926;C0018488;C1313497;C1538440;C3273279;C3814444,false;true;true;false;false;false,19689/20013
without hypertension at baseline to hypertension,C0020538;C0168634;C1442488;C1963138,true;true;false;false,19690/20013
without metabolic syndrome,C0524620,true,19691/20013
without mets,C0812270;C1705694;C2939420,false;false;false,19692/20013
without psoriasis ( n = nmbr ),C0033860,true,19693/20013
without tamsulosin,C0257343,true,19694/20013
wml load at follow - up mri stratified by baseline severity of wml load,C1550025;C0589120;C0024485;C1824234;C3890166;C1522577;C1704685;C3274571;C1704782;C1708715,false;false;true;false;false;false;false;false;false;false,19695/20013
womac function score,C0031843;C0449820;C4050231;C0542341;C0700205;C1705273,true;false;false;false;false;false,19696/20013
womac pain score,C0582148,false,19697/20013
womac stiffness score,C0427008;C0449820;C4050231,false;false;false,19698/20013
women ( % ),C0043210,true,19699/20013
women ( n ( % ) ),C0043210,true,19700/20013
women ( n = nmbr ) events,C0043210;C0441471;C3541888,true;false;false,19701/20013
women ethnic origin,C0043210;C0015031,true;true,19702/20013
women t  ,C0043210,true,19703/20013
women taking estrogen,C0043210,true,19704/20013
women : < nmbr mg / dl ( < nmbr . nmbr mmol / l ),C0043210;C0439269;C1532563,true;false;false,19705/20013
women  qvanmbr - sfc,C0043210;C4521536,true;false,19706/20013
womens,,,19707/20013
worldwide black patients,C0005680;C0030705;C0027567;C0085756;C0439541,true;true;true;true;false,19708/20013
worldwide non - black patients,C1829939;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,19709/20013
wrist,C0043262;C1322271,true;true,19710/20013
wt,C1883559;C2700323,false;false,19711/20013
x cr nmbr . nmbr x age,C0201975;C0001779;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;false;true;false;false;false,19712/20013
x ? = nmbr - nmbr  p = nmbr - nmbr,,,19713/20013
x ? = nmbr - l  p = nmbr - nmbr,,,19714/20013
x ? = l - nmbr  p = nmbr - nmbr,,,19715/20013
xnmbr,,,19716/20013
xnmbr = nmbr - nmbr  p = nmbr - nmbr,,,19717/20013
xnmbr = nmbr - l  p = nmbr - nmbr,,,19718/20013
xnmbr = nmbr  p = nmbr - nmbr,,,19719/20013
xnmbr years,C0439234,false,19720/20013
xanthine,C0043314;C0043318,true;true,19721/20013
xanthinesg,,,19722/20013
xho  p = o - nmbr,C4050013,false,19723/20013
xi = ° - ° nmbr,C1720296,false,19724/20013
xi = nmbr - nmbr  p = nmbr - nmbr,C1720296,false,19725/20013
xi = nmbr . nmbr,C1720296,false,19726/20013
xi = nmbr - nmbr,C1720296,false,19727/20013
xi = nmbr,C1720296,false,19728/20013
xi = nmbr - nmbr  p = nmbr - l,C1720296,false,19729/20013
xi = nmbr - nmbr  p = o - l,C1720296,false,19730/20013
xi = nmbr - nmbr  p = nmbr,C1720296,false,19731/20013
xi = nmbr - l  p = nmbr - nmbr,C1720296,false,19732/20013
xi = l ’ nmbr  p = nmbr - nmbr,C1720296,false,19733/20013
xi = o - nmbr  p = o - nmbr,C1720296,false,19734/20013
xi = oo  p = o - nmbr,C1720296,false,19735/20013
yaa,,,19736/20013
year - nmbr,C0439234;C0439508,false;false,19737/20013
year from randomization,C0439234;C0034656;C0439508,false;true;false,19738/20013
year of publication of primary results,C0439234;C0034036;C0205225;C1274040;C1546471;C2825142;C0439612;C0439631;C0034037;C1704324;C0439508,false;true;false;false;false;false;false;false;true;false;false,19739/20013
year,C0439234;C0439508,false;false,19740/20013
yearl,,,19741/20013
years ( mean ± sd ),C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,19742/20013
years ( sd ),C0439234;C2699239,false;false,19743/20013
years duration oa,C0439234;C0449238;C0029408;C3887876;C2926735,false;false;true;false;false,19744/20013
years male gender,C0439234;C0086582;C1706180,false;true;false,19745/20013
years modified hoehn and yahr stage,C0439234,false,19746/20013
years of education *,C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,19747/20013
years of education,C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,19748/20013
years of follow - up,C0439234;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,19749/20013
years since diagnosis,C0439234,false,19750/20013
years since diagnosis of type nmbr diabetes,C0439234,false,19751/20013
years since last gout flare,C0439234,false,19752/20013
years since mi ( median,C0439234,false,19753/20013
years since pd diagnosis,C0439234,false,19754/20013
years since symptom onset,C0439234,false,19755/20013
years with gout,C0439234;C0018099,false;true,19756/20013
years with gouty arthritis,C0439234;C0003868,false;true,19757/20013
years ),C0439234,false,19758/20013
yes ( % ) weight [kg] ( interaction : p = nmbr . nmbr ),C1549445;C0005910;C0022718;C1704675;C0439209;C4054209;C0043100;C1305866;C1705104;C1705108;C1710701,false;true;true;false;false;false;true;false;false;false;false,19759/20013
yes ( any ),C1549445;C1705108;C1710701,false;false;false,19760/20013
yes ( n,C1549445;C1705108;C1710701,false;false;false,19761/20013
yes vs . no,C1549445;C1705108;C1710701,false;false;false,19762/20013
younger subjects ( aged < nmbr years ),C0332239,false,19763/20013
zoledronic acid,C0257685,true,19764/20013
zoledronic acid ( n = nmbr ),C0257685,true,19765/20013
zoledronic acid arm,C0257685;C0446516;C3715044;C4553528,true;true;false;false,19766/20013
zt = nmbr,,,19767/20013
placebo - ezetimibe nmbr / simvastatin nmbr - fenofibrate nmbr - ezetimibe nmbr / simvastatin nmbr / ezetimibe nmbr,C0032042;C1532737;C0033228;C1696465;C1706408,true;true;true;false;false,19768/20013
l - dopa / carbidopa - l - dopa / carbidopa / entacapone,C0353697;C0165921,true;true,19769/20013
arb - arb / ccb,C3888198;C0006684,false;true,19770/20013
other - candesartan,C0717550,true,19771/20013
benazepril / hydrochlorothiazide - benazepril / amlodipine,C0717481;C0051696,false;true,19772/20013
atenolol - losartan,C0004147;C0126174,true;true,19773/20013
amlodipine - amlodipine / valsartan,C1962523,true,19774/20013
mycophenolate mofetil - cyclophosphamide,C0209368;C0010583,true;true,19775/20013
atorvastatin - pravastatin,C0286651;C0085542,true;true,19776/20013
placebo - abatacept nmbr / nmbr - abatacept nmbr / nmbr,C0032042;C1619966;C1696465;C1706408,true;true;false;false,19777/20013
bivalirudin - heparin plus gpi,C0168273;C0019134;C1415351;C0770546,true;true;false;false,19778/20013
olmesartan / ccb - olmesartan / diuretic,C1098320;C0006684,true;true,19779/20013
comparator - linagliptin,C1707454;C2746078;C4553389;C4553390,false;true;false;false,19780/20013
placebo - linagliptin,C0032042;C2746078;C1696465;C1706408,true;true;false;false,19781/20013
placebo - dexlansoprazole,C0032042;C2348248;C1696465;C1706408,true;true;false;false,19782/20013
placebo - carisbamate nmbrmg - carisbamate nmbrmg,C0032042;C1871983;C1319635;C1696465;C1706408,true;true;false;false;false,19783/20013
ezetimibe / simvastatin - double dose statin - rosuvastatin,C1532737;C0205173;C0178602;C0360714;C0965129;C0869039;C1114758;C1705764;C1705765,true;false;false;true;true;false;false;false;false,19784/20013
stent / abciximab - stent / placebo,C0038257;C0288672;C0032042;C1696465;C1706408,true;true;true;false;false,19785/20013
insulin lispro mix nmbr / lispro mix nmbr - insulin glargine / insulin lispro,C0293359,true,19786/20013
ideglira - ideg - lira,C4308663;C1555441,true;false,19787/20013
placebo - ideglira,C0032042;C4308663;C1696465;C1706408,true;true;false;false,19788/20013
ideglira - ideg,C4308663,true,19789/20013
budesonide - budesonide / formoterol,C1276807,false,19790/20013
placebo - vonoprazan nmbr - vonoprazan nmbr,C0032042;C4080009;C1696465;C1706408,true;true;false;false,19791/20013
fluticasone - fluticasone / salmeterol,C0939232,true,19792/20013
febuxostat - febuxostat / lesinurad nmbr - febuxostat / lesinurad nmbr,C0249529;C3886073,true;true,19793/20013
telmisartan / amlodipine - telmisartan / amlodipine / hydrochlorothiazide,C0939233;C0051696;C2733369;C0020261,true;true;true;true,19794/20013
chlorthalidone - amlodipine - lisinopril,C0008294;C0051696;C0065374,true;true;true,19795/20013
placebo - famotidine nmbr - famotidine nmbr,C0032042;C0015620;C1696465;C1706408,true;true;false;false,19796/20013
air insulin - insulin glargine - air insulin / insulin glargine,C0001861;C0907402;C3536832,true;true;false,19797/20013
olmesartan nmbr - olmesartan nmbr / hydrochlorothiazide nmbr . nmbr,C1098320;C0020261,true;true,19798/20013
sdc nmbr . nmbr - nmbr . nmbr ng / ml,C1419891;C0439275;C3273112,false;false;false,19799/20013
hf symptomatic improvement,C0018488;C0231220;C2986411;C1313497;C1538440;C3273279,true;false;false;true;false;false,19800/20013
hf symptom unchanged,C0018488;C1457887;C3854129;C1313497;C1538440;C3273279,true;false;false;true;false;false,19801/20013
hf symptom worsened,C0018488;C1457887;C3854129;C1313497;C1538440;C3273279,true;false;false;true;false;false,19802/20013
cv death / hf hospitalization,C3538987;C0011065;C0018488;C0019993;C1313497;C1538440;C3273279;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;true;false;false;false;false;false;true;false,19803/20013
vertebral fracture,C0080179,true,19804/20013
nonvertebral fracture,C0016658,true,19805/20013
main accord endpoint,C0205225;C0680240;C2349179;C2826544;C1542147,false;false;false;false;false,19806/20013
fatal / nonfatal mi ( excluding silent mi ),C1302234;C3810814;C1705232,false;false;false,19807/20013
cardiovascular death or nonfatal mi ( excluding silent mi ),C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,19808/20013
combined efficacy and safety endpoint,C0205195;C1280519;C1707887,false;false;false,19809/20013
mean change from baseline bp at week nmbr,C0392747;C0168634;C0488053;C1442488;C0443172;C1705241;C4319952;C0444504;C1268766;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false,19810/20013
median change in atheroma volume,C0549183;C0392747;C0264956;C0449468;C1690016;C1705102;C2700258;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false;false;false;false,19811/20013
nonvertebral fractures,C0016658,true,19812/20013
clinical vertebral fractures,C0205210;C0080179,false;true,19813/20013
complete clinical response at week nmbr,C0205197;C3853530;C4283785,false;false;false,19814/20013
death or mi at nmbr days,C0011065;C1306577;C4082313;C4552775,true;false;false;false,19815/20013
nmbr - year mortality,C0439234;C0026565;C0026566;C0439508,false;true;true;false,19816/20013
net adverse clinical events at day nmbr,C1456447;C0877248;C0205210;C0332173;C0439228;C0439505;C1705413;C3853572;C3887809;C3890893,true;false;false;false;false;false;false;false;false;false,19817/20013
adas - cog,C3539026,false,19818/20013
cdr - sob,C4521843;C0013404,false;true,19819/20013
adcs - adl,C3641947,false,19820/20013
npi,C1412208;C1549728;C3539727,false;false;false,19821/20013
proportion of > = nmbr % responder rates,C1709707;C0871208;C1521828,false;false;false,19822/20013
ldl - c concentration,C0086045;C1446561;C3827302,true;false;false,19823/20013
non - hdlc concentration,C1518422;C1704429;C0086045;C1446561;C3827302,false;true;true;false;false,19824/20013
hdlc - concentration,C1704429;C0086045;C1446561;C3827302,true;true;false;false,19825/20013
apolipoprotein a,C0003592;C0523508,true;false,19826/20013
complete ulcer healing at week nmbr,C0205197;C0333293;C0332174;C0439230;C0725685;C3853530;C4283785,false;false;false;false;false;false;false,19827/20013
major amputations at week nmbr,C0205082;C0002688;C0332174;C0439230;C0205164;C4318856;C4521762,false;true;false;false;false;false;false,19828/20013
mean percentage of nights without heartburn,C0444504;C0439165;C0240526;C1549488;C1561533;C2347634;C2348143,false;false;false;false;false;false;false,19829/20013
new or worsening vertebral fracture at nmbr months,C0205314,false,19830/20013
new vertebral fracture at nmbr months,C0205314;C0080179;C0439231,false;true;false,19831/20013
seizure reduction from baseline,C0036572;C0301630;C0168634;C1442488;C0392756;C1293152;C4551656;C1959629;C4553401,true;false;true;false;false;false;false;false;false,19832/20013
apolipoprotein a - i,C0085201;C1677784,true;true,19833/20013
hbanmbrc at week nmbr,C0019016;C0332174;C0439230;C1825777;C3538758,true;false;false;false;false,19834/20013
primary endpoint at nmbr days,C2986535;C0439228,false;false,19835/20013
primary endpoint at nmbr months,C2986535;C0439231,false;false,19836/20013
dual i extension - end of trial hbanmbrc,C0205173;C0021966;C0231448;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1880641;C0221138;C1554184,false;true;false;false;true;true;false;false;false;false;false;false,19837/20013
dual iv - end of trial hbanmbrc,C0205173;C0444972;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1554184,false;false;false;true;true;false;false;false;false,19838/20013
dual ii - end of trial hbanmbrc,C0205173;C0444967;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1554184,false;false;false;true;true;false;false;false;false,19839/20013
proportion of days without heartburn at week nmbr,C1709707;C0439228,false;false,19840/20013
first severe asthma exacerbation,C0205435;C0581126;C4086268;C0205082;C0349790;C4050465;C4050466;C1279901,false;false;false;false;false;false;false;false,19841/20013
change in fevnmbr at week nmbr,C0392747;C3714541;C0443172;C1705241;C4319952,false;true;false;false;false,19842/20013
serum ua < nmbrmg / dl by month nmbr,C0229671;C0041580;C0439269;C0332177;C0439231;C0042014;C1546774;C1550100,true;true;false;false;false;true;false;false,19843/20013
control of sitting bp at week nmbr,C0243148;C0277814;C0037623;C1415692;C1708288;C4318478;C2584297;C4050224;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;true;false;false;false;true;false;false;false;false;false;false,19844/20013
rate of atrial fibrillation,C0871208;C0004238;C0344434;C1963067;C1521828,false;true;false;false;false,19845/20013
combined nmbr - year cvd,C0205195;C0439234;C0007222;C0439508,false;false;true;false,19846/20013
percentage of days without heartburn,C0439165;C0439228;C1549488;C1561533,false;false;false;false,19847/20013
bp goal at week nmbr,C0037623;C0018017;C0332174;C0439230;C1571704;C1415692;C1708288;C4318478,true;true;false;false;false;false;false;false,19848/20013
previous use of digoxin,C0205156;C1524063;C0012265;C1552607,false;false;true;false,19849/20013
cardiothoracic ratio,C4055270;C0456603;C1547037,false;false;false,19850/20013
retinal severity change,C0035298;C0439793;C0392747;C0443172;C1705241;C4319952;C0522510,true;false;false;false;false;false;false,19851/20013
concomitant statin use,C0521115;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,19852/20013
study protocol,C1507394;C2348563;C2599718,false;false;true,19853/20013
concomitant mao - b inhibitor use,C0521115;C0595265;C0042153;C0457083;C1947944;C2917433,false;false;true;false;false;false,19854/20013
ckd at baseline,C1561643;C0168634;C1442488,true;true;false,19855/20013
acei use,,,19856/20013
beta blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,19857/20013
nitrate use,C0028125;C0042153;C0457083;C1947944;C0699857;C3848573,true;true;false;false;false;false,19858/20013
sirolimus eluting stent,C0072980;C0038257,true;true,19859/20013
vessel disease,C0042373,true,19860/20013
kilip class,C0456387;C1518526;C1705943,false;false;false,19861/20013
time to randomisation from symptom onset ( h ),C0040223;C0034656;C3541383,true;true;false,19862/20013
time from symptoms onset to nmbrst balloon inflation ( h ),C0683368;C0449244;C1457887,true;false;false,19863/20013
time from randomisation to nmbrst balloon inflation ( h ),C0040223;C0034656;C3541383,true;true;false,19864/20013
first medical contact,C0205435;C0199168;C0332158;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;false;false;false;false;false,19865/20013
stent placement,C0522776,false,19866/20013
previous mi and tnmbrdm,C0205156;C3810814;C1552607,false;false;false,19867/20013
baseline peripheral artery disease,C0168634;C1704436;C4025272;C1442488,true;true;false;false,19868/20013
fibrinolytic agent given,C0016018,true,19869/20013
shock risk indext,C0036974;C0035647;C4552904,true;true;false,19870/20013
aetiology,C0015127;C1314792;C1524003,true;true;false,19871/20013
baseline nmbr - min walk distance m,C0168634;C0702093;C0429886;C0369637;C0441923;C1524029;C3813700;C1442488,true;false;false;false;false;false;false;false,19872/20013
baseline who functional class,C0168634;C1442488,true;false,19873/20013
age at baseline years,C1510829;C0168634;C1442488,false;true;false,19874/20013
diabetes and untreated hypertension,C0011847;C0011849,false;true,19875/20013
clinically evident vascular disease,C3887511;C0042373,false;true,19876/20013
history of statin use,C0019664;C0360714;C1524063;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,19877/20013
baseline bmd t score at femoral neck,C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,19878/20013
prior treatment status,C1514463;C0449438;C0332152;C0749659;C2826257,false;false;false;false;false,19879/20013
inclusion diagnosis,C0007637;C0011900;C1704338;C1704656;C1512693,true;true;true;false;false,19880/20013
modified braunwald class,C0392747;C0456387;C1518526;C1705943;C3889737,false;false;false;false;false,19881/20013
high - risk criterion,C0332167;C0243161;C3272283;C4050568;C4319571,false;true;false;false;false,19882/20013
cadillac score,C0449820;C4050231,false;false,19883/20013
arterial access site,C3272298,false,19884/20013
vessels with stenosis > nmbr %,C0679403,false,19885/20013
stent type implanted,C0038257;C0332307;C1547052,true;false;false,19886/20013
heparin pre - randomization,C0019134;C0332152;C0034656;C0740175;C2257086;C3669034;C0770546,true;false;true;false;false;false;false,19887/20013
pnmbrynmbr inhibitor loading dos,C0369773;C1999216;C1708715;C1428722;C2603361,false;false;false;false;false,19888/20013
pnmbrynmbr inhibitor maintenance,C0369773;C1999216;C0024501;C2603361,false;false;true;false,19889/20013
primary management strategy,C0205225;C0001554;C0679199;C0376636;C1273870;C3273539;C0439612;C0439631,false;true;false;true;false;false;false;false,19890/20013
clinical dementia rating score,C4304227,false,19891/20013
cholinesterase inhibitor use,C0008425;C0042153;C0457083;C1947944;C3536756;C4521309,true;true;false;false;false;false,19892/20013
apolipoprotein e carrier,C0003595;C0007294;C0560175;C1325398;C1706209;C3273162,true;true;true;false;false;false,19893/20013
prior exposure to levetiracetam,C0332152;C0274281;C0377265;C3693636;C0332157;C2826257,false;false;true;false;false;false,19894/20013
prior exposure to carbamazepine,C0332152;C0274281;C0006949;C0006950;C0682993;C0332157;C2826257,false;false;true;false;false;false;false,19895/20013
prior exposure to topiramate,C0332152;C0274281;C0076829;C0332157;C2826257,false;false;true;false;false,19896/20013
prior exposure to lamotrigine,C0332152;C0274281;C0064636;C0524166;C0332157;C2826257,false;false;true;false;false;false,19897/20013
thienopyridine use,C1120149;C0042153;C0457083;C1947944,true;true;false;false,19898/20013
intent to use gp iib / iiia,C0162425;C1283828;C1550453,true;false;false,19899/20013
intent to use dti,C0162425;C1283828;C1550453,true;false;false,19900/20013
troponin or ckmb value,C0041199,true,19901/20013
timi score,,,19902/20013
investigator - reported hypoglycaemia,C0035173,true,19903/20013
nocturnal heartburn severity,C0240526;C0018834;C0439793;C0522510,false;true;false;false,19904/20013
concurrent medication,C0205420;C0013227;C3244316;C4284232,false;true;false;false,19905/20013
antiepileptic drug type at baseline,C0003299;C0332307;C0168634;C1442488;C1547052;C3537002;C0457591,true;false;true;false;false;false;false,19906/20013
cardiogenic shock,C0036980,true,19907/20013
type of mi,C0332307;C3810814;C1547052,false;false;false,19908/20013
target vessel diameter,C0449618;C1301886,false;false,19909/20013
onset of chest pain,C0206132;C0024902;C0332162,true;true;false,19910/20013
received pci,C1514756;C4049621,false;false,19911/20013
acei or arb pre - randomisation,,,19912/20013
acei or arb post - randomisation,,,19913/20013
bb after randomisation,C0004739;C0034656;C0332297,true;true;false,19914/20013
acei / arb and bb after randomisation,C3888198,false,19915/20013
pulsed blood pressure,C0232108,false,19916/20013
admission crcl,C0184666;C1846718;C0809949,false;false;false,19917/20013
admission k,C0184666;C0597277;C1708601;C0809949,false;false;false;false,19918/20013
randomisation,C0034656,true,19919/20013
nerd grade,C0441800;C0919553;C3244287,false;false;false,19920/20013
asthma control,C0004096;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;false;false;false;false;false,19921/20013
eosinophil count ( cells / microlitre ),C0200638;C0439378;C0750879,false;false;false,19922/20013
baseline uric acid,C0168634;C0041980;C1442488,true;true;false,19923/20013
disease stage,C0699749,false,19924/20013
chronic heart failure class ii - iii,C0018802;C0441887;C1710602;C4082587;C2698969;C0441886;C0439070;C1705160;C2698968;C0264716,true;false;false;false;false;false;false;false;false;false,19925/20013
prior mi / stroke,C0332152;C3810814;C0038454;C4554100;C2826257,false;false;true;false;false,19926/20013
cardiovascular status,C0007226;C0449438;C3887460,true;false;false,19927/20013
diabetic retinopathy at baseline,C0011884;C0168634;C1442488,true;true;false,19928/20013
type of reflux disease,C0457464;C0232483;C1882919;C4317146,false;false;false;false,19929/20013
number of symptom days per week,C0237753;C1457887;C0439228;C3854129;C0449788,false;false;false;false;false,19930/20013
cardiac surgery type,C0018821;C0332307;C1547052;C0524727,true;false;false;true,19931/20013
hiatus hernia,C3489393,true,19932/20013
h . pylori infection,C0850666,false,19933/20013
hypertension severity,C0020538;C0439793;C0522510;C1963138,true;false;false;false,19934/20013
> = nmbry,,,19935/20013
> nmbr or incident vitrectomy or photocoagulation,,,19936/20013
stage nmbr ( cockcroft - gault ),C0205390;C1300072;C1306673,false;false;false,19937/20013
stage nmbr ( four - variable modification of diet in kidney disease ),C0205390;C1300072;C1306673,false;false;false,19938/20013
western eu,C1705493;C0015179;C3665627,false;true;false,19939/20013
eastern eu,C1707877;C0015179;C3665627,false;true;false,19940/20013
< - nmbr . nmbr,,,19941/20013
> - nmbr . nmbr,,,19942/20013
atorvastatin nmbrmg,C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,19943/20013
< = nmbr,,,19944/20013
ii - iii,C1710602;C0439070;C1705160;C4082587,false;false;false;false,19945/20013
pci - hospital,C4049621;C0019994;C1510665,false;true;false,19946/20013
non - pci hospital / ambulance,C1518422;C4049621;C0019994;C0002422;C3846685;C1510665,false;false;true;true;false;false,19947/20013
non - european,C1518422;C0239307;C1535514,false;false;false,19948/20013
< nmbr . nmbr ml / min / nmbr . nmbr mnmbr,C0439445;C0369637;C0441923,false;false;false,19949/20013
ipah / fpah / drug and toxin,C0152171;C1419079;C0013227;C1254351,false;false;true;false,19950/20013
repaired congenital shunt,C0205340;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,19951/20013
past or nonsmoker,C1444637;C4284302,false;false,19952/20013
> - nmbr . nmbr to < - nmbr . nmbr,C0040363;C0041260;C1883351,true;true;false,19953/20013
na ï ve,C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;false;false;false;false;false;false,19954/20013
recent,C0332185,false,19955/20013
inadequate,C0205412;C0439856,false;false,19956/20013
non - q - wave ml,C1518422;C0429089;C0439526;C1705224;C3887665;C1305738,false;false;false;false;false;false,19957/20013
no rest angina,C0002965;C0152172,true;false,19958/20013
rest angina,C0002965;C0152172,true;false,19959/20013
no antianginal drug,C1874267;C0013227;C1254351;C3537168,false;true;false;false,19960/20013
nmbr antianginal drug,C1874267;C0013227;C1254351;C3537168,false;true;false;false,19961/20013
nmbr antianginal drugs,C1874267;C0013227;C3687832;C3537168,false;true;false;false,19962/20013
intermediate risk,C3640764,false,19963/20013
single vessel disease,C0037179;C0042373;C0087136;C0205171,true;true;true;false,19964/20013
at least one drug - eluting stent,C0205447;C1322815,false;true,19965/20013
all bare metal stents,C2825200,false,19966/20013
prasugrel or ticagrelor,C1620287,true,19967/20013
non - lad,C1518422,false,19968/20013
pci procedure,C4049621;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,19969/20013
non pci procedure,C1518422;C4049621;C0184661;C2700391;C3274430;C3539779,false;false;true;false;false;false,19970/20013
non europe,C1518422;C0015176,false;true,19971/20013
> nmbryears,C0439234,false,19972/20013
< mild,C2945599,false,19973/20013
mild - < moderate,C1299392,false,19974/20013
moderate - < severe,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,19975/20013
severe - very severe,C0205082;C0442824;C2984081;C4050465;C4050466,false;false;false;false;false,19976/20013
< nmbrmmhg,C0439475,false,19977/20013
> nmbrmmhg,C0439475,false,19978/20013
enzyme inducing,C0014442;C4521602,true;false,19979/20013
non - enzyme inducing,C1518422;C0014442;C4521602,false;true;false,19980/20013
> nmbr . nmbrmm,C4330985;C4554674,false;false,19981/20013
< = nmbr . nmbrmm,C4330985;C4554674,false;false,19982/20013
> = nmbrh,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,19983/20013
< = nmbr ml / min,C0439445,false,19984/20013
pre - hospital,C0332152;C0019994;C1510665;C0740175;C2257086;C3669034,false;true;false;false;false;false,19985/20013
in - hospital,C0019994;C1510665,true;false,19986/20013
< = nmbr %,,,19987/20013
russia / ukraine / belarus,C0035970;C0041580;C0006539,true;true;true,19988/20013
> = nmbrmg / dl,C0439269,false,19989/20013
< = nmbr . nmbr %,,,19990/20013
established disease,C0443211;C0012634;C1272684,false;true;false,19991/20013
risk factors only,C0035648;C0205171;C1720467;C1553898,true;false;false;false,19992/20013
pre - mixed insulin,C0332152;C0205430;C3160715;C0740175;C2257086;C3669034,false;false;false;false;false;false,19993/20013
yes  proliferative,C1549445;C1705108;C1710701,false;false;false,19994/20013
yes  non - proliferative,C1549445;C1705108;C1710701,false;false;false,19995/20013
yes  unknown,C1549445;C1705108;C1710701,false;false;false,19996/20013
erosive reflux disease,C0439679;C0232483;C0012634;C1882919;C4317146,false;false;true;false;false,19997/20013
gastrooesophageal reflux disease,C0017168;C4553201,true;false,19998/20013
non - cabg or combined,C1518422;C0010055,false;true,19999/20013
tx,C0041403,true,20000/20013
txnmbr,C0041403,true,20001/20013
amlodipione - chlorthalidone,C0008294,true,20002/20013
lisinopril - chlorthalidone,C0065374;C0008294,true;true,20003/20013
famotidine nmbr - famotidine nmbr,C0015620,true,20004/20013
placebo - famotidine nmbr,C0032042;C0015620;C1696465;C1706408,true;true;false;false,20005/20013
air insulin - air insulin / insulin glargine,C0001861;C0907402;C3536832,true;true;false,20006/20013
insulin glargine - air insulin / insulin glargine,C0907402;C0001861;C3536832,true;true;false,20007/20013
placebo - vonoprazan nmbr,C0032042;C4080009;C1696465;C1706408,true;true;false;false,20008/20013
febuxostat - febuxostat / lesinurad nmbr,C0249529;C3886073,true;true,20009/20013
or_value,,,20010/20013
ornmbr,,,20011/20013
ornmbr_value,,,20012/20013
